Citrus Sinensis ID: 009595
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 531 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SKB2 | 641 | Leucine-rich repeat recep | yes | no | 0.595 | 0.492 | 0.639 | 1e-124 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.480 | 0.231 | 0.416 | 8e-48 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.521 | 0.266 | 0.381 | 8e-46 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.495 | 0.259 | 0.394 | 3e-45 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.538 | 0.228 | 0.373 | 6e-45 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.499 | 0.219 | 0.389 | 7e-45 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.499 | 0.219 | 0.389 | 1e-44 | |
| Q9FRS6 | 1029 | Leucine-rich repeat recep | no | no | 0.431 | 0.222 | 0.427 | 1e-44 | |
| Q9LYU7 | 401 | Inactive leucine-rich rep | no | no | 0.544 | 0.720 | 0.341 | 5e-44 | |
| Q9SYQ8 | 980 | Receptor protein kinase C | no | no | 0.512 | 0.277 | 0.383 | 5e-44 |
| >sp|Q9SKB2|SBIR1_ARATH Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 OS=Arabidopsis thaliana GN=SOBIR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 444 bits (1143), Expect = e-124, Method: Compositional matrix adjust.
Identities = 209/327 (63%), Positives = 263/327 (80%), Gaps = 11/327 (3%)
Query: 170 LLLAAVRGGGQNRGPTIFSPLIEK-EDLAFLEKEDCSASLEKIRSRASGEIYIAELPESN 228
L++ A+RG + GP+IFSPLI+K EDLAFLE E+ ASLE I GE++ AELP SN
Sbjct: 311 LIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSN 370
Query: 229 GKMIAIKKVKQV----------DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278
GK+IA+KKV Q D+ LN KMRQ+R+EI T G IRHRN++PLLAH+ RP+
Sbjct: 371 GKIIAVKKVIQPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRPE 430
Query: 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI 338
CH LV E+M+ GSL +IL DV G +EL W ARH+IA GI +GLEYLHM H PRIIHR++
Sbjct: 431 CHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDL 490
Query: 339 TPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIY 398
P++VL+DDDMEARI+DFGLA+ MPD ++TS VAGTVGYIAPE++QT KF++KCDIY
Sbjct: 491 KPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDIY 550
Query: 399 SFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLL 458
SFGV+L +LV+GKLPSD+FFQHT+E SL++WMRN++TSENP+ AID KL+ G++EQMLL
Sbjct: 551 SFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQMLL 610
Query: 459 VLKIACFCTLDDPEERPNSKDVRSMLS 485
VLKIAC+CTLDDP++RPNSKDVR+MLS
Sbjct: 611 VLKIACYCTLDDPKQRPNSKDVRTMLS 637
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Promotes the activation of plant defense and cell death. Functions as an inhibitor/regulator of abscission, probably by regulating membrane trafficking during abscission. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 192 bits (487), Expect = 8e-48, Method: Compositional matrix adjust.
Identities = 118/283 (41%), Positives = 168/283 (59%), Gaps = 28/283 (9%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQ------VDNSLLNIKMRQVRAEIMTAGQIRHRNIV 268
A G +Y AE+ S G++IA+KK+ DNS RAEI T G+IRHRNIV
Sbjct: 809 ACGTVYKAEM--SGGEVIAVKKLNSRGEGASSDNSF--------RAEISTLGKIRHRNIV 858
Query: 269 PLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRE--LEWLARHRIARGIVSGLEYLH 326
L + +LL+ E+M GSL E + +G + L+W AR+RIA G GL YLH
Sbjct: 859 KLYGFCYHQNSNLLLYEYMSKGSLGE---QLQRGEKNCLLDWNARYRIALGAAEGLCYLH 915
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
RP+I+HR+I +++L+D+ +A + DFGLA+L+ +++ S S VAG+ GYIAPEY
Sbjct: 916 HDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSK-SMSAVAGSYGYIAPEYA 974
Query: 387 QTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN-RAIDS 445
T+K +EKCDIYSFGV+L L+ GK P Q + LV W+R + + P D+
Sbjct: 975 YTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGD---LVNWVRRSIRNMIPTIEMFDA 1031
Query: 446 KLLGNGYE--EQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
+L N +M LVLKIA FCT + P RP ++V +M+++
Sbjct: 1032 RLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 185 bits (469), Expect = 8e-46, Method: Compositional matrix adjust.
Identities = 111/291 (38%), Positives = 170/291 (58%), Gaps = 14/291 (4%)
Query: 203 DCSASLEKIRSRAS-GEIYIAELPESNGKMIAIKKV--KQVDNSLLNIKMRQVRAEIMTA 259
+C + + I S G +Y AE+P NG++IA+KK+ K +N + + V AE+
Sbjct: 716 ECLSKTDNILGMGSTGTVYKAEMP--NGEIIAVKKLWGKNKENGKIRRRKSGVLAEVDVL 773
Query: 260 GQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQG-RRELEWLARHRIARGI 318
G +RHRNIV LL DC +L+ E+M NGSL ++L+ + EW A ++IA G+
Sbjct: 774 GNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEWTALYQIAIGV 833
Query: 319 VSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTV 378
G+ YLH P I+HR++ PS++L+D D EAR+ADFG+A+L+ S S+VAG+
Sbjct: 834 AQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLI---QTDESMSVVAGSY 890
Query: 379 GYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438
GYIAPEY TL+ +K DIYS+GV+L ++ GK + F E S+V W+R+ + ++
Sbjct: 891 GYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFG--EGNSIVDWVRSKLKTKE 948
Query: 439 PNRAIDSKLLGNGYE---EQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
+ K +G E+M +L+IA CT P +RP +DV +L +
Sbjct: 949 DVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQE 999
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 183 bits (465), Expect = 3e-45, Method: Compositional matrix adjust.
Identities = 110/279 (39%), Positives = 170/279 (60%), Gaps = 16/279 (5%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
A+G +Y AE+ S+ ++A+KK+ + + + E+ G++RHRNIV LL +
Sbjct: 709 ATGIVYKAEMSRSS-TVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFL 767
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDV-SQGRRELEWLARHRIARGIVSGLEYLHMYHRPRI 333
++V EFM NG+L + ++ + GR ++W++R+ IA G+ GL YLH P +
Sbjct: 768 YNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPV 827
Query: 334 IHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSE 393
IHR+I +++L+D +++ARIADFGLAR+M + + S+VAG+ GYIAPEY TLK E
Sbjct: 828 IHRDIKSNNILLDANLDARIADFGLARMM--ARKKETVSMVAGSYGYIAPEYGYTLKVDE 885
Query: 394 KCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMR-----NVMTSENPNRAIDSKLL 448
K DIYS+GV+L L+ G+ P + F E +V W+R N+ E A+D +
Sbjct: 886 KIDIYSYGVVLLELLTGRRPLEPEFG--ESVDIVEWVRRKIRDNISLEE----ALDPNVG 939
Query: 449 GNGY-EEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
Y +E+MLLVL+IA CT P++RP+ +DV SML +
Sbjct: 940 NCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISMLGE 978
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 6e-45, Method: Compositional matrix adjust.
Identities = 114/305 (37%), Positives = 175/305 (57%), Gaps = 19/305 (6%)
Query: 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL 270
I S SG++Y AEL NG+ IA+KK+ D+ + N + E+ T G IRHR++V L
Sbjct: 954 IGSGGSGKVYKAEL--KNGETIAVKKILWKDDLMSN---KSFNREVKTLGTIRHRHLVKL 1008
Query: 271 LAHMVRP--DCHLLVSEFMKNGSLLEIL--NDVSQGRRELEWLARHRIARGIVSGLEYLH 326
+ + +LL+ E+M NGS+ + L N+ ++ + L W R +IA G+ G+EYLH
Sbjct: 1009 MGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLH 1068
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH--AQVSTSIVAGTVGYIAPE 384
P I+HR+I S+VL+D ++EA + DFGLA+++ + S ++ AG+ GYIAPE
Sbjct: 1069 YDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPE 1128
Query: 385 YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM----TSENPN 440
Y +LK +EK D+YS G++L +V GK+P++ F EE +VRW+ V+ SE
Sbjct: 1129 YAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFD--EETDMVRWVETVLDTPPGSEARE 1186
Query: 441 RAIDSKL--LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDVDFLKM 498
+ IDS+L L EE VL+IA CT P+ERP+S+ L + + + +M
Sbjct: 1187 KLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYLLNVFNNRAASYREM 1246
Query: 499 HKRMD 503
D
Sbjct: 1247 QTDTD 1251
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (461), Expect = 7e-45, Method: Compositional matrix adjust.
Identities = 109/280 (38%), Positives = 165/280 (58%), Gaps = 15/280 (5%)
Query: 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL 270
+ S G++Y A+L + G ++AIKK+ V R+ AE+ T G+I+HRN+VPL
Sbjct: 894 VGSGGFGDVYKAQLKD--GSVVAIKKLIHVSGQ----GDREFTAEMETIGKIKHRNLVPL 947
Query: 271 LAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR 330
L + + LLV E+MK GSL ++L+D + +L W AR +IA G GL +LH
Sbjct: 948 LGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIKLNWPARRKIAIGAARGLAFLHHNCI 1007
Query: 331 PRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK 390
P IIHR++ S+VL+D+++EAR++DFG+ARLM +S S +AGT GY+ PEY+Q+ +
Sbjct: 1008 PHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1067
Query: 391 FSEKCDIYSFGVLLAVLVMGKLPSD--DFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLL 448
S K D+YS+GV+L L+ GK P+D DF + +LV W++ + D +LL
Sbjct: 1068 CSTKGDVYSYGVVLLELLTGKQPTDSADF----GDNNLVGWVK-LHAKGKITDVFDRELL 1122
Query: 449 GN--GYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
E ++L LK+AC C D +RP V +M +
Sbjct: 1123 KEDASIEIELLQHLKVACACLDDRHWKRPTMIQVMAMFKE 1162
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (459), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 109/280 (38%), Positives = 165/280 (58%), Gaps = 15/280 (5%)
Query: 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL 270
+ S G++Y A+L + G ++AIKK+ V R+ AE+ T G+I+HRN+VPL
Sbjct: 894 VGSGGFGDVYKAQLKD--GSVVAIKKLIHVSGQ----GDREFTAEMETIGKIKHRNLVPL 947
Query: 271 LAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR 330
L + + LLV E+MK GSL ++L+D + +L W AR +IA G GL +LH
Sbjct: 948 LGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIKLNWPARRKIAIGAARGLAFLHHNCI 1007
Query: 331 PRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK 390
P IIHR++ S+VL+D+++EAR++DFG+ARLM +S S +AGT GY+ PEY+Q+ +
Sbjct: 1008 PHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1067
Query: 391 FSEKCDIYSFGVLLAVLVMGKLPSD--DFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLL 448
S K D+YS+GV+L L+ GK P+D DF + +LV W++ + D +LL
Sbjct: 1068 CSTKGDVYSYGVVLLELLTGKQPTDSADF----GDNNLVGWVK-LHAKGKITDVFDRELL 1122
Query: 449 GN--GYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
E ++L LK+AC C D +RP V +M +
Sbjct: 1123 KEDASIEIELLQHLKVACACLDDRHWKRPTMIQVMAMFKE 1162
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (458), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 101/236 (42%), Positives = 150/236 (63%), Gaps = 7/236 (2%)
Query: 255 EIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRI 314
E+ G +RHRNIV +L ++ ++V E+M NG+L L+ + +WL+R+ +
Sbjct: 772 EVNLLGGLRHRNIVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNV 831
Query: 315 ARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIV 374
A G+V GL YLH P IIHR+I +++L+D ++EARIADFGLA++M H + S+V
Sbjct: 832 AVGVVQGLNYLHNDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMML--HKNETVSMV 889
Query: 375 AGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM-RNV 433
AG+ GYIAPEY TLK EK DIYS GV+L LV GK+P D F+ + + +V W+ R V
Sbjct: 890 AGSYGYIAPEYGYTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFEDSID--VVEWIRRKV 947
Query: 434 MTSENPNRAIDSKLLGNGYE--EQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487
+E+ ID+ + G+ E+MLL L+IA CT P++RP+ +DV +ML++
Sbjct: 948 KKNESLEEVIDASIAGDCKHVIEEMLLALRIALLCTAKLPKDRPSIRDVITMLAEA 1003
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYU7|CRN_ARATH Inactive leucine-rich repeat receptor-like protein kinase CORYNE OS=Arabidopsis thaliana GN=CRN PE=1 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (454), Expect = 5e-44, Method: Compositional matrix adjust.
Identities = 107/313 (34%), Positives = 179/313 (57%), Gaps = 24/313 (7%)
Query: 182 RGPTIFSPLIEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVD 241
+GP +FSP I + L S ++ + S +G+ Y L NG ++A+K++ ++
Sbjct: 99 KGPVVFSPKITPKSL----HAALSNGIQLLGSDLNGKYYKMVL--DNGLVVAVKRLGSLE 152
Query: 242 N-------SLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLE 294
S ++K R+++ E+ +RHRN++ L A++ D LV ++M NGSL +
Sbjct: 153 GVGSPESSSSKSVK-RRLQKELELLAGLRHRNLMSLRAYVRESDEFSLVYDYMPNGSLED 211
Query: 295 ILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354
++N V EL W R R+A GIV GL+YLH +I+H N+ P++V++D + E R+A
Sbjct: 212 VMNKVRTKEVELGWEIRLRVAVGIVKGLQYLHFSCETQILHYNLKPTNVMLDSEFEPRLA 271
Query: 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPS 414
D GLA++MP H VS Y APE Q+ ++++K DI+SFG++L VL+ G+ P+
Sbjct: 272 DCGLAKIMPSSHTAVSC--------YSAPESSQSNRYTDKSDIFSFGMILGVLLTGRDPT 323
Query: 415 DDFFQHTEE-KSLVRWMRNVMTSENPNRAIDSKLLGNGYEE-QMLLVLKIACFCTLDDPE 472
F + + SL +W++++ S A+D +LG EE +ML+ L+I C D P
Sbjct: 324 HPFCEESASGGSLGQWLKHLQQSGEAREALDKTILGEEVEEDEMLMALRITIICLSDFPA 383
Query: 473 ERPNSKDVRSMLS 485
+RP+S ++ ML+
Sbjct: 384 DRPSSDELVHMLT 396
|
Involved in the perception of CLV3 peptide that acts as a mobile signal regulating meristems maintenance. Modulates root, shoot and flower apical meristems maintenance and floral organ development regulation, probably via CLAVATA (CLV)-like pathways involving at least CLV3 and CLE19. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 179 bits (454), Expect = 5e-44, Method: Compositional matrix adjust.
Identities = 112/292 (38%), Positives = 160/292 (54%), Gaps = 20/292 (6%)
Query: 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI 262
+C I +G +Y +P N +AIK++ + AEI T G+I
Sbjct: 690 ECLKEENIIGKGGAGIVYRGSMP--NNVDVAIKRLVGRGTGRSD---HGFTAEIQTLGRI 744
Query: 263 RHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGL 322
RHR+IV LL ++ D +LL+ E+M NGSL E+L+ G L+W RHR+A GL
Sbjct: 745 RHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGH--LQWETRHRVAVEAAKGL 802
Query: 323 EYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIA 382
YLH P I+HR++ +++L+D D EA +ADFGLA+ + DG A S +AG+ GYIA
Sbjct: 803 CYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGYIA 862
Query: 383 PEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS-ENPNR 441
PEY TLK EK D+YSFGV+L L+ GK P +F E +VRW+RN P+
Sbjct: 863 PEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEF---GEGVDIVRWVRNTEEEITQPSD 919
Query: 442 A------IDSKLLGNGYE-EQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
A +D +L GY ++ V KIA C ++ RP ++V ML++
Sbjct: 920 AAIVVAIVDPRL--TGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHMLTN 969
|
Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 531 | ||||||
| 255540437 | 633 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.674 | 0.565 | 0.649 | 1e-134 | |
| 224133744 | 630 | predicted protein [Populus trichocarpa] | 0.595 | 0.501 | 0.691 | 1e-132 | |
| 224119518 | 627 | predicted protein [Populus trichocarpa] | 0.595 | 0.503 | 0.675 | 1e-130 | |
| 356508750 | 636 | PREDICTED: leucine-rich repeat receptor- | 0.595 | 0.496 | 0.675 | 1e-128 | |
| 24421095 | 633 | receptor-like protein kinase [Nicotiana | 0.595 | 0.499 | 0.678 | 1e-126 | |
| 356516603 | 631 | PREDICTED: leucine-rich repeat receptor- | 0.595 | 0.500 | 0.666 | 1e-125 | |
| 449440606 | 643 | PREDICTED: leucine-rich repeat receptor- | 0.595 | 0.491 | 0.642 | 1e-124 | |
| 297822929 | 641 | hypothetical protein ARALYDRAFT_482113 [ | 0.595 | 0.492 | 0.642 | 1e-123 | |
| 15225153 | 641 | putative leucine-rich repeat transmembra | 0.595 | 0.492 | 0.639 | 1e-122 | |
| 225456834 | 632 | PREDICTED: leucine-rich repeat receptor- | 0.589 | 0.495 | 0.684 | 1e-121 |
| >gi|255540437|ref|XP_002511283.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223550398|gb|EEF51885.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1250), Expect = e-134, Method: Compositional matrix adjust.
Identities = 243/374 (64%), Positives = 289/374 (77%), Gaps = 16/374 (4%)
Query: 124 STAMSKVKEVNARLQDIAWQINVLGLKASSGGKSKNVRQRFPTTPSLLLAAVRGGGQNRG 183
ST + K+ + + + W + L A +G S V F L+LA +RGGG++ G
Sbjct: 260 STGNAPHKKKSGKRKLSGWILGFLA-GAVAGSMSGFV---FSVMFKLILATIRGGGKDSG 315
Query: 184 PTIFSP-LIEK-EDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQV- 240
P IFSP LI+K E+LAFLEKED ++LE I GE+Y AELP SNGKMIAIKK+ Q
Sbjct: 316 PAIFSPHLIKKAENLAFLEKEDGLSNLELIGRGGCGEVYKAELPGSNGKMIAIKKIVQPP 375
Query: 241 ---------DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGS 291
D LLN KMRQ+R+EI T GQIRHRN++PLLAH+ RPDCH LV EFMKNGS
Sbjct: 376 RDAAELTEEDTKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHVSRPDCHCLVYEFMKNGS 435
Query: 292 LLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA 351
L +IL+DV QG+REL+WLARHRIA G+ SGLEYLH H PRIIHR++ P++VL+DDDMEA
Sbjct: 436 LQDILSDVEQGKRELDWLARHRIAIGVASGLEYLHTSHSPRIIHRDLKPANVLLDDDMEA 495
Query: 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGK 411
RIADFGLA+ MPD + V+TS VAGTVGYIAPEYHQTLKF++KCDIYSFGVLL VLVMGK
Sbjct: 496 RIADFGLAKAMPDANTHVTTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLGVLVMGK 555
Query: 412 LPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDP 471
LPSD+FFQ T E SLV+WMRN+MTSENP++AID K+ GNG+EEQMLLVLKIACFCTLDDP
Sbjct: 556 LPSDEFFQTTREMSLVKWMRNIMTSENPSQAIDPKMNGNGFEEQMLLVLKIACFCTLDDP 615
Query: 472 EERPNSKDVRSMLS 485
+RPNSKD+R MLS
Sbjct: 616 RQRPNSKDIRCMLS 629
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224133744|ref|XP_002321650.1| predicted protein [Populus trichocarpa] gi|222868646|gb|EEF05777.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 477 bits (1227), Expect = e-132, Method: Compositional matrix adjust.
Identities = 226/327 (69%), Positives = 271/327 (82%), Gaps = 11/327 (3%)
Query: 170 LLLAAVRGGGQNRGPTIFSPLIEK-EDLAFLEKEDCSASLEKIRSRASGEIYIAELPESN 228
++LAAV+GGG++ GP IFSPLI++ EDLAFLEK+D A+LE I GE+Y AELP SN
Sbjct: 300 IVLAAVKGGGRDGGPAIFSPLIKRAEDLAFLEKDDGLANLEVIGKGGCGEVYKAELPGSN 359
Query: 229 GKMIAIKKVKQV----------DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278
GKMIAIKK+ Q D+ LL+ KMRQ+++EI T G IRHRN++PLLAH+ RPD
Sbjct: 360 GKMIAIKKIIQPPKDAAELTEEDSKLLHKKMRQIQSEINTVGHIRHRNLLPLLAHVSRPD 419
Query: 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI 338
CH LV E MKNGSL + LN V++GRREL+WLARHRIA G+ SGLEYLH+ H PRIIHR++
Sbjct: 420 CHYLVYELMKNGSLQDALNHVTEGRRELDWLARHRIAVGVASGLEYLHLSHSPRIIHRDL 479
Query: 339 TPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIY 398
P++VL+DD MEARIADFGLA+ MPD ++TS VAGTVGYIAPEYHQTLKF++KCDIY
Sbjct: 480 KPANVLLDDSMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIY 539
Query: 399 SFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLL 458
SFGV+L VLVMGKLPSD+FFQ+T E SLV+WMRN+MTSENP +AID KL+GNG EEQMLL
Sbjct: 540 SFGVVLGVLVMGKLPSDEFFQNTREMSLVKWMRNIMTSENPRQAIDPKLMGNGLEEQMLL 599
Query: 459 VLKIACFCTLDDPEERPNSKDVRSMLS 485
VLKIACFCT+DDP++RPNSKDVR MLS
Sbjct: 600 VLKIACFCTIDDPKQRPNSKDVRCMLS 626
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119518|ref|XP_002318094.1| predicted protein [Populus trichocarpa] gi|222858767|gb|EEE96314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1211), Expect = e-130, Method: Compositional matrix adjust.
Identities = 221/327 (67%), Positives = 272/327 (83%), Gaps = 11/327 (3%)
Query: 170 LLLAAVRGGGQNRGPTIFSPLIEK-EDLAFLEKEDCSASLEKIRSRASGEIYIAELPESN 228
++LAAV+GGG++ GP IFSPLI+K EDLAFLEK++ A+LE I GE++ AELP SN
Sbjct: 297 IVLAAVKGGGRDVGPAIFSPLIKKAEDLAFLEKDEGLANLEIIGRGGCGEVFKAELPGSN 356
Query: 229 GKMIAIKKVKQV----------DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278
GKMIA+KK+ Q D+ +LN KMRQ+++EI T G IRHRN++PLLAH+ RPD
Sbjct: 357 GKMIAVKKIIQPPKDAAELSEEDSKVLNKKMRQIQSEINTVGHIRHRNLLPLLAHVSRPD 416
Query: 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI 338
CH LV EFMKNGSL ++LN V++G+REL+WLARH+IA G+ SGLEYLH+ H P+IIHR++
Sbjct: 417 CHYLVYEFMKNGSLQDVLNQVTEGKRELDWLARHKIAVGVASGLEYLHLSHSPQIIHRDL 476
Query: 339 TPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIY 398
P++VL+DDDMEARIADFGLA+ MPD ++TS VAGTVGYIAPEYHQTLKF+EKCDIY
Sbjct: 477 KPANVLLDDDMEARIADFGLAKAMPDAKTHITTSNVAGTVGYIAPEYHQTLKFTEKCDIY 536
Query: 399 SFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLL 458
SFGV+L VLVMGKLPSD FFQ T E SLV+WMRN+M SENP++AID KL+G+G EEQMLL
Sbjct: 537 SFGVVLGVLVMGKLPSDAFFQSTRELSLVKWMRNIMISENPSQAIDPKLIGHGLEEQMLL 596
Query: 459 VLKIACFCTLDDPEERPNSKDVRSMLS 485
VLKIACFCT+DDP++RP+SKDVR MLS
Sbjct: 597 VLKIACFCTIDDPKQRPSSKDVRCMLS 623
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508750|ref|XP_003523117.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 465 bits (1197), Expect = e-128, Method: Compositional matrix adjust.
Identities = 221/327 (67%), Positives = 266/327 (81%), Gaps = 11/327 (3%)
Query: 170 LLLAAVRGGGQNRGPTIFSPLIEK-EDLAFLEKEDCSASLEKIRSRASGEIYIAELPESN 228
L LA ++G G+ GP I+SPLI+K EDLAFLEKE+ ASLE I GE+Y AELP SN
Sbjct: 306 LALALIKGRGRKAGPDIYSPLIKKAEDLAFLEKEEGIASLEIIGRGGCGEVYKAELPGSN 365
Query: 229 GKMIAIKKVKQV----------DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278
GKMIAIKK+ Q D+ +LN KMRQ+R+EI T GQIRHRN++PLLAH+ RP+
Sbjct: 366 GKMIAIKKIVQPPKDGAELAEEDSKVLNKKMRQIRSEINTVGQIRHRNLLPLLAHVSRPE 425
Query: 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI 338
CH LV EFMKNGSL + L+ V +G EL+WL+RH+I+ G+ +GLEYLHM H PRIIHR++
Sbjct: 426 CHYLVYEFMKNGSLQDTLSKVERGESELDWLSRHKISLGVAAGLEYLHMNHNPRIIHRDL 485
Query: 339 TPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIY 398
P+++L+DDDMEARIADFGLA+ MPD ++TS VAGTVGYIAPEYHQ LKF++KCDIY
Sbjct: 486 KPANILLDDDMEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEYHQILKFTDKCDIY 545
Query: 399 SFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLL 458
S+GV+L VLV+GKLPSDDFFQHTEE SLV+WMR ++SENP AI+SKLLGNGYEEQMLL
Sbjct: 546 SYGVILGVLVIGKLPSDDFFQHTEEMSLVKWMRKTLSSENPKEAINSKLLGNGYEEQMLL 605
Query: 459 VLKIACFCTLDDPEERPNSKDVRSMLS 485
VLKIACFCT+DDP+ERPNSKDVR MLS
Sbjct: 606 VLKIACFCTMDDPKERPNSKDVRCMLS 632
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|24421095|dbj|BAC07504.2| receptor-like protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 457 bits (1177), Expect = e-126, Method: Compositional matrix adjust.
Identities = 222/327 (67%), Positives = 264/327 (80%), Gaps = 11/327 (3%)
Query: 170 LLLAAVRGGGQNRGPTIFSPLIEK-EDLAFLEKEDCSASLEKIRSRASGEIYIAELPESN 228
L++ VR G + TI+SPLI+K EDLAFLEKED ASLE I GE+Y AELP SN
Sbjct: 303 LVMFFVRKGKTDGSLTIYSPLIKKAEDLAFLEKEDGVASLEMIGKGGCGEVYRAELPGSN 362
Query: 229 GKMIAIKKVKQV----------DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278
GK+IAIKK+ Q D LN KMRQV++EI GQIRHRN++PLLAHM RPD
Sbjct: 363 GKIIAIKKILQPPMDAAELAEEDTKALNKKMRQVKSEIQILGQIRHRNLLPLLAHMPRPD 422
Query: 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI 338
CH LV E+MKNGSL +IL V++G REL+WL RHRIA GI +GLEYLH+ H IIHR++
Sbjct: 423 CHYLVYEYMKNGSLQDILQQVTEGTRELDWLGRHRIAVGIATGLEYLHINHSQCIIHRDL 482
Query: 339 TPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIY 398
P++VL+DDDMEARIADFGLA+ +PD H V+TS VAGTVGYIAPEYHQTLKF++KCDIY
Sbjct: 483 KPANVLLDDDMEARIADFGLAKAVPDAHTHVTTSNVAGTVGYIAPEYHQTLKFTDKCDIY 542
Query: 399 SFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLL 458
SFGV+LAVLV+GKLPSD+FFQHT E SLV+W+RNVMTSE+P RAID KL+G+G+EEQMLL
Sbjct: 543 SFGVVLAVLVIGKLPSDEFFQHTPEMSLVKWLRNVMTSEDPKRAIDPKLIGSGFEEQMLL 602
Query: 459 VLKIACFCTLDDPEERPNSKDVRSMLS 485
VLKIACFCTL++P+ERPNSKDVR ML+
Sbjct: 603 VLKIACFCTLENPKERPNSKDVRCMLT 629
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516603|ref|XP_003526983.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1173), Expect = e-125, Method: Compositional matrix adjust.
Identities = 218/327 (66%), Positives = 263/327 (80%), Gaps = 11/327 (3%)
Query: 170 LLLAAVRGGGQNRGPTIFSPLIEK-EDLAFLEKEDCSASLEKIRSRASGEIYIAELPESN 228
L LA ++G G+ GP I+SPLI+K EDLAFLEKE+ ASLE I GE+Y AELP SN
Sbjct: 301 LALALIKGRGRKAGPDIYSPLIKKAEDLAFLEKEEGMASLEIIGRGGCGEVYKAELPGSN 360
Query: 229 GKMIAIKKVKQV----------DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278
GKMIAIKK+ Q D+ +LN KMRQ+R+EI T GQIRHRN++PLLAH+ RP
Sbjct: 361 GKMIAIKKIIQPPKEGAELAEEDSKVLNKKMRQIRSEITTVGQIRHRNLLPLLAHVSRPG 420
Query: 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI 338
CH LV EFMKNGSL + L+ V G EL+WL+RH+IA G+ +GLEYLH+ H PRIIHR++
Sbjct: 421 CHYLVYEFMKNGSLHDTLSKVEVGEFELDWLSRHKIALGVAAGLEYLHLNHNPRIIHRDL 480
Query: 339 TPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIY 398
P+++L+DDDMEARIADFGLA+ MPD ++TS VAGTVGYIAPEYHQ LKF++KCDIY
Sbjct: 481 KPANILLDDDMEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEYHQILKFTDKCDIY 540
Query: 399 SFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLL 458
SFGV+L VLV+GKLPS +FFQHTEE SLV+WMR +++SENP AID+KLLGNGYE+QMLL
Sbjct: 541 SFGVILGVLVIGKLPSHEFFQHTEEMSLVKWMRKILSSENPKEAIDTKLLGNGYEDQMLL 600
Query: 459 VLKIACFCTLDDPEERPNSKDVRSMLS 485
VLKIACFCT+DDP+ERPNSKDV MLS
Sbjct: 601 VLKIACFCTMDDPKERPNSKDVWCMLS 627
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440606|ref|XP_004138075.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] gi|449501343|ref|XP_004161343.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 452 bits (1162), Expect = e-124, Method: Compositional matrix adjust.
Identities = 210/327 (64%), Positives = 265/327 (81%), Gaps = 11/327 (3%)
Query: 170 LLLAAVRGGGQNRGPTIFSP-LIEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESN 228
L++AA++GG +N GP+IF+P LI+++DLAFLE+++ ASL+ I GE+Y AELPE +
Sbjct: 303 LVIAAIKGGSKNSGPSIFAPKLIKRDDLAFLERDNALASLQLIGKGGCGEVYKAELPEKS 362
Query: 229 GKMIAIKKVKQV----------DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278
GKM AIKK+ Q ++ ++ KMRQ+++EI T G+IRHRN++PL+AH+ RPD
Sbjct: 363 GKMFAIKKITQPPKDAAELIEEESRHMSKKMRQIKSEIRTVGEIRHRNLLPLVAHVPRPD 422
Query: 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI 338
CH LV E MKNGSL ++LN VS G +EL+WL RH IA G+ SGLEYLHM H PRIIHR++
Sbjct: 423 CHYLVYELMKNGSLQDMLNQVSAGVKELDWLTRHNIALGVASGLEYLHMNHTPRIIHRDL 482
Query: 339 TPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIY 398
P++VL+DD MEARIADFGLA+ MPD ++ S VAGTVGYIAPEYHQTLKF++KCDIY
Sbjct: 483 KPANVLLDDGMEARIADFGLAKAMPDAQTHMTASNVAGTVGYIAPEYHQTLKFTDKCDIY 542
Query: 399 SFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLL 458
FGVLL VLV+GKLPSD+FFQ+T+E SLV+WM+NVMTS+NP AID KLLGNG+EEQMLL
Sbjct: 543 GFGVLLGVLVIGKLPSDEFFQNTDEMSLVKWMKNVMTSDNPRGAIDPKLLGNGWEEQMLL 602
Query: 459 VLKIACFCTLDDPEERPNSKDVRSMLS 485
LKIACFCT+D+P+ERPNSKDVR MLS
Sbjct: 603 ALKIACFCTMDNPKERPNSKDVRCMLS 629
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297822929|ref|XP_002879347.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] gi|297325186|gb|EFH55606.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1156), Expect = e-123, Method: Compositional matrix adjust.
Identities = 210/327 (64%), Positives = 265/327 (81%), Gaps = 11/327 (3%)
Query: 170 LLLAAVRGGGQNRGPTIFSPLIEK-EDLAFLEKEDCSASLEKIRSRASGEIYIAELPESN 228
L++ A+RG G+ GP+IFSPLI+K EDLAFLE E+ ASLE I GE++ AELP SN
Sbjct: 311 LIIQAIRGSGKPSGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSN 370
Query: 229 GKMIAIKKVKQV----------DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278
GK+IA+KKV Q D+ +N KMRQ+R+EI T GQIRHRN++PLLAH+ RP+
Sbjct: 371 GKIIAVKKVIQPPKDADELTDEDSKFMNKKMRQIRSEISTVGQIRHRNLLPLLAHVSRPE 430
Query: 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI 338
CH LV E+M+ GSL +IL DV G +EL W ARH+IA GI +GLEYLHM H PRIIHR++
Sbjct: 431 CHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDL 490
Query: 339 TPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIY 398
P++VL+DDDMEARI+DFGLA++MPD ++TS VAGTVGYIAPE++QT KF+ KCDIY
Sbjct: 491 KPANVLLDDDMEARISDFGLAKVMPDAVTHITTSNVAGTVGYIAPEFYQTHKFTAKCDIY 550
Query: 399 SFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLL 458
SFGV+L +LV+GKLPSD+FFQHT+E SL++WMRN++TSENP+ AID KL+ G++EQMLL
Sbjct: 551 SFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMEQGFDEQMLL 610
Query: 459 VLKIACFCTLDDPEERPNSKDVRSMLS 485
VLKIAC+CTLDDP++RPNSKDVR+MLS
Sbjct: 611 VLKIACYCTLDDPKQRPNSKDVRTMLS 637
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15225153|ref|NP_180747.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|75265989|sp|Q9SKB2.1|SBIR1_ARATH RecName: Full=Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1; AltName: Full=Protein EVERSHED; AltName: Full=Protein SUPPRESSOR OF BIR1-1; Flags: Precursor gi|13877675|gb|AAK43915.1|AF370596_1 putative receptor-like protein kinase [Arabidopsis thaliana] gi|4887748|gb|AAD32284.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|224589537|gb|ACN59302.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330253505|gb|AEC08599.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1143), Expect = e-122, Method: Compositional matrix adjust.
Identities = 209/327 (63%), Positives = 263/327 (80%), Gaps = 11/327 (3%)
Query: 170 LLLAAVRGGGQNRGPTIFSPLIEK-EDLAFLEKEDCSASLEKIRSRASGEIYIAELPESN 228
L++ A+RG + GP+IFSPLI+K EDLAFLE E+ ASLE I GE++ AELP SN
Sbjct: 311 LIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSN 370
Query: 229 GKMIAIKKVKQV----------DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278
GK+IA+KKV Q D+ LN KMRQ+R+EI T G IRHRN++PLLAH+ RP+
Sbjct: 371 GKIIAVKKVIQPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRPE 430
Query: 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI 338
CH LV E+M+ GSL +IL DV G +EL W ARH+IA GI +GLEYLHM H PRIIHR++
Sbjct: 431 CHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDL 490
Query: 339 TPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIY 398
P++VL+DDDMEARI+DFGLA+ MPD ++TS VAGTVGYIAPE++QT KF++KCDIY
Sbjct: 491 KPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDIY 550
Query: 399 SFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLL 458
SFGV+L +LV+GKLPSD+FFQHT+E SL++WMRN++TSENP+ AID KL+ G++EQMLL
Sbjct: 551 SFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQMLL 610
Query: 459 VLKIACFCTLDDPEERPNSKDVRSMLS 485
VLKIAC+CTLDDP++RPNSKDVR+MLS
Sbjct: 611 VLKIACYCTLDDPKQRPNSKDVRTMLS 637
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456834|ref|XP_002276125.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 443 bits (1140), Expect = e-121, Method: Compositional matrix adjust.
Identities = 223/326 (68%), Positives = 265/326 (81%), Gaps = 13/326 (3%)
Query: 171 LLAAVRGGGQNRGPTIFSPLIEK-EDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNG 229
LL VRGGG+ GP IFSPLI+K EDLAFLEK+D ASLE I GE+Y AELP G
Sbjct: 305 LLVLVRGGGKESGPAIFSPLIKKAEDLAFLEKDDGLASLEIIGKGGCGEVYRAELP--GG 362
Query: 230 KMIAIKKVKQV----------DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279
K+IAIKK+ Q D+ LLN KMRQ+R+EI T G IRHRN++PLLAH+ RP+C
Sbjct: 363 KLIAIKKIVQPPKDAAELAEEDSKLLNKKMRQIRSEIQTVGNIRHRNLLPLLAHVSRPNC 422
Query: 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNIT 339
H LV EFMKNGSL ++L VS+G REL+WLARHR+A G+ +GLEYLHM H PRIIHR++
Sbjct: 423 HYLVYEFMKNGSLQDMLTQVSEGTRELDWLARHRVALGVAAGLEYLHMSHSPRIIHRDLK 482
Query: 340 PSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYS 399
P ++L+DDDMEARIADFGLA+ +PD + V+TS VAGTVGYIAPEYHQTLKF++KCDIYS
Sbjct: 483 PGNILLDDDMEARIADFGLAKAVPDANTHVTTSNVAGTVGYIAPEYHQTLKFTDKCDIYS 542
Query: 400 FGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLV 459
FGVLL VLV+GKLPSDDFFQHT E SLV+WM N+ TS++P+RAID KL+GNG+EEQMLLV
Sbjct: 543 FGVLLGVLVVGKLPSDDFFQHTAEMSLVKWMANIRTSDDPSRAIDRKLMGNGFEEQMLLV 602
Query: 460 LKIACFCTLDDPEERPNSKDVRSMLS 485
LKIACFCT+DD + RPNSKDVR+MLS
Sbjct: 603 LKIACFCTVDDAKIRPNSKDVRTMLS 628
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 531 | ||||||
| TAIR|locus:2045228 | 641 | SOBIR1 "SUPPRESSOR OF BIR1 1" | 0.666 | 0.552 | 0.587 | 8.7e-111 | |
| TAIR|locus:2161158 | 1041 | PXY "PHLOEM INTERCALATED WITH | 0.572 | 0.292 | 0.381 | 1.1e-46 | |
| UNIPROTKB|Q942F3 | 1121 | P0480C01.18-1 "cDNA clone:J033 | 0.517 | 0.245 | 0.404 | 2.7e-46 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.491 | 0.237 | 0.418 | 6.4e-46 | |
| TAIR|locus:2168907 | 966 | XIP1 "XYLEM INTERMIXED WITH PH | 0.532 | 0.292 | 0.367 | 2.6e-44 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.521 | 0.273 | 0.390 | 4.8e-44 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.502 | 0.213 | 0.395 | 6e-44 | |
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.504 | 0.260 | 0.388 | 6.6e-44 | |
| TAIR|locus:2183906 | 401 | CRN "CORYNE" [Arabidopsis thal | 0.544 | 0.720 | 0.341 | 3.5e-43 | |
| TAIR|locus:2203000 | 355 | AT1G78530 [Arabidopsis thalian | 0.572 | 0.856 | 0.363 | 5.7e-43 |
| TAIR|locus:2045228 SOBIR1 "SUPPRESSOR OF BIR1 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1094 (390.2 bits), Expect = 8.7e-111, P = 8.7e-111
Identities = 218/371 (58%), Positives = 279/371 (75%)
Query: 127 MSKVKEVNARLQDIAWQINVLGLKASS-GGKSKNVRQRFPTTPSLLLAAVRGGGQNRGPT 185
+ K K+ + + + AW +LG + GG F L++ A+RG + GP+
Sbjct: 272 LKKKKKKSKKKKVAAW---ILGFVVGAIGGTISGFV--FSVLFKLIIQAIRGSEKPPGPS 326
Query: 186 IFSPLIEK-EDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQV---- 240
IFSPLI+K EDLAFLE E+ ASLE I GE++ AELP SNGK+IA+KKV Q
Sbjct: 327 IFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSNGKIIAVKKVIQPPKDA 386
Query: 241 ------DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLE 294
D+ LN KMRQ+R+EI T G IRHRN++PLLAH+ RP+CH LV E+M+ GSL +
Sbjct: 387 DELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRPECHYLVYEYMEKGSLQD 446
Query: 295 ILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354
IL DV G +EL W ARH+IA GI +GLEYLHM H PRIIHR++ P++VL+DDDMEARI+
Sbjct: 447 ILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDLKPANVLLDDDMEARIS 506
Query: 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPS 414
DFGLA+ MPD ++TS VAGTVGYIAPE++QT KF++KCDIYSFGV+L +LV+GKLPS
Sbjct: 507 DFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDIYSFGVILGILVIGKLPS 566
Query: 415 DDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEER 474
D+FFQHT+E SL++WMRN++TSENP+ AID KL+ G++EQMLLVLKIAC+CTLDDP++R
Sbjct: 567 DEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQMLLVLKIACYCTLDDPKQR 626
Query: 475 PNSKDVRSMLS 485
PNSKDVR+MLS
Sbjct: 627 PNSKDVRTMLS 637
|
|
| TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 499 (180.7 bits), Expect = 1.1e-46, P = 1.1e-46
Identities = 123/322 (38%), Positives = 184/322 (57%)
Query: 175 VRGGGQNRGPTIFSPLIEKEDLAFLEKE--DCSASLEKIRSRAS-GEIYIAELPESNGKM 231
V GGG+N G L + L F + +C + + I S G +Y AE+P NG++
Sbjct: 686 VDGGGRNGGDIGPWKLTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMP--NGEI 743
Query: 232 IAIKKV--KQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKN 289
IA+KK+ K +N + + V AE+ G +RHRNIV LL DC +L+ E+M N
Sbjct: 744 IAVKKLWGKNKENGKIRRRKSGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPN 803
Query: 290 GSLLEILNDVSQGRREL-EWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD 348
GSL ++L+ + EW A ++IA G+ G+ YLH P I+HR++ PS++L+D D
Sbjct: 804 GSLDDLLHGGDKTMTAAAEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDAD 863
Query: 349 MEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLV 408
EAR+ADFG+A+L+ S S+VAG+ GYIAPEY TL+ +K DIYS+GV+L ++
Sbjct: 864 FEARVADFGVAKLI---QTDESMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEII 920
Query: 409 MGKLPSDDFFQHTEEKSLVRWMRNVM-TSENPNRAIDSKLLGNG---YEEQMLLVLKIAC 464
GK + F E S+V W+R+ + T E+ +D K +G E+M +L+IA
Sbjct: 921 TGKRSVEPEFG--EGNSIVDWVRSKLKTKEDVEEVLD-KSMGRSCSLIREEMKQMLRIAL 977
Query: 465 FCTLDDPEERPNSKDVRSMLSD 486
CT P +RP +DV +L +
Sbjct: 978 LCTSRSPTDRPPMRDVLLILQE 999
|
|
| UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 482 (174.7 bits), Expect = 2.7e-46, Sum P(2) = 2.7e-46
Identities = 117/289 (40%), Positives = 170/289 (58%)
Query: 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVP 269
+I S G++Y A+L + GK++AIKK+ V R+ AE+ T G+I+HRN+VP
Sbjct: 812 QIGSGGFGDVYKAQLKD--GKVVAIKKLIHVSGQ----GDREFTAEMETIGKIKHRNLVP 865
Query: 270 LLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH 329
LL + + LLV ++MK GSL ++L+D + ++L W AR +IA G GL +LH
Sbjct: 866 LLGYCKAGEERLLVYDYMKFGSLEDVLHDRKKIGKKLNWEARRKIAVGAARGLAFLHHNC 925
Query: 330 RPRIIHRNITPSSVLIDDDMEARIADFGLARLMP--DGHAQVSTSIVAGTVGYIAPEYHQ 387
P IIHR++ S+VLID+ +EAR++DFG+ARLM D H VST +AGT GY+ PEY+Q
Sbjct: 926 IPHIIHRDMKSSNVLIDEQLEARVSDFGMARLMSVVDTHLSVST--LAGTPGYVPPEYYQ 983
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447
+ + + K D+YS+GV+L L+ GK P+D E+ +LV W++ T D +L
Sbjct: 984 SFRCTTKGDVYSYGVVLLELLTGKPPTDSA-DFGEDNNLVGWVKQ-HTKLKITDVFDPEL 1041
Query: 448 LGN--GYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDVD 494
L E ++L LKIAC C D P RP V +M + VD
Sbjct: 1042 LKEDPSVELELLEHLKIACACLDDRPSRRPTMLKVMAMFKEIQAGSTVD 1090
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 483 (175.1 bits), Expect = 6.4e-46, Sum P(2) = 6.4e-46
Identities = 116/277 (41%), Positives = 166/277 (59%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
A G +Y AE+ S G++IA+KK+ + RAEI T G+IRHRNIV L
Sbjct: 809 ACGTVYKAEM--SGGEVIAVKKLNSRGEGASSDN--SFRAEISTLGKIRHRNIVKLYGFC 864
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQGRRE--LEWLARHRIARGIVSGLEYLHMYHRPR 332
+ +LL+ E+M GSL E L +G + L+W AR+RIA G GL YLH RP+
Sbjct: 865 YHQNSNLLLYEYMSKGSLGEQLQ---RGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQ 921
Query: 333 IIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS 392
I+HR+I +++L+D+ +A + DFGLA+L+ +++ S S VAG+ GYIAPEY T+K +
Sbjct: 922 IVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSK-SMSAVAGSYGYIAPEYAYTMKVT 980
Query: 393 EKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN-RAIDSKLLGNG 451
EKCDIYSFGV+L L+ GK P Q + LV W+R + + P D++L N
Sbjct: 981 EKCDIYSFGVVLLELITGKPPVQPLEQGGD---LVNWVRRSIRNMIPTIEMFDARLDTND 1037
Query: 452 YE--EQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
+M LVLKIA FCT + P RP ++V +M+++
Sbjct: 1038 KRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074
|
|
| TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 476 (172.6 bits), Expect = 2.6e-44, P = 2.6e-44
Identities = 110/299 (36%), Positives = 174/299 (58%)
Query: 196 LAFLEKEDCSASLEK--IRSRASGEIYIAELPESNGKMIAIKKVKQVDN--SLLNIKM-- 249
++F ++E + ++K + SG +Y EL +G+++A+KK+ N S KM
Sbjct: 645 ISFDQREILESLVDKNIVGHGGSGTVYRVEL--KSGEVVAVKKLWSQSNKDSASEDKMHL 702
Query: 250 -RQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEW 308
++++ E+ T G IRH+NIV L ++ DC LLV E+M NG+L + L+ +G LEW
Sbjct: 703 NKELKTEVETLGSIRHKNIVKLFSYFSSLDCSLLVYEYMPNGNLWDALH---KGFVHLEW 759
Query: 309 LARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ 368
RH+IA G+ GL YLH P IIHR+I +++L+D + + ++ADFG+A+++
Sbjct: 760 RTRHQIAVGVAQGLAYLHHDLSPPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGKD 819
Query: 369 VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR 428
+T+++AGT GY+APEY + K + KCD+YSFGV+L L+ GK P D F E K++V
Sbjct: 820 STTTVMAGTYGYLAPEYAYSSKATIKCDVYSFGVVLMELITGKKPVDSCFG--ENKNIVN 877
Query: 429 WMRN-VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
W+ + T E +D K L + M+ L++A CT P RP +V +L D
Sbjct: 878 WVSTKIDTKEGLIETLD-KRLSESSKADMINALRVAIRCTSRTPTIRPTMNEVVQLLID 935
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 474 (171.9 bits), Expect = 4.8e-44, P = 4.8e-44
Identities = 112/287 (39%), Positives = 174/287 (60%)
Query: 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR 263
C I A+G +Y AE+ S+ ++A+KK+ + + + E+ G++R
Sbjct: 698 CIKESNMIGMGATGIVYKAEMSRSS-TVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLR 756
Query: 264 HRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQ-GRRELEWLARHRIARGIVSGL 322
HRNIV LL + ++V EFM NG+L + ++ + GR ++W++R+ IA G+ GL
Sbjct: 757 HRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGL 816
Query: 323 EYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIA 382
YLH P +IHR+I +++L+D +++ARIADFGLAR+M + + S+VAG+ GYIA
Sbjct: 817 AYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM--ARKKETVSMVAGSYGYIA 874
Query: 383 PEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN-VMTSENPNR 441
PEY TLK EK DIYS+GV+L L+ G+ P + F E +V W+R + + +
Sbjct: 875 PEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFG--ESVDIVEWVRRKIRDNISLEE 932
Query: 442 AIDSKLLGN-GY-EEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
A+D + GN Y +E+MLLVL+IA CT P++RP+ +DV SML +
Sbjct: 933 ALDPNV-GNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISMLGE 978
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 463 (168.0 bits), Expect = 6.0e-44, Sum P(2) = 6.0e-44
Identities = 113/286 (39%), Positives = 171/286 (59%)
Query: 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL 270
I S SG++Y AEL NG+ IA+KK+ D+ + N + E+ T G IRHR++V L
Sbjct: 954 IGSGGSGKVYKAEL--KNGETIAVKKILWKDDLMSN---KSFNREVKTLGTIRHRHLVKL 1008
Query: 271 LAHMV-RPD-CHLLVSEFMKNGSLLEIL--NDVSQGRRELEWLARHRIARGIVSGLEYLH 326
+ + + D +LL+ E+M NGS+ + L N+ ++ + L W R +IA G+ G+EYLH
Sbjct: 1009 MGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLH 1068
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ--VSTSIVAGTVGYIAPE 384
P I+HR+I S+VL+D ++EA + DFGLA+++ + S ++ AG+ GYIAPE
Sbjct: 1069 YDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPE 1128
Query: 385 YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT----SENPN 440
Y +LK +EK D+YS G++L +V GK+P++ F EE +VRW+ V+ SE
Sbjct: 1129 YAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFD--EETDMVRWVETVLDTPPGSEARE 1186
Query: 441 RAIDSKL--LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484
+ IDS+L L EE VL+IA CT P+ERP+S+ L
Sbjct: 1187 KLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232
|
|
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 462 (167.7 bits), Expect = 6.6e-44, Sum P(2) = 6.6e-44
Identities = 110/283 (38%), Positives = 168/283 (59%)
Query: 215 ASGEIYIAELPESNGKMIAIKKV---KQVDNSLLNIKMRQ-----VRAEIMTAGQIRHRN 266
A G +Y AE+ +A+KK+ N + + + + E+ G +RHRN
Sbjct: 724 AIGIVYKAEVMRRPLLTVAVKKLWRSPSPQNDIEDHHQEEDEEDDILREVNLLGGLRHRN 783
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
IV +L ++ ++V E+M NG+L L+ + +WL+R+ +A G+V GL YLH
Sbjct: 784 IVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNVAVGVVQGLNYLH 843
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
P IIHR+I +++L+D ++EARIADFGLA++M H + S+VAG+ GYIAPEY
Sbjct: 844 NDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMML--HKNETVSMVAGSYGYIAPEYG 901
Query: 387 QTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN-VMTSENPNRAIDS 445
TLK EK DIYS GV+L LV GK+P D F+ + + +V W+R V +E+ ID+
Sbjct: 902 YTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFEDSID--VVEWIRRKVKKNESLEEVIDA 959
Query: 446 KLLGNGYE--EQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
+ G+ E+MLL L+IA CT P++RP+ +DV +ML++
Sbjct: 960 SIAGDCKHVIEEMLLALRIALLCTAKLPKDRPSIRDVITMLAE 1002
|
|
| TAIR|locus:2183906 CRN "CORYNE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 456 (165.6 bits), Expect = 3.5e-43, P = 3.5e-43
Identities = 107/313 (34%), Positives = 180/313 (57%)
Query: 182 RGPTIFSPLIEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVD 241
+GP +FSP I + L S ++ + S +G+ Y L NG ++A+K++ ++
Sbjct: 99 KGPVVFSPKITPKSL----HAALSNGIQLLGSDLNGKYYKMVL--DNGLVVAVKRLGSLE 152
Query: 242 -------NSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLE 294
+S ++K R+++ E+ +RHRN++ L A++ D LV ++M NGSL +
Sbjct: 153 GVGSPESSSSKSVK-RRLQKELELLAGLRHRNLMSLRAYVRESDEFSLVYDYMPNGSLED 211
Query: 295 ILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354
++N V EL W R R+A GIV GL+YLH +I+H N+ P++V++D + E R+A
Sbjct: 212 VMNKVRTKEVELGWEIRLRVAVGIVKGLQYLHFSCETQILHYNLKPTNVMLDSEFEPRLA 271
Query: 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPS 414
D GLA++MP H VS Y APE Q+ ++++K DI+SFG++L VL+ G+ P+
Sbjct: 272 DCGLAKIMPSSHTAVSC--------YSAPESSQSNRYTDKSDIFSFGMILGVLLTGRDPT 323
Query: 415 DDFFQHTEEK-SLVRWMRNVMTSENPNRAIDSKLLGNGYEE-QMLLVLKIACFCTLDDPE 472
F + + SL +W++++ S A+D +LG EE +ML+ L+I C D P
Sbjct: 324 HPFCEESASGGSLGQWLKHLQQSGEAREALDKTILGEEVEEDEMLMALRITIICLSDFPA 383
Query: 473 ERPNSKDVRSMLS 485
+RP+S ++ ML+
Sbjct: 384 DRPSSDELVHMLT 396
|
|
| TAIR|locus:2203000 AT1G78530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 454 (164.9 bits), Expect = 5.7e-43, P = 5.7e-43
Identities = 122/336 (36%), Positives = 186/336 (55%)
Query: 175 VRGGGQNRGPTIF-SPLIEK--EDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKM 231
V+GGG+ +F S L+ D+ F++K ++ + + S G +Y + +S
Sbjct: 46 VKGGGKM---VMFRSQLLNSVSSDM-FMKKTHKLSNKDILGSGGFGTVYRLVIDDST--T 99
Query: 232 IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGS 291
A+K++ + + + R E+ I+HRNIV L + P +LL+ E M NGS
Sbjct: 100 FAVKRLNRGTSE----RDRGFHRELEAMADIKHRNIVTLHGYFTSPHYNLLIYELMPNGS 155
Query: 292 LLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA 351
L L+ GR+ L+W +R+RIA G G+ YLH P IIHR+I S++L+D +MEA
Sbjct: 156 LDSFLH----GRKALDWASRYRIAVGAARGISYLHHDCIPHIIHRDIKSSNILLDHNMEA 211
Query: 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGK 411
R++DFGLA LM VST VAGT GY+APEY T K + K D+YSFGV+L L+ G+
Sbjct: 212 RVSDFGLATLMEPDKTHVST-FVAGTFGYLAPEYFDTGKATMKGDVYSFGVVLLELLTGR 270
Query: 412 LPSDD-FFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEE--QMLLVLKIACFCTL 468
P+DD FF+ E LV W++ V+ + ID++L G+ +E +M V IA C
Sbjct: 271 KPTDDEFFE--EGTKLVTWVKGVVRDQREEVVIDNRLRGSSVQENEEMNDVFGIAMMCLE 328
Query: 469 DDPEERPNSKDVRSMLSDTALIKDVDFLKMHKRMDF 504
+P RP +M T ++K ++++K+ R F
Sbjct: 329 PEPAIRP------AM---TEVVKLLEYIKLSTRSSF 355
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00150657 | hypothetical protein (630 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 531 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-41 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-28 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-21 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-12 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.003 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 6e-41
Identities = 83/273 (30%), Positives = 131/273 (47%), Gaps = 28/273 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
LEK+ + G++Y+A ++ GK++AIK +K + ++ EI +++H NI
Sbjct: 4 LEKLGEGSFGKVYLARDKKT-GKLVAIKVIK---KKKIKKDRERILREIKILKKLKHPNI 59
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L D LV E+ + G L ++L +GR E AR R I+S LEYLH
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLS-EDEARF-YLRQILSALEYLHS 115
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
I+HR++ P ++L+D+D ++ADFGLAR + G + T+ V GT Y+APE
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPG--EKLTTFV-GTPEYMAPEVLL 169
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447
+ + DI+S GV+L L+ GK P F + L + + P S
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKPP---FPGDDQLLELFKKIGKPKPPFPPPEWDIS-- 224
Query: 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
E L+ K DPE+R +++
Sbjct: 225 -----PEAKDLIRK--LLVK--DPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 24/274 (8%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L K+ S + G +Y A+ GK++A+K +K+ + K + R EI ++ H NI
Sbjct: 4 LRKLGSGSFGTVYKAKHK-GTGKIVAVKILKKRSEK--SKKDQTARREIRILRRLSHPNI 60
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L+ D LV E+ + G L + L S+G E A+ IA I+ GLEYLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKK-IALQILRGLEYLH- 115
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
IIHR++ P ++L+D++ +IADFGLA+ + + T+ V GT Y+APE
Sbjct: 116 --SNGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLL 171
Query: 388 T-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSK 446
+ K D++S GV+L L+ GK P F L +R ++ D
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPP---FSGENILDQLQL-IRRILGPPLE---FDEP 224
Query: 447 LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
+G EE L+ K DP +RP ++++
Sbjct: 225 KWSSGSEEAKDLIKKCLNK----DPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 6e-38
Identities = 65/195 (33%), Positives = 105/195 (53%), Gaps = 14/195 (7%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
G +Y+A + GK +AIK +K+ D+ + + ++ EI ++ H NIV L
Sbjct: 5 GFGTVYLARDKK-TGKKVAIKIIKKEDS---SSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
+ LV E+ + GSL ++L + +L RI I+ GLEYLH II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSNG---II 114
Query: 335 HRNITPSSVLID-DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE-YHQTLKFS 392
HR++ P ++L+D D+ + ++ADFGL++L+ + + T + GT Y+APE +S
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYS 172
Query: 393 EKCDIYSFGVLLAVL 407
EK DI+S GV+L L
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 68/276 (24%), Positives = 117/276 (42%), Gaps = 31/276 (11%)
Query: 217 GEIYIAELPESNGKMI--AIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
GE+Y +L +GK A+K +K + + E ++ H N+V LL
Sbjct: 9 GEVYKGKLKGKDGKTTEVAVKTLK---EDASEEERKDFLKEARVMKKLGHPNVVRLLGVC 65
Query: 275 VRPDCHLLVSEFMKNGSLLEIL-----NDVSQGRRELEWLARHRIARGIVSGLEYLHMYH 329
+ LV E+M+ G LL+ L S + L A I G+EYL
Sbjct: 66 TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--- 122
Query: 330 RPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL 389
+ +HR++ + L+ +D+ +I+DFGL+R + D + + ++APE +
Sbjct: 123 SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG 182
Query: 390 KFSEKCDIYSFGVLL-AVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLL 448
F+ K D++SFGVLL + +G P EE ++ ++R P
Sbjct: 183 IFTSKSDVWSFGVLLWEIFTLGATPYPGL--SNEE--VLEYLRKGYRLPKPE-------- 230
Query: 449 GNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484
+E + ++ C DPE+RP ++ L
Sbjct: 231 -YCPDE----LYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 8e-29
Identities = 56/193 (29%), Positives = 95/193 (49%), Gaps = 17/193 (8%)
Query: 217 GEIYIAELPESNGK---MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH 273
GE+Y +L GK +A+K +K+ + + + A IM ++ H N+V LL
Sbjct: 13 GEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLR-EARIMR--KLDHPNVVKLLGV 69
Query: 274 MVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRI 333
+ +V E+M+ G LL L R +L A I G+EYL
Sbjct: 70 CTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLE---SKNF 123
Query: 334 IHRNITPSSVLIDDDMEARIADFGLARLMPDG--HAQVSTSIVAGTVGYIAPEYHQTLKF 391
IHR++ + L+ +++ +I+DFGL+R + D + + + + ++APE + KF
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL---PIRWMAPESLKEGKF 180
Query: 392 SEKCDIYSFGVLL 404
+ K D++SFGVLL
Sbjct: 181 TSKSDVWSFGVLL 193
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 8e-29
Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 208 LEKIRSRASGEIYIAEL---PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH 264
+K+ A GE+Y L E +A+K +K+ + + + A IM ++ H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLE-EASIMK--KLSH 60
Query: 265 RNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEY 324
NIV LL + + +V+E+M G LL+ L + +L ++A I G+EY
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 325 LHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE 384
L +HR++ + L+ +++ +I+DFGL+R + + + ++APE
Sbjct: 118 L---ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174
Query: 385 YHQTLKFSEKCDIYSFGVLL 404
+ KF+ K D++SFGVLL
Sbjct: 175 SLKDGKFTSKSDVWSFGVLL 194
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
LEKI GE+Y A + GK +AIK +K K ++ EI + +H NI
Sbjct: 5 LEKIGKGGFGEVYKA-RHKRTGKEVAIKVIKLESKE----KKEKIINEIQILKKCKHPNI 59
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V ++ D +V EF GSL ++L +Q E +A + + ++ GLEYLH
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTE-SQIAY--VCKELLKGLEYLHS 116
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI----VAGTVGYIAP 383
IIHR+I +++L+ D E ++ DFGL+ AQ+S + + GT ++AP
Sbjct: 117 NG---IIHRDIKAANILLTSDGEVKLIDFGLS-------AQLSDTKARNTMVGTPYWMAP 166
Query: 384 EYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
E + K DI+S G+ L GK P
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 12/191 (6%)
Query: 217 GEIYIAEL---PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH 273
GE+Y L + +A+K +K+ + + + A IM ++ H NIV LL
Sbjct: 13 GEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR-EARIMR--KLDHPNIVKLLGV 69
Query: 274 MVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRI 333
+ ++V E+M G LL+ L +EL A I G+EYL
Sbjct: 70 CTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLE---SKNF 124
Query: 334 IHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSE 393
IHR++ + L+ +++ +I+DFGL+R + D + ++APE + KF+
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-YYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 394 KCDIYSFGVLL 404
K D++SFGVLL
Sbjct: 184 KSDVWSFGVLL 194
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 71/253 (28%), Positives = 118/253 (46%), Gaps = 36/253 (14%)
Query: 229 GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288
GK+ A+KK+ + +Q+ E+ T +V + +V E+M
Sbjct: 26 GKIYALKKIHVDGDEE---FRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82
Query: 289 NGSLLEILNDVSQGRRELEW----LARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
GSL ++L ++ + LA IAR I+ GL+YLH IIHR+I PS++L
Sbjct: 83 GGSLADLL------KKVGKIPEPVLAY--IARQILKGLDYLHTKRH--IIHRDIKPSNLL 132
Query: 345 IDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
I+ E +IADFG+++++ + Q +T + GTV Y++PE Q +S DI+S G+ L
Sbjct: 133 INSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQGESYSYAADIWSLGLTL 190
Query: 405 AVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLK--I 462
+GK P F + S M+ + P+ L + + + I
Sbjct: 191 LECALGKFP----FLPPGQPSFFELMQAICDGPPPS------LPAEEFSPEF----RDFI 236
Query: 463 ACFCTLDDPEERP 475
+ C DP++RP
Sbjct: 237 SA-CLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-28
Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 26/281 (9%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV 268
E + SR NG +K++ V++ + EI G+++H NIV
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS--------EIADMGKLQHPNIV 746
Query: 269 PLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY 328
L+ L+ E+++ +L E+L ++S W R +IA GI L +LH
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLS-------WERRRKIAIGIAKALRFLHCR 799
Query: 329 HRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT 388
P ++ N++P ++ID E + RL G T + Y+APE +T
Sbjct: 800 CSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS-AYVAPETRET 852
Query: 389 LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLL 448
+EK DIY FG++L L+ GK P+D F S+V W R + + + ID +
Sbjct: 853 KDITEKSDIYGFGLILIELLTGKSPADAEFGVHG--SIVEWARYCYSDCHLDMWIDPSIR 910
Query: 449 GNG--YEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487
G+ + +++ V+ +A CT DP RP + DV L
Sbjct: 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 66/264 (25%), Positives = 119/264 (45%), Gaps = 27/264 (10%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
+ G +Y+A + G+++A+K V+ +S ++ + EI ++H NIV
Sbjct: 12 SFGSVYLALD-KDTGELMAVKSVELSGDSEE--ELEALEREIRILSSLQHPNIVRYYGSE 68
Query: 275 V--RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR 332
+ + E++ GSL +L + + E + R + R I+ GL YLH
Sbjct: 69 RDEEKNTLNIFLEYVSGGSLSSLLK---KFGKLPEPVIR-KYTRQILEGLAYLH---SNG 121
Query: 333 IIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS 392
I+HR+I +++L+D D ++ADFG A+ + D T V GT ++APE + ++
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 393 EKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGY 452
DI+S G + + GK P + + + + + + E P I L
Sbjct: 182 RAADIWSLGCTVIEMATGKPP---WSELGNPMAAL--YKIGSSGEPPE--IPEHLS---- 230
Query: 453 EEQMLLVLKIACFCTLDDPEERPN 476
E+ L+ C DP++RP
Sbjct: 231 -EEAKDFLR-KCLRR--DPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 1e-27
Identities = 76/281 (27%), Positives = 119/281 (42%), Gaps = 23/281 (8%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH-RN 266
L K+ + GE+Y+A K++A+K + + S + + EI + H N
Sbjct: 5 LRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKE-VERFLREIQILASLNHPPN 59
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
IV L LV E++ GSL ++L + + E A I I+S LEYLH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF-ILAQILSALEYLH 118
Query: 327 MYHRPRIIHRNITPSSVLID-DDMEARIADFGLARLMPDG----HAQVSTSIVAGTVGYI 381
IIHR+I P ++L+D D ++ DFGLA+L+PD S GT GY+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 382 APEYHQTLKF---SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438
APE L S DI+S G+ L L+ G P + + ++ + + T
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKD 479
+ + + L+ K DP+ R +S
Sbjct: 236 AS-PLSPSNPELISKAASDLLKK----LLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (258), Expect = 9e-25
Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 31/216 (14%)
Query: 212 RSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAE--IMTAGQIRHRNIVP 269
R + +G++Y M +KK K + + E I++ +I H IV
Sbjct: 13 RKKDTGKLYA---------MKVLKKKKIIKRKEVE----HTLTERNILS--RINHPFIVK 57
Query: 270 LLAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY 328
L + L LV E+ G L L S+ R E AR A IV LEYLH
Sbjct: 58 LHYAFQTEE-KLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAE-IVLALEYLH-- 110
Query: 329 HRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT 388
II+R++ P ++L+D D ++ DFGLA+ + ++ +T GT Y+APE
Sbjct: 111 -SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLG 167
Query: 389 LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
+ + D +S GVLL ++ GK P F+ ++
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPP---FYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH 264
S L+ + GE L + G+ +A+K +K + + AE +RH
Sbjct: 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAA-----QAFLAEASVMTTLRH 59
Query: 265 RNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEY 324
N+V LL +++ + +V+E+M GSL++ L S+GR + + A + G+EY
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEY 117
Query: 325 LHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE 384
L +HR++ +VL+ +D+ A+++DFGLA+ A V + APE
Sbjct: 118 LE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPE 169
Query: 385 YHQTLKFSEKCDIYSFGVLL 404
+ KFS K D++SFG+LL
Sbjct: 170 ALREKKFSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 71/277 (25%), Positives = 126/277 (45%), Gaps = 34/277 (12%)
Query: 214 RASGEIYIAELPE---SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL 270
R G Y E+ E N +AIK +K D+ L K + + E+ ++RH++++ L
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKS-DDLL---KQQDFQKEVQALKRLRHKHLISL 67
Query: 271 LAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR 330
A + +++E M+ GSLL L +G+ L + +A + G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQ-VLPVASLIDMACQVAEGMAYLEEQN- 124
Query: 331 PRIIHRNITPSSVLIDDDMEARIADFGLARLMPDG-HAQVSTSIVAGTVGYIAPEYHQTL 389
IHR++ ++L+ +D+ ++ADFGLARL+ + + I + APE
Sbjct: 125 --SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAASHG 179
Query: 390 KFSEKCDIYSFGVLL-AVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLL 448
FS K D++SFG+LL + G++P H + R ++ P
Sbjct: 180 TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCP--------- 230
Query: 449 GNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485
Q + + + C+ +PE+RP+ K +R L
Sbjct: 231 ------QEIYKIMLECWAA--EPEDRPSFKALREELD 259
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 86/317 (27%), Positives = 137/317 (43%), Gaps = 89/317 (28%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
LEKI ASGE+Y A + ++ AIKK++ + I EI+ +H NI
Sbjct: 24 LEKIGEGASGEVYKATDRATGKEV-AIKKMRLRKQNKELIIN-----EILIMKDCKHPNI 77
Query: 268 VPLLAHMVRPDCHL------LVSEFMKNGSLLEIL--NDVSQGRRELEWLARHRIA---R 316
V D +L +V E+M GSL +I+ N V + +IA R
Sbjct: 78 VDYY------DSYLVGDELWVVMEYMDGGSLTDIITQNFVR--------MNEPQIAYVCR 123
Query: 317 GIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS------ 370
++ GLEYLH + IHR+I ++L+ D ++ADFG A AQ++
Sbjct: 124 EVLQGLEYLHSQNV---IHRDIKSDNILLSKDGSVKLADFGFA-------AQLTKEKSKR 173
Query: 371 TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM 430
S+V GT ++APE + + K DI+S G++ + G+ P ++
Sbjct: 174 NSVV-GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP---------------YL 217
Query: 431 RNVMTSENPNRA---IDSKLL-----GNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS 482
R E P RA I +K + + + L C + DPE+RP++++
Sbjct: 218 R-----EPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN---KCLVKDPEKRPSAEE--- 266
Query: 483 MLSDTALIKDVDFLKMH 499
L++ FLK
Sbjct: 267 ------LLQH-PFLKKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 1e-21
Identities = 62/280 (22%), Positives = 121/280 (43%), Gaps = 54/280 (19%)
Query: 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQ-VRAEIMTAGQIRHRNIV 268
+R ++ G++Y+ K++D S ++ K R+ E+ ++ H NI+
Sbjct: 18 LVRRKSDGKLYVL---------------KEIDLSNMSEKEREDALNEVKILKKLNHPNII 62
Query: 269 PLLAHMVRPDCHLLVSEFMKNGSLLE-ILNDVSQGR--RE---LEWLARHRIARGIVSGL 322
+V E+ G L + I +G+ E L+W + + L
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLAL 116
Query: 323 EYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIA 382
+YLH +I+HR+I P ++ + + ++ DFG+++++ ++ ++V GT Y++
Sbjct: 117 KYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVV-GTPYYLS 171
Query: 383 PEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442
PE Q ++ K DI+S G +L L K P F+ L ++ + P
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGENLLEL---ALKILKGQYPP-- 222
Query: 443 IDSKLLGNGYEEQML-LVLKIACFCTLD-DPEERPNSKDV 480
+ + Y ++ LV + L DPEERP+ +
Sbjct: 223 -----IPSQYSSELRNLVSSL-----LQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 77/276 (27%), Positives = 126/276 (45%), Gaps = 29/276 (10%)
Query: 208 LEKIRSRASGEIYIAE-LPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN 266
+E I A+ +Y A LP N + +AIK++ D + ++R E+ Q H N
Sbjct: 6 IEVIGVGATAVVYAAICLP--NNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILN-DVSQGRRELEWLARHRIARGIVSGLEYL 325
+V V D LV ++ GSLL+I+ +G + +A + + ++ GLEYL
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT--VLKEVLKGLEYL 118
Query: 326 HMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDG---HAQVSTSIVAGTVGYIA 382
H + IHR+I ++L+ +D +IADFG++ + DG +V + V GT ++A
Sbjct: 119 HSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMA 174
Query: 383 PE-YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441
PE Q + K DI+SFG+ L G P + K L+ ++N S
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP---PMKVLMLTLQNDPPSLETGA 231
Query: 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS 477
D K + + + L C DP +RP +
Sbjct: 232 --DYKKYSKSFRKMISL-------CLQKDPSKRPTA 258
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 7e-21
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIK---MRQVRAEIMTAGQIRHR 265
+ I A G +Y L G +AIK++ SL IK ++ + EI ++H
Sbjct: 6 DLIGRGAFGVVYKG-LNLETGDFVAIKQI-----SLEKIKEEALKSIMQEIDLLKNLKHP 59
Query: 266 NIVPLLAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIV---SG 321
NIV + + L ++ E+ +NGSL +I+ G +A + G
Sbjct: 60 NIVKYIGS-IETSDSLYIILEYAENGSLRQIIK--KFGP-----FPESLVAVYVYQVLQG 111
Query: 322 LEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI 381
L YLH +IHR+I +++L D ++ADFG+A + D ++ V GT ++
Sbjct: 112 LAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWM 166
Query: 382 APEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
APE + S DI+S G + L+ G P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 59/192 (30%), Positives = 99/192 (51%), Gaps = 20/192 (10%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276
GE+Y + + +A+K +K+ D + +++ A +M +I+H N+V LL R
Sbjct: 20 GEVYEG-VWKKYSLTVAVKTLKE-DTMEVEEFLKE--AAVMK--EIKHPNLVQLLGVCTR 73
Query: 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHR 336
+++EFM G+LL+ L + R+E+ + +A I S +EYL + IHR
Sbjct: 74 EPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 128
Query: 337 NITPSSVLIDDDMEARIADFGLARLMPD----GHAQVSTSIVAGTVGYIAPEYHQTLKFS 392
++ + L+ ++ ++ADFGL+RLM HA I + APE KFS
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-----KWTAPESLAYNKFS 183
Query: 393 EKCDIYSFGVLL 404
K D+++FGVLL
Sbjct: 184 IKSDVWAFGVLL 195
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
LEK+ + G +Y A + + G+++AIK V V+ L I EI Q I
Sbjct: 8 LEKLGEGSYGSVYKA-IHKETGQVVAIKVV-PVEEDLQEII-----KEISILKQCDSPYI 60
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V + +V E+ GS+ +I+ ++ E E A I + GLEYLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA---ILYQTLKGLEYLH- 116
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
+ IHR+I ++L++++ +A++ADFG++ + D A+ +T V GT ++APE Q
Sbjct: 117 --SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQ 172
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLP 413
+ ++ K DI+S G+ + GK P
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 59/279 (21%), Positives = 126/279 (45%), Gaps = 32/279 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
LE I + G + +S+GK++ K++ ++ + +Q+ +E+ +++H NI
Sbjct: 5 LETIGKGSFGTVRKVR-RKSDGKILVWKEIDY--GNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 268 VPLLAHMVRPDCHLL--VSEFMKNGSLLEILNDVSQGRRELEWLARH---RIARGIVSGL 322
V ++ L V E+ + G L ++ + + ++E +++ RI ++ L
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQL---IQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 323 EYLH--MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
H ++HR++ P+++ +D + ++ DFGLA+++ + T + GT Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV--GTPYY 176
Query: 381 IAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440
++PE + + EK DI+S G L+ L P F + L ++ P
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP----FTARNQLQLASKIKEGKFRRIPY 232
Query: 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKD 479
R Y ++ V+K DP++RP++++
Sbjct: 233 R----------YSSELNEVIK---SMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 9e-19
Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 30/236 (12%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
A+IM ++RH +V L A + +V+E+M GSLL+ L + L L
Sbjct: 52 AQIMK--KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD-- 107
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH--AQVST 371
+A I G+ YL IHR++ ++L+ +++ +IADFGLARL+ D A+
Sbjct: 108 MAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164
Query: 372 SIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWM 430
+ + APE +F+ K D++SFG+LL +V G++P + + R
Sbjct: 165 KF---PIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY 221
Query: 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
R P + ML C DPEERP + ++S L D
Sbjct: 222 RMPRPPNCPEE----------LYDLMLQ-------CWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 52/163 (31%), Positives = 87/163 (53%), Gaps = 13/163 (7%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
A+IM ++RH ++ L A + +V+E MK GSLLE L + +L L
Sbjct: 52 AQIMK--KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLID-- 107
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDG--HAQVST 371
+A + SG+ YL + IHR++ +VL+ ++ ++ADFGLAR++ + A+
Sbjct: 108 MAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA 164
Query: 372 SIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLP 413
+ + APE +FS K D++SFG+LL +V G++P
Sbjct: 165 KF---PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 54/189 (28%), Positives = 99/189 (52%), Gaps = 18/189 (9%)
Query: 226 ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285
E G+ +A+K +K ++ + E ++ H+N+V LL ++ ++ V E
Sbjct: 26 EYTGQKVAVKNIK------CDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYI-VME 78
Query: 286 FMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345
M G+L+ L ++GR + + + + + G+EYL +++HR++ ++L+
Sbjct: 79 LMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILV 133
Query: 346 DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL- 404
+D A+++DFGLAR+ G V S + V + APE + KFS K D++S+GVLL
Sbjct: 134 SEDGVAKVSDFGLARVGSMG---VDNSKLP--VKWTAPEALKHKKFSSKSDVWSYGVLLW 188
Query: 405 AVLVMGKLP 413
V G+ P
Sbjct: 189 EVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 217 GEIYIAELPESNGKMIAIKKVK------QVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL 270
G +Y+A L + G+M+A+K+V+ +S ++ +R+EI T + H NIV
Sbjct: 15 GRVYLA-LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQY 73
Query: 271 LAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR 330
L + + E++ GS+ L + GR E E L R ++ GL YLH
Sbjct: 74 LGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFE-EQLVRF-FTEQVLEGLAYLH---S 126
Query: 331 PRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE----YH 386
I+HR++ ++L+D D +I+DFG+++ D + + G+V ++APE Y
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 387 QTLKFSEKCDIYSFGVLLAVLVMGKLP-SDD 416
Q +S K DI+S G ++ + G+ P SD+
Sbjct: 187 QG--YSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 47/129 (36%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
E+M GSL +IL QGR L + IA ++ GL YLH H+ IIHR++ PS++L
Sbjct: 79 EYMDGGSLDKIL-KEVQGRIPERILGK--IAVAVLKGLTYLHEKHK--IIHRDVKPSNIL 133
Query: 345 IDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
++ + ++ DFG++ + + A+ GT Y+APE Q +S K DI+S G+ L
Sbjct: 134 VNSRGQIKLCDFGVSGQLVNSLAKTF----VGTSSYMAPERIQGNDYSVKSDIWSLGLSL 189
Query: 405 AVLVMGKLP 413
L G+ P
Sbjct: 190 IELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIK-MRQVRAEIMTAGQIRHRNI 267
E + S + G +Y L +G A+K+V D+ + ++Q+ EI +++H NI
Sbjct: 6 ELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L D + E + GSL ++L + L R I+ GLEYLH
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL----YTRQILLGLEYLHD 120
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEY-H 386
+ +HR+I +++L+D + ++ADFG+A+ + G+ ++APE
Sbjct: 121 RN---TVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIA 174
Query: 387 QTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQ 419
Q + DI+S G + + GK P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 34/219 (15%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNI--KMRQVRAE--IMTAGQIRHRNIVPLLA 272
+ +A+ E+N K AIK +D L K++ V+ E ++T H I+ L
Sbjct: 15 STVVLAKEKETN-KEYAIK---ILDKRQLIKEKKVKYVKIEKEVLTR-LNGHPGIIKLYY 69
Query: 273 HMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR 332
+ V E+ NG LL+ + G + + R A I+ LEYLH
Sbjct: 70 TFQDEENLYFVLEYAPNGELLQYIRKY--GSLDEKC-TRFYAAE-ILLALEYLH---SKG 122
Query: 333 IIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVA----------------- 375
IIHR++ P ++L+D DM +I DFG A+++ + S A
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 376 -GTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
GT Y++PE + D+++ G ++ ++ GK P
Sbjct: 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 56/188 (29%), Positives = 94/188 (50%), Gaps = 17/188 (9%)
Query: 227 SNGKMIAIKKV--KQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284
G+ +A+KKV ++++ + N +R EI +H +V LL +LV
Sbjct: 23 ETGETVALKKVALRRLEGGIPNQALR----EIKALQACQHPYVVKLLDVFPHGSGFVLVM 78
Query: 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
E+M L E+L D + E + + R ++ G+ Y+H I+HR++ P+++L
Sbjct: 79 EYMP-SDLSEVLRDEERPLPEAQ--VK-SYMRMLLKGVAYMH---ANGIMHRDLKPANLL 131
Query: 345 IDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE--YHQTLKFSEKCDIYSFGV 402
I D +IADFGLARL + ++ + VA T Y APE Y K+ D+++ G
Sbjct: 132 ISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGAR-KYDPGVDLWAVGC 189
Query: 403 LLAVLVMG 410
+ A L+ G
Sbjct: 190 IFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 64/248 (25%), Positives = 113/248 (45%), Gaps = 44/248 (17%)
Query: 201 KEDCSASLEKIRSRASGEIYIAEL----PESNGKMIAIKKVKQV-DNSLLNIKMRQVRAE 255
+ D ++ A G++++ E PE++ +++A+K +K+ N R+ AE
Sbjct: 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFERE--AE 60
Query: 256 IMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEIL------------NDVSQGR 303
++T +H NIV D ++V E+M++G L + L D G
Sbjct: 61 LLTN--FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118
Query: 304 RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363
L L +IA I SG+ YL H +HR++ + L+ D+ +I DFG++R
Sbjct: 119 LTLSQL--LQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSR--- 170
Query: 364 DGHAQVSTS---IVAGT----VGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLPSD 415
V T+ V G + ++ PE KF+ + D++SFGV+L + GK P
Sbjct: 171 ----DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-- 224
Query: 416 DFFQHTEE 423
++ + E
Sbjct: 225 -WYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 75/292 (25%), Positives = 130/292 (44%), Gaps = 40/292 (13%)
Query: 221 IAELPESNGKMIAIKKVKQVDNSLLNIKM-------RQVRAEIMTAGQIRHRNIVPLL-- 271
I++L NG ++ KVK + + K VR +I+ QI H P +
Sbjct: 10 ISDLGAGNGG--SVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVS 67
Query: 272 ---AHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY 328
A + + + EFM GSL I G +E L + IA +V GL YL+
Sbjct: 68 FYGAFLNENNI-CMCMEFMDCGSLDRIYKKG--GPIPVEILGK--IAVAVVEGLTYLYNV 122
Query: 329 HRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT 388
HR I+HR+I PS++L++ + ++ DFG++ + + A GT Y++PE Q
Sbjct: 123 HR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT----FVGTSTYMSPERIQG 176
Query: 389 LKFSEKCDIYSFGVLLAVLVMGKLP----SDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444
K++ K D++S G+ + L +GK P + D + ++ ++ ++ P
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP----- 231
Query: 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKDVD 494
+L + + E + + C L DP ERP + + +M +VD
Sbjct: 232 -RLPSSDFPEDLRDFVDA---CLLKDPTERPTPQQLCAMPPFIQALRASNVD 279
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 209 EKIRSRASGEIYIAELPESNGKMI--AIKKVKQVDNSLLNIKMRQVR-AEIMTAGQIRHR 265
+K+ + G + E S GK+I A+K +K + L +I ++ A IM + + H
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK--SDKLSDIMDDFLKEAAIMHS--LDHE 56
Query: 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYL 325
N++ L +V ++V+E GSLL+ L + G + L A I +G+ YL
Sbjct: 57 NLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTL--CDYAVQIANGMRYL 113
Query: 326 HMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ-VSTSIVAGTVGYIAPE 384
R IHR++ ++L+ D + +I DFGL R +P V + + APE
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
Query: 385 YHQTLKFSEKCDIYSFGVLL 404
+T FS D++ FGV L
Sbjct: 171 SLRTRTFSHASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 47/163 (28%), Positives = 87/163 (53%), Gaps = 13/163 (7%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
A IM GQ H NI+ L + + ++++E+M+NGSL + L + +
Sbjct: 56 ASIM--GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR---ENDGKFTVGQLVG 110
Query: 314 IARGIVSGLEYL--HMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVST 371
+ RGI SG++YL Y +HR++ ++L++ ++ +++DFGL+R + D A +T
Sbjct: 111 MLRGIASGMKYLSEMNY-----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT 165
Query: 372 SIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
+ + APE KF+ D++SFG+++ V+ G+ P
Sbjct: 166 KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 43/209 (20%)
Query: 227 SNGKMIAIKKVKQVDNSLLN--IKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284
G+++AIKK+K + I +R EI +++H NI+ LL LV
Sbjct: 23 ETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIGLLDVFGHKSNINLVF 81
Query: 285 EFM--------KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHR 336
EFM K+ S++ D+ ++ + GLEYLH I+HR
Sbjct: 82 EFMETDLEKVIKDKSIVLTPADIKS------YMLM------TLRGLEYLHSNW---ILHR 126
Query: 337 NITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE-------YHQTL 389
++ P+++LI D ++ADFGLAR + +++ +V T Y APE Y
Sbjct: 127 DLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRAPELLFGARHYGVG- 183
Query: 390 KFSEKCDIYSFGVLLAVLVMGK--LPSDD 416
D++S G + A L++ LP D
Sbjct: 184 -----VDMWSVGCIFAELLLRVPFLPGDS 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 66/215 (30%), Positives = 96/215 (44%), Gaps = 25/215 (11%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI----RHRNIVPLLA 272
GE+ ++ ++ GKM A KK+ + +K R+ + +I R IV L
Sbjct: 7 GEVCACQV-KATGKMYACKKLDKK-----RLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 273 HMVRPDCHLLVSEFMKNGSL-LEILNDVSQGRRELEWLARHRI-ARGIVSGLEYLHMYHR 330
D LV M G L I N G E AR A I+ GLE+LH +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPE----ARAIFYAAQIICGLEHLH---Q 113
Query: 331 PRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK 390
RI++R++ P +VL+DD RI+D GLA + G AGT GY+APE Q
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEV 170
Query: 391 FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKS 425
+ D ++ G L ++ G+ P F Q E+
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSP---FRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 3e-17
Identities = 71/234 (30%), Positives = 110/234 (47%), Gaps = 27/234 (11%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
A+IM ++RH +VPL A +V + +V+EFM GSLL+ L + +L L
Sbjct: 52 AQIMK--KLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD-- 106
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
+A I G+ Y+ R IHR++ +++L+ D++ +IADFGLARL+ D
Sbjct: 107 MAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG- 162
Query: 374 VAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRN 432
+ + APE +F+ K D++SFG+LL LV G++P + + R R
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
Query: 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
P E M L C DP+ERP + ++S L D
Sbjct: 223 PCPQGCP----------ESLHELMKL-------CWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 72/289 (24%), Positives = 117/289 (40%), Gaps = 30/289 (10%)
Query: 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI 262
+ L ++ A G + L G + A+K + N L +Q+ E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKN-TGMIFALKTITTDPNPDL---QKQILRELEINKSC 56
Query: 263 RHRNIVPLL-AHMVRPDCHL-LVSEFMKNGSLLEILNDV-SQGRRELEWLARHRIARGIV 319
+ IV A + + + E+ + GSL I V +G R E + +IA ++
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-GKIAESVL 115
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS-TSIVAGTV 378
GL YLH +IIHR+I PS++L+ + ++ DFG++ G S GT
Sbjct: 116 KGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFTGTS 167
Query: 379 GYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSL--VRWMRNVMTS 436
Y+APE Q +S D++S G+ L + + P F E L + + ++
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP----FPPEGEPPLGPIELLSYIVNM 223
Query: 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485
NP D G + E+ + C DP RP D ML
Sbjct: 224 PNP-ELKDEPGNGIKWSEEFKDFI---KQCLEKDPTRRPTPWD---MLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 56/191 (29%), Positives = 81/191 (42%), Gaps = 21/191 (10%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMV-----RPDCHLL 282
KM A+K + + +R V E ++ H P L ++ + +L
Sbjct: 24 TKKMFAMKYMNKQKCVEKG-SVRNVLNERRILQELNH----PFLVNLWYSFQDEENMYL- 77
Query: 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSS 342
V + + G L L SQ + E + I IV LEYLH IIHR+I P +
Sbjct: 78 VVDLLLGGDLRYHL---SQKVKFSEEQVKFWICE-IVLALEYLH---SKGIIHRDIKPDN 130
Query: 343 VLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGV 402
+L+D+ I DF +A + STS GT GY+APE +S D +S GV
Sbjct: 131 ILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQGYSVAVDWWSLGV 187
Query: 403 LLAVLVMGKLP 413
+ GK P
Sbjct: 188 TAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 5e-17
Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 27/234 (11%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
A++M ++RH +V L A +V + +V+E+M GSLL+ L L L
Sbjct: 52 AQVMK--KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-- 106
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
+A I SG+ Y+ R +HR++ +++L+ +++ ++ADFGLARL+ D
Sbjct: 107 MAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG- 162
Query: 374 VAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRN 432
+ + APE +F+ K D++SFG+LL L G++P + R R
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 222
Query: 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
E P D + C C +PEERP + +++ L D
Sbjct: 223 PCPPECPESLHD-----------------LMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 18/208 (8%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L+ +++ GE L + G +A+K +K + + AE Q+RH N+
Sbjct: 8 LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN------DATAQAFLAEASVMTQLRHSNL 61
Query: 268 VPLLAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
V LL +V L +V+E+M GSL++ L S+GR L + + + +EYL
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
+ +HR++ +VL+ +D A+++DFGL + A + V + APE
Sbjct: 120 ANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL 171
Query: 387 QTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
+ KFS K D++SFG+LL + G++P
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 77/292 (26%), Positives = 127/292 (43%), Gaps = 36/292 (12%)
Query: 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKV-----------KQVDNSLLNIKMRQVRA 254
A LE + S A G +Y + ++A+K++ ++ D S+ +I V
Sbjct: 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDI----VSE 58
Query: 255 EIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRI 314
+ Q+RH NIV + D +V + ++ L E N + + ++ I
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 315 ARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIV 374
+V L YLH RI+HR++TP+++++ +D + I DFGLA+ TS V
Sbjct: 119 FVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTS-V 173
Query: 375 AGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434
GT+ Y PE + + EK D+++FG +L + + P F T SL + V
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP----FYSTNMLSLA--TKIVE 227
Query: 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
P L Y E + V+ C D E RP+ V +M+SD
Sbjct: 228 AVYEP-------LPEGMYSEDVTDVIT---SCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 21/215 (9%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L KI G +Y A G+++AIKK+K S I +R EI ++ H NI
Sbjct: 4 LGKIGEGTYGVVYKARDKL-TGEIVAIKKIKLRFESEG-IPKTALR-EIKLLKELNHPNI 60
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIAR---GIVSGLEY 324
+ LL LV EFM L +++ D +G L I ++ GL +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRG------LPESLIKSYLYQLLQGLAF 113
Query: 325 LHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE 384
H I+HR++ P ++LI+ + ++ADFGLAR + T V T Y APE
Sbjct: 114 CH---SHGILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVV-TRWYRAPE 168
Query: 385 YHQTLKF-SEKCDIYSFGVLLAVLVMGK--LPSDD 416
K S DI+S G + A L+ + P
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 15/185 (8%)
Query: 229 GKMIAIKKVKQV--DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286
G+++AIKK K+ D + +R+V+ Q+RH NIV L R LV E+
Sbjct: 26 GEIVAIKKFKESEDDEDVKKTALREVK----VLRQLRHENIVNLKEAFRRKGRLYLVFEY 81
Query: 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346
++ +LLE+L G L A ++ + Y H IIHR+I P ++L+
Sbjct: 82 VER-TLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVS 134
Query: 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH-QTLKFSEKCDIYSFGVLLA 405
+ ++ DFG AR + A T VA T Y APE + + D+++ G ++A
Sbjct: 135 ESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTNYGKPVDVWAIGCIMA 193
Query: 406 VLVMG 410
L+ G
Sbjct: 194 ELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 26/203 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+++I S G++Y A + G+++AIK +K ++ EI + RH NI
Sbjct: 8 IQRIGSGTYGDVYKARDIAT-GELVAIKVIKLEPGD----DFEIIQQEISMLKECRHPNI 62
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V +R D +V E+ GSL +I R L L + R + GL YLH
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ---VTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVA-----GTVGYIA 382
+ IHR+I +++L+ +D + ++ADFG++ AQ++ +I GT ++A
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYWMA 169
Query: 383 PEYHQTLK---FSEKCDIYSFGV 402
PE + + KCDI++ G+
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
A++M ++ H N+V L + +V+E+M NG LL L + +G+ EWL
Sbjct: 50 AKVMM--KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLD-- 104
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
+ + +EYL IHR++ + L+ +D +++DFGLAR + D S
Sbjct: 105 MCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ-- 159
Query: 374 VAGT---VGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLPSDDFFQHTEEKSLVRW 429
GT V + PE +FS K D++SFGVL+ V GK+P + F +S+
Sbjct: 160 --GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG 217
Query: 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP 475
R P A V I C + PE+RP
Sbjct: 218 YR----LYRPKLAPTE-------------VYTIMYSCWHEKPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 32/218 (14%)
Query: 208 LEKIRSRASGEIYIAEL----PESNGKMIAIKKVKQVDNSLLNIKMRQ-VRAEIMTAGQI 262
LE++ A G++Y EL + +AIK +K +N+ K++Q R E +
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK--ENA--EPKVQQEFRQEAELMSDL 65
Query: 263 RHRNIVPLLAHMVR--PDCHLLVSEFMKNGSLLEIL------------NDVSQGRRELEW 308
+H NIV LL + P C L E++ +G L E L + + L+
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLF--EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 309 LARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM--PDGH 366
IA I +G+EYL +H +HR++ + L+ + + +I+DFGL+R + D +
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 367 AQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
S S++ V ++ PE KF+ + DI+SFGV+L
Sbjct: 181 RVQSKSLLP--VRWMPPEAILYGKFTTESDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 71/234 (30%), Positives = 112/234 (47%), Gaps = 27/234 (11%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
A+IM ++RH +V L A +V + +V+E+M GSLL+ L D +GR L+
Sbjct: 52 AQIMK--KLRHDKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKD-GEGR-ALKLPNLVD 106
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
+A + +G+ Y+ R IHR++ +++L+ D + +IADFGLARL+ D
Sbjct: 107 MAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG- 162
Query: 374 VAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRN 432
+ + APE +F+ K D++SFG+LL LV G++P + + R R
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
Query: 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
+ P E ML C DPEERP + ++S L D
Sbjct: 223 PCPQDCP----------ISLHELML-------QCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 229 GKMIAIKKVKQVDNSLLNIKMRQ----------VRAEIMTAGQIRHRNIVPLLAHMVRPD 278
GK++AIKKVK ++ S K RQ E+ +I+H NI+ L+ V D
Sbjct: 34 GKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93
Query: 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI 338
LV + M L ++++ + L I I++GL LH ++ +HR++
Sbjct: 94 FINLVMDIM-ASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDL 145
Query: 339 TPSSVLIDDDMEARIADFGLAR------LMPDGHAQVS-------TSIVAGTVGYIAPE- 384
+P+++ I+ +IADFGLAR + TS V T+ Y APE
Sbjct: 146 SPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV-TLWYRAPEL 204
Query: 385 YHQTLKFSEKCDIYSFGVLLAVLVMGK--LPSDD 416
K+ D++S G + A L+ GK P ++
Sbjct: 205 LMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 64/273 (23%), Positives = 124/273 (45%), Gaps = 33/273 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQ--VRAEIMTAGQIRHR 265
L KI + G ++ + +++ ++ A+K Q+D S +N + R+ + + A ++
Sbjct: 5 LNKIGKGSFGVVFKV-VRKADKRVYAMK---QIDLSKMNRREREEAIDEARVLA-KLDSS 59
Query: 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYL 325
I+ + +V E+ +NG L ++L Q R L R I+ GL +L
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLK--MQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 326 HMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEY 385
H +I+HR+I ++ +D +I D G+A+L+ D +T + GT Y++PE
Sbjct: 118 H---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPEL 172
Query: 386 HQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR-WMRNVMTSENPNRAID 444
+ ++EK D+++ GV+L GK P F + +L+ +R V
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHP----FDANNQGALILKIIRGVF---------- 218
Query: 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS 477
+ Y +Q+ ++ C D +RP++
Sbjct: 219 -PPVSQMYSQQLAQLIDQ---CLTKDYRQRPDT 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 49/226 (21%)
Query: 208 LEKIR---SRASGEIYIAELPESNGKMIAIKKV-KQVDNSLLNIKMRQVRAEIMTAGQIR 263
LE++ S A G +Y + G++ A+K + ++++ RQ+ EI +
Sbjct: 76 LERVNRIGSGAGGTVYKV-IHRPTGRLYALKVIYGNHEDTVR----RQICREIEILRDVN 130
Query: 264 HRNIVPLLAHMVRPDCH-----------LLVSEFMKNGSLLEILNDVSQGRRELEWLARH 312
H N+V CH LL EFM GSL +G +
Sbjct: 131 HPNVV---------KCHDMFDHNGEIQVLL--EFMDGGSL--------EGTHIADEQFLA 171
Query: 313 RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTS 372
+AR I+SG+ YLH R I+HR+I PS++LI+ +IADFG++R++ ++S
Sbjct: 172 DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228
Query: 373 IVAGTVGYIAPE-----YHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
+ GT+ Y++PE + DI+S GV + +G+ P
Sbjct: 229 V--GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 79/267 (29%), Positives = 118/267 (44%), Gaps = 40/267 (14%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAE--IMTAGQIRHR 265
L+ I A G +Y+A+ S G AIK +K+ D N ++ V+AE IM Q
Sbjct: 1 LKPISKGAFGSVYLAK-KRSTGDYFAIKVLKKSDMIAKN-QVTNVKAERAIMMI-QGESP 57
Query: 266 NIVPLLAHMVRPDCHLLVSEFMKNG---SLLEILNDVSQGRRELEWLARHRIARGIVSGL 322
+ L D LV E++ G SL++ L G +W A+ IA +V G+
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-----GGLPEDW-AKQYIAE-VVLGV 110
Query: 323 EYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIA 382
E LH + IIHR+I P ++LID ++ DFGL+R + V GT Y+A
Sbjct: 111 EDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFV-GTPDYLA 161
Query: 383 PEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP-----SDDFFQHTEEKSLVRWMRNVMTSE 437
PE + + D +S G ++ + G P D F + + + W V
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR-INWPEEVKEFC 220
Query: 438 NP------NRAIDS---KLLG-NGYEE 454
+P NR + K LG NGY+E
Sbjct: 221 SPEAVDLINRLLCMDPAKRLGANGYQE 247
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 58/218 (26%), Positives = 108/218 (49%), Gaps = 36/218 (16%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQ------VRAEIMTAGQ 261
+ +I G++Y A + G+++A+KK++ ++N ++ +R EI +
Sbjct: 4 IAQIGEGTYGQVYKAR-NKKTGELVALKKIR-MEN------EKEGFPITAIR-EIKLLQK 54
Query: 262 IRHRNIVPLLAHMV---RPDCHLLVSEFMK---NGSLLEILNDVSQGRRELEWLARHRIA 315
+RH NIV L + + ++ V E+M G L ++ + +
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYM-VFEYMDHDLTGLLDSPEVKFTESQ------IKC-YM 106
Query: 316 RGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVA 375
+ ++ GL+YLH I+HR+I S++LI++D ++ADFGLAR ++ T+ V
Sbjct: 107 KQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
Query: 376 GTVGYIAPE--YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
T+ Y PE T ++ + D++S G +LA L +GK
Sbjct: 164 -TLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 8e-16
Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 19/217 (8%)
Query: 217 GEIY--IAELPESNGKMIAIKKVKQVDNSLLNIKMRQ---VRAEIMTAGQIRHRNIVPLL 271
GE++ I ++P +AIK +K K RQ A IM GQ H NI+ L
Sbjct: 19 GEVFRGILKMPGRKEVAVAIKTLKPGYTE----KQRQDFLSEASIM--GQFSHHNIIRLE 72
Query: 272 AHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP 331
+ + ++++E+M+NG+L + L D + + + RGI +G++YL +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG---MLRGIAAGMKYLSDMN-- 127
Query: 332 RIIHRNITPSSVLIDDDMEARIADFGLARLMPDG-HAQVSTSIVAGTVGYIAPEYHQTLK 390
+HR++ ++L++ ++E +++DFGL+R++ D +TS + + APE K
Sbjct: 128 -YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 391 FSEKCDIYSFGVLL-AVLVMGKLPSDDFFQHTEEKSL 426
F+ D++SFG+++ V+ G+ P D H K++
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-16
Identities = 68/271 (25%), Positives = 120/271 (44%), Gaps = 31/271 (11%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276
GE+++ +N +A+K +K ++++ A +M ++H +V L A + +
Sbjct: 20 GEVWMGYY--NNSTKVAVKTLKP---GTMSVQAFLEEANLMKT--LQHDKLVRLYAVVTK 72
Query: 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHR 336
+ +++E+M GSLL+ L G+ L L + I G+ Y+ R IHR
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID--FSAQIAEGMAYIE---RKNYIHR 127
Query: 337 NITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCD 396
++ ++VL+ + + +IADFGLAR++ D + + APE F+ K D
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG-AKFPIKWTAPEAINFGSFTIKSD 186
Query: 397 IYSFGVLL-AVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQ 455
++SFG+LL ++ GK+P +L R R P+ D
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD----------- 235
Query: 456 MLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
I C + EERP ++S+L D
Sbjct: 236 ------IMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 9e-16
Identities = 53/197 (26%), Positives = 85/197 (43%), Gaps = 13/197 (6%)
Query: 209 EKIRSRASGEIYIAELPESNGKM-IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
EKI G++Y L G +A+K + L K Q E Q H NI
Sbjct: 1 EKIGKGNFGDVYKGVL---KGNTEVAVKTCRSTLPPDLKRKFLQ---EAEILKQYDHPNI 54
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L+ V+ +V E + GSLL L + L A G+EYL
Sbjct: 55 VKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAA---GMEYLE- 110
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
IHR++ + L+ ++ +I+DFG++R G VS + + + APE
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 388 TLKFSEKCDIYSFGVLL 404
+++ + D++S+G+LL
Sbjct: 169 YGRYTSESDVWSYGILL 185
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 75/282 (26%), Positives = 133/282 (47%), Gaps = 36/282 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
++K+ + GE+++ + +AIK +KQ ++ + A +M Q++H +
Sbjct: 11 VKKLGAGQFGEVWMGYY--NGHTKVAIKSLKQ---GSMSPEAFLAEANLMK--QLQHPRL 63
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L A +V + +++E+M+NGSL++ L + + L +A I G+ ++
Sbjct: 64 VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID--MAAQIAEGMAFIE- 119
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH--AQVSTSIVAGTVGYIAPEY 385
R IHR++ +++L+ + + +IADFGLARL+ D A+ + + APE
Sbjct: 120 --RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF---PIKWTAPEA 174
Query: 386 HQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444
F+ K D++SFG+LL +V G++P M N +N R
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPG-------------MTNPEVIQNLERGYR 221
Query: 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
N EE L+ C + PEERP + +RS+L D
Sbjct: 222 MPRPDNCPEELYELMRL----CWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 22/207 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+E I S A G + + + +GK +AIKK+ + K R +R E+ +H NI
Sbjct: 10 IENIGSGAYG-VVCSAIDTRSGKKVAIKKIPHAFDVPTLAK-RTLR-ELKILRHFKHDNI 66
Query: 268 VPLLAHMVRPDCHL-----LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGL 322
+ + ++RP +V + M++ L I++ S E R+ + + ++ GL
Sbjct: 67 IAIR-DILRPPGADFKDVYVVMDLMES-DLHHIIH--SDQPLTEE-HIRYFLYQ-LLRGL 120
Query: 323 EYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM---PDGHAQVSTSIVAGTVG 379
+Y+H +IHR++ PS++L+++D E RI DFG+AR + P H T VA T
Sbjct: 121 KYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-TRW 176
Query: 380 YIAPEYHQTL-KFSEKCDIYSFGVLLA 405
Y APE +L +++ D++S G + A
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFA 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
KI G++Y A + G+++A+K+++ DN IK ++ E+ ++H N+
Sbjct: 5 GNKIGGGTFGKVYTA-VNLDTGELMAVKEIRIQDNDPKTIK--EIADEMKVLELLKHPNL 61
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V V + + E+ G+L E+L GR E + R ++ GL YLH
Sbjct: 62 VKYYGVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIR-VYTLQLLEGLAYLHS 117
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG---YIAPE 384
+ I+HR+I P+++ +D + ++ DFG A + + + V G Y+APE
Sbjct: 118 HG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN-NTTTMGEEVQSLAGTPAYMAPE 173
Query: 385 YHQTLKFSEK---CDIYSFGVLLAVLVMGKLP 413
K DI+S G ++ + GK P
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 56/223 (25%), Positives = 107/223 (47%), Gaps = 39/223 (17%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRA----EIMTAGQIRHRNIVPLLAHMVRPDCHLL 282
S G+ +A+KK ++++ +Q R E++ +H NIV + + + D +
Sbjct: 42 STGRQVAVKK--------MDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV 93
Query: 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSS 342
V EF++ G+L +I V+ R E +A + ++ L +LH +IHR+I S
Sbjct: 94 VMEFLEGGALTDI---VTHTRMNEEQIAT--VCLAVLKALSFLHAQ---GVIHRDIKSDS 145
Query: 343 VLIDDDMEARIADFGLARLMPDGHAQVSTSI-----VAGTVGYIAPEYHQTLKFSEKCDI 397
+L+ D +++DFG AQVS + + GT ++APE L + + DI
Sbjct: 146 ILLTSDGRVKLSDFGFC-------AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198
Query: 398 YSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440
+S G+++ +V G+ P +F + ++ M+ + + P
Sbjct: 199 WSLGIMVIEMVDGEPP---YF----NEPPLQAMKRIRDNLPPK 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 68/223 (30%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL 270
I A G +++A+ +S G + AIK +K+ D N QV E Q + +V L
Sbjct: 1 ISKGAYGRVFLAK-KKSTGDIYAIKVIKKADMIRKNQV-DQVLTERDILSQAQSPYVVKL 58
Query: 271 LAHMVRPDCHLLVSEFMKNG---SLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
LV E++ G SLLE + + E +AR IA IV LEYLH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLD------EDVARIYIAE-IVLALEYLHS 111
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLA------RLMPDGHAQVSTSIVAGTVGYI 381
IIHR++ P ++LID + ++ DFGL+ R + + + GT YI
Sbjct: 112 N---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 382 APEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
APE S+ D +S G +L ++G P F T E+
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPP---FHGETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 14/180 (7%)
Query: 229 GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL--LAHMVRPDCHLLVSEF 286
G+ +A+K + S EI + H NIV + L+ E+
Sbjct: 33 GEQVAVKSLNH---SGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY 89
Query: 287 MKNGSLLEILNDVSQGRRELEWLARH-RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345
+ +GSL + L Q R+ L R + I G++YL R IHR++ ++L+
Sbjct: 90 LPSGSLRDYL----QRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILV 142
Query: 346 DDDMEARIADFGLARLMPDGHA-QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
+ + +I+DFGLA+++P+ + + APE +T KFS D++SFGV L
Sbjct: 143 ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 9e-15
Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 27/233 (11%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
A++M ++ H +V L + +V+EFM+NG LL L QG+ + L
Sbjct: 50 AKVMM--KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ-RQGKLSKDMLLS-- 104
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
+ + + G+EYL R IHR++ + L+ +++DFG+ R + D S+S
Sbjct: 105 MCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSG 160
Query: 374 VAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLPSDDFFQHTEEKSLVRWMRN 432
V + PE K+S K D++SFGVL+ V GK+P E+KS +
Sbjct: 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP-------FEKKSNYEVVE- 212
Query: 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485
M S R KL E M C + PE RP ++ ++
Sbjct: 213 -MISRG-FRLYRPKLASMTVYEVMYS-------CWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 50/223 (22%), Positives = 89/223 (39%), Gaps = 27/223 (12%)
Query: 206 ASLEKIRSRASGE-------IYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMT 258
LEKI+ SG ++I E E +AIK L + EI+
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEG-EKVKIPVAIK-------VLREETSPKANKEILD 58
Query: 259 AGQI----RHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRI 314
+ H ++V LL + L+++ M G LL+ V + +
Sbjct: 59 EAYVMASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDY---VRNHKDNIGSQYLLNW 114
Query: 315 ARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIV 374
I G+ YL R++HR++ +VL+ +I DFGLA+L+ +
Sbjct: 115 CVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGG 171
Query: 375 AGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLPSDD 416
+ ++A E ++ K D++S+GV + ++ G P +
Sbjct: 172 KVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 54/191 (28%), Positives = 94/191 (49%), Gaps = 14/191 (7%)
Query: 229 GKMIAIKKVKQVDNSLLNIK--MRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL-LVSE 285
G ++A+K+V V N+ + + +R EI ++ H +I+ +L D H L E
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG-ATCEDSHFNLFVE 83
Query: 286 FMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345
+M GS+ +L+ + + ++ RG+ YLH +IIHR++ +++LI
Sbjct: 84 WMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLS----YLH---ENQIIHRDVKGANLLI 136
Query: 346 DDD-MEARIADFGLA-RLMPDG-HAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGV 402
D RIADFG A RL G A + GT+ ++APE + ++ CD++S G
Sbjct: 137 DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGC 196
Query: 403 LLAVLVMGKLP 413
++ + K P
Sbjct: 197 VIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
EKI ASG +Y A + + G+ +AIK++ K + EI+ + +H NI
Sbjct: 24 FEKIGQGASGTVYTA-IDVATGQEVAIKQMNLQQQP----KKELIINEILVMRENKHPNI 78
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L + D +V E++ GSL +++ + ++ + R + LE+LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHS 133
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGL-ARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
+IHR+I ++L+ D ++ DFG A++ P+ Q S + GT ++APE
Sbjct: 134 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWMAPEVV 187
Query: 387 QTLKFSEKCDIYSFGVLLAVLVMGKLP 413
+ K DI+S G++ +V G+ P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 80/323 (24%), Positives = 146/323 (45%), Gaps = 62/323 (19%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
LE I + GE+Y A +N +++AIK + ++ + I+ Q EI Q R I
Sbjct: 6 LECIGKGSFGEVYKAIDKRTN-QVVAIKVI-DLEEAEDEIEDIQ--QEIQFLSQCRSPYI 61
Query: 268 VPLLAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
++ L ++ E+ GS L++L G+ + ++A I R ++ GLEYLH
Sbjct: 62 TKYYGSFLK-GSKLWIIMEYCGGGSCLDLLK---PGKLDETYIAF--ILREVLLGLEYLH 115
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIV-----AGTVGYI 381
IHR+I +++L+ ++ + ++ADFG++ Q+++++ GT ++
Sbjct: 116 ---EEGKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFWM 165
Query: 382 APEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441
APE + + EK DI+S G+ L G+ P D +R + + + P
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD-------LHPMRVLFLIPKNNPP-- 216
Query: 442 AIDSKLLGNGYEEQMLLVLK--IACFCTLDDPEERPNSKDVRSMLSDTALIKDVDFLKMH 499
L GN + + K ++ C DP+ERP++K+ L+K F+K
Sbjct: 217 ----SLEGNKFSKP----FKDFVSL-CLNKDPKERPSAKE---------LLKH-KFIKKA 257
Query: 500 KRMDFDNDDCVELIQQEIYTEWL 522
K+ LI++ +W
Sbjct: 258 KK----TSYLTLLIER--IKKWK 274
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 54/163 (33%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGT 377
I+SGLE+LH + RII+R++ P +VL+D+D RI+D GLA + DG Q T AGT
Sbjct: 106 IISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYAGT 160
Query: 378 VGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437
G++APE Q ++ D ++ GV L ++ + P F+ EK V E
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP----FRARGEK--------VENKE 208
Query: 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLD-DPEERPNSKD 479
R ++ + Y ++ K C L DPE+R +D
Sbjct: 209 LKQRILNDSV---TYPDKFSPASKSFCEALLAKDPEKRLGFRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 70/280 (25%), Positives = 137/280 (48%), Gaps = 48/280 (17%)
Query: 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRA----EIMTAGQIRHR 265
KI ++G + IA + +S+GK++A+KK ++++ +Q R E++ +H
Sbjct: 27 KIGEGSTGIVCIATV-KSSGKLVAVKK--------MDLRKQQRRELLFNEVVIMRDYQHE 77
Query: 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYL 325
N+V + + D +V EF++ G+L +I V+ R E +IA ++ L+ L
Sbjct: 78 NVVEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEE-----QIAAVCLAVLKAL 129
Query: 326 HMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI-----VAGTVGY 380
+ H +IHR+I S+L+ D +++DFG AQVS + + GT +
Sbjct: 130 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC-------AQVSKEVPRRKSLVGTPYW 182
Query: 381 IAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440
+APE L + + DI+S G+++ +V G+ P +F K++ + +R+ + + N
Sbjct: 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP---YFNEPPLKAM-KMIRDNLPPKLKN 238
Query: 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
S L G+ +++L + DP +R + ++
Sbjct: 239 LHKVSPSL-KGFLDRLL----------VRDPAQRATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 64/221 (28%), Positives = 115/221 (52%), Gaps = 23/221 (10%)
Query: 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQ-----VRAEIMTAGQIRHR 265
I S + G +Y+ + S+G+++A+K+V+ S + ++ + EI +++H
Sbjct: 8 IGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYL 325
NIV L + D + E++ GS+ +LN+ G E E L R+ + R I+ GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFE-ETLVRNFV-RQILKGLNYL 122
Query: 326 HMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR-------LMPDGHAQVSTSIVAGTV 378
H IIHR+I +++L+D+ +I+DFG+++ A+ S + G+V
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS---LQGSV 176
Query: 379 GYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQ 419
++APE + ++ K DI+S G L+ ++ GK P D Q
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 58/230 (25%), Positives = 112/230 (48%), Gaps = 28/230 (12%)
Query: 191 IEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKM-IAIKKVKQVDNSLLNIKM 249
I+ +DL FL + +G+ + + + G+ +AIK +K+ S+ +
Sbjct: 1 IDPKDLTFL------------KELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEF 46
Query: 250 RQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWL 309
+ A++M ++ H +V L + +V+E+M NG LL L + + +
Sbjct: 47 IE-EAKVMM--KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLR---EHGKRFQPS 100
Query: 310 ARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQV 369
+ + + G+ YL + IHR++ + L+DD +++DFGL+R + D +
Sbjct: 101 QLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD--EY 155
Query: 370 STSIVAG-TVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLPSDDF 417
++S+ + V + PE KFS K D+++FGVL+ V +GK+P + F
Sbjct: 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 56/169 (33%), Positives = 87/169 (51%), Gaps = 19/169 (11%)
Query: 269 PLLAHM---VRPDCHLL-VSEFMKNGSLLEILNDVSQGRRELEWLARHRI-ARGIVSGLE 323
P L H+ + HL V E++ G L+ + GR + R R A I+ GL+
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS--GRFDEA---RARFYAAEIICGLQ 110
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAP 383
+LH + II+R++ +VL+D D +IADFG+ + +G + ST GT YIAP
Sbjct: 111 FLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAP 165
Query: 384 EYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN 432
E + K++E D +SFGVLL +++G+ P F +E L + N
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSP----FHGEDEDELFDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 24/187 (12%)
Query: 226 ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH----- 280
+ G+M+A+K +K+ + N + EI + H NIV + C
Sbjct: 30 DGTGEMVAVKTLKR-ECGQQN--TSGWKKEINILKTLYHENIVKY-----KGCCSEQGGK 81
Query: 281 --LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI 338
L+ E++ GSL + L +L A+ I G+ YLH H IHR++
Sbjct: 82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ-----ICEGMAYLHSQH---YIHRDL 133
Query: 339 TPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGT-VGYIAPEYHQTLKFSEKCDI 397
+VL+D+D +I DFGLA+ +P+GH + V + A E + KFS D+
Sbjct: 134 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDV 193
Query: 398 YSFGVLL 404
+SFGV L
Sbjct: 194 WSFGVTL 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI----RHRNIVPLLAHMVRPDCHLL 282
+ GKM A KK+++ IK R+ + + QI R +V L D L
Sbjct: 23 ATGKMYACKKLEKK-----RIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCL 77
Query: 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSS 342
V M G L + + + E + A I GLE LH + RI++R++ P +
Sbjct: 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFY--AAEICCGLEDLH---QERIVYRDLKPEN 132
Query: 343 VLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGV 402
+L+DD RI+D GLA +P+G + GTVGY+APE + +++ D ++ G
Sbjct: 133 ILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGC 189
Query: 403 LLAVLVMGKLPSDDFFQHTEEK 424
LL ++ G+ P FQ ++K
Sbjct: 190 LLYEMIAGQSP----FQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 69/221 (31%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLN--IKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
G++ +AEL + G+ A+K +K+ D L++ ++ V ++ P L H+
Sbjct: 9 GKVLLAEL-KGKGEYFAVKALKK-DVVLIDDDVECTMVEKRVLALAWEN-----PFLTHL 61
Query: 275 V---RPDCHLL-VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR 330
+ HL V EF+ G L+ + D +GR +L + A IV GL++LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFY--AAEIVCGLQFLH---S 114
Query: 331 PRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK 390
II+R++ +V++D D +IADFG+ + G + ST GT YIAPE Q LK
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQGLK 172
Query: 391 FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMR 431
++ D +SFGVLL +++G+ P F +E L +R
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSP----FHGDDEDELFESIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 74/268 (27%), Positives = 129/268 (48%), Gaps = 31/268 (11%)
Query: 229 GKMIAIKK-VKQVDNSLLN-IKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286
G+++AIKK ++ D+ ++ I MR++R Q+RH N+V L+ R LV EF
Sbjct: 26 GQIVAIKKFLESEDDKMVKKIAMREIR----MLKQLRHENLVNLIEVFRRKKRLYLVFEF 81
Query: 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346
+ + +L+D+ + L+ + I+ G+E+ H ++ IIHR+I P ++L+
Sbjct: 82 VDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVS 134
Query: 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH-QTLKFSEKCDIYSFGVLLA 405
++ DFG AR + +V T VA T Y APE K+ DI++ G L+
Sbjct: 135 QSGVVKLCDFGFARTLA-APGEVYTDYVA-TRWYRAPELLVGDTKYGRAVDIWAVGCLVT 192
Query: 406 VLVMGK--LPSD---DFFQHTEEK--SLVRWMRNVMTSENPNRAI-------DSKLLGNG 451
++ G+ P D D H + +L+ + + +NP A + + L
Sbjct: 193 EMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF-QKNPLFAGMRLPEVKEIEPLEKR 251
Query: 452 YEEQMLLVLKIACFCTLDDPEERPNSKD 479
+ + LVL +A C DP++RP+S
Sbjct: 252 FPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 57/234 (24%), Positives = 106/234 (45%), Gaps = 27/234 (11%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
A +M ++H +V L A + + ++ ++EFM GSLL+ L ++ L L
Sbjct: 52 ANVMKT--LQHDKLVKLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLID-- 106
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
+ I G+ ++ + IHR++ +++L+ + +IADFGLAR++ D + +
Sbjct: 107 FSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREG 162
Query: 374 VAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLA-VLVMGKLPSDDFFQHTEEKSLVRWMRN 432
+ + APE F+ K D++SFG+LL ++ G++P ++L R R
Sbjct: 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM 222
Query: 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
P + + C + PEERP + ++S+L D
Sbjct: 223 PRPENCPEELYNIMMR-----------------CWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 58/212 (27%), Positives = 108/212 (50%), Gaps = 17/212 (8%)
Query: 209 EKIRSRASGEIYIAEL--PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN 266
E I + GE+ L P +AIK +K + + R +E GQ H N
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLK---SGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYL- 325
I+ L + + ++++EFM+NG+L L + G+ + L + RGI +G++YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLR-QNDGQFTVIQLVG--MLRGIAAGMKYLS 123
Query: 326 HMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS-TSIVAGT--VGYIA 382
M + +HR++ ++L++ ++ +++DFGL+R + D + + TS + G + + A
Sbjct: 124 EMNY----VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 383 PEYHQTLKFSEKCDIYSFG-VLLAVLVMGKLP 413
PE KF+ D++S+G V+ V+ G+ P
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 14/218 (6%)
Query: 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTA 259
+ E+ LE+I + GE+Y + +++AIK + D ++ ++ EI
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKG-IDNRTKEVVAIKII---DLEEAEDEIEDIQQEITVL 56
Query: 260 GQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIV 319
Q I ++ ++ E++ GS L++L G E ++A I R I+
Sbjct: 57 SQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK---PGPLEETYIAT--ILREIL 111
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG 379
GL+YLH R IHR+I ++VL+ + + ++ADFG+A + D Q+ + GT
Sbjct: 112 KGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPF 166
Query: 380 YIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDF 417
++APE + + K DI+S G+ L G+ P+ D
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
EKI ASG +Y A + + G+ +AIK++ N K + EI+ + ++ NI
Sbjct: 24 FEKIGQGASGTVYTA-IDIATGQEVAIKQM----NLQQQPKKELIINEILVMRENKNPNI 78
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L + D +V E++ GSL +++ + ++ + R L+ L
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQALDF 130
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGL-ARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
H ++IHR+I ++L+ D ++ DFG A++ P+ Q S + GT ++APE
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWMAPEVV 187
Query: 387 QTLKFSEKCDIYSFGVLLAVLVMGKLP 413
+ K DI+S G++ +V G+ P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 29/218 (13%)
Query: 215 ASGEIYIAE----LPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL 270
A G++++AE LPE + ++A+K +K+ S R+ AE++T ++H++IV
Sbjct: 17 AFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQRE--AELLTV--LQHQHIVRF 72
Query: 271 LAHMVRPDCHLLVSEFMKNGSL-------------LEILNDVSQGRRELEWLARHRIARG 317
L+V E+M++G L L DV+ G+ L + IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA--IASQ 130
Query: 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR-LMPDGHAQVSTSIVAG 376
I SG+ YL H +HR++ + L+ + +I DFG++R + + +V +
Sbjct: 131 IASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML- 186
Query: 377 TVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
+ ++ PE KF+ + DI+SFGV+L + GK P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV 268
EKI ASG ++ A + G+ +AIK++ N K + EI+ ++++ NIV
Sbjct: 25 EKIGQGASGTVFTAI-DVATGQEVAIKQI----NLQKQPKKELIINEILVMKELKNPNIV 79
Query: 269 PLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY 328
L + D +V E++ GSL +++ + ++ + R + LE+LH
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA-----AVCRECLQALEFLHA- 133
Query: 329 HRPRIIHRNITPSSVLIDDDMEARIADFGL-ARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
++IHR+I +VL+ D ++ DFG A++ P+ Q S + GT ++APE
Sbjct: 134 --NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWMAPEVVT 188
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLP 413
+ K DI+S G++ +V G+ P
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 226 ESNGKMIAIKKV-KQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL-LV 283
++ GKM A KK+ K+ KM + EI+ ++ IV L A+ HL LV
Sbjct: 15 KNTGKMYACKKLDKKRLKKKSGEKMALLEKEILE--KVNSPFIVNL-AYAFESKTHLCLV 71
Query: 284 SEFMKNGSLLEILNDVSQGRRELEWLARH--RIARGIVSGLEYLHMYHRPRIIHRNITPS 341
M G L + +V + E+E + + +I GI LH+ H I++R++ P
Sbjct: 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI------LHL-HSMDIVYRDMKPE 124
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFG 401
+VL+DD R++D GLA + DG + + AGT GY+APE + +S D ++ G
Sbjct: 125 NVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMG 181
Query: 402 VLLAVLVMGKLPSDDFFQHTEEKSLVR 428
+ +V G+ P D + ++ L R
Sbjct: 182 CSIYEMVAGRTPFKDHKEKVAKEELKR 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI----RHRNIVPLLAHMVRPDCHLL 282
+ GKM A KK+++ IK R+ A + QI R +V L D L
Sbjct: 23 ATGKMYACKKLEKK-----RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 77
Query: 283 VSEFMKNGSL-LEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
V M G L I N + G E + A I GLE LH R RI++R++ P
Sbjct: 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVF---YAAEITCGLEDLH---RERIVYRDLKPE 131
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFG 401
++L+DD RI+D GLA +P+G GTVGY+APE + +++ D + G
Sbjct: 132 NILLDDYGHIRISDLGLAVEIPEGETIRGR---VGTVGYMAPEVVKNERYTFSPDWWGLG 188
Query: 402 VLLAVLVMGKLPSDDFFQHTEEKSLVRW 429
L+ ++ GK P F+ +EK V+
Sbjct: 189 CLIYEMIEGKSP----FRQRKEK--VKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 54/194 (27%), Positives = 100/194 (51%), Gaps = 13/194 (6%)
Query: 223 ELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282
+LP +AIK +K + R +E GQ H NI+ L + + ++
Sbjct: 26 KLPGKREIPVAIKTLKA---GYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82
Query: 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH-MYHRPRIIHRNITPS 341
V+E+M+NGSL L G+ + L + RGI SG++YL M + +HR++
Sbjct: 83 VTEYMENGSLDAFLRK-HDGQFTVIQLVG--MLRGIASGMKYLSDMGY----VHRDLAAR 135
Query: 342 SVLIDDDMEARIADFGLARLMPDG-HAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSF 400
++L++ ++ +++DFGL+R++ D A +T + + APE KF+ D++S+
Sbjct: 136 NILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSY 195
Query: 401 GVLL-AVLVMGKLP 413
G+++ V+ G+ P
Sbjct: 196 GIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (170), Expect = 5e-13
Identities = 57/191 (29%), Positives = 90/191 (47%), Gaps = 24/191 (12%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFM 287
G+++A+KK++ DN I +R EI +++H NIV LL + LV E+
Sbjct: 23 TGEIVALKKIRL-DNEEEGIPSTALR-EISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80
Query: 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347
L+ D G + I ++ GL Y H RI+HR++ P ++LI+
Sbjct: 81 DMD--LKKYLDKRPGPLSPNLI--KSIMYQLLRGLAYCH---SHRILHRDLKPQNILINR 133
Query: 348 DMEARIADFGLARL--MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKC-----DIYSF 400
D ++ADFGLAR +P + +V T+ Y APE + K DI+S
Sbjct: 134 DGVLKLADFGLARAFGIPL--RTYTHEVV--TLWYRAPE----ILLGSKHYSTAVDIWSV 185
Query: 401 GVLLAVLVMGK 411
G + A ++ GK
Sbjct: 186 GCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQ-VRAEIMTAGQIRHRNIVPLLAHMV 275
G +Y + S+ + A+K+V D ++ K R+ EI + H NI+ +
Sbjct: 14 GSVYKVK-RLSDNQFYALKEV---DLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL 69
Query: 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIH 335
+ +V E+ G L + ++ + R+ + RI ++ GL+ LH +I+H
Sbjct: 70 DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILH 126
Query: 336 RNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKC 395
R++ +++L+ + +I D G+++++ A+ T I GT Y+APE + +S K
Sbjct: 127 RDLKSANILLVANDLVKIGDLGISKVLKKNMAK--TQI--GTPHYMAPEVWKGRPYSYKS 182
Query: 396 DIYSFGVLLAVLVMGKLP 413
DI+S G LL + P
Sbjct: 183 DIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 48/223 (21%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQ---VRAE--IMTAGQIRHRNIVP 269
A GE+++ ++ G++ A+K +++ D IK Q VRAE I+ IV
Sbjct: 13 AFGEVWLVRDKDT-GQVYAMKVLRKSDM----IKRNQIAHVRAERDILA--DADSPWIVK 65
Query: 270 LLAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY 328
L + + HL LV E+M G L+ +L + E AR IA +V L+ +H
Sbjct: 66 LYYSF-QDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEET-ARFYIAE-LVLALDSVH-- 118
Query: 329 HRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI--------------- 373
+ IHR+I P ++LID D ++ADFGL + M +
Sbjct: 119 -KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 374 ------------VAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
GT YIAPE + + +CD +S GV+L
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 57/186 (30%), Positives = 95/186 (51%), Gaps = 14/186 (7%)
Query: 229 GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMV--RPDCHLLVSEF 286
G+++A+KKV+ +DN I + +R EI +RH NIV L +V D LV E+
Sbjct: 32 GEIVALKKVR-MDNERDGIPISSLR-EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY 89
Query: 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346
+ L +L+++ E + + ++ GL+YLH IIHR++ S++L+
Sbjct: 90 CEQ-DLASLLDNMPTPFSESQVKC---LMLQLLRGLQYLH---ENFIIHRDLKVSNLLLT 142
Query: 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE-YHQTLKFSEKCDIYSFGVLLA 405
D +IADFGLAR ++ +V T+ Y APE ++ D+++ G +LA
Sbjct: 143 DKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILA 200
Query: 406 VLVMGK 411
L+ K
Sbjct: 201 ELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 74/291 (25%), Positives = 128/291 (43%), Gaps = 49/291 (16%)
Query: 215 ASGEIYIAE---LPESNGKM-IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL 270
A G++++AE L + KM +A+K +K D +L K Q AE++T ++H +IV
Sbjct: 17 AFGKVFLAECYNLSPTKDKMLVAVKALK--DPTLAARKDFQREAELLT--NLQHEHIVKF 72
Query: 271 LAHMVRPDCHLLVSEFMKNGSLLEIL------------NDVSQGRRELEWLARHRIARGI 318
D ++V E+MK+G L + L Q + EL IA I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 319 VSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR-LMPDGHAQVSTSIVAGT 377
SG+ YL H +HR++ + L+ ++ +I DFG++R + + +V +
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML-P 188
Query: 378 VGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436
+ ++ PE KF+ + D++SFGV+L + GK P +FQ +
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---WFQLS--------------- 230
Query: 437 ENPNRAIDSKLLGNGYEEQMLL---VLKIACFCTLDDPEERPNSKDVRSML 484
I+ G E + V I C +P++R N K++ +L
Sbjct: 231 --NTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRA----EIMTAGQ 261
S KI ++G + IA + GK +A+KK ++++ +Q R E++
Sbjct: 25 DSFIKIGEGSTGIVCIAT-EKHTGKQVAVKK--------MDLRKQQRRELLFNEVVIMRD 75
Query: 262 IRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSG 321
H N+V + + D +V EF++ G+L +I V+ R E +A + ++
Sbjct: 76 YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIAT--VCLSVLRA 130
Query: 322 LEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI-----VAG 376
L YLH +IHR+I S+L+ D +++DFG AQVS + + G
Sbjct: 131 LSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFC-------AQVSKEVPKRKSLVG 180
Query: 377 TVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
T ++APE L + + DI+S G+++ ++ G+ P
Sbjct: 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 42/129 (32%), Positives = 71/129 (55%), Gaps = 10/129 (7%)
Query: 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
E M GSL ++L GR L + I+ ++ GL YL H+ I+HR++ PS++L
Sbjct: 79 EHMDGGSLDQVLKKA--GRIPENILGK--ISIAVLRGLTYLREKHK--IMHRDVKPSNIL 132
Query: 345 IDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
++ E ++ DFG++ + D A S V GT Y++PE Q ++ + DI+S G+ L
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSMAN---SFV-GTRSYMSPERLQGTHYTVQSDIWSLGLSL 188
Query: 405 AVLVMGKLP 413
+ +G+ P
Sbjct: 189 VEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 58/192 (30%), Positives = 89/192 (46%), Gaps = 19/192 (9%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI----RHRNIVPLLAHMVRPDCHLL 282
+ GKM A K++++ IK R+ + + QI + +V L D L
Sbjct: 23 ATGKMYACKRLEKK-----RIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCL 77
Query: 283 VSEFMKNGSL-LEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
V M G L I N + G E L A I+ GLE LH R ++R++ P
Sbjct: 78 VLTIMNGGDLKFHIYNMGNPGFEEERALF---YAAEILCGLEDLH---RENTVYRDLKPE 131
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFG 401
++L+DD RI+D GLA +P+G S GTVGY+APE +++ D + G
Sbjct: 132 NILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLG 188
Query: 402 VLLAVLVMGKLP 413
L+ ++ G+ P
Sbjct: 189 CLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 9e-13
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 33/201 (16%)
Query: 226 ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL---- 281
+ G+ +AIKK+ V + L++ K R +R EI +RH NI+ LL ++RP
Sbjct: 22 KRTGRKVAIKKISNVFDDLIDAK-RILR-EIKLLRHLRHENIIGLL-DILRPPSPEDFND 78
Query: 282 --LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNIT 339
+V+E M+ L+ V + + L I+ GL+YLH + +IHR++
Sbjct: 79 VYIVTELMETD-----LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLK 130
Query: 340 PSSVLIDDDMEARIADFGLARLMPDGHAQVS--TSIVAGTVGYIAPE-------YHQTLK 390
PS++L++ + + +I DFGLAR + + T V T Y APE Y + +
Sbjct: 131 PSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAI- 188
Query: 391 FSEKCDIYSFGVLLAVLVMGK 411
DI+S G + A L+ K
Sbjct: 189 -----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
EKI ASG +Y A + + G+ +AI+++ N K + EI+ + ++ NI
Sbjct: 25 FEKIGQGASGTVYTA-MDVATGQEVAIRQM----NLQQQPKKELIINEILVMRENKNPNI 79
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L + D +V E++ GSL +++ + ++ + R + LE+LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLH- 133
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGL-ARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
++IHR+I ++L+ D ++ DFG A++ P+ Q S + GT ++APE
Sbjct: 134 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWMAPEVV 188
Query: 387 QTLKFSEKCDIYSFGVLLAVLVMGKLP 413
+ K DI+S G++ ++ G+ P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 15/185 (8%)
Query: 224 LPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVP---LLAHMVRPDCH 280
L ++ G+++A+KK++ +R EI ++H NIV + R +
Sbjct: 28 LQDNTGEVVAVKKLQHSTAE----HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83
Query: 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITP 340
L V E++ GSL + L + R L+ A I G+EYL R +HR++
Sbjct: 84 L-VMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLAT 136
Query: 341 SSVLIDDDMEARIADFGLARLMP-DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYS 399
++L++ + +I DFGL +++P D + + APE KFS D++S
Sbjct: 137 RNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWS 196
Query: 400 FGVLL 404
FGV+L
Sbjct: 197 FGVVL 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 14/218 (6%)
Query: 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTA 259
+ E+ LEKI + GE++ + K++AIK + D ++ ++ EI
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII---DLEEAEDEIEDIQQEITVL 56
Query: 260 GQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIV 319
Q + ++ ++ E++ GS L++L ++ I R I+
Sbjct: 57 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREIL 111
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG 379
GL+YLH + IHR+I ++VL+ + E ++ADFG+A + D Q+ + GT
Sbjct: 112 KGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPF 166
Query: 380 YIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDF 417
++APE + + K DI+S G+ L G+ P +
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 47/150 (31%), Positives = 80/150 (53%), Gaps = 15/150 (10%)
Query: 271 LAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH 329
L + + + +L LV ++ G LL +L+ R E +AR IA +++ +H H
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLA----IHSIH 119
Query: 330 RPRIIHRNITPSSVLIDDDMEARIADFG-LARLMPDGHAQVSTSIVAGTVGYIAPEYHQT 388
+ +HR+I P +VL+D + R+ADFG ++ DG Q +S+ GT YI+PE Q
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ--SSVAVGTPDYISPEILQA 177
Query: 389 L-----KFSEKCDIYSFGVLLAVLVMGKLP 413
+ K+ +CD +S GV + ++ G+ P
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI----RHRNIVPLLAHMVRPDCHLL 282
+ GKM A KK+++ IK R+ A + +I R +V L D L
Sbjct: 23 ATGKMYACKKLEKK-----RIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCL 77
Query: 283 VSEFMKNGSL-LEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
V M G L I N + G E + A + GLE L R RI++R++ P
Sbjct: 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIF---YAAELCCGLEDLQ---RERIVYRDLKPE 131
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFG 401
++L+DD RI+D GLA +P+G + GTVGY+APE K++ D + G
Sbjct: 132 NILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLG 188
Query: 402 VLLAVLVMGKLPSDDFFQHTEEKSLVRW 429
L+ ++ G+ P F+ +E+ V+
Sbjct: 189 CLIYEMIQGQSP----FRKRKER--VKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 31/197 (15%)
Query: 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQV---RAEIMTAGQIRHRNI 267
+R + SG+ Y K+++ K+ +K++QV E IRH +
Sbjct: 20 VRHKGSGKYYAL-------KILSKAKI---------VKLKQVEHVLNEKRILQSIRHPFL 63
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L LV E++ G L L GR AR A+ +V LEYLH
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPV-ARFYAAQ-VVLALEYLHS 119
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
I++R++ P ++L+D D +I DFG A+ + T + GT Y+APE
Sbjct: 120 LD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIIL 171
Query: 388 TLKFSEKCDIYSFGVLL 404
+ + + D ++ G+L+
Sbjct: 172 SKGYGKAVDWWALGILI 188
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 22/187 (11%)
Query: 229 GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--DCHLLVSEF 286
G+ +AIKK+ + ++ + K + E+ +RH NI+ L + P D + V+E
Sbjct: 35 GQNVAIKKIMKPFSTPVLAK--RTYRELKLLKHLRHENIISLSDIFISPLEDIYF-VTEL 91
Query: 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346
+ L+ + R LE I+ GL+Y+H ++HR++ PS++LI+
Sbjct: 92 LGTD-----LHRLLTSRP-LEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILIN 142
Query: 347 DDMEARIADFGLARLM-PDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLL 404
++ + +I DFGLAR+ P VST Y APE T K+ + DI+S G +
Sbjct: 143 ENCDLKICDFGLARIQDPQMTGYVSTRY------YRAPEIMLTWQKYDVEVDIWSAGCIF 196
Query: 405 AVLVMGK 411
A ++ GK
Sbjct: 197 AEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 64/257 (24%), Positives = 115/257 (44%), Gaps = 22/257 (8%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQ-VRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286
+G +A+KKV+ D L++ K R EI Q+ H N++ A + + +V E
Sbjct: 26 DGVPVALKKVQIFD--LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83
Query: 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346
G L ++ + +R + + + S LE HM+ R R++HR+I P++V I
Sbjct: 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE--HMHSR-RVMHRDIKPANVFIT 140
Query: 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAV 406
++ D GL R + S+V GT Y++PE ++ K DI+S G LL
Sbjct: 141 ATGVVKLGDLGLGRFF-SSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
Query: 407 LVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFC 466
+ + P + ++ +L + + + P L + Y E++ ++ C
Sbjct: 199 MAALQSPF-----YGDKMNLYSLCKKIEQCDYP------PLPSDHYSEEL---RQLVNMC 244
Query: 467 TLDDPEERPNSKDVRSM 483
DPE+RP+ V +
Sbjct: 245 INPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 19/192 (9%)
Query: 226 ESNGKMIAIKKVKQ---VDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL- 281
+S + A+K VK+ V+ + +E + H IV L + ++
Sbjct: 15 KSKNRTFALKCVKKRHIVETGQ----QEHIFSEKEILEECNHPFIVKLYRTF-KDKKYIY 69
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
++ E+ G L IL D G + E+ AR IA +V EYLH II+R++ P
Sbjct: 70 MLMEYCLGGELWTILRDR--GLFD-EYTARFYIA-CVVLAFEYLH---NRGIIYRDLKPE 122
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFG 401
++L+D + ++ DFG A+ + G T GT Y+APE + D +S G
Sbjct: 123 NLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLG 179
Query: 402 VLLAVLVMGKLP 413
+LL L+ G+ P
Sbjct: 180 ILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 10/205 (4%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVK-QVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH 273
A G +Y+ ++ G+ +A+K+V D+ ++ + EI ++H IV
Sbjct: 14 AFGRVYLCYDVDT-GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72
Query: 274 MVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRI 333
+ + + E+M GS + + + E + R + R I+ G+EYLH I
Sbjct: 73 LRDDETLSIFMEYMPGGS---VKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNMI 125
Query: 334 IHRNITPSSVLIDDDMEARIADFGLA-RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS 392
+HR+I +++L D ++ DFG + RL + V GT +++PE +
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 393 EKCDIYSFGVLLAVLVMGKLPSDDF 417
K D++S G + ++ K P +F
Sbjct: 186 RKADVWSVGCTVVEMLTEKPPWAEF 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 43/138 (31%), Positives = 74/138 (53%), Gaps = 14/138 (10%)
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
LV ++ G LL +L+ R E +AR +A +++ + H+ +HR+I P
Sbjct: 78 LVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLA----IDSVHQLGYVHRDIKPD 131
Query: 342 SVLIDDDMEARIADFG-LARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-----KFSEKC 395
+VL+D + R+ADFG RL+ DG V +++ GT YI+PE Q + ++ +C
Sbjct: 132 NVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVGTPDYISPEILQAMEDGKGRYGPEC 189
Query: 396 DIYSFGVLLAVLVMGKLP 413
D +S GV + ++ G+ P
Sbjct: 190 DWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 44/129 (34%), Positives = 73/129 (56%), Gaps = 10/129 (7%)
Query: 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
E M GSL ++L + + E+ L + IA ++ GL YL H+ I+HR++ PS++L
Sbjct: 83 EHMDGGSLDQVLKEAKRIPEEI--LGKVSIA--VLRGLAYLREKHQ--IMHRDVKPSNIL 136
Query: 345 IDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
++ E ++ DFG++ + D A S V GT Y++PE Q +S + DI+S G+ L
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDSMAN---SFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
Query: 405 AVLVMGKLP 413
L +G+ P
Sbjct: 193 VELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 6e-12
Identities = 56/214 (26%), Positives = 108/214 (50%), Gaps = 23/214 (10%)
Query: 215 ASGEIYIAEL----PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL 270
A G++++AE PE + ++A+K +K ++ R+ AE++T ++H +IV
Sbjct: 17 AFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHRE--AELLT--NLQHEHIVKF 72
Query: 271 LAHMVRPDCHLLVSEFMKNGSLLEILND-------VSQGR--RELEWLARHRIARGIVSG 321
V D ++V E+MK+G L + L +++G EL IA+ I +G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 322 LEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR-LMPDGHAQVSTSIVAGTVGY 380
+ YL H +HR++ + L+ +++ +I DFG++R + + +V + + +
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML-PIRW 188
Query: 381 IAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
+ PE KF+ + D++S GV+L + GK P
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 45/138 (32%), Positives = 76/138 (55%), Gaps = 14/138 (10%)
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
LV ++ G LL +L+ R E +AR +A +++ ++ +H H +HR+I P
Sbjct: 78 LVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIA-IDSVHQLH---YVHRDIKPD 131
Query: 342 SVLIDDDMEARIADFG-LARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-----KFSEKC 395
++L+D + R+ADFG +LM DG Q +S+ GT YI+PE Q + K+ +C
Sbjct: 132 NILMDMNGHIRLADFGSCLKLMEDGTVQ--SSVAVGTPDYISPEILQAMEDGKGKYGPEC 189
Query: 396 DIYSFGVLLAVLVMGKLP 413
D +S GV + ++ G+ P
Sbjct: 190 DWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 44/129 (34%), Positives = 72/129 (55%), Gaps = 10/129 (7%)
Query: 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
E M GSL ++L GR + L + IA ++ GL YL H+ I+HR++ PS++L
Sbjct: 83 EHMDGGSLDQVLKKA--GRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSNIL 136
Query: 345 IDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
++ E ++ DFG++ + D A S V GT Y++PE Q +S + DI+S G+ L
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDSMAN---SFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
Query: 405 AVLVMGKLP 413
+ +G+ P
Sbjct: 193 VEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 40/221 (18%)
Query: 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAE--IMTAGQIR 263
++ +R +A+G+IY A+K +K+ L + E I++ I
Sbjct: 15 GEVQVVREKATGDIY------------AMKVMKK-SVLLAQETVSFFEEERDILS---IS 58
Query: 264 HRNIVPLLAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRE---LEWLARHRIARGIV 319
+ +P L + + +L LV E+ G LL +LN R E E +A+ +A ++
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLN-----RYEDQFDEDMAQFYLAELVL 113
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG-LARLMPDGHAQVSTSIVAGTV 378
+ +H H+ +HR+I P +VLID ++ADFG ARL + V++ + GT
Sbjct: 114 A----IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM--VNSKLPVGTP 167
Query: 379 GYIAPEYHQTLKFSEK------CDIYSFGVLLAVLVMGKLP 413
YIAPE T+ K CD +S GV+ ++ G+ P
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR---H 264
L +I A G +Y A + G+ +A+KKV+ V S I + +R EI Q+ H
Sbjct: 4 LAEIGEGAYGTVYKAR-DLNTGRFVALKKVR-VPLSEEGIPLSTLR-EIALLKQLESFEH 60
Query: 265 RNIVPLL--AHMVRPDCHL---LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIV 319
NIV LL H R D L LV E + L L+ + + + R ++
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLP-PETIKD-LMRQLL 117
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG 379
G+++LH + RI+HR++ P ++L+ D + +IADFGLAR+ A TS+V T+
Sbjct: 118 RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVV-TLW 171
Query: 380 YIAPEYHQTLKFSEKCDIYSFGVLLAVL 407
Y APE ++ D++S G + A L
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 50/217 (23%), Positives = 100/217 (46%), Gaps = 14/217 (6%)
Query: 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTA 259
+ E+ LE+I + GE++ + + + +K +D ++ ++ EI
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKG----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVL 56
Query: 260 GQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIV 319
Q + ++ ++ E++ GS L++L ++ + + I+
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKE-----IL 111
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG 379
GL+YLH + IHR+I ++VL+ + + ++ADFG+A + D Q+ + GT
Sbjct: 112 KGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPF 166
Query: 380 YIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDD 416
++APE Q + K DI+S G+ L G+ P+ D
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 21/223 (9%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQ-VDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMV 275
G++ +AEL ++ ++ A+K +K+ V +++ ++ A +H + L +
Sbjct: 9 GKVLLAELKGTD-ELYAVKVLKKDVILQDDDVECTMTEKRVL-ALAGKHPFLTQLHSCFQ 66
Query: 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIH 335
D V E++ G L+ + + R E AR A IV GL++LH II+
Sbjct: 67 TKDRLFFVMEYVNGGDLM---FHIQRSGRFDEPRARFYAAE-IVLGLQFLH---ERGIIY 119
Query: 336 RNITPSSVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEK 394
R++ +VL+D + +IADFG+ + + G V+TS GT YIAPE +
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTPDYIAPEILSYQPYGPA 176
Query: 395 CDIYSFGVLLAVLVMGKLP-----SDDFFQHTEEKSLV--RWM 430
D ++ GVLL ++ G+ P D+ FQ E + RW+
Sbjct: 177 VDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWL 219
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 25/214 (11%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLN--IKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
G++++AEL +N + AIK +K+ D L++ ++ V +++ H P L H+
Sbjct: 9 GKVFLAELKGTN-QFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAW-EH----PFLTHL 61
Query: 275 ---VRPDCHLL-VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR 330
+ +L V E++ G L+ + Q + + A I+ GL++LH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHI----QSCHKFDLPRATFYAAEIICGLQFLH---S 114
Query: 331 PRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK 390
I++R++ ++L+D D +IADFG+ + G A+ T GT YIAPE K
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQK 172
Query: 391 FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
++ D +SFGVLL +++G+ P F H EE+
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP---FHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 54/212 (25%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQV-RAEIMTAGQIRHRN 266
++KI + G+IY+A+ + + +K++D + + +K ++ + E++ +++H N
Sbjct: 5 IKKIGEGSFGKIYLAKAKSDSEHCV----IKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILND----VSQGRRELEWLARHRIARGIVSGL 322
IV A +V E+ G L++ +N + + L W + I GL
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLGL 114
Query: 323 EYLHMYHRPRIIHRNITPSSVLIDDD-MEARIADFGLARLMPDGHAQVSTSIVAGTVGYI 381
+++H +I+HR+I ++ + + M A++ DFG+AR + D T + GT Y+
Sbjct: 115 KHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV--GTPYYL 169
Query: 382 APEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
+PE Q ++ K DI+S G +L L K P
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 60/250 (24%), Positives = 114/250 (45%), Gaps = 22/250 (8%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQ-VRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286
+ K +A+KKV+ + +++ K RQ EI Q+ H N++ L + + +V E
Sbjct: 26 DRKPVALKKVQIFE--MMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83
Query: 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346
G L +++ + +R + + + S +E HM+ R R++HR+I P++V I
Sbjct: 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE--HMHSR-RVMHRDIKPANVFIT 140
Query: 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAV 406
++ D GL R + S+V GT Y++PE ++ K DI+S G LL
Sbjct: 141 ATGVVKLGDLGLGRFF-SSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
Query: 407 LVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFC 466
+ + P + ++ +L + + + P L Y E++ ++ C
Sbjct: 199 MAALQSPF-----YGDKMNLFSLCQKIEQCDYP------PLPTEHYSEKL---RELVSMC 244
Query: 467 TLDDPEERPN 476
DP++RP+
Sbjct: 245 IYPDPDQRPD 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 32/196 (16%)
Query: 227 SNGKMIAIKKVKQVDNSLLN-IKMRQVRAEIMTAGQIR----HRNIVPLLAHMVRPDCHL 281
G+++AIKK+K+ S + +R+V++ +R H NIV L + R + L
Sbjct: 22 ETGELVAIKKMKKKFYSWEECMNLREVKS-------LRKLNEHPNIVKLK-EVFRENDEL 73
Query: 282 -LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITP 340
V E+M G+L +++ D +G+ E + R I I+ GL ++H + HR++ P
Sbjct: 74 YFVFEYM-EGNLYQLMKD-RKGKPFSESVIRS-IIYQILQGLAHIHKHG---FFHRDLKP 127
Query: 341 SSVLIDDDMEARIADFGLAR---LMPDGHAQVSTSIVAGTVGYIAPE--YHQTLKFSEKC 395
++L+ +IADFGLAR P VST Y APE T +S
Sbjct: 128 ENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR------WYRAPEILLRST-SYSSPV 180
Query: 396 DIYSFGVLLAVLVMGK 411
DI++ G ++A L +
Sbjct: 181 DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 65/254 (25%), Positives = 116/254 (45%), Gaps = 30/254 (11%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQ-VRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286
+G+++A+KKV+ + +++ K RQ EI Q+ H N++ LA + + +V E
Sbjct: 26 DGRVVALKKVQIFE--MMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83
Query: 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346
G L ++ + +R + + + S LE HM H RI+HR+I P++V I
Sbjct: 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE--HM-HSKRIMHRDIKPANVFIT 140
Query: 347 DDMEARIADFGLARLMPD----GHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGV 402
++ D GL R H+ V GT Y++PE ++ K DI+S G
Sbjct: 141 ATGVVKLGDLGLGRFFSSKTTAAHSLV------GTPYYMSPERIHENGYNFKSDIWSLGC 194
Query: 403 LLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKI 462
LL + + P F+ ++ +L + + + P L + Y E++ ++
Sbjct: 195 LLYEMAALQSP---FYG--DKMNLYSLCKKIEKCDYP------PLPADHYSEELRDLVSR 243
Query: 463 ACFCTLDDPEERPN 476
C DPE+RP+
Sbjct: 244 ---CINPDPEKRPD 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 24/203 (11%)
Query: 226 ESNGKMIAIKKV---KQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282
+ ++A+KK+ L ++ EI+T+ Q++H NI+P + + +
Sbjct: 22 KPTNTLVAVKKINLDSCSKEDLK-----LLQQEIITSRQLQHPNILPYVTSFIVDSELYV 76
Query: 283 VSEFMKNGSLLEIL-NDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
VS M GS ++L +G EL A I + +++ L+Y+H IHR++ S
Sbjct: 77 VSPLMAYGSCEDLLKTHFPEGLPEL---AIAFILKDVLNALDYIHSKG---FIHRSVKAS 130
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG------YIAPE--YHQTLKFSE 393
+L+ D + ++ + M H + + +++PE ++E
Sbjct: 131 HILLSGDGKVVLSGLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNE 189
Query: 394 KCDIYSFGVLLAVLVMGKLPSDD 416
K DIYS G+ L G +P D
Sbjct: 190 KSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 60/246 (24%), Positives = 108/246 (43%), Gaps = 40/246 (16%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+++I S G++Y A + G++ AIK +K + V+ EI+ +H NI
Sbjct: 14 IQRIGSGTYGDVYKAR-NVNTGELAAIKVIKLEPGEDFAV----VQQEIIMMKDCKHSNI 68
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V +R D + EF GSL D+ L ++R + GL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSL----QDIYHVTGPLSESQIAYVSRETLQGLYYLHS 124
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVA-----GTVGYIA 382
+ +HR+I +++L+ D+ ++ADFG++ AQ++ +I GT ++A
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMA 174
Query: 383 PEYHQTLK---FSEKCDIYSFGVLLAVLVMGKLPSDDF-------------FQHTEEKSL 426
PE + +++ CDI++ G+ L + P D FQ + K
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDK 234
Query: 427 VRWMRN 432
++W +
Sbjct: 235 MKWSNS 240
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 57/185 (30%), Positives = 87/185 (47%), Gaps = 34/185 (18%)
Query: 232 IAIKKVKQVDNSLLNIKMRQVR-AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNG 290
+A+K +KQ + K +R A +M Q+ H IV L+ +LV E G
Sbjct: 26 VAVKTLKQ--EHIAAGKKEFLREASVMA--QLDHPCIVRLIGVCKGEPL-MLVMELAPLG 80
Query: 291 SLLEILNDVSQGRRE------LEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
LL+ L + RRE E H++A G + YL H +HR++ +VL
Sbjct: 81 PLLKYL----KKRREIPVSDLKELA--HQVAMG----MAYLESKH---FVHRDLAARNVL 127
Query: 345 IDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG-----YIAPEYHQTLKFSEKCDIYS 399
+ + +A+I+DFG++R + G S A T G + APE KFS K D++S
Sbjct: 128 LVNRHQAKISDFGMSRALGAG----SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWS 183
Query: 400 FGVLL 404
+GV L
Sbjct: 184 YGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 25/182 (13%)
Query: 228 NGKMIAIKKV----KQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283
+++AIKK+ KQ N K + + E+ Q+RH N + +R LV
Sbjct: 39 TNEVVAIKKMSYSGKQS-----NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93
Query: 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSV 343
E+ GS +IL + +E+E A I G + GL YLH + R IHR+I ++
Sbjct: 94 MEYCL-GSASDILEVHKKPLQEVEIAA---ICHGALQGLAYLHSHER---IHRDIKAGNI 146
Query: 344 LIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL---KFSEKCDIYSF 400
L+ + ++ADFG A L+ ++ V GT ++APE + ++ K D++S
Sbjct: 147 LLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSL 200
Query: 401 GV 402
G+
Sbjct: 201 GI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+EKI G +Y A + G+++A+KK++ +D + +R EI ++ H NI
Sbjct: 5 VEKIGEGTYGVVYKARNKLT-GEVVALKKIR-LDTETEGVPSTAIR-EISLLKELNHPNI 61
Query: 268 VPLLAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
V LL ++ + L LV EF+ L+ D S L + I + L+ L
Sbjct: 62 VKLL-DVIHTENKLYLVFEFLHQD--LKKFMDASP----LSGIPLPLIKSYLFQLLQGLA 114
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
H R++HR++ P ++LI+ + ++ADFGLAR + +V T+ Y APE
Sbjct: 115 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 172
Query: 387 QTLKF-SEKCDIYSFGVLLAVLVMGK--LPSD 415
K+ S DI+S G + A +V + P D
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 67/280 (23%), Positives = 135/280 (48%), Gaps = 48/280 (17%)
Query: 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRA----EIMTAGQIRHR 265
KI ++G + IA S G+ +A+K +++++ +Q R E++ +H+
Sbjct: 28 KIGEGSTGIVCIAREKHS-GRQVAVK--------MMDLRKQQRRELLFNEVVIMRDYQHQ 78
Query: 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYL 325
N+V + + + ++ EF++ G+L +I VSQ R E +A + ++ L YL
Sbjct: 79 NVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQTRLNEEQIAT--VCESVLQALCYL 133
Query: 326 HMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI-----VAGTVGY 380
H +IHR+I S+L+ D +++DFG AQ+S + + GT +
Sbjct: 134 H---SQGVIHRDIKSDSILLTLDGRVKLSDFGFC-------AQISKDVPKRKSLVGTPYW 183
Query: 381 IAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440
+APE + + DI+S G+++ +V G+ P +F + +++ R +R+ + N
Sbjct: 184 MAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP---YFSDSPVQAMKR-LRDSPPPKLKN 239
Query: 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
S +L + + E+ML +P+ER ++++
Sbjct: 240 AHKISPVLRD-FLERML----------TREPQERATAQEL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 43/168 (25%), Positives = 85/168 (50%), Gaps = 8/168 (4%)
Query: 238 KQVDNSLLNIK-MRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEIL 296
K+V+ + L+ K R EI+ ++H NI+ H + + L+ E+ G+L + +
Sbjct: 31 KEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI 90
Query: 297 NDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356
E E + + IVS + Y+H + I+HR+I ++ + ++ DF
Sbjct: 91 VRQKGQLFEEEMVLWYLFQ--IVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDF 145
Query: 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
G+++++ ++ T V GT Y++PE Q +K++ K DI++ G +L
Sbjct: 146 GISKILGSEYSMAET--VVGTPYYMSPELCQGVKYNFKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV 268
E+I GE++ L N +A+K ++ L K Q A I+ Q H NIV
Sbjct: 1 ERIGRGNFGEVFSGRLRADN-TPVAVKSCRETLPPDLKAKFLQ-EARILK--QYSHPNIV 56
Query: 269 PLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY 328
L+ + +V E ++ G L L ++G R L+ ++ +G+EYL
Sbjct: 57 RLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGPR-LKVKELIQMVENAAAGMEYLESK 113
Query: 329 HRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT 388
H IHR++ + L+ + +I+DFG++R DG + + V + APE
Sbjct: 114 H---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY 170
Query: 389 LKFSEKCDIYSFGVLL 404
++S + D++SFG+LL
Sbjct: 171 GRYSSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 67/270 (24%), Positives = 122/270 (45%), Gaps = 40/270 (14%)
Query: 223 ELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282
+LP +AI ++ + + R AE +T GQ H NIV L + R + ++
Sbjct: 27 KLPSKRELPVAIHTLR---AGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83
Query: 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIA--RGIVSGLEYL-HMYHRPRIIHRNIT 339
V+E+M NG+L L + E + +A + G+ SG++YL M + +H+ +
Sbjct: 84 VTEYMSNGALDSFLR-----KHEGQLVAGQLMGMLPGLASGMKYLSEMGY----VHKGLA 134
Query: 340 PSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG-YIAPEYHQTLKFSEKCDIY 398
VL++ D+ +I+ F RL D + T++ + + APE Q FS D++
Sbjct: 135 AHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVW 192
Query: 399 SFGVLL-AVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS--KLLGNGYEEQ 455
SFG+++ V+ G+ P D M+ ++ +A++ +L
Sbjct: 193 SFGIVMWEVMSYGERPYWD-----------------MSGQDVIKAVEDGFRLPAPRNCPN 235
Query: 456 MLLVLKIACFCTLDDPEERPNSKDVRSMLS 485
+L L + C+ + ERP + S+LS
Sbjct: 236 LLHQLMLDCW--QKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQ---VDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH 273
G++ +A L ES G++ A+K +K+ + + + M + R I++ + H + L
Sbjct: 9 GKVMLARLKES-GRLYAVKVLKKDVILQDDDVECTMTEKR--ILSLAR-NHPFLTQLYCC 64
Query: 274 MVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRI 333
PD V EF+ G L+ + + RR E AR A I S L +LH I
Sbjct: 65 FQTPDRLFFVMEFVNGGDLM---FHIQKSRRFDEARARFYAAE-ITSALMFLH---DKGI 117
Query: 334 IHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSE 393
I+R++ +VL+D + ++ADFG+ + +TS GT YIAPE Q + +
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 394 KCDIYSFGVLLAVLVMGKLP-----SDDFFQ 419
D ++ GVLL ++ G P DD F+
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 44/222 (19%)
Query: 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN 266
+L + S A G++ A ++ K +AIKK+ + S ++ K R R E+ + H N
Sbjct: 19 NLSPVGSGAYGQVCSAFDTKTGRK-VAIKKLSRPFQSAIHAK-RTYR-ELRLLKHMDHEN 75
Query: 267 IVPLLAHMVRPDCHL-------LVSEFMKNGSLLEILNDVSQGRRELEWLARHRI---AR 316
++ LL + P L LV+ M LN++ + ++ L+ I
Sbjct: 76 VIGLL-DVFTPASSLEDFQDVYLVTHLMGAD-----LNNIVKCQK----LSDDHIQFLVY 125
Query: 317 GIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAG 376
I+ GL+Y+H IIHR++ PS++ +++D E +I DFGLAR D T VA
Sbjct: 126 QILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVA- 177
Query: 377 TVGYIAPE-------YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
T Y APE Y+QT+ DI+S G ++A L+ GK
Sbjct: 178 TRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 51/208 (24%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 226 ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL-LVS 284
++ + A+K+++ +S + R E + +++H NIV D HL +V
Sbjct: 22 VNSDQKYAMKEIRLPKSSS---AVEDSRKEAVLLAKMKHPNIVAF-KESFEADGHLYIVM 77
Query: 285 EFMKNGSLLEILNDVSQGR-----RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNIT 339
E+ G L++ + +G+ L+W + + G++++H R++HR+I
Sbjct: 78 EYCDGGDLMQKIKL-QRGKLFPEDTILQWFVQ------MCLGVQHIH---EKRVLHRDIK 127
Query: 340 PSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYS 399
++ + + + ++ DFG ARL+ A T + GT Y+ PE + + ++ K DI+S
Sbjct: 128 SKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV--GTPYYVPPEIWENMPYNNKSDIWS 185
Query: 400 FGVLLAVLVMGKLPSDDFFQHTEEKSLV 427
G +L L K P FQ K+L+
Sbjct: 186 LGCILYELCTLKHP----FQANSWKNLI 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 36/204 (17%)
Query: 217 GEIYIAELPESNGKMI--AIKKVKQVDNSLLNIKMRQVRAEIMTAGQI----RHRNIVPL 270
G +Y L +S+G+ I A+K + ++ + + +V + + G I H N++ L
Sbjct: 9 GCVYHGTLIDSDGQKIHCAVKSLNRITD------LEEV-EQFLKEGIIMKDFSHPNVLSL 61
Query: 271 LAHMVRPD-CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARG--IVSGLEYLHM 327
L + + L+V +MK+G L + + + I G + G+EYL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPT-----VKDLIGFGLQVAKGMEYLA- 115
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD-------GHAQVSTSIVAGTVGY 380
+ +HR++ + ++D+ ++ADFGLAR + D H V +
Sbjct: 116 --SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP-----VKW 168
Query: 381 IAPEYHQTLKFSEKCDIYSFGVLL 404
+A E QT KF+ K D++SFGVLL
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLL 192
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 38/107 (35%), Positives = 61/107 (57%), Gaps = 9/107 (8%)
Query: 313 RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTS 372
+IA IV LEYLH + +IHR++ PS+VLI+ + + ++ DFG++ + D V+ +
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD---SVAKT 161
Query: 373 IVAGTVGYIAPEY---HQTLK-FSEKCDIYSFGVLLAVLVMGKLPSD 415
I AG Y+APE K + K D++S G+ + L G+ P D
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 27/196 (13%)
Query: 232 IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL-------LVS 284
+A+KK+ + SL I R+ E+ ++H N++ LL + P + LV+
Sbjct: 43 VAVKKLSRPFQSL--IHARRTYRELRLLKHMKHENVIGLL-DVFTPATSIENFNEVYLVT 99
Query: 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
M LN++ + ++ + + I + ++ GL+Y+H IIHR++ PS+V
Sbjct: 100 NLMGAD-----LNNIVKCQKLSDEHVQFLIYQ-LLRGLKYIH---SAGIIHRDLKPSNVA 150
Query: 345 IDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVL 403
+++D E RI DFGLAR D T VA T Y APE + +++ DI+S G +
Sbjct: 151 VNEDCELRILDFGLARQADDE----MTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCI 205
Query: 404 LAVLVMGK--LPSDDF 417
+A L+ GK P +D+
Sbjct: 206 MAELLKGKALFPGNDY 221
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 44/169 (26%), Positives = 71/169 (42%), Gaps = 31/169 (18%)
Query: 210 KIRSRASGEIYIAELPESN-GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV 268
I G +Y A+ GK AIKK K I R EI +++H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLRELKHENVV 65
Query: 269 PL----LAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIV----- 319
L L H + L+ ++ ++ L +I+ Q +R I +V
Sbjct: 66 SLVEVFLEHADK--SVYLLFDYAEH-DLWQIIKFHRQAKR-------VSIPPSMVKSLLW 115
Query: 320 ---SGLEYLHMYHRPRIIHRNITPSSVLIDDDMEAR----IADFGLARL 361
+G+ YLH ++HR++ P+++L+ + R I D GLARL
Sbjct: 116 QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 27/200 (13%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEI-MTAGQIRHRNIVP------ 269
G++Y A + G+++AIK + +++ IK E + H NI
Sbjct: 20 GKVYKARH-KKTGQLVAIKIMDIIEDEEEEIK-----EEYNILRKYSNHPNIATFYGAFI 73
Query: 270 LLAHMVRPDCHLLVSEFMKNGSLLEILNDV-SQGRR-ELEWLARHRIARGIVSGLEYLHM 327
D LV E GS+ +++ + +G+R + EW+A I R + GL YLH
Sbjct: 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGLAYLHE 131
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE--- 384
+IHR+I ++L+ + E ++ DFG++ + + +T I GT ++APE
Sbjct: 132 NK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI--GTPYWMAPEVIA 186
Query: 385 --YHQTLKFSEKCDIYSFGV 402
+ + D++S G+
Sbjct: 187 CDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 17/184 (9%)
Query: 225 PESNGKMIAIKKVKQVDNSLLNIKMR-QVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283
P S G++ K Q D +L I + E M + H +++ + +V +V
Sbjct: 76 PGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135
Query: 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSV 343
+ ++ +++ R L I + I+ GL YLH RIIHR++ ++
Sbjct: 136 LPHYSS----DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENI 188
Query: 344 LIDDDMEARIADFGLARL---MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSF 400
I+D + I D G A+ P +AGTV APE K++ K DI+S
Sbjct: 189 FINDVDQVCIGDLGAAQFPVVAPAFLG------LAGTVETNAPEVLARDKYNSKADIWSA 242
Query: 401 GVLL 404
G++L
Sbjct: 243 GIVL 246
|
Length = 357 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 41/204 (20%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRA---EIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283
S IAIK++ + D R V+ EI ++HRNIV L +
Sbjct: 31 STQVRIAIKEIPERD-------SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83
Query: 284 SEFMKNGSLLEILNDVSQGRRELEW--LARHRIA-----RGIVSGLEYLHMYHRPRIIHR 336
E + GSL +L +W L + + I+ GL+YLH +I+HR
Sbjct: 84 MEQVPGGSLSALL--------RSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHR 132
Query: 337 NITPSSVLIDD-DMEARIADFG----LARLMPDGHAQVSTSIVAGTVGYIAPEY--HQTL 389
+I +VL++ +I+DFG LA + P T GT+ Y+APE
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMAPEVIDKGPR 186
Query: 390 KFSEKCDIYSFGVLLAVLVMGKLP 413
+ DI+S G + + GK P
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 56/194 (28%), Positives = 98/194 (50%), Gaps = 23/194 (11%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLL--AHMVRPDCH---LL 282
+GK +A+KK+ V +L++ K R R E+ +H N++ L D +
Sbjct: 24 DGKRVALKKMPNVFQNLVSCK-RVFR-ELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81
Query: 283 VSEFMKNGSLLEILNDVSQGRRELEW--LARHRIARGIVSGLEYLHMYHRPRIIHRNITP 340
V+E M++ L +I+ VS + + ++I R GL+YL H I+HR+I P
Sbjct: 82 VTELMQS-DLHKII--VSPQPLSSDHVKVFLYQILR----GLKYL---HSAGILHRDIKP 131
Query: 341 SSVLIDDDMEARIADFGLARLM-PDGHAQVSTSIVAGTVGYIAPEYHQTLK-FSEKCDIY 398
++L++ + +I DFGLAR+ PD ++ +V T Y APE + ++ DI+
Sbjct: 132 GNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--TQYYRAPEILMGSRHYTSAVDIW 189
Query: 399 SFGVLLAVLVMGKL 412
S G + A L+ ++
Sbjct: 190 SVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVR---AEIMTAGQIRHRNIVPLLAH 273
G + IA+ + G+ AIK +K+ + +KM+QV+ E ++ H IV ++
Sbjct: 32 GRVRIAKH-KGTGEYYAIKCLKKREI----LKMKQVQHVAQEKSILMELSHPFIVNMMCS 86
Query: 274 MVRPDCHLLVSEFMKNGSLLEIL-------NDVSQGRRELEWLARHRIARGIVSGLEYLH 326
+ + EF+ G L L NDV A+ A +V EYLH
Sbjct: 87 FQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV----------AKFYHAE-LVLAFEYLH 135
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
II+R++ P ++L+D+ ++ DFG A+ +PD T + GT Y+APE
Sbjct: 136 ---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAPEVI 187
Query: 387 QTLKFSEKCDIYSFGVLLAVLVMGKLP-SDDFFQHTEEKSLV 427
Q+ + D ++ GVLL + G P DD EK L
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229
|
Length = 329 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 48/193 (24%), Positives = 92/193 (47%), Gaps = 13/193 (6%)
Query: 227 SNGKMIAIKKVKQVDNSLLNI--KMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284
+ G++IA+K+V+ +++L + +++ E+ ++H NIV L + + +
Sbjct: 22 NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81
Query: 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
EF+ GS+ ILN L + + I+ G+ YLH ++HR+I ++V+
Sbjct: 82 EFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVM 134
Query: 345 IDDDMEARIADFGLARLMPDGHAQVSTS----IVAGTVGYIAPEYHQTLKFSEKCDIYSF 400
+ + ++ DFG AR + + S + GT ++APE + K DI+S
Sbjct: 135 LMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSI 194
Query: 401 GVLLAVLVMGKLP 413
G + + GK P
Sbjct: 195 GCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 209 EKIR---SRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQ-VRAEIMTAGQIRH 264
EKIR A G +++ +I +KQ+ + R + E + H
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVI----IKQIPVEQMTKDERLAAQNECQVLKLLSH 58
Query: 265 RNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEY 324
NI+ + + ++V E+ G+L E + R L I V L
Sbjct: 59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK-----RCNSLLDEDTILHFFVQILLA 113
Query: 325 LHMYHRPRIIHRNITPSSVLIDD-DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAP 383
LH H I+HR++ ++L+D M +I DFG+++++ ++ V GT YI+P
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISP 170
Query: 384 EYHQTLKFSEKCDIYSFGVLL 404
E + +++K DI++ G +L
Sbjct: 171 ELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 16/167 (9%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
A++M ++ H +V L LV EFM++G L + L +G+ E L
Sbjct: 50 AQVMM--KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLR-AQRGKFSQETLLG-- 104
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
+ + G+ YL +IHR++ + L+ ++ +++DFG+ R + D ST
Sbjct: 105 MCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST-- 159
Query: 374 VAGT---VGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLPSDD 416
GT V + +PE K+S K D++SFGVL+ V GK P ++
Sbjct: 160 --GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 24/197 (12%)
Query: 229 GKMIAIKKVKQVDNSLLNIKMRQVRAEI-MTAGQIRHRNIVPLLAHMVR--PDCH----L 281
G++ AIK + ++ + +++ EI M HRNI ++ P H
Sbjct: 41 GQLAAIKVMDVTED-----EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
LV EF GS+ +++ + + +W+A I R I+ GL +LH + +IHR+I
Sbjct: 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAHK---VIHRDIKGQ 150
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEY-----HQTLKFSEKCD 396
+VL+ ++ E ++ DFG++ + + +T I GT ++APE + + + D
Sbjct: 151 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIACDENPDATYDYRSD 208
Query: 397 IYSFGVLLAVLVMGKLP 413
I+S G+ + G P
Sbjct: 209 IWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+EKI G +Y + G+++A+KK++ +++ + +R EI +++H NI
Sbjct: 5 IEKIGEGTYGVVYKGR-NKKTGQIVAMKKIR-LESEEEGVPSTAIR-EISLLKELQHPNI 61
Query: 268 VPLLAHMVRPDCHLLVSEF--MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYL 325
V L +++ L+ EF M L+ L EL ++I +GI+
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL------ 115
Query: 326 HMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL--MPDGHAQVSTSIVAGTVGYIAP 383
H R++HR++ P ++LID+ ++ADFGLAR +P +V T V T+ Y AP
Sbjct: 116 -FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---VRVYTHEVV-TLWYRAP 170
Query: 384 E-YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
E + ++S DI+S G + A + K
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 19/175 (10%)
Query: 249 MRQV---RAEIMTAGQIRHRNIVPLLAHMVRPDCHLL-VSEFMKNGSLLEILNDVSQGRR 304
Q R E ++ H NIV LL P L V E++ +L E+L + G
Sbjct: 19 EHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL--AADGA- 75
Query: 305 ELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI---DDDMEARIADFGLARL 361
L R ++ L+ L H I+HR++ P ++++ A++ DFG+ L
Sbjct: 76 ----LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTL 131
Query: 362 MPDGHAQVSTSI-----VAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGK 411
+P ++ V GT Y APE + + D+Y++G++ + G+
Sbjct: 132 LPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 41/142 (28%), Positives = 70/142 (49%), Gaps = 21/142 (14%)
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
+ +EFM GSL DV R++ RIA +V GL YL +I+HR++ PS
Sbjct: 76 ICTEFMDGGSL-----DVY---RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPS 124
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIV---AGTVGYIAPEYHQTLKFSEKCDIY 398
++L++ + ++ DFG++ Q+ SI GT Y+APE ++ D++
Sbjct: 125 NMLVNTRGQVKLCDFGVST-------QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVW 177
Query: 399 SFGVLLAVLVMGKLPSDDFFQH 420
S G+ L +G+ P ++
Sbjct: 178 SLGISFMELALGRFPYPQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 71/243 (29%), Positives = 116/243 (47%), Gaps = 49/243 (20%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276
GE+Y ++ GKM A+K + + IKM+Q G+ N +L+ +
Sbjct: 8 GEVYGCRKADT-GKMYAMKCLDKK-----RIKMKQ--------GETLALNERIMLSLVST 53
Query: 277 PDCHLLVS---EFMKNGSLLEILNDVSQGRRELEW-LARHRI---------ARGIVSGLE 323
DC +V F L IL+ ++ G +L + L++H + A I+ GLE
Sbjct: 54 GDCPFIVCMTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEKEMRFYATEIILGLE 111
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA----RLMPDGHAQVSTSIVAGTVG 379
HM++R +++R++ P+++L+D+ RI+D GLA + P HA V GT G
Sbjct: 112 --HMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASV------GTHG 160
Query: 380 YIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQH-TEEKSLVRWMRNVMTSE 437
Y+APE Q + D +S G +L L+ G P F QH T++K + M + E
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEIDRMTLTVNVE 217
Query: 438 NPN 440
P+
Sbjct: 218 LPD 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 72/243 (29%), Positives = 117/243 (48%), Gaps = 49/243 (20%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276
GE+Y ++ GKM A+K + + IKM+Q G+ N +L+ +
Sbjct: 8 GEVYGCRKADT-GKMYAMKCLDKK-----RIKMKQ--------GETLALNERIMLSLVST 53
Query: 277 PDCHLLVS---EFMKNGSLLEILNDVSQGRRELEW-LARHRI---------ARGIVSGLE 323
DC +V F L IL+ ++ G +L + L++H + A I+ GLE
Sbjct: 54 GDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEAEMRFYAAEIILGLE 111
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA----RLMPDGHAQVSTSIVAGTVG 379
HM++R +++R++ P+++L+D+ RI+D GLA + P HA V GT G
Sbjct: 112 --HMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASV------GTHG 160
Query: 380 YIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQH-TEEKSLVRWMRNVMTSE 437
Y+APE Q + + D +S G +L L+ G P F QH T++K + M M E
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEIDRMTLTMAVE 217
Query: 438 NPN 440
P+
Sbjct: 218 LPD 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 9e-10
Identities = 48/199 (24%), Positives = 93/199 (46%), Gaps = 32/199 (16%)
Query: 229 GKMIAIKKVK-QVDNSLLNIKMRQVRAEIMTAGQIRHR----NIVPLLAHMVRPDCHLLV 283
G +A+K+++ ++D S K Q+ E+ I H+ IV +
Sbjct: 26 GVTMAMKEIRLELDES----KFNQIIMEL----DILHKAVSPYIVDFYGAFFIEGAVYMC 77
Query: 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSV 343
E+M GSL ++ E + R RI +V GL++L H IIHR++ P++V
Sbjct: 78 MEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKGLKFLKEEHN--IIHRDVKPTNV 134
Query: 344 LIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG---YIAPEY------HQTLKFSEK 394
L++ + + ++ DFG++ + S+ +G Y+APE +Q ++ +
Sbjct: 135 LVNGNGQVKLCDFGVS-------GNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQ 187
Query: 395 CDIYSFGVLLAVLVMGKLP 413
D++S G+ + + +G+ P
Sbjct: 188 SDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 69/290 (23%), Positives = 121/290 (41%), Gaps = 62/290 (21%)
Query: 219 IYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVP--------- 269
I I E P + + +K VK S + + + + E + H+NI+P
Sbjct: 26 ILIDEKP-GKEEEVFVKTVKD-HASEIQVTL--LLQESCLLYGLSHQNILPILHVCIEDG 81
Query: 270 -----LLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEY 324
L +M + L F++ L E N + ++L +A I G+ Y
Sbjct: 82 EPPFVLYPYMNWGNLKL----FLQQCRLGEANNPQALSTQQLVHMAIQ-----IACGMSY 132
Query: 325 LHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR-LMP-DGHAQVSTSIVAGT----- 377
LH +IH++I + +ID++++ +I D L+R L P D H G
Sbjct: 133 LHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC-------LGDNENRP 182
Query: 378 VGYIAPEYHQTLKFSEKCDIYSFGVLLAVLV-MGKLPSDDFFQHTEEKSLVRWMRNVMTS 436
V ++A E ++S D++SFGVLL L+ +G+ P + + + ++++
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP----YVEIDPFEMAAYLKDGYRL 238
Query: 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
P D ++ V+ AC C DPEERP+ + L+D
Sbjct: 239 AQPINCPD----------ELFAVM--AC-CWALDPEERPSFSQLVQCLTD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 1e-09
Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 19/175 (10%)
Query: 251 QVRAEI-MTAGQIRHRNIVPLLAHMVRP------DCHLLVSEFMKNGSLLEILNDVSQGR 303
+++ EI M HRNI ++ D LV EF GS+ +++ +
Sbjct: 48 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT 107
Query: 304 RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363
+ EW+A I R I+ GL +LH + ++IHR+I +VL+ ++ E ++ DFG++ +
Sbjct: 108 LKEEWIAY--ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162
Query: 364 DGHAQVSTSIVAGTVGYIAPEY-----HQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
+ +T I GT ++APE + + K D++S G+ + G P
Sbjct: 163 RTVGRRNTFI--GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 48/193 (24%), Positives = 95/193 (49%), Gaps = 24/193 (12%)
Query: 230 KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLL-AHMVRPDCHLLVSEFMK 288
K+I I+ +++++ ++ I +I++ + +H NIV L A+ +L+ EF
Sbjct: 36 KIIQIESEEELEDFMVEI-------DILS--ECKHPNIVGLYEAYFYENKLWILI-EFCD 85
Query: 289 NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD 348
G+L I+ ++ +G E + + R ++ L +LH ++IHR++ ++L+ D
Sbjct: 86 GGALDSIMLELERGLTEPQIRY---VCRQMLEALNFLH---SHKVIHRDLKAGNILLTLD 139
Query: 349 MEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSE-----KCDIYSFGVL 403
+ ++ADFG++ + T I GT ++APE F + K DI+S G+
Sbjct: 140 GDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFKDNPYDYKADIWSLGIT 197
Query: 404 LAVLVMGKLPSDD 416
L L + P +
Sbjct: 198 LIELAQMEPPHHE 210
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 26/212 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L+++ S A G + A L G +AIKK+ + S L K R R E+ ++H N+
Sbjct: 20 LKQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAK-RAYR-ELRLLKHMKHENV 76
Query: 268 VPLLAHMVRPDCHL-------LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVS 320
+ LL + PD L LV FM L +++ +++L ++
Sbjct: 77 IGLL-DVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLSEDRIQFLVYQ-----MLK 129
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
GL+Y+H IIHR++ P ++ +++D E +I DFGLAR + T Y
Sbjct: 130 GLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWY 181
Query: 381 IAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGK 411
APE + +++ DI+S G ++A ++ GK
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 46/185 (24%), Positives = 88/185 (47%), Gaps = 16/185 (8%)
Query: 224 LPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL-L 282
+PE + I + +K + + +++ ++ G + H IV LL + P L L
Sbjct: 29 IPEGDSIKIPVA-IKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLG--ICPGASLQL 85
Query: 283 VSEFMKNGSLLEIL---NDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNIT 339
V++ GSLL+ + D +R L W + I G+ YL + R++HRN+
Sbjct: 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEEH---RMVHRNLA 136
Query: 340 PSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYS 399
++L+ D +IADFG+A L+ + S + ++A E +++ + D++S
Sbjct: 137 ARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWS 196
Query: 400 FGVLL 404
+GV +
Sbjct: 197 YGVTV 201
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 32/105 (30%), Positives = 54/105 (51%), Gaps = 9/105 (8%)
Query: 313 RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTS 372
++ IV L YL H +IHR++ PS++L+D ++ DFG++ + D A+ +
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS- 174
Query: 373 IVAGTVGYIAPEY----HQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
AG Y+APE K+ + D++S G+ L L G+ P
Sbjct: 175 --AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 52/215 (24%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 208 LEKIRSRASGEIYIAEL----PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR 263
+E++ G++Y L P + +AIK +K D + ++ + + E M +++
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK--DKAEGPLR-EEFKHEAMMRSRLQ 66
Query: 264 HRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEIL------------NDVSQGRRELEWLAR 311
H NIV LL + + ++ + + L E L +D + LE
Sbjct: 67 HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126
Query: 312 HRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM--PDGHAQV 369
I I +G+E+L +H ++H+++ +VL+ D + +I+D GL R + D + +
Sbjct: 127 VHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 370 STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
S++ + +++PE KFS DI+S+GV+L
Sbjct: 184 GNSLLP--IRWMSPEAIMYGKFSIDSDIWSYGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 65/274 (23%), Positives = 118/274 (43%), Gaps = 44/274 (16%)
Query: 232 IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGS 291
+A+K +K+ +S ++R + +E Q+ H +++ L + LL+ E+ K GS
Sbjct: 33 VAVKMLKENASS---SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGS 89
Query: 292 LLEILND---------VSQGRRELEWLARH-----------RIARGIVSGLEYLHMYHRP 331
L L + S G R +L A I G++YL
Sbjct: 90 LRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EM 146
Query: 332 RIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKF 391
+++HR++ +VL+ + + +I+DFGL+R + + + V S V ++A E +
Sbjct: 147 KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY 206
Query: 392 SEKCDIYSFGVLLAVLV-MGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGN 450
+ + D++SFGVLL +V +G P + + L ++ E P N
Sbjct: 207 TTQSDVWSFGVLLWEIVTLGGNP----YPGIAPERLFNLLKTGYRMERPE---------N 253
Query: 451 GYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484
EE L+L C +P++RP D+ L
Sbjct: 254 CSEEMYNLMLT----CWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L +I G +Y A + G+++A+KK+K ++ + +R EI +++H NI
Sbjct: 10 LNRIEEGTYGVVYRA-RDKKTGEIVALKKLK-MEKEKEGFPITSLR-EINILLKLQHPNI 66
Query: 268 VPLLAHMV---RPDCHLLVSEFMKNG--SLLEILND-VSQGRRELEWLARHRIARGIVSG 321
V + +V D +V E++++ SL+E + Q E++ L ++SG
Sbjct: 67 VTV-KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQS--EVKCLMLQ-----LLSG 118
Query: 322 LEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI 381
+ +LH I+HR++ S++L+++ +I DFGLAR + T +V T+ Y
Sbjct: 119 VAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS-PLKPYTQLVV-TLWYR 173
Query: 382 APE-YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
APE ++S D++S G + A L+ K
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 46/191 (24%), Positives = 89/191 (46%), Gaps = 24/191 (12%)
Query: 227 SNGKMIAIKK--------VKQVDNSLLNIKMRQ-VRAEIMTAGQIRHRNIVPLLAHMVRP 277
S GK I +K +K+++ S ++ K R+ R E+ ++H NIV
Sbjct: 12 SFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71
Query: 278 DCHLLVSEFMKNGSLLEILND----VSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRI 333
+V ++ + G L + +N + + L+W + I L+++H +I
Sbjct: 72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALKHVH---DRKI 122
Query: 334 IHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSE 393
+HR+I ++ + D ++ DFG+AR++ T I GT Y++PE + ++
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI--GTPYYLSPEICENRPYNN 180
Query: 394 KCDIYSFGVLL 404
K DI++ G +L
Sbjct: 181 KSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 54/213 (25%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQ---VDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH 273
G++ +AEL ++ ++ AIK +K+ + + ++ M + R + A H + L
Sbjct: 9 GKVMLAELKGTD-EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK---HPFLTALHCC 64
Query: 274 MVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRI 333
D V E++ G L+ + + R+ E +R A + L +LH R +
Sbjct: 65 FQTKDRLFFVMEYVNGGDLM---FQIQRSRKFDEPRSRFYAAE-VTLALMFLH---RHGV 117
Query: 334 IHRNITPSSVLIDDDMEARIADFGLAR--LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKF 391
I+R++ ++L+D + ++ADFG+ + ++ V+T+ GT YIAPE Q L++
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----VTTTTFCGTPDYIAPEILQELEY 173
Query: 392 SEKCDIYSFGVLLAVLVMGKLP-----SDDFFQ 419
D ++ GVL+ ++ G+ P DD F+
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAE---IMTAGQIRHRNIVPLLAH 273
G++ +AE + G++ AIK +K+ D + ++ + E TA RH +V L A
Sbjct: 13 GKVLLAEY-KKTGELYAIKALKKGD-IIARDEVESLMCEKRIFETANSERHPFLVNLFAC 70
Query: 274 MVRPDCHLLVSEFMKNGSL-LEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR 332
D V E+ G L + I DV R + + A +V GL+YLH +
Sbjct: 71 FQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC------VVLGLQYLH---ENK 121
Query: 333 IIHRNITPSSVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEYHQTLKF 391
I++R++ ++L+D + +IADFGL + M G TS GT ++APE +
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM--GFGD-RTSTFCGTPEFLAPEVLTETSY 178
Query: 392 SEKCDIYSFGVLLAVLVMGK--LPSDD 416
+ D + GVL+ +++G+ P DD
Sbjct: 179 TRAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 48/166 (28%), Positives = 83/166 (50%), Gaps = 18/166 (10%)
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
LV+++M G L L +GR E A+ IA +V LE+LH Y I++R++ P
Sbjct: 73 LVTDYMSGGELFWHLQ--KEGRFS-EDRAKFYIAE-LVLALEHLHKYD---IVYRDLKPE 125
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK-FSEKCDIYSF 400
++L+D + DFGL++ + +T+ GT Y+APE K +++ D +S
Sbjct: 126 NILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSL 183
Query: 401 GVLLAVLVMGKLPSDDFFQHTEEK------SLVRWMRNVMTSENPN 440
GVL+ + G P + + T++ VR+ +NV++ E
Sbjct: 184 GVLVFEMCCGWSPF--YAEDTQQMYRNIAFGKVRFPKNVLSDEGRQ 227
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 76/298 (25%), Positives = 131/298 (43%), Gaps = 48/298 (16%)
Query: 208 LEKIRSRASGEIYIAEL---PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH 264
+E++ A G+IY L + +++AIK +K ++N + +Q E ++ H
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQ---EASLMAELHH 66
Query: 265 RNIVPLLAHMVR--PDCHLLVSEFMKNGSLLEIL------NDVSQGRRE-------LEWL 309
NIV LL + + P C L E++ G L E L +DV E L+
Sbjct: 67 PNIVCLLGVVTQEQPVCMLF--EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 310 ARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM--PDGHA 367
IA I +G+EYL + +H+++ ++LI + + +I+D GL+R + D +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181
Query: 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLV 427
S++ + ++ PE KFS DI+SFGV+L + L F + E +V
Sbjct: 182 VQPKSLLP--IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239
Query: 428 RWMRNVMTSEN-PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484
R + + SE+ P R + + C + P RP KD+ + L
Sbjct: 240 RKRQLLPCSEDCPPR-----------------MYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 16/164 (9%)
Query: 263 RHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILN-----------DVSQGRRE-LEWLA 310
+H+NI+ LL + ++ E+ G+L E L D+++ E L +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 311 RHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS 370
A + G+EYL R IHR++ +VL+ +D +IADFGLAR + D
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 371 TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
TS V ++APE ++ + D++SFG+L+ + +G P
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN 266
+L + S A G + A G +A+KK+ + S+++ K R R E+ ++H N
Sbjct: 21 NLSPVGSGAYGSV-CAAFDTKTGLRVAVKKLSRPFQSIIHAK-RTYR-ELRLLKHMKHEN 77
Query: 267 IVPLLAHMVRPDCHL-------LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIV 319
++ LL + P L LV+ M LN++ + ++ + + I + I+
Sbjct: 78 VIGLL-DVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQFLIYQ-IL 130
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG 379
GL+Y+H IIHR++ PS++ +++D E +I DFGLAR H + T
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRW 182
Query: 380 YIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGK 411
Y APE + +++ DI+S G ++A L+ G+
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 47/188 (25%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 232 IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGS 291
+AIK + + N++ E + + H ++V LL + P L V++ M +G
Sbjct: 39 VAIKILNETTGPKANVEFMD---EALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGC 94
Query: 292 LLEILN---DVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD 348
LL+ ++ D + L W + I G+ YL R++HR++ +VL+
Sbjct: 95 LLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE---ERRLVHRDLAARNVLVKSP 145
Query: 349 MEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVL 407
+I DFGLARL+ + + + ++A E KF+ + D++S+GV + ++
Sbjct: 146 NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 205
Query: 408 VMGKLPSD 415
G P D
Sbjct: 206 TFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 53/288 (18%), Positives = 115/288 (39%), Gaps = 49/288 (17%)
Query: 217 GEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLA 272
GE+++A+ E ++ +K +++ + L + R+ E+ ++ H+N+V LL
Sbjct: 19 GEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRR---ELDMFRKLSHKNVVRLLG 75
Query: 273 HMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRE------LEWLARHRIARGIVSGLEYLH 326
+ H ++ E+ G L + L ++ + E L + + I G+++L
Sbjct: 76 LCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR--LMPDGHAQVSTSIVAGTVGYIAPE 384
R +HR++ + L+ E +++ L++ + + + I + ++APE
Sbjct: 135 ---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI---PLRWLAPE 188
Query: 385 YHQTLKFSEKCDIYSFGVLL------AVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438
Q FS K D++SFGVL+ L L ++ + L
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL-ELPVPEGCPSR 247
Query: 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
+ K+ C +P++RP+ ++ S L +
Sbjct: 248 --------------------LYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 24/175 (13%)
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
IA V L YL + IIHR++ PS++L+D + ++ DFG++ + D A+ +
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TR 166
Query: 374 VAGTVGYIAPEYHQTL---KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM 430
AG Y+APE + + D++S G+ L + GK P + S+ +
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW------NSVFDQL 220
Query: 431 RNVMTSENPNRAIDSKLLGNGYEEQ--MLLVLKIACFCTLDDPEERPNSKDVRSM 483
V+ + P +L N E + V I C + D +RP K++
Sbjct: 221 TQVVKGDPP-------ILSNSEEREFSPSFVNFIN-LCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 24/163 (14%)
Query: 282 LVSEFMKNGSLLEILN--DVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNIT 339
+V E+M G L+ +++ D+ + +W AR A +V L+ +H IHR++
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPE-----KW-ARFYTAE-VVLALDAIHSMG---FIHRDVK 169
Query: 340 PSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL----KFSEKC 395
P ++L+D ++ADFG M D + V GT YI+PE ++ + +C
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228
Query: 396 DIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438
D +S GV L +++G P F+ SLV +M +N
Sbjct: 229 DWWSVGVFLYEMLVGDTP---FY----ADSLVGTYSKIMDHKN 264
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 34/284 (11%)
Query: 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTA 259
+ E+ L +I + G +Y A +N +++A+KK+ N K + + E+
Sbjct: 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTN-EVVAVKKM-SYSGKQTNEKWQDIIKEVKFL 75
Query: 260 GQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIV 319
Q++H N + ++ LV E+ GS ++L + +E+E A I G +
Sbjct: 76 QQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA---ITHGAL 131
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG 379
GL YLH ++ +IHR+I ++L+ + + ++ADFG A ++ V GT
Sbjct: 132 QGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPY 182
Query: 380 YIAPEYHQTL---KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436
++APE + ++ K D++S G+ L K P F +L +N +
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNDSPT 239
Query: 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
N DS +C P+ERP S ++
Sbjct: 240 LQSNEWTDS-------------FRGFVDYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 49/198 (24%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
++++ S G++Y A G++ A+K +K ++ ++ EI + +H NI
Sbjct: 14 IQRVGSGTYGDVYKAR-NLHTGELAAVKIIKLEPGDDFSL----IQQEIFMVKECKHCNI 68
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V + + + E+ GSL D+ L L + R + GL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSL----QDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
+ +HR+I +++L+ D+ + ++ADFG+A + A+ + I GT ++APE
Sbjct: 125 KGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAA 179
Query: 388 TLK---FSEKCDIYSFGV 402
K +++ CDI++ G+
Sbjct: 180 VEKNGGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 18/217 (8%)
Query: 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTA 259
+ E + L +I + G +Y A ++ +++AIKK+ N K + + E+
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNS-EVVAIKKM-SYSGKQSNEKWQDIIKEVRFL 69
Query: 260 GQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIV 319
++RH N + +R LV E+ GS ++L + +E+E A + G +
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA---VTHGAL 125
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG 379
GL YLH ++ +IHR++ ++L+ + ++ DFG A +M + V GT
Sbjct: 126 QGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPY 176
Query: 380 YIAPEYHQTL---KFSEKCDIYSFGVLLAVLVMGKLP 413
++APE + ++ K D++S G+ L K P
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 60/212 (28%)
Query: 228 NGKMIAIKKV-----KQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCHL 281
+++A+KK+ D R R EIM ++ H NIV LL ++++ +
Sbjct: 31 TKEVVALKKIFDAFRNATD------AQRTFR-EIMFLQELGDHPNIVKLL-NVIKAENDK 82
Query: 282 ---LVSEFM---------KNGSLLEILNDVSQGRRELEWLARHR--IARGIVSGLEYLHM 327
LV E+M N IL DV H+ I ++ L+Y+H
Sbjct: 83 DIYLVFEYMETDLHAVIRAN-----ILEDV------------HKRYIMYQLLKALKYIH- 124
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARL---MPDGHA-QVSTSIVAGTVGYIAP 383
+IHR++ PS++L++ D ++ADFGLAR + + V T VA T Y AP
Sbjct: 125 --SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA-TRWYRAP 181
Query: 384 EYHQTL----KFSEKCDIYSFGVLLAVLVMGK 411
E L ++++ D++S G +L +++GK
Sbjct: 182 E---ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 55/194 (28%), Positives = 93/194 (47%), Gaps = 20/194 (10%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLL-AHMVRPDCH---L 281
S + +AIKK+ V + + K R +R E+ R H+NI L +V P
Sbjct: 25 SEEETVAIKKITNVFSKKILAK-RALR-ELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
L E M+ L+ + + + L I+ GL+Y+H ++HR++ P
Sbjct: 83 LYEELMEAD-----LHQIIRSGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPG 134
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVS---TSIVAGTVGYIAPEYHQTLK-FSEKCDI 397
++L++ D E +I DFGLAR + + + T VA T Y APE + + +++ D+
Sbjct: 135 NLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-TRWYRAPEIMLSFQSYTKAIDV 193
Query: 398 YSFGVLLAVLVMGK 411
+S G +LA L+ K
Sbjct: 194 WSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 49/188 (26%), Positives = 88/188 (46%), Gaps = 12/188 (6%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276
GE++ L + +A+K K+ L IK A I+ Q H NIV L+ +
Sbjct: 9 GEVFKGTLKDKTP--VAVKTCKEDLPQELKIKFLS-EARILK--QYDHPNIVKLIGVCTQ 63
Query: 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHR 336
+V E + G L L + + EL+ + A +G+ YL + IHR
Sbjct: 64 RQPIYIVMELVPGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 337 NITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCD 396
++ + L+ ++ +I+DFG++R DG S+ + + + APE ++S + D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDG-IYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 397 IYSFGVLL 404
++S+G+LL
Sbjct: 177 VWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVR--AEIMTAGQIRHRNIVPLL- 271
A G +Y A P S G +A+K V+ V + + + VR A + H NIV L+
Sbjct: 12 AYGTVYKARDPHS-GHFVALKSVR-VQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMD 69
Query: 272 -AHMVRPDCHLLVSEFMK--NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY 328
R D V+ + + L L+ V E + + R + GL++LH
Sbjct: 70 VCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETI--KDLMRQFLRGLDFLHA- 126
Query: 329 HRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT 388
I+HR++ P ++L+ + ++ADFGLAR+ Q++ + V T+ Y APE
Sbjct: 127 --NCIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVLLQ 181
Query: 389 LKFSEKCDIYSFGVLLA 405
++ D++S G + A
Sbjct: 182 STYATPVDMWSVGCIFA 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 51/186 (27%), Positives = 92/186 (49%), Gaps = 16/186 (8%)
Query: 228 NGKMIAIKK-VKQVDNSLLN-IKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285
G+++AIKK V+ D+ ++ I +R++R Q++H N+V L+ R LV E
Sbjct: 25 TGQIVAIKKFVESEDDPVIKKIALREIR----MLKQLKHPNLVNLIEVFRRKRKLHLVFE 80
Query: 286 FMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345
+ + ++L L +G + H I + I L+ ++ H+ IHR++ P ++LI
Sbjct: 81 YCDH-TVLNELEKNPRG------VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI 133
Query: 346 DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH-QTLKFSEKCDIYSFGVLL 404
+ ++ DFG AR++ T VA T Y APE ++ D+++ G +
Sbjct: 134 TKQGQIKLCDFGFARILTGPGDDY-TDYVA-TRWYRAPELLVGDTQYGPPVDVWAIGCVF 191
Query: 405 AVLVMG 410
A L+ G
Sbjct: 192 AELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 49/182 (26%), Positives = 90/182 (49%), Gaps = 10/182 (5%)
Query: 230 KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKN 289
+++AIKK K + + +K +R E+ ++ NIV L R LV E+++
Sbjct: 27 EIVAIKKFKDSEENE-EVKETTLR-ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK 84
Query: 290 GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM 349
++LE+L ++ G + ++ I ++ +H H+ I+HR+I P ++LI +
Sbjct: 85 -NMLELLEEMPNG------VPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND 137
Query: 350 EARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM 409
++ DFG AR + +G T VA T Y +PE + + D++S G +L L
Sbjct: 138 VLKLCDFGFARNLSEGSNANYTEYVA-TRWYRSPELLLGAPYGKAVDMWSVGCILGELSD 196
Query: 410 GK 411
G+
Sbjct: 197 GQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 28/201 (13%)
Query: 224 LPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMV--RPDCHL 281
LP M+A+K +K+ + S Q A +M + H NIV LL +P C
Sbjct: 30 LPYEPFTMVAVKMLKE-EASADMQADFQREAALMA--EFDHPNIVKLLGVCAVGKPMC-- 84
Query: 282 LVSEFMKNGSLLEILNDVS------------------QGRRELEWLARHRIARGIVSGLE 323
L+ E+M G L E L S L + IA+ + +G+
Sbjct: 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMA 144
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAP 383
YL +HR++ + L+ ++M +IADFGL+R + ++ A + ++ P
Sbjct: 145 YLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP 201
Query: 384 EYHQTLKFSEKCDIYSFGVLL 404
E +++ + D++++GV+L
Sbjct: 202 ESIFYNRYTTESDVWAYGVVL 222
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 20/150 (13%)
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRI--ARGIVSGLEYLHMYHRPRIIHRNIT 339
V E++ G L+ + V + + H + A I GL +LH II+R++
Sbjct: 78 FVMEYVNGGDLMYQIQQVGRFKEP------HAVFYAAEIAIGLFFLH---SKGIIYRDLK 128
Query: 340 PSSVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIY 398
+V++D + +IADFG+ + M DG V+T GT YIAPE + + D +
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 185
Query: 399 SFGVLLAVLVMGKLP-----SDDFFQHTEE 423
+FGVLL ++ G+ P D+ FQ E
Sbjct: 186 AFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 55/223 (24%), Positives = 108/223 (48%), Gaps = 39/223 (17%)
Query: 209 EKIRSRASGEIYIAEL-----------PESNGK--MIAIKKVK-QVDNSLLNIKMRQVRA 254
EK+ GE+++ E PE +G+ ++A+K ++ V + N +++++
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK- 69
Query: 255 EIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARH-- 312
IM+ ++++ NI+ LL V D +++E+M+NG L + L+ +RE+E H
Sbjct: 70 -IMS--RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLS-----QREIESTFTHAN 121
Query: 313 -----------RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361
+A I SG++YL + +HR++ + L+ + +IADFG++R
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRN 178
Query: 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
+ G + ++A E KF+ D+++FGV L
Sbjct: 179 LYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 33/212 (15%)
Query: 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQ---VRAEIMTAGQI 262
+ +R R S Y K++AI +V I+++Q V E ++
Sbjct: 15 GRVHLVRDRISEHYYAL-------KVMAIPEV---------IRLKQEQHVHNEKRVLKEV 58
Query: 263 RHRNIVPLLAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSG 321
H I+ L L ++ E++ G L L + A IV
Sbjct: 59 SHPFIIRLFWTE-HDQRFLYMLMEYVPGGELFSYL----RNSGRFSNSTGLFYASEIVCA 113
Query: 322 LEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI 381
LEYLH I++R++ P ++L+D + ++ DFG A+ + D T + GT Y+
Sbjct: 114 LEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPEYL 165
Query: 382 APEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
APE Q+ ++ D ++ G+L+ +++G P
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 69/269 (25%), Positives = 113/269 (42%), Gaps = 50/269 (18%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRA---EIMTAGQIRHRNIVPLLAHMVRPDCHL-L 282
++GK IKK+ +L N R+ +A E Q++H NIV D L +
Sbjct: 23 TDGKQYVIKKL-----NLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI 77
Query: 283 VSEFMKNGSLLEILNDVSQG-----RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRN 337
V F + G L L + +G + +EW + I L+YLH H I+HR+
Sbjct: 78 VMGFCEGGDLYHKLKE-QKGKLLPENQVVEWFVQ------IAMALQYLHEKH---ILHRD 127
Query: 338 ITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDI 397
+ +V + ++ D G+AR++ + ST I GT Y++PE ++ K D+
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI--GTPYYMSPELFSNKPYNYKSDV 185
Query: 398 YSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL--LGNGYEEQ 455
++ G V M L F + SLV R I+ KL + Y +
Sbjct: 186 WALGC--CVYEMATLKHA--FNAKDMNSLVY------------RIIEGKLPPMPKDYSPE 229
Query: 456 MLLVLKIACFCTLDDPEERPNSKDVRSML 484
+ ++ PE+RP V+S+L
Sbjct: 230 LGELIA-TMLSK--RPEKRP---SVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 66/240 (27%), Positives = 116/240 (48%), Gaps = 51/240 (21%)
Query: 211 IRSRASGEIYIAELPESNGKMIAIKKV-KQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV- 268
I + A G +Y+ E+ + A+KK+ KQ N +L +++QV E R+I+
Sbjct: 9 ISNGAYGAVYLVRHKETRQRF-AMKKINKQ--NLILRNQIQQVFVE---------RDILT 56
Query: 269 ----PLLAHMVRPDC------HL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARG 317
P + M C HL +V E+++ G +L ++ G ++ +AR A
Sbjct: 57 FAENPFVVSMF---CSFETKRHLCMVMEYVEGGDCATLLKNI--GALPVD-MARMYFAET 110
Query: 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL--------MPDGHAQV 369
+++ LEYLH Y I+HR++ P ++LI ++ DFGL+++ + +GH +
Sbjct: 111 VLA-LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 370 ST-----SIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
T V GT YIAPE + + D ++ G++L ++G +P FF T E+
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP---FFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 75/317 (23%), Positives = 137/317 (43%), Gaps = 71/317 (22%)
Query: 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHR 265
SL+++ S A G + A + + G+ +AIKK+ + S I ++ E+ ++H
Sbjct: 18 TSLKQVGSGAYGSVCSA-IDKRTGEKVAIKKLSRPFQS--EIFAKRAYRELTLLKHMQHE 74
Query: 266 NIVPLLAHMV-RPDCH-----LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIV 319
N++ LL LV +M+ L+ + ++++L ++
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQ-----ML 127
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG 379
GL+Y+H IIHR++ P ++ +++D E +I DFGLAR HA + T
Sbjct: 128 CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRW 179
Query: 380 YIAPE-------YHQTLKFSEKCDIYSFGVLLAVLVMGK--------------------L 412
Y APE Y+QT+ DI+S G ++A ++ GK +
Sbjct: 180 YRAPEVILNWMHYNQTV------DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 233
Query: 413 PSDDFFQHTEE-------KSLVRWMRNVMTSENPN---RAID--SKLLGNGYEEQML--L 458
P +F Q E+ KSL ++ R ++ P +A+D K+L ++++
Sbjct: 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATE 293
Query: 459 VLKIACFCTLDDPEERP 475
L+ F + D +E
Sbjct: 294 ALEHPYFDSFRDADEET 310
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 27/88 (30%), Positives = 52/88 (59%), Gaps = 6/88 (6%)
Query: 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGT 377
++ GL++LH + R++HR++ P ++L+ + ++ADFGLAR+ Q++ + V T
Sbjct: 119 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVT 172
Query: 378 VGYIAPEYHQTLKFSEKCDIYSFGVLLA 405
+ Y APE ++ D++S G + A
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFA 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 39/127 (30%), Positives = 61/127 (48%), Gaps = 20/127 (15%)
Query: 315 ARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR--LMPDGHAQVSTS 372
A I GL +LH II+R++ +V++D + +IADFG+ + + +T
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTR 159
Query: 373 IVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP-----SDDFFQHTEE---- 423
GT YIAPE + + D ++FGVLL ++ G+ P D+ FQ E
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219
Query: 424 --KSLVR 428
KSL +
Sbjct: 220 YPKSLSK 226
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 30/93 (32%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
L++LH II+R++ P ++L+D++ ++ DFGL++ D + GTV Y
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEY 164
Query: 381 IAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
+APE ++ D +SFGVL+ ++ G LP
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 63/237 (26%), Positives = 111/237 (46%), Gaps = 21/237 (8%)
Query: 181 NRGPTIFSPLIEKEDLAFLEK-EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQ 239
+R ++ P E +L F E E L +I + G +Y A +N +++AIKK+
Sbjct: 4 SRAGSLKDP--EIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTN-EVVAIKKM-S 59
Query: 240 VDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDV 299
N K + + E+ +I+H N + +R LV E+ GS ++L
Sbjct: 60 YSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH 118
Query: 300 SQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359
+ +E+E A I G + GL YLH ++ +IHR+I ++L+ + + ++ADFG A
Sbjct: 119 KKPLQEVEIAA---ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA 172
Query: 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTL---KFSEKCDIYSFGVLLAVLVMGKLP 413
+ ++ V GT ++APE + ++ K D++S G+ L K P
Sbjct: 173 SIASPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 27/218 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVK--QVDNSLLNIKMRQVRAEIMTAGQIRHR 265
+EKI G +Y A +N + IA+KK++ Q D + + +R EI +++H
Sbjct: 7 VEKIGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIR----EISLLKEMQHG 61
Query: 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARG----IVSG 321
NIV L + LV E++ L+ ++ R+ + I+ G
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQILRG 114
Query: 322 LEYLHMYHRPRIIHRNITPSSVLIDDDMEA-RIADFGLARLMPDGHAQVSTSIVAGTVGY 380
+ Y H + R++HR++ P ++LID A ++ADFGLAR + +V T+ Y
Sbjct: 115 IAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWY 169
Query: 381 IAPEYHQTLK-FSEKCDIYSFGVLLAVLVMGK--LPSD 415
APE + +S DI+S G + A +V K P D
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 40/118 (33%), Positives = 63/118 (53%), Gaps = 12/118 (10%)
Query: 315 ARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR-LMPDGHAQVSTSI 373
A I GL +LH R II+R++ +V++D + +IADFG+ + M DG V+T
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRT 160
Query: 374 VAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP-----SDDFFQHTEEKSL 426
GT YIAPE + + D +++GVLL ++ G+ P D+ FQ E ++
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV 218
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 27/198 (13%)
Query: 229 GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL------- 281
G+ +AIKK+ + ++ + K R R E++ + H+NI+ LL ++ P L
Sbjct: 41 GQNVAIKKLSRPFQNVTHAK-RAYR-ELVLMKLVNHKNIIGLL-NVFTPQKSLEEFQDVY 97
Query: 282 LVSEFMKNGSLLEILN-DVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITP 340
LV E M + +L +++ D+ R + +L ++ G+++LH IIHR++ P
Sbjct: 98 LVMELM-DANLCQVIQMDLDHER--MSYLLYQ-----MLCGIKHLH---SAGIIHRDLKP 146
Query: 341 SSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSF 400
S++++ D +I DFGLAR G + + T V T Y APE + + E DI+S
Sbjct: 147 SNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 203
Query: 401 GVLLAVLVMGKL--PSDD 416
G ++ ++ G + P D
Sbjct: 204 GCIMGEMIRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 24/168 (14%)
Query: 263 RHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIAR------ 316
+H+NI+ LL + ++ E+ G+L E L + RR + IAR
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYSYDIARVPDEQM 134
Query: 317 ----------GIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH 366
+ G+EYL + IHR++ +VL+ ++ +IADFGLAR + +
Sbjct: 135 TFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 367 AQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
T+ V ++APE ++ + D++SFGVL+ + +G P
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 57/279 (20%), Positives = 111/279 (39%), Gaps = 52/279 (18%)
Query: 236 KVKQVDNSLLNIKMRQVRAEIMTAGQIR-------------HRNIVPLL------AHMVR 276
++ Q D S L + ++ ++ +I T +I H N++ L+ + + +
Sbjct: 19 QLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78
Query: 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARH-------RIARGIVSGLEYLHMYH 329
+++ FMK+G L L L L + I G+EYL
Sbjct: 79 IPKPMVILPFMKHGDLHSFLL-----YSRLGGLPEKLPLQTLLKFMVDIALGMEYLS--- 130
Query: 330 RPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL 389
IHR++ + ++ +DM +ADFGL++ + G I V +IA E
Sbjct: 131 NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR 190
Query: 390 KFSEKCDIYSFGVLL-AVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLL 448
++ K D+++FGV + + G+ P + E + ++R+ + P +D
Sbjct: 191 VYTSKSDVWAFGVTMWEIATRGQTP----YPGVENHEIYDYLRHGNRLKQPEDCLDE--- 243
Query: 449 GNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487
+ + C DP++RP +R +L +
Sbjct: 244 ----------LYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 199 LEK--EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVK-QVDNSLLNIKMRQVRAE 255
LEK E A++ K R+R +GEI +A+K++ + + +R E
Sbjct: 5 LEKLGEGTYATVYKGRNRTTGEI------------VALKEIHLDAEEGTPSTAIR----E 48
Query: 256 IMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIA 315
I +++H NIV L + + +LV E+M L+ D R L+
Sbjct: 49 ISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFT 106
Query: 316 RGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVA 375
++ G+ + H R++HR++ P ++LI+ E ++ADFGLAR S +V
Sbjct: 107 YQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV- 162
Query: 376 GTVGYIAPE-YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
T+ Y AP+ + +S DI+S G ++A ++ G+
Sbjct: 163 -TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 262 IRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRREL-EWLARHRIARGIVS 320
+ H N++ L + +LLV EF G L L ++ + R+A + S
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
GL +LH IH ++ + + D+ +I D+GLA ++ A + +
Sbjct: 112 GLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 381 IAPE----YHQTL---KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433
+APE Q L ++K +I+S GV + + + ++E+ L + +R
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTM--WELFTAADQPYPDLSDEQVLKQVVREQ 226
Query: 434 MTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485
+ P +D K YE FC L DPE RP +++V +L+
Sbjct: 227 DI-KLPKPQLDLKYSDRWYEVMQ--------FCWL-DPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 24/202 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAE--IMTAGQIRHR 265
L ++ G++++A+ ++ G+++A+K++K+ LN ++R V E I+T +
Sbjct: 6 LTQVGQGGYGQVFLAKKKDT-GEIVALKRMKKSLLFKLN-EVRHVLTERDILTTT--KSE 61
Query: 266 NIVPLLAHMVRPDCHLLVSEFMKNG---SLLEILNDVSQGRRELEWLARHRIARGIVSGL 322
+V LL + L E++ G +LL L +S+ AR +A +
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH------ARFYMAEMFEA-- 113
Query: 323 EYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIA 382
+ H IHR++ P + LID ++ DFGL++ G + S+V G+ Y+A
Sbjct: 114 --VDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVV-GSPDYMA 166
Query: 383 PEYHQTLKFSEKCDIYSFGVLL 404
PE + + D +S G +L
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCML 188
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 43/203 (21%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFM 287
G +AIKK+ ++ R +R EI + +H NI+ +L ++RP
Sbjct: 29 TGVKVAIKKISPFEHQTFCQ--RTLR-EIKILRRFKHENIIGILD-IIRPPS-------- 76
Query: 288 KNGSLLEILNDVS--QGRRELEWLARHRIARG--------------IVSGLEYLHMYHRP 331
E NDV Q EL +++ + I+ GL+Y+H
Sbjct: 77 -----FESFNDVYIVQ---ELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH---SA 125
Query: 332 RIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS--TSIVAGTVGYIAPEYHQTL 389
++HR++ PS++L++ + + +I DFGLAR+ H T VA T Y APE
Sbjct: 126 NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA-TRWYRAPEIMLNS 184
Query: 390 K-FSEKCDIYSFGVLLAVLVMGK 411
K +++ DI+S G +LA ++ +
Sbjct: 185 KGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQ--VDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
GE+Y+A P + +A+KK+++ +N LL K R +R E A + H IVP+ +
Sbjct: 16 GEVYLAYDPVC-SRRVALKKIREDLSENPLL--KKRFLR-EAKIAADLIHPGIVPVYSIC 71
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQG---RRELEWL----ARHRIARGIVSGLEYLHM 327
D +++ +L +L V Q +EL A I I + +EY+H
Sbjct: 72 SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH- 130
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI-------------- 373
++HR++ P ++L+ E I D+G A + + I
Sbjct: 131 --SKGVLHRDLKPDNILLGLFGEVVILDWGAA-IFKKLEEEDLLDIDVDERNICYSSMTI 187
Query: 374 ---VAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
+ GT Y+APE + SE DIY+ GV+L
Sbjct: 188 PGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221
|
Length = 932 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVK--QVDNSLLNIKMRQVRAEIMTAGQIRHR 265
+EKI G +Y A + G+++A+KK++ D + + +R EI ++ H
Sbjct: 4 VEKIGEGTYGVVYKA-RDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHP 58
Query: 266 NIVPLLAHMVRPDCHLLVSEF--MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLE 323
NIV LL + + LV EF + ++ ++ ++ G+
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIK-----SYLYQLLQGIA 113
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAP 383
Y H + R++HR++ P ++LID + ++ADFGLAR + +V T+ Y AP
Sbjct: 114 YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 168
Query: 384 EYHQTLK-FSEKCDIYSFGVLLAVLVMGK 411
E + +S DI+S G + A +V +
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L+ I S A G I A G +A+KK+ + + + K R R E++ + H+NI
Sbjct: 26 LKPIGSGAQG-IVCAAFDTVLGINVAVKKLSRPFQNQTHAK-RAYR-ELVLLKCVNHKNI 82
Query: 268 VPLLAHMVRPDCHL-------LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVS 320
+ LL ++ P L LV E M + +L ++++ EL+ + ++
Sbjct: 83 ISLL-NVFTPQKSLEEFQDVYLVMELM-DANLCQVIH------MELDHERMSYLLYQMLC 134
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
G+++LH IIHR++ PS++++ D +I DFGLAR + T Y
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV---TRYY 188
Query: 381 IAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTE 422
APE + + E DI+S G ++ LV G + FQ T+
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKGSV----IFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 62/273 (22%), Positives = 112/273 (41%), Gaps = 52/273 (19%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH---MVRPDCHL-LV 283
N K + I+ K+ + + EI +I NI+ + +V L L+
Sbjct: 42 NNKEVIIRTFKKFHKGHKVL-IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLI 100
Query: 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY-HRPRIIHRNITPSS 342
E+ G L E+L+ ++L + + +A GL L+ Y ++P ++N+T S
Sbjct: 101 LEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVS 153
Query: 343 VLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK--FSE---KCDI 397
L+ ++ + +I GL +++ +S V ++ ++ L FSE K DI
Sbjct: 154 FLVTENYKLKIICHGLEKIL--------SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDI 205
Query: 398 YSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQM- 456
YS GV+L + GK+P F++ K I ++ ++
Sbjct: 206 YSLGVVLWEIFTGKIP----FENLTTKE-----------------IYDLIINKNNSLKLP 244
Query: 457 ----LLVLKIACFCTLDDPEERPNSKDVRSMLS 485
L + I CT D +RPN K++ LS
Sbjct: 245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVP 269
++R R + IY + I+K V S ++ AE Q+ IVP
Sbjct: 11 QVRKRDTQRIY---------ALKTIRKAHIVSRS----EVTHTLAERTVLAQVNCPFIVP 57
Query: 270 LLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH 329
L P+ LV F+ G L L +GR + AR A + + LE LH ++
Sbjct: 58 LKFSFQSPEKLYLVLAFINGGELFHHLQ--REGRFD-LSRARFYTAELLCA-LENLHKFN 113
Query: 330 RPRIIHRNITPSSVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEYHQT 388
+I+R++ P ++L+D + DFGL +L M D T+ GT Y+APE
Sbjct: 114 ---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLG 167
Query: 389 LKFSEKCDIYSFGVLLAVLVMGKLPSDD 416
+++ D ++ GVLL ++ G P D
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPPFYD 195
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 53/280 (18%)
Query: 228 NGKMIAIKKVKQVDNSLLNI-KMRQVRAEIMTAGQIRHRNIVPLLAHMV--RPDCHLLVS 284
GK AIK +K+ SL + +R+++A + H NI+ L+ + + LV
Sbjct: 23 TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSP---HPNILRLIEVLFDRKTGRLALVF 79
Query: 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIAR---GIVSGLEYLHMYHRPRIIHRNITPS 341
E M + +L E++ +GR+ L R+ ++ L+ HM HR I HR+I P
Sbjct: 80 ELM-DMNLYELI----KGRKRP--LPEKRVKSYMYQLLKSLD--HM-HRNGIFHRDIKPE 129
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKF-SEKCDIYSF 400
++LI DD ++ADFG R + +++ + T Y APE T + K DI++
Sbjct: 130 NILIKDD-ILKLADFGSCRGI---YSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAV 185
Query: 401 G-VLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS--------ENPNRAID------- 444
G V +L + L F T E + + +V+ + +R ++
Sbjct: 186 GCVFFEILSLFPL-----FPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKK 240
Query: 445 ----SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
KLL N E + L+ K+ + DP+ER +K
Sbjct: 241 GTGLRKLLPNASAEGLDLLKKLLAY----DPDERITAKQA 276
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 32/108 (29%), Positives = 55/108 (50%), Gaps = 10/108 (9%)
Query: 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAG 376
IVS L YLH +++R++ ++++D D +I DFGL + + DG + G
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCG 157
Query: 377 TVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
T Y+APE + + D + GV++ ++ G+LP F+ EK
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 32/237 (13%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL------ 270
G++Y A + G+++A+KKV+ +DN + +R EI Q+ HRNIV L
Sbjct: 21 GQVYKAR-DKDTGELVALKKVR-LDNEKEGFPITAIR-EIKILRQLNHRNIVNLKEIVTD 77
Query: 271 ----LAHMVRPDCHLLVSEFMKN---GSLLEILNDVSQGRRELEWLARHRIARGIVSGLE 323
L LV E+M + G L L S+ + + ++ GL
Sbjct: 78 KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-------SFMKQLLEGLN 130
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAP 383
Y H + +HR+I S++L+++ + ++ADFGLARL ++ T+ V T+ Y P
Sbjct: 131 YCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYRPP 186
Query: 384 E-YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439
E ++ D++S G +L L K FQ +E + + + + S P
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFTKK----PIFQANQELAQLELISRLCGSPCP 239
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 26/220 (11%)
Query: 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN 266
+L+ I S A G I A + +AIKK+ + + + K R R E++ + H+N
Sbjct: 21 NLKPIGSGAQG-IVCAAYDAVLDRNVAIKKLSRPFQNQTHAK-RAYR-ELVLMKCVNHKN 77
Query: 267 IVPLLAHMVRPDCHL-------LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIV 319
I+ LL ++ P L LV E M + +L +++ + EL+ + ++
Sbjct: 78 IISLL-NVFTPQKSLEEFQDVYLVMELM-DANLCQVI------QMELDHERMSYLLYQML 129
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG 379
G+++LH IIHR++ PS++++ D +I DFGLAR G + + T V T
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-TRY 183
Query: 380 YIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKL--PSDDF 417
Y APE + + E DI+S G ++ +V K+ P D+
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 325 LHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI---VAGTVGYI 381
+H H +IHR+I +++L+ + ++ DFG +++ A VS + GT Y+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA---ATVSDDVGRTFCGTPYYV 212
Query: 382 APEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSD 415
APE + +S+K D++S GVLL L+ K P D
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHR 265
LEKI G ++ A+ E+ +++A+K+V ++D+ + +R EI +++H+
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRET-HEIVALKRV-RLDDDDEGVPSSALR-EICLLKELKHK 59
Query: 266 NIVPLLAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARG----IVS 320
NIV L ++ D L LV E+ L+ D G + I + ++
Sbjct: 60 NIV-RLYDVLHSDKKLTLVFEYCDQD--LKKYFDSCNGDID------PEIVKSFMFQLLK 110
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
GL + H ++ ++HR++ P ++LI+ + E ++ADFGLAR S +V T+ Y
Sbjct: 111 GLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWY 165
Query: 381 IAPEYHQTLK-FSEKCDIYSFGVLLAVLVMGKLP 413
P+ K +S D++S G + A L P
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL 270
+R +ASG+ Y ++ + K + I K +V ++L ++ + RH + L
Sbjct: 14 VREKASGKYYAMKILK---KEVIIAK-DEVAHTLTESRVLK---------NTRHPFLTSL 60
Query: 271 LAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR 330
D V E++ G E+ +S+ R E R A IVS L+YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGG---ELFFHLSRERVFSEDRTRFYGAE-IVSALDYLH---S 113
Query: 331 PRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK 390
+I++R++ ++++D D +I DFGL + A + T GT Y+APE +
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDND 171
Query: 391 FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
+ D + GV++ ++ G+LP F+ EK
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP---FYNQDHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN 266
+L+ I S A G I A + +AIKK+ + + + K R R E++ + H+N
Sbjct: 28 NLKPIGSGAQG-IVCAAYDAILERNVAIKKLSRPFQNQTHAK-RAYR-ELVLMKCVNHKN 84
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEIL--NDVSQGRRELEWLARHRIARGIVSGLEY 324
I+ LL ++ P L EF ++E++ N + EL+ + ++ G+++
Sbjct: 85 IIGLL-NVFTPQKSL--EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 325 LHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE 384
LH IIHR++ PS++++ D +I DFGLAR G + + T V T Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-TRYYRAPE 195
Query: 385 YHQTLKFSEKCDIYSFGVLLAVLVMGKL--PSDDF 417
+ + E DI+S G ++ ++ G + P D
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 208 LEKIRSRASGEIYIAEL----PESN--GKMIAIKKVK--QVDNSLLNIKMRQVRAEIMTA 259
L++IR G EL PE + G+ +A+K +K N + ++K EI
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-----KEIEIL 60
Query: 260 GQIRHRNIVPLLAHMVRPDCH-------LLVSEFMKNGSLLEILNDVSQGRRELEWLARH 312
+ H NIV + C L+ EF+ +GSL E L + + ++ +
Sbjct: 61 RNLYHENIVKY-----KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQL 112
Query: 313 RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD--GHAQVS 370
+ A I G++YL + +HR++ +VL++ + + +I DFGL + + + V
Sbjct: 113 KYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169
Query: 371 TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLV 408
+ + Y APE KF D++SFGV L L+
Sbjct: 170 DDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 51/191 (26%), Positives = 90/191 (47%), Gaps = 18/191 (9%)
Query: 229 GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH-----LLV 283
G+ +AIKK+ V + + R +R EI +RH +IV + M+ P +V
Sbjct: 25 GEKVAIKKINDVFEHVSD-ATRILR-EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 82
Query: 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSV 343
E M++ L+ V + +L ++ L+Y+H + + HR++ P ++
Sbjct: 83 FELMESD-----LHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNI 134
Query: 344 LIDDDMEARIADFGLARLM-PDGHAQVSTSIVAGTVGYIAPEYHQTL--KFSEKCDIYSF 400
L + D + +I DFGLAR+ D + + T Y APE + K++ DI+S
Sbjct: 135 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 194
Query: 401 GVLLAVLVMGK 411
G + A ++ GK
Sbjct: 195 GCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 58/241 (24%), Positives = 101/241 (41%), Gaps = 52/241 (21%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
A GE+ + ++N + A+K +++ D + N + V+AE + + +V L
Sbjct: 13 AFGEVCLVRKVDTN-ALYAMKTLRKADVLMRN-QAAHVKAERDILAEADNEWVVKLYYSF 70
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
D V +++ G ++ +L + G E E LAR IA + +E +H + I
Sbjct: 71 QDKDNLYFVMDYIPGGDMMSLL--IRLGIFE-EDLARFYIAE-LTCAIESVH---KMGFI 123
Query: 335 HRNITPSSVLIDDDMEARIADFGLAR----------LMPDGHAQVST------------- 371
HR+I P ++LID D ++ DFGL H + +
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 372 -------------------SIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKL 412
S+V GT YIAPE +++ CD +S GV+L +++G+
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLV-GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 413 P 413
P
Sbjct: 243 P 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 41/216 (18%)
Query: 215 ASGEIYIAE---LPESNGKM-IAIKKVKQ--VDNSLLNIKMRQVRAEIMTAGQI-RHRNI 267
A G++ AE L N +A+K +K + L ++ +E+ I +H+NI
Sbjct: 24 AFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLV-----SEMEMMKMIGKHKNI 78
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIAR---------GI 318
+ LL + +V E+ +G+L + L + RR A R +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFL----RARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 319 VS-------GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ--- 368
VS G+E+L + IHR++ +VL+ +D +IADFGLAR D H
Sbjct: 135 VSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLAR---DIHHIDYY 188
Query: 369 VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
T+ V ++APE ++ + D++SFGVLL
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 224
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 49/210 (23%), Positives = 83/210 (39%), Gaps = 28/210 (13%)
Query: 282 LVSEFMKNGSLLEIL---NDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI 338
LV++ M G LL+ + D + L W + I G+ YL R++HR++
Sbjct: 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE---EVRLVHRDL 135
Query: 339 TPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIY 398
+VL+ +I DFGLARL+ + + ++A E +F+ + D++
Sbjct: 136 AARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVW 195
Query: 399 SFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLL 458
S+GV + L+ D E L+ + + P ID
Sbjct: 196 SYGVTVWELMTFGAKPYDGIPAREIPDLLE--KGERLPQPPICTID-------------- 239
Query: 459 VLKIACFCTLDDPEERPNSKDVRSMLSDTA 488
V I C + D E RP +++ S A
Sbjct: 240 VYMIMVKCWMIDSECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 211 IRSRASGEIY----IAELPESNGKM-IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHR 265
+ S A GE+Y L +G + +A+K +++ + + A +M H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLM--SNFNHP 59
Query: 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARH---RIARGIVSGL 322
NIV LL + + ++ E M+ G LL L D R L I + G
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 323 EYLHMYHRPRIIHRNITPSSVLI-----DDDMEARIADFGLAR-LMPDGHAQVSTSIVAG 376
YL H IHR++ + L+ D D +I DFGLAR + + + +
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL- 175
Query: 377 TVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
V ++APE KF+ + D++SFGVL+ +L +G+ P
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGT 377
IVS LEYLH +++R+I ++++D D +I DFGL + A + T GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 158
Query: 378 VGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
Y+APE + + D + GV++ ++ G+LP F+ E+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHER 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 45/176 (25%), Positives = 84/176 (47%), Gaps = 13/176 (7%)
Query: 236 KVKQVDNSLLNIKM---RQVRAEIMTAGQIRHRNIVPLLAHMV---RPDCHLLVSEFMKN 289
+ KQ+D ++ +K + VR E+M +I H+ P + M+ + +LV E
Sbjct: 19 RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASG 78
Query: 290 GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM 349
G L + L S + E+ + + G++YL +HR++ +VL+ +
Sbjct: 79 GPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQH 132
Query: 350 EARIADFGLAR-LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
A+I+DFGL++ L D + S + + APE KFS + D++S+G+ +
Sbjct: 133 YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITM 188
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 24/168 (14%)
Query: 263 RHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRR----------------EL 306
+H+NI+ LL + ++ E+ G+L E L + RR +L
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYL----RARRPPGMDYSFDTCKLPEEQL 131
Query: 307 EWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH 366
+ A + G+EYL + IHR++ +VL+ +D +IADFGLAR + +
Sbjct: 132 TFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID 188
Query: 367 AQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
T+ V ++APE ++ + D++SFGVLL + +G P
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 56/272 (20%), Positives = 112/272 (41%), Gaps = 46/272 (16%)
Query: 237 VKQVDNSLLNIKMRQVRAEIMTAGQIR-------------HRNIVPLLAHMVRPDCH--- 280
+K D S + ++ ++A+I ++ I H N++ L+ +R
Sbjct: 20 LKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79
Query: 281 ---LLVSEFMKNGSLLEILNDVSQGRR----ELEWLARHRIARGIVSGLEYLHMYHRPRI 333
+++ FMK+G L L G L+ L R I I SG+EYL
Sbjct: 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI--DIASGMEYLS---SKNF 134
Query: 334 IHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSE 393
IHR++ + +++++M +ADFGL++ + G V ++A E ++
Sbjct: 135 IHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTT 194
Query: 394 KCDIYSFGVLL-AVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGY 452
D+++FGV + ++ G+ P + E + ++ + P ++
Sbjct: 195 HSDVWAFGVTMWEIMTRGQTP----YAGVENSEIYNYLIKGNRLKQPPDCLED------- 243
Query: 453 EEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484
V ++ C C +P+ RP+ + +R L
Sbjct: 244 ------VYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 67/285 (23%), Positives = 116/285 (40%), Gaps = 55/285 (19%)
Query: 217 GEIY--IAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
G++Y + PE+ +A+K K + + K Q A IM Q H +IV L+ +
Sbjct: 20 GDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMR--QFDHPHIVKLIG-V 75
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
+ + +V E G L L + L+ + + + + L YL R +
Sbjct: 76 ITENPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYLE---SKRFV 129
Query: 335 HRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEK 394
HR+I +VL+ ++ DFGL+R + D + S + ++APE +F+
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLPIKWMAPESINFRRFTSA 188
Query: 395 CDIYSFGVLL-AVLVMGKLPSDDFFQHTEEKSLVRWMRN---VMTSENPNRAIDSKLLGN 450
D++ FGV + +L++G P FQ ++N + EN R
Sbjct: 189 SDVWMFGVCMWEILMLGVKP----FQ---------GVKNNDVIGRIENGER--------- 226
Query: 451 GYEEQMLLVLKIACFCTLD---------DPEERPNSKDVRSMLSD 486
L + C TL DP +RP ++++ LSD
Sbjct: 227 -------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 37/137 (27%), Positives = 70/137 (51%), Gaps = 15/137 (10%)
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
+V E+M G L+ ++++ + W AR A +++ L H IHR++ P
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEK---W-ARFYTAEVVLA----LDAIHSMGFIHRDVKPD 171
Query: 342 SVLIDDDMEARIADFGLA-RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK----FSEKCD 396
++L+D ++ADFG ++ +G + T++ GT YI+PE ++ + +CD
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV--GTPDYISPEVLKSQGGDGYYGRECD 229
Query: 397 IYSFGVLLAVLVMGKLP 413
+S GV L +++G P
Sbjct: 230 WWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 16/164 (9%)
Query: 263 RHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEIL------------NDVSQGRRELEWLA 310
+H+NI+ LL + ++ E+ G+L E L N +L +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 311 RHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS 370
A + G+EYL + IHR++ +VL+ +D +IADFGLAR +
Sbjct: 142 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 371 TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
T+ V ++APE ++ + D++SFGVLL + +G P
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 42/144 (29%), Positives = 70/144 (48%), Gaps = 13/144 (9%)
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
V E+ G E+ +S+ R E AR A IVS L+YLH +++R++
Sbjct: 72 FVMEYANGG---ELFFHLSRERVFSEDRARFYGAE-IVSALDYLHS--EKNVVYRDLKLE 125
Query: 342 SVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSF 400
++++D D +I DFGL + + DG + GT Y+APE + + D +
Sbjct: 126 NLMLDKDGHIKITDFGLCKEGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 182
Query: 401 GVLLAVLVMGKLPSDDFFQHTEEK 424
GV++ ++ G+LP F+ EK
Sbjct: 183 GVVMYEMMCGRLP---FYNQDHEK 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 49/220 (22%), Positives = 100/220 (45%), Gaps = 32/220 (14%)
Query: 209 EKIRSRASGEIYIAE---LPESNGKM------------IAIKKVK-QVDNSLLNIKMRQV 252
EK+ GE+++ E L + + K +A+K ++ ++ +++V
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 253 RAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEIL-------NDVSQGRRE 305
+ I++ ++ NI LL ++ E+M+NG L + L + ++ +
Sbjct: 71 K--ILS--RLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126
Query: 306 LEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR-LMPD 364
L + +A I SG+ YL + +HR++ + L+ + +IADFG++R L
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183
Query: 365 GHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
+ +V + ++A E KF+ K D+++FGV L
Sbjct: 184 DYYRVQGRAPL-PIRWMAWESVLLGKFTTKSDVWAFGVTL 222
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 229 GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL-LVSEFM 287
GK+ A+K +K+ R E IR + L + + D L L+ +++
Sbjct: 28 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYI 87
Query: 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347
G E+ +SQ R E + IV LE+LH + II+R+I ++L+D
Sbjct: 88 NGG---ELFTHLSQRERFKEQEVQIYSGE-IVLALEHLH---KLGIIYRDIKLENILLDS 140
Query: 348 DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ--TLKFSEKCDIYSFGVLLA 405
+ + DFGL++ + + + S GT+ Y+AP+ + + D +S GVL+
Sbjct: 141 NGHVVLTDFGLSKEFHEDEVERAYSF-CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMY 199
Query: 406 VLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439
L+ G P F E+ S R ++ SE P
Sbjct: 200 ELLTGASP---FTVDGEKNSQAEISRRILKSEPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 18/179 (10%)
Query: 264 HRNIVPLLAHMVRPDCHL-----LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGI 318
H N+V + D + LV E GS+ E++ + + L+ I G
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 319 VSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTV 378
+ GL++LH RIIHR++ +++L+ + ++ DFG++ + + +TS+ GT
Sbjct: 138 LLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTP 192
Query: 379 GYIAPEY---HQTLKFS--EKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN 432
++APE Q +S +CD++S G+ L G P F K+L + RN
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP---LFDMHPVKTLFKIPRN 248
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 39/138 (28%), Positives = 68/138 (49%), Gaps = 17/138 (12%)
Query: 282 LVSEFMKNGSLLEILN--DVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNIT 339
+V E+M G L+ +++ DV + +W A+ A +++ L H +IHR++
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE-----KW-AKFYTAEVVLA----LDAIHSMGLIHRDVK 169
Query: 340 PSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK----FSEKC 395
P ++L+D ++ADFG M D V GT YI+PE ++ + +C
Sbjct: 170 PDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228
Query: 396 DIYSFGVLLAVLVMGKLP 413
D +S GV L +++G P
Sbjct: 229 DWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 44/186 (23%), Positives = 78/186 (41%), Gaps = 26/186 (13%)
Query: 232 IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGS 291
+AIK V + + I+ A +M + ++V LL + L+V E M G
Sbjct: 39 VAIKTVNENASMRERIEFLN-EASVMK--EFNCHHVVRLLGVVSTGQPTLVVMELMAKGD 95
Query: 292 LLEIL------NDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345
L L + + G ++A I G+ YL +HR++ + ++
Sbjct: 96 LKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMV 152
Query: 346 DDDMEARIADFGLARLM-------PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIY 398
+D+ +I DFG+ R + G + V ++APE + F+ K D++
Sbjct: 153 AEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP-------VRWMAPESLKDGVFTTKSDVW 205
Query: 399 SFGVLL 404
SFGV+L
Sbjct: 206 SFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 48/154 (31%), Positives = 79/154 (51%), Gaps = 18/154 (11%)
Query: 213 SR-ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKM-RQVRAEIMTAGQIRHRNIVPL 270
SR A G++Y+ ++N K+ A+K VK+ D ++N M QV+AE + IV L
Sbjct: 13 SRGAFGKVYLGR-KKNNSKLYAVKVVKKAD--MINKNMVHQVQAERDALALSKSPFIVHL 69
Query: 271 LAHMVRPDCHLLVSEFMKNG---SLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+ + LV E++ G SLL I E +A I+ + L+YLH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD------EEMAVKYISE-VALALDYLH- 121
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361
R IIHR++ P ++LI ++ ++ DFGL+++
Sbjct: 122 --RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 39/160 (24%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 251 QVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRREL---- 306
Q E ++ H IV A + D +++E+ + L L ++ + L
Sbjct: 48 QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ 107
Query: 307 --EWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD 364
EW + ++ G+ Y+H RI+HR++ ++ + +++ +I DFG++RL+
Sbjct: 108 VCEWFIQ------LLLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM- 156
Query: 365 GHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
G ++T+ GT Y++PE + + K DI+S G +L
Sbjct: 157 GSCDLATTF-TGTPYYMSPEALKHQGYDSKSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 15/146 (10%)
Query: 264 HRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLE 323
H NIV LL L+++E+ G LL L + LE L + + G+
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS--FSYQVAKGMA 155
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR-LMPDGHAQVSTSIVAGT----V 378
+L IHR++ +VL+ +I DFGLAR +M D S +V G V
Sbjct: 156 FLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND-----SNYVVKGNARLPV 207
Query: 379 GYIAPEYHQTLKFSEKCDIYSFGVLL 404
++APE ++ + D++S+G+LL
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILL 233
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 40/171 (23%), Positives = 76/171 (44%), Gaps = 21/171 (12%)
Query: 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGT 377
I SG+EYL IHR++ + +++++M +ADFGL++ + +G I
Sbjct: 121 IASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 378 VGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436
V +IA E ++ K D++SFGV + + G+ P + E + ++R
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP----YPGVENSEIYDYLRQGNRL 233
Query: 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487
+ P +D + + C L +P++RP+ + +R L
Sbjct: 234 KQPPDCLDG-------------LYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 71/269 (26%), Positives = 120/269 (44%), Gaps = 35/269 (13%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
A G++Y A+ E+ G + A K ++ L M EI H IV LL
Sbjct: 24 AFGKVYKAKNKET-GALAAAKVIETKSEEELEDYM----VEIEILATCNHPYIVKLLGAF 78
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
++ EF G++ I+ ++ +G E + I R ++ L+YLH +II
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI---QVICRQMLEALQYLH---SMKII 132
Query: 335 HRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE--YHQTLK-- 390
HR++ +VL+ D + ++ADFG++ + + I GT ++APE +T+K
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCETMKDT 190
Query: 391 -FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLG 449
+ K DI+S G+ L + + P E + +R + + SE P + SK
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPH-------HELNPMRVLLKIAKSEPPTLSQPSK--- 240
Query: 450 NGYEEQMLLVLKIACFCTLD-DPEERPNS 477
+ + LK A LD PE RP++
Sbjct: 241 --WSMEFRDFLKTA----LDKHPETRPSA 263
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 58/244 (23%), Positives = 99/244 (40%), Gaps = 54/244 (22%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
A GE+ +A ++ + A+K +++ D LL ++ V+AE + + +V L
Sbjct: 13 AFGEVCLARKVDTKA-LYAMKTLRKKD-VLLRNQVAHVKAERDILAEADNEWVVRLYYSF 70
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
D V +++ G ++ +L + G E LAR IA + + H+ I
Sbjct: 71 QDKDNLYFVMDYIPGGDMMSLL--IRMGIFP-EDLARFYIAELTCA----VESVHKMGFI 123
Query: 335 HRNITPSSVLIDDDMEARIADFGLA----------------------------------- 359
HR+I P ++LID D ++ DFGL
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183
Query: 360 ----RLMP------DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM 409
RL P H + + GT YIAPE +++ CD +S GV+L +++
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 243
Query: 410 GKLP 413
G+ P
Sbjct: 244 GQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 51/200 (25%), Positives = 93/200 (46%), Gaps = 30/200 (15%)
Query: 229 GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288
K +A+KK+ D ++ EI ++ H NIV + ++ P L +
Sbjct: 30 DKRVAVKKIVLTDPQ----SVKHALREIKIIRRLDHDNIVKVY-EVLGPSGSDLTEDV-- 82
Query: 289 NGSLLEILNDVSQGRRELEWLARHRIARGIVS-------------GLEYLHMYHRPRIIH 335
GSL E LN V + +E + + +G +S GL+Y+H ++H
Sbjct: 83 -GSLTE-LNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIH---SANVLH 137
Query: 336 RNITPSSVLID-DDMEARIADFGLARLMPDGHAQVSTSIVAGTVG--YIAPE-YHQTLKF 391
R++ P++V I+ +D+ +I DFGLAR++ D H + G V Y +P +
Sbjct: 138 RDLKPANVFINTEDLVLKIGDFGLARIV-DPHYSHKGYLSEGLVTKWYRSPRLLLSPNNY 196
Query: 392 SEKCDIYSFGVLLAVLVMGK 411
++ D+++ G + A ++ GK
Sbjct: 197 TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 14/160 (8%)
Query: 255 EIMTAGQIRHRNIVPL--LAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARH 312
E+ ++H NIV L + H R C LV E++ + L + L++ ++ H
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTER--CLTLVFEYLDS-DLKQYLDNCGN------LMSMH 103
Query: 313 RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTS 372
+ + L L H+ +I+HR++ P ++LI++ E ++ADFGLAR S
Sbjct: 104 NVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE 163
Query: 373 IVAGTVGYIAPE-YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
+V T+ Y P+ + ++S D++ G +L + G+
Sbjct: 164 VV--TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVK-QVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH 273
A GE+Y+ ++ G+ +A+K+V D+ + ++ + EI +RH IV
Sbjct: 14 AFGEVYLCYDADT-GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72
Query: 274 MVRPDCHLL--VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP 331
+ P+ L E+M GS+ D + L R R I+ G+ YLH
Sbjct: 73 LRDPEEKKLSIFVEYMPGGSI----KDQLKAYGALTENVTRRYTRQILQGVSYLH---SN 125
Query: 332 RIIHRNITPSSVLIDDDMEARIADFGLA-RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK 390
I+HR+I +++L D ++ DFG + R+ + V GT +++PE
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG 185
Query: 391 FSEKCDIYSFGVLLAVLVMGKLPSDDF 417
+ K D++S + ++ K P ++
Sbjct: 186 YGRKADVWSVACTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 30/102 (29%), Positives = 57/102 (55%), Gaps = 7/102 (6%)
Query: 313 RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTS 372
+ A + +G++YL + IHR++ +VL+ +++ ++IADFGL+R V +
Sbjct: 123 QFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKT 176
Query: 373 IVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
+ V ++A E ++ K D++SFGVLL ++ +G P
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 38/203 (18%)
Query: 226 ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH----- 280
E+N K +AIKK+ ++ ++ K R +R EI + H N++ + ++ P
Sbjct: 28 ETNEK-VAIKKIANAFDNRIDAK-RTLR-EIKLLRHLDHENVIAI-KDIMPPPHREAFND 83
Query: 281 -LLVSEFMKNGSLLEILNDVSQGRRE------LEWLARHRIARGIVSGLEYLHMYHRPRI 333
+V E M + L +I+ SQ + L L R GL+Y+H +
Sbjct: 84 VYIVYELM-DTDLHQIIRS-SQTLSDDHCQYFLYQLLR---------GLKYIH---SANV 129
Query: 334 IHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSE 393
+HR++ PS++L++ + + +I DFGLAR + ++ +V T Y APE L SE
Sbjct: 130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV--TRWYRAPEL--LLNCSE 185
Query: 394 ---KCDIYSFGVLLAVLVMGKLP 413
D++S G + A L +G+ P
Sbjct: 186 YTTAIDVWSVGCIFAEL-LGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQ-VDNSLLNIK-MRQVRAEIMTAGQIRHRNIVPLLAHM 274
GE+Y A + G+++A+KK+ + I +R EI +++H N+VPL+ M
Sbjct: 22 GEVYKARQIK-TGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVPLI-DM 75
Query: 275 V--RPD-------CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYL 325
RPD +V+ +M + L +L + +L ++ G+ YL
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYL 131
Query: 326 HMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL------MPDGHAQVS----TSIVA 375
H I+HR+I +++LID+ +IADFGLAR P G T++V
Sbjct: 132 H---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV 188
Query: 376 GTVGYIAPEYHQTLK-FSEKCDIYSFGVLLAVLVMGK 411
T Y PE + ++ DI+ G + A + +
Sbjct: 189 -TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 56/196 (28%), Positives = 85/196 (43%), Gaps = 27/196 (13%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286
GK+ A+K +K K VR + TA RNI+ + H D L+ F
Sbjct: 22 DTGKIFAMKVLK---------KATIVRNQKDTAHTKAERNILEAVKHPFIVD---LIYAF 69
Query: 287 MKNGSLLEILNDVSQGR------RE---LEWLARHRIARGIVSGLEYLHMYHRPRIIHRN 337
G L IL +S G RE +E A ++ I LE+LH + II+R+
Sbjct: 70 QTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE-ISLALEHLH---QQGIIYRD 125
Query: 338 ITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDI 397
+ P ++L+D ++ DFGL + H T GT+ Y+APE + D
Sbjct: 126 LKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDW 183
Query: 398 YSFGVLLAVLVMGKLP 413
+S G L+ ++ G P
Sbjct: 184 WSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 51/190 (26%), Positives = 86/190 (45%), Gaps = 26/190 (13%)
Query: 239 QVDNSLLNIKMRQVRAEIMTAGQIRH----RNIVPLLAHMVRPDCHLLVSEFMKNGSLLE 294
+ + +K+ Q +A I+ + +H RN+ LL ++ P L F L
Sbjct: 17 KAEEKFYAVKVLQKKA-ILKKKEEKHIMSERNV--LLKNVKHPFLVGLHFSFQTADKLYF 73
Query: 295 ILNDVSQG------RRE---LEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345
+L+ ++ G +RE LE AR A I S L YLH + I++R++ P ++L+
Sbjct: 74 VLDYINGGELFYHLQRERCFLEPRARFYAAE-IASALGYLHSLN---IVYRDLKPENILL 129
Query: 346 DDDMEARIADFGLAR--LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVL 403
D + DFGL + + +G +TS GT Y+APE + D + G +
Sbjct: 130 DSQGHIVLTDFGLCKENIEHNG----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAV 185
Query: 404 LAVLVMGKLP 413
L ++ G P
Sbjct: 186 LYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 19/163 (11%)
Query: 264 HRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARH----------- 312
H NI+ LL L E+ +G+LL+ L + + +
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 313 -RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVST 371
A + G++YL + + IHR++ ++L+ ++ A+IADFGL+R V
Sbjct: 115 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 168
Query: 372 SIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
++ V ++A E ++ D++S+GVLL ++ +G P
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 19/163 (11%)
Query: 264 HRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVS--- 320
H NI+ LL L E+ +G+LL+ L + + + A + S
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 321 ---------GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVST 371
G++YL + + IHR++ ++L+ ++ A+IADFGL+R V
Sbjct: 127 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 180
Query: 372 SIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
++ V ++A E ++ D++S+GVLL ++ +G P
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 43/162 (26%), Positives = 83/162 (51%), Gaps = 20/162 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L KI GE++ A + +++A+KKV ++N + +R EI ++H N+
Sbjct: 17 LAKIGQGTFGEVFKAR-HKKTKQIVALKKVL-MENEKEGFPITALR-EIKILQLLKHENV 73
Query: 268 VPLL---------AHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGI 318
V L+ + + +L V EF ++ L +L++ + E ++ + +
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYL-VFEFCEH-DLAGLLSNKNVKFTLSE---IKKVMKML 128
Query: 319 VSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360
++GL Y+H R +I+HR++ +++LI D ++ADFGLAR
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 38/157 (24%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 255 EIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILND-------VSQGRRELE 307
EI +++ NI+ LLA + D +++E+M+NG L + L+ +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 308 WLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367
+ +A I SG++YL + +HR++ + L+ + +IADFG++R + G
Sbjct: 129 YSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
+ +++ E KF+ D+++FGV L
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 49/226 (21%)
Query: 215 ASGEIYIAE---LPESNGKM-IAIKKVKQV--DNSLLNIKMRQVRAEIMTAGQIRHRNIV 268
A GE+Y ++ +A+K + + + + M A IM + H+NIV
Sbjct: 18 AFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLME---ALIM--SKFNHQNIV 72
Query: 269 PLLAHMVRPDCHLLVSEFMKNGSLLEIL--NDVSQGR-RELEWLARHRIARGIVSGLEYL 325
L+ ++ E M G L L N R L AR + G +YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 326 HMYHRPRIIHRNITPSSVLIDD---DMEARIADFGLAR--------------LMPDGHAQ 368
H IHR+I + L+ A+IADFG+AR ++P
Sbjct: 133 EENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP----- 184
Query: 369 VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
+ ++ PE F+ K D++SFGVLL + +G +P
Sbjct: 185 ---------IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAG 260
K D LEK+ + +Y + + NGK++A+K ++ + +R + G
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGK-SKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKG 59
Query: 261 QIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVS 320
++H NIV L + + LV E++ L + ++ G L ++
Sbjct: 60 -LKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGG---LHPENVKLFLFQLLR 114
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
GL Y+H + I+HR++ P ++LI D E ++ADFGLAR S +V T+ Y
Sbjct: 115 GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWY 169
Query: 381 IAPE-YHQTLKFSEKCDIYSFGVLLAVLVMG 410
P+ + ++S D++ G + ++ G
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 4/85 (4%)
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR-LMPDGHAQVSTSIVAGTVG 379
G++YL + +HR++ +VL+ A+I+DFGL++ L D + + + V
Sbjct: 107 GMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK 163
Query: 380 YIAPEYHQTLKFSEKCDIYSFGVLL 404
+ APE KFS K D++SFGVL+
Sbjct: 164 WYAPECMNYYKFSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 41/138 (29%), Positives = 70/138 (50%), Gaps = 15/138 (10%)
Query: 281 LLVSEFMKNGSLLEILNDVSQGRREL-EWLARHRIARGIVSGLEYLHMYHRPRIIHRNIT 339
LV E++ G L+ + Q +R+L E AR A ++ L+ H II+R++
Sbjct: 72 FLVIEYVNGGDLMFHM----QRQRKLPEEHARFYAAEICIA----LNFLHERGIIYRDLK 123
Query: 340 PSSVLIDDDMEARIADFGLAR--LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDI 397
+VL+D D ++ D+G+ + L P +TS GT YIAPE + ++ D
Sbjct: 124 LDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 398 YSFGVLLAVLVMGKLPSD 415
++ GVL+ ++ G+ P D
Sbjct: 180 WALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 4e-06
Identities = 37/143 (25%), Positives = 68/143 (47%), Gaps = 14/143 (9%)
Query: 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHR 336
H+L+ +++K+G L ++L + +L +I R +V L LH ++ IIH
Sbjct: 81 LKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHN 133
Query: 337 NITPSSVLIDDDME-ARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKC 395
+I +VL D + + D+GL +++ + S GT+ Y +PE + +
Sbjct: 134 DIKLENVLYDRAKDRIYLCDYGLCKIIG------TPSCYDGTLDYFSPEKIKGHNYDVSF 187
Query: 396 DIYSFGVLLAVLVMGKLPSDDFF 418
D ++ GVL L+ GK P +
Sbjct: 188 DWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 28/202 (13%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH----RNIVPLLAHMVRPDCHLL 282
S GK++ K+ + D S +K+ Q + I+ + H RN+ LL ++ P L
Sbjct: 7 SFGKVLLAKR--KSDGSFYAVKVLQ-KKTILKKKEQNHIMAERNV--LLKNLKHPFLVGL 61
Query: 283 VSEFMKNGSLLEILNDVSQG---------RRELEWLARHRIARGIVSGLEYLHMYHRPRI 333
F L +L+ V+ G R LE AR A + S + YLH + I
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAE-VASAIGYLHSLN---I 117
Query: 334 IHRNITPSSVLIDDDMEARIADFGLAR--LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKF 391
I+R++ P ++L+D + DFGL + + P+ +TS GT Y+APE + +
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE----TTSTFCGTPEYLAPEVLRKEPY 173
Query: 392 SEKCDIYSFGVLLAVLVMGKLP 413
D + G +L ++ G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 64/259 (24%), Positives = 112/259 (43%), Gaps = 27/259 (10%)
Query: 237 VKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEIL 296
VK++ S + + E ++H N++ L +LLV EF G L L
Sbjct: 27 VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL 86
Query: 297 NDVSQGRREL---EWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARI 353
S + EL + R+A I GL LH+ H+ IH ++ + L+ D+ +I
Sbjct: 87 R--SCRKAELMTPDPTTLQRMACEIALGL--LHL-HKNNFIHSDLALRNCLLTADLTVKI 141
Query: 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEY----HQTLKF---SEKCDIYSFGVLLAV 406
D+GL+ V+ + + +IAPE H L +++ +++S GV +
Sbjct: 142 GDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWE 201
Query: 407 LVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFC 466
L +L S + ++E+ L +R + P + L YE + FC
Sbjct: 202 LF--ELGSQPYRHLSDEQVLTYTVRE-QQLKLPKPRLKLPLSDRWYE--------VMQFC 250
Query: 467 TLDDPEERPNSKDVRSMLS 485
L PE+RP++++V +LS
Sbjct: 251 WL-QPEQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 46/179 (25%), Positives = 85/179 (47%), Gaps = 26/179 (14%)
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
I R ++ L+Y+H + +IHR+I +++L+ + ++ DFG+A L+ ++ ST
Sbjct: 106 IIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-- 160
Query: 374 VAGTVGYIAPEYHQTLK-FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN 432
GT ++APE K + K DI+S G+ + + G P D R M
Sbjct: 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-------RAMML 213
Query: 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIK 491
+ S+ P +L NGY + + + C ++P+ER ++++ L + IK
Sbjct: 214 IPKSKPP------RLEDNGYSKLL---REFVAACLDEEPKERLSAEE----LLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 51/192 (26%), Positives = 87/192 (45%), Gaps = 21/192 (10%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTA-----GQIRHRNIVPLLAHMVRPDCHLL 282
+GK A+K +++ +LN R+ + IM ++H +V L +
Sbjct: 19 DGKCYAVKVLQK--KIVLN---RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYF 73
Query: 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSS 342
V +F+ G E+ + + R E AR A I S L YLH I++R++ P +
Sbjct: 74 VLDFVNGG---ELFFHLQRERSFPEPRARFYAAE-IASALGYLHSI---NIVYRDLKPEN 126
Query: 343 VLIDDDMEARIADFGLARLMPDGHAQV-STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFG 401
+L+D + DFGL + +G AQ +T+ GT Y+APE + + D + G
Sbjct: 127 ILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLG 183
Query: 402 VLLAVLVMGKLP 413
+L ++ G P
Sbjct: 184 AVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (116), Expect = 6e-06
Identities = 58/248 (23%), Positives = 114/248 (45%), Gaps = 42/248 (16%)
Query: 208 LEKIRSRASGEIYIAELPESNG----KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR 263
++KI + GE+++ + + K I+ + +K+ + S L I++ +R +++
Sbjct: 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMR-------ELK 70
Query: 264 HRNIVPLLAHMVRPDCHLL--VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSG 321
H+NIV + + L + EF G L + + ++E A I R ++
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 322 LEYLH-MYHRP---RIIHRNITPSSVLIDDDME-----------------ARIADFGLAR 360
L Y H + P R++HR++ P ++ + + A+I DFGL++
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 361 LMPDGHAQVSTSIVAGTVGYIAPEY--HQTLKFSEKCDIYSFGVLLAVLVMGKLP---SD 415
+ G ++ S V GT Y +PE H+T + +K D+++ G ++ L GK P ++
Sbjct: 191 NI--GIESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247
Query: 416 DFFQHTEE 423
+F Q E
Sbjct: 248 NFSQLISE 255
|
Length = 1021 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 37/136 (27%), Positives = 66/136 (48%), Gaps = 13/136 (9%)
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
V EF+ G L+ + + R+ E AR A ++ L+ H II+R++
Sbjct: 73 FVIEFVSGGDLM---FHMQRQRKLPEEHARFYSAEISLA----LNFLHERGIIYRDLKLD 125
Query: 342 SVLIDDDMEARIADFGLAR--LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYS 399
+VL+D + ++ D+G+ + + P +TS GT YIAPE + + D ++
Sbjct: 126 NVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIAPEILRGEDYGFSVDWWA 181
Query: 400 FGVLLAVLVMGKLPSD 415
GVL+ ++ G+ P D
Sbjct: 182 LGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 12/207 (5%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVK-QVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH 273
A G +Y+ ++ G+ +A+K+V+ ++ + ++ + EI + H IV
Sbjct: 14 AFGRVYLCYDADT-GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72
Query: 274 MVRPDCHLL--VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP 331
+ P L E M GS+ D + L + R I+ G+ YLH
Sbjct: 73 LRDPMERTLSIFMEHMPGGSI----KDQLKSYGALTENVTRKYTRQILEGVSYLH---SN 125
Query: 332 RIIHRNITPSSVLIDDDMEARIADFGLA-RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK 390
I+HR+I +++L D ++ DFG + RL + V GT +++PE
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185
Query: 391 FSEKCDIYSFGVLLAVLVMGKLPSDDF 417
+ K DI+S G + ++ K P +F
Sbjct: 186 YGRKADIWSVGCTVVEMLTEKPPWAEF 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 49/210 (23%), Positives = 92/210 (43%), Gaps = 39/210 (18%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH----RNIVPLLA 272
G + +A + +AIK+ + +++I+ Q+ H R I+ +
Sbjct: 44 GRVILATYKNEDFPPVAIKRFE--------------KSKIIKQKQVDHVFSERKILNYIN 89
Query: 273 HMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR---------IARGIVSGLE 323
H P C L F K+ S L ++ + G +L R++ A IV E
Sbjct: 90 H---PFCVNLYGSF-KDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE 145
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAP 383
YL + I++R++ P ++L+D D ++ DFG A+++ T + GT YIAP
Sbjct: 146 YLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAP 197
Query: 384 EYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
E + + D ++ G+ + +++G P
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 39/158 (24%), Positives = 74/158 (46%), Gaps = 10/158 (6%)
Query: 255 EIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRI 314
E+ ++H NIV L + LV E++ + L + L+D + H +
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNS------INMHNV 106
Query: 315 ARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIV 374
+ L L+ HR +++HR++ P ++LI++ E ++ADFGLAR S +V
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV 166
Query: 375 AGTVGYIAPE-YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
T+ Y P+ + +S + D++ G + + G+
Sbjct: 167 --TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 55/261 (21%), Positives = 100/261 (38%), Gaps = 44/261 (16%)
Query: 207 SLEKIR---SRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR 263
+KI+ G +++ L + GK+ A+K + + + N K+++V E +
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGT-GKLFALKVLDKKEMIKRN-KVKRVLTEQEILATLD 59
Query: 264 HRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLE 323
H + L A LV ++ G L +L G+ E +AR A ++ LE
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQ-RQPGKCLSEEVARFYAAE-VLLALE 117
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL--------ARLMPDGHAQVSTSIVA 375
YLH+ I++R++ P ++L+ + ++DF L + S V
Sbjct: 118 YLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 376 -------------------GTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDD 416
GT YIAPE D ++ G+LL ++ G P
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP--- 231
Query: 417 FFQHTEEKSLVRWMRNVMTSE 437
F +++ N++ E
Sbjct: 232 FKGSNRDETF----SNILKKE 248
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 13/160 (8%)
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
L+ +++ G E+ + Q E R IA IV L++LH + II+R+I
Sbjct: 82 LILDYVNGG---ELFTHLYQREHFTESEVRVYIAE-IVLALDHLH---QLGIIYRDIKLE 134
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK--FSEKCDIYS 399
++L+D + + DFGL++ + + S GT+ Y+APE + + D +S
Sbjct: 135 NILLDSEGHVVLTDFGLSKEFLAEEEERAYSF-CGTIEYMAPEVIRGGSGGHDKAVDWWS 193
Query: 400 FGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439
GVL L+ G P F E+ S R ++ S+ P
Sbjct: 194 LGVLTFELLTGASP---FTVDGEQNSQSEISRRILKSKPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 35/111 (31%), Positives = 51/111 (45%), Gaps = 7/111 (6%)
Query: 303 RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362
R E AR A I S L YLH II+R++ P ++L+D + DFGL +
Sbjct: 91 RSFPEPRARFYAAE-IASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK-- 144
Query: 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
+TS GT Y+APE + + D + G +L ++ G LP
Sbjct: 145 EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG-LP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 19/151 (12%)
Query: 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITP 340
V E++ G L+ + + R+ E AR A I L YLH II+R++
Sbjct: 72 FFVIEYVNGGDLM---FHMQRQRKLPEEHARFYSAE-ISLALNYLH---ERGIIYRDLKL 124
Query: 341 SSVLIDDDMEARIADFGLAR--LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIY 398
+VL+D + ++ D+G+ + L P +TS GT YIAPE + + D +
Sbjct: 125 DNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYIAPEILRGEDYGFSVDWW 180
Query: 399 SFGVLLAVLVMGKLP------SDDFFQHTEE 423
+ GVL+ ++ G+ P SD+ Q+TE+
Sbjct: 181 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 211
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 31/86 (36%), Positives = 49/86 (56%), Gaps = 11/86 (12%)
Query: 334 IHRNITPSSVLIDDDMEARIADFGLAR-LMPDGHAQVSTSIVAGT----VGYIAPEYHQT 388
IHR++ +VL+ D A+I DFGLAR +M D S +V G V ++APE
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMND-----SNYVVKGNARLPVKWMAPESIFD 288
Query: 389 LKFSEKCDIYSFGVLL-AVLVMGKLP 413
++ + D++S+G+LL + +GK P
Sbjct: 289 CVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 43/183 (23%), Positives = 81/183 (44%), Gaps = 46/183 (25%)
Query: 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM---PD----GHAQVS 370
+ G+E+L + IHR++ ++L+ ++ +I DFGLAR + PD G A++
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 371 TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP------SDDFFQHTEE 423
+ ++APE ++ + D++SFGVLL + +G P ++F + +E
Sbjct: 239 -------LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE 291
Query: 424 KSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483
+ +R P A + I C ++PE+RP ++ +
Sbjct: 292 GTRMR---------APEYATPE-------------IYSIMLDCWHNNPEDRPTFSELVEI 329
Query: 484 LSD 486
L D
Sbjct: 330 LGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 45/189 (23%), Positives = 84/189 (44%), Gaps = 11/189 (5%)
Query: 229 GKMIAIKKVK-QVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMV-RPDCHLLV-SE 285
G+ +A K+V+ ++ + ++ + EI ++H IV + R + L + E
Sbjct: 27 GRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86
Query: 286 FMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345
+M GS+ D + L + R I+ G+ YLH I+HR+I +++L
Sbjct: 87 YMPGGSV----KDQLKAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILR 139
Query: 346 DDDMEARIADFGLA-RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
D ++ DFG + RL + V GT +++PE + K D++S G +
Sbjct: 140 DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTV 199
Query: 405 AVLVMGKLP 413
++ K P
Sbjct: 200 VEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 6/95 (6%)
Query: 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGT 377
++ GL Y+H I+HR++ P ++LI E ++ADFGLAR S+ +V T
Sbjct: 112 LLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--T 166
Query: 378 VGYIAPE-YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
+ Y P+ +S DI+ G + ++ G+
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 19/40 (47%), Positives = 28/40 (70%), Gaps = 3/40 (7%)
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360
GL Y H R R++HR++ P ++LI + E ++ADFGLAR
Sbjct: 115 GLAYCH--QR-RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 40/170 (23%), Positives = 80/170 (47%), Gaps = 18/170 (10%)
Query: 255 EIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELE------- 307
E+ +++ NI+ LL V D +++E+M+NG L + L+ +E
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 308 --------WLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359
+ + +A I SG++YL + +HR++ + L+ +++ +IADFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM 409
R + G + ++A E KF+ D+++FGV L ++M
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 39/188 (20%), Positives = 83/188 (44%), Gaps = 17/188 (9%)
Query: 232 IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGS 291
+AIK++++ + N +++ E + + ++ LL + L +++ M G
Sbjct: 39 VAIKELREATSPKAN---KEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGC 94
Query: 292 LLEIL---NDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD 348
LL+ + D + L W + I G+ YL ++HR++ +VL+
Sbjct: 95 LLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEERR---LVHRDLAARNVLVKTP 145
Query: 349 MEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVL 407
+I DFGLA+L+ + + ++A E ++ + D++S+GV + ++
Sbjct: 146 QHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 205
Query: 408 VMGKLPSD 415
G P D
Sbjct: 206 TFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 41/159 (25%), Positives = 78/159 (49%), Gaps = 12/159 (7%)
Query: 255 EIMTAGQIRHRNIVPLLAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
E+ ++H NIV L +V D L LV E++ + L + ++D ++ H
Sbjct: 54 EVSLLKDLKHANIVTL-HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGN------IMSMHN 105
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
+ + L L HR +++HR++ P ++LI++ E ++ADFGLAR S +
Sbjct: 106 VKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV 165
Query: 374 VAGTVGYIAPE-YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
V T+ Y P+ + ++S + D++ G + + G+
Sbjct: 166 V--TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 3/156 (1%)
Query: 253 RAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARH 312
R+E+ H IV D LL+ E+ G L + + Q +E +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK---QIKQRLKEHLPFQEY 169
Query: 313 RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTS 372
+ + L H +++HR++ +++ + ++ DFG ++ D + S
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 373 IVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLV 408
GT Y+APE + ++S+K D++S GV+L L+
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 16/197 (8%)
Query: 229 GKMIAIKKVKQVD-NSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR--PDCHLLVSE 285
GK+ ++KV D L +K+ Q A + A + H + VR P L
Sbjct: 14 GKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA 73
Query: 286 FMKNGSLLEILNDVSQG-------RRELEWLARHRIARG-IVSGLEYLHMYHRPRIIHRN 337
F L IL+ VS G +R+ R G I+ LE+LH + I++R+
Sbjct: 74 FQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRD 130
Query: 338 ITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKC-D 396
I ++L+D + + DFGL++ + + S GT+ Y+APE + K D
Sbjct: 131 IKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF-CGTIEYMAPEIIRGKGGHGKAVD 189
Query: 397 IYSFGVLLAVLVMGKLP 413
+S G+L+ L+ G P
Sbjct: 190 WWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 58/247 (23%), Positives = 101/247 (40%), Gaps = 60/247 (24%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNI-KMRQVRAEIMTAGQIRHRNIVPLLAH 273
A GE+ +A ++ + A+K +++ D +LN ++ V+AE + + +V L
Sbjct: 13 AFGEVCLACKVDT-HALYAMKTLRKKD--VLNRNQVAHVKAERDILAEADNEWVVKLYYS 69
Query: 274 MVRPDCHLLVSEFMKNGSLLEILNDVSQGRREL--EWLARHRIARGIVSGLEYLHMYHRP 331
D V +++ G ++ +L R E+ E LAR IA ++ + H+
Sbjct: 70 FQDKDNLYFVMDYIPGGDMMSLLI-----RMEVFPEVLARFYIAELTLA----IESVHKM 120
Query: 332 RIIHRNITPSSVLIDDDMEARIADFGLA-------------------------------- 359
IHR+I P ++LID D ++ DFGL
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 360 -------RLMP------DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAV 406
RL H + + GT YIAPE +++ CD +S GV+L
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 407 LVMGKLP 413
+++G+ P
Sbjct: 241 MLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 20/223 (8%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVK--QVDNSLLNIKMRQVRAEIMTAGQIRHR 265
LEKI G++Y A ++ GK++A+KK + + + +R++ M + I
Sbjct: 6 LEKIGEGTYGKVYKAR-DKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI--- 61
Query: 266 NIVPLLA--HMVRPD---CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVS 320
IV LL H+ + LV E++ + + ++ R L ++
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEA-RIADFGLARLMPDGHAQVSTSIVAGTVG 379
G+ + H + ++HR++ P ++L+D +IAD GL R + IV T+
Sbjct: 122 GVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLW 176
Query: 380 YIAPE-YHQTLKFSEKCDIYSFGVLLAVLVMGK--LPSDDFFQ 419
Y APE + +S DI+S G + A + + P D Q
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 24/201 (11%)
Query: 228 NGKMIAIKKV--KQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285
G+ + ++++ + N ++ ++ E+ + H NIVP A + + +V+
Sbjct: 24 TGEYVTVRRINLEACTNEMVTF----LQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79
Query: 286 FMKNGSLLE-ILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
FM GS + I G EL A I +G++ L+Y+H +HR++ S +L
Sbjct: 80 FMAYGSAKDLICTHFMDGMSEL---AIAYILQGVLKALDYIHHMG---YVHRSVKASHIL 133
Query: 345 IDDDMEARIADFGL-ARLMPDGHAQVSTSI------VAGTVGYIAPE-YHQTLK-FSEKC 395
I D + ++ GL + L H Q + + +++PE Q L+ + K
Sbjct: 134 ISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS 191
Query: 396 DIYSFGVLLAVLVMGKLPSDD 416
DIYS G+ L G +P D
Sbjct: 192 DIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 70/287 (24%), Positives = 106/287 (36%), Gaps = 73/287 (25%)
Query: 248 KMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEIL-NDVSQGRREL 306
++ ++ E++ + RH NI+ ++S FM GS +L +G E
Sbjct: 42 HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEA 101
Query: 307 EWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG-LARLMPDG 365
L + I G + GL YLH + IHRNI S +LI D ++ L L+ +G
Sbjct: 102 --LIGN-ILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155
Query: 366 H--------AQVSTSIVAGTVGYIAPE-YHQTLK-FSEKCDIYSFGVLLAVLVMGKLPSD 415
Q STS++ +++PE Q L ++ K DIYS G+ L G++P
Sbjct: 156 QKAKVVYDFPQFSTSVLP----WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211
Query: 416 DF----------------------FQHTE---------------EKSLVRWMRNVMTSE- 437
D F E E + M MTSE
Sbjct: 212 DMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSER 271
Query: 438 --NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS 482
P+ S N E C DPE+RP++ + S
Sbjct: 272 LRTPSSKTFSPAFQNLVE-----------LCLQQDPEKRPSASSLLS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 42/176 (23%), Positives = 76/176 (43%), Gaps = 32/176 (18%)
Query: 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGT 377
+ G+E+L + IHR++ ++L+ ++ +I DFGLAR + V
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 378 VGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP------SDDFFQHTEEKSLVRWM 430
+ ++APE ++ + D++SFGVLL + +G P +++F Q ++ + +R
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR-- 297
Query: 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
EN I +L C DP+ERP + +L D
Sbjct: 298 ----APENATPEIYRIMLA----------------CWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDV------SQGRRELE 307
A +M H +V LL + + L+V E M +G L L + + GR
Sbjct: 60 ASVMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117
Query: 308 WLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM--PDG 365
++A I G+ YL+ + +HR++ + ++ D +I DFG+ R + D
Sbjct: 118 LQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174
Query: 366 HAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
+ + ++ V ++APE + F+ D++SFGV+L
Sbjct: 175 YRKGGKGLLP--VRWMAPESLKDGVFTTSSDMWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 40/150 (26%), Positives = 64/150 (42%), Gaps = 20/150 (13%)
Query: 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRREL--EWLARHRIARGIVSGLE 323
N+V L ++V D LV + + G L ++ E W A +V L+
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAE------MVVALD 99
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG--YI 381
LH R I+ R++ P+++L+DD ++ F +V S V Y
Sbjct: 100 ALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWS-------EVEDSCDGEAVENMYC 149
Query: 382 APEYHQTLKFSEKCDIYSFGVLLAVLVMGK 411
APE + +E CD +S G +L L+ GK
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 52/241 (21%), Positives = 98/241 (40%), Gaps = 44/241 (18%)
Query: 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN 266
SL+ I A GE+ + + + G + A+K +++ D L ++ +RAE +
Sbjct: 5 SLKVIGRGAFGEVRLVQ-KKDTGHIYAMKILRKAD-MLEKEQVAHIRAERDILVEADGAW 62
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
+V + L+ EF+ G ++ +L + + L+ I + +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLL-------MKKDTLSEEATQFYIAETVLAID 115
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA------------------- 367
H+ IHR+I P ++L+D +++DFGL + H
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 368 ---------------QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKL 412
Q++ S V GT YIAPE +++ CD +S GV++ +++G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 413 P 413
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 53/241 (21%), Positives = 99/241 (41%), Gaps = 44/241 (18%)
Query: 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN 266
SL+ I A GE+ + + + G + A+K +++ D L ++ +RAE +
Sbjct: 5 SLKVIGRGAFGEVRLVQ-KKDTGHVYAMKILRKAD-MLEKEQVGHIRAERDILVEADSLW 62
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
+V + L+ EF+ G ++ +L E + IA +++ +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEE---TQFYIAETVLA----ID 115
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH-------------------- 366
H+ IHR+I P ++L+D +++DFGL + H
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 367 --------------AQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKL 412
Q++ S V GT YIAPE +++ CD +S GV++ +++G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 413 P 413
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 27/91 (29%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
+AR ++S ++Y+H IIHR+I +VL++ + + DFG A +
Sbjct: 265 VARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 374 VAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
+AGTV APE ++ DI+S G+++
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVI 352
|
Length = 461 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 36/142 (25%), Positives = 73/142 (51%), Gaps = 12/142 (8%)
Query: 282 LVSEFMKNGSLLEILND-VSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITP 340
LV E GS+ +++ + +G R E + + + ++ GL++LH+ + IHR++
Sbjct: 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM-GLQHLHV---NKTIHRDVKG 152
Query: 341 SSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEY---HQTL--KFSEKC 395
+++L+ + ++ DFG++ + + +TS+ GT ++APE Q L + +C
Sbjct: 153 NNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPEVIACEQQLDSTYDARC 210
Query: 396 DIYSFGVLLAVLVMGKLPSDDF 417
D++S G+ L G P D
Sbjct: 211 DVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 55/275 (20%), Positives = 117/275 (42%), Gaps = 37/275 (13%)
Query: 221 IAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280
+ + PE+ +AIK V + + I+ A +M H +V LL + +
Sbjct: 31 VKDEPETR---VAIKTVNEAASMRERIEFLN-EASVMKEFNCHH--VVRLLGVVSQGQPT 84
Query: 281 LLVSEFMKNGSLLEIL--------NDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR 332
L++ E M G L L N+ Q L+ + + +A I G+ YL+ +
Sbjct: 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ--MAGEIADGMAYLNA---NK 139
Query: 333 IIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS 392
+HR++ + ++ +D +I DFG+ R + + V +++PE + F+
Sbjct: 140 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 199
Query: 393 EKCDIYSFGVLL-AVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNG 451
D++SFGV+L + + + P +Q + ++R++ + P+ D
Sbjct: 200 TYSDVWSFGVVLWEIATLAEQP----YQGMSNEQVLRFVMEGGLLDKPDNCPD------- 248
Query: 452 YEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
++ ++ C +P+ RP+ ++ S + +
Sbjct: 249 ------MLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 29/89 (32%), Positives = 49/89 (55%), Gaps = 10/89 (11%)
Query: 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHR 336
P C + EFM G +I +++ Q +R++ + + R +++GL LH R I+HR
Sbjct: 284 PGC---LEEFMMAGK--KIPDNMPQDKRDINVI--KGVMRQVLTGLRKLH---RIGIVHR 333
Query: 337 NITPSSVLIDDDMEARIADFGLARLMPDG 365
+I P ++L+ D + +I DFG A M G
Sbjct: 334 DIKPENLLVTVDGQVKIIDFGAAVDMCTG 362
|
Length = 507 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 28/91 (30%), Positives = 43/91 (47%), Gaps = 4/91 (4%)
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
I R ++ ++YLH RIIHR+I ++ I+ + + DFG A P
Sbjct: 187 IERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYG 242
Query: 374 VAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL 404
AGT+ APE + DI+S G++L
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVL 273
|
Length = 391 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 55/253 (21%), Positives = 108/253 (42%), Gaps = 57/253 (22%)
Query: 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQ---VRAEIMTAGQIR 263
S++ I A GE+ + + ++ + A+KK+++ + ++ Q VRAE +
Sbjct: 5 SIKVIGRGAFGEVRLVQKKDTG-HIYAMKKLRKSEM----LEKEQVAHVRAERDILAEAD 59
Query: 264 HRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRREL--EWLARHRIARGIVSG 321
+ +V L + L+ E++ G ++ +L +++ E R IA I++
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM-----KKDTFTEEETRFYIAETILA- 113
Query: 322 LEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAG----- 376
+ H+ IHR+I P ++L+D +++DFGL + H I++
Sbjct: 114 ---IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 377 ----------------------------TVG---YIAPEYHQTLKFSEKCDIYSFGVLLA 405
TVG YIAPE ++++CD +S GV++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 406 VLVMGKLP--SDD 416
+++G P SD+
Sbjct: 231 EMLVGYPPFCSDN 243
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 38/167 (22%), Positives = 73/167 (43%), Gaps = 22/167 (13%)
Query: 251 QVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE--------FMKNGSLLEILNDVSQG 302
Q+ EI+ G++ H NI+ + + ++++ FM +
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDE-------AFDWK 261
Query: 303 RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362
R L R I + ++ +EY+H ++IHR+I ++ ++ D + + DFG A M
Sbjct: 262 DRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTA--M 315
Query: 363 PDGHAQVSTSI-VAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLV 408
P + + GTV +PE + E DI+S G++L ++
Sbjct: 316 PFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 54/241 (22%), Positives = 104/241 (43%), Gaps = 33/241 (13%)
Query: 215 ASGEIYIAELPESN----GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL 270
A G++Y A+ E+ K+I K +++++ ++ EI H NIV L
Sbjct: 17 AFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV---------EIDILASCDHPNIVKL 67
Query: 271 LAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR 330
L + ++ EF G++ ++ ++ + L +I LE L+ H
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELERP------LTEPQIRVVCKQTLEALNYLHE 121
Query: 331 PRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEY----- 385
+IIHR++ ++L D + ++ADFG++ + + I GT ++APE
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCET 179
Query: 386 HQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS 445
+ + K D++S G+ L + + P E + +R + + SE P A S
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPH-------HELNPMRVLLKIAKSEPPTLAQPS 232
Query: 446 K 446
+
Sbjct: 233 R 233
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 27/97 (27%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGT 377
+ G+E+L + IHR++ ++L+ ++ +I DFGLAR + V
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 378 VGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
+ ++APE ++ + D++SFGVLL + +G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 34/119 (28%), Positives = 60/119 (50%), Gaps = 9/119 (7%)
Query: 297 NDVSQGRRELEWLA-RHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355
+D S+G L+ L+ +++ARG +E+L +HR++ +VL+ +I D
Sbjct: 228 DDGSEGLTTLDLLSFTYQVARG----MEFLA---SKNCVHRDLAARNVLLAQGKIVKICD 280
Query: 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
FGLAR + VS V ++APE ++ D++S+G+LL + +G P
Sbjct: 281 FGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 31/106 (29%), Positives = 54/106 (50%), Gaps = 14/106 (13%)
Query: 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR-LMPDGHAQVSTSIVAG 376
+ +G+E+L +HR++ +VLI + +I DFGLAR +M D S I G
Sbjct: 248 VANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD-----SNYISKG 299
Query: 377 T----VGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLPSDDF 417
+ + ++APE ++ D++SFG+LL + +G P +
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.003
Identities = 39/161 (24%), Positives = 76/161 (47%), Gaps = 27/161 (16%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKV---KQVDNSLLNIKMRQVR----AEIMTAG 260
++ I+ A EIY+ + + A+ K K+ + L+ ++R+ R A IM+
Sbjct: 1 MKLIKRGAEAEIYLGD----FLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMS-- 54
Query: 261 QIRHRNI-VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIV 319
+ R + VP + + V P+ ++V E+++ L +++N E L+R I R
Sbjct: 55 RARKAGVNVPAV-YFVDPENFIIVMEYIEGEPLKDLIN---SNGMEELELSR-EIGR--- 106
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360
+ H IIH ++T S++++ + + DFGLA
Sbjct: 107 ----LVGKLHSAGIIHGDLTTSNMILSGG-KIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 36/238 (15%)
Query: 262 IRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSG 321
++H NI+ L V +LLV E+ + G L L+ RR + L R+A I +G
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 322 LEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL--ARLMPDGHAQVSTSIVAGTVG 379
+ ++H ++ +H ++ + + D+ ++ D+G+ +R D V +
Sbjct: 112 VTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP--LR 166
Query: 380 YIAPE----YHQTLKFSEK---CDIYSFGVLLAVLV-MGKLPSDDFFQHTEEKSLVRWMR 431
++APE +H L +E+ ++++ GV L L P R
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----------R 215
Query: 432 NVMTSENPNRAIDSKL----LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485
V+ ++ KL L Y E+ VL+ FC L PE+R +++V +L+
Sbjct: 216 EVLNHVIKDQ--QVKLFKPQLELPYSERWYEVLQ---FCWL-SPEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 531 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.26 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.99 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.96 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.85 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.82 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.78 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.5 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.45 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.36 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.2 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.19 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.15 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.11 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.03 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.01 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.01 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.95 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.93 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.92 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 97.9 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.84 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.84 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.64 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.49 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.39 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.39 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.35 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.3 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.22 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.04 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.91 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.75 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.73 | |
| PLN02236 | 344 | choline kinase | 96.7 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.28 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.17 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.98 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.83 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.79 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.79 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.71 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.7 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.95 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.85 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.7 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.69 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.64 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.52 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.52 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.41 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.91 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-50 Score=405.72 Aligned_cols=280 Identities=34% Similarity=0.556 Sum_probs=240.2
Q ss_pred hhhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 199 LEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 199 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
..++++|...+.||+||||.||+|... +|+.||||++....... ..+|..|+.++.+++|||+|+|+|||.+.+
T Consensus 71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~--~~~~vAVK~~~~~~~~~----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~ 144 (361)
T KOG1187|consen 71 RKATNNFSESNLIGEGGFGTVYKGVLS--DGTVVAVKRLSSNSGQG----EREFLNEVEILSRLRHPNLVKLLGYCLEGG 144 (361)
T ss_pred HHHHhCCchhcceecCCCeEEEEEEEC--CCCEEEEEEecCCCCcc----hhHHHHHHHHHhcCCCcCcccEEEEEecCC
Confidence 458899999999999999999999886 66899999887644321 244999999999999999999999999998
Q ss_pred -ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 279 -CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 279 -~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
..+||||||++|||.++|...... .++|..+.+|+.++|+||+|||+.+.+.||||||||+|||||+++++||+|||
T Consensus 145 ~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFG 222 (361)
T KOG1187|consen 145 EHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFG 222 (361)
T ss_pred ceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCcc
Confidence 499999999999999999863222 88999999999999999999999887889999999999999999999999999
Q ss_pred CCccCCC-CCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 358 LARLMPD-GHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 358 la~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
+++..+. .... .+.. .||.+|+|||+...+..+.++|||||||++.||+||+.|.+... ......+..|.+..+..
T Consensus 223 La~~~~~~~~~~-~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 223 LAKLGPEGDTSV-STTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLLEE 299 (361)
T ss_pred CcccCCccccce-eeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHHHC
Confidence 9976554 2211 1111 79999999999999999999999999999999999999877543 23344589999999999
Q ss_pred CCCCcccccccc-CCCcH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 437 ENPNRAIDSKLL-GNGYE-EQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 437 ~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
+...+.+|+++. ..... ..+..+..++.+|++.+|..||+|.+|++.|+.+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 899999999987 33333 678889999999999999999999999999966543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=380.56 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=215.1
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC-ceEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD-CHLL 282 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~~l 282 (531)
....+..||+|..|+||++.++. +++.+|+|.+..... ....+++.+|+.+++.++|||||.+||.|+.+. ..+|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~-t~~i~AlK~I~~~~~---~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKP-TGKIYALKVILLNID---PALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcC-CCeEEEEEeecccCC---HHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 45667899999999999998875 899999999954333 234788999999999999999999999999988 4999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
+||||.+|||++++.. .+.+++....+++.++++||.|||. .++||||||||+|||+++.|.|||||||.+..+
T Consensus 156 ~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred ehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 9999999999999975 3679999999999999999999995 478999999999999999999999999999988
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
.++ .....+||..|||||.+.+..|+.++||||||++++|+++|+.||... .......++.+..+...+.|...
T Consensus 230 vnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~--~~~~~~~~~Ll~~Iv~~ppP~lP 303 (364)
T KOG0581|consen 230 VNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP--NPPYLDIFELLCAIVDEPPPRLP 303 (364)
T ss_pred hhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc--CCCCCCHHHHHHHHhcCCCCCCC
Confidence 776 234578999999999999999999999999999999999999998653 12233455556665554444322
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
- ..++ .++..++..||+.||.+|||+.++++|
T Consensus 304 ~------~~fS---~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 304 E------GEFS---PEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred c------ccCC---HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 1122 247778889999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=387.15 Aligned_cols=254 Identities=30% Similarity=0.444 Sum_probs=208.2
Q ss_pred cccccccccceeEEEEEeeeCCCCeE-EEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC-ceEEE
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKM-IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD-CHLLV 283 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~~lv 283 (531)
...+.||+|+||+||+|.| .|+. ||||++......... .+.|.+|+.+|.+++|||||+++|+|..+. .+++|
T Consensus 44 ~~~~~iG~G~~g~V~~~~~---~g~~~vavK~~~~~~~~~~~--~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKW---RGTDVVAVKIISDPDFDDES--RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred hhhhhcccCCceeEEEEEe---CCceeEEEEEecchhcChHH--HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 3445699999999999999 5776 999999876544433 778999999999999999999999999987 79999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeeccCCCCeeeCCCC-CEEEeecCCCcc
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR-IIHRNITPSSVLIDDDM-EARIADFGLARL 361 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlkp~NILl~~~~-~vkL~Dfgla~~ 361 (531)
|||+++|+|.+++... ....+++..+..++.+||+||.||| +.+ ||||||||+|||++.++ ++||+|||+++.
T Consensus 119 tEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 9999999999999752 4678999999999999999999999 566 99999999999999997 999999999987
Q ss_pred CCCCCccceecccccCccccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQ--TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
..... ...+...||+.|||||++. ...|+.++|||||||++|||+||+.||.+... .++...+.. ...++
T Consensus 194 ~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~~~~v~~--~~~Rp 265 (362)
T KOG0192|consen 194 KVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQVASAVVV--GGLRP 265 (362)
T ss_pred ecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHh--cCCCC
Confidence 65432 2223367999999999999 56899999999999999999999999988643 222222211 11112
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
... .. ....+..++.+||..||..||++.+++..|+.+
T Consensus 266 ~~p-------~~---~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 266 PIP-------KE---CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred CCC-------cc---CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 111 00 122477888899999999999999999999764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=356.54 Aligned_cols=261 Identities=22% Similarity=0.326 Sum_probs=212.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccce-eEEeCCc-e
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLA-HMVRPDC-H 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~-~~~~~~~-~ 280 (531)
..|.+.++||+|.||+||++.... +|..+|.|.+.-... ....++....|+.+|++|+|||||++++ .+..... +
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~-~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLL-DGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeecc-Ccchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 457889999999999999998754 899999999984332 2334788999999999999999999999 5555555 7
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR-PRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
+||||||.+|+|...++..+..++.+++.++|+++.|++.||..+|+... ..|+||||||.||+++.+|.+||+||||+
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 99999999999999999988889999999999999999999999996422 34999999999999999999999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
+.+.+.... ....+|||.||+||.+...+|+.+|||||+||++|||+.-+.||.+. ++....+.+.+...+
T Consensus 176 r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~L~~KI~qgd~~ 246 (375)
T KOG0591|consen 176 RFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLSLCKKIEQGDYP 246 (375)
T ss_pred hHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHHHHHHHHHcCCCC
Confidence 998776433 34588999999999999999999999999999999999999998763 333333333333222
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
. +..+.+ ...+..|+..|+..||..||+...+++.+
T Consensus 247 ~------~p~~~Y---S~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 247 P------LPDEHY---STDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred C------CcHHHh---hhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 1 111222 23477778889999999999954444433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=364.39 Aligned_cols=203 Identities=27% Similarity=0.427 Sum_probs=182.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||+|+||+||+|+++. ++..||||.+....... ...+.+..|+.+|+.++|||||++++++..++.+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~-~~~~VAIK~i~~~~l~~--k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKK-SGTEVAIKCIAKKKLNK--KLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccceehhhccCcceEEEEEeEecc-CCceEEeeeehhhccCH--HHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 4678888899999999999999886 67999999998754222 22667889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC------CCEEEee
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD------MEARIAD 355 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~------~~vkL~D 355 (531)
+|||||+||+|.+|++. .+.+++.++..++.|||.||++|| +++||||||||+||||+.. ..+||+|
T Consensus 86 lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred EEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecc
Confidence 99999999999999986 568999999999999999999999 7889999999999999765 4689999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDF 417 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~ 417 (531)
||+|+.+..+.. ....+|+|-|||||++...+|+.|+|+||+|+|+|++++|+.||+..
T Consensus 159 FGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 159 FGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred cchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999999876533 34589999999999999999999999999999999999999998753
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=371.46 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=209.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhh---HHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLN---IKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
.+.|-..+.||+|+||.|-+|..+ .+|+.||||++......... .......+|+++|++|+|||||+++++|..++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~-~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEK-KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEc-ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 466778899999999999999765 48999999999764432211 11234579999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC---CCEEEee
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD---MEARIAD 355 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~---~~vkL~D 355 (531)
..|+||||++||+|.+++-. ++.+.+..-..++.|++.|+.||| +.||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999965 667788888899999999999999 8899999999999999766 6799999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHH
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK---FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN 432 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~ 432 (531)
||+|+..... ..+.+.||||.|.|||++.+.. +..++|+||+||+||-++||.+||.+..... .+.+.+
T Consensus 323 FGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---sl~eQI-- 394 (475)
T KOG0615|consen 323 FGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---SLKEQI-- 394 (475)
T ss_pred cchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc---cHHHHH--
Confidence 9999987644 2345689999999999998764 3458899999999999999999998765433 122211
Q ss_pred HhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 433 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..+.-. + .+..+....+..+++|.+||..||++|||+.|+++|
T Consensus 395 --~~G~y~--f----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 --LKGRYA--F----GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred --hcCccc--c----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 111111 1 123455666778999999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=377.88 Aligned_cols=252 Identities=25% Similarity=0.342 Sum_probs=210.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
..|...+.||+|||+.||.++... +|..||+|++.+..... ....+.+.+||++.++|.|||||+++++|++.+.+||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~-tge~~A~KvVpk~~l~k-~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD-TGEVVAVKVVPKKLLKK-PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC-CCcEEEEEEeehHHhcC-cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 678889999999999999998743 89999999998633222 2236778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|.|+|..++|..+++. .+++++..+..+++||+.||.||| +.+|+|||||..|+|++++.+|||+|||||..+
T Consensus 96 vLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeee
Confidence 9999999999999975 688999999999999999999999 778999999999999999999999999999988
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
....... .+.||||.|+|||++.....+..+||||+||+||.||+|++||+.. ...+..+-++..- ...|.
T Consensus 169 e~~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk----~vkety~~Ik~~~-Y~~P~-- 239 (592)
T KOG0575|consen 169 EYDGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK----TVKETYNKIKLNE-YSMPS-- 239 (592)
T ss_pred cCccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc----hHHHHHHHHHhcC-ccccc--
Confidence 7553322 3489999999999999999999999999999999999999998753 1122222222210 00111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. ......+||.++|++||.+|||+.+|+.+
T Consensus 240 ---~--------ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 240 ---H--------LSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---c--------cCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 11236778889999999999999999984
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=375.87 Aligned_cols=257 Identities=28% Similarity=0.436 Sum_probs=216.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
..+..++.||+|-||.|+.|.|+ ....||+|.++..... ...|.+|+.+|++|+|+|||+++|+|..+..+||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~--~~~~vavk~ik~~~m~-----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN--GSTKVAVKTIKEGSMS-----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc--CCCcccceEEeccccC-----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 44567889999999999999995 3448999999875443 4678899999999999999999999999889999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|||||+.|+|.++|+. ..+..+.....+.++.|||+|++||+ ++++|||||.++||||++++.+||+||||++..
T Consensus 279 VtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc
Confidence 9999999999999986 45677899999999999999999999 788999999999999999999999999999966
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
.+...... ....-...|.|||.+..+.|+.+||||||||+||||.| |+.||.++.. .++++.+.....-++|..
T Consensus 354 ~d~~Y~~~-~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----~ev~~~le~GyRlp~P~~ 428 (468)
T KOG0197|consen 354 GDDEYTAS-EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----EEVLELLERGYRLPRPEG 428 (468)
T ss_pred CCCceeec-CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----HHHHHHHhccCcCCCCCC
Confidence 55543322 22334678999999999999999999999999999999 9999887643 344444555444455544
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
+.+ .+.+++..||+.+|++|||+..+...|+++.-
T Consensus 429 CP~-------------~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 429 CPD-------------EVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCH-------------HHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 333 38889999999999999999999999987653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=349.71 Aligned_cols=264 Identities=22% Similarity=0.296 Sum_probs=210.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
-+.|.+++.||+|+||.||.++.. .+++.||+|++++..... ....+....|..+|.+++||+||+++-.|.+.+.+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~K~~iv~-~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKK-DTGKIYAMKVLKKKKIVE-KKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEc-ccCceeehhhhhhhHhhh-hhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 367889999999999999999876 589999999998654332 223677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+|+||+.||.|..+|++ .+.+++..+.-++..|+.||.||| ++|||||||||+|||+|.+|+++|+||||++.
T Consensus 102 lVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence 99999999999999975 678999999999999999999999 88899999999999999999999999999995
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
.-.... .+...+||+.|||||++.+.+|+..+|.||+|+++|||++|.+||..... ..+.........+.
T Consensus 175 ~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-------~~~~~~I~~~k~~~- 244 (357)
T KOG0598|consen 175 DLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-------KKMYDKILKGKLPL- 244 (357)
T ss_pred cccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-------HHHHHHHhcCcCCC-
Confidence 443322 23458999999999999999999999999999999999999999876422 22222222222111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCCCch
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDV 493 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 493 (531)
.+ ...+ ...++++...|..||++|--...=...++..+.+.++
T Consensus 245 --~p----~~ls---~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 245 --PP----GYLS---EEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred --CC----ccCC---HHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 11 1111 1367788889999999996422222234444444444
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=338.55 Aligned_cols=266 Identities=20% Similarity=0.306 Sum_probs=214.0
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|+.+.++|+|+||+||+++.+. +|+.||||++...... ..+.+..++||++|++++|||+|.++++|......++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~-TgqIVAIKkF~Esedd--~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD-TGQIVAIKKFVESEDD--PVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC-cccEEEEEeeccCCcc--HHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence 467888899999999999998765 8999999999865432 3446778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|+|||+. ++.+-|.. ....++.....+++.|++.|+.|+| ++++|||||||+|||++.+|.+||||||+|+.+
T Consensus 79 VFE~~dh-TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L 151 (396)
T KOG0593|consen 79 VFEYCDH-TVLHELER---YPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTL 151 (396)
T ss_pred Eeeecch-HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhh
Confidence 9999988 77776765 3456889999999999999999999 788999999999999999999999999999988
Q ss_pred CCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH--------
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV-------- 433 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~-------- 433 (531)
...... .+..+.|..|.|||.+.+ .+|+..+|||++||++.||++|.+-|.+. +...++....+..
T Consensus 152 ~~pgd~--YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~---SDiDQLy~I~ktLG~L~prhq 226 (396)
T KOG0593|consen 152 SAPGDN--YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR---SDIDQLYLIRKTLGNLIPRHQ 226 (396)
T ss_pred cCCcch--hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc---chHHHHHHHHHHHcccCHHHH
Confidence 743322 244678999999999988 58999999999999999999999988664 3334444333321
Q ss_pred --hcc------CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 434 --MTS------ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 434 --~~~------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+.. -.....-++.-....++.....+++++..||+.||.+|+|.++++.+
T Consensus 227 ~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 227 SIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111 11112222222233455555678999999999999999999998874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=346.42 Aligned_cols=268 Identities=26% Similarity=0.369 Sum_probs=214.5
Q ss_pred hhhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 199 LEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 199 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
-...+.|+..+.||.|..++||+|.... .++.||||++....... ....+.+|+..|+.++||||++++..|..+.
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p-~~e~VAIK~inLEkc~~---~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIP-TNEVVAIKIINLEKCNN---DLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecc-cCCEEEEEEeehhhhhh---hHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 3345788999999999999999998865 67999999998755443 2688999999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
.+|+||.||.+||+.+++...- ...+++..+..|++++++||.||| .+|.||||||+.||||+++|.|||+|||.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCcee
Confidence 9999999999999999998733 345999999999999999999999 88999999999999999999999999999
Q ss_pred CccCCCCCccce-e-cccccCccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 359 ARLMPDGHAQVS-T-SIVAGTVGYIAPEYHQTL--KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 359 a~~~~~~~~~~~-~-~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
+..+.++..... . ...+||+.|||||++... .|+.|+|||||||+..||++|..||..+.+ .+.+ +..+.
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP---mkvL---l~tLq 246 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP---MKVL---LLTLQ 246 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh---HHHH---HHHhc
Confidence 887765432222 1 457899999999996433 799999999999999999999999988744 1111 22222
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+.+ ....-..+..+........+.+++..||..||.+|||+++++.+
T Consensus 247 n~p--p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 247 NDP--PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCC--CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 222 11111111111112222357888889999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=348.62 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=201.5
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC--ce
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD--CH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~ 280 (531)
.++...+.||+|+||.||++.... +|...|||.+....... .+.+.+|+.+|++++|||||+++|...... .+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~-~g~~~AvK~v~~~~~~~----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK-TGELMAVKSVELEDSPT----SESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred chhhhhccccCccceEEEEEEecC-CCcceeeeeeecccchh----HHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 456778899999999999998764 58999999998753222 667889999999999999999999755444 58
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC-CCCEEEeecCCC
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD-DMEARIADFGLA 359 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vkL~Dfgla 359 (531)
+++|||+++|||.+++.. .+. .+++..+..+++||++||.||| ++|++||||||+|||++. ++.+||+|||++
T Consensus 92 ~i~mEy~~~GsL~~~~~~--~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKR--YGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLA 165 (313)
T ss_pred EeeeeccCCCcHHHHHHH--cCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccc
Confidence 999999999999999986 333 7999999999999999999999 889999999999999999 799999999999
Q ss_pred ccCCC-CCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 360 RLMPD-GHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 360 ~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
..... ...........||+.|||||++.++ ....++|||||||++.||+||+.||.+.. .....++ +......
T Consensus 166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--~~~~~~~---~ig~~~~ 240 (313)
T KOG0198|consen 166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--EEAEALL---LIGREDS 240 (313)
T ss_pred cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--chHHHHH---HHhccCC
Confidence 87764 1111222347899999999999863 33459999999999999999999998741 1111111 1111111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
.| .+. .. ......+++..|+..||++|||+.+++++.
T Consensus 241 ~P--~ip----~~----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 241 LP--EIP----DS----LSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred CC--CCC----cc----cCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11 111 11 112367788889999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=351.62 Aligned_cols=278 Identities=26% Similarity=0.306 Sum_probs=215.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--C
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--D 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~ 278 (531)
..+.|+.+++||+|.||.||+|+... +|+.||+|+++...... .......+||.+|++|+||||+++.+..... .
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~-tgkivALKKvr~d~~~~--~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLE-TGKIVALKKVRFDNEKE--GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecc-cCcEEEEEEeecccCCC--cchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 45778899999999999999998765 89999999998755321 2256788999999999999999999988876 6
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
.+|+|+|||++ +|.-++.. ..-.+++.++..++.|++.||+||| .+||+|||||.+|||||.+|.+||+||||
T Consensus 192 siYlVFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGL 264 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGL 264 (560)
T ss_pred eEEEEEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccc
Confidence 88999999988 89988863 4567999999999999999999999 88999999999999999999999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
|+++....... .+..+-|..|.|||++.|. .|+..+|+||.||||.||++|++.|.+. .+.+++-.. -.+...+
T Consensus 265 Ar~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~---tEveQl~kI-fklcGSP 339 (560)
T KOG0600|consen 265 ARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR---TEVEQLHKI-FKLCGSP 339 (560)
T ss_pred eeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc---cHHHHHHHH-HHHhCCC
Confidence 99887654433 3456679999999999886 6999999999999999999999998764 233333222 2223222
Q ss_pred CCCcccccccc---------------CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCcCCCch
Q 009595 438 NPNRAIDSKLL---------------GNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS--MLSDTALIKDV 493 (531)
Q Consensus 438 ~~~~~~d~~l~---------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~~~ 493 (531)
....+.-..+. .+.+.......++|+..+|..||.+|.|+.++++ .+..-..++++
T Consensus 340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p 412 (560)
T KOG0600|consen 340 TEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDP 412 (560)
T ss_pred ChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCc
Confidence 22221100110 0011112234788889999999999999999886 34333444444
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=356.34 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=213.1
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
....|....+||+|+.|.||.|.... +++.||||++....... .+-+..|+.+|+..+|+|||++++.|...+.+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~-~~~~VaiK~m~l~~Q~~----keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKIS-TKQEVAIKRMDLRKQPK----KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred hhhhhcchhhhccccccceeeeeecc-CCceEEEEEEEeccCCc----hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 45678889999999999999998654 78889999998755443 56688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|.|||||+||+|.|.+.. ..+++.++..|++.+++||+||| .+||+|||||.+|||++.+|.+||+|||++.
T Consensus 346 WVVMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred EEEEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeee
Confidence 999999999999999974 55899999999999999999999 8899999999999999999999999999999
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
.+...... ....+|||.|||||+.....|+++.||||||++++||+-|.+||-.-. -...++.+...+.+.
T Consensus 418 qi~~~~~K--R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-------PlrAlyLIa~ng~P~ 488 (550)
T KOG0578|consen 418 QISEEQSK--RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-------PLRALYLIATNGTPK 488 (550)
T ss_pred ccccccCc--cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-------hHHHHHHHhhcCCCC
Confidence 88766543 245789999999999999999999999999999999999999984311 112233333334443
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
......+ ...+.+++.+||..|+.+|||+.++|+|
T Consensus 489 lk~~~kl--------S~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 LKNPEKL--------SPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCCcccc--------CHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 3222222 2348889999999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=352.51 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=205.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhh-hHHHHHHHHHHHHHhcCC-CCcccccceeEEeCC
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLL-NIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPD 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~ 278 (531)
..+.|...+.||+|+||.|+.|.... +|+.||+|++........ ......+.+|+.+++.++ ||||+++++++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~-t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRL-TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeecc-CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 35788999999999999999998765 689999997765311101 122456668999999998 999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC-CCEEEeecC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD-MEARIADFG 357 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkL~Dfg 357 (531)
.+|+|||||.||+|++++.+ .+.+.+..+..+++|+++|++||| ++||+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999975 678889999999999999999999 7899999999999999999 999999999
Q ss_pred CCccCC-CCCccceecccccCccccCcccccCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 358 LARLMP-DGHAQVSTSIVAGTVGYIAPEYHQTLK-FS-EKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 358 la~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
++.... .. ......+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.. ...+... +.
T Consensus 167 ~s~~~~~~~---~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~----~~~l~~k---i~ 236 (370)
T KOG0583|consen 167 LSAISPGED---GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN----VPNLYRK---IR 236 (370)
T ss_pred cccccCCCC---CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc----HHHHHHH---Hh
Confidence 999874 22 2234589999999999999987 85 78999999999999999999998731 1222222 11
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS 482 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 482 (531)
... .. +. .... ...+..++.+||..||.+|+|+.+|+.
T Consensus 237 ~~~-~~--~p-----~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 237 KGE-FK--IP-----SYLL--SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred cCC-cc--CC-----CCcC--CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 111 10 11 1110 224788999999999999999999985
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=351.68 Aligned_cols=265 Identities=23% Similarity=0.341 Sum_probs=204.6
Q ss_pred cccccccccccccceeEEEEEeee----CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEe
Q 009595 202 EDCSASLEKIRSRASGEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVR 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 276 (531)
.++|.+.+.||+|+||.||+|.+. ..+++.||||++...... .....+..|+.++..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA---SEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch---HHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 467888999999999999999752 234578999999753322 1246788999999999 89999999998876
Q ss_pred CC-ceEEEEeccCCCCHHHHHhhccCC-----------------------------------------------------
Q 009595 277 PD-CHLLVSEFMKNGSLLEILNDVSQG----------------------------------------------------- 302 (531)
Q Consensus 277 ~~-~~~lv~E~~~~gsL~~~l~~~~~~----------------------------------------------------- 302 (531)
.. .++++|||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 44 578999999999999999752110
Q ss_pred -----CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccC
Q 009595 303 -----RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGT 377 (531)
Q Consensus 303 -----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt 377 (531)
...+++..+..++.|+++||.||| +++|+||||||+|||++.++.+||+|||+++...............++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 234778888999999999999999 788999999999999999999999999999876443222222334567
Q ss_pred ccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHH
Q 009595 378 VGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQM 456 (531)
Q Consensus 378 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 456 (531)
+.|+|||++.+..++.++|||||||++|||++ |..||.+.... ..+...+. . +..... + .. ..
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~---~~~~~~~~---~-~~~~~~--~---~~----~~ 303 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN---EEFCQRLK---D-GTRMRA--P---EN----AT 303 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHh---c-CCCCCC--C---CC----CC
Confidence 88999999998899999999999999999997 99998764221 11211111 1 111110 0 11 12
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 457 LLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 457 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 24788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=349.70 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=211.0
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCc
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 279 (531)
...+|.+.+.||.|+|++|++|.... +++.||||++.+..-. .+...+.+..|-.+|.+| .||.|++||--|.+...
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~-t~keYAiKVl~K~~Ii-ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKA-TGKEYAIKVLDKRYII-KEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecC-CCceeeHhhhhHHHHH-hhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45778899999999999999998775 8899999999754322 222356778899999999 89999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
+|+|+||+++|+|.++|.. -+.+++.-...++.+|+.||+||| .+|||||||||+|||||+|+++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999986 477999999999999999999999 889999999999999999999999999999
Q ss_pred ccCCCCCcc---------ce--ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHH
Q 009595 360 RLMPDGHAQ---------VS--TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR 428 (531)
Q Consensus 360 ~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~ 428 (531)
+.+...... .. ...++||..|.+||++..+..+..+|+|+||||+|+|+.|++||.+... ..++.
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----yliFq 297 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----YLIFQ 297 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----HHHHH
Confidence 988643221 11 1458999999999999999999999999999999999999999976532 22222
Q ss_pred HHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 429 WMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 429 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
-+..+.- .. +..++ ..+.+|+.+.|..||++|+|.++|-+|.
T Consensus 298 kI~~l~y-~f----------p~~fp---~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 298 KIQALDY-EF----------PEGFP---EDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHhcc-cC----------CCCCC---HHHHHHHHHHHccCccccccHHHHhhCc
Confidence 2222111 10 11111 2377888899999999999998888764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=353.73 Aligned_cols=245 Identities=27% Similarity=0.459 Sum_probs=201.4
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.+..++.||+|+.|.||.|++ .++.||||+++.... .+|+-|++|+||||+.|.|+|....++||
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl---~netVAVKKV~elkE-----------TdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRL---HNETVAVKKVRELKE-----------TDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred HHhhhhhhhccCcccceeeeec---cCceehhHHHhhhhh-----------hhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 3445678999999999999998 678899999975332 47888999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|||||..|-|...|+. ...+.......|..+||.|+.||| .+.|||||||+-||||..+..|||+|||-++..
T Consensus 190 iMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhh
Confidence 9999999999999975 677888888999999999999999 677999999999999999999999999999987
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC-CCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE-NPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~-~~~~ 441 (531)
.+..+. ..++||..|||||++.+.+.++|+|||||||||||||||..||.+.... ..++.-+ +...
T Consensus 263 ~~~STk---MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----------AIIwGVGsNsL~ 329 (904)
T KOG4721|consen 263 SDKSTK---MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----------AIIWGVGSNSLH 329 (904)
T ss_pred hhhhhh---hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----------eeEEeccCCccc
Confidence 665333 3478999999999999999999999999999999999999999764221 0111111 1111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.. .+..+++- +.-|+..||+..|..|||+++|+.||+=..
T Consensus 330 Lp----vPstcP~G---fklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 330 LP----VPSTCPDG---FKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred cc----CcccCchH---HHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 11 12223332 444667799999999999999999996543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=345.13 Aligned_cols=258 Identities=23% Similarity=0.337 Sum_probs=214.1
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|..+..||+|+||.||+|+-+ .+|..+|+|++++......+ ++..+..|-.+|...++|+||++|..|.+.+.+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk-~Tg~iyAmK~LkKS~M~~~~-Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKK-DTGEIYAMKILKKSEMLKKN-QVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred CcccchhheeeccccceeEEEEEEc-cCCcEEeeecccHHHHHhhh-hHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 3477899999999999999999865 48999999999886554433 367788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
||||||++||++..+|.. ...|++..+..++.+++.|+..+| +.|+|||||||+|+|||..|++||+||||+.
T Consensus 217 YLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999975 678999999999999999999999 8899999999999999999999999999986
Q ss_pred cCCCC----------------------Ccc-----ce------------------ecccccCccccCcccccCCCCCchh
Q 009595 361 LMPDG----------------------HAQ-----VS------------------TSIVAGTVGYIAPEYHQTLKFSEKC 395 (531)
Q Consensus 361 ~~~~~----------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~ 395 (531)
-+... ... .. ....+|||-|||||++.+.+|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 43210 000 00 0125799999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCC
Q 009595 396 DIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP 475 (531)
Q Consensus 396 DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 475 (531)
|.||+|||+||||.|.+||....+.+.-..+..|-.......... + .....+||++|+. ||.+|-
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~------~--------s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVD------L--------SDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCc------c--------cHHHHHHHHHHhc-CHHHhc
Confidence 999999999999999999988777777777777765543221111 1 0347889999998 999997
Q ss_pred C---HHHHHH
Q 009595 476 N---SKDVRS 482 (531)
Q Consensus 476 s---~~evl~ 482 (531)
- +.||-+
T Consensus 435 G~~G~~EIK~ 444 (550)
T KOG0605|consen 435 GSKGAEEIKK 444 (550)
T ss_pred CcccHHHHhc
Confidence 6 445544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=345.32 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=214.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.+.||+|+||+||+|+-+ .+.+.||+|.+.+...... ..+.+.+|+++++.++|||||.++++|++...+++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK-~t~~~vAik~i~K~gr~~k--~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRK-YTIQVVAIKFIDKSGRNEK--ELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccc-cceeEEEEEEehhcCCchH--HHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence 56888899999999999999865 4788999999987655433 37889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|+|||.| +|+.+|.. ...+++..+..++.++.+||.||| +.+|+|||+||.|||++.+|++|+||||+++.+
T Consensus 79 Vte~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAM 150 (808)
T ss_pred Eehhhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhc
Confidence 9999977 99999976 788999999999999999999999 788999999999999999999999999999988
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
..... ..+...|||.|||||+..+.+|+..+|+||+|||+||+.+|++||-. ..+...++.+...+....
T Consensus 151 ~~~t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------~si~~Lv~~I~~d~v~~p- 220 (808)
T KOG0597|consen 151 STNTS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------RSITQLVKSILKDPVKPP- 220 (808)
T ss_pred ccCce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------HHHHHHHHHHhcCCCCCc-
Confidence 76532 23457899999999999999999999999999999999999999742 345555555554332111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
......+..++...|..||.+|.|-.+++.|-
T Consensus 221 ----------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 221 ----------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred ----------ccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 12223478888899999999999999988764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=314.73 Aligned_cols=281 Identities=24% Similarity=0.297 Sum_probs=219.7
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
..|...+++|+|.||+||+|.... +|+.||||+++..... +....+..+||..|+.++||||+.++++|...+.+.|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~-t~~~VAIKKIkl~~~k--dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE-TGKRVAIKKIKLGNAK--DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC-CCcEEEEEEeeccccc--cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence 467788999999999999998765 8999999999875332 1224567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|+|||+. +|...++. ....++...+..++.++++||+||| .+.|+||||||.|+|++++|.+||+|||+++.+
T Consensus 79 VfEfm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 79 VFEFMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFF 151 (318)
T ss_pred EEEeccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhcc
Confidence 9999988 99999974 4567888999999999999999999 788999999999999999999999999999998
Q ss_pred CCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
......... .+-|..|.|||.+.|. .|+..+|+||.|||+.||+.|.+-|.+. ...+++...++ .+..+.+..
T Consensus 152 ~~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~---sDidQL~~If~-~LGTP~~~~ 225 (318)
T KOG0659|consen 152 GSPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD---SDIDQLSKIFR-ALGTPTPDQ 225 (318)
T ss_pred CCCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC---chHHHHHHHHH-HcCCCCccc
Confidence 776544332 3679999999998876 6999999999999999999988766543 33334433333 223332222
Q ss_pred cccccccC--------------CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCchhhhhhc
Q 009595 442 AIDSKLLG--------------NGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKDVDFLKMH 499 (531)
Q Consensus 442 ~~d~~l~~--------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~~~~ 499 (531)
+.+-.-.+ ..++......++++..+|..||.+|+|+++++++ +...+++.++.-+..|
T Consensus 226 WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p 299 (318)
T KOG0659|consen 226 WPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIP 299 (318)
T ss_pred CccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCC
Confidence 22111111 1233344557899999999999999999999875 4555666555444444
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=343.48 Aligned_cols=253 Identities=24% Similarity=0.380 Sum_probs=210.7
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
....|+..+.||+|.||.||+|.... +++.||+|++......+ .+..+++|+.++.++++|||.++|+.+..+..+
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~-t~k~vAiKii~Le~~~d---eIediqqei~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNK-TKKVVAIKIIDLEEAED---EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred cccccccchhccccccceeeeeeecc-ccceEEEEEechhhcch---hhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence 34567788999999999999998765 78999999998654433 267788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
+++||||.||++.+.+.. ...+++....-++++++.||.||| ..+.+|||||+.|||+..+|.+||+|||.+.
T Consensus 87 wiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred HHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceee
Confidence 999999999999999964 455578888889999999999999 7789999999999999999999999999999
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
.+....... ..++|||.|||||++.+..|+.++||||||++.+||++|.+|+.+.++-.... .+.
T Consensus 160 ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------lIp------ 224 (467)
T KOG0201|consen 160 QLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------LIP------ 224 (467)
T ss_pred eeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------ecc------
Confidence 887654433 55899999999999998899999999999999999999999998876622111 111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
....|.+.. .+. ..+.+++..||+.||+.|||+.+++++
T Consensus 225 k~~PP~L~~-~~S---~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 225 KSAPPRLDG-DFS---PPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCCCcccc-ccC---HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 111222222 222 236777888999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=363.51 Aligned_cols=266 Identities=25% Similarity=0.363 Sum_probs=216.6
Q ss_pred hcccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 276 (531)
...+....+.||+|.||.||+|+... .....||||.++..... +...+|.+|++++..++|||||+|+|+|..
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~---~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN---QARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH---HHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 34555678999999999999998632 23467999999875543 237889999999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHhhccC------C----CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQ------G----RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~ 346 (531)
++.+|+|+|||..|+|.+||..... . ..+++..+.+.|+.|||.|+.||- ++.+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceec
Confidence 9999999999999999999976321 1 233888999999999999999999 56699999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhH
Q 009595 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKS 425 (531)
Q Consensus 347 ~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~ 425 (531)
++..|||+||||++.+-..+.......-.-..+|||||.+..++|+.+||||||||+|||+.+ |+.||.++.. ++
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn----~E 713 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN----QE 713 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch----HH
Confidence 999999999999998766554433323334789999999999999999999999999999999 9999988644 33
Q ss_pred HHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 426 LVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 426 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
.++.++...--++|... +..++.|+..||+.+|.+|||+++|-..|+....
T Consensus 714 VIe~i~~g~lL~~Pe~C-------------P~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 714 VIECIRAGQLLSCPENC-------------PTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHHcCCcccCCCCC-------------CHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 33333332222222221 2358999999999999999999999999987543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=335.45 Aligned_cols=268 Identities=21% Similarity=0.327 Sum_probs=205.5
Q ss_pred cccccccccccccceeEEEEEeeeC---------------CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE---------------SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN 266 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~---------------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn 266 (531)
.++|.+.++||+|+||.||+|.+.. .++..||+|.+...... .....+.+|+.++.+++|||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK---NARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH---HHHHHHHHHHHHHhhcCCCC
Confidence 3577888999999999999997532 13447999998764322 22567889999999999999
Q ss_pred ccccceeEEeCCceEEEEeccCCCCHHHHHhhccC---------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 009595 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQ---------------GRRELEWLARHRIARGIVSGLEYLHMYHRP 331 (531)
Q Consensus 267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 331 (531)
|+++++++...+..++||||+++|+|.+++..... ....+++.....++.|++.||.||| +.
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~ 157 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SL 157 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HC
Confidence 99999999999999999999999999999865221 1134788889999999999999999 77
Q ss_pred CeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh--
Q 009595 332 RIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-- 409 (531)
Q Consensus 332 ~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-- 409 (531)
+++||||||+|||++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 899999999999999999999999999987654433222334456889999999988899999999999999999987
Q ss_pred CCCCCCCcccchhhhHHHHHHHHHhccC-CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 410 GKLPSDDFFQHTEEKSLVRWMRNVMTSE-NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 410 g~~P~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
+..||.+... ......+....... .......+ . .....+.+++.+||..||.+|||+.+|.+.|++
T Consensus 238 ~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~----~---~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 238 KEQPYGELTD----EQVIENAGEFFRDQGRQVYLFRP----P---PCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCCcCCH----HHHHHHHHHHhhhccccccccCC----C---CCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5677765432 22222222221111 00000000 0 112347889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=341.60 Aligned_cols=266 Identities=23% Similarity=0.293 Sum_probs=211.4
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCC-
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPD- 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~- 278 (531)
..++|..+++||.|+||.||+|+... +|..||||+++.......+ -.-.+|+..|++|+ |||||++.+++.+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~-~~~~VAIK~MK~Kf~s~ee---~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE-TGELVAIKKMKKKFYSWEE---CMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC-CCceeeHHHHHhhhccHHH---HHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 45789999999999999999998765 7888999999875544322 22457999999998 999999999999888
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
.+|+|||||+. +|+++++.+ +..+++..+..|+.||++||+|+| ++|+.|||+||+|||+.....+||+|||+
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGL 156 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGL 156 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccc
Confidence 99999999977 999999862 678999999999999999999999 89999999999999999999999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
|+.+.+... .+..+.|..|.|||++.. +-|+.+.|+|++|||++|+.+-++-|.+. .+.+++... ..++..+
T Consensus 157 ARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~---sE~Dqi~KI-c~VLGtP 229 (538)
T KOG0661|consen 157 AREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA---SEIDQIYKI-CEVLGTP 229 (538)
T ss_pred ccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC---cHHHHHHHH-HHHhCCC
Confidence 998866543 344678999999998764 56899999999999999999999888764 233333332 2222221
Q ss_pred CCCcccc------------ccc----cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 438 NPNRAID------------SKL----LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 438 ~~~~~~d------------~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
....... +.. ...-.+.......+++.+|+.-||.+|||+.+.+++-
T Consensus 230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred ccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1111111 000 0111222345688899999999999999999999965
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=330.50 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=213.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
..+|++.+.||+|.||.|-+|... ..|+.||||.+++....+ ++..-.+.+||++|+.|+||||+.+|++|.+.+...
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~-~sgR~VAiKsIrKdkIkd-eqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEH-KSGREVAIKSIRKDKIKD-EQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhc-cCCcEeehhhhhhhhccc-HHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 467889999999999999999764 379999999998755433 344677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
|||||..+|.|+||+.. .+.+++..+..+++||.+|+.||| +++++|||||.+|||+|.++++||+||||+..
T Consensus 130 ivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhh
Confidence 99999999999999976 678999999999999999999999 88999999999999999999999999999998
Q ss_pred CCCCCccceecccccCccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKF-SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
+...... ..+||+|-|.+||++.+.+| ++.+|.|||||+||.|+.|..||++.. ...+++.+....
T Consensus 203 y~~~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D----hk~lvrQIs~Ga------ 269 (668)
T KOG0611|consen 203 YADKKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD----HKRLVRQISRGA------ 269 (668)
T ss_pred hccccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch----HHHHHHHhhccc------
Confidence 7665433 34899999999999999988 689999999999999999999998752 233333332211
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
...+.- .....-||.+||..||.+|.|+.+|..|-
T Consensus 270 -YrEP~~--------PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 270 -YREPET--------PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -ccCCCC--------CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111110 11256688999999999999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=333.15 Aligned_cols=255 Identities=24% Similarity=0.314 Sum_probs=200.9
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 284 (531)
|...+.||+|+||.||+|.... +|+.||+|.+........ .....+.+|+.++.+++||||+++++++...+..++||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~-~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKR-KGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEec-CCceEEEEEeeHhhhhhh-hhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 6778899999999999998764 789999999875432211 12345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCC
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~ 364 (531)
||+++|+|.+++.. .....+++..+..++.|++.||.||| +++++||||||+|||++.++.++|+|||++.....
T Consensus 80 e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 80 TIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred EecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999999988864 23346899999999999999999999 78899999999999999999999999999987644
Q ss_pred CCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcccc
Q 009595 365 GHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444 (531)
Q Consensus 365 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 444 (531)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...+ ..... ...
T Consensus 155 ~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~~~~~--~~~ 225 (285)
T cd05631 155 GET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV----KEDQE--EYS 225 (285)
T ss_pred CCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh----hcccc--cCC
Confidence 322 123568999999999999999999999999999999999999997643222112221111 11110 010
Q ss_pred ccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 009595 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-----SKDVRSM 483 (531)
Q Consensus 445 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 483 (531)
.. ....+.+++.+||+.||.+||+ +.+++++
T Consensus 226 ----~~----~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 226 ----EK----FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ----cc----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 11 1224778899999999999997 6777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=323.19 Aligned_cols=307 Identities=23% Similarity=0.281 Sum_probs=223.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe-----
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR----- 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----- 276 (531)
...|..++.||.|+||.|..+.... +|+.||||++....... ...++..+|+.+|+.++|+||+.+++.+..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~-t~~~VAIKKi~~~F~~~--~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKR-TGEKVAIKKILNPFENQ--IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred cceecccccccCcceeeEEEEEEcC-CCCEeehhhhhhhhhch--HHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 3455567899999999999998775 78999999997433332 236788899999999999999999998865
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
-..+|+|+|+|+. +|...++. ++.++......++.|+++||.|+| +.+|+||||||+|+|++.+..+|||||
T Consensus 98 f~DvYiV~elMet-DL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 98 FNDVYLVFELMET-DLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred cceeEEehhHHhh-HHHHHHHc----CccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccc
Confidence 3467999999955 99999975 566999999999999999999999 678999999999999999999999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHH-------
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR------- 428 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~------- 428 (531)
|+|+...........+..+-|..|.|||++.+ ..|+...||||.|||+.||++|++-|.+.........+..
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 99998865322222345677999999998765 4799999999999999999999998876321100000000
Q ss_pred ---------HHHHHhc-cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCCCchhhhhh
Q 009595 429 ---------WMRNVMT-SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDVDFLKM 498 (531)
Q Consensus 429 ---------~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~ 498 (531)
.++..+. .+.........+++ ......++|+.+||..||.+|+|+.+.++|---....++.+-...
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp----~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~ 325 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFP----NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVC 325 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcC----CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCC
Confidence 0011111 01011111111122 222347889999999999999999999997533322222211111
Q ss_pred ccCC-CCCChHHHHHhhHHHHhhhhc
Q 009595 499 HKRM-DFDNDDCVELIQQEIYTEWLS 523 (531)
Q Consensus 499 ~~~~-~~~~~~~~~~~~~~~~~~~~~ 523 (531)
+... +++.....+.+++.+|.|.+.
T Consensus 326 ~~~~~~~~~~~~~~~~r~~i~~e~~~ 351 (359)
T KOG0660|consen 326 QPIFDSFEHELTEEELRELIYKEILD 351 (359)
T ss_pred CCCCccccccccHHHHHHHHHHHHHh
Confidence 1111 145556799999999999543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=346.73 Aligned_cols=252 Identities=24% Similarity=0.324 Sum_probs=209.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+-|...+.||.|+.|.|-.|+... +|+.+|||++...... .+.....+.+||-+|+.+.||||+++|+++.+...+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~-TGqlaaiKii~k~~~~-s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAE-TGQLAAIKIIPKRSEL-SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhccc-ccceeEEEeecccccc-ccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 456778899999999999999875 8999999999765322 22235668899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|.||++||.|++++-. ++++++..+.+++.||+.|+.||| ..+|+||||||+|+|||..+++||+|||+|..-
T Consensus 90 vlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE 162 (786)
T ss_pred EEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc
Confidence 9999999999999965 788999999999999999999999 667999999999999999999999999999875
Q ss_pred CCCCccceecccccCccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKF-SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
..+.- ..+-||+|.|.+||++.|.+| +.++||||+|||||.||||+.||++. ....+...++...-.- ..
T Consensus 163 ~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd----Nir~LLlKV~~G~f~M--Ps 233 (786)
T KOG0588|consen 163 VPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD----NIRVLLLKVQRGVFEM--PS 233 (786)
T ss_pred cCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc----cHHHHHHHHHcCcccC--CC
Confidence 54432 234689999999999999998 57899999999999999999999863 3334443333221110 01
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
. ...+..+|+.+|+..||..|.|+.+|++|-
T Consensus 234 --------~----Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 234 --------N----ISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred --------c----CCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 1 112367788899999999999999999975
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=345.16 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=208.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+...+.+.||+|.||+||+|.| .|. ||||++........ ..+.|..|+..+++-+|.||+-+.|+|..+.. .|
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~w---hGd-VAVK~Lnv~~pt~~--qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRW---HGD-VAVKLLNVDDPTPE--QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred HHhhccceeccccccceeeccc---ccc-eEEEEEecCCCCHH--HHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 4456788999999999999999 455 99999987665543 58999999999999999999999999988766 99
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|+-+|+|-+|+.+|+- ....+...+...|++||++|+.||| .++|||||||+.||++.++++|||+||||+...
T Consensus 465 iTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 9999999999999984 3467899999999999999999999 889999999999999999999999999998765
Q ss_pred CCCCccceecccccCccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQT---LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
.............|...|||||++.. .+|+..+||||||||+|||+||..||..-.. ++++ -+...+..
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~----dqIi----fmVGrG~l 610 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR----DQII----FMVGRGYL 610 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh----hheE----EEeccccc
Confidence 43322223334568889999999864 4799999999999999999999999973221 1111 11111211
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCC
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALI 490 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 490 (531)
..|.- ....+....+.+|+..||..++++||.+.+|+..|..+.+.
T Consensus 611 --~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 611 --MPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred --Cccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 11111 11222233567777889999999999999999988887664
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.63 Aligned_cols=263 Identities=20% Similarity=0.295 Sum_probs=206.1
Q ss_pred cccccccccccccceeEEEEEeee----CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEe
Q 009595 202 EDCSASLEKIRSRASGEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVR 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 276 (531)
.++|.+.+.||+|+||.||+|.+. ..++..||||+++...... ....+.+|+.++..+ +||||++++++|..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT---EREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcH---HHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 457888999999999999999742 2356689999997543221 246788899999999 89999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHhhccC-------------------------------------------------------
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQ------------------------------------------------------- 301 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------- 301 (531)
.+..++|||||++|+|.+++.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999964211
Q ss_pred ----------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCC
Q 009595 302 ----------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDG 365 (531)
Q Consensus 302 ----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~ 365 (531)
....+++..+..++.||+.||.||| +++++||||||+|||++.++.+||+|||++......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 0124788899999999999999999 778999999999999999999999999999876543
Q ss_pred CccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCcccc
Q 009595 366 HAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444 (531)
Q Consensus 366 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 444 (531)
..........++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...+...+........+
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~---~~~~~~~~~~~~~~~~~----- 339 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV---DSKFYKMIKEGYRMLSP----- 339 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc---hHHHHHHHHhCccCCCC-----
Confidence 32222223345678999999999999999999999999999998 8889876422 12233332221111100
Q ss_pred ccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 445 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
.. ....+.+++.+||+.||++|||+.+|++.|++
T Consensus 340 -----~~---~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 -----EC---APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -----CC---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 01 11247889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=315.94 Aligned_cols=240 Identities=21% Similarity=0.270 Sum_probs=201.1
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|+.++.||.|+||.|.+++.+. +|..||+|++....--. -.+.+....|..+|+.+.||+++++++.|.+.+.+|+
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~-~g~yYAmKvL~k~~vVk-lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKH-SGNYYAMKVLDKQKVVK-LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhheeeeccCccceEEEEEEcc-CCceeehhhcCHHHHHH-HHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 567888999999999999999876 68999999998754333 2346778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||++||.|.+++++ .+.+++..+.-++.+|+.||+||| ..+|++|||||+|||+|++|.+||+|||.|+.+
T Consensus 122 vmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 9999999999999976 578999999999999999999999 677999999999999999999999999999987
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
... +.+.||||.|+|||++...+|+.++|.|+|||++|||+.|.+||.+..+ ..+.+.+ .. + ..
T Consensus 195 ~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI---~~-~---~v 258 (355)
T KOG0616|consen 195 SGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKI---LE-G---KV 258 (355)
T ss_pred cCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHH---Hh-C---cc
Confidence 554 3458999999999999999999999999999999999999999976543 2222211 11 1 11
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCC
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEER 474 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 474 (531)
.-|.. ..+ .+.+|+...|+.|-++|
T Consensus 259 ~fP~~---fs~----~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 KFPSY---FSS----DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCCcc---cCH----HHHHHHHHHHhhhhHhh
Confidence 11111 111 26777788888999888
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.83 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=199.5
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe----CCceEEEE
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR----PDCHLLVS 284 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~lv~ 284 (531)
..||+|++|.||+|.+ +|+.||||.+....... ....+.+.+|+.+|.+++||||++++|++.+ ....++||
T Consensus 26 ~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~ 101 (283)
T PHA02988 26 VLIKENDQNSIYKGIF---NNKEVIIRTFKKFHKGH-KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101 (283)
T ss_pred eEEeeCCceEEEEEEE---CCEEEEEEecccccccc-HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence 5799999999999987 78999999997643322 2235678899999999999999999999876 34678999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCC
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~ 364 (531)
||+++|+|.+++.. ...+++.....++.+++.||.|||. ..+++||||||+||+++.++.+||+|||+++.+..
T Consensus 102 Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 102 EYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred EeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 99999999999975 4578899999999999999999994 24788999999999999999999999999886544
Q ss_pred CCccceecccccCccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 365 GHAQVSTSIVAGTVGYIAPEYHQT--LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 365 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
.. ....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+... ..+...+. ..+.. ..
T Consensus 176 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----~~~~~~i~---~~~~~-~~ 242 (283)
T PHA02988 176 PP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----KEIYDLII---NKNNS-LK 242 (283)
T ss_pred cc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----HHHHHHHH---hcCCC-CC
Confidence 32 12457899999999876 6799999999999999999999999976422 22222211 11111 01
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
++. . ....+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 243 ~~~----~----~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 LPL----D----CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCC----c----CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 110 1 1224788999999999999999999999998754
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=320.19 Aligned_cols=280 Identities=22% Similarity=0.244 Sum_probs=218.2
Q ss_pred hhhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC-
Q 009595 199 LEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP- 277 (531)
Q Consensus 199 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~- 277 (531)
+...+.|..+++|++|+||.||+|+.+. +++.||+|+++..... +...-...+||.+|.+++|||||.+..+.+..
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~-t~eIVALKr~kmekek--~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKK-TDEIVALKRLKMEKEK--EGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCC-cceeEEeeeccccccc--CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 4455778899999999999999998765 7899999999865432 11134467899999999999999999987753
Q ss_pred -CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 278 -DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 278 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
+.+|+|||||+. +|.+++... ..++....+..++.|+++|+.||| .+.|+||||||+|+|++..|.+||+||
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEeccc
Confidence 578999999988 999999864 367888999999999999999999 778999999999999999999999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
|+|+.+++... ..+..+-|..|.|||.+.+. .|+...|+||+|||+.||+++++-|.+-. +..++...++.
T Consensus 222 GLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s---E~dQl~~If~l--- 293 (419)
T KOG0663|consen 222 GLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS---EIDQLDKIFKL--- 293 (419)
T ss_pred chhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc---hHHHHHHHHHH---
Confidence 99999877633 23446679999999998876 59999999999999999999999887643 23333333222
Q ss_pred cCCCCccccccccC----------CC--------cHH--HHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCch
Q 009595 436 SENPNRAIDSKLLG----------NG--------YEE--QMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKDV 493 (531)
Q Consensus 436 ~~~~~~~~d~~l~~----------~~--------~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~ 493 (531)
-+.|.+.+.+.+.. .. +.. -.+.-.+|+...|..||.+|.|+.+.+++ +.+.+.++++
T Consensus 294 lGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P 373 (419)
T KOG0663|consen 294 LGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDP 373 (419)
T ss_pred hCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCCh
Confidence 23333333332210 00 001 11346778888999999999999999875 5666667766
Q ss_pred hhh
Q 009595 494 DFL 496 (531)
Q Consensus 494 ~~~ 496 (531)
++.
T Consensus 374 ~~~ 376 (419)
T KOG0663|consen 374 SMF 376 (419)
T ss_pred hhc
Confidence 543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=331.00 Aligned_cols=270 Identities=17% Similarity=0.193 Sum_probs=202.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.+.||+|+||.||+|.... +++.||+|++....... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE-TKEIVAIKKFKDSEENE--EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC-CCcEEEEEEEecccccc--cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence 368889999999999999998764 68899999997643221 225667889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|..+... ...+++..+..++.|++.||.||| ..+++||||||+||+++.++.+||+|||++...
T Consensus 78 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 78 VFEYVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNL 150 (287)
T ss_pred EEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence 9999998766654432 356899999999999999999999 778999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHH--------HHHHh
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRW--------MRNVM 434 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~--------~~~~~ 434 (531)
...... ......|++.|+|||++.+..++.++|||||||++|||++|+.||...........+... .....
T Consensus 151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 151 SEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred cccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 543221 123356899999999999888999999999999999999999999764221111111110 00000
Q ss_pred ccCCCCccccccccC-C-----CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 435 TSENPNRAIDSKLLG-N-----GYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~-~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..+.......+.... . ........+.+++.+||+.||.+|||+.++++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000 0 000122358899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=334.51 Aligned_cols=249 Identities=20% Similarity=0.278 Sum_probs=200.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|+||.||+|.... +|+.||+|++....... ......+.+|+.++++++||||+++++++.+....++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI-SEHYYALKVMAIPEVIR-LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHHhh-hHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence 367888999999999999998754 68899999997532211 1225668889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ...+++.....++.|++.||.||| +++++||||||+|||++.++.+||+|||++...
T Consensus 79 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 79 LMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred EEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 9999999999999965 456899999999999999999999 788999999999999999999999999998876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ..+... .... ...
T Consensus 152 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~----~~~~~~---i~~~-~~~-- 216 (291)
T cd05612 152 RDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP----FGIYEK---ILAG-KLE-- 216 (291)
T ss_pred cCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH---HHhC-CcC--
Confidence 4321 235689999999999988899999999999999999999999875422 112211 1111 111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-----SKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 483 (531)
+. ... ...+.+++.+||+.||.+||+ +.+++++
T Consensus 217 ~~----~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 FP----RHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CC----ccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00 011 124788999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=333.14 Aligned_cols=202 Identities=22% Similarity=0.375 Sum_probs=176.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||++.... +|..||+|.+...... .....+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP-SGLIMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC-CCcEEEEEEeecccCH---HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 4678999999999999999998754 7889999999764321 22567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+++||||||+|||++.++.+||+|||++..
T Consensus 80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 80 ICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (331)
T ss_pred EEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence 99999999999999965 4568999999999999999999994 24699999999999999999999999999886
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDF 417 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~ 417 (531)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 154 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 64432 12356899999999999989999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=342.73 Aligned_cols=264 Identities=22% Similarity=0.342 Sum_probs=205.7
Q ss_pred cccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEe
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVR 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 276 (531)
.++|...+.||+|+||.||+|.+.. .++..||||++....... ....+.+|+.+++.+ +||||++++++|..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD---EREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH---HHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 4578889999999999999997532 234579999997643322 256788999999999 89999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHhhccC-------------------------------------------------------
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQ------------------------------------------------------- 301 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------- 301 (531)
.+..++|||||++|+|.+++.....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999999864210
Q ss_pred -----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccce
Q 009595 302 -----------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS 370 (531)
Q Consensus 302 -----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~ 370 (531)
....+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++...........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 1124788889999999999999999 78899999999999999999999999999987654332222
Q ss_pred ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccC
Q 009595 371 TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLG 449 (531)
Q Consensus 371 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 449 (531)
.....+++.|+|||++.+..++.++|||||||++|+|++ |+.||....... .+...+........+
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~~~~~~~~~---------- 337 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVKRGYQMSRP---------- 337 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHHcccCccCC----------
Confidence 223345678999999988899999999999999999997 999987643211 122221111111100
Q ss_pred CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 450 NGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 450 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
... ...+.+++.+||+.||.+|||+.++++.|+++
T Consensus 338 ~~~---~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 DFA---PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011 12478899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=340.07 Aligned_cols=257 Identities=19% Similarity=0.274 Sum_probs=204.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|.+.+.||+|+||.||+|.... +++.||||++....... ......+..|+.++..++||||+++++++...+..|+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD-TGEIVALKRMKKSLLFK-LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC-CCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence 368889999999999999998764 68899999997543211 1225678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++...
T Consensus 79 v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 79 AMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred EEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 9999999999999965 456889999999999999999999 778999999999999999999999999998865
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+..|... .. .+ ..
T Consensus 152 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~--~~-~~ 222 (333)
T cd05600 152 VT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET-LQ--RP-VY 222 (333)
T ss_pred cc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-cc--CC-CC
Confidence 44 123457899999999999989999999999999999999999999764322111111111100 00 00 00
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.++. ......+.+++.+||..+|.+|||+.+++++
T Consensus 223 ~~~~------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DDPR------FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred Cccc------cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000 1122347888999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=349.53 Aligned_cols=257 Identities=18% Similarity=0.238 Sum_probs=205.7
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
..|...+.||+|++|.||+|......+..||+|.+...... ....+..|+.+++.++||||+++++++...+..|+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~----~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDER----QAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHH----HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 44888999999999999999876544778899977543322 24567789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.........+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++..+
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99999999999988754344567899999999999999999999 778999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
............+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..+. ...........
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----~~~~---~~~~~~~~~~~- 291 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----REIM---QQVLYGKYDPF- 291 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----HHHH---HHHHhCCCCCC-
Confidence 554322223446799999999999998999999999999999999999999865321 1222 22111111100
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+ .. ....+.+++.+||..||.+|||+.+++.+
T Consensus 292 --~---~~----~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 292 --P---CP----VSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --C---cc----CCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 0 01 11247889999999999999999998753
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=345.55 Aligned_cols=263 Identities=27% Similarity=0.360 Sum_probs=209.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCC---eEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNG---KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
++....++||+|+||.||+|.+...++ ..||||..+.... .....+..|.+|+++|++++|||||++||++.....
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~-~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE-LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc-ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 444556899999999999999976544 2389999985322 223347889999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
+++|||+|+||+|.++|.. ....++...+..++.+.|.||+||| +++++||||-.+|+|++.++.+||+||||+
T Consensus 236 l~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred cEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 9999999999999999986 2236999999999999999999999 788999999999999999999999999998
Q ss_pred ccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHH-HHHhccC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWM-RNVMTSE 437 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~-~~~~~~~ 437 (531)
+........ .....-...|+|||.+....|+.++|||||||++||+.+ |..||.+.... ++..++ .......
T Consensus 310 ~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 310 RAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVKNGYRMP 383 (474)
T ss_pred cCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHhcCccCC
Confidence 865421111 111234678999999999999999999999999999999 88898876432 333333 2222111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCCC
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIK 491 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 491 (531)
.+. .....+..++.+||..||++||||.++.+.|+.+....
T Consensus 384 ~~~-------------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 384 IPS-------------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred CCC-------------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 111 12234667778999999999999999999998875443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=330.01 Aligned_cols=265 Identities=18% Similarity=0.252 Sum_probs=199.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||.|+||.||+|.... +++.||+|.++...... ....+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKL-TENLVALKEIRLEHEEG---APCTAIREVSLLKNLKHANIVTLHDIIHTERCLT 79 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECC-CCCEEEEEEecccccCC---cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 3568899999999999999998654 78899999997543221 1345678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++ +|.+++.. ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++..
T Consensus 80 lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~ 152 (288)
T cd07871 80 LVFEYLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARA 152 (288)
T ss_pred EEEeCCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceee
Confidence 99999975 99998864 2345788899999999999999999 78899999999999999999999999999876
Q ss_pred CCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... .....|++.|+|||.+.+ ..++.++||||+||++|+|+||+.||.+..... .+ ..+......+...
T Consensus 153 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~---~~-~~~~~~~~~~~~~ 226 (288)
T cd07871 153 KSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE---EL-HLIFRLLGTPTEE 226 (288)
T ss_pred ccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HH-HHHHHHhCCCChH
Confidence 5432211 123567999999998865 468999999999999999999999987543211 11 1111111111000
Q ss_pred cc--------ccccccCC----C----cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RA--------IDSKLLGN----G----YEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~--------~d~~l~~~----~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. ......+. . .+.....+.+++.+||+.||.+|||+.++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 227 TWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred HhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00000000 0 00112347889999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=336.86 Aligned_cols=249 Identities=22% Similarity=0.289 Sum_probs=202.0
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|+||.||+|.... +++.||+|.+....... ......+.+|+.++++++||||+++++++...+..|+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKG-TGEYYAIKCLKKREILK-MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 678889999999999999998764 68899999997532211 1225678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ...+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++...
T Consensus 96 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 9999999999999975 456889999999999999999999 788999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ..... .... +....
T Consensus 169 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~---~i~~-~~~~~- 234 (329)
T PTZ00263 169 PDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FRIYE---KILA-GRLKF- 234 (329)
T ss_pred CCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----HHHHH---HHhc-CCcCC-
Confidence 4432 235689999999999998999999999999999999999999865322 11111 1111 11110
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-----SKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 483 (531)
+ ... ...+.+++.+||+.||.+||+ +.+++.|
T Consensus 235 --p----~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 --P----NWF---DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --C----CCC---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 111 124778999999999999997 5777655
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=333.85 Aligned_cols=265 Identities=22% Similarity=0.328 Sum_probs=196.4
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC-----
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD----- 278 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----- 278 (531)
+|...+.||+|+||.||+|.... +|..||||++....... .....+.+|+.++++++||||+++++++....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKINDVFEHV--SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC-CCCEEEEEEechhhccc--hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 47788999999999999998654 78899999987532221 12456788999999999999999999886432
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
..|+|||||. ++|.+++.. ...+++..+..++.|+++||.||| +.+++||||||+|||++.++.+||+|||+
T Consensus 78 ~~~lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~ 149 (338)
T cd07859 78 DIYVVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGL 149 (338)
T ss_pred eEEEEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcc
Confidence 4799999995 599999864 456899999999999999999999 77899999999999999999999999999
Q ss_pred CccCCCCCc-cceecccccCccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 359 ARLMPDGHA-QVSTSIVAGTVGYIAPEYHQT--LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 359 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
++....... ........||+.|+|||++.+ ..++.++|||||||++|+|+||+.||.+.... .....+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~----~~~~~~~~~~~ 225 (338)
T cd07859 150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV----HQLDLITDLLG 225 (338)
T ss_pred ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH----HHHHHHHHHhC
Confidence 986543221 111133568999999999866 57899999999999999999999998653211 11111111110
Q ss_pred cCCCC-----------------ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPN-----------------RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~-----------------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+.+. ....+......++.....+.+++.+||+.||++|||+.+++++
T Consensus 226 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 0000000000011112347789999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=303.90 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=210.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|++.+.||.|.||.||.|+.+. ++-.||+|++.+..- .......++.+|+++-+.|+||||+++|++|.+....|+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekk-s~~IvalKVlfKsqi-~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKK-SLFIVALKVLFKSQI-LKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred hhccccccccCCccccEeEeeecc-CCcEEEEeeeeHHHH-HHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 678889999999999999999875 688899999976542 233346789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
++||..+|+|...|.. +....+++.....++.|+|.||.|+| .++|+||||||+|+|++.++.+|++|||.+...
T Consensus 100 ilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999975 34567889999999999999999999 788999999999999999999999999998876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
+.+ ...+.+||.-|.|||...+..++..+|+|++|++.||++.|.+||+.....+. ..+..+.- .
T Consensus 175 p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et---YkrI~k~~--------~ 239 (281)
T KOG0580|consen 175 PSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET---YKRIRKVD--------L 239 (281)
T ss_pred CCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH---HHHHHHcc--------c
Confidence 533 23457899999999999999999999999999999999999999976532221 11111111 1
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+|. .......++|.+|+..+|.+|.+..+++++
T Consensus 240 ~~p~-------~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 KFPS-------TISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cCCc-------ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1111 111237889999999999999999999876
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=333.84 Aligned_cols=246 Identities=21% Similarity=0.276 Sum_probs=197.1
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccC
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 288 (531)
+.||+|+||.||+|.... +|+.||+|++....... ......+..|+.++++++||||+++++++...+..|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKA-TGKYYAMKILKKEVIIA-KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 369999999999998754 78999999997533211 1224567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCcc
Q 009595 289 NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ 368 (531)
Q Consensus 289 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~ 368 (531)
+|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~- 150 (323)
T cd05571 79 GGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-
Confidence 9999999965 457899999999999999999999 77899999999999999999999999999875432221
Q ss_pred ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcccccccc
Q 009595 369 VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLL 448 (531)
Q Consensus 369 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 448 (531)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+. . .... +.
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~~~~~---~-~~~~--~p---- 215 (323)
T cd05571 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFELIL---M-EEIR--FP---- 215 (323)
T ss_pred -cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC----HHHHHHHHH---c-CCCC--CC----
Confidence 1234579999999999999899999999999999999999999986532 122222211 1 1111 00
Q ss_pred CCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 449 GNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 449 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
.. ....+.+++.+||+.||.+|| ++.+++++
T Consensus 216 ~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RT----LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CC----CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 11 122478899999999999999 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=323.34 Aligned_cols=261 Identities=26% Similarity=0.379 Sum_probs=206.7
Q ss_pred ccccccccccccceeEEEEEeeeCC----CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 203 DCSASLEKIRSRASGEIYIAELPES----NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
+.|...+.||+|+||.||+|..... ....||+|.+...... .....+.+|+.++.+++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP---KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH---HHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 4577889999999999999987532 2257999998754322 22567889999999999999999999999888
Q ss_pred ceEEEEeccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~ 346 (531)
..+++|||+++|+|.+++..... ....+++.....++.|++.||.||| .++++|+||||+||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVG 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEc
Confidence 99999999999999999975311 1145888999999999999999999 77899999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhH
Q 009595 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKS 425 (531)
Q Consensus 347 ~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~ 425 (531)
.++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+... ..
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~----~~ 234 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN----QE 234 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH----HH
Confidence 999999999999986544332222233456889999999988899999999999999999998 9999876432 22
Q ss_pred HHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 426 LVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 426 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
+...+.. +..... + ......+.+++.+||+.||.+||++.+|+++|+.
T Consensus 235 ~~~~i~~----~~~~~~------~---~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRS----RQLLPC------P---EDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHc----CCcCCC------c---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 3332221 111110 0 1122358889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=323.15 Aligned_cols=253 Identities=28% Similarity=0.462 Sum_probs=195.1
Q ss_pred ccccccccceeEEEEEeee---CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 207 SLEKIRSRASGEIYIAELP---ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 207 ~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
..+.||.|.||.||+|.+. ...+..|+||.++..... .....+.+|+..+++++||||++++|++...+..++|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSE---EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSH---HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccc---ccceeeeeccccccccccccccccccccccccccccc
Confidence 4678999999999999987 223568999999653322 1267788999999999999999999999988889999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++|+|.+++.. .....+++..+..++.|+++||.||| +++++|++|+|+||++++++.+||+|||++....
T Consensus 80 ~e~~~~g~L~~~L~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKS--KNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EE--TTEBHHHHHHH--TCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999999986 23467899999999999999999999 6779999999999999999999999999998774
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
............+...|+|||.+.+..++.++||||||+++|||++ |+.||.+... ..+...+........+
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----~~~~~~~~~~~~~~~~--- 227 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----EEIIEKLKQGQRLPIP--- 227 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----HHHHHHHHTTEETTSB---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccccccccceec---
Confidence 3322222233456789999999998889999999999999999999 7899876522 2333333222111111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
..+ ...+.+++..||..||.+|||+.++++.|
T Consensus 228 -------~~~---~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 -------DNC---PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------TTS---BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------cch---hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111 12377899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=327.32 Aligned_cols=267 Identities=21% Similarity=0.277 Sum_probs=199.8
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..++|.+.+.||+|+||.||+|.... +++.||||++....... ....+.+|+.+++.++||||+++++++......
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKV-NGKLVALKVIRLQEEEG---TPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECC-CCCEEEEEEeccccccc---cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeE
Confidence 35789999999999999999998754 68899999997543221 134567899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+. ++|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++.
T Consensus 79 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 151 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR 151 (303)
T ss_pred EEEEECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcce
Confidence 99999996 588888864 2356888899999999999999999 7889999999999999999999999999987
Q ss_pred cCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ....+..... ....+..
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~-~~~~~~~ 226 (303)
T cd07869 152 AKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFL-VLGTPNE 226 (303)
T ss_pred eccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHH-HhCCCCh
Confidence 5433221 12235689999999988654 578999999999999999999999976422 1111211111 1111000
Q ss_pred Cc--------ccccc-c---cCCCcHH------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 440 NR--------AIDSK-L---LGNGYEE------QMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 440 ~~--------~~d~~-l---~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. ...+. . ....... ....+.+++.+||+.||.+|||+.++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 00000 0 0000000 11346789999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=338.29 Aligned_cols=251 Identities=19% Similarity=0.242 Sum_probs=202.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.+....+..||+|.+....... ......+..|+.++..++||||+++++++...+..|
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK-QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 3678889999999999999998765455789999997532211 122567888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++..
T Consensus 108 lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999999975 457899999999999999999999 78899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
..... ....||+.|+|||++.+..++.++|||||||++|||++|..||.+... ..... .... +...
T Consensus 181 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~---~i~~-~~~~- 246 (340)
T PTZ00426 181 VDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----LLIYQ---KILE-GIIY- 246 (340)
T ss_pred cCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----HHHHH---HHhc-CCCC-
Confidence 54321 235789999999999988899999999999999999999999975422 11111 1111 1110
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
+. ...+ ..+.+++.+||+.||.+|+ |+++++++
T Consensus 247 -~p-----~~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 -FP-----KFLD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -CC-----CCCC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01 1111 2367889999999999995 88888876
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=327.98 Aligned_cols=269 Identities=20% Similarity=0.252 Sum_probs=196.3
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC---CCCcccccceeEEe----
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI---RHRNIVPLLAHMVR---- 276 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~---- 276 (531)
+|.+.+.||+|+||.||+|.....+++.||+|.+........ ....+.+|+.+++.+ +||||+++++++..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC--chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 678899999999999999987555678899999875432211 123445677666655 79999999998852
Q ss_pred -CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 277 -PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 277 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
....++||||+. ++|.+++.. .....+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 456899999996 599999975 33456899999999999999999999 78899999999999999999999999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
||++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.........+.+.......
T Consensus 154 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 154 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 230 (290)
T ss_pred ccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 99998664431 223456899999999998888999999999999999999999999764322211122111100000
Q ss_pred cCCCCc------cccccc---cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPNR------AIDSKL---LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~~------~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+.. ...+.. .....+.....+.+++.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000000 000000 000001122347789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.15 Aligned_cols=260 Identities=21% Similarity=0.276 Sum_probs=207.3
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC--
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD-- 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-- 278 (531)
..++|.+.+.||+|+||+||+|.... +|+.||||.+....... .....+.+|+..+..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~i~~~~~~~--~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVS-DGEPFAVKVVDMEGMSE--ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcC-CCCEEEEEEEecccCCH--HHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 45789999999999999999998654 78999999997643322 23567889999999999999999988765432
Q ss_pred ------ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEE
Q 009595 279 ------CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEAR 352 (531)
Q Consensus 279 ------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vk 352 (531)
.+++||||+++|+|.+++.........+++..+..++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEE
Confidence 367999999999999999765445567999999999999999999999 78899999999999999999999
Q ss_pred EeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHH
Q 009595 353 IADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN 432 (531)
Q Consensus 353 L~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~ 432 (531)
|+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.+... . ..+..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~----~---~~~~~ 256 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM----E---EVMHK 256 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH----H---HHHHH
Confidence 9999999876543222223446799999999999999999999999999999999999999875321 1 12222
Q ss_pred HhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 433 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
........ +. .. ....+.+++.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~--~~----~~----~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRYDP--LP----PS----ISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCCCC--CC----CC----CCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 22111111 11 11 12347889999999999999999999876
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=328.96 Aligned_cols=201 Identities=22% Similarity=0.388 Sum_probs=175.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|+..++||.|+||.||++.... ++..+|+|.+...... .....+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~-~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP-SGLIMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC-CCcEEEEEEeecccCH---HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 4678999999999999999998754 6888999998764322 22567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ...+++.....++.+++.||.|||+ ..+++|+||||+|||++.++.+||+|||++..
T Consensus 80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 80 ICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 99999999999999965 4568899999999999999999994 34799999999999999999999999999876
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDD 416 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~ 416 (531)
+.... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 154 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 154 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred hhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 54321 1235689999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=319.41 Aligned_cols=258 Identities=23% Similarity=0.309 Sum_probs=203.3
Q ss_pred ccccccccccccceeEEEEEeeeC--CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 203 DCSASLEKIRSRASGEIYIAELPE--SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
.+|.+.+.||+|+||.||+|.+.. ..+..||+|.++..... .....+.+|+.++.+++||||+++++++...+..
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD---KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH---HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 567888999999999999997643 34668999999864322 2246788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++.. ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++|||.+.
T Consensus 82 ~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 82 MIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 999999999999999974 2346899999999999999999999 7889999999999999999999999999876
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
....... .......++..|+|||.+.+..++.++|||||||++||+++ |..||.+... ..+...+.... ..
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~----~~~~~~~~~~~---~~ 227 (266)
T cd05064 156 EDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG----QDVIKAVEDGF---RL 227 (266)
T ss_pred cccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHHHHCCC---CC
Confidence 5432211 11112345678999999999999999999999999999775 9999875422 22222221111 11
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
. .+ . .....+.+++.+||+.+|.+|||+.+|.+.|..+
T Consensus 228 ~---~~----~---~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 P---AP----R---NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred C---CC----C---CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 00 1 1123478899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=335.32 Aligned_cols=255 Identities=20% Similarity=0.280 Sum_probs=212.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc-e
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC-H 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-~ 280 (531)
.++|..++.+|+|+||.++.++.+. +++.|++|.+......... .+....|+.+++++.|||||.+++.|..++. +
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~-~~~~~vlK~I~l~~~t~~~--r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l 79 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS-DDKLYVLKKINLEKLTEPE--RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL 79 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc-CCceEEEEEEeccccCchh--hHHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence 4678899999999999999998765 6778999999875544332 5578899999999999999999999999988 8
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
+|||+||+||+|.+.+... .+..+++..+..|+.|++.|+.||| ++.|+|||||++|||++.++.|||+|||+|+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAK 154 (426)
T ss_pred EEEEeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhh
Confidence 9999999999999999873 3577999999999999999999999 7789999999999999999999999999999
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
.+...... ....+||+.||.||.+.+.+|+.++|||||||++|||++-+.+|..... ..++.-+....- .|
T Consensus 155 ~l~~~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m----~~Li~ki~~~~~--~P- 225 (426)
T KOG0589|consen 155 ILNPEDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM----SELILKINRGLY--SP- 225 (426)
T ss_pred hcCCchhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch----HHHHHHHhhccC--CC-
Confidence 98776522 2447899999999999999999999999999999999999999876422 222222111110 11
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
........+..++..|+..+|..||++.+++..
T Consensus 226 ----------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 ----------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111222347788889999999999999999886
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=359.61 Aligned_cols=263 Identities=24% Similarity=0.374 Sum_probs=211.6
Q ss_pred ccccccccccccceeEEEEEeeeCCCCe----EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGK----MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
...+..+.||+|.||.||.|.+...+|. .||||.+..... .+....|.+|..+|+.++|||||+++|+|.+..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~---~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS---EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC---HHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 4456678999999999999999776665 388998876443 234788999999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhccC---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQ---GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
..+|++|||++|+|..||++.+. ....++....+.++.+||+|+.||+ ++++|||||..+|+||+....|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999986321 1456899999999999999999999 67799999999999999999999999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHh
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
||||+.+.+...........-...|||||.+..+.|+.++|||||||++||++| |..||.+..+ .++.. ...
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n----~~v~~---~~~ 918 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN----FEVLL---DVL 918 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch----HHHHH---HHH
Confidence 999996555433322222233568999999999999999999999999999999 8999876533 22222 222
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..++.. . +.++++ .+++++..||+.+|++||++..|++.+..+.
T Consensus 919 ~ggRL~---~----P~~CP~---~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 919 EGGRLD---P----PSYCPE---KLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred hCCccC---C----CCCCCh---HHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 333211 1 122222 4789999999999999999999999887763
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=329.21 Aligned_cols=244 Identities=21% Similarity=0.323 Sum_probs=193.7
Q ss_pred ccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccCCC
Q 009595 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNG 290 (531)
Q Consensus 211 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 290 (531)
||+|+||.||+|.... +++.||+|.+....... ......+..|+.++.+++||||+++++++...+..|+||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~-~~~~~aiK~i~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRD-TQRIYALKTIRKAHIVS-RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECC-CCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 7999999999998754 68899999997532211 223567788999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccce
Q 009595 291 SLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS 370 (531)
Q Consensus 291 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~ 370 (531)
+|.+++.. ...+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++........ .
T Consensus 79 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 149 (312)
T cd05585 79 ELFHHLQR----EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--K 149 (312)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--c
Confidence 99999965 456899999999999999999999 78899999999999999999999999999886433221 1
Q ss_pred ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCC
Q 009595 371 TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGN 450 (531)
Q Consensus 371 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 450 (531)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... .. ......... .. + +.
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~----~~---~~~~~~~~~-~~--~-----~~ 214 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV----NE---MYRKILQEP-LR--F-----PD 214 (312)
T ss_pred cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH----HH---HHHHHHcCC-CC--C-----CC
Confidence 2346799999999999998999999999999999999999999875321 11 122222211 10 0 01
Q ss_pred CcHHHHHHHHHHHHHcccCCCCCCCCH---HHHHHH
Q 009595 451 GYEEQMLLVLKIACFCTLDDPEERPNS---KDVRSM 483 (531)
Q Consensus 451 ~~~~~~~~l~~li~~cl~~dP~~RPs~---~evl~~ 483 (531)
. ....+.+++.+||..||.+||++ .+++.+
T Consensus 215 ~---~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 215 G---FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred c---CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 1 11247788999999999999865 555443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=322.74 Aligned_cols=265 Identities=22% Similarity=0.340 Sum_probs=208.2
Q ss_pred cccccccccccccceeEEEEEeee----CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
..+|.+.+.||+|+||.||++... ..++..+|+|.+...... ....+..|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN----ARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH----HHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 356788899999999999999752 224567899988754322 256788999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHhhcc---------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVS---------QGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD 348 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~ 348 (531)
+..++||||+++++|.+++.... .....+++..+..++.|++.||.||| +++++||||||+||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccC
Confidence 99999999999999999997532 11235899999999999999999999 7889999999999999999
Q ss_pred CCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHH
Q 009595 349 MEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLV 427 (531)
Q Consensus 349 ~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~ 427 (531)
+.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ....
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~----~~~~ 232 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----NEVI 232 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHH
Confidence 9999999999986644322222223445788999999998889999999999999999998 8999865432 1122
Q ss_pred HHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCC
Q 009595 428 RWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALI 490 (531)
Q Consensus 428 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 490 (531)
..+. ...... . + ... ...+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 233 ~~i~---~~~~~~-~--~---~~~----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 233 ECIT---QGRVLQ-R--P---RTC----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHH---cCCcCC-C--C---CCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 2211 111111 0 0 111 12488899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=317.36 Aligned_cols=259 Identities=23% Similarity=0.364 Sum_probs=206.8
Q ss_pred ccccccccccccceeEEEEEeeeCC--CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 203 DCSASLEKIRSRASGEIYIAELPES--NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
++|+..+.||+|+||.||+|.+... +...||||.+...... .....+..|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD---KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh---HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 5678899999999999999988542 2457999998754322 2256788899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
+++|||+++++|.+++.. ....+++..+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 81 MIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred EEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhh
Confidence 999999999999999964 2346899999999999999999999 7889999999999999999999999999999
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ..+...+......+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~ 230 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----QDVIKAVEDGYRLPPP 230 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----HHHHHHHHcCCCCCCC
Confidence 8753322222223345678999999998899999999999999999998 9999865422 2232222211111111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
. .....+.+++.+||+.+|++||++.+++++|.++
T Consensus 231 ----------~---~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 231 ----------M---DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----------C---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 1123478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=317.71 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=205.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...++||+|++|.||+|... ++..||+|.+...... .+.+..|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKPGTMS-----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec--CCceEEEEEccCCchh-----HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 367888999999999999999864 5677999998753322 567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
++|||+++|+|.+++.. .....+++..+..++.+++.||.||| ..+++||||||+||+++.++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 152 (261)
T cd05072 78 IITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARV 152 (261)
T ss_pred EEEecCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCcccee
Confidence 99999999999999975 23456888899999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... ......++..|+|||.+.+..++.++||||||+++|+|+| |..||..... ......+......+..
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~~~~~~~~~~- 226 (261)
T cd05072 153 IEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN----SDVMSALQRGYRMPRM- 226 (261)
T ss_pred cCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH----HHHHHHHHcCCCCCCC-
Confidence 6543221 1122345778999999988889999999999999999998 9999865322 2222222211110000
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.. ....+.+++.+||..+|++|||+.++++.|+++
T Consensus 227 --------~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 227 --------EN----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --------CC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11 123478899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=316.11 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=200.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|...+.||+|+||.||++.+. .+..+|+|.+...... ...+..|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~--~~~~~a~K~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR--AQIKVAIKAINEGAMS-----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec--cCceEEEEecccCCcc-----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 34677889999999999999875 5667999988754322 3567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++... ...+++..+..++.|++.||.||| +++++|+||+|+||+++.++.+||+|||++...
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~ 150 (256)
T cd05114 77 VTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150 (256)
T ss_pred EEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCcccc
Confidence 99999999999998641 245889999999999999999999 778999999999999999999999999998866
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
....... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ......+.. ...+.
T Consensus 151 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~~~~~i~~---~~~~~- 221 (256)
T cd05114 151 LDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEVVEMISR---GFRLY- 221 (256)
T ss_pred CCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHC---CCCCC-
Confidence 4432221 122345678999999988889999999999999999999 8999865321 222222222 11111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
.+.. ....+.+++.+||..||.+|||+.++++.|.
T Consensus 222 --~~~~-------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 --RPKL-------ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCC-------CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111 1124788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=320.89 Aligned_cols=262 Identities=26% Similarity=0.339 Sum_probs=206.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC----
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD---- 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---- 278 (531)
-.|...+.+|+|+||.||.|...+ ++..||||++-.+... -.+|+.+|+.++|||||++.-+|....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e-~~~~vAIKKv~~d~r~--------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRE-TEEEVAIKKVLQDKRY--------KNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcC-CCceeEEEEecCCCCc--------CcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 456778999999999999999886 5889999999765442 236999999999999999999886432
Q ss_pred -ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC-CCEEEeec
Q 009595 279 -CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD-MEARIADF 356 (531)
Q Consensus 279 -~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkL~Df 356 (531)
+..+|||||+. ||.++++.+...+..++...+.-++.||.+||.||| ..||+||||||.|+|+|.+ |.+|||||
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDF 170 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDF 170 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccC
Confidence 34589999988 999999876667788999999999999999999999 6789999999999999976 89999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
|.|+.+..+....+ ...|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+. +...++...++.+-.
T Consensus 171 GSAK~L~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~---s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 171 GSAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD---SSVDQLVEIIKVLGT 244 (364)
T ss_pred CcceeeccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC---CHHHHHHHHHHHhCC
Confidence 99999988766544 4568899999998876 6999999999999999999999998774 334445444432211
Q ss_pred -------cCCCC--ccccccccCCC-----cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 -------SENPN--RAIDSKLLGNG-----YEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 -------~~~~~--~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+. +...+.+.... ......+..+++.++|..+|.+|.++.+++.+
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11111 11111111111 11222457889999999999999999999874
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=336.42 Aligned_cols=266 Identities=21% Similarity=0.298 Sum_probs=207.1
Q ss_pred hcccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEE
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMV 275 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~ 275 (531)
..+.|.+.+.||+|+||.||+|.+.. ..+..||||++...... .....+..|+.+++++. ||||+++++++.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS---SEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 46788899999999999999998632 12357999999754322 22567889999999996 999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccC------------------------------------------------------
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQ------------------------------------------------------ 301 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 301 (531)
.....|+|||||++|+|.+++.....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999999864210
Q ss_pred --------------------------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCe
Q 009595 302 --------------------------------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSV 343 (531)
Q Consensus 302 --------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 343 (531)
....+++..+..++.|+++||.||| ..+++||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhE
Confidence 1134788888999999999999999 77899999999999
Q ss_pred eeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchh
Q 009595 344 LIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTE 422 (531)
Q Consensus 344 Ll~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~ 422 (531)
|++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-- 346 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-- 346 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--
Confidence 999999999999999987654332222233456788999999998889999999999999999997 99998764321
Q ss_pred hhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 423 EKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 423 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..+...+.. ...+. .. ......+.+++.+||+.||++|||+.+|.+.|.++-
T Consensus 347 -~~~~~~~~~---~~~~~--~~--------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 -STFYNKIKS---GYRMA--KP--------DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -HHHHHHHhc---CCCCC--CC--------ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 112111111 11110 00 111234788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=329.38 Aligned_cols=246 Identities=21% Similarity=0.285 Sum_probs=195.7
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccC
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 288 (531)
+.||+|+||.||++.... +|..||+|++....... ......+..|+.+++.++||||+++++++...+..|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 369999999999998654 78999999997532211 1225567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCcc
Q 009595 289 NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ 368 (531)
Q Consensus 289 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~ 368 (531)
+|+|..++.. ...+++..+..++.||+.||.||| +++++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 150 (323)
T cd05595 79 GGELFFHLSR----ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-
Confidence 9999998865 456899999999999999999999 77899999999999999999999999999875432221
Q ss_pred ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcccccccc
Q 009595 369 VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLL 448 (531)
Q Consensus 369 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 448 (531)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+ ... ... +.
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~~---~~~-~~~--~p---- 215 (323)
T cd05595 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELI---LME-EIR--FP---- 215 (323)
T ss_pred -ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHH---hcC-CCC--CC----
Confidence 12335799999999999998999999999999999999999999865321 1121111 111 110 00
Q ss_pred CCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 449 GNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 449 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
... ...+.+++.+||+.||.+|| ++.+++++
T Consensus 216 ~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 RTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCC----CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 111 12477899999999999998 78888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=326.68 Aligned_cols=260 Identities=20% Similarity=0.324 Sum_probs=203.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCe----EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGK----MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
..+|...+.||+|+||.||+|.+.. ++. .||+|.+...... .....+..|+.+++.++||||++++|++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSP---KANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEec-CCCccceeEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 3568899999999999999998753 333 4899998753321 2256788899999999999999999998764
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
..++++||+++|+|.+++.. ....+++...+.++.|++.||.||| +++++||||||+|||++.++.+||+|||
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG 154 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFG 154 (316)
T ss_pred -CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccc
Confidence 57899999999999999974 2346888999999999999999999 7789999999999999999999999999
Q ss_pred CCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 358 LARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 358 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||.+... ..+...+.. .
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~----~~~~~~~~~---~ 227 (316)
T cd05108 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEISSILEK---G 227 (316)
T ss_pred ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHhC---C
Confidence 9997765433222223345678999999999899999999999999999998 9999876422 122222211 1
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
.... .+. . ....+.+++.+||..||.+|||+.+++..|..+..
T Consensus 228 ~~~~---~~~---~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 228 ERLP---QPP---I----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCC---CCC---C----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 1110 010 0 11247789999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.22 Aligned_cols=258 Identities=19% Similarity=0.279 Sum_probs=200.1
Q ss_pred cccccccccccceeEEEEEeee--CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 204 CSASLEKIRSRASGEIYIAELP--ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
+|.+.+.||+|+||.||+++.. ..+++.||+|++..............+..|+.++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998763 2367899999997543222223356678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++.. ...+++..+..++.||+.||.||| +.+++||||||+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999965 456899999999999999999999 7789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||...........+.. ...... +
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~~~-~ 228 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR---RILKCD-P 228 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH---HHhcCC-C
Confidence 65433222 12345799999999998765 478899999999999999999999965322222222221 111111 1
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
. +... ....+.+++.+||+.||.+|| ++.+++++
T Consensus 229 ~------~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 229 P------FPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred C------CCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1 0011 112377889999999999999 66677665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=318.61 Aligned_cols=261 Identities=23% Similarity=0.341 Sum_probs=206.6
Q ss_pred ccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 203 DCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
++|.+.+.||+|+||.||+|.... .++..||||.+...... .....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN---DARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH---HHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 567888999999999999997642 24578999999764332 12567889999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhcc----------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVS----------QGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD 348 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~ 348 (531)
..++||||+++|+|.+++.... .....+++..+..++.|++.||.||| .++++||||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCC
Confidence 9999999999999999997532 12345788999999999999999999 7789999999999999999
Q ss_pred CCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHH
Q 009595 349 MEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLV 427 (531)
Q Consensus 349 ~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~ 427 (531)
+.++|+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||.+... ....
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~----~~~~ 234 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN----EEVI 234 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHH
Confidence 9999999999886543322211223346788999999999999999999999999999998 9999865422 2222
Q ss_pred HHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 428 RWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 428 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
..+. .+..... . . .....+.+++.+||..||.+|||+.++++.|++
T Consensus 235 ~~~~----~~~~~~~-~-----~---~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 ECIT----QGRLLQR-P-----R---TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHH----cCCcCCC-C-----C---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 2222 1111110 0 0 112347889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.93 Aligned_cols=257 Identities=20% Similarity=0.312 Sum_probs=197.3
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
.|..++.||+|+||+||+|.... +++.||||++....... ......+..|+.++.+++||||+++++++.+.+..|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~~~aiK~i~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD-THALYAMKTLRKKDVLN-RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 47788999999999999998754 78899999997633211 22356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++|+|.+++.. ...+++..+..++.|++.||.||| ..+|+||||||+|||++.++++||+|||++..+.
T Consensus 80 ~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 80 MDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 999999999999965 456889999999999999999999 7889999999999999999999999999976432
Q ss_pred CCCc---------------------------------------------cceecccccCccccCcccccCCCCCchhhHH
Q 009595 364 DGHA---------------------------------------------QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIY 398 (531)
Q Consensus 364 ~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 398 (531)
.... .......+||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 1000 0001235799999999999988899999999
Q ss_pred HHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHH--cccCCCCCCCC
Q 009595 399 SFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACF--CTLDDPEERPN 476 (531)
Q Consensus 399 SlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPs 476 (531)
||||++|||++|+.||...........+..+ ...... .+ .....+ .+.+++.+ |+..+|..||+
T Consensus 233 SlG~il~elltG~~Pf~~~~~~~~~~~i~~~------~~~~~~--~~--~~~~s~----~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINW------ENTLHI--PP--QVKLSP----EAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCCHHHHHHHHHcc------ccccCC--CC--CCCCCH----HHHHHHHHHccCcccccCCCC
Confidence 9999999999999999764321111111111 000100 00 001122 24555555 56677778999
Q ss_pred HHHHHHH
Q 009595 477 SKDVRSM 483 (531)
Q Consensus 477 ~~evl~~ 483 (531)
+.+++.|
T Consensus 299 ~~~~l~h 305 (381)
T cd05626 299 ADDIKAH 305 (381)
T ss_pred HHHHhcC
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=315.51 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=204.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
..|...+.||+|++|.||+|.+.. +++.||+|.+...... ...+.+|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTME-----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec-CCceEEEEEecCCchH-----HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 456778899999999999998764 6888999998753321 4568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
+|||+++++|.+++.. .....+++..+..++.|+++||.||| .++++||||||+||+++.++.+||+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~ 154 (263)
T cd05052 80 ITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 154 (263)
T ss_pred EEEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccc
Confidence 9999999999999965 33456899999999999999999999 778999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.. .......+.... .+..
T Consensus 155 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~----~~~~~~~~~~~~---~~~~ 226 (263)
T cd05052 155 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELLEKGY---RMER 226 (263)
T ss_pred ccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHHCCC---CCCC
Confidence 543221 1112334678999999998899999999999999999998 999986532 122222221111 1110
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
... ....+.+++.+||..||++|||+.++++.|+.+
T Consensus 227 -------~~~---~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 -------PEG---CPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -------CCC---CCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 011 123478899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=337.07 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=204.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|+||.||+|.... +|+.||||++....... ......+..|+.++..++||||+++++++.+.+..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD-TGQVYAMKVLRKSDMIK-RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC-CCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence 368889999999999999998764 68999999997532211 1225678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ...+++..+..++.|++.||.||| .+|++||||||+|||++.++.+||+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 151 (350)
T cd05573 79 VMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKM 151 (350)
T ss_pred EEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence 9999999999999975 367899999999999999999999 788999999999999999999999999999876
Q ss_pred CCCC---------------------------ccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009595 363 PDGH---------------------------AQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSD 415 (531)
Q Consensus 363 ~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~ 415 (531)
.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 5432 0011234569999999999999999999999999999999999999997
Q ss_pred CcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 009595 416 DFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-SKDVRSM 483 (531)
Q Consensus 416 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 483 (531)
..........+..|. ......... . ....+.+++.+|+. ||.+||+ +.+++++
T Consensus 232 ~~~~~~~~~~i~~~~------~~~~~p~~~----~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 232 SDTLQETYNKIINWK------ESLRFPPDP----P----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCHHHHHHHHhccC------CcccCCCCC----C----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 643211111111110 000000000 0 12347788889997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=321.07 Aligned_cols=252 Identities=26% Similarity=0.337 Sum_probs=196.9
Q ss_pred ccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccCCC
Q 009595 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNG 290 (531)
Q Consensus 211 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 290 (531)
||+|+||+||++.... +|+.||+|.+....... ......+..|+.+++.++||||+++.+++......++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRA-TGKLYACKKLNKKRLKK-RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEcc-CCcEEEEEeeeHHHHhh-hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 6999999999998754 78899999997543221 122456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccce
Q 009595 291 SLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS 370 (531)
Q Consensus 291 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~ 370 (531)
+|.+++.........+++..+..++.|++.||.||| +++++||||||+||+++.++.++|+|||++..+......
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 153 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-- 153 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence 999888654344567899999999999999999999 778999999999999999999999999999876544322
Q ss_pred ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCC
Q 009595 371 TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGN 450 (531)
Q Consensus 371 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 450 (531)
.....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+. ....... . .. .
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~~~~-~--~~-----~- 221 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---QRILNDS-V--TY-----P- 221 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH---HhhcccC-C--CC-----c-
Confidence 223568999999999999999999999999999999999999997532211111111 1111110 0 00 0
Q ss_pred CcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 451 GYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 451 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
......+.+++.+||+.||.+|| ++.+++++
T Consensus 222 --~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 --DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred --ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 11223477889999999999999 55666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=315.50 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=210.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.+.||+|+||.||+|.... +++.||||.+....... ......+..|+.+++.++||||+++++++...+..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL-DRKPVALKKVQIFEMMD-AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC-CCCEEEEEEeeccccCC-HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 468889999999999999998764 68899999886533222 2235678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
++||+++|+|.+++.........++......++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 99999999999998764444566899999999999999999999 788999999999999999999999999998876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
...... .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ....+.........+...
T Consensus 157 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~ 229 (267)
T cd08228 157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQKIEQCDYPPLP 229 (267)
T ss_pred cchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHHHhcCCCCCCC
Confidence 543221 1234688999999999888899999999999999999999999854321 111222221111111110
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.......+.+++.+||..+|.+|||+.++++.|+++
T Consensus 230 ---------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 230 ---------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111224588899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=331.31 Aligned_cols=249 Identities=20% Similarity=0.274 Sum_probs=196.6
Q ss_pred cccccccceeEEEEEeee--CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEe
Q 009595 208 LEKIRSRASGEIYIAELP--ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 285 (531)
++.||+|+||.||+++.. ..+++.||||++..............+..|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999763 236789999999754322222234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCC
Q 009595 286 FMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDG 365 (531)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~ 365 (531)
|+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 81 YLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 9999999999965 456788888999999999999999 778999999999999999999999999998754332
Q ss_pred CccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccc
Q 009595 366 HAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS 445 (531)
Q Consensus 366 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 445 (531)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... +....... . .+.+
T Consensus 154 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~----~~~---~~~~~~~~-~--~~~~ 221 (323)
T cd05584 154 GT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR----KKT---IDKILKGK-L--NLPP 221 (323)
T ss_pred CC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH----HHH---HHHHHcCC-C--CCCC
Confidence 21 12335799999999999988899999999999999999999999875422 111 11111111 1 0111
Q ss_pred cccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 446 KLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 446 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
.. ...+.+++.+||+.||.+|| ++.+++++
T Consensus 222 ----~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 222 ----YL----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ----CC----CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11 12478899999999999999 78887775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=337.28 Aligned_cols=257 Identities=20% Similarity=0.314 Sum_probs=199.6
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|+||+||+|.... +|+.||||++....... ......+..|+.++..++||||+++++++...+..|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD-TGHIYAMKKLRKSEMLE-KEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC-CCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence 368889999999999999998764 68899999997532211 1235667889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+|||++.++.++|+|||++..+
T Consensus 79 v~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 79 IMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred EECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999999965 456899999999999999999999 778999999999999999999999999998765
Q ss_pred CCCCccc------------------------------------eecccccCccccCcccccCCCCCchhhHHHHHHHHHH
Q 009595 363 PDGHAQV------------------------------------STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAV 406 (531)
Q Consensus 363 ~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~e 406 (531)
....... .....+||+.|+|||++.+..++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 231 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence 3221000 0012469999999999999899999999999999999
Q ss_pred HHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 009595 407 LVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN---SKDVRSM 483 (531)
Q Consensus 407 lltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 483 (531)
|++|..||.+...... .. ......... .+... ... ...+.+++.+|+. +|.+|++ +.+++++
T Consensus 232 l~~G~~Pf~~~~~~~~----~~---~i~~~~~~~-~~~~~---~~~---s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 232 MLVGYPPFCSDNPQET----YR---KIINWKETL-QFPDE---VPL---SPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred hhcCCCCCCCCCHHHH----HH---HHHcCCCcc-CCCCC---CCC---CHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999999976432111 11 111111000 00000 011 1236677888886 9999998 8887774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=328.90 Aligned_cols=246 Identities=21% Similarity=0.300 Sum_probs=196.7
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccC
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 288 (531)
+.||+|+||.||++.... +|+.||+|++....... ......+..|+.+++.++||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKA-SGKYYAMKILKKEVIIA-KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 368999999999998754 78999999997532211 2225677889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCcc
Q 009595 289 NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ 368 (531)
Q Consensus 289 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~ 368 (531)
+|+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~- 150 (328)
T cd05593 79 GGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA- 150 (328)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-
Confidence 9999998864 456899999999999999999999 78899999999999999999999999999875432211
Q ss_pred ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcccccccc
Q 009595 369 VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLL 448 (531)
Q Consensus 369 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 448 (531)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..+... .... ... +.
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~----~~~~~~---~~~~-~~~--~p---- 215 (328)
T cd05593 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFEL---ILME-DIK--FP---- 215 (328)
T ss_pred -ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH----HHHHHH---hccC-Ccc--CC----
Confidence 12345799999999999988999999999999999999999999865321 122111 1111 110 00
Q ss_pred CCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 449 GNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 449 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
... ...+.+++.+||..||.+|| ++.+++++
T Consensus 216 ~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTL----SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 111 12477889999999999997 88888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=333.61 Aligned_cols=206 Identities=23% Similarity=0.362 Sum_probs=176.5
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|+..+.||+|+||+||+|.... +++.||||++....... ......+..|+.++..++||||+++++++.+...+|+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD-TGHVYAMKILRKADMLE-KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC-CCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence 367889999999999999998654 68899999997533211 2235678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ...+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.+
T Consensus 79 v~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 79 IMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred EEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 9999999999999975 467899999999999999999999 788999999999999999999999999998765
Q ss_pred CCCCcc---------------------------------ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh
Q 009595 363 PDGHAQ---------------------------------VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM 409 (531)
Q Consensus 363 ~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt 409 (531)
...... ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence 321100 00123579999999999999899999999999999999999
Q ss_pred CCCCCCCc
Q 009595 410 GKLPSDDF 417 (531)
Q Consensus 410 g~~P~~~~ 417 (531)
|+.||.+.
T Consensus 232 G~~Pf~~~ 239 (363)
T cd05628 232 GYPPFCSE 239 (363)
T ss_pred CCCCCCCC
Confidence 99999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=313.80 Aligned_cols=256 Identities=26% Similarity=0.392 Sum_probs=204.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||+|++|.||+|.+. +++.||+|.++..... .+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGTMD-----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec--CCeEEEEEeeCCCccc-----HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 356888999999999999999864 5678999998754322 456888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
++|||+++++|.+++.. .....+++.....++.+++.||.||| +++++||||||+||+++.++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 78 IVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARV 152 (261)
T ss_pred eeeecccCCcHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence 99999999999999975 22356899999999999999999999 77899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
........ .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+... ..+...+......+.+
T Consensus 153 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~~~- 226 (261)
T cd05068 153 IKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----AEVLQQVDQGYRMPCP- 226 (261)
T ss_pred ccCCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCCCC-
Confidence 65332111 111223457999999998899999999999999999999 9999865421 2222222111110000
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
. .....+.+++.+|++.+|.+||++.++++.|+++
T Consensus 227 --------~----~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 227 --------P----GCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --------C----cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0 1123478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=334.07 Aligned_cols=261 Identities=20% Similarity=0.224 Sum_probs=197.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
...|...+.||+|+||.||++.... +++.||+|... ...+.+|+.++++++||||+++++++......+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~-~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNK-TCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECC-CCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 3679999999999999999998754 78899999653 234568999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+|+|++. ++|.+++.. ...+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++..
T Consensus 160 lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 160 LILPRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred EEEecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 9999995 589998864 456889999999999999999999 77899999999999999999999999999875
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch----hhhHHHHHHHHHhccC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHT----EEKSLVRWMRNVMTSE 437 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~----~~~~l~~~~~~~~~~~ 437 (531)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||-...... ....+...+.. ....
T Consensus 232 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~-~g~~ 309 (391)
T PHA03212 232 PVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR-SGTH 309 (391)
T ss_pred ccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH-hcCC
Confidence 4332111 1234579999999999999899999999999999999999998864321100 01111111111 1000
Q ss_pred CCCcccc-------------------cccc--CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 438 NPNRAID-------------------SKLL--GNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 438 ~~~~~~d-------------------~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
......+ +... ..........+.+++.+||+.||.+|||+.+++++
T Consensus 310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000 0000 00011223458889999999999999999999863
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=321.09 Aligned_cols=256 Identities=25% Similarity=0.316 Sum_probs=201.5
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
.|+..+.||+|+||.||++.... +++.||+|.+....... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC-CCceEEEEEEehhhhhh-hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 36778999999999999998654 68899999997533221 11245577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++|+|.+++.. .....+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|||++....
T Consensus 79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 79 LTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred EeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 999999999998865 33456899999999999999999999 6789999999999999999999999999988764
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
..... ....|++.|+|||++.+..++.++||||||+++|+|++|+.||.+.........+... .......
T Consensus 154 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~----~~~~~~~--- 223 (285)
T cd05605 154 EGETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR----VKEDQEE--- 223 (285)
T ss_pred CCCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH----hhhcccc---
Confidence 43221 2346899999999999888999999999999999999999999764221111111111 1111110
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
........+.+++.+||+.||.+|| ++.+++++
T Consensus 224 -------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 224 -------YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -------cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0011223478899999999999999 77777665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=335.94 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=204.3
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCc
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 279 (531)
..++|..++.||+|.||.|+++..+. +++.||||.+++..--. +..++..+.|.+++... +||.+++++.+|.+.+.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~-~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKG-TNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcC-CCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 45788999999999999999999876 77899999998755332 22367888899998888 59999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
+|+||||+.||++..+.+ ...+++..+.-++..|+.||.||| ++||||||||.+|||||.+|.+||+||||+
T Consensus 444 l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccc
Confidence 999999999999544433 477999999999999999999999 889999999999999999999999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
+....... .+++++|||.|||||++.+..|+..+|.|||||+||||+.|..||++. .++.+++-+..
T Consensus 516 Ke~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd----dEee~FdsI~~------- 582 (694)
T KOG0694|consen 516 KEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD----DEEEVFDSIVN------- 582 (694)
T ss_pred cccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHhc-------
Confidence 97543322 456799999999999999999999999999999999999999998763 33444443321
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS 477 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 477 (531)
.+...|.. .+ .+.+.++.++|..||++|-.+
T Consensus 583 d~~~yP~~----ls---~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 DEVRYPRF----LS---KEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCCc----cc---HHHHHHHHHHhccCcccccCC
Confidence 12222221 11 246778889999999999877
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=317.88 Aligned_cols=262 Identities=18% Similarity=0.309 Sum_probs=203.3
Q ss_pred cccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
.++|+..+.||+|+||.||+|.+.. .++..||||.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM---RERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4668889999999999999987532 24567999998643321 1245688999999999999999999999998
Q ss_pred CceEEEEeccCCCCHHHHHhhccCC------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCE
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQG------RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA 351 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v 351 (531)
...++||||+++|+|.+++...... ...+++..+..++.|++.||.||| +.+++|+||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCE
Confidence 9999999999999999999753211 234677888999999999999999 7789999999999999999999
Q ss_pred EEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHH
Q 009595 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~ 430 (531)
+|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+... ......+
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~----~~~~~~~ 234 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----EQVLRFV 234 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH
Confidence 9999999886654332222223345788999999998889999999999999999999 7889865422 2222221
Q ss_pred HHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
.....+.. ... ....+.+++.+||+.||.+|||+.++++.|++
T Consensus 235 ---~~~~~~~~-------~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 ---MEGGLLDK-------PDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ---HcCCcCCC-------CCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111110 011 12347889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=324.09 Aligned_cols=261 Identities=28% Similarity=0.357 Sum_probs=201.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchh----------hhHHHHHHHHHHHHHhcCCCCccccc
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSL----------LNIKMRQVRAEIMTAGQIRHRNIVPL 270 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~~Ei~~l~~l~hpnIv~l 270 (531)
.-+.|++.+.||+|.||.|-+|+.. .+++.||||++.+..... .-...+...+||.+|++++|||||+|
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~-~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDE-VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeec-CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4478999999999999999999765 489999999996533210 00013578899999999999999999
Q ss_pred ceeEEeC--CceEEEEeccCCCCHHHHHhhccCCCcc-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC
Q 009595 271 LAHMVRP--DCHLLVSEFMKNGSLLEILNDVSQGRRE-LEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347 (531)
Q Consensus 271 ~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~ 347 (531)
+++..++ +.+|||+|||..|.+... ..... +++.+++++++++..||+||| .+|||||||||+|+||++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcC
Confidence 9998764 688999999998876533 22344 999999999999999999999 788999999999999999
Q ss_pred CCCEEEeecCCCccCCCCCc---cceecccccCccccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 009595 348 DMEARIADFGLARLMPDGHA---QVSTSIVAGTVGYIAPEYHQTLK----FSEKCDIYSFGVLLAVLVMGKLPSDDFFQH 420 (531)
Q Consensus 348 ~~~vkL~Dfgla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~P~~~~~~~ 420 (531)
+|++||+|||.+.....+.. .......+|||.|+|||...++. .+.+.||||+||+||+|+.|+.||-+.+
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-- 323 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-- 323 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--
Confidence 99999999999887633211 11112368999999999887632 3578999999999999999999986542
Q ss_pred hhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 421 TEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 421 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
...+++.+.. .+ ... ...++..+.+.+||.++|..||.+|.+..+|..|.--
T Consensus 324 --~~~l~~KIvn---~p-L~f--------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 324 --ELELFDKIVN---DP-LEF--------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred --HHHHHHHHhc---Cc-ccC--------CCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 2233332221 11 111 1122334568899999999999999999999888743
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=314.96 Aligned_cols=256 Identities=26% Similarity=0.384 Sum_probs=207.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
..+|...++||.|+||.||+|... ++..+++|.+....... ...+..|+.+++.++||||+++++++......+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~--~~~~~~~k~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWK--NRVRVAIKILKSDDLLK----QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEec--CCCcEEEEeccccchhh----HHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 356888999999999999999876 47889999987654322 456888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. .....+++..+..++.|++.||.||| +++++|+||+|+||+++.++.+||+|||++..
T Consensus 79 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 79 IITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARL 153 (261)
T ss_pred EEEeecccCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhh
Confidence 99999999999999975 33456899999999999999999999 77899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
........ ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... .......+........+
T Consensus 154 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~----~~~~~~~~~~~~~~~~~- 226 (261)
T cd05148 154 IKEDVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN----NHEVYDQITAGYRMPCP- 226 (261)
T ss_pred cCCccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC----HHHHHHHHHhCCcCCCC-
Confidence 65432211 23345778999999988889999999999999999998 899986542 12222322211111100
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
. .....+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 227 ---------~---~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 227 ---------A---KCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---------C---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0 1112478899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=328.64 Aligned_cols=265 Identities=22% Similarity=0.333 Sum_probs=205.3
Q ss_pred cccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEe
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVR 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 276 (531)
.++|.+.+.||+|+||.||+|.... .+++.||+|++...... .....+..|+.++.++ +||||++++++|..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA---SEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH---HHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 4578889999999999999996422 24578999999753322 1245677899999999 89999999998865
Q ss_pred C-CceEEEEeccCCCCHHHHHhhccCC-----------------------------------------------------
Q 009595 277 P-DCHLLVSEFMKNGSLLEILNDVSQG----------------------------------------------------- 302 (531)
Q Consensus 277 ~-~~~~lv~E~~~~gsL~~~l~~~~~~----------------------------------------------------- 302 (531)
. ..++++|||+++|+|.+++......
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4 5678999999999999998642110
Q ss_pred ----CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCc
Q 009595 303 ----RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTV 378 (531)
Q Consensus 303 ----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~ 378 (531)
...+++..+..++.|++.||.||| ..+|+||||||+|||++.++.++|+|||++..+.............++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 136889999999999999999999 7889999999999999999999999999998765443333333455678
Q ss_pred cccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHH
Q 009595 379 GYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQML 457 (531)
Q Consensus 379 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 457 (531)
.|+|||++.+..++.++|||||||++|||++ |..||.+.... ..+...+. .+.... . + . ....
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---~~~~~~~~----~~~~~~-~-~----~---~~~~ 303 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---EEFCRRLK----EGTRMR-A-P----E---YATP 303 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---HHHHHHHh----ccCCCC-C-C----c---cCCH
Confidence 8999999999999999999999999999998 99998753221 11222111 111110 0 0 0 1123
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 458 LVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 458 ~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.+.+++.+||+.+|.+||++.+++++|+++.
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 4788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=312.02 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=196.6
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccC
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 288 (531)
+.||+|+||.||+|.... +++.||+|.+...... .....+.+|+.++++++||||+++++++......++||||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~-~~~~~a~k~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA-DNTPVAVKSCRETLPP---DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEec-CCceEEEEecCccCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 469999999999998754 6889999988653322 124678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCcc
Q 009595 289 NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ 368 (531)
Q Consensus 289 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~ 368 (531)
+++|.+++.. ....+++..++.++.|++.||.||| +++++||||||+||+++.++.+||+|||++.........
T Consensus 77 ~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 77 GGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred CCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccccccccc
Confidence 9999999964 2346889999999999999999999 788999999999999999999999999998865433211
Q ss_pred ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 369 VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 369 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+.. ..... .
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~----~~~~~~~~~---~~~~~--~---- 217 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN----QQTREAIEQ---GVRLP--C---- 217 (252)
T ss_pred ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH----HHHHHHHHc---CCCCC--C----
Confidence 11111223567999999998889999999999999999998 8889865422 111111111 11110 0
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
... ....+.+++.+||+.||++|||+.++++.|.
T Consensus 218 -~~~---~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 -PEL---CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -ccc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 011 1234788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=315.64 Aligned_cols=263 Identities=25% Similarity=0.364 Sum_probs=218.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
+++-|.++++||+|+||.||+|.+++ .|+.+|||.+..... .+.+.+|+.+|.++..|++|++||.+.....+
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~E-sG~v~AIK~VPV~sD------LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL 103 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRE-SGHVLAIKKVPVDTD------LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL 103 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhc-cCcEEEEEecCccch------HHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence 55678899999999999999998876 799999999986443 67888999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++|||||-.|+..+.++. .++++++..+..+++..+.||+||| ...-+|||||..|||++.+|.+||+|||.+.
T Consensus 104 WIVMEYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAG 177 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAG 177 (502)
T ss_pred EeehhhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccc
Confidence 999999999999999974 4678999999999999999999999 5558999999999999999999999999999
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
.+.+..... +...|||.|||||++..-.|+.++||||||++..||..|++||.+.++-.... +....+|.
T Consensus 178 QLTDTMAKR--NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF--------MIPT~PPP 247 (502)
T KOG0574|consen 178 QLTDTMAKR--NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF--------MIPTKPPP 247 (502)
T ss_pred hhhhhHHhh--CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE--------eccCCCCC
Confidence 887654433 34789999999999999999999999999999999999999998876522111 11222222
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh-ccCcCCCch
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML-SDTALIKDV 493 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L-~~~~~~~~~ 493 (531)
..-. .......+-+++..||...|++|-|+.++++|- -..++++++
T Consensus 248 TF~K-------PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I 294 (502)
T KOG0574|consen 248 TFKK-------PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDI 294 (502)
T ss_pred CCCC-------hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccH
Confidence 2222 233344577889999999999999999999864 334444444
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=318.70 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=200.6
Q ss_pred ccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccCCC
Q 009595 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNG 290 (531)
Q Consensus 211 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 290 (531)
||+|+||.||++.... +|+.||+|.+....... ......+..|+.++++++||||+++++++......++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKN-TGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEcc-CCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 7999999999998764 68999999996532211 111344566999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccce
Q 009595 291 SLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS 370 (531)
Q Consensus 291 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~ 370 (531)
+|.+++.. .....+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 79 ~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--- 150 (277)
T cd05607 79 DLKYHIYN--VGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--- 150 (277)
T ss_pred CHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---
Confidence 99998864 33456889999999999999999999 78899999999999999999999999999887654322
Q ss_pred ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCC
Q 009595 371 TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGN 450 (531)
Q Consensus 371 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 450 (531)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.+........ .......... ... . ..
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~-~~~--~----~~ 220 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE---ELKRRTLEDE-VKF--E----HQ 220 (277)
T ss_pred eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH---HHHHHhhccc-ccc--c----cc
Confidence 123568999999999998889999999999999999999999987543211111 1122221111 100 0 00
Q ss_pred CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCCCc
Q 009595 451 GYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKD 492 (531)
Q Consensus 451 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 492 (531)
.....+.+++..||+.||.+||++.++++.+........
T Consensus 221 ---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 221 ---NFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred ---cCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 112247889999999999999999888766665554443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=313.33 Aligned_cols=257 Identities=20% Similarity=0.300 Sum_probs=210.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|..++.||+|.-|+||+++... ++..+|+|++.+..... .....+...|-+||+.++||.++.||..+..+...|+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~-t~~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRG-TNCLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecC-CCceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 567788999999999999999875 56889999998755433 3346788899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|||||+||+|+.+++. +..+.+++..+.-++..++-||+||| -.|||+|||||+||||.++|+|.|+||.|+..+
T Consensus 155 ~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999986 77788999999999999999999999 778999999999999999999999999998754
Q ss_pred CCC-------C--------------------------cc---------------------ceecccccCccccCcccccC
Q 009595 363 PDG-------H--------------------------AQ---------------------VSTSIVAGTVGYIAPEYHQT 388 (531)
Q Consensus 363 ~~~-------~--------------------------~~---------------------~~~~~~~gt~~y~aPE~~~~ 388 (531)
... . .. .....++||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 210 0 00 01124679999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHccc
Q 009595 389 LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTL 468 (531)
Q Consensus 389 ~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~ 468 (531)
...+.++|.|+|||++|||+.|..||.+... .+.+.+.+...+. .. ..+.....+.+||.+.|.
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~---~~Tl~NIv~~~l~-----Fp--------~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN---KETLRNIVGQPLK-----FP--------EEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCc---hhhHHHHhcCCCc-----CC--------CCCcchhHHHHHHHHHhc
Confidence 9999999999999999999999999987643 3444444333221 11 111233458899999999
Q ss_pred CCCCCCCC----HHHHHH
Q 009595 469 DDPEERPN----SKDVRS 482 (531)
Q Consensus 469 ~dP~~RPs----~~evl~ 482 (531)
+||++|.. +.||-+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999999 555554
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=319.55 Aligned_cols=264 Identities=22% Similarity=0.314 Sum_probs=207.9
Q ss_pred ccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 203 DCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
.+|...+.||+|+||.||+|+... .++..+++|.+....... ...+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA----RKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHH----HHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 457778899999999999997532 245568899886543222 466889999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~ 346 (531)
..++||||+++++|.+++..... ....+++..+..++.|++.||.||| +++++||||||+||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEc
Confidence 99999999999999999975321 1245899999999999999999999 78899999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhH
Q 009595 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKS 425 (531)
Q Consensus 347 ~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~ 425 (531)
.++.++|+|||++................|+..|+|||.+.+..++.++||||||+++|||+| |+.||..... ..
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~ 233 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----TE 233 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HH
Confidence 999999999999986554332222233456789999999998899999999999999999998 9999865432 11
Q ss_pred HHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCC
Q 009595 426 LVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALI 490 (531)
Q Consensus 426 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 490 (531)
..+.+ ..+...... . .....+.+++.+||+.||++|||+.++++.|+++...
T Consensus 234 ~~~~~----~~~~~~~~~------~---~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 234 VIECI----TQGRVLERP------R---VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHH----hCCCCCCCC------c---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 22221 111111100 0 1123478899999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.93 Aligned_cols=257 Identities=21% Similarity=0.296 Sum_probs=197.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|..++.||+|+||.||++.... +++.||||.+...... .......+..|+.++.+++||||+++++++.+....|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD-TGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence 367889999999999999998764 7889999999753221 12235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus 79 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 79 IMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999965 456889999999999999999999 788999999999999999999999999998643
Q ss_pred CCCCc------------cc---------------------------------eecccccCccccCcccccCCCCCchhhH
Q 009595 363 PDGHA------------QV---------------------------------STSIVAGTVGYIAPEYHQTLKFSEKCDI 397 (531)
Q Consensus 363 ~~~~~------------~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 397 (531)
..... .. .....+||+.|+|||++.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 231 (377)
T cd05629 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence 21100 00 0012469999999999998899999999
Q ss_pred HHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCC---
Q 009595 398 YSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEER--- 474 (531)
Q Consensus 398 wSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R--- 474 (531)
|||||++|||++|..||.+..... ... ............+. ......+.+++.+|+. +|.+|
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~----~~~---~i~~~~~~~~~p~~-------~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSENSHE----TYR---KIINWRETLYFPDD-------IHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred EecchhhhhhhcCCCCCCCCCHHH----HHH---HHHccCCccCCCCC-------CCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 999999999999999996543211 111 11111000000000 0011246778888997 66665
Q ss_pred CCHHHHHHH
Q 009595 475 PNSKDVRSM 483 (531)
Q Consensus 475 Ps~~evl~~ 483 (531)
||+.+++.+
T Consensus 297 ~~~~~~l~h 305 (377)
T cd05629 297 GGAHEIKSH 305 (377)
T ss_pred CCHHHHhcC
Confidence 599988886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=312.72 Aligned_cols=274 Identities=22% Similarity=0.259 Sum_probs=211.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCc-ccccceeEEeCC---
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN-IVPLLAHMVRPD--- 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~--- 278 (531)
..|..+++||+|+||+||+|+... +|+.||+|+++..... +.......+|+.+++.++|+| |+++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~-~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKR-TGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEec-CCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence 457788999999999999999875 7899999999875442 112455678999999999999 999999998877
Q ss_pred ---ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 279 ---CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 279 ---~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
..++|+||+.. +|..++.........++...+..++.||+.||+||| +++|+||||||+|||++++|.+||+|
T Consensus 88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeec
Confidence 78999999977 999999874433246777899999999999999999 78899999999999999999999999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH-
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV- 433 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~- 433 (531)
||+|+.+.-.... .+..++|..|.|||++.+. .|+...||||+|||+.||++++.-|.+... ..++....+..
T Consensus 164 FGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lG 238 (323)
T KOG0594|consen 164 FGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLG 238 (323)
T ss_pred cchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcC
Confidence 9999976543222 3446789999999999887 699999999999999999999988877643 33333332221
Q ss_pred --hccCCCCcccccccc--------CCCcHHH----HHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCc
Q 009595 434 --MTSENPNRAIDSKLL--------GNGYEEQ----MLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTA 488 (531)
Q Consensus 434 --~~~~~~~~~~d~~l~--------~~~~~~~----~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 488 (531)
-...+|....-+..- ....... .....+++.+||+.+|.+|.|++.+++| +.++.
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 111222211111110 0001111 1357889999999999999999999987 55553
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=326.90 Aligned_cols=267 Identities=22% Similarity=0.323 Sum_probs=216.2
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
+.+...+.++||+|-||.|..+... .+..||||+++...... ....|.+|+++|.+|+||||++++|+|..++.+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeve--g~lkVAVK~Lr~~a~~~---~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVE--GPLKVAVKILRPDATKN---ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred chhheehhhhhcCcccceeEEEEec--CceEEEEeecCcccchh---HHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 3455567899999999999999874 46899999998755433 268899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++|+|||++|+|.+|+..... +.+.-.....|+.||++|++||. +.++|||||.+.|+|+++++++||+|||+++
T Consensus 611 cmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCccccc
Confidence 999999999999999986322 22444556679999999999999 5669999999999999999999999999999
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM--GKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
.+..+.........+-..+|||||.+..++++.++|||+||+++||+++ ...||+++.. +++++-...+...+.
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENAGEFFRDQG 761 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhhhhhcCCCC
Confidence 8877766555556667889999999999999999999999999999764 7889987644 344444444444332
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
....... +..+ ...+.+++.+||+.|..+|||++++..+|.+.
T Consensus 762 ~~~~l~~---P~~c---p~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSR---PPAC---PQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccC---CCcC---cHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2222111 1112 22478999999999999999999999998764
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=325.74 Aligned_cols=242 Identities=22% Similarity=0.307 Sum_probs=189.4
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHH-HHhcCCCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIM-TAGQIRHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||+|+||+||+|.... +|+.||+|++......... ....+..|.. +++.++||||+++++++...+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~-~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA-DGKFYAVKVLQKKAILKKK-EQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhh-HHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 369999999999998754 7899999999753322111 1334445554 567899999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|.+++.. ...+++..+..++.||+.||.||| +++++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 79 NGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 99999999865 457899999999999999999999 78899999999999999999999999999875433221
Q ss_pred cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..+. ....... .. +.+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~---~~i~~~~-~~--~~~-- 217 (323)
T cd05575 152 --TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT----AEMY---DNILNKP-LR--LKP-- 217 (323)
T ss_pred --ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH----HHHH---HHHHcCC-CC--CCC--
Confidence 22345799999999999998999999999999999999999999865321 1121 1122111 10 111
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSKD 479 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 479 (531)
.. ...+.+++.+||+.||.+||++.+
T Consensus 218 --~~----~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 218 --NI----SVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred --CC----CHHHHHHHHHHhhcCHHhCCCCCC
Confidence 11 224788999999999999999853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=329.22 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=193.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|..++.||+|+||.||+|.... +++.||||++...... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRP-TGRLYALKVIYGNHED---TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECC-CCCEEEEEEEecCCcH---HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 556778899999999999998754 6889999999654322 235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+.. ..++..+..++.||+.||.||| +.+++||||||+|||++.++.+||+|||++..+
T Consensus 150 v~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 150 LLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred EEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 99999999986532 3456777889999999999999 778999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTL-----KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
...... .....||..|+|||.+... ..+.++|||||||++|||++|+.||...... .............
T Consensus 219 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~----~~~~~~~~~~~~~ 292 (353)
T PLN00034 219 AQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG----DWASLMCAICMSQ 292 (353)
T ss_pred cccccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc----cHHHHHHHHhccC
Confidence 433211 1235789999999987432 2456899999999999999999998732211 1111111111111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+.. .......+.+++.+||+.||.+|||+.+++++
T Consensus 293 ~~~~----------~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEA----------PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCC----------CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1100 01112347889999999999999999999986
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=312.21 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=209.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|++|.||+|.... +++.+|||.+....... ......+..|+.+++.++||||+++++++...+..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~-~~~~~~vK~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL-DGVPVALKKVQIFDLMD-AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC-CCceEEEEeeeehhhhh-HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 467788999999999999998654 78899999887533221 2225678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
+|||+++++|.+++.........+++...+.++.+++.||.||| +++++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 99999999999998754444567899999999999999999999 788999999999999999999999999998876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+... ..............+..
T Consensus 157 ~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~- 228 (267)
T cd08229 157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCDYPPL- 228 (267)
T ss_pred ccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhhhhcCCCCCC-
Confidence 543221 1235688999999999888899999999999999999999999864321 11111122111111110
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
... .....+.+++.+||+.||.+|||+.+|++.++++
T Consensus 229 -----~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 -----PSD---HYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -----Ccc---cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 011 1223478899999999999999999999998775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=312.92 Aligned_cols=261 Identities=20% Similarity=0.334 Sum_probs=203.1
Q ss_pred ccccccccccceeEEEEEeeeCCC--CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc---
Q 009595 205 SASLEKIRSRASGEIYIAELPESN--GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC--- 279 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~--- 279 (531)
|.+.+.||+|+||.||+|...... +..||+|.++...... .....+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY--SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 456789999999999999875422 4679999997543322 225678899999999999999999998876554
Q ss_pred ---eEEEEeccCCCCHHHHHhhccC--CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe
Q 009595 280 ---HLLVSEFMKNGSLLEILNDVSQ--GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 280 ---~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
.+++|||+++|+|..++..... ....+++.....++.|++.||.||| +.+++||||||+||++++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEEC
Confidence 7899999999999999865322 2346899999999999999999999 7789999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+... ..+...+..
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----~~~~~~~~~- 230 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----HEIYDYLRH- 230 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHc-
Confidence 9999987654432222223345678999999988889999999999999999999 8899865422 222222221
Q ss_pred hccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 434 MTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 434 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
...+.. .. .....+.+++.+||+.||.+|||+.++++.|+++
T Consensus 231 --~~~~~~------~~----~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 --GNRLKQ------PE----DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --CCCCCC------Cc----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111110 01 1123488899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=338.72 Aligned_cols=263 Identities=19% Similarity=0.234 Sum_probs=196.3
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC---
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--- 277 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--- 277 (531)
....|...+.||+|+||.||+|.... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICID-TSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECC-CCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 34679999999999999999998754 78899999986532 1234699999999999999999876542
Q ss_pred -----CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC-CE
Q 009595 278 -----DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM-EA 351 (531)
Q Consensus 278 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~v 351 (531)
..+++||||+++ +|.+++.........+++..+..++.||+.||.||| +++|+||||||+|||++.++ .+
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~v 210 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTL 210 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCce
Confidence 246789999975 888888654455677999999999999999999999 77899999999999998664 79
Q ss_pred EEeecCCCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHH
Q 009595 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~ 430 (531)
||+|||+++.+...... ....||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ...+...+
T Consensus 211 kL~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~---~~~~~~i~ 284 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS---VDQLVRII 284 (440)
T ss_pred eeeccccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHH
Confidence 99999999876543222 235689999999988664 689999999999999999999999976422 12222222
Q ss_pred HHHhccCCC----------CccccccccCCCcH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 431 RNVMTSENP----------NRAIDSKLLGNGYE-----EQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 431 ~~~~~~~~~----------~~~~d~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. ...+.. .....+........ .....+.+++.+||..||.+|||+.+++++
T Consensus 285 ~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 285 QV-LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HH-hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 11 110000 00000000000000 112357889999999999999999999875
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=311.39 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=200.5
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|...+.||+|+||.||.|.+. ++..||+|.+...... ...+.+|+.++.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~--~~~~~aik~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS-----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec--CCCcEEEEEcCCCccc-----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 45778899999999999999875 4556999998754322 3568889999999999999999999998889999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
+|||+++|+|.+++.. ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+++..
T Consensus 77 v~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~ 150 (256)
T cd05113 77 VTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150 (256)
T ss_pred EEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceec
Confidence 9999999999999964 1236899999999999999999999 788999999999999999999999999998866
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+. ....+.
T Consensus 151 ~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~~---~~~~~~- 221 (256)
T cd05113 151 LDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----SETVEKVS---QGLRLY- 221 (256)
T ss_pred CCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHHHh---cCCCCC-
Confidence 443221 1122335678999999988889999999999999999998 9999865422 12222221 111110
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
.+. . ....+.+++.+||+.||.+|||+.++++.|+
T Consensus 222 --~~~---~----~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 --RPH---L----ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCC---C----CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000 0 1235888999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.42 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=203.5
Q ss_pred ccccccccccccceeEEEEEeee---CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 203 DCSASLEKIRSRASGEIYIAELP---ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
..|+..+.||+|+||.||+|.+. ...+..|++|.+...... .....+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP---QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH---HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 45677899999999999999853 235578999999753322 224678889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQ-------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~ 346 (531)
.|+||||+++|+|.+++..... ....+++.....++.|++.||.||| +++++||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIG 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEc
Confidence 9999999999999999853211 1235788899999999999999999 77899999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhH
Q 009595 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKS 425 (531)
Q Consensus 347 ~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~ 425 (531)
.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||.+... ..
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~----~~ 234 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----QE 234 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HH
Confidence 999999999999987654332222233446778999999988889999999999999999998 9999865321 22
Q ss_pred HHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 426 LVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 426 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
+...+.. ...+. . .... ...+.+++.+||+.||.+||++.+|.++|..
T Consensus 235 ~~~~~~~---~~~~~--~-----~~~~---~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRK---RQLLP--C-----SEDC---PPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHc---CCcCC--C-----CCCC---CHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 2222221 11110 0 0111 1247788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=317.01 Aligned_cols=261 Identities=23% Similarity=0.336 Sum_probs=204.5
Q ss_pred ccccccccccceeEEEEEeeeCC----CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 205 SASLEKIRSRASGEIYIAELPES----NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
|...+.||+|+||.||+|..... ....+++|.+...... .....+..|+.+++.++||||+++++.+...+..
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS---SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH---HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 56778999999999999986421 2356888888754322 2256788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccC--------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCC
Q 009595 281 LLVSEFMKNGSLLEILNDVSQ--------------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITP 340 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp 340 (531)
++++||+.+|+|.+++..... ....+++..++.++.|++.||.||| +.+++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhh
Confidence 999999999999999865221 1235789999999999999999999 78899999999
Q ss_pred CCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 009595 341 SSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQ 419 (531)
Q Consensus 341 ~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~ 419 (531)
+|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+...
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999986544322222223445778999999988889999999999999999998 9999865422
Q ss_pred chhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 420 HTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 420 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..+...+........+ .. ....+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 236 ----~~~~~~~~~~~~~~~~----------~~---~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 236 ----ERLFNLLKTGYRMERP----------EN---CSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ----HHHHHHHhCCCCCCCC----------CC---CCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 2333332221111111 11 1124788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=314.98 Aligned_cols=259 Identities=21% Similarity=0.317 Sum_probs=201.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCe----EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGK----MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
+.|...+.||.|+||.||+|.+.. +++ .+++|.+..... ......+..|+..+++++||||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIP-EGDSIKIPVAIKTIQDRSG---RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcC-CCCceeeEEEEeecccccc---hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 567778999999999999998753 344 477777753221 1224667788889999999999999998754 5
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
..++++||+++|+|.+++.. ....+++.....++.|++.||.||| +++++||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~ 155 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGV 155 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCcc
Confidence 67889999999999999974 2356899999999999999999999 77899999999999999999999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+... ..+.+.+.. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~~~~~~---~~ 228 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEVPDLLEK---GE 228 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHC---CC
Confidence 987654433223334557789999999998899999999999999999998 9999876432 222222221 11
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
.+. .+.. + ...+..++.+||..||.+|||+.++++.|..+..
T Consensus 229 ~~~---~~~~----~---~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 229 RLA---QPQI----C---TIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred cCC---CCCC----C---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111 1111 1 1236778889999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=325.21 Aligned_cols=254 Identities=21% Similarity=0.286 Sum_probs=196.6
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||+|+||.||+|.... +++.||+|+++...... ......+..|..++..+ +||||+++++++......|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~i~~~~~~~-~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK-TRRIYAMKVIKKELVND-DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 368999999999998764 78899999998643221 22356688899999988 7999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|.+++.. ...+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 151 (329)
T cd05588 79 SGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD 151 (329)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence 99999998864 457999999999999999999999 78899999999999999999999999999875322211
Q ss_pred cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch-hhhHHHHHHHHHhccCCCCcccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHT-EEKSLVRWMRNVMTSENPNRAIDSK 446 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~ 446 (531)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||+...... ......+++.......... +..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~p~- 226 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--IPR- 226 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC--CCC-
Confidence 1234679999999999999899999999999999999999999996422111 0111122222222222111 111
Q ss_pred ccCCCcHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 009595 447 LLGNGYEEQMLLVLKIACFCTLDDPEERPN------SKDVRSM 483 (531)
Q Consensus 447 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~ 483 (531)
.. ...+.+++.+||+.||.+||| +.+++++
T Consensus 227 ---~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 227 ---SL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ---CC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11 123778999999999999998 5666654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=335.97 Aligned_cols=205 Identities=23% Similarity=0.358 Sum_probs=174.0
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
.|..++.||+|+||+||+|.... +++.||+|++...... .......+..|+.++++++||||+++++++.+.+..|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~-~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD-TKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC-CCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 47889999999999999998754 7889999999753221 122356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
||||++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..+.
T Consensus 80 ~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 80 MDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence 999999999999965 356888999999999999999999 7789999999999999999999999999975331
Q ss_pred CCC---------------------------------------------ccceecccccCccccCcccccCCCCCchhhHH
Q 009595 364 DGH---------------------------------------------AQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIY 398 (531)
Q Consensus 364 ~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 398 (531)
... ........+||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 100 00001234699999999999998999999999
Q ss_pred HHHHHHHHHHhCCCCCCCc
Q 009595 399 SFGVLLAVLVMGKLPSDDF 417 (531)
Q Consensus 399 SlGvil~elltg~~P~~~~ 417 (531)
||||++|||++|+.||...
T Consensus 233 SlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred echHHHHHHHhCCCCCCCC
Confidence 9999999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=323.99 Aligned_cols=249 Identities=23% Similarity=0.306 Sum_probs=193.8
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHH---hcCCCCcccccceeEEeCCceE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTA---GQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l---~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
|.+.+.||+|+||.||+|.... +|+.||||+++...... ......+..|+.++ +.++||||+++++++...+..|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK-TGELYAIKALKKGDIIA-RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 5678899999999999998764 78899999997542111 11244566666554 5678999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|..++.. ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 79 lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 99999999999988853 46899999999999999999999 78899999999999999999999999999875
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+... ...... ..... +.
T Consensus 151 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~----~~~~~~---i~~~~-~~- 219 (324)
T cd05589 151 GMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE----EEVFDS---IVNDE-VR- 219 (324)
T ss_pred CCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH----HHHHHH---HHhCC-CC-
Confidence 432221 12346799999999999998999999999999999999999999875421 122211 11111 10
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
. +... ...+.+++.+||+.||.+|| ++.+++++
T Consensus 220 -~-----p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 -Y-----PRFL---SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -C-----CCCC---CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0 0111 12377899999999999999 46666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=323.34 Aligned_cols=245 Identities=24% Similarity=0.365 Sum_probs=191.0
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||+|+||.||+|.... +++.||+|.++...... ......+..|..++..+ +||||+++++++...+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG-TNEFFAIKALKKDVVLE-DDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 369999999999998764 68889999997532211 11234455666666654 8999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|.+++.. ...+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++........
T Consensus 79 ~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 151 (316)
T cd05592 79 NGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG 151 (316)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence 99999999865 456899999999999999999999 78899999999999999999999999999986543322
Q ss_pred cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ..+...+ .. ..+. +
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----~~~~~~i---~~-~~~~--~---- 215 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----DELFDSI---LN-DRPH--F---- 215 (316)
T ss_pred --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----HHHHHHH---Hc-CCCC--C----
Confidence 22346799999999999988999999999999999999999999975422 2222211 11 1111 0
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSK-DVRS 482 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 482 (531)
+... ...+.+++.+||+.||.+||++. ++++
T Consensus 216 -~~~~---~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 -PRWI---SKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -CCCC---CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 0111 12367888999999999999975 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=336.94 Aligned_cols=256 Identities=21% Similarity=0.319 Sum_probs=196.1
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
.|.+++.||+|+||.||+|+... +++.||||++...... .......+.+|+.+++.++||||+++++.+...+.+|+|
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~-~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVD-TNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECC-CCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 58889999999999999998764 6889999999753221 112256688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..+.
T Consensus 80 ~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 80 MDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 999999999999965 456888899999999999999999 7889999999999999999999999999975331
Q ss_pred CCC-----------------------------------------ccceecccccCccccCcccccCCCCCchhhHHHHHH
Q 009595 364 DGH-----------------------------------------AQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGV 402 (531)
Q Consensus 364 ~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv 402 (531)
... ........+||+.|+|||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 000 000012357999999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCC---CHHH
Q 009595 403 LLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP---NSKD 479 (531)
Q Consensus 403 il~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~e 479 (531)
++|||++|+.||.+.........+..| .... .+.. ...... .+.+++.+|+ .+|.+|+ |+.+
T Consensus 233 ilyell~G~~Pf~~~~~~~~~~~i~~~-------~~~~-~~~~--~~~~s~----~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAETQLKVINW-------ETTL-HIPS--QAKLSR----EASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred eeeehhhCCCCCCCCCHHHHHHHHhcc-------Cccc-cCCC--CCCCCH----HHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 999999999999764321111111111 0000 0000 011112 2455666665 4999999 8888
Q ss_pred HHHH
Q 009595 480 VRSM 483 (531)
Q Consensus 480 vl~~ 483 (531)
++++
T Consensus 298 ll~h 301 (376)
T cd05598 298 IKAH 301 (376)
T ss_pred HhCC
Confidence 8876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=325.70 Aligned_cols=249 Identities=20% Similarity=0.269 Sum_probs=191.4
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHH-HHHhcCCCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEI-MTAGQIRHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei-~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||+|+||.||+|.... +++.||+|++......... ....+..|. .+++.++||||+++++++...+..|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~-~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA-EEKFYAVKVLQKKAILKKK-EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHHhhh-HHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 369999999999998754 6788999999753321111 123344444 4567889999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|.+++.. ...+++.....++.||+.||.||| +.|++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 79 NGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 99999999965 456788888889999999999999 78899999999999999999999999999875433221
Q ss_pred cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ......+ .... .. ..+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i---~~~~-~~--~~~-- 217 (325)
T cd05602 152 --TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDNI---LNKP-LQ--LKP-- 217 (325)
T ss_pred --CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH----HHHHHHH---HhCC-cC--CCC--
Confidence 12346799999999999998999999999999999999999999865322 1222211 1111 10 111
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
. ....+.+++.+||+.||.+||++.+.+..+.+
T Consensus 218 --~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 218 --N----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred --C----CCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 1 11247788899999999999998854444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=330.12 Aligned_cols=247 Identities=20% Similarity=0.276 Sum_probs=195.9
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccC
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 288 (531)
+.||+|+||.||++.... +|+.||+|++....... ......+..|+.++..++||||+++++++...+..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA-TGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 369999999999998654 78899999997532211 1224567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCcc
Q 009595 289 NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ 368 (531)
Q Consensus 289 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~ 368 (531)
+|+|.+++.. ...+++..+..++.||+.||.|||+ ..+++||||||+|||++.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 79 GGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence 9999998864 4578999999999999999999993 268999999999999999999999999998754322211
Q ss_pred ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcccccccc
Q 009595 369 VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLL 448 (531)
Q Consensus 369 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 448 (531)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||..... ..+...+. . .... +.
T Consensus 153 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~----~~~~~~i~---~-~~~~--~p---- 216 (325)
T cd05594 153 --MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELIL---M-EEIR--FP---- 216 (325)
T ss_pred --cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH----HHHHHHHh---c-CCCC--CC----
Confidence 2235699999999999998999999999999999999999999865321 22222111 1 1110 00
Q ss_pred CCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 449 GNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 449 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
... ...+.+++.+||+.||.+|| ++.+++++
T Consensus 217 ~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTL----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCC----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 111 12377889999999999996 89998876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=315.46 Aligned_cols=260 Identities=23% Similarity=0.321 Sum_probs=203.8
Q ss_pred cccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 204 CSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.|...+.||.|+||.||+|.... ..+..||+|.+...... .....+..|+.++.+++||||+++++++.....
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG---PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH---HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 46778899999999999998642 23578999999754322 225668899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhcc------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVS------------QGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~ 347 (531)
.++++||+.+++|.+++.... .....+++..+..++.|++.||.||| +++++||||||+||+++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecC
Confidence 999999999999999985311 11235788889999999999999999 778999999999999999
Q ss_pred CCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHH
Q 009595 348 DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSL 426 (531)
Q Consensus 348 ~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l 426 (531)
++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.+... ..+
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~ 235 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDV 235 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHH
Confidence 99999999999887654432222233456789999999988889999999999999999998 8888865422 222
Q ss_pred HHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 427 VRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 427 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
...+.. ..... . ... ....+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 236 ~~~i~~---~~~~~--~-----~~~---~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRN---RQVLP--C-----PDD---CPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHc---CCcCC--C-----CCC---CCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222221 11110 0 011 12247889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=297.24 Aligned_cols=266 Identities=22% Similarity=0.273 Sum_probs=210.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC--
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD-- 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-- 278 (531)
..++|.+.+.+|.|||+-||.++.- .+++.||+|++......+ .+..++|++..++++|||+++++++...+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~-s~~~~YAlKkI~c~~~~~----~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGL-STGHLYALKKILCHSQED----IEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred cCceEEEeeeecCCCceeeeeeccc-CcccchhhheeeccchHH----HHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 4578999999999999999999843 488999999998866443 677889999999999999999999776543
Q ss_pred ---ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 279 ---CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 279 ---~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
..||+++|...|||.+.+...+..+..+++...+.|+.++.+||.+||.. ..++.||||||+|||+.+++.++|.|
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEe
Confidence 48999999999999999998888888999999999999999999999954 34599999999999999999999999
Q ss_pred cCCCccCCCCCcc-------ceecccccCccccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhH
Q 009595 356 FGLARLMPDGHAQ-------VSTSIVAGTVGYIAPEYHQTL---KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKS 425 (531)
Q Consensus 356 fgla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~ 425 (531)
||.+....-.-.. ..-.....|..|.|||.+.-. ..++++|||||||+||+|+.|..||+.......
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg--- 249 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG--- 249 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC---
Confidence 9998865421100 001123468999999988643 578999999999999999999999975433111
Q ss_pred HHHHHHHHhccCCCCcc-ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 426 LVRWMRNVMTSENPNRA-IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 426 l~~~~~~~~~~~~~~~~-~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
....+ ..+...-.......+.+.+++.+|++.||.+||++.+++..+..+
T Consensus 250 ------------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 250 ------------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ------------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111 011111111112445688999999999999999999999998765
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=312.26 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=204.0
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 284 (531)
|...+.||+|+||+||++.... +++.||+|++......... ......|+.++++++||||+++++++......++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~-~~~~~~~K~~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK-NGQKVAVKIIDKSEIEEEE--REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT-TTEEEEEEEEESTTHHHHH--HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC-CCeEEEEEEeccccccccc--cchhhhhhhccccccccccccccccccccccccccc
Confidence 5678899999999999998765 7788999999876543322 333455999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCC
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~ 364 (531)
||+++++|.+++.. ...+++..+..++.|+++||.+|| +.+++|+||||+||+++.++.++|+|||.+.....
T Consensus 78 ~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~ 150 (260)
T PF00069_consen 78 EYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE 150 (260)
T ss_dssp EEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred cccccccccccccc----cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999999973 467899999999999999999999 67899999999999999999999999999886522
Q ss_pred CCccceecccccCccccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 365 GHAQVSTSIVAGTVGYIAPEYHQ-TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 365 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
.. .......+++.|+|||++. +..++.++||||+|+++|+|++|..||...........+..............
T Consensus 151 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 225 (260)
T PF00069_consen 151 NN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ--- 225 (260)
T ss_dssp TT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS---
T ss_pred cc--cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc---
Confidence 21 2234467899999999998 77899999999999999999999999986522222222222222111111110
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.......+.+++..||+.||++|||+.+++++
T Consensus 226 --------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 --------SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --------cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001458999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=342.05 Aligned_cols=259 Identities=23% Similarity=0.384 Sum_probs=216.1
Q ss_pred ccccccccccccceeEEEEEeeeCCC--CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESN--GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
....+.+.||.|.||+|++|.++... ...||||.++.... +.....|+.|+.+|.+++||||++|.|+......+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt---ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT---EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc---HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 45577899999999999999987532 24799999987544 34478899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
.||+|||++|+|+.||+. ..+.+.+.+...++++||.|+.||. +.++|||||..+|||++++..+|++||||++
T Consensus 706 MIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred EEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEecccccee
Confidence 999999999999999985 3466999999999999999999999 7889999999999999999999999999999
Q ss_pred cCCCCCcc-ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 361 LMPDGHAQ-VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 361 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
.+.+.... .++....=..+|.|||.+...+++.++|||||||+|||.++ |..||-++.. ++.+.-+...+.-+.
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----QdVIkaIe~gyRLPp 855 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVIKAIEQGYRLPP 855 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----HHHHHHHHhccCCCC
Confidence 88665422 22222222578999999999999999999999999999887 9999877644 333444444444444
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
|..+.. .|.+|++.||++|-.+||.+.+|+..|.++
T Consensus 856 PmDCP~-------------aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 856 PMDCPA-------------ALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred CCCCcH-------------HHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 443322 389999999999999999999999999875
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=330.13 Aligned_cols=257 Identities=21% Similarity=0.231 Sum_probs=201.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|+||.||++.... +|+.||+|+++..... .......+..|+.+++.++||||+++++++...+..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA-TGDIYAMKVMKKSVLL-AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC-CCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 368889999999999999998764 7889999999864321 12235678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++..+
T Consensus 79 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 79 VMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred EECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 99999999999999752 356899999999999999999999 788999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQ------TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
...... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...... . .+......
T Consensus 153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~----~~~~i~~~ 224 (330)
T cd05601 153 TANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---K----TYNNIMNF 224 (330)
T ss_pred CCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH---H----HHHHHHcC
Confidence 544322 223357899999999986 456789999999999999999999999754221 1 11111111
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.......+ .......+.+++..||. ||.+|||+.+++.+
T Consensus 225 ~~~~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 225 QRFLKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCccCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11110000 00112247778888997 99999999998875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=317.42 Aligned_cols=262 Identities=21% Similarity=0.287 Sum_probs=206.1
Q ss_pred cccccccccccccceeEEEEEeee----CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEe
Q 009595 202 EDCSASLEKIRSRASGEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVR 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 276 (531)
.++|...+.||+|+||.||++... ...+..||||.++..... .....+..|+.+++++ +||||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS---SEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh---HHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 356888999999999999999752 224567999998754322 1256788999999999 79999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
.+..+++|||+++|+|.+++.. .....+++.....++.+++.||.||| +++++|+||||+|||++.++.++|+||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCC
Confidence 9999999999999999999975 22334899999999999999999999 778999999999999999999999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
|++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ..+...+.
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~---~~~~~~~~---- 258 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD---SKFYKLIK---- 258 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch---HHHHHHHH----
Confidence 99987654332222223456788999999998889999999999999999998 99998764321 11222211
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.+..... ... ....+.+++.+||..+|.+|||+.++++.|.++
T Consensus 259 ~~~~~~~------~~~---~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 EGYRMAQ------PEH---APAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCCcCCC------CCC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111000 000 123488899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=326.18 Aligned_cols=245 Identities=22% Similarity=0.242 Sum_probs=193.5
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCC-cccccceeEEeCCceEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHR-NIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp-nIv~l~~~~~~~~~~~l 282 (531)
+|...+.||+|+||.||+|.... +++.||||++...... .......+..|+.++..+.|+ +|+++++++...+..|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVII-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC-CCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 47788999999999999998754 6788999999753221 112256678899999999765 58889999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ...+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++...
T Consensus 79 v~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 79 VMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999999999965 456889999999999999999999 788999999999999999999999999998754
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
..... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+... ..+...+. .. ...
T Consensus 152 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~---~~-~~~-- 219 (324)
T cd05587 152 IFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQSIM---EH-NVS-- 219 (324)
T ss_pred CCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHH---cC-CCC--
Confidence 32211 12345799999999999999999999999999999999999999975422 22222111 11 110
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS 477 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 477 (531)
+. .. ....+.+++.+||..||.+||+.
T Consensus 220 ~~----~~----~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YP----KS----LSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CC----CC----CCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 01 11247788999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=322.62 Aligned_cols=240 Identities=24% Similarity=0.321 Sum_probs=190.8
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||+|+||.||+|+... +++.||||++....... ......+..|..++..+ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE-SGRLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcC-CCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 369999999999998754 68899999997532111 12245677788888876 7999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|.+++.. ...+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 79 NGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred CCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence 99999999865 456899999999999999999999 78899999999999999999999999999876432221
Q ss_pred cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..+... ..... .. .+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~~~~---i~~~~-~~---~~-- 216 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE----DDLFEA---ILNDE-VV---YP-- 216 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHHHHH---HhcCC-CC---CC--
Confidence 12345799999999999988999999999999999999999999975422 222221 11111 10 01
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCCCH
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNS 477 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 477 (531)
.. ....+.+++.+||+.||.+||++
T Consensus 217 --~~---~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 --TW---LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred --CC---CCHHHHHHHHHHcccCHHHCCCC
Confidence 11 11247889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=315.90 Aligned_cols=269 Identities=20% Similarity=0.304 Sum_probs=203.0
Q ss_pred cccccccccccccceeEEEEEeee---------------CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELP---------------ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN 266 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~---------------~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn 266 (531)
.++|++.+.||+|+||.||++... ..++..||+|.+...... .....+..|+.+++.++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK---NARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCC
Confidence 356889999999999999998532 113446899999754321 22567889999999999999
Q ss_pred ccccceeEEeCCceEEEEeccCCCCHHHHHhhccCC-------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccC
Q 009595 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQG-------RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNIT 339 (531)
Q Consensus 267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 339 (531)
|+++++++...+..+++|||+++|+|.+++...... ...+++..+..++.|++.||.||| +.+++|+|||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlk 157 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLA 157 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCC
Confidence 999999999999999999999999999999763211 134778899999999999999999 7789999999
Q ss_pred CCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCc
Q 009595 340 PSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM--GKLPSDDF 417 (531)
Q Consensus 340 p~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~P~~~~ 417 (531)
|+||+++.++.++|+|||++..+.............+++.|+|||...++.++.++|||||||++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999986644332222223345678999999888889999999999999999998 77887654
Q ss_pred ccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 418 FQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 418 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
... ..................... ... ....+.+++.+||+.||.+|||+.+|++.|++
T Consensus 238 ~~~----~~~~~~~~~~~~~~~~~~~~~---~~~---~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 238 SDE----QVIENTGEFFRDQGRQVYLPK---PAL---CPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ChH----HHHHHHHHHHhhccccccCCC---CCC---CCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 221 111111111111100000000 011 11357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=324.11 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=195.2
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||+|+||.||+|.... +++.||+|++....... ......+..|+.++.++ +||||+++++++...+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK-TERIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEhhHhcc-hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 469999999999998764 68899999998643221 12255677899888777 8999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|.+++.. ...+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 79 NGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence 99999998864 457899999999999999999999 77899999999999999999999999999875432211
Q ss_pred cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh-hhHHHHHHHHHhccCCCCcccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTE-EKSLVRWMRNVMTSENPNRAIDSK 446 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~ 446 (531)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ......++.......... +.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~p-- 225 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IP-- 225 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC--CC--
Confidence 12346799999999999999999999999999999999999999963221111 111112222222111111 11
Q ss_pred ccCCCcHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 009595 447 LLGNGYEEQMLLVLKIACFCTLDDPEERPNS------KDVRSM 483 (531)
Q Consensus 447 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 483 (531)
.. ....+.+++.+||+.||.+||++ .+++++
T Consensus 226 --~~----~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 226 --RS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred --CC----CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11 11247789999999999999984 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=330.77 Aligned_cols=257 Identities=19% Similarity=0.272 Sum_probs=200.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||++.... +++.||+|++....... ......+..|+.+++.++||||+++++++.++...|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKS-SKQVYAMKLLSKFEMIK-RSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 4678889999999999999998764 78899999997532111 112455778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999999864 35788889999999999999999 77899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTL----KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ... ........
T Consensus 192 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~---~~~i~~~~ 263 (370)
T cd05596 192 MDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGT---YSKIMDHK 263 (370)
T ss_pred ccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH----HHH---HHHHHcCC
Confidence 6443221 12345799999999988653 378899999999999999999999875322 111 11111111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEE--RPNSKDVRSM 483 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 483 (531)
.... +.. .......+.+++.+||..+|.+ |||+.+++++
T Consensus 264 ~~~~-~~~------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 NSLT-FPD------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CcCC-CCC------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1100 000 0011234778899999999988 9999999886
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=309.13 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=210.7
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|++|.||+|.... +|+.||+|.++...... ......+.+|+.++++++|+||+++++++...+..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~-~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL-DGRVVALKKVQIFEMMD-AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC-CCCEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 578889999999999999998764 78899999987533222 1225678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.........+++..+..++.+++.||.||| +.|++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 99999999999999764444567899999999999999999999 788999999999999999999999999998866
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
...... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..............+.
T Consensus 157 ~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~-- 227 (267)
T cd08224 157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEKCDYPP-- 227 (267)
T ss_pred cCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cHHHHHhhhhcCCCCC--
Confidence 543221 1234688999999999888899999999999999999999999854321 1222221111111110
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.. .......+.+++.+||..+|.+|||+.+|++.|+++
T Consensus 228 ----~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 ----LP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ----CC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 00 012223578899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=313.57 Aligned_cols=262 Identities=19% Similarity=0.296 Sum_probs=206.3
Q ss_pred cccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
.++|...+.||+|+||.||+|.... ..+..||+|.+...... .....+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM---RERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH---HHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 4678889999999999999998753 23478999998654322 1245688899999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHhhccCC------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCE
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQG------RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA 351 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v 351 (531)
...++||||+++|+|.+++...... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCE
Confidence 9999999999999999999753221 234788899999999999999999 7889999999999999999999
Q ss_pred EEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHH
Q 009595 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~ 430 (531)
||+|||+++.+.............++..|+|||.+.+..++.++|||||||++||++| |..||.+... ..+...+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~~~~ 234 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----EEVLKFV 234 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH----HHHHHHH
Confidence 9999999886654332222233456789999999988889999999999999999998 9999865322 2233322
Q ss_pred HHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
. ....+.. +... ...+.+++.+||+.+|++|||+.++++.|+.
T Consensus 235 ~---~~~~~~~-------~~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 I---DGGHLDL-------PENC---PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred h---cCCCCCC-------CCCC---CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 2 1111110 0111 2357889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=308.05 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=197.2
Q ss_pred cccccceeEEEEEeee-CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccC
Q 009595 210 KIRSRASGEIYIAELP-ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288 (531)
Q Consensus 210 ~ig~G~~g~Vy~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 288 (531)
.||+|+||.||+|.+. ..++..+|+|+++..... ....+.+..|+.+++.+.||||+++++++. .+..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc--HHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 6899999999999763 235788999998754322 223567889999999999999999999875 456789999999
Q ss_pred CCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCcc
Q 009595 289 NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ 368 (531)
Q Consensus 289 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~ 368 (531)
+|+|.+++.. ...+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 79 LGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999999964 356899999999999999999999 788999999999999999999999999999876544322
Q ss_pred ce-ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCcccccc
Q 009595 369 VS-TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSK 446 (531)
Q Consensus 369 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 446 (531)
.. .....++..|+|||.+.+..++.++|+||||+++|||++ |..||.+... ..+...+.. ...+.. +
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~i~~---~~~~~~---~- 220 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEVTQMIES---GERMEC---P- 220 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHC---CCCCCC---C-
Confidence 11 122334678999999988889999999999999999998 9999876422 222222221 111110 0
Q ss_pred ccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 447 LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 447 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
... ...+.+++.+||+.||.+|||+.+|.+.|++.
T Consensus 221 --~~~----~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 --QRC----PPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --CCC----CHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111 12478899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=310.51 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=204.3
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||+|++|.||+|.... +++.|++|.+...... ......+..|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA-DKRVYAMKQIDLSKMN--RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC-CCcEEEEEEeehhhCC--HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence 36778899999999999998764 6889999998754322 22356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++++|.+++.. .....+++..++.++.+++.||.||| ..+++|+||+|+||+++.++.++|+|||++..+.
T Consensus 78 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 78 MEYAENGDLHKLLKM--QRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred EEeCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence 999999999999976 23457899999999999999999999 7789999999999999999999999999988765
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
..... .....|++.|+|||+..+..++.++|+||||+++|+|++|+.||..... ...... ......+. +
T Consensus 153 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~---~~~~~~~~--~ 221 (256)
T cd08529 153 DNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GALILK---IIRGVFPP--V 221 (256)
T ss_pred Cccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHH---HHcCCCCC--C
Confidence 44222 1235688999999999988899999999999999999999999865421 111111 11111111 0
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.......+.+++.+||+.+|++||++.+++++
T Consensus 222 --------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 --------SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --------ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00122348889999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=310.88 Aligned_cols=259 Identities=21% Similarity=0.351 Sum_probs=199.1
Q ss_pred cccccccccceeEEEEEeeeCCCCe--EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC------
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGK--MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP------ 277 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------ 277 (531)
.+.+.||+|+||.||+|.+.. ++. .||+|.++...... .....+..|+.+++.++||||+++++++...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~-~~~~~~~a~k~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQ-DDSILKVAVKTMKIAICTR--SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred ccccccCcccCceEEEeEEcc-CCCeeeEEEEecccCcCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 456789999999999998754 333 68999887543222 2257788999999999999999999987532
Q ss_pred CceEEEEeccCCCCHHHHHhhcc--CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVS--QGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
...+++|||+++|+|.+++.... .....+++.....++.|++.||.||| .++++||||||+|||++.++.+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECC
Confidence 24689999999999999885322 12345899999999999999999999 77899999999999999999999999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHh
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
||++..+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+...+..
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~-- 229 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----SEIYDYLRQ-- 229 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHc--
Confidence 999987654432222223346778999999998899999999999999999999 8899865321 222222221
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
...+.. . .. ....+.+++.+||+.||.+|||+.++++.|+++
T Consensus 230 -~~~~~~--~----~~----~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 -GNRLKQ--P----PD----CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -CCCCCC--C----CC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111110 0 11 122478899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=323.03 Aligned_cols=246 Identities=20% Similarity=0.298 Sum_probs=194.5
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||+|+||.||+|+... +++.||||++...... .......+..|..++..+ +||||+++++++...+..|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG-TDEVYAIKVLKKDVIL-QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECC-CCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 369999999999998754 6889999999753221 112245677788888866 8999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 79 NGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence 99999999865 456889999999999999999999 77899999999999999999999999999876433222
Q ss_pred cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..... ........ .+
T Consensus 152 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~----~~~~~---~i~~~~~~----~p-- 216 (321)
T cd05591 152 T--TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE----DDLFE---SILHDDVL----YP-- 216 (321)
T ss_pred c--ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH----HHHHH---HHHcCCCC----CC--
Confidence 1 2345789999999999988999999999999999999999999975422 22222 11111110 01
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERP-------NSKDVRSM 483 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~ 483 (531)
... ...+.+++..||+.||.+|| ++.+++++
T Consensus 217 --~~~---~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 --VWL---SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CCC---CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 001 12477889999999999999 77777765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=314.39 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=201.7
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..++|.+.+.||+|+||.||+|.... +++.||+|++....... ...+..|+.++++++||||+++++++......
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~~aik~~~~~~~~~----~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLH-TGELAAVKIIKLEPGDD----FSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECC-CCeEEEEEEEecCccch----HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 34678999999999999999998754 78899999997543322 45677899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++.
T Consensus 82 ~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 82 WICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccce
Confidence 999999999999999864 356899999999999999999999 7789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQ---TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
....... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||....+... .........
T Consensus 155 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~---~~~~~~~~~--- 226 (267)
T cd06646 155 KITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLMSKSNF--- 226 (267)
T ss_pred eeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh---heeeecCCC---
Confidence 7643321 112356889999999874 34578899999999999999999999864322111 100000000
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
.+....+ .......+.+++.+||..||.+|||+.+++++|
T Consensus 227 ~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKLKD-------KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCcc-------ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000000 011223578899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=316.71 Aligned_cols=263 Identities=23% Similarity=0.314 Sum_probs=207.0
Q ss_pred cccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEe
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVR 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 276 (531)
.++|...+.||+|+||.||++.... .....+|+|.+...... .....+.+|+.++.++ +||||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 4568888999999999999998743 23467999998754322 2246688899999999 89999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHhhcc------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCee
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVS------------QGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIL 344 (531)
.+..+++|||+++|+|.+++.... .....+++..+..++.|++.||.||| .++++||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEE
Confidence 999999999999999999997522 23456899999999999999999999 778999999999999
Q ss_pred eCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhh
Q 009595 345 IDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEE 423 (531)
Q Consensus 345 l~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~ 423 (531)
++.++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 240 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---- 240 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH----
Confidence 99999999999999987655432222223345678999999988889999999999999999998 9999865422
Q ss_pred hHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 424 KSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 424 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
......+.. ...+.. .......+.+++.+||..||.+|||+.++++.|+.+
T Consensus 241 ~~~~~~~~~---~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 241 EELFKLLKE---GYRMEK----------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHHHHc---CCcCCC----------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 222222211 111110 001123488899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=319.92 Aligned_cols=245 Identities=25% Similarity=0.386 Sum_probs=192.2
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||+|+||.||+|.... +++.||||.++...... +.....+..|..++... +||||+++++++.+.+.+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG-TNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 369999999999998764 68889999997642111 11234566677777764 9999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|.+++.. ...+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05619 79 NGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151 (316)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence 99999999965 356889999999999999999999 78899999999999999999999999999875433222
Q ss_pred cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+...+.. ..+. . +
T Consensus 152 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~~~~i~~----~~~~--~-~-- 216 (316)
T cd05619 152 K--TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE----EELFQSIRM----DNPC--Y-P-- 216 (316)
T ss_pred c--eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh----CCCC--C-C--
Confidence 1 2335789999999999998999999999999999999999999875422 222222211 1111 0 0
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSK-DVRS 482 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 482 (531)
.. ....+.+++.+||+.||.+||++. ++.+
T Consensus 217 --~~---~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 --RW---LTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --cc---CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 01 112367889999999999999997 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=312.26 Aligned_cols=259 Identities=21% Similarity=0.317 Sum_probs=203.3
Q ss_pred cccccccccccccceeEEEEEeeeCCCCe----EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGK----MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
...|...+.||.|+||+||+|.+.. +++ .||+|.+...... .....+..|+.++..+.||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~va~K~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIP-DGENVKIPVAIKVLRENTSP---KANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEec-CCCccceEEEEEEecCCCCH---HHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 3567888999999999999998754 344 4899998754332 224668889999999999999999998875
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
...++++||+++|+|.+++.. ....+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG 154 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFG 154 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCC
Confidence 457899999999999999864 2356899999999999999999999 7889999999999999999999999999
Q ss_pred CCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 358 LARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 358 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
+++.+.............+++.|+|||...+..++.++|||||||++|||++ |..||..... ..+..++....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~~~-- 228 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDLLEKGE-- 228 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHCCC--
Confidence 9987754332222222345678999999988899999999999999999998 8999865422 22333332211
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.+.. . .. ....+.+++.+||..||.+||++.++++.|..+.
T Consensus 229 -~~~~--~----~~----~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 -RLPQ--P----PI----CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred -cCCC--C----cc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1110 0 01 1224788999999999999999999999997764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=308.98 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=198.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
..|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGAMS-----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec--CCccEEEEEeccCCCC-----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence 34678899999999999999875 4667999998653322 3457789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|.+++... ...+++.....++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++..
T Consensus 77 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~ 150 (256)
T cd05059 77 VTEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV 150 (256)
T ss_pred EEecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceec
Confidence 99999999999999641 236899999999999999999999 778999999999999999999999999998866
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
.+..... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ......+.... .+..
T Consensus 151 ~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~~~---~~~~ 222 (256)
T cd05059 151 LDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN----SEVVESVSAGY---RLYR 222 (256)
T ss_pred ccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH----HHHHHHHHcCC---cCCC
Confidence 4432211 111224567999999998899999999999999999999 8999865422 12222221111 1110
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
+ . .....+.+++.+||..+|.+|||+.++++.|
T Consensus 223 ---~----~---~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 ---P----K---LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---C----C---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0 0 1122488899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=328.09 Aligned_cols=265 Identities=20% Similarity=0.304 Sum_probs=204.9
Q ss_pred hcccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEE
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMV 275 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~ 275 (531)
+.+++.+.+.||+|+||.||+|.+.. ..+..||+|++....... ....+..|+.++.++. ||||+++++++.
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS---EKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh---HHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 44667788999999999999998632 245689999997643322 2456889999999997 999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccC------------------------------------------------------
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQ------------------------------------------------------ 301 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 301 (531)
..+..++||||+++|+|.+++.....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999965211
Q ss_pred ----------------------------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCC
Q 009595 302 ----------------------------------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341 (531)
Q Consensus 302 ----------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 341 (531)
....+++.....++.|++.||.||| .++++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence 1124677788899999999999999 788999999999
Q ss_pred CeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccc
Q 009595 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQH 420 (531)
Q Consensus 342 NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~ 420 (531)
|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~- 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM- 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence 99999999999999999986543322122223457889999999988889999999999999999998 8999865421
Q ss_pred hhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 421 TEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 421 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
...+...+.. ...+. .+ .. ....+.+++.+||..+|.+||++.+|++.|+++
T Consensus 348 --~~~~~~~~~~---~~~~~---~p---~~----~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 348 --NEQFYNAIKR---GYRMA---KP---AH----ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred --hHHHHHHHHc---CCCCC---CC---CC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112221111 11111 00 01 123478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=308.64 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=202.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|.+.++||+|+||.||+|... +++.||+|.+...... ...+..|+.++++++||||+++++++. .+..+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~--~~~~~a~K~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGSMS-----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC--CCceEEEEEecCCCCc-----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 466888999999999999999864 6788999999764432 456888999999999999999999764 56789
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
++|||+++|+|.+++.. .....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 77 ~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 151 (260)
T cd05067 77 IITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARL 151 (260)
T ss_pred EEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceee
Confidence 99999999999999865 33456899999999999999999999 77899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+... ......+......+.
T Consensus 152 ~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~~~~~-- 224 (260)
T cd05067 152 IEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN----PEVIQNLERGYRMPR-- 224 (260)
T ss_pred cCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh----HHHHHHHHcCCCCCC--
Confidence 6533221 1122346778999999988889999999999999999999 9999875432 222222211111000
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
... ....+.+++.+||+.+|.+|||+++++..|+.
T Consensus 225 --------~~~---~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 --------PDN---CPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --------CCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011 12348889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=308.00 Aligned_cols=257 Identities=19% Similarity=0.310 Sum_probs=202.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch-hhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS-LLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
++|...+.||+|++|.||.|.... +++.||+|.+...... ........+.+|+.++++++||||+++++++...+..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD-TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC-CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 467888999999999999997643 6889999998754322 12223567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+|+||+++++|.+++.. ...+++.....++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 81 IFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999999975 456888999999999999999999 77899999999999999999999999999876
Q ss_pred CCCCCccce-ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVS-TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
......... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~----~~~~~~~~ 226 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---MAAIFK----IATQPTNP 226 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---HHHHHH----HhccCCCC
Confidence 543221111 1234578899999999998899999999999999999999999865321 111111 11111110
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+. . .....+.+++.+||..+|.+|||+.+++++
T Consensus 227 -~~~----~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 -QLP----S----HVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCC----c----cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 010 1 112247789999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=312.08 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=208.0
Q ss_pred cccccccccccccceeEEEEEeeeCC---CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe-C
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPES---NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR-P 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~ 277 (531)
.++|...+.||+|+||.||+|.+... .+..|++|.+...... .....+..|+.+++.++||||+++++++.. +
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE---IQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 46788889999999999999988642 2678999998753322 225678889999999999999999998776 4
Q ss_pred CceEEEEeccCCCCHHHHHhhccCC----CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEE
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQG----RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARI 353 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL 353 (531)
...++++||+++|+|.+++...... ...+++..+..++.+++.||.||| +.+++|+||||+||++++++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEE
Confidence 6789999999999999999763322 156899999999999999999999 778999999999999999999999
Q ss_pred eecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHH
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRN 432 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~ 432 (531)
+|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||....+ ..+..++..
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~ 234 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP----FEMAAYLKD 234 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH----HHHHHHHHc
Confidence 99999987654433222223446778999999988889999999999999999999 9999875422 223333222
Q ss_pred HhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 433 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
. ..+... .. ....+.+++.+||..||++|||+.++++.|+++.
T Consensus 235 ~---~~~~~~-------~~---~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 G---YRLAQP-------IN---CPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred C---CCCCCC-------Cc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1 111110 01 1124788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=313.45 Aligned_cols=262 Identities=20% Similarity=0.328 Sum_probs=204.2
Q ss_pred cccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
.++|.+.+.||+|+||.||+|.... ..+..||+|.+....... ....+..|+.+++.++||||+++++++...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR---ERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH---HHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4678889999999999999997532 235589999886543221 134577899999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHhhccC------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCE
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQ------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA 351 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v 351 (531)
...++||||+++|+|.+++..... .....++..+..++.|++.||.||| +++++||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcE
Confidence 999999999999999999975321 1244567788899999999999999 7889999999999999999999
Q ss_pred EEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHH
Q 009595 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~ 430 (531)
+|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .....
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~----~~~~~-- 232 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----EQVLK-- 232 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH--
Confidence 9999999886644332222223345778999999998889999999999999999998 7889865322 22222
Q ss_pred HHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
.......+... . .....+.+++.+||+.||.+|||+.++++.|.+
T Consensus 233 -~~~~~~~~~~~-------~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 277 (288)
T cd05061 233 -FVMDGGYLDQP-------D---NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277 (288)
T ss_pred -HHHcCCCCCCC-------C---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 22222111110 0 112358889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=320.27 Aligned_cols=246 Identities=23% Similarity=0.313 Sum_probs=195.2
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||+|+||.||+|.... +++.||||+++...... ......+..|+.++..+ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG-TDELYAVKVLKKDVILQ-DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 469999999999998764 67889999998643211 12245677888888888 7999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 79 ~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 79 NGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence 99999999865 457899999999999999999999 78899999999999999999999999999875322221
Q ss_pred cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ...+...+ .. .... + +
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~----~~~~~~~i---~~-~~~~--~-~-- 216 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD----EDELFQSI---LE-DEVR--Y-P-- 216 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC----HHHHHHHH---Hc-CCCC--C-C--
Confidence 1223568999999999999999999999999999999999999986532 12222211 11 1111 0 0
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNS-----KDVRSM 483 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 483 (531)
.. ....+.+++.+||+.||.+|||+ .+++++
T Consensus 217 --~~---~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 --RW---LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred --Cc---CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11 12247889999999999999999 777764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=323.99 Aligned_cols=249 Identities=21% Similarity=0.265 Sum_probs=192.1
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHH-HHhcCCCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIM-TAGQIRHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||+|+||.||+|.... +|+.||+|++........ .....+..|.. +++.++||||+++++++...+..|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL-DGKCYAVKVLQKKIVLNR-KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 369999999999998654 789999999975422111 12344555554 567789999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|..++.. ...+++..+..++.||+.||.||| +.|++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 79 NGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 99999998864 467899999999999999999999 78899999999999999999999999999875432211
Q ss_pred cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..+. ......... ..+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~~---~~~~~~~~~---~~~-- 217 (325)
T cd05604 152 --TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV----AEMY---DNILHKPLV---LRP-- 217 (325)
T ss_pred --CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH----HHHH---HHHHcCCcc---CCC--
Confidence 12346799999999999999999999999999999999999999865321 1121 111111110 111
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
.. ...+.+++.+|++.||.+||++.+.++.+..
T Consensus 218 --~~----~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05604 218 --GA----SLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250 (325)
T ss_pred --CC----CHHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence 11 1236788899999999999998754444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=320.28 Aligned_cols=245 Identities=26% Similarity=0.365 Sum_probs=192.1
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||+|+||.||+|.... +|+.||+|.++...... +.....+..|..++... +||||+++++++...+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG-KGEYFAVKALKKDVVLI-DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 469999999999998764 78899999997632111 11245566788887754 8999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|.+++.. ...+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05620 79 NGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151 (316)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence 99999999865 456889999999999999999999 78899999999999999999999999999875432221
Q ss_pred cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ...+...+.. ..+.. +
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~----~~~~~~~~~~----~~~~~---~-- 216 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD----EDELFESIRV----DTPHY---P-- 216 (316)
T ss_pred --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHh----CCCCC---C--
Confidence 1234679999999999999999999999999999999999999986532 1222222211 11110 0
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSK-DVRS 482 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 482 (531)
.. ....+.+++.+||+.||.+||++. ++++
T Consensus 217 --~~---~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 217 --RW---ITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred --CC---CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 01 112477899999999999999985 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=326.70 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=214.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
..+....+||-|.||.||.|.|+. ..-.||||.++.+... +..|++|+.+|+.+.|||+|+++|+|..+..+||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKk-yslTvAVKtLKEDtMe-----veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTME-----VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeec-cceeeehhhhhhcchh-----HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 345567899999999999999986 4566999999875443 7889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|+|||..|+|.+||+. .....++....+.++.||++|++||. .+++|||||...|+|+.++..||++||||++.+
T Consensus 341 iTEfM~yGNLLdYLRe--cnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRE--CNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEecccCccHHHHHHH--hchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999987 66777888899999999999999999 888999999999999999999999999999988
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... ......-.+.|.|||.+..+.++.++|||+|||+|||+.| |-.||.+.. .-+.+..+...+.-..|.-
T Consensus 416 tgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid----lSqVY~LLEkgyRM~~PeG 490 (1157)
T KOG4278|consen 416 TGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYGLLEKGYRMDGPEG 490 (1157)
T ss_pred cCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc----HHHHHHHHhccccccCCCC
Confidence 654332 2222334678999999999999999999999999999999 888987642 2334444433333222221
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
++ ..+++|++.||+-+|.+||++.++.+.++.+..
T Consensus 491 ----------CP---pkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 491 ----------CP---PKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ----------CC---HHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 11 137889999999999999999999999977643
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=315.52 Aligned_cols=269 Identities=19% Similarity=0.290 Sum_probs=207.8
Q ss_pred cccccccccccccceeEEEEEeeeCCC---------------CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESN---------------GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN 266 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn 266 (531)
.++|.+.+.||+|+||.||+|...... +..||+|.+...... .....+.+|+.++.+++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD---NAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH---HHHHHHHHHHHHHHhcCCCC
Confidence 357888999999999999998764322 245899998754332 22567889999999999999
Q ss_pred ccccceeEEeCCceEEEEeccCCCCHHHHHhhccC-------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccC
Q 009595 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQ-------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNIT 339 (531)
Q Consensus 267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 339 (531)
|+++++++...+..+++|||+++++|.+++..... ....+++..++.++.|++.||.||| +.+++|+|||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlk 157 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLA 157 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccc
Confidence 99999999999999999999999999999976321 1236899999999999999999999 7789999999
Q ss_pred CCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCc
Q 009595 340 PSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM--GKLPSDDF 417 (531)
Q Consensus 340 p~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~P~~~~ 417 (531)
|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999999887654433222334556789999999988889999999999999999998 67787653
Q ss_pred ccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 418 FQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 418 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
.. ..................... ........+.+++.+||+.||.+|||+.+|++.|++
T Consensus 238 ~~----~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 238 TD----QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred Ch----HHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 22 222222222211111111110 001112358889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=325.48 Aligned_cols=242 Identities=20% Similarity=0.294 Sum_probs=193.1
Q ss_pred ccccccceeEEEEEeee--CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEec
Q 009595 209 EKIRSRASGEIYIAELP--ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 286 (531)
+.||+|+||.||+++.. ..+|+.||+|++...... ......+..|+.++++++||||+++++++...+..|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK--VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 57999999999998753 246889999999763322 11245567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCC
Q 009595 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH 366 (531)
Q Consensus 287 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~ 366 (531)
+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 80 LRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999999964 456899999999999999999999 7789999999999999999999999999988654432
Q ss_pred ccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcccccc
Q 009595 367 AQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSK 446 (531)
Q Consensus 367 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 446 (531)
.. .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...... ..... .. +..
T Consensus 153 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----~~~~~~---i~~~~-~~--~p~- 219 (318)
T cd05582 153 KK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR----KETMTM---ILKAK-LG--MPQ- 219 (318)
T ss_pred Cc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH----HHHHHH---HHcCC-CC--CCC-
Confidence 21 2235789999999999988899999999999999999999999875421 112111 11111 10 000
Q ss_pred ccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 009595 447 LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKD 479 (531)
Q Consensus 447 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 479 (531)
. ....+.+++.+||+.||.+|||+.+
T Consensus 220 ---~----~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 ---F----LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---C----CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1 1124778999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=314.16 Aligned_cols=259 Identities=23% Similarity=0.320 Sum_probs=202.0
Q ss_pred ccccccccccccceeEEEEEeee----CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 203 DCSASLEKIRSRASGEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
.++...++||+|+||.||++... ..++..+|+|.+...... ....+..|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES----ARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHH----HHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 45677889999999999999642 234668999988754332 2567889999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhccC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQ-----------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~ 347 (531)
..+++|||+++|+|.+++..... ....+++..+..++.|++.||.||| +.+++||||||+|||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcC
Confidence 99999999999999999975321 1135889999999999999999999 788999999999999999
Q ss_pred CCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHH
Q 009595 348 DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSL 426 (531)
Q Consensus 348 ~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l 426 (531)
++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ...
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~ 233 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN----TEA 233 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH----HHH
Confidence 99999999999876543322111223345788999999998899999999999999999998 8999865422 111
Q ss_pred HHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 427 VRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 427 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
..... ..... . .+ ... ...+.+++.+||+.||.+||++.+|++.|+
T Consensus 234 ~~~~~---~~~~~-~--~~---~~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 IECIT---QGREL-E--RP---RTC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHH---cCccC-C--CC---CCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11111 11111 0 00 011 123788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=321.58 Aligned_cols=253 Identities=23% Similarity=0.295 Sum_probs=195.3
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||+|+||.||+|.... +++.||+|++....... ......+..|+.++.++ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK-NDQIYAMKVVKKELVHD-DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 369999999999998764 68899999998643221 22356788899999888 6999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|.+++.. ...+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 151 (327)
T cd05617 79 NGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD 151 (327)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence 99999998864 457999999999999999999999 77899999999999999999999999999875332211
Q ss_pred cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ....++.......... +.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~--~p--- 223 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-NTEDYLFQVILEKPIR--IP--- 223 (327)
T ss_pred --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-ccHHHHHHHHHhCCCC--CC---
Confidence 123467999999999999999999999999999999999999999643221111 1111111111111111 00
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNS------KDVRSM 483 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 483 (531)
... ...+.+++.+||+.||.+||++ .++.++
T Consensus 224 --~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 224 --RFL---SVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred --CCC---CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 011 1236788899999999999985 466554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=302.60 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=207.0
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
.++.|++.+.||+|.|+.||++... .+|+.+|+|++........ ..+.+.+|+++-+.|+||||+++.+.+......
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~-~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhc-cchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 4577888899999999999998654 5899999998865443322 267788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC---CCEEEeecC
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD---MEARIADFG 357 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~---~~vkL~Dfg 357 (531)
|+|+|+|+|++|..-+-. .-..++..+-.+++||+++|.|+| .++|||||+||+|+++.+. --+||+|||
T Consensus 86 ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred EEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccc
Confidence 999999999999876643 245788888999999999999999 8899999999999999643 459999999
Q ss_pred CCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 358 LARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 358 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
++..+.++... ...+|||.|||||++...+|+..+|||+.|||||-|+.|.+||.+. ....+++.+...--.
T Consensus 159 vAi~l~~g~~~---~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~----~~~rlye~I~~g~yd- 230 (355)
T KOG0033|consen 159 LAIEVNDGEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----DQHRLYEQIKAGAYD- 230 (355)
T ss_pred eEEEeCCcccc---ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc----cHHHHHHHHhccccC-
Confidence 99988744322 3478999999999999999999999999999999999999998663 333444433321111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
++ +..++.......+|+.+||..||.+|.|+.|.+.|
T Consensus 231 -----~~----~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 231 -----YP----SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred -----CC----CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 11 12233334457889999999999999999998764
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=321.39 Aligned_cols=264 Identities=22% Similarity=0.313 Sum_probs=202.1
Q ss_pred cccccccccccccceeEEEEEeee----CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEe
Q 009595 202 EDCSASLEKIRSRASGEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVR 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 276 (531)
.++|.+.+.||+|+||.||+|.+. ..+++.||||+++..... .....+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh---HHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 467889999999999999999742 235789999999754322 1246688899999999 78999999998865
Q ss_pred C-CceEEEEeccCCCCHHHHHhhccC------------------------------------------------------
Q 009595 277 P-DCHLLVSEFMKNGSLLEILNDVSQ------------------------------------------------------ 301 (531)
Q Consensus 277 ~-~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 301 (531)
. ...+++|||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 467899999999999999864210
Q ss_pred ---------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccceec
Q 009595 302 ---------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTS 372 (531)
Q Consensus 302 ---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~ 372 (531)
....+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++.............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 0124678888999999999999999 7889999999999999999999999999988764332222222
Q ss_pred ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCC
Q 009595 373 IVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNG 451 (531)
Q Consensus 373 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 451 (531)
...+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ..+...+.. .... .. + ..
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~---~~~~-~~--~----~~ 306 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKE---GTRM-RA--P----DY 306 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc---HHHHHHHhc---cCCC-CC--C----CC
Confidence 3345678999999988889999999999999999997 99998654221 112111111 1111 00 0 00
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 452 YEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 452 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
. ...+.+++..||+.||.+|||+.+|+++|+.+
T Consensus 307 ~---~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 307 T---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred C---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 12478899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=326.90 Aligned_cols=266 Identities=23% Similarity=0.323 Sum_probs=198.2
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC-----
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD----- 278 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----- 278 (531)
+|+..+.||+|+||.||+|.... +|+.||||.+....... .....+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR-DGKRVALKKMPNVFQNL--VSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC-CCCEEEEEeccccccch--HHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence 36778899999999999998653 78999999986532221 12467889999999999999999999998776
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
..|+||||+.+ +|.+++.. ...+++..+..++.||+.||.||| +.+++||||||+|||++.++.+||+|||+
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~ 149 (372)
T cd07853 78 EIYVVTELMQS-DLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGL 149 (372)
T ss_pred eEEEEeecccc-CHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccc
Confidence 78999999964 88888854 467899999999999999999999 77899999999999999999999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHH--------
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRW-------- 429 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~-------- 429 (531)
+......... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.........+.+.
T Consensus 150 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 150 ARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred eeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 9865433221 12234678999999998775 4789999999999999999999999764321111111110
Q ss_pred -------HHHHh-ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 430 -------MRNVM-TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 430 -------~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..... ......... ..+. .........+.+++.+||+.||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSL-PVLY-TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCch-HHhc-ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000 000000000 0000 0001112357889999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=306.46 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=199.0
Q ss_pred ccccccceeEEEEEeeeCCCC--eEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEec
Q 009595 209 EKIRSRASGEIYIAELPESNG--KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 286 (531)
++||+|+||.||+|.+...++ ..||+|.+...... .....+..|+.+++++.||||+++++++. .+..++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence 479999999999998755442 68999999765432 22567888999999999999999999876 4568999999
Q ss_pred cCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCC
Q 009595 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH 366 (531)
Q Consensus 287 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~ 366 (531)
+++|+|.+++.. ...+++..+..++.|++.||.||| ..+++|+||||+||+++.++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 77 APLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred CCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 999999999975 347899999999999999999999 7789999999999999999999999999998765433
Q ss_pred ccce-ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCcccc
Q 009595 367 AQVS-TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444 (531)
Q Consensus 367 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 444 (531)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..+...+........+
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~----- 220 (257)
T cd05060 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAMLESGERLPRP----- 220 (257)
T ss_pred cccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHHcCCcCCCC-----
Confidence 2211 112224568999999988899999999999999999998 9999875422 2233332221110000
Q ss_pred ccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 445 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.. ....+.+++.+||..||.+|||+.++++.|+.+.
T Consensus 221 -----~~---~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 -----EE---CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -----CC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11 1134788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.06 Aligned_cols=241 Identities=20% Similarity=0.294 Sum_probs=188.0
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHH-HHhcCCCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIM-TAGQIRHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||+|+||.||+|.... +|+.||+|++......... ....+..|.. +++.++||||+++++++...+..|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~-~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS-DGSFYAVKVLQKKTILKKK-EQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHHHHhh-HHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 369999999999998754 7889999999753322111 2344555554 678899999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|..++.. ...+++..+..++.||+.||.||| ..+++||||||+||+++.++.+||+|||++........
T Consensus 79 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (321)
T cd05603 79 NGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE 151 (321)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence 99999998864 456888889999999999999999 77899999999999999999999999999875432221
Q ss_pred cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ...+.. ...... .. +.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~---~i~~~~-~~--~~--- 216 (321)
T cd05603 152 --TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----VSQMYD---NILHKP-LQ--LP--- 216 (321)
T ss_pred --ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC----HHHHHH---HHhcCC-CC--CC---
Confidence 1234578999999999998889999999999999999999999986532 112222 111111 10 00
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCCCHH
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSK 478 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 478 (531)
... ...+.+++.+||+.||.+||++.
T Consensus 217 -~~~----~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 -GGK----TVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCC----CHHHHHHHHHHccCCHhhcCCCC
Confidence 111 12477899999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=316.72 Aligned_cols=264 Identities=23% Similarity=0.299 Sum_probs=205.1
Q ss_pred cccccccccccccceeEEEEEeeeC------CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE------SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHM 274 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~ 274 (531)
.+.|.+.+.||+|+||.||++.... .++..+|+|.+...... .....+..|+.++..+ +||||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE---KDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh---HHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3678899999999999999997632 12357999999754321 1246688899999999 799999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCC
Q 009595 275 VRPDCHLLVSEFMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSS 342 (531)
Q Consensus 275 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 342 (531)
...+..++||||+++|+|.+++..... ....+++..+..++.|++.||.||| +.+++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHh
Confidence 999999999999999999999976321 1235889999999999999999999 7789999999999
Q ss_pred eeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccch
Q 009595 343 VLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHT 421 (531)
Q Consensus 343 ILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~ 421 (531)
|+++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~--- 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---
Confidence 9999999999999999886654322222222334578999999988889999999999999999998 888886432
Q ss_pred hhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 422 EEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 422 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
...+...+.. ..... . .......+.+++.+||..+|.+|||+.++++.|.++.
T Consensus 248 -~~~~~~~~~~----~~~~~-~--------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 248 -VEELFKLLKE----GHRMD-K--------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred -HHHHHHHHHc----CCCCC-C--------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1222222221 11110 0 0111234778999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=298.23 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=209.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch----hhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeC
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS----LLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRP 277 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~ 277 (531)
..|...+.||.|++++|-++..+. +|..+|+|++...... ......+.-.+|+.+|+++ .||||+++.+++..+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~-t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKE-TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcc-cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 556778899999999999987665 7888999998643221 1233456677899999999 799999999999999
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
..+++|+|.|+.|.|+|+|.. ...+++....+|++|+.+|++||| .++||||||||+|||++++.++||+|||
T Consensus 96 sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccc
Confidence 999999999999999999975 678999999999999999999999 8889999999999999999999999999
Q ss_pred CCccCCCCCccceecccccCccccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHH
Q 009595 358 LARLMPDGHAQVSTSIVAGTVGYIAPEYHQT------LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMR 431 (531)
Q Consensus 358 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~ 431 (531)
++..+..+... ...||||+|+|||.+.. ..|+...|+|++|+|+|.|+.|.+||-. ..+.- .++
T Consensus 169 Fa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH----RkQml---MLR 238 (411)
T KOG0599|consen 169 FACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH----RKQML---MLR 238 (411)
T ss_pred eeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH----HHHHH---HHH
Confidence 99988776443 34799999999998753 3689999999999999999999999732 22111 122
Q ss_pred HHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 432 NVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 432 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+..+. -. ..+..+.+......+||.+||+.||.+|.|+++++.|
T Consensus 239 ~ImeGk-yq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 239 MIMEGK-YQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHhcc-cc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 222221 11 1233455566678999999999999999999999885
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=305.27 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=204.5
Q ss_pred ccccccceeEEEEEeeeC--CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEec
Q 009595 209 EKIRSRASGEIYIAELPE--SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 286 (531)
+.||+|+||.||+|.... ..+..|++|.+....... ....+..|+..+..++||||+++++++......+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE---ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh---HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence 469999999999998863 127789999998654432 367788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCC-----CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 287 MKNGSLLEILNDVSQG-----RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 287 ~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+++++|.+++...... ...+++..+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 9999999999763211 367899999999999999999999 78899999999999999999999999999988
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
..............+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ..+...+.. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~---~~~~~ 227 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----EEVLEYLRK---GYRLP 227 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHc---CCCCC
Confidence 765432222234567889999999988889999999999999999999 6999876522 222222222 11110
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
.+ .. ....+.+++.+||..||.+|||+.+++++|+
T Consensus 228 ---~~----~~---~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 ---KP----EY---CPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CC----cc---CChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01 01 1234888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=308.26 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=201.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|.+.+.||+|++|.||+|... .+..+|+|.+...... ...+.+|+.++++++||||+++++++. ....+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~~~~-----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTMS-----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec--CCceeEEEEecCCCCC-----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 356788999999999999999765 5667999999764432 356889999999999999999999875 45689
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
++|||+++++|.+++.. .....+++..+..++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 77 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 77 IVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARL 151 (260)
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeee
Confidence 99999999999999975 23356899999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+... ......+.. ...+.
T Consensus 152 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~~~---~~~~~ 223 (260)
T cd05070 152 IEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN----REVLEQVER---GYRMP 223 (260)
T ss_pred ccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHc---CCCCC
Confidence 6543211 1112335678999999988889999999999999999999 8999865422 222222221 11111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
. . ......+.+++.+||..||.+|||+.++.+.|++
T Consensus 224 ~-------~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 C-------P---QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred C-------C---CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 0 0112348889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=321.26 Aligned_cols=245 Identities=21% Similarity=0.233 Sum_probs=194.1
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 282 (531)
+|...+.||+|+||.||+|.... +++.||+|.+....... ......+..|..++..+ +||+|+++++++...+..|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 36788999999999999998754 67899999997643211 12245566788888777 58999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++...
T Consensus 79 v~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 79 VMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred EEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 9999999999999865 456889999999999999999999 778999999999999999999999999998754
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+... ..+...+.. .. ..
T Consensus 152 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~---~~-~~-- 219 (323)
T cd05616 152 MWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIME---HN-VA-- 219 (323)
T ss_pred CCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----HHHHHHHHh---CC-CC--
Confidence 32221 12346799999999999999999999999999999999999999976422 222222211 11 10
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS 477 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 477 (531)
+. .. ....+.+++.+||+.||.+|++.
T Consensus 220 ~p----~~----~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YP----KS----MSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC----Cc----CCHHHHHHHHHHcccCHHhcCCC
Confidence 00 01 12247889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=313.49 Aligned_cols=255 Identities=25% Similarity=0.336 Sum_probs=199.7
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 284 (531)
|...+.||+|+||.||++.... +++.||+|.+....... ......+..|+.++++++|+||+.+++.+...+..++||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKK-RKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcC-CCceEEEEEEehhhccc-hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 5677899999999999998765 78899999987543221 112355678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCC
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~ 364 (531)
||+++|+|.+++.. .....+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 80 TLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred EecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999999999864 23346899999999999999999999 78899999999999999999999999999876543
Q ss_pred CCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcccc
Q 009595 365 GHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444 (531)
Q Consensus 365 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 444 (531)
.... ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..................... .
T Consensus 155 ~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~------- 223 (285)
T cd05630 155 GQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE-E------- 223 (285)
T ss_pred Cccc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh-h-------
Confidence 3221 2346899999999999889999999999999999999999999754221111111111111100 0
Q ss_pred ccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 009595 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-----SKDVRSM 483 (531)
Q Consensus 445 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 483 (531)
..... ...+.+++..||+.||.+||| +.+++++
T Consensus 224 --~~~~~----~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 224 --YSEKF----SPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred --cCccC----CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 00111 123778899999999999999 7777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=310.20 Aligned_cols=262 Identities=23% Similarity=0.300 Sum_probs=202.2
Q ss_pred cccccccccccccceeEEEEEeeeCC----CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPES----NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
.++|...+.||+|++|.||+|.+... .+..||+|.+....... ....+..|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ---DESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 35688899999999999999987531 35678999886543221 245688899999999999999999999998
Q ss_pred CceEEEEeccCCCCHHHHHhhccC---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC---CE
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQ---GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM---EA 351 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~---~v 351 (531)
...++||||+++++|.+++..... ....+++..+..++.||+.||.||| .++++||||||+||+++.++ .+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcce
Confidence 999999999999999999976321 1135899999999999999999999 67899999999999998754 59
Q ss_pred EEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHH
Q 009595 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~ 430 (531)
||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||+.... ..+...+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~----~~~~~~~ 234 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN----QEVMEFV 234 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH
Confidence 9999999987643322211122234568999999998899999999999999999997 9999875322 2222221
Q ss_pred HHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
. ....+.. + .. . ...+.+++.+||+.+|.+|||+.+|+++|.+
T Consensus 235 ~---~~~~~~~---~---~~-~---~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 235 T---GGGRLDP---P---KG-C---PGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred H---cCCcCCC---C---CC-C---CHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1 1111110 0 11 1 1347889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=312.22 Aligned_cols=268 Identities=20% Similarity=0.281 Sum_probs=202.8
Q ss_pred cccccccccccccceeEEEEEeeeCC-------------CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCccc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPES-------------NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV 268 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-------------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv 268 (531)
.++|.+.+.||+|+||.||++..... ....||+|.++..... .....+.+|+.++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK---TARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH---HHHHHHHHHHHHHHhCCCCCcC
Confidence 35788899999999999999875321 1235899998754322 2256788999999999999999
Q ss_pred ccceeEEeCCceEEEEeccCCCCHHHHHhhccC--------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCC
Q 009595 269 PLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQ--------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITP 340 (531)
Q Consensus 269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp 340 (531)
++++++......++||||+++++|.+++..... ....+++..++.++.|++.||.||| +.+++|+||||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp 157 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLAT 157 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccCh
Confidence 999999999999999999999999999964211 1134788899999999999999999 77899999999
Q ss_pred CCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCcc
Q 009595 341 SSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM--GKLPSDDFF 418 (531)
Q Consensus 341 ~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~P~~~~~ 418 (531)
+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999999986644332222233445778999999988889999999999999999998 566776542
Q ss_pred cchhhhHHHHHHHHHhcc-CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 419 QHTEEKSLVRWMRNVMTS-ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 419 ~~~~~~~l~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
. ..+.......... ........+. .....+.+++.+||..||.+|||+.+|++.|.+
T Consensus 238 ~----~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 D----EQVIENTGEFFRNQGRQIYLSQTP-------LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred h----HHHHHHHHHhhhhccccccCCCCC-------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 2 1222211111111 1110000010 011358899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=306.41 Aligned_cols=253 Identities=27% Similarity=0.427 Sum_probs=199.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.+.||+|++|.||+|.+. .+..+|+|.+...... ...+.+|+.++++++||||+++++++. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~lK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWN--GTTKVAIKTLKPGTMM-----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEc--CCceEEEEEcccCCcc-----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 55788899999999999999875 3456999988654322 456788999999999999999999775 456889
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
+|||+++|+|.+++.. .....+++..+..++.+++.||.||| +.+++|+||+|+||++++++.++|+|||++...
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 78 VTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred EEEcCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 9999999999999975 23345889999999999999999999 778999999999999999999999999999866
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... ......++..|+|||...+..++.++||||||+++|+|+| |..||.+... .....++... ..+.
T Consensus 153 ~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~~---~~~~- 223 (260)
T cd05069 153 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN----REVLEQVERG---YRMP- 223 (260)
T ss_pred cCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcC---CCCC-
Confidence 443211 1122345778999999988889999999999999999999 8999876422 2222222211 1110
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
. .......+.+++.+||+.||.+||++.++++.|++
T Consensus 224 -~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 -C--------PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -C--------CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 01122358889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=314.49 Aligned_cols=269 Identities=23% Similarity=0.290 Sum_probs=198.4
Q ss_pred cccccccccceeEEEEEeee---CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--Cce
Q 009595 206 ASLEKIRSRASGEIYIAELP---ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--DCH 280 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~ 280 (531)
...+.||+|+||+||.+.+. ..++..||+|.+...... .....+.+|+.+++.++||||+++++++... ...
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ---QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 77899999999999887542 236778999999764321 1256678899999999999999999987653 357
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
+++|||+++|+|.+++.. ..+++..+..++.|++.||.||| +++++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccc
Confidence 899999999999999964 35899999999999999999999 7789999999999999999999999999998
Q ss_pred cCCCCCccce-ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVS-TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
.......... .....++..|+|||.+.+..++.++||||||+++|+|+||..||....... ................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQMTVVRL 233 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccccccchhhh
Confidence 7654322111 112345667999999988889999999999999999999999976432100 0000000000000000
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
....+..............+.+++..||+.||++|||+.++++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 000000000000011123588899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.76 Aligned_cols=257 Identities=19% Similarity=0.283 Sum_probs=198.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||++.... +++.||+|.+....... ......+.+|+.+++.++||||+++++++..+...|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKS-SQKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 4678899999999999999998764 68899999997532211 112456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999964 35788899999999999999999 78899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLK----FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... .. . ........
T Consensus 192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~---~~-~---~~~i~~~~ 263 (370)
T cd05621 192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL---VG-T---YSKIMDHK 263 (370)
T ss_pred cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH---HH-H---HHHHHhCC
Confidence 643322 1223467999999999987543 78899999999999999999999965321 11 1 11111111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEE--RPNSKDVRSM 483 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 483 (531)
.... +.. .......+.+++..||..++.+ |||+.+++++
T Consensus 264 ~~~~-~p~------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 NSLN-FPE------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cccC-CCC------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1100 000 0011234677788888755543 8899999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=330.85 Aligned_cols=264 Identities=20% Similarity=0.245 Sum_probs=198.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
...|.+.+.||+|+||.||+|.... .++.||||.... ..+.+|+.++++++||||+++++++...+..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~-~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD-YPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC-CCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 4578999999999999999998764 678899996432 23557999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+|||++. ++|.+++.. ....+++..+..++.|++.||.||| .++|+||||||+|||++.++.+||+|||+++.
T Consensus 237 lv~e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~ 309 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACF 309 (461)
T ss_pred EEEEccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCcee
Confidence 9999995 699998864 2346899999999999999999999 77899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCccc----chhhhHHHHHHHHHhcc-
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQ----HTEEKSLVRWMRNVMTS- 436 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~----~~~~~~l~~~~~~~~~~- 436 (531)
..............||+.|+|||++.+..++.++|||||||++|||++|..|+-.... ......+...+......
T Consensus 310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~ 389 (461)
T PHA03211 310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV 389 (461)
T ss_pred cccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence 6443222222345799999999999999999999999999999999998876432111 11122233322221100
Q ss_pred -CCCCcc---------------ccccccCCCcH---HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 437 -ENPNRA---------------IDSKLLGNGYE---EQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 437 -~~~~~~---------------~d~~l~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..+... ..+......+. .....+.+|+.+||+.||.+|||+.|++++
T Consensus 390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 00000000011 112247889999999999999999999986
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=307.61 Aligned_cols=255 Identities=26% Similarity=0.415 Sum_probs=201.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|.+.++||+|+||.||+|.+. +...||+|.+...... ...+..|+.++++++||||+++++++. ....+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~valK~~~~~~~~-----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEec--CCceEEEEecccCccC-----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 356889999999999999999875 3456999999753332 356788999999999999999999764 45689
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. .....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 77 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 77 IVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred EEEEcCCCCcHHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceee
Confidence 99999999999999975 22346789999999999999999999 78899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
+...... ......++..|+|||...+..++.++||||||+++|+|+| |..||.+... ...... ........
T Consensus 152 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~----~~~~~~---~~~~~~~~ 223 (262)
T cd05071 152 IEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQ---VERGYRMP 223 (262)
T ss_pred ccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh----HHHHHH---HhcCCCCC
Confidence 6543221 1122346778999999988889999999999999999999 8889865422 111111 11111110
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
. .......+.+++.+|++.||.+|||+.++++.|++.
T Consensus 224 ~----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 C----------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred C----------ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0 111223578999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=296.76 Aligned_cols=251 Identities=21% Similarity=0.380 Sum_probs=203.2
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCceEEEE
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 284 (531)
..+..||+|+-|.|+++.... +|..+|||.+....+.. ..+++...+.++.... +|+||+.+|+|..+..+++.|
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs-~~~iiAVK~M~rt~Nke---e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRS-TGHIIAVKQMRRTGNKE---ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hhHHhhcCCCccceEEEEEcc-cceEEEEEeecccCCHH---HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 456789999999999999875 78999999998765543 2677888888887774 999999999999999999999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCC
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~ 364 (531)
|.|.. .+..++... .+++|+..+-++...+..||.||.. +++|+|||+||+|||+|..|++||||||++.++.+
T Consensus 171 elMs~-C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHH-HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec
Confidence 99955 777777653 4569999999999999999999997 56899999999999999999999999999999888
Q ss_pred CCccceecccccCccccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 365 GHAQVSTSIVAGTVGYIAPEYHQTL---KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 365 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
+..+ +...|.+.|||||.+... .|+.++||||||++++||+||+.||.+... -++.+..+++...|..
T Consensus 245 SkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t------dFe~ltkvln~ePP~L 315 (391)
T KOG0983|consen 245 SKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT------DFEVLTKVLNEEPPLL 315 (391)
T ss_pred cccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc------cHHHHHHHHhcCCCCC
Confidence 7554 346799999999998643 689999999999999999999999987422 2334444444332221
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+.. ..++ ..+.+++..||+.|+.+||.+.+++++
T Consensus 316 --~~~---~gFS---p~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 --PGH---MGFS---PDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --Ccc---cCcC---HHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 111 1122 236677778999999999999999886
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=329.73 Aligned_cols=206 Identities=24% Similarity=0.378 Sum_probs=176.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|...+.||+|+||.||++.... +++.||+|++....... ......+..|+.++.+++||||+++++++.+.+.+|+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD-TGHIYAMKILRKADMLE-KEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 357889999999999999998764 78899999997532211 2235678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+|||++.++.++|+|||++..+
T Consensus 79 v~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 79 IMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred EEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 9999999999999965 456899999999999999999999 788999999999999999999999999998755
Q ss_pred CCCCcc---------------------------------ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh
Q 009595 363 PDGHAQ---------------------------------VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM 409 (531)
Q Consensus 363 ~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt 409 (531)
...... ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence 321100 00113579999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 009595 410 GKLPSDDF 417 (531)
Q Consensus 410 g~~P~~~~ 417 (531)
|+.||.+.
T Consensus 232 G~~Pf~~~ 239 (360)
T cd05627 232 GYPPFCSE 239 (360)
T ss_pred CCCCCCCC
Confidence 99999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=327.32 Aligned_cols=262 Identities=21% Similarity=0.251 Sum_probs=202.1
Q ss_pred cccccccccccccceeEEEEEeeeC-CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE-SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
...|.+++.||.|+||.||++.... ..+..||+|.+.... ...+|+.++++++||||+++++++......
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK---------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc---------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 4579999999999999999997532 346789999886432 234799999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+|||++. ++|.+++.. ...+++..+..++.||+.||.||| .++|+||||||+|||++.++.++|+|||++.
T Consensus 162 ~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEEehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 99999996 589998843 467899999999999999999999 7789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC---
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE--- 437 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~--- 437 (531)
...............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+...++.....+
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 76554333333346799999999999999999999999999999999999999866433222222322222111000
Q ss_pred -------------------CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 438 -------------------NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 438 -------------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+...+...+.... ....+.+++.+||..||.+|||+.+++.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYG---MHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccC---cchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000000 11246778899999999999999999987
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=308.88 Aligned_cols=258 Identities=20% Similarity=0.298 Sum_probs=192.0
Q ss_pred ccccccceeEEEEEeeeC-CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPE-SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||+|+||.||+|.+.. .++..+|+|.++...... ....+.+|+.++++++||||+++++++......++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ---EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChH---HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence 368999999999997642 245679999887644321 2356888999999999999999999999988999999999
Q ss_pred CCCCHHHHHhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCC
Q 009595 288 KNGSLLEILNDVSQ-GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH 366 (531)
Q Consensus 288 ~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~ 366 (531)
++|+|.+++..... .....++..+..++.|++.||.||| +.+++|+||||+||+++.++++||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 99999999975322 1234667788889999999999999 7789999999999999999999999999987654433
Q ss_pred ccceecccccCccccCcccccCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 367 AQVSTSIVAGTVGYIAPEYHQTL-------KFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 367 ~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
.........|+..|+|||++.+. .++.++|+||||+++|||++ |+.||...... ......... .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~---~- 226 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----QVLTYTVRE---Q- 226 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----HHHHHHhhc---c-
Confidence 22222335578899999988642 35789999999999999996 99999764321 111111110 0
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
......+.+... . ...+.+++..|+ .+|.+|||+.+|+..|+
T Consensus 227 ~~~~~~~~~~~~-~---~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 QLKLPKPRLKLP-L---SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCCCccCCC-C---ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 011111111111 1 123667888898 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=320.84 Aligned_cols=256 Identities=21% Similarity=0.323 Sum_probs=211.8
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCc
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDC 279 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~ 279 (531)
....|...+.||.|.||.||.+..+. +|+.+|+|.+........ .....+.+|+.+|+++. |||||.+++++.+...
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~-tg~~~A~K~i~k~~~~~~-~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKS-TGKEVACKVIPKRKLRGK-EDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecC-CCceeEEEEeehhhcccc-ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 34678888999999999999998765 699999999976544221 12567889999999998 9999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC----CCEEEee
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD----MEARIAD 355 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~----~~vkL~D 355 (531)
+++|||+|.||.|.+.+... .+++..+..++.|++.++.||| ..||+||||||+|+|+... +.+|++|
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEee
Confidence 99999999999999999763 3999999999999999999999 7889999999999999543 4799999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
||++...... ......+||+.|+|||++...+|+..+||||+|+++|.|++|..||.+... ...... +..
T Consensus 183 FGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~---~~~~~~----i~~ 252 (382)
T KOG0032|consen 183 FGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE---FEIFLA----ILR 252 (382)
T ss_pred CCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh---hHHHHH----HHc
Confidence 9999988762 234568999999999999999999999999999999999999999876432 111111 111
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+.. ......++.....+.+++..|+..||..|+|+.++++|
T Consensus 253 -~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 253 -GDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111 11233444555568889999999999999999999997
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=311.63 Aligned_cols=262 Identities=22% Similarity=0.338 Sum_probs=203.9
Q ss_pred cccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
.++|...+.||+|+||.||+|.... .++..||+|.+...... .....+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---DMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH---HHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 4678889999999999999998642 25678999998754322 2246688899999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHhhcc------------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVS------------------QGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNIT 339 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 339 (531)
+..+++|||+++|+|.+++.... .....+++..++.++.|++.||.||| .++++|||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~ 157 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLA 157 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeeccccc
Confidence 99999999999999999997421 11235788899999999999999999 7789999999
Q ss_pred CCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcc
Q 009595 340 PSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFF 418 (531)
Q Consensus 340 p~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~ 418 (531)
|+||+++.++.++|+|||++..+.............++..|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999876543322111122335678999999988899999999999999999998 888886542
Q ss_pred cchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 419 QHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 419 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
. ..... ........ .. .. .....+.+++.+||+.||.+|||+.++++.|++
T Consensus 238 ~----~~~~~---~~~~~~~~-~~------~~---~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 H----EEVIY---YVRDGNVL-SC------PD---NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H----HHHHH---HHhcCCCC-CC------CC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 2 12222 21111111 00 00 112348889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=318.94 Aligned_cols=265 Identities=18% Similarity=0.236 Sum_probs=198.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||+|+||.||+|.... +++.||+|.+....... ....+.+|+.++++++||||+++++++..++..+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKL-TENLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecC-CCCeEEEEEeeccccCC---cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence 3678899999999999999998754 67889999997543221 1345678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++ +|.+++.. ....+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++..
T Consensus 81 lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 153 (309)
T cd07872 81 LVFEYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA 153 (309)
T ss_pred EEEeCCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcccccee
Confidence 99999976 89888864 2345788899999999999999999 78899999999999999999999999999876
Q ss_pred CCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... .....+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||.+.........+ ......+...
T Consensus 154 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~----~~~~~~~~~~ 227 (309)
T cd07872 154 KSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI----FRLLGTPTEE 227 (309)
T ss_pred cCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HHHhCCCCHH
Confidence 5433221 123467899999998865 46889999999999999999999999754321111111 1111100000
Q ss_pred cc-----------cc-ccccC----CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RA-----------ID-SKLLG----NGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~-----------~d-~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. .+ +.... .........+.+++.+||+.||.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred HHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00 00 00000 0001112347789999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=314.41 Aligned_cols=265 Identities=21% Similarity=0.304 Sum_probs=206.7
Q ss_pred cccccccccccccceeEEEEEeee------CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELP------ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHM 274 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~ 274 (531)
.++|.+.+.||+|+||.||+|.+. ..++..||+|.+...... .....+..|+.+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch---HHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 467788899999999999999752 123457999998753221 2256788999999999 899999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCC
Q 009595 275 VRPDCHLLVSEFMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSS 342 (531)
Q Consensus 275 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 342 (531)
......+++|||+++|+|.+++..... ....+++..+..++.|++.||.||| ++|++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccce
Confidence 999999999999999999999976321 1245788899999999999999999 7789999999999
Q ss_pred eeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccch
Q 009595 343 VLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHT 421 (531)
Q Consensus 343 ILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~ 421 (531)
|+++.++.+||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--- 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--- 244 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---
Confidence 9999999999999999987754433222233456788999999988889999999999999999998 788876532
Q ss_pred hhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 422 EEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 422 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
...+...+. ....... .. .....+.+++.+||+.+|.+|||+.++++.|.++..
T Consensus 245 -~~~~~~~~~---~~~~~~~-------~~---~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 245 -VEELFKLLK---EGHRMDK-------PA---NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred -HHHHHHHHH---cCCcCCC-------CC---CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 122222221 1111110 01 112347889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=315.34 Aligned_cols=268 Identities=21% Similarity=0.241 Sum_probs=194.2
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC---CCCcccccceeEEe----
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI---RHRNIVPLLAHMVR---- 276 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~---- 276 (531)
+|...+.||+|+||.||+|.... +|+.||+|.+........ ....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~-~~~~~aiK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH-SGHFVALKSVRVQTNEDG--LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC-CCcEEEEEEeccCcCCCC--CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 47788999999999999998764 788999999875322110 123344566666554 79999999998764
Q ss_pred -CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 277 -PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 277 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
....+++|||+.+ +|.+++.. .....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|
T Consensus 78 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~d 151 (288)
T cd07863 78 RETKVTLVFEHVDQ-DLRTYLDK--VPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLAD 151 (288)
T ss_pred CCceEEEEEccccc-CHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECc
Confidence 2457899999975 89998875 23355899999999999999999999 77899999999999999999999999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...+.....
T Consensus 152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 152 FGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred cCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 999987654321 12356899999999999889999999999999999999999998654221111111111100000
Q ss_pred cCCCC------cccccc---ccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPN------RAIDSK---LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~------~~~d~~---l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+. ....+. ......+.....+.+++.+||+.||.+|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 000000 0000111223457889999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=307.05 Aligned_cols=259 Identities=23% Similarity=0.368 Sum_probs=204.0
Q ss_pred ccccccccccccceeEEEEEeeeCCC--CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESN--GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
.+|.+.+.||+|+||.||+|.+...+ +..+|+|.+...... .....+..|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE---KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 46778899999999999999875432 347999988753322 2256788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++++|.+++.. ....+++.....++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 81 MIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred EEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccc
Confidence 999999999999999974 2346899999999999999999999 7889999999999999999999999999998
Q ss_pred cCCCCCccce-ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 361 LMPDGHAQVS-TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 361 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
.+........ .....++..|+|||.+.+..++.++|+||||+++||+++ |..||.+... ......+.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~----~~~~~~~~~~~---~ 227 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN----QDVIKAIEEGY---R 227 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH----HHHHHHHhCCC---c
Confidence 7655432211 112233568999999998889999999999999999886 9999865422 12222222111 1
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
+... . .....+.+++.+|++.+|.+|||+.++++.|.++
T Consensus 228 ~~~~------~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 LPAP------M----DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCC------C----CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1100 0 1123478899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=323.31 Aligned_cols=267 Identities=22% Similarity=0.291 Sum_probs=197.3
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC---
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD--- 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 278 (531)
.++|...+.||+|+||.||++.... +|..||||.+....... .....+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTV-LGINVAVKKLSRPFQNQ--THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcC-CCceeEEEEecccccch--hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 4788999999999999999998654 78899999997543221 22566778999999999999999999886543
Q ss_pred ---ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 279 ---CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 279 ---~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
..|+||||+.+ +|.+.+. ..++...+..++.|++.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEec
Confidence 46999999976 6777764 34788889999999999999999 78899999999999999999999999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHH---------
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSL--------- 426 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l--------- 426 (531)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+
T Consensus 167 fg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (359)
T cd07876 167 FGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243 (359)
T ss_pred CCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence 99987653322 123356899999999999989999999999999999999999999754211100000
Q ss_pred ------HHHHHHHhccC--CCCccccc---c-cc---CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 427 ------VRWMRNVMTSE--NPNRAIDS---K-LL---GNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 427 ------~~~~~~~~~~~--~~~~~~d~---~-l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
...+....... .+...... . .. ..........+.+++.+||..||.+|||+.+++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00001100000 00000000 0 00 000001123478899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=311.14 Aligned_cols=255 Identities=23% Similarity=0.298 Sum_probs=198.9
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 284 (531)
|...+.||+|+||+||+|.+.. +++.||+|.+....... ......+..|+.++++++|+||+.+++.+...+..+++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRA-TGKMYACKRLEKKRIKK-RKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECC-CCcEEEEEEeehhhhhh-hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 5677899999999999998764 68899999997543221 112345678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCC
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~ 364 (531)
||+++++|.+++.. .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 80 TIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred EeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 99999999998865 23456999999999999999999999 78899999999999999999999999999876543
Q ss_pred CCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcccc
Q 009595 365 GHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444 (531)
Q Consensus 365 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 444 (531)
.... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ .......... .... ..
T Consensus 155 ~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~-~~~~--~~ 225 (285)
T cd05632 155 GESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLE-TEEV--YS 225 (285)
T ss_pred CCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhc-cccc--cC
Confidence 3221 234689999999999888899999999999999999999999975422111 1111111111 1110 11
Q ss_pred ccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 009595 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-----SKDVRSM 483 (531)
Q Consensus 445 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 483 (531)
.. ....+.+++..||+.||.+||+ +.+++.+
T Consensus 226 -----~~---~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 226 -----AK---FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -----cc---CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11 1123678889999999999999 5555553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=308.93 Aligned_cols=252 Identities=20% Similarity=0.323 Sum_probs=198.6
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||+|+||.||+|.... ++..||+|.+...... .....+..|+.++.+++||||+++++++...+..++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLL-TRRILAVKVIPLDITV---ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcC-CCcEEEEEEEecCCCh---HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 56778899999999999998654 7888999999754321 1245688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++++|..+. .+++.....++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 78 ~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 78 TEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV 146 (279)
T ss_pred EecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence 9999999987542 3678888999999999999999 7889999999999999999999999999998664
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........................+ ..
T Consensus 147 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~- 220 (279)
T cd06619 147 NSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP-VL- 220 (279)
T ss_pred ccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC-CC-
Confidence 332 233578999999999998889999999999999999999999987543222111111111111111111 10
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.... ....+.+++.+||+.||.+||++.+++++
T Consensus 221 ----~~~~---~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 ----PVGQ---FSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ----CCCc---CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0011 12247889999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=304.49 Aligned_cols=251 Identities=19% Similarity=0.282 Sum_probs=195.6
Q ss_pred cccccceeEEEEEeeeCC-CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccC
Q 009595 210 KIRSRASGEIYIAELPES-NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288 (531)
Q Consensus 210 ~ig~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 288 (531)
.||+|+||.||+|.+... ++..||+|.+..... ......+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC---hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence 489999999999977532 455799999875432 122467889999999999999999999875 457899999999
Q ss_pred CCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCcc
Q 009595 289 NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ 368 (531)
Q Consensus 289 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~ 368 (531)
+|+|.+++.. ....+++..+..++.|++.||.||| .++++||||||+||+++.++.+||+|||++.........
T Consensus 78 ~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 78 GGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151 (257)
T ss_pred CCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence 9999999864 2356899999999999999999999 778999999999999999999999999999866443221
Q ss_pred ce-ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCcccccc
Q 009595 369 VS-TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSK 446 (531)
Q Consensus 369 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 446 (531)
.. .....+++.|+|||.+.+..++.++||||||+++|++++ |..||.+... ..+...+.. ...+. .+
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~---~~~~~--~~-- 220 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----PEVMSFIEQ---GKRLD--CP-- 220 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHHHHC---CCCCC--CC--
Confidence 11 112234578999999988889999999999999999996 9999876532 122222211 11111 11
Q ss_pred ccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 447 LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 447 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.. ....+.+++.+||..||++||++.+|.+.|+.+
T Consensus 221 --~~----~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 --AE----CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --CC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11 123477899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=305.08 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=204.3
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|.+.+.||+|++|.||+|... ++..||||.+...... ...+..|+.++++++||||+++++++......+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGTMS-----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc--CCceEEEEEecCCccC-----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 467888999999999999999865 5577999998764432 456888999999999999999999999888999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++++|.+++.. .....+++..+..++.+++.||.||| +++++|+||+|+||+++.++.++|+|||++..
T Consensus 78 ~v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~ 152 (261)
T cd05034 78 IVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARL 152 (261)
T ss_pred EEEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECcccccee
Confidence 99999999999999975 23356899999999999999999999 77899999999999999999999999999887
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
+....... .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+... ......+........+.
T Consensus 153 ~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~~~~~~~~~~~~~ 227 (261)
T cd05034 153 IEDDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN----REVLEQVERGYRMPRPP 227 (261)
T ss_pred ccchhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCCCCC
Confidence 65422111 112234678999999998889999999999999999998 9999865421 22222221111111110
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
. ....+.+++.+||..+|.+||++.++.+.|+.
T Consensus 228 ---------~----~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 ---------N----CPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---------C----CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0 12347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.86 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=198.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEE-eCCceE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMV-RPDCHL 281 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~ 281 (531)
..|...+.||+|+||.||++.. .|..||+|.+..... .+.+..|+.++++++||||+++++++. .....+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~---~~~~~~~k~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDAT------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE---cCCcEEEEEeCCCch------HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 4678889999999999999976 578899999865322 456888999999999999999999765 456789
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
++|||+++++|.+++.. .....+++..+..++.|++.||.||| .++++||||||+||+++.++.+||+|||++..
T Consensus 77 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 77 IVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 151 (256)
T ss_pred EEEECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCcccee
Confidence 99999999999999975 23345889999999999999999999 78899999999999999999999999999886
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
..... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.... ...+...+.. +...
T Consensus 152 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~----~~~~~~~~~~----~~~~ 218 (256)
T cd05082 152 ASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPRVEK----GYKM 218 (256)
T ss_pred ccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHhc----CCCC
Confidence 54322 12334678999999988889999999999999999998 999986431 1222222221 1111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.. .. .....+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 219 ~~------~~---~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 DA------PD---GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CC------CC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 10 01 1123478899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=303.99 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=200.4
Q ss_pred ccccccceeEEEEEeeeCCCCe--EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEec
Q 009595 209 EKIRSRASGEIYIAELPESNGK--MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 286 (531)
+.||+|++|.||+|.+...+++ .||||.+...... ...+.+..|+.++++++||||+++++++.. ...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence 4689999999999988643443 6899999865542 336788999999999999999999999888 889999999
Q ss_pred cCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCC
Q 009595 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH 366 (531)
Q Consensus 287 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~ 366 (531)
+++|+|.+++.... ...+++...+.++.|++.||.||| .++++|+||+|+||+++.++.+||+|||++..+....
T Consensus 77 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 77 APLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred cCCCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccc
Confidence 99999999997622 156899999999999999999999 7889999999999999999999999999998775532
Q ss_pred ccce-ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCcccc
Q 009595 367 AQVS-TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444 (531)
Q Consensus 367 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 444 (531)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..+...... .. .... .
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~---~~-~~~~-~ 222 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----SQILKKIDK---EG-ERLE-R 222 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHh---cC-CcCC-C
Confidence 2211 123457789999999998899999999999999999999 9999865422 112221111 11 0000 0
Q ss_pred ccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 445 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
.. .....+.+++.+||+.+|++|||+.++++.|.+
T Consensus 223 ----~~---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 223 ----PE---ACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred ----Cc---cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 01 112347889999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=322.29 Aligned_cols=262 Identities=21% Similarity=0.274 Sum_probs=197.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC----
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP---- 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 277 (531)
.++|...+.||+|+||.||++.... .++.||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECC-CCcEEEEEEeCccccCc--hhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 4789999999999999999998654 68889999997533221 1245677899999999999999999987543
Q ss_pred --CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 278 --DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 278 --~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
..+|+||||+++ +|.+++. ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEe
Confidence 357999999965 7888774 34788889999999999999999 78899999999999999999999999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... .... +.....
T Consensus 170 fG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~-~~~~~~ 242 (364)
T cd07875 170 FGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNK-VIEQLG 242 (364)
T ss_pred CCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH---HHHH-HHHhcC
Confidence 999986544321 233568999999999999999999999999999999999999997542211 1111 111000
Q ss_pred cC------------------CCCcc---c---ccc-cc---CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SE------------------NPNRA---I---DSK-LL---GNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~------------------~~~~~---~---d~~-l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+ .+... . .+. +. ..........+.+++.+||+.||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00000 0 000 00 00011112357899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=314.74 Aligned_cols=264 Identities=23% Similarity=0.318 Sum_probs=204.7
Q ss_pred cccccccccccccceeEEEEEeee------CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELP------ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHM 274 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~ 274 (531)
.++|.+.+.||+|+||.||+|... ......+|+|.+...... .....+..|+.+++++ +||||+++++++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD---KDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh---HHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 467788999999999999999752 123457899998753322 2256688899999999 699999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCC
Q 009595 275 VRPDCHLLVSEFMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSS 342 (531)
Q Consensus 275 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 342 (531)
......+++|||+++|+|.+++..... ....+++.....++.|++.||.||| ++|++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecccccee
Confidence 998899999999999999999975321 1245889999999999999999999 7889999999999
Q ss_pred eeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccch
Q 009595 343 VLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHT 421 (531)
Q Consensus 343 ILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~ 421 (531)
||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-- 242 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-- 242 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999987654322211122234568999999988889999999999999999999 8889865321
Q ss_pred hhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 422 EEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 422 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..+...+.. +..... .. .....+.+++.+||..||.+|||+.++++.|.++.
T Consensus 243 --~~~~~~~~~----~~~~~~------~~---~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 243 --EELFKLLRE----GHRMDK------PS---NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred --HHHHHHHHc----CCCCCC------CC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 222222221 111100 00 11224778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=305.61 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=203.0
Q ss_pred ccccccccccccceeEEEEEeeeCCC--CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESN--GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
++|+..+.||+|+||.||+|...... ...+|+|.+...... .....+..|+.++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE---KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH---HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 46778899999999999999875422 237999998754322 1256788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.
T Consensus 82 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 82 MIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred EEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccce
Confidence 999999999999999864 2356899999999999999999999 7789999999999999999999999999988
Q ss_pred cCCCCCcccee-cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 361 LMPDGHAQVST-SIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 361 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
........... .....++.|+|||++.+..++.++||||||+++|||++ |+.||..... ..+...+. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~~~~~~i~---~~~~ 228 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HEVMKAIN---DGFR 228 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHHHHh---cCCC
Confidence 76543222111 11223557999999988889999999999999999997 9999865321 22222222 1111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.... . .....+.+++.+||..+|.+||++.+|++.|.++
T Consensus 229 ~~~~------~----~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 LPAP------M----DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCC------C----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1110 0 1123478899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=323.80 Aligned_cols=267 Identities=22% Similarity=0.270 Sum_probs=198.5
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC---
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--- 277 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--- 277 (531)
..++|...+.||+|+||.||++.... .++.||||.+....... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC-CCceEEEEEeCCcccCh--HHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 34789999999999999999997653 68899999997543222 2246677899999999999999999988643
Q ss_pred ---CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe
Q 009595 278 ---DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 278 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
...|+||||+++ +|.+.+. ..+++..+..++.|++.||.||| ++|++||||||+|||++.++.+||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEe
Confidence 346999999976 7877774 34788889999999999999999 7889999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHH------
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR------ 428 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~------ 428 (531)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+............
T Consensus 162 Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 162 DFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred eCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999986544322 2235689999999999998999999999999999999999999975321111100000
Q ss_pred ---------HHHHHhcc-CCCCcccccccc--------CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 429 ---------WMRNVMTS-ENPNRAIDSKLL--------GNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 429 ---------~~~~~~~~-~~~~~~~d~~l~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+...... +.......+... ..........+.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 000000000000 00011123457899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=306.51 Aligned_cols=259 Identities=22% Similarity=0.390 Sum_probs=202.5
Q ss_pred ccccccccccccceeEEEEEeeeCCC--CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESN--GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..|...+.||+|+||.||+|...... +..||||.+..... ......+..|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT---EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC---HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 34677899999999999999876422 23699999875422 22356789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 81 MIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred EEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccc
Confidence 999999999999999864 2356899999999999999999999 7889999999999999999999999999988
Q ss_pred cCCCCCccceecccc---cCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 361 LMPDGHAQVSTSIVA---GTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
............... .+..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+..++......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~~~~~i~~~~~~ 230 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVINAIEQDYRL 230 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HHHHHHHHcCCcC
Confidence 665432221111111 2457999999998899999999999999999886 9999865422 2233332211110
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
+.+ .+....+.+++.+||..+|.+||++.+++..|+.+
T Consensus 231 ~~~-------------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 PPP-------------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCc-------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 100 01123477899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=308.22 Aligned_cols=267 Identities=22% Similarity=0.336 Sum_probs=200.4
Q ss_pred cccccccccccccceeEEEEEee---eCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC-
Q 009595 202 EDCSASLEKIRSRASGEIYIAEL---PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP- 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~- 277 (531)
+..|.+.+.||+|+||.||.+.. ...++..||+|.+...... ....+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE----HLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHH----HHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 35778899999999999999975 2346789999998764432 256788999999999999999999987543
Q ss_pred -CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 278 -DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 278 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
...++||||+++|+|.+++.. ....+++..+..++.|++.||.||| .+|++||||||+||+++.++.+||+||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCC
Confidence 467899999999999999964 2346899999999999999999999 788999999999999999999999999
Q ss_pred CCCccCCCCCccce-ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch--------hhhHHH
Q 009595 357 GLARLMPDGHAQVS-TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHT--------EEKSLV 427 (531)
Q Consensus 357 gla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~--------~~~~l~ 427 (531)
|++........... .....++..|+|||.+.+..++.++||||||+++|||++|..|+......- ......
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05081 153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV 232 (284)
T ss_pred cccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccch
Confidence 99987654432211 111223456999999988889999999999999999999877754321100 000000
Q ss_pred HHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 428 RWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 428 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
..+........... ........+.+++.+||..+|++|||+.+|++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLP---------APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 01111111110000 0011123488899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=323.52 Aligned_cols=258 Identities=19% Similarity=0.278 Sum_probs=198.3
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||++.... +++.||+|++....... ......+.+|+.+++.++||||+++++++......+
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~-~~~~~aiK~i~~~~~~~-~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKS-TRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECC-CCcEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 4788999999999999999998764 78899999997532211 122456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ..++...+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 99999999999999864 35788888999999999999999 78899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLK----FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ... ........
T Consensus 192 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~---~~~i~~~~ 263 (371)
T cd05622 192 MNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGT---YSKIMNHK 263 (371)
T ss_pred cCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----HHH---HHHHHcCC
Confidence 6543221 123467999999999987543 78899999999999999999999975321 111 12222111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEE--RPNSKDVRSML 484 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 484 (531)
......+. ......+.+++..||..++.+ ||++.+++++.
T Consensus 264 ~~~~~~~~-------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 NSLTFPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CcccCCCc-------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11110000 011224677888899844433 77888888864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=309.29 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=200.3
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.... +++.||+|.++...... ...+.+|+.+++.++||||+++++++...+..+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~----~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVN-TGELAAIKVIKLEPGED----FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcC-CCcEEEEEEEecCchhH----HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 4578889999999999999998754 68899999987643222 455778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++++|.+++.. ...+++.....++.|++.||.||| ..+++|+||||+||+++.++.++|+|||++..
T Consensus 83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 83 ICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred EEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 99999999999999865 457899999999999999999999 77899999999999999999999999999876
Q ss_pred CCCCCccceecccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQ---TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
...... ......|++.|+|||.+. ...++.++|+|||||++|+|++|..||....+. ..+...... ...
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~---~~~~~~~~~---~~~ 227 (267)
T cd06645 156 ITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM---RALFLMTKS---NFQ 227 (267)
T ss_pred ccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch---hhHHhhhcc---CCC
Confidence 543321 123456899999999874 446889999999999999999999998543221 111111110 000
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+....+ ...+ ...+.+++.+||..||++|||+.+++++
T Consensus 228 ~~~~~~----~~~~---~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 228 PPKLKD----KMKW---SNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCcccc----cCCC---CHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 110000 0011 1247789999999999999999998875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.39 Aligned_cols=255 Identities=21% Similarity=0.302 Sum_probs=199.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
++.|+..+.||.|+||.||+|.... ++..+++|.+...... ....+..|+.+++.++||||+++++++......+
T Consensus 4 ~~~~~i~~~lg~g~~g~v~~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 78 (282)
T cd06643 4 EEFWEIIGELGDGAFGKVYKAQNKE-TGVLAAAKVIDTKSEE----ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 78 (282)
T ss_pred HHHHHHHhhcccCCCeEEEEEEECC-CCeEEEEEEeCCCCHH----HHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEE
Confidence 3446778899999999999998754 6788999998654322 2567888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|..++.. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 79 ~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 79 ILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccc
Confidence 99999999999998763 2356899999999999999999999 77899999999999999999999999999876
Q ss_pred CCCCCccceecccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQ-----TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
...... ......|++.|+|||++. +..++.++|||||||++|+|++|+.||..... ....... ...
T Consensus 153 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~----~~~ 223 (282)
T cd06643 153 NTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKI----AKS 223 (282)
T ss_pred cccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHH----hhc
Confidence 543321 112356899999999874 34577899999999999999999999875422 1111111 111
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
..+... .+ .. ....+.+++.+||+.||.+|||+.+++++-
T Consensus 224 ~~~~~~-~~----~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 224 EPPTLA-QP----SR---WSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred CCCCCC-Cc----cc---cCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 111111 11 11 123478899999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.47 Aligned_cols=261 Identities=21% Similarity=0.303 Sum_probs=202.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|+||.||++.... ++..||+|.+...... .....+.+|+.++.+++||||+++++++..++.+++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP-SGLIMARKLIHLEIKP---AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC-CCeEEEEEEeccccCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 357889999999999999998764 6888999998754321 225668889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|.+++.. ...+++.....++.|+++||.|||+ ..+++|+||||+|||++.++.++|+|||++...
T Consensus 77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (308)
T cd06615 77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 150 (308)
T ss_pred EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence 9999999999999975 3568999999999999999999994 258999999999999999999999999998765
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
.... .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... .....+.............
T Consensus 151 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~ 222 (308)
T cd06615 151 IDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKES 222 (308)
T ss_pred cccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch----hhHHHhhcCccccccccCC
Confidence 4332 1235689999999999888899999999999999999999999864321 1111111110000000000
Q ss_pred ---------------------------ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 443 ---------------------------IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 443 ---------------------------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
..+.+... .....+.+++.+||..||++|||+.+++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSG---AFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cccccCCCCCccchhhHHHHHHHHhcCCCccCcCc---ccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000 0123478899999999999999999998873
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=317.30 Aligned_cols=244 Identities=21% Similarity=0.249 Sum_probs=193.0
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCceEEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv 283 (531)
|+..+.||+|+||.||+|.... +|+.||+|++....... ......+..|..++..+. ||+|+++++++...+..|+|
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 6678899999999999998754 78899999997532211 122456778888988885 57788899999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++|+|.+++.. ...+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++....
T Consensus 80 ~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 80 MEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 999999999999865 456899999999999999999999 7789999999999999999999999999987543
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ..+...+.. .. .. .
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~~---~~-~~--~ 220 (323)
T cd05615 153 VDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DELFQSIME---HN-VS--Y 220 (323)
T ss_pred CCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHh---CC-CC--C
Confidence 3221 12345689999999999988899999999999999999999999976422 222222111 11 10 0
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS 477 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 477 (531)
+ .. ....+.+++.+||+.||.+|++.
T Consensus 221 -p---~~----~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 -P---KS----LSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -C---cc----CCHHHHHHHHHHcccCHhhCCCC
Confidence 0 01 11247788999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=307.94 Aligned_cols=254 Identities=21% Similarity=0.347 Sum_probs=198.6
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeC--
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRP-- 277 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~-- 277 (531)
+++.|...+.||.|+||.||+|.... +++.||+|.+...... ...+..|+.++.++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~~aik~~~~~~~~-----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTGDE-----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcC-CCcEEEEEEEEcCCcc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 56778889999999999999998764 6889999999754322 34577899999998 799999999998753
Q ss_pred ----CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEE
Q 009595 278 ----DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARI 353 (531)
Q Consensus 278 ----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL 353 (531)
...+++|||+.+|+|.+++.. .....+++..+..++.|++.||.||| .++++|+||+|+||+++.++.++|
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l 152 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKL 152 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEE
Confidence 357899999999999999975 23456889999999999999999999 678999999999999999999999
Q ss_pred eecCCCccCCCCCccceecccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHH
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ-----TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR 428 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~ 428 (531)
+|||++......... .....|++.|+|||++. +..++.++|||||||++|||++|+.||.+.......
T Consensus 153 ~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~----- 225 (272)
T cd06637 153 VDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----- 225 (272)
T ss_pred ccCCCceeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----
Confidence 999998865433221 23356899999999886 335788999999999999999999998654221111
Q ss_pred HHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 429 WMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 429 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. ..... ..... ... ....+.+++.+||..||.+|||+.+++.+
T Consensus 226 -~~-~~~~~-~~~~~-----~~~---~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 226 -FL-IPRNP-APRLK-----SKK---WSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -HH-HhcCC-CCCCC-----CCC---cCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 01111 11100 111 12247889999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=302.64 Aligned_cols=250 Identities=28% Similarity=0.427 Sum_probs=203.5
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|...+.||+|++|.||+|.. .|+.||+|.+..... ..+++..|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~---~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY---RGQKVAVKCLKDDST-----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred hhccceeeeecCCCceEEEEEe---cCcEEEEEEeccchh-----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 5677889999999999999986 588899999976443 25678899999999999999999999998899999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|.+++.. .....+++.....++.|++.||.||| ..+++|+||||+||+++.++.++|+|||.++..
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 78 VTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEA 152 (256)
T ss_pred EEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccc
Confidence 9999999999999975 22346899999999999999999999 788999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
..... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..+...+.. .....
T Consensus 153 ~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~----~~~~~ 219 (256)
T cd05039 153 SQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPHVEK----GYRME 219 (256)
T ss_pred ccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHhc----CCCCC
Confidence 43321 2234668999999988889999999999999999997 9999865421 222222211 11110
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
. . . .....+.+++.+||..+|.+|||+.++++.|+.+
T Consensus 220 ~-~-----~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 A-P-----E---GCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred C-c-----c---CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0 0 0 1123478899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=303.54 Aligned_cols=252 Identities=20% Similarity=0.305 Sum_probs=201.5
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||.|+||.||++.... ++..||+|.++..... ...+.+..|+.+++.++||||+++++++...+..+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN-SDQKYAMKEIRLPKSS---SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC-CCceEEEEEEEcCcch---HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 36778999999999999998764 6888999998753322 1256778899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++|+|.+++.. .....++......++.|++.||.||| +++++|+||||+||+++.++.++|+|||++....
T Consensus 77 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 77 MEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT 151 (255)
T ss_pred EeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeec
Confidence 999999999999864 23456789999999999999999999 7889999999999999999999999999988665
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
..... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||..... .... ......... . +
T Consensus 152 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~~~~---~~~~~~~~~-~-~ 220 (255)
T cd08219 152 SPGAY--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW----KNLI---LKVCQGSYK-P-L 220 (255)
T ss_pred ccccc--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH----HHHH---HHHhcCCCC-C-C
Confidence 43221 1235689999999999888899999999999999999999999865321 1111 111111111 0 0
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. .. ....+.+++.+||+.||.+|||+.+++..
T Consensus 221 ~-----~~---~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 P-----SH---YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred C-----cc---cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 11 11247789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=311.46 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=202.8
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
....|+..+.||+|++|.||+|.... +++.|++|.+....... ...+..|+.+++.++||||+++++.+......
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~v~ik~~~~~~~~~----~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQPK----KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECC-CCcEEEEEEEecCCcch----HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 45688899999999999999997643 78899999997644332 45678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++++|.+++.. ..+++.....++.|++.||.||| ..+++||||||+||+++.++.++|+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred EEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccch
Confidence 999999999999999864 45788899999999999999999 7789999999999999999999999999988
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
........ .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+ ...+.... ..+.+.
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~---~~~~~~~~----~~~~~~ 235 (296)
T cd06654 165 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIA----TNGTPE 235 (296)
T ss_pred hccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH---HHhHHHHh----cCCCCC
Confidence 65433211 1234688999999999888899999999999999999999999865322 11111111 111111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. . .......+.+++.+||..||.+|||+.+++++
T Consensus 236 ~~-~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 LQ-N-------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CC-C-------ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00 0 11122347889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=344.11 Aligned_cols=263 Identities=19% Similarity=0.286 Sum_probs=202.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--Cc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--DC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~ 279 (531)
.+.|.+++.||.|+||+||+|.... ++..||+|.+....... .....+..|+.++.+++|||||+++++|... ..
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~-tg~~vAlKvIk~~~l~e--~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKR-TQEFFCWKAISYRGLKE--REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC-CCeEEEEEEEeccccCH--HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3678999999999999999998764 68889999987543222 2256788999999999999999999988653 56
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEeeccCCCCeeeCC--------
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH----RPRIIHRNITPSSVLIDD-------- 347 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----~~~ivH~Dlkp~NILl~~-------- 347 (531)
+||||||+++|+|.++|.........+++..++.|+.||+.||.|||+.+ ..+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999764444467999999999999999999999532 156999999999999964
Q ss_pred ---------CCCEEEeecCCCccCCCCCccceecccccCccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009595 348 ---------DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT--LKFSEKCDIYSFGVLLAVLVMGKLPSDD 416 (531)
Q Consensus 348 ---------~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~P~~~ 416 (531)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||+|+|+||+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 23589999999987644322 123578999999999864 3588999999999999999999999964
Q ss_pred cccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccC
Q 009595 417 FFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS--MLSDT 487 (531)
Q Consensus 417 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 487 (531)
.. ....+.. .....+... + ... ...+.+|+..||..+|.+|||+.+++. .+..+
T Consensus 246 ~~---~~~qli~---~lk~~p~lp--i-----~~~----S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 246 AN---NFSQLIS---ELKRGPDLP--I-----KGK----SKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CC---cHHHHHH---HHhcCCCCC--c-----CCC----CHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 32 1112222 111111110 0 011 124788999999999999999999984 45444
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=322.32 Aligned_cols=263 Identities=21% Similarity=0.284 Sum_probs=214.8
Q ss_pred hhhhhhcccccccccccccceeEEEEEeeeCCCCe--EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCccccccee
Q 009595 196 LAFLEKEDCSASLEKIRSRASGEIYIAELPESNGK--MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH 273 (531)
Q Consensus 196 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~ 273 (531)
+..+..++.....++||+|.||.|++|.|...+|+ .||||+++...... ....|.+|+.+|.+|+|||+++|||+
T Consensus 103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~---~mddflrEas~M~~L~H~hliRLyGv 179 (1039)
T KOG0199|consen 103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA---IMDDFLREASHMLKLQHPHLIRLYGV 179 (1039)
T ss_pred cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch---hHHHHHHHHHHHHhccCcceeEEeee
Confidence 34455666677889999999999999999887776 58999998765543 47899999999999999999999998
Q ss_pred EEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEE
Q 009595 274 MVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARI 353 (531)
Q Consensus 274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL 353 (531)
..+ ....+|||+++.|||.+.|+. .....+.......++.|||.||.||. .+++|||||...|+|+.....|||
T Consensus 180 Vl~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI 253 (1039)
T KOG0199|consen 180 VLD-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKI 253 (1039)
T ss_pred ecc-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeee
Confidence 877 677899999999999999986 55677888999999999999999999 778999999999999999999999
Q ss_pred eecCCCccCCCCCccceec-ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHH
Q 009595 354 ADFGLARLMPDGHAQVSTS-IVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMR 431 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~ 431 (531)
+||||.+.+......+.+. ...-...|+|||.+....|+.++|||+|||++|||.| |..||.+... .++...+-
T Consensus 254 ~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----~qIL~~iD 329 (1039)
T KOG0199|consen 254 CDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----IQILKNID 329 (1039)
T ss_pred ecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----HHHHHhcc
Confidence 9999999988766554433 2334668999999999999999999999999999999 8899887643 22221111
Q ss_pred HHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 432 NVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 432 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
...+.. ......+.+++++..||..+|.+|||+..|.+.+
T Consensus 330 ---~~erLp----------RPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 ---AGERLP----------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ---ccccCC----------CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 111111 1112234589999999999999999999997433
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=305.53 Aligned_cols=257 Identities=19% Similarity=0.300 Sum_probs=188.6
Q ss_pred cccccceeEEEEEeeeCC-CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccC
Q 009595 210 KIRSRASGEIYIAELPES-NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288 (531)
Q Consensus 210 ~ig~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 288 (531)
.||+|+||.||+|..... ....+++|.+...... .....+.+|+.+++.++||||+++++++......++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS---KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh---HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 699999999999975421 2234667766543321 225678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCcc
Q 009595 289 NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ 368 (531)
Q Consensus 289 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~ 368 (531)
+|+|.+++..........+......++.|++.||.||| +.+++||||||+|||++.++.++|+|||++.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 99999999764333445677788899999999999999 678999999999999999999999999998643322211
Q ss_pred ceecccccCccccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 369 VSTSIVAGTVGYIAPEYHQT-------LKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 369 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
.......|+..|+|||++.. ..++.++||||||+++|||++ |..||..... ...... ..... ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~~~---~~~~~-~~ 227 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD----REVLNH---VIKDQ-QV 227 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH---HHhhc-cc
Confidence 22234567899999998743 245789999999999999997 5678765322 111111 11111 11
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
...++.+... + ...+.+++..|| .+|.+|||+.+|++.|.
T Consensus 228 ~~~~~~~~~~-~---~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQLELP-Y---SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCccCCC-C---cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1122222111 1 123666778899 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.85 Aligned_cols=193 Identities=23% Similarity=0.324 Sum_probs=165.2
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
...+|.+.+.||+|+||.||+|.... ++..||+|..... ....|+.++++++||||+++++++......
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPG-QPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECC-CCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence 45679999999999999999998764 6778999975432 224589999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+. ++|.+++.. ....+++..+..++.||+.||.||| .++|+||||||+|||++.++.+||+|||+++
T Consensus 133 ~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 205 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205 (357)
T ss_pred EEEEEccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccc
Confidence 99999995 589998864 2456899999999999999999999 7789999999999999999999999999987
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPS 414 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~ 414 (531)
...... ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 206 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 206 FPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 543221 112356899999999999999999999999999999999865553
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=308.12 Aligned_cols=259 Identities=23% Similarity=0.367 Sum_probs=207.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|+..+.||+|+||+||++.... +|+.||+|++...... .....+..|+.+++.++||||+++++++.....+++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIP-TGTVMAKKVVHIGAKS---SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcC-CCcEEEEEEEEecCcc---hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 567888999999999999998753 6889999998754321 225678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|.+++.. .+.+++.....++.+++.||.|||+ ..+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 81 CMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred EEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 9999999999999865 3568999999999999999999995 357999999999999999999999999998755
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc----hhhhHHHHHHHHHhccCC
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQH----TEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~----~~~~~l~~~~~~~~~~~~ 438 (531)
.... .....|+..|+|||++.+..++.++|+|||||++|+|+||+.||...... .....+..++........
T Consensus 155 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd06620 155 INSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP 230 (284)
T ss_pred hhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC
Confidence 3322 12356899999999998888999999999999999999999999764332 122233344443332221
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
+... .. .....+.+++.+||..||.+|||+.+++++.
T Consensus 231 ~~~~------~~---~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 PRLP------SS---DFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCC------ch---hcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1110 01 1223478899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=306.41 Aligned_cols=257 Identities=21% Similarity=0.320 Sum_probs=188.1
Q ss_pred cccccceeEEEEEeeeC-CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccC
Q 009595 210 KIRSRASGEIYIAELPE-SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288 (531)
Q Consensus 210 ~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 288 (531)
.||+|+||.||+|.... .....+++|.+..... ......+.+|+.+++.++||||+++++++......++||||++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT---PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCC---hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 69999999999997532 2345688888764332 2224668889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 289 NGSLLEILNDVSQG-RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 289 ~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
+|+|.+++...... ....++.....++.|++.||.||| +++++||||||+|||++.++++||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 99999999763321 233567788899999999999999 77899999999999999999999999999875433222
Q ss_pred cceecccccCccccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 368 QVSTSIVAGTVGYIAPEYHQT-------LKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
........+++.|+|||++.. ..++.++|||||||++|||++ |..||..... ..... .......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~~---~~~~~~~- 227 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD----EQVLK---QVVREQD- 227 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHH---HHhhccC-
Confidence 112223446778999998642 356889999999999999999 7888865422 11111 1111111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
.....+.+... . ...+..++..|| .||.+|||+.+|++.|.
T Consensus 228 ~~~~~~~~~~~-~---~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 IKLPKPQLDLK-Y---SDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCCCccccc-C---CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111111111 1 123556677788 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=301.25 Aligned_cols=256 Identities=26% Similarity=0.410 Sum_probs=204.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||.|+||.||+|.... +++.+++|.+...... ....+.+|+.++++++||||+++++++.....++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIA-TGELVAIKVIKLEPGD----DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecC-CCCEEEEEEEEcCchh----hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence 4678889999999999999998754 6778999999865433 2577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
++|||+++++|.+++.. ....+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++..
T Consensus 77 l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 77 IVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred EEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchh
Confidence 99999999999999865 2256889999999999999999999 77899999999999999999999999999887
Q ss_pred CCCCCccceecccccCccccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTL---KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
...... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.... ........... .
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~---~~~~~~~~~~~---~ 222 (262)
T cd06613 151 LTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM---RALFLISKSNF---P 222 (262)
T ss_pred hhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccC---C
Confidence 654321 11235688899999998776 7899999999999999999999998764321 11111111100 0
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+... .........+.+++.+||..||.+|||+.+++.+
T Consensus 223 ~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 223 PPKL-------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred Cccc-------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1000 0112233458889999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=303.10 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=202.5
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...++||+|+||.||+|... .+..+|+|.+..... ....+.+|+.++++++|+||+++++++.. ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec--CCccEEEEecCCChh-----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 467888999999999999999764 566799998875322 14678889999999999999999998877 7789
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
++|||+++|+|.+++.. .....+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.+||+|||++..
T Consensus 77 ~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 151 (260)
T cd05073 77 IITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARV 151 (260)
T ss_pred EEEEeCCCCcHHHHHHh--CCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceee
Confidence 99999999999999975 23456788899999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... ......++..|+|||.+.+..++.++|+||||+++|+++| |..||..... ..+...+.. +...
T Consensus 152 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~~~----~~~~ 222 (260)
T cd05073 152 IEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRALER----GYRM 222 (260)
T ss_pred ccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHhC----CCCC
Confidence 6543221 1122345678999999988889999999999999999999 9999875422 222222221 1111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
... ......+.+++.+||+.+|.+||++.++.+.|+.+
T Consensus 223 ~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 223 PRP---------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCc---------ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 000 11123478899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=318.30 Aligned_cols=259 Identities=20% Similarity=0.252 Sum_probs=195.4
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.+.||+|+||.||++.... +++.||+|++...... .......+..|+.++..++||||+++++++...+..|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN-TGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence 368889999999999999998764 6889999999753211 12225668889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ....+++..+..++.||+.||.||| +++++||||||+|||++.++.+||+|||++..+
T Consensus 79 v~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 79 VMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred EEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 9999999999999964 2356889999999999999999999 788999999999999999999999999998766
Q ss_pred CCCCccceecccccCccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQT-----LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
...... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+... ... ........
T Consensus 153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~----~~~---~~~i~~~~ 224 (331)
T cd05597 153 LADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VET---YGKIMNHK 224 (331)
T ss_pred CCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH----HHH---HHHHHcCC
Confidence 543221 1123568999999999863 3578899999999999999999999865321 111 11111111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHH
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLD--DPEERPNSKDVRSM 483 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~ 483 (531)
... .+.+. ... ....+.+++.+|+.. ++..||++.+++++
T Consensus 225 ~~~-~~~~~-~~~----~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 225 EHF-QFPPD-VTD----VSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred Ccc-cCCCc-cCC----CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 000 01100 011 122356666666644 34448899998887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=307.42 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=200.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|.+++.||.|+||.||+|.... ++..|++|.+...... ....+..|+.+++.++||||+++++++......
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKE-TGALAAAKVIETKSEE----ELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL 84 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECC-CCceEEEEEeccCCHH----HHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence 45778999999999999999998754 6889999999764322 256788899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++++|..++.+ ....+++..+..++.|++.||.||| ..+++||||+|+||+++.++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred EEEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccce
Confidence 999999999999988754 2356899999999999999999999 7889999999999999999999999999987
Q ss_pred cCCCCCccceecccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQ-----TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
........ .....+++.|+|||++. ...++.++|||||||++|+|++|..||..... .. .+.....
T Consensus 159 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~----~~~~~~~ 229 (292)
T cd06644 159 KNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MR----VLLKIAK 229 (292)
T ss_pred eccccccc--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HH----HHHHHhc
Confidence 64332211 12346789999999885 34568899999999999999999999865422 11 1111111
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+..... . .....+.+++.+||..||.+||++.+++++
T Consensus 230 ~~~~~~~~~-----~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 230 SEPPTLSQP-----S---KWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCCccCCCC-----c---ccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111111111 0 111247788999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=325.87 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=205.7
Q ss_pred hcccc-cccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 201 KEDCS-ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 201 ~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
+.++| ...+.||+|+|-+||+|.+. .+|-.||--.++...........++|..|+.+|+.|+||||+++|.++.+...
T Consensus 37 p~gRy~k~~evLGrGafKtVYka~De-~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n 115 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKAFDE-EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN 115 (632)
T ss_pred CCCceeehhhhcccccceeeeecccc-ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence 34444 44678999999999999764 47877876555543333334447899999999999999999999999987654
Q ss_pred --eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC-CCEEEeec
Q 009595 280 --HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD-MEARIADF 356 (531)
Q Consensus 280 --~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkL~Df 356 (531)
..+|+|.+..|+|..|+.+ .+.++......|++||+.||.|||+. .++|||||||.+||+|+++ |.|||+|+
T Consensus 116 ~~in~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDL 190 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDL 190 (632)
T ss_pred ceeeeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecch
Confidence 7789999999999999987 56788889999999999999999986 6899999999999999875 89999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
|||.....+.. ....|||.|||||... ..|++.+||||||++++||+|+..||.... ...+++..+......
T Consensus 191 GLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~---n~AQIYKKV~SGiKP 262 (632)
T KOG0584|consen 191 GLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT---NPAQIYKKVTSGIKP 262 (632)
T ss_pred hHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC---CHHHHHHHHHcCCCH
Confidence 99998766543 2368999999999987 689999999999999999999999998763 234444443332222
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
......-|| .+.++|.+|+.. .++|||+.|++.+
T Consensus 263 ~sl~kV~dP------------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 263 AALSKVKDP------------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHhhccCCH------------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 222222222 388899999999 9999999999873
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=312.76 Aligned_cols=265 Identities=17% Similarity=0.239 Sum_probs=198.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
-+.|...+.||.|+||.||+|.... ++..||+|.+........ ...+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~vaiK~~~~~~~~~~---~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKL-TDNLVALKEIRLEHEEGA---PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcC-CCcEEEEEEEecccccCc---hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 3678899999999999999998754 678899999975432211 345678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++ +|.+++.. ....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 153 (301)
T cd07873 81 LVFEYLDK-DLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA 153 (301)
T ss_pred EEEecccc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence 99999974 99998864 2346889999999999999999999 78899999999999999999999999999876
Q ss_pred CCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... .....+++.|+|||.+.+. .++.++||||||+++|+|+||+.||..... ......+..........
T Consensus 154 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~----~~~~~~~~~~~~~~~~~ 227 (301)
T cd07873 154 KSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV----EEQLHFIFRILGTPTEE 227 (301)
T ss_pred cCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCChh
Confidence 5433211 1234578899999987654 578899999999999999999999875422 11111111111111000
Q ss_pred c---cc---------cccccCC----CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 R---AI---------DSKLLGN----GYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~---~~---------d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. .. .+..... ........+.+++.+||+.||.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 228 TWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 00 0000000 000112347789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=305.59 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=200.5
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchh-----hhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSL-----LNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
|.....||.|++|.||+|.... +++.||+|.+....... .......+..|+.++++++||||+++++++.....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNAS-SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred ccccceeecCCCeEEEEEEecC-CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5667899999999999998654 67889999886543321 12234678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.+++|||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999975 356888899999999999999999 778999999999999999999999999999
Q ss_pred ccCCCCCcc----ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 360 RLMPDGHAQ----VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 360 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
+........ .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.+... ...+. ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~----~~~~ 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIF----KIGE 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHHHH----HHhc
Confidence 876532111 111234578999999999988899999999999999999999999976421 11111 1111
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+. +.. .....+.+++.+||+.||.+||++.+++++
T Consensus 227 ~~~~~------~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 NASPE------IPS----NISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cCCCc------CCc----ccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 11110 101 112347888999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=309.17 Aligned_cols=259 Identities=24% Similarity=0.301 Sum_probs=199.5
Q ss_pred ccccccccccccceeEEEEEeeeCCCCe--EEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCc
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGK--MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 279 (531)
++|.+.+.||+|+||.||+|.... ++. .+++|.++..... ...+.+..|+.++.++ +||||+++++++...+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~~~ik~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKK-DGLKMNAAIKMLKEFASE---NDHRDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecC-CCCcceeEEEEccccCCH---HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 467888999999999999998754 333 4788888743221 1256688899999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~ 347 (531)
.+++|||+++|+|.+++..... ....+++..+..++.|++.||.||| +++++||||||+|||++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~ 154 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGE 154 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECC
Confidence 9999999999999999965221 1135889999999999999999999 788999999999999999
Q ss_pred CCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHH
Q 009595 348 DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSL 426 (531)
Q Consensus 348 ~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l 426 (531)
++.+||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+
T Consensus 155 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~----~~~ 227 (297)
T cd05089 155 NLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC----AEL 227 (297)
T ss_pred CCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHH
Confidence 9999999999986432211 1111223557999999988889999999999999999997 9999865432 122
Q ss_pred HHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 427 VRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 427 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
... ......+. . +.. ....+.+++.+||..+|.+|||+.++++.|..+.
T Consensus 228 ~~~---~~~~~~~~--~-----~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 228 YEK---LPQGYRME--K-----PRN---CDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HHH---HhcCCCCC--C-----CCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 221 11111110 0 011 1124788999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=301.51 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=200.4
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
..|+..+.||.|+||.||+|.+. ++..+|+|.+...... ...+..|+.++++++||||+++++++......++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREGAMS-----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe--CCCeEEEEECCCCCCC-----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 35677899999999999999875 4778999998754332 3457889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|.+++.. ....+++..+..++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 77 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 150 (256)
T cd05112 77 VFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV 150 (256)
T ss_pred EEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeec
Confidence 9999999999999864 2345789999999999999999999 778999999999999999999999999998866
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
........ ....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+...+... ...
T Consensus 151 ~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~---~~~-- 220 (256)
T cd05112 151 LDDQYTSS-TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN----SEVVETINAG---FRL-- 220 (256)
T ss_pred ccCccccc-CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHHhCC---CCC--
Confidence 44322111 12335678999999988889999999999999999998 9999865321 2222222111 011
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
..+.. ....+.+++.+||+.+|.+|||+.++++.|.
T Consensus 221 -~~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 221 -YKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11111 1135888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=307.57 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=202.5
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
+.++|.+.+.||.|++|.||+|.... ++..||+|.+...... ....+..|+.++++++||||+++++++......
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKE-TGLFAAAKIIQIESEE----ELEDFMVEIDILSECKHPNIVGLYEAYFYENKL 77 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcC-CCcEEEEEEEeeCCHH----HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeE
Confidence 34678999999999999999998764 6889999999754332 256788899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 78 WILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred EEEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccch
Confidence 999999999999999864 2356899999999999999999999 7789999999999999999999999999987
Q ss_pred cCCCCCccceecccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQ-----TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
........ .....|++.|+|||.+. +..++.++|+||||+++|+|++|+.||..... ...+ .....
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~~~~----~~~~~ 222 (280)
T cd06611 152 KNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---MRVL----LKILK 222 (280)
T ss_pred hhcccccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---HHHH----HHHhc
Confidence 65433221 12356899999999875 34567899999999999999999999876422 1111 11111
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+..... .. ....+.+++..||+.||.+|||+.+++++
T Consensus 223 ~~~~~~~~~-----~~---~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 223 SEPPTLDQP-----SK---WSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCCCcCCc-----cc---CCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111111110 11 11247788999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=304.89 Aligned_cols=259 Identities=21% Similarity=0.336 Sum_probs=204.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCe----EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGK----MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
.+.|...+.||+|+||.||+|.+.. +|. .+|+|.+..... ......+.+|+.++.+++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIP-EGEKVKIPVAIKVLREETS---PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEec-CCCCcceEEEEEeccCCCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 3567888999999999999998753 333 689998875433 2235678899999999999999999999887
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
...++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg 154 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFG 154 (279)
T ss_pred CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCc
Confidence 788999999999999999974 2345899999999999999999999 6889999999999999999999999999
Q ss_pred CCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 358 LARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 358 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
++................++..|+|||.+....++.++|+||||+++||+++ |+.||.+... ..+...+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~---~ 227 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----VEIPDLLEK---G 227 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----HHHHHHHhC---C
Confidence 9987654332222222234568999999988889999999999999999999 9999876432 222222221 1
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..... +.. ....+.+++.+||..||..|||+.++++.|.++.
T Consensus 228 ~~~~~---~~~-------~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 228 ERLPQ---PPI-------CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CCCCC---CCC-------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11100 000 1123778889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=300.73 Aligned_cols=258 Identities=20% Similarity=0.328 Sum_probs=205.8
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe--CCceE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR--PDCHL 281 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~ 281 (531)
+|...+.||.|+||.||++.... ++..||+|.+...... ......+..|+.++++++||||+++++++.. ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS-DGKILVWKEIDYGNMT--EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC-CCCEEEEEEEecccCC--HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 36778899999999999998764 7888999998754332 2235678889999999999999999998764 34678
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH--RPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
++|||+++++|.+++.........+++..++.++.+++.||.|||..+ ..+++|+||+|+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999999765445577999999999999999999999554 678999999999999999999999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
.......... ....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... ...+...+.. +..
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~----~~~ 227 (265)
T cd08217 158 KILGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN----QLQLASKIKE----GKF 227 (265)
T ss_pred ccccCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----HHHHHHHHhc----CCC
Confidence 8776543211 23468999999999988889999999999999999999999987542 1222222211 111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. .+ .......+.+++.+|+..+|.+|||+.+|+++
T Consensus 228 ~-~~--------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 R-RI--------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred C-CC--------ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 01 11122358889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=298.28 Aligned_cols=248 Identities=22% Similarity=0.309 Sum_probs=196.0
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccC
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 288 (531)
+.||+|+||.||+|... ++..||+|.+....... ....+..|+.++++++||||+++++++...+..++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDLPQE---LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEec--CCcEEEEEecCCcCCHH---HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence 36999999999999864 67889999987543221 24468889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCcc
Q 009595 289 NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ 368 (531)
Q Consensus 289 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~ 368 (531)
+++|.+++.. ....+++..+..++.+++.||.||| .++++||||+|+||+++.++.+||+|||++.........
T Consensus 76 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 76 GGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence 9999999864 2345789999999999999999999 788999999999999999999999999998765433221
Q ss_pred ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 369 VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 369 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
. .....+++.|+|||++.+..++.++||||||+++|++++ |..||.+.... .....+. .+.... ..
T Consensus 150 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~~~~~----~~~~~~-~~--- 216 (250)
T cd05085 150 S-SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QAREQVE----KGYRMS-CP--- 216 (250)
T ss_pred c-CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHHHH----cCCCCC-CC---
Confidence 1 122334678999999988889999999999999999998 99998754221 1111111 111110 00
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
. .....+.+++.+||..+|.+|||+.++++.|.
T Consensus 217 --~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 --Q---KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --C---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0 11234888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=308.74 Aligned_cols=267 Identities=23% Similarity=0.273 Sum_probs=197.9
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||+|++|.||+|.... ++..||+|.+....... .....+..|+.++++++||||+++++++..+...++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK-TGQIVAMKKIRLESEEE--GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECC-CCcEEEEEEeccccccC--CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence 36778999999999999998754 68899999986533221 1245677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||++ ++|.+++..... ...+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++....
T Consensus 78 ~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred EecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 99997 589998865322 356899999999999999999999 7889999999999999999999999999987654
Q ss_pred CCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC---CC
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE---NP 439 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~---~~ 439 (531)
.... ......+++.|+|||.+.+. .++.++||||||+++|+|+||+.||.+.... .............. .+
T Consensus 153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd07861 153 IPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI---DQLFRIFRILGTPTEDVWP 227 (285)
T ss_pred CCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhCCCChhhhh
Confidence 3221 11234578899999988654 5789999999999999999999998754221 11111111110000 00
Q ss_pred --Cc---------cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 440 --NR---------AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 440 --~~---------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. .................+.+++.+||..||.+|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 228 GVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred cchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00 000000000000112346789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=307.00 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=201.7
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|...+.||+|+||.||+|.... ++..||+|.+...... .....+..|+.++++++||||+++++++......++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR-TKEVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC-CCeEEEEEEeccccch---HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 456778899999999999998654 6889999998754322 225678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|.+++.. ..+++..+..++.|++.||.||| .++++|+||+|+||+++.++.++|+|||++..+
T Consensus 80 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 80 IMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred EEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccc
Confidence 9999999999999853 46889999999999999999999 788999999999999999999999999998876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
..... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.+..+.. .. ........+
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~---~~~~~~~~~--- 219 (277)
T cd06642 152 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----VL---FLIPKNSPP--- 219 (277)
T ss_pred cCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----HH---hhhhcCCCC---
Confidence 54322 1123467899999999998889999999999999999999999987543211 11 111111111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+. ......+.+++.+||+.+|.+|||+.+++++
T Consensus 220 ---~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 ---TLE----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---CCC----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 010 1122347889999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=308.16 Aligned_cols=252 Identities=24% Similarity=0.385 Sum_probs=201.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
..+|+..+.||.|++|.||+|.... +|+.|++|.+....... ...+.+|+.+++.++||||+++++++...+..+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~v~iK~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVA-TGQEVAIKQINLQKQPK----KELIINEILVMKELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcC-CCcEEEEEEEecccCch----HHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence 4568999999999999999997644 78899999997543322 456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+|+||+++++|.+++.. ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 93 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 93 VVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred EEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchh
Confidence 99999999999999864 45899999999999999999999 77899999999999999999999999999886
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
....... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ..... + .....+..
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~---~~~~~-~---~~~~~~~~ 235 (296)
T cd06655 165 ITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYL-I---ATNGTPEL 235 (296)
T ss_pred ccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-H---HhcCCccc
Confidence 5443221 12346889999999999888999999999999999999999998654221 11111 1 11111110
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..+ ......+.+++.+||..||.+|||+.+++++
T Consensus 236 -~~~-------~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 -QNP-------EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -CCc-------ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000 1112247788999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=314.66 Aligned_cols=203 Identities=22% Similarity=0.341 Sum_probs=167.4
Q ss_pred cccccccc--ceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEE
Q 009595 207 SLEKIRSR--ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 207 ~~~~ig~G--~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 284 (531)
.+++||+| +||+||++.... +|+.||+|.+...... +.....+..|+.+++.++||||+++++++..++..++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP-TGEYVTVRRINLEACT--NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecc-cCcEEEEEEechhhcc--HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 45789999 789999998764 7899999999764322 122567788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCC
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~ 364 (531)
||+++|+|.+++... ....+++..+..++.|++.||.||| +.+++||||||+|||++.++.++++||+.+.....
T Consensus 79 e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 79 SFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred eccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence 999999999999642 2345899999999999999999999 77899999999999999999999999987554322
Q ss_pred CCccc-----eecccccCccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 009595 365 GHAQV-----STSIVAGTVGYIAPEYHQT--LKFSEKCDIYSFGVLLAVLVMGKLPSDDF 417 (531)
Q Consensus 365 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~P~~~~ 417 (531)
..... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 11100 0112346778999999876 46899999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.30 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=204.5
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
++..|.-++.||.|+||.||.|+... +.+.||||++.-...... ..-..+.+|+..|.+++|||+|.+.|+|..+...
T Consensus 24 PEklf~dLrEIGHGSFGAVYfArd~~-n~evVAIKKMsySGKQs~-EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 24 PEKLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSN-EKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA 101 (948)
T ss_pred HHHHHHHHHHhcCCccceeEEeeccC-ccceeeeeeccccccccH-HHHHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence 55678889999999999999998765 788999999976544332 2246788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|||||||-| |-.|++.- ..+++.+..+..|+.+.++||.||| +.+.||||||..|||+++.|.|||+|||.+.
T Consensus 102 WLVMEYClG-SAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAs 174 (948)
T KOG0577|consen 102 WLVMEYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSAS 174 (948)
T ss_pred HHHHHHHhc-cHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchh
Confidence 999999955 88888863 4578889999999999999999999 6679999999999999999999999999987
Q ss_pred cCCCCCccceecccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQ---TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
.... ...++|||.|||||++. .+.|+-++|||||||++.||.-.++|+-.+.. ..-++ .+....
T Consensus 175 i~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA---MSALY----HIAQNe 241 (948)
T KOG0577|consen 175 IMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALY----HIAQNE 241 (948)
T ss_pred hcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH---HHHHH----HHHhcC
Confidence 6433 24588999999999875 46799999999999999999999999755422 11122 221111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
. |.+.+..|++ .+..++..||+.-|.+|||..+++.|-
T Consensus 242 s------PtLqs~eWS~---~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 242 S------PTLQSNEWSD---YFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred C------CCCCCchhHH---HHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 1 1223333443 466777789999999999999998865
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=310.57 Aligned_cols=199 Identities=21% Similarity=0.329 Sum_probs=161.4
Q ss_pred cccccccceeEEEEEeeeC-CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe--CCceEEEE
Q 009595 208 LEKIRSRASGEIYIAELPE-SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR--PDCHLLVS 284 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lv~ 284 (531)
..+||+|+||+||+|.... .+++.||+|.+..... ...+.+|+.++++++||||+++++++.. ....+++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 3589999999999998642 3567899999875432 2346689999999999999999998864 45678999
Q ss_pred eccCCCCHHHHHhhccC-----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee----CCCCCEEEee
Q 009595 285 EFMKNGSLLEILNDVSQ-----GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI----DDDMEARIAD 355 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl----~~~~~vkL~D 355 (531)
||+.+ +|.+++..... ....+++..+..++.|++.||.||| +.+++||||||+|||+ +.++.+||+|
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 99965 89988754211 1235889999999999999999999 7889999999999999 4567899999
Q ss_pred cCCCccCCCCCcc-ceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009595 356 FGLARLMPDGHAQ-VSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDD 416 (531)
Q Consensus 356 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~ 416 (531)
||+++........ .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||..
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 9999876543221 122345789999999998774 589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=314.27 Aligned_cols=262 Identities=26% Similarity=0.346 Sum_probs=196.0
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC---
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--- 277 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--- 277 (531)
-.++|...+.||+|+||.||+|.... ++..||||.+....... .....+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTR-LRQKVAVKKLSRPFQSL--IHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECC-CCCEEEEEEeCchhhhh--HHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 34778999999999999999998654 68899999997533221 2245677899999999999999999987543
Q ss_pred ---CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe
Q 009595 278 ---DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 278 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
...|++++++ +++|.+++.. ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEc
Confidence 3468999998 7799988753 46899999999999999999999 7789999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... ...+..+. ..
T Consensus 161 Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~-~~ 231 (343)
T cd07878 161 DFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY---IDQLKRIM-EV 231 (343)
T ss_pred CCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHH-HH
Confidence 999998754421 23568999999999876 4688999999999999999999999865321 11111111 11
Q ss_pred hccCCCCcc--cc-----------ccccC----CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 434 MTSENPNRA--ID-----------SKLLG----NGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 434 ~~~~~~~~~--~d-----------~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.....+... +. +.... .........+.+++.+||+.||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 100000000 00 00000 0000011236789999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=301.80 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=203.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
++.|...+.||+|++|.||+|.... ++..|++|.+..... ...+.+|+.++++++||||+++++++......|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKE-TGQVVAIKVVPVEED------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcC-CCcEEEEEEeecHHH------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence 4678899999999999999998764 578899999875321 567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+++||+++++|.+++.. ....+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++..
T Consensus 75 l~~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 75 IVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred EEEecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchh
Confidence 99999999999999864 2457899999999999999999999 67899999999999999999999999999887
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
....... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... ... .......+..
T Consensus 149 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~---~~~----~~~~~~~~~~ 219 (256)
T cd06612 149 LTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR---AIF----MIPNKPPPTL 219 (256)
T ss_pred cccCccc--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---hhh----hhccCCCCCC
Confidence 6554321 123457899999999988899999999999999999999999987542211 110 0000000000
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.........+.+++.+||+.||.+|||+.+++++
T Consensus 220 --------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 --------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred --------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0011122357889999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=311.22 Aligned_cols=259 Identities=23% Similarity=0.313 Sum_probs=200.0
Q ss_pred ccccccccccccceeEEEEEeeeCCCCe--EEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCc
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGK--MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 279 (531)
++|.+.+.||+|+||.||+|.+.. ++. .+++|.+...... .....+.+|+.++.++ +||||+++++++...+.
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~-~~~~~~~~ik~~~~~~~~---~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEcc-CCceeeEEEEEecccCCH---HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 567888999999999999998754 454 4577776543221 2256788899999999 89999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~ 347 (531)
.++||||+++|+|.+++..... ....+++..+..++.|++.||.||| ++|++||||||+|||++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecC
Confidence 9999999999999999975321 1236889999999999999999999 788999999999999999
Q ss_pred CCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHH
Q 009595 348 DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSL 426 (531)
Q Consensus 348 ~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l 426 (531)
++.+||+|||++...... .......++..|+|||.+.+..++.++|||||||++|||+| |..||..... ...
T Consensus 160 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~ 232 (303)
T cd05088 160 NYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AEL 232 (303)
T ss_pred CCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh----HHH
Confidence 999999999998643211 11112234678999999988889999999999999999998 9999865422 122
Q ss_pred HHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 427 VRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 427 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
...+ .....+... .. ....+.+++.+||+.+|.+|||+.++++.|..+.
T Consensus 233 ~~~~---~~~~~~~~~------~~----~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 233 YEKL---PQGYRLEKP------LN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHHH---hcCCcCCCC------CC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2211 111111100 01 1124788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=340.40 Aligned_cols=265 Identities=23% Similarity=0.306 Sum_probs=202.4
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...++||+|+||.||+|.... +|+.||+|++...... .....+++.+|+.++++++||||+++++++...+..++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~-tg~~VAIK~I~~~l~~-~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV-CSRRVALKKIREDLSE-NPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC-CCcEEEEEEECccccc-CHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 578899999999999999998654 6889999999753322 12235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCC-------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 283 VSEFMKNGSLLEILNDVSQG-------RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
||||++||+|.+++...... ....++..+..++.||++||.||| ++|++||||||+||+++.++.++|+|
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEe
Confidence 99999999999998752211 234566778899999999999999 77899999999999999999999999
Q ss_pred cCCCccCCCCCc----------------cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 009595 356 FGLARLMPDGHA----------------QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQ 419 (531)
Q Consensus 356 fgla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~ 419 (531)
||++........ .......+||+.|+|||.+.+..++.++|||||||++|||+||+.||.....
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 999986621100 0011235699999999999999999999999999999999999999865211
Q ss_pred chhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhccC
Q 009595 420 HTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-NSKDVRSMLSDT 487 (531)
Q Consensus 420 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~ 487 (531)
..+.. ..... .+.... ........+.+++.+|+..||.+|| ++.++.+.|+..
T Consensus 237 ----~ki~~--~~~i~--~P~~~~-------p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 237 ----RKISY--RDVIL--SPIEVA-------PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ----hhhhh--hhhcc--Chhhcc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11100 01000 010000 0111223477899999999999995 566677776654
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=305.25 Aligned_cols=266 Identities=20% Similarity=0.298 Sum_probs=202.2
Q ss_pred ccccccccccccceeEEEEEeee---CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--
Q 009595 203 DCSASLEKIRSRASGEIYIAELP---ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP-- 277 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-- 277 (531)
..|..++.||+|+||.||.+.+. ..++..||+|.++..... .....+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG---NHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH---HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 34678899999999999999753 236788999998754322 2256788999999999999999999988775
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
...++||||+++++|.+++.. ....+++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg 154 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFG 154 (284)
T ss_pred CceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCc
Confidence 568899999999999999864 1246899999999999999999999 7889999999999999999999999999
Q ss_pred CCccCCCCCccc-eecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCccc--------chhhhHHHH
Q 009595 358 LARLMPDGHAQV-STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQ--------HTEEKSLVR 428 (531)
Q Consensus 358 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~--------~~~~~~l~~ 428 (531)
++..+....... ......|+..|+|||.+.+..++.++||||||+++|+|+|++.|+..... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05079 155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR 234 (284)
T ss_pred cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence 998765432211 11234567789999999888899999999999999999998776432110 000111111
Q ss_pred HHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 429 WMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 429 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.+.......... . ... ....+.+++.+||+.||.+|||+.++++.|+++
T Consensus 235 ~~~~~~~~~~~~--~----~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGKRLP--R----PPN----CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCccCC--C----CCC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111111100 0 011 123588899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=313.84 Aligned_cols=258 Identities=20% Similarity=0.294 Sum_probs=204.8
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCc
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 279 (531)
....|+++++||+||++.||++... +.+.||+|++..... ..+....+..|+..|.+| .|.+||++++|-..++.
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s--~~~iyalkkv~~~~~--D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS--DKQIYALKKVVLLEA--DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC--CCcchhhhHHHHhhc--CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 5677899999999999999999653 567899988865332 344578899999999999 69999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
+|+||||-+. +|..+|+.. ....+...+..+..|++.|+.+.| ..||||.||||.|+|+-. |.+||+|||+|
T Consensus 435 lYmvmE~Gd~-DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA 506 (677)
T KOG0596|consen 435 LYMVMECGDI-DLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIA 506 (677)
T ss_pred EEEEeecccc-cHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechh
Confidence 9999999866 999999862 233343377789999999999999 788999999999999976 58999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHH
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-----------KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR 428 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~ 428 (531)
..+............+||+.||+||.+... +.+.++||||||||||+|+.|+.||..+ .+...
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------~n~~a 580 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------INQIA 580 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH------HHHHH
Confidence 999887777777778999999999987532 2567999999999999999999998654 12222
Q ss_pred HHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 429 WMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 429 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
.+..+...+ .+.-.+. .+..+ .+++++..||..||.+|||..+++++-
T Consensus 581 Kl~aI~~P~--~~Iefp~-~~~~~-----~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 581 KLHAITDPN--HEIEFPD-IPEND-----ELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred HHHhhcCCC--ccccccC-CCCch-----HHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 222222211 1111111 12222 288899999999999999999999864
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=309.01 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=201.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCe----EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGK----MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
.+.|...+.||+|+||.||+|.+.. +|. .||+|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVP-EGETVKIPVAIKILNETTGP---KANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEec-CCCcceeeEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 4567788999999999999998754 343 5788888654322 1234678899999999999999999988754
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
..++++||+++|+|.+++.. ....+++..+..++.|++.||.||| .++++|+||||+||+++.++.+||+|||
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg 154 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFG 154 (303)
T ss_pred -CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccc
Confidence 56799999999999999864 2346889999999999999999999 7789999999999999999999999999
Q ss_pred CCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 358 LARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 358 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+... .....++...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~~~~~~~~~--- 227 (303)
T cd05110 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----REIPDLLEKG--- 227 (303)
T ss_pred ccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHCC---
Confidence 9987654333222233445778999999998889999999999999999997 9999865422 2233332211
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..+.. + .. ....+.+++..||..+|.+||++.++++.|..+.
T Consensus 228 ~~~~~---~---~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 228 ERLPQ---P---PI----CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CCCCC---C---CC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11110 0 00 1124778899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=301.39 Aligned_cols=255 Identities=22% Similarity=0.301 Sum_probs=199.9
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch--hhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS--LLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
|...+.||+|+||.||+|... +|+.+|+|.+...... ........+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred ccccceEeccCCeEEEEEEEc--CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 667889999999999999763 7889999998754321 222335678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
+|||+++++|.+++.+ ...+++..+..++.|++.||.||| ..+++|+||+|+||++++++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999965 356889999999999999999999 778999999999999999999999999998865
Q ss_pred CCCCc----cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 363 PDGHA----QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 363 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
..... ........|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ....... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~~~---~~~~~~ 226 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR---LAAMFYI---GAHRGL 226 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh---HHHHHHh---hhccCC
Confidence 32111 1111235689999999999988899999999999999999999999865321 1111111 000010
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. +.+... ....+.+++.+||..+|.+||++.+++++
T Consensus 227 ~-----~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 M-----PRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred C-----CCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 111111 12347889999999999999999998863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=300.45 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=191.7
Q ss_pred ccccccceeEEEEEeeeCC--CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEE-eCCceEEEEe
Q 009595 209 EKIRSRASGEIYIAELPES--NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMV-RPDCHLLVSE 285 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~lv~E 285 (531)
+.||+|+||.||+|.+... .+..||+|.+...... .....+..|+.+++.++||||+++++++. .+...+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL---EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH---HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence 4689999999999986432 3457999988643221 22567888999999999999999999776 4556789999
Q ss_pred ccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCC
Q 009595 286 FMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDG 365 (531)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~ 365 (531)
|+.+|+|.+++... ...+++.....++.|++.||.||| ..+++||||||+|||++.++.+||+|||++......
T Consensus 78 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 78 YMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 99999999999641 234677778889999999999999 778999999999999999999999999998865432
Q ss_pred Ccc--ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 366 HAQ--VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMG-KLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 366 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
... .......++..|+|||.+.+..++.++||||||+++|||++| ..||.... ...+... ......+..
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----~~~~~~~---~~~~~~~~~- 223 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD----SFDITVY---LLQGRRLLQ- 223 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHH---HhcCCCCCC-
Confidence 111 111223457789999999888899999999999999999995 55654421 1222222 211111110
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
+ .. ....+.+++.+||..+|++||++.++++.|+++
T Consensus 224 --~----~~---~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 224 --P----EY---CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred --C----Cc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 11 112478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=306.98 Aligned_cols=269 Identities=20% Similarity=0.282 Sum_probs=200.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|+..+.||+|++|.||+|.... +|+.||+|.+....... ...+.+..|+.++++++||||+++++++......++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE-TGQIVAIKKFVESEDDP--VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC-CCcEEEEEEEeecccCc--cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 467888999999999999998764 68899999987543211 123567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|..++.. ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 78 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07847 78 VFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARIL 150 (286)
T ss_pred EEeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceec
Confidence 9999999888877643 346899999999999999999999 788999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH-------h
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV-------M 434 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~-------~ 434 (531)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+....+....... .
T Consensus 151 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 151 TGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred CCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 554321 123457889999998876 457899999999999999999999997643221111111111000 0
Q ss_pred ccCCC-CccccccccC-----CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 435 TSENP-NRAIDSKLLG-----NGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 435 ~~~~~-~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..... .....+.... .........+.+++.+||+.||.+|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000 0000000000 0011123457889999999999999999998865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=303.61 Aligned_cols=250 Identities=23% Similarity=0.393 Sum_probs=202.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
..|+..+.||.|+||.||+|.... ++..||+|.+...... .....+..|+.++++++||||+++++++.+....++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR-TQQVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc-CCEEEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 457788999999999999998754 6889999998754321 225678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ..+++.....++.+++.||.||| ..+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 80 IMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred EEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceec
Confidence 9999999999999863 45788889999999999999999 788999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
...... .....++..|+|||.+.+..++.++|+||||+++|||+||..||.+..+.. ... .. ....+.
T Consensus 152 ~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~---~~-~~~~~~-- 219 (277)
T cd06640 152 TDTQIK--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLF---LI-PKNNPP-- 219 (277)
T ss_pred cCCccc--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hhh---hh-hcCCCC--
Confidence 543221 123467889999999988889999999999999999999999987643211 111 11 111111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.........+.+++.+||+.+|.+||++.+++.+
T Consensus 220 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 -------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1112233457889999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=302.28 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=193.9
Q ss_pred ccccccceeEEEEEeeeCCCCe--EEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceEEEEe
Q 009595 209 EKIRSRASGEIYIAELPESNGK--MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHLLVSE 285 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 285 (531)
+.||+|+||.||+|.... ++. .+++|.+...... .....+..|+.++.++ +||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcC-CCCeeEEEEEEccccCCH---HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 368999999999998764 443 4688888743221 1245788899999999 89999999999999999999999
Q ss_pred ccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEE
Q 009595 286 FMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARI 353 (531)
Q Consensus 286 ~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL 353 (531)
|+++|+|.+++..... ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEE
Confidence 9999999999975321 1235789999999999999999999 788999999999999999999999
Q ss_pred eecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHH
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRN 432 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~ 432 (531)
+|||++....... .......+..|+|||++.+..++.++||||||+++|||++ |..||.+... ......
T Consensus 154 ~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~~~~--- 223 (270)
T cd05047 154 ADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEK--- 223 (270)
T ss_pred CCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH----HHHHHH---
Confidence 9999986332111 1111233567999999988889999999999999999997 9999865321 122221
Q ss_pred HhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 433 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
......... ... ....+.+++.+||..||.+|||+.+++..|.++
T Consensus 224 ~~~~~~~~~------~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 224 LPQGYRLEK------PLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred HhCCCCCCC------CCc----CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 111111100 011 122478899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=300.35 Aligned_cols=262 Identities=24% Similarity=0.375 Sum_probs=205.6
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch------hhhHHHHHHHHHHHHHhc-CCCCcccccceeEEe
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS------LLNIKMRQVRAEIMTAGQ-IRHRNIVPLLAHMVR 276 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~ 276 (531)
.|++.+.||+|+||.||+|......++.+|+|.+...... ........+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 3678889999999999999987545788999988643211 112235667788888865 799999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
.+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999999986644455678999999999999999999994 367999999999999999999999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
|++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ... .......
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~----~~~---~~~~~~~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM----LSL---ATKIVEA 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH----HHH---HHHHhhc
Confidence 9998765432 22345689999999999988899999999999999999999999864321 111 1111111
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
.... .. ... ....+.+++.+||+.||.+||++.++..++.+
T Consensus 229 ~~~~--~~----~~~---~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 VYEP--LP----EGM---YSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cCCc--CC----ccc---CCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1110 00 001 12347889999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=306.15 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=200.1
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEE----
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMV---- 275 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~---- 275 (531)
..++|+..+.||+|+||.||+|.... +++.+|+|.+...... ...+..|+.+++.+ +||||+++++++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~-----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKK-NGSKAAVKILDPIHDI-----DEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECC-CCceeEEEeeccccch-----HHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 56889999999999999999998754 6889999988653221 34567899999999 7999999999874
Q ss_pred -eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe
Q 009595 276 -RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 276 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
.....++||||+++++|.+++.........+++..+..++.|++.||.||| ..+++||||||+||+++.++.++|+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEc
Confidence 345689999999999999988754334567889999999999999999999 7789999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-----LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRW 429 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~ 429 (531)
|||++......... .....|++.|+|||.+.. ..++.++|||||||++|+|++|+.||...... ..+...
T Consensus 167 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~~~ 241 (286)
T cd06638 167 DFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RALFKI 241 (286)
T ss_pred cCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHhhc
Confidence 99998876443221 123468999999998753 34788999999999999999999998754221 111111
Q ss_pred HHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 430 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
. .........+. .+ ...+.+++.+||+.||.+|||+.++++++
T Consensus 242 ----~-~~~~~~~~~~~----~~---~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 ----P-RNPPPTLHQPE----LW---SNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ----c-ccCCCcccCCC----Cc---CHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1 11111111111 11 12478899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=298.10 Aligned_cols=253 Identities=20% Similarity=0.284 Sum_probs=200.4
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC-CceEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP-DCHLL 282 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-~~~~l 282 (531)
+|...+.||.|++|.||++.... +++.||+|.+....... .....+..|+.++++++||||+++++.+... ...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT-DGKQYVIKKLNLRNASR--RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC-CCcEEEEEEEehhhcCH--HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence 47888999999999999998754 67889999997533221 2256688899999999999999999987644 45789
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
+|||+++++|.+++.. .....+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 78 v~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 78 VMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred EecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence 9999999999999975 23456899999999999999999999 788999999999999999999999999998876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
..... ......|++.|+|||++.+..++.++||||||+++++|++|+.||..... . ...........+.
T Consensus 153 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----~---~~~~~~~~~~~~~-- 221 (257)
T cd08223 153 ENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM----N---SLVYRIIEGKLPP-- 221 (257)
T ss_pred cccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----H---HHHHHHHhcCCCC--
Confidence 44322 12335689999999999998899999999999999999999999864321 1 1111111111110
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+ .......+.+++.+||+.||.+|||+.+++.+
T Consensus 222 ----~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 ----M----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----C----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 01122358889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=317.66 Aligned_cols=259 Identities=20% Similarity=0.245 Sum_probs=196.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.+.||+|+||.||+++... +++.||+|.+...... .......+..|+.++..++||||+++++++...+..|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH-TERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 468889999999999999998764 6888999999753211 12224567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++...
T Consensus 79 v~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 79 VMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred EEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999974 2356889999999999999999999 788999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQT-----LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ... ........
T Consensus 153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~---~~~i~~~~ 224 (331)
T cd05624 153 NQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL----VET---YGKIMNHE 224 (331)
T ss_pred cCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH----HHH---HHHHHcCC
Confidence 543221 2234579999999998875 4678899999999999999999999865321 111 11111111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEE--RPNSKDVRSM 483 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 483 (531)
... .+. .........+.+++.+|+..++.+ |+++.+++++
T Consensus 225 ~~~-~~p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 225 ERF-QFP-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred Ccc-cCC-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 000 111112234777888888765543 4677777765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=304.51 Aligned_cols=241 Identities=17% Similarity=0.237 Sum_probs=186.5
Q ss_pred cccccceeEEEEEeeeCC-----------------------CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCc
Q 009595 210 KIRSRASGEIYIAELPES-----------------------NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN 266 (531)
Q Consensus 210 ~ig~G~~g~Vy~~~~~~~-----------------------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn 266 (531)
+||+|+||.||+|.+... ....|++|.+..... .....+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR----DIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH----HHHHHHHHHHHHHhcCCCCC
Confidence 699999999999975321 123588888865322 12456888999999999999
Q ss_pred ccccceeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC
Q 009595 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346 (531)
Q Consensus 267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~ 346 (531)
|+++++++......++||||+++|+|..++.. ....+++..+..++.|++.||.||| +++++||||||+|||++
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLA 151 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEe
Confidence 99999999999999999999999999999864 2456889999999999999999999 78899999999999997
Q ss_pred CCC-------CEEEeecCCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCc
Q 009595 347 DDM-------EARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLV-MGKLPSDDF 417 (531)
Q Consensus 347 ~~~-------~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell-tg~~P~~~~ 417 (531)
..+ .+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||...
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred ccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 643 4899999987654322 12356888999998865 46899999999999999985 699998754
Q ss_pred ccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 418 FQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 418 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
.... ......... ... .... ..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 226 ~~~~----~~~~~~~~~---~~~--------~~~~----~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 226 TPSE----KERFYEKKH---RLP--------EPSC----KELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ChHH----HHHHHHhcc---CCC--------CCCC----hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 3211 111111110 000 0011 23788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=300.45 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=204.3
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|+..+.||.|+||.||.++... +++.+++|.+....... .....+.+|+.++++++||||+++++++...+..+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~-~~~~~~~k~~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE-DDSLVVWKEVNLTRLSE--KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC-CCcEEEEEEEeecccch--hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence 47888999999999999998664 78889999987543322 2256688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++|+|.+++... ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 78 MEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152 (256)
T ss_pred EEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence 9999999999999752 2456899999999999999999999 6789999999999999999999999999988765
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||..... .. .............
T Consensus 153 ~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----~~---~~~~~~~~~~~~~-- 221 (256)
T cd08221 153 SEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP----LN---LVVKIVQGNYTPV-- 221 (256)
T ss_pred cccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH----HH---HHHHHHcCCCCCC--
Confidence 4432 12335689999999999888889999999999999999999999865321 11 1112111111110
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
. ......+.+++.+||..+|.+|||+.++++++
T Consensus 222 ~--------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 V--------SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred c--------cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0 11123478899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=317.63 Aligned_cols=240 Identities=20% Similarity=0.242 Sum_probs=184.3
Q ss_pred ccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC---CCCcccccceeEEeCCceEEEEecc
Q 009595 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI---RHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 211 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
||+|+||+||+|.... +++.||||++....... ......+..|..++..+ +||||+++++++......|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKD-TRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECC-CCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 7999999999998754 78899999997532211 11234455566766655 7999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|.+++.. ...+++..+..++.||++||.||| +++|+||||||+|||++.++.+||+|||++........
T Consensus 79 ~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 79 SGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred CCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence 99999999865 467899999999999999999999 77899999999999999999999999999876433222
Q ss_pred cceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSK 446 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 446 (531)
. ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ..+.. .... +... +.
T Consensus 152 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~----~~~~~---~i~~-~~~~--~~-- 217 (330)
T cd05586 152 T--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT----QQMYR---NIAF-GKVR--FP-- 217 (330)
T ss_pred C--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH----HHHHH---HHHc-CCCC--CC--
Confidence 1 2346799999999998765 478999999999999999999999865321 11111 1111 1110 00
Q ss_pred ccCCCcHHHHHHHHHHHHHcccCCCCCCCCHH
Q 009595 447 LLGNGYEEQMLLVLKIACFCTLDDPEERPNSK 478 (531)
Q Consensus 447 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 478 (531)
... ....+.+++.+||+.||.+||++.
T Consensus 218 --~~~---~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 218 --KNV---LSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred --Ccc---CCHHHHHHHHHHcCCCHHHCCCCC
Confidence 001 112467889999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=311.71 Aligned_cols=263 Identities=23% Similarity=0.315 Sum_probs=204.3
Q ss_pred ccccccccccccceeEEEEEeeeC------CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPE------SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMV 275 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 275 (531)
..|.+.+.||+|+||.||+|.... ..+..||+|.+...... .....+..|+.+++++ +||||+++++++.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD---KDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH---HHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 467889999999999999997532 12346899988753221 2256788999999999 8999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCe
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSV 343 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 343 (531)
.....+++|||+++|+|.+++..... ....+++..+..++.|++.||.||| .++++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceE
Confidence 99999999999999999999975321 1235788899999999999999999 78899999999999
Q ss_pred eeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchh
Q 009595 344 LIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTE 422 (531)
Q Consensus 344 Ll~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~ 422 (531)
+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---- 241 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---- 241 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC----
Confidence 999999999999999987654332222222344678999999998889999999999999999998 888886532
Q ss_pred hhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 423 EKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 423 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
...+...+. ....... .. .....+.+++.+||+.+|.+|||+.++++.|..+.
T Consensus 242 ~~~~~~~~~---~~~~~~~------~~----~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 242 VEELFKLLK---EGHRMDK------PA----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHHHH---cCCCCCC------CC----CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 122222211 1111110 01 11224778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=303.81 Aligned_cols=267 Identities=21% Similarity=0.328 Sum_probs=204.5
Q ss_pred ccccccccccccceeEEEEEeeeC---CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe--C
Q 009595 203 DCSASLEKIRSRASGEIYIAELPE---SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR--P 277 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~ 277 (531)
..|...+.||+|+||.||+|.+.. .++..||||.+...... .....+..|+.+++.+.||||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 456778899999999999998642 25788999999865443 236778999999999999999999999877 5
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
...+++|||+++++|.+++.. ....+++..+..++.|++.||.||| ..+++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg 154 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFG 154 (284)
T ss_pred CceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccc
Confidence 578999999999999999975 2235899999999999999999999 7789999999999999999999999999
Q ss_pred CCccCCCCCccce-ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh-------hHHHHH
Q 009595 358 LARLMPDGHAQVS-TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEE-------KSLVRW 429 (531)
Q Consensus 358 la~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~-------~~l~~~ 429 (531)
++........... .....++..|+|||.+.+..++.++||||||+++|||+||..|+......... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 9987764322111 11233456799999998888999999999999999999999997653221100 000111
Q ss_pred HHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 430 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
+........... .+ . .....+.+++.+||+.+|.+|||+.+|++.|..+
T Consensus 235 ~~~~~~~~~~~~--~~----~---~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLP--RP----P---SCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCC--CC----c---cCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111000 00 0 1113588899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=307.48 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=202.2
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
....|...+.||+|++|.||+|.... +++.||+|.+....... ...+..|+.+++.++||||+++++++...+..
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIA-TGQEVAIKQMNLQQQPK----KELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECC-CCCEEEEEEEecCccch----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 34778899999999999999998643 78899999997543322 45678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++++|.+++.. ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.
T Consensus 92 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred EEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccce
Confidence 999999999999999864 45788899999999999999999 7789999999999999999999999999988
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
........ .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... ..+.. ....+.+.
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~---~~~~~----~~~~~~~~ 234 (297)
T cd06656 164 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYL----IATNGTPE 234 (297)
T ss_pred EccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc---hheee----eccCCCCC
Confidence 65443221 12346889999999999888999999999999999999999998653221 11100 00111111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. .. .......+.+++.+||..||.+|||+.+++++
T Consensus 235 ~-~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 L-QN-------PERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred C-CC-------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00 11122347789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=303.86 Aligned_cols=255 Identities=19% Similarity=0.316 Sum_probs=200.5
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
.|+..+.||+|+||.||++.... ++..||+|.+...... .....+.+|+.++++++||||+++++++...+..++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~-~~~~~a~k~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRP-TGVTMAMKEIRLELDE---SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcC-CCcEEEEEEeecccCH---HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence 57888999999999999998764 6889999998753221 1256788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++++|.+++... .....+++..+..++.+++.||.|||+ +.+++|+||||+||+++.++.++|+|||++..+.
T Consensus 78 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 78 MEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999999999988642 113478999999999999999999994 3589999999999999999999999999987664
Q ss_pred CCCccceecccccCccccCcccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLK------FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
.... ....|++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||..... ......+.......
T Consensus 155 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~ 226 (286)
T cd06622 155 ASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY----ANIFAQLSAIVDGD 226 (286)
T ss_pred CCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch----hhHHHHHHHHhhcC
Confidence 3322 2345788999999885543 57899999999999999999999865321 22222222222211
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+. + .......+.+++.+||..+|.+||++.+++++
T Consensus 227 ~~~--~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 PPT--L--------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCC--C--------CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111 1 11123347889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=296.36 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=197.5
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccC
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 288 (531)
++||.|++|.||++... .++.||+|.+...... .....+..|+.++++++||||+++++++......++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~--~~~~v~~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK--GNTEVAVKTCRSTLPP---DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEe--CCCcEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence 47999999999999875 3888999998764432 225678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCcc
Q 009595 289 NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ 368 (531)
Q Consensus 289 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~ 368 (531)
+++|.+++.. ....+++.....++.+++.||.||| +++++||||+|+||+++.++.++|+|||++.........
T Consensus 76 ~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 76 GGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence 9999999964 2346788999999999999999999 778999999999999999999999999998866533222
Q ss_pred ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 369 VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 369 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
.......++..|+|||.+.+..++.++|+||||+++|+|+| |..||..... ......+.... ... .+
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~----~~~~~~~~~~~---~~~---~~-- 217 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN----QQTRERIESGY---RMP---AP-- 217 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH----HHHHHHHhcCC---CCC---CC--
Confidence 11122334667999999988889999999999999999999 8888865432 11112111110 000 00
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
. .....+.+++.+||..+|.+|||+.++++.|.
T Consensus 218 --~---~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 --Q---LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred --c---cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 0 11235888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=302.48 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=197.7
Q ss_pred ccccccceeEEEEEeeeC-----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 209 EKIRSRASGEIYIAELPE-----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+.||+|+||.||+|.... ..+..+|||.+...... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD---QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch---hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 369999999999998743 12367999988653211 1256788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccC---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC-----CEEEee
Q 009595 284 SEFMKNGSLLEILNDVSQ---GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM-----EARIAD 355 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-----~vkL~D 355 (531)
|||+++++|.+++..... ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 999999999999975322 2245788999999999999999999 77899999999999999877 899999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHh
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
||++................++..|+|||.+.+..++.++||||||+++|+|+| |..||..... ......+..
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~~~~~~~~~-- 228 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQHVTA-- 228 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----HHHHHHHhc--
Confidence 999886654322222223345788999999999899999999999999999998 9999865322 222222111
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
...+. . .. .....+.+++.+||..+|.+||++.++++.|.+
T Consensus 229 -~~~~~---~----~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 -GGRLQ---K----PE---NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -CCccC---C----cc---cchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11110 0 01 112357889999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=303.75 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=202.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||.|++|.||+|.... +++.||+|.+...... .....+..|+.+++.++||||+++++++......++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR-TNQVVAIKVIDLEEAE---DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC-CCeEEEEEEeeccccc---hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 357788999999999999998764 7889999999754321 124567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|+||+++++|.+++.. ..+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++...
T Consensus 77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 148 (274)
T cd06609 77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQL 148 (274)
T ss_pred EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceee
Confidence 9999999999999964 27899999999999999999999 778999999999999999999999999999877
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
..... ......|++.|+|||.+.+..++.++||||||+++|+|+||+.||....+. ... ..... ..+...
T Consensus 149 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----~~~---~~~~~-~~~~~~ 218 (274)
T cd06609 149 TSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM----RVL---FLIPK-NNPPSL 218 (274)
T ss_pred ccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH----HHH---HHhhh-cCCCCC
Confidence 54421 123356888999999999888999999999999999999999998754321 111 11111 111111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. ... ....+.+++.+||..||.+|||+.+++++
T Consensus 219 ~-----~~~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 E-----GNK---FSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred c-----ccc---cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 010 12247788999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=300.23 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=204.7
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||+|++|.||++.... +++.+|+|.+...... .....+.+|+.++++++||||+++++++.....++++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRP-TGKIMAVKTIRLEINE---AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcC-CCcEEEEEEEecccCh---HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 56778899999999999998754 6888999999764332 2356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR-PRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
+||+++++|.+++... ...+++.....++.|++.||.||| + .+++|+||+|+||+++.++.++|+|||.+...
T Consensus 78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 78 MEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151 (265)
T ss_pred EEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence 9999999999999752 267889999999999999999999 6 88999999999999999999999999998765
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
..... ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ........+........+...
T Consensus 152 ~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 225 (265)
T cd06605 152 VNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND--PPDGIFELLQYIVNEPPPRLP 225 (265)
T ss_pred HHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc--ccccHHHHHHHHhcCCCCCCC
Confidence 43211 115688999999999988999999999999999999999999865421 112223333333322221111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. .....+.+++.+||..||.+|||+.+++.+
T Consensus 226 ------~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 ------SG---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ------hh---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11 022347889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=328.14 Aligned_cols=261 Identities=23% Similarity=0.276 Sum_probs=205.7
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCccccccee-EEe--
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAH-MVR-- 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~-~~~-- 276 (531)
...+.++.+.|.+|||+.||.|.... .|..||+|++-..+... .+.+.+||.+|++|. |||||.+++. ...
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~-~~~~~AlKrm~~~de~~----L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVK-GGKKYALKRMYVNDEEA----LNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecC-CCceeeeeeeecCCHHH----HHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 44566788999999999999998863 44899999998764443 778889999999995 9999999993 221
Q ss_pred ----CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEE
Q 009595 277 ----PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEAR 352 (531)
Q Consensus 277 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vk 352 (531)
.-.++|.||||.||+|-|++..+.+ ..|++..+++|+.++++|+.+||.. ..+|||||||-+||||+.+|+.|
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEE
Confidence 1356899999999999999987544 3499999999999999999999976 67899999999999999999999
Q ss_pred EeecCCCccCCCCCcccee-------cccccCccccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh
Q 009595 353 IADFGLARLMPDGHAQVST-------SIVAGTVGYIAPEYH---QTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTE 422 (531)
Q Consensus 353 L~Dfgla~~~~~~~~~~~~-------~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~ 422 (531)
|||||.+............ -...-|+.|.|||.+ .+.+.++|+|||+|||+||-|+....||++....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-- 264 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-- 264 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--
Confidence 9999998754332211000 012358999999965 4668899999999999999999999999864210
Q ss_pred hhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 423 EKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 423 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
..++....-.-.+.+...+.+||..||+.||.+||++-+++..+..+..
T Consensus 265 ------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 265 ------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ------------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 0011111011124556678999999999999999999999999977643
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=300.67 Aligned_cols=260 Identities=23% Similarity=0.343 Sum_probs=200.8
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch------hhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS------LLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
+|...+.||.|+||.||+|.... +|+.||+|.+...... ......+.+..|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT-TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecC-CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 35667899999999999997653 6889999988642211 1122245788899999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred CceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999999975 356889999999999999999999 7789999999999999999999999999
Q ss_pred CCccCCCCCccceecccccCccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 358 LARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK--FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 358 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
++................|+..|+|||.+.... ++.++|+||||+++|++++|..||..... ...+... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~----~~ 226 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMFKL----GN 226 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---HHHHHHh----hc
Confidence 988654432222223456889999999987654 78999999999999999999999864321 1111111 11
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. ....+... ........+.+++.+||.+||.+|||+.+++++
T Consensus 227 ~~-~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 KR-SAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cc-cCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11 11111111 111223458889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=315.80 Aligned_cols=259 Identities=20% Similarity=0.247 Sum_probs=196.0
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|+||.||++.... +++.||+|++...... .......+..|+.++..++||||+++++++...+..++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN-ADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC-CCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence 367889999999999999998764 6788999999653221 12224557889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++...
T Consensus 79 v~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 79 VMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred EEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence 9999999999999974 2346899999999999999999999 788999999999999999999999999998765
Q ss_pred CCCCccceecccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQ-----TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...........
T Consensus 153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~ 224 (332)
T cd05623 153 MEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHK 224 (332)
T ss_pred ccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCC
Confidence 43322 1223457999999999886 34578999999999999999999999865321 11122222111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHH
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLD--DPEERPNSKDVRSM 483 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~ 483 (531)
... .+. .........+.+++.+|+.. ++..||++.+++++
T Consensus 225 ~~~-~~p-----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 225 ERF-QFP-----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccc-cCC-----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 100 000 00111122366677776654 44447899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=298.35 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=197.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|++.+.||+|+||.||.+.. +++.||+|.+..... ...+.+|+.+++.++||||+++++++.. +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~~~------~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCDVT------AQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc---CCCceEEEeecCcch------HHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEE
Confidence 4578889999999999999875 678899999875321 4568889999999999999999998865 45799
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
+|||+++++|.+++.. .....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 76 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 76 VMELMSKGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred EEECCCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceec
Confidence 9999999999999975 23446889999999999999999999 788999999999999999999999999998764
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
.... .....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||..... ......+. .+....
T Consensus 151 ~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~----~~~~~~ 217 (254)
T cd05083 151 SMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL----KEVKECVE----KGYRME 217 (254)
T ss_pred cccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH----HHHHHHHh----CCCCCC
Confidence 3321 11234578999999988899999999999999999998 9999865422 12222111 111111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
. .. .....+.+++.+||+.+|.+||++.++++.|++
T Consensus 218 ~------~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 P------PE---GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred C------CC---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 01 112347889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=301.39 Aligned_cols=263 Identities=23% Similarity=0.345 Sum_probs=204.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--Cce
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--DCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~ 280 (531)
++|...+.||.|++|.||+|.... +++.+|+|.+...... .....+.+|+.++++++||||+++++++... ..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN-TGMIFALKTITTDPNP---DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC-CCeEEEEEEEecCCch---HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 357788999999999999998754 6889999999754332 2256788899999999999999999988654 468
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++++|.+++.........++......++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 153 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG 153 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence 9999999999999988754444567899999999999999999999 7789999999999999999999999999987
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCccc-chhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQ-HTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~-~~~~~~l~~~~~~~~~~~~~ 439 (531)
....... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... .........++... ..+
T Consensus 154 ~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 226 (287)
T cd06621 154 ELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PNP 226 (287)
T ss_pred ccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cch
Confidence 6543321 124578899999999888899999999999999999999999875421 01112222322221 111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. +.... .........+.+++.+||..||.+|||+.+++++
T Consensus 227 ~--~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 227 E--LKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred h--hccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1 11000 0001123457899999999999999999999884
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=299.26 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=196.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+++.....||+|+||.||+|.... ++..|++|.+....... .+.+.+|+.++++++||||+++++++..++..+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~~k~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLS-TQVRIAIKEIPERDSRY----VQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecC-CCcEEEEEEecCCCHHH----HHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3444555789999999999998754 67889999987644322 567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC-CCCEEEeecCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRREL--EWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD-DMEARIADFGL 358 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vkL~Dfgl 358 (531)
+|+||+++++|.+++... ...+ ++..+..++.|++.||.||| .++++||||||+||+++. ++.++|+|||+
T Consensus 82 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 82 IFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 999999999999999752 1234 77888889999999999999 788999999999999976 67999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK--FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
+......... .....|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||....... ...+......
T Consensus 156 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~----~~~~~~~~~~- 228 (268)
T cd06624 156 SKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ----AAMFKVGMFK- 228 (268)
T ss_pred heecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh----hhHhhhhhhc-
Confidence 8766433221 12345789999999986643 7889999999999999999999986532111 1111110000
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..+ .+ .......+.+++.+||..+|.+|||+.+++++
T Consensus 229 ~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 IHP------EI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cCC------CC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000 00 01112347889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=296.00 Aligned_cols=252 Identities=20% Similarity=0.295 Sum_probs=201.3
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||+|++|.||++.... ++..+|+|.+....... .....+..|+.+++.++||||+++++.+...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA-DQKLVIIKQIPVEQMTK--DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC-CCcEEEEEEEecccccc--HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence 47788999999999999998754 78889999997643222 2357788999999999999999999999988999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC-CCEEEeecCCCccC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD-MEARIADFGLARLM 362 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkL~Dfgla~~~ 362 (531)
|||+++++|.+++.. .....+++..+..++.+++.||.||| +++++|+||+|+||+++.+ +.++|+|||++...
T Consensus 78 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 78 MEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EecCCCCCHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 999999999999975 23456899999999999999999999 7889999999999999865 46899999999876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
...... ....|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ..... .........
T Consensus 153 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~~---~~~~~~~~~-- 220 (256)
T cd08220 153 SSKSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL----PALVL---KIMSGTFAP-- 220 (256)
T ss_pred CCCccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch----HHHHH---HHHhcCCCC--
Confidence 544221 235688999999999888889999999999999999999999865321 11111 111111110
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. .. ....+.+++.+||..||.+|||+.+++++
T Consensus 221 ~~----~~----~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 IS----DR----YSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CC----CC----cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00 01 12247889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=301.99 Aligned_cols=257 Identities=21% Similarity=0.370 Sum_probs=202.2
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCC-
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPD- 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~- 278 (531)
+.++|...+.||+|++|.||+|.... +++.|++|.+...... ...+..|+.+++++ .||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~-----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKK-TGQLVAIKIMDIIEDE-----EEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECC-CCcEEEEEEEecCchh-----HHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 45889999999999999999998764 6788999998764432 45688999999999 7999999999987644
Q ss_pred -----ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEE
Q 009595 279 -----CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARI 353 (531)
Q Consensus 279 -----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL 353 (531)
.+++||||+++++|.+++.........+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l 154 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKL 154 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEE
Confidence 489999999999999998764434567899999999999999999999 788999999999999999999999
Q ss_pred eecCCCccCCCCCccceecccccCccccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHH
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-----KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR 428 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~ 428 (531)
+|||++......... .....|+..|+|||.+... .++.++||||||+++|+|++|+.||..... ...+..
T Consensus 155 ~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~ 229 (275)
T cd06608 155 VDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP---MRALFK 229 (275)
T ss_pred CCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch---HHHHHH
Confidence 999998866443222 1235689999999987542 467899999999999999999999865422 111111
Q ss_pred HHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 429 WMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 429 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..... ...... .......+.+++.+||..||++|||+.+++++
T Consensus 230 ----~~~~~-~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 230 ----IPRNP-PPTLKS-------PENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ----hhccC-CCCCCc-------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111 111110 11123357889999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=299.75 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=201.8
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchh--hhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSL--LNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
+|+..+.||+|++|.||+|.... +++.||+|.+....... .......+..|+.++++++||||+++++++...+..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~-~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK-TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcC-CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEE
Confidence 36777899999999999998653 78899999997543221 1223678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC-CEEEeecCCCc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM-EARIADFGLAR 360 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkL~Dfgla~ 360 (531)
+||||+++++|.+++.. ...+++.....++.|++.||.||| +++++|+||+|+||+++.++ .++|+|||++.
T Consensus 80 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 80 LFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 99999999999999975 356889999999999999999999 77899999999999998776 59999999988
Q ss_pred cCCCCCcc--ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 361 LMPDGHAQ--VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 361 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
........ .......|+..|+|||.+.+..++.++||||+|+++|+|++|..||........ ............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~ 228 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKIASATT 228 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HHHHHHHhccCC
Confidence 76543211 111234688999999999888899999999999999999999999864322111 111111111110
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. .........+.+++.+||..+|.+|||+.+++++
T Consensus 229 ~~---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 AP---------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CC---------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 10 1111122347889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=326.18 Aligned_cols=260 Identities=17% Similarity=0.197 Sum_probs=189.5
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC------CCcccccceeEE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR------HRNIVPLLAHMV 275 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~------hpnIv~l~~~~~ 275 (531)
.++|.+.+.||+|+||.||+|.... +++.||||+++..... ...+..|+.++..++ |++|+++++++.
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRK-RKEYCAVKIVRNVPKY-----TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcC-CCeEEEEEEEecchhh-----HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 4789999999999999999998754 6888999999743221 233445666666554 456888888887
Q ss_pred eC-CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC-----
Q 009595 276 RP-DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM----- 349 (531)
Q Consensus 276 ~~-~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~----- 349 (531)
.. ..+|+|||++ +++|.+++.. ...+++..+..++.||+.||.|||+ +.||+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccc
Confidence 64 4678999998 7799998865 4578999999999999999999993 25899999999999998765
Q ss_pred -----------CEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 009595 350 -----------EARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFF 418 (531)
Q Consensus 350 -----------~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~ 418 (531)
.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||++..
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4999999987643221 234679999999999999999999999999999999999999997643
Q ss_pred cchhhhHHHHHHHHHhccC---------------------CCCcccccc----ccCC-Cc--HHHHHHHHHHHHHcccCC
Q 009595 419 QHTEEKSLVRWMRNVMTSE---------------------NPNRAIDSK----LLGN-GY--EEQMLLVLKIACFCTLDD 470 (531)
Q Consensus 419 ~~~~~~~l~~~~~~~~~~~---------------------~~~~~~d~~----l~~~-~~--~~~~~~l~~li~~cl~~d 470 (531)
.. .....+....... ......++. .... .. ......+.+|+..||+.|
T Consensus 350 ~~----~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 350 NL----EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred hH----HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 21 1111111110000 000000000 0000 00 001234779999999999
Q ss_pred CCCCCCHHHHHHH
Q 009595 471 PEERPNSKDVRSM 483 (531)
Q Consensus 471 P~~RPs~~evl~~ 483 (531)
|.+|||+.++++|
T Consensus 426 P~~R~ta~e~L~H 438 (467)
T PTZ00284 426 RQKRLNARQMTTH 438 (467)
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999984
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=299.31 Aligned_cols=261 Identities=20% Similarity=0.310 Sum_probs=200.6
Q ss_pred ccccccccccceeEEEEEeeeC--CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC----
Q 009595 205 SASLEKIRSRASGEIYIAELPE--SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD---- 278 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---- 278 (531)
|.+.+.||+|+||.||+|.+.. .++..||||.+....... ...+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS--SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh--HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 4567789999999999998643 246889999997643322 22567889999999999999999999886532
Q ss_pred --ceEEEEeccCCCCHHHHHhhccC--CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe
Q 009595 279 --CHLLVSEFMKNGSLLEILNDVSQ--GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 279 --~~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
..++++||+++|+|.+++..... ....+++.....++.|++.||.||| +.+++||||||+||+++.++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEEC
Confidence 24789999999999988753221 1235788999999999999999999 6789999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
|||+++...............+++.|++||.+.+..++.++||||||+++|+|++ |+.||..... ..+..+...
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~- 230 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYNYLIK- 230 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHHHHHc-
Confidence 9999987654332222223345678999999988889999999999999999999 8899865422 223222221
Q ss_pred hccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 434 MTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 434 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
...... . . .....+.+++.+||..+|.+|||+.++++.|+++
T Consensus 231 --~~~~~~--~----~----~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 --GNRLKQ--P----P----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --CCcCCC--C----C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111110 0 1 1123588899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=302.18 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=195.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHH-HhcCCCCcccccceeEEeCCceE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMT-AGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
++|.+.+.||+|+||.||+|.... +|+.||+|.+........ ...+..|+.. ++.++||||+++++++......|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~---~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP-TGTIMAVKRIRATVNSQE---QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC-CCcEEEEEEEecCCCcHH---HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 367888999999999999998764 689999999976433221 2344456654 56679999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP-RIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++|||++ |+|.+++.........+++..++.++.|++.||.||| ++ +++||||||+||+++.++.+||+|||++.
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999997 5999988764444567899999999999999999999 54 89999999999999999999999999988
Q ss_pred cCCCCCccceecccccCccccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQT----LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
....... .....|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... ....+.. ....
T Consensus 153 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~----~~~~ 223 (283)
T cd06617 153 YLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQ----VVEE 223 (283)
T ss_pred ccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHH----HHhc
Confidence 7644321 123468899999998865 4568899999999999999999999864321 1111111 1111
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..+... ... ....+.+++.+||..+|.+|||+.+++++
T Consensus 224 ~~~~~~------~~~---~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 224 PSPQLP------AEK---FSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCCC------ccc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111110 011 12347889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=305.71 Aligned_cols=251 Identities=22% Similarity=0.394 Sum_probs=198.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|.....||+|+||.||++.... ++..||||.+...... ....+..|+..++.++||||+++++.+...+..++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKH-TGKQVAVKKMDLRKQQ----RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECC-CCCEEEEEEEecchHH----HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 445556789999999999998654 6889999998653322 25668899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|.+++.. ..+++.....++.|++.||.||| +++++||||||+||+++.++.++|+|||++...
T Consensus 97 v~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 97 VMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred EEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 9999999999998853 45888999999999999999999 678999999999999999999999999998765
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
...... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.... +...
T Consensus 169 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~~~~~~~----~~~~ 238 (292)
T cd06658 169 SKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----LQAMRRIRDNL----PPRV 238 (292)
T ss_pred cccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcC----CCcc
Confidence 433221 1235689999999999888899999999999999999999999865321 11111111111 1110
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+. ......+.+++.+||..||.+|||+.+++++
T Consensus 239 ~~~-------~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 KDS-------HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccc-------cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000 0112247778889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=307.24 Aligned_cols=269 Identities=23% Similarity=0.322 Sum_probs=199.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|+..+.||+|+||.||+|.+.. +++.||+|.+....... .....+..|+.+++.++||||+++++++......++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE-TGQIVAIKKFLESEDDK--MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC-CCCEEEEEeHhhccCcc--hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 357888999999999999998754 68899999986543322 224567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|..+... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++...
T Consensus 78 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07846 78 VFEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150 (286)
T ss_pred EEecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence 9999999888887653 345899999999999999999999 678999999999999999999999999998876
Q ss_pred CCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH-------h
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV-------M 434 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~-------~ 434 (531)
...... .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+..+.... .
T Consensus 151 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 151 AAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred cCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 543322 1234578999999988753 47889999999999999999999986432211111111110000 0
Q ss_pred ccCCC-Ccccccccc-----CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 435 TSENP-NRAIDSKLL-----GNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 435 ~~~~~-~~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..... .....+... ....+.....+.+++.+||..+|.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000 000000000 00011223458889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=298.26 Aligned_cols=242 Identities=19% Similarity=0.268 Sum_probs=187.1
Q ss_pred ccccccceeEEEEEeeeCC-----------CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 209 EKIRSRASGEIYIAELPES-----------NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
+.||+|+||.||+|.+... ....|++|.+...... ....+..|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRD----ISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhh----HHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4689999999999986321 1235888887653322 245688899999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC-------
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME------- 350 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~------- 350 (531)
...++||||+++|+|..++.. ....+++..+..++.|+++||.||| +++++||||||+|||++.++.
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred CCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCce
Confidence 999999999999999998864 2356899999999999999999999 788999999999999987664
Q ss_pred EEEeecCCCccCCCCCccceecccccCccccCccccc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCcccchhhhHHHH
Q 009595 351 ARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ-TLKFSEKCDIYSFGVLLAVLV-MGKLPSDDFFQHTEEKSLVR 428 (531)
Q Consensus 351 vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-tg~~P~~~~~~~~~~~~l~~ 428 (531)
++++|||++...... ....|+..|+|||.+. +..++.++|||||||++|||+ +|..||...... ...
T Consensus 151 ~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~~- 219 (262)
T cd05077 151 IKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA----EKE- 219 (262)
T ss_pred eEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh----HHH-
Confidence 899999998755322 2245788999999886 456899999999999999998 588887643211 111
Q ss_pred HHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 429 WMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 429 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
......... ... ....+.+++.+||+.||.+||++.+|++.|+
T Consensus 220 ---~~~~~~~~~-------~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 ---RFYEGQCML-------VTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ---HHHhcCccC-------CCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111111100 011 1234788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.69 Aligned_cols=257 Identities=22% Similarity=0.364 Sum_probs=201.0
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeC--
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRP-- 277 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~-- 277 (531)
..++|...+.||+|+||.||+|.... +++.+|+|.+...... ...+..|+.++.++ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~-~~~~~aik~~~~~~~~-----~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKK-DGSLAAVKILDPISDV-----DEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECC-CCCEEEEEEecccccH-----HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 46889999999999999999998654 7889999998653321 34567899999998 899999999998754
Q ss_pred ---CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe
Q 009595 278 ---DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 278 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
...++||||+++|+|.+++.........+++..+..++.|++.||.||| ..+++|+||||+||+++.++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEe
Confidence 3579999999999999998754344567899999999999999999999 7789999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-----KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRW 429 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~ 429 (531)
|||++......... .....|+..|+|||.+... .++.++|||||||++|+|++|+.||..... ...+..+
T Consensus 171 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~---~~~~~~~ 245 (291)
T cd06639 171 DFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP---VKTLFKI 245 (291)
T ss_pred ecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH---HHHHHHH
Confidence 99998876543221 1234688999999987643 368899999999999999999999875422 1112211
Q ss_pred HHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 430 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.... +....++ ......+.+++.+||+.||.+|||+.+++++
T Consensus 246 ----~~~~-~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 ----PRNP-PPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ----hcCC-CCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 1111111 1112347889999999999999999999876
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=298.61 Aligned_cols=256 Identities=20% Similarity=0.304 Sum_probs=196.0
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch-hhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--Cc
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS-LLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--DC 279 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~ 279 (531)
.+|...+.||+|+||.||+|.... ++..|++|.+...... ........+.+|+.++++++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD-TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC-CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 367888999999999999998654 6889999998654321 1222356788999999999999999999988753 56
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++++||+++++|.+++.. ...+++.....++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 7899999999999999965 345888999999999999999999 778999999999999999999999999998
Q ss_pred ccCCCCCc-cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 360 RLMPDGHA-QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 360 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
........ ........++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+. .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---~~~~~----~~~~~~~ 226 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIF----KIATQPT 226 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---HHHHH----HHhcCCC
Confidence 86543211 1111234578999999999988899999999999999999999999875422 11111 1111111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. +.+ .......+..++ +||..+|.+|||+.+|+.+
T Consensus 227 ~-----~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 N-----PQL----PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred C-----CCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0 111 011112345555 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=299.89 Aligned_cols=261 Identities=27% Similarity=0.444 Sum_probs=205.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|+..+.||.|++|+||+|.... ++..+++|++....... ....+.+|+..++.++||||+++++.+......++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP-NNEKVAIKRIDLEKCQT---SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC-CCcEEEEEEeccCCcch---HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence 367889999999999999998654 78899999987543222 36778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|.+++..... ...+++.....++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++..+
T Consensus 77 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~ 152 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASL 152 (267)
T ss_pred EEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence 9999999999999975211 256899999999999999999999 788999999999999999999999999998877
Q ss_pred CCCCccc--eecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 363 PDGHAQV--STSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 363 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
....... ......|+..|+|||.+... .++.++|+||||+++|+|++|+.||...... ..+..... ...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~----~~~~ 225 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQ----NDPP 225 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhc----CCCC
Confidence 6543221 22335689999999998776 7899999999999999999999998754221 11112111 1111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
....+ .........+.+++.+||..||.+|||+.+++++
T Consensus 226 ~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETG-----ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCc-----cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11000 0011223457889999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=319.51 Aligned_cols=258 Identities=22% Similarity=0.319 Sum_probs=207.5
Q ss_pred hhhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 199 LEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 199 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
+.+.+.|.++..||.|+||.||+|..+. ++-..|-|.+...... ....+.-||.+|..+.||+||++++.|+.++
T Consensus 28 lnP~d~WeIiGELGDGAFGKVyKA~nke-t~~lAAaKvIetkseE----ELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 28 LNPRDHWEIIGELGDGAFGKVYKAVNKE-TKLLAAAKVIETKSEE----ELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred CCHHHHHHHHhhhcCccchhhhhhhccc-chhhhhhhhhcccchh----HHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 4456777888899999999999998763 5666678888654333 3788999999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
.++|+.|||.||-.+..+-. ....+.+..+..+++|++.||.||| +++|||||||..|||++-+|.++|+|||.
T Consensus 103 kLwiliEFC~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGV 176 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGV 176 (1187)
T ss_pred ceEEEEeecCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccc
Confidence 99999999999999988764 3567999999999999999999999 78899999999999999999999999999
Q ss_pred CccCCCCCccceecccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQ-----TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
+....... .....+.|||.|||||+.. ..+|+.++|||||||+|.||..+.+|.++..+ .+.+..+
T Consensus 177 SAKn~~t~--qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVllKi 247 (1187)
T KOG0579|consen 177 SAKNKSTR--QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKI 247 (1187)
T ss_pred cccchhHH--hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHHHH
Confidence 77543322 2224578999999999875 34799999999999999999999999776533 2223333
Q ss_pred hccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 434 MTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 434 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
....+|.. .-| ..|. ..+.+++.+||..||..||++.++++|-
T Consensus 248 aKSePPTL-lqP----S~Ws---~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 248 AKSEPPTL-LQP----SHWS---RSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred hhcCCCcc-cCc----chhh---hHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 33333332 222 2222 3467778889999999999999999864
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=315.38 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=206.8
Q ss_pred cccccccccccceeEEEEEeeeCC-CCe--EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 204 CSASLEKIRSRASGEIYIAELPES-NGK--MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+..++||.|-||.||+|.+... .|. .||||..+.+...+. .+.|..|..+|++++|||||+++|+|.+ ...
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~---tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD---TEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh---HHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 345678999999999999998543 343 578888876443322 6779999999999999999999999976 478
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
+||||+++-|.|..||+. ....++..+...++.||..||.||| +..+|||||..+|||+.+...|||+|||+++
T Consensus 466 WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhh
Confidence 999999999999999985 4567899999999999999999999 6779999999999999999999999999999
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
.+.+...... +...-...|||||.+.-.+++.++|||.|||++||++. |..||.+....+....+ -++.++
T Consensus 540 ~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------EnGeRl 611 (974)
T KOG4257|consen 540 YLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------ENGERL 611 (974)
T ss_pred hccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------cCCCCC
Confidence 9887654433 23344678999999999999999999999999999987 99999875443322211 111111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
. - +..+ ...|..|+.+||..||.+||.+.++...|+++.
T Consensus 612 P---~----P~nC---Pp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 612 P---C----PPNC---PPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred C---C----CCCC---ChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 1 1 1111 124778999999999999999999999887653
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=304.92 Aligned_cols=265 Identities=21% Similarity=0.247 Sum_probs=196.5
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||.|+||.||+|.... +|+.||+|.+....... .....+.+|+.++++++||||+++++++.+....+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~-~g~~~~~k~~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC-CCcEEEEEEeecccccc--cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence 36778899999999999998764 68899999997533211 1134567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
+||+.+ +|.+++.. ....+++..+..++.||++||.||| ..+++||||||+||+++.++.++|+|||++....
T Consensus 78 ~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 78 FEYCDQ-DLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred EecCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 999975 88888764 2356899999999999999999999 7789999999999999999999999999988654
Q ss_pred CCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC----
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN---- 438 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~---- 438 (531)
..... .....+++.|+|||.+.+. .++.++|||||||++|+|+||..|+..... ....+.. +........
T Consensus 151 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~-~~~~~~~~~~~~~ 225 (284)
T cd07839 151 IPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKR-IFRLLGTPTEESW 225 (284)
T ss_pred CCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHH-HHHHhCCCChHHh
Confidence 33221 1234578899999988765 478999999999999999999998643211 1111111 111110000
Q ss_pred ------CCccccccccC-----CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 ------PNRAIDSKLLG-----NGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ------~~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+.....+.... ...+.....+.+++.+||+.||.+|||+.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000000000 0011122457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=305.34 Aligned_cols=257 Identities=19% Similarity=0.285 Sum_probs=202.5
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||+|++|.||+|.... +++.||+|.+....... ......+..|+.++..++||||+++++.+......|+|
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKG-TGKLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcC-CCcEEEEEEEeccccch-HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 57888999999999999998764 68899999997643322 22356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+.+++|.+++.. .....+++.....++.|++.||.||| ..+++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 80 MDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999999874 33457899999999999999999999 7889999999999999999999999999987654
Q ss_pred CCCcc---------------------------ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009595 364 DGHAQ---------------------------VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDD 416 (531)
Q Consensus 364 ~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~ 416 (531)
..... .......||..|+|||.+.+..++.++||||||+++|+|++|+.||.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 32111 011234688999999999988899999999999999999999999875
Q ss_pred cccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC----HHHHHHH
Q 009595 417 FFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN----SKDVRSM 483 (531)
Q Consensus 417 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~~ 483 (531)
... ...+... .... ..... .......+.+++.+||..||.+||| +.+++.+
T Consensus 235 ~~~---~~~~~~~----~~~~-~~~~~--------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 235 SNR---DETFSNI----LKKE-VTFPG--------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred Cch---HHHHHHH----hcCC-ccCCC--------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 422 1111111 1111 11000 0012345888999999999999999 6666653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=302.52 Aligned_cols=249 Identities=21% Similarity=0.274 Sum_probs=200.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|+..+.||+|++|.||++.... +++.||+|.+....... ......+..|+.++++++||||+++++++......++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG-SGKYYALKILSKAKIVK-LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence 367889999999999999998764 68899999997533211 1225678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|.+++.. ...++...+..++.|++.||.||| ..+++|+||+|+||+++.++.+||+|||++...
T Consensus 79 v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 79 VMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999999975 467899999999999999999999 788999999999999999999999999998876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...... .. .+.+.
T Consensus 152 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~---~~-~~~~~-- 216 (290)
T cd05580 152 KGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----IQIYEK---IL-EGKVR-- 216 (290)
T ss_pred CCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH---Hh-cCCcc--
Confidence 544 2234689999999999888889999999999999999999999865321 111111 11 11111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
+. ... ...+.+++.+||..||.+|| ++.+++++
T Consensus 217 ~~----~~~----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 217 FP----SFF----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CC----ccC----CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11 111 23478899999999999999 66666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=293.77 Aligned_cols=258 Identities=22% Similarity=0.373 Sum_probs=207.5
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceEEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv 283 (531)
.+-+..||.|.||+|++-.++. .|+.+|||+++..... ....++..|..+..+- +.||||++||.+..++..|+.
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~-sg~~mAVKrIr~~n~~---keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKP-SGKLMAVKRIRSNNIE---KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCc-cCcEEEEEEeeeccch---HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 3446789999999999998765 7999999999876652 2356788888766555 799999999999999999999
Q ss_pred EeccCCCCHHHHHhh-ccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 284 SEFMKNGSLLEILND-VSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||+|.- ||+.+... +......+++.....|+.-...||.||.. ...|||||+||+|||++..|.+||||||++..+
T Consensus 142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 999965 88776543 22345679999999999999999999986 567999999999999999999999999999988
Q ss_pred CCCCccceecccccCccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTL--KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
.++-. .+.-.|...|||||.+... .|+.+|||||||++|||++||+.||... .++++.+........|.
T Consensus 219 v~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w------~svfeql~~Vv~gdpp~ 289 (361)
T KOG1006|consen 219 VDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW------DSVFEQLCQVVIGDPPI 289 (361)
T ss_pred HHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH------HHHHHHHHHHHcCCCCe
Confidence 76633 3446799999999998644 5899999999999999999999999765 34666666666555554
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+.. .......+..++..|+..|-+.||++.++..+
T Consensus 290 l~~~~~-----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 290 LLFDKE-----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ecCccc-----ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 433322 22233347778888999999999999988764
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=296.40 Aligned_cols=253 Identities=20% Similarity=0.292 Sum_probs=202.4
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|+..+.||+|+||.||.+.... +|+.||+|.+....... .....+..|+.++++++||||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~-~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE-DGKQYVIKEINISKMSP--KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC-CCCEEEEEEEEhHhCCh--HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence 47788999999999999998764 78899999997543222 1246788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++++|.+++.. .....+++.....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 78 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 78 MDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152 (256)
T ss_pred EecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence 999999999999865 22346788999999999999999999 7789999999999999999999999999998765
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
..... .....|++.|+|||++.+..++.++|+||||+++++|++|+.||.... .... +........+..
T Consensus 153 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~~~~---~~~~~~~~~~~~-- 221 (256)
T cd08218 153 STVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN----MKNL---VLKIIRGSYPPV-- 221 (256)
T ss_pred cchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC----HHHH---HHHHhcCCCCCC--
Confidence 43221 123457889999999988889999999999999999999999986421 1111 222222111110
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.......+.+++.+||+.+|.+||++.+++++
T Consensus 222 --------~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 --------SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --------cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 01112347889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.58 Aligned_cols=198 Identities=22% Similarity=0.346 Sum_probs=160.5
Q ss_pred ccccccceeEEEEEeeeC-CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe--CCceEEEEe
Q 009595 209 EKIRSRASGEIYIAELPE-SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR--PDCHLLVSE 285 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E 285 (531)
.+||+|+||.||+|.... .++..||+|.+..... ...+.+|+.++++++||||+++++++.. ....++|||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 579999999999998642 2457899999875432 2346789999999999999999998854 457789999
Q ss_pred ccCCCCHHHHHhhcc-----CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee----CCCCCEEEeec
Q 009595 286 FMKNGSLLEILNDVS-----QGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI----DDDMEARIADF 356 (531)
Q Consensus 286 ~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl----~~~~~vkL~Df 356 (531)
|+.+ +|.+++.... .....+++..+..++.|++.||.||| +.+++||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9965 8888875321 11235888999999999999999999 7789999999999999 55678999999
Q ss_pred CCCccCCCCCcc-ceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009595 357 GLARLMPDGHAQ-VSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDD 416 (531)
Q Consensus 357 gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~ 416 (531)
|+++........ .......||+.|+|||.+.+. .++.++|||||||++|||+||+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 999876543221 112345689999999998764 578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=306.25 Aligned_cols=257 Identities=19% Similarity=0.273 Sum_probs=209.5
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+-|...+.||+|.|..|-+|++-- +|..||||++.+..... .....+.+|++.|+.++|||||++|++......+|
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVF-TGekVAVKviDKTKlD~--~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVF-TGEKVAVKVIDKTKLDT--LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhc-ccceeEEEEecccccch--hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 3667888899999999999997653 89999999998755433 22567888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC-CCCCEEEeecCCCc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID-DDMEARIADFGLAR 360 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~-~~~~vkL~Dfgla~ 360 (531)
||+|+-.+|+|+||+-. ....+.+..+.+++.||..|+.|+|..| +|||||||+|+.+- .-|-|||+|||++.
T Consensus 94 LiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred EEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccc
Confidence 99999999999999975 3466899999999999999999999555 99999999999875 45889999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS-EKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
.+..+... +..||+..|-|||++.+..|+ +++||||||||||.|+||+.||......+ .+...+-..+
T Consensus 168 kf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---TLTmImDCKY----- 236 (864)
T KOG4717|consen 168 KFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---TLTMIMDCKY----- 236 (864)
T ss_pred cCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---hhhhhhcccc-----
Confidence 87665432 457899999999999999986 68999999999999999999998653322 2221111110
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCc
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTA 488 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 488 (531)
....-...+..+||..||..||.+|.|.++|... |+.+.
T Consensus 237 ----------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 237 ----------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred ----------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 1122233468899999999999999999998863 44443
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=301.89 Aligned_cols=242 Identities=17% Similarity=0.267 Sum_probs=187.1
Q ss_pred ccccccceeEEEEEeeeCC------CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 209 EKIRSRASGEIYIAELPES------NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.||+|+||.||+|..... ....|++|.+..... ...+.+..|+.+++.++||||+++++++..++..++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR----NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhH----HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence 4699999999999986431 123488888764322 225678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC--------EEEe
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME--------ARIA 354 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~--------vkL~ 354 (531)
||||+++|+|.+++.. ....+++..+..++.|++.||.||| +++++||||||+||+++.++. ++++
T Consensus 77 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~ 150 (258)
T cd05078 77 VQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150 (258)
T ss_pred EEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEec
Confidence 9999999999999974 2346889999999999999999999 788999999999999987765 6999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCC-CCCCCcccchhhhHHHHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGK-LPSDDFFQHTEEKSLVRWMRN 432 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~-~P~~~~~~~~~~~~l~~~~~~ 432 (531)
|||++...... ....+++.|+|||++.+. .++.++||||||+++|+|++|. .||..... .........
T Consensus 151 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~ 220 (258)
T cd05078 151 DPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS----QKKLQFYED 220 (258)
T ss_pred ccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH----HHHHHHHHc
Confidence 99987754322 234578899999998864 5789999999999999999985 56543221 111111111
Q ss_pred HhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 433 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
... +. ...+ ..+.+++.+||+.||.+|||+.++++.|+
T Consensus 221 ---~~~----~~----~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ---RHQ----LP----APKW----TELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---ccc----CC----CCCc----HHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 00 1111 24788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=304.33 Aligned_cols=266 Identities=22% Similarity=0.287 Sum_probs=201.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|++|.||+|.... +++.||+|.+...... ......+..|+.++++++||||+++++++...+..++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA-TGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC-CCcEEEEehhhhhccc--ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence 367889999999999999998764 6889999998753322 1225678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
+|||++++.|..+... ...+++..+..++.+++.||.||| ..+++|+||+|+||+++.++.+||+|||++...
T Consensus 78 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~ 150 (288)
T cd07833 78 VFEYVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARAL 150 (288)
T ss_pred EEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence 9999998766665543 355899999999999999999999 778999999999999999999999999998876
Q ss_pred CCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC--
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP-- 439 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~-- 439 (531)
...... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||.+.... ..+.. .........+
T Consensus 151 ~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~-~~~~~~~~~~~~ 225 (288)
T cd07833 151 RARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLYL-IQKCLGPLPPSH 225 (288)
T ss_pred CCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-HHHHhCCCCHHH
Confidence 654321 12335678899999999888 7899999999999999999999998754221 11111 1111100000
Q ss_pred ---------------CccccccccCCCcHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 440 ---------------NRAIDSKLLGNGYEE-QMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 440 ---------------~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.....+......++. ....+.+++.+||..+|.+|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000000000111 13558899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=294.60 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=200.2
Q ss_pred cccccccccceeEEEEEeeeCCC---CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 206 ASLEKIRSRASGEIYIAELPESN---GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++.+.||.|+||.||++.+.... +..||+|.+....... ....+..|+.++..++||||+++++++...+..++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ---QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH---HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 45688999999999999886422 4889999997644321 26778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
+|||+++++|.+++... ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 i~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 79 VMEYMEGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEeccCCCCHHHHHHhh--hhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceec
Confidence 99999999999999751 1122899999999999999999999 778999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
........ ....+++.|+|||.+.+..++.++||||+|+++++|++ |..||.... ...+...+.. ...+..
T Consensus 154 ~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~----~~~~~~~~~~---~~~~~~ 225 (258)
T smart00219 154 YDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS----NEEVLEYLKK---GYRLPK 225 (258)
T ss_pred cccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHhc---CCCCCC
Confidence 65422221 12336789999999988889999999999999999998 788876531 1222222211 111100
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
+ .. ....+.+++.+||..||.+|||+.++++.|
T Consensus 226 ---~---~~----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ---P---EN----CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---C---Cc----CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 01 223488899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=302.71 Aligned_cols=263 Identities=24% Similarity=0.274 Sum_probs=198.6
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|+..+.||.|++|.||+|.... +|+.||||.+....... .....+..|+.++++++||||+++++++...+..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETE--GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC-CCCEEEEEEcccccccc--ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 47788999999999999998754 78899999987543221 1245688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+. ++|.+++.. .....+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.+||+|||++....
T Consensus 78 ~e~~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 78 FEFLH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred eeccc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99996 589998865 33457899999999999999999999 7789999999999999999999999999988654
Q ss_pred CCCccceecccccCccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLK-FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
..... .....+++.|+|||.+.+.. ++.++||||||+++|+|+||+.||.... ....+...+...- .+...
T Consensus 152 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~---~~~~~ 223 (284)
T cd07860 152 VPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS---EIDQLFRIFRTLG---TPDEV 223 (284)
T ss_pred cCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHHhC---CCChh
Confidence 33221 12345688999999887654 5889999999999999999999986532 2222222221110 00000
Q ss_pred ccc-------------cccC----CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDS-------------KLLG----NGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~-------------~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..+ .... .........+.+++.+||+.||.+|||+.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 224 VWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 0000 0000112346789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=297.62 Aligned_cols=256 Identities=20% Similarity=0.272 Sum_probs=197.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch-hhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--Cc
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS-LLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--DC 279 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~ 279 (531)
.+|...+.||+|+||.||.|.... +|+.||||.+...... ........+..|+.++++++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD-TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC-CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 467888999999999999998653 7889999998643221 1122357788999999999999999999988663 46
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
++++|||+++++|.+++.. ...+++.....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 7899999999999999875 345788889999999999999999 778999999999999999999999999998
Q ss_pred ccCCCCCcc-ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 360 RLMPDGHAQ-VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 360 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
......... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+... ...+. .....+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~----~~~~~~~ 226 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---MAAIF----KIATQPT 226 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---HHHHH----HHhcCCC
Confidence 865432111 112234588999999999888899999999999999999999999875421 11111 1111111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. .........+.+++.+|+. +|.+||++.+++++
T Consensus 227 ~~---------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 NP---------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CC---------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00 0111222346778888884 99999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=297.41 Aligned_cols=259 Identities=21% Similarity=0.300 Sum_probs=201.3
Q ss_pred ccccccccccccceeEEEEEeeeCC--CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 203 DCSASLEKIRSRASGEIYIAELPES--NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..|...+.||.|+||.||+|.+... ....|+||........ ...+.+..|+.++++++||||+++++++.. ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP---SVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH---HHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 4577889999999999999987532 2346899988754322 225678899999999999999999998875 567
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++.. ....+++..+..++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 82 WIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred EEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceee
Confidence 899999999999999964 2345899999999999999999999 7789999999999999999999999999988
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
......... .....++..|+|||.+....++.++||||||+++|||++ |..||..... ......+.. ...+
T Consensus 156 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~~~~~~~---~~~~ 227 (270)
T cd05056 156 YLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN----NDVIGRIEN---GERL 227 (270)
T ss_pred eccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHc---CCcC
Confidence 765442211 122334568999999988889999999999999999986 9999875432 122222211 1111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
.. ... ....+.+++.+|+..+|.+|||+.++++.|.++..
T Consensus 228 ~~-------~~~---~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 PM-------PPN---CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CC-------CCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 10 011 12247889999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=318.24 Aligned_cols=246 Identities=25% Similarity=0.375 Sum_probs=199.4
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccC
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 288 (531)
-.||+|.||+||.|++.. +...+|||-+....... .+-+..||.+.++|+|.|||+++|.+..++.+-|.||-++
T Consensus 581 vVLGKGTYG~VYA~RD~~-tqvrIaIKEIpekdsr~----~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMD-TQVRIAIKEIPEKDSRE----VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeecccc-ceeEEEeeecccccchh----hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence 479999999999998764 66779999997654433 6778899999999999999999999999988899999999
Q ss_pred CCCHHHHHhhccCCCccC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC-CCCCEEEeecCCCccCCCC
Q 009595 289 NGSLLEILNDVSQGRREL--EWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID-DDMEARIADFGLARLMPDG 365 (531)
Q Consensus 289 ~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~-~~~~vkL~Dfgla~~~~~~ 365 (531)
||||.++|+.. -+++ .+.+.-.+..||++||.||| .+.|||||||-+|+|++ -.|.+||+|||-++++..-
T Consensus 656 GGSLSsLLrsk---WGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 656 GGSLSSLLRSK---WGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred CCcHHHHHHhc---cCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC
Confidence 99999999862 2445 77888899999999999999 77799999999999996 5799999999999877543
Q ss_pred CccceecccccCccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 366 HAQVSTSIVAGTVGYIAPEYHQTL--KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 366 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
. ..+..+.||..|||||++..+ +|+.++|||||||++.||.||++||....... ...+. -.+++ .
T Consensus 730 n--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFk--VGmyK-------v 796 (1226)
T KOG4279|consen 730 N--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFK--VGMYK-------V 796 (1226)
T ss_pred C--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhh--hccee-------c
Confidence 3 334568899999999999876 58999999999999999999999997653211 11111 00000 0
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS 482 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 482 (531)
-+....+.......+|.+|+.+||..|||++++++
T Consensus 797 ----HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 797 ----HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ----CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11223344456888999999999999999999987
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=294.60 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=200.3
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch-hhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS-LLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
|...+.||+|++|.||+|.... +++.|++|.+...... ......+.+..|+.+++.++||||+++++++.....++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLD-DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred ccccceeeecCCceEEEEEEcC-CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5667889999999999998754 6889999998754321 1122356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
+||+++++|.+++.. ...+++.....++.|++.||.||| ..+++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999975 346889999999999999999999 7789999999999999999999999999988764
Q ss_pred CCCccceecccccCccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLK-FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
... ......|++.|+|||.+.... ++.++|+||||+++|+|++|+.||..... ......+... ...+ .
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~---~~~~--~ 222 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIGRS---KELP--P 222 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHHHHHHhc---ccCC--C
Confidence 433 123356889999999987766 89999999999999999999999876431 1111111110 0111 0
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+.+ .....+.+++.+||..+|.+||++.+++.+
T Consensus 223 ~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 IPD--------HLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCC--------CcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111 112347788999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=302.87 Aligned_cols=260 Identities=20% Similarity=0.269 Sum_probs=201.5
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|+||.||++.... +++.|++|.+....... ......+..|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~ik~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE-TRQRFAMKKINKQNLIL-RNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC-CCcEEEEEEeehhhhhh-HHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 357888999999999999998754 68899999987643211 1225678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|.+++.. ...+++..+..++.+++.||.||| +.+++||||||+||+++.++.++|+|||+++..
T Consensus 79 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 79 VMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151 (305)
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999999965 356899999999999999999999 778999999999999999999999999998742
Q ss_pred CCCC-------------ccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHH
Q 009595 363 PDGH-------------AQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRW 429 (531)
Q Consensus 363 ~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~ 429 (531)
.... .........|+..|+|||.+.+..++.++|+||||+++|||++|..||.+... ..+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~----~~~~-- 225 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP----EELF-- 225 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH--
Confidence 1110 00111224578899999999888899999999999999999999999865321 1211
Q ss_pred HHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 430 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
....... ....... . .....+.+++.+||+.||.+||++.++.+.|+.
T Consensus 226 -~~~~~~~-~~~~~~~---~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 226 -GQVISDD-IEWPEGD---E----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -HHHHhcc-cCCCCcc---c----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111111 0000000 0 112247889999999999999998777777766
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=303.25 Aligned_cols=250 Identities=20% Similarity=0.337 Sum_probs=198.2
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
.|.....||+|+||.||+|.... +++.||+|.+....... ...+.+|+.++..++||||+++++++..++..+++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~----~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKH-SGRQVAVKMMDLRKQQR----RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcC-CCCEEEEEEEEecccch----HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence 34455689999999999998754 68899999986543222 45678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++++|.+++.. ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 97 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 97 MEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168 (297)
T ss_pred EecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence 999999999998753 46889999999999999999999 7789999999999999999999999999987654
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
..... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ......+. ....+....
T Consensus 169 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~~---~~~~~~~~~ 239 (297)
T cd06659 169 KDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAMKRLR---DSPPPKLKN 239 (297)
T ss_pred ccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHh---ccCCCCccc
Confidence 43221 1235689999999999888899999999999999999999999864321 11111111 111111000
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. ......+.+++.+||+.+|.+|||+.+++++
T Consensus 240 ~--------~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 A--------HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred c--------CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 0112247788999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.05 Aligned_cols=304 Identities=20% Similarity=0.279 Sum_probs=214.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC---
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD--- 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 278 (531)
.++|.+.+.||+|+||.||+|.... +|+.||+|.+...... .....+..|+.++++++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKP-TGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcC-CCCeEEEEEecccccc---hhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 4678999999999999999998754 7889999998643221 12456778999999999999999999876543
Q ss_pred --ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 279 --CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 279 --~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
..++++||+.+ +|.+++.. ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+||
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~df 150 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDF 150 (336)
T ss_pred cceEEEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcc
Confidence 47999999965 88888753 56899999999999999999999 778999999999999999999999999
Q ss_pred CCCccCCCCCccc-eecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 357 GLARLMPDGHAQV-STSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 357 gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
|++.......... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+... ......+....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~----~~~~~~~~~~~ 226 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY----LHQLNLILGVL 226 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHc
Confidence 9988764432211 1123568999999998654 4688999999999999999999999865321 11111111111
Q ss_pred ccCCCCcc----------------ccccc-cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCchhh
Q 009595 435 TSENPNRA----------------IDSKL-LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKDVDF 495 (531)
Q Consensus 435 ~~~~~~~~----------------~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~ 495 (531)
..+.+... ..+.. .....+.....+.+++.+||+.||.+|||+.+++++ +.......+...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~ 306 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPV 306 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCccc
Confidence 11110000 00000 000001123458899999999999999999999997 665432221111
Q ss_pred --hhhccCCCCCChHHHHHhhHHHHhhhh
Q 009595 496 --LKMHKRMDFDNDDCVELIQQEIYTEWL 522 (531)
Q Consensus 496 --~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (531)
.+.+.+..--.+.-...+|..+|.++.
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 307 AEEPFPFDFELFDDLPKEKLKELIFEEIM 335 (336)
T ss_pred CCCCCChhhccccccCHHHHHHHHHHHhc
Confidence 122322221122246677777777754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=302.24 Aligned_cols=255 Identities=22% Similarity=0.370 Sum_probs=198.1
Q ss_pred hhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEe--
Q 009595 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVR-- 276 (531)
Q Consensus 200 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~-- 276 (531)
.+.+.|+..+.||.|+||.||+|.... +++.+|+|.+...... ...+..|+.++.++ +||||+++++++..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~a~K~~~~~~~~-----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTEDE-----EEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcC-CCcEEEEEEEecChHH-----HHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 356788999999999999999998764 7889999998653321 45677899999998 79999999998853
Q ss_pred ----CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEE
Q 009595 277 ----PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEAR 352 (531)
Q Consensus 277 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vk 352 (531)
....+++|||+++|+|.+++... ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 45679999999999999999752 2345888889999999999999999 77899999999999999999999
Q ss_pred EeecCCCccCCCCCccceecccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHH
Q 009595 353 IADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ-----TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLV 427 (531)
Q Consensus 353 L~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~ 427 (531)
|+|||++........ ......|++.|+|||.+. +..++.++|||||||++|+|++|..||.+.... ..+.
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~~~ 236 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM---RALF 236 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH---hhhh
Confidence 999999886543221 112356899999999875 345788999999999999999999998654221 1111
Q ss_pred HHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 428 RWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 428 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. ..... ... .... .....+.+++.+||..||.+|||+.+++++
T Consensus 237 ~----~~~~~-~~~-----~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 L----IPRNP-PPK-----LKSK---KWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred h----HhhCC-CCC-----Cccc---ccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 1 11111 100 0011 112358889999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=294.58 Aligned_cols=254 Identities=27% Similarity=0.394 Sum_probs=206.5
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||.|++|.||+|.... +++.|+||++...... .....+..|+..+..++||||+++++++......++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKP-TGKIYALKKIHVDGDE---EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcC-CCcEEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence 57788999999999999998765 6889999999765432 2357788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR-PRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|||+++++|.+++.. ...+++.....++.|+++||.||| . .+++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~ 150 (264)
T cd06623 78 LEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL 150 (264)
T ss_pred EEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999999999975 367899999999999999999999 6 88999999999999999999999999998876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
....... ....++..|+|||.+.+..++.++|+||||+++|+|+||+.||...... ........+. ....+.
T Consensus 151 ~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~---~~~~~~-- 222 (264)
T cd06623 151 ENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAIC---DGPPPS-- 222 (264)
T ss_pred ccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHh---cCCCCC--
Confidence 5443221 2345789999999999888999999999999999999999998765321 1122222222 111111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
... .. ....+.+++.+||..+|++|||+.+++++
T Consensus 223 ~~~----~~---~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPA----EE---FSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCc----cc---CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 10 22358889999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.72 Aligned_cols=265 Identities=25% Similarity=0.288 Sum_probs=201.5
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||+|++|.||+|.... +|..||+|++....... .....+.+|+.++++++||||+++++++......++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~vK~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE-TGETVALKKVALRRLEG--GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC-CCceEEEEEEEcccccc--hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence 36778899999999999998754 68899999997644221 2246788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+ +++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 78 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 78 MEYM-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFS 150 (286)
T ss_pred eccc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence 9999 99999998642 356899999999999999999999 7789999999999999999999999999988765
Q ss_pred CCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc-
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR- 441 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~- 441 (531)
.... .......|+..|+|||.+.+. .++.++||||+|+++|+|++|..||..... ......+........+..
T Consensus 151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07832 151 EEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND----IEQLAIVFRTLGTPNEETW 225 (286)
T ss_pred CCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH----HHHHHHHHHHcCCCChHHH
Confidence 4432 112235689999999988654 468999999999999999999888754321 111111111111110000
Q ss_pred -----------cccccc----cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 -----------AIDSKL----LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 -----------~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+.. .....++....+.+++.+||..||.+|||+.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 000011223568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=299.87 Aligned_cols=250 Identities=24% Similarity=0.413 Sum_probs=201.1
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|...+.||+|+||.||+|.... ++..||+|.+...... .....+.+|+.++.+++||||+++++++..+...++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~-~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECC-CCcEEEEEEeccccch---HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence 457778899999999999997653 6889999988643321 225678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|.+++.. ..+++..+..++.+++.|+.||| ..+++|+||+|+||+++.++.++|+|||++..+
T Consensus 80 v~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 80 IMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred EEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceec
Confidence 9999999999999863 46889999999999999999999 788999999999999999999999999998766
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... .... ........+.
T Consensus 152 ~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~---~~~~~~~~~~-- 220 (277)
T cd06641 152 TDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MKVL---FLIPKNNPPT-- 220 (277)
T ss_pred ccchhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----HHHH---HHHhcCCCCC--
Confidence 443211 1234678899999999888889999999999999999999999865422 1111 1111111111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. . .....+.+++.+||..+|.+||++.+++++
T Consensus 221 ~~----~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LE----G----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CC----c----ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11 1 112347788999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=296.61 Aligned_cols=261 Identities=19% Similarity=0.340 Sum_probs=202.6
Q ss_pred ccccccccccccceeEEEEEeeeCC----CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 203 DCSASLEKIRSRASGEIYIAELPES----NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
++|.....||.|+||.||+|..... ....|++|.+...... .....+..|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE---NLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch---HHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 5678889999999999999986432 3467899988653322 12567889999999999999999999999989
Q ss_pred ceEEEEeccCCCCHHHHHhhccCC-----CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEE
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQG-----RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARI 353 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL 353 (531)
..++||||+++|+|.+++...... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEE
Confidence 999999999999999999753211 126899999999999999999999 778999999999999999999999
Q ss_pred eecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHH
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRN 432 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~ 432 (531)
+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+... ..+......
T Consensus 159 ~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----~~~~~~~~~ 233 (275)
T cd05046 159 SLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----EEVLNRLQA 233 (275)
T ss_pred cccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch----HHHHHHHHc
Confidence 99999875433221 12223456788999999988888999999999999999999 7889865321 222222111
Q ss_pred HhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 433 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
+....... .. ....+.+++.+||..||.+|||+.+++..|.+
T Consensus 234 ----~~~~~~~~-----~~---~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 234 ----GKLELPVP-----EG---CPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred ----CCcCCCCC-----CC---CCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11111000 11 11248889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=300.15 Aligned_cols=266 Identities=19% Similarity=0.248 Sum_probs=197.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||+|++|.||+|.... +++.||||.+........ ...+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKL-TGQLVALKEIRLEHEEGA---PFTAIREASLLKDLKHANIVTLHDIIHTKKTLT 79 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcC-CCcEEEEEEEecccccCC---chhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence 3678899999999999999998653 688999999975432211 234667999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+.+ +|.+++.. ....+++.....++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++.
T Consensus 80 lv~e~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 80 LVFEYLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARA 152 (291)
T ss_pred EEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence 99999975 99998864 2346889999999999999999999 77899999999999999999999999999875
Q ss_pred CCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.... ......+......+.+.
T Consensus 153 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 227 (291)
T cd07844 153 KSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV---EDQLHKIFRVLGTPTEE 227 (291)
T ss_pred cCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHHHHHHhcCCCChh
Confidence 4322111 122346889999998865 45789999999999999999999998654311 11111111111111000
Q ss_pred cc----------------ccccccCCCcHH--HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RA----------------IDSKLLGNGYEE--QMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~----------------~d~~l~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. ..+......... ....+.+++.+||+.||.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 000000000000 01356789999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=306.30 Aligned_cols=302 Identities=22% Similarity=0.290 Sum_probs=219.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC----
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP---- 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 277 (531)
...|...+.||.|+||+||+|.... +++.||||.+....... .....+..|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSE-TNEKVAIKKIANAFDNR--IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecC-CCCeEEEEEeccccccc--chhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 3568889999999999999998754 78999999987532221 1145567899999999999999999987654
Q ss_pred -CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 278 -DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 278 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
...|+|+||+. ++|.+++.. ...+++.....++.|++.||.||| +++++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Df 152 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDF 152 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcC
Confidence 24799999996 589998864 457899999999999999999999 778999999999999999999999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
|++......... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+ .....
T Consensus 153 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~~ 226 (337)
T cd07858 153 GLARTTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLI----TELLG 226 (337)
T ss_pred ccccccCCCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHH----HHHhC
Confidence 999876543211 123457889999998765 46889999999999999999999998654221111111 11111
Q ss_pred cCCCC------------------ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCchhh
Q 009595 436 SENPN------------------RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKDVDF 495 (531)
Q Consensus 436 ~~~~~------------------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~ 495 (531)
..... ....... ....+.....+.+++.+||+.||.+|||+.+++++ +..+........
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~ 305 (337)
T cd07858 227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV 305 (337)
T ss_pred CCChHHhhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc
Confidence 00000 0000000 00011223457899999999999999999999998 766544444434
Q ss_pred hhhccCCCCCChH-HHHHhhHHHHhhh
Q 009595 496 LKMHKRMDFDNDD-CVELIQQEIYTEW 521 (531)
Q Consensus 496 ~~~~~~~~~~~~~-~~~~~~~~~~~~~ 521 (531)
...+-..+|+..+ ..+++++-++.|-
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (337)
T cd07858 306 CQTPFSFDFEEDALTEEDIKELIYNEM 332 (337)
T ss_pred CCCccchhhhhhhcCHHHHHHHHHHHH
Confidence 4555566666655 4556666666653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=300.89 Aligned_cols=271 Identities=23% Similarity=0.249 Sum_probs=201.6
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchh-hhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSL-LNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+|...+.||.|++|.||+|.... +|+.||||.+....... .......+..|+.++++++||||+++++++......++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE-TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC-CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 36778899999999999998754 68899999997644321 11124556789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+ +|+|.+++.. ....+++..+..++.||++||.||| ..+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 80 VFEFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred EEccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 99999 8899999964 1136899999999999999999999 778999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC-
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN- 440 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~- 440 (531)
....... ....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+..... .+...... .......
T Consensus 153 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~-~~~~~~~~ 226 (298)
T cd07841 153 GSPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEA-LGTPTEEN 226 (298)
T ss_pred cCCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHH-cCCCchhh
Confidence 5543221 22356888999998855 457899999999999999999987776532211 11111111 0000000
Q ss_pred --------ccccccccC-----CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCc
Q 009595 441 --------RAIDSKLLG-----NGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTA 488 (531)
Q Consensus 441 --------~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 488 (531)
......... .........+.+++.+||+.||.+|||+.+++++ +.+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 000000000 0011223458899999999999999999999986 44443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=293.25 Aligned_cols=240 Identities=19% Similarity=0.281 Sum_probs=188.3
Q ss_pred ccccccceeEEEEEeeeCCCC---------eEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 209 EKIRSRASGEIYIAELPESNG---------KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
+.||+|+||.||+|....... ..+++|.+...... ...+.+|+.++++++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-----SLAFFETASLMSQLSHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-----HHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence 469999999999998864221 35778877643321 4678889999999999999999999888 77
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC-------CEE
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM-------EAR 352 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-------~vk 352 (531)
.++||||+++|+|.+++... ...+++..+..++.|++.||.||| +++++||||||+||+++.++ .+|
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEE
Confidence 89999999999999999752 226889999999999999999999 78899999999999999887 799
Q ss_pred EeecCCCccCCCCCccceecccccCccccCcccccCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHH
Q 009595 353 IADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL--KFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRW 429 (531)
Q Consensus 353 L~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~ 429 (531)
|+|||++...... ....++..|+|||++.+. .++.++||||||+++|+|++ |..||...... ....+
T Consensus 149 l~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~----~~~~~ 218 (259)
T cd05037 149 LSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS----EKERF 218 (259)
T ss_pred eCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch----hHHHH
Confidence 9999998865441 224567889999998876 78999999999999999999 57777654221 11111
Q ss_pred HHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 430 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
.. ..... ..+ . ...+.+++.+||..+|.+|||+.++++.|+
T Consensus 219 ~~---~~~~~---~~~-----~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQ---DQHRL---PMP-----D----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred Hh---cCCCC---CCC-----C----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11 00000 000 0 035888999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=292.65 Aligned_cols=256 Identities=23% Similarity=0.377 Sum_probs=201.9
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||+|+||.||+|.... +++.|++|.+...... ......+..|+.+++.++||||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~-~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD-TGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC-CCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence 46778999999999999998654 6889999999865443 23367899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
+||+++++|.+++.. ...+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.+||+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~ 150 (264)
T cd06626 78 MEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK 150 (264)
T ss_pred EecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence 999999999999964 345788999999999999999999 7789999999999999999999999999988765
Q ss_pred CCCccce--ecccccCccccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 364 DGHAQVS--TSIVAGTVGYIAPEYHQTLK---FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 364 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
....... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||..... ....... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---~~~~~~~---~~~~~~ 224 (264)
T cd06626 151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---EFQIMFH---VGAGHK 224 (264)
T ss_pred CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---hHHHHHH---HhcCCC
Confidence 4432211 11346788999999988766 88999999999999999999999965421 1111111 111111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+.. .. .......+.+++.+||+.+|.+|||+.+++.+
T Consensus 225 ~~~--~~------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 225 PPI--PD------SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCC--Cc------ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 110 00 00112346789999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=303.93 Aligned_cols=274 Identities=20% Similarity=0.260 Sum_probs=199.8
Q ss_pred cccccccccccceeEEEEEeeeCC-CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--Cce
Q 009595 204 CSASLEKIRSRASGEIYIAELPES-NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--DCH 280 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~ 280 (531)
.|...+.||+|++|.||+|..... ++..||+|.+...... .......+.+|+.++++++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-YTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 367788999999999999987542 5789999999864311 111245677899999999999999999999988 789
Q ss_pred EEEEeccCCCCHHHHHhhccCCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC----CCCEEEee
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD----DMEARIAD 355 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~----~~~vkL~D 355 (531)
++||||+++ +|.+++....... ..+++..+..++.|++.||.||| +.+++||||||+||+++. ++.+||+|
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 999999975 7888776433322 37899999999999999999999 778999999999999999 89999999
Q ss_pred cCCCccCCCCCc-cceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccch------hhhHHH
Q 009595 356 FGLARLMPDGHA-QVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHT------EEKSLV 427 (531)
Q Consensus 356 fgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~------~~~~l~ 427 (531)
||++........ ........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+..... ....+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999987654322 1122335678999999987764 57899999999999999999999997543221 001111
Q ss_pred HHHHHHhccCCCC------------c---cccccccC-CCcH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 428 RWMRNVMTSENPN------------R---AIDSKLLG-NGYE-------EQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 428 ~~~~~~~~~~~~~------------~---~~d~~l~~-~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..+.. +....+. . ........ .... .....+.+++.+||+.||++|||+.+++++
T Consensus 236 ~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 236 RIFEV-LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHH-hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11111 1000000 0 00000000 0000 122358889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=297.87 Aligned_cols=267 Identities=19% Similarity=0.212 Sum_probs=196.6
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
+.+.|...+.||+|+||.||+|.... +|..||+|.+....... ....+.+|+.+++.++||||+++++++......
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 78 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRI-NGQLVALKVISMKTEEG---VPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcC-CCcEEEEEEecccCcCC---CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeE
Confidence 34778999999999999999998654 68889999997543221 123567899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+. ++|.+++.. ....+++..+..++.|++.||.||| ..+++|+||||+||+++.+++++|+|||++.
T Consensus 79 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred EEEEeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEecccccc
Confidence 99999996 588877753 2345778888899999999999999 7789999999999999999999999999987
Q ss_pred cCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
........ .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||..... ....+.. .......+..
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~-~~~~~~~~~~ 226 (291)
T cd07870 152 AKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEK-IWTVLGVPTE 226 (291)
T ss_pred ccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHH-HHHHcCCCCh
Confidence 65432211 1234578999999998764 578899999999999999999999975422 1111111 1111110000
Q ss_pred C------------ccccccccCCCcH------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 440 N------------RAIDSKLLGNGYE------EQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 440 ~------------~~~d~~l~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. ............. .....+.+++.+|+..||++|||+.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 227 DTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 0000000000000 012347789999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=300.29 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=201.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||++.... ++..||+|.+....... ...+..|+.+++.++||||+++++++...+..|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~----~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA-TGQEVAIKQMNLQQQPK----KELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC-CCCEEEEEEeccccchH----HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 3678889999999999999997543 67889999986433222 466788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+|+||+++++|.+++.. ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 93 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred EEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 99999999999999864 45788899999999999999999 78899999999999999999999999999876
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
....... .....|++.|+|||.+.+..++.++|+||||+++|++++|+.||...... ..+. .....+.+..
T Consensus 165 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~---~~~~----~~~~~~~~~~ 235 (293)
T cd06647 165 ITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALY----LIATNGTPEL 235 (293)
T ss_pred ccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---hhee----ehhcCCCCCC
Confidence 5443221 12346889999999998888999999999999999999999998653211 1111 1111111111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. ........+.+++.+||..+|.+||++.+++.+
T Consensus 236 ~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 Q--------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred C--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011122347889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=295.20 Aligned_cols=252 Identities=24% Similarity=0.299 Sum_probs=201.5
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||.|+||.||+|.... ++..||+|.+....... ....+.+.+|+.++++++||||+++++++..+...++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD-TKKMFAMKYMNKQKCVE-KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc-CCcEEEEEEEehhhhcc-hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 47788999999999999998754 68889999997543221 12357788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
+||+++++|.+++.. ...+++..+..++.|+++||.||| ..+++|+||+|+||++++++.++|+|||++....
T Consensus 79 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~ 151 (258)
T cd05578 79 VDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT 151 (258)
T ss_pred EeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence 999999999999975 357889999999999999999999 7789999999999999999999999999988765
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
.... .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ....+ ........+ ..
T Consensus 152 ~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~----~~~~~~~~~--~~ 221 (258)
T cd05578 152 PDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQI----RAKQETADV--LY 221 (258)
T ss_pred CCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHH----HHHhccccc--cC
Confidence 4321 12356888999999998888999999999999999999999998754321 11111 111111111 01
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCH--HHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS--KDVRS 482 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~ 482 (531)
.+ .....+.+++.+||..||.+||++ +++++
T Consensus 222 ~~--------~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 222 PA--------TWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cc--------cCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 11 112457889999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=297.62 Aligned_cols=258 Identities=22% Similarity=0.334 Sum_probs=197.6
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCceEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~l 282 (531)
+|...+.||+|+||.||++.... +++.||+|.+...... .....+..|+.++.++. ||||+++++++..+...++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~-~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKP-SGTIMAVKRIRSTVDE---KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECC-CCCEEEEEEehhccCh---HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 45667899999999999998764 6889999999754332 22566888999999996 9999999999999899999
Q ss_pred EEeccCCCCHHHHHhhc-cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 283 VSEFMKNGSLLEILNDV-SQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+|||+.. +|.++.... ......+++.....++.+++.||.|||+ ..+++||||||+||+++.++.++|+|||++..
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 9999865 776654321 1223678999999999999999999994 35899999999999999999999999999986
Q ss_pred CCCCCccceecccccCccccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTL---KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+...... ....|++.|+|||.+.+. .++.++||||||+++|+|++|+.||.... .....+........
T Consensus 158 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~ 228 (288)
T cd06616 158 LVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKGDP 228 (288)
T ss_pred hccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCCCC
Confidence 6543222 224578999999998776 68999999999999999999999986542 12222222222111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+.. ...........+.+++.+||+.||.+|||+.+|+.+
T Consensus 229 ~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 PIL------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcC------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 111111223357889999999999999999998875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=299.82 Aligned_cols=268 Identities=21% Similarity=0.256 Sum_probs=199.7
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--Cce
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--DCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~ 280 (531)
++|...+.||.|+||.||+|.+.. +++.+|+|.++..... ......+.+|+.++.+++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK-TGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC-CCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 568889999999999999998754 6889999999754332 11234567899999999999999999998877 889
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+||||+.+ +|.+++... ...+++.....++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~lv~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~ 154 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAR 154 (293)
T ss_pred EEEehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCcee
Confidence 999999975 999998652 236899999999999999999999 6789999999999999999999999999988
Q ss_pred cCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHH--------
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMR-------- 431 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~-------- 431 (531)
........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+...+.
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 155 EYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred eccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 76554221 1234578899999988764 468899999999999999999999875432111111111100
Q ss_pred ---HHhcc--CCCCccccccccCCCcHH--HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 432 ---NVMTS--ENPNRAIDSKLLGNGYEE--QMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 432 ---~~~~~--~~~~~~~d~~l~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..... ..........+ ....+. ....+.+++.+||+.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred Hhhccchhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 00000000000 011111 13457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=346.52 Aligned_cols=262 Identities=29% Similarity=0.501 Sum_probs=210.5
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
..+...+.||+|+||.||+|.... ++..||||.+...... ...|+..+++++|||||+++|+|...+..++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIK-NGMQFVVKEINDVNSI--------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECC-CCcEEEEEEccCCccc--------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 456667899999999999998753 7889999998753321 1246888999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.++++ .++|..+..++.|+++||.|||+.+.++++||||||+||+++.++..++. ||.....
T Consensus 761 v~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 761 IHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred EEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 999999999999995 27899999999999999999997767899999999999999999888875 6654432
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
... ....||+.|+|||++.+..++.++|||||||++|||+||+.||+.... ....+..|.+...........
T Consensus 833 ~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 904 (968)
T PLN00113 833 CTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWARYCYSDCHLDMW 904 (968)
T ss_pred ccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHHHHHhcCccchhhe
Confidence 211 123678999999999999999999999999999999999999864322 234566676655444434444
Q ss_pred ccccccC--CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 443 IDSKLLG--NGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 443 ~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
+++.+.. .........+.+++.+||+.||.+||||.++++.|+++..
T Consensus 905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 4544322 2234556678899999999999999999999999988754
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=297.54 Aligned_cols=265 Identities=24% Similarity=0.287 Sum_probs=197.2
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 284 (531)
|+..+.||.|++|.||+|.... +|..||+|++....... .....+..|+.+++.++||||+++++++...+..+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL-TGEIVALKKIRLETEDE--GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC-CCCEEEEEEeecccccc--cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence 5667899999999999998754 78999999997543221 11356778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCC
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~ 364 (531)
||++ ++|.+++.. .....+++..+..++.|++.||.||| +++++||||+|+||+++.++.++|+|||++.....
T Consensus 78 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 78 EFLD-LDLKKYMDS--SPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV 151 (283)
T ss_pred eccC-cCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence 9995 599999875 22246899999999999999999999 67899999999999999999999999999876543
Q ss_pred CCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC-----
Q 009595 365 GHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN----- 438 (531)
Q Consensus 365 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~----- 438 (531)
.... .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||..... ...+...++.......
T Consensus 152 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 152 PVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE---IDQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred Cccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHHhhh
Confidence 3211 1223568899999987664 578899999999999999999999865422 1222222211100000
Q ss_pred ----CC--ccc---cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 ----PN--RAI---DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ----~~--~~~---d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. ... ...............+.+++.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 000 0000000011112357889999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=291.96 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=200.4
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||+|+||.||+|.... +|..||+|.+....... .....+.+|+.+++.++||||+++++.+......++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPV--KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC-CCceEEEEEeeHhhccc--hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence 46778999999999999998764 67889999987642221 1245678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC-CEEEeecCCCccC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM-EARIADFGLARLM 362 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkL~Dfgla~~~ 362 (531)
+||+++++|.+++.. .....+++..+..++.++++||.||| ..+++|+||+|+||++++++ .++|+|||.+...
T Consensus 78 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 78 MEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred EecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 999999999999975 23345799999999999999999999 67899999999999999886 4699999998876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
....... ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ...+..........
T Consensus 153 ~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~-- 221 (257)
T cd08225 153 NDSMELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQGYFAP-- 221 (257)
T ss_pred cCCcccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhcccCCC--
Confidence 5432221 224588999999999888899999999999999999999999864321 11222222111110
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. . .....+.+++.+||..+|++|||+.+++.+
T Consensus 222 ~~----~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 IS----P----NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CC----C----CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11 1 112247889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=295.94 Aligned_cols=250 Identities=21% Similarity=0.348 Sum_probs=198.6
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
.|...+.||.|++|.||++.... +++.+++|.+....... .+.+.+|+.+++.++||||+++++++...+..+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~~~----~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKS-TGRQVAVKKMDLRKQQR----RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECC-CCCEEEEEEEeccchhH----HHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence 45556799999999999998654 68889999986533222 45678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
+||+++++|.+++.. ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++....
T Consensus 95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 999999999999864 45888999999999999999999 7789999999999999999999999999887654
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
..... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ... +....... +....
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~~~---~~~~~~~~-~~~~~ 236 (285)
T cd06648 167 KEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQA---MKRIRDNL-PPKLK 236 (285)
T ss_pred cCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----HHH---HHHHHhcC-CCCCc
Confidence 33221 1235689999999999888899999999999999999999999865321 111 11111111 11100
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+ ......+.+++.+||..+|.+|||+.+++++
T Consensus 237 ~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 NL-------HKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cc-------ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 00 0112348889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=299.46 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=198.7
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
....|...+.||+|+||.||+|.... +|+.||+|.+....... ......+.+|+.+++.++||||+++++++...+..
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~v~iK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcC-CCcEEEEEEEeccccCc-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 34668889999999999999998754 68899999986543222 12246788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+.+ +|.+++.. ....+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++.
T Consensus 91 ~lv~e~~~g-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~ 163 (307)
T cd06607 91 WLVMEYCLG-SASDILEV---HKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSAS 163 (307)
T ss_pred EEEHHhhCC-CHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcce
Confidence 999999974 88887753 2346899999999999999999999 7789999999999999999999999999987
Q ss_pred cCCCCCccceecccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQ---TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
..... ....|++.|+|||++. ...++.++||||||+++|||+||+.||.+.... .. ........
T Consensus 164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---~~----~~~~~~~~ 230 (307)
T cd06607 164 LVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SA----LYHIAQND 230 (307)
T ss_pred ecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH---HH----HHHHhcCC
Confidence 65332 2245788999999874 356888999999999999999999998653211 11 11111111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
.+.. .. ......+.+++.+||..||.+||++.+++.+.
T Consensus 231 ~~~~------~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 231 SPTL------SS---NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CCCC------Cc---hhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 1110 01 11223578899999999999999999998763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=296.42 Aligned_cols=249 Identities=22% Similarity=0.389 Sum_probs=197.8
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC---CCcccccceeEEeCCce
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR---HRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~ 280 (531)
.|+..+.||+|+||.||+|.+.. +++.||+|.+....... ....+.+|+.++++++ ||||+++++++......
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP-TGRVVALKIINLDTPDD---DVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC-CCcEEEEEEecCCCCch---hHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence 46778899999999999998754 78899999987533221 2456778999999986 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++++|.+++.. ..+++.....++.+++.||.||| ..+++|+||+|+||+++.++.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAA 149 (277)
T ss_pred EEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCcee
Confidence 999999999999999864 36899999999999999999999 7789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
........ .....|+..|+|||.+.++ .++.++|+||||+++|+|++|..||..... ..... ..... .+
T Consensus 150 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~---~~~~~-~~ 219 (277)
T cd06917 150 LLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA----FRAMM---LIPKS-KP 219 (277)
T ss_pred ecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh----hhhhh---ccccC-CC
Confidence 77654322 1234689999999988654 468899999999999999999999875422 11111 11111 11
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS 482 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 482 (531)
. .+.... ....+.+++.+||+.||.+||++.+++.
T Consensus 220 ~-----~~~~~~---~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 220 P-----RLEDNG---YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred C-----CCCccc---CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1 111111 2234788999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=295.77 Aligned_cols=245 Identities=26% Similarity=0.315 Sum_probs=190.3
Q ss_pred ccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccCCC
Q 009595 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNG 290 (531)
Q Consensus 211 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 290 (531)
||+|+||+||++.... +|+.||+|.+....... ......+..|+.++++++||||+++++++...+..|+||||++++
T Consensus 1 lg~g~~g~vy~~~~~~-~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKA-TGKMYACKKLDKKRLKK-RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcC-CCcEEEEEEEehhhhhh-hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 6899999999997654 78999999997533221 112455678999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccce
Q 009595 291 SLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS 370 (531)
Q Consensus 291 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~ 370 (531)
+|.+++.. .....+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~L~~~l~~--~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 150 (277)
T cd05577 79 DLKYHIYN--VGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--- 150 (277)
T ss_pred cHHHHHHH--cCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---
Confidence 99999975 22346899999999999999999999 77899999999999999999999999999876543211
Q ss_pred ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCC
Q 009595 371 TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGN 450 (531)
Q Consensus 371 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 450 (531)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+.. ..... +.. . +.
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~-~~~-----~-~~ 219 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR----RTLEM-AVE-----Y-PD 219 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh----ccccc-ccc-----C-Cc
Confidence 1234578899999999888899999999999999999999999865432111111111 10000 000 0 00
Q ss_pred CcHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 009595 451 GYEEQMLLVLKIACFCTLDDPEERPNSKD 479 (531)
Q Consensus 451 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e 479 (531)
.....+.+++.+||+.||.+||+..+
T Consensus 220 ---~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 220 ---KFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ---cCCHHHHHHHHHHccCChhHccCCCc
Confidence 11234788999999999999995444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=299.43 Aligned_cols=266 Identities=22% Similarity=0.254 Sum_probs=196.7
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCc--
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDC-- 279 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~-- 279 (531)
++|...+.||+|+||.||+|.+.. +|+.||+|.+....... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~-~~~~v~lK~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN-TGKLVALKKTRLEMDEE--GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC-CCcEEEEEeehhhcccc--CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 367888999999999999998754 78899999986543211 11356778999999995 6999999998887665
Q ss_pred ---eEEEEeccCCCCHHHHHhhccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC-CCCEEEe
Q 009595 280 ---HLLVSEFMKNGSLLEILNDVSQG-RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD-DMEARIA 354 (531)
Q Consensus 280 ---~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vkL~ 354 (531)
.|+||||+++ +|.+++...... ...+++..+..++.||+.||.||| .++++||||+|+||+++. ++.+||+
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~ 153 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIA 153 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEe
Confidence 7999999986 899988653222 356899999999999999999999 778999999999999998 8899999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
|||++..+....... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.... ..+.......
T Consensus 154 dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~ 228 (295)
T cd07837 154 DLGLGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL---QQLLHIFKLL 228 (295)
T ss_pred ecccceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHh
Confidence 999988654332211 22356889999998765 45789999999999999999999998653221 1222211111
Q ss_pred hccCCCCccccccc----------------cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 434 MTSENPNRAIDSKL----------------LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 434 ~~~~~~~~~~d~~l----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. .+.....+.. .....+.....+.+++.+||..||.+|||+.+++.+
T Consensus 229 -~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 229 -G--TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred -C--CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0100000000 000001123447889999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=296.25 Aligned_cols=269 Identities=21% Similarity=0.276 Sum_probs=199.2
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|+..+.||.|++|.||+|.... +|..||||.+....... ....+..|+.++++++||||+++++++...+..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT-TGEIVALKEIHLDAEEG---TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC-CCeEEEEEEeccccccc---chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence 47788999999999999998754 78899999997643221 135567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++ +|.+++.... ....+++..+..++.|++.||.||| ..+++||||+|+||++++++.++|+|||++....
T Consensus 77 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 77 FEYMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred EecCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 999985 8999886522 1346899999999999999999999 6789999999999999999999999999987654
Q ss_pred CCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHH--------HHh
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMR--------NVM 434 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~--------~~~ 434 (531)
..... .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.........+.+... ...
T Consensus 152 ~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 152 IPVNT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred CCccc--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 33211 1234578899999988664 578899999999999999999999876432221111111100 000
Q ss_pred ccCCCCccccc---cccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 435 TSENPNRAIDS---KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 435 ~~~~~~~~~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
........... .......+.....+.+++..|++.||.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000000 00000011123457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=303.73 Aligned_cols=303 Identities=21% Similarity=0.297 Sum_probs=210.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeC--C
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRP--D 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~--~ 278 (531)
.++|...+.||+|+||.||+|.... +|+.+|+|.+........ ....+.+|+.+++++ +||||+++++++... .
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~vK~~~~~~~~~~--~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRR-TKEVVALKKIFDAFRNAT--DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcC-CCeEEEEEeeccccCcch--hhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 4678889999999999999998753 688999998864322211 145567899999999 999999999988654 3
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
..++||||+.+ +|.+++.. ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRA-----NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred eEEEEeccccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 57999999975 99998864 27788899999999999999999 77899999999999999999999999999
Q ss_pred CccCCCCCcc---ceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHH----
Q 009595 359 ARLMPDGHAQ---VSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM---- 430 (531)
Q Consensus 359 a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~---- 430 (531)
+......... .......|++.|+|||.+.+ ..++.++||||||+++|+|+||+.||.+.........+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9876543221 12233568999999998765 457889999999999999999999986543211111111100
Q ss_pred ------------HHHhcc-CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCchhh
Q 009595 431 ------------RNVMTS-ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKDVDF 495 (531)
Q Consensus 431 ------------~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~ 495 (531)
...+.. ....... ...........+.+++.+||+.||.+|||+.+++++ +.+........-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~ 309 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKP----LDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPV 309 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccc----hhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCC
Confidence 000000 0000000 000011123457889999999999999999999986 444322211111
Q ss_pred hhhccCCCCCChH--HHHHhhHHHHhh
Q 009595 496 LKMHKRMDFDNDD--CVELIQQEIYTE 520 (531)
Q Consensus 496 ~~~~~~~~~~~~~--~~~~~~~~~~~~ 520 (531)
...+....++... ++..-+.++|.|
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (337)
T cd07852 310 LPYPITIPLDDNVKLSVAEYRNKLYEE 336 (337)
T ss_pred CCCCccCCccccceeeHHHHHhhhhhc
Confidence 1233333333322 555555666654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.08 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=205.0
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||+|++|.||++.... ++..+|+|.+....... .....+..|+.++++++||||+++++++......++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS-DNQFYALKEVDLGSMSQ--KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC-CCCEEEEEEEehhhccH--HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence 46778999999999999998654 68889999997643322 2256677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++++|.+++.........+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.+||+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK 154 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence 9999999999999764444567899999999999999999999 7889999999999999999999999999998765
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
... .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..+..... . +....
T Consensus 155 ~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~---~-~~~~~-- 220 (256)
T cd08530 155 KNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----QDLRYKVQ---R-GKYPP-- 220 (256)
T ss_pred cCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHh---c-CCCCC--
Confidence 541 1224578899999999988899999999999999999999999875421 11211111 1 11110
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
........+.+++.+||..+|.+|||+.+++++
T Consensus 221 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 -------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111223458889999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=299.84 Aligned_cols=273 Identities=20% Similarity=0.266 Sum_probs=199.0
Q ss_pred hhhhhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe
Q 009595 197 AFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276 (531)
Q Consensus 197 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 276 (531)
.+....+.|...+.||+|+||.||+|.... +++.||||.+....... .....+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~aik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKK-TKQIVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred cccchhhheEEEEEeecCCCEEEEEEEECC-CCcEEEEEEEeccCCcC--CchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 344556789999999999999999998754 78999999986533221 113345679999999999999999998876
Q ss_pred CC--------ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC
Q 009595 277 PD--------CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD 348 (531)
Q Consensus 277 ~~--------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~ 348 (531)
.. ..++||||+.+ +|.+++.. ....+++..+..++.|++.||.||| +.+++|+||||+||+++.+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~ 155 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKD 155 (310)
T ss_pred ccccccCCCceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCC
Confidence 54 34999999965 88888864 2346899999999999999999999 6789999999999999999
Q ss_pred CCEEEeecCCCccCCCCCcc--ceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhH
Q 009595 349 MEARIADFGLARLMPDGHAQ--VSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKS 425 (531)
Q Consensus 349 ~~vkL~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~ 425 (531)
+.+||+|||++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~----~ 231 (310)
T cd07865 156 GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ----H 231 (310)
T ss_pred CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH----H
Confidence 99999999999876543221 111234578899999988665 4788999999999999999999998654221 1
Q ss_pred HHHHHHHHhccCCCCcc--------ccc-cccCCC---cH------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 426 LVRWMRNVMTSENPNRA--------IDS-KLLGNG---YE------EQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 426 l~~~~~~~~~~~~~~~~--------~d~-~l~~~~---~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
....+........+... .+. ...... .. .....+.+++.+||..||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 232 QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 11111111111000000 000 000000 00 011346789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=310.16 Aligned_cols=197 Identities=26% Similarity=0.352 Sum_probs=171.5
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-C-----CcccccceeEEeC
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-H-----RNIVPLLAHMVRP 277 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h-----pnIv~l~~~~~~~ 277 (531)
+|.+.+.||+|+||.|.+|... .+++.||||+++..... ..+...|+.+|..|+ | -|||+++++|.-.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~-~T~e~VAIKIiKN~k~f-----~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDH-KTGEIVAIKIIKNKKRF-----LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEec-CCCcEEEEEeeccChHH-----HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 6788999999999999999655 48999999999875543 566778999999996 4 4799999999999
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC--CCEEEee
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD--MEARIAD 355 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~--~~vkL~D 355 (531)
+..|||+|.+.. +|.++++. ..-..++...+..++.||+.||.+|| ..+|||+||||+||||..- ..|||+|
T Consensus 261 ~HlciVfELL~~-NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred cceeeeehhhhh-hHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEe
Confidence 999999999966 99999987 44566999999999999999999999 7889999999999999653 4799999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDF 417 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~ 417 (531)
||.+........ ....+..|.|||++.+.+|+.+.||||||||++||.+|.+-|.+.
T Consensus 335 FGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 335 FGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 999887655432 345688899999999999999999999999999999997776654
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=289.90 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=195.8
Q ss_pred ccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccCCC
Q 009595 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNG 290 (531)
Q Consensus 211 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 290 (531)
||.|++|.||+|.... ++..||+|.+....... ......+..|+.+++.++||||+++++++..+...+++|||++++
T Consensus 1 lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKS-KNRTFALKCVKKRHIVE-TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECC-CCcEEEEEEEehhcchh-hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 6899999999998754 68899999997643322 122567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccce
Q 009595 291 SLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS 370 (531)
Q Consensus 291 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~ 370 (531)
+|.+++.. ...++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 79 ~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~ 148 (262)
T cd05572 79 ELWTILRD----RGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---K 148 (262)
T ss_pred cHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---c
Confidence 99999965 345889999999999999999999 7889999999999999999999999999998775542 1
Q ss_pred ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCC
Q 009595 371 TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGN 450 (531)
Q Consensus 371 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 450 (531)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... . .............. ... .
T Consensus 149 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~---~~~~~~~~~~~~~~-~~~-----~ 217 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--P---MEIYNDILKGNGKL-EFP-----N 217 (262)
T ss_pred cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--H---HHHHHHHhccCCCC-CCC-----c
Confidence 12356889999999998888999999999999999999999998754310 1 11222222111000 000 0
Q ss_pred CcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 009595 451 GYEEQMLLVLKIACFCTLDDPEERPN-----SKDVRS 482 (531)
Q Consensus 451 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 482 (531)
. ....+.+++.+||..||.+||+ +.++++
T Consensus 218 ~---~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 Y---IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred c---cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 0 1234888999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=289.56 Aligned_cols=249 Identities=24% Similarity=0.292 Sum_probs=189.8
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHH-HhcCCCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMT-AGQIRHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||.|+||.||+|.... +|+.||+|.+.......... ...+..|..+ ....+||||+++++++...+..|+|+||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~-~~~~vavK~~~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecC-CCCeEEEEEecchhhhHHHH-HHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 569999999999998754 68899999987543222111 2334445444 44568999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++++|.+++.. ...+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 150 (260)
T cd05611 80 NGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-- 150 (260)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceecccc--
Confidence 99999999965 356889999999999999999999 678999999999999999999999999998764331
Q ss_pred cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
....|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ......+. ...... ....
T Consensus 151 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~----~~~~~~--~~~~ 216 (260)
T cd05611 151 ----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----DAVFDNIL----SRRINW--PEEV 216 (260)
T ss_pred ----ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHH----hcccCC--CCcc
Confidence 234578999999999888889999999999999999999999865322 11111111 111100 0000
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
.......+.+++.+||+.||.+|||+..+.+.|..
T Consensus 217 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 217 ----KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ----cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 00112347889999999999999988766665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.72 Aligned_cols=264 Identities=20% Similarity=0.313 Sum_probs=193.8
Q ss_pred cccccc--ceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEec
Q 009595 209 EKIRSR--ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286 (531)
Q Consensus 209 ~~ig~G--~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 286 (531)
..||.| +||+||.+.... +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~-~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP-TGTLVTVRITDLENCTE--EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcC-CCcEEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence 456766 999999998754 78999999997543322 2357888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCC
Q 009595 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH 366 (531)
Q Consensus 287 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~ 366 (531)
+.+|+|.+++... ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.++++||+.+.......
T Consensus 81 ~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 81 MAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred ccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence 9999999999762 2345889999999999999999999 7789999999999999999999999998654332211
Q ss_pred ccc-----eecccccCccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc----
Q 009595 367 AQV-----STSIVAGTVGYIAPEYHQTL--KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT---- 435 (531)
Q Consensus 367 ~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~---- 435 (531)
... ......++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.... ......+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~ 232 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT---QMLLQKLKGPPYSPLD 232 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH---HHHHHHhcCCCCCCcc
Confidence 100 00112346679999998764 4789999999999999999999999764321 111111110000
Q ss_pred ----------------------------cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 ----------------------------SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ----------------------------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...........+...........+.+++.+||..||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000000000111111112233568899999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=287.14 Aligned_cols=255 Identities=20% Similarity=0.334 Sum_probs=205.7
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||.|++|.||++.... ++..|++|.+....... .....+..|+++++.++|||++++++.+...+..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS-DGKLYVLKEIDLSNMSE--KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC-CCcEEEEEEeecccCCh--HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence 46778899999999999998764 68899999997644321 2256788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
+||+++++|.+++.........+++..+..++.+++.||.||| ..+++|+||+|+||+++.++.++|+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence 9999999999999864333477999999999999999999999 6789999999999999999999999999998765
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
.... ......|++.|+|||...+..++.++|+||+|+++++|++|..||..... ..+. ........+. +
T Consensus 155 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~---~~~~~~~~~~--~ 223 (258)
T cd08215 155 STVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL----LELA---LKILKGQYPP--I 223 (258)
T ss_pred cCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH----HHHH---HHHhcCCCCC--C
Confidence 5431 22335688999999999888899999999999999999999999865321 1221 1111111111 0
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. .....+.+++.+||..+|.+|||+.+++++
T Consensus 224 -----~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 -----PS---QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -----CC---CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 112347889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=294.29 Aligned_cols=262 Identities=20% Similarity=0.264 Sum_probs=202.5
Q ss_pred cccccccccccceeEEEEEeee--CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 204 CSASLEKIRSRASGEIYIAELP--ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
+|...+.||+|++|.||++... ..+++.||||.++.............+..|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999999753 2367889999997543322233356788899999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++.. ...+++.....++.|+++||.||| ..+++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999864 356889999999999999999999 7789999999999999999999999999988
Q ss_pred cCCCCCccceecccccCccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLK--FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
......... .....|+..|+|||.+.+.. .+.++||||||+++|+|++|..||...........+ .........
T Consensus 154 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~ 229 (288)
T cd05583 154 EFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI---SRRILKSKP 229 (288)
T ss_pred ccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH---HHHHHccCC
Confidence 765432211 12346889999999987664 788999999999999999999998532111111111 112211111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
+. + .. ....+.+++.+||+.||++|||+.++.+.|+..
T Consensus 230 ~~----~---~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 230 PF----P---KT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CC----C---cc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 10 0 01 112477889999999999999999888877664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=293.82 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=203.5
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|...+.||+|++|.||+|.+.. ++..|++|.+..... ....+..|+.++++++||||+++++++......
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA-TGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc-CCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 45678888999999999999998764 578899999976443 256688899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++++||+++++|.+++.... ..+++..+..++.+++.||.||| ..|++|+||+|+||+++.++.++|+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhh
Confidence 99999999999999997621 37899999999999999999999 7889999999999999999999999999987
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... .... .......+.
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~~ 235 (286)
T cd06614 165 QLTKEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALF----LITTKGIPP 235 (286)
T ss_pred hhccchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhcCCCC
Confidence 65443221 12345788999999998888999999999999999999999998653221 1111 111111111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. .+. ......+.+++.+||+.+|.+|||+.+++++
T Consensus 236 ~-~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 L-KNP-------EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred C-cch-------hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 000 1112347889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=305.23 Aligned_cols=267 Identities=22% Similarity=0.305 Sum_probs=197.6
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC---
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--- 277 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--- 277 (531)
..+.|...+.||+|+||.||+|.... +|+.||+|.+....... .....+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV-TGQNVAIKKLSRPFQNV--THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC-CCCEEEEEecCccccCh--hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 34778999999999999999998654 78899999986432221 1245677899999999999999999987643
Q ss_pred ---CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe
Q 009595 278 ---DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 278 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
...|+||||+.+ +|.+.+.. .++...+..++.|++.||.||| ..|++||||||+||+++.++.+||+
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 91 EEFQDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred cccCcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEc
Confidence 346999999965 89988853 2888899999999999999999 7789999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHH------
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR------ 428 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~------ 428 (531)
|||++........ .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...........+..
T Consensus 161 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 161 DFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred cCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999987644322 1234578999999999998999999999999999999999999865321111000000
Q ss_pred -----H----HHHHhccCCC------Ccccccccc----CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 429 -----W----MRNVMTSENP------NRAIDSKLL----GNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 429 -----~----~~~~~~~~~~------~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. .......... ...+..... ..........+.+++.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0000000000 000000000 00011223457899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=287.18 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=204.4
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--CceEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--DCHLL 282 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~l 282 (531)
|...+.||+|++|.||+|.... +++.|++|.+...... ......+.+|+.++++++||||+++++.+... ...++
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKD-TGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred ceeeeEeeecCceEEEEEEECC-CCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 6677899999999999998764 6889999999765432 22367788999999999999999999999988 88999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
++||+++++|.+++.. ...+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 79 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 79 FLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRL 151 (260)
T ss_pred EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence 9999999999999975 338899999999999999999999 688999999999999999999999999999877
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
.............++..|+|||.+.+..++.++||||||+++++|++|..||..... . ...+.......... .
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~----~~~~~~~~~~~~~~-~ 224 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--P----MAALYKIGSSGEPP-E 224 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--h----HHHHHhccccCCCc-C
Confidence 665431112335688999999999888899999999999999999999999876431 1 11111111101110 0
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. ......+.+++.+|+..||.+||++.+++.+
T Consensus 225 ~~--------~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 225 IP--------EHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CC--------cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 10 1113458889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.86 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=198.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe----C
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR----P 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~ 277 (531)
.++|+..+.||.|++|.||+|.... +|+.||+|++....... .....+..|+.++++++||||+++++++.. .
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~valK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR-SGKKVAIKKIPHAFDVP--TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC-CCCEEEEEEeccccccc--cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 4678889999999999999998764 68899999987543221 125667789999999999999999998763 3
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
...++||||+. |+|.+++.. ...+++..+..++.|++.||.||| .++++||||||+||+++.++.+||+|||
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred ceEEEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccc
Confidence 46799999996 589998864 455899999999999999999999 7789999999999999999999999999
Q ss_pred CCccCCCCCcc--ceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 358 LARLMPDGHAQ--VSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 358 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+..... .+ ..+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~-~~~~~~~ 228 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QL-KLILSVL 228 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HH-HHHHHHh
Confidence 98866443211 11123568899999998765 458899999999999999999999996542211 11 1111111
Q ss_pred ccCCCCccc---------------cc--cc-cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 435 TSENPNRAI---------------DS--KL-LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 435 ~~~~~~~~~---------------d~--~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
..+ +.... .. .. .....+.....+.+++.+||+.||.+|||+.+++.+-
T Consensus 229 g~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 229 GSP-SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred CCC-hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 000 00000 00 00 0000111234588999999999999999999998854
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=292.99 Aligned_cols=263 Identities=16% Similarity=0.171 Sum_probs=187.8
Q ss_pred cccccccccccccceeEEEEEeeeCCC---CeEEEEEEEeccCchhh-hH-H-----HHHHHHHHHHHhcCCCCcccccc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESN---GKMIAIKKVKQVDNSLL-NI-K-----MRQVRAEIMTAGQIRHRNIVPLL 271 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~~vavK~~~~~~~~~~-~~-~-----~~~~~~Ei~~l~~l~hpnIv~l~ 271 (531)
.+.|.+.+.||+|+||.||+|.+.. + +..+|+|.......... +. . ......+...+..+.|+||++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~-~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCAS-DHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcC-CcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 3678999999999999999998753 3 45667776543222110 00 0 11122344556677999999999
Q ss_pred eeEEeCC----ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC
Q 009595 272 AHMVRPD----CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347 (531)
Q Consensus 272 ~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~ 347 (531)
+++.... ..++++|++.. ++.+.+.. ....++..+..++.|++.||.||| +++++||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcC
Confidence 9766543 33678888744 77777754 233577888899999999999999 778999999999999999
Q ss_pred CCCEEEeecCCCccCCCCCcc-----ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh
Q 009595 348 DMEARIADFGLARLMPDGHAQ-----VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTE 422 (531)
Q Consensus 348 ~~~vkL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~ 422 (531)
++.++|+|||+++.+...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||.+......
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999876432211 112235699999999999999999999999999999999999999986522221
Q ss_pred hhH--HHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 423 EKS--LVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 423 ~~~--l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
... ..++...... +... + .. ....+.+++..|+..+|.+||++.++.+.|.
T Consensus 242 ~~~~~~~~~~~~~~~-~~~~--~------~~---~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRLHE-GKIK--I------KN---ANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHhhh-hhhc--c------CC---CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111 1112222211 1110 0 01 1235788899999999999999999998763
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.96 Aligned_cols=257 Identities=22% Similarity=0.320 Sum_probs=204.2
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
-.-++....+||.|.||.||.|... .+|...|+|-++..... ......+.+|..++..++|||+|++||+-...+.+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~-~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNL-DTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecC-CccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 3455677889999999999999754 48999999988754433 23367788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
+|.||||++|+|.+.+.. +...++.....+..|++.|+.||| +.|||||||||.||+++.+|.+|++|||.|.
T Consensus 1310 ~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeeccccee
Confidence 999999999999999964 455677777789999999999999 7889999999999999999999999999999
Q ss_pred cCCCCCccc--eecccccCccccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 361 LMPDGHAQV--STSIVAGTVGYIAPEYHQTL---KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 361 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
.+....... ......||+.|||||++.+. +-..++||||+|||+.||+||+.||..+. .+..+--.+.....
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d---ne~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD---NEWAIMYHVAAGHK 1459 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc---chhHHHhHHhccCC
Confidence 887652111 12246799999999999764 35678999999999999999999997652 22222222222211
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..-|.. ....-.+++.+||..||++|.++.+++++
T Consensus 1460 Pq~P~~-------------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 PQIPER-------------LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCCchh-------------hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111111 22346788999999999999999888775
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=320.25 Aligned_cols=276 Identities=19% Similarity=0.241 Sum_probs=191.3
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCc-------------hhhhHHHHHHHHHHHHHhcCCCCccc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDN-------------SLLNIKMRQVRAEIMTAGQIRHRNIV 268 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~~~Ei~~l~~l~hpnIv 268 (531)
.+.|.+++.||+|+||.||++.+....+..+++|.+..... .........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 46799999999999999999877544444333332111000 00111245678999999999999999
Q ss_pred ccceeEEeCCceEEEEeccCCCCHHHHHhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC
Q 009595 269 PLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQ-GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347 (531)
Q Consensus 269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~ 347 (531)
++++++...+..|+|++++. ++|.+++..... ............++.|++.||.||| .++|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence 99999999999999999995 488888754211 1122345567789999999999999 778999999999999999
Q ss_pred CCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCcccchhhhHH
Q 009595 348 DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP-SDDFFQHTEEKSL 426 (531)
Q Consensus 348 ~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P-~~~~~~~~~~~~l 426 (531)
++.+||+|||++..+....... .....||+.|+|||++.+..++.++|||||||++|||++|..+ +.+. .......+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~-~~~~~~~~ 380 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDG-GGKPGKQL 380 (501)
T ss_pred CCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC-CCCHHHHH
Confidence 9999999999998765432221 2235799999999999999999999999999999999998764 4332 22222233
Q ss_pred HHHHHHHhc--cCCCCc---c---cccc-c--cCCCcHH------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 427 VRWMRNVMT--SENPNR---A---IDSK-L--LGNGYEE------QMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 427 ~~~~~~~~~--~~~~~~---~---~d~~-l--~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+..... ...+.. . ++.. . ....... ....+.+++.+||+.||.+|||+.+++++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 222221100 000000 0 0000 0 0000000 11236677889999999999999999874
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=296.53 Aligned_cols=266 Identities=23% Similarity=0.217 Sum_probs=195.7
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||.|++|.||+|.... +|+.||+|.+....... .....+..|+.++++++||||+++++++......++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV-TNETIALKKIRLEQEDE--GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC-CCcEEEEEehhhccccc--cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence 468888999999999999998754 68899999986543211 124567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC-CCCEEEeecCCCcc
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD-DMEARIADFGLARL 361 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vkL~Dfgla~~ 361 (531)
||||++ ++|.+++.. .....+++..+..++.||+.||.||| +++++|+||+|+||+++. ++.+||+|||++..
T Consensus 79 v~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~ 152 (294)
T PLN00009 79 VFEYLD-LDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (294)
T ss_pred EEeccc-ccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence 999996 488888754 22334678888899999999999999 778999999999999985 56799999999976
Q ss_pred CCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... .....+++.|+|||.+.+. .++.++||||||+++|+|+||+.||...... ..+...+.. ...+...
T Consensus 153 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~~~~~-~~~~~~~ 226 (294)
T PLN00009 153 FGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFKIFRI-LGTPNEE 226 (294)
T ss_pred cCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHH-hCCCChh
Confidence 5433211 1234578899999988664 5789999999999999999999998653221 111111111 0000000
Q ss_pred cc-----------ccccccC----CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RA-----------IDSKLLG----NGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~-----------~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. ..+.... ...+.....+.+++.+|++.||.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0000000 0011122347889999999999999999999874
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=296.10 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=200.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
..|...+.||+|+||.||+|.... ++..||+|.+....... ......+..|+.++++++|||++++++++......++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~-~~~~valK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQS-NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcC-CCcEEEEEEEecCCCCc-hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 447788899999999999998754 68899999987543322 2235678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+.+ +|.+.+.. ....+++..+..++.+++.||.||| ..+++||||+|+||+++.++.++|+|||++...
T Consensus 103 v~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 103 VMEYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred EEeCCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 9999975 88887753 2356899999999999999999999 778999999999999999999999999998754
Q ss_pred CCCCccceecccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQ---TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
... ....|++.|+|||.+. +..++.++||||||+++|+|++|+.||.... ....+..+.. ...+
T Consensus 176 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~~~~~~----~~~~ 242 (317)
T cd06635 176 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQ----NESP 242 (317)
T ss_pred CCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHh----ccCC
Confidence 332 2346889999999874 4568899999999999999999999986532 1111222111 1111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.. .. ......+.+++.+||+.+|.+||++.++++++-...
T Consensus 243 ~~------~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 243 TL------QS---NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CC------CC---ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 10 00 112234788999999999999999999999875543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=299.80 Aligned_cols=267 Identities=23% Similarity=0.292 Sum_probs=197.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--C
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--D 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~ 278 (531)
..++|...+.||.|+||.||+|.... +|+.||+|.+....... .....+.+|+.++++++||||+++++++... +
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTT-SGEIVALKKVRMDNERD--GIPISSLREITLLLNLRHPNIVELKEVVVGKHLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECC-CCcEEEEEEEEeccCCC--CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence 34678999999999999999998764 78999999997543221 1123456799999999999999999998765 4
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
..++||||+.+ +|.+++... ...+++..+..++.|++.||.||| ..+++||||||+||+++.++.+||+|||+
T Consensus 82 ~~~lv~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~ 154 (309)
T cd07845 82 SIFLVMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGL 154 (309)
T ss_pred eEEEEEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccce
Confidence 68999999965 899988642 356899999999999999999999 77899999999999999999999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
+.......... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...... .....+......+
T Consensus 155 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~----~~~~~~~~~~~~~ 228 (309)
T cd07845 155 ARTYGLPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI----EQLDLIIQLLGTP 228 (309)
T ss_pred eeecCCccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCC
Confidence 98765432211 22345788999998865 45789999999999999999999998754221 1111111111110
Q ss_pred CCCc-------------cccccccC---CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 438 NPNR-------------AIDSKLLG---NGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 438 ~~~~-------------~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.... ........ .........+.+++.+||+.||++|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 00000000 0001113457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=298.27 Aligned_cols=266 Identities=26% Similarity=0.384 Sum_probs=202.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHh--cCCCCcccccceeEEeCC-
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAG--QIRHRNIVPLLAHMVRPD- 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~--~l~hpnIv~l~~~~~~~~- 278 (531)
.......+.||+|.||.||+|.+ +++.||||++.... .+.|..|-++.+ .+.|+||++++++-...+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL---~~~~VAVKifp~~~-------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL---DNRLVAVKIFPEQE-------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc---cCceeEEEecCHHH-------HHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 34456678999999999999998 67999999998633 566777766665 458999999999766555
Q ss_pred ---ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEeeccCCCCeeeCCCC
Q 009595 279 ---CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY------HRPRIIHRNITPSSVLIDDDM 349 (531)
Q Consensus 279 ---~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~ivH~Dlkp~NILl~~~~ 349 (531)
.++||++|.+.|||.+||.. ..++|....+++..+++||+|||+. ++++|+|||||+.||||..|+
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl 353 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL 353 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence 88999999999999999985 6799999999999999999999964 367899999999999999999
Q ss_pred CEEEeecCCCccCCCCCccceecccccCccccCcccccCCC-CC-----chhhHHHHHHHHHHHHhCCCCCC--------
Q 009595 350 EARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK-FS-----EKCDIYSFGVLLAVLVMGKLPSD-------- 415 (531)
Q Consensus 350 ~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwSlGvil~elltg~~P~~-------- 415 (531)
+..|+|||||..+............+||.+|||||++.+.- +. .+.||||+|.|||||++....+.
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 99999999999988665555555689999999999997652 22 47999999999999998643321
Q ss_pred Cccc-----chhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 416 DFFQ-----HTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 416 ~~~~-----~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
-.+. +..-++..+.+-. ...+|.. ... +.. ...+..+.+.+..||..||+-|.|+.=+.+++.++.-
T Consensus 434 lpfe~evG~hPt~e~mq~~VV~--kK~RP~~--p~~-W~~--h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQELVVR--KKQRPKI--PDA-WRK--HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CchhHHhcCCCCHHHHHHHHHh--hccCCCC--hhh-hhc--CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1111 1111222221111 1111111 000 011 1345568999999999999999999999998877654
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=293.21 Aligned_cols=260 Identities=24% Similarity=0.240 Sum_probs=193.9
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeC--CceE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRP--DCHL 281 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~--~~~~ 281 (531)
|...+.||+|+||.||+|.... ++..||+|.++....... ......|+.++.++. ||||+++++++.+. +..+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~-~~~~~aik~~~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK-TGKYYAIKCMKKHFKSLE---QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcC-CCcEEEEEEehhccCCch---hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 5667899999999999998754 688999999875432221 223456888898885 99999999999887 8899
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++ +|.+++.. ....+++..+..++.|++.||.||| ..+++||||+|+||+++. +.+||+|||++..
T Consensus 77 lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~ 148 (282)
T cd07831 77 LVFELMDM-NLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRG 148 (282)
T ss_pred EEEecCCc-cHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccc
Confidence 99999975 88888864 2356899999999999999999999 778999999999999999 9999999999987
Q ss_pred CCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC-
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP- 439 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~- 439 (531)
....... ....+++.|+|||.+.. ..++.++|||||||++|||++|..||.+.... ..+............
T Consensus 149 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~ 221 (282)
T cd07831 149 IYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL----DQIAKIHDVLGTPDAE 221 (282)
T ss_pred cccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH----HHHHHHHHHcCCCCHH
Confidence 6543221 22457899999997654 45788999999999999999999999754221 122222211111000
Q ss_pred ----------CccccccccCCC----cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 440 ----------NRAIDSKLLGNG----YEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 440 ----------~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.....+...... .......+.+++.+||++||.+|||+.+++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000000 11224568999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=285.33 Aligned_cols=250 Identities=29% Similarity=0.439 Sum_probs=202.2
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 284 (531)
|...+.||+|++|.||++.... ++..+++|++..... .....+.+|+..+++++||||+++++++......++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred ceeeeeeccCCceEEEEEEECC-CCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 6677899999999999998754 688999999976543 12577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCC
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~ 364 (531)
||+++++|.+++... ...+++..+..++.+++.||.||| ..+++||||+|+||+++.++.++|+|||.+.....
T Consensus 77 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 77 EFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD 150 (253)
T ss_pred ecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence 999999999998752 257899999999999999999999 78899999999999999999999999999887665
Q ss_pred CCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcccc
Q 009595 365 GHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444 (531)
Q Consensus 365 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 444 (531)
... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...... ..... ......
T Consensus 151 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~----~~~~~-~~~~~~ 219 (253)
T cd05122 151 TKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFK----IATNG-PPGLRN 219 (253)
T ss_pred ccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch---HHHHHH----HHhcC-CCCcCc
Confidence 432 2345688999999999888889999999999999999999999865321 111111 11111 111111
Q ss_pred ccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 445 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. . .....+.+++.+||+.||.+|||+.+++++
T Consensus 220 ~----~---~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 P----E---KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred c----c---ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0 012348889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=291.25 Aligned_cols=246 Identities=22% Similarity=0.280 Sum_probs=186.1
Q ss_pred cccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHH---HHhcCCCCcccccceeEEeCCceEEEEec
Q 009595 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIM---TAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286 (531)
Q Consensus 210 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~---~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 286 (531)
.||+|+||.||++.... +++.||+|.+......... ....+..|.. ++...+||||+.+++++...+..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQ-GETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECC-CCcEEEEEEEEccccccch-HHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 48999999999998753 6889999998754322111 1222333443 33445799999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCC
Q 009595 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH 366 (531)
Q Consensus 287 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~ 366 (531)
+++|+|.+++.. ...+++..+..++.|++.||.||| ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 79 MNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 999999999864 456899999999999999999999 7789999999999999999999999999987654332
Q ss_pred ccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccc
Q 009595 367 AQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS 445 (531)
Q Consensus 367 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 445 (531)
. ....|++.|+|||.+.+ ..++.++|||||||++|+|++|..||....... ...+.. ..... . .
T Consensus 152 ~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~----~~~~~-~-----~ 216 (279)
T cd05633 152 P----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDR----MTLTV-N-----V 216 (279)
T ss_pred c----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-HHHHHH----HhhcC-C-----c
Confidence 1 23468999999998864 568899999999999999999999997543211 111111 11000 0 0
Q ss_pred cccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 446 KLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 446 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
.+.. .....+.+++.+||+.||.+|| |+++++++
T Consensus 217 ~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPD----SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCcc----ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0101 1123478889999999999999 58888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=292.49 Aligned_cols=265 Identities=25% Similarity=0.361 Sum_probs=203.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHh--cCCCCcccccceeEEeC---
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAG--QIRHRNIVPLLAHMVRP--- 277 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~--~l~hpnIv~l~~~~~~~--- 277 (531)
......+.||+|.||+||+|.| .|+.||||++...++ ..+.+|.++.+ .|+|+||+.+++.-..+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w---rGe~VAVKiF~srdE-------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW---RGEDVAVKIFSSRDE-------RSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred heeEEEEEecCccccceeeccc---cCCceEEEEecccch-------hhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 4567789999999999999999 689999999987553 34555655554 46999999999976543
Q ss_pred -CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEeeccCCCCeeeCCCCCE
Q 009595 278 -DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM-----YHRPRIIHRNITPSSVLIDDDMEA 351 (531)
Q Consensus 278 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~ivH~Dlkp~NILl~~~~~v 351 (531)
.+++||++|.+.|||+|||.. ..++....++++..+|+||++||. .+++.|.|||||+.|||+.+++.+
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 367999999999999999974 678999999999999999999994 356789999999999999999999
Q ss_pred EEeecCCCccCCCCC--ccceecccccCccccCcccccCCC----C--CchhhHHHHHHHHHHHHhC----------CCC
Q 009595 352 RIADFGLARLMPDGH--AQVSTSIVAGTVGYIAPEYHQTLK----F--SEKCDIYSFGVLLAVLVMG----------KLP 413 (531)
Q Consensus 352 kL~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwSlGvil~elltg----------~~P 413 (531)
-|+|+|||....... .....+..+||.+|||||++...- | -..+||||||.|+||++.. +.|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 999999998765442 223345688999999999986531 2 2479999999999999863 568
Q ss_pred CCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 414 SDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 414 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
|.+..+.+... +.++...-.......++++. ...+.+..+.+++..||..+|.-|-|+-.|-+.|.++.
T Consensus 436 yyd~Vp~DPs~---eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 436 YYDVVPSDPSF---EEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cccCCCCCCCH---HHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 87765433221 12222221111111122211 23356677999999999999999999999999988876
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=293.08 Aligned_cols=264 Identities=22% Similarity=0.297 Sum_probs=198.5
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--CceEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--DCHLL 282 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~l 282 (531)
|...+.||+|++|.||+|.... +|+.+|+|.+...... ......+..|+.++++++||||+++++++... +..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~-~~~~~~~K~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK-TGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC-CCeEEEEEEEeccccc--ccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 5677899999999999998764 6889999999865311 12245677899999999999999999999887 78999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++ +|.+++.. ....+++..+..++.|++.||.||| ..+++|+||+|+||++++++.++|+|||++...
T Consensus 78 v~e~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 78 VFEYMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPY 150 (287)
T ss_pred Eeccccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence 9999975 89988864 1257899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ...+........+..
T Consensus 151 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~----~~~~~~~~~~~~~~~ 225 (287)
T cd07840 151 TKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ----LEKIFELCGSPTDEN 225 (287)
T ss_pred cCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCchhh
Confidence 554321 1223456889999997765 4578999999999999999999999876432111 111111111110000
Q ss_pred cc----------------cccccCCCcHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AI----------------DSKLLGNGYEE-QMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~----------------d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. .+......... ....+.+++.+||..||.+|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 00000000111 13457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=287.52 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=198.1
Q ss_pred ccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccCCC
Q 009595 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNG 290 (531)
Q Consensus 211 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 290 (531)
||.|+||.||++.... +|+.|++|.+....... ......+..|+.++++++||||+++++.+......|++|||++++
T Consensus 1 lg~g~~~~vy~~~~~~-~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKS-TGDIYAIKVIKKADMIR-KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECC-CCCEEEEEEecchhhhh-hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 6899999999998753 68899999997543321 233677889999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc---
Q 009595 291 SLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA--- 367 (531)
Q Consensus 291 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~--- 367 (531)
+|.+++.. ...+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 79 DLASLLEN----VGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 99999975 347899999999999999999999 78899999999999999999999999999886543321
Q ss_pred ---cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcccc
Q 009595 368 ---QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444 (531)
Q Consensus 368 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 444 (531)
........++..|+|||...+..++.++||||||+++|+|++|..||..... ......+.. +.......
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~----~~~~~~~~ 223 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP----EEIFQNILN----GKIEWPED 223 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhc----CCcCCCcc
Confidence 1122345678899999999888889999999999999999999999865422 222222111 11110000
Q ss_pred ccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 445 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
......+.+++.+||+.+|.+|||+..+.+.|+.
T Consensus 224 --------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 224 --------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred --------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0012357889999999999999999766666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=292.10 Aligned_cols=248 Identities=21% Similarity=0.373 Sum_probs=196.6
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEe
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 285 (531)
....+||+|+||.||++.... ++..||||.+...... ....+..|+.+++.++||||+++++++...+..++|||
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKS-SGKLVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 97 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcC-CCeEEEEEEecccchh----HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence 345789999999999998754 7889999988643321 25668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCC
Q 009595 286 FMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDG 365 (531)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~ 365 (531)
|+++++|.+++.. ..+++.....++.|++.||.||| ..|++|+||+|+||+++.++.++|+|||++......
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 98 FLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred cCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 9999999998753 45788999999999999999999 778999999999999999999999999998765443
Q ss_pred CccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccc
Q 009595 366 HAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS 445 (531)
Q Consensus 366 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 445 (531)
... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+.... +.....
T Consensus 170 ~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~----~~~~~~~~~~~----~~~~~~- 238 (292)
T cd06657 170 VPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMKMIRDNL----PPKLKN- 238 (292)
T ss_pred ccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhhC----CcccCC-
Confidence 211 1235688999999999888889999999999999999999999865321 11112222111 110000
Q ss_pred cccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 446 KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 446 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.......+.+++.+||..||.+||++.+++++
T Consensus 239 ------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 239 ------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ------cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 00112237788999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=305.78 Aligned_cols=291 Identities=21% Similarity=0.291 Sum_probs=227.6
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|.+...||+|.|+.|..|+... ++..||||.+.+...+... ...+.+|+.+|..++|||||+++.+......+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~-t~~~VaiK~idkt~ln~~~--~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHIL-TGTEVAIKIIDKTQLNPSK--RQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecC-CCceEEEEEehhcccChHH--HHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 45788999999999999999999876 6889999999876554332 45588999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+||||+.+|.+++++.. .....+..+..++.|+.+|++||| .++|+|||||++||||+.+.++||+|||++.
T Consensus 131 ylV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred EEEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccce
Confidence 999999999999999976 556666888999999999999999 7889999999999999999999999999999
Q ss_pred cCCCCCccceecccccCccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKF-SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
.+..+... ...+|++.|.|||++.+.+| ++++|+||+|+++|-|++|..||++-.-.+-.... +.. .-+.
T Consensus 204 ~~~~~~~l---qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv---l~g---k~rI 274 (596)
T KOG0586|consen 204 FFDYGLML---QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV---LRG---KYRI 274 (596)
T ss_pred eecccccc---cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh---eee---eecc
Confidence 88754332 34789999999999999887 68999999999999999999999863211100000 000 0001
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh------c--cCcCCCch--hhh-----hhccCCCC
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML------S--DTALIKDV--DFL-----KMHKRMDF 504 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L------~--~~~~~~~~--~~~-----~~~~~~~~ 504 (531)
... + .....++++++|.++|.+|+++.++..+- + .+.+.... +|- .....+.+
T Consensus 275 p~~----m--------s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~~~l~p~~e~~~~~~~~~r~~~m~~~G~ 342 (596)
T KOG0586|consen 275 PFY----M--------SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEARLLAPLIERSTPFILAKRILHMNSIGH 342 (596)
T ss_pred cce----e--------echhHHHHHHhhccCccccCCHHHhhhhcccchhhhhhhhhcccccCccchhhHHHHHHHhhcc
Confidence 111 1 11266788889999999999999998753 1 11111111 111 23345667
Q ss_pred CChHHHHHhhHHHHhhhh
Q 009595 505 DNDDCVELIQQEIYTEWL 522 (531)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~ 522 (531)
..++..+++...+|++.-
T Consensus 343 ~~~~i~~sL~~~k~d~i~ 360 (596)
T KOG0586|consen 343 RRLKIEESLAKQKFDDIN 360 (596)
T ss_pred chhhHHHHHhhhhHHHHH
Confidence 888888888888888765
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=291.79 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=196.9
Q ss_pred cccccccccccceeEEEEEeeeC--CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 204 CSASLEKIRSRASGEIYIAELPE--SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
+|+..+.||.|+||.||.|.... .+|..||+|++............+.+..|+.++.++ +||||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 36778899999999999997632 368899999997643322222346678899999999 699999999999988899
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999965 456888999999999999999999 7889999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTL--KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
........ ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||....... ..............
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~~ 229 (290)
T cd05613 154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEP 229 (290)
T ss_pred eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc---cHHHHHHHhhccCC
Confidence 76443221 11235688999999998753 46789999999999999999999986421111 11222222222111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
+. . . .....+.+++.+||..||.+|| ++.+++.+
T Consensus 230 ~~---~-----~---~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 230 PY---P-----Q---EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CC---C-----c---cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 10 0 0 0112477899999999999997 55555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=291.39 Aligned_cols=255 Identities=20% Similarity=0.373 Sum_probs=195.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
.++|...+.||+|++|.||+|.+.. +++.||||.++...... ....+..|+.++.+. .||||+++++++......
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~~~---~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKK-TGHVMAVKQMRRTGNKE---ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECC-CCeEEEEEEEeccCChH---HHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 4678889999999999999998764 58999999997643221 144566677767666 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|++|||+.+ +|.+++.. ....+++..+..++.+++.||.|||+ ..+++||||+|+||+++.++.+||+|||++.
T Consensus 90 ~~v~e~~~~-~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 90 FICMELMST-CLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred EEEeeccCc-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 999999854 88887754 23478999999999999999999994 2589999999999999999999999999988
Q ss_pred cCCCCCccceecccccCccccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLK----FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
.+...... ....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||..... . .+.+......
T Consensus 164 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~---~~~~~~~~~~ 234 (296)
T cd06618 164 RLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---E---FEVLTKILQE 234 (296)
T ss_pred hccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh---H---HHHHHHHhcC
Confidence 76543222 2235788999999987553 78899999999999999999999865311 1 1122222222
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..+... .. . .....+.+++.+||..||.+||++.+++++
T Consensus 235 ~~~~~~-~~----~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 235 EPPSLP-PN----E---GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCC-CC----C---CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111110 00 0 112347889999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=285.88 Aligned_cols=256 Identities=20% Similarity=0.286 Sum_probs=197.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCc-hhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--Cc
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDN-SLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--DC 279 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~ 279 (531)
.+|...+.||+|+||.||+|.... ++..||+|.+..... .........+.+|+.++++++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD-TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC-CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 467888999999999999998654 788999998854321 11223357888999999999999999999988764 45
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
+++++||+++++|.+++.. ...+++.....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 7899999999999999864 345788899999999999999999 778999999999999999999999999999
Q ss_pred ccCCCCCc-cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 360 RLMPDGHA-QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 360 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
........ ........|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.+... ...+. .....+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~----~~~~~~~ 226 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIF----KIATQPT 226 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHHHH----HHHcCCC
Confidence 86543211 1111234688999999999888899999999999999999999999875421 11111 1111111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. .+ + ......+.+++.+||. +|..|||+.+++.|
T Consensus 227 ~~-~~-----p---~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 227 KP-ML-----P---DGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CC-CC-----C---cccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11 11 1 1122347788889998 57999999988875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=287.79 Aligned_cols=244 Identities=20% Similarity=0.285 Sum_probs=187.8
Q ss_pred ccccccccc--cccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCc
Q 009595 203 DCSASLEKI--RSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 203 ~~~~~~~~i--g~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 279 (531)
+.|.+.+.+ |+|+||.||++.... ++..+|+|.+....... .|+.....+ +||||+++++++...+.
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKP-TQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcC-CCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 455555555 999999999998654 68889999987533211 122222222 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC-CEEEeecCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM-EARIADFGL 358 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkL~Dfgl 358 (531)
.++||||+++|+|.+++.. ...+++..+..++.|+++||.||| +.+++||||+|+||+++.++ .++|+|||+
T Consensus 84 ~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 9999999999999999975 348899999999999999999999 77899999999999999988 999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+...... ....|+..|+|||++.+..++.++||||||+++|+|++|+.||....... .....+.... . ..
T Consensus 157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~-~-~~ 226 (267)
T PHA03390 157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ-Q-KK 226 (267)
T ss_pred ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh-c-cc
Confidence 8865432 12457899999999998889999999999999999999999997542211 1112222221 1 10
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-SKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 483 (531)
. .. .......+.+++.+||+.||.+||+ +.+++++
T Consensus 227 ~-~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 227 L-PF---------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred C-Cc---------ccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 1 00 0112234788999999999999996 5888754
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=290.41 Aligned_cols=264 Identities=25% Similarity=0.291 Sum_probs=196.5
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC---CCCcccccceeEEeCCc--
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI---RHRNIVPLLAHMVRPDC-- 279 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~-- 279 (531)
|...+.||+|+||.||+|.... +++.||+|.+....... .....+..|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN-TGRFVALKKVRVPLSEE--GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECC-CCCEEEEEEeccccccc--hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 5677899999999999999864 68899999997543221 1234455677766555 69999999999988776
Q ss_pred ---eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 280 ---HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 280 ---~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
.+++|||+.+ +|.+++.. .....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 78 ~~~~~l~~e~~~~-~l~~~l~~--~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~df 151 (287)
T cd07838 78 ELKLTLVFEHVDQ-DLATYLSK--CPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADF 151 (287)
T ss_pred CceeEEEehhccc-CHHHHHHH--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEecc
Confidence 8999999975 89998865 22346899999999999999999999 778999999999999999999999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
|++......... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+... ...+..........
T Consensus 152 g~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~ 225 (287)
T cd07838 152 GLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE---ADQLDKIFDVIGLP 225 (287)
T ss_pred CcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh---HHHHHHHHHHcCCC
Confidence 998876543221 223578899999999988899999999999999999999999875432 12222222111100
Q ss_pred CC---CCcc------ccc---cccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 437 EN---PNRA------IDS---KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 437 ~~---~~~~------~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. +... ... .......+.....+.+++.+||+.||.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 0000 000 00011112233557889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=297.33 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=195.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC---
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD--- 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 278 (531)
.++|...+.||+|+||.||+|.... +|+.||||.+...... +.....+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKR-TGEKVAIKKLSRPFQS--EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCC-CCcEEEEEEecCcccc--ccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 3678889999999999999998653 6889999998753221 112456788999999999999999999887543
Q ss_pred ---ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 279 ---CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 279 ---~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
.+++|+||+.. +|.+++. ..+++..+..++.|++.||.||| ..+++||||||+||+++.++.+||+|
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred CCceEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEee
Confidence 45899999965 7777652 35889999999999999999999 77899999999999999999999999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
||++....... ....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+... ......+....
T Consensus 161 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~----~~~~~~~~~~~ 231 (342)
T cd07879 161 FGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQILKVT 231 (342)
T ss_pred CCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhc
Confidence 99987653321 23457889999998876 4688999999999999999999999975321 11111111110
Q ss_pred ccCCC------------------CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCc
Q 009595 435 TSENP------------------NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTA 488 (531)
Q Consensus 435 ~~~~~------------------~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 488 (531)
..+.+ .......+ ...++.....+.+++.+||+.||.+|||+.+++.+ ++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDF-STLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred CCCCHHHHHHhcccchHHHHhhcCCcccchH-HHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000 00000000 00001122347789999999999999999999976 66554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=285.04 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=202.7
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
+|...+.||+|++|.||++.... +++.|++|.+...... ......+.+|+.++++++|||++++++++......+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE-TGDFVAIKQISLEKIK--EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC-CCcEEEEEEecccccC--HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence 36778899999999999998653 6788999999865432 12367789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++++|.+++.. ...+++..+..++.|++.||.||| +.|++||||+|+||+++.++.++|+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 150 (254)
T cd06627 78 LEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLN 150 (254)
T ss_pred EecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence 999999999999965 367899999999999999999999 7889999999999999999999999999998776
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
..... .....++..|+|||...+..++.++||||+|+++|+|++|..||..... ...... ......+ .+
T Consensus 151 ~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~----~~~~~~~--~~ 219 (254)
T cd06627 151 DVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFR----IVQDDHP--PL 219 (254)
T ss_pred CCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHH----HhccCCC--CC
Confidence 54332 1234678999999998887889999999999999999999999865321 111111 1111111 11
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. .....+.+++.+||..+|++|||+.+++.+
T Consensus 220 ~~--------~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 220 PE--------GISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CC--------CCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 11 112347889999999999999999998853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=296.75 Aligned_cols=254 Identities=26% Similarity=0.338 Sum_probs=204.3
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|...+.||+||||.||-+.... +|+.||.|.+.+... ...........|-.+|.+++.|.||.+--.|.+.+.+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvra-TGKMYAcKkL~KKRi-Kkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRA-TGKMYACKKLDKKRI-KKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred cccceeeeEEEecccccceeEEEEec-chhhHHHHHHHHHHH-HHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 45678889999999999999988764 899999998865322 1122234567799999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+|+..|+||+|.-+|.+ .+++.+++..+..++.+|+.||.+|| +.+||+|||||+|||+|+.|+++|+|+|||.
T Consensus 261 ClVLtlMNGGDLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred EEEEEeecCCceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEE
Confidence 999999999999988876 45578999999999999999999999 8889999999999999999999999999999
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
.+..+.... ..+||.+|||||++.++.|+...|.||+||++|||+.|+.||...-.-...+.+.+-+..
T Consensus 336 ei~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~-------- 404 (591)
T KOG0986|consen 336 EIPEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE-------- 404 (591)
T ss_pred ecCCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--------
Confidence 988875543 358999999999999999999999999999999999999998764332222222211111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSK 478 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 478 (531)
++.-.++.+++ ...+++...|+.||.+|-...
T Consensus 405 ---~~~ey~~kFS~---eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 405 ---DPEEYSDKFSE---EAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ---chhhcccccCH---HHHHHHHHHHccCHHHhccCC
Confidence 11112233333 355566678899999997655
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=290.52 Aligned_cols=263 Identities=25% Similarity=0.297 Sum_probs=199.9
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 284 (531)
|...+.||.|++|.||+|.... +++.+++|.+....... .....+..|+.++++++||||+++++++..++..++|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL-TGEIVAIKKIKLRFESE--GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCC-CCcEEEEEEeccccccc--hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence 4567889999999999998754 68899999987643321 22467788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCC
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~ 364 (531)
||+++ +|.+++.. ....+++..+..++.+++.||.||| ..+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 78 e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 78 EFMDT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGS 150 (283)
T ss_pred eccCC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence 99976 89888864 2257899999999999999999999 77899999999999999999999999999887655
Q ss_pred CCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc--
Q 009595 365 GHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR-- 441 (531)
Q Consensus 365 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~-- 441 (531)
... ......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||...... ..+.. +......+.+..
T Consensus 151 ~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~ 224 (283)
T cd05118 151 PVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI---DQLFK-IFRTLGTPDPEVWP 224 (283)
T ss_pred Ccc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-HHHHcCCCchHhcc
Confidence 431 11234578899999998776 7899999999999999999999998654221 11111 111111110000
Q ss_pred -ccc---------cc----ccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 -AID---------SK----LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 -~~d---------~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
... +. ......+.....+.+++.+||+.||.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 00 0000112234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=294.00 Aligned_cols=267 Identities=23% Similarity=0.298 Sum_probs=198.3
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC---
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD--- 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 278 (531)
.+.|.+.+.||.|+||.||+|.... +|+.||+|.+........ ....+..|+.++++++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~--~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKD-TGELVALKKVRLDNEKEG--FPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECC-CCcEEEEEEEeecccccC--chHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 4678889999999999999998764 688999999975432211 1345678999999999999999999887654
Q ss_pred -------ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCE
Q 009595 279 -------CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA 351 (531)
Q Consensus 279 -------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v 351 (531)
..++|+||+++ +|.+++.. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcE
Confidence 78999999976 78887754 2346899999999999999999999 7789999999999999999999
Q ss_pred EEeecCCCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHH
Q 009595 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~ 430 (531)
||+|||++......... ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||..... ...+. .+
T Consensus 156 kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~-~~ 230 (302)
T cd07864 156 KLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLE-LI 230 (302)
T ss_pred EeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHH-HH
Confidence 99999999876544321 11223467889999987654 578899999999999999999999865321 11111 12
Q ss_pred HHHhccCCCCccc-----------cccc-----cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 431 RNVMTSENPNRAI-----------DSKL-----LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 431 ~~~~~~~~~~~~~-----------d~~l-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
........+.... +... ...........+.+++..||+.||.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2221111111000 0000 000000112457889999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=293.02 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=191.1
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEecc
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
.+.+|.|+++.||++.. +++.||||++....... .....+..|+.+++.++||||+++++++...+..+++|||+
T Consensus 7 ~~~~~~~~~v~~~~~~~---~~~~~avK~~~~~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP---TNTLVAVKKINLDSCSK--EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hHhhcCCceEEEEEecC---CCCEEEEEEEeccccch--hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence 34455556655555543 78999999997642222 23677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|.+++... ....+++.....++.|++.||.||| +.+|+||||||+||+++.++.+||+|||.+........
T Consensus 82 ~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 82 AYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred CCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence 999999999752 2346889999999999999999999 77899999999999999999999999998876543211
Q ss_pred -----cceecccccCccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc----c
Q 009595 368 -----QVSTSIVAGTVGYIAPEYHQTL--KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT----S 436 (531)
Q Consensus 368 -----~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~----~ 436 (531)
........++..|+|||.+.+. .++.++|||||||++|||++|+.||.+... ...+.+....... .
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~ 233 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA---TQMLLEKVRGTVPCLLDK 233 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCcccccc
Confidence 1111234567889999998763 588999999999999999999999975421 1111111110000 0
Q ss_pred C-------CCCc----cccc----cccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 437 E-------NPNR----AIDS----KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 437 ~-------~~~~----~~d~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. .... ..++ .............+.+++.+||..||.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 0000 0000 00000111223457889999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=292.46 Aligned_cols=300 Identities=22% Similarity=0.269 Sum_probs=215.5
Q ss_pred cccccccccccceeEEEEEeeeCCC--CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeC---
Q 009595 204 CSASLEKIRSRASGEIYIAELPESN--GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRP--- 277 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~--- 277 (531)
+|...+.||+|+||.||++.... . +..||+|.+....... .....+.+|+.+++++ .||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~-~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAE-TSEEETVAIKKITNVFSKK--ILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCC-CCcCceEEEEEeccccccc--hhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 36778899999999999998754 4 7789999987532221 1245677899999999 599999999875432
Q ss_pred -CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 278 -DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 278 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
...++++||+. ++|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+||
T Consensus 78 ~~~~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Df 149 (332)
T cd07857 78 FNELYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDF 149 (332)
T ss_pred CCcEEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcC
Confidence 45688999986 599998854 467899999999999999999999 778999999999999999999999999
Q ss_pred CCCccCCCCCcc--ceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 357 GLARLMPDGHAQ--VSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 357 gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
|++..+...... .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... .....+...
T Consensus 150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~----~~~~~~~~~ 225 (332)
T cd07857 150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV----DQLNQILQV 225 (332)
T ss_pred CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH----HHHHHHHHH
Confidence 999876543211 11223568999999998765 46899999999999999999999998653211 111111111
Q ss_pred hccCCC---------C--------ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCchh
Q 009595 434 MTSENP---------N--------RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKDVD 494 (531)
Q Consensus 434 ~~~~~~---------~--------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~ 494 (531)
...+.. . ............+.....+.+++.+||+.||.+|||+.+++.+ |.+...+...+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~ 305 (332)
T cd07857 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEP 305 (332)
T ss_pred hCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccc
Confidence 000000 0 0000000000001112357889999999999999999998864 33333333445
Q ss_pred hhhhccCCCCCChHHHHHhhHHHH
Q 009595 495 FLKMHKRMDFDNDDCVELIQQEIY 518 (531)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~ 518 (531)
+|..+-..+|-+++.-+-++..+-
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~ 329 (332)
T cd07857 306 VCQKPFDFSFESEDSMEELRDMII 329 (332)
T ss_pred cccccccCCccccccHHHHHHHHh
Confidence 688888888888888777776654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=295.37 Aligned_cols=268 Identities=21% Similarity=0.255 Sum_probs=196.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC---
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD--- 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 278 (531)
.++|...+.||.|++|.||+|.... +++.||+|.+........ ....+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK-TGRVVALKKILMHNEKDG--FPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC-CCcEEEEEEEEeccCCCC--cchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 4789999999999999999998754 688899999875432211 1234668999999999999999999875433
Q ss_pred -----ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEE
Q 009595 279 -----CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARI 353 (531)
Q Consensus 279 -----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL 353 (531)
.+++||||+.+ +|...+.. ....+++..+..++.|+++||.||| ..+++|+||||+||++++++.++|
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l 156 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKI 156 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence 46999999965 78777753 2457999999999999999999999 778999999999999999999999
Q ss_pred eecCCCccCCCCCccc---------eecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 009595 354 ADFGLARLMPDGHAQV---------STSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEE 423 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~ 423 (531)
+|||++.......... ......|++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.......
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~ 236 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999998654332111 11234578889999987654 5789999999999999999999998754332211
Q ss_pred hHHHHHHHHHhccCCCCc-------------ccccccc---CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 424 KSLVRWMRNVMTSENPNR-------------AIDSKLL---GNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 424 ~~l~~~~~~~~~~~~~~~-------------~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..+.. ......+.. ....... ..........+.+++.+||..||.+|||+.+++.+
T Consensus 237 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 237 HLIFK----LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHH----HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11111 111100000 0000000 00011112457889999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=298.65 Aligned_cols=270 Identities=24% Similarity=0.319 Sum_probs=203.7
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC-----
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD----- 278 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----- 278 (531)
+|.+.+.||.|++|.||+|.... ++..||||.+...... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR-TGRKVAIKKISNVFDD--LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC-CCcEEEEEeecccccc--chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 46788999999999999998753 5889999999764321 122567888999999999999999999988765
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
..|++|||+++ +|.+++.. ...+++..+..++.+++.||.||| ..|++||||||+||+++.++.++|+|||+
T Consensus 78 ~~~lv~e~~~~-~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~ 149 (330)
T cd07834 78 DVYIVTELMET-DLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGL 149 (330)
T ss_pred ceEEEecchhh-hHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCc
Confidence 78999999975 89998864 347899999999999999999999 77899999999999999999999999999
Q ss_pred CccCCCCCcc-ceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 359 ARLMPDGHAQ-VSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 359 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
+......... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.... .....+......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~ 225 (330)
T cd07834 150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI----DQLNLIVEVLGT 225 (330)
T ss_pred eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH----HHHHHHHHhcCC
Confidence 9876554210 112234578899999999887 7899999999999999999999998764321 111112211111
Q ss_pred CCCCccc--cccc---------------cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCc
Q 009595 437 ENPNRAI--DSKL---------------LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTA 488 (531)
Q Consensus 437 ~~~~~~~--d~~l---------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 488 (531)
..+.... .... .....+.....+.+++.+||+.||.+|||+.+++.+ ++.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 1110000 0000 000011123457889999999999999999999986 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=289.70 Aligned_cols=266 Identities=21% Similarity=0.268 Sum_probs=196.1
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCceEEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv 283 (531)
|.+.+.||+|++|+||+|.... +++.|+||.+........ .....+|+..+++++ ||||+++++++...+..++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE-TGELVAIKKMKKKFYSWE---ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECC-CCcEEEEEEehhhccchh---HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence 4667899999999999998754 678899999875433211 233456899999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+ +|+|.+++.. .....+++..+..++.|++.+|.||| +++++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~e~~-~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~ 150 (283)
T cd07830 77 FEYM-EGNLYQLMKD--RKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIR 150 (283)
T ss_pred EecC-CCCHHHHHHh--cccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceecc
Confidence 9999 7799999875 22357899999999999999999999 7789999999999999999999999999988765
Q ss_pred CCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHH---------H
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN---------V 433 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~---------~ 433 (531)
..... ....|+..|+|||.+.. ..++.++|+||||+++++|++|+.||...............+.. .
T Consensus 151 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07830 151 SRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227 (283)
T ss_pred CCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHh
Confidence 43221 22457889999998754 45789999999999999999999998654321111111111000 0
Q ss_pred hccCCCCccccccc---cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 434 MTSENPNRAIDSKL---LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 434 ~~~~~~~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.............. .....+.....+.+++.+||+.||.+|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000000 000011112458899999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=282.64 Aligned_cols=252 Identities=22% Similarity=0.268 Sum_probs=203.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|..++.||+|.||.|.+++-+. +|+.||+|++++...-..+. +..-..|-++|+..+||.+..+.-.|...+.+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKa-t~k~YAiKIlkKeviiakdE-VAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKA-TGKLYAIKILKKEVIIAKDE-VAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecc-cCceeehhhhhhhheeehHH-hhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 4778899999999999999998664 89999999998754433332 556677999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||..||.|.-+|.. ...+++.....+-..|.+||.||| +++||+||||.+|+|+|.+|++||+|||+++.
T Consensus 245 FVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchh
Confidence 99999999999998865 567888888889999999999999 78899999999999999999999999999985
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
--... ..++.+||||.|+|||++....|+..+|.|.+||++|||+||+.||.. .....+++.+... .-..+
T Consensus 318 ~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn----~dh~kLFeLIl~e--d~kFP- 388 (516)
T KOG0690|consen 318 EIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN----KDHEKLFELILME--DLKFP- 388 (516)
T ss_pred ccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc----cchhHHHHHHHhh--hccCC-
Confidence 33221 234679999999999999999999999999999999999999999864 2334455443221 00011
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-----SKDVRS 482 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 482 (531)
..-.++ ...|+.-.|..||.+|.. ++||.+
T Consensus 389 -------r~ls~e----AktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 389 -------RTLSPE----AKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred -------ccCCHH----HHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 111122 445666688899999953 556655
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=285.99 Aligned_cols=246 Identities=22% Similarity=0.263 Sum_probs=186.5
Q ss_pred cccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHH---HHHHhcCCCCcccccceeEEeCCceEEEEec
Q 009595 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAE---IMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286 (531)
Q Consensus 210 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E---i~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 286 (531)
.||+|+||.||+|.... +++.||+|.+.......... ...+..| +..++...||||+.+++++...+..++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEec-CCCEEEEEEeeccccccchh-HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence 48999999999997654 68899999987543221110 1112233 3445556899999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCC
Q 009595 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH 366 (531)
Q Consensus 287 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~ 366 (531)
++||+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++..+....
T Consensus 79 ~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 79 MNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 999999998864 457999999999999999999999 7789999999999999999999999999987654332
Q ss_pred ccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccc
Q 009595 367 AQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS 445 (531)
Q Consensus 367 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 445 (531)
. ....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||.+...... .... .. .....+.
T Consensus 152 ~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~---~~-~~~~~~~----- 217 (278)
T cd05606 152 P----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEID---RM-TLTMAVE----- 217 (278)
T ss_pred C----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHHH---HH-hhccCCC-----
Confidence 1 234689999999998754 688999999999999999999999976422111 1111 11 1111110
Q ss_pred cccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 446 KLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 446 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
+.... ...+.+++.+||..+|.+|| ++.+++++
T Consensus 218 -~~~~~----s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 218 -LPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -CCCcC----CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 00111 23478888999999999999 88888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=290.22 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=201.7
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCceE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~ 281 (531)
++|...+.||+|++|.||+|.... +|..||+|++....... ......+..|+.++++++ ||||+++++++...+..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE-TNKEYAIKILDKRQLIK-EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC-CCCEEEEEEechHhccc-hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence 367888999999999999998764 78899999987532211 122467888999999998 999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 79 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 79 FVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred EEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccc
Confidence 99999999999999975 347999999999999999999999 77899999999999999999999999999887
Q ss_pred CCCCCcc------------------ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 009595 362 MPDGHAQ------------------VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEE 423 (531)
Q Consensus 362 ~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~ 423 (531)
....... .......|+..|+|||...+..++.++|+||||++++++++|+.||.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---- 227 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---- 227 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----
Confidence 6543211 112234678999999999888899999999999999999999999875421
Q ss_pred hHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCH----HHHHHH
Q 009595 424 KSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS----KDVRSM 483 (531)
Q Consensus 424 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~ 483 (531)
......+. ..... +. . .....+.+++.+||+.||.+|||+ .+++++
T Consensus 228 ~~~~~~~~---~~~~~---~~-----~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 YLTFQKIL---KLEYS---FP-----P---NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHHH---hcCCC---CC-----C---ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 11111111 10000 00 0 112347889999999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=289.73 Aligned_cols=250 Identities=23% Similarity=0.366 Sum_probs=195.0
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|...+.||+|+||.||+|.... +|+.|++|.+........ .....+..|+.+++.++||||+++++++......|+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~ik~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSH-TNEVVAVKKMSYSGKQTN-EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECC-CCcEEEEEEEeccccCch-HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 346667889999999999998654 788999999975433221 224568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+. |+|.+++.. ....+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.+||+|||++...
T Consensus 99 v~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 99 VMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred EEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 999996 488888764 2356899999999999999999999 778999999999999999999999999997643
Q ss_pred CCCCccceecccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQ---TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
.. .....|+..|+|||++. ...++.++||||||+++|+|++|..||...... ..+ ........+
T Consensus 172 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~~~----~~~~~~~~~ 238 (313)
T cd06633 172 SP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SAL----YHIAQNDSP 238 (313)
T ss_pred CC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHH----HHHHhcCCC
Confidence 22 12356889999999874 456888999999999999999999998654211 111 111111111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. . ... ....+.+++.+||+.+|.+||++.+++.+
T Consensus 239 ~~-~-----~~~---~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 TL-Q-----SNE---WTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CC-C-----ccc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 0 111 11247889999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=296.85 Aligned_cols=297 Identities=25% Similarity=0.351 Sum_probs=213.7
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc-
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC- 279 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~- 279 (531)
..++|...+.||+|++|.||+|.... +++.||||.+....... .....+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTK-TGRKVAIKKLSRPFQSA--IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECC-CCcEEEEEecccccchh--hHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 35678999999999999999998764 68889999986532221 124567789999999999999999998776554
Q ss_pred -----eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe
Q 009595 280 -----HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 280 -----~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.||| +.|++||||+|+||+++.++.++|+
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEc
Confidence 89999999 6699999863 46899999999999999999999 7789999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
|||++...... .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||.+..... .+ ..+...
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~-~~i~~~ 231 (343)
T cd07851 161 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QL-KRIMNL 231 (343)
T ss_pred ccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HH-HHHHHh
Confidence 99998866433 1234578899999987653 67899999999999999999999986542211 11 111111
Q ss_pred hccCCCCcccccccc---------------CCC----cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCc
Q 009595 434 MTSENPNRAIDSKLL---------------GNG----YEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKD 492 (531)
Q Consensus 434 ~~~~~~~~~~d~~l~---------------~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~ 492 (531)
... +...+..... ... .......+.+++.+||..||.+|||+.+|+++ +.+.....+
T Consensus 232 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~ 309 (343)
T cd07851 232 VGT--PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED 309 (343)
T ss_pred cCC--CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence 110 0000000000 000 00113458899999999999999999999875 344333322
Q ss_pred hhhhhhccCCCCCChH-HHHHhhHHHHhhh
Q 009595 493 VDFLKMHKRMDFDNDD-CVELIQQEIYTEW 521 (531)
Q Consensus 493 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 521 (531)
... ..+....+++.+ -+..+++.+|-+.
T Consensus 310 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (343)
T cd07851 310 EPV-APPYDQSFESRDLTVDEWKELVYKEI 338 (343)
T ss_pred ccc-ccccCcchhhhhcCHHHHHHHhHHHH
Confidence 211 222222333333 6677888888664
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=291.18 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=198.5
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
...|...+.||+|++|.||+|.... ++..+|+|.+....... ......+.+|+.+++.++|||++++++++......+
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcC-CCcEEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 3557778899999999999998764 68889999987432221 122456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+. |+|.+++.. ....+++..+..++.+++.||.||| ..+++||||+|+||+++.++.++|+|||++..
T Consensus 92 lv~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 92 LVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred EEEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCccccee
Confidence 9999996 588887753 2345889999999999999999999 77899999999999999999999999999876
Q ss_pred CCCCCccceecccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQ---TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
.... ....|++.|+|||.+. ...++.++|||||||++|+|++|..||.+... ......+ .....
T Consensus 165 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~----~~~~~ 231 (308)
T cd06634 165 MAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHI----AQNES 231 (308)
T ss_pred ecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH---HHHHHHH----hhcCC
Confidence 5332 2345789999999874 34678899999999999999999999865321 1111111 11111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
+.. ... .....+.+++.+||..+|.+||++.+++.+.--..
T Consensus 232 ~~~------~~~---~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 232 PAL------QSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CCc------Ccc---cccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 110 011 12234788999999999999999999998854433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=293.23 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=195.3
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC--
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD-- 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-- 278 (531)
..++|...+.||+|+||.||+|.... +|..||||.+...... ......+..|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRR-TGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECC-CCcEEEEEEecccccc--hHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 35779999999999999999998654 7899999998643222 222456788999999999999999999887543
Q ss_pred ----ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe
Q 009595 279 ----CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 279 ----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
.+++||||+ +++|.+++.. ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEe
Confidence 358999999 6799988853 46899999999999999999999 7889999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
|||++....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.... ..+...+...
T Consensus 161 dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~ 232 (343)
T cd07880 161 DFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL---DQLMEIMKVT 232 (343)
T ss_pred ecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhc
Confidence 999988654321 22457889999998876 45889999999999999999999998754221 1111111100
Q ss_pred ----------hccCCCCc------cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 434 ----------MTSENPNR------AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 434 ----------~~~~~~~~------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
........ ...+.............+.+++.+|++.||.+|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000000000001112347889999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=295.96 Aligned_cols=268 Identities=24% Similarity=0.246 Sum_probs=196.1
Q ss_pred ccccc-cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhH----------HHHHHHHHHHHHhcCCCCcccccc
Q 009595 203 DCSAS-LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNI----------KMRQVRAEIMTAGQIRHRNIVPLL 271 (531)
Q Consensus 203 ~~~~~-~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~----------~~~~~~~Ei~~l~~l~hpnIv~l~ 271 (531)
++|.. .+.||+|+||+||+|.... +++.||||.+.......... ....+.+|+.++++++||||++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTL-TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECC-CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 45543 4679999999999998654 68899999987543221000 012467899999999999999999
Q ss_pred eeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCE
Q 009595 272 AHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA 351 (531)
Q Consensus 272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v 351 (531)
+++...+..++||||+. |+|.+++.. ...+++.....++.|++.||.||| ..+++|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCE
Confidence 99999999999999997 599999864 456899999999999999999999 7789999999999999999999
Q ss_pred EEeecCCCccCCCCCc------------cceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 009595 352 RIADFGLARLMPDGHA------------QVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFF 418 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~ 418 (531)
+|+|||++........ ........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999987652110 0111223468889999988764 46899999999999999999999987543
Q ss_pred cchhhhHHHHHHHHHhccCCCC----cc----------ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 419 QHTEEKSLVRWMRNVMTSENPN----RA----------IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 419 ~~~~~~~l~~~~~~~~~~~~~~----~~----------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
... .+ ..+......+... .. ..+.............+.+++.+||+.||.+|||+.+++.+
T Consensus 239 ~~~---~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 239 EID---QL-GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHH---HH-HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 211 11 1111111111100 00 00000000011123457889999999999999999999874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=317.89 Aligned_cols=265 Identities=22% Similarity=0.341 Sum_probs=195.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe-----
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR----- 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----- 276 (531)
...|+.++.||+||||.||+++.+. +|+.||||++.... .......+.+|+.++++|+|||||++|..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKl-DGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKL-DGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecc-cchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 3567889999999999999999776 89999999998754 23346788999999999999999998864431
Q ss_pred --------------------------------------------------------------------------------
Q 009595 277 -------------------------------------------------------------------------------- 276 (531)
Q Consensus 277 -------------------------------------------------------------------------------- 276 (531)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred --------------------------C--------CceEEEEeccCCCCHHHHHhhccCCCccC-CHHHHHHHHHHHHHH
Q 009595 277 --------------------------P--------DCHLLVSEFMKNGSLLEILNDVSQGRREL-EWLARHRIARGIVSG 321 (531)
Q Consensus 277 --------------------------~--------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~~ia~~ 321 (531)
+ ..+||-||||+..+|.+++.+ +... .....++++++|++|
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEG 709 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHH
Confidence 0 234788999999777777764 1121 456789999999999
Q ss_pred HHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC----------------CCCccceecccccCccccCccc
Q 009595 322 LEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP----------------DGHAQVSTSIVAGTVGYIAPEY 385 (531)
Q Consensus 322 L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~ 385 (531)
|.|+| ++|+|||||||.||++++++.|||+|||++.... .+......+..+||.-|+|||+
T Consensus 710 LaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 99999 7889999999999999999999999999998721 0111112356789999999999
Q ss_pred ccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHH
Q 009595 386 HQTL---KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKI 462 (531)
Q Consensus 386 ~~~~---~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 462 (531)
+.+. .|+.|+|+||+|||++||+. ||.-. .+...+..-++ .+..+.. + +.+.+....-.++
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts---MERa~iL~~LR----~g~iP~~--~----~f~~~~~~~e~sl 850 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS---MERASILTNLR----KGSIPEP--A----DFFDPEHPEEASL 850 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCch---HHHHHHHHhcc----cCCCCCC--c----ccccccchHHHHH
Confidence 8765 49999999999999999985 44322 22222222222 2222221 1 1222233335678
Q ss_pred HHHcccCCCCCCCCHHHHHHHhccCcCCCchhh
Q 009595 463 ACFCTLDDPEERPNSKDVRSMLSDTALIKDVDF 495 (531)
Q Consensus 463 i~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 495 (531)
|.++++.||++|||+.+++.. ++.++..+++
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~s--~llppe~~el 881 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLNS--ELLPPEESEL 881 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhhc--cCCCccchHH
Confidence 889999999999999998763 3444444444
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=282.95 Aligned_cols=256 Identities=18% Similarity=0.271 Sum_probs=197.2
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchh-hhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSL-LNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+|.+.+.||+|+||.||++.+.. .+..+++|.++...... .......+..|+.+++.++||||+++++++......++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK-AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC-CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 36778899999999999998754 35556666665422211 11123456679999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|.+++.........+++..+..++.|++.||.||| +.+++|+||+|+||+++. +.++|+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeec
Confidence 99999999999999765455577999999999999999999999 788999999999999975 57999999998776
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
...... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ............+.
T Consensus 156 ~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~~~~~~~~~~~-- 224 (260)
T cd08222 156 MGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSVVLRIVEGPTPS-- 224 (260)
T ss_pred CCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCCCCC--
Confidence 443221 1235578899999999888889999999999999999999999864311 11111211111111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. .......+.+++.+||..||.+||++.+++++
T Consensus 225 ~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 L--------PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred C--------cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0 11222357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=256.63 Aligned_cols=266 Identities=22% Similarity=0.271 Sum_probs=203.6
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
..|...++||+|.||+||+|+... +++.||+|+++..... +.+.....+||.+++.+.|.|||+++++...+..+.+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~-t~eivalkrvrldddd--egvpssalreicllkelkhknivrl~dvlhsdkkltl 78 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRE-THEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCC-ccceEEEEEEeccCCC--CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence 456778999999999999998654 7899999999865432 2335678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|+|||.. +|..+... .++.++......++.|+++||.++| ++++.|||+||.|.|++.+|.+|++|||+++.+
T Consensus 79 vfe~cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglaraf 151 (292)
T KOG0662|consen 79 VFEFCDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAF 151 (292)
T ss_pred eHHHhhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhc
Confidence 9999966 89888874 4678999999999999999999999 677999999999999999999999999999987
Q ss_pred CCCCccceecccccCccccCcccccCCC-CCchhhHHHHHHHHHHHHhC-CCCCCCcccchhhhHHHHHHHHHhc---cC
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLK-FSEKCDIYSFGVLLAVLVMG-KLPSDDFFQHTEEKSLVRWMRNVMT---SE 437 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg-~~P~~~~~~~~~~~~l~~~~~~~~~---~~ 437 (531)
+-..... +..+-|..|.+|.++.+.+ |+...|+||.|||+.|+... ++-|.+. +...++.+.++..-. ..
T Consensus 152 gipvrcy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~---dvddqlkrif~~lg~p~ed~ 226 (292)
T KOG0662|consen 152 GIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN---DVDDQLKRIFRLLGTPTEDQ 226 (292)
T ss_pred CCceEee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC---cHHHHHHHHHHHhCCCcccc
Confidence 6553222 3345689999999998875 78999999999999999984 4445443 444455444443211 11
Q ss_pred CCC--ccccccccC-----CCcHHHH----HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 438 NPN--RAIDSKLLG-----NGYEEQM----LLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 438 ~~~--~~~d~~l~~-----~~~~~~~----~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+|. ...|-...+ ..+.+.+ ..-++++...+.-+|.+|.++++.+++
T Consensus 227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111 111111111 1122222 224566677777799999999998875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=293.68 Aligned_cols=264 Identities=19% Similarity=0.283 Sum_probs=193.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC----
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP---- 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 277 (531)
.++|...+.||.|+||.||+|.... +|..||+|.+....... .+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~-~~~~v~iK~i~~~~~~~----~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSD-CDKRVAVKKIVLTDPQS----VKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECC-CCcEEEEEEEecCCCch----HHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 4788999999999999999998754 78899999997654322 56678899999999999999999876543
Q ss_pred ----------CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC
Q 009595 278 ----------DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347 (531)
Q Consensus 278 ----------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~ 347 (531)
...++||||+++ +|.+++.. ..+++..+..++.|++.||.||| +.+++||||||+||+++.
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~ 149 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYMET-DLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINT 149 (342)
T ss_pred ccccccccccceEEEEeecccc-cHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcC
Confidence 357899999974 99988853 46889999999999999999999 778999999999999974
Q ss_pred -CCCEEEeecCCCccCCCCCccc-eecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhh
Q 009595 348 -DMEARIADFGLARLMPDGHAQV-STSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424 (531)
Q Consensus 348 -~~~vkL~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~ 424 (531)
++.++|+|||++..+....... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 5678999999987654321111 1122457889999997654 467889999999999999999999997543211111
Q ss_pred HHHHHH------------H---HHhc-cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 425 SLVRWM------------R---NVMT-SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 425 ~l~~~~------------~---~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...... . .... ............ .......+.+++.+||+.||.+|||+.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDL----LPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHH----ccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 111000 0 0000 000000000000 00112347889999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=303.54 Aligned_cols=204 Identities=27% Similarity=0.402 Sum_probs=173.8
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC------C
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP------D 278 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~ 278 (531)
+..-+.||+||||.||+|+.++ +|+.||||.++..... ...+...+|+++|++++|||||+++++-.+. .
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnke-tG~~vAvK~~~~~~~~---r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKE-TGRLVAVKTFNKESSL---RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred eeehhhhcCCccceeeeecccc-cccchhHHhhhhhccc---chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 3455789999999999998665 8999999999864321 1267788999999999999999999965443 3
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC--CCCC--EEEe
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID--DDME--ARIA 354 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~--~~~~--vkL~ 354 (531)
...+|||||.||||...+++. .+...+++...+.++.++..||.||| .+||+||||||.||++- .+|+ -||+
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cceEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeee
Confidence 568999999999999999863 34567999999999999999999999 78999999999999993 3343 6999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQ 419 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~ 419 (531)
|||.|+.+.++.. ....+||+.|++||.+.. ..|+..+|.|||||++|+.+||..||.....
T Consensus 167 DfG~Arel~d~s~---~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 167 DFGAARELDDNSL---FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccccccCCCCCe---eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 9999999988753 345899999999999984 7899999999999999999999999976544
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=288.82 Aligned_cols=266 Identities=21% Similarity=0.297 Sum_probs=196.1
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe-CCc
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR-PDC 279 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~ 279 (531)
..++|+..+.||.|+||.||+|.... +++.||||++....... .....+..|+.++++++||||+++++++.. ...
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQL-TGQNVAIKKIMKPFSTP--VLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECC-CCCEEEEEEeccccccc--chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 46789999999999999999998654 78899999886432211 224667789999999999999999998865 457
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++++||+ +++|.+++.. ..+++.....++.|+++||.||| ..+++||||+|+||+++.++.++|+|||++
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccc
Confidence 89999999 5699988853 45788888899999999999999 778999999999999999999999999998
Q ss_pred ccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHH--------
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM-------- 430 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~-------- 430 (531)
....... ....+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||...........+.+.+
T Consensus 156 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 156 RIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred cccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 7543321 22457889999998766 568999999999999999999999986543211111111110
Q ss_pred HHHhccCCCCcccccccc-----CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 431 RNVMTSENPNRAIDSKLL-----GNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.................. ....+.....+.+++.+||+.+|.+|||+.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000000 00001112458889999999999999999999886
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=276.93 Aligned_cols=255 Identities=20% Similarity=0.286 Sum_probs=204.4
Q ss_pred cccccc-cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEe---
Q 009595 202 EDCSAS-LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVR--- 276 (531)
Q Consensus 202 ~~~~~~-~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~--- 276 (531)
++.|.+ .++||-|-.|.|..+..+. +|+.+|+|++... ....+|+++.-.. .|||||.++++|.+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~-T~ekfALKvL~Ds---------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKR-TQEKFALKVLLDS---------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred hhhheehhhhhccccCCceEEEEecc-chhhhHHHHHhcC---------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 455543 5789999999999997665 8999999999752 2345788876666 69999999998764
Q ss_pred -CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC---CCCEE
Q 009595 277 -PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD---DMEAR 352 (531)
Q Consensus 277 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vk 352 (531)
..++.+|||.|+||.|++.+++ .+...+++..+..|+.||..|+.||| ..+|.||||||+|+|... |..+|
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lK 204 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLK 204 (400)
T ss_pred CceeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceE
Confidence 4677899999999999999987 66778999999999999999999999 677999999999999964 45799
Q ss_pred EeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHH
Q 009595 353 IADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN 432 (531)
Q Consensus 353 L~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~ 432 (531)
|+|||+|+...... .....+.||.|.|||++...+|+..+|+||+||++|-|+||.+||-.... ..+.-.++.
T Consensus 205 LtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg----~aispgMk~ 277 (400)
T KOG0604|consen 205 LTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKR 277 (400)
T ss_pred ecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC----ccCChhHHh
Confidence 99999999765432 23446789999999999999999999999999999999999999865433 222223333
Q ss_pred HhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 433 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
.+..+.-.. ....|+...+...++|+.+|+.+|++|.|+.+++++-
T Consensus 278 rI~~gqy~F------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 278 RIRTGQYEF------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred HhhccCccC------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 333222211 1345667777788899999999999999999999864
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=285.29 Aligned_cols=263 Identities=24% Similarity=0.288 Sum_probs=198.2
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 284 (531)
|+..+.||+|++|.||+|.... +++.||+|.+...... ......+..|+.+++.++||||+++++++...+..++||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK-TGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecC-CCcEEEEEEecccccc--ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence 4567889999999999998764 6889999999864311 112456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCC
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~ 364 (531)
||+++ +|.+++... ...+++..+..++.+++.||.||| ..+++||||+|+||+++.++.++|+|||++.....
T Consensus 78 e~~~~-~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 78 EYCDM-DLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred cCcCc-CHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 99975 999999752 146899999999999999999999 77899999999999999999999999999887654
Q ss_pred CCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC---
Q 009595 365 GHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN--- 440 (531)
Q Consensus 365 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~--- 440 (531)
.... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.. ........
T Consensus 151 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 224 (282)
T cd07829 151 PLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ----ILGTPTEESWP 224 (282)
T ss_pred Cccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH----HhCCCcHHHHH
Confidence 3221 1223457889999998776 789999999999999999999999865322111111111 11000000
Q ss_pred --------ccccccc----cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 --------RAIDSKL----LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 --------~~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...-+.. .....+.....+.+++.+||..||++||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred hhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000 000011113458999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.20 Aligned_cols=263 Identities=24% Similarity=0.346 Sum_probs=195.4
Q ss_pred hhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--
Q 009595 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP-- 277 (531)
Q Consensus 200 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-- 277 (531)
...++|...+.||+|+||.||+|.... +|+.||+|++....... .....+.+|+.++.+++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSI--IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcC-CCeEEEEEEecCcchhh--HHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 356889999999999999999997653 78899999997533221 1245677899999999999999999987643
Q ss_pred ----CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEE
Q 009595 278 ----DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARI 353 (531)
Q Consensus 278 ----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL 353 (531)
...|++++++ +++|.+++.. ..+++..+..++.|+++||.||| +.+++||||||+||+++.++.+||
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEE
Confidence 3467888887 7799988853 45899999999999999999999 778999999999999999999999
Q ss_pred eecCCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHH-
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMR- 431 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~- 431 (531)
+|||++...... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998865332 123467899999998866 4688899999999999999999999864322111111111000
Q ss_pred ---------------HHhc--cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 432 ---------------NVMT--SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 432 ---------------~~~~--~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
.... ...+..... .........+.+++.+||+.||.+|||+.+++.+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFA-----NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchh-----hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000 000000000 00001123478899999999999999999998763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=275.50 Aligned_cols=274 Identities=22% Similarity=0.266 Sum_probs=201.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCC-e--EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe-C
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNG-K--MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR-P 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~ 277 (531)
-..|+.+..||+|.||.||+|.-...++ + .+|||+++...... ....+.-+|+.+++.++||||+.+..++.. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t--GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT--GISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC--CcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 3567888899999999999996544333 2 69999998653321 123455679999999999999999999887 7
Q ss_pred CceEEEEeccCCCCHHHHHhhccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC----CCEE
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQG-RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD----MEAR 352 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~----~~vk 352 (531)
..+++++||.+. +|.+.++-.+.. ...++......|+.||+.|+.||| ++-|+||||||+|||+..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence 789999999988 999988754332 256899999999999999999999 6679999999999999888 8999
Q ss_pred EeecCCCccCCCCCcc-ceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh------h
Q 009595 353 IADFGLARLMPDGHAQ-VSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEE------K 424 (531)
Q Consensus 353 L~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~------~ 424 (531)
|+|||+++.+.+.-.. .+....+-|..|.|||.+.+. .|+.+.|||+.|||+.||+|-.+-|.+....... .
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 9999999988665322 233446679999999999887 5899999999999999999988777542111110 1
Q ss_pred HHHHHHHHHhccCCCCccccccc--cCCC----------------cHHHH-------HHHHHHHHHcccCCCCCCCCHHH
Q 009595 425 SLVRWMRNVMTSENPNRAIDSKL--LGNG----------------YEEQM-------LLVLKIACFCTLDDPEERPNSKD 479 (531)
Q Consensus 425 ~l~~~~~~~~~~~~~~~~~d~~l--~~~~----------------~~~~~-------~~l~~li~~cl~~dP~~RPs~~e 479 (531)
++.+. -.++ +.|.....+.+ .++. ..... ....+|+..+|..||.+|.|+++
T Consensus 257 Ql~rI-f~vL--G~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q 333 (438)
T KOG0666|consen 257 QLDRI-FEVL--GTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ 333 (438)
T ss_pred HHHHH-HHHc--CCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence 11111 1111 22221111111 1111 00111 12677888999999999999999
Q ss_pred HHHHh
Q 009595 480 VRSML 484 (531)
Q Consensus 480 vl~~L 484 (531)
.+++.
T Consensus 334 Aleh~ 338 (438)
T KOG0666|consen 334 ALEHP 338 (438)
T ss_pred Hhccc
Confidence 88865
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=275.27 Aligned_cols=240 Identities=25% Similarity=0.308 Sum_probs=192.4
Q ss_pred ccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccCCC
Q 009595 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNG 290 (531)
Q Consensus 211 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 290 (531)
||.|+||.||++.... +++.||+|.+....... ......+..|+.++++++||||+++++.+..+...++||||++++
T Consensus 1 lg~G~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKD-TGKLYAMKVLKKKKIIK-RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECC-CCcEEEEEEeehhhhcc-hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 6899999999998754 68899999987643321 123567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccce
Q 009595 291 SLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS 370 (531)
Q Consensus 291 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~ 370 (531)
+|.+++.. ...+++.....++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 79 ~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~ 149 (250)
T cd05123 79 ELFSHLSK----EGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--R 149 (250)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--c
Confidence 99999975 346899999999999999999999 68899999999999999999999999999887654321 1
Q ss_pred ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCC
Q 009595 371 TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGN 450 (531)
Q Consensus 371 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 450 (531)
.....++..|+|||...+...+.++|+||||+++|+|++|..||..... ......+. . ... .+...
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~---~-~~~--~~~~~---- 215 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKIL---K-DPL--RFPEF---- 215 (250)
T ss_pred ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHh---c-CCC--CCCCC----
Confidence 2335678899999999888889999999999999999999999864321 22222211 1 111 01110
Q ss_pred CcHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 009595 451 GYEEQMLLVLKIACFCTLDDPEERPNSKD 479 (531)
Q Consensus 451 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e 479 (531)
. ...+.+++.+||..||.+|||+.+
T Consensus 216 ~----~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 L----SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred C----CHHHHHHHHHHhcCCHhhCCCccc
Confidence 0 234788999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=300.21 Aligned_cols=255 Identities=22% Similarity=0.366 Sum_probs=212.3
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEe---
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVR--- 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~--- 276 (531)
..+-|.+.+.||.|.+|.||+++... +++..|+|+.......+ ..+..|.++++.. .|||++.+||++..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~-~~~~aa~kI~~~~~d~d-----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVK-TGQLAAIKIMDPTEDEE-----EEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeee-cCceeeeEeecCCcccc-----HHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 56788999999999999999998765 89999999998766553 3455688899888 79999999998864
Q ss_pred --CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe
Q 009595 277 --PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 277 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
++++|||||||.+||..|+++... +..+.|..+..|++.++.||.+|| +..++|||||-.|||++.++.|||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEe
Confidence 678999999999999999999865 678999999999999999999999 7789999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-----KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRW 429 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~ 429 (531)
|||++..+...... ..+..|||.|||||++... .|+.++|+||||++..||.-|.+|+-++++
T Consensus 166 DFGvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP---------- 233 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP---------- 233 (953)
T ss_pred eeeeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----------
Confidence 99999987765433 3457899999999998654 477899999999999999999999988766
Q ss_pred HHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 430 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
++.++.-++ ...+.+ ..+....+.+.++|..||..|..+||++.++++|
T Consensus 234 mraLF~IpR---NPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 234 MRALFLIPR---NPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhhhccCCC---CCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 233322211 111222 2344555678899999999999999999998875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=258.37 Aligned_cols=223 Identities=23% Similarity=0.383 Sum_probs=185.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
.+....+..||+|++|.|-+-++.. +|...|+|.+...-++. ..++...|+.+..+. .+|.+|.+||.+.....+
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~-sg~imAvKri~~tvn~q---~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQ-SGTIMAVKRIRATVNSQ---EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeecc-CCeEEEEeeehhhcChH---HHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 3444567789999999998887764 89999999998755432 356677888876665 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++.||.|.. ||..+.......+..+++...-+|+..+.+||.|||+ +..++|||+||+|||++.+|++|+||||++.
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999976 9999888776778899999999999999999999997 6789999999999999999999999999999
Q ss_pred cCCCCCccceecccccCccccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQT----LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
.+.++-.. +...|...|||||.+.. ..|+.++||||||+++.||.+++.||+... .-+..++.....
T Consensus 198 ~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~------tpF~qLkqvVee 268 (282)
T KOG0984|consen 198 YLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG------TPFQQLKQVVEE 268 (282)
T ss_pred eehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC------CHHHHHHHHhcC
Confidence 88776433 33568999999998754 369999999999999999999999997643 234445555555
Q ss_pred CCCC
Q 009595 437 ENPN 440 (531)
Q Consensus 437 ~~~~ 440 (531)
+.|.
T Consensus 269 p~P~ 272 (282)
T KOG0984|consen 269 PSPQ 272 (282)
T ss_pred CCCC
Confidence 5444
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=312.85 Aligned_cols=257 Identities=25% Similarity=0.288 Sum_probs=202.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|.+++.||+|+||.|..++.+. +++.||+|++.+-... .......|..|-.+|..-+.+=|++++-.|.++.++|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~-t~~VYAMK~lnK~eMl-Kr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKS-TEKVYAMKILNKWEML-KRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeec-cccchhHHHhhHHHHh-hchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 3678889999999999999999875 7899999999762211 1112577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+|||||+||+|..++.. ...+|+..+..++..|.-||.-|| +.|+|||||||+|||+|..|++||+|||.+-.
T Consensus 152 lVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred EEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHh
Confidence 99999999999999976 237999999999999999999999 77899999999999999999999999999988
Q ss_pred CCCCCccceecccccCccccCccccc----C-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQ----T-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
+..... ......+|||-|++||++. + +.|++.+|.||+||++|||+.|..||.. +.++.-...+++.
T Consensus 225 m~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-------dslveTY~KIm~h 296 (1317)
T KOG0612|consen 225 MDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-------DSLVETYGKIMNH 296 (1317)
T ss_pred cCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-------HHHHHHHHHHhch
Confidence 774433 3346689999999999985 2 5699999999999999999999999853 2333333333332
Q ss_pred C-CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHh
Q 009595 437 E-NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN---SKDVRSML 484 (531)
Q Consensus 437 ~-~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L 484 (531)
. ....+ +. .+......+||++.+. +|..|-. +.++-.|.
T Consensus 297 k~~l~FP-~~-------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 297 KESLSFP-DE-------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred hhhcCCC-cc-------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 1 11111 11 1122335566665554 7888888 77777653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=270.71 Aligned_cols=254 Identities=21% Similarity=0.315 Sum_probs=197.0
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceEEEEec
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHLLVSEF 286 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~ 286 (531)
.+.||+|+|+.|--++... +|..||||++.+.... ...++.+|++++.++ .|+||++++++|.++..+|||||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~-t~~EYAVKiidKq~gH----sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQ-TGKEYAVKIIDKQPGH----SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHHhcCccceeeeeeeeec-cchhhhhhhhhcCCch----HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 3689999999999886543 8899999999765332 277889999999999 699999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC---EEEeecCCCccCC
Q 009595 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME---ARIADFGLARLMP 363 (531)
Q Consensus 287 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~---vkL~Dfgla~~~~ 363 (531)
|.||+|.+++.. ...+++..+..++.+|+.||.||| .+||.||||||+|||..+... +|||||.|..-+.
T Consensus 158 m~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 158 MRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred ccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence 999999999976 677999999999999999999999 899999999999999976554 8999998876432
Q ss_pred CC--Ccc---ceecccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch-----------h
Q 009595 364 DG--HAQ---VSTSIVAGTVGYIAPEYHQ-----TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHT-----------E 422 (531)
Q Consensus 364 ~~--~~~---~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~-----------~ 422 (531)
.. ... ......+|+..|||||+.. ...|+.++|.||||||+|-|++|..||.+.-..+ -
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C 310 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC 310 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence 21 111 1123467999999999763 2258999999999999999999999997643211 1
Q ss_pred hhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 423 EKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 423 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+..+++-+.. +.-.. ....|........+++...+..|+.+|-++.+++++
T Consensus 311 Q~~LFesIQE----GkYeF------PdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 311 QNKLFESIQE----GKYEF------PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHHHHHHhc----cCCcC------ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 2223322221 11111 011233344456777778888999999999988873
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=308.64 Aligned_cols=149 Identities=26% Similarity=0.389 Sum_probs=131.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.++||+|+||.||+|.... +++.||||++....... ......+..|+.++..++||||+++++++......|+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiKvi~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKN-NSKLYAVKVVKKADMIN-KNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEehhhccC-HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 678899999999999999998754 68899999997543221 2235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
||||+.+++|.+++.. ...+++..++.++.||+.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999965 346888899999999999999999 6789999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.63 Aligned_cols=262 Identities=25% Similarity=0.355 Sum_probs=208.8
Q ss_pred ccccccccccccceeEEEEEeeeCCC------CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESN------GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMV 275 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 275 (531)
++..+.+.||+|.||.|++|...... ...||||.++..... ...+.+..|+.+|+.+ .||||+.++|+|.
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~---~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS---SEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc---HHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 33355669999999999999864211 457999999875544 2378899999999999 6999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhcc---C-------CC--ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCe
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVS---Q-------GR--RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSV 343 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 343 (531)
.....++|+||+..|+|.++++..+ . .. ..++....+.++.|||.|++||+ +.+++||||..+||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhE
Confidence 9999999999999999999998643 0 01 23889999999999999999999 77799999999999
Q ss_pred eeCCCCCEEEeecCCCccCCCCCccceeccccc--CccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccc
Q 009595 344 LIDDDMEARIADFGLARLMPDGHAQVSTSIVAG--TVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQH 420 (531)
Q Consensus 344 Ll~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~ 420 (531)
|+..+..+||+|||+++...+....... .-.| ...|||||.+....|+.++|||||||+||||.| |..||.+..
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-- 526 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-- 526 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--
Confidence 9999999999999999976554332211 1112 346999999999999999999999999999999 899987632
Q ss_pred hhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 421 TEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 421 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
....+..+++.......|..+. ..+.+++..||+.+|.+||++.++.+.|...
T Consensus 527 -~~~~l~~~l~~G~r~~~P~~c~-------------~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 -PTEELLEFLKEGNRMEQPEHCS-------------DEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -cHHHHHHHHhcCCCCCCCCCCC-------------HHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1233444555443333333221 2478899999999999999999999999884
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=298.35 Aligned_cols=257 Identities=23% Similarity=0.344 Sum_probs=208.5
Q ss_pred cccccccccccceeEEEEEeeeCCCCe----EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGK----MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.....++||+|+||+||+|.|--. |+ +||||++....... ....+..|+..|.+++|||+++++|+|....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pe-ge~vKipVaiKvl~~~t~~~---~s~e~LdeAl~masldHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPE-GENVKIPVAIKVLIEFTSPK---ASIELLDEALRMASLDHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecC-CceecceeEEEEeeccCCch---hhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence 345567999999999999998643 43 78999987643321 2567889999999999999999999998765
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
+.||++|++.|+|.++++. .+..+.....+.|..|||+||.||| .++++||||-.+|||+.+-..+|+.|||++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchh
Confidence 7899999999999999985 4567888899999999999999999 788999999999999999999999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+.+.............-.+.|||-|.+....|+.++|||||||++||++| |..||++... .++.+.++...+-..
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~----~eI~dlle~geRLsq 921 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA----EEIPDLLEKGERLSQ 921 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH----HHhhHHHhccccCCC
Confidence 98877655555554555788999999999999999999999999999999 9999987643 233333332111111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
|.. + .-.+..++.+||..|+..||+++++...+.+.+
T Consensus 922 Ppi----------C---tiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 922 PPI----------C---TIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred CCC----------c---cHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 111 1 113777888999999999999999999887754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=290.70 Aligned_cols=248 Identities=22% Similarity=0.340 Sum_probs=201.2
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEecc
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
-+.||+|.||+||-|+.+. +|+.||||++.+...... ...++..|+.+|.+++||.||.+...|++.+.++.|||.+
T Consensus 569 devLGSGQFG~VYgg~hRk-tGrdVAvKvIdKlrFp~k--qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRK-TGRDVAVKVIDKLRFPTK--QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecc-cCceeeeeeeecccCCCc--hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence 4789999999999998875 899999999976544322 2477889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC---CCEEEeecCCCccCCC
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD---MEARIADFGLARLMPD 364 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~---~~vkL~Dfgla~~~~~ 364 (531)
.| +..+.+-. ...+.+++..-..++.||+.||.||| -++|+|+||||+|||+.+. .++||||||.|+.++.
T Consensus 646 ~G-DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 646 HG-DMLEMILS--SEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred cc-hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 66 55555543 45678999999999999999999999 7889999999999999654 5799999999999877
Q ss_pred CCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcccc
Q 009595 365 GHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444 (531)
Q Consensus 365 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 444 (531)
.... ...+|||.|+|||++.+..|...-|+||.|||+|--++|..||... +++-+.+... .. +.
T Consensus 720 ksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd------EdIndQIQNA------aF-My 783 (888)
T KOG4236|consen 720 KSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED------EDINDQIQNA------AF-MY 783 (888)
T ss_pred hhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc------cchhHHhhcc------cc-cc
Confidence 6433 3478999999999999999999999999999999999999998653 2222222211 01 11
Q ss_pred ccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 445 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
| ++-+.+.....+++|...|+..-.+|-|....+.+
T Consensus 784 P---p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 784 P---PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred C---CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 1 23345555568889999999999999997765543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=272.09 Aligned_cols=220 Identities=20% Similarity=0.220 Sum_probs=174.6
Q ss_pred cceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccCCCCHH
Q 009595 214 RASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLL 293 (531)
Q Consensus 214 G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~ 293 (531)
|.+|.||++.... +++.||+|.+..... +..|...+....||||+++++++...+..+++|||+++|+|.
T Consensus 4 g~~~~v~~~~~~~-~~~~~~~K~i~~~~~---------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTR-TQQTFILKGLRKSSE---------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEcc-CCcEEEEEeecchhh---------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 8999999998764 788999999976431 223455555667999999999999999999999999999999
Q ss_pred HHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecc
Q 009595 294 EILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373 (531)
Q Consensus 294 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~ 373 (531)
+++.. ...+++.....++.|+++||.||| +++++||||||+||+++.++.++++|||++....... ..
T Consensus 74 ~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~ 141 (237)
T cd05576 74 SHISK----FLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DG 141 (237)
T ss_pred HHHHH----hcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----cc
Confidence 99865 345899999999999999999999 7889999999999999999999999999877654321 12
Q ss_pred cccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcH
Q 009595 374 VAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYE 453 (531)
Q Consensus 374 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 453 (531)
..++..|+|||...+..++.++||||+|+++|||++|..|+..... . . ... .. + .+ +..
T Consensus 142 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~-~----~--------~~~-~~--~--~~-~~~-- 200 (237)
T cd05576 142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS-G----I--------NTH-TT--L--NI-PEW-- 200 (237)
T ss_pred CCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch-h----c--------ccc-cc--c--CC-ccc--
Confidence 3457789999999888899999999999999999999988643210 0 0 000 00 0 00 011
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCH
Q 009595 454 EQMLLVLKIACFCTLDDPEERPNS 477 (531)
Q Consensus 454 ~~~~~l~~li~~cl~~dP~~RPs~ 477 (531)
....+.+++.+||+.||.+||++
T Consensus 201 -~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 201 -VSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred -CCHHHHHHHHHHccCCHHHhcCC
Confidence 12347889999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=267.09 Aligned_cols=275 Identities=21% Similarity=0.287 Sum_probs=203.8
Q ss_pred hhhhhhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEE
Q 009595 196 LAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMV 275 (531)
Q Consensus 196 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 275 (531)
..++...+.|....+||+|.||+||+|+.+. +|+.||+|++-..+.. ...-....+|+.+|..+.|+|++.+++.|.
T Consensus 10 ~P~~~~~~~yek~~kigqGtfgeVFkAr~~n-~~kkvalkkvlmeneK--eGfpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 10 EPFCDEVSKYEKLAKIGQGTFGEVFKARSKN-TGKKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred CCceecchHHHHHHhcCCchHHHHHHHhhcC-ccchhHHHHHHHhccc--cCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 3455667888899999999999999998765 6788998877432211 111345678999999999999999999876
Q ss_pred e--------CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC
Q 009595 276 R--------PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347 (531)
Q Consensus 276 ~--------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~ 347 (531)
. ...+|+|+++|+. +|.-+|.+ ....++..++.+++.++..||.|+| +..|+|||+||.|+||+.
T Consensus 87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~ 159 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITK 159 (376)
T ss_pred hccCCcccccceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcC
Confidence 4 2347999999988 89999864 3467899999999999999999999 778999999999999999
Q ss_pred CCCEEEeecCCCccCCCCC--ccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhh
Q 009595 348 DMEARIADFGLARLMPDGH--AQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424 (531)
Q Consensus 348 ~~~vkL~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~ 424 (531)
+|.+||+|||+++.++.+. .....+..+-|..|.+||.+.+. .|+++.|||..|||+.||.||.+-+.+. .+.
T Consensus 160 dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn----teq 235 (376)
T KOG0669|consen 160 DGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN----TEQ 235 (376)
T ss_pred CceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC----hHH
Confidence 9999999999998775432 22233456669999999988876 6899999999999999999999876553 222
Q ss_pred HHHHHHHHHhccCCC---Ccccc----cc-----ccCCC---cHHHH------HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 425 SLVRWMRNVMTSENP---NRAID----SK-----LLGNG---YEEQM------LLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 425 ~l~~~~~~~~~~~~~---~~~~d----~~-----l~~~~---~~~~~------~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+-...+..+...-.+ +..-. .. +.... ..+.. ....+|+..++..||.+||++.+++.+
T Consensus 236 qql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 236 QQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 222333332221111 10000 00 00001 11111 246788889999999999999998876
Q ss_pred h
Q 009595 484 L 484 (531)
Q Consensus 484 L 484 (531)
-
T Consensus 316 ~ 316 (376)
T KOG0669|consen 316 D 316 (376)
T ss_pred h
Confidence 4
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=273.22 Aligned_cols=246 Identities=22% Similarity=0.250 Sum_probs=194.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
...|..+..||.|+||.|.+|.-+. +.+.||||++++...-..+ .++.-+.|-++|... +-|.+++++.+|.+-+.+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkg-tdELyAiKiLkKDViiQdD-Dvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKG-TDELYAIKILKKDVIIQDD-DVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred ecccceEEEeccCccceeeeecccC-cchhhhhhhhccceeeecC-cccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 3567889999999999999997654 6778999999865332111 144455677888776 578899999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+||||+.||+|--.+++ -+.+.+..+..++..||-||-+|| ++|||+||||.+|||+|.+|++||+|||+++
T Consensus 426 yFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccc
Confidence 999999999999988876 456777788889999999999999 8899999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
.-... ...+..++|||.|+|||++...+|+..+|.|||||+||||+.|+.||++. .+..++.-+.....
T Consensus 499 Eni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe----DE~elF~aI~ehnv----- 567 (683)
T KOG0696|consen 499 ENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE----DEDELFQAIMEHNV----- 567 (683)
T ss_pred ccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHHccC-----
Confidence 54332 23456789999999999999999999999999999999999999999874 33444443333211
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN 476 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 476 (531)
..| ... ..+...++...|...|.+|..
T Consensus 568 --syP----Ksl---SkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 568 --SYP----KSL---SKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --cCc----ccc---cHHHHHHHHHHhhcCCccccC
Confidence 111 111 123556777788889999854
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=282.19 Aligned_cols=268 Identities=22% Similarity=0.377 Sum_probs=208.4
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
-|..++.||-|+||+|.++... .+...||+|.+++.+--. ...+.....|-.||...+.+-||+||-.|.+.+.+|+|
T Consensus 630 mFvkik~iGvGAFGeV~Lv~Kv-DT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKV-DTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ceEEEeeecccccceeEEEeec-chhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 4567889999999999999654 467889999998754322 22356788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||++||++-++|.+ -+.+++..+..++..+..|+++.| +.|+|||||||+|||||.+|++||+||||+.-+.
T Consensus 708 MdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999976 467888889999999999999999 8899999999999999999999999999987431
Q ss_pred ---------CCCc-------------------------------cceecccccCccccCcccccCCCCCchhhHHHHHHH
Q 009595 364 ---------DGHA-------------------------------QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVL 403 (531)
Q Consensus 364 ---------~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi 403 (531)
.++- .+.....+||+.|+|||++....|+..+|.||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 0000 011124679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 404 LAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 404 l~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
||||+.|+.||.+..+.+.+..+.+|-..+.-. .+..-..+....+.+| |+ +++.|.. +...+.
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~----------~~~~ls~e~~~li~kL---c~--sad~RLG-kng~d~ 924 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIP----------YQGNLSKEALDLIQKL---CC--SADSRLG-KNGADQ 924 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhccccc----------cccccCHHHHHHHHHH---hc--Chhhhhc-ccchhh
Confidence 999999999999888877777777774432211 1222334444444444 54 4555644 234445
Q ss_pred hccCcCCCchhhh
Q 009595 484 LSDTALIKDVDFL 496 (531)
Q Consensus 484 L~~~~~~~~~~~~ 496 (531)
++...++..++|.
T Consensus 925 vKaHpfFkgIDfs 937 (1034)
T KOG0608|consen 925 VKAHPFFKGIDFS 937 (1034)
T ss_pred hhcCccccccchH
Confidence 5666666666654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=281.88 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=202.5
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
.+...+..||-||||.|=++..+. ....+|+|++++..--+. .+.+.+..|-.+|..++.|.||++|.-|.+...+|+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~-~~~~fAlKilkK~hIVdt-kQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNS-QKATFALKILKKKHIVDT-KQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecc-cchHHHHHHHhHhhccch-hHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 345567789999999999998753 222489998876543332 235677889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
+||-|-||.|+..|+. .+.++..+...++..+.+|+.||| +++||+|||||+|++++.+|-+||.|||+|+.+
T Consensus 498 LmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 498 LMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999999999976 677888899999999999999999 888999999999999999999999999999998
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
..+.. +.+++|||.|.|||++.+...+.++|.||||+++|||++|.+||.+..+-.....+...+-.. ..|
T Consensus 571 ~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---~~P--- 641 (732)
T KOG0614|consen 571 GSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---EFP--- 641 (732)
T ss_pred ccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh---hcc---
Confidence 87743 345899999999999999999999999999999999999999998764422222222211111 001
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-----SKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 483 (531)
........+|+.+.++.+|.+|.. +.+|-.|
T Consensus 642 ----------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 642 ----------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred ----------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 111223566777888899999987 4455543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=283.27 Aligned_cols=242 Identities=20% Similarity=0.264 Sum_probs=191.8
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCc
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 279 (531)
..+.|.....+|.|+|+.|-.+.... +++..++|++...... ..+|+.++... +||||+++.+.+.+...
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~-t~~~~~vkii~~~~~~--------~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSP-TDQEPAVKIISKRADD--------NQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccc-cccchhheeccccccc--------cccccchhhhhcCCCcceeecceecCCce
Confidence 35677888889999999999997764 6788999999875221 23577666665 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee-CCCCCEEEeecCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI-DDDMEARIADFGL 358 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl-~~~~~vkL~Dfgl 358 (531)
.|+|||++.|+-|.+.+.. .+... ..+..|+.+|+.|+.||| .+|||||||||+|||+ ++.++++|+|||.
T Consensus 391 ~~~v~e~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~ 462 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGF 462 (612)
T ss_pred eeeeehhccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEech
Confidence 9999999999988888764 22233 667779999999999999 7889999999999999 6899999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+...... ....+-|..|.|||++....|++++|+||||++||+|++|+.||..... ..++ ... +..+.
T Consensus 463 a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~---~~ei---~~~-i~~~~ 530 (612)
T KOG0603|consen 463 WSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA---GIEI---HTR-IQMPK 530 (612)
T ss_pred hhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc---hHHH---HHh-hcCCc
Confidence 9877654 1223558899999999999999999999999999999999999875422 1111 121 11111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. ........+|+.+||+.||.+||++.++..+
T Consensus 531 ~s------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 531 FS------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred cc------------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 11 1222347788899999999999999998775
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=271.73 Aligned_cols=262 Identities=22% Similarity=0.277 Sum_probs=201.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhH---HHHHHHHHHHHHhcCCCCcccccceeEE-eCC
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNI---KMRQVRAEIMTAGQIRHRNIVPLLAHMV-RPD 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~ 278 (531)
++|-.+.+||+|||+.||+|.+- ...+.||||+-..+.....+. ..+...+|.++.+.|+||.||++|++|. +.+
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl-~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDL-TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhccc-chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 45667899999999999999764 367889999886655443222 2356778999999999999999999986 457
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC---CCCEEEee
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD---DMEARIAD 355 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkL~D 355 (531)
.+|-|+|||+|.+|+-||.. ++.+++..+..|+.||..||.||... +.+|||-||||.|||+-. .|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 88999999999999999975 67889999999999999999999987 688999999999999943 57899999
Q ss_pred cCCCccCCCCCcc-----ceecccccCccccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHH
Q 009595 356 FGLARLMPDGHAQ-----VSTSIVAGTVGYIAPEYHQTL----KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSL 426 (531)
Q Consensus 356 fgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l 426 (531)
|||++.+.+.... .-++...||..|++||.+.-+ +.+.++||||.|||+|..+.|+.||... .....+
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn---qsQQdI 693 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN---QSQQDI 693 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc---hhHHHH
Confidence 9999988654322 224567899999999987544 4688999999999999999999998643 222222
Q ss_pred HHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 009595 427 VRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS 482 (531)
Q Consensus 427 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 482 (531)
... ..+++.........|.+. ....++|.+||+..-++|....++..
T Consensus 694 Lqe-NTIlkAtEVqFP~KPvVs--------seAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 LQE-NTILKATEVQFPPKPVVS--------SEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred Hhh-hchhcceeccCCCCCccC--------HHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 221 122222222222222221 23677889999999999988777665
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=257.48 Aligned_cols=240 Identities=30% Similarity=0.438 Sum_probs=192.4
Q ss_pred ceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccCCCCHHH
Q 009595 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLE 294 (531)
Q Consensus 215 ~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~ 294 (531)
+||.||+|.... +|+.+|+|++........ ...+..|+..+++++|+||+++++++......++++||+.+++|.+
T Consensus 1 ~~g~v~~~~~~~-~~~~~~~k~~~~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKK-TGKLVAIKVIKKEKIKKK---RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECC-CCcEEEEEEecccccccH---HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 589999998864 678999999976443221 4678899999999999999999999999999999999999999999
Q ss_pred HHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccceeccc
Q 009595 295 ILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIV 374 (531)
Q Consensus 295 ~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~ 374 (531)
++.. ...+++.....++.+++.++.||| ..+++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 77 ~~~~----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~ 146 (244)
T smart00220 77 LLKK----RGRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTF 146 (244)
T ss_pred HHHh----ccCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccc
Confidence 9975 233889999999999999999999 6789999999999999999999999999998776542 12335
Q ss_pred ccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHH
Q 009595 375 AGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEE 454 (531)
Q Consensus 375 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 454 (531)
.++..|+|||.+.+..++.++||||||+++++|++|..||... .....+...+... ........ . .
T Consensus 147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~---~~~~~~~~~~~~~---~~~~~~~~-----~---~ 212 (244)
T smart00220 147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKP---KPPFPPPE-----W---K 212 (244)
T ss_pred cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHhcc---CCCCcccc-----c---c
Confidence 6788999999998888899999999999999999999998653 1222222222211 11110000 0 0
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 009595 455 QMLLVLKIACFCTLDDPEERPNSKDVRS 482 (531)
Q Consensus 455 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 482 (531)
....+.+++.+|+..+|++||++.++++
T Consensus 213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 213 ISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 1234888999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-33 Score=267.11 Aligned_cols=260 Identities=19% Similarity=0.268 Sum_probs=203.3
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC--CCc----ccccceeEE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR--HRN----IVPLLAHMV 275 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hpn----Iv~l~~~~~ 275 (531)
..+|.++..+|+|.||.|..+.+.. ++..||||+++.-... .+...-|+.++.++. .|+ +|.+.+||.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~-~~~~vAlKIik~V~kY-----reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRE-TKEHVALKIIKNVDKY-----REAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecC-CCceehHHHHHHHHHH-----hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 6789999999999999999997765 4889999999864332 566677999999993 333 788889999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC--------
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD-------- 347 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-------- 347 (531)
..+..|||+|.+ |.|+.+++.. ++-.+++...+..++.|+++++.+|| +.+++|-||||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEec
Confidence 999999999998 6699999976 56678999999999999999999999 788999999999999941
Q ss_pred ------------CCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009595 348 ------------DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSD 415 (531)
Q Consensus 348 ------------~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~ 415 (531)
+..|+|+|||.|..-.... +..+.|..|.|||++.+-+++.++||||+||||+|+.||..-|.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 3458999999998754433 34677999999999999999999999999999999999998876
Q ss_pred CcccchhhhHHHHHHHHHhccCCCCcccccc---------------c------------------cCCCcHHHHHHHHHH
Q 009595 416 DFFQHTEEKSLVRWMRNVMTSENPNRAIDSK---------------L------------------LGNGYEEQMLLVLKI 462 (531)
Q Consensus 416 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~---------------l------------------~~~~~~~~~~~l~~l 462 (531)
.. +..+.+ ..+..++. +.|...+... . .-.....+...|.+|
T Consensus 311 tH---en~EHL-aMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL 385 (415)
T KOG0671|consen 311 TH---ENLEHL-AMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL 385 (415)
T ss_pred cC---CcHHHH-HHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence 43 222333 22222222 2222111111 0 001122344569999
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 009595 463 ACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 463 i~~cl~~dP~~RPs~~evl~~ 483 (531)
+..+|..||.+|+|+.|++++
T Consensus 386 l~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 386 LRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHccCccccccHHHHhcC
Confidence 999999999999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=287.52 Aligned_cols=264 Identities=19% Similarity=0.196 Sum_probs=170.1
Q ss_pred hcccccccccccccceeEEEEEeeeCCC----CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCccccccee---
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESN----GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH--- 273 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~--- 273 (531)
..++|...+.||+|+||.||+|.+.. + +..||||++...... +....+ .+....+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~-~~~~~~~~vAvK~~~~~~~~------e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVN-KQSKKEGKYVLKKATEYGAV------EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcC-CccccCcEEEEEEecccchh------HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 45789999999999999999998764 5 788999988643221 111111 1122223333332221
Q ss_pred ---EEeCCceEEEEeccCCCCHHHHHhhccCC----------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 009595 274 ---MVRPDCHLLVSEFMKNGSLLEILNDVSQG----------------RRELEWLARHRIARGIVSGLEYLHMYHRPRII 334 (531)
Q Consensus 274 ---~~~~~~~~lv~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 334 (531)
.......++||||+.+++|.+++...... ........+..++.|++.||.||| +++|+
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIi 277 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIV 277 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEE
Confidence 23456789999999999999998642100 001123345679999999999999 77899
Q ss_pred eeccCCCCeeeCC-CCCEEEeecCCCccCCCCCccceecccccCccccCcccccCC----------------------CC
Q 009595 335 HRNITPSSVLIDD-DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL----------------------KF 391 (531)
Q Consensus 335 H~Dlkp~NILl~~-~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~ 391 (531)
||||||+|||++. ++.+||+|||+++.+...... ......|++.|+|||.+... .+
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 9999999999986 579999999999866443222 22346789999999965322 23
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCcccc------hhhhHHHHHHHHHhccCCCCccccccccC--CCcHHHHHHHHHHH
Q 009595 392 SEKCDIYSFGVLLAVLVMGKLPSDDFFQH------TEEKSLVRWMRNVMTSENPNRAIDSKLLG--NGYEEQMLLVLKIA 463 (531)
Q Consensus 392 ~~~~DvwSlGvil~elltg~~P~~~~~~~------~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~li 463 (531)
+.++|||||||++|||+++..|++..... .....+..|....... ..+.+.. +..........+|+
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi 430 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELL 430 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHH
Confidence 44679999999999999987775431100 0000011111111000 0000000 00000112356899
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 009595 464 CFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 464 ~~cl~~dP~~RPs~~evl~~ 483 (531)
.+||+.||.+|||+.++++|
T Consensus 431 ~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 431 KSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHccCCcccCCCHHHHhCC
Confidence 99999999999999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=274.58 Aligned_cols=269 Identities=20% Similarity=0.254 Sum_probs=181.7
Q ss_pred hcccccccccccccceeEEEEEeee---------------CCCCeEEEEEEEeccCchhhhH----------HHHHHHHH
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELP---------------ESNGKMIAIKKVKQVDNSLLNI----------KMRQVRAE 255 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~---------------~~~~~~vavK~~~~~~~~~~~~----------~~~~~~~E 255 (531)
..++|.+.++||+|+||.||+|... ...++.||||++.......... ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3578999999999999999999641 1245689999997543221110 01233457
Q ss_pred HHHHhcCCCCcc-----cccceeEEe--------CCceEEEEeccCCCCHHHHHhhccC--------------------C
Q 009595 256 IMTAGQIRHRNI-----VPLLAHMVR--------PDCHLLVSEFMKNGSLLEILNDVSQ--------------------G 302 (531)
Q Consensus 256 i~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~--------------------~ 302 (531)
+.++.+++|.++ ++++++|.. ....++||||+++|+|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677777653 3567999999999999999874211 0
Q ss_pred CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccC
Q 009595 303 RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIA 382 (531)
Q Consensus 303 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 382 (531)
...+++..+..++.|++.+|.||| ..+++||||||+|||++.++.+||+|||++......... ......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123467788899999999999999 678999999999999999999999999999765433211 1122335889999
Q ss_pred cccccCCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCcccchhhh-----HHHHHHHHHh
Q 009595 383 PEYHQTLK--------------------F--SEKCDIYSFGVLLAVLVMGKL-PSDDFFQHTEEK-----SLVRWMRNVM 434 (531)
Q Consensus 383 PE~~~~~~--------------------~--~~~~DvwSlGvil~elltg~~-P~~~~~~~~~~~-----~l~~~~~~~~ 434 (531)
||.+.... + ..+.||||+||++|+|++|.. ||.+........ .+..|. ..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~ 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MY 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hh
Confidence 99875432 1 124799999999999999976 765421111111 111111 11
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDP---EERPNSKDVRSM 483 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~ 483 (531)
......... +........+++.++|..+| .+|+|+.++++|
T Consensus 457 ~~~~~~~~~--------~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQKYDFSL--------LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccCCCccc--------ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111111111 11122347778888888765 789999999876
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=252.08 Aligned_cols=204 Identities=23% Similarity=0.301 Sum_probs=176.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
-+.|..++.||+|+|..|..+++.. +.+.||+|++++.-.++ +..+.-.+.|-.+..+. +||.+|.++.+|.++..+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~-t~qiyamkvvkkel~nd-dedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKK-TDQIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcc-cceeeehhhHHHHhcCC-cccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 3668889999999999999998875 78889999997643322 12245566777777776 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++|.||++||+|--++++ ...+|+..+..+...|.-||.||| ++|||+||||.+|+|+|..|++||+|+|+++
T Consensus 327 ffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhh
Confidence 999999999999887765 578999999999999999999999 8999999999999999999999999999988
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDD 416 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~ 416 (531)
.--... -.++.++|||.|.|||.+.+..|+...|.|++|++++||+.|+.||+-
T Consensus 400 e~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 400 EGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred cCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 533222 234568999999999999999999999999999999999999999974
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=258.01 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=210.6
Q ss_pred hcccccccccccccceeEEEEEeeeCC----CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPES----NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 276 (531)
...++...-.+-+|.||.||.|.|.+. +.+.|-+|.++... ...+...+..|...+..+.|||+..+.+++..
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A---S~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA---SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc---cHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 445677778899999999999977532 23456777776533 23457889999999999999999999998865
Q ss_pred -CCceEEEEeccCCCCHHHHHhhc----cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCE
Q 009595 277 -PDCHLLVSEFMKNGSLLEILNDV----SQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA 351 (531)
Q Consensus 277 -~~~~~lv~E~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v 351 (531)
....+.++.++.-|+|..+|..- ....+.++-.+...++.|++.|++||| +.+|||.||..+|+++|+..++
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeE
Confidence 45678889999889999999721 123456777888889999999999999 8889999999999999999999
Q ss_pred EEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHH
Q 009595 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~ 430 (531)
||+|=.+++.+...+.+.-.........||+||.+.+..|+..+||||||++||||+| |+.||.+..+.+.. .++
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~----~yl 511 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME----HYL 511 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH----HHH
Confidence 9999999998877776665555556788999999999999999999999999999998 99998876554333 333
Q ss_pred HHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
+....-..|.. +++ ++..++.-||..+|++||++++++..|.+.
T Consensus 512 kdGyRlaQP~N----------CPD---eLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 512 KDGYRLAQPFN----------CPD---ELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred hccceecCCCC----------CcH---HHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 33222222222 222 477788889999999999999999999763
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=283.82 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=191.0
Q ss_pred cccccccccccccee-EEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 203 DCSASLEKIRSRASG-EIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g-~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
..|...+.+|.|+.| .||+|.+ .|+.||||++-... .....+|+..|+.- +|||||++|+.-.+....
T Consensus 509 ~~~~~~eilG~Gs~Gt~Vf~G~y---e~R~VAVKrll~e~-------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~ 578 (903)
T KOG1027|consen 509 LFFSPKEILGYGSNGTVVFRGVY---EGREVAVKRLLEEF-------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFL 578 (903)
T ss_pred eeeccHHHcccCCCCcEEEEEee---CCceehHHHHhhHh-------HHHHHHHHHHHHhccCCCceEEEEeeccCCceE
Confidence 334556789999987 5899988 78999999996532 45677899999988 699999999988888899
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC---C--CCEEEee
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD---D--MEARIAD 355 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~--~~vkL~D 355 (531)
||+.|.|.. ||.+++.................++.|+++||++|| ..+||||||||.||||+. + .+++|+|
T Consensus 579 YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSD 654 (903)
T KOG1027|consen 579 YIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISD 654 (903)
T ss_pred EEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecc
Confidence 999999977 999999752000011111445678999999999999 567999999999999975 3 4789999
Q ss_pred cCCCccCCCCCccce-ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCcccchhhhHHHHHHHHH
Q 009595 356 FGLARLMPDGHAQVS-TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMG-KLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 356 fgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
||+++.+..+..... .....||.+|+|||.+....-+.++||||+|||+|+.++| .+||.+....+.+ +
T Consensus 655 fglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--I------- 725 (903)
T KOG1027|consen 655 FGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--I------- 725 (903)
T ss_pred cccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--h-------
Confidence 999998876543322 3457799999999999998888899999999999999885 9999876432211 1
Q ss_pred hccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 434 MTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 434 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
.........+. +.... ...+||.+|+++||..||++.+|+.|-
T Consensus 726 l~~~~~L~~L~----~~~d~----eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 726 LTGNYTLVHLE----PLPDC----EAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred hcCccceeeec----cCchH----HHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 11111111111 11111 578899999999999999999998753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=237.72 Aligned_cols=260 Identities=21% Similarity=0.310 Sum_probs=196.4
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeC--
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRP-- 277 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~-- 277 (531)
..++|++++++|+|.+++||.|... .+++.++||+++.-. .+.+.+|+.+|..|+ ||||+++++...++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~-~~~eK~ViKiLKPVk-------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINI-TNNEKCVIKILKPVK-------KKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred ccchHHHHHHHcCccHhhHhccccc-CCCceEEEeeechHH-------HHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 5688999999999999999999754 377889999998643 566889999999996 99999999988765
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC-CCEEEeec
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD-MEARIADF 356 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkL~Df 356 (531)
....+|+||+++.+...+. +.++...+..++.+++.||.||| +.||.|||+||.|+++|.. -.++|+||
T Consensus 108 ktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred cCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeec
Confidence 3567999999997766655 45777888899999999999999 7889999999999999875 46999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
|+|.++-.+. ..+..+.+..|-.||.+-.- .|+..-|+|||||++..|+..+.||- .+++...+++...+-+-.
T Consensus 178 GLAEFYHp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF--hG~dN~DQLVkIakVLGt 252 (338)
T KOG0668|consen 178 GLAEFYHPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF--HGHDNYDQLVKIAKVLGT 252 (338)
T ss_pred chHhhcCCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc--CCCCCHHHHHHHHHHhCh
Confidence 9999875442 22335567778899987654 57889999999999999999999973 333444555544431100
Q ss_pred cC------CCCccccccc----------------cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SE------NPNRAIDSKL----------------LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~------~~~~~~d~~l----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. .-.-.++++. .++.-.-...+.++++...|..|-.+|||++|.+.|
T Consensus 253 ~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 253 DELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00 0000011111 011111122457888889999999999999998875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=246.01 Aligned_cols=300 Identities=23% Similarity=0.295 Sum_probs=214.7
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC---
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--- 277 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--- 277 (531)
...+|.-+..+|.|.- .|..+.+. -.+++||+|++........ ..++..+|..++..+.|+||++++.+|.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~-v~~~~v~ikk~~~pf~n~~--~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQ-VLGRPVAIKKLSRPFQNQT--HAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchh-hccCceehhhhcCccccCc--cchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 3456777888999988 56555443 3788999999866533321 246678899999999999999999988753
Q ss_pred ---CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe
Q 009595 278 ---DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 278 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
..+|+|||||.. +|...+. -.++-.+...+..|++.|+.||| +.||+||||||+||++..++.+||.
T Consensus 91 ~~~~e~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~ 160 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKIL 160 (369)
T ss_pred HHHHhHHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeec
Confidence 356999999965 9999885 45777888999999999999999 7889999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
|||+++.-... ...+..+.|..|.|||++.+..|.+.+||||.||++.||++|+.-|.+- ..+..|.+..-
T Consensus 161 dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~------d~idQ~~ki~~ 231 (369)
T KOG0665|consen 161 DFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK------DHIDQWNKIIE 231 (369)
T ss_pred cchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc------hHHHHHHHHHH
Confidence 99999865433 2345567899999999999988999999999999999999999887542 22222222211
Q ss_pred ccCCCCccccccc----------------------cC--------CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 435 TSENPNRAIDSKL----------------------LG--------NGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 435 ~~~~~~~~~d~~l----------------------~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
..+.+...+-.++ .+ +........+.+++.+||..||++|.|+++++.|-
T Consensus 232 ~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 232 QLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 1111111111100 00 01122335688899999999999999999999975
Q ss_pred cc-CcC-CCchhhhhh-ccCCCCCChH-HHHHhhHHHHhhhhc
Q 009595 485 SD-TAL-IKDVDFLKM-HKRMDFDNDD-CVELIQQEIYTEWLS 523 (531)
Q Consensus 485 ~~-~~~-~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~ 523 (531)
-- ++. +..++-... +.+..++.++ ....|+.++|.|...
T Consensus 312 Y~~vw~~~~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~ 354 (369)
T KOG0665|consen 312 YIKVWYDPDEVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQR 354 (369)
T ss_pred eeeeecccccccCCCCchhhhhcccccCCHHHHHHHHHHHHHh
Confidence 22 111 001100011 1222344444 488999999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=270.22 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=205.5
Q ss_pred hhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 200 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
++.+.|..+..+|+|.+|.||+++... +++..|+|+++.....+ ..-+++|+-+++.++||||+.++|.+...+.
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~-s~elaavkvVkLep~dd----~~~iqqei~~~~dc~h~nivay~gsylr~dk 86 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKR-SGELAAVKVVKLEPGDD----FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK 86 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccc-cCchhhheeeeccCCcc----ccccccceeeeecCCCcChHHHHhhhhhhcC
Confidence 356788999999999999999999875 78999999998755443 6677889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.+++||||.+|+|.+..+ ...++++.++..+++..++||.||| ..|-+|||||-.||++++.|.+|++|||.+
T Consensus 87 lwicMEycgggslQdiy~----~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred cEEEEEecCCCcccceee----ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCch
Confidence 999999999999999875 3688999999999999999999999 778999999999999999999999999998
Q ss_pred ccCCCCCccceecccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQ---TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
..+...-.. ...+.||+.|||||+.. .+.|...+|||++|++..|+.--+.|.-+.++- ..++-.-+ ..
T Consensus 160 aqitati~K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---r~l~LmTk---S~ 231 (829)
T KOG0576|consen 160 AQITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---RALFLMTK---SG 231 (829)
T ss_pred hhhhhhhhh--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---HHHHHhhc---cC
Confidence 876554222 23478999999999764 457999999999999999999888885444331 11111101 11
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS 482 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 482 (531)
..+...-|+ ..+.+ .+.+++..|+..+|++|||+..+++
T Consensus 232 ~qpp~lkDk----~kws~---~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 232 FQPPTLKDK----TKWSE---FFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCcccCC----ccchH---HHHHHHHHHhcCCCccCCChhhhee
Confidence 122222232 23333 3566777799999999999987765
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-31 Score=244.60 Aligned_cols=269 Identities=22% Similarity=0.291 Sum_probs=196.3
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC-----c
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD-----C 279 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~ 279 (531)
.+.-+-||-|+||.||.+.+.. +|+.||.|++..-..+.. ..+.+.+|+.+|..++|.|++..++...... .
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPR-dgrrvalkK~pnvfq~L~--s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPR-SGKRVALKKMPNVFQNLA--SCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred CCCCCcccccceeEEEeccCCC-CccchhHhhcchHHHHHH--HHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 3456789999999999998775 799999999976443322 2678889999999999999999998765432 4
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.|.++|.|.. +|+..+- +...++...+.-++.||++||.||| ..+|.||||||.|+|++++..+||||||++
T Consensus 132 iYV~TELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccc
Confidence 5788999965 8888774 4678888889999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHH--------
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM-------- 430 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~-------- 430 (531)
+......... ++..+-|..|.|||.+.+. .|+.+.||||.|||+.|++..+.-|..-.+-..-+-+.+.+
T Consensus 204 Rvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 204 RTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred cccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 9765443322 3445568899999999887 58999999999999999999888775433222111122211
Q ss_pred -------HHHhccCCCCccccccccCCCcH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 431 -------RNVMTSENPNRAIDSKLLGNGYE-EQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 431 -------~~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
+...-...+....-+.+..-..+ ........+.+.++.+||..|.+..+.+.++.
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111111111111111111111 11123455667799999999999999988773
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=229.04 Aligned_cols=213 Identities=33% Similarity=0.522 Sum_probs=183.3
Q ss_pred ccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccCCC
Q 009595 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNG 290 (531)
Q Consensus 211 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 290 (531)
||+|++|.||++.... +++.+++|++....... ....+.+|+..++.+.|++|+++++++......++++||+.++
T Consensus 1 l~~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecC-CCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 6899999999998753 58899999998654321 2467889999999999999999999999989999999999989
Q ss_pred CHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC-CCCEEEeecCCCccCCCCCccc
Q 009595 291 SLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD-DMEARIADFGLARLMPDGHAQV 369 (531)
Q Consensus 291 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vkL~Dfgla~~~~~~~~~~ 369 (531)
+|.+++... ...+++..+..++.++++++.+|| ..+++|+||+|.||+++. ++.++|+|||.+........
T Consensus 77 ~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-- 148 (215)
T cd00180 77 SLKDLLKEN---EGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-- 148 (215)
T ss_pred cHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--
Confidence 999999751 146889999999999999999999 678999999999999999 89999999999887655421
Q ss_pred eecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcccccccc
Q 009595 370 STSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLL 448 (531)
Q Consensus 370 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 448 (531)
......+...|++||..... .++.++|+|++|+++++|
T Consensus 149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------- 187 (215)
T cd00180 149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------- 187 (215)
T ss_pred hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------
Confidence 12234578899999998877 788999999999999999
Q ss_pred CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 449 GNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 449 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
..+.+++..|+..||.+||++.+++.+|
T Consensus 188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1377889999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=230.03 Aligned_cols=263 Identities=20% Similarity=0.289 Sum_probs=194.5
Q ss_pred ccchhhhhhhhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccc
Q 009595 191 IEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVP 269 (531)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~ 269 (531)
+...++..+.-.+.|.+.+.+|.|.||.+-+++++. +++.+++|-+...... .+.|.+|...--.| .|.||+.
T Consensus 12 I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~-s~t~ivlKavp~p~tt-----~~dF~rEfhY~~~Ls~H~hIi~ 85 (378)
T KOG1345|consen 12 IPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQ-SKTRIVLKAVPRPQTT-----QADFVREFHYSFFLSPHQHIID 85 (378)
T ss_pred cccccccccchhhhhhHHHHhcccceeeEEeeeccC-CceEEEeeccCcchhh-----HHHHHHHhccceeeccchhhhH
Confidence 344555556667889999999999999999999875 6778999999865433 67899999877777 5999999
Q ss_pred ccee-EEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC--
Q 009595 270 LLAH-MVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID-- 346 (531)
Q Consensus 270 l~~~-~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~-- 346 (531)
-|++ |...+.+++++||++.|+|.+-+.. ..+-+....+++.|+++||.|+| ++++||||||.+||||-
T Consensus 86 tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~ 157 (378)
T KOG1345|consen 86 TYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDA 157 (378)
T ss_pred HHHHHhhcCceEEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecC
Confidence 8874 5667788899999999999998853 55778888899999999999999 78899999999999993
Q ss_pred CCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCcccch
Q 009595 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-----KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHT 421 (531)
Q Consensus 347 ~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~P~~~~~~~~ 421 (531)
+..++||||||+.+..+.... ...-+..|.+||..... ...+.+|+|.|||++|.++||+.||.... .
T Consensus 158 df~rvKlcDFG~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~--~ 230 (378)
T KOG1345|consen 158 DFYRVKLCDFGLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS--I 230 (378)
T ss_pred CccEEEeeecccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh--c
Confidence 335899999999886544321 12235679999976432 24678999999999999999999997432 2
Q ss_pred hhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 009595 422 EEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS 482 (531)
Q Consensus 422 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 482 (531)
......+|+.-.... ... -|+.+....+. +..+..+-|.++|++|--..++.+
T Consensus 231 ~d~~Y~~~~~w~~rk--~~~--~P~~F~~fs~~----a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 231 MDKPYWEWEQWLKRK--NPA--LPKKFNPFSEK----ALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred cCchHHHHHHHhccc--Ccc--CchhhcccCHH----HHHHHHHhcCCcccccchhHHHHH
Confidence 333445554432221 111 12222233333 555666788999999944444433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=253.32 Aligned_cols=203 Identities=26% Similarity=0.382 Sum_probs=174.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch----hhhHHHHHHHHHHHHHhcCC---CCccccccee
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS----LLNIKMRQVRAEIMTAGQIR---HRNIVPLLAH 273 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~ 273 (531)
....|+.+..+|.|+||.|+.|.+++ +...|+||.+.+..-- ..+...-.+-.||.+|..++ |+||++++++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~-n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKE-NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred ccccceeeeeccccccceEEEeeecc-cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 33558889999999999999999886 5778999998764321 11122344667999999997 9999999999
Q ss_pred EEeCCceEEEEecc-CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEE
Q 009595 274 MVRPDCHLLVSEFM-KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEAR 352 (531)
Q Consensus 274 ~~~~~~~~lv~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vk 352 (531)
|++.+.+||+||-. +|-+|++++.. ++.+++..+..|+.|++-|+++|| ..||||||||-+|+.++++|-+|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEE
Confidence 99999999999975 56799999975 788999999999999999999999 88999999999999999999999
Q ss_pred EeecCCCccCCCCCccceecccccCccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 009595 353 IADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKF-SEKCDIYSFGVLLAVLVMGKLPSD 415 (531)
Q Consensus 353 L~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~ 415 (531)
|+|||.+....++. ...++||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus 711 lidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999988776652 345789999999999999987 677899999999999999988874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-28 Score=239.20 Aligned_cols=134 Identities=25% Similarity=0.365 Sum_probs=114.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-----C---Cccccccee
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-----H---RNIVPLLAH 273 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----h---pnIv~l~~~ 273 (531)
.++|-+.++||.|.|++||++.+.. +.+.||+|+++..... .+....||++|++++ | .+||+|++.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq-~~r~VAlKVvKSAqhY-----tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQ-NKRYVALKVVKSAQHY-----TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred CceEEEEEeccccccceeEEEeecc-CCeEEEEEEEehhhHH-----HHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 3788899999999999999997654 7889999999864433 466778999999983 3 359999998
Q ss_pred EEe----CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC
Q 009595 274 MVR----PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346 (531)
Q Consensus 274 ~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~ 346 (531)
|.- +..+|+|+|++ |.+|..+|.. ...+.++...+..|++||+.||.|||. ..||||-||||+|||+.
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLC 222 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeee
Confidence 864 45789999999 6699999986 556789999999999999999999998 45999999999999994
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-29 Score=247.46 Aligned_cols=263 Identities=18% Similarity=0.222 Sum_probs=201.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC------CCcccccceeEE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR------HRNIVPLLAHMV 275 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~------hpnIv~l~~~~~ 275 (531)
...|.+....|+|-|++|..|.... .|..||||++..+..- .+.=++|+.+|++|+ --|+++++..|.
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~-r~~~vAiKIIRnNE~M-----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQA-RGQEVAIKIIRNNEVM-----HKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred cceeEEEeccccceeeeeeeccccC-CCCeeEEEEeecchHH-----hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 4678888899999999999998764 6779999999875432 355668999999994 347999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC-CCEEEe
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD-MEARIA 354 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkL~ 354 (531)
...++|||+|-+.- +|.+.|..+.. +..|....+..++.|+.-||..|. ..||+|.||||+|||+++. ..+|||
T Consensus 505 hknHLClVFE~Lsl-NLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 505 HKNHLCLVFEPLSL-NLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hcceeEEEehhhhc-hHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeec
Confidence 99999999998854 99999987544 356778888999999999999999 6789999999999999875 568999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
|||.|......... ...-+..|.|||++.|.+|+...|+||.||+||||.||+.-|.+...+ +...++..+-
T Consensus 580 DfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN----~MLrl~me~K 651 (752)
T KOG0670|consen 580 DFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN----QMLRLFMELK 651 (752)
T ss_pred cCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH----HHHHHHHHhc
Confidence 99999887665322 122356799999999999999999999999999999999998774332 2222221110
Q ss_pred c------------------c-----------------------CCCCccccccc-----cCCCcHHHHHHHHHHHHHccc
Q 009595 435 T------------------S-----------------------ENPNRAIDSKL-----LGNGYEEQMLLVLKIACFCTL 468 (531)
Q Consensus 435 ~------------------~-----------------------~~~~~~~d~~l-----~~~~~~~~~~~l~~li~~cl~ 468 (531)
. . ..|..-+-..+ .++........+.+|+..||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 0 0 00000000000 122234456779999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 009595 469 DDPEERPNSKDVRSM 483 (531)
Q Consensus 469 ~dP~~RPs~~evl~~ 483 (531)
.||.+|.|..+.+.|
T Consensus 732 LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 732 LDPEKRITVNQALKH 746 (752)
T ss_pred cChhhcCCHHHHhcC
Confidence 999999999998875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=225.52 Aligned_cols=200 Identities=31% Similarity=0.467 Sum_probs=171.1
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 284 (531)
|...+.||.|++|.||++.... +++.+++|.+...... .....+.+|+..+..++|+|++++++++......++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG-TGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC-CCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence 4567889999999999998763 5788999999865433 12677889999999999999999999999989999999
Q ss_pred eccCCCCHHHHHhhccCCCcc-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 285 EFMKNGSLLEILNDVSQGRRE-LEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
||+++++|.+++.. ... +++.....++.+++.++.+|| ..+++|+||+|+||+++.++.++|+|||++....
T Consensus 77 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 77 EYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred eccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 99999999999975 223 788999999999999999999 6789999999999999999999999999988776
Q ss_pred CCCccceecccccCccccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYH-QTLKFSEKCDIYSFGVLLAVLVMGKLPSDD 416 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~P~~~ 416 (531)
..... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 150 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 150 RDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred Ccccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 54311 12335678899999998 666788899999999999999999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=264.13 Aligned_cols=198 Identities=17% Similarity=0.203 Sum_probs=140.0
Q ss_pred cCCC-CcccccceeE-------EeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 009595 261 QIRH-RNIVPLLAHM-------VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR 332 (531)
Q Consensus 261 ~l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 332 (531)
.++| +||++++++| .....+++++||+ +++|.+++.. ....+++..+..++.||++||.||| ++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAH---SQG 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHH---hCC
Confidence 3445 6888888877 3335678889988 5599999964 2456999999999999999999999 788
Q ss_pred eEeeccCCCCeeeCCC-------------------CCEEEeecCCCccCCCCCc--------------cceecccccCcc
Q 009595 333 IIHRNITPSSVLIDDD-------------------MEARIADFGLARLMPDGHA--------------QVSTSIVAGTVG 379 (531)
Q Consensus 333 ivH~Dlkp~NILl~~~-------------------~~vkL~Dfgla~~~~~~~~--------------~~~~~~~~gt~~ 379 (531)
|+||||||+||||+.. +.+|++|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4455666666553211000 001112468999
Q ss_pred ccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHH
Q 009595 380 YIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLV 459 (531)
Q Consensus 380 y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 459 (531)
|||||++.+..++.++|||||||+||||++|..|+.... ..+... .... .+... .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~-~~~~---~~~~~----------~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSL-RHRV---LPPQI----------LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHH-HHhh---cChhh----------hhcCHHH
Confidence 999999999999999999999999999999988864321 111111 1110 01000 0011224
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 460 LKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 460 ~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
..++.+||++||.+|||+.+++++-
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhch
Confidence 5778889999999999999998753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=227.62 Aligned_cols=198 Identities=23% Similarity=0.328 Sum_probs=165.4
Q ss_pred cccccccccccccceeEEEEEeeeCC--CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPES--NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPD 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 278 (531)
.+.|..+++||.|.|++||++..... ..+.||+|.+..... ..++..|++.|..+ .+.||+++.+++..++
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~------p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS------PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC------chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 46678899999999999999987642 567899999976443 56688999999999 6999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC-CCCEEEeecC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD-DMEARIADFG 357 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vkL~Dfg 357 (531)
.+.+|+||+++.+-.+++.. ++...+..+++.+..||.++| .+|||||||||+|+|.+. .+.-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEech
Confidence 99999999999998888854 667888899999999999999 899999999999999975 4678999999
Q ss_pred CCccCCCC-------C-----------------------------------ccceecccccCccccCcccccCC-CCCch
Q 009595 358 LARLMPDG-------H-----------------------------------AQVSTSIVAGTVGYIAPEYHQTL-KFSEK 394 (531)
Q Consensus 358 la~~~~~~-------~-----------------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 394 (531)
++...... . .........||++|.|||++... ..+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 99821100 0 00001235699999999998765 46889
Q ss_pred hhHHHHHHHHHHHHhCCCCCC
Q 009595 395 CDIYSFGVLLAVLVMGKLPSD 415 (531)
Q Consensus 395 ~DvwSlGvil~elltg~~P~~ 415 (531)
+||||.|+|+.-+++++.||-
T Consensus 259 iDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred cceeeccceeehhhccccccc
Confidence 999999999999999999984
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=204.90 Aligned_cols=167 Identities=20% Similarity=0.218 Sum_probs=125.5
Q ss_pred CCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccc
Q 009595 290 GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQV 369 (531)
Q Consensus 290 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~ 369 (531)
|||.+++.. ....+++..++.++.|++.||.||| +.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc---
Confidence 699999974 2356999999999999999999999 444 999999999999999 99988654321
Q ss_pred eecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccC
Q 009595 370 STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLG 449 (531)
Q Consensus 370 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 449 (531)
..||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....+..+..... ...+...
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~-~~~~~~~------- 129 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILEILLNGMP-ADDPRDR------- 129 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHHHHHHhc-cCCcccc-------
Confidence 2589999999999999999999999999999999999999865322 1111112221111 1111000
Q ss_pred CCcHHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 450 NGYEEQML--LVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 450 ~~~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
........ .+.+++.+||..||.+|||+.++++++..+
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 01111222 588999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-23 Score=210.26 Aligned_cols=264 Identities=22% Similarity=0.267 Sum_probs=195.4
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCC----CcccccceeE-EeCC
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH----RNIVPLLAHM-VRPD 278 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h----pnIv~l~~~~-~~~~ 278 (531)
.|.+.++||+|+||.||.|.........+|+|......... ...+..|+.++..+.. +++..+++.. ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC----CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 78999999999999999998754334578999887643321 1146678888888862 6888999888 4777
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC-----CCEEE
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD-----MEARI 353 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-----~~vkL 353 (531)
..++||+.+ |.||.++..... .+.++..+...++.|++.+|.++| +.|++||||||+|+++... ..+.|
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEE
Confidence 889999998 779999886532 578999999999999999999999 7889999999999999765 46999
Q ss_pred eecCCCc--cCCCCCc----cce--ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhH
Q 009595 354 ADFGLAR--LMPDGHA----QVS--TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKS 425 (531)
Q Consensus 354 ~Dfgla~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~ 425 (531)
.|||+++ .+..... ... .....||..|.++....+...+.+.|+||++.++.++..|..||...........
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~ 248 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK 248 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH
Confidence 9999999 4322221 111 1245699999999999999999999999999999999999999976543222222
Q ss_pred HHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCC
Q 009595 426 LVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALI 490 (531)
Q Consensus 426 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 490 (531)
+........... .....+.+ +.++...+-..+...+|.+..+...|.+....
T Consensus 249 ~~~~~~~~~~~~----------~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 249 FEKDPRKLLTDR----------FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHHHhhhhcccc----------ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 222211111110 11222333 33344444457999999999999998775443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=215.15 Aligned_cols=171 Identities=18% Similarity=0.138 Sum_probs=130.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch-hhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS-LLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
.+.|...+.||+|+||+||+|.+...+++.||||++...... ........+.+|+.+|++++|+||+..+.. .+..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence 467899999999999999999876556888899987532110 112235678999999999999999853322 2457
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecc-CCCCeeeCCCCCEEEeecCCC
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI-TPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NILl~~~~~vkL~Dfgla 359 (531)
|+||||++|++|.. +.. .. ...++.+++++|.||| ++||+|||| ||+|||++.++.+||+|||++
T Consensus 94 ~LVmE~~~G~~L~~-~~~----~~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 94 GLVRGWTEGVPLHL-ARP----HG------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred EEEEEccCCCCHHH-hCc----cc------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 99999999999973 211 11 1357889999999999 789999999 999999999999999999999
Q ss_pred ccCCCCCccce------ecccccCccccCcccccCC
Q 009595 360 RLMPDGHAQVS------TSIVAGTVGYIAPEYHQTL 389 (531)
Q Consensus 360 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 389 (531)
+.+........ .....+++.|+|||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 97765432111 1345688899999988643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=190.15 Aligned_cols=264 Identities=23% Similarity=0.291 Sum_probs=201.4
Q ss_pred hhhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCC-CcccccceeEEeC
Q 009595 199 LEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH-RNIVPLLAHMVRP 277 (531)
Q Consensus 199 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~ 277 (531)
+...+.|..+++||+|+||.+|.|.... +|..||||.-..... -.++..|..+...|++ ..|..+..+..+.
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~-~ge~VAiK~Es~~a~------hpqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISIT-SGEEVAIKLESSKAK------HPQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeecc-CCceEEEEeecccCC------CcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 3446889999999999999999998764 899999999876443 3456789999998864 7788888888888
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC---CCCEEEe
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD---DMEARIA 354 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkL~ 354 (531)
..-.+|||.. |.||.++++- ....++..+.+-++-|++.-++|+| .++++||||||+|+|+.- ...+.|+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred ccceeeeecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEE
Confidence 8999999998 8899998863 3567899999999999999999999 778999999999999964 3568999
Q ss_pred ecCCCccCCCCCcc-----ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHH
Q 009595 355 DFGLARLMPDGHAQ-----VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRW 429 (531)
Q Consensus 355 Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~ 429 (531)
|||+++.+.+..+. .......||.+|.+-....+..-+.+.|+-|+|.+|.+..-|..||.+..+....+.....
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 99999988665322 1224567999999988877777889999999999999999999999998664443333222
Q ss_pred HHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 430 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
...-.. .+ .......++.+ +...+..|-..-=.+-|...-+.+.+.-
T Consensus 237 ~EkK~s--~~-----ie~LC~G~P~E---F~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 237 SEKKMS--TP-----IEVLCKGFPAE---FAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred HHhhcC--CC-----HHHHhCCCcHH---HHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 211111 11 11122333333 3344556777777788998877766533
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=191.52 Aligned_cols=261 Identities=21% Similarity=0.302 Sum_probs=199.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
.-.|.+.++||+|.||+++.|+.- -++++||||.-..... .-++..|.+..+.| ..++|...|-+...+-.-
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl-~nne~VAIKfEPrkS~------APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNL-YNNEPVAIKFEPRKSE------APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred cccceeccccccCcceeeeccccc-ccCceEEEEeccccCC------cchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 356888999999999999999754 4899999998876443 45677888888888 579999999887777788
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC-----CCEEEee
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD-----MEARIAD 355 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-----~~vkL~D 355 (531)
.||+|++ |.||.|+.. ..+..++..++.-++.|++.-++|+| .+.+|.|||||+|+||... ..+.++|
T Consensus 100 iLVidLL-GPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred hhhhhhh-CcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEe
Confidence 8999998 889999886 34678999999999999999999999 6779999999999999643 3589999
Q ss_pred cCCCccCCCCCccc-----eecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHH
Q 009595 356 FGLARLMPDGHAQV-----STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 356 fgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~ 430 (531)
||+|+.+.+..+.. ......||.+||+-....+..-+.+.|+-|+|-++++.|-|..||.+.-.....+.. +.+
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY-eKI 251 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY-EKI 251 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH-HHh
Confidence 99999887654321 224567999999999999999999999999999999999999999987553332221 111
Q ss_pred HHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
+..............+++++..-...+. ..+=.+-|.+.-+...+.+
T Consensus 252 ------Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 252 ------GETKRSTPIEVLCEGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred ------ccccccCCHHHHHhcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHH
Confidence 1112222222233446665555444433 3466677998876665544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-21 Score=195.98 Aligned_cols=265 Identities=28% Similarity=0.369 Sum_probs=198.2
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCC-cccccceeEEeCCceEEE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHR-NIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp-nIv~l~~~~~~~~~~~lv 283 (531)
|...+.||.|+||.||.+... ..+++|.+........ .....+.+|+.++..+.|+ +|+++++.+......+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKS-KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec----cEEEEEeechhhccch-hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence 566788999999999999864 6789999976544321 1267788999999999988 799999999777778999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC-CEEEeecCCCccC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM-EARIADFGLARLM 362 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkL~Dfgla~~~ 362 (531)
++++.+++|.+++...... ..++......++.+++.++.|+| ..+++|||+||+||+++..+ .++++|||++...
T Consensus 77 ~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 9999999999777642111 36888999999999999999999 77799999999999999988 7999999999866
Q ss_pred CCCCccc----eecccccCccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 363 PDGHAQV----STSIVAGTVGYIAPEYHQT---LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 363 ~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
....... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...............+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 5443221 2345789999999999987 57889999999999999999999997654321011222222222211
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. ........ .........+.+++..|+..+|..|.+.......
T Consensus 233 ~-~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSP----SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCc----cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1 00000000 0001122347778888999999999999987765
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=195.11 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=187.1
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEe
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 285 (531)
..+.+|....+|+.|+|+| .|..+++|++....-. ....+.|..|.-.|+-+.||||+.++|.|..+..+.++..
T Consensus 193 nl~tkl~e~hsgelwrgrw---qgndivakil~vr~~t--~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRW---QGNDIVAKILNVREVT--ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhccCCCcccccccc---cCcchhhhhhhhhhcc--hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 4567899999999999999 5667888888653322 2235779999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe--ecCCCccCC
Q 009595 286 FMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA--DFGLARLMP 363 (531)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~--Dfgla~~~~ 363 (531)
||+-|||+..|+. +..-.++-.++.+++.++|+|++|||+.. +-|..--|.+..+++|++.+++|. |--++.
T Consensus 268 ~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--- 341 (448)
T KOG0195|consen 268 YMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--- 341 (448)
T ss_pred eccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee---
Confidence 9999999999986 44556777889999999999999999873 445556789999999999887763 221111
Q ss_pred CCCccceecccccCccccCcccccCCCC---CchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKF---SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
......-.|.||+||.+...+- -..+|+|||.+++||+.|...||.+..+-+..-. ..+..-++.
T Consensus 342 ------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk------ialeglrv~ 409 (448)
T KOG0195|consen 342 ------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK------IALEGLRVH 409 (448)
T ss_pred ------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh------hhhcccccc
Confidence 1111234789999999987653 3579999999999999999999988655332211 111111110
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
+. +.....+.+++.-|++.||.+||.+..|+-.|++.
T Consensus 410 --ip--------pgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 410 --IP--------PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred --CC--------CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 11 11122366677779999999999999999888764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-23 Score=224.59 Aligned_cols=259 Identities=18% Similarity=0.226 Sum_probs=187.2
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEecc--CchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQV--DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
...+.+|.|.+|.|+.+.... .....+.|..... ...........+..|+.+-..+.|||++..+..+......+-+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~-~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRS-DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecC-CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence 456789999999777765432 3444444443310 1111111123377889999999999999888877776666666
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
||||++ +|..++.. ...+....+..++.|++.|+.|+| ..|+.|||+|++|++++.+|.+||+|||.+..+.
T Consensus 400 mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 999999 99999965 357888889999999999999999 7889999999999999999999999999998765
Q ss_pred CCCcc--ceecccccCccccCcccccCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 364 DGHAQ--VSTSIVAGTVGYIAPEYHQTLKFSE-KCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 364 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
..... ......+|+..|+|||++.+..|.+ ..||||.|++++.|++|+.||......... + ..........
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~--~----~~~~~~~~~~ 545 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS--F----KTNNYSDQRN 545 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc--h----hhhccccccc
Confidence 54333 3345678999999999999999876 589999999999999999998654332111 0 0000000000
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS 482 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 482 (531)
...-..............++.++|++||.+|.|+.+|++
T Consensus 546 ---~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 ---IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ---cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000001112223345778899999999999999999876
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-21 Score=183.01 Aligned_cols=174 Identities=11% Similarity=0.177 Sum_probs=133.4
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHH------HHHHHHHHhcCCCCcccccceeE
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQ------VRAEIMTAGQIRHRNIVPLLAHM 274 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~------~~~Ei~~l~~l~hpnIv~l~~~~ 274 (531)
-.++|...+.+|.|+||.||.+.. ++..+|||.+......... .... +.+|+..+.++.||+|..+..++
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~-~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTER-FLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCchHH-HHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 468899999999999999999754 4667999999765443322 2223 67999999999999999999886
Q ss_pred EeC--------CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC
Q 009595 275 VRP--------DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346 (531)
Q Consensus 275 ~~~--------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~ 346 (531)
... ...+++|||++|.+|.++.. ++. ....+++.+|..+| ..|++|||++|+||+++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVS 169 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEe
Confidence 643 35789999999999988742 222 24568999999999 88999999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHH
Q 009595 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLV 408 (531)
Q Consensus 347 ~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 408 (531)
.+| ++|+|||........... ..+.....|..++|+||||+++....
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999987654322110 01333334667899999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-21 Score=176.68 Aligned_cols=143 Identities=17% Similarity=0.151 Sum_probs=110.0
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhh----------------------HHHHHHHHHHHHHhcCCCC
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLN----------------------IKMRQVRAEIMTAGQIRHR 265 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~----------------------~~~~~~~~Ei~~l~~l~hp 265 (531)
...||+|++|.||+|... +|+.||||+++........ ........|+..+.++.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 357999999999999875 7999999999764321110 0112334599999999888
Q ss_pred cccccceeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeeccCCCCee
Q 009595 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYL-HMYHRPRIIHRNITPSSVL 344 (531)
Q Consensus 266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlkp~NIL 344 (531)
++.....+.. ...+|||||+++++|...... ...++......++.|++.+|.++ | ..||+||||||+|||
T Consensus 80 ~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIl 150 (190)
T cd05147 80 GIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLL 150 (190)
T ss_pred CCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEE
Confidence 8755443322 234899999998877655322 35688899999999999999999 6 678999999999999
Q ss_pred eCCCCCEEEeecCCCccC
Q 009595 345 IDDDMEARIADFGLARLM 362 (531)
Q Consensus 345 l~~~~~vkL~Dfgla~~~ 362 (531)
++ ++.++|+|||++...
T Consensus 151 i~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EE-CCcEEEEEccccccC
Confidence 98 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=211.24 Aligned_cols=257 Identities=19% Similarity=0.257 Sum_probs=183.8
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
.+...+.||++.|=.|.+|+.+ .|. |+||++-+......-....+-..|++ ...++|||.+++.-+.......|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~--eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR--EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC--Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 5677889999999999999875 466 89999865443221111333344555 5566999999999988888888999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
-+|..+ +|+|.+.. ++-+...+..-|+.|++.||.-+| +.||+|||||.+|||+++=+.+.|+||...+...
T Consensus 100 Rqyvkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTY 171 (1431)
T ss_pred HHHHhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCcc
Confidence 999977 99999954 677888888889999999999999 8899999999999999999999999998766432
Q ss_pred --CCCcc---ceecccccCccccCcccccCC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHH
Q 009595 364 --DGHAQ---VSTSIVAGTVGYIAPEYHQTL----------K-FSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSL 426 (531)
Q Consensus 364 --~~~~~---~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l 426 (531)
...+. .-..+...-.+|+|||.+... + .+++.||||+||++.||++ |++||.- -++
T Consensus 172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL 244 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQL 244 (1431)
T ss_pred CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHH
Confidence 11111 111111223479999977431 2 6789999999999999999 6777752 122
Q ss_pred HHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 427 VRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 427 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
..+-... ...+...+. .+ .+ ..+++++..|++.||++|.|+.+.++.-..+.+
T Consensus 245 ~aYr~~~--~~~~e~~Le-~I-ed------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 245 LAYRSGN--ADDPEQLLE-KI-ED------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred HhHhccC--ccCHHHHHH-hC-cC------ccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 2221110 000000000 00 00 138889999999999999999999998666543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.4e-20 Score=172.18 Aligned_cols=145 Identities=17% Similarity=0.184 Sum_probs=112.6
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCch----------------------hhhHHHHHHHHHHHHHhcCCCC
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS----------------------LLNIKMRQVRAEIMTAGQIRHR 265 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~~Ei~~l~~l~hp 265 (531)
...||+|++|.||+|... +|+.||||+++..... ........+..|+..+.++.|+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 457999999999999865 7999999999865321 0011123346789999999999
Q ss_pred cccccceeEEeCCceEEEEeccCCCCHHHH-HhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCee
Q 009595 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEI-LNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344 (531)
Q Consensus 266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIL 344 (531)
+|.....+... ..++||||++|+++... +. ...++......++.+++.++.++|+ ..|++||||||+||+
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIl 150 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNIL 150 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEE
Confidence 98665554433 34899999998765443 32 2456778889999999999999993 278999999999999
Q ss_pred eCCCCCEEEeecCCCccCCC
Q 009595 345 IDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 345 l~~~~~vkL~Dfgla~~~~~ 364 (531)
++ ++.++|+|||++.....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 88999999999886544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.9e-20 Score=178.98 Aligned_cols=237 Identities=16% Similarity=0.181 Sum_probs=152.6
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCC----------CcccccceeE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH----------RNIVPLLAHM 274 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h----------pnIv~l~~~~ 274 (531)
....+.||.|++|.||.+.+.. +|+.+|+|++...... .....+.+.+|.-....+.+ -.++-.++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~-t~~~~avkvf~~~~~~-~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVE-TGEEFAVKVFLLPADA-SANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TTEEEEEEEEEESSTT-HTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred EEEccccccCCceEEEEEEEcc-CCceEEEEEEeccccc-chHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 3556789999999999998765 7899999999766533 23346777777655544432 1222222222
Q ss_pred E---------eCC--------ceEEEEeccCCCCHHHHHhhc---cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 009595 275 V---------RPD--------CHLLVSEFMKNGSLLEILNDV---SQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334 (531)
Q Consensus 275 ~---------~~~--------~~~lv~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 334 (531)
. ... ..+++|+-+.+ ||.+++... ......+....+..+..|+++.+++|| ..|++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceE
Confidence 1 111 23678888855 898886532 222334566677788899999999999 78899
Q ss_pred eeccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccC--------CCCCchhhHHHHHHHHHH
Q 009595 335 HRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT--------LKFSEKCDIYSFGVLLAV 406 (531)
Q Consensus 335 H~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~e 406 (531)
|+||+|+|++++.+|.++|+||+.....+..... ...+..|.|||.... ..++.+.|.|++|+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999887765432111 234577999997643 247889999999999999
Q ss_pred HHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCC
Q 009595 407 LVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEER 474 (531)
Q Consensus 407 lltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 474 (531)
|+||..||+.......... .+.. +.+..+.+..||..+|+.||.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~---------------------~f~~-C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW---------------------DFSR-CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG---------------------GGTT-SS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc---------------------cchh-cCCcCHHHHHHHHHHccCCcccC
Confidence 9999999975432111100 1122 22555668889999999999887
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=191.17 Aligned_cols=220 Identities=23% Similarity=0.352 Sum_probs=167.3
Q ss_pred HhcCCCCcccccceeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecc
Q 009595 259 AGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI 338 (531)
Q Consensus 259 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 338 (531)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+.. ....+++.....++++|+.||.|||+ +....|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeee
Confidence 4678999999999999999999999999999999999975 45678999999999999999999996 333499999
Q ss_pred CCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCC-------CCchhhHHHHHHHHHHHHhCC
Q 009595 339 TPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK-------FSEKCDIYSFGVLLAVLVMGK 411 (531)
Q Consensus 339 kp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlGvil~elltg~ 411 (531)
+++|+++|....+||+|||+.................-..-|.|||.+.+.. .+.+.||||||++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999988764311111111122345699999987641 467799999999999999999
Q ss_pred CCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCC
Q 009595 412 LPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALI 490 (531)
Q Consensus 412 ~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 490 (531)
.||+..........++..++. .+ ...+-|.+.... +....+..++..||..+|.+||++..+-..++.+-..
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~---~~--~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK---GG--SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChHHHHHHHHh---cC--CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 999875444443445544444 11 111112221111 2223588899999999999999999999999887554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.4e-20 Score=169.03 Aligned_cols=189 Identities=16% Similarity=0.126 Sum_probs=141.1
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCceEEEE
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 284 (531)
.....|++|+||+||.+.. .+..++.+.+..............+.+|+++|++|. |++|++++++ +..+++|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~---~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG---GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec---CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 3467899999999997754 678888888876443222222336889999999995 5889999886 4569999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecc-CCCCeeeCCCCCEEEeecCCCccCC
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI-TPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
||+.|.+|.+.+.. . ...++.+++++|.++| ..||+|||| ||.|||++.++.++|+|||++....
T Consensus 78 eyI~G~~L~~~~~~-----~------~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 78 SYLAGAAMYQRPPR-----G------DLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred eeecCccHHhhhhh-----h------hHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 99999998754421 1 1347789999999999 788999999 7999999999999999999998654
Q ss_pred CCCcc----c-------eecccccCccccCcccccCC-CCC-chhhHHHHHHHHHHHHhCCCCCC
Q 009595 364 DGHAQ----V-------STSIVAGTVGYIAPEYHQTL-KFS-EKCDIYSFGVLLAVLVMGKLPSD 415 (531)
Q Consensus 364 ~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvil~elltg~~P~~ 415 (531)
..... . .......++.|++|+...-. ..+ ...+.++-|.-+|.++|+..|+-
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 33210 0 01123367888888754322 333 67889999999999999998853
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-19 Score=175.81 Aligned_cols=259 Identities=20% Similarity=0.235 Sum_probs=171.9
Q ss_pred ccccccccccccceeEEEEEeeeCC----------------------------------CCeEEEEEEEeccCc-hhhhH
Q 009595 203 DCSASLEKIRSRASGEIYIAELPES----------------------------------NGKMIAIKKVKQVDN-SLLNI 247 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~----------------------------------~~~~vavK~~~~~~~-~~~~~ 247 (531)
+.|.+.+.||+|....||.+..... ..-+.|||.+-..+. +....
T Consensus 157 ddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~~ 236 (598)
T KOG4158|consen 157 DDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDAH 236 (598)
T ss_pred hhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchHH
Confidence 5688899999999999998876430 001456776643222 22233
Q ss_pred HHHHHHHHHH------HH--------h-------c-CCCCcccccceeEEe---------------------------CC
Q 009595 248 KMRQVRAEIM------TA--------G-------Q-IRHRNIVPLLAHMVR---------------------------PD 278 (531)
Q Consensus 248 ~~~~~~~Ei~------~l--------~-------~-l~hpnIv~l~~~~~~---------------------------~~ 278 (531)
..+.+-+|.- .+ + + -+|||||++.++|.+ +.
T Consensus 237 iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~ 316 (598)
T KOG4158|consen 237 ILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPK 316 (598)
T ss_pred HHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCc
Confidence 3455555531 11 1 1 269999999987754 34
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee--CCC--CCEEEe
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI--DDD--MEARIA 354 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl--~~~--~~vkL~ 354 (531)
.+|+||.-.+. ||..++-. ...+.....-++.|+++|+.||| ++||.|||+|++|||+ |+| ..+.|+
T Consensus 317 tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 317 TLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred eEEEehhcchh-hHHHHHhc-----CCCchHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEc
Confidence 56999998877 99999953 45566677789999999999999 8899999999999999 333 468999
Q ss_pred ecCCCccCCCCCcccee----cccccCccccCcccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhh
Q 009595 355 DFGLARLMPDGHAQVST----SIVAGTVGYIAPEYHQTLK------FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~ 424 (531)
|||++-.-....-+... -..-|.-..||||+....+ .-.++|.|+.|.+.||+++...||..- ++..-
T Consensus 388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r--Gem~L 465 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR--GEMLL 465 (598)
T ss_pred ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCccccc--chhee
Confidence 99987654432111111 1234677899999886432 235899999999999999999998651 11111
Q ss_pred HHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 425 SLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 425 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
+...+-. ...| .+.+... ..+.+++...|+.||++|||..-....|.-
T Consensus 466 ~~r~Yqe----~qLP------alp~~vp----p~~rqlV~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 466 DTRTYQE----SQLP------ALPSRVP----PVARQLVFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred chhhhhh----hhCC------CCcccCC----hHHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence 1111100 0101 1111111 236778888999999999998877776643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.4e-20 Score=190.99 Aligned_cols=228 Identities=21% Similarity=0.276 Sum_probs=174.2
Q ss_pred ccccceeEEEEEee--eCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCceEEEEecc
Q 009595 211 IRSRASGEIYIAEL--PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 211 ig~G~~g~Vy~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+|.|.||.|+.+.- ....|..||+|..+.......... ....|-.++..++ ||.++++...+..+...+++++|.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 68899999987643 122567788888866443322211 4445777788886 999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
.||.|...+.. ...+.+.....+...++-++.++| +.+++|||+|++||+++.+|++++.|||+++.......
T Consensus 80 rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 80 RGGDLFTRLSK----EVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred ccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 99999988854 456677777778888999999999 88899999999999999999999999999987655422
Q ss_pred cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccc
Q 009595 368 QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447 (531)
Q Consensus 368 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 447 (531)
.+||..|||||++. .....+|.||||++++||+||..||.. +.++.++.....
T Consensus 153 ------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~~~~-------- 205 (612)
T KOG0603|consen 153 ------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKAELE-------- 205 (612)
T ss_pred ------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhhccC--------
Confidence 38999999999998 467789999999999999999999865 122222221111
Q ss_pred cCCCcHHHHHHHHHHHHHcccCCCCCCCCH
Q 009595 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNS 477 (531)
Q Consensus 448 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 477 (531)
....-......++..++..+|..|--.
T Consensus 206 ---~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 206 ---MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ---CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 111222335666667777888888665
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-18 Score=161.32 Aligned_cols=135 Identities=16% Similarity=0.206 Sum_probs=103.7
Q ss_pred ccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-----CCCcccccceeEEeCC---
Q 009595 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-----RHRNIVPLLAHMVRPD--- 278 (531)
Q Consensus 207 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-----~hpnIv~l~~~~~~~~--- 278 (531)
..+.||+|+||.||. +.. ++.. +||++....... .+.+.+|+.+++.+ .||||++++|++.++.
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~-~~~k-~IKv~~~~~~~~----~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPE-DAQR-CIKIVYHRGDGG----DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred CcceecCCCceEEEE--CCC-CcCe-EEEEEeccccch----HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 356899999999995 432 4444 699887643222 46688999999999 6799999999998864
Q ss_pred ceE-EEEec--cCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeeccCCCCeeeCC----CCC
Q 009595 279 CHL-LVSEF--MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGL-EYLHMYHRPRIIHRNITPSSVLIDD----DME 350 (531)
Q Consensus 279 ~~~-lv~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dlkp~NILl~~----~~~ 350 (531)
.++ +|+|| +.+|||.+++.+ ..+++. ..++.+++.++ .||| +.+|+||||||+|||++. +++
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCc
Confidence 333 78999 557999999964 235544 35677888777 9999 788999999999999974 348
Q ss_pred EEEeecCCC
Q 009595 351 ARIADFGLA 359 (531)
Q Consensus 351 vkL~Dfgla 359 (531)
++|+||+.+
T Consensus 148 ~~LiDg~G~ 156 (210)
T PRK10345 148 PVVCDNIGE 156 (210)
T ss_pred EEEEECCCC
Confidence 999995443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.7e-18 Score=163.54 Aligned_cols=154 Identities=17% Similarity=0.153 Sum_probs=115.0
Q ss_pred hhhhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchh--------------------hhHHHHHHHHHHH
Q 009595 198 FLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSL--------------------LNIKMRQVRAEIM 257 (531)
Q Consensus 198 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~~~Ei~ 257 (531)
+++....|.+.+.||+|++|.||+|.+...+|+.||||+++...... .......+..|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 34444567888999999999999997233479999999997543210 0111234678999
Q ss_pred HHhcCCCCc--ccccceeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC-eE
Q 009595 258 TAGQIRHRN--IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR-II 334 (531)
Q Consensus 258 ~l~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-iv 334 (531)
++.++.+.+ +.+++++ ...++||||+++++|...... ...........++.|++.+|.+|| ..| ++
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~g~ii 171 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLY---KEGELV 171 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHH---hcCCEE
Confidence 999997533 3333432 235899999999888765422 234556667789999999999999 788 99
Q ss_pred eeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 335 HRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 335 H~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
||||||+||+++ ++.++|+|||++....
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999999 8899999999877543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.5e-18 Score=185.76 Aligned_cols=196 Identities=21% Similarity=0.272 Sum_probs=157.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC---CCcccccceeEEeC
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR---HRNIVPLLAHMVRP 277 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~ 277 (531)
....|.+-+.||.|+||.||.|... +|+.||+|+-+......--+ ..+ ++.+|+ -+.|..+...+.-.
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~--~~~~~alK~e~P~~~WEfYI-~~q------~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHS--NGKLVALKVEKPPNPWEFYI-CLQ------VMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecC--CCcEEEEEeecCCCceeeee-hHH------HHHhhchhhhcchHHHHHHHccC
Confidence 3456778899999999999999876 59999999998765542111 122 222232 25667777777778
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC-------CCC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD-------DME 350 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-------~~~ 350 (531)
+..+||+||.+-|||.++++ ..+.+++.....++.|++..+..|| ..+||||||||+|+||.. +-.
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccc
Confidence 88899999999999999996 4678899999999999999999999 778999999999999942 345
Q ss_pred EEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 009595 351 ARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKL 412 (531)
Q Consensus 351 vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~ 412 (531)
++|+|||.+..+.--.........++|-.+-.+|...|.+.+..+|.|.++.+++.||.|+.
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999999876543322234455778999999999999999999999999999999999974
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=157.76 Aligned_cols=138 Identities=23% Similarity=0.347 Sum_probs=115.1
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCch----hhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEE
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS----LLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 284 (531)
+.||+|++|.||+|.+ +|..+++|+....... ........+.+|+.++..+.|+||.....++......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 5799999999999987 6778999987643221 11122356788999999999999988888887888889999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
||++|++|.+++.. . .. ....++.+++.+|.++| ..+++|+|++|.|||++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999864 1 11 77889999999999999 77899999999999999 78999999998775
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-17 Score=154.95 Aligned_cols=134 Identities=22% Similarity=0.356 Sum_probs=110.0
Q ss_pred cccccceeEEEEEeeeCCCCeEEEEEEEeccCc----hhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEe
Q 009595 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDN----SLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285 (531)
Q Consensus 210 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 285 (531)
.||+|++|.||+|.+ +|..+++|....... .+......++..|+.++..+.|+++.....++...+..++|||
T Consensus 1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec---CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEE
Confidence 489999999999986 678899998754321 1122234678899999999999887777666777778899999
Q ss_pred ccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 286 FMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
|++|++|.+++.. ... .++.+++.+|.+|| ..+++|+|++|.||+++ ++.++++|||++..
T Consensus 78 ~~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEE----GND-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhh----cHH-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999998853 111 78999999999999 78899999999999999 78999999999775
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4e-18 Score=172.65 Aligned_cols=175 Identities=26% Similarity=0.397 Sum_probs=129.6
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
++||.|++|...+|.+|+... ......++...+.++.|++.|+.| ++.+|+|+||.||+...+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 578999999999999999742 233456788889999999999998 5799999999999999999999999999
Q ss_pred CccCCCCC----ccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHH
Q 009595 359 ARLMPDGH----AQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 359 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
........ .....+..+||..||+||.+.+..|+.++||||||++|+|+++ -..+++-.. .+..+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~ 472 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDI 472 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhh
Confidence 88766543 2233456789999999999999999999999999999999998 444432110 01111
Q ss_pred hccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 009595 434 MTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480 (531)
Q Consensus 434 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 480 (531)
-... +++. ....+++ =+.++.+++.+.|.+||++.+.
T Consensus 473 r~g~-----ip~~-~~~d~p~----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 RDGI-----IPPE-FLQDYPE----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hcCC-----CChH-HhhcCcH----HHHHHHHhcCCCcccCchHHHH
Confidence 0111 1111 1112222 2456677999999999955443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.8e-17 Score=151.74 Aligned_cols=141 Identities=16% Similarity=0.206 Sum_probs=108.7
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhh------------------hHHHHHHHHHHHHHhcCCCCc
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLL------------------NIKMRQVRAEIMTAGQIRHRN 266 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~~~~Ei~~l~~l~hpn 266 (531)
|...+.||+|+||.||++... +|+.||||++........ .........|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 667789999999999999764 799999999865331100 011234677899999998874
Q ss_pred --ccccceeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCee
Q 009595 267 --IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344 (531)
Q Consensus 267 --Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIL 344 (531)
++..++ ....++||||++|++|...... .....++.+++.++.++| ..|++||||+|+||+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nil 157 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNIL 157 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEE
Confidence 333333 2456899999999998765421 234568899999999999 688999999999999
Q ss_pred eCCCCCEEEeecCCCccCCC
Q 009595 345 IDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 345 l~~~~~vkL~Dfgla~~~~~ 364 (531)
++.++.++|+|||++.....
T Consensus 158 l~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EcCCCcEEEEECCccccCCC
Confidence 99999999999999876544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.9e-17 Score=173.90 Aligned_cols=140 Identities=21% Similarity=0.295 Sum_probs=112.3
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccC--ch--hhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVD--NS--LLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~--~~--~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.|...+.||+|+||.||+|.+. +..+++|+..... .. ........+.+|+.++..++|++|+....++.....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~---~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL---GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccCccceeccCCcEEEEEEeec---CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3456789999999999999873 4445555432211 11 112234678899999999999999998888888778
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++||||+++++|.+++. ....++.+++.+|.+|| +.+++||||||+|||+ .++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999999884 24578999999999999 7889999999999999 6779999999998
Q ss_pred ccC
Q 009595 360 RLM 362 (531)
Q Consensus 360 ~~~ 362 (531)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.3e-17 Score=178.15 Aligned_cols=214 Identities=23% Similarity=0.277 Sum_probs=145.4
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
.+..|..++.|..|++|.||.++++. +.++.|+|+-++ .. +.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~-trqrfa~kiNkq-~l---------ilRn--ilt~a~npfvv------------ 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKE-TRQRFAMKINKQ-NL---------ILRN--ILTFAGNPFVV------------ 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccc-cccchhhccccc-ch---------hhhc--cccccCCccee------------
Confidence 45778899999999999999998764 566788843332 11 1110 22223333333
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+-...+.. -++++... +.+++||| +.||+|||+||+|.+|+.-|++|++|||+++
T Consensus 136 ---------gDc~tllk~----~g~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 136 ---------GDCATLLKN----IGPLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 191 (1205)
T ss_pred ---------chhhhhccc----CCCCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhh
Confidence 344445532 23444433 66899999 7889999999999999999999999999987
Q ss_pred cCCCCCc-------------cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHH
Q 009595 361 LMPDGHA-------------QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLV 427 (531)
Q Consensus 361 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~ 427 (531)
....... .......+|||.|.|||++....|+..+|.|++|+|+||.+-|..||.+..+ +.++
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp----eelf 267 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP----EELF 267 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH----HHHH
Confidence 5421110 1112356899999999999999999999999999999999999999876533 3333
Q ss_pred HHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHH
Q 009595 428 RWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSK 478 (531)
Q Consensus 428 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 478 (531)
..+.... ..++.. |.. ...+..+++.+.|+.+|..|--..
T Consensus 268 g~visd~-i~wpE~--dea--------~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 268 GQVISDD-IEWPEE--DEA--------LPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hhhhhhh-cccccc--CcC--------CCHHHHHHHHHHHHhChHhhcccc
Confidence 3322211 011111 111 122367788889999999995444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.4e-17 Score=177.68 Aligned_cols=262 Identities=21% Similarity=0.259 Sum_probs=193.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~ 280 (531)
...|...+.||+|+|+.|-.......+...+|+|.+...... .....++..|..+-..+. |+|++.+++.....+..
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~--~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKS--EDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCc--cchhhhcCccccccccccccccccccCCccCCCccc
Confidence 345666777999999999888765545566777777654311 112455667888888886 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC-CEEEeecCCC
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM-EARIADFGLA 359 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkL~Dfgla 359 (531)
+++++|..||++.+.+.. ......+......++.|+..++.|+|. ..++.|+|+||+|.+++..+ .++++|||++
T Consensus 97 ~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred ccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhh
Confidence 999999999999988831 122245666777899999999999995 45799999999999999999 9999999999
Q ss_pred ccCCC-CCccceeccccc-CccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 360 RLMPD-GHAQVSTSIVAG-TVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 360 ~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
..+.. ..........+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++.... .......|....
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~--~~~~~~~~~~~~--- 247 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR--KDGRYSSWKSNK--- 247 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc--ccccceeecccc---
Confidence 98877 444444556778 9999999999885 446789999999999999999999875432 112222222211
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS 482 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 482 (531)
...... ...... ....+++..++..+|..|.+.+++..
T Consensus 248 ~~~~~~----~~~~~~----~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 GRFTQL----PWNSIS----DQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccC----ccccCC----hhhhhcccccccCCchhccccccccc
Confidence 000011 111111 22566777788899999999887654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.1e-15 Score=134.04 Aligned_cols=135 Identities=17% Similarity=0.228 Sum_probs=111.9
Q ss_pred ccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCC--CcccccceeEEeCCceEEEE
Q 009595 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH--RNIVPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 207 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lv~ 284 (531)
.++.||+|+++.||++.. ++..+++|....... ...+..|+..+..+.| +++++++++....+..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~---~~~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT---KDEDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEe---cCCeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEE
Confidence 356899999999999987 347799999865432 3457789999999976 58999998888778899999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
||++++++..+ +......++.+++++|.++|..+..+++|+|++|.||+++..+.++++|||.+..
T Consensus 73 e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99988766543 4455667899999999999966556899999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-15 Score=144.54 Aligned_cols=139 Identities=14% Similarity=0.205 Sum_probs=106.1
Q ss_pred ccccc-ccceeEEEEEeeeCCCCeEEEEEEEeccCc-------h--hhhHHHHHHHHHHHHHhcCCCCcc--cccceeEE
Q 009595 208 LEKIR-SRASGEIYIAELPESNGKMIAIKKVKQVDN-------S--LLNIKMRQVRAEIMTAGQIRHRNI--VPLLAHMV 275 (531)
Q Consensus 208 ~~~ig-~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-------~--~~~~~~~~~~~Ei~~l~~l~hpnI--v~l~~~~~ 275 (531)
...|| .||.|+||.+.. .+..++||.+..... . ........+.+|+.++..+.|++| +..+++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~---~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT---PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred CceeecCCCCccEEEEEe---CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 35787 899999999976 477899998854211 0 011224567889999999998885 66776644
Q ss_pred eCCc----eEEEEeccCC-CCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC
Q 009595 276 RPDC----HLLVSEFMKN-GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME 350 (531)
Q Consensus 276 ~~~~----~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~ 350 (531)
.... .++|||+++| .+|.+++.. ..++.. .+.+++.+|.+|| ..||+||||||.|||++.++.
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~ 180 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGK 180 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCC
Confidence 3322 2599999997 699998853 234443 3678999999999 889999999999999999999
Q ss_pred EEEeecCCCcc
Q 009595 351 ARIADFGLARL 361 (531)
Q Consensus 351 vkL~Dfgla~~ 361 (531)
++|+|||.+..
T Consensus 181 v~LIDfg~~~~ 191 (239)
T PRK01723 181 FWLIDFDRGEL 191 (239)
T ss_pred EEEEECCCccc
Confidence 99999998775
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.6e-15 Score=135.99 Aligned_cols=141 Identities=19% Similarity=0.235 Sum_probs=97.5
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHH--------------------HHHHHHHHHHhcCCCCc-
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKM--------------------RQVRAEIMTAGQIRHRN- 266 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~--------------------~~~~~Ei~~l~~l~hpn- 266 (531)
.+.||+|+||.||+|... +|+.||||++............ .....|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 467999999999999865 7899999998764322111000 01134555665654433
Q ss_pred -ccccceeEEeCCceEEEEeccCCCCHHH-HHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeeccCCCCe
Q 009595 267 -IVPLLAHMVRPDCHLLVSEFMKNGSLLE-ILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR-PRIIHRNITPSSV 343 (531)
Q Consensus 267 -Iv~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dlkp~NI 343 (531)
+.++++. ...++||||++++++.. .+.. .... .....++.+++.++.++| . .+++|+||||+||
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-----~~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Ni 146 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKD-----VRLL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNI 146 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhh-----hhhc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhE
Confidence 3334332 24589999999854321 1211 0001 456789999999999999 5 7899999999999
Q ss_pred eeCCCCCEEEeecCCCccCCC
Q 009595 344 LIDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 344 Ll~~~~~vkL~Dfgla~~~~~ 364 (531)
+++ ++.++|+|||.+.....
T Consensus 147 li~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EEE-CCcEEEEECcccccccC
Confidence 999 88999999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.1e-15 Score=142.15 Aligned_cols=209 Identities=21% Similarity=0.297 Sum_probs=149.9
Q ss_pred HHHHhcCCCCcccccceeEEeC-----CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 009595 256 IMTAGQIRHRNIVPLLAHMVRP-----DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR 330 (531)
Q Consensus 256 i~~l~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 330 (531)
+..+-++.|-|||+++.|+.+. ....+++|||..|+|.++|++.+.....+....-.+|+.||.+||.|||++ .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 4455677899999999988753 356899999999999999999888888899888899999999999999987 7
Q ss_pred CCeEeeccCCCCeeeCCCCCEEEeecCCCcc--CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHH
Q 009595 331 PRIIHRNITPSSVLIDDDMEARIADFGLARL--MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLV 408 (531)
Q Consensus 331 ~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~--~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 408 (531)
..++|+++..+.|++..+|-+|++--.-... ..............+.++|.+||.-.....+..+|||+||+...||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 8999999999999999999888753221111 01111111122344678999999877777788999999999999999
Q ss_pred hCCCCC-CCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 409 MGKLPS-DDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 409 tg~~P~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
.+..-- ..-.....++.+.+.+ ......+ -+.++..|++..|..||+|++++-|.-.
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i----------~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVI----------IGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred HheeccCCCcceeehhhhhhhhe----------eeccCcc-----------ccCcCcccccCCCCCCcchhhhhcCcee
Confidence 886542 1111111111111110 0011111 2346677999999999999998876533
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.7e-13 Score=139.52 Aligned_cols=144 Identities=17% Similarity=0.284 Sum_probs=98.1
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHH------------------------------------HHH
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKM------------------------------------RQV 252 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~------------------------------------~~~ 252 (531)
+.||+|++|.||+|+.. +|+.||||+.+........... -.+
T Consensus 123 ~plasaSigQVh~A~l~--~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV--DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEec--CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 57999999999999886 7999999999764322111000 024
Q ss_pred HHHHHHHhcC----C-CCcccccceeE-EeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHH-HHHHH
Q 009595 253 RAEIMTAGQI----R-HRNIVPLLAHM-VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVS-GLEYL 325 (531)
Q Consensus 253 ~~Ei~~l~~l----~-hpnIv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~L~~L 325 (531)
..|+..+.++ . +|+| .+-.++ ......++||||++|++|.++..... ...+ ...++..++. .+..+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 201 RREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHHH
Confidence 4455555554 2 3333 222222 22345689999999999998765311 1122 2345565655 36677
Q ss_pred HhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCC
Q 009595 326 HMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 326 H~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~ 364 (531)
| ..|++|+|++|.||+++.+++++++|||++..+..
T Consensus 274 ~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 274 L---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred H---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7 78899999999999999999999999999877643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.3e-13 Score=139.69 Aligned_cols=254 Identities=19% Similarity=0.201 Sum_probs=183.7
Q ss_pred hcccccccccccc--cceeEEEEEee--eCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEE
Q 009595 201 KEDCSASLEKIRS--RASGEIYIAEL--PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMV 275 (531)
Q Consensus 201 ~~~~~~~~~~ig~--G~~g~Vy~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 275 (531)
....+.....+|. |.+|.||.+.. .. ++..+|+|.-+........ ..+-.+|+...+.+ .|+|.++.+..+.
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~-s~~~~a~k~s~~p~s~p~~--~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSE-SPHKFAVKKSKIPFSPPLD--SKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCccc-CCcccccccccCCCCCccc--cccccchhhcccccCccccccccCcccc
Confidence 3455677889999 99999999987 43 6778999985433221111 23344677777777 5999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeeccCCCCeeeCCC-CC
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVS----GLEYLHMYHRPRIIHRNITPSSVLIDDD-ME 350 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~ 350 (531)
..+..++-+|+|. .+|.++... ....++....+....+..+ ||.++| ..+++|-|+||.||++..+ ..
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred cCCcceeeecccc-chhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccce
Confidence 9999999999995 588888864 2345788888889999998 999999 7789999999999999999 88
Q ss_pred EEEeecCCCccCCCCCcccee---cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHH
Q 009595 351 ARIADFGLARLMPDGHAQVST---SIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLV 427 (531)
Q Consensus 351 vkL~Dfgla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~ 427 (531)
.+++|||+...+.+....... ....|...|++||...+ -++..+|+|++|.++.+..+|..++..... .
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-------~ 333 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN-------S 333 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC-------C
Confidence 999999999988766432221 22357889999998866 578899999999999999998766432100 0
Q ss_pred HHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 009595 428 RWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS 482 (531)
Q Consensus 428 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 482 (531)
.|.. .... . +. .+.+......+...+..+++.+|..|++.+.+..
T Consensus 334 ~W~~--~r~~---~-ip----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 SWSQ--LRQG---Y-IP----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred Cccc--cccc---c-Cc----hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0100 0000 0 11 1111111223455777899999999999886655
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.2e-11 Score=126.25 Aligned_cols=166 Identities=19% Similarity=0.243 Sum_probs=126.5
Q ss_pred CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCC
Q 009595 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELE 307 (531)
Q Consensus 228 ~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~ 307 (531)
++.+|.|...+..... ......+-+..|+.++||||++++..+...+..|||+|-+. .|..++.+ +.
T Consensus 36 ~~~~vsVF~~~~~~~~----~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~ 102 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGE----VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LG 102 (690)
T ss_pred cCCceEEEEEeCCCch----hhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hH
Confidence 6778888888765441 24556677889999999999999999999999999999884 68888865 23
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCccccc
Q 009595 308 WLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387 (531)
Q Consensus 308 ~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 387 (531)
......-+.||+.||.|||+ +.+++|++|.-+.|+++..|..||++|.++........ ......-.-.|..|+.+.
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcC
Confidence 55666789999999999996 66899999999999999999999999998765433221 111111223466666543
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCC
Q 009595 388 TLKFSEKCDIYSFGVLLAVLVMGKL 412 (531)
Q Consensus 388 ~~~~~~~~DvwSlGvil~elltg~~ 412 (531)
... -..|.|-||++++++..|..
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCccc
Confidence 322 35799999999999999943
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.9e-12 Score=137.22 Aligned_cols=150 Identities=14% Similarity=0.164 Sum_probs=92.8
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchh------------------------------hhHHHHHH-
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSL------------------------------LNIKMRQV- 252 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~------------------------------~~~~~~~~- 252 (531)
.|.. +.||+|++|.||+|+... +|+.||||+.+...... .+...+.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~-~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKD-NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECC-CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 3444 689999999999998863 49999999998642211 00111223
Q ss_pred -----HHHHHHHhcC----CCCcccccceeEEe-CCceEEEEeccCCCCHHHHHhhccCC--CccCCHHHHHHHHHHHHH
Q 009595 253 -----RAEIMTAGQI----RHRNIVPLLAHMVR-PDCHLLVSEFMKNGSLLEILNDVSQG--RRELEWLARHRIARGIVS 320 (531)
Q Consensus 253 -----~~Ei~~l~~l----~hpnIv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~--~~~l~~~~~~~i~~~ia~ 320 (531)
..|+..+.++ .+.+.+.+-.++.+ ....+|||||++|++|.++-.-...+ ...+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 3333333333 13333333333322 34567999999999998742210011 0123233333333333
Q ss_pred HHHHHHhcCCCCeEeeccCCCCeeeCCCC----CEEEeecCCCccCCCC
Q 009595 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDM----EARIADFGLARLMPDG 365 (531)
Q Consensus 321 ~L~~LH~~~~~~ivH~Dlkp~NILl~~~~----~vkL~Dfgla~~~~~~ 365 (531)
. ..|++|+|++|.||+++.++ +++++|||++..++..
T Consensus 277 -----f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 -----F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -----H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 2 56899999999999999888 9999999999887543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.6e-12 Score=114.95 Aligned_cols=131 Identities=18% Similarity=0.227 Sum_probs=94.7
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCccc-ccceeEEeCCceEEEEec
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV-PLLAHMVRPDCHLLVSEF 286 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv-~l~~~~~~~~~~~lv~E~ 286 (531)
++.++.|.++.||++.. .+..|++|........ ...+..|+.++..+.+.+++ +++.+. ....++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~---~~~~~~lK~~~~~~~~-----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV---ANKKYVVRIPGNGTEL-----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEE---CCeEEEEEeCCCCccc-----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEe
Confidence 45789999999999986 5778999998654321 22356788899888655544 444432 3345899999
Q ss_pred cCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH--RPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 287 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
++|.++.+.- . ....++.+++++|..||... ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 73 i~G~~l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 73 IEGSELLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cCCCcccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9998765430 0 11235678999999999532 22369999999999999 66899999998663
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.1e-11 Score=105.71 Aligned_cols=135 Identities=21% Similarity=0.346 Sum_probs=106.9
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEecc----CchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEE
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQV----DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 284 (531)
..+++|+-+.+|.+.+ -|.++++|.=... ..-+......+...|++++.++.--.|...+=+..+++...|+|
T Consensus 2 ~~i~~GAEa~i~~~~~---~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDF---LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeec---cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence 3688999999999977 4555666644221 12233444677889999999998777777777778888889999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
||++|..|.+.+... ...++..+-.-+.-|| ..||+|+||.++||++.+++ +.++||||+..
T Consensus 79 e~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA-----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999999898651 2457778888899999 88999999999999998875 99999999774
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.2e-10 Score=103.62 Aligned_cols=147 Identities=21% Similarity=0.236 Sum_probs=112.5
Q ss_pred ccccccccceeEEEEEeeeCCCCeEEEEEEEecc----CchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQV----DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 207 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
.+..+-+|+-+.|+++.+ .|+.+.||.-... ..-+......+..+|++.+.+++--.|.-..=++.+...-.|
T Consensus 11 ~l~likQGAEArv~~~~~---~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF---SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeecc---CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE
Confidence 567899999999999988 6888778754221 112333446788899999999977677766666777777789
Q ss_pred EEeccCC-CCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC---CEEEeecCC
Q 009595 283 VSEFMKN-GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM---EARIADFGL 358 (531)
Q Consensus 283 v~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~---~vkL~Dfgl 358 (531)
+|||++| .++.+++... ............++..|-+.+.-|| ..+++|+||..+||++.+++ .+.++|||+
T Consensus 88 ~ME~~~g~~~vk~~i~~~--~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILST--MEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred EEEeccchhHHHHHHHHH--ccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecc
Confidence 9999977 5888888652 2333333444678999999999999 88899999999999997655 358999999
Q ss_pred Ccc
Q 009595 359 ARL 361 (531)
Q Consensus 359 a~~ 361 (531)
+..
T Consensus 163 s~~ 165 (229)
T KOG3087|consen 163 SSV 165 (229)
T ss_pred hhc
Confidence 664
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.6e-10 Score=106.87 Aligned_cols=142 Identities=15% Similarity=0.111 Sum_probs=98.8
Q ss_pred ccccccceeEEEEEeeeCC-----CCeEEEEEEEeccCch----------------------hhhHHHHHHHHHHHHHhc
Q 009595 209 EKIRSRASGEIYIAELPES-----NGKMIAIKKVKQVDNS----------------------LLNIKMRQVRAEIMTAGQ 261 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~-----~~~~vavK~~~~~~~~----------------------~~~~~~~~~~~Ei~~l~~ 261 (531)
..||.|.-+.||.|..... .+..+|||+.+..... .......-..+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4689999999999965311 2478999988643221 001111223389999999
Q ss_pred CCC--CcccccceeEEeCCceEEEEeccCCCCHHH-HHhhccCCCccCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeec
Q 009595 262 IRH--RNIVPLLAHMVRPDCHLLVSEFMKNGSLLE-ILNDVSQGRRELEWLARHRIARGIVSGLEYL-HMYHRPRIIHRN 337 (531)
Q Consensus 262 l~h--pnIv~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~D 337 (531)
+.. -++..++++ ...+|||||+.++.+.. .+.. ..++......+..+++.+|..| | ..|++|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 853 455566653 46689999997644322 2321 2344455667889999999999 7 77899999
Q ss_pred cCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 338 ITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 338 lkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|++.||+++ ++.+.|+|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 4689999999877654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.7e-11 Score=125.66 Aligned_cols=248 Identities=17% Similarity=0.164 Sum_probs=174.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
...|..+..||.|.|+.|+....+..++..|++|.+........+ ...-..|+.+...+ .|.++++.+..+...+..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~--di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS--DIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh--hhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 456788999999999999998765457888999988765443322 12223466666666 689999999888888888
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC-CCEEEeecCCC
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD-MEARIADFGLA 359 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkL~Dfgla 359 (531)
|+=.|||+++++.....- ...+.+...+.+..|++.++.++| .+.++|+|++|+||++..+ +.-+++|||+.
T Consensus 342 ~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccc
Confidence 899999999988876622 355777788899999999999999 7889999999999999886 78899999998
Q ss_pred ccCCCCCccceecccccCcccc--CcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYI--APEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
..+..... ...++-+++ +|.......+..+.|++|||..+.+.++|..--... ..|... ..+
T Consensus 415 t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---------~~~~~i--~~~ 478 (524)
T KOG0601|consen 415 TRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---------VQSLTI--RSG 478 (524)
T ss_pred cccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCccc---------ccceee--ecc
Confidence 75332211 122333444 555555667889999999999999999986532111 011110 011
Q ss_pred -CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 438 -NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 438 -~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
.+.. +.....+..+...+..+++..||++.++..+..
T Consensus 479 ~~p~~-----------~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 479 DTPNL-----------PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cccCC-----------CchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1110 001122444555688899999999988766543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.7e-10 Score=105.67 Aligned_cols=144 Identities=20% Similarity=0.248 Sum_probs=106.3
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCC--CcccccceeEEeCC---ceEE
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH--RNIVPLLAHMVRPD---CHLL 282 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~---~~~l 282 (531)
.+.|+.|.++.||++... +|..+++|......... ....+..|+.++..+.+ .++.+++.+..... ..++
T Consensus 3 ~~~l~~G~~n~~~~v~~~--~g~~~ilK~~~~~~~~~---~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~ 77 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG--GGRRLVLRRPPPGALLP---SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFY 77 (223)
T ss_pred ceecCCCccceEEEEEec--CCcceEEEeCCCcccCc---ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceE
Confidence 357899999999999764 46789999986543210 13457789999999865 44567777665532 5689
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH--------------------------------- 329 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------- 329 (531)
||||++|.++.+.+.. ..++......++.+++++|..||+..
T Consensus 78 v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (223)
T cd05154 78 VMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTD 152 (223)
T ss_pred EEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccc
Confidence 9999999887765421 34566666777788888888887421
Q ss_pred --------------------CCCeEeeccCCCCeeeCC--CCCEEEeecCCCcc
Q 009595 330 --------------------RPRIIHRNITPSSVLIDD--DMEARIADFGLARL 361 (531)
Q Consensus 330 --------------------~~~ivH~Dlkp~NILl~~--~~~vkL~Dfgla~~ 361 (531)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 153 EPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56789999987663
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.5e-09 Score=106.48 Aligned_cols=171 Identities=15% Similarity=0.229 Sum_probs=129.1
Q ss_pred ceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe----CCceEEEEeccCC-
Q 009595 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR----PDCHLLVSEFMKN- 289 (531)
Q Consensus 215 ~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~lv~E~~~~- 289 (531)
-..+.|++... .+|..|++|++....... ......-++.++++.|+|||++.+++.. ...+++|++|.++
T Consensus 288 ~~~Ttyk~~s~-~DG~~YvLkRlhg~r~~~----~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 288 FSITTYKATSN-VDGNAYVLKRLHGDRDQS----TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred ccceeEeeeec-cCCceeeeeeeccccccC----cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 45678888655 489999999994332222 1122345788999999999999998873 4567899999986
Q ss_pred CCHHHHHhhcc-----------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 290 GSLLEILNDVS-----------QGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 290 gsL~~~l~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
++|.++..... ..+...++...|.++.|+..||.++| +.|+..+-|.|.+|+++++.+++|..+|.
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i 439 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGI 439 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccc
Confidence 78888764321 22345788999999999999999999 67799999999999999999999999888
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKL 412 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~ 412 (531)
...+..... +-+. --.+-|.=.||.+++.|.||..
T Consensus 440 ~Dvl~~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 440 MDVLQEDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred eeeecCCCC----------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 766544320 1111 1236789999999999999954
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.3e-10 Score=126.71 Aligned_cols=252 Identities=20% Similarity=0.190 Sum_probs=163.5
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.+.+.+-+-+|.+|.++.+.-. ..|..-++|.......-. ....+....+-.++-..+||-++.....+......++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa-~sgh~~~~~v~~~ap~i~-~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPA-GSGHTRPSKVHGLAPKIR-TNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred ccceecccccCCCCcccccCCcc-ccccccchhhhccchhhc-cccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45566667788888888877543 244444444443221110 0002223333333333456777776666666778899
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
+++|..+++|...++. .+..+.......+..+..+++||| ...+.|+|++|.|++...++..+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999976 223444444556666788899999 555899999999999999999999999843322
Q ss_pred CC------C--C-------------c--------cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 009595 363 PD------G--H-------------A--------QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413 (531)
Q Consensus 363 ~~------~--~-------------~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P 413 (531)
.. . . . ........||+.|.+||.+.+......+|.|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0 0 0 0112345689999999999999999999999999999999999999
Q ss_pred CCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHH
Q 009595 414 SDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSK 478 (531)
Q Consensus 414 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 478 (531)
|....+ .++++ .+.+.. .. ......+......+++...+..+|.+|-.+.
T Consensus 1035 ~na~tp----q~~f~---ni~~~~-~~-------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETP----QQIFE---NILNRD-IP-------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcch----hhhhh---ccccCC-CC-------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 876543 22221 111110 00 0111111222355667778888999998876
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.1e-08 Score=100.06 Aligned_cols=145 Identities=15% Similarity=0.137 Sum_probs=100.3
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchh-hhH------HHHHHHHHHHHHhcCCCCccc--ccceeEEe---
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSL-LNI------KMRQVRAEIMTAGQIRHRNIV--PLLAHMVR--- 276 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~------~~~~~~~Ei~~l~~l~hpnIv--~l~~~~~~--- 276 (531)
+.+.......|+++.+ .|+.|.||......-.. ... -...+.+|...+.+|..-+|. .++++...
T Consensus 28 e~v~~~~~rrvvr~~~---~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~ 104 (268)
T PRK15123 28 EVFRELEGRRTLRFEL---AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSN 104 (268)
T ss_pred cEEecCCCceEEEEEE---CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCC
Confidence 3444444445667766 68889999774322110 000 011377899988888544444 34445433
Q ss_pred --CCceEEEEeccCCC-CHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC------
Q 009595 277 --PDCHLLVSEFMKNG-SLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD------ 347 (531)
Q Consensus 277 --~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~------ 347 (531)
....+||||++++. +|.+++.... ....+......++.+++..+.-|| ..|++|+|++++|||++.
T Consensus 105 ~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 105 PATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred CccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCC
Confidence 23468999999885 8999986421 234456677789999999999999 889999999999999975
Q ss_pred -CCCEEEeecCCCcc
Q 009595 348 -DMEARIADFGLARL 361 (531)
Q Consensus 348 -~~~vkL~Dfgla~~ 361 (531)
++.+.|+||+.+..
T Consensus 180 ~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 180 EDLKLSVIDLHRAQI 194 (268)
T ss_pred CCceEEEEECCcccc
Confidence 46899999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.3e-09 Score=95.98 Aligned_cols=130 Identities=19% Similarity=0.286 Sum_probs=82.6
Q ss_pred EEEEEeeeCCCCeEEEEEEEeccCch----------------------hhhHHHHHHHHHHHHHhcCCCC--ccccccee
Q 009595 218 EIYIAELPESNGKMIAIKKVKQVDNS----------------------LLNIKMRQVRAEIMTAGQIRHR--NIVPLLAH 273 (531)
Q Consensus 218 ~Vy~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~ 273 (531)
.||.|... +|..+|||+.+..... ..........+|.+.|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~--~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAIDP--DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEEC--TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEECC--CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 38888764 7889999988643211 2222346678999999999765 45566543
Q ss_pred EEeCCceEEEEeccC--CCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEeeccCCCCeeeCCCCC
Q 009595 274 MVRPDCHLLVSEFMK--NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEY-LHMYHRPRIIHRNITPSSVLIDDDME 350 (531)
Q Consensus 274 ~~~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~Dlkp~NILl~~~~~ 350 (531)
...+|||||++ |..+..+... .++......++.+++..+.. +| ..|++||||.+.||+++.+ .
T Consensus 79 ----~~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 79 ----NRNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp ----ETTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-C
T ss_pred ----eCCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-e
Confidence 24579999998 5445443321 11123345567777775555 56 7899999999999999988 9
Q ss_pred EEEeecCCCccCC
Q 009595 351 ARIADFGLARLMP 363 (531)
Q Consensus 351 vkL~Dfgla~~~~ 363 (531)
+.++|||.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999877543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=8.6e-08 Score=95.58 Aligned_cols=262 Identities=13% Similarity=0.116 Sum_probs=157.2
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccc--------cceeEEe
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVP--------LLAHMVR 276 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~--------l~~~~~~ 276 (531)
...+-||+||-+.+|-.-. -...+-|+......... .+.+..|... .||-+-. ++|- ..
T Consensus 14 ~~gr~LgqGgea~ly~l~e----~~d~VAKIYh~Pppa~~-------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~ 81 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE----VRDQVAKIYHAPPPAAQ-------AQKVAELAATPDAPLLNYRVAWPQATLHGG-RR 81 (637)
T ss_pred CCCccccCCccceeeecch----hhchhheeecCCCchHH-------HHHHHHhccCCCCcchhhhhcccHHHhhCC-Cc
Confidence 4567899999999996532 12245566655433211 1123333333 5664333 1221 11
Q ss_pred CCceEEEEeccCCC-CHHHHHhh--ccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEE
Q 009595 277 PDCHLLVSEFMKNG-SLLEILND--VSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARI 353 (531)
Q Consensus 277 ~~~~~lv~E~~~~g-sL~~~l~~--~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL 353 (531)
.....+.|..+.+. -..++++. ..++-+...|...++.++.++.+..-|| ..|.+-+|+.++|+|+.+++.+.|
T Consensus 82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~L 158 (637)
T COG4248 82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVL 158 (637)
T ss_pred cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEE
Confidence 12256788887663 34444432 2244566889999999999999999999 778999999999999999999999
Q ss_pred eecCCCccCCCCCccceecccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCcccch-----h
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ-----TLKFSEKCDIYSFGVLLAVLVMG-KLPSDDFFQHT-----E 422 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg-~~P~~~~~~~~-----~ 422 (531)
.|-.......++.. ....+|.+.|.+||.-. +..-+...|.|.+|+++++++.| +.||.+..... .
T Consensus 159 VdsDsfqi~~ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~ 235 (637)
T COG4248 159 VDSDSFQINANGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL 235 (637)
T ss_pred EcccceeeccCCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc
Confidence 98665444333322 23367899999999654 33456789999999999999986 99998753221 1
Q ss_pred hhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHhccC
Q 009595 423 EKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLD--DPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 423 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~~ 487 (531)
+..+....-..-....+.....+.-. -+.--...+-.+..+|+.. ++.-|||++..+..|..+
T Consensus 236 E~~Ia~g~f~ya~~~~~g~~p~P~~~--P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 236 ETDIAHGRFAYASDQRRGLKPPPRSI--PLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred hhhhhcceeeechhccCCCCCCCCCC--ChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 11121110000000001000001000 0001111244555667753 366899999999888655
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4e-08 Score=93.35 Aligned_cols=139 Identities=19% Similarity=0.264 Sum_probs=98.8
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch------------------hhhHHHHHHHHHHHHHhcCCCC-
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS------------------LLNIKMRQVRAEIMTAGQIRHR- 265 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~~~~~Ei~~l~~l~hp- 265 (531)
..+..+||-|.-+.||.|... .|.++|||.-+....+ ..........+|...|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HhhccccccCccceEEEEECC--CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 355689999999999999875 7999999976533221 1122345678899999998655
Q ss_pred -cccccceeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCee
Q 009595 266 -NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344 (531)
Q Consensus 266 -nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIL 344 (531)
.+.+.+++ +...+||||++|-.|...- ++......++..|++-+.-+- ..|+||+|+++-||+
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIl 234 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNIL 234 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEE
Confidence 67777774 5668999999885544321 122223334444544444444 567999999999999
Q ss_pred eCCCCCEEEeecCCCcc
Q 009595 345 IDDDMEARIADFGLARL 361 (531)
Q Consensus 345 l~~~~~vkL~Dfgla~~ 361 (531)
++++|.+.++||--+..
T Consensus 235 V~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 235 VTEDGDIVVIDWPQAVP 251 (304)
T ss_pred EecCCCEEEEeCccccc
Confidence 99999999999976554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.3e-08 Score=89.93 Aligned_cols=143 Identities=13% Similarity=0.115 Sum_probs=102.2
Q ss_pred ccccceeEEEEEeeeCCCCeEEEEEEEeccCchh-h-hHHHHHHHHHHHHHhcCCCCc--ccccceeEEe----CCceEE
Q 009595 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSL-L-NIKMRQVRAEIMTAGQIRHRN--IVPLLAHMVR----PDCHLL 282 (531)
Q Consensus 211 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~-~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~----~~~~~l 282 (531)
-|+||.+.|+.... .|..+-+|+-....... . ......|.+|+..+.+|..-+ +.++...... .-.-+|
T Consensus 26 ~~rgG~SgV~r~~~---~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER---NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe---CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEE
Confidence 46689999998876 46678888775211111 0 112578999999999885333 4444422111 123579
Q ss_pred EEeccCC-CCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC--EEEeecCCC
Q 009595 283 VSEFMKN-GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME--ARIADFGLA 359 (531)
Q Consensus 283 v~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~--vkL~Dfgla 359 (531)
|+|-+.| -||.+++.+ ....+.+...+..++.+++..+.-|| ..|+.|+|+.+.||+++.++. ++++||.-+
T Consensus 103 VTe~L~g~~~L~~~l~~--~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQ--HAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhc--CCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9998764 589999864 22335577777889999999999999 888999999999999986667 999999876
Q ss_pred cc
Q 009595 360 RL 361 (531)
Q Consensus 360 ~~ 361 (531)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 54
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.8e-07 Score=86.93 Aligned_cols=106 Identities=21% Similarity=0.304 Sum_probs=82.1
Q ss_pred HHHHHHHHHHHhcCCCCc--ccccceeEEeCC----ceEEEEeccCC-CCHHHHHhhccCCCccCCHHHHHHHHHHHHHH
Q 009595 249 MRQVRAEIMTAGQIRHRN--IVPLLAHMVRPD----CHLLVSEFMKN-GSLLEILNDVSQGRRELEWLARHRIARGIVSG 321 (531)
Q Consensus 249 ~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~~----~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~ 321 (531)
.....+|...+..|..-+ ++..+++..... ..++|+|++++ -+|.+++... ...+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHH
Confidence 456778888888775443 445555555422 34899999988 4799998752 225666778899999999
Q ss_pred HHHHHhcCCCCeEeeccCCCCeeeCCCC---CEEEeecCCCcc
Q 009595 322 LEYLHMYHRPRIIHRNITPSSVLIDDDM---EARIADFGLARL 361 (531)
Q Consensus 322 L~~LH~~~~~~ivH~Dlkp~NILl~~~~---~vkL~Dfgla~~ 361 (531)
+.-|| ..||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 131 i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 88999999999999999887 899999997664
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.3e-08 Score=104.36 Aligned_cols=150 Identities=18% Similarity=0.250 Sum_probs=97.5
Q ss_pred HHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc------cce-ecccccCccccCcccccCCC
Q 009595 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA------QVS-TSIVAGTVGYIAPEYHQTLK 390 (531)
Q Consensus 318 ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~------~~~-~~~~~gt~~y~aPE~~~~~~ 390 (531)
++.||.|+|. +.++||++|.|++|.++.++..||+.|+.+........ ... .........|.|||++.+..
T Consensus 108 v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 108 VADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred ccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 4489999996 77899999999999999999999999998765433111 000 01122456799999999988
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCC
Q 009595 391 FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDD 470 (531)
Q Consensus 391 ~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~d 470 (531)
.+.++|+||+|+++|-+..|..+.-....+.....+. .... +-... ....+...++.+-+.+.+..+
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~---~~~~--~~~~~--------~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS---RNLL--NAGAF--------GYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhh---hccc--ccccc--------cccccCcHHHHHHHHHHhcCC
Confidence 8999999999999999985554432222111111110 0000 00000 011222234666677789999
Q ss_pred CCCCCCHHHHHH
Q 009595 471 PEERPNSKDVRS 482 (531)
Q Consensus 471 P~~RPs~~evl~ 482 (531)
+..||++..+..
T Consensus 253 ~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 253 SAVRPTLDLLLS 264 (700)
T ss_pred cccCcchhhhhc
Confidence 999997665543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=3e-07 Score=97.26 Aligned_cols=146 Identities=18% Similarity=0.239 Sum_probs=91.5
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHH------------------------------HH------H
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKM------------------------------RQ------V 252 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~------------------------------~~------~ 252 (531)
+-|++++-|.||+|++. +|+.||||+.+.+-........ +. +
T Consensus 131 ~PiAsASIaQVH~A~L~--sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 131 EPIASASIAQVHRAVLK--SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CchhhhhHhhheeEEec--CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 57999999999999997 6999999999865443211111 11 2
Q ss_pred HHHHHHHhcC-----CCCcccccceeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHH-HHHHH
Q 009595 253 RAEIMTAGQI-----RHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSG-LEYLH 326 (531)
Q Consensus 253 ~~Ei~~l~~l-----~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-L~~LH 326 (531)
.+|...+.++ +.|+|.-..=|+.....-.|+|||++|-.+.+...-.. ..++.. .++..++++ +.-+-
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k---~ia~~~~~~f~~q~~ 282 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRK---ELAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHH---HHHHHHHHHHHHHHH
Confidence 2333333333 12332211112223456689999999988888743211 223322 222222222 11122
Q ss_pred hcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCC
Q 009595 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDG 365 (531)
Q Consensus 327 ~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~ 365 (531)
..|++|+|..|.||+++.+|++.+.|||+...+...
T Consensus 283 ---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 283 ---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 468999999999999999999999999998877544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.45 E-value=2e-06 Score=82.31 Aligned_cols=140 Identities=9% Similarity=0.077 Sum_probs=84.6
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCc--ccccceeEEeCCceEEEEe
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN--IVPLLAHMVRPDCHLLVSE 285 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~E 285 (531)
...||+|..+.||+. .|..+++|....... .....+|.++++.+..-+ +.+.+++....+...+|||
T Consensus 6 ~~~i~~G~t~~~y~~-----~~~~~VlR~~~~~~~------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e 74 (226)
T TIGR02172 6 WTQTGEGGNGESYTH-----KTGKWMLKLYNPGFD------KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE 74 (226)
T ss_pred heeecCCCCcceeEe-----cCCCEEEEeCCCCCC------HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence 468999999999984 244578888865332 334578999998885433 4677777777777889999
Q ss_pred ccCCCC-HHHHH---------------------hhccCCCccCCHHHHHHHHHH----------HHH-HHHHHHhc-CCC
Q 009595 286 FMKNGS-LLEIL---------------------NDVSQGRRELEWLARHRIARG----------IVS-GLEYLHMY-HRP 331 (531)
Q Consensus 286 ~~~~gs-L~~~l---------------------~~~~~~~~~l~~~~~~~i~~~----------ia~-~L~~LH~~-~~~ 331 (531)
+++|.+ +...+ +........++... ..+..+ +.+ ...+|... ...
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 998863 22111 10000011111000 000000 001 11222211 134
Q ss_pred CeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 332 RIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 332 ~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
.++|+|+.|.||++++++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 578999999999999888 9999998755
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.6e-06 Score=78.65 Aligned_cols=142 Identities=16% Similarity=0.250 Sum_probs=92.0
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHH-----HHHHHHHHHHhcCCC---Ccccccce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKM-----RQVRAEIMTAGQIRH---RNIVPLLA 272 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~-----~~~~~Ei~~l~~l~h---pnIv~l~~ 272 (531)
..++|...+.+......-|.+... +|..+++|..+......+.... ....+.+..+..++. -.+..++-
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei---~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI---DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE---CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 457777788888877777777665 7888999998765433221111 112333443434422 22333333
Q ss_pred eEEe-----CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC
Q 009595 273 HMVR-----PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347 (531)
Q Consensus 273 ~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~ 347 (531)
+... ....+++|||++|..|.+... ++. .+...+.+++.-|| ..|++|+|+.|.|++++.
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEEC
Confidence 3222 234568999999987766542 222 24456777889999 789999999999999986
Q ss_pred CCCEEEeecCCCcc
Q 009595 348 DMEARIADFGLARL 361 (531)
Q Consensus 348 ~~~vkL~Dfgla~~ 361 (531)
+ .++++||+..+.
T Consensus 171 ~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 171 N-GIRIIDTQGKRM 183 (229)
T ss_pred C-cEEEEECccccc
Confidence 5 599999987553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.9e-05 Score=71.04 Aligned_cols=105 Identities=19% Similarity=0.216 Sum_probs=81.6
Q ss_pred HHHHHHHhcCCC-CcccccceeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 009595 253 RAEIMTAGQIRH-RNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP 331 (531)
Q Consensus 253 ~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 331 (531)
..|.-++..+.+ +++++++|+|- .+++.||...+++....... ..--..+|..+.+|+.++++.+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 347888888865 69999999983 36799999877654221000 0012468999999999999999999976556
Q ss_pred CeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 332 RIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 332 ~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
.+.-.|++|+|+-+++++++|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 6888999999999999999999999876654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.8e-07 Score=96.46 Aligned_cols=190 Identities=19% Similarity=0.139 Sum_probs=137.5
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCc-ccccceeEEeCCc
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN-IVPLLAHMVRPDC 279 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~ 279 (531)
++..+.....+++|+++.+++.+-. ..+....+.+... ....-++++|.+++||| .+..++.+..++.
T Consensus 240 k~kws~~fh~fvK~altknpKkRpt--aeklL~h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPT--AEKLLQHPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCC--hhhheeceeeccc---------hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence 4455667788999999999988653 2233345555442 22345889999999999 7777787888888
Q ss_pred eEEEEeccCCC-CHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 280 HLLVSEFMKNG-SLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 280 ~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
.+++++++.+| +-..... ...-.+.......+.+.-++++++||+. .-+|+| ||+..+ +..+.+||+.
T Consensus 309 ~~i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v 377 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAV 377 (829)
T ss_pred cchhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccC
Confidence 99999999876 2221111 1122233444556777778899999943 247888 777665 6789999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSD 415 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~ 415 (531)
...+.... ..+...+++.|+|||+...+.+....|+|++|.-..+|.-|-.|-.
T Consensus 378 ~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 378 PPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 88776653 2345678999999999999999999999999988888888877743
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.8e-05 Score=76.69 Aligned_cols=142 Identities=10% Similarity=0.061 Sum_probs=83.9
Q ss_pred ccccccce-eEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCceEEEEec
Q 009595 209 EKIRSRAS-GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCHLLVSEF 286 (531)
Q Consensus 209 ~~ig~G~~-g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~ 286 (531)
+.|..|.+ ..||+... .+..+.||+..... ...+.+|+.++..+. +--+.+++++....+..++|||+
T Consensus 4 ~~~~~g~~~~~v~~~~~---~~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 73 (244)
T cd05150 4 ERVTEGQSGATVYRLDG---KNPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSA 73 (244)
T ss_pred eecCCCCCcCeEEEEcC---CCCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEe
Confidence 34555665 78898864 34678888886532 123556888887773 44466777777666678999999
Q ss_pred cCCCCHHHHHh-------------------hccCCCccCCHH--HHHHHHH--------------------HHHHHHHHH
Q 009595 287 MKNGSLLEILN-------------------DVSQGRRELEWL--ARHRIAR--------------------GIVSGLEYL 325 (531)
Q Consensus 287 ~~~gsL~~~l~-------------------~~~~~~~~l~~~--~~~~i~~--------------------~ia~~L~~L 325 (531)
++|.+|..... .......+.... ....... .+...+..|
T Consensus 74 i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 153 (244)
T cd05150 74 VPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAEL 153 (244)
T ss_pred eCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHH
Confidence 99987764421 100000011100 0000000 011112222
Q ss_pred Hh----cCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 326 HM----YHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 326 H~----~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
-. .....++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 154 EATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 11 113559999999999999998778899998654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.7e-05 Score=74.29 Aligned_cols=144 Identities=18% Similarity=0.211 Sum_probs=82.1
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCC--cccccceeEEe---CCceEE
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHR--NIVPLLAHMVR---PDCHLL 282 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~~~~---~~~~~l 282 (531)
++.++.|..+.||++... +..+++|..... .. ...+..|..++..+... .+.+++.+... ....++
T Consensus 2 i~~l~~G~~n~~~~v~~~---~~~~vlK~~~~~--~~----~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~ 72 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD---DGRYVLKFYRPP--DA----AERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL 72 (239)
T ss_dssp EEEEEESSSSEEEEEEET---TSEEEEEEESSH--HH----HHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred CccCCCCCeeeEEEEEEC---CcEEEEEEeCCC--CC----HHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence 467899999999999763 358999998654 11 45667888888887433 35566664432 234689
Q ss_pred EEeccCCCCHHH----------------HHhh---ccCCCccCCHHH---------HHHH------------HHHHHH-H
Q 009595 283 VSEFMKNGSLLE----------------ILND---VSQGRRELEWLA---------RHRI------------ARGIVS-G 321 (531)
Q Consensus 283 v~E~~~~gsL~~----------------~l~~---~~~~~~~l~~~~---------~~~i------------~~~ia~-~ 321 (531)
+|++++|.++.. .+.. ............ .... ...+.. .
T Consensus 73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (239)
T PF01636_consen 73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL 152 (239)
T ss_dssp EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence 999999988777 1111 100111111100 0000 111222 2
Q ss_pred HHHHHh----cCCCCeEeeccCCCCeeeC-CCCCEEEeecCCCc
Q 009595 322 LEYLHM----YHRPRIIHRNITPSSVLID-DDMEARIADFGLAR 360 (531)
Q Consensus 322 L~~LH~----~~~~~ivH~Dlkp~NILl~-~~~~vkL~Dfgla~ 360 (531)
+..++. .....++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 333332 1356799999999999999 66667899998644
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.03 E-value=8.8e-05 Score=70.25 Aligned_cols=140 Identities=19% Similarity=0.259 Sum_probs=91.1
Q ss_pred cccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhh--------------------HHHHHHHHHHHHHhcCC--CCcc
Q 009595 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLN--------------------IKMRQVRAEIMTAGQIR--HRNI 267 (531)
Q Consensus 210 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~--------------------~~~~~~~~Ei~~l~~l~--hpnI 267 (531)
.|..|.-+.||+|... ++..+|||+.+........ ....=..+|+.-|.++. +=.+
T Consensus 55 ~istGKEA~Vy~a~~~--~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 55 CISTGKEANVYLAETG--DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eecCCcceEEEeeccC--CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 5777778899998753 6889999999754332111 00111345666666663 3334
Q ss_pred cccceeEEeCCceEEEEeccCCCC-HHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC
Q 009595 268 VPLLAHMVRPDCHLLVSEFMKNGS-LLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346 (531)
Q Consensus 268 v~l~~~~~~~~~~~lv~E~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~ 346 (531)
.+.+++. ...|||||+.... -.-.|. ..++.......+..++++.+.-|-. ..++||+||+.=|||+.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH 201 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE
Confidence 4445433 3469999995421 000111 1222333566777888888888773 47899999999999999
Q ss_pred CCCCEEEeecCCCccCC
Q 009595 347 DDMEARIADFGLARLMP 363 (531)
Q Consensus 347 ~~~~vkL~Dfgla~~~~ 363 (531)
++.+.++|||-+....
T Consensus 202 -~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 -DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CCeEEEEECccccccC
Confidence 7899999999877654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.1e-05 Score=83.23 Aligned_cols=145 Identities=17% Similarity=0.245 Sum_probs=89.3
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhh---------------------------hHHHHH------HHHH
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLL---------------------------NIKMRQ------VRAE 255 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~---------------------------~~~~~~------~~~E 255 (531)
+-||.-+.|.||+|+.+ +|+.||||+-+..-.... +...+. |.+|
T Consensus 167 ~piaaASlaQVhrA~L~--~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK--NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEec--CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 57999999999999987 699999998875433210 000111 3333
Q ss_pred HHHHhc----CCCCc------ccccceeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHH
Q 009595 256 IMTAGQ----IRHRN------IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYL 325 (531)
Q Consensus 256 i~~l~~----l~hpn------Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L 325 (531)
++-..+ +.|-+ |.++|-.+ .....|+||||+|..+.|.-.-. ...++.... +..+.++ |+
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~i---~~~l~~~--~~ 314 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAID---KRGISPHDI---LNKLVEA--YL 314 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHH---HcCCCHHHH---HHHHHHH--HH
Confidence 333322 23444 33333322 23568999999998776642210 123444433 3333332 22
Q ss_pred HhcCCCCeEeeccCCCCeeeCC----CCCEEEeecCCCccCCCC
Q 009595 326 HMYHRPRIIHRNITPSSVLIDD----DMEARIADFGLARLMPDG 365 (531)
Q Consensus 326 H~~~~~~ivH~Dlkp~NILl~~----~~~vkL~Dfgla~~~~~~ 365 (531)
+..-..|++|+|-.|.||++.. ++.+.+.|||+...++..
T Consensus 315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2222457999999999999984 678999999998876554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.01 E-value=6e-05 Score=84.49 Aligned_cols=201 Identities=18% Similarity=0.182 Sum_probs=140.1
Q ss_pred HHHHHHHHHHHhcCCCCcccccceeEEeCCce----EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHH
Q 009595 249 MRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH----LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEY 324 (531)
Q Consensus 249 ~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~----~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~ 324 (531)
+.....|+..+.+..|+|++.++.|....... .+..++|...++.+.+.. -..++..+...+..++.+||.|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHH
Confidence 44555678888899999999999987664333 345688888888888864 5678889999999999999999
Q ss_pred HHhcCCCCeEeeccCCC---CeeeCCCCCEEEe--ecCCCccCCCCCccceecccccCccccCcccccCCCCC--chhhH
Q 009595 325 LHMYHRPRIIHRNITPS---SVLIDDDMEARIA--DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS--EKCDI 397 (531)
Q Consensus 325 LH~~~~~~ivH~Dlkp~---NILl~~~~~vkL~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~Dv 397 (531)
+|.. ...|.-+..+ +.-.+.++.+.++ ||+....+.+...... ...+..|.+||......+. ...|+
T Consensus 302 ~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 302 LHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred HHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHH
Confidence 9954 3555555444 5555667777777 9988887765433221 2335668888887766544 44799
Q ss_pred HHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCH
Q 009595 398 YSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS 477 (531)
Q Consensus 398 wSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 477 (531)
|++|..+..+..|..+-.-. ......+ +..... .+......|+.-++++|+++
T Consensus 376 ~~lgll~~~~~~~~~i~~~~----------~~~~~~l--------------~~~~~~---~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKS----------AVPVSLL--------------DVLSTS---ELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred HHHHHHHhhhhhcCcccccc----------cchhhhh--------------ccccch---hhhhhhhhhcchhhhhccch
Confidence 99999999999887652111 0000000 000100 25667778999999999999
Q ss_pred HHHHHHhcc
Q 009595 478 KDVRSMLSD 486 (531)
Q Consensus 478 ~evl~~L~~ 486 (531)
.+++.+.--
T Consensus 429 ~~ll~~~f~ 437 (1351)
T KOG1035|consen 429 LELLTHPFL 437 (1351)
T ss_pred hhhhhchhc
Confidence 999987633
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.95 E-value=7.2e-05 Score=69.17 Aligned_cols=129 Identities=18% Similarity=0.321 Sum_probs=90.8
Q ss_pred ccccccccccccce-eEEEEEeeeCCCCeEEEEEEEec---cCc--------hh------hhHHHHHHHHHHHHHhcCC-
Q 009595 203 DCSASLEKIRSRAS-GEIYIAELPESNGKMIAIKKVKQ---VDN--------SL------LNIKMRQVRAEIMTAGQIR- 263 (531)
Q Consensus 203 ~~~~~~~~ig~G~~-g~Vy~~~~~~~~~~~vavK~~~~---~~~--------~~------~~~~~~~~~~Ei~~l~~l~- 263 (531)
..++.++.||.|.- |.||+++. +|+.||+|.+.. ... .. ......-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I---~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI---DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE---CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 67888999999999 99999998 789999999422 100 00 0123456888998888874
Q ss_pred --CCcc--cccceeEEeC------------------CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHH
Q 009595 264 --HRNI--VPLLAHMVRP------------------DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSG 321 (531)
Q Consensus 264 --hpnI--v~l~~~~~~~------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~ 321 (531)
+.++ |+++||..-. ....||.||++... .+.. .-+.++.+-
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~d 176 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRD 176 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHH
Confidence 4456 8999987432 12257888776532 1222 234456666
Q ss_pred HHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 322 LEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 322 L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
|..+| ..||+-+|+++.|.. .-+|+|||.+
T Consensus 177 l~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 177 LKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 77888 888999999999997 4589999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=7.3e-05 Score=67.01 Aligned_cols=129 Identities=15% Similarity=0.192 Sum_probs=91.4
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCccc-ccceeEEeCCceEEEE
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV-PLLAHMVRPDCHLLVS 284 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv-~l~~~~~~~~~~~lv~ 284 (531)
...+.|++|++|.||.+.| .|..+|+|+-+.+.. ...+..|+++|..+.--++- ++|.|. .-.+.|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~---~~~~~a~Kvrr~ds~------r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~m 91 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW---RGGEVALKVRRRDSP------RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRM 91 (201)
T ss_pred hhhhhhhcccccEEEEeec---cCceEEEEEecCCcc------hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhh
Confidence 4567899999999999998 567899998876543 67788999999888766554 344432 224569
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccC-CCCeeeCCCCCEEEeecCCCcc
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNIT-PSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk-p~NILl~~~~~vkL~Dfgla~~ 361 (531)
||+.|-.|.+.-.. .+- +-+..+++.-.-|- ..||-|+.|. |...++..++.+.|+||.-|..
T Consensus 92 e~i~G~~L~~~~~~-------~~r----k~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 92 EYIDGRPLGKLEIG-------GDR----KHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcCcchhhhhhc-------ccH----HHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 99999888876542 011 22334555544455 6789999997 5555555555999999998774
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.92 E-value=8.1e-05 Score=84.81 Aligned_cols=81 Identities=10% Similarity=0.148 Sum_probs=56.1
Q ss_pred cccccccceeEEEEEeeeCCC-CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcc--cccceeEEeC---Cce
Q 009595 208 LEKIRSRASGEIYIAELPESN-GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNI--VPLLAHMVRP---DCH 280 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnI--v~l~~~~~~~---~~~ 280 (531)
++.++.|.++.+|........ ...+++|+........ ....+.+|+.+|+.+. |++| .+++.+|.+. +..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~---~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ---SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc---cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 678899999999998764211 1467888765432111 1345778999999995 6665 6777777654 357
Q ss_pred EEEEeccCCCC
Q 009595 281 LLVSEFMKNGS 291 (531)
Q Consensus 281 ~lv~E~~~~gs 291 (531)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999998854
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.90 E-value=2.3e-05 Score=88.65 Aligned_cols=127 Identities=14% Similarity=0.074 Sum_probs=103.3
Q ss_pred HHHHHHHHHHHHHHHHHHHhHhchHHHHHHHHHHHHHHHHHHHHHhhhhcCchHHHHHHHHHHHHHhchhhhhhHHHHHH
Q 009595 25 ENIETILKKLTKDWLGQFARDAQIQADLIGWKKMMAKINKVLDDAIEKQTKEESVKIWLGKLQHLACDVDFLLDEFQTEA 104 (531)
Q Consensus 25 ~~~~~~~~kl~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~a~~~~~~~~~~~~w~~~~~~~~yd~ed~~d~~~~~~ 104 (531)
|.+++.++|+.+++.+++....|+.+.+..|++.|..++.+|.||+.++.+...++.|...+++++|++||+++.|.++.
T Consensus 3 ~~~s~~~~~~~~~l~~~~~~~~~~~~~i~~Lk~~L~~l~~~l~d~~a~~~~~~~~~~~~e~~~~~~~~~e~~~~~~~v~~ 82 (889)
T KOG4658|consen 3 ACVSFGVEKLDQLLNRESECLDGKDNYILELKENLKALQSALEDLDAKRDDLERRVNWEEDVGDLVYLAEDIIWLFLVEE 82 (889)
T ss_pred eEEEEehhhHHHHHHHHHHHHhchHHHHHHHHHHHHHHHHHHHHHHhhcchHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 44566788999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred HHHHHhhcCc----ccccc--ccccccchhhHHHHHHHHHhhhhhhhhccccc
Q 009595 105 FQRMLLQDGV----DDAVD--KSEDSTAMSKVKEVNARLQDIAWQINVLGLKA 151 (531)
Q Consensus 105 ~~~~~~~~~~----~~~~~--~~~~~~~~~~ik~i~~rl~~i~~~~~~~~lk~ 151 (531)
...+...... ..+.. ..+.+.....+..+.+|+-.+.+....++.+.
T Consensus 83 ~~~~~~~~l~~~~~~~~~~c~~~~~~~~~~~~~~~~~rv~~~l~~ve~l~~~~ 135 (889)
T KOG4658|consen 83 IERKANDLLSTRSVERQRLCLCGFCSKNVSDSYKYGKRVSKVLREVESLGSKG 135 (889)
T ss_pred HHHHHhHHhhhhHHHHHHHhhhhhHhHhhhhhHhHHHHHHHHHHHHHHhcccc
Confidence 7764432211 11111 13345666677778888888888888887654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00027 Score=65.80 Aligned_cols=132 Identities=17% Similarity=0.232 Sum_probs=88.7
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCch------------hhhHHHHHHHHHHHHHhcCC------CCcccc
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS------------LLNIKMRQVRAEIMTAGQIR------HRNIVP 269 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~~~~Ei~~l~~l~------hpnIv~ 269 (531)
...||+|+.=.||.- + ......||+....... ......++..+|+.....+. +.+|.+
T Consensus 6 ~~~i~~G~~R~cy~H--P--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CcccccCCCceEEEC--C--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 357999999999853 3 4555789998765500 00001345556666555554 888999
Q ss_pred cceeEEeCCceEEEEeccCC------CCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCe
Q 009595 270 LLAHMVRPDCHLLVSEFMKN------GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSV 343 (531)
Q Consensus 270 l~~~~~~~~~~~lv~E~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 343 (531)
++|+..++-...+|+|.+.+ -||.+++.. ..++. .....+.++ ..||- ...|+.+|++|+||
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NI 149 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNI 149 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccE
Confidence 99999999999999998643 368888853 34555 333444444 44555 45599999999999
Q ss_pred eeCCC--C--CEEEee
Q 009595 344 LIDDD--M--EARIAD 355 (531)
Q Consensus 344 Ll~~~--~--~vkL~D 355 (531)
++... + .+.|+|
T Consensus 150 v~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEecCCCceEEEEEe
Confidence 99532 2 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.84 E-value=8.4e-05 Score=71.58 Aligned_cols=74 Identities=11% Similarity=0.075 Sum_probs=44.4
Q ss_pred ccccccccee-EEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCC---cccccceeEEeC---Cce
Q 009595 208 LEKIRSRASG-EIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHR---NIVPLLAHMVRP---DCH 280 (531)
Q Consensus 208 ~~~ig~G~~g-~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~l~~~~~~~---~~~ 280 (531)
++.|+.||+. .||+.. ..+++|..+... . ...+..|...+..+... .+.++++..... ...
T Consensus 2 ~~~~~~gG~~n~vy~~~------~~~VlR~~~~~~-~-----~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~ 69 (235)
T cd05155 2 IEPVDSGGTDNATFRLG------DDMSVRLPSAAG-Y-----AGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP 69 (235)
T ss_pred ceeccCCCcccceEEcC------CceEEEcCCccc-h-----HHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence 3567877776 588752 247777654321 1 34677899888877432 233444433222 234
Q ss_pred EEEEeccCCCCHH
Q 009595 281 LLVSEFMKNGSLL 293 (531)
Q Consensus 281 ~lv~E~~~~gsL~ 293 (531)
+++|++++|.++.
T Consensus 70 ~~l~~~i~G~~l~ 82 (235)
T cd05155 70 WSVYRWLEGETAT 82 (235)
T ss_pred eEEEEeecCCCCC
Confidence 7899999987664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00066 Score=67.77 Aligned_cols=78 Identities=12% Similarity=0.120 Sum_probs=55.7
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCC---CcccccceeEEe---CCc
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH---RNIVPLLAHMVR---PDC 279 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h---pnIv~l~~~~~~---~~~ 279 (531)
...+.||.|..+.||..... ++ .+.+|..+.... ...+..|...|+.+.. -.+.++++++.. .+.
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~--~~-~~~~k~~~~~~~------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~ 87 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS--QG-NPMPLMARSFST------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP 87 (297)
T ss_pred heeeecCCccceeEEEEEcC--CC-CEEEEEeccccc------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence 44678999999999998642 34 477777543111 3467789999988843 367788887754 356
Q ss_pred eEEEEeccCCCCH
Q 009595 280 HLLVSEFMKNGSL 292 (531)
Q Consensus 280 ~~lv~E~~~~gsL 292 (531)
.+||||+++++++
T Consensus 88 ~~LVmE~i~G~~~ 100 (297)
T PRK10593 88 DVLLLERLRGVSV 100 (297)
T ss_pred eEEEEeccCCEec
Confidence 8999999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00053 Score=65.85 Aligned_cols=76 Identities=12% Similarity=0.174 Sum_probs=46.3
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCc-ccccceeEEeCCceEEEEec
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN-IVPLLAHMVRPDCHLLVSEF 286 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~E~ 286 (531)
++.|..|-.+.+|++......+..|++|+........ ....+|+.++..+...+ .+++++.+. -.++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-----~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-----IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-----ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEe
Confidence 3567788889999986431014678899775432211 11235888888774333 334444322 2489999
Q ss_pred cCCCCH
Q 009595 287 MKNGSL 292 (531)
Q Consensus 287 ~~~gsL 292 (531)
++|.++
T Consensus 74 i~G~~l 79 (235)
T cd05157 74 IPGRTL 79 (235)
T ss_pred eCCCcC
Confidence 998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00056 Score=68.19 Aligned_cols=145 Identities=17% Similarity=0.188 Sum_probs=83.7
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCc--cccccee------EEeC
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN--IVPLLAH------MVRP 277 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~------~~~~ 277 (531)
..++.+..|....+|+... ++..+++|+..... ...+..|+.++..+.+.+ +.+++.. ....
T Consensus 17 ~~i~~i~~G~~n~~y~v~~---~~~~~vLr~~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~ 86 (296)
T cd05153 17 LSFEGISAGIENTNYFVTT---DSGRYVLTLFEKVS-------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA 86 (296)
T ss_pred hheecccCccccceEEEEe---CCCcEEEEEcCCCC-------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence 3466788888899999864 34568999876411 234556777777664322 4444431 1234
Q ss_pred CceEEEEeccCCCCHHH----HH----------hhccCC-C------ccCCHHHHH----------HHHHHHHHHHHHHH
Q 009595 278 DCHLLVSEFMKNGSLLE----IL----------NDVSQG-R------RELEWLARH----------RIARGIVSGLEYLH 326 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~----~l----------~~~~~~-~------~~l~~~~~~----------~i~~~ia~~L~~LH 326 (531)
+..++|++|++|.++.. .+ +..... . ....|.... .....+..++.++.
T Consensus 87 ~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~ 166 (296)
T cd05153 87 GKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQD 166 (296)
T ss_pred CceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHH
Confidence 56689999998866421 11 110000 0 011111110 01112233444444
Q ss_pred h----cCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 327 M----YHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 327 ~----~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
. ....+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 167 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 167 AFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2 113579999999999999998777899998755
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0022 Score=64.41 Aligned_cols=146 Identities=16% Similarity=0.209 Sum_probs=79.7
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCC--ccccccee------EEeC
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHR--NIVPLLAH------MVRP 277 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~------~~~~ 277 (531)
..++.++.|....+|++.. ++..+++|+...... ...+..|+.++..|... ++.+++.. ....
T Consensus 25 ~~i~~~~~G~~n~~y~v~t---~~~~~vLK~~~~~~~------~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT---DVGRYILTLYEKRVK------AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred eeccccCCccccceEEEEe---CCCcEEEEEecCCCC------HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 3456777787889998864 334588898765321 12233455555555221 13344331 1124
Q ss_pred CceEEEEeccCCCCHH-----------HH---HhhccCC----Cc---c-CCHHHHH------------HHHHHHHHHHH
Q 009595 278 DCHLLVSEFMKNGSLL-----------EI---LNDVSQG----RR---E-LEWLARH------------RIARGIVSGLE 323 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~-----------~~---l~~~~~~----~~---~-l~~~~~~------------~i~~~ia~~L~ 323 (531)
+..+++++|++|.++. .. ++....+ .. . -.|.... .....+...+.
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 5678999999885431 11 1110010 00 0 0111000 01112333455
Q ss_pred HHHh----cCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 324 YLHM----YHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 324 ~LH~----~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++.. ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5532 125789999999999999998777899998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.39 E-value=6.1e-05 Score=86.19 Aligned_cols=163 Identities=12% Similarity=0.074 Sum_probs=118.0
Q ss_pred HHHHHHHHHHhcCCCCcccccceeEEe--CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHh
Q 009595 250 RQVRAEIMTAGQIRHRNIVPLLAHMVR--PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327 (531)
Q Consensus 250 ~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~ 327 (531)
+....|...++...|+++...+.-... ....+.+++|+.+|.+.+.+-+.....+.+..........+......-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 444555566667789998877664432 345689999999999999997644444445444444444443555555554
Q ss_pred cC--CCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHH
Q 009595 328 YH--RPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLA 405 (531)
Q Consensus 328 ~~--~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ 405 (531)
.. ..-.+|+++|+.|.++..+.++|++++|+.+...... .......+++.|+.|+....-.++.++|+|+.|+.+|
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 32 3447899999999999999999999999988322221 1224467788999999998888999999999999999
Q ss_pred HHHhCCCCC
Q 009595 406 VLVMGKLPS 414 (531)
Q Consensus 406 elltg~~P~ 414 (531)
+..-|..||
T Consensus 1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred HHhcccHHH
Confidence 998887764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0016 Score=63.43 Aligned_cols=140 Identities=11% Similarity=0.054 Sum_probs=77.5
Q ss_pred cccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcc-cccceeEEeCCceEEEEeccC
Q 009595 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI-VPLLAHMVRPDCHLLVSEFMK 288 (531)
Q Consensus 210 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~ 288 (531)
.+..|-.+.+|+... ++..+++|......... .-....|..+++.+...++ .+++..+ . -++||||++
T Consensus 3 ~~~~G~tn~~y~~~~---~~~~~vlR~~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~ 71 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH---PGISFVWRPQSPVCKAL----GVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLE 71 (256)
T ss_pred cCCCcCcCCeEEEEe---CCccEEEeeCCcccccc----cCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEecc
Confidence 456688889998863 67778898765422111 0123568888888854333 3344432 2 368999999
Q ss_pred CCCHHHH-----------------HhhccCCCccCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCCeEee
Q 009595 289 NGSLLEI-----------------LNDVSQGRRELEWLA-RHRIARGI---------VSGLEYLHMY-----HRPRIIHR 336 (531)
Q Consensus 289 ~gsL~~~-----------------l~~~~~~~~~l~~~~-~~~i~~~i---------a~~L~~LH~~-----~~~~ivH~ 336 (531)
|.++... ++.......+++... ...+..++ ...+..+-.. ....++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 8665321 111111111222211 11111111 1112222111 12458999
Q ss_pred ccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 337 NITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 337 Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
|+.|.||++++++ +.|+||+.+..
T Consensus 152 Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 152 DVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCCcCcEEEeCCC-CEEEeccccCc
Confidence 9999999999876 78999987653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00025 Score=69.42 Aligned_cols=142 Identities=14% Similarity=0.163 Sum_probs=95.5
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch------------------hhhHHHHHHHHHHHHHhcCC-C
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS------------------LLNIKMRQVRAEIMTAGQIR-H 264 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~~~~~Ei~~l~~l~-h 264 (531)
-++..+.||-|.-+.||.+... .|++.++|.-+....+ ..-...-...+|+..|+.|. |
T Consensus 93 v~svGnqIGVGKESDIY~v~d~--~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE--EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhhccccccccccceEEEecC--CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 4567889999999999999765 6888998865322211 11111234577888888884 3
Q ss_pred C-cccccceeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCe
Q 009595 265 R-NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSV 343 (531)
Q Consensus 265 p-nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 343 (531)
. -+.+.+++ +..++|||++.|..|...-+ ..+..+. ...+..-+--|. ..|+||+|..-=||
T Consensus 171 gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-------v~d~~~l---y~~lm~~Iv~la---~~GlIHgDFNEFNi 233 (465)
T KOG2268|consen 171 GFPVPKPIDH----NRHCVVMELVDGYPLRQVRH-------VEDPPTL---YDDLMGLIVRLA---NHGLIHGDFNEFNI 233 (465)
T ss_pred CCCCCCcccc----cceeeHHHhhcccceeeeee-------cCChHHH---HHHHHHHHHHHH---HcCceecccchhee
Confidence 2 24455543 46789999999877765432 1222222 233333344455 78999999999999
Q ss_pred eeCCCCCEEEeecCCCccCCC
Q 009595 344 LIDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 344 Ll~~~~~vkL~Dfgla~~~~~ 364 (531)
++++++.++++||--......
T Consensus 234 mv~dd~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 234 MVKDDDKIVVIDFPQMVSTSH 254 (465)
T ss_pred EEecCCCEEEeechHhhccCC
Confidence 999999999999976554443
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0045 Score=63.94 Aligned_cols=80 Identities=10% Similarity=0.069 Sum_probs=53.5
Q ss_pred cccccccceeEEEEEeeeCCCC-eEEEEEEEeccCc---hhhhHHHHHHHHHHHHHhcCC---CCcccccceeEEeCCce
Q 009595 208 LEKIRSRASGEIYIAELPESNG-KMIAIKKVKQVDN---SLLNIKMRQVRAEIMTAGQIR---HRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~-~~vavK~~~~~~~---~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~ 280 (531)
.+.||.|.++.||++... +| +.|+||.-..... ..+.....+...|...|..+. ..++++++.+ +.+..
T Consensus 31 ~~elggGn~N~VyrV~~~--~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDT--EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeC--CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCC
Confidence 467999999999999874 45 5799998642211 111112456677888887762 3456677765 44567
Q ss_pred EEEEeccCCCC
Q 009595 281 LLVSEFMKNGS 291 (531)
Q Consensus 281 ~lv~E~~~~gs 291 (531)
++||||+++..
T Consensus 107 ~lVME~L~~~~ 117 (401)
T PRK09550 107 VTVMEDLSDHK 117 (401)
T ss_pred EEEEecCCCcc
Confidence 89999998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.012 Score=59.45 Aligned_cols=31 Identities=26% Similarity=0.373 Sum_probs=26.5
Q ss_pred CCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 330 RPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 330 ~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
..++||+|+.|.||+++.+...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4689999999999999976556899998755
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0068 Score=60.61 Aligned_cols=77 Identities=17% Similarity=0.269 Sum_probs=47.4
Q ss_pred cccccccceeEEEEEeeeC-----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCc-ccccceeEEeCCceE
Q 009595 208 LEKIRSRASGEIYIAELPE-----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN-IVPLLAHMVRPDCHL 281 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~ 281 (531)
++.+..|-...+|++.... ..++.|++|+....... ......|..++..+...+ ..++++++.. .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~-----~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL-----LIDRERELVVFARLSERNLGPKLYGIFPN----G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc-----eechHHHHHHHHHHHhCCCCCceEEEeCC----C
Confidence 3456677788999887531 12478999997654322 223456887887774333 3355554432 3
Q ss_pred EEEeccCCCCHH
Q 009595 282 LVSEFMKNGSLL 293 (531)
Q Consensus 282 lv~E~~~~gsL~ 293 (531)
+|+||++|.++.
T Consensus 74 ~v~e~i~G~~l~ 85 (302)
T cd05156 74 RIEEFIPSRTLT 85 (302)
T ss_pred chhheeCCCcCC
Confidence 689999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.013 Score=58.60 Aligned_cols=141 Identities=16% Similarity=0.171 Sum_probs=83.6
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEec-cCchhhhHHHHHHHHHHHHHhcCCC--CcccccceeEEeCC--ce
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQ-VDNSLLNIKMRQVRAEIMTAGQIRH--RNIVPLLAHMVRPD--CH 280 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~--~~ 280 (531)
.+++.+..|....+|.... +++.+++. ... .... .......+|..+++.+.- --+...+++|.++. ..
T Consensus 28 ~~v~~~~~G~sn~t~~~~~---~~~~~vlR-~P~~~~~~---~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p 100 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGD---TGQKYVLR-KPPRGDPV---ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP 100 (321)
T ss_pred ceeeeccCCcccceEEEec---CCceEEEe-cCCccccc---hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence 3445555555556665543 47778888 331 1111 114556678888877743 33455667776665 66
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHH-HHHHHHHHHHHh--------------------------------
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIA-RGIVSGLEYLHM-------------------------------- 327 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~-~~ia~~L~~LH~-------------------------------- 327 (531)
+.||+|++|..+.+.+.. .+.. ..++ ..+++.|.-||+
T Consensus 101 f~v~~~veGe~~~~~~~~-------~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~ 171 (321)
T COG3173 101 FYVMEWVEGEVVWSALPP-------ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKK 171 (321)
T ss_pred eEEEEEecceeccCcCCc-------ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHH
Confidence 999999988432222211 0000 0111 133344444442
Q ss_pred ------------------c-----CCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 328 ------------------Y-----HRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 328 ------------------~-----~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
. +...++|+|+.+.|++++.++-+=|.||+++..-
T Consensus 172 ~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 172 ELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred hccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1 1345999999999999999888999999998753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.012 Score=58.19 Aligned_cols=31 Identities=26% Similarity=0.617 Sum_probs=25.5
Q ss_pred CCeEeeccCCCCeeeCCCCC-EEEeecCCCcc
Q 009595 331 PRIIHRNITPSSVLIDDDME-ARIADFGLARL 361 (531)
Q Consensus 331 ~~ivH~Dlkp~NILl~~~~~-vkL~Dfgla~~ 361 (531)
..++|+|+.|.||+++.++. +-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999997653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.012 Score=60.03 Aligned_cols=144 Identities=15% Similarity=0.228 Sum_probs=81.0
Q ss_pred cccccccceeEEEEEeeeCC---CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcc-cccceeEEeCCceEEE
Q 009595 208 LEKIRSRASGEIYIAELPES---NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI-VPLLAHMVRPDCHLLV 283 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv 283 (531)
+..+..|-...+|++.+... .++.|++|+........ +.+ ..|..++..+..-++ .++++.+..+ .|
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~----idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF----FDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee----ech-HHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 45666688899999875321 23678999886543221 222 468888888744333 3555655332 57
Q ss_pred EeccCCCCHHHH-----------------HhhccCCCc--cCCHHHHHHHHHHH-----------------HHHHHHH--
Q 009595 284 SEFMKNGSLLEI-----------------LNDVSQGRR--ELEWLARHRIARGI-----------------VSGLEYL-- 325 (531)
Q Consensus 284 ~E~~~~gsL~~~-----------------l~~~~~~~~--~l~~~~~~~i~~~i-----------------a~~L~~L-- 325 (531)
++|+++.+|... ++....... ...+.....+..++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 899987666421 111110111 11222222332211 1112222
Q ss_pred --Hh-cCCCCeEeeccCCCCeeeCC-CCCEEEeecCCCc
Q 009595 326 --HM-YHRPRIIHRNITPSSVLIDD-DMEARIADFGLAR 360 (531)
Q Consensus 326 --H~-~~~~~ivH~Dlkp~NILl~~-~~~vkL~Dfgla~ 360 (531)
.. .....++|+|+++.|||+++ ++.+.++||..+.
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11 12446899999999999976 4689999998755
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.037 Score=57.13 Aligned_cols=85 Identities=9% Similarity=0.042 Sum_probs=53.5
Q ss_pred ccccccccceeEEEEEeeeCCCCeEEEEEEEeccCc---hhhhHHHHHHHHHHHHHhcCC---CCcccccceeEEeCCce
Q 009595 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDN---SLLNIKMRQVRAEIMTAGQIR---HRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 207 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~ 280 (531)
..+.||.|....||+... .+..|+||+-..... ..+.....+-..|...|..+. ..++.+++.++. +..
T Consensus 36 ~~~eiggGn~N~VyrV~~---~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~ 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS---SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMA 110 (418)
T ss_pred eEEEcCCCceeeEEEEEc---CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCC
Confidence 356799999999999875 345689998762211 000011334445566666553 347778888776 456
Q ss_pred EEEEeccCC--CCHHHHH
Q 009595 281 LLVSEFMKN--GSLLEIL 296 (531)
Q Consensus 281 ~lv~E~~~~--gsL~~~l 296 (531)
+++|||+++ ..+.+-+
T Consensus 111 vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 111 LIGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEEeecCCcceehhhhh
Confidence 789999976 2344444
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.046 Score=55.49 Aligned_cols=84 Identities=7% Similarity=0.005 Sum_probs=50.4
Q ss_pred cccccceeEEEEEeeeCCCCeEEEEEEEeccCc---hhhhHHHHHHHHHHHHHhcCC--CC-cccccceeEEeCCceEEE
Q 009595 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDN---SLLNIKMRQVRAEIMTAGQIR--HR-NIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 210 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~Ei~~l~~l~--hp-nIv~l~~~~~~~~~~~lv 283 (531)
.||.|...-||++... ..++.|+||.-..... ..+.....+..-|...|.... .| .++++|. .+++...+|
T Consensus 2 EigdGnlN~VfrV~~~-~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQ-EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcC-CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccccceeh
Confidence 4799999999999863 1225799997643211 111222455566777776652 34 3445554 345566799
Q ss_pred EeccCCC-CHHHHH
Q 009595 284 SEFMKNG-SLLEIL 296 (531)
Q Consensus 284 ~E~~~~g-sL~~~l 296 (531)
||+++.. .|.+.|
T Consensus 79 MEdL~~~~ilR~~L 92 (370)
T TIGR01767 79 MEDLSHHKIARKGL 92 (370)
T ss_pred HhhCccchHHHHHH
Confidence 9998543 333444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.076 Score=53.18 Aligned_cols=30 Identities=20% Similarity=0.357 Sum_probs=25.8
Q ss_pred CCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 330 RPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 330 ~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 467999999999999988 678999998644
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.029 Score=56.26 Aligned_cols=103 Identities=19% Similarity=0.179 Sum_probs=68.3
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
...|++|++. |++|.. + +...+.+...++.+.++.+.-+.. .-..-|||+.-.||||+ +|+|.|+||.
T Consensus 299 ~y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEee
Confidence 3457788876 444432 1 334677888888888888777764 56789999999999999 9999999999
Q ss_pred CCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHH
Q 009595 358 LARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSF 400 (531)
Q Consensus 358 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 400 (531)
+++.-... .... ....--|-.+.|. -+..-+||-+
T Consensus 367 lsRl~~~q-~~is------y~rldhp~lF~G~-dd~QFeIYrl 401 (488)
T COG5072 367 LSRLSYSQ-GIIS------YNRLDHPDLFNGV-DDYQFEIYRL 401 (488)
T ss_pred eeecccCC-ceee------ccccCchhhhcCc-cceeeeHHHH
Confidence 99843222 1111 1223345555533 2556677763
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.048 Score=55.31 Aligned_cols=144 Identities=10% Similarity=0.203 Sum_probs=77.9
Q ss_pred cccccccceeEEEEEeeeCCC--CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcc-cccceeEEeCCceEEEE
Q 009595 208 LEKIRSRASGEIYIAELPESN--GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI-VPLLAHMVRPDCHLLVS 284 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~ 284 (531)
++.|..|-...+|+......+ +..|++|+........ + .-..|..+++.+..-++ .++++++. .. +|.
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~----I-dR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~ 89 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV----I-DRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQ 89 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE----e-chHHHHHHHHHHHhcCCCCceeEEeC--Cc--Eee
Confidence 445666888889988654221 2378899876543221 1 12358888888754444 35555542 22 588
Q ss_pred eccCCCCHHH-------HH----------hhccCC-Cc-cCCHHHHHHHHHHH----------------------HHHHH
Q 009595 285 EFMKNGSLLE-------IL----------NDVSQG-RR-ELEWLARHRIARGI----------------------VSGLE 323 (531)
Q Consensus 285 E~~~~gsL~~-------~l----------~~~~~~-~~-~l~~~~~~~i~~~i----------------------a~~L~ 323 (531)
+|+++.+|.. .+ +..... .. .-.+.....+..++ ..-+.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 9987765521 01 111100 01 11222222222221 11111
Q ss_pred HHHhc-----CCCCeEeeccCCCCeeeCC-CCCEEEeecCCCc
Q 009595 324 YLHMY-----HRPRIIHRNITPSSVLIDD-DMEARIADFGLAR 360 (531)
Q Consensus 324 ~LH~~-----~~~~ivH~Dlkp~NILl~~-~~~vkL~Dfgla~ 360 (531)
.+... ...-++|+|+.+.|||+++ ++.++++||..|.
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11110 1224799999999999974 5789999998755
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.031 Score=55.39 Aligned_cols=76 Identities=17% Similarity=0.186 Sum_probs=48.1
Q ss_pred ccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC---CCCcccccceeEEeCCceE
Q 009595 205 SASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI---RHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~~~ 281 (531)
.+..+.++.|....+|.... +++.+.||.-.... ...|..|..-|+.| ..-.+.+++++....+..+
T Consensus 19 i~~~~~v~GG~i~~a~~~~~---~~~~~FvK~~~~~~-------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~f 88 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDT---DGGSYFVKVNSESG-------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAF 88 (288)
T ss_dssp --EEEEE--SSSSEEEEEET---TS-EEEEEEEEGGG-------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCE
T ss_pred eeeeEecCCCChhheEEEEC---CCccEEEEecChhh-------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCce
Confidence 34567889899999998863 78889999987422 34567788877777 3445778888887777789
Q ss_pred EEEeccCCC
Q 009595 282 LVSEFMKNG 290 (531)
Q Consensus 282 lv~E~~~~g 290 (531)
|||||++.+
T Consensus 89 Llle~l~~~ 97 (288)
T PF03881_consen 89 LLLEFLEMG 97 (288)
T ss_dssp EEEE-----
T ss_pred EEEEeecCC
Confidence 999999775
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.034 Score=51.98 Aligned_cols=153 Identities=11% Similarity=0.055 Sum_probs=90.6
Q ss_pred cceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEeccCCCCHH
Q 009595 214 RASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLL 293 (531)
Q Consensus 214 G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~ 293 (531)
||.++.-+++.. - -+..+|+++...... ...-+..+.++++++. .|+++..- ....+.++.|+|-...
T Consensus 73 ~gNsTl~~~kt~--i-G~L~lKKi~slp~~~---~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTK--I-GPLFLKKIRSLPCCI---NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-- 140 (308)
T ss_pred CCceEEEEeccc--c-chhhhhhccCCCccc---chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc--
Confidence 445555555432 2 346677776544321 1344566777776653 46666531 3445678999984411
Q ss_pred HHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecc
Q 009595 294 EILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373 (531)
Q Consensus 294 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~ 373 (531)
..+ ..++.-=+.+|.-.|+. ..+.+|||..|+||+-|+.|.+||.|-+..-. .
T Consensus 141 -----------i~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~--------- 193 (308)
T PF07387_consen 141 -----------INF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N--------- 193 (308)
T ss_pred -----------cch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--h---------
Confidence 111 11222224667888865 57899999999999999999999999875221 0
Q ss_pred cccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCC
Q 009595 374 VAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGK 411 (531)
Q Consensus 374 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~ 411 (531)
+..|.--| ....+.++.+-+|=.-+++++...
T Consensus 194 ---~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 194 ---QVNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred ---eeeEEeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence 11121111 123567788877777777777643
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.12 Score=52.00 Aligned_cols=31 Identities=23% Similarity=0.369 Sum_probs=27.8
Q ss_pred CCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 330 RPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 330 ~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
..+++|+|+.++|+++++++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4579999999999999999999999998655
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.27 Score=49.64 Aligned_cols=143 Identities=17% Similarity=0.156 Sum_probs=90.9
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCch----------------------hhhHHHHHHHHHHHHHhcCCCCc
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS----------------------LLNIKMRQVRAEIMTAGQIRHRN 266 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~~Ei~~l~~l~hpn 266 (531)
.+|.-|.-+.||-|.-. +|..+|||+.+..-.. ....+.-=..+|++-|.+++...
T Consensus 150 GCiSTGKEANVYHat~~--dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEE--DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccCccceeEeeecC--CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 46677888899998653 8999999988643211 10111112345777777776555
Q ss_pred ccccceeEEeCCceEEEEeccCCCC-HHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee
Q 009595 267 IVPLLAHMVRPDCHLLVSEFMKNGS-LLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345 (531)
Q Consensus 267 Iv~l~~~~~~~~~~~lv~E~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl 345 (531)
|.-.--... ....|||+|+-... -.-.|. ...++...+..+-.+++.-+.-|-. ..++||.||.-=|+|+
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheE
Confidence 433222222 23479999994311 111121 2345656677777888888888876 4479999999999998
Q ss_pred CCCCCEEEeecCCCccCC
Q 009595 346 DDDMEARIADFGLARLMP 363 (531)
Q Consensus 346 ~~~~~vkL~Dfgla~~~~ 363 (531)
.+ |.+.++|-+-+....
T Consensus 299 hd-G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 299 HD-GKLYIIDVSQSVEHD 315 (520)
T ss_pred EC-CEEEEEEccccccCC
Confidence 65 589999988766543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.054 Score=56.64 Aligned_cols=48 Identities=21% Similarity=0.240 Sum_probs=37.8
Q ss_pred HHHHHHHHHHhcCCCCcccccceeEEeC-CceEEEEeccCCCCHHHHHhh
Q 009595 250 RQVRAEIMTAGQIRHRNIVPLLAHMVRP-DCHLLVSEFMKNGSLLEILND 298 (531)
Q Consensus 250 ~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~ 298 (531)
.++.-...+++.+.|+|...++++-... ....+|||+++. ||.+.+..
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~ 75 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKT 75 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHh
Confidence 4456677889999999999999876543 356789999955 99999864
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.13 Score=53.18 Aligned_cols=77 Identities=13% Similarity=0.290 Sum_probs=44.6
Q ss_pred cccccccceeEEEEEeeeCCCCeE-----EEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcc-cccceeEEeCCceE
Q 009595 208 LEKIRSRASGEIYIAELPESNGKM-----IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI-VPLLAHMVRPDCHL 281 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~-----vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~ 281 (531)
++.|..|-.+.+|++......+.. |.++......... + .-.+|+.+++.+...++ .++++.+. -+
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~----I-dR~~E~~i~~~Ls~~glgP~l~~~f~----~g 125 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV----I-DNDLQYNIAKLLGDNNFGPKIIGRFG----DF 125 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceE----e-ccHHHHHHHHHHHhCCCCCeEEEecC----CE
Confidence 456767889999998754322222 3333322111111 1 12458888888865444 45566553 25
Q ss_pred EEEeccCCCCHH
Q 009595 282 LVSEFMKNGSLL 293 (531)
Q Consensus 282 lv~E~~~~gsL~ 293 (531)
+++||++|-+|.
T Consensus 126 ~l~efIeGr~l~ 137 (383)
T PTZ00384 126 TIQEWVEGNTMG 137 (383)
T ss_pred EEEEEeccccCC
Confidence 899999887654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.66 Score=46.92 Aligned_cols=29 Identities=28% Similarity=0.416 Sum_probs=24.5
Q ss_pred CCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 330 RPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 330 ~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
..++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 45789999999999995 4 57899999755
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.14 Score=48.32 Aligned_cols=75 Identities=16% Similarity=0.142 Sum_probs=51.0
Q ss_pred ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC---CCcccccceeEEeCCceEEEEe
Q 009595 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR---HRNIVPLLAHMVRPDCHLLVSE 285 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lv~E 285 (531)
+.+.-|.--..|...+ ...++.||+-.... ...|..|+.-|..|. .-++.+++.+....+..|+|||
T Consensus 22 ~~v~gG~inea~~v~d---g~~~~FvK~n~~~~-------~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle 91 (286)
T COG3001 22 EEVSGGDINEAWRLRD---GTDPFFVKCNQREQ-------LSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLE 91 (286)
T ss_pred cccCCccccceeEeec---CCcceEEEecchhh-------HHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEe
Confidence 3444444455555543 45678888765422 566888887777774 3456777877788889999999
Q ss_pred ccCCCCHH
Q 009595 286 FMKNGSLL 293 (531)
Q Consensus 286 ~~~~gsL~ 293 (531)
|.+-|.+.
T Consensus 92 ~L~~~~~d 99 (286)
T COG3001 92 YLPTGPLD 99 (286)
T ss_pred eccCCCCC
Confidence 99876655
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.12 Score=53.13 Aligned_cols=79 Identities=8% Similarity=0.031 Sum_probs=50.5
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCc--hhhhHHHHHHHHHHHHHhcCC--CC-cccccceeEEeCCceEE
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDN--SLLNIKMRQVRAEIMTAGQIR--HR-NIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~Ei~~l~~l~--hp-nIv~l~~~~~~~~~~~l 282 (531)
.+.||.|...-||++.... .++.|+||.-..... .++.....+..-|...|+... .| .++++|.+ ++....+
T Consensus 34 ~~eigdGnlN~VfrV~~~~-~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~ 110 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ-KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCC 110 (409)
T ss_pred eeEcCCCceEEEEEEeeCC-CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhH
Confidence 5678999999999998632 256799987642111 122223566667777777662 34 45556553 4456678
Q ss_pred EEeccCC
Q 009595 283 VSEFMKN 289 (531)
Q Consensus 283 v~E~~~~ 289 (531)
|||+++.
T Consensus 111 vMEdL~~ 117 (409)
T PRK12396 111 VMEDLSD 117 (409)
T ss_pred HHHhCcc
Confidence 9999854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.49 Score=55.40 Aligned_cols=32 Identities=28% Similarity=0.470 Sum_probs=27.0
Q ss_pred CCCeEeeccCCCCeeeCCCC--CEE-EeecCCCcc
Q 009595 330 RPRIIHRNITPSSVLIDDDM--EAR-IADFGLARL 361 (531)
Q Consensus 330 ~~~ivH~Dlkp~NILl~~~~--~vk-L~Dfgla~~ 361 (531)
..++||+|+.+.|||++.++ ++. |+|||.+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 46799999999999999875 555 999998664
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.3 Score=49.28 Aligned_cols=143 Identities=19% Similarity=0.276 Sum_probs=78.8
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC---CCc---cccccee----EEeC
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR---HRN---IVPLLAH----MVRP 277 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hpn---Iv~l~~~----~~~~ 277 (531)
...|.+ .-..+|..... +|+ +++|+.... .. ...+..|+..|..|. .|= +..+-|- ...+
T Consensus 31 ~~~l~s-~eN~~f~~~~~--~g~-~iLki~~~~-~~-----~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~ 100 (331)
T COG2334 31 LRGLNS-EENSNFRVQTE--DGR-YILKIYRPG-WT-----RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG 100 (331)
T ss_pred cccccc-ccCceEEEEec--CCC-eEEEEecCC-CC-----HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC
Confidence 445555 56778888653 444 589988875 22 344556677776662 111 2333331 1112
Q ss_pred CceEEEEeccCCCCHHH-----HH--------------hhcc----CCCccCCHH-------------HHHHHHHHHHHH
Q 009595 278 DCHLLVSEFMKNGSLLE-----IL--------------NDVS----QGRRELEWL-------------ARHRIARGIVSG 321 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~-----~l--------------~~~~----~~~~~l~~~-------------~~~~i~~~ia~~ 321 (531)
...+-+++|++|..+.. .+ +... .......|. ........+...
T Consensus 101 ~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~ 180 (331)
T COG2334 101 PRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAA 180 (331)
T ss_pred ceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHH
Confidence 36678899999877662 11 1111 000112222 001122333333
Q ss_pred HHHHHh----cCCCC---eEeeccCCCCeeeCCCCC-EEEeecCCCc
Q 009595 322 LEYLHM----YHRPR---IIHRNITPSSVLIDDDME-ARIADFGLAR 360 (531)
Q Consensus 322 L~~LH~----~~~~~---ivH~Dlkp~NILl~~~~~-vkL~Dfgla~ 360 (531)
+..+.. .-..+ +||+|+.|.||+++.+.. +.++||+-+.
T Consensus 181 ~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 181 LDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 444332 11233 999999999999999875 8999999755
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.91 E-value=0.21 Score=51.08 Aligned_cols=62 Identities=19% Similarity=0.257 Sum_probs=42.2
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD 348 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~ 348 (531)
..++-+|..|-++..++.. ...++....+++.-...|+--+-- -.+++|.|+.|.||++..+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEec
Confidence 3567778889899988864 334555555555555555443332 3469999999999999543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 531 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-38 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-18 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-18 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-17 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-17 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-05 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 3e-81
Identities = 90/269 (33%), Positives = 150/269 (55%), Gaps = 7/269 (2%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276
G++Y L +G ++A+K++K + + Q + E+ HRN++ L +
Sbjct: 44 GKVYKGRLA--DGTLVAVKRLK--EERTQGGE-LQFQTEVEMISMAVHRNLLRLRGFCMT 98
Query: 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHR 336
P LLV +M NGS+ L + + + L+W R RIA G GL YLH + P+IIHR
Sbjct: 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 158
Query: 337 NITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCD 396
++ +++L+D++ EA + DFGLA+LM V+T+ V GT+G+IAPEY T K SEK D
Sbjct: 159 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKSSEKTD 217
Query: 397 IYSFGVLLAVLVMGKLPSDDFFQHTEEKS-LVRWMRNVMTSENPNRAIDSKLLGNGYEEQ 455
++ +GV+L L+ G+ D ++ L+ W++ ++ + +D L GN +E+
Sbjct: 218 VFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE 277
Query: 456 MLLVLKIACFCTLDDPEERPNSKDVRSML 484
+ ++++A CT P ERP +V ML
Sbjct: 278 VEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 5e-66
Identities = 78/258 (30%), Positives = 124/258 (48%), Gaps = 8/258 (3%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFM 287
N +A+KK+ + + +Q EI + +H N+V LL D LV +M
Sbjct: 53 NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347
NGSLL+ L+ G L W R +IA+G +G+ +LH IHR+I +++L+D+
Sbjct: 113 PNGSLLDRLSC-LDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDE 168
Query: 348 DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVL 407
A+I+DFGLAR V TS + GT Y+APE + + K DIYSFGV+L +
Sbjct: 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEI 227
Query: 408 VMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCT 467
+ G D +H E + L+ + E K + + + + +A C
Sbjct: 228 ITGLPAVD---EHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCL 284
Query: 468 LDDPEERPNSKDVRSMLS 485
+ +RP+ K V+ +L
Sbjct: 285 HEKKNKRPDIKKVQQLLQ 302
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-64
Identities = 74/277 (26%), Positives = 124/277 (44%), Gaps = 12/277 (4%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276
G++Y L +G +A+K+ S I + EI T RH ++V L+
Sbjct: 53 GKVYKGVLR--DGAKVALKRRTP--ESSQGI--EEFETEIETLSFCRHPHLVSLIGFCDE 106
Query: 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHR 336
+ +L+ ++M+NG+L L + W R I G GL YLH IIHR
Sbjct: 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHR 163
Query: 337 NITPSSVLIDDDMEARIADFGLARLMPDG-HAQVSTSIVAGTVGYIAPEYHQTLKFSEKC 395
++ ++L+D++ +I DFG+++ + +ST +V GT+GYI PEY + +EK
Sbjct: 164 DVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKS 222
Query: 396 DIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQ 455
D+YSFGV+L ++ + E +L W + + +D L E
Sbjct: 223 DVYSFGVVLFEVLCARSAIVQ-SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPES 281
Query: 456 MLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKD 492
+ A C E+RP+ DV L +++
Sbjct: 282 LRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-52
Identities = 67/310 (21%), Positives = 119/310 (38%), Gaps = 40/310 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
LE G ++ A+L + +A+K D Q E+ + ++H NI
Sbjct: 29 LEVKARGRFGCVWKAQL---LNEYVAVKIFPIQDKQSW-----QNEYEVYSLPGMKHENI 80
Query: 268 VPLLAHMVRPDCH----LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLE 323
+ + R L++ F + GSL + L + W IA + GL
Sbjct: 81 LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIAETMARGLA 135
Query: 324 YLHM-------YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAG 376
YLH H+P I HR+I +VL+ +++ A IADFGLA G + T G
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 377 TVGYIAPEY-----HQTLKFSEKCDIYSFGVLLAVLVMGKLPSDD--------FFQHTEE 423
T Y+APE + + D+Y+ G++L L +D F + +
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255
Query: 424 KSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483
+ M+ V+ + + + M ++ + C D E R ++ V
Sbjct: 256 HPSLEDMQEVVVHKKKRPVLRDYWQKH---AGMAMLCETIEECWDHDAEARLSAGCVGER 312
Query: 484 LSDTALIKDV 493
++ + ++
Sbjct: 313 ITQMQRLTNI 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-45
Identities = 63/209 (30%), Positives = 110/209 (52%), Gaps = 9/209 (4%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV 268
EKI + + G ++ AE +G +A+K + + D ++ + E+ ++RH NIV
Sbjct: 43 EKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFH--AERVNEFLREVAIMKRLRHPNIV 97
Query: 269 PLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY 328
+ + +P +V+E++ GSL +L+ S R +L+ R +A + G+ YLH
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHN- 155
Query: 329 HRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT 388
P I+HRN+ ++L+D ++ DFGL+RL +S+ AGT ++APE +
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRD 213
Query: 389 LKFSEKCDIYSFGVLLAVLVMGKLPSDDF 417
+EK D+YSFGV+L L + P +
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNL 242
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-44
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 29/235 (12%)
Query: 191 IEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMR 250
I+ +L E I G++Y A G +A+K + + ++ +
Sbjct: 4 IDFAELTLEEI---------IGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIE 51
Query: 251 QVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLA 310
VR E ++H NI+ L ++ LV EF + G L +L+ + +
Sbjct: 52 NVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDI 106
Query: 311 RHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEAR--------IADFGLARLM 362
A I G+ YLH IIHR++ S++LI +E I DFGLAR
Sbjct: 107 LVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW 166
Query: 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDF 417
+ + AG ++APE + FS+ D++S+GVLL L+ G++P
Sbjct: 167 ----HRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 57/249 (22%), Positives = 109/249 (43%), Gaps = 31/249 (12%)
Query: 179 GQNRGPTIFSPLIEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVK 238
G + P P + ++ + ++ I G ++ L + ++AIK +
Sbjct: 4 GGSEFPKSRLPTLADNEIEYEKQ---------IGKGGFGLVHKGRL-VKDKSVVAIKSLI 53
Query: 239 QV---DNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEI 295
+ + K ++ + E+ + H NIV L M P +V EF+ G L
Sbjct: 54 LGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHR 111
Query: 296 LNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID-----DDME 350
L D ++W + R+ I G+EY+ P I+HR++ ++ + +
Sbjct: 112 LLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVC 167
Query: 351 ARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE--YHQTLKFSEKCDIYSFGVLLAVLV 408
A++ADFGL++ S S + G ++APE + ++EK D YSF ++L ++
Sbjct: 168 AKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 409 MGKLPSDDF 417
G+ P D++
Sbjct: 223 TGEGPFDEY 231
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-42
Identities = 53/229 (23%), Positives = 100/229 (43%), Gaps = 27/229 (11%)
Query: 190 LIEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKM 249
+I+ +++ E + A G + A+ K +AIK+++
Sbjct: 4 MIDYKEIEVEEV---------VGRGAFGVVCKAKW---RAKDVAIKQIESESE------R 45
Query: 250 RQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWL 309
+ E+ ++ H NIV L + P C LV E+ + GSL +L+ ++
Sbjct: 46 KAFIVELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHG-AEPLPYYTAA 102
Query: 310 ARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME-ARIADFGLARLMPDGHAQ 368
G+ YLH +IHR++ P ++L+ +I DFG A +
Sbjct: 103 HAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QT 158
Query: 369 VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDF 417
T+ G+ ++APE + +SEKCD++S+G++L ++ + P D+
Sbjct: 159 HMTNNK-GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-41
Identities = 59/232 (25%), Positives = 92/232 (39%), Gaps = 29/232 (12%)
Query: 191 IEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMR 250
I+ + L FL K + SGE++ G I +K +K D S K R
Sbjct: 7 IDFKQLNFLTK---------LNENHSGELWKGRW---QGNDIVVKVLKVRDWS--TRKSR 52
Query: 251 QVRAEIMTAGQIRHRNIVPLL-AHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEW 308
E H N++P+L A P H L++ +M GSL +L++ ++
Sbjct: 53 DFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQ 110
Query: 309 LARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ 368
+ A + G+ +LH P I + SV+ID+DM ARI+ +
Sbjct: 111 SQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF------ 163
Query: 369 VSTSIVAGTVGYIAPE---YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDF 417
S ++APE D++SF VLL LV ++P D
Sbjct: 164 QSPG-RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 62/292 (21%), Positives = 112/292 (38%), Gaps = 42/292 (14%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV 268
E + G+ G+++ +K++ + D R E+ + H N++
Sbjct: 16 EVLGKGCFGQAIKVTH-RETGEVMVMKELIRFDEET----QRTFLKEVKVMRCLEHPNVL 70
Query: 269 PLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY 328
+ + + ++E++K G+L I+ + W R A+ I SG+ YLH
Sbjct: 71 KFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLH-- 125
Query: 329 HRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI------------VAG 376
IIHR++ + L+ ++ +ADFGLARLM D Q V G
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 377 TVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEE--KSLVRWMRNVM 434
++APE + EK D++SFG++L ++ D+ T + ++ ++
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244
Query: 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
P I C DPE+RP+ + L
Sbjct: 245 PPNCPPS-----------------FFPITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-40
Identities = 61/313 (19%), Positives = 113/313 (36%), Gaps = 51/313 (16%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVD-NSLLNIKMRQVRAEIMTAGQIRHRNI 267
E I G +Y L + + +A+K + + +N I + H NI
Sbjct: 19 ELIGRGRYGAVYKGSL---DERPVAVKVFSFANRQNFIN------EKNIYRVPLMEHDNI 69
Query: 268 VPLLAHMVRPDCH-----LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGL 322
+ R LLV E+ NGSL + L+ +W++ R+A + GL
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRGL 124
Query: 323 EYLHM------YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM------PDGHAQVS 370
YLH +++P I HR++ +VL+ +D I+DFGL+ + G +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 371 TSIVAGTVGYIAPEY-------HQTLKFSEKCDIYSFGVLL---AVLVMGKLPSDD---- 416
GT+ Y+APE ++ D+Y+ G++ + P +
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 417 ---FFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEE 473
F M+ +++ E N + + + C D E
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN--SLAVRSLKETIEDCWDQDAEA 302
Query: 474 RPNSKDVRSMLSD 486
R ++ +++
Sbjct: 303 RLTAQXAEERMAE 315
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-40
Identities = 58/291 (19%), Positives = 121/291 (41%), Gaps = 46/291 (15%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
++I S + G +Y + +G +A+K + + +++ + E+ + RH NI
Sbjct: 29 GQRIGSGSFGTVYKGKW---HGD-VAVKMLNVTAPT--PQQLQAFKNEVGVLRKTRHVNI 82
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+ + +V+++ + SL L+ + E IAR G++YLH
Sbjct: 83 LLFMG-YSTAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLH- 137
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE--- 384
IIHR++ +++ + +D +I DFGLA ++G++ ++APE
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 385 YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444
+ +S + D+Y+FG++L L+ G+LP + + + + M
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIEM-------------- 237
Query: 445 SKLLGNGYEEQMLLVLKIAC---------FCTLDDPEERPNSKDVRSMLSD 486
+G G L ++ C C +ERP+ + + + +
Sbjct: 238 ---VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 61/340 (17%), Positives = 124/340 (36%), Gaps = 51/340 (15%)
Query: 179 GQNRGPTIFSPLIEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVK 238
G G + + + +++ I GE+++ + G+ +A+K
Sbjct: 22 GSGSGLPLLVQRTIAKQIQMVKQ---------IGKGRYGEVWMGKW---RGEKVAVKVFF 69
Query: 239 QVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC----HLLVSEFMKNGSLLE 294
+ + EI +RH NI+ +A ++ L++++ +NGSL +
Sbjct: 70 TTEEA-----SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYD 124
Query: 295 ILNDVSQGRRELEWLARHRIARGIVSGLEYLHM-----YHRPRIIHRNITPSSVLIDDDM 349
L L+ + ++A VSGL +LH +P I HR++ ++L+ +
Sbjct: 125 YLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179
Query: 350 EARIADFGLARLMPDG--HAQVSTSIVAGTVGYIAPE------YHQTLKFSEKCDIYSFG 401
IAD GLA + + GT Y+ PE + D+YSFG
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239
Query: 402 VLLAVLVMGKLPSDD-------FFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEE 454
++L + + + MR ++ + + ++ +
Sbjct: 240 LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLR 299
Query: 455 QMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDVD 494
QM ++ C +P R + V+ L+ + + D
Sbjct: 300 QMGKLMTE---CWAHNPASRLTALRVKKTLAK--MSESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-39
Identities = 62/303 (20%), Positives = 117/303 (38%), Gaps = 40/303 (13%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
LE + GE++ G+ +A+K D K E+ +RH NI
Sbjct: 13 LECVGKGRYGEVWRGSW---QGENVAVKIFSSRDE-----KSWFRETELYNTVMLRHENI 64
Query: 268 VPLLAHMVRPDC----HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLE 323
+ +A + L++ + + GSL + L L+ ++ RI I SGL
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLA 119
Query: 324 YLHM-----YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI--VAG 376
+LH+ +P I HR++ ++L+ + + IAD GLA + Q+ G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 377 TVGYIAPE------YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDD-------FFQHTEE 423
T Y+APE ++ DI++FG++L + + + F+
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 424 KSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483
MR V+ + I ++ + + ++K C +P R + ++
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE---CWYQNPSARLTALRIKKT 296
Query: 484 LSD 486
L+
Sbjct: 297 LTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 63/304 (20%), Positives = 117/304 (38%), Gaps = 42/304 (13%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVD-NSLLNIKMRQVRAEIMTAGQIRHRN 266
E I GE++ + G+ +A+K + S AEI +RH N
Sbjct: 47 QESIGKGRFGEVWRGKW---RGEEVAVKIFSSREERSWFR------EAEIYQTVMLRHEN 97
Query: 267 IVPLLAHMVRPD----CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGL 322
I+ +A + + LVS++ ++GSL + LN R + ++A SGL
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGL 152
Query: 323 EYLHM-----YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDG--HAQVSTSIVA 375
+LHM +P I HR++ ++L+ + IAD GLA ++ +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 376 GTVGYIAPE------YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDD-------FFQHTE 422
GT Y+APE + + ++ DIY+ G++ + ++
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272
Query: 423 EKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS 482
V MR V+ + I ++ M +++ C+ + R + ++
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR-ECWYA--NGAARLTALRIKK 329
Query: 483 MLSD 486
LS
Sbjct: 330 TLSQ 333
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 49/218 (22%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
E I G++Y +G+ +AI+ + ++ +++ + E+M Q RH N+
Sbjct: 38 GELIGKGRFGQVYHGRW---HGE-VAIRLIDIERDN--EDQLKAFKREVMAYRQTRHENV 91
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V + + P +++ K +L ++ D + L+ +IA+ IV G+ YL
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYL-- 146
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM---PDGHAQVSTSIVAGTVGYIAPE 384
H I+H+++ +V D+ + I DFGL + G + I G + ++APE
Sbjct: 147 -HAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 385 ---------YHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
L FS+ D+++ G + L + P
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-33
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMR-QVRAEIMTAGQIRHRNIVPLLAHMV 275
+ + ++ ++ A K V + + LL R ++ EI + H+++V
Sbjct: 55 AKCFEISDADT-KEVFAGKIVPK--SLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111
Query: 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIH 335
D +V E + SLLE+ + E AR R IV G +YLH R R+IH
Sbjct: 112 DNDFVFVVLELCRRRSLLELH--KRRKALT-EPEAR-YYLRQIVLGCQYLH---RNRVIH 164
Query: 336 RNITPSSVLIDDDMEARIADFGLA-RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEK 394
R++ ++ +++D+E +I DFGLA ++ DG + GT YIAPE S +
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVL--CGTPNYIAPEVLSKKGHSFE 221
Query: 395 CDIYSFGVLLAVLVMGKLPSDD 416
D++S G ++ L++GK P +
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFET 243
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMR-QVRAEIMTAGQIRHRNIVPLLAHMV 275
+ + ++ ++ A K V + + LL R ++ EI + H+++V
Sbjct: 29 AKCFEISDADT-KEVFAGKIVPK--SLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85
Query: 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIH 335
D +V E + SLLE+ + E AR R IV G +YLH R R+IH
Sbjct: 86 DNDFVFVVLELCRRRSLLELH--KRRKALT-EPEAR-YYLRQIVLGCQYLH---RNRVIH 138
Query: 336 RNITPSSVLIDDDMEARIADFGLA-RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEK 394
R++ ++ +++D+E +I DFGLA ++ DG + GT YIAPE S +
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVL--CGTPNYIAPEVLSKKGHSFE 195
Query: 395 CDIYSFGVLLAVLVMGKLPSDD 416
D++S G ++ L++GK P +
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFET 217
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMR-QVRAEIMTAGQIRHRNIVPLLAHMV 275
+Y AE + G +AIK + + ++ M +V+ E+ Q++H +I+ L +
Sbjct: 25 AGVYRAESIHT-GLEVAIKMIDK--KAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81
Query: 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIH 335
+ LV E NG + L ++ + E ARH + I++G+ YLH + I+H
Sbjct: 82 DSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFM-HQIITGMLYLHSHG---ILH 135
Query: 336 RNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKC 395
R++T S++L+ +M +IADFGLA + H + T GT YI+PE +
Sbjct: 136 RDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIATRSAHGLES 193
Query: 396 DIYSFGVLLAVLVMGKLPSDD 416
D++S G + L++G+ P D
Sbjct: 194 DVWSLGCMFYTLLIGRPPFDT 214
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 63/276 (22%), Positives = 115/276 (41%), Gaps = 33/276 (11%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV 268
+I + +Y L +A +++ D L + ++ + E ++H NIV
Sbjct: 32 IEIGRGSFKTVYKG-LDTETTVEVAWCELQ--DRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 269 PLL---AHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEY 324
V+ + LV+E M +G+L L + ++ R I+ GL++
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQF 144
Query: 325 LHMYHRPRIIHRNITPSSVLID-DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAP 383
LH P IIHR++ ++ I +I D GLA L A+ V GT ++AP
Sbjct: 145 LH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAP 199
Query: 384 EYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443
E ++ K+ E D+Y+FG+ + + + P ++E ++ + R V TS +
Sbjct: 200 EMYEE-KYDESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRV-TSGVKPASF 251
Query: 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKD 479
D E ++ C + +ER + KD
Sbjct: 252 DKVA----IPEVKEIIEG--CIRQ--NKDERYSIKD 279
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 63/301 (20%), Positives = 102/301 (33%), Gaps = 41/301 (13%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL--LVS 284
G + AIK +N + E ++ H+NIV L A L+
Sbjct: 32 KTGDLFAIK---VFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88
Query: 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
EF GSL +L + S E + R +V G+ +L I+HRNI P +++
Sbjct: 89 EFCPCGSLYTVLEEPSNAYGLPESEFLI-VLRDVVGGMNHLR---ENGIVHRNIKPGNIM 144
Query: 345 I----DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE--------YHQTLKFS 392
D ++ DFG AR + D VS + GT Y+ P+ K+
Sbjct: 145 RVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPDMYERAVLRKDHQKKYG 201
Query: 393 EKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNG- 451
D++S GV G LP F + M ++T + + NG
Sbjct: 202 ATVDLWSIGVTFYHAATGSLP---FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGP 258
Query: 452 --YEEQMLLVLKIACFCTLD-----------DPEERPNSKDVRSMLSDTALIKDVDFLKM 498
+ M + ++ + D E+ + SD +
Sbjct: 259 IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNSHHHHH 318
Query: 499 H 499
H
Sbjct: 319 H 319
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 4e-30
Identities = 63/326 (19%), Positives = 112/326 (34%), Gaps = 45/326 (13%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL--LVS 284
G + AIK +N + E ++ H+NIV L A L+
Sbjct: 32 KTGDLFAIK---VFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88
Query: 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
EF GSL +L + S E + R +V G+ +L I+HRNI P +++
Sbjct: 89 EFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLR---ENGIVHRNIKPGNIM 144
Query: 345 I----DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE--------YHQTLKFS 392
D ++ DFG AR + D VS + GT Y+ P+ K+
Sbjct: 145 RVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPDMYERAVLRKDHQKKYG 201
Query: 393 EKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNG- 451
D++S GV G LP F + M ++T + + NG
Sbjct: 202 ATVDLWSIGVTFYHAATGSLP---FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGP 258
Query: 452 --YEEQMLLVLKIACFCTLD-----------DPEERPNSKDVRSMLSDTALIKDVDFLKM 498
+ M + ++ + D E+ + SD + +
Sbjct: 259 IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSL 318
Query: 499 HK----RMDFDNDDCVELIQQEIYTE 520
+ ++ + + + + +Y +
Sbjct: 319 QQMTAHKIYIHSYNTATIFHELVYKQ 344
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 56/290 (19%), Positives = 116/290 (40%), Gaps = 54/290 (18%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276
G++ A + + AIKK++ + K+ + +E+M + H+ +V A +
Sbjct: 20 GQVVKAR-NALDSRYYAIKKIRHTEE-----KLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 277 PDCHL-------------LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLE 323
+ + E+ +NG+L +++ S+ + R+ R I+ L
Sbjct: 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYW-RLFRQILEALS 130
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVA-------- 375
Y+H IIHR++ P ++ ID+ +I DFGLA+ + +
Sbjct: 131 YIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 376 ----GTVGYIAPE-YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM 430
GT Y+A E T ++EK D+YS G++ ++ F E ++++ +
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP------FSTGMERVNILKKL 241
Query: 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
R + + N + + ++ DP +RP ++ +
Sbjct: 242 R------SVSIEFPPDFDDNKMKVEKKIIRL--LIDH--DPNKRPGARTL 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 57/289 (19%), Positives = 106/289 (36%), Gaps = 49/289 (16%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276
+ + E +G A+K++ + + + E H NI+ L+A+ +R
Sbjct: 43 SYVDLVE-GLHDGHFYALKRILCHEQQ----DREEAQREADMHRLFNHPNILRLVAYCLR 97
Query: 277 PDCH----LLVSEFMKNGSLLEILNDVSQGRREL-EWLARHRIARGIVSGLEYLHMYHRP 331
L+ F K G+L + + L E + GI GLE +H
Sbjct: 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLGICRGLEAIH---AK 153
Query: 332 RIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVA-------GTVGYIAPE 384
HR++ P+++L+ D+ + + D G ++ T+ Y APE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 385 ---YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLV-----RWMRNVMTS 436
E+ D++S G +L ++ G+ P D FQ + +L ++ S
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHS 273
Query: 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485
+ ++S M+ V DP +RP+ + S L
Sbjct: 274 SALWQLLNS----------MMTV----------DPHQRPHIPLLLSQLE 302
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-28
Identities = 64/320 (20%), Positives = 116/320 (36%), Gaps = 38/320 (11%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQ-VRAEIMTAGQIRHRNIVPLLA------HMVRPDC 279
G+ +AIK+ +Q L+ K R+ EI ++ H N+V + D
Sbjct: 37 DTGEQVAIKQCRQ----ELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92
Query: 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNIT 339
LL E+ + G L + LN E R + I S L YLH RIIHR++
Sbjct: 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT-LLSDISSALRYLH---ENRIIHRDLK 148
Query: 340 PSSVLIDDDMEAR---IADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCD 396
P ++++ + I D G A+ + G GT+ Y+APE + K++ D
Sbjct: 149 PENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE---FVGTLQYLAPELLEQKKYTVTVD 205
Query: 397 IYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR--WMRNVMTSENPNRAIDSKLLGNGYE- 453
+SFG L + G P +Q + VR +++ ++ A+ +
Sbjct: 206 YWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNH 265
Query: 454 ----EQMLLVLKIACFCTLDDPEERPNSKDVR-----SMLSDTALIKDVDFLKMHK---- 500
L + C +R L +K + + M
Sbjct: 266 LSGILAGKLERWLQCMLMW-HQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVH 324
Query: 501 RMDFDNDDCVELIQQEIYTE 520
++ ++ ++ + +
Sbjct: 325 TYPVTENENLQNLKSWLQQD 344
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 53/231 (22%), Positives = 93/231 (40%), Gaps = 34/231 (14%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKV--KQVDNSLLNIKMRQVRAEIMTAGQIRHR 265
L++I S S +++ ++ AIK V ++ DN + R EI +++
Sbjct: 33 LKQIGSGGSSKVFQVL--NEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQH 86
Query: 266 N--IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLE 323
+ I+ L + + +V E N L L + + W + + ++ +
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK---KKKSIDPWERKS-YWKNMLEAVH 141
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAP 383
+H + I+H ++ P++ LI D M ++ DFG+A M V GTV Y+ P
Sbjct: 142 TIH---QHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 384 E-----------YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEE 423
E K S K D++S G +L + GK P FQ
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIIN 244
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 45/220 (20%), Positives = 91/220 (41%), Gaps = 30/220 (13%)
Query: 217 GEIYIAELPESNGKMIAIKKVK-------------QVDNSLLNIKMRQVRAEIMTAGQIR 263
+I + E + K A+KK + D + K + E+ I+
Sbjct: 45 NKIILCE---KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101
Query: 264 HRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEIL-----NDVSQGRRELEWLARHRIARGI 318
+ + + D ++ E+M+N S+L+ D + + + I + +
Sbjct: 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-CIIKSV 160
Query: 319 VSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTV 378
++ Y+H I HR++ PS++L+D + +++DFG + M D + S GT
Sbjct: 161 LNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--GS--RGTY 214
Query: 379 GYIAPE--YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDD 416
++ PE +++ K DI+S G+ L V+ +P
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 52/173 (30%), Positives = 88/173 (50%), Gaps = 15/173 (8%)
Query: 249 MRQVRAEIMTAGQIRHRNIVPLLAHMVRP-DCHL-LVSEFMKNGSLLEILNDVSQGRREL 306
+ QV EI ++ H N+V L+ + P + HL +V E + G ++E+ +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPLS- 135
Query: 307 EWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH 366
E AR + ++ G+EYLH +IIHR+I PS++L+ +D +IADFG++
Sbjct: 136 EDQAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 367 AQVSTSIVAGTVGYIAPEYHQTLKFS---EKCDIYSFGVLLAVLVMGKLPSDD 416
A +S + GT ++APE + + D+++ GV L V G+ P D
Sbjct: 192 ALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 34/231 (14%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKV--KQVDNSLLNIKMRQVRAEIMTAGQIRH- 264
L++I S S +++ ++ AIK V ++ DN + R EI +++
Sbjct: 14 LKQIGSGGSSKVFQVL--NEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQH 67
Query: 265 -RNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLE 323
I+ L + + +V E N L L + + W + + ++ +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKS-YWKNMLEAVH 122
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAP 383
+H + I+H ++ P++ LI D M ++ DFG+A M V GTV Y+ P
Sbjct: 123 TIH---QHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 384 E-----------YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEE 423
E K S K D++S G +L + GK P FQ
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIIN 225
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKM-RQVRAEIMTAGQIRHRNIVPLLAHMV 275
G +Y+A +S ++A+K + + L + Q+R E+ +RH NI+ L +
Sbjct: 23 GNVYLAREKQS-KFILALKVLFK--AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79
Query: 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIH 335
L+ E+ G++ L + + E + + L Y H +IH
Sbjct: 80 DATRVYLILEYAPLGTVYREL--QKLSKFD-EQRTA-TYITELANALSYCHSKR---VIH 132
Query: 336 RNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKC 395
R+I P ++L+ E +IADFG + P GT+ Y+ PE + EK
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--DL--CGTLDYLPPEMIEGRMHDEKV 188
Query: 396 DIYSFGVLLAVLVMGKLPSDD 416
D++S GVL ++GK P +
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEA 209
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 36/296 (12%), Positives = 78/296 (26%), Gaps = 49/296 (16%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
+++ E + A+K V + ++ ++ A ++ +
Sbjct: 74 DRSVVFLVRDVER-LEDFALK-VFTMGAENSRSELERLHEATFAAARLLGESPEEARDRR 131
Query: 275 --------------------------VRPDCHLLVSEFMK--NGSLLEILNDVSQGRREL 306
+LL+ L L+ V R +
Sbjct: 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDE 191
Query: 307 EWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH 366
LA H + ++ L ++H + TP ++ I D + D +
Sbjct: 192 GILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-- 246
Query: 367 AQVSTSIVAGTVGYIAPEY--HQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
+ V Y E+ T F+ + + G+ + + LP F
Sbjct: 247 ---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGLVTPG 299
Query: 425 SLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
W R + ++ + L+ + F D R +
Sbjct: 300 IKGSWKRPSLRVPGT-DSLAFGSCTPLPDFVKTLIGRFLNF----DRRRRLLPLEA 350
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 57/280 (20%), Positives = 118/280 (42%), Gaps = 47/280 (16%)
Query: 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQ-VRAEIMTAGQIRHRNIV 268
KIR ++ G+I + K++D + +Q + +E+ +++H NIV
Sbjct: 24 KIRRKSDGKILV---------------WKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 68
Query: 269 PLLAHMV-RPDCHL-LVSEFMKNGSLLEILNDVSQGRRELE----WLARHRIARGIVSGL 322
++ R + L +V E+ + G L ++ ++ R+ L+ R+ + L
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL----RVMTQLTLAL 124
Query: 323 EYLHMYHRP--RIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
+ H ++HR++ P++V +D ++ DFGLAR++ + T + GT Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYY 182
Query: 381 IAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440
++PE + ++EK DI+S G LL L P F +K L + +
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKELA---GKIREGKFRR 235
Query: 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
+ Y +++ ++ RP+ +++
Sbjct: 236 -------IPYRYSDELNEIIT-RMLNL--KDYHRPSVEEI 265
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKM-RQVRAEIMTAGQIRHRNIVPLLAHMV 275
G +Y+A ++ ++A+K + + + L + Q+R EI +RH NI+ + +
Sbjct: 28 GNVYLAREKQN-KFIMALKVLFK--SQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84
Query: 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIH 335
L+ EF G L + L GR + E + + L Y H +IH
Sbjct: 85 DRKRIYLMLEFAPRGELYKEL--QKHGRFD-EQRSA-TFMEELADALHYCHERK---VIH 137
Query: 336 RNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKC 395
R+I P ++L+ E +IADFG + P + GT+ Y+ PE + EK
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKV 193
Query: 396 DIYSFGVLLAVLVMGKLPSDD 416
D++ GVL ++G P D
Sbjct: 194 DLWCAGVLCYEFLVGMPPFDS 214
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 52/231 (22%), Positives = 91/231 (39%), Gaps = 34/231 (14%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKV--KQVDNSLLNIKMRQVRAEIMTAGQIRH- 264
L++I S S +++ ++ AIK V ++ DN + R EI +++
Sbjct: 61 LKQIGSGGSSKVFQVL--NEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQH 114
Query: 265 -RNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLE 323
I+ L + + +V E N L L + + W + + ++ +
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKS-YWKNMLEAVH 169
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAP 383
+H + I+H ++ P++ LI D M ++ DFG+A M V G V Y+ P
Sbjct: 170 TIH---QHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 384 E-----------YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEE 423
E K S K D++S G +L + GK P FQ
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIIN 272
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 54/299 (18%), Positives = 106/299 (35%), Gaps = 48/299 (16%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAH-- 273
+Y A+ +G+ A+K++ + K R + E+ ++ H NIV +
Sbjct: 42 AFVYEAQ-DVGSGREYALKRLLSNEEE----KNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96
Query: 274 -----MVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY 328
L+ + G L+E L + +I ++++H
Sbjct: 97 IGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL-KIFYQTCRAVQHMH-R 154
Query: 329 HRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVA----------GTV 378
+P IIHR++ ++L+ + ++ DFG A + ++ T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 379 GYIAPE---YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435
Y PE + EK DI++ G +L +L + P +D + +
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQ 274
Query: 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDVD 494
+ I + ML V +PEER + +V L + A ++V+
Sbjct: 275 YTVFHSLIRA----------MLQV----------NPEERLSIAEVVHQLQEIAAARNVN 313
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 58/274 (21%), Positives = 116/274 (42%), Gaps = 29/274 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQ-VRAEIMTAGQIRHRN 266
L+KI + G+ + + +G+ IK +++ S ++ K R+ R E+ ++H N
Sbjct: 29 LQKIGEGSFGKAILVK-STEDGRQYVIK---EINISRMSSKEREESRREVAVLANMKHPN 84
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
IV +V ++ + G L + +N +G E I L+++H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINA-QKGVLFQEDQIL-DWFVQICLALKHVH 142
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
+I+HR+I ++ + D ++ DFG+AR++ I GT Y++PE
Sbjct: 143 ---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI--GTPYYLSPEIC 197
Query: 387 QTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSK 446
+ ++ K DI++ G +L L K F+ K+LV +++ P
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA----FEAGSMKNLV---LKIISGSFPP------ 244
Query: 447 LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
+ Y + ++ F +P +RP+ +
Sbjct: 245 -VSLHYSYDLRSLVS-QLFKR--NPRDRPSVNSI 274
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
E+I GE++ L ++ ++A+K ++ L K Q A I+ Q H NI
Sbjct: 119 GEQIGRGNFGEVFSGRL-RADNTLVAVKSCRETLPPDLKAKFLQ-EARILK--QYSHPNI 174
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L+ + +V E ++ G L L L ++ +G+EYL
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI-----A 382
IHR++ + L+ + +I+DFG++R DG +G + + A
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG-----VYAASGGLRQVPVKWTA 283
Query: 383 PEYHQTLKFSEKCDIYSFGVLL 404
PE ++S + D++SFG+LL
Sbjct: 284 PEALNYGRYSSESDVWSFGILL 305
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 61/259 (23%), Positives = 112/259 (43%), Gaps = 30/259 (11%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQ-VRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285
+G +A+KKV+ L++ K R EI Q+ H N++ A + + +V E
Sbjct: 55 LDGVPVALKKVQ--IFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112
Query: 286 FMKNGSLLEILNDVSQGRRELE----WLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
G L ++ + +R + W + + S LE++H R++HR+I P+
Sbjct: 113 LADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQLCSALEHMH---SRRVMHRDIKPA 165
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFG 401
+V I ++ D GL R + + GT Y++PE ++ K DI+S G
Sbjct: 166 NVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLG 223
Query: 402 VLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLK 461
LL + + P F + ++ +L + + + P L + Y E++ ++
Sbjct: 224 CLLYEMAALQSP---F--YGDKMNLYSLCKKIEQCDYP------PLPSDHYSEELRQLVN 272
Query: 462 IACFCTLDDPEERPNSKDV 480
C DPE+RP+ V
Sbjct: 273 -MCINP--DPEKRPDVTYV 288
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 52/255 (20%), Positives = 88/255 (34%), Gaps = 52/255 (20%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV----------PLLAHMVR 276
+ AIK+++ + L +V E+ ++ H IV
Sbjct: 28 VDDCNYAIKRIRLPNREL---AREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84
Query: 277 PDCHLL--VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
L + + +L + +N E E I I +E+LH ++
Sbjct: 85 SPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHIFLQIAEAVEFLH---SKGLM 140
Query: 335 HRNITPSSVLIDDDMEARIADFGLARLM-----------PDGHAQVSTSIVAGTVGYIAP 383
HR++ PS++ D ++ DFGL M P T V GT Y++P
Sbjct: 141 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV-GTKLYMSP 199
Query: 384 EYHQTLKFSEKCDIYSFGVLLAVLVM-----------------GKLPSDDFFQHTEEKSL 426
E +S K DI+S G++L L+ K P ++ E +
Sbjct: 200 EQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVM 259
Query: 427 VRWMRNVMTSENPNR 441
V+ M S +P
Sbjct: 260 VQD----MLSPSPME 270
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 47/302 (15%)
Query: 237 VKQVDNSLLN-IKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEI 295
+K +D + LN ++++ E+ + H NIV L + L+ E+ G + +
Sbjct: 45 IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDY 104
Query: 296 LNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354
L V+ GR +E E AR R IVS ++Y H + RI+HR++ ++L+D DM +IA
Sbjct: 105 L--VAHGRMKEKE--AR-SKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIA 156
Query: 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS-EKCDIYSFGVLLAVLVMGKLP 413
DFG + G ++ G Y APE Q K+ + D++S GV+L LV G LP
Sbjct: 157 DFGFSNEFTVGG-KLDAF--CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
Query: 414 SDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEE 473
F K L + + D + L + L++ +P +
Sbjct: 214 ----FDGQNLKELRERVLRGKYRIPFYMSTDCENLLK----RFLVL----------NPIK 255
Query: 474 RPNSKDVR---------------SMLSDTALIKDVDFLKMHKRMDFDNDDCVELIQQEIY 518
R + + + I D + + M + ++ E + + Y
Sbjct: 256 RGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESLSKMKY 315
Query: 519 TE 520
E
Sbjct: 316 DE 317
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 60/327 (18%), Positives = 118/327 (36%), Gaps = 56/327 (17%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+ ++ + G ++ S G ++A K + Q+ E+ + I
Sbjct: 38 ISELGAGNGGVVFKVSHKPS-GLVMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYI 93
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V + E M GSL ++L GR + L + ++ ++ GL YL
Sbjct: 94 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGK--VSIAVIKGLTYLRE 149
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI---VAGTVGYIAPE 384
H+ I+HR++ PS++L++ E ++ DFG++ Q+ S+ GT Y++PE
Sbjct: 150 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSMANSFVGTRSYMSPE 200
Query: 385 YHQTLKFSEKCDIYSFGVLLAVLVMGK--LPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442
Q +S + DI+S G+ L + +G+ +P D + T P
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260
Query: 443 IDSKLLGNGYEEQMLLVLKIACF------------------------CTLDDPEERPNSK 478
+ + ++ + C + +P ER + K
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320
Query: 479 DVRSMLSDTALIKDVDFLKMHKRMDFD 505
++ F+K + D
Sbjct: 321 Q---LMVH-------AFIKRSDAEEVD 337
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 3e-25
Identities = 23/172 (13%), Positives = 46/172 (26%), Gaps = 21/172 (12%)
Query: 263 RHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGL 322
R ++ R +L + E+L S + L AR ++ ++ L
Sbjct: 173 RDMWVLSRFFLYPRMQSNL--------QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 224
Query: 323 EYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIA 382
LH ++H + P +++D + F A
Sbjct: 225 ASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGF-APPETTA 280
Query: 383 PE-----YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRW 429
H + D ++ G+ + + LP W
Sbjct: 281 ERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NTDDAALGGSEW 328
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 48/221 (21%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 229 GKMIAIKKV--KQVDNSLLNIKMRQVRAEIMTAGQIRHR--NIVPLLAHMVRPDCHLLVS 284
+AIK V ++ + +V E++ ++ ++ LL RPD +L+
Sbjct: 68 NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127
Query: 285 EFMKN-GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSV 343
E + L + + +G + E LAR ++ + + H ++HR+I ++
Sbjct: 128 ERPEPVQDLFDFI--TERGALQ-EELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENI 180
Query: 344 LID-DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS-EKCDIYSFG 401
LID + E ++ DFG L+ D GT Y PE+ + ++ ++S G
Sbjct: 181 LIDLNRGELKLIDFGSGALLKDTVYTDF----DGTRVYSPPEWIRYHRYHGRSAAVWSLG 236
Query: 402 VLLAVLVMGKLPSDD------------FFQHTEEKSLVRWM 430
+LL +V G +P + +E + L+RW
Sbjct: 237 ILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 277
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 60/245 (24%), Positives = 109/245 (44%), Gaps = 45/245 (18%)
Query: 253 RAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARH 312
E+ + Q+ H+NIV ++ DC+ LV E+++ +L E + L
Sbjct: 59 EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAI 114
Query: 313 RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTS 372
I+ G+++ H RI+HR+I P ++LID + +I DFG+A+ + + T+
Sbjct: 115 NFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTN 170
Query: 373 IVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDF---------FQHTEE 423
V GTV Y +PE + E DIYS G++L +++G+ P F +H ++
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP---FNGETAVSIAIKHIQD 227
Query: 424 KSLVRWMRNVMTSENPN--RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVR 481
+ NV T + +++ + ++L+ T D R K ++
Sbjct: 228 S-----VPNVTTDVRKDIPQSLSN------------VILR----ATEKDKANRY--KTIQ 264
Query: 482 SMLSD 486
M D
Sbjct: 265 EMKDD 269
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 30/230 (13%)
Query: 229 GKMIAIK---KVKQVDNSLLNIKMR-QVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284
K + +K K K +++ + +V EI ++ H NI+ +L LV
Sbjct: 49 NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108
Query: 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
E +G L++ + + R E LA I R +VS + YL IIHR+I +++
Sbjct: 109 EKHGSG--LDLFAFIDRHPRLDEPLAS-YIFRQLVSAVGYLR---LKDIIHRDIKDENIV 162
Query: 345 IDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS-EKCDIYSFGVL 403
I +D ++ DFG A + G T GT+ Y APE + + +++S GV
Sbjct: 163 IAEDFTIKLIDFGSAAYLERGK-LFYTF--CGTIEYCAPEVLMGNPYRGPELEMWSLGVT 219
Query: 404 LAVLVMGKLPSDDFFQ------------HTEEKSLVRWMRNVMTSENPNR 441
L LV + P + + E SLV + P R
Sbjct: 220 LYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQP----VPER 265
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 63/193 (32%), Positives = 102/193 (52%), Gaps = 20/193 (10%)
Query: 229 GKMIAIK---KVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285
G +A+K + K ++ +++ EI RH +I+ L + P +V E
Sbjct: 36 GHKVAVKILNRQKIRSLDVVG----KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91
Query: 286 FMKNGSLLEILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
++ G L + + GR E+E AR R+ + I+S ++Y H R ++HR++ P +VL
Sbjct: 92 YVSGGELFDYI--CKHGRVEEME--AR-RLFQQILSAVDYCH---RHMVVHRDLKPENVL 143
Query: 345 IDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS-EKCDIYSFGVL 403
+D M A+IADFGL+ +M DG + TS G+ Y APE ++ + DI+S GV+
Sbjct: 144 LDAHMNAKIADFGLSNMMSDGE-FLRTS--CGSPNYAAPEVISGRLYAGPEVDIWSCGVI 200
Query: 404 LAVLVMGKLPSDD 416
L L+ G LP DD
Sbjct: 201 LYALLCGTLPFDD 213
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 41/222 (18%), Positives = 81/222 (36%), Gaps = 30/222 (13%)
Query: 229 GKMIAIKKV--KQVDNSLLNIKMRQVRAEI----MTAGQIRHRNIVPLLAHMVRPDCHLL 282
+AIK + +V E+ H ++ LL + +L
Sbjct: 56 RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115
Query: 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSS 342
V E ++ + +++ E +R +V+ +++ H ++HR+I +
Sbjct: 116 VLERPLPAQ--DLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH---SRGVVHRDIKDEN 169
Query: 343 VLIDDDM-EARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS-EKCDIYSF 400
+LID A++ DFG L+ D GT Y PE+ ++ ++S
Sbjct: 170 ILIDLRRGCAKLIDFGSGALLHDEPYTDF----DGTRVYSPPEWISRHQYHALPATVWSL 225
Query: 401 GVLLAVLVMGKLPSDD------------FFQHTEEKSLVRWM 430
G+LL +V G +P + + +L+R
Sbjct: 226 GILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALIRRC 267
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 46/218 (21%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 191 IEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKM-IAIKKVKQVDNSLLNIKM 249
+++++L + ++ G + ++ +AIK +KQ +M
Sbjct: 6 LKRDNLLIADI--------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM 57
Query: 250 RQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWL 309
+ A+IM Q+ + IV L+ + + + +LV E G L + L R E+
Sbjct: 58 MR-EAQIM--HQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLV---GKREEIPVS 110
Query: 310 ARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQV 369
+ + G++YL +HR++ +VL+ + A+I+DFGL++ + +
Sbjct: 111 NVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 167
Query: 370 STSIVAGT---VGYIAPEYHQTLKFSEKCDIYSFGVLL 404
+ + + + APE KFS + D++S+GV +
Sbjct: 168 TAR--SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 203
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 27/214 (12%), Positives = 67/214 (31%), Gaps = 28/214 (13%)
Query: 231 MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK-- 288
++ ++ ++ + N + + + ++ + + +
Sbjct: 124 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 183
Query: 289 --NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346
+ E+L S + L AR ++ ++ L LH Y ++H + P +++D
Sbjct: 184 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLD 240
Query: 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEY-----------HQTLKFSEKC 395
+ F DG VS+ + G+ PE + +
Sbjct: 241 QRGGVFLTGFEHLV--RDGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSF 294
Query: 396 DIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRW 429
D ++ G+++ + LP W
Sbjct: 295 DAWALGLVIYWIWCADLP----ITKDAALGGSEW 324
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 60/284 (21%), Positives = 109/284 (38%), Gaps = 56/284 (19%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-----RHRNIVP 269
A G I + + + +A+K++ E+ Q+ H N++
Sbjct: 36 AEGTIVYRGM--FDNRDVAVKRILP-------ECFSFADREV----QLLRESDEHPNVIR 82
Query: 270 LLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH 329
+ E +L E + + L + + SGL +LH
Sbjct: 83 YFCTEKDRQFQYIAIELC-AATLQEYV--EQKDFAHLGLEPIT-LLQQTTSGLAHLH--- 135
Query: 330 RPRIIHRNITPSSVLI-----DDDMEARIADFGLAR-LMPDGHAQVSTSIVAGTVGYIAP 383
I+HR++ P ++LI ++A I+DFGL + L H+ S V GT G+IAP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 384 EY---HQTLKFSEKCDIYSFGVLLA-VLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439
E + DI+S G + V+ G P F + + ++ + + +P
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP---FGKSLQRQANILLGACSLDCLHP 252
Query: 440 NRAIDSK---LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
+ D L+ E+M+ + DP++RP++K V
Sbjct: 253 EKHEDVIARELI-----EKMIAM----------DPQKRPSAKHV 281
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-24
Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 191 IEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMR 250
+E+ D+ K + GE+Y + + +A+K +K+ D + ++
Sbjct: 217 MERTDITMKHK---------LGGGQYGEVYEGVWKKYSLT-VAVKTLKE-DTMEVEEFLK 265
Query: 251 QVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLA 310
+ A +M +I+H N+V LL R +++EFM G+LL+ L R+E+ +
Sbjct: 266 E--AAVMK--EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVV 319
Query: 311 RHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS 370
+A I S +EYL + IHRN+ + L+ ++ ++ADFGL+RLM
Sbjct: 320 LLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376
Query: 371 TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
+ + APE KFS K D+++FGVLL + G P
Sbjct: 377 AGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 50/197 (25%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 229 GKMIAIK---KVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285
+ +A+K + VD ++ EI + H N+V H + L E
Sbjct: 32 EEAVAVKIVDMKRAVDC------PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85
Query: 286 FMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345
+ G L + + E A+ R +++G+ YLH I HR+I P ++L+
Sbjct: 86 YCSGGELFDRI--EPDIGMP-EPDAQ-RFFHQLMAGVVYLH---GIGITHRDIKPENLLL 138
Query: 346 DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE------YHQTLKFSEKCDIYS 399
D+ +I+DFGLA + + + + + GT+ Y+APE +H +E D++S
Sbjct: 139 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH-----AEPVDVWS 193
Query: 400 FGVLLAVLVMGKLPSDD 416
G++L ++ G+LP D
Sbjct: 194 CGIVLTAMLAGELPWDQ 210
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 64/338 (18%), Positives = 123/338 (36%), Gaps = 38/338 (11%)
Query: 148 GLKASSGGKSKNVRQRFPTTPSLLLAAVRGGGQNRG--PTIFSPLIEKEDLAFLEKEDCS 205
G + S G++ ++ T S R G + + + ++ D + E+
Sbjct: 1 GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM 60
Query: 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHR 265
++ + GE++ + G A+KKV+ L ++ E++ +
Sbjct: 61 THQPRVGRGSFGEVHRM-KDKQTGFQCAVKKVR-----LEVFRVE----ELVACAGLSSP 110
Query: 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYL 325
IVPL + + E ++ GSL +++ Q E A + + GLEYL
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALY-YLGQALEGLEYL 166
Query: 326 HMYHRPRIIHRNITPSSVLIDDD-MEARIADFGLARLMPDGHAQVSTSI---VAGTVGYI 381
H RI+H ++ +VL+ D A + DFG A + S + GT ++
Sbjct: 167 ---HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 382 APEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441
APE K DI+S ++ ++ G P +F+ + + P R
Sbjct: 224 APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR-------GPLCLKIASEPPPIR 276
Query: 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKD 479
I ++ +P R ++ +
Sbjct: 277 EIPPSC-----APLTAQAIQ-EGLRK--EPVHRASAME 306
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 20/195 (10%)
Query: 217 GEIYIAELPESNGKMI--AIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
GE+ L + + AIK +K A IM GQ H NI+ L +
Sbjct: 63 GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLS-EASIM--GQFDHPNIIRLEGVV 119
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
R ++V+E+M+NGSL L + + + RG+ +G+ YL +
Sbjct: 120 TRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYV 173
Query: 335 HRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI-----APEYHQTL 389
HR++ +VL+D ++ +++DFGL+R++ D + T G I APE
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDD----PDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 390 KFSEKCDIYSFGVLL 404
FS D++SFGV++
Sbjct: 230 TFSSASDVWSFGVVM 244
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 28/220 (12%)
Query: 191 IEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKM-IAIKKVKQVDNSLLNIKM 249
++++ L +KE + S G + +A+K +K N
Sbjct: 13 LDRKLLTLEDKE--------LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 64
Query: 250 RQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWL 309
A +M Q+ + IV ++ + + +LV E + G L + L Q R ++
Sbjct: 65 LLAEANVM--QQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYL----QQNRHVKDK 117
Query: 310 ARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQV 369
+ + G++YL +HR++ +VL+ A+I+DFGL++ +
Sbjct: 118 NIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD---- 170
Query: 370 STSIVAGTVGYI-----APEYHQTLKFSEKCDIYSFGVLL 404
A T G APE KFS K D++SFGVL+
Sbjct: 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 210
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 9e-24
Identities = 49/216 (22%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 193 KEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKM-IAIKKVKQVDNSLLNIKMRQ 251
K+ FL++++ + ++ G + ++ +AIK +KQ +M +
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 385
Query: 252 VRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLAR 311
A+IM Q+ + IV L+ + + + +LV E G L + L R E+
Sbjct: 386 -EAQIM--HQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNV 438
Query: 312 HRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVST 371
+ + G++YL +HRN+ +VL+ + A+I+DFGL++ + + +
Sbjct: 439 AELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495
Query: 372 SIVAGT---VGYIAPEYHQTLKFSEKCDIYSFGVLL 404
+ + + APE KFS + D++S+GV +
Sbjct: 496 R--SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 529
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 42/194 (21%), Positives = 82/194 (42%), Gaps = 32/194 (16%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV---------------PLL 271
+GK IK+V + E+ ++ H NIV
Sbjct: 34 IDGKTYVIKRV--------KYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85
Query: 272 AHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR 330
L + EF G+L + + +G + + LA + I G++Y+H
Sbjct: 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALE-LFEQITKGVDYIH---S 140
Query: 331 PRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK 390
++I+R++ PS++ + D + +I DFGL + + T GT+ Y++PE +
Sbjct: 141 KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGKRTRSK-GTLRYMSPEQISSQD 197
Query: 391 FSEKCDIYSFGVLL 404
+ ++ D+Y+ G++L
Sbjct: 198 YGKEVDLYALGLIL 211
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 50/197 (25%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 229 GKMIAIK---KVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285
+ +A+K + VD ++ EI + H N+V H + L E
Sbjct: 32 EEAVAVKIVDMKRAVDC------PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85
Query: 286 FMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345
+ G L + + E A+ R +++G+ YLH I HR+I P ++L+
Sbjct: 86 YCSGGELFDRI--EPDIGMP-EPDAQ-RFFHQLMAGVVYLH---GIGITHRDIKPENLLL 138
Query: 346 DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE------YHQTLKFSEKCDIYS 399
D+ +I+DFGLA + + + + + GT+ Y+APE +H +E D++S
Sbjct: 139 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH-----AEPVDVWS 193
Query: 400 FGVLLAVLVMGKLPSDD 416
G++L ++ G+LP D
Sbjct: 194 CGIVLTAMLAGELPWDQ 210
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 16/193 (8%)
Query: 217 GEIYIAELPESNGKMI--AIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
GE+ L + K I AIK +K A IM GQ H NI+ L +
Sbjct: 59 GEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG-EASIM--GQFDHPNIIRLEGVV 115
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
+ ++V+E+M+NGSL L + + + + RGI SG++YL +
Sbjct: 116 TKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDMG---YV 169
Query: 335 HRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGT---VGYIAPEYHQTLKF 391
HR++ ++LI+ ++ +++DFGL R++ D T+ G + + +PE KF
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT--RGGKIPIRWTSPEAIAYRKF 227
Query: 392 SEKCDIYSFGVLL 404
+ D++S+G++L
Sbjct: 228 TSASDVWSYGIVL 240
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 12/166 (7%)
Query: 253 RAEIMTAGQIRHRNIVPLL----AHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEW 308
R E A + H IV + A +V E++ +L +I++ +
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTP 115
Query: 309 LARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ 368
+ L + H + IIHR++ P++++I ++ DFG+AR + D
Sbjct: 116 KRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 369 V-STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
V T+ V GT Y++PE + + D+YS G +L ++ G+ P
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 48/191 (25%), Positives = 88/191 (46%), Gaps = 15/191 (7%)
Query: 230 KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP-DCHL-LVSEFM 287
K++ KK++++ N N+K + EI ++RH+N++ L+ + + +V E+
Sbjct: 36 KILKKKKLRRIPNGEANVK----K-EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC 90
Query: 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347
G + E+L+ V + R A ++ GLEYLH I+H++I P ++L+
Sbjct: 91 VCG-MQEMLDSVPEKRFP-VCQAH-GYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTT 144
Query: 348 DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSE--KCDIYSFGVLLA 405
+I+ G+A + A + G+ + PE L K DI+S GV L
Sbjct: 145 GGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLY 204
Query: 406 VLVMGKLPSDD 416
+ G P +
Sbjct: 205 NITTGLYPFEG 215
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 54/194 (27%), Positives = 101/194 (52%), Gaps = 17/194 (8%)
Query: 217 GEIYIAELPESNGKM---IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH 273
GE+Y L S+GK +AIK +K + A IM GQ H NI+ L
Sbjct: 58 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG-EAGIM--GQFSHHNIIRLEGV 114
Query: 274 MVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRI 333
+ + ++++E+M+NG+L + L + E L + RGI +G++YL +
Sbjct: 115 ISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANMN---Y 168
Query: 334 IHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGT---VGYIAPEYHQTLK 390
+HR++ ++L++ ++ +++DFGL+R++ D T+ +G + + APE K
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT--SGGKIPIRWTAPEAISYRK 226
Query: 391 FSEKCDIYSFGVLL 404
F+ D++SFG+++
Sbjct: 227 FTSASDVWSFGIVM 240
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-23
Identities = 57/294 (19%), Positives = 117/294 (39%), Gaps = 55/294 (18%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
+SG + G+ +A+K++ + + ++ +++T H N++
Sbjct: 27 SSGTVVFQG--SFQGRPVAVKRMLIDFCDIA---LMEI--KLLTES-DDHPNVIRYYCSE 78
Query: 275 VRPDCHLLVSEFMKNGSLLEIL---NDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP 331
+ E N +L +++ N + + + + R I SG+ +LH
Sbjct: 79 TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 134
Query: 332 RIIHRNITPSSVLID-------------DDMEARIADFGLARLMPDGHAQVSTSI--VAG 376
+IIHR++ P ++L+ +++ I+DFGL + + G + T++ +G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 377 TVGYIAPE-------YHQTLKFSEKCDIYSFGVLL-AVLVMGKLPSDDFFQHTEEKSLVR 428
T G+ APE + + DI+S G + +L GK P F +S +
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP---FGDKYSRESNI- 250
Query: 429 WMRNVMTSENPNRAIDSKLLGNGYE--EQMLLVLKIACFCTLDDPEERPNSKDV 480
+R + + + D L+ + QM+ DP +RP + V
Sbjct: 251 -IRGIFSLDEMKCLHDRSLIAEATDLISQMIDH----------DPLKRPTAMKV 293
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-23
Identities = 62/305 (20%), Positives = 129/305 (42%), Gaps = 44/305 (14%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEI-MTAGQIRHRN 266
+ ++ A G + S G+++A+K+++ NS + +++ ++ ++ +
Sbjct: 12 IMELGRGAYGVVEKMRHVPS-GQIMAVKRIRATVNSQ---EQKRLLMDLDISMRTVDCPF 67
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRREL--EWLARHRIARGIVSGLEY 324
V + R + E M + SL + V + + + L + IA IV LE+
Sbjct: 68 TVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEH 124
Query: 325 LHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE 384
LH +IHR++ PS+VLI+ + ++ DFG++ + D A+ I AG Y+APE
Sbjct: 125 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCKPYMAPE 179
Query: 385 ----YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440
+S K DI+S G+ + L + + P + + + ++ V+ +P
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFP------YDSWGTPFQQLKQVVEEPSP- 232
Query: 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDVDFLKMHK 500
+L + + + + C + +ERP + ++ F +H+
Sbjct: 233 -----QLPADKFSAEFVDFTSQ---CLKKNSKERPTYPE---LMQH-------PFFTLHE 274
Query: 501 RMDFD 505
D
Sbjct: 275 SKGTD 279
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 38/192 (19%), Positives = 83/192 (43%), Gaps = 15/192 (7%)
Query: 217 GEIYIAELPESNGKM---IAIKKVKQVDNSLLNIKMRQVR-AEIMTAGQIRHRNIVPLLA 272
G +Y K+ +AIK+++ + + + A +M + + ++ LL
Sbjct: 29 GTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVM--ASVDNPHVCRLLG 84
Query: 273 HMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR 332
+ L+++ M G LL+ + + + ++L I G+ YL R
Sbjct: 85 -ICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLN--WCVQIAKGMNYLE---DRR 137
Query: 333 IIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS 392
++HR++ +VL+ +I DFGLA+L+ + + ++A E ++
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 393 EKCDIYSFGVLL 404
+ D++S+GV +
Sbjct: 198 HQSDVWSYGVTV 209
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 7e-23
Identities = 31/214 (14%), Positives = 69/214 (32%), Gaps = 25/214 (11%)
Query: 217 GEIYIAELPESN----GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLA 272
++Y A + N + +K K + I Q+ + + +
Sbjct: 79 AQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYI-GTQLMERL---KPSMQHMFMKFYS 134
Query: 273 HMVRPDCHLLVSEFMKNGSLLEILNDV--SQGRRELEWLARHRIARGIVSGLEYLHMYHR 330
+ + +LV E G+LL +N + + + L A ++ +E +H
Sbjct: 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS-FAMRMLYMIEQVH---D 190
Query: 331 PRIIHRNITPSSVLIDDDMEA-----------RIADFGLARLMPDGHAQVSTSIVAGTVG 379
IIH +I P + ++ + + D G + M + T G
Sbjct: 191 CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSG 250
Query: 380 YIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
+ E ++ + D + + ++ G
Sbjct: 251 FQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 7e-23
Identities = 63/246 (25%), Positives = 115/246 (46%), Gaps = 26/246 (10%)
Query: 170 LLLAAVRGGGQNRGPTIFSPLIEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNG 229
L Q +G + I +E L K + GE+++ NG
Sbjct: 243 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVK---------LGQGCFGEVWMGTW---NG 290
Query: 230 KM-IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288
+AIK +K +++ A++M ++RH +V L A +V + +V+E+M
Sbjct: 291 TTRVAIKTLKP-GTMSPEAFLQE--AQVM--KKLRHEKLVQLYA-VVSEEPIYIVTEYMS 344
Query: 289 NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD 348
GSLL+ L + + L +A I SG+ Y+ R +HR++ +++L+ ++
Sbjct: 345 KGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGEN 399
Query: 349 MEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVL 407
+ ++ADFGLARL+ D + + + APE +F+ K D++SFG+LL +
Sbjct: 400 LVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458
Query: 408 VMGKLP 413
G++P
Sbjct: 459 TKGRVP 464
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-23
Identities = 39/203 (19%), Positives = 77/203 (37%), Gaps = 27/203 (13%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276
G IY+A NG+ + +K + ++ AE ++ H +IV + +
Sbjct: 94 GWIYLALDRNVNGRPVVLKGLVHSGDAEA---QAMAMAERQFLAEVVHPSIVQIFNFVEH 150
Query: 277 PDCHL-----LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP 331
D H +V E++ SL + + I+ L YLH
Sbjct: 151 TDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIA--YLLEILPALSYLH---SI 201
Query: 332 RIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-K 390
+++ ++ P ++++ ++ + ++ D G + + GT G+ APE
Sbjct: 202 GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPE--IVRTG 252
Query: 391 FSEKCDIYSFGVLLAVLVMGKLP 413
+ DIY+ G LA L +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPT 275
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 14/188 (7%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276
G +Y SN IAIK++ + D+ + + EI ++H+NIV L
Sbjct: 36 GIVYAG-RDLSNQVRIAIKEIPERDSR----YSQPLHEEIALHKHLKHKNIVQYLGSFSE 90
Query: 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHR 336
+ E + GSL +L ++ E + I+ GL+YLH +I+HR
Sbjct: 91 NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQILEGLKYLH---DNQIVHR 146
Query: 337 NITPSSVLIDDDM-EARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE--YHQTLKFSE 393
+I +VLI+ +I+DFG ++ + + T GT+ Y+APE + +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGK 204
Query: 394 KCDIYSFG 401
DI+S G
Sbjct: 205 AADIWSLG 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 64/246 (26%), Positives = 113/246 (45%), Gaps = 26/246 (10%)
Query: 170 LLLAAVRGGGQNRGPTIFSPLIEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNG 229
L Q +G + I +E L K + GE+++ NG
Sbjct: 160 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVK---------LGQGCFGEVWMGTW---NG 207
Query: 230 KM-IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288
+AIK +K S A++M ++RH +V L A +V + +V+E+M
Sbjct: 208 TTRVAIKTLKPGTMSPEAFLQE---AQVM--KKLRHEKLVQLYA-VVSEEPIYIVTEYMS 261
Query: 289 NGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD 348
GSLL+ L + + L +A I SG+ Y+ R +HR++ +++L+ ++
Sbjct: 262 KGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGEN 316
Query: 349 MEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVL 407
+ ++ADFGLARL+ D + + + APE +F+ K D++SFG+LL +
Sbjct: 317 LVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375
Query: 408 VMGKLP 413
G++P
Sbjct: 376 TKGRVP 381
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 24/198 (12%)
Query: 217 GEIYIAE---LPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH 273
G + + L ++ G+++A+KK++ L R+ EI+ ++H NIV
Sbjct: 24 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE--IEIL--KSLQHDNIVKYKGV 79
Query: 274 MVRPDCH--LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP 331
L+ E++ GSL + L + + ++ + + I G+EYL
Sbjct: 80 CYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG---TK 133
Query: 332 RIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI-----APEYH 386
R IHR++ ++L++++ +I DFGL +++P G APE
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EFFKVKEPGESPIFWYAPESL 189
Query: 387 QTLKFSEKCDIYSFGVLL 404
KFS D++SFGV+L
Sbjct: 190 TESKFSVASDVWSFGVVL 207
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 24/198 (12%)
Query: 217 GEIYIAE---LPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH 273
G + + L ++ G+++A+KK++ L R+ EI+ ++H NIV
Sbjct: 55 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE--IEILK--SLQHDNIVKYKGV 110
Query: 274 MVRPDCH--LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP 331
L+ E++ GSL + L + + ++ + + I G+EYL
Sbjct: 111 CYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG---TK 164
Query: 332 RIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI-----APEYH 386
R IHR++ ++L++++ +I DFGL +++P G APE
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EYYKVKEPGESPIFWYAPESL 220
Query: 387 QTLKFSEKCDIYSFGVLL 404
KFS D++SFGV+L
Sbjct: 221 TESKFSVASDVWSFGVVL 238
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 50/259 (19%), Positives = 86/259 (33%), Gaps = 37/259 (14%)
Query: 211 IRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL 270
+R + E + I +K M +I +N V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 271 LAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR 330
L + + + +L + +N + E I I +E+LH
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNR-RCSLEDREHGVCLHIFIQIAEAVEFLH---S 182
Query: 331 PRIIHRNITPSSVLIDDDMEARIADFGLARLM-----------PDGHAQVSTSIVAGTVG 379
++HR++ PS++ D ++ DFGL M P T V GT
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV-GTKL 241
Query: 380 YIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-----------------GKLPSDDFFQHTE 422
Y++PE +S K DI+S G++L L+ K P ++ +
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQ 301
Query: 423 EKSLVRWMRNVMTSENPNR 441
E +V+ M S +P
Sbjct: 302 EHMMVQD----MLSPSPTE 316
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 1e-22
Identities = 63/191 (32%), Positives = 104/191 (54%), Gaps = 16/191 (8%)
Query: 229 GKMIAIKKVKQVDNSLLNIKMR-QVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFM 287
G +A+K + + + ++ + ++R EI RH +I+ L + P +V E++
Sbjct: 41 GHKVAVKILNR--QKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98
Query: 288 KNGSLLEILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346
G L + + GR E E +R R+ + I+SG++Y H R ++HR++ P +VL+D
Sbjct: 99 SGGELFDYI--CKNGRLDEKE--SR-RLFQQILSGVDYCH---RHMVVHRDLKPENVLLD 150
Query: 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS-EKCDIYSFGVLLA 405
M A+IADFGL+ +M DG + TS G+ Y APE ++ + DI+S GV+L
Sbjct: 151 AHMNAKIADFGLSNMMSDGE-FLRTS--CGSPNYAAPEVISGRLYAGPEVDIWSSGVILY 207
Query: 406 VLVMGKLPSDD 416
L+ G LP DD
Sbjct: 208 ALLCGTLPFDD 218
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 45/238 (18%), Positives = 80/238 (33%), Gaps = 41/238 (17%)
Query: 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVP 269
K+RS+ G +Y A+K+ + R++ +H V
Sbjct: 75 KVRSKEDGRLY------------AVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQHPCCVR 121
Query: 270 LLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH 329
L L +E SL + G E R + L +LH
Sbjct: 122 LEQAWEEGGILYLQTELC-GPSLQQHCEA--WGASLPEAQVW-GYLRDTLLALAHLH--- 174
Query: 330 RPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL 389
++H ++ P+++ + ++ DFGL + G A G Y+APE Q
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEVQE-GDPRYMAPELLQG- 230
Query: 390 KFSEKCDIYSFGVLL----------------AVLVMGKLPSDDFFQHTEE-KSLVRWM 430
+ D++S G+ + L G LP + + E +S++ M
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMM 288
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 230 KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKN 289
++I+ +K + V EI ++ H I+ + D ++ V E M+
Sbjct: 166 RIISKRKFAIGSAREAD-PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYI-VLELMEG 223
Query: 290 GSLLE-ILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI-- 345
G L + + V R +E + ++ ++YLH IIHR++ P +VL+
Sbjct: 224 GELFDKV---VGNKRLKEAT--CKL-YFYQMLLAVQYLH---ENGIIHRDLKPENVLLSS 274
Query: 346 -DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE---YHQTLKFSEKCDIYSFG 401
++D +I DFG ++++ + + GT Y+APE T ++ D +S G
Sbjct: 275 QEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331
Query: 402 VLLAVLVMGKLPSDDFFQHTEEKSL 426
V+L + + G P F +H + SL
Sbjct: 332 VILFICLSGYPP---FSEHRTQVSL 353
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276
G++++ E S+G +K ++ + M Q+ AEI + H NI+ +
Sbjct: 36 GDVHLVEE-RSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED 91
Query: 277 PDCHLLVSEFMKNGSLLE-ILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIH 335
+V E + G LLE I++ ++G+ E + + +++ L Y H H ++H
Sbjct: 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-ELMKQMMNALAYFHSQH---VVH 147
Query: 336 RNITPSSVLI---DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS 392
+++ P ++L +I DFGLA L + ST+ GT Y+APE + +
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAA-GTALYMAPEVFKR-DVT 203
Query: 393 EKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
KCDI+S GV++ L+ G LP F + E+
Sbjct: 204 FKCDIWSAGVVMYFLLTGCLP---FTGTSLEE 232
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 44/200 (22%), Positives = 82/200 (41%), Gaps = 27/200 (13%)
Query: 217 GEIYIAEL---PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLA- 272
G++ + ++ G+ +A+K +K +++ EI+ + H NIV
Sbjct: 35 GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK-EIEIL--RNLYHENIVKYKGI 91
Query: 273 ---HMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH 329
L+ EF+ +GSL E L + ++ + + A I G++YL
Sbjct: 92 CTEDGGNGIK--LIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLG--- 143
Query: 330 RPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI-----APE 384
+ +HR++ +VL++ + + +I DFGL + + APE
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK----EYYTVKDDRDSPVFWYAPE 199
Query: 385 YHQTLKFSEKCDIYSFGVLL 404
KF D++SFGV L
Sbjct: 200 CLMQSKFYIASDVWSFGVTL 219
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 30/201 (14%)
Query: 217 GEIYIAELPESNGKMI--AIKKVKQVDNSLLNIKMRQVR-----AEIMTAGQIRHRNIVP 269
G +Y L +++GK I A+K + + + +V IM H N++
Sbjct: 103 GCVYHGTLLDNDGKKIHCAVKSLNR------ITDIGEVSQFLTEGIIM--KDFSHPNVLS 154
Query: 270 LLAHMVRPDC-HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY 328
LL +R + L+V +MK+G L + + + G+++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 329 HRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI-----AP 383
+HR++ + ++D+ ++ADFGLAR M + + S+ T + A
Sbjct: 212 K---FVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNKTGAKLPVKWMAL 265
Query: 384 EYHQTLKFSEKCDIYSFGVLL 404
E QT KF+ K D++SFGVLL
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLL 286
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 230 KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKN 289
K+I+ +K + V EI ++ H I+ + D ++ V E M+
Sbjct: 41 KIISKRKFAIGSAREAD-PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYI-VLELMEG 98
Query: 290 GSLLE-ILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI-- 345
G L + + V R +E + ++ ++YLH IIHR++ P +VL+
Sbjct: 99 GELFDKV---VGNKRLKEAT--CKL-YFYQMLLAVQYLH---ENGIIHRDLKPENVLLSS 149
Query: 346 -DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE---YHQTLKFSEKCDIYSFG 401
++D +I DFG ++++ + + GT Y+APE T ++ D +S G
Sbjct: 150 QEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206
Query: 402 VLLAVLVMGKLPSDDFFQHTEEKSL 426
V+L + + G P F +H + SL
Sbjct: 207 VILFICLSGYPP---FSEHRTQVSL 228
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 191 IEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQ--VDNSLLNIK 248
+ ++L L+ I G++ + + G +A+K +K + L
Sbjct: 190 LNMKELKLLQT---------IGKGEFGDVMLGDY---RGNKVAVKCIKNDATAQAFLA-- 235
Query: 249 MRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELE 307
A +M Q+RH N+V LL +V L +V+E+M GSL++ L S+GR L
Sbjct: 236 ----EASVM--TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLG 287
Query: 308 WLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367
+ + + +EYL +HR++ +VL+ +D A+++DFGL +
Sbjct: 288 GDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------- 337
Query: 368 QVSTSIVAGT---VGYIAPEYHQTLKFSEKCDIYSFGVLL 404
++S V + APE + KFS K D++SFG+LL
Sbjct: 338 -EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 376
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 3e-22
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
AE+M ++ H +V L + LV+EFM++G L + L R
Sbjct: 54 AEVM--MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLG 108
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
+ + G+ YL +IHR++ + L+ ++ +++DFG+ R + D ST
Sbjct: 109 MCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-- 163
Query: 374 VAGT---VGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
GT V + +PE ++S K D++SFGVL+ V GK+P
Sbjct: 164 --GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 30/201 (14%)
Query: 217 GEIYIAELPESNGKMI--AIKKVKQVDNSLLNIKMRQVR-----AEIMTAGQIRHRNIVP 269
G +Y L +++GK I A+K + + + +V IM H N++
Sbjct: 39 GCVYHGTLLDNDGKKIHCAVKSLNR------ITDIGEVSQFLTEGIIM--KDFSHPNVLS 90
Query: 270 LLAHMVRPDC-HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY 328
LL +R + L+V +MK+G L + + + G++YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 329 HRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI-----AP 383
+HR++ + ++D+ ++ADFGLAR M + + S+ T + A
Sbjct: 148 K---FVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMAL 201
Query: 384 EYHQTLKFSEKCDIYSFGVLL 404
E QT KF+ K D++SFGVLL
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLL 222
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-22
Identities = 73/282 (25%), Positives = 128/282 (45%), Gaps = 27/282 (9%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
E I S A+ + A + +AIK +++ M ++ EI Q H NI
Sbjct: 20 QEVIGSGATAVVQAA-YCAPKKEKVAIK---RINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEIL-NDVSQGRRELEWLARHRIA---RGIVSGLE 323
V V D LV + + GS+L+I+ + V++G + L IA R ++ GLE
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI---VAGTVGY 380
YLH + IHR++ ++L+ +D +IADFG++ + G + GT +
Sbjct: 136 YLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 381 IAPE-YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439
+APE Q + K DI+SFG+ L G P + ++ K L ++T +N
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAP---YHKYPPMKVL------MLTLQND 243
Query: 440 NRAIDSKLLGNGYEEQMLLVLK--IACFCTLDDPEERPNSKD 479
++++ + ++ + I+ C DPE+RP + +
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRKMISL-CLQKDPEKRPTAAE 284
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 14/197 (7%)
Query: 217 GEIYIAELPESNGKMI--AIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLA-- 272
G + L + +G + A+K +K ++S I+ A M H N++ LL
Sbjct: 48 GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM--KDFSHPNVIRLLGVC 105
Query: 273 ---HMVRPDCHLLVSEFMKNGSLLEIL--NDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+++ FMK G L L + + G + + + I G+EYL
Sbjct: 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN 165
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
+ +HR++ + ++ DDM +ADFGL++ + G I V +IA E
Sbjct: 166 RN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA 222
Query: 388 TLKFSEKCDIYSFGVLL 404
++ K D+++FGV +
Sbjct: 223 DRVYTSKSDVWAFGVTM 239
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 25/198 (12%)
Query: 217 GEIYIAEL---PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLA- 272
G++ + + G+M+A+K +K D + + +I+ + H +I+
Sbjct: 45 GKVSLYCYDPTNDGTGEMVAVKALKA-DAGPQHRSGWKQEIDIL--RTLYHEHIIKYKGC 101
Query: 273 -HMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP 331
LV E++ GSL + L S G +L A+ I G+ YLH
Sbjct: 102 CEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH---AQ 153
Query: 332 RIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI-----APEYH 386
IHR++ +VL+D+D +I DFGLA+ +P+GH G APE
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH----EYYRVREDGDSPVFWYAPECL 209
Query: 387 QTLKFSEKCDIYSFGVLL 404
+ KF D++SFGV L
Sbjct: 210 KEYKFYYASDVWSFGVTL 227
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 8e-22
Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 34/209 (16%)
Query: 230 KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-----RHRNIVPLLAHMVRPDCHLLVS 284
K+I + + E+ I H NI+ L LV
Sbjct: 48 KIIDVTGGGSFSAEEVQELREATLKEV----DILRKVSGHPNIIQLKDTYETNTFFFLVF 103
Query: 285 EFMKNGSLLEILNDVSQGR---RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
+ MK G L + L + +E R I R ++ + LH + I+HR++ P
Sbjct: 104 DLMKKGELFDYL--TEKVTLSEKE----TRK-IMRALLEVICALHKLN---IVHRDLKPE 153
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE------YHQTLKFSEKC 395
++L+DDDM ++ DFG + + G V GT Y+APE + ++
Sbjct: 154 NILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 210
Query: 396 DIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
D++S GV++ L+ G P F+ +
Sbjct: 211 DMWSTGVIMYTLLAGSPP---FWHRKQML 236
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 9e-22
Identities = 50/154 (32%), Positives = 79/154 (51%), Gaps = 14/154 (9%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
A +M +I+H N+V LL R +++EFM G+LL+ L R+E+ +
Sbjct: 60 AAVM--KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLY 115
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
+A I S +EYL + IHR++ + L+ ++ ++ADFGL+RLM
Sbjct: 116 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-- 170
Query: 374 VAGT---VGYIAPEYHQTLKFSEKCDIYSFGVLL 404
G + + APE KFS K D+++FGVLL
Sbjct: 171 --GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 202
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 59/190 (31%), Positives = 104/190 (54%), Gaps = 15/190 (7%)
Query: 229 GKMIAIKKVKQVDNSLLNIKMR-QVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFM 287
+ +A+K + + L M +V EI +RH +I+ L + P ++V E+
Sbjct: 34 QQKVALKFISR--QLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA 91
Query: 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347
G L + + V + R E R R + I+ +EY H R +I+HR++ P ++L+DD
Sbjct: 92 -GGELFDYI--VEKKRMT-EDEGR-RFFQQIICAIEYCH---RHKIVHRDLKPENLLLDD 143
Query: 348 DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS-EKCDIYSFGVLLAV 406
++ +IADFGL+ +M DG+ + TS G+ Y APE ++ + D++S G++L V
Sbjct: 144 NLNVKIADFGLSNIMTDGN-FLKTS--CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYV 200
Query: 407 LVMGKLPSDD 416
+++G+LP DD
Sbjct: 201 MLVGRLPFDD 210
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 50/194 (25%), Positives = 77/194 (39%), Gaps = 17/194 (8%)
Query: 217 GEIYIAELPESNGKMI--AIKKVKQVDNSLLNIKMRQVR-AEIMTAGQIRHRNIVPLLAH 273
G + E +GK + A+K +K S +R M + HRN++ L
Sbjct: 32 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM--HSLDHRNLIRLYG- 88
Query: 274 MVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRI 333
+V +V+E GSLL+ L + + R A + G+ YL R
Sbjct: 89 VVLTPPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 142
Query: 334 IHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGT---VGYIAPEYHQTLK 390
IHR++ ++L+ +I DFGL R +P + APE +T
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ--EHRKVPFAWCAPESLKTRT 200
Query: 391 FSEKCDIYSFGVLL 404
FS D + FGV L
Sbjct: 201 FSHASDTWMFGVTL 214
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 37/192 (19%), Positives = 81/192 (42%), Gaps = 15/192 (7%)
Query: 217 GEIYIAELPESNGKM---IAIKKVKQVDNSLLNIKMRQVR-AEIMTAGQIRHRNIVPLLA 272
G +Y K+ +AIK+++ + + + A +M + + ++ LL
Sbjct: 29 GTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVM--ASVDNPHVCRLLG 84
Query: 273 HMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR 332
+ L+++ M G LL+ + + + + I G+ YL R
Sbjct: 85 -ICLTSTVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLE---DRR 137
Query: 333 IIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS 392
++HR++ +VL+ +I DFGLA+L+ + + ++A E ++
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 393 EKCDIYSFGVLL 404
+ D++S+GV +
Sbjct: 198 HQSDVWSYGVTV 209
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 39/161 (24%), Positives = 64/161 (39%), Gaps = 8/161 (4%)
Query: 253 RAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARH 312
+ E TAG+++ ++VP+ + + L +L QG
Sbjct: 82 QREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR--QGPLAPPRAVA- 138
Query: 313 RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTS 372
I R I S L+ H HR++ P ++L+ D A + DFG+A D
Sbjct: 139 -IVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLG 193
Query: 373 IVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
GT+ Y+APE + + DIY+ +L + G P
Sbjct: 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 63/308 (20%), Positives = 118/308 (38%), Gaps = 46/308 (14%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEI-MTAGQIRHRN 266
L +I A G + S G+++A+K+++ + + +Q+ ++ +
Sbjct: 27 LGEIGRGAYGSVNKMVHKPS-GQIMAVKRIRSTVDEK---EQKQLLMDLDVVMRSSDCPY 82
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDV---SQGRRELEWLARHRIARGIVSGLE 323
IV + R + E M + S + V E L + I V L
Sbjct: 83 IVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKALN 139
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAP 383
+L + IIHR+I PS++L+D ++ DFG++ + D A+ AG Y+AP
Sbjct: 140 HLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMAP 194
Query: 384 E----YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439
E + + D++S G+ L L G+ P + + S+ + V+ + P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFP------YPKWNSVFDQLTQVVKGDPP 248
Query: 440 NRAIDSKLLGNGYEEQMLLVLK--IACFCTLDDPEERPNSKDVRSMLSDTALIKDVDFLK 497
L N E + + C D +RP K+ +L F+
Sbjct: 249 Q-------LSNSEEREFSPSFINFVNL-CLTKDESKRPKYKE---LLKH-------PFIL 290
Query: 498 MHKRMDFD 505
M++ +
Sbjct: 291 MYEERAVE 298
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 15/154 (9%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
A++M + H +V L + +++E+M NG LL L + R +
Sbjct: 70 AKVM--MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLE 124
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
+ + + +EYL + +HR++ + L++D +++DFGL+R + D S
Sbjct: 125 MCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-- 179
Query: 374 VAGT---VGYIAPEYHQTLKFSEKCDIYSFGVLL 404
G+ V + PE KFS K DI++FGVL+
Sbjct: 180 --GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 56/195 (28%), Positives = 102/195 (52%), Gaps = 15/195 (7%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
LEK+ + G +Y A E+ G+++AIK+V + ++++ EI Q ++
Sbjct: 34 LEKLGEGSYGSVYKAIHKET-GQIVAIKQVP------VESDLQEIIKEISIMQQCDSPHV 86
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V + +V E+ GS+ +I+ ++ E + +A I + + GLEYLH
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE-DEIAT--ILQSTLKGLEYLH- 142
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
R IHR+I ++L++ + A++ADFG+A + D A+ +T I GT ++APE Q
Sbjct: 143 --FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI--GTPFWMAPEVIQ 198
Query: 388 TLKFSEKCDIYSFGV 402
+ ++ DI+S G+
Sbjct: 199 EIGYNCVADIWSLGI 213
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
A+ M ++ H +V + +V+E++ NG LL L + LE
Sbjct: 54 AQTM--MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLLE 108
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
+ + G+ +L + IHR++ + L+D D+ +++DFG+ R + D S
Sbjct: 109 MCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV-- 163
Query: 374 VAGT---VGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLP 413
GT V + APE K+S K D+++FG+L+ V +GK+P
Sbjct: 164 --GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 30/201 (14%)
Query: 217 GEIYIAELPESNGKMI--AIKKVKQVDNSLLNIKMRQVR-----AEIMTAGQIRHRNIVP 269
G +Y E + I AIK + + +M+QV +M + H N++
Sbjct: 35 GVVYHGEYIDQAQNRIQCAIKSLSR------ITEMQQVEAFLREGLLM--RGLNHPNVLA 86
Query: 270 LLAHMVRPDCHLL-VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY 328
L+ M+ P+ + +M +G LL+ + +R + G+EYL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLA-- 141
Query: 329 HRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI-----AP 383
+ +HR++ + ++D+ ++ADFGLAR + + S+ + A
Sbjct: 142 -EQKFVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTAL 197
Query: 384 EYHQTLKFSEKCDIYSFGVLL 404
E QT +F+ K D++SFGVLL
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLL 218
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 43/191 (22%), Positives = 85/191 (44%), Gaps = 13/191 (6%)
Query: 217 GEIYIAEL--PESNGKM-IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH 273
G ++ + K+ + IK ++ + + G + H +IV LL
Sbjct: 27 GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD-HMLAI--GSLDHAHIVRLLG- 82
Query: 274 MVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRI 333
+ LV++++ GSLL+ + +G + L I G+ YL +
Sbjct: 83 LCPGSSLQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLN--WGVQIAKGMYYLE---EHGM 136
Query: 334 IHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSE 393
+HRN+ +VL+ + ++ADFG+A L+P Q+ S + ++A E K++
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH 196
Query: 394 KCDIYSFGVLL 404
+ D++S+GV +
Sbjct: 197 QSDVWSYGVTV 207
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 191 IEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKM-IAIKKVKQVDNSLLNIKM 249
I +E L +K + + GE+++A N +A+K +K ++ +
Sbjct: 185 IPRESLKLEKK---------LGAGQFGEVWMATY---NKHTKVAVKTMKPG-----SMSV 227
Query: 250 RQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWL 309
AE ++H +V L A +V + +++EFM GSLL+ L S +
Sbjct: 228 EAFLAEANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLK--SDEGSKQPLP 284
Query: 310 ARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQV 369
+ I G+ ++ + IHR++ +++L+ + +IADFGLAR++ D
Sbjct: 285 KLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341
Query: 370 STSIVAGT---VGYIAPEYHQTLKFSEKCDIYSFGVLL 404
G + + APE F+ K D++SFG+LL
Sbjct: 342 RE----GAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 45/195 (23%), Positives = 80/195 (41%), Gaps = 23/195 (11%)
Query: 217 GEIYIAELPESNGKMI--AIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
G+++ + AIK K + + K Q A M Q H +IV L+ +
Sbjct: 29 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ-EALTM--RQFDHPHIVKLIG-V 84
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
+ + ++ E G L L + L+ + A + + L YL R +
Sbjct: 85 ITENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 335 HRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI-----APEYHQTL 389
HR+I +VL+ + ++ DFGL+R M D ++ + G + APE
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPESINFR 192
Query: 390 KFSEKCDIYSFGVLL 404
+F+ D++ FGV +
Sbjct: 193 RFTSASDVWMFGVCM 207
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 49/198 (24%), Positives = 85/198 (42%), Gaps = 24/198 (12%)
Query: 217 GEIYIAE---LPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH 273
G + + L ++ G ++A+K+++ R+ +I+ + IV
Sbjct: 37 GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE--IQIL--KALHSDFIVKYRGV 92
Query: 274 MVRPDCH--LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP 331
P LV E++ +G L + L R L+ + I G+EYL
Sbjct: 93 SYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLG---SR 146
Query: 332 RIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI-----APEYH 386
R +HR++ ++L++ + +IADFGLA+L+P V G APE
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY----YVVREPGQSPIFWYAPESL 202
Query: 387 QTLKFSEKCDIYSFGVLL 404
FS + D++SFGV+L
Sbjct: 203 SDNIFSRQSDVWSFGVVL 220
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 45/198 (22%), Positives = 85/198 (42%), Gaps = 15/198 (7%)
Query: 217 GEIYIAELPESNGKMI--AIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLA-- 272
G + A+L + +G + A+K +K + +I+ A M + H ++ L+
Sbjct: 37 GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK--EFDHPHVAKLVGVS 94
Query: 273 ----HMVRPDCHLLVSEFMKNGSLLEIL--NDVSQGRRELEWLARHRIARGIVSGLEYLH 326
R +++ FMK+G L L + + + L R I G+EYL
Sbjct: 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS 154
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
+ IHR++ + ++ +DM +ADFGL+R + G V ++A E
Sbjct: 155 SRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESL 211
Query: 387 QTLKFSEKCDIYSFGVLL 404
++ D+++FGV +
Sbjct: 212 ADNLYTVHSDVWAFGVTM 229
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 15/203 (7%)
Query: 227 SNGKMIAIKKV-KQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285
G+ A+K V S + ++ E ++H +IV LL +V E
Sbjct: 47 ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFE 106
Query: 286 FMKNGSLLE-ILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
FM L I+ G E +A H R I+ L Y H + IIHR++ P VL
Sbjct: 107 FMDGADLCFEIVKRADAGFVYSEAVASH-YMRQILEALRYCHDNN---IIHRDVKPHCVL 162
Query: 345 I---DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFG 401
+ ++ ++ FG+A + + GT ++APE + + + D++ G
Sbjct: 163 LASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCG 220
Query: 402 VLLAVLVMGKLPSDDFFQHTEEK 424
V+L +L+ G LP F T+E+
Sbjct: 221 VILFILLSGCLP----FYGTKER 239
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 6e-21
Identities = 54/320 (16%), Positives = 110/320 (34%), Gaps = 45/320 (14%)
Query: 217 GEIYIAELPESNGKMIAIKKVK--QVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
+ +A + G+ + ++++ N ++ ++ E+ + H NIVP A
Sbjct: 41 MTVNLA-RYKPTGEYVTVRRINLEACSNEMVTF----LQGELHVSKLFNHPNIVPYRATF 95
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
+ + +V+ FM GS +++ +A I +G++ L+Y+H +
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY--ILQGVLKALDYIH---HMGYV 150
Query: 335 HRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVST-----SIVAGTVGYIAPE-YHQT 388
HR++ S +LI D + ++ M + + +++PE Q
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN 210
Query: 389 LK-FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN----------VMTSE 437
L+ + K DIYS G+ L G +P F + L+ + + E
Sbjct: 211 LQGYDAKSDIYSVGITACELANGHVP---FKDMPATQMLLEKLNGTVPCLLDTSTIPAEE 267
Query: 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDVD--- 494
S + + + + P R S + L ++ D
Sbjct: 268 LTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE-QCLQRNPDARP 326
Query: 495 ---------FLKMHKRMDFD 505
F K KR +
Sbjct: 327 SASTLLNHSFFKQIKRRASE 346
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 6e-21
Identities = 42/195 (21%), Positives = 76/195 (38%), Gaps = 23/195 (11%)
Query: 217 GEIYIAELPESNGKMI--AIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
GE+Y G+ I A+K K+ K A IM + H +IV L+ +
Sbjct: 26 GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS-EAVIM--KNLDHPHIVKLIG-I 81
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
+ + ++ E G L L + + L+ L + I + YL +
Sbjct: 82 IEEEPTWIIMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYLE---SINCV 135
Query: 335 HRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI-----APEYHQTL 389
HR+I ++L+ ++ DFGL+R + D +V + +PE
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIED------EDYYKASVTRLPIKWMSPESINFR 189
Query: 390 KFSEKCDIYSFGVLL 404
+F+ D++ F V +
Sbjct: 190 RFTTASDVWMFAVCM 204
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 7e-21
Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 35/209 (16%)
Query: 230 KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-----RHRNIVPLLAHMVRPDCHLLVS 284
K++ + + L ++ R E I H +I+ L+ LV
Sbjct: 125 KIMEVTAERLSPEQLEEVREA-TRRET----HILRQVAGHPHIITLIDSYESSSFMFLVF 179
Query: 285 EFMKNGSLLEILNDVSQGR---RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
+ M+ G L + L + +E R I R ++ + +LH + I+HR++ P
Sbjct: 180 DLMRKGELFDYL--TEKVALSEKE----TRS-IMRSLLEAVSFLHANN---IVHRDLKPE 229
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE------YHQTLKFSEKC 395
++L+DD+M+ R++DFG + + G + GT GY+APE + ++
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEV 286
Query: 396 DIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
D+++ GV+L L+ G P F+ +
Sbjct: 287 DLWACGVILFTLLAGSPP---FWHRRQIL 312
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 57/193 (29%), Positives = 97/193 (50%), Gaps = 28/193 (14%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQ--VDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
G++ + + G +A+K +K + L A +M Q+RH N+V LL +
Sbjct: 35 GDVMLGDY---RGNKVAVKCIKNDATAQAFLA------EASVM--TQLRHSNLVQLLGVI 83
Query: 275 VRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRI 333
V L +V+E+M GSL++ L S+GR L + + + +EYL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 334 IHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGT--VGYIAPEYHQTLKF 391
+HR++ +VL+ +D A+++DFGL + + S++ G V + APE + KF
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 191
Query: 392 SEKCDIYSFGVLL 404
S K D++SFG+LL
Sbjct: 192 STKSDVWSFGILL 204
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 46/154 (29%), Positives = 81/154 (52%), Gaps = 15/154 (9%)
Query: 254 AEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR 313
A +M Q++H+ +V L A +V + +++E+M+NGSL++ L + +L
Sbjct: 59 ANLM--KQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLD 113
Query: 314 IARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI 373
+A I G+ ++ IHR++ +++L+ D + +IADFGLARL+ D
Sbjct: 114 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-- 168
Query: 374 VAGT---VGYIAPEYHQTLKFSEKCDIYSFGVLL 404
G + + APE F+ K D++SFG+LL
Sbjct: 169 --GAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 78/328 (23%), Positives = 142/328 (43%), Gaps = 68/328 (20%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKV---KQVDNSLLNIKMRQVRAEIMTAGQIRH 264
KI ++G + +A S G+ +A+K + KQ LL E++ +H
Sbjct: 50 YVKIGEGSTGIVCLAREKHS-GRQVAVKMMDLRKQQRRELL-------FNEVVIMRDYQH 101
Query: 265 RNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEY 324
N+V + + + ++ EF++ G+L +I VSQ R E +A + ++ L Y
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQVRLNEEQIAT--VCEAVLQALAY 156
Query: 325 LHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI-----VAGTVG 379
LH +IHR+I S+L+ D +++DFG AQ+S + + GT
Sbjct: 157 LH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFC-------AQISKDVPKRKSLVGTPY 206
Query: 380 YIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439
++APE ++ + DI+S G+++ +V G+ P + + + + M+ + S P
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP------YFSDSPV-QAMKRLRDSPPP 259
Query: 440 ---NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDVDFL 496
N S +L + E+ML+ DP+ER +++ +L FL
Sbjct: 260 KLKNSHKVSPVL-RDFLERMLVR----------DPQERATAQE---LLDH-------PFL 298
Query: 497 KMHKRMDFDNDDCVELIQQEIYTEWLSS 524
+ V LIQ Y + S+
Sbjct: 299 LQTG----LPECLVPLIQL--YRKQTST 320
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
EKI ASG +Y A + + G+ +AI+++ + + EI+ + ++ NI
Sbjct: 25 FEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIIN----EILVMRENKNPNI 79
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L + D +V E++ GSL ++ V++ + +A + R + LE+LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAA--VCRECLQALEFLH- 133
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI-----VAGTVGYIA 382
++IHR+I ++L+ D ++ DFG AQ++ + GT ++A
Sbjct: 134 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFC-------AQITPEQSKRSTMVGTPYWMA 184
Query: 383 PEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
PE + K DI+S G++ ++ G+ P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 14/195 (7%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
LEKI + GE++ + K++AIK +D ++ ++ EI Q +
Sbjct: 27 LEKIGKGSFGEVFKG-IDNRTQKVVAIK---IIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
++ ++ E++ GS L++L G + +A I R I+ GL+YLH
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIAT--ILREILKGLDYLH- 136
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
+ IHR+I ++VL+ + E ++ADFG+A + D + +T + GT ++APE +
Sbjct: 137 --SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIK 192
Query: 388 TLKFSEKCDIYSFGV 402
+ K DI+S G+
Sbjct: 193 QSAYDSKADIWSLGI 207
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 54/241 (22%), Positives = 82/241 (34%), Gaps = 49/241 (20%)
Query: 227 SNGKMIAIKKV-KQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285
+ AIK + K + + +++ E+ ++ H NI L LV E
Sbjct: 49 QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVME 108
Query: 286 FMKNGSLLEILNDVSQGRRELEWLARH--------------------------------- 312
G LL+ LN +
Sbjct: 109 LCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREK 168
Query: 313 ---RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEAR--IADFGLARLMPDGHA 367
I R I S L YLH I HR+I P + L + + DFGL++ +
Sbjct: 169 LISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225
Query: 368 --QVSTSIVAGTVGYIAPE--YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEE 423
+ AGT ++APE + KCD +S GVLL +L+MG +P F +
Sbjct: 226 GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP---FPGVNDA 282
Query: 424 K 424
Sbjct: 283 D 283
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 46/212 (21%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEI-MTAGQIRHRN 266
L ++ S G+++ ++ G +IA+K Q+ S + +++ ++ +
Sbjct: 30 LGEMGSGTCGQVWKMRFRKT-GHVIAVK---QMRRSGNKEENKRILMDLDVVLKSHDCPY 85
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
IV + + E M ++ + E L + + IV L YL
Sbjct: 86 IVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPE-RILGK--MTVAIVKALYYLK 141
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE-- 384
H +IHR++ PS++L+D+ + ++ DFG++ + D A+ + AG Y+APE
Sbjct: 142 EKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS---AGCAAYMAPERI 196
Query: 385 ---YHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
+ + D++S G+ L L G+ P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 36/200 (18%)
Query: 229 GKMIAIK---KVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285
+++A+K + +D V+ EI+ +RH NIV ++ P ++ E
Sbjct: 45 KELVAVKYIERGAAID--------ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96
Query: 286 FMKNGSLLEILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
+ G L E + + GR E E AR + ++SG+ Y H +I HR++ + L
Sbjct: 97 YASGGELYERI--CNAGRFSEDE--AR-FFFQQLLSGVSYCH---SMQICHRDLKLENTL 148
Query: 345 IDDDMEAR--IADFGLARLMPDGHAQVSTSIVAGTVGYIAPE------YHQTLKFSEKCD 396
+D R I DFG ++ Q +++ GT YIAPE Y + D
Sbjct: 149 LDGSPAPRLKICDFGYSKSSVLHS-QPKSTV--GTPAYIAPEVLLRQEYD-----GKIAD 200
Query: 397 IYSFGVLLAVLVMGKLPSDD 416
++S GV L V+++G P +D
Sbjct: 201 VWSCGVTLYVMLVGAYPFED 220
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 215 ASGEIYIAELPESNG----KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPL 270
+ GE+ IA + K I V+ VD + + EI + H NI+ L
Sbjct: 21 SWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD---------RFKQEIEIMKSLDHPNIIRL 71
Query: 271 LAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYH 329
LV E G L E + V + RE + A I + ++S + Y H +
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERV--VHKRVFRESD--AAR-IMKDVLSAVAYCHKLN 126
Query: 330 RPRIIHRNITPSSVLI---DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
+ HR++ P + L D ++ DFGLA G GT Y++P+
Sbjct: 127 ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQVL 180
Query: 387 QTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
+ + +CD +S GV++ VL+ G P F T+ +
Sbjct: 181 EG-LYGPECDEWSAGVMMYVLLCGYPP---FSAPTDSE 214
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 5e-20
Identities = 45/195 (23%), Positives = 80/195 (41%), Gaps = 23/195 (11%)
Query: 217 GEIYIAELPESNGKMI--AIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
G+++ + AIK K + + K Q A M Q H +IV L+ +
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ-EALTM--RQFDHPHIVKLIG-V 459
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
+ + ++ E G L L + L+ + A + + L YL R +
Sbjct: 460 ITENPVWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 335 HRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI-----APEYHQTL 389
HR+I +VL+ + ++ DFGL+R M D ++ + G + APE
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPESINFR 567
Query: 390 KFSEKCDIYSFGVLL 404
+F+ D++ FGV +
Sbjct: 568 RFTSASDVWMFGVCM 582
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 5e-20
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 230 KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKN 289
K+I KK+ D +++ E +++H NIV L + H LV + +
Sbjct: 37 KIINTKKLSARD-------FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89
Query: 290 GSLLEILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI--- 345
G L E + V++ E + A H + I+ + Y H I+HRN+ P ++L+
Sbjct: 90 GELFEDI--VAREFYSEAD--ASH-CIQQILESIAYCH---SNGIVHRNLKPENLLLASK 141
Query: 346 DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLA 405
++ADFGLA + D A AGT GY++PE + +S+ DI++ GV+L
Sbjct: 142 AKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILY 198
Query: 406 VLVMGKLPSDDFFQHTEEK 424
+L++G P F+ + +
Sbjct: 199 ILLVGYPP---FWDEDQHR 214
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-20
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 20/213 (9%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
A GE+ + + AIK +++ S+ ++ E+ + H NI+ L
Sbjct: 49 AYGEVLLCRD-KVTHVERAIKIIRK--TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF 105
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
+ LV E K G L + + + + + E A I + ++SG+ YLH ++ I+
Sbjct: 106 EDKRNYYLVMECYKGGELFDEI--IHRMKFN-EVDAAV-IIKQVLSGVTYLHKHN---IV 158
Query: 335 HRNITPSSVLI---DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKF 391
HR++ P ++L+ + D +I DFGL+ + + GT YIAPE + K+
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE---RLGTAYYIAPEVLRK-KY 214
Query: 392 SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
EKCD++S GV+L +L+ G P F T+++
Sbjct: 215 DEKCDVWSIGVILFILLAGYPP---FGGQTDQE 244
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 7e-20
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
+ GE+ + + A+K + + S N + E+ ++ H NI+ L +
Sbjct: 34 SFGEVLKCKD-RITQQEYAVKVINK--ASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
+V E G L + + + + R E A I + + SG+ Y+H ++ I+
Sbjct: 91 EDSSSFYIVGELYTGGELFDEI--IKRKRFS-EHDAAR-IIKQVFSGITYMHKHN---IV 143
Query: 335 HRNITPSSVLI---DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE-YHQTLK 390
HR++ P ++L+ + D + +I DFGL+ + GT YIAPE
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIAPEVLRG--T 198
Query: 391 FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
+ EKCD++S GV+L +L+ G P F+ E
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP---FYGKNEYD 229
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 45/208 (21%), Positives = 86/208 (41%), Gaps = 32/208 (15%)
Query: 217 GEIYIAELPESNGK----MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLA 272
G++++AE + ++A+K +K+ S R+ AE++ ++H++IV
Sbjct: 55 GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQRE--AELL--TMLQHQHIVRFFG 110
Query: 273 HMVRPDCHLLVSEFMKNGSLLEIL-----------NDVSQGRRELEWLARHRIARGIVSG 321
L+V E+M++G L L L +A + +G
Sbjct: 111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAG 170
Query: 322 LEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI 381
+ YL H +HR++ + L+ + +I DFG++R + G +
Sbjct: 171 MVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-----YRVGGRTML 222
Query: 382 -----APEYHQTLKFSEKCDIYSFGVLL 404
PE KF+ + D++SFGV+L
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVL 250
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 31/222 (13%)
Query: 217 GEIYIAELPESNGKMIAIKKVK---------QVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
GE+ + + ++ AIK +K DN + ++ EI + H NI
Sbjct: 50 GEVLLCK-EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNI 108
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+ L LV+EF + G L E + +++ + + E A + I + I+SG+ YLH
Sbjct: 109 IKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFD-ECDAAN-IMKQILSGICYLHK 164
Query: 328 YHRPRIIHRNITPSSVLI---DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE 384
++ I+HR+I P ++L+ + + +I DFGL+ + GT YIAPE
Sbjct: 165 HN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRL-GTAYYIAPE 218
Query: 385 YHQTLK--FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
LK ++EKCD++S GV++ +L+ G P F ++
Sbjct: 219 ---VLKKKYNEKCDVWSCGVIMYILLCGYPP---FGGQNDQD 254
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 33/209 (15%)
Query: 217 GEIYIAEL----PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLA 272
G++++AE P + ++A+K +K + R+ AE++T ++H +IV
Sbjct: 29 GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQRE--AELLT--NLQHEHIVKFYG 84
Query: 273 HMVRPDCHLLVSEFMKNGSLLEIL------------NDVSQGRRELEWLARHRIARGIVS 320
D ++V E+MK+G L + L Q + EL IA I S
Sbjct: 85 VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIAS 144
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
G+ YL H +HR++ + L+ ++ +I DFG++R + G
Sbjct: 145 GMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY-----YRVGGHTM 196
Query: 381 I-----APEYHQTLKFSEKCDIYSFGVLL 404
+ PE KF+ + D++SFGV+L
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVIL 225
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 230 KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKN 289
K+I+ ++VKQ + + E+ Q+ H NI+ L LV E
Sbjct: 57 KVISKRQVKQKTD------KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110
Query: 290 GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI---D 346
G L + + +S+ R E A I R ++SG+ Y+H I+HR++ P ++L+
Sbjct: 111 GELFDEI--ISRKRFS-EVDAAR-IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKS 163
Query: 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAV 406
D RI DFGL+ GT YIAPE + EKCD++S GV+L +
Sbjct: 164 KDANIRIIDFGLSTHFEASKKMKD---KIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYI 219
Query: 407 LVMGKLPSDDFFQHTEEK 424
L+ G P F E
Sbjct: 220 LLSGCPP---FNGANEYD 234
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 2e-19
Identities = 48/206 (23%), Positives = 80/206 (38%), Gaps = 27/206 (13%)
Query: 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVP 269
++ RA+G + A K + + VR EI T +RH +V
Sbjct: 175 RVTERATGNNFAA-------KFVMTPHESDKET---------VRKEIQTMSVLRHPTLVN 218
Query: 270 LLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH 329
L + +++ EFM G L E + D E E A R + GL ++H +
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE--AVE-YMRQVCKGLCHMHENN 275
Query: 330 RPRIIHRNITPSSVLIDDDMEARI--ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
+H ++ P +++ + DFGL + S + GT + APE +
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAE 329
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLP 413
D++S GVL +L+ G P
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 41/198 (20%), Positives = 79/198 (39%), Gaps = 16/198 (8%)
Query: 217 GEIYIAEL----PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLA 272
G +Y + +AIK V + + I+ A +M + ++V LL
Sbjct: 39 GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASVMK--EFNCHHVVRLLG 95
Query: 273 HMVRPDCHLLVSEFMKNGSLLEIL------NDVSQGRRELEWLARHRIARGIVSGLEYLH 326
+ + L++ E M G L L + ++A I G+ YL+
Sbjct: 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN 155
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
+HR++ + ++ +D +I DFG+ R + + V +++PE
Sbjct: 156 ANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 212
Query: 387 QTLKFSEKCDIYSFGVLL 404
+ F+ D++SFGV+L
Sbjct: 213 KDGVFTTYSDVWSFGVVL 230
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 33/218 (15%)
Query: 212 RSRASGEIYIAELPESNGKMIAIK--KVKQVDNSLLNIKMRQV---RAEIMTAGQIRHRN 266
R A+ Y AIK + + + IK +V E ++ H
Sbjct: 50 RELATSREY------------AIKILEKRHI------IKENKVPYVTRERDVMSRLDHPF 91
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
V L + + KNG LL+ + + E R A IVS LEYLH
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAE-IVSALEYLH 147
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
IIHR++ P ++L+++DM +I DFG A+++ Q + GT Y++PE
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204
Query: 387 QTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
+ D+++ G ++ LV G P F E
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPP---FRAGNEYL 239
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 31/218 (14%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLA----HMVRPDCHL 281
G+ A+K + + R E+ Q +IV +L C L
Sbjct: 52 RTGQKCALKLLY---------DSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102
Query: 282 LVSEFMKNGSLLE-ILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITP 340
++ E M+ G L I Q E E A I R I + +++LH ++ I HR++ P
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTERE--AAE-IMRDIGTAIQFLHSHN---IAHRDVKP 156
Query: 341 SSVLI---DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDI 397
++L + D ++ DFG A+ + T T Y+APE K+ + CD+
Sbjct: 157 ENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQT--PCYTPYYVAPEVLGPEKYDKSCDM 212
Query: 398 YSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435
+S GV++ +L+ G P F+ +T + R +
Sbjct: 213 WSLGVIMYILLCGFPP---FYSNTGQAISPGMKRRIRL 247
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 237 VKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCHLLVSEFMKNGSLLE- 294
VK ++ +I+ R V E+ Q + HRN++ L+ D LV E M+ GS+L
Sbjct: 43 VKIIEKQPGHIRSR-VFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSH 101
Query: 295 ILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI---DDDME 350
I + ELE A + + + S L++L H I HR++ P ++L +
Sbjct: 102 I---HKRRHFNELE--AS-VVVQDVASALDFL---HNKGIAHRDLKPENILCEHPNQVSP 152
Query: 351 ARIADFGLARLMPDGHAQVSTSI-----VAGTVGYIAPE-----YHQTLKFSEKCDIYSF 400
+I DF L + S G+ Y+APE + + ++CD++S
Sbjct: 153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL 212
Query: 401 GVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438
GV+L +L+ G P F +N
Sbjct: 213 GVILYILLSGYPP---FVGRCGSDCGWDRGEACPACQN 247
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 47/206 (22%), Positives = 90/206 (43%), Gaps = 31/206 (15%)
Query: 217 GEIYIAELPESNGKM-IAIKKVKQVDNSLLNIKMRQVR-AEIMTAGQI-RHRNIVPLLAH 273
G++ A + + +M AIK++K + + + E++ ++ H NI+ LL
Sbjct: 39 GQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVL--CKLGHHPNIINLLGA 94
Query: 274 MVRPDCHLLVSEFMKNGSLLEIL------------NDVSQGRRELEWLARHRIARGIVSG 321
L E+ +G+LL+ L + L A + G
Sbjct: 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 154
Query: 322 LEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI 381
++YL + + IHR++ ++L+ ++ A+IADFGL+R V ++ V ++
Sbjct: 155 MDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWM 208
Query: 382 APE---YHQTLKFSEKCDIYSFGVLL 404
A E Y ++ D++S+GVLL
Sbjct: 209 AIESLNYS---VYTTNSDVWSYGVLL 231
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 230 KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKN 289
K+I KK+ D +++ E +++H NIV L + H LV + +
Sbjct: 60 KIINTKKLSARD-------FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 112
Query: 290 GSLLEILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI--- 345
G L E + V++ E + A H + I+ + Y H I+HRN+ P ++L+
Sbjct: 113 GELFEDI--VAREFYSEAD--ASH-CIQQILESIAYCH---SNGIVHRNLKPENLLLASK 164
Query: 346 DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLA 405
++ADFGLA + D A AGT GY++PE + +S+ DI++ GV+L
Sbjct: 165 AKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILY 221
Query: 406 VLVMGKLPSDDFFQHTEEK 424
+L++G P F+ + +
Sbjct: 222 ILLVGYPP---FWDEDQHR 237
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+ ++ A G++Y A + G + A K ++ ++ EI H I
Sbjct: 24 VGELGDGAFGKVYKA-KNKETGALAAAKVIETKSEE----ELEDYIVEIEILATCDHPYI 78
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V LL ++ EF G++ I+ ++ +G E + + R ++ L +LH
Sbjct: 79 VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQV--VCRQMLEALNFLH- 134
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE--- 384
RIIHR++ +VL+ + + R+ADFG++ + + I GT ++APE
Sbjct: 135 --SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVM 190
Query: 385 --YHQTLKFSEKCDIYSFGV 402
+ + K DI+S G+
Sbjct: 191 CETMKDTPYDYKADIWSLGI 210
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286
+ A+K + + S N + E+ ++ H NI+ L + +V E
Sbjct: 45 ITQQEYAVKVINK--ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102
Query: 287 MKNGSLLE-ILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
G L + I + + R E + A I + + SG+ Y+H ++ I+HR++ P ++L
Sbjct: 103 YTGGELFDEI---IKRKRFSEHD--AAR-IIKQVFSGITYMHKHN---IVHRDLKPENIL 153
Query: 345 I---DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFG 401
+ + D + +I DFGL+ + GT YIAPE + + EKCD++S G
Sbjct: 154 LESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIAPEVLRG-TYDEKCDVWSAG 209
Query: 402 VLLAVLVMGKLPSDDFFQHTEEK 424
V+L +L+ G P F+ E
Sbjct: 210 VILYILLSGTPP---FYGKNEYD 229
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286
GK+ A+K +K+ + + EI +I+H NIV L + LV +
Sbjct: 32 LTGKLFALKCIKK--SPAFRDSS--LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87
Query: 287 MKNGSLLE-ILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
+ G L + I + +G E + A + + ++S ++YLH I+HR++ P ++L
Sbjct: 88 VSGGELFDRI---LERGVYTEKD--ASL-VIQQVLSAVKYLHENG---IVHRDLKPENLL 138
Query: 345 I---DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFG 401
+++ + I DFGL+++ +G S GT GY+APE +S+ D +S G
Sbjct: 139 YLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIG 194
Query: 402 VLLAVLVMGKLPSDDFFQHTEEK 424
V+ +L+ G P F++ TE K
Sbjct: 195 VITYILLCGYPP---FYEETESK 214
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 7e-19
Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQ----VRAEIMTAGQIRHRNIVPLLA 272
GE++ ++ + GK+ A KK+ + +K R+ E ++ R IV L
Sbjct: 199 GEVFACQMKAT-GKLYACKKLNKKR-----LKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 273 HMVRPDCHL-LVSEFMKNGSL-LEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHR 330
L LV M G + I N E A A+ IVSGLE+LH +
Sbjct: 253 AFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLH---Q 307
Query: 331 PRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK 390
II+R++ P +VL+DDD RI+D GLA + G + AGT G++APE +
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMAPELLLGEE 365
Query: 391 FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437
+ D ++ GV L ++ + P F E+ + V+
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGP---FRARGEKVENKELKQRVLEQA 409
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 8e-19
Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 21/225 (9%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI----RHRNIVPLLA 272
GE+ ++ + GKM A KK+++ IK R+ A + QI R +V L
Sbjct: 198 GEVCACQVRAT-GKMYACKKLEKKR-----IKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 273 HMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR 332
D LV M G L + + Q E A A I GLE LH R R
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAE-ICCGLEDLH---RER 306
Query: 333 IIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS 392
I++R++ P ++L+DD RI+D GLA +P+G + GTVGY+APE + +++
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYT 363
Query: 393 EKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437
D ++ G LL ++ G+ P F Q ++ R V
Sbjct: 364 FSPDWWALGCLLYEMIAGQSP---FQQRKKKIKREEVERLVKEVP 405
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 22/194 (11%)
Query: 237 VKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLE-I 295
VK + + +++ + + H NIV L LV E + G L E I
Sbjct: 41 VKIISKRMEANTQKEI--TALKLCE-GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI 97
Query: 296 LNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI---DDDMEA 351
+ E E A + I R +VS + ++H ++HR++ P ++L +D++E
Sbjct: 98 ---KKKKHFSETE--ASY-IMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEI 148
Query: 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGK 411
+I DFG ARL P + + T T+ Y APE + E CD++S GV+L ++ G+
Sbjct: 149 KIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206
Query: 412 LPSDDFFQHTEEKS 425
+P F H +
Sbjct: 207 VP---FQSHDRSLT 217
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 49/210 (23%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 217 GEIYIAEL----PESNGKMIAIKKVKQVDNSLLNIKMRQVR-AEIMTAGQIRHRNIVPLL 271
G++Y L P + +AIK +K D + ++ A + +++H N+V LL
Sbjct: 23 GKVYKGHLFGPAPGEQTQAVAIKTLK--DKAEGPLREEFRHEAMLR--ARLQHPNVVCLL 78
Query: 272 AHMVRPDCHLLVSEFMKNGSLLEIL------------NDVSQGRRELEWLARHRIARGIV 319
+ + ++ + +G L E L +D + LE + I
Sbjct: 79 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIA 138
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVG 379
+G+EYL +H ++H+++ +VL+ D + +I+D GL R + +
Sbjct: 139 AGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYA-----ADYYKLLGNS 190
Query: 380 YI-----APEYHQTLKFSEKCDIYSFGVLL 404
+ APE KFS DI+S+GV+L
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVL 220
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 42/206 (20%), Positives = 80/206 (38%), Gaps = 27/206 (13%)
Query: 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVP 269
+ +A+G +++A K I V+ EI Q+ H ++
Sbjct: 69 RCVEKATGRVFVA-------KFINTPYPLDKYT---------VKNEISIMNQLHHPKLIN 112
Query: 270 LLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH 329
L +L+ EF+ G L + + ++ + E + R GL+++H +
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVIN-YMRQACEGLKHMHEHS 169
Query: 330 RPRIIHRNITPSSVLIDDDMEARI--ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
I+H +I P +++ + + + DFGLA + + T + APE
Sbjct: 170 ---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVD 223
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLP 413
D+++ GVL VL+ G P
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 49/204 (24%), Positives = 80/204 (39%), Gaps = 28/204 (13%)
Query: 217 GEIYIAELPESNGK----MIAIKKVKQVDNSLLNIKMRQVR-AEIMTAGQIRHRNIVPLL 271
GE+Y ++ +A+K + + ++ + A I+ + H+NIV +
Sbjct: 85 GEVYEGQVSGMPNDPSPLQVAVKTLP--EVCSEQDELDFLMEALII--SKFNHQNIVRCI 140
Query: 272 AHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR---IARGIVSGLEYLHMY 328
++ ++ E M G L L + + LA +AR I G +YL
Sbjct: 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 200
Query: 329 HRPRIIHRNITPSSVLID---DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI---- 381
H IHR+I + L+ A+I DFG+AR + G +
Sbjct: 201 H---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-----YRKGGCAMLPVKW 252
Query: 382 -APEYHQTLKFSEKCDIYSFGVLL 404
PE F+ K D +SFGVLL
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLL 276
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 16/198 (8%)
Query: 217 GEIYIAELPESNGK----MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLA 272
GE+Y ++ +A+K + +V + + A I+ + H+NIV +
Sbjct: 44 GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM-EALII--SKFNHQNIVRCIG 100
Query: 273 HMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHR---IARGIVSGLEYLHMYH 329
++ ++ E M G L L + + LA +AR I G +YL H
Sbjct: 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 160
Query: 330 RPRIIHRNITPSSVLID---DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
IHR+I + L+ A+I DFG+AR + V ++ PE
Sbjct: 161 ---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 217
Query: 387 QTLKFSEKCDIYSFGVLL 404
F+ K D +SFGVLL
Sbjct: 218 MEGIFTSKTDTWSFGVLL 235
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 55/195 (28%), Positives = 88/195 (45%), Gaps = 28/195 (14%)
Query: 237 VKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLE-I 295
VK +D S + ++ EI+ +H NI+ L +V+E MK G LL+ I
Sbjct: 52 VKIIDKSKRDPT-EEI--EILLR-YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI 107
Query: 296 LNDVSQGR---RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA- 351
+ Q RE A + I +EYLH ++HR++ PS++L D+
Sbjct: 108 ---LRQKFFSERE----ASA-VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNP 156
Query: 352 ---RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLV 408
RI DFG A+ + + + T T ++APE + + CDI+S GVLL ++
Sbjct: 157 ESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTML 214
Query: 409 MGKLPSDDFFQHTEE 423
G P F ++
Sbjct: 215 TGYTP---FANGPDD 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 22/200 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L +I + G +Y A N +++AIKK+ N K + + E+ ++RH N
Sbjct: 59 LREIGHGSFGAVYFA-RDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRHPNT 116
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+ +R LV E+ GS ++L + +E +A + G + GL YLH
Sbjct: 117 IQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQE-VEIAA--VTHGALQGLAYLH- 171
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS--TSIVAGTVGYIAPE- 384
+IHR++ ++L+ + ++ DFG A + ++ S V GT ++APE
Sbjct: 172 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSFV-GTPYWMAPEV 221
Query: 385 --YHQTLKFSEKCDIYSFGV 402
++ K D++S G+
Sbjct: 222 ILAMDEGQYDGKVDVWSLGI 241
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEI-MTAGQIRHRN 266
+E + + G++Y G++ AIK + + IK EI M HRN
Sbjct: 29 VELVGNGTYGQVYKG-RHVKTGQLAAIKVMDVTGDEEEEIK-----QEINMLKKYSHHRN 82
Query: 267 IVP-----LLAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVS 320
I + + D L LV EF GS+ +++ + + EW+A I R I+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILR 140
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
GL +LH + ++IHR+I +VL+ ++ E ++ DFG++ + + +T I GT +
Sbjct: 141 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYW 195
Query: 381 IAPEYHQTLKFSE-----KCDIYSFGV 402
+APE + + K D++S G+
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGI 222
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 47/206 (22%), Positives = 84/206 (40%), Gaps = 27/206 (13%)
Query: 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVP 269
K A+G A K+I + +K + V+ EI Q+ H N++
Sbjct: 107 KCEETATGLKLAA-------KIIKTRGMKDKEE---------VKNEISVMNQLDHANLIQ 150
Query: 270 LLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH 329
L + +LV E++ G L + + + + E + I G+ ++ H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRI--IDESYNLTELDTI-LFMKQICEGIRHM---H 204
Query: 330 RPRIIHRNITPSSVLIDDDMEARI--ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
+ I+H ++ P ++L + +I DFGLAR + GT ++APE
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPEFLAPEVVN 261
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLP 413
S D++S GV+ +L+ G P
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 18/194 (9%)
Query: 227 SNGKMIAIK--KVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284
S G A K K +Q S + ++ E+ Q+ H N++ L +L+
Sbjct: 35 STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLIL 94
Query: 285 EFMKNGSLLEILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSV 343
E + G L + L + E E A + I+ G+ YLH I H ++ P ++
Sbjct: 95 ELVSGGELFDFL--AQKESLSEEE--ATS-FIKQILDGVNYLHTKK---IAHFDLKPENI 146
Query: 344 LI----DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYS 399
++ ++ DFGLA + DG + GT ++APE + D++S
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWS 203
Query: 400 FGVLLAVLVMGKLP 413
GV+ +L+ G P
Sbjct: 204 IGVITYILLSGASP 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 48/209 (22%), Positives = 86/209 (41%), Gaps = 26/209 (12%)
Query: 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVP 269
K R +++G Y A K I ++ + + ++ E+ Q+ H NI+
Sbjct: 30 KCREKSTGLEYAA-------KFIKKRQSRASRRG---VCREEIEREVSILRQVLHPNIIT 79
Query: 270 LLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMY 328
L +L+ E + G L + L + E E A + I+ G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEE--ATS-FIKQILDGVNYLHTK 134
Query: 329 HRPRIIHRNITPSSVLI----DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE 384
I H ++ P ++++ ++ DFGLA + DG + GT ++APE
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPE 188
Query: 385 YHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
+ D++S GV+ +L+ G P
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 45/204 (22%), Positives = 86/204 (42%), Gaps = 26/204 (12%)
Query: 212 RSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLL 271
R + +G+ Y A K I +++ + ++ E+ +IRH NI+ L
Sbjct: 25 RQKGTGKEYAA-------KFIKKRRLSSSRRG---VSREEIEREVNILREIRHPNIITLH 74
Query: 272 AHMVRPDCHLLVSEFMKNGSLLEILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHR 330
+L+ E + G L + L + E E A + I+ G+ YLH
Sbjct: 75 DIFENKTDVVLILELVSGGELFDFL--AEKESLTEDE--ATQ-FLKQILDGVHYLHSKR- 128
Query: 331 PRIIHRNITPSSVLI----DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
I H ++ P ++++ + ++ DFG+A + G+ + GT ++APE
Sbjct: 129 --IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIV 183
Query: 387 QTLKFSEKCDIYSFGVLLAVLVMG 410
+ D++S GV+ +L+ G
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSG 207
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 39/229 (17%), Positives = 83/229 (36%), Gaps = 40/229 (17%)
Query: 191 IEKEDLAFLEKEDCSASLEKIRSRASGEIYIAEL------PESNGKMIAIKKVKQVDNSL 244
I EDL F E + +I+ + + + +K + + +
Sbjct: 5 IRNEDLIFNES---------LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY 55
Query: 245 LNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRR 304
A +M ++ H+++V V D ++LV EF+K GSL L +
Sbjct: 56 SESFFEA--ASMM--SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKN 108
Query: 305 ELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI--------TPSSVLIDDDMEARIADF 356
+ L + +A+ + + + +L +IH N+ + +++D
Sbjct: 109 CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165
Query: 357 GLARLMPDGHAQVSTSIVAGTVGYIAPE-YHQTLKFSEKCDIYSFGVLL 404
G++ + + I+ + ++ PE + D +SFG L
Sbjct: 166 GISITV------LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTL 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 33/216 (15%)
Query: 214 RASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAH 273
+G+ Y A +I KK+ D+ ++ E ++H NIV L
Sbjct: 33 VLAGQEYAA-------MIINTKKLSARDHQ-------KLEREARICRLLKHPNIVRLHDS 78
Query: 274 MVRPDCHLLVSEFMKNGSLLE-ILNDVSQGR-RELEWLARHRIARGIVSGLEYLHMYHRP 331
+ H L+ + + G L E I V++ E + A H + I+ + + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDI---VAREYYSEAD--ASH-CIQQILEAVLHCHQMG-- 130
Query: 332 RIIHRNITPSSVLI---DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT 388
++HRN+ P ++L+ ++ADFGLA + AGT GY++PE +
Sbjct: 131 -VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRK 187
Query: 389 LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
+ + D+++ GV+L +L++G P F+ + +
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPP---FWDEDQHR 220
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276
+Y + + K A+K +K+ + + VR EI ++ H NI+ L
Sbjct: 67 SIVYRCK-QKGTQKPYALKVLKK------TVDKKIVRTEIGVLLRLSHPNIIKLKEIFET 119
Query: 277 PDCHLLVSEFMKNGSLLE-ILNDVSQGR---RELEWLARHRIARGIVSGLEYLHMYHRPR 332
P LV E + G L + I V +G R+ A + I+ + YLH
Sbjct: 120 PTEISLVLELVTGGELFDRI---VEKGYYSERD----AAD-AVKQILEAVAYLHENG--- 168
Query: 333 IIHRNITPSSVLI---DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL 389
I+HR++ P ++L D +IADFGL++++ V GT GY APE +
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGC 225
Query: 390 KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSL 426
+ + D++S G++ +L+ G P F+ ++ +
Sbjct: 226 AYGPEVDMWSVGIITYILLCGFEP---FYDERGDQFM 259
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 2e-17
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 29/229 (12%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-------RHRNIVP 269
GE+Y + GKM A+K + + IKM+Q + + IV
Sbjct: 203 GEVYGCRKAD-TGKMYAMKCLDKKR-----IKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 270 LLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH 329
+ PD + + M G L L SQ E R A I+ GLE++H
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAE-IILGLEHMH--- 309
Query: 330 RPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE-YHQT 388
+++R++ P+++L+D+ RI+D GLA GT GY+APE +
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKG 365
Query: 389 LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437
+ + D +S G +L L+ G P F+ + K R +T
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTLTMA 410
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L+ I S A G + A + +AIKK+ + + + K R R E++ + H+NI
Sbjct: 67 LKPIGSGAQGIVCAA-YDAVLDRNVAIKKLSRPFQNQTHAK-RAYR-ELVLMKCVNHKNI 123
Query: 268 VPLLAHMVRPDCHL-------LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVS 320
+ LL ++ P L LV E M L V + EL+ + ++
Sbjct: 124 ISLL-NVFTPQKTLEEFQDVYLVMELMDAN-----LCQVI--QMELDHERMSYLLYQMLC 175
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
G+++LH IIHR++ PS++++ D +I DFGLAR T V T Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVV-TRYY 229
Query: 381 IAPEYHQTLKFSEKCDIYSFGVLLAVLVMGK 411
APE + + E DI+S G ++ +V K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 45/207 (21%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 217 GEIYIAE---LPESNGKM-IAIKKVKQVDNSLLNIKMRQVR-AEIMTAGQI-RHRNIVPL 270
G++ A L + + + +A+K +K + + K + +IM+ + +H NIV L
Sbjct: 60 GKVVEATAFGLGKEDAVLKVAVKMLK--STAHADEKEALMSELKIMS--HLGQHENIVNL 115
Query: 271 LAHMVRPDCHLLVSEFMKNGSLLEIL----------NDVSQGRRELEWLARHRIARGIVS 320
L L+++E+ G LL L + + +
Sbjct: 116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQ 175
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
G+ +L IHR++ +VL+ + A+I DFGLAR + + + V +
Sbjct: 176 GMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 232
Query: 381 IAPE---YHQTLKFSEKCDIYSFGVLL 404
+APE ++ + D++S+G+LL
Sbjct: 233 MAPESIFDC---VYTVQSDVWSYGILL 256
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 42/275 (15%), Positives = 92/275 (33%), Gaps = 52/275 (18%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286
+G + AIK+ K+ ++ + +R A +H ++V + D L+ +E+
Sbjct: 34 LDGCIYAIKRSKKPLAGSVDEQ-NALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY 92
Query: 287 MKNGSLLEILNDVSQGRREL-EWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345
GSL + +++ + E + + + GL Y+H ++H +I PS++ I
Sbjct: 93 CNGGSLADAISENYRIMSYFKEAELK-DLLLQVGRGLRYIH---SMSLVHMDIKPSNIFI 148
Query: 346 DDD-------------------MEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE-Y 385
+ +I D G + + G ++A E
Sbjct: 149 SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE------GDSRFLANEVL 202
Query: 386 HQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS 445
+ K DI++ + + + + + P
Sbjct: 203 QENYTHLPKADIFALALTVVCAAGAEPL---PRNGDQ-------WHEIRQGRLPR----- 247
Query: 446 KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
+ ++ +LK DPE RP++ +
Sbjct: 248 --IPQVLSQEFTELLK-VMIHP--DPERRPSAMAL 277
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 48/204 (23%), Positives = 82/204 (40%), Gaps = 28/204 (13%)
Query: 212 RSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLL 271
+S + Y+A K + +K QV V+ EI RHRNI+ L
Sbjct: 25 VETSSKKTYMA-------KFVKVKGTDQVL----------VKKEISILNIARHRNILHLH 67
Query: 272 AHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP 331
+ +++ EF+ + E + + E + L++LH ++
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVS-YVHQVCEALQFLHSHN-- 122
Query: 332 RIIHRNITPSSVLIDDDMEA--RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL 389
I H +I P +++ + +I +FG AR + G ++ Y APE HQ
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHD 178
Query: 390 KFSEKCDIYSFGVLLAVLVMGKLP 413
S D++S G L+ VL+ G P
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP 202
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 43/216 (19%)
Query: 217 GEIYIAELPESNGK------MIAIKKVKQVDNSLLNIKMRQVR-AEIMTAGQI-RHRNIV 268
G++ +AE + +A+K +K D++ V E+M I +H+NI+
Sbjct: 49 GQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMK--MIGKHKNII 104
Query: 269 PLLAHMVRPDCHLLVSEFMKNGSLLEIL------------NDVSQGRRELEWLARHRIAR 316
LL + ++ E+ G+L E L + ++ +
Sbjct: 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164
Query: 317 GIVSGLEYLHMYHRPRIIH-----RNITPSSVLIDDDMEARIADFGLARLMPDGHAQVST 371
+ G+EYL IH RN VL+ ++ +IADFGLAR + + T
Sbjct: 165 QLARGMEYLASQK---CIHRDLAARN-----VLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 372 SIVAGTVGYIAPE---YHQTLKFSEKCDIYSFGVLL 404
+ V ++APE ++ + D++SFGVL+
Sbjct: 217 TNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVLM 249
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 217 GEIYIAEL------PESNGKMIAIKKVKQVDNSLLNIKMRQVR-AEIMTAGQI-RHRNIV 268
G++ +AE + +A+K +K ++ + E+M I +H+NI+
Sbjct: 83 GQVVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKDLSDLISEMEMMK--MIGKHKNII 138
Query: 269 PLLAHMVRPDCHLLVSEFMKNGSLLEIL------------NDVSQGRRELEWLARHRIAR 316
LL + ++ E+ G+L E L N +L A
Sbjct: 139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 198
Query: 317 GIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAG 376
+ G+EYL + IHR++ +VL+ +D +IADFGLAR + T+
Sbjct: 199 QVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 255
Query: 377 TVGYIAPE---YHQTLKFSEKCDIYSFGVLL 404
V ++APE ++ + D++SFGVLL
Sbjct: 256 PVKWMAPEALFDR---IYTHQSDVWSFGVLL 283
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 46/196 (23%), Positives = 84/196 (42%), Gaps = 27/196 (13%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLA----HMVRPDCHL 281
+ A+K ++ + R E+ + + +IV ++ C L
Sbjct: 85 RTQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135
Query: 282 LVSEFMKNGSLLE-ILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITP 340
+V E + G L I + Q E E A I + I ++YLH + I HR++ P
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTERE--ASE-IMKSIGEAIQYLHSIN---IAHRDVKP 189
Query: 341 SSVLI---DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDI 397
++L + ++ DFG A+ + ++T T Y+APE K+ + CD+
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTT--PCYTPYYVAPEVLGPEKYDKSCDM 246
Query: 398 YSFGVLLAVLVMGKLP 413
+S GV++ +L+ G P
Sbjct: 247 WSLGVIMYILLCGYPP 262
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 44/211 (20%), Positives = 86/211 (40%), Gaps = 33/211 (15%)
Query: 217 GEIYIAE---LPESNGKMI-AIKKVKQVDNSLLNIKMRQVR-AEIMTAGQI-RHRNIVPL 270
G++ A L +S+ M A+K +K ++ L + + ++++ + H NIV L
Sbjct: 37 GKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTEREALMSELKVLS--YLGNHMNIVNL 92
Query: 271 LAHMVRPDCHLLVSEFMKNGSLLEIL--------------NDVSQGRRELEWLARHRIAR 316
L L+++E+ G LL L + L+ +
Sbjct: 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 152
Query: 317 GIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAG 376
+ G+ +L IHR++ ++L+ +I DFGLAR + + V
Sbjct: 153 QVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 377 TVGYIAPE---YHQTLKFSEKCDIYSFGVLL 404
V ++APE ++ + D++S+G+ L
Sbjct: 210 PVKWMAPESIFNC---VYTFESDVWSYGIFL 237
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 45/194 (23%), Positives = 82/194 (42%), Gaps = 18/194 (9%)
Query: 227 SNGKMIAIK--KVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284
S G A K K ++ +S + + E+ +I+H N++ L +L+
Sbjct: 34 STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 93
Query: 285 EFMKNGSLLE-ILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSV 343
E + G L + + S E A + I++G+ YLH I H ++ P ++
Sbjct: 94 ELVAGGELFDFLAEKESLTEEE----AT-EFLKQILNGVYYLHSLQ---IAHFDLKPENI 145
Query: 344 LI----DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYS 399
++ +I DFGLA + G+ + GT ++APE + D++S
Sbjct: 146 MLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWS 202
Query: 400 FGVLLAVLVMGKLP 413
GV+ +L+ G P
Sbjct: 203 IGVITYILLSGASP 216
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 46/210 (21%), Positives = 87/210 (41%), Gaps = 32/210 (15%)
Query: 217 GEIYIAEL----PESNGKMIAIKKVKQVDNSLLNIKMRQVR-AEIMTAGQI-RHRNIVPL 270
G++ A+ + + +A+K +K + + + + +I+ I H N+V L
Sbjct: 41 GQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKILI--HIGHHLNVVNL 96
Query: 271 LAHMVRPDCHL-LVSEFMKNGSLLEIL------------NDVSQGRRELEWLARHRIARG 317
L +P L ++ EF K G+L L + L +
Sbjct: 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 156
Query: 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGT 377
+ G+E+L + IHR++ ++L+ + +I DFGLAR + V
Sbjct: 157 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213
Query: 378 VGYIAPE---YHQTLKFSEKCDIYSFGVLL 404
+ ++APE ++ + D++SFGVLL
Sbjct: 214 LKWMAPETIFDR---VYTIQSDVWSFGVLL 240
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 43/216 (19%)
Query: 217 GEIYIAELPESNGK------MIAIKKVKQVDNSLLNIKMRQVR-AEIMTAGQI-RHRNIV 268
G++ +AE + +A+K +K D++ V E+M I +H+NI+
Sbjct: 95 GQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMK--MIGKHKNII 150
Query: 269 PLLAHMVRPDCHLLVSEFMKNGSLLEIL------------NDVSQGRRELEWLARHRIAR 316
LL + ++ E+ G+L E L + ++ +
Sbjct: 151 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 210
Query: 317 GIVSGLEYLHMYHRPRIIH-----RNITPSSVLIDDDMEARIADFGLARLMPDGHAQVST 371
+ G+EYL + IH RN VL+ ++ +IADFGLAR + + T
Sbjct: 211 QLARGMEYLA---SQKCIHRDLAARN-----VLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 372 SIVAGTVGYIAPE---YHQTLKFSEKCDIYSFGVLL 404
+ V ++APE ++ + D++SFGVL+
Sbjct: 263 TNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVLM 295
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 58/226 (25%)
Query: 217 GEIYIAELPESNGK----MIAIKKVKQVDNSLLNIKMRQVR-AEIMTAGQIRHRNIVPLL 271
G ++ A P M+A+K +K + + +++ R A +M + + NIV LL
Sbjct: 61 GRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQREAALMA--EFDNPNIVKLL 116
Query: 272 AHMVRPDCHLLVSEFMKNGSLLEIL--------------------NDVSQGRRELEWLAR 311
L+ E+M G L E L S G L +
Sbjct: 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQ 176
Query: 312 HRIARGIVSGLEYLHMYHRPRIIH-----RNITPSSVLIDDDMEARIADFGLARLMPDGH 366
IAR + +G+ YL +H RN L+ ++M +IADFGL+R +
Sbjct: 177 LCIARQVAAGMAYLSERK---FVHRDLATRN-----CLVGENMVVKIADFGLSRNIYSAD 228
Query: 367 AQVSTSIVAGTVGYI-----APE---YHQTLKFSEKCDIYSFGVLL 404
A I PE Y+ +++ + D++++GV+L
Sbjct: 229 Y-----YKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVL 266
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L+ I S A G + A + +AIKK+ + + + K R R E++ + H+NI
Sbjct: 30 LKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAK-RAYR-ELVLMKCVNHKNI 86
Query: 268 VPLLAHMVRPDCHL-------LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVS 320
+ LL ++ P L +V E M + +L +++ + EL+ + ++
Sbjct: 87 IGLL-NVFTPQKSLEEFQDVYIVMELM-DANLCQVI------QMELDHERMSYLLYQMLC 138
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
G+++LH IIHR++ PS++++ D +I DFGLAR T V T Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVV-TRYY 192
Query: 381 IAPEYHQTLKFSEKCDIYSFGVLLAVLVMGK 411
APE + + E DI+S G ++ ++ G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 39/212 (18%), Positives = 88/212 (41%), Gaps = 34/212 (16%)
Query: 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHR-NIV 268
+ S+++G+ Y A K + ++ Q ++ EI + ++
Sbjct: 47 QCISKSTGQEYAA-------KFLKKRRRGQDC-------RAEILHEIAVLELAKSCPRVI 92
Query: 269 PLLAHMVRPDCHLLVSEFMKNGSLLE-ILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
L +L+ E+ G + L ++++ E + + + I+ G+ YLH
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND--VIR-LIKQILEGVYYLH- 148
Query: 328 YHRPRIIHRNITPSSVLI---DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE 384
+ I+H ++ P ++L+ + +I DFG++R + + GT Y+APE
Sbjct: 149 --QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPE 203
Query: 385 YHQTLKF---SEKCDIYSFGVLLAVLVMGKLP 413
L + + D+++ G++ +L+ P
Sbjct: 204 ---ILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 5e-16
Identities = 48/221 (21%), Positives = 89/221 (40%), Gaps = 48/221 (21%)
Query: 217 GEIYIAELPESNGK----MIAIKKVKQVDNSLLNIKMRQVR-AEIMTAGQIRHRNIVPLL 271
G++ A G+ +A+K +K +N+ + + ++ Q+ H +++ L
Sbjct: 37 GKVVKATAFHLKGRAGYTTVAVKMLK--ENASPSELRDLLSEFNVLK--QVNHPHVIKLY 92
Query: 272 AHMVRPDCHLLVSEFMKNGSLLEIL--------NDVSQGRRELEWLARH----------- 312
+ LL+ E+ K GSL L + G H
Sbjct: 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDL 152
Query: 313 -RIARGIVSGLEYLHMYHRPRIIHR-----NITPSSVLIDDDMEARIADFGLARLMPDGH 366
A I G++YL ++HR N +L+ + + +I+DFGL+R + +
Sbjct: 153 ISFAWQISQGMQYLAEMK---LVHRDLAARN-----ILVAEGRKMKISDFGLSRDVYEED 204
Query: 367 AQVSTSIVAGTVGYIAPE---YHQTLKFSEKCDIYSFGVLL 404
+ V S V ++A E H ++ + D++SFGVLL
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDH---IYTTQSDVWSFGVLL 242
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 47/212 (22%), Positives = 83/212 (39%), Gaps = 43/212 (20%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH----RNIVPLLAH--MVR----- 276
KM A+K + + + + ++R+ I+ L H +V
Sbjct: 39 TKKMYAMKYMN--------------KQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84
Query: 277 --PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
+ +V + + G L L Q E + I +V L+YL II
Sbjct: 85 QDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICE-LVMALDYLQNQR---II 137
Query: 335 HRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE---YHQTLKF 391
HR++ P ++L+D+ I DF +A ++P + +AGT Y+APE + +
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 392 SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEE 423
S D +S GV L+ G+ P + +
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRP---YHIRSST 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 212 RSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAE--IMTAGQIRHRNIVP 269
+ + +G++Y A+K + + + L ++ R E ++ R I
Sbjct: 81 KMKQTGQVY------------AMKIMNK-WDMLKRGEVSCFREERDVLV--NGDRRWITQ 125
Query: 270 LLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH 329
L + LV E+ G LL +L+ G R +AR +A IV ++ +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAE-IVMAIDSVHRLG 182
Query: 330 RPRIIHRNITPSSVLIDDDMEARIADFGLA-RLMPDGHAQVSTSIVAGTVGYIAPE---- 384
+HR+I P ++L+D R+ADFG +L DG V + + GT Y++PE
Sbjct: 183 ---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG--TVRSLVAVGTPDYLSPEILQA 237
Query: 385 ---YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
T + +CD ++ GV + G+ P F+ + +
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP---FYADSTAE 277
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 38/216 (17%)
Query: 217 GEIYIAE---LPESNGKMI-AIKKVKQVDNSLLNIKMRQVR-AEIMTAGQI-RHRNIVPL 270
G++ A + ++ + A+K +K + + + + + ++MT Q+ H NIV L
Sbjct: 59 GKVMNATAYGISKTGVSIQVAVKMLK--EKADSSEREALMSELKMMT--QLGSHENIVNL 114
Query: 271 LAHMVRPDCHLLVSEFMKNGSLLEIL----NDVSQGRRELEWLARH-------------- 312
L L+ E+ G LL L S+ E E R
Sbjct: 115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 174
Query: 313 -RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVST 371
A + G+E+L +HR++ +VL+ +I DFGLAR + V
Sbjct: 175 LCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR 231
Query: 372 SIVAGTVGYIAPE---YHQTLKFSEKCDIYSFGVLL 404
V ++APE ++ K D++S+G+LL
Sbjct: 232 GNARLPVKWMAPESLFEG---IYTIKSDVWSYGILL 264
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 77.6 bits (190), Expect = 5e-15
Identities = 85/614 (13%), Positives = 183/614 (29%), Gaps = 159/614 (25%)
Query: 16 REIVSNFYSENIETILKKLTKDWLGQFARDAQIQADLIGWKKMMAKINKVLDDAIEKQTK 75
++I+S F ++ K +D +I +I K ++ ++ + KQ
Sbjct: 19 KDILSVFEDAFVDNFDCKDVQDMPKSILSKEEID-HIIMSKDAVSGTLRLFWTLLSKQ-- 75
Query: 76 EESVKIWLGKLQHLACDVDFLLDEFQTEAFQRMLLQDGVDDAVDKSEDST---------- 125
EE V+ ++ ++ L + FL+ +TE Q ++ + D+ +
Sbjct: 76 EEMVQKFVEEV--LRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR 133
Query: 126 --AMSKVKEVNARLQDIAWQINVLGLKASSGGKS---------KNVRQRFP--------- 165
K+++ L+ + + G+ S GK+ V+ +
Sbjct: 134 LQPYLKLRQALLELRPAKN-VLIDGVLGS--GKTWVALDVCLSYKVQCKMDFKIFWLNLK 190
Query: 166 --TTPSLLLAAVRGGGQNRGPTIFSPLIEKEDLAFLEKEDCSASLEKIRSRASGEIYIAE 223
+P +L + Q I + D + K + ++R + Y
Sbjct: 191 NCNSPETVLEML----QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246
Query: 224 L--------PES------NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVP 269
L ++ + K++ + KQV + L + + + + +
Sbjct: 247 LLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT-LTPDEVKS 305
Query: 270 LLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQ-GRRELEWLAR---------HRIARGIV 319
LL + L E + + + S + LA ++ I
Sbjct: 306 LLLKYLDCRPQDLPRE-VLTTNPRRL----SIIAESIRDGLATWDNWKHVNCDKLTTIIE 360
Query: 320 SGLEYL------HMYHRPRII--HRNITPSSVL-------IDDDMEARIADFGLARLMPD 364
S L L M+ R + +I P+ +L I D+ + + + +
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHI-PTILLSLIWFDVIKSDVM-VVVNKLHKYSLVE 418
Query: 365 GHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDI-----------YSFGVLLAVLVMGKLP 413
+ ST I L+ K + Y+ +
Sbjct: 419 KQPKESTI-------SI---PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPY 468
Query: 414 SDD-FFQH----------TEEKSL-------VRWMRNVMTSENPNRAIDSKLLGNGYEEQ 455
D F+ H E +L R++ + R + +G
Sbjct: 469 LDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKI------RHDSTAWNASGSILN 522
Query: 456 MLLVLKI-ACFCTLDDPEERPNSKDVRSMLSDTALIKDV-DFLKMHKRMDFDNDDCVELI 513
L LK + +DP+ L+ + DFL + + +L+
Sbjct: 523 TLQQLKFYKPYICDNDPK-------------YERLVNAILDFLPKIEE-NLICSKYTDLL 568
Query: 514 Q-------QEIYTE 520
+ + I+ E
Sbjct: 569 RIALMAEDEAIFEE 582
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 35/212 (16%)
Query: 212 RSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQV---RAE--IMTAGQIRHRN 266
+ + + +++ A+K + + + +K + R E ++ +
Sbjct: 94 KLKNADKVF------------AMKILNKWEM----LKRAETACFREERDVLV--NGDSKW 135
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
I L + LV ++ G LL +L+ R E +AR +A +V ++ +H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAE-MVIAIDSVH 192
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
H +HR+I P ++L+D + R+ADFG + + S+ V GT YI+PE
Sbjct: 193 QLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEIL 248
Query: 387 QTLKFSEK-----CDIYSFGVLLAVLVMGKLP 413
Q ++ + CD +S GV + ++ G+ P
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 43/224 (19%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRN 266
+ K+ E++ A + +N + + +K +K V K + R EI +R N
Sbjct: 41 VRKLGRGKYSEVFEA-INITNNEKVVVKILKPVK------KKKIKR-EIKILENLRGGPN 92
Query: 267 IVPLLAHMVRPDCH---LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLE 323
I+ L +V+ LV E + N ++ ++ ++ R + I+ L+
Sbjct: 93 IITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLT------DYDIRFYM-YEILKALD 144
Query: 324 YLHMYHRPRIIHRNITPSSVLID-DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIA 382
Y H I+HR++ P +V+ID + + R+ D+GLA G Q VA + +
Sbjct: 145 YC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVA-SRYFKG 198
Query: 383 PE-------YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQ 419
PE Y +L D++S G +LA ++ K P FF
Sbjct: 199 PELLVDYQMYDYSL------DMWSLGCMLASMIFRKEP---FFH 233
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 49/211 (23%), Positives = 82/211 (38%), Gaps = 36/211 (17%)
Query: 212 RSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQV---RAE--IMTAGQIRHRN 266
R +++ ++Y A+K + + + IK E IM
Sbjct: 89 RHKSTRKVY------------AMKLLSKFEM----IKRSDSAFFWEERDIMA--FANSPW 130
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
+V L +V E+M G L+ ++ E AR A +V L+ +H
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWARFYTAE-VVLALDAIH 185
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE-- 384
IHR++ P ++L+D ++ADFG M + V GT YI+PE
Sbjct: 186 SMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVL 241
Query: 385 --YHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
+ +CD +S GV L +++G P
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+ S A G + A S G+ +AIKK+ + S + K R R E++ ++H N+
Sbjct: 29 PTHVGSGAYGSVCSAIDKRS-GEKVAIKKLSRPFQSEIFAK-RAYR-ELLLLKHMQHENV 85
Query: 268 VPLLAHMVRPDCHL-------LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVS 320
+ LL + P L LV FM L +I+ + + ++
Sbjct: 86 IGLL-DVFTPASSLRNFYDFYLVMPFM-QTDLQKIM------GLKFSEEKIQYLVYQMLK 137
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
GL+Y+H ++HR++ P ++ +++D E +I DFGLAR T V T Y
Sbjct: 138 GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVV-TRWY 189
Query: 381 IAPEYH-QTLKFSEKCDIYSFGVLLAVLVMGK 411
APE + +++ DI+S G ++A ++ GK
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 212 RSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLL 271
+ +A+G Y A+K +K+ + + ++ E RH + L
Sbjct: 168 KEKATGRYY------------AMKILKK-EVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 272 AHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP 331
D V E+ G E+ +S+ R E AR A IVS L+YLH
Sbjct: 215 YSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAE-IVSALDYLHSEKN- 269
Query: 332 RIIHRNITPSSVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEYHQTLK 390
+++R++ ++++D D +I DFGL + + DG + GT Y+APE +
Sbjct: 270 -VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYLAPEVLEDND 325
Query: 391 FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
+ D + GV++ ++ G+LP F+ EK
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLP---FYNQDHEK 356
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 53/192 (27%), Positives = 91/192 (47%), Gaps = 26/192 (13%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL-LVSEF 286
G+++AIKK + + +K +R EI Q+RH N+V LL + + LV EF
Sbjct: 49 TGRIVAIKKFLE-SDDDKMVKKIAMR-EIKLLKQLRHENLVNLL-EVCKKKKRWYLVFEF 105
Query: 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346
+ + ++L+ L G L++ + I++G+ + H IIHR+I P ++L+
Sbjct: 106 VDH-TILDDLELFPNG---LDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVS 158
Query: 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE-------YHQTLKFSEKCDIYS 399
++ DFG AR + +V VA T Y APE Y + D+++
Sbjct: 159 QSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWYRAPELLVGDVKY------GKAVDVWA 210
Query: 400 FGVLLAVLVMGK 411
G L+ + MG+
Sbjct: 211 IGCLVTEMFMGE 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L+ + S A G + A + G +AIKK+ + S L K R R E+ +RH N+
Sbjct: 30 LQPVGSGAYGAVCSAVDGRT-GAKVAIKKLYRPFQSELFAK-RAYR-ELRLLKHMRHENV 86
Query: 268 VPLLAHMVRPDCHL-------LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVS 320
+ LL + PD L LV FM L + + +L + ++
Sbjct: 87 IGLL-DVFTPDETLDDFTDFYLVMPFMGTD-----LGKLMK-HEKLGEDRIQFLVYQMLK 139
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
GL Y+H IIHR++ P ++ +++D E +I DFGLAR T V T Y
Sbjct: 140 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVV-TRWY 191
Query: 381 IAPEYH-QTLKFSEKCDIYSFGVLLAVLVMGK 411
APE +++++ DI+S G ++A ++ GK
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L + S A G + A ++ G +A+KK+ + S+++ K R R E+ ++H N+
Sbjct: 34 LSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAK-RTYR-ELRLLKHMKHENV 90
Query: 268 VPLLAHMVRPDCHL-------LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVS 320
+ LL + P L LV+ M LN++ + ++ L + I+
Sbjct: 91 IGLL-DVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQK-LTDDHVQFLIYQILR 143
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
GL+Y+H IIHR++ PS++ +++D E +I DFGLAR A T VA T Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVA-TRWY 195
Query: 381 IAPEYH-QTLKFSEKCDIYSFGVLLAVLVMGK 411
APE + +++ DI+S G ++A L+ G+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 11/134 (8%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL-LVSEF 286
G+++AIKK + IK +R EI Q++H N+V LL + R L LV E+
Sbjct: 27 TGQIVAIKKFLE-SEDDPVIKKIALR-EIRMLKQLKHPNLVNLL-EVFRRKRRLHLVFEY 83
Query: 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346
+ ++L L+ +G + I + + + H + IHR++ P ++LI
Sbjct: 84 CDH-TVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILIT 136
Query: 347 DDMEARIADFGLAR 360
++ DFG AR
Sbjct: 137 KHSVIKLCDFGFAR 150
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 1e-13
Identities = 65/233 (27%), Positives = 112/233 (48%), Gaps = 32/233 (13%)
Query: 189 PLIEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIK 248
+E+L F + LEK+ G +Y A+ +S G+++A+K+++ +D I
Sbjct: 7 HSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAK--DSQGRIVALKRIR-LDAEDEGIP 63
Query: 249 MRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEW 308
+R EI ++ H NIV L+ + C LV EFM+ L ++L++ G
Sbjct: 64 STAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG------ 115
Query: 309 LARHRI---ARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDG 365
L +I ++ G+ + H+ RI+HR++ P ++LI+ D ++ADFGLAR
Sbjct: 116 LQDSQIKIYLYQLLRGVAHC---HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172
Query: 366 HAQVSTSIVAGTVGYIAPE-------YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
+ +V T+ Y AP+ Y S DI+S G + A ++ GK
Sbjct: 173 VRSYTHEVV--TLWYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 44/219 (20%), Positives = 90/219 (41%), Gaps = 32/219 (14%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
G + + + + G +AIKKV Q D + R+++ + + H NI
Sbjct: 28 ERMAGQGTFGTVQLGKEKST-GMSVAIKKVIQ-DPRF---RNRELQ-IMQDLAVLHHPNI 81
Query: 268 VPLLAHMVRP------DCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVS 320
V L ++ D +L +V E++ +L + + + + ++
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 321 GLEYLHMYHRPRIIHRNITPSSVLID-DDMEARIADFGLARLMPDGHAQVSTSIVAGTVG 379
+ LH+ + HR+I P +VL++ D ++ DFG A+ + + + + +
Sbjct: 141 SIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYIC-SRY 196
Query: 380 YIAPE-------YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
Y APE Y + DI+S G + A +++G+
Sbjct: 197 YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+ I + + G +Y A+L +S G+++AIKKV Q K + R E+ ++ H NI
Sbjct: 59 TKVIGNGSFGVVYQAKLCDS-GELVAIKKVLQD-------KRFKNR-ELQIMRKLDHCNI 109
Query: 268 VPLLAHMVRP-----DCHL-LVSEFMKNGSLLEILNDVSQGRRELEW----LARHRIARG 317
V L + +L LV +++ ++ + S+ ++ L L +++ R
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA-RIADFGLARLMPDGHAQVSTSIVAG 376
L Y+H I HR+I P ++L+D D ++ DFG A+ + G + + S +
Sbjct: 169 ----LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYIC- 218
Query: 377 TVGYIAPE-------YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
+ Y APE Y + D++S G +LA L++G+
Sbjct: 219 SRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 47/222 (21%), Positives = 90/222 (40%), Gaps = 48/222 (21%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQ--------VRAEIMTA 259
L+K+ +Y + ++A+K+ I++ +R E+
Sbjct: 7 LDKLGEGTYATVYKGKSKL-TDNLVALKE----------IRLEHEEGAPCTAIR-EVSLL 54
Query: 260 GQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRI---AR 316
++H NIV L + LV E++ L + L+D + H +
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI------INMHNVKLFLF 107
Query: 317 GIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAG 376
++ GL Y HR +++HR++ P ++LI++ E ++ADFGLAR +V
Sbjct: 108 QLLRGLAYC---HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-- 162
Query: 377 TVGYIAPE-------YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
T+ Y P+ Y S + D++ G + + G+
Sbjct: 163 TLWYRPPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 45/220 (20%), Positives = 92/220 (41%), Gaps = 46/220 (20%)
Query: 217 GEIYIA-ELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLL-AHM 274
G +Y A + K A+K+++ S+ + EI +++H N++ L +
Sbjct: 35 GHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVISLQKVFL 88
Query: 275 VRPDCHL-LVSEFMKN--GSLLEILNDVSQGRRELEWLARHR--IARGIVSGLEYLHMYH 329
D + L+ ++ ++ +++ ++ ++ + I+ G+ YLH
Sbjct: 89 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--- 145
Query: 330 RPRIIHRNITPSSVLIDDDMEAR----IADFGLARL-------MPDGHAQVSTSIVAGTV 378
++HR++ P+++L+ + R IAD G ARL + D V V T
Sbjct: 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV----V--TF 199
Query: 379 GYIAPE-------YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
Y APE Y ++ DI++ G + A L+ +
Sbjct: 200 WYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 40/202 (19%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQ--------VRAEIMTAGQIRHRNIVPLLAHMVRPD 278
+ G +A+K+ +K+ +R EI +++H NIV L + +
Sbjct: 28 TTGVYVALKE----------VKLDSEEGTPSTAIR-EISLMKELKHENIVRLYDVIHTEN 76
Query: 279 CHLLVSEFMKN--GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHR 336
LV EFM N ++ + R L ++ ++ GL + H +I+HR
Sbjct: 77 KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY-FQWQLLQGLAFCH---ENKILHR 132
Query: 337 NITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE-------YHQTL 389
++ P ++LI+ + ++ DFGLAR S+ +V T+ Y AP+ Y
Sbjct: 133 DLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRAPDVLMGSRTY---- 186
Query: 390 KFSEKCDIYSFGVLLAVLVMGK 411
S DI+S G +LA ++ GK
Sbjct: 187 --STSIDIWSCGCILAEMITGK 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 5e-13
Identities = 46/197 (23%), Positives = 85/197 (43%), Gaps = 30/197 (15%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286
+++A+K+V+ +D+ + +R EI +++H+NIV L + LV EF
Sbjct: 25 ETHEIVALKRVR-LDDDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82
Query: 287 MKNGSLLEILNDVSQGRRELEWLARHRI---ARGIVSGLEYLHMYHRPRIIHRNITPSSV 343
L + + + L + ++ GL + H ++HR++ P ++
Sbjct: 83 CDQ-DLKKYFDSCNGD------LDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNL 132
Query: 344 LIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE-------YHQTLKFSEKCD 396
LI+ + E ++A+FGLAR S +V T+ Y P+ Y S D
Sbjct: 133 LINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLY------STSID 184
Query: 397 IYSFGVLLAVLVMGKLP 413
++S G + A L P
Sbjct: 185 MWSAGCIFAELANAGRP 201
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 49/216 (22%), Positives = 87/216 (40%), Gaps = 34/216 (15%)
Query: 212 RSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQV---RAEIMTAGQIRHRNIV 268
+ + SG Y A+K + + +K++Q+ E + +V
Sbjct: 61 KHKESGNHY------------AMKILDKQKV----VKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 269 PLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY 328
L +V E++ G + L + R E AR A+ IV EYLH
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQ-IVLTFEYLHSL 160
Query: 329 HRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT 388
+I+R++ P ++LID ++ DFG A+ + T + GT +APE +
Sbjct: 161 D---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILS 212
Query: 389 LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
+++ D ++ GVL+ + G P FF +
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP---FFADQPIQ 245
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 49/220 (22%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDN--------SLLNIK-MRQVRAEIMT 258
+ +I A G+++ A ++ G+ +A+K+V+ V ++ + +R +
Sbjct: 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLETF--- 71
Query: 259 AGQIRHRNIVPLL--AHMVRPDCHL---LVSEFMKN--GSLLEILNDVSQGRRELEWLAR 311
H N+V L + R D LV E + + L+ + + ++ +
Sbjct: 72 ----EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 312 HRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVST 371
++ GL++LH R++HR++ P ++L+ + ++ADFGLAR+ T
Sbjct: 128 Q-----LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALT 177
Query: 372 SIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGK 411
S+V T+ Y APE ++ D++S G + A + K
Sbjct: 178 SVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 38/204 (18%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL------ 281
G+ +A+KKV ++N + +R EI ++H N+V L+
Sbjct: 41 TGQKVALKKVL-MENEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGS 98
Query: 282 --LVSEFMKN--GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRN 337
LV +F ++ LL + + + + + +++GL Y+H R +I+HR+
Sbjct: 99 IYLVFDFCEHDLAGLLS-----NVLVKFTLSEIKR-VMQMLLNGLYYIH---RNKILHRD 149
Query: 338 ITPSSVLIDDDMEARIADFGLARLM---PDGHAQVSTSIVAGTVGYIAPE-------YHQ 387
+ ++VLI D ++ADFGLAR + T+ V T+ Y PE Y
Sbjct: 150 MKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDY-- 206
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGK 411
D++ G ++A +
Sbjct: 207 ----GPPIDLWGAGCIMAEMWTRS 226
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 52/227 (22%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L I A G + A + +AIKK+ ++ R +R EI + RH NI
Sbjct: 32 LSYIGEGAYGMVCSAYDNLN-KVRVAIKKISPFEHQTYCQ--RTLR-EIKILLRFRHENI 87
Query: 268 VPLLAHMVRPDCHL------LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARG---- 317
+ + ++R +V + M + L +++ +
Sbjct: 88 IGIN-DIIRAPTIEQMKDVYIVQDLM--ETDL------------------YKLLKTQHLS 126
Query: 318 ----------IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM--PDG 365
I+ GL+Y+H ++HR++ PS++L++ + +I DFGLAR+
Sbjct: 127 NDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 366 HAQVSTSIVAGTVGYIAPEYHQTLK-FSEKCDIYSFGVLLAVLVMGK 411
H T VA T Y APE K +++ DI+S G +LA ++ +
Sbjct: 184 HTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 23/164 (14%), Positives = 52/164 (31%), Gaps = 38/164 (23%)
Query: 250 RQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWL 309
++ + + +I + +L + L+V+E+++ GSL E+ +
Sbjct: 76 QETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPV 129
Query: 310 ARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQV 369
R + + + + H R + PS V + D + +A
Sbjct: 130 GAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYP------------- 173
Query: 370 STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
+ + + DI G L L++ + P
Sbjct: 174 ---------ATMPDA-------NPQDDIRGIGASLYALLVNRWP 201
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 23/199 (11%)
Query: 227 SNGKMIAIKKVK--QVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284
+ +++AIKK+K + I +R EI ++ H NI+ LL LV
Sbjct: 33 NTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVF 91
Query: 285 EFMKNGSLLEILNDVSQGRRELE---WLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
+FM+ L I+ D S ++ + GLEYL H+ I+HR++ P+
Sbjct: 92 DFMET-DLEVIIKDNSLVLTPSHIKAYMLM------TLQGLEYL---HQHWILHRDLKPN 141
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE--YHQTLKFSEKCDIYS 399
++L+D++ ++ADFGLA+ + + +V T Y APE + + D+++
Sbjct: 142 NLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TRWYRAPELLFGAR-MYGVGVDMWA 198
Query: 400 FGVLLAVLVMGK--LPSDD 416
G +LA L++ LP D
Sbjct: 199 VGCILAELLLRVPFLPGDS 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 3e-12
Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 30/193 (15%)
Query: 229 GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMK 288
G+ A+KK++ ++ I +R EI +++H NIV L + +LV E +
Sbjct: 26 GETFALKKIR-LEKEDEGIPSTTIR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83
Query: 289 NGSLLEILNDVSQGRRELEWLARHRI---ARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345
L ++L+ G L +++G+ Y H R++HR++ P ++LI
Sbjct: 84 Q-DLKKLLDVCEGG------LESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLI 133
Query: 346 DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE-------YHQTLKFSEKCDIY 398
+ + E +IADFGLAR + + IV T+ Y AP+ Y S DI+
Sbjct: 134 NREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMGSKKY------STTIDIW 185
Query: 399 SFGVLLAVLVMGK 411
S G + A +V G
Sbjct: 186 SVGCIFAEMVNGT 198
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 49/203 (24%), Positives = 82/203 (40%), Gaps = 33/203 (16%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKM--------RQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278
S G +AIK+V + + + R +R EI H NI+ L +
Sbjct: 44 SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIRLLNHFHHPNILGLR-DIFVHF 101
Query: 279 CHL------LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR 332
LV+E M+ L ++++ R + I+ GL LH
Sbjct: 102 EEPAMHKLYLVTELMRT-DLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLH---EAG 154
Query: 333 IIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE----YHQT 388
++HR++ P ++L+ D+ + I DF LAR D T V Y APE +
Sbjct: 155 VVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVT-HRWYRAPELVMQFKG- 210
Query: 389 LKFSEKCDIYSFGVLLAVLVMGK 411
F++ D++S G ++A + K
Sbjct: 211 --FTKLVDMWSAGCVMAEMFNRK 231
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 4e-12
Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 35/198 (17%)
Query: 212 RSRASGEIYIAELPESNGKMIAIK--KVKQVDNSLLNIKMRQV---RAEIMTAGQIRHRN 266
RSR +G Y A+K K + V ++++QV E + + H
Sbjct: 26 RSRHNGRYY------------AMKVLKKEIV------VRLKQVEHTNDERLMLSIVTHPF 67
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
I+ + ++ ++++ G L +L + +R +A+ A + LEYLH
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFPNPVAKFYAAE-VCLALEYLH 123
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
II+R++ P ++L+D + +I DFG A+ +PD T + GT YIAPE
Sbjct: 124 SKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVV 175
Query: 387 QTLKFSEKCDIYSFGVLL 404
T +++ D +SFG+L+
Sbjct: 176 STKPYNKSIDWWSFGILI 193
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 217 GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMT-----AGQIRHRNIVPLL 271
G++ ++E + ++ A+K +K+ + M A + + L
Sbjct: 355 GKVMLSERKGT-DELYAVKILKKDV-----VIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 272 AHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP 331
+ D V E++ G +++ + Q R E A A I GL +L
Sbjct: 409 SCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQSKG-- 462
Query: 332 RIIHRNITPSSVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEYHQTLK 390
II+R++ +V++D + +IADFG+ + + DG V+T GT YIAPE
Sbjct: 463 -IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---VTTKTFCGTPDYIAPEIIAYQP 518
Query: 391 FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
+ + D ++FGVLL ++ G+ P F E++
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAP---FEGEDEDE 549
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 6e-12
Identities = 47/197 (23%), Positives = 83/197 (42%), Gaps = 24/197 (12%)
Query: 227 SNGKMIAIKKVK--QVDNSLLNIKMRQVRAEI---MTAGQIRHRNIVPLL--AHMVRPDC 279
+G +A+K V+ + + VR E+ H N+V L+ R D
Sbjct: 32 HSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPNVVRLMDVCATSRTDR 90
Query: 280 HL---LVSEFMKN--GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
+ LV E + + L+ ++ L R + GL++LH I+
Sbjct: 91 EIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ-----FLRGLDFLH---ANCIV 142
Query: 335 HRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEK 394
HR++ P ++L+ ++ADFGLAR+ + T +V T+ Y APE ++
Sbjct: 143 HRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPVVV-TLWYRAPEVLLQSTYATP 199
Query: 395 CDIYSFGVLLAVLVMGK 411
D++S G + A + K
Sbjct: 200 VDMWSVGCIFAEMFRRK 216
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 9e-12
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 64/217 (29%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL------ 281
G+++AIKK++ D L + R +R EI +H NI+ + ++ RPD
Sbjct: 35 TGEIVAIKKIEPFDKPLFAL--RTLR-EIKILKHFKHENIITIF-NIQRPDSFENFNEVY 90
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARG--------------IVSGLEYLHM 327
++ E M + L HR+ + ++ LH
Sbjct: 91 IIQELM--QTDL------------------HRVISTQMLSDDHIQYFIYQTLRAVKVLH- 129
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM---------PDGHAQVSTSIVAGTV 378
+IHR++ PS++LI+ + + ++ DFGLAR++ P G VA T
Sbjct: 130 --GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA-TR 186
Query: 379 GYIAPE----YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
Y APE K+S D++S G +LA L + +
Sbjct: 187 WYRAPEVMLTSA---KYSRAMDVWSCGCILAELFLRR 220
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 43/199 (21%), Positives = 85/199 (42%), Gaps = 34/199 (17%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286
+ +AIK+++ +++ + +R E+ +++HRNI+ L + + L+ E+
Sbjct: 57 VTNETVAIKRIR-LEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114
Query: 287 MKN--GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
+N ++ DVS + +++G+ + H R +HR++ P ++L
Sbjct: 115 AENDLKKYMDKNPDVSMRVIK-------SFLYQLINGVNFCH---SRRCLHRDLKPQNLL 164
Query: 345 IDDDMEAR-----IADFGLARLMPDGHAQVSTSIVAGTVGYIAPE-------YHQTLKFS 392
+ + I DFGLAR Q + I+ T+ Y PE Y S
Sbjct: 165 LSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYRPPEILLGSRHY------S 216
Query: 393 EKCDIYSFGVLLAVLVMGK 411
DI+S + A ++M
Sbjct: 217 TSVDIWSIACIWAEMLMKT 235
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 27/214 (12%)
Query: 212 RSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLL 271
R +A+G Y A+K +++ + + ++ E RH + L
Sbjct: 25 REKATGRYY------------AMKILRK-EVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 272 AHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP 331
D V E+ G E+ +S+ R E AR A IVS LEYLH
Sbjct: 72 YAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAE-IVSALEYLHSRD-- 125
Query: 332 RIIHRNITPSSVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEYHQTLK 390
+++R+I ++++D D +I DFGL + + DG + GT Y+APE +
Sbjct: 126 -VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEYLAPEVLEDND 181
Query: 391 FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
+ D + GV++ ++ G+LP F+ E+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP---FYNQDHER 212
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 52/218 (23%), Positives = 98/218 (44%), Gaps = 37/218 (16%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+ I + + G ++ A+L ES+ +AIKKV Q D K + R E+ ++H N+
Sbjct: 45 CKVIGNGSFGVVFQAKLVESD--EVAIKKVLQ-D------KRFKNR-ELQIMRIVKHPNV 94
Query: 268 VPLLAHMVRPDCHL-------LVSEFMKNGSLLEILNDVSQGRRELEW----LARHRIAR 316
V L + LV E++ ++ ++ ++ + L +++ R
Sbjct: 95 VDLK-AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 317 GIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM-EARIADFGLAR-LMPDGHAQVSTSIV 374
L Y+H I HR+I P ++L+D ++ DFG A+ L+ + + S +
Sbjct: 153 S----LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG---EPNVSYI 202
Query: 375 AGTVGYIAPE-YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
+ Y APE ++ DI+S G ++A L+ G+
Sbjct: 203 C-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 46/144 (31%), Positives = 73/144 (50%), Gaps = 14/144 (9%)
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
V EF+ G L+ + + RR E AR A I+S L +LH II+R++
Sbjct: 101 FVMEFVNGGDLMFHI---QKSRRFDEARARFYAAE-IISALMFLH---DKGIIYRDLKLD 153
Query: 342 SVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSF 400
+VL+D + ++ADFG+ + + +G V+T+ GT YIAPE Q + + D ++
Sbjct: 154 NVLLDHEGHCKLADFGMCKEGICNG---VTTATFCGTPDYIAPEILQEMLYGPAVDWWAM 210
Query: 401 GVLLAVLVMGKLPSDDFFQHTEEK 424
GVLL ++ G P F E+
Sbjct: 211 GVLLYEMLCGHAP---FEAENEDD 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 41/240 (17%), Positives = 82/240 (34%), Gaps = 48/240 (20%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+ + + + G + ES GK A+KKV L + R E+ + H NI
Sbjct: 12 GKTLGTGSFGIVCEVFDIES-GKRFALKKV-------LQDPRYKNR-ELDIMKVLDHVNI 62
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLAR---------------- 311
+ L+ + + + +
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 312 --HRIARGIVSG---LEYLH----MY---------HRPRIIHRNITPSSVLID-DDMEAR 352
H++ + + + +Y H I HR+I P ++L++ D +
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLK 182
Query: 353 IADFGLARLMPDGHAQVSTSIVAGTVGYIAPE-YHQTLKFSEKCDIYSFGVLLAVLVMGK 411
+ DFG A+ + S + + + Y APE +++ D++S G + L++GK
Sbjct: 183 LCDFGSAKKLIPSEP--SVAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 32/145 (22%), Positives = 64/145 (44%), Gaps = 7/145 (4%)
Query: 273 HMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARH---RIARGIVSGLEYLHMYH 329
+ S F++ SL ++ + + ++L + + G+E+L
Sbjct: 154 DSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--- 210
Query: 330 RPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL 389
+ IHR++ ++L+ + +I DFGLAR + V + ++APE
Sbjct: 211 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 270
Query: 390 KFSEKCDIYSFGVLL-AVLVMGKLP 413
++ + D++SFGVLL + +G P
Sbjct: 271 VYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 13/158 (8%)
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
L+ +++ G L L SQ R E + + IV LE+LH II+R+I
Sbjct: 136 LILDYINGGELFTHL---SQRERFTEHEVQIYVGE-IVLALEHLHKLG---IIYRDIKLE 188
Query: 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK--FSEKCDIYS 399
++L+D + + DFGL++ + + GT+ Y+AP+ + + D +S
Sbjct: 189 NILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRGGDSGHDKAVDWWS 247
Query: 400 FGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437
GVL+ L+ G P F E+ S R ++ SE
Sbjct: 248 LGVLMYELLTGASP---FTVDGEKNSQAEISRRILKSE 282
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 4e-11
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKM-RQVRAEIMTAGQIRHRNI 267
+KI + ++Y A M +KK + KM R + ++ H I
Sbjct: 44 KKISGSDARQLY-A--------MKVLKKATLKVRDRVRTKMERDILV------EVNHPFI 88
Query: 268 VPLLAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
V L L L+ +F++ G L L S+ E + +A + L++LH
Sbjct: 89 VKLHYAFQTEG-KLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAE-LALALDHLH 143
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEY 385
II+R++ P ++L+D++ ++ DFGL++ + GTV Y+APE
Sbjct: 144 SLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPEV 197
Query: 386 HQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
++ D +SFGVL+ ++ G LP
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 24/204 (11%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMT-----AGQIRHRNIVPLLAHMVRPDCHL 281
+ AIK +K+ + M M + H + + +
Sbjct: 40 KTNQFFAIKALKKDV-----VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
V E++ G L+ + + A A I+ GL++LH I++R++
Sbjct: 95 FVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAE-IILGLQFLHSKG---IVYRDLKLD 147
Query: 342 SVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSF 400
++L+D D +IADFG+ + M T+ GT YIAPE K++ D +SF
Sbjct: 148 NILLDKDGHIKIADFGMCKENMLGDA---KTNTFCGTPDYIAPEILLGQKYNHSVDWWSF 204
Query: 401 GVLLAVLVMGKLPSDDFFQHTEEK 424
GVLL +++G+ P F EE+
Sbjct: 205 GVLLYEMLIGQSP---FHGQDEEE 225
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 35/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL------ 281
+++AIKK+ +V L++ K R +R EI ++ H ++V +L +V P
Sbjct: 77 EKRVVAIKKILRVFEDLIDCK-RILR-EIAILNRLNHDHVVKVL-DIVIPKDVEKFDELY 133
Query: 282 LVSEFMKNGSLLEI-LNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITP 340
+V E + + + L L + ++ G++Y+H I+HR++ P
Sbjct: 134 VVLEIA------DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKP 184
Query: 341 SSVLIDDDMEARIADFGLAR 360
++ L++ D ++ DFGLAR
Sbjct: 185 ANCLVNQDCSVKVCDFGLAR 204
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 9e-11
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 30/219 (13%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMR-QVRAEIMTAGQIRHRNI 267
K+ +G+I+ A+K +K+ + N K +AE +++H I
Sbjct: 37 RKVTGANTGKIF------------AMKVLKK-AMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 268 VPLLAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
V L+ L L+ E++ G L L + +E A +A I L +LH
Sbjct: 84 VDLIYAFQTGG-KLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAE-ISMALGHLH 138
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEY 385
II+R++ P +++++ ++ DFGL + + DG T GT+ Y+APE
Sbjct: 139 QKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT---VTHTFCGTIEYMAPEI 192
Query: 386 HQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424
+ D +S G L+ ++ G P F +K
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPP---FTGENRKK 228
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 38/170 (22%), Positives = 70/170 (41%), Gaps = 23/170 (13%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL------ 281
K +AIKKV ++ L++ K R +R EI +++ I+ L ++ PD L
Sbjct: 50 TEKNVAIKKVNRMFEDLIDCK-RILR-EITILNRLKSDYIIRLY-DLIIPDDLLKFDELY 106
Query: 282 LVSEFMKNGSLLEI-LNDVSQGRRELEWLARHR--IARGIVSGLEYLHMYHRPRIIHRNI 338
+V E + L + + L H I ++ G ++H IIHR++
Sbjct: 107 IVLEIA------DSDLKKLFKTPIFLT--EEHIKTILYNLLLGENFIH---ESGIIHRDL 155
Query: 339 TPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT 388
P++ L++ D ++ DFGLAR + + + +
Sbjct: 156 KPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 37/133 (27%), Positives = 66/133 (49%), Gaps = 11/133 (8%)
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
V E++ G +++ + + R+ E AR A I L YLH II+R++
Sbjct: 87 FVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG---IIYRDLKLD 139
Query: 342 SVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSF 400
+VL+D + ++ D+G+ + + G +TS GT YIAPE + + D ++
Sbjct: 140 NVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 196
Query: 401 GVLLAVLVMGKLP 413
GVL+ ++ G+ P
Sbjct: 197 GVLMFEMMAGRSP 209
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 46/206 (22%), Positives = 88/206 (42%), Gaps = 40/206 (19%)
Query: 228 NGKMIAIKKV---KQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVS 284
K +AIKK+ +R EI ++ H NIV + ++ P L
Sbjct: 35 CDKRVAIKKIVLTDPQSVK------HALR-EIKIIRRLDHDNIVKVF-EILGPSGSQLTD 86
Query: 285 EFMKNGSLLEI----------LNDVSQGRRELEWLARHR--IARGIVSGLEYLHMYHRPR 332
+ L + L +V + LE H ++ GL+Y+H +
Sbjct: 87 DVGSLTELNSVYIVQEYMETDLANVLEQGPLLE---EHARLFMYQLLRGLKYIHSAN--- 140
Query: 333 IIHRNITPSSVLID-DDMEARIADFGLARLM--PDGHAQVSTSIVAGTVGYIAPE----Y 385
++HR++ P+++ I+ +D+ +I DFGLAR+M H + + T Y +P
Sbjct: 141 VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSP 199
Query: 386 HQTLKFSEKCDIYSFGVLLAVLVMGK 411
+ +++ D+++ G + A ++ GK
Sbjct: 200 N---NYTKAIDMWAAGCIFAEMLTGK 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 43/144 (29%), Positives = 71/144 (49%), Gaps = 14/144 (9%)
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
V E++ G +++ + Q R E A A I GL +L II+R++
Sbjct: 98 FVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQSKG---IIYRDLKLD 150
Query: 342 SVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSF 400
+V++D + +IADFG+ + + DG V+T GT YIAPE + + D ++F
Sbjct: 151 NVMLDSEGHIKIADFGMCKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 207
Query: 401 GVLLAVLVMGKLPSDDFFQHTEEK 424
GVLL ++ G+ P F E++
Sbjct: 208 GVLLYEMLAGQAP---FEGEDEDE 228
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 38/133 (28%), Positives = 60/133 (45%), Gaps = 11/133 (8%)
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
V +++ G L L + R LE AR A I S L YLH + I++R++ P
Sbjct: 116 FVLDYINGGELFYHL---QRERCFLEPRARFYAAE-IASALGYLHSLN---IVYRDLKPE 168
Query: 342 SVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSF 400
++L+D + DFGL + + +TS GT Y+APE + D +
Sbjct: 169 NILLDSQGHIVLTDFGLCKENIEHNS---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 225
Query: 401 GVLLAVLVMGKLP 413
G +L ++ G P
Sbjct: 226 GAVLYEMLYGLPP 238
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 37/133 (27%), Positives = 66/133 (49%), Gaps = 11/133 (8%)
Query: 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341
V E++ G +++ + + R+ E AR A I L YLH II+R++
Sbjct: 130 FVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG---IIYRDLKLD 182
Query: 342 SVLIDDDMEARIADFGLARL-MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSF 400
+VL+D + ++ D+G+ + + G +TS GT YIAPE + + D ++
Sbjct: 183 NVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 239
Query: 401 GVLLAVLVMGKLP 413
GVL+ ++ G+ P
Sbjct: 240 GVLMFEMMAGRSP 252
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 9e-10
Identities = 41/196 (20%), Positives = 74/196 (37%), Gaps = 48/196 (24%)
Query: 227 SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLA----HMVRPDCHL 281
+ A+K ++ + R E+ + + +IV ++ C L
Sbjct: 41 RTQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91
Query: 282 LVSEFMKNGSLLE-ILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITP 340
+V E + G L I + Q E E A I + I ++YLH + I HR++ P
Sbjct: 92 IVMECLDGGELFSRIQDRGDQAFTERE--ASE-IMKSIGEAIQYLHSIN---IAHRDVKP 145
Query: 341 SSVLI---DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDI 397
++L + ++ DFG A E K+ + CD+
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFA-----------------------KETTGE-KYDKSCDM 181
Query: 398 YSFGVLLAVLVMGKLP 413
+S GV++ +L+ G P
Sbjct: 182 WSLGVIMYILLCGYPP 197
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 45/222 (20%), Positives = 92/222 (41%), Gaps = 64/222 (28%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCHL---LV 283
G+++A+KK+ + + + R R EIM ++ H NIV LL +++R D LV
Sbjct: 33 TGEVVAVKKIFDAFQNSTDAQ-RTFR-EIMILTELSGHENIVNLL-NVLRADNDRDVYLV 89
Query: 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARG--------------IVSGLEYLHMYH 329
++M + L H + R ++ ++YLH
Sbjct: 90 FDYM--ETDL------------------HAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 330 RPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL 389
++HR++ PS++L++ + ++ADFGL+R + + ++ + Q +
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 390 --------------------KFSEKCDIYSFGVLLAVLVMGK 411
K+++ D++S G +L ++ GK
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 20/158 (12%)
Query: 264 HRNIVPLL---AHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIV 319
+I+ LL H H+ +V E + +LL ++ L ++ +I++ ++
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYV--KQISKQLL 141
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLIDD------DMEARIADFGLARLMPDGHAQVSTSI 373
GL+Y+H IIH +I P +VL++ ++ +IAD G A + SI
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHYTNSI 196
Query: 374 VAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGK 411
T Y +PE + DI+S L+ L+ G
Sbjct: 197 Q--TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 38/196 (19%), Positives = 70/196 (35%), Gaps = 16/196 (8%)
Query: 312 HRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI--DDDMEARIADFGLARLMPDGHAQV 369
+ A I+ L+ LH + RIIH ++ P ++L+ ++ DFG + H +V
Sbjct: 203 RKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE---HQRV 256
Query: 370 STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRW 429
T I + Y APE ++ D++S G +LA L+ G +E +
Sbjct: 257 YTYIQ--SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP----LLPGEDEGDQLAC 310
Query: 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489
M ++ + +D+ + D + R L
Sbjct: 311 MIELL-GMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPE 369
Query: 490 IKD-VDFLKMHKRMDF 504
++ + LK F
Sbjct: 370 SREWGNALKGCDDPLF 385
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 2e-05
Identities = 32/210 (15%), Positives = 57/210 (27%), Gaps = 53/210 (25%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI----- 262
EKI GE++ + +AIK + L+N ++ EI+ I
Sbjct: 25 CEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELS 81
Query: 263 --------RHRNIVPLL-AHMVRPDCHL-----------------------------LVS 284
R + L H V+ +V
Sbjct: 82 LLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVL 141
Query: 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVL 344
EF G LE + + I + + L R HR++ +VL
Sbjct: 142 EFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVL 194
Query: 345 IDDDMEARIADFGLARLMPDGHAQVSTSIV 374
+ ++ + + SI+
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 41/195 (21%), Positives = 81/195 (41%), Gaps = 28/195 (14%)
Query: 228 NGKMIAIKKVKQVDNSLLNIKM--RQVRAEIMTAGQIRHR------NIVPLLAHMVRPDC 279
+ +AIK +K N K Q + E+ + IV L H + +
Sbjct: 78 EQEWVAIKIIK-------NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN- 129
Query: 280 HL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI 338
HL LV E + +L ++L + R + + A+ + + L +L IIH ++
Sbjct: 130 HLCLVFEMLSY-NLYDLLRN--TNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDL 185
Query: 339 TPSSVLIDDDMEA--RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCD 396
P ++L+ + + +I DFG + + ++ I + Y +PE + + D
Sbjct: 186 KPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQ--SRFYRSPEVLLGMPYDLAID 240
Query: 397 IYSFGVLLAVLVMGK 411
++S G +L + G+
Sbjct: 241 MWSLGCILVEMHTGE 255
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 25/108 (23%), Positives = 50/108 (46%), Gaps = 10/108 (9%)
Query: 313 RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARI--ADFGLARLMPDGHAQV- 369
++A ++ LE+LH +H N+T ++ +D + ++++ A +G A V
Sbjct: 163 QVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219
Query: 370 ----STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
S S G + +I+ + H+ S + D+ S G + + G LP
Sbjct: 220 YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV 268
KI S + G+IY+ + G+ +AIK K Q+ E ++ +
Sbjct: 15 RKIGSGSFGDIYLGTD-IAAGEEVAIKLECV------KTKHPQLHIESKIYKMMQGGVGI 67
Query: 269 P-LLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
P + D +++V E + G LE L + + L+ + +A ++S +EY+H
Sbjct: 68 PTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLL--LADQMISRIEYIHS 123
Query: 328 YHRPRIIHRNITPSSVLIDDDMEA---RIADFGLAR--LMPDGHAQVSTS---IVAGTVG 379
+ IHR++ P + L+ + I DFGLA+ H + + GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 380 YIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
Y + H ++ S + D+ S G +L +G LP
Sbjct: 181 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 23/214 (10%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV 268
KI S + GEIY+ + +AIK K Q+ E ++ +
Sbjct: 13 RKIGSGSFGEIYLGTN-IQTNEEVAIKLENV------KTKHPQLLYESKIYRILQGGTGI 65
Query: 269 P-LLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
P + V D ++LV + + G LE L + + L+ + +A +++ +E++H
Sbjct: 66 PNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLM--LADQMINRVEFVHS 121
Query: 328 YHRPRIIHRNITPSSVLIDDDMEAR---IADFGLARL--MPDGHAQV---STSIVAGTVG 379
+HR+I P + L+ A I DFGLA+ H + + GT
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 380 YIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
Y + H ++ S + D+ S G +L + G LP
Sbjct: 179 YASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 22/108 (20%), Positives = 46/108 (42%), Gaps = 10/108 (9%)
Query: 313 RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARI--ADFGLARLMPDGHAQV- 369
+++ I+ LEY+H + +H +I S++L++ ++ D+GLA
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 370 ----STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
GT+ + + + H + S + D+ G + + G LP
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 9e-04
Identities = 21/108 (19%), Positives = 46/108 (42%), Gaps = 10/108 (9%)
Query: 313 RIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARI--ADFGLARLMPDGHAQV- 369
++ ++ LEY+H +H +I +++L+ ++ AD+GL+
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 370 ----STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413
GT+ + + + H+ + S + D+ G + + GKLP
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 531 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 3qfl_A | 115 | MLA10; coiled-coil, (CC) domain, NLRS, nucleotide- | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.87 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.64 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.46 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.79 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.55 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.36 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.23 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.16 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.14 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.06 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.88 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.68 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.64 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.53 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.51 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.45 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.96 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.2 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.37 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.43 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.19 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=438.41 Aligned_cols=264 Identities=22% Similarity=0.345 Sum_probs=213.0
Q ss_pred cccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
.++|.+.+.||+|+||+||+|++.. .++..||||+++..... ..+.|.+|+.+|++++|||||+++|+|.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~----~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN----ARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChH----HHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 3567888999999999999998742 35789999999764332 267899999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHhhcc---------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVS---------QGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD 348 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~ 348 (531)
+..|||||||++|||.++|.... .....+++..+..++.||++||.||| +++|+||||||+|||++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCC
Confidence 99999999999999999997531 22357999999999999999999999 6789999999999999999
Q ss_pred CCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHH
Q 009595 349 MEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLV 427 (531)
Q Consensus 349 ~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~ 427 (531)
+++||+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+... ..+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~----~~~~ 240 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----NEVI 240 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHH
Confidence 9999999999987655443333344679999999999999999999999999999999999 8999976532 2333
Q ss_pred HHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 428 RWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 428 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
..+.. ...+.. +..+ ...+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 241 ~~i~~---~~~~~~-------p~~~---~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 241 ECITQ---GRVLQR-------PRTC---PQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHHH---TCCCCC-------CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHc---CCCCCC-------Cccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 33322 211111 1111 1247889999999999999999999999987643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-55 Score=439.70 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=205.5
Q ss_pred ccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 203 DCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
.++...++||+|+||+||+|++.. .+++.||||+++..... ..+.|.+|+.+|++++|||||+++|+|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~----~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES----ARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHH----HHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHH----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 456778899999999999998642 35789999999764332 2678999999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhccC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQ-----------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~ 347 (531)
.+|||||||++|+|.+++..... ...++++..+..++.||++||.||| +++||||||||+||||+.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECC
Confidence 99999999999999999975321 1346999999999999999999999 678999999999999999
Q ss_pred CCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHH
Q 009595 348 DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSL 426 (531)
Q Consensus 348 ~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l 426 (531)
++++||+|||+++.+.........+...||+.|||||++.+..|+.++|||||||++|||+| |+.||.+... ..+
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~----~~~ 269 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN----TEA 269 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH----HHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH----HHH
Confidence 99999999999997755444334445779999999999999999999999999999999999 8999976532 233
Q ss_pred HHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 427 VRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 427 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
...+... ..+.. +..+ ...+.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus 270 ~~~i~~g---~~~~~-------p~~~---~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 270 IDCITQG---RELER-------PRAC---PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHT---CCCCC-------CTTC---CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHcC---CCCCC-------cccc---cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 3333221 11111 1111 1247889999999999999999999999988753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=437.61 Aligned_cols=262 Identities=24% Similarity=0.328 Sum_probs=211.4
Q ss_pred ccccccccccccceeEEEEEeee----CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 203 DCSASLEKIRSRASGEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
..+.+.++||+|+||+||+|.+. ..+++.||||+++..... ...+.|.+|+.+|++++|||||+++|+|...+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~---~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG---PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh---HHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 44567889999999999999873 235789999999754322 22577999999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID 346 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~ 346 (531)
.++||||||++|||.++|..... ....+++..+..++.|||+||.||| +++||||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEEC
Confidence 99999999999999999965221 1246899999999999999999999 67899999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhH
Q 009595 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKS 425 (531)
Q Consensus 347 ~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~ 425 (531)
+++++||+|||+++.+.........+..+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+... ..
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~----~~ 255 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QD 255 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH----HH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH----HH
Confidence 999999999999987654433333455789999999999999999999999999999999998 8999976532 33
Q ss_pred HHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 426 LVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 426 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
+...+.. ...+.. +..+ ...+.+++.+||+.||.+|||+.+|+++|+..
T Consensus 256 ~~~~i~~---~~~~~~-------p~~~---~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 VVEMIRN---RQVLPC-------PDDC---PAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHT---TCCCCC-------CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHc---CCCCCC-------cccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 3333332 211111 1111 12478899999999999999999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=430.49 Aligned_cols=260 Identities=25% Similarity=0.391 Sum_probs=201.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.+.+.++||+|+||+||+|++. + .||||+++...... ...+.|.+|+.+|++++|||||+++|++.. +.++|
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~-~vAvK~~~~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---G-DVAVKILKVVDPTP--EQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---S-EEEEEECCCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---C-cEEEEEEEecCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 56677899999999999999863 3 49999997544332 236789999999999999999999998764 57899
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|||||++|+|.++|.. ....+++..+..++.||++||.||| +++||||||||+||||++++++||+|||+|+..
T Consensus 109 VmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 9999999999999974 2457999999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQT---LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
............+||+.|||||++.+ .+|+.++|||||||++|||+||+.||.+... ...+...+......+..
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~---~~~~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN---RDQIIFMVGRGYASPDL 259 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHHHHHHTTCCCCCS
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh---HHHHHHHHhcCCCCCCc
Confidence 55433333455789999999999864 4689999999999999999999999976432 12222222221111111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
. .... .....+.+++.+||+.||.+|||+.+|+++|+.+
T Consensus 260 ~-----~~~~----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 260 S-----KLYK----NCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp T-----TSCT----TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred c-----cccc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 1111 1123478899999999999999999999998765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=436.36 Aligned_cols=257 Identities=20% Similarity=0.296 Sum_probs=206.4
Q ss_pred hhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 200 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
...++|.+++.||+|+||+||+|.... +|+.||||++....... ...+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTE-DGRQYVIKEINISRMSS--KEREESRREVAVLANMKHPNIVQYRESFEENGS 97 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETT-TCCEEEEEEEECTTSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CcccceEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEehHHCCH--HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence 345789999999999999999998754 79999999998654332 236789999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
+|||||||+||+|.+++.. .....+++..+..++.||+.||.||| +++|+||||||+||||+.+|.+||+|||++
T Consensus 98 ~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla 172 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999999975 33456899999999999999999999 778999999999999999999999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
+.+..... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+... ..+ +..+.....+
T Consensus 173 ~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~----~~~---~~~i~~~~~~ 243 (350)
T 4b9d_A 173 RVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM----KNL---VLKIISGSFP 243 (350)
T ss_dssp SCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHH---HHHHHHTCCC
T ss_pred eeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHH---HHHHHcCCCC
Confidence 87644321 22346899999999999999999999999999999999999999976421 222 2222222222
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. . ... ...+.+|+.+||+.||.+|||+.+++++
T Consensus 244 ~~--~----~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 PV--S----LHY----SYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CC--C----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC--C----ccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1 111 1247889999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-54 Score=432.44 Aligned_cols=257 Identities=21% Similarity=0.342 Sum_probs=211.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
...|..+++||+|+||+||+|.... +|+.||||++....... .+.+.+|+.+|++++|||||++++++.+.+.+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~-tg~~vAiK~i~~~~~~~----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRS-SGKLVAVKKMDLRKQQR----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEGGGCSS----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECC-CCCEEEEEEEecCchhH----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3568999999999999999998764 79999999997644332 456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
||||||+||+|.+++.. ..+++..+..++.||+.||.||| +++|+||||||+||||+.+|.+||+|||+++.
T Consensus 148 ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 219 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 219 (346)
T ss_dssp EEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCcee
Confidence 99999999999999974 46899999999999999999999 77899999999999999999999999999998
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
+...... ....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+... ..+...+.. ...+..
T Consensus 220 ~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~~---~~~~~~ 290 (346)
T 4fih_A 220 VSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMKMIRD---NLPPRL 290 (346)
T ss_dssp CCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHH---SSCCCC
T ss_pred cCCCCCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHHHHHHc---CCCCCC
Confidence 7654322 2457899999999999999999999999999999999999999976422 222222222 111111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCc
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTA 488 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 488 (531)
... ......+.+|+.+||+.||++|||+.++++| +.+..
T Consensus 291 ~~~--------~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 291 KNL--------HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp SCG--------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred Ccc--------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 111 1112347889999999999999999999885 44433
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=427.87 Aligned_cols=265 Identities=20% Similarity=0.277 Sum_probs=215.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.+.||+|+||+||+|+... +|+.||||++....... ....+.+.+|+.+|++++|||||++++++.+.+.+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~-~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECC-CCCEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 568999999999999999998764 79999999997532211 1225778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|||||+||+|.+++.. .+.+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 110 vmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 9999999999999976 467999999999999999999999 778999999999999999999999999999987
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
............+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.. ...+...+ .... ..
T Consensus 183 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i---~~~~-~~-- 252 (311)
T 4aw0_A 183 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EGLIFAKI---IKLE-YD-- 252 (311)
T ss_dssp CTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHH---HHTC-CC--
T ss_pred CCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH---HcCC-CC--
Confidence 65444444456789999999999999999999999999999999999999997532 22222222 2211 11
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCchh
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKDVD 494 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~ 494 (531)
+.. ... ..+.+|+.+||+.||++|||+.|++.+ +.+.+++.+.+
T Consensus 253 ~p~----~~s----~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 253 FPE----KFF----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp CCT----TCC----HHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred CCc----ccC----HHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 111 111 247889999999999999999987532 44455554443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=427.03 Aligned_cols=254 Identities=21% Similarity=0.264 Sum_probs=205.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|...++||+|+||.||+|.+.. +|+.||||+++.... ..+|+.+|++++|||||++++++.+++.+
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~-~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQ-TGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREGPWV 125 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECC-CCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 44668888999999999999998764 799999999986432 23699999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC-CEEEeecCCC
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM-EARIADFGLA 359 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkL~Dfgla 359 (531)
|||||||+||+|.+++.. ...+++..+..++.||+.||.||| +++||||||||+||||+.+| .+||+|||+|
T Consensus 126 ~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla 198 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHA 198 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred EEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence 999999999999999976 457999999999999999999999 78899999999999999987 6999999999
Q ss_pred ccCCCCCcc---ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 360 RLMPDGHAQ---VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 360 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
+.+...... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.........+ ...
T Consensus 199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-------~~~ 271 (336)
T 4g3f_A 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI-------ASE 271 (336)
T ss_dssp EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH-------HHS
T ss_pred eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH-------HcC
Confidence 987543221 1223468999999999999999999999999999999999999999875443222211 112
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 486 (531)
..+...+. ... ...+.+++.+||+.||.+|||+.|++++|..
T Consensus 272 ~~~~~~~~----~~~----s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 272 PPPIREIP----PSC----APLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp CCGGGGSC----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCchhcC----ccC----CHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 21111111 111 2347889999999999999999999998855
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=415.60 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=198.7
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe----CCceE
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR----PDCHL 281 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~ 281 (531)
...++||+|+||+||+|.+.. ++..||||.+....... ...+.|.+|+.+|++++|||||+++++|.+ ...+|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECC-CCeEEEEEEEchhhCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 556789999999999998764 78899999997644332 236789999999999999999999999865 34679
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeeccCCCCeeeCC-CCCEEEeecCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR--IIHRNITPSSVLIDD-DMEARIADFGL 358 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NILl~~-~~~vkL~Dfgl 358 (531)
||||||+||+|.+++.. ...+++..+..++.||+.||.||| +++ |+||||||+|||++. ++.+||+|||+
T Consensus 106 lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcC
Confidence 99999999999999976 467999999999999999999999 555 999999999999985 79999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
|+...... ....+||+.|||||++.+ +|+.++|||||||++|||+||+.||.+... ...+. ........
T Consensus 179 a~~~~~~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~---~~~~~---~~i~~~~~ 247 (290)
T 3fpq_A 179 ATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIY---RRVTSGVK 247 (290)
T ss_dssp GGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---HHHHH---HHHTTTCC
T ss_pred CEeCCCCc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc---HHHHH---HHHHcCCC
Confidence 98644321 234689999999998865 699999999999999999999999975422 12222 22222211
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+ ..++. ... ..+.+++.+||+.||.+|||+.++++|
T Consensus 248 ~-~~~~~----~~~----~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 248 P-ASFDK----VAI----PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp C-GGGGG----CCC----HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C-CCCCc----cCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 11111 111 237889999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-53 Score=433.82 Aligned_cols=256 Identities=21% Similarity=0.335 Sum_probs=211.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|..+++||+|+||.||+|.... +|+.||||++....... .+.+.+|+.+|++++|||||++++++.+.+.+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~-tg~~vAiK~i~~~~~~~----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRS-SGKLVAVKKMDLRKQQR----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEESTTCSS----GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECC-CCCEEEEEEEeccchhH----HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence 4679999999999999999998764 79999999997654333 456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
||||||+||+|.+++.. ..+++..+..++.||+.||.||| +++||||||||+||||+.+|.+||+|||+|+.
T Consensus 225 iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~ 296 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 296 (423)
T ss_dssp EEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceE
Confidence 99999999999999974 46899999999999999999999 77899999999999999999999999999998
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
+...... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+... ..+...+. ....+..
T Consensus 297 ~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~---~~~~~~~ 367 (423)
T 4fie_A 297 VSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMKMIR---DNLPPRL 367 (423)
T ss_dssp CCSSCCC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHH---HSCCCCC
T ss_pred CCCCCcc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHHHHHH---cCCCCCC
Confidence 7654322 2457899999999999999999999999999999999999999975422 22222222 1111111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccC
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDT 487 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 487 (531)
... ... ...+.+|+.+||..||.+|||+.++++| |.+.
T Consensus 368 ~~~----~~~----s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 368 KNL----HKV----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp SCT----TSS----CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ccc----ccC----CHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 111 111 1247889999999999999999999885 4543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-53 Score=427.00 Aligned_cols=265 Identities=22% Similarity=0.295 Sum_probs=214.4
Q ss_pred hcccccccccccccceeEEEEEeeeCC----CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCC-CcccccceeEE
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPES----NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH-RNIVPLLAHMV 275 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~ 275 (531)
..++|.+.+.||+|+||+||+|.+... .++.||||.+....... ..+.|.+|+.+|.+++| ||||+++|+|.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~---~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS---EHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH---HHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 357889999999999999999987532 34689999997644322 25779999999999965 99999999997
Q ss_pred eC-CceEEEEeccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCC
Q 009595 276 RP-DCHLLVSEFMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSS 342 (531)
Q Consensus 276 ~~-~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 342 (531)
.. ..++||||||++|+|.++|+.... ....+++..+..++.|||+||.||| +++||||||||+|
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~N 215 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN 215 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccc
Confidence 65 568999999999999999976321 1345899999999999999999999 6789999999999
Q ss_pred eeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccch
Q 009595 343 VLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHT 421 (531)
Q Consensus 343 ILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~ 421 (531)
||+++++++||+|||+|+.+............+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+...
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~-- 293 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-- 293 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC--
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999998766544445556789999999999999999999999999999999998 9999987532
Q ss_pred hhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 422 EEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 422 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
...+...+........| ..+ ...+.+++.+||+.||.+|||+.+|+++|+.+
T Consensus 294 -~~~~~~~i~~g~~~~~p----------~~~---~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 294 -DEEFCRRLKEGTRMRAP----------DYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp -SHHHHHHHHHTCCCCCC----------TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHHHcCCCCCCC----------ccC---CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 22233333322111111 111 12478899999999999999999999999765
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=408.50 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=191.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.+.||+|+||+||+|.... +|+.||||++....... ......+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT-TGQKVALKIINKKVLAK-SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT-TCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEeHHHcCC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 679999999999999999998754 79999999997643322 1225678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||| +|+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.++++||+|||+|+..
T Consensus 91 vmEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EEECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EEeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeec
Confidence 99999 6799999976 467999999999999999999999 778999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKF-SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
..... ....+||+.|||||++.+..| +.++||||+||++|+|+||+.||.+.. ...+... ..... +.
T Consensus 163 ~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~----~~~~~~~---i~~~~-~~- 230 (275)
T 3hyh_A 163 TDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES----IPVLFKN---ISNGV-YT- 230 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHH---HHHTC-CC-
T ss_pred CCCCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC----HHHHHHH---HHcCC-CC-
Confidence 54322 234689999999999998876 579999999999999999999997532 2222222 22211 11
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+.. .. ...+.+++.+||+.||.+|||+.++++|
T Consensus 231 -~p~----~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 231 -LPK----FL----SPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -CCT----TS----CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -CCC----CC----CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111 11 1247889999999999999999999884
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=412.52 Aligned_cols=270 Identities=23% Similarity=0.292 Sum_probs=200.7
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC----
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD---- 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---- 278 (531)
..|...++||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||+++|+|..++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~~~~~-----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREER-----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE---TTEEEEEEEECGGGHH-----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccchh-----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 3467788999999999999987 6899999999753321 223345777778899999999999998754
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeeccCCCCeeeCCCCCEEE
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY-----HRPRIIHRNITPSSVLIDDDMEARI 353 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlkp~NILl~~~~~vkL 353 (531)
.+|||||||++|||.++++. ..+++..+..++.|+++||.|||+. +.++|+||||||+|||++.++++||
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki 149 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEE
Confidence 57999999999999999975 4689999999999999999999953 2348999999999999999999999
Q ss_pred eecCCCccCCCCCcc--ceecccccCccccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCCcccch----
Q 009595 354 ADFGLARLMPDGHAQ--VSTSIVAGTVGYIAPEYHQTL------KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHT---- 421 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~P~~~~~~~~---- 421 (531)
+|||+++........ ......+||+.|||||++.+. .++.++|||||||++|||+||..||.......
T Consensus 150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~ 229 (303)
T 3hmm_A 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred EeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence 999999876544322 122346799999999998764 46789999999999999999987764321100
Q ss_pred ----hhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 422 ----EEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 422 ----~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
................... .+.... ...+....+.+|+.+||+.||.+|||+.+|++.|+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~rp-~~p~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 230 DLVPSDPSVEEMRKVVCEQKLRP-NIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCC-CCCGGG---GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcccccchHHHHHHHHhcccCCC-CCCccc---cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0011111122222111111 111111 122445568899999999999999999999999987654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=414.48 Aligned_cols=246 Identities=20% Similarity=0.274 Sum_probs=193.8
Q ss_pred ccccccccccccceeEEEEEeee--CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 203 DCSASLEKIRSRASGEIYIAELP--ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
++|.+++.||+|+||+||+|+.. ..+++.||||+++.......+ ...+.+|+.+|++++|||||++++++.+++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD--RVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE--CC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH--HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 56999999999999999999763 236789999999754322111 34577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+|||||+||+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.+|.+||+|||+|+
T Consensus 102 ~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp EEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred EEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccce
Confidence 999999999999999976 457999999999999999999999 7789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
........ ....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+... ..+.. ...... +.
T Consensus 175 ~~~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~----~~~~~---~i~~~~-~~ 244 (304)
T 3ubd_A 175 ESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR----KETMT---MILKAK-LG 244 (304)
T ss_dssp C-----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH---HHHHCC-CC
T ss_pred eccCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH----HHHHH---HHHcCC-CC
Confidence 76543322 2347899999999999999999999999999999999999999976422 22222 222211 11
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS 477 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 477 (531)
. . .... ..+.+++.+||+.||.+|||+
T Consensus 245 ~--p----~~~s----~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 245 M--P----QFLS----PEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp C--C----TTSC----HHHHHHHHHHTCSSGGGSTTC
T ss_pred C--C----CcCC----HHHHHHHHHHcccCHHHCCCC
Confidence 0 0 1111 247889999999999999996
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=401.23 Aligned_cols=254 Identities=20% Similarity=0.302 Sum_probs=190.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC----
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD---- 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---- 278 (531)
++|..++.||+|+||+||+|+... +|+.||||+++..... ...+.+.+|+.+|++++|||||++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~---~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV-DDCNYAIKRIRLPNRE---LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT-TCCEEEEEEEEECSSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred hhCEEeeEEecCCCeEEEEEEECC-CCCEEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 458899999999999999998754 7899999999765432 22567899999999999999999999987644
Q ss_pred --------ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC
Q 009595 279 --------CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME 350 (531)
Q Consensus 279 --------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~ 350 (531)
.+|+|||||++|+|.+++.... .....++..+..++.||++||.||| +++|+||||||+|||++.++.
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~ 156 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDV 156 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCC
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCc
Confidence 3689999999999999997521 1234566778899999999999999 678999999999999999999
Q ss_pred EEEeecCCCccCCCCCcc----------ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 009595 351 ARIADFGLARLMPDGHAQ----------VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQH 420 (531)
Q Consensus 351 vkL~Dfgla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~ 420 (531)
+||+|||+|+.+...... ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-- 231 (299)
T 4g31_A 157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-- 231 (299)
T ss_dssp EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--
Confidence 999999999977543221 11234679999999999999999999999999999999996 775321
Q ss_pred hhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 421 TEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 421 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.....+........+. ........+.+++.+||+.||.+|||+.+++++
T Consensus 232 ----~~~~~~~~~~~~~~p~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 232 ----ERVRTLTDVRNLKFPP----------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp ----HHHHHHHHHHTTCCCH----------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----HHHHHHHHHhcCCCCC----------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111122222211111 112222346779999999999999999999873
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=407.13 Aligned_cols=265 Identities=21% Similarity=0.301 Sum_probs=203.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe-----
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR----- 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----- 276 (531)
.++|.+++.||+|+||+||+|.... +|+.||||+++...... ...+.+.+|+.+|+.++|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~-t~~~vAiK~i~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRL-TGQQVAIKKIPNAFDVV--TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEETTTTSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECC-CCCEEEEEEECccccch--HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 3679999999999999999998764 79999999997644332 225678899999999999999999998764
Q ss_pred -CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 277 -PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 277 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
...+|||||||+ |+|.+++.. ...+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~D 201 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGD 201 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECC
T ss_pred cCCEEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEee
Confidence 357899999996 589999964 568999999999999999999999 77899999999999999999999999
Q ss_pred cCCCccCCCCC--ccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHH
Q 009595 356 FGLARLMPDGH--AQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN 432 (531)
Q Consensus 356 fgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~ 432 (531)
||+++.+.... ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+... ...+ ..+..
T Consensus 202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l-~~I~~ 277 (398)
T 4b99_A 202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQL-QLIMM 277 (398)
T ss_dssp CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHH-HHHHH
T ss_pred cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHH-HHHHH
Confidence 99998765432 12223457899999999998875 468999999999999999999999976422 1222 22222
Q ss_pred HhccCCCCccccccc---------------cCCC----cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 433 VMTSENPNRAIDSKL---------------LGNG----YEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 433 ~~~~~~~~~~~d~~l---------------~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
....+.. ...... .... ++.....+.+|+.+||..||.+|||+.++++|
T Consensus 278 ~~g~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 278 VLGTPSP--AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHCCCCG--GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hcCCCCh--HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1111111 000000 0000 00112347889999999999999999999885
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=389.17 Aligned_cols=199 Identities=23% Similarity=0.350 Sum_probs=170.4
Q ss_pred cccccccccccccceeEEEEEeeeC--CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE--SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPD 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 278 (531)
.+.|.+.++||+|+||+||+|+.+. .+++.||||.+..... ..++.+|+.+|+.+ +||||+++++++.+.+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~------~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH------PIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC------HHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC------HHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 4779999999999999999998642 3578899999976433 34577899999998 6999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC-CCEEEeecC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD-MEARIADFG 357 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkL~Dfg 357 (531)
.+|+|||||++|+|.+++. .+++..+..++.||+.||.||| ++||+||||||+|||++.+ +.+||+|||
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 9999999999999999984 3889999999999999999999 7789999999999999876 799999999
Q ss_pred CCccCCCCCcc--------------------------ceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhC
Q 009595 358 LARLMPDGHAQ--------------------------VSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMG 410 (531)
Q Consensus 358 la~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg 410 (531)
+|+........ ...+..+||+.|+|||++.+. .|+.++||||+||++|||+||
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99865433211 112345799999999999876 489999999999999999999
Q ss_pred CCCCCC
Q 009595 411 KLPSDD 416 (531)
Q Consensus 411 ~~P~~~ 416 (531)
+.||..
T Consensus 244 ~~Pf~~ 249 (361)
T 4f9c_A 244 RYPFYK 249 (361)
T ss_dssp CSSSSC
T ss_pred CCCCCC
Confidence 999854
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=405.36 Aligned_cols=253 Identities=23% Similarity=0.287 Sum_probs=208.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.+.||+|+||.||+|.... +|+.||+|++....... .+.+.+|+.+|+.++|||||++++++.+...+||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~-tg~~~AiK~i~~~~~~~----~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPHESD----KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSHHH----HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECC-CCCEEEEEEEeccchhh----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 679999999999999999998764 79999999997654332 5678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC--CCEEEeecCCCc
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD--MEARIADFGLAR 360 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~--~~vkL~Dfgla~ 360 (531)
|||||+||+|.+++.. ....+++..+..++.||+.||.||| +++|+||||||+|||++.+ +.+||+|||+++
T Consensus 232 v~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~ 305 (573)
T 3uto_A 232 IYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305 (573)
T ss_dssp EEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred EEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeecccee
Confidence 9999999999999963 2457999999999999999999999 7789999999999999854 899999999999
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
.+..... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+... ..... .+......
T Consensus 306 ~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~----~~~~~---~i~~~~~~- 374 (573)
T 3uto_A 306 HLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----DETLR---NVKSCDWN- 374 (573)
T ss_dssp ECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHH---HHHTTCCC-
T ss_pred EccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHHH---HHHhCCCC-
Confidence 8765432 2346899999999999999999999999999999999999999976422 22222 22211111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+........ ...+.+|+.+||+.||.+|||+.++++|
T Consensus 375 --~~~~~~~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 375 --MDDSAFSGI----SEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp --CCSGGGTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CCcccccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111111 2247789999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=403.15 Aligned_cols=255 Identities=21% Similarity=0.254 Sum_probs=202.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchh--hhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSL--LNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.++|.+++.||+|+||.||+|+... +|+.||||++....... ..........++.+++.++|||||++++++.+.+.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~-tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEecccCeEEEEEEECC-CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 3679999999999999999998764 89999999997532111 11112223345677888999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
+|||||||+||+|.++|.. ...+++..+..++.||+.||.||| ++|||||||||+||||+.+|++||+|||+|
T Consensus 267 lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp EEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEeccccee
Confidence 9999999999999999976 467999999999999999999999 788999999999999999999999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+.+.... ....+||+.|||||++.. ..|+.++|+|||||++|||++|+.||.+...... ..+ ........
T Consensus 340 ~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i---~~~i~~~~- 410 (689)
T 3v5w_A 340 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEI---DRMTLTMA- 410 (689)
T ss_dssp EECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHH---HHHHHHCC-
T ss_pred eecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHH---HHhhcCCC-
Confidence 8775543 234689999999999974 5799999999999999999999999976432211 122 22222211
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-----SKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 483 (531)
+.. . .... ..+.+|+.+||+.||.+|++ +.+|++|
T Consensus 411 ~~~--p----~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 VEL--P----DSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CCC--C----TTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCC--C----ccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 110 0 1111 23788999999999999998 5777664
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=373.56 Aligned_cols=278 Identities=25% Similarity=0.401 Sum_probs=232.4
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..++|...+.||+|+||.||+|.+. +|+.||||++....... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPESSQG----IEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT--TCCEEEEEECCSCCSSH----HHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHhccCccceeecCCCeeEEEEEEC--CCCEEEEEEecccChHH----HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 5688999999999999999999864 68899999987654332 56788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++.........+++..+..++.|++.||.||| .++++||||||+||+++.++.+||+|||++.
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999999999999999754334456999999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
...............||+.|+|||++.+..++.++||||||+++|+|+||+.||....+.. ......|.......+...
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-CCCHHHHTHHHHTTTCCC
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH-HHHHHHHhhhccccccHH
Confidence 7654333223344568999999999988899999999999999999999999997654422 233445554444445555
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..+++.+...........+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 555655555666777888999999999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=373.63 Aligned_cols=285 Identities=32% Similarity=0.554 Sum_probs=236.5
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..++|...+.||+|+||.||+|... +|+.||||++........ ...+.+|+.+++.++||||+++++++......
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQGG---ELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC-----C---CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccCchH---HHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 5688999999999999999999754 688999999976432211 23578999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+..+++||||||+|||++.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999999998755556679999999999999999999995433489999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-cchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFF-QHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~-~~~~~~~l~~~~~~~~~~~~~ 439 (531)
......... .....||+.|+|||++.+..++.++||||||+++|+|+||+.||+... ..........|+.........
T Consensus 183 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 3uim_A 183 LMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261 (326)
T ss_dssp ECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred ccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence 776543332 244569999999999988889999999999999999999999996322 112233455666666666666
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCCC
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIK 491 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 491 (531)
....+..+...........+.+++.+||+.||.+|||+.+|+++|+......
T Consensus 262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 6666666666777888888999999999999999999999999998865443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=370.63 Aligned_cols=289 Identities=23% Similarity=0.315 Sum_probs=224.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.... +|+.||||++....... .....+.+|+.+++.++||||+++++++...+..|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHIL-TGREVAIKIIDKTQLNP--TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEhhcCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 4789999999999999999998754 78999999997643322 23567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ...+++..+..++.|+++||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp EEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred EEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 99999999999999975 356899999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS-EKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
...... ....+||+.|+|||++.+..+. .++|||||||++|+|+||+.||.+... ..+... ..... ..
T Consensus 164 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~---i~~~~-~~ 232 (328)
T 3fe3_A 164 FTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL----KELRER---VLRGK-YR 232 (328)
T ss_dssp GSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH---HHHCC-CC
T ss_pred cCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH----HHHHHH---HHhCC-CC
Confidence 654432 2346799999999999888765 899999999999999999999976422 222221 11111 11
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh--cc------CcC-------CCchhhhhhccCCCCC
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML--SD------TAL-------IKDVDFLKMHKRMDFD 505 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L--~~------~~~-------~~~~~~~~~~~~~~~~ 505 (531)
. . ... ...+.+++.+||..||.+|||+.+++++- .. +.+ ..+....+....+.++
T Consensus 233 ~--p----~~~----s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (328)
T 3fe3_A 233 I--P----FYM----STDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMGYS 302 (328)
T ss_dssp C--C----TTS----CHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTCCCCCCCCCCCCCCCHHHHHHHHHTTCC
T ss_pred C--C----CCC----CHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcccccCcccCCCcCcccHHHHHHHHHCCCC
Confidence 0 0 011 12377899999999999999999999862 11 111 1111223444556666
Q ss_pred ChHHHHHhhHHHHhhh
Q 009595 506 NDDCVELIQQEIYTEW 521 (531)
Q Consensus 506 ~~~~~~~~~~~~~~~~ 521 (531)
.++..+++++.+|.+.
T Consensus 303 ~~~~~~~l~~~~~~~~ 318 (328)
T 3fe3_A 303 QEEIQESLSKMKYDEI 318 (328)
T ss_dssp HHHHHHHHHTTCCSHH
T ss_pred HHHHHHHHHcCCCCHH
Confidence 6667777776666554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=357.80 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=207.5
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|...+.||+|+||+||+|.... +|+.||||++....... .+.+.+|+.++++++||||+++++++...+..
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQPK----KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTT-TCCEEEEEEEEGGGCSC----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECC-CCcEEEEEEeecccccH----HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 34779999999999999999997653 78999999997644333 46688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++.. ..+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp EEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence 999999999999999975 35899999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ...+... .....+.
T Consensus 165 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~----~~~~~~~ 235 (297)
T 3fxz_A 165 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLI----ATNGTPE 235 (297)
T ss_dssp ECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHH----HHHCSCC
T ss_pred ecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----HhCCCCC
Confidence 76554332 2346799999999999999999999999999999999999999975422 1111111 1111111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..... .....+.+++.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~--------~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 LQNPE--------KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CSCGG--------GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCcc--------ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111 112347889999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=356.19 Aligned_cols=260 Identities=24% Similarity=0.422 Sum_probs=210.3
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.+.. +++.||+|.+...... ..+.+.+|+.++++++||||+++++++...+..+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~~va~K~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRE-TGEVMVMKELIRFDEE----TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEESCCCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECC-CCcEEEEEEeccCCHH----HHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4678889999999999999998764 7899999998654332 2677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ....+++..+..++.|+++||.||| +.+++||||||+|||++.++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp EEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 99999999999999975 2456899999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccce------------ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhh--HHH
Q 009595 362 MPDGHAQVS------------TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK--SLV 427 (531)
Q Consensus 362 ~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~--~l~ 427 (531)
......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~ 237 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence 654322111 114579999999999999999999999999999999999999987643322111 111
Q ss_pred HHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 428 RWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 428 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
...... .+... ...+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 238 ~~~~~~----~~~~~-------------~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 238 GFLDRY----CPPNC-------------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HHHHHT----CCTTC-------------CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccccc----CCCCC-------------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111111 11110 0127889999999999999999999999988743
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=362.34 Aligned_cols=268 Identities=24% Similarity=0.307 Sum_probs=208.5
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc-
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC- 279 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~- 279 (531)
..++|...+.||+|+||+||+|.+ .++.||||++...... ......|+.++++++||||+++++++.....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQL---LNEYVAVKIFPIQDKQ-----SWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEE---TTEEEEEEEECGGGHH-----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred chhhchhhheecccCceEEEEEEE---CCCEEEEEEeecCchH-----HHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 457899999999999999999987 5899999999754322 3455669999999999999999999987543
Q ss_pred ---eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeEeeccCCCCeeeC
Q 009595 280 ---HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP----------RIIHRNITPSSVLID 346 (531)
Q Consensus 280 ---~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~----------~ivH~Dlkp~NILl~ 346 (531)
+++||||+++|+|.+++.. ..+++..+..++.|++.||.||| +. +++||||||+|||++
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~ 165 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLK 165 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEEC
T ss_pred CceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEEC
Confidence 6999999999999999975 45899999999999999999999 66 999999999999999
Q ss_pred CCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCcccch
Q 009595 347 DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-----KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHT 421 (531)
Q Consensus 347 ~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~P~~~~~~~~ 421 (531)
.++.+||+|||++..+.............||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.....
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 9999999999999877655443334456799999999998863 46678999999999999999999997532211
Q ss_pred hh---------hHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 422 EE---------KSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 422 ~~---------~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.. .....+........ ....+..... .......+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDMQEVVVHKK-KRPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSC-CCCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhhhhccCCchhhhhhhhhccc-CCCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 01111111111111 1111111111 1123455889999999999999999999999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=366.49 Aligned_cols=265 Identities=22% Similarity=0.320 Sum_probs=213.5
Q ss_pred hcccccccccccccceeEEEEEeeeC------CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCccccccee
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPE------SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAH 273 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~ 273 (531)
..++|.+.+.||+|+||.||+|.+.. .++..||||+++..... .....+.+|+.+++.+ +||||++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH---HHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH---HHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 34788999999999999999998632 34568999999764332 2367789999999999 89999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCC
Q 009595 274 MVRPDCHLLVSEFMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341 (531)
Q Consensus 274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 341 (531)
+...+..|+||||+++|+|.+++..... ....+++..+..++.||+.||.||| +++|+||||||+
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~ 232 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAAR 232 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGG
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchh
Confidence 9999999999999999999999986321 1245899999999999999999999 678999999999
Q ss_pred CeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccc
Q 009595 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQH 420 (531)
Q Consensus 342 NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~ 420 (531)
|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..||.+...
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~- 311 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV- 311 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 99999999999999999987665433333344567889999999999999999999999999999999 9999876432
Q ss_pred hhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 421 TEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 421 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..+...+........+ .. ....+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 312 ---~~~~~~~~~~~~~~~~---------~~----~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 312 ---EELFKLLKEGHRMDKP---------AN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp ---GGHHHHHHTTCCCCCC---------TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHHhcCCCCCCC---------CC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2232222221111111 11 1124788999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=356.77 Aligned_cols=261 Identities=27% Similarity=0.393 Sum_probs=202.1
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..++|.+.+.||+|+||+||+|.+ +|+.||||++....... .....+.+|+.++++++||||+++++++...+..
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHA--ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCCSH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ChhHceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 347789999999999999999976 68899999997654332 2357788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR--IIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
++||||+++|+|.+++.... ....+++..++.++.|++.||.||| +.+ ++||||||+|||++.++.+||+|||+
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred EEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999999999997511 1134899999999999999999999 777 99999999999999999999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+... ......+... ...
T Consensus 186 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~----~~~~~~~~~~--~~~ 257 (309)
T 3p86_A 186 SRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP----AQVVAAVGFK--CKR 257 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH----HHHHHHHHHS--CCC
T ss_pred Ccccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhc--CCC
Confidence 986543321 12346799999999999999999999999999999999999999976432 2222222111 111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.. +. .... ..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 258 ~~--~~----~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 258 LE--IP----RNLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp CC--CC----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC--CC----ccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 10 11 1111 24788999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=369.00 Aligned_cols=261 Identities=21% Similarity=0.302 Sum_probs=210.3
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|...+.||+|+||.||+|.+.. +++.||||.++..... .....+.+|+.+|++++||||+++++++...+..
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRA-DNTLVAVKSCRETLPP---DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEECCTTSCH---HHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred chHHeEEeeEeccCCCCeEEEEEEec-CCeEEEEEEccccCCH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 45678899999999999999998764 6889999999754322 2256788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||+++
T Consensus 188 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 999999999999999975 2346899999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
...............+++.|+|||.+.+..++.++|||||||++|||+| |..||.+... ......+... ...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~----~~~~~~~~~~---~~~ 334 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN----QQTREFVEKG---GRL 334 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH----HHHHHHHHTT---CCC
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcC---CCC
Confidence 7554322222122345778999999998899999999999999999998 9999876532 2222222221 111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
. .+ ..+ ...+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 335 ~---~~----~~~---~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 335 P---CP----ELC---PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp C---CC----TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---CC----CCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1 01 111 124788999999999999999999999998753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=351.81 Aligned_cols=270 Identities=30% Similarity=0.463 Sum_probs=214.5
Q ss_pred ccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEec
Q 009595 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEF 286 (531)
Q Consensus 207 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 286 (531)
..+.||+|+||.||+|.. +++.||||++............+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 35 ~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 111 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY 111 (307)
T ss_dssp TCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cCCccccCCCeEEEEEEE---CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence 348999999999999986 68899999997543222223367789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCC
Q 009595 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH 366 (531)
Q Consensus 287 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~ 366 (531)
+++|+|.+++.... ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 112 ~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 112 MPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187 (307)
T ss_dssp CTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS
T ss_pred cCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc
Confidence 99999999997532 2356899999999999999999999 6789999999999999999999999999998766543
Q ss_pred ccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC-CCccccc
Q 009595 367 AQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN-PNRAIDS 445 (531)
Q Consensus 367 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~d~ 445 (531)
.........||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+... ...... ....++.
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 263 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE---IEDEEKTIEDYIDK 263 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHH---HHTTSCCHHHHSCS
T ss_pred ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHH---hhhhhhhhhhhccc
Confidence 3333345679999999998865 5889999999999999999999999765433222222221 111111 1111122
Q ss_pred cccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 446 KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 446 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
. ...........+.+++.+||+.||.+|||+.+++++|+++.
T Consensus 264 ~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 264 K-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp S-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred c-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1 23344566677899999999999999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=359.78 Aligned_cols=257 Identities=20% Similarity=0.294 Sum_probs=207.5
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhh--hHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLL--NIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.+.|.+.+.||+|+||.||+|.... +|+.||+|++........ ......+.+|+.++++++||||+++++++.+...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECC-CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4678999999999999999998764 789999999986543211 0124678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC----CEEEee
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM----EARIAD 355 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~----~vkL~D 355 (531)
+++||||+++|+|.+++.. ...+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999964 467999999999999999999999 67899999999999998876 799999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
||++........ ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ..... ....
T Consensus 163 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~----~~~~~---~i~~ 232 (361)
T 2yab_A 163 FGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLA---NITA 232 (361)
T ss_dssp CSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHH---HHHT
T ss_pred cCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHHHH---HHHh
Confidence 999987765422 2346799999999999998999999999999999999999999976422 22222 1111
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. . .+++...... ...+.+++.+||..||.+|||+.+++++
T Consensus 233 ~~-~--~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 233 VS-Y--DFDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp TC-C--CCCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cC-C--CCCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 1 0111111111 2347889999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.31 Aligned_cols=267 Identities=23% Similarity=0.349 Sum_probs=209.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|.+.+.||+|+||.||+|.... +++.||+|.+....... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTI-LNIKVAIKAIFIPPREK-EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT-TCSEEEEEEEECCSSCC-HHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECC-CCCeEEEEEeccCcccc-HHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 4679999999999999999998654 78899999996543322 233678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 88 lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 99999999999999976 357899999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
....... ......||+.|+|||.+.+..++.++||||||+++|+|+||+.||.+..... ..........+..
T Consensus 161 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~~~ 232 (294)
T 4eqm_A 161 LSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIKHIQDSVPNV 232 (294)
T ss_dssp C--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-------HHHHHHSSCCCCH
T ss_pred ccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhhccCCCc
Confidence 6543222 2234579999999999999999999999999999999999999997642211 1111122221111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhccCcCCC
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-NSKDVRSMLSDTALIK 491 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 491 (531)
. ...... ....+.+++.+||..||.+|| ++.++.+.|..+....
T Consensus 233 ~--~~~~~~----~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 233 T--TDVRKD----IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp H--HHSCTT----SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred c--hhcccC----CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0 011111 123478899999999999998 9999999998875443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=363.18 Aligned_cols=266 Identities=21% Similarity=0.306 Sum_probs=211.6
Q ss_pred hcccccccccccccceeEEEEEeee----CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEE
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMV 275 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 275 (531)
..++|.+.+.||+|+||.||+|.+. ..+++.||||++...... ...+.+.+|+.++.++ +||||+++++++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH---HHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 5688999999999999999999852 346689999999764332 2256789999999999 8999999999988
Q ss_pred eCCc-eEEEEeccCCCCHHHHHhhccCC----------------------------------------------------
Q 009595 276 RPDC-HLLVSEFMKNGSLLEILNDVSQG---------------------------------------------------- 302 (531)
Q Consensus 276 ~~~~-~~lv~E~~~~gsL~~~l~~~~~~---------------------------------------------------- 302 (531)
..+. .++||||+++|+|.+++......
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 7654 89999999999999999763211
Q ss_pred ----------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccceec
Q 009595 303 ----------RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTS 372 (531)
Q Consensus 303 ----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~ 372 (531)
...+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++.............
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 122899999999999999999999 6789999999999999999999999999998775544434444
Q ss_pred ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCC
Q 009595 373 IVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNG 451 (531)
Q Consensus 373 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 451 (531)
...||+.|+|||++.+..++.++||||||+++|||+| |..||.+.... ..+...+........+. ..
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~---------~~ 321 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGTRMRAPD---------YT 321 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---HHHHHHHHHTCCCCCCT---------TC
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh---HHHHHHHHcCCCCCCCC---------CC
Confidence 5678999999999999999999999999999999998 99999764322 22222222211111110 11
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 452 YEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 452 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
...+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus 322 ----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 322 ----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 124788999999999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=353.83 Aligned_cols=253 Identities=21% Similarity=0.258 Sum_probs=206.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|.+.+.||+|+||.||+|.... +++.||+|.+...... ...+.+|+.+++.++||||+++++++.+.+..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVKGTD-----QVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCCTHH-----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECC-CCcEEEEEEEecCccc-----HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 3678999999999999999998754 7899999999754321 456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC--CCCEEEeecCCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD--DMEARIADFGLA 359 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~--~~~vkL~Dfgla 359 (531)
+|||||++|+|.+++.. ....+++..+..++.|++.||.||| +.|++||||||+|||++. ++.+||+|||++
T Consensus 78 lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 78 MIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 99999999999999964 2346899999999999999999999 678999999999999987 789999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
..+..... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ..+... .......
T Consensus 152 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~---i~~~~~~ 221 (321)
T 1tki_A 152 RQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----QQIIEN---IMNAEYT 221 (321)
T ss_dssp EECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHH---HHHTCCC
T ss_pred eECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH----HHHHHH---HHcCCCC
Confidence 88765432 2346789999999999998899999999999999999999999976422 222221 1111111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+...... ....+.+++.+||..||.+|||+.+++++
T Consensus 222 ---~~~~~~~~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 222 ---FDEEAFKE----ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---CCHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CChhhhcc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01111111 12347889999999999999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=344.96 Aligned_cols=258 Identities=22% Similarity=0.334 Sum_probs=210.5
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.++.+++||||+++++++......+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGSMS-----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECBTTBC-----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred hhheeeeeeeccCCCceEEEEEec--CceeEEEEEeccCCCc-----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 477899999999999999999775 6778999999865433 356889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++... ...+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence 999999999999999752 346899999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... ......+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||..... ......+. ......
T Consensus 154 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~---~~~~~~ 225 (268)
T 3sxs_A 154 VLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN----SEVVLKVS---QGHRLY 225 (268)
T ss_dssp CCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHHHH---TTCCCC
T ss_pred cchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh----HHHHHHHH---cCCCCC
Confidence 6554322 2233456788999999998889999999999999999999 9999876432 11111111 111111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCC
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALI 490 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 490 (531)
.+ ... ...+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 226 ---~~----~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 226 ---RP----HLA---SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ---CC----TTS---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ---CC----CcC---hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11 111 12478899999999999999999999999987653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=346.85 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=209.5
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++++++||||+++++++......+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEEECTTSBC-----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hhhceeeheecCCCccEEEEEEec--CCCeEEEEEecccccC-----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence 467889999999999999999875 6788999999865443 356889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRF 155 (269)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred EEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccc
Confidence 99999999999999964 3456899999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
...... .......||+.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ......+.... .+.
T Consensus 156 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~----~~~~~~~~~~~---~~~ 227 (269)
T 4hcu_A 156 VLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEVVEDISTGF---RLY 227 (269)
T ss_dssp BCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTTC---CCC
T ss_pred cccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH----HHHHHHHhcCc---cCC
Confidence 654321 12233457888999999998899999999999999999999 9999876422 22222222111 110
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.+. .. ...+.+++.+||+.||.+|||+.+++++|+++.
T Consensus 228 ---~~~---~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 228 ---KPR---LA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp ---CCT---TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCC---cC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 111 11 124788999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=350.08 Aligned_cols=277 Identities=21% Similarity=0.258 Sum_probs=214.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC--c
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD--C 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~ 279 (531)
.+.|.+.+.||+|+||.||+|.... +|+.||||++....... ....+.+|+.++++++||||+++++++.... .
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECGGGGGS---CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECC-CCcEEEEEEeccccccc---hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 4678999999999999999998764 68999999997533221 1566788999999999999999999988765 7
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee----CCCCCEEEee
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI----DDDMEARIAD 355 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl----~~~~~vkL~D 355 (531)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred EEEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence 7999999999999999975322 233899999999999999999999 6789999999999999 7888899999
Q ss_pred cCCCccCCCCCccceecccccCccccCccccc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHH
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ--------TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLV 427 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~ 427 (531)
||++......... ....||+.|+|||++. +..++.++|||||||++|||+||+.||...........+.
T Consensus 160 fg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 160 FGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp CTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred CCCceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 9999877654322 2356999999999886 5678999999999999999999999997543333333332
Q ss_pred HHHHHHhccCCCCcc---------c--cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 428 RWMRNVMTSENPNRA---------I--DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 428 ~~~~~~~~~~~~~~~---------~--d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
..+............ . ...............+.+++.+||+.||.+|||+.+++++.++.+-
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 222221111100000 0 0001122345566678899999999999999999999999987543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=355.49 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=208.1
Q ss_pred cccccccccccccceeEEEEEeeeC--CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE--SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.+.|.+.+.||+|+||.||+|.+.. ..+..||||++...... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE---RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 4678999999999999999998753 13456999999764332 225778999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 125 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp CEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred cEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 9999999999999999964 2457999999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCcc-ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 360 RLMPDGHAQ-VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 360 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+... ..+...+.......
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~~~~~~~~~~~~~ 274 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----RDVISSVEEGYRLP 274 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHHHHHHHTTCCCC
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHHcCCCCC
Confidence 877554222 22233456789999999998899999999999999999999 9999876432 22222222211111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.+ .. ....+.+++.+||..||.+|||+.++++.|+.+.
T Consensus 275 ~~---------~~----~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 275 AP---------MG----CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp CC---------TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC---------CC----cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 01 1124788999999999999999999999998863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=361.31 Aligned_cols=265 Identities=24% Similarity=0.315 Sum_probs=214.7
Q ss_pred hcccccccccccccceeEEEEEeeeC------CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCccccccee
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPE------SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAH 273 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~ 273 (531)
..++|.+.+.||+|+||.||+|.+.. ..+..||||++...... .....+.+|+.+++++ +||||++++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE---KDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH---HHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 34788999999999999999998642 23468999999765332 2357788999999999 99999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCC
Q 009595 274 MVRPDCHLLVSEFMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341 (531)
Q Consensus 274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 341 (531)
+...+..++||||+++|+|.+++..... ....+++..+..++.|++.||.||| +.+|+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcc
Confidence 9999999999999999999999986331 1245899999999999999999999 678999999999
Q ss_pred CeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccc
Q 009595 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQH 420 (531)
Q Consensus 342 NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~ 420 (531)
|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-- 298 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-- 298 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--
Confidence 99999999999999999987765443333345667899999999999999999999999999999999 999987642
Q ss_pred hhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 421 TEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 421 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
...+...+........+ ... ...+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus 299 --~~~~~~~~~~~~~~~~~---------~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 299 --VEELFKLLKEGHRMDKP---------SNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp --HHHHHHHHHTTCCCCCC---------SSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHHHHcCCCCCCC---------ccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 22333333221111111 111 124788999999999999999999999998864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=354.42 Aligned_cols=252 Identities=21% Similarity=0.273 Sum_probs=205.4
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|..++.||+|+||.||+|.... +|+.||+|++....... ......+.+|+.+++.++||||+++++++...+..|+
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEeHHHhhh-hhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 678999999999999999998754 78999999997532111 1125678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 83 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 83 VMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999999999999975 456899999999999999999999 678999999999999999999999999999864
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ..+...+. ... ..
T Consensus 156 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~---~~~-~~-- 223 (337)
T 1o6l_A 156 ISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELIL---MEE-IR-- 223 (337)
T ss_dssp CCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH---HCC-CC--
T ss_pred ccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH----HHHHHHHH---cCC-CC--
Confidence 43222 22346799999999999999999999999999999999999999865321 22222211 111 11
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
+. ... ...+.+++.+||+.||.+|| ++.++++|
T Consensus 224 ~p----~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 FP----RTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CC----TTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CC----CCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 00 111 12478899999999999999 89999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=357.48 Aligned_cols=266 Identities=21% Similarity=0.336 Sum_probs=213.3
Q ss_pred hcccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 276 (531)
..++|...+.||+|+||.||+|.... .+++.||||++...... .....+.+|+.++++++||||+++++++..
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---DMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 56789999999999999999998863 34589999999864332 235678999999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCC--------------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEee
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQG--------------------RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHR 336 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 336 (531)
.+..++||||+++|+|.+++...... ...+++..++.++.||++||.||| +++++||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 99999999999999999999763211 257899999999999999999999 6789999
Q ss_pred ccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 009595 337 NITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSD 415 (531)
Q Consensus 337 Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~ 415 (531)
||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987654332222334568999999999998899999999999999999999 999987
Q ss_pred CcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 416 DFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 416 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
+... ..+...+. ....+. . .... ...+.+++.+||+.||.+|||+.+++++|+++..
T Consensus 279 ~~~~----~~~~~~~~---~~~~~~--~-----~~~~---~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 279 GMAH----EEVIYYVR---DGNILA--C-----PENC---PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TSCH----HHHHHHHH---TTCCCC--C-----CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCh----HHHHHHHh---CCCcCC--C-----CCCC---CHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 6422 22222221 111111 0 0111 1247889999999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=351.57 Aligned_cols=265 Identities=22% Similarity=0.329 Sum_probs=213.7
Q ss_pred hcccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 276 (531)
..++|...+.||+|+||.||+|.... .++..||||++...... ...+.+.+|+.++++++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP---SELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH---HHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 35778999999999999999998632 34588999999754322 235778899999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHhhccC--------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEee
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQ--------------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHR 336 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 336 (531)
.+..++||||+++|+|.+++..... ....+++..++.++.|+++||.||| +++++||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCccc
Confidence 9999999999999999999986332 1234899999999999999999999 6789999
Q ss_pred ccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 009595 337 NITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSD 415 (531)
Q Consensus 337 Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~ 415 (531)
||||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987765543333344567889999999998889999999999999999999 999987
Q ss_pred CcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 416 DFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 416 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
+... ..+...+........+ .. ....+.+++.+||+.||.+|||+.+++++|+++.
T Consensus 255 ~~~~----~~~~~~~~~~~~~~~~---------~~----~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 255 GIPP----ERLFNLLKTGHRMERP---------DN----CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp TCCG----GGHHHHHHTTCCCCCC---------TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCH----HHHHHHhhcCCcCCCC---------cc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 6433 2232222221111111 11 1124788999999999999999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=372.35 Aligned_cols=262 Identities=24% Similarity=0.388 Sum_probs=211.6
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|...+.||+|+||.||+|.+. ++..||||+++..... .+.+.+|+.+|++++||||+++++++. .+..
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGSMS-----VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET--TTEEEEEEEECTTSBC-----HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred chHHeEEEEEcccCCceEEEEEEEC--CccEEEEEEecCCCcc-----HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 4577899999999999999999875 5788999999864432 567899999999999999999999886 5678
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++... ....+++..+..++.||+.||.||| +++++||||||+|||++.++.+||+|||+++
T Consensus 258 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp EEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 9999999999999999742 2246888999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+... ..+...+........+
T Consensus 333 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~----~~~~~~i~~~~~~~~~ 407 (454)
T 1qcf_A 333 VIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRALERGYRMPRP 407 (454)
T ss_dssp GBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHHHTCCCCCC
T ss_pred EcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCCCC
Confidence 76543211 1123446789999999998899999999999999999999 9999976532 2233322222111111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCCCch
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDV 493 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 493 (531)
. .+ ...+.+++.+||+.||.+|||+.+|++.|+++.....+
T Consensus 408 ~----------~~---~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 408 E----------NC---PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp T----------TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred C----------CC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 1 11 12478899999999999999999999999997654443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=349.72 Aligned_cols=250 Identities=20% Similarity=0.338 Sum_probs=204.5
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLV 283 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv 283 (531)
.|...+.||+|+||.||+|.... +|+.||||++....... .+.+.+|+.++++++||||+++++++...+..++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~-~g~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKH-SGRQVAVKMMDLRKQQR----RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTCCS----HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECC-CCcEEEEEEEeccchhH----HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 36667899999999999998753 78999999997654332 56688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCC
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~ 363 (531)
|||+++|+|.+++.. ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++....
T Consensus 121 ~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 192 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 192 (321)
T ss_dssp ECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecc
Confidence 999999999999863 46899999999999999999999 6789999999999999999999999999998765
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+. ....+....
T Consensus 193 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----~~~~~~~~---~~~~~~~~~ 263 (321)
T 2c30_A 193 KDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAMKRLR---DSPPPKLKN 263 (321)
T ss_dssp SSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHH---HSSCCCCTT
T ss_pred cCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHh---cCCCCCcCc
Confidence 43222 2346799999999999999999999999999999999999999875422 12222222 221111111
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. .....+.+++.+||+.||.+|||+.+++++
T Consensus 264 ~~--------~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 264 SH--------KVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp GG--------GSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cc--------cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 112247889999999999999999999985
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=363.52 Aligned_cols=256 Identities=19% Similarity=0.250 Sum_probs=206.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||+|+||.||+|.... +|+.||+|++....... .....+.+|+.+++.++||||+++++++.+.+..|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~-~~~~~a~K~i~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVL-AGQEYAAMIINTKKLSA--RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETT-TTEEEEEEEEESCSCHH--HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECC-CCcEEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 4678999999999999999997654 79999999998654432 22567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC---CCCCEEEeecCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID---DDMEARIADFGL 358 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~---~~~~vkL~Dfgl 358 (531)
+|||||++|+|.+++.. ...+++..+..++.||+.||.||| ++||+||||||+|||++ .++.+||+|||+
T Consensus 87 lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999999976 466999999999999999999999 67899999999999998 467899999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ...+...+...... .
T Consensus 160 a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~----~~~~~~~i~~~~~~-~ 232 (444)
T 3soa_A 160 AIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED----QHRLYQQIKAGAYD-F 232 (444)
T ss_dssp CBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHTCCC-C
T ss_pred eEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHhCCCC-C
Confidence 9876554322 234679999999999999899999999999999999999999986532 22222222221100 0
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. ..+......+.+++.+||+.||.+|||+.+++++
T Consensus 233 ~~---------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 PS---------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CT---------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Cc---------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 0011112347889999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=351.64 Aligned_cols=257 Identities=20% Similarity=0.299 Sum_probs=206.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhh--hHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLL--NIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.+.|...+.||+|+||.||+|.... +|+.||+|.+........ ......+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccceEeceEEeeCCCeEEEEEEECC-CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3668899999999999999998754 789999999976433211 1125678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC----CEEEee
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM----EARIAD 355 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~----~vkL~D 355 (531)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+|||++.++ .+||+|
T Consensus 89 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 9999999999999999964 467999999999999999999999 67899999999999999887 899999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ......+..
T Consensus 162 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~~~~--- 231 (326)
T 2y0a_A 162 FGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSA--- 231 (326)
T ss_dssp CTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHH---
T ss_pred CCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH----HHHHHHHHh---
Confidence 999987754322 2335799999999999988999999999999999999999999865422 111111111
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.... ......... ...+.+++.+||..||.+|||+.+++++
T Consensus 232 ~~~~---~~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 232 VNYE---FEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp TCCC---CCHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCCC---cCccccccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1100 011111111 2347889999999999999999999985
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=363.78 Aligned_cols=264 Identities=22% Similarity=0.323 Sum_probs=208.7
Q ss_pred cccccccccccccceeEEEEEeee----CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
.++|.+.+.||+|+||.||+|.+. ..+++.||||++....... ....+.+|+.++++++||||+++++++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ---DELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH---HHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh---hHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 467899999999999999999853 2357789999997543322 245688899999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHhhccC---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC---CE
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQ---GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM---EA 351 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~---~v 351 (531)
...++||||+++|+|.+++..... ....+++..++.++.||++||.||| +++|+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999986432 2245899999999999999999999 67899999999999999555 59
Q ss_pred EEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHH
Q 009595 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~ 430 (531)
||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+| |..||..... ..+...+
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~----~~~~~~i 299 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----QEVLEFV 299 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHH
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH
Confidence 9999999986533222222234568999999999999899999999999999999998 9999876422 2232222
Q ss_pred HHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.. ...+.. .... ...+.+++.+||+.||.+|||+.+|+++|..+.
T Consensus 300 ~~---~~~~~~-------~~~~---~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 300 TS---GGRMDP-------PKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HT---TCCCCC-------CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hc---CCCCCC-------CccC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 22 111111 0111 124788999999999999999999999997764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=356.26 Aligned_cols=257 Identities=22% Similarity=0.356 Sum_probs=204.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|.+.+.||+|+||.||+|.... +++.||||++....... ..+.+.+|+.+++.++||||+++++++...+..|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVD---CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECC-CCcEEEEEEEEcccccc---hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 4789999999999999999998754 78899999997543321 1356788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.||+||||||+|||++.++.+||+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 154 (323)
T ss_dssp EEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccce
Confidence 99999999999999854 567999999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKF-SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
+.............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ......+... ....
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~----~~~~ 228 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWKEK----KTYL 228 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT--SHHHHHHHTT----CTTS
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHhcc----cccC
Confidence 654333223345679999999999988775 77999999999999999999999764321 1112221111 1000
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
. ........+.+++.+||+.||.+|||+.+++++-
T Consensus 229 ~---------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 229 N---------PWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp T---------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred C---------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 0 0011123477899999999999999999998763
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=349.76 Aligned_cols=266 Identities=20% Similarity=0.298 Sum_probs=214.8
Q ss_pred hcccccccccccccceeEEEEEee----eCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEE
Q 009595 201 KEDCSASLEKIRSRASGEIYIAEL----PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMV 275 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 275 (531)
..++|...+.||+|+||.||+|.+ ...+++.||||++...... ...+.+.+|+.++.++ +||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL---TEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH---HHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 457899999999999999999986 3346789999999864432 2257788999999999 9999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccC--------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCC
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQ--------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 341 (531)
..+..++||||+++|+|.+++..... ....+++..++.++.|+++||.||| +.+++||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccc
Confidence 99999999999999999999976321 1225899999999999999999999 678999999999
Q ss_pred CeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccc
Q 009595 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQH 420 (531)
Q Consensus 342 NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~ 420 (531)
||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|+|+| |+.||.+....
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999988766544333344567889999999998899999999999999999999 99998765322
Q ss_pred hhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 421 TEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 421 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..+...+........+ .. ....+.+++.+||+.||.+|||+.+++++|+++.
T Consensus 255 ---~~~~~~~~~~~~~~~~----------~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 255 ---SKFYKMIKEGFRMLSP----------EH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ---HHHHHHHHHTCCCCCC----------TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---hHHHHHhccCCCCCCc----------cc---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 2222222221111111 11 1124788999999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=344.08 Aligned_cols=258 Identities=26% Similarity=0.326 Sum_probs=193.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.+ +|+.||||++............+.+.+|+.+++.++||||+++++++...+..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE---TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred hhheeeeeeeccCCCeEEEEEEE---cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 36789999999999999999987 588999999976544433334577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC--------CCCEEE
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD--------DMEARI 353 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~--------~~~vkL 353 (531)
+||||+++++|.+++. ...+++..+..++.|++.||.|||+.+..+++||||||+||+++. ++.+||
T Consensus 83 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999985 357899999999999999999999432223999999999999986 778999
Q ss_pred eecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
+|||++........ ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+... ..... ..
T Consensus 158 ~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~---~~ 226 (271)
T 3dtc_A 158 TDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG----LAVAY---GV 226 (271)
T ss_dssp CCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH----HHHHH---HH
T ss_pred ccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHH---hh
Confidence 99999986654322 235689999999999998999999999999999999999999976422 11111 11
Q ss_pred hccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 434 MTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 434 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.... ...... ... ...+.+++.+||+.||.+|||+.+++++|+++
T Consensus 227 ~~~~-~~~~~~----~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 AMNK-LALPIP----STC----PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HTSC-CCCCCC----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hcCC-CCCCCC----ccc----CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111 111111 111 12478899999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=349.19 Aligned_cols=267 Identities=22% Similarity=0.359 Sum_probs=204.1
Q ss_pred cccccccccccccceeEEEEEee---eCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC-
Q 009595 202 EDCSASLEKIRSRASGEIYIAEL---PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP- 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~- 277 (531)
.++|.+.+.||+|+||.||+|.+ ...+++.||||++...... ..+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE----HLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHH----HHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 47789999999999999999985 3447899999999764432 256788999999999999999999998653
Q ss_pred -CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 278 -DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 278 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
...++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred CCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccC
Confidence 458999999999999999975 2345899999999999999999999 678999999999999999999999999
Q ss_pred CCCccCCCCCcc-ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc--------hhhhHHH
Q 009595 357 GLARLMPDGHAQ-VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQH--------TEEKSLV 427 (531)
Q Consensus 357 gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~--------~~~~~l~ 427 (531)
|++......... .......|++.|+|||.+.+..++.++||||||+++|+|+||..|+...... .......
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 999876543221 1222345778899999999999999999999999999999999998653210 0001111
Q ss_pred HHHHHHhc-cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 428 RWMRNVMT-SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 428 ~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..+..... ...... +..+ ...+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~-------~~~~---~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 239 FHLIELLKNNGRLPR-------PDGC---PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHHHHTTCCCCC-------CTTC---CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccCcCCC-------CcCc---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111111 111110 0111 134788999999999999999999999998753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=356.81 Aligned_cols=268 Identities=22% Similarity=0.268 Sum_probs=211.3
Q ss_pred hcccccccccccccceeEEEEEeee----CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEE
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMV 275 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 275 (531)
..++|...+.||+|+||.||+|.+. ..++..||||++...... .....+.+|+.++.++ +||||+++++++.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS---SEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4578999999999999999999862 235678999999753321 2256788999999999 8999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccCC-------------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEee
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQG-------------------RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHR 336 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 336 (531)
..+..++||||+++|+|.+++...... ...+++..+..++.|++.||.||| ..|++||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 999999999999999999999753211 134799999999999999999999 6789999
Q ss_pred ccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 009595 337 NITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSD 415 (531)
Q Consensus 337 Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~ 415 (531)
||||+|||++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|+|+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999987655433333445667899999999998899999999999999999998 999997
Q ss_pred CcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCC
Q 009595 416 DFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALI 490 (531)
Q Consensus 416 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 490 (531)
+.... ..+...+........+ ... ...+.+++.+||..||.+|||+.+++++|+.+...
T Consensus 277 ~~~~~---~~~~~~~~~~~~~~~~---------~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVD---ANFYKLIQNGFKMDQP---------FYA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCS---HHHHHHHHTTCCCCCC---------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcH---HHHHHHHhcCCCCCCC---------CCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 65322 2222222221111111 011 12478899999999999999999999999886543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=351.40 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=203.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|..++.||+|+||+||+|... +|+.||+|++...... ......+.+|+.++++++||||+++++++......+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAED--EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET--TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC--CCCEEEEEEEeccccc--chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 478999999999999999999874 6899999999754322 112467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++ +|.+++.. ....+++..+..++.|++.||.||| +.||+||||||+|||++.++.+||+|||++..
T Consensus 96 lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp EEEECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCcee
Confidence 99999986 88888864 3456899999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......... +......+.+.
T Consensus 169 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~~~~~~~~ 242 (311)
T 3niz_A 169 FGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK----IFSILGTPNPR 242 (311)
T ss_dssp TTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH----HHHHHCCCCTT
T ss_pred cCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHHHHCCCChH
Confidence 6543222 233578999999999876 4689999999999999999999999976543322222 22222222221
Q ss_pred cccccc-----------ccCC-C----cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSK-----------LLGN-G----YEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~-----------l~~~-~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...... .... . .+.....+.+++.+||+.||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 110000 0000 0 00112347889999999999999999999974
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=346.65 Aligned_cols=265 Identities=23% Similarity=0.346 Sum_probs=202.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhc--CCCCcccccceeEEeC--
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQ--IRHRNIVPLLAHMVRP-- 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~-- 277 (531)
.++|...+.||+|+||.||+|.+ +|+.||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSRD-------EKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGGG-------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cCcEEEEEeeccCCCcEEEEEEE---CCEEEEEEEecccc-------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 46789999999999999999987 68999999997532 2334456655555 8999999999987653
Q ss_pred --CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeeccCCCCeeeCCCCC
Q 009595 278 --DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY-----HRPRIIHRNITPSSVLIDDDME 350 (531)
Q Consensus 278 --~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlkp~NILl~~~~~ 350 (531)
...++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. ++++++||||||+|||++.++.
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred CCceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC
Confidence 457899999999999999963 5689999999999999999999932 1568999999999999999999
Q ss_pred EEEeecCCCccCCCCCccc--eecccccCccccCcccccCC------CCCchhhHHHHHHHHHHHHhC----------CC
Q 009595 351 ARIADFGLARLMPDGHAQV--STSIVAGTVGYIAPEYHQTL------KFSEKCDIYSFGVLLAVLVMG----------KL 412 (531)
Q Consensus 351 vkL~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg----------~~ 412 (531)
+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||+|| ..
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 9999999998665443221 12335799999999999876 455799999999999999999 88
Q ss_pred CCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 413 PSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 413 P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
||.+........... ............+.... ........+.+++.+||+.||.+|||+.++++.|+++
T Consensus 232 pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDM---RKVVCVDQQRPNIPNRW---FSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTTSCSSCCHHHH---HHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCCCCcchhhh---hHHHhccCCCCCCChhh---ccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 886654332222211 11111111111111111 1123455688999999999999999999999999865
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=357.41 Aligned_cols=255 Identities=21% Similarity=0.311 Sum_probs=195.3
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..++|...+.||+|+||.||++.... +++.||||++...... ...+.+|+.+++.++||||+++++++......
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAAI-----DENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETT-TCCEEEEEEEESSTTS-----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECC-CCcEEEEEEEecCccc-----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 45789999999999999999998764 7899999999764432 34577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC--EEEeecCC
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME--ARIADFGL 358 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~--vkL~Dfgl 358 (531)
++||||+++|+|.+++.. ...+++..+..++.|++.||.||| ++||+||||||+|||++.++. +||+|||+
T Consensus 92 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 92 AIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 999999999999999965 356999999999999999999999 678999999999999987765 99999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEK-CDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
++....... .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+........ ..+.......
T Consensus 165 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~---~~~~~~~~~~ 238 (361)
T 3uc3_A 165 SKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR---KTIQRILSVK 238 (361)
T ss_dssp C------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH---HHHHHHHTTC
T ss_pred cccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH---HHHHHHhcCC
Confidence 885433221 233579999999999988887655 899999999999999999997643322222 2222222211
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. ...+. .. ...+.+++.+||+.||.+|||+.++++|
T Consensus 239 ~~-~~~~~----~~----s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 YS-IPDDI----RI----SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CC-CCTTS----CC----CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CC-CCCcC----CC----CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11 00000 01 1247889999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=355.32 Aligned_cols=255 Identities=23% Similarity=0.311 Sum_probs=206.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||+|+||.||+|.... +|+.||+|++....... .....+.+|+.++++++||||+++++++...+..|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECC-CCCEEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 4678999999999999999998754 78999999998654332 22567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC---CCEEEeecCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD---MEARIADFGL 358 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~---~~vkL~Dfgl 358 (531)
+||||+++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||+
T Consensus 105 lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 99999999999999964 467899999999999999999999 6789999999999999865 4599999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ..+...+..... ..
T Consensus 178 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~----~~~~~~i~~~~~-~~ 249 (362)
T 2bdw_A 178 AIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYAQIKAGAY-DY 249 (362)
T ss_dssp CBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCC-CC
T ss_pred ceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhCCC-CC
Confidence 987764432 2346799999999999998999999999999999999999999865422 222222221110 00
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. ..+......+.+++.+||..||.+|||+.+++++
T Consensus 250 ~~---------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PS---------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CT---------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Cc---------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10 0011112347889999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=344.45 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=206.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.+. ++..||||++...... ...+.+|+.++.+++||||+++++++......+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET--TTEEEEEEEECTTSBC-----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCCCCC-----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 467899999999999999999875 6778999999865433 356889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ....+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++..
T Consensus 96 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 96 IITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp EEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred EEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccc
Confidence 99999999999999974 2356899999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
...... .......+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||..... ......+........+
T Consensus 170 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~~~~~~~~~~- 243 (283)
T 3gen_A 170 VLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETAEHIAQGLRLYRP- 243 (283)
T ss_dssp BCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHHHHTTCCCCCC-
T ss_pred cccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh----hHHHHHHhcccCCCCC-
Confidence 654321 11223456788999999998899999999999999999998 9999976532 1222222211111111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
... ...+.+++.+||+.||.+|||+.+++++|.++.
T Consensus 244 ---------~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 244 ---------HLA---SEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp ---------TTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CcC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 011 124788999999999999999999999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=354.30 Aligned_cols=261 Identities=20% Similarity=0.265 Sum_probs=206.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhh-hHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLL-NIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
.+.|.+.+.||+|+||.||+|.... +|+.||||++........ ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRE-TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECC-CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4678999999999999999998754 789999999964321100 01146788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC---EEEeecC
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME---ARIADFG 357 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~---vkL~Dfg 357 (531)
|+|||||++|+|.+++.........+++..+..++.||+.||.||| +++|+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999999988764444456899999999999999999999 678999999999999987654 9999999
Q ss_pred CCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 358 LARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 358 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
++......... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ..+...+ ....
T Consensus 179 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~i---~~~~ 248 (351)
T 3c0i_A 179 VAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-----ERLFEGI---IKGK 248 (351)
T ss_dssp TCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-----HHHHHHH---HHTC
T ss_pred ceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-----HHHHHHH---HcCC
Confidence 99877654321 234679999999999999999999999999999999999999997631 1222211 1111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. ..+..... ....+.+++.+||+.||.+|||+.+++++
T Consensus 249 ~~---~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 249 YK---MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CC---CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC---CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 11111111 12347889999999999999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=343.39 Aligned_cols=266 Identities=21% Similarity=0.236 Sum_probs=203.5
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|+||+||+|.... +|+.||||++....... .....+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEESSCSST--THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC-CCceEEEEeeeccCCcC--CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence 578999999999999999998764 78999999997644322 225678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++ +|.+++.. ....+++..+..++.|++.||.||| +.|++||||||+|||++.++.+||+|||++...
T Consensus 79 v~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 79 VFEFCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp EEECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999976 67666653 2467999999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLK-FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||... .........+...........
T Consensus 152 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~---~~~~~~~~~i~~~~~~~~~~~ 226 (292)
T 3o0g_A 152 GIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG---NDVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC---SSHHHHHHHHHHHHCCCCTTT
T ss_pred CCcccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC---CCHHHHHHHHHHHhCCCChhh
Confidence 543222 23457899999999998765 799999999999999999998885322 122222222222222111111
Q ss_pred cccc---------------cccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AIDS---------------KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~d~---------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.... .......+.....+.+++.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 00000111222357889999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=358.76 Aligned_cols=306 Identities=19% Similarity=0.249 Sum_probs=209.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCC--
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPD-- 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~-- 278 (531)
.++|...+.||+|+||.||+|.... +|+.||||++....... .....+.+|+.++..+. ||||+++++++...+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRR-TGEVVAVKKIFDAFQNS--TDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETT-TCCEEEEEEECC--CCH--HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECC-CCCEEEEEEecccccCh--HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 3679999999999999999998654 78999999996543222 22567788999999997 999999999997654
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
.+|+|||||++ +|.+++.. ..+++..+..++.|++.||.||| +.||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~lv~e~~~~-~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 85 DVYLVFDYMET-DLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp CEEEEEECCSE-EHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecccCc-CHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 68999999975 99999974 46899999999999999999999 67899999999999999999999999999
Q ss_pred CccCCCCCc-------------------cceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 009595 359 ARLMPDGHA-------------------QVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFF 418 (531)
Q Consensus 359 a~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~ 418 (531)
++.+..... ....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 987643110 111234679999999999876 578999999999999999999999997643
Q ss_pred cchhhhHHHHHHHHHhccCCCCcccc--------------------ccccCCCcH-------------HHHHHHHHHHHH
Q 009595 419 QHTEEKSLVRWMRNVMTSENPNRAID--------------------SKLLGNGYE-------------EQMLLVLKIACF 465 (531)
Q Consensus 419 ~~~~~~~l~~~~~~~~~~~~~~~~~d--------------------~~l~~~~~~-------------~~~~~l~~li~~ 465 (531)
. ...+...+ .....+....... .......++ .....+.+++.+
T Consensus 236 ~---~~~~~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 311 (388)
T 3oz6_A 236 T---MNQLERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK 311 (388)
T ss_dssp H---HHHHHHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred H---HHHHHHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence 2 12222211 1111111000000 000000000 112347889999
Q ss_pred cccCCCCCCCCHHHHHHH--hccCcCCCchhhhhhccCCCCC--ChHHHHHhhHHHHhhhhc
Q 009595 466 CTLDDPEERPNSKDVRSM--LSDTALIKDVDFLKMHKRMDFD--NDDCVELIQQEIYTEWLS 523 (531)
Q Consensus 466 cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 523 (531)
||+.||.+|||+.++++| +.....+.+...+......++. .....+.++..+|.+..+
T Consensus 312 ~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (388)
T 3oz6_A 312 LLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISR 373 (388)
T ss_dssp HCCSSGGGSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHHHHH
T ss_pred hhccCcccCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHH
Confidence 999999999999999987 4444322222122222222232 223567777778877654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=357.12 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=200.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
.++|..++.||+|+||.||+|.... +|+.||||++....... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AvK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKE-TGDLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHH-HTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcC-CCCEEEEEEEEHHHhcc-hhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 3779999999999999999998764 78999999997642211 12256678899999988 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+|||||++|+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEcccccee
Confidence 999999999999999976 456999999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ..+...+ .... ..
T Consensus 173 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i---~~~~-~~ 242 (353)
T 3txo_A 173 EGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE----DDLFEAI---LNDE-VV 242 (353)
T ss_dssp CSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH---HHCC-CC
T ss_pred ecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH----HHHHHHH---HcCC-CC
Confidence 6443322 22446899999999999988899999999999999999999999976422 2222211 1111 11
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS------KDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 483 (531)
. +... ...+.+++.+||+.||.+||++ .++++|
T Consensus 243 ~-------p~~~---~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 243 Y-------PTWL---HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp C-------CTTS---CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred C-------CCCC---CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 0 0111 1237789999999999999998 677663
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=346.75 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=204.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|+||.||+|.... +|+.||+|++....... ......+.+|+.+++.++||||+++++++.+....|+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 678999999999999999998754 78999999997532211 1125677889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++...
T Consensus 84 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 84 IMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp EECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceec
Confidence 9999999999999975 457899999999999999999999 788999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .... ....... ..
T Consensus 157 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~---~~i~~~~-~~-- 221 (318)
T 1fot_A 157 PDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----MKTY---EKILNAE-LR-- 221 (318)
T ss_dssp SSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHH---HHHHHCC-CC--
T ss_pred CCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHH---HHHHhCC-CC--
Confidence 442 2346799999999999999999999999999999999999999975422 1111 1122111 11
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
+. .... ..+.+++.+||..||.+|| ++.++++|
T Consensus 222 ~p----~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 222 FP----PFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CC----TTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CC----CCCC----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 00 1111 2478899999999999999 88888764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=358.55 Aligned_cols=261 Identities=22% Similarity=0.357 Sum_probs=198.2
Q ss_pred cccccccccccccceeEEEEEeeeC--CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE--SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.++|.+.+.||+|+||.||+|.+.. .++..||||.++..... ...+.+.+|+.++++++||||+++++++.....
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE---KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 4678899999999999999998652 25678999999764322 235779999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++||||+++|+|.+++.. ....+++..+..++.|+++||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 121 ~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp CEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 9999999999999999974 2456899999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCcc-ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 360 RLMPDGHAQ-VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 360 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
+........ .......+++.|+|||++.+..++.++||||||+++|||++ |+.||.+... ..+...+.......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~----~~~~~~i~~~~~~~ 270 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGYRLP 270 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH----HHHHHHHHTTEECC
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCC
Confidence 876543221 11222345788999999999999999999999999999998 9999876422 22222222211111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.+. .....+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 271 ~~~-------------~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 271 PPM-------------DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp CCT-------------TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCc-------------cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 111 11234788999999999999999999999998763
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=371.19 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=213.8
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
....|...+.||+|+||.||+|.+.. ++..||||.+...... .+.+.+|+.+|++++||||+++++++......
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTME-----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGG-GTEEEEEEECCSSSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcC-CCeEEEEEEecCcccc-----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 34678889999999999999998864 5889999999764432 56789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++.. .....+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 292 ~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp EEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEEccCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccce
Confidence 999999999999999976 33466899999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
........ ......+++.|+|||++.+..++.++|||||||++|||+| |..||.+... ..+...+........+
T Consensus 367 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~~~ 441 (495)
T 1opk_A 367 LMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYELLEKDYRMERP 441 (495)
T ss_dssp CCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG----GGHHHHHHTTCCCCCC
T ss_pred eccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCCCC
Confidence 76543221 2233456789999999998899999999999999999999 9999876532 2222322221111111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCC
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALI 490 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 490 (531)
..+ ...+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 442 ----------~~~---~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 442 ----------EGC---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp ----------TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred ----------CCC---CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 111 12478899999999999999999999999987543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=356.79 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=203.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|.+++.||+|+||.||+|.... +++.||+|++....... ......+.+|+.+++.++||||+++++++.+....|+
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKND-TKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETT-TCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEehhhccc-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 678999999999999999998764 78899999997533211 1125678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+.+|+|.+++.. ...+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+|||++..+
T Consensus 93 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999975 467999999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQT---LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ...+...+.. .. .
T Consensus 166 ~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~---~~-~ 237 (384)
T 4fr4_A 166 PRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTFET---TV-V 237 (384)
T ss_dssp CTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHHHH---CC-C
T ss_pred cCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhh---cc-c
Confidence 54422 234679999999999864 458999999999999999999999997543222 1222222111 11 1
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-SKDVRS 482 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 482 (531)
.. +..+ ...+.+++.+||+.||.+||+ +.++++
T Consensus 238 ~~-------p~~~---s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 TY-------PSAW---SQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CC-------CTTS---CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CC-------CCcC---CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 10 0111 124788999999999999999 677665
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=357.73 Aligned_cols=261 Identities=20% Similarity=0.264 Sum_probs=202.5
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
.++|..++.||+|+||.||+|+... +++.||+|+++...... ......+..|..++.++ +||||+++++++.+.+..
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~-~~~~~AvK~~~k~~~~~-~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKK-TDRIYAMRVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhhhccC-HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 4678999999999999999998764 78999999998643222 12245677899999887 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+||||+++|+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 129 ~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence 999999999999999975 457999999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh-hHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEE-KSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~-~~l~~~~~~~~~~~~~ 439 (531)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+.........
T Consensus 202 ~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 279 (396)
T 4dc2_A 202 EGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279 (396)
T ss_dssp CCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC
T ss_pred ecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc
Confidence 6433222 234578999999999999999999999999999999999999999643211110 0001111111111111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS------KDVRSM 483 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 483 (531)
.. . ... ...+.+++.+||+.||.+||++ .++++|
T Consensus 280 ~~--p----~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 280 RI--P----RSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CC--C----TTS----CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CC--C----CcC----CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 10 0 111 1247889999999999999996 566553
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=349.75 Aligned_cols=266 Identities=21% Similarity=0.314 Sum_probs=193.7
Q ss_pred hcccccccccccccceeEEEEEeeeCCCC--eEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNG--KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
..++|...+.||+|+||.||+|.+...++ ..||||++....... ...+.+.+|+.++++++||||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS--SDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C--HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH--HHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 45789999999999999999998764222 279999997643222 22677899999999999999999999998776
Q ss_pred ce------EEEEeccCCCCHHHHHhhccCC--CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC
Q 009595 279 CH------LLVSEFMKNGSLLEILNDVSQG--RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME 350 (531)
Q Consensus 279 ~~------~lv~E~~~~gsL~~~l~~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~ 350 (531)
.. ++||||+++|+|.+++...... ...+++..+..++.|+++||.||| +.+++||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCC
Confidence 55 9999999999999999753322 225899999999999999999999 678999999999999999999
Q ss_pred EEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHH
Q 009595 351 ARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRW 429 (531)
Q Consensus 351 vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~ 429 (531)
+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.... .+...
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~~ 251 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA----EIYNY 251 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHH
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH----HHHHH
Confidence 99999999987655433333334557889999999999999999999999999999999 99998764332 22222
Q ss_pred HHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 430 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
+. ....... . .. ....+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 252 ~~---~~~~~~~--~----~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 252 LI---GGNRLKQ--P----PE----CMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HH---TTCCCCC--C----TT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hh---cCCCCCC--C----Cc----cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 21 1111111 0 11 1124788999999999999999999999998864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=354.03 Aligned_cols=260 Identities=20% Similarity=0.324 Sum_probs=201.3
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCe----EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGK----MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 276 (531)
..++|...+.||+|+||.||+|.+.. +++ .||+|.+..... ......+.+|+.++++++||||+++++++..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATS---PKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcC-CCceEEEEEEEeecccccC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 35778999999999999999998754 444 357887754322 1225678899999999999999999999987
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
. ..++|+||+.+|+|.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 89 ~-~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Df 161 (327)
T 3poz_A 89 S-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp S-SEEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCT
T ss_pred C-CeEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccC
Confidence 5 47899999999999999975 2456899999999999999999999 678999999999999999999999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
|+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.+... ..+...+.....
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~~~~~~~ 237 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEISSILEKGER 237 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHHHHHHTTCC
T ss_pred cceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH----HHHHHHHHcCCC
Confidence 99987765544333344567889999999999999999999999999999999 9999976533 222222222111
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
...+. . ....+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus 238 ~~~~~---------~----~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 238 LPQPP---------I----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp CCCCT---------T----BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred CCCCc---------c----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11110 1 1124788999999999999999999999997753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=353.93 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=202.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|.+.+.||+|+||.||+|.... +|+.||||++....... ......+.+|+.+++.++||||+++++++......+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYK-TQQKVALKFISRQLLKK-SDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHH-TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEehHHccc-hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3789999999999999999998754 78999999997532211 111356889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+ +|+|.+++.. ...+++..+..++.|++.||.||| +.|++||||||+|||++.++.+||+|||++..
T Consensus 86 lv~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI 157 (336)
T ss_dssp EEECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred EEEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEecccee
Confidence 999999 6799999875 456999999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKF-SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... ...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+........ .....
T Consensus 158 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-----------~i~~~ 223 (336)
T 3h4j_B 158 MTDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-----------KVNSC 223 (336)
T ss_dssp TTTSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-----------CCCSS
T ss_pred ccCCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-----------HHHcC
Confidence 6554322 33579999999999988776 789999999999999999999997643211100 00000
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
... .+... ...+.+++.+||..||.+|||+.+++++
T Consensus 224 ~~~----~p~~~---s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 VYV----MPDFL---SPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCC----CCTTS---CHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCC----CcccC---CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000 01111 1247889999999999999999999885
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=346.13 Aligned_cols=264 Identities=25% Similarity=0.309 Sum_probs=199.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|+||.||+|... +|+.||+|++....... .....+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDE--GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGG--CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcC--CCCEEEEEEEecccccc--ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence 57889999999999999999873 78999999997543321 113567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++ +|.+++.. ....+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++...
T Consensus 78 v~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF 150 (288)
T ss_dssp EEECCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred EEEecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence 9999976 99999864 2356899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... ...+...... ........
T Consensus 151 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~-~~~~~~~~ 224 (288)
T 1ob3_A 151 GIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRI-LGTPNSKN 224 (288)
T ss_dssp CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHH-HCCCCTTT
T ss_pred Cccccc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHH-HCCCChhh
Confidence 433221 2235689999999998764 589999999999999999999999976432 2222222221 11111100
Q ss_pred c--------ccccc-------cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 A--------IDSKL-------LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~--------~d~~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. .++.. ...........+.+++.+||+.||.+|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 00000 000001122347889999999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=349.43 Aligned_cols=260 Identities=21% Similarity=0.277 Sum_probs=203.6
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~ 281 (531)
++|...+.||+|+||.||+|+... +++.||+|++....... ......+..|+.++.++ +||||+++++++.+....|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKK-TDRIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEGGGSCS-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEhHHhcc-hHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 678999999999999999998764 78999999998643222 22356788899999988 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 87 lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence 99999999999999975 356899999999999999999999 67899999999999999999999999999986
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh-hHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEE-KSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~-~~l~~~~~~~~~~~~~~ 440 (531)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+..........
T Consensus 160 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~ 237 (345)
T 3a8x_A 160 GLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 237 (345)
T ss_dssp SCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC
T ss_pred ccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC
Confidence 433222 223468999999999999999999999999999999999999999653211100 00011111111111111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS------KDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 483 (531)
+. ... ...+.+++.+||+.||.+||++ .++++|
T Consensus 238 --~p----~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 238 --IP----RSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp --CC----TTS----CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred --CC----CCC----CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 00 111 1247889999999999999996 566553
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=354.23 Aligned_cols=254 Identities=19% Similarity=0.239 Sum_probs=206.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|.+.+.||+|+||.||+|.... +|+.||+|++....... ...+.+|+.++++++||||+++++++......+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYPLD----KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSHHH----HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECC-CCCEEEEEEecccchhh----HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 3678999999999999999998754 78899999997654322 457889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC--CCCEEEeecCCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD--DMEARIADFGLA 359 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~--~~~vkL~Dfgla 359 (531)
+||||+++|+|.+++.. ....+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||++
T Consensus 125 lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 125 LILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp EEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccc
Confidence 99999999999999864 2346899999999999999999999 678999999999999974 578999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ......+. .....
T Consensus 199 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~i~---~~~~~ 268 (387)
T 1kob_A 199 TKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVK---RCDWE 268 (387)
T ss_dssp EECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHH---HCCCC
T ss_pred eecCCCcce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----HHHHHHHH---hCCCC
Confidence 877554322 235799999999999999999999999999999999999999976422 11222111 11111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.++..... ....+.+++.+||..||.+|||+.+++++
T Consensus 269 ---~~~~~~~~----~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 ---FDEDAFSS----VSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---CCSSTTTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---CCcccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11111111 12347889999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=352.37 Aligned_cols=259 Identities=22% Similarity=0.325 Sum_probs=203.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeE----EEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKM----IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
.++|...+.||+|+||.||+|.+.. +++. ||+|.+....... ....+.+|+.++++++||||+++++++. .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~~K~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKSGRQ---SFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECC-TTCSCCEEEEEEEECCTTSCS---CBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred HhHceeeeeeeecCCceEEEEEEcC-CCceEEEEEEEEeccccccHH---HHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 4678999999999999999998754 4543 7888775432211 1345678999999999999999999886 4
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
+..++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCC
Confidence 678999999999999999974 2357889999999999999999999 6789999999999999999999999999
Q ss_pred CCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 358 LARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 358 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
+++.+.............||+.|+|||++.+..++.++||||||+++|+|+| |+.||.+... ..+...+......
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~~~ 236 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL----AEVPDLLEKGERL 236 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT----THHHHHHHTTCBC
T ss_pred cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH----HHHHHHHHcCCCC
Confidence 9998766544444445678889999999998899999999999999999999 9999976432 2222222221111
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..+.. .+. .+.+++.+||..||.+|||+.+++++|+.+.
T Consensus 237 ~~~~~------~~~-------~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 237 AQPQI------CTI-------DVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CCCTT------BCT-------TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCCc------CcH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 111 2677999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=364.12 Aligned_cols=252 Identities=26% Similarity=0.401 Sum_probs=204.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC-c
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD-C 279 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~ 279 (531)
..+.|...+.||+|+||.||+|.+ +|+.||||+++.... .+.+.+|+.+|++++||||+++++++.... .
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~---~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDAT------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEESSCTT------SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe---cCCeEEEEEeCCchH------HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 456788999999999999999987 588999999976432 467889999999999999999999987765 7
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++|||||++|+|.+++.. .....+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++
T Consensus 262 ~~iv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp EEEEEECCTTCBHHHHHHH--HCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 8999999999999999986 33345799999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+...... ....+++.|+|||++.+..++.++||||||+++|||+| |+.||.+..... +...+.... .
T Consensus 337 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----~~~~i~~~~---~ 404 (450)
T 1k9a_A 337 KEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKGY---K 404 (450)
T ss_dssp EECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----HHHHHHTTC---C
T ss_pred ccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHcCC---C
Confidence 8643321 22357889999999999999999999999999999998 999997653322 222222111 1
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
+.. +..+ ...+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 405 ~~~-------p~~~---~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 405 MDA-------PDGC---PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp CCC-------CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC-------CCcC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 110 0111 124788999999999999999999999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=349.14 Aligned_cols=268 Identities=22% Similarity=0.269 Sum_probs=191.5
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|..++.||+|+||.||+|.... +|+.||+|++....... ....+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT-TGVYVALKEVKLDSEEG---TPSTAIREISLMKELKHENIVRLYDVIHTENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSS-SCCEEEEEEEECCSTTC---SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECC-CCcEEEEEEeecccccc---cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence 4678899999999999999998654 78999999997643221 1356778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccC--CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQ--GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
+||||++ |+|.+++..... ....+++..+..++.|++.||.||| +.||+||||||+|||++.++.+||+|||++
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence 9999998 599999876332 2245899999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
......... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.... .....+........
T Consensus 156 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~~~~~~~~ 229 (317)
T 2pmi_A 156 RAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE----EQLKLIFDIMGTPN 229 (317)
T ss_dssp EETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCSCC
T ss_pred eecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCC
Confidence 876543221 2335789999999998764 6899999999999999999999999764322 22222222211111
Q ss_pred CCccc--------cccc---cCCCc---------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAI--------DSKL---LGNGY---------EEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~--------d~~l---~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..... .+.. ..... ......+.+++.+||+.||.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000 0000 00000 0112358889999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=363.18 Aligned_cols=261 Identities=20% Similarity=0.243 Sum_probs=206.0
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..++|...+.||+|+||+||+|.... +++.||+|++....... ......+.+|+.++..++||||+++++++.+.+..
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~-~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKN-ADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcC-CCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 45789999999999999999998764 68999999997532111 11133478899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+|||||++|+|.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 150 ~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp EEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 999999999999999974 2457999999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQ-----TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.........+ +.....
T Consensus 224 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i---~~~~~~ 299 (437)
T 4aw2_A 224 KLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---MNHKER 299 (437)
T ss_dssp ECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HTHHHH
T ss_pred hcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh---hhcccc
Confidence 76554332 224468999999999987 457899999999999999999999999764322111111 111111
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEE--RPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 483 (531)
...+... .... ..+.+++.+||..+|.+ ||++.++++|
T Consensus 300 ~~~p~~~------~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 300 FQFPTQV------TDVS----ENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCCCSSC------CCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccCCccc------ccCC----HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1111110 1111 23778889999888888 9999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=350.33 Aligned_cols=261 Identities=20% Similarity=0.236 Sum_probs=209.3
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
.++|...+.||+|+||.||+|.... +|+.||||++..... ...+..|+.+++++ +||||+++++++...+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLY-TNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETT-TTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECC-CCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 4678999999999999999998643 799999999975432 23477899999999 999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC-----EEEee
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME-----ARIAD 355 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~-----vkL~D 355 (531)
++||||+ +++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+|
T Consensus 81 ~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~D 153 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIID 153 (330)
T ss_dssp EEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECC
T ss_pred EEEEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEE
Confidence 9999999 89999999752 457999999999999999999999 678999999999999998887 99999
Q ss_pred cCCCccCCCCCccc-----eecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHH
Q 009595 356 FGLARLMPDGHAQV-----STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 356 fgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~ 430 (531)
||++..+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+....
T Consensus 154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 233 (330)
T 2izr_A 154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233 (330)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred cccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence 99998765432211 1235679999999999999999999999999999999999999998754332222222221
Q ss_pred HHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
...... +. ......++ .+.+++..||..||.+||++.+|.+.|+++
T Consensus 234 ~~~~~~--~~-----~~~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 234 DTKRAT--PI-----EVLCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHHHS--CH-----HHHTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hhhccC--CH-----HHHhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 111111 10 00111122 488899999999999999999999999764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=358.17 Aligned_cols=280 Identities=19% Similarity=0.287 Sum_probs=210.7
Q ss_pred hhhhccccccccccccc--ceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEE
Q 009595 198 FLEKEDCSASLEKIRSR--ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMV 275 (531)
Q Consensus 198 ~~~~~~~~~~~~~ig~G--~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 275 (531)
++...++|.+.+.||+| +||.||+|.... +|+.||||++....... .....+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKP-TGEYVTVRRINLEACSN--EMVTFLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETT-TCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcC-CCCEEEEEEecccccCh--HHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 34556889999999999 999999998764 78999999998644322 33677889999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
..+..++|||||++|+|.+++.. .....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred ECCEEEEEEEccCCCCHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcc
Confidence 99999999999999999999976 33356899999999999999999999 67899999999999999999999999
Q ss_pred cCCCccCCCCCc-----cceecccccCccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHH
Q 009595 356 FGLARLMPDGHA-----QVSTSIVAGTVGYIAPEYHQT--LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR 428 (531)
Q Consensus 356 fgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~ 428 (531)
||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...... +..
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~ 248 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLE 248 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH---HHH
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHH
Confidence 999875432211 111123478999999999987 5789999999999999999999999976432221 111
Q ss_pred HHHHHhcc-----CCCCccc-------------c------------ccc-cCCCcHHHHHHHHHHHHHcccCCCCCCCCH
Q 009595 429 WMRNVMTS-----ENPNRAI-------------D------------SKL-LGNGYEEQMLLVLKIACFCTLDDPEERPNS 477 (531)
Q Consensus 429 ~~~~~~~~-----~~~~~~~-------------d------------~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 477 (531)
.+...... ..+.... . ... ...........+.+++.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta 328 (389)
T 3gni_B 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328 (389)
T ss_dssp C--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence 11100000 0000000 0 000 000111122458889999999999999999
Q ss_pred HHHHHH--hccCc
Q 009595 478 KDVRSM--LSDTA 488 (531)
Q Consensus 478 ~evl~~--L~~~~ 488 (531)
.+++++ ++++.
T Consensus 329 ~ell~hp~f~~~~ 341 (389)
T 3gni_B 329 STLLNHSFFKQIK 341 (389)
T ss_dssp HHHTTSGGGGGC-
T ss_pred HHHhcCHHHHHHh
Confidence 999976 55543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=338.05 Aligned_cols=254 Identities=25% Similarity=0.314 Sum_probs=203.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--Cc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--DC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~ 279 (531)
.++|...+.||+|+||.||+|.+ +++.||||++....... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~~avK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW---QGNDIVVKVLKVRDWST--RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECCTTCCH--HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEE---CCeeEEEEEecccccCH--HHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 36788999999999999999987 58899999998654332 2256789999999999999999999999887 78
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeeccCCCCeeeCCCCCEEEeecC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR--IIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
.++||||+++|+|.+++.. .....+++..+..++.|++.||.||| +.+ ++||||||+||+++.++.++|+|||
T Consensus 84 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~ 158 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMAD 158 (271)
T ss_dssp CEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred eEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEecc
Confidence 8999999999999999975 33346899999999999999999999 667 9999999999999999999999999
Q ss_pred CCccCCCCCccceecccccCccccCcccccCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 358 LARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSE---KCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 358 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
++..... ....||+.|+|||.+.+..++. ++||||||+++|+|++|+.||.+.... ... ....
T Consensus 159 ~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~---~~~~ 224 (271)
T 3kmu_A 159 VKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM----EIG---MKVA 224 (271)
T ss_dssp SCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH----HHH---HHHH
T ss_pred ceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH----HHH---HHHH
Confidence 8664322 2346899999999998765444 899999999999999999999764321 111 1111
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
....... .. ... ...+.+++..||+.||.+|||+.++++.|+++.
T Consensus 225 ~~~~~~~-~~----~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 225 LEGLRPT-IP----PGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HSCCCCC-CC----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred hcCCCCC-CC----CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111111 11 111 124788999999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=343.10 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=214.0
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..++|...+.||+|+||.||+|.+.. ++..||+|.+...... .+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTME-----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGG-GTEEEEEEEECSCSTH-----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred cccceeEEeecCCCCceeEEEeEecC-CCEEEEEEecCcCHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 35778999999999999999998764 6889999999764432 56788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++.. .....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.
T Consensus 85 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccce
Confidence 999999999999999976 34566999999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
....... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+... ..+...+........+
T Consensus 160 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~----~~~~~~~~~~~~~~~~ 234 (288)
T 3kfa_A 160 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYELLEKDYRMERP 234 (288)
T ss_dssp TSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----GGHHHHHHTTCCCCCC
T ss_pred eccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHhccCCCCCC
Confidence 7765432 22234567889999999998899999999999999999999 9999876432 2222222221111111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
. . . ...+.+++.+||..||.+|||+.++++.|+.+..
T Consensus 235 ~---------~-~---~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 235 E---------G-C---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp T---------T-C---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C---------C-C---CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 1 1 1 1247889999999999999999999999987643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=341.45 Aligned_cols=263 Identities=17% Similarity=0.205 Sum_probs=210.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
.++|...+.||+|+||.||+|.... +|+.||||++..... ...+.+|+.++..+ +||||+++++++......
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECC-CCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 4678999999999999999998643 799999999975432 23467899999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC-----EEEee
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME-----ARIAD 355 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~-----vkL~D 355 (531)
++||||+ +++|.+++.. ....+++..+..++.|++.||.||| +++++||||||+|||++.++. +||+|
T Consensus 82 ~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp EEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred EEEEEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 9999999 8999999975 2346899999999999999999999 788999999999999987776 99999
Q ss_pred cCCCccCCCCCcc-----ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHH
Q 009595 356 FGLARLMPDGHAQ-----VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 356 fgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~ 430 (531)
||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.........+....
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence 9999877554221 12244679999999999999999999999999999999999999998754333222222222
Q ss_pred HHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
....... . . .+.... ...+.+++.+||+.||.+|||+.+|++.|+++.
T Consensus 235 ~~~~~~~-~-~----~~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 235 EKKQSTP-L-R----ELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HHHHHSC-H-H----HHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred hhccCcc-H-H----HHHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 2111111 0 0 000111 124788999999999999999999999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=350.67 Aligned_cols=252 Identities=22% Similarity=0.323 Sum_probs=181.7
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCceEEEEec
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCHLLVSEF 286 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~ 286 (531)
.+.||+|+||.||+|.... +|+.||||++.... ...+.+|+.++..+. ||||+++++++.+....|+||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~-------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKK-SNQAFAVKIISKRM-------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETT-TCCEEEEEEEEGGG-------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECC-CCCEEEEEEEChhh-------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence 4789999999999998754 78999999997532 355678999999996 99999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC---CEEEeecCCCccCC
Q 009595 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM---EARIADFGLARLMP 363 (531)
Q Consensus 287 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~---~vkL~Dfgla~~~~ 363 (531)
+++|+|.+++.. ...+++..+..++.|++.||.||| +++|+||||||+|||++.++ .+||+|||++....
T Consensus 88 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 88 LNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp CCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999976 467999999999999999999999 67899999999999997765 89999999998765
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
..... ....+||+.|+|||++.+..++.++||||||+++|+|++|+.||...............+....... ...
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~-~~~-- 235 (325)
T 3kn6_A 161 PDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD-FSF-- 235 (325)
T ss_dssp C------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC-CCC--
T ss_pred CCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC-CCC--
Confidence 44322 2345789999999999999999999999999999999999999976432211122222223222221 110
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. ..+......+.+++.+||+.||.+|||+.+++++
T Consensus 236 ~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 236 EG----EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CS----HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred Cc----ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 10 0111123458889999999999999999998864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=344.14 Aligned_cols=255 Identities=22% Similarity=0.294 Sum_probs=197.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhh----------------------hHHHHHHHHHHHHH
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLL----------------------NIKMRQVRAEIMTA 259 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~----------------------~~~~~~~~~Ei~~l 259 (531)
.++|...+.||+|+||.||+|.... +++.||||++........ ....+.+.+|+.++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN-DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT-TTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC-CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4678999999999999999998654 789999999975432110 11235688999999
Q ss_pred hcCCCCcccccceeEEe--CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 009595 260 GQIRHRNIVPLLAHMVR--PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRN 337 (531)
Q Consensus 260 ~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 337 (531)
++++||||+++++++.. ....++||||+++|+|.+++. ...+++..+..++.|++.||.||| +.+++|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~D 162 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRD 162 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccC
Confidence 99999999999999986 567899999999999987653 357999999999999999999999 67899999
Q ss_pred cCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCC
Q 009595 338 ITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK---FSEKCDIYSFGVLLAVLVMGKLPS 414 (531)
Q Consensus 338 lkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~P~ 414 (531)
|||+|||++.++.+||+|||++......... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999876554322 23467999999999998765 478899999999999999999998
Q ss_pred CCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 415 DDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 415 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+... ..+...+. . ........ ... ...+.+++.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~----~~~~~~~~---~-~~~~~~~~----~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 241 MDERI----MCLHSKIK---S-QALEFPDQ----PDI----AEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CCSSH----HHHHHHHH---H-CCCCCCSS----SCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCccH----HHHHHHHh---c-ccCCCCCc----ccc----CHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 75421 11221111 1 11111000 111 1247889999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=348.46 Aligned_cols=265 Identities=22% Similarity=0.322 Sum_probs=211.5
Q ss_pred hcccccccccccccceeEEEEEeeeC------CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCccccccee
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPE------SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAH 273 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~ 273 (531)
..++|...+.||+|+||.||+|.+.. .++..||||++...... .....+.+|+.+++++ +||||++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH---HHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 45788999999999999999998632 35678999999764322 2367788999999999 89999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCC
Q 009595 274 MVRPDCHLLVSEFMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341 (531)
Q Consensus 274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 341 (531)
+...+..++||||+++|+|.+++..... ....+++..++.++.|++.||.||| +.+++||||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccc
Confidence 9999999999999999999999976321 1234899999999999999999999 678999999999
Q ss_pred CeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccc
Q 009595 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQH 420 (531)
Q Consensus 342 NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~ 420 (531)
||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~- 265 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV- 265 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-
Confidence 99999999999999999987765443333344567889999999988889999999999999999999 9999876422
Q ss_pred hhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 421 TEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 421 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..+...+........+ ... ...+.+++.+||..||.+|||+.++++.|+.+.
T Consensus 266 ---~~~~~~~~~~~~~~~~---------~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 266 ---EELFKLLKEGHRMDKP---------ANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp ---HHHHHHHHHTCCCCCC---------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHHhcCCCCCCC---------ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2233222221111111 111 124788999999999999999999999998864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=350.27 Aligned_cols=249 Identities=18% Similarity=0.215 Sum_probs=204.6
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|..++.||+|+||.||+|.... +|+.||||++....... ......+.+|+.+++.++||||+++++++.+....|+
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECC-CCCEEEEEEEEhHHhcc-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 678999999999999999998754 78999999997533211 1125678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++...
T Consensus 119 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceec
Confidence 9999999999999976 356899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ..+... .... ....
T Consensus 192 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~---i~~~-~~~~- 257 (350)
T 1rdq_E 192 KGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----IQIYEK---IVSG-KVRF- 257 (350)
T ss_dssp SSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH---HHHC-CCCC-
T ss_pred cCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH----HHHHHH---HHcC-CCCC-
Confidence 443 1335799999999999999999999999999999999999999875422 222221 1111 1110
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-----SKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 483 (531)
. ... ...+.+++.+||+.||.+||+ +.++++|
T Consensus 258 -p----~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 258 -P----SHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -C----TTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -C----CCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 0 111 124788999999999999998 8888764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=337.02 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=203.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHH---HHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIK---MRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
.++|...+.||+|+||.||+|.... +++.||||++........... .+.+.+|+.++++++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVK-DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETT-TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hccceehhccccCCceeEEEEEEcC-CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 4778999999999999999998754 788999999975443322111 267889999999999999999999886544
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeeccCCCCeeeCCCCC-----E
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR--IIHRNITPSSVLIDDDME-----A 351 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NILl~~~~~-----v 351 (531)
++||||+++|+|.+++.. ....+++..+..++.|++.||.||| ..+ ++||||||+|||++.++. +
T Consensus 97 --~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred --eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 799999999999998864 3457999999999999999999999 677 999999999999988776 9
Q ss_pred EEeecCCCccCCCCCccceecccccCccccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHH
Q 009595 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ--TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRW 429 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~ 429 (531)
||+|||++...... .....||+.|+|||++. ...++.++||||||+++|+|++|+.||....... ......
T Consensus 169 kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~ 241 (287)
T 4f0f_A 169 KVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK--IKFINM 241 (287)
T ss_dssp EECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH--HHHHHH
T ss_pred EeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH--HHHHHH
Confidence 99999999854332 23467899999999984 4467899999999999999999999997643321 111111
Q ss_pred HHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 430 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
+.. ...... +. ... ...+.+++.+||+.||.+|||+.++++.|+++
T Consensus 242 ~~~---~~~~~~-~~----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 IRE---EGLRPT-IP----EDC----PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHH---SCCCCC-CC----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred Hhc---cCCCCC-CC----ccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 111111 11 111 12478899999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=352.63 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=203.8
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCc
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 279 (531)
..++|...+.||+|+||.||+|.... +|+.||||+++...... ......+..|..++..+ +||||+++++++.+.+.
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34789999999999999999998764 78999999997632111 11245677899999877 99999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.|+||||+++|+|.+++.. ...+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999975 356899999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
+........ ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ..+...+.. . .+
T Consensus 166 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~---~-~~ 235 (345)
T 1xjd_A 166 KENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRM---D-NP 235 (345)
T ss_dssp BCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH---C-CC
T ss_pred hhcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHh---C-CC
Confidence 865433222 2446899999999999999999999999999999999999999975422 222222211 1 11
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSK-DVRS 482 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 482 (531)
.. +... ...+.+++.+||..||.+||++. ++++
T Consensus 236 ~~-------p~~~---s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 236 FY-------PRWL---EKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CC-------CTTS---CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC-------Cccc---CHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 10 0111 12478899999999999999997 6654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=347.05 Aligned_cols=266 Identities=21% Similarity=0.302 Sum_probs=212.0
Q ss_pred hcccccccccccccceeEEEEEeee----CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEE
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMV 275 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 275 (531)
..++|.+.+.||+|+||.||+|.+. ..+++.||||++...... .....+.+|+.++.++ +||||+++++++.
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc---HHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 4578999999999999999999853 246789999999764432 2256788999999999 7999999999988
Q ss_pred eCC-ceEEEEeccCCCCHHHHHhhccCC------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCC
Q 009595 276 RPD-CHLLVSEFMKNGSLLEILNDVSQG------------RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSS 342 (531)
Q Consensus 276 ~~~-~~~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 342 (531)
..+ ..++||||+++|+|.+++...... ...+++..+..++.|+++||.||| +.+++||||||+|
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~N 178 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN 178 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccce
Confidence 755 489999999999999999763221 122889999999999999999999 6789999999999
Q ss_pred eeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccch
Q 009595 343 VLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHT 421 (531)
Q Consensus 343 ILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~ 421 (531)
|+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||.+....
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~- 257 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID- 257 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-
T ss_pred EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh-
Confidence 9999999999999999987765444344445678999999999999899999999999999999998 99999764322
Q ss_pred hhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 422 EEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 422 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..+...+........+ ... ...+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus 258 --~~~~~~~~~~~~~~~~---------~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 258 --EEFCRRLKEGTRMRAP---------DYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp --HHHHHHHHHTCCCCCC---------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHhccCccCCCC---------CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2222222221111101 111 124788999999999999999999999998763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=344.75 Aligned_cols=254 Identities=19% Similarity=0.286 Sum_probs=198.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC----
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD---- 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---- 278 (531)
++|...+.||+|+||.||+|.... +|+.||||++....... ..+.+.+|+.++++++||||+++++++....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKV-DDCNYAIKRIRLPNREL---AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETT-TCCEEEEEEEECCSTTT---HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcC-CCcEEEEEEeecCCchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 578899999999999999998754 78999999997544321 2577899999999999999999999886543
Q ss_pred -----------------------------------------------------ceEEEEeccCCCCHHHHHhhccCCCcc
Q 009595 279 -----------------------------------------------------CHLLVSEFMKNGSLLEILNDVSQGRRE 305 (531)
Q Consensus 279 -----------------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~~~~~ 305 (531)
..++|||||++|+|.+++.... ....
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~ 160 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLED 160 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGG
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccc
Confidence 2799999999999999997632 2345
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCcc----------ceecccc
Q 009595 306 LEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ----------VSTSIVA 375 (531)
Q Consensus 306 l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~----------~~~~~~~ 375 (531)
.++..++.++.|++.||.||| +++++||||||+|||++.++.+||+|||++......... .......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 677778999999999999999 678999999999999999999999999999887654211 1123457
Q ss_pred cCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHH
Q 009595 376 GTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQ 455 (531)
Q Consensus 376 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 455 (531)
||+.|+|||++.+..++.++||||||+++|+|++|..|+... ... .........+ ......
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------~~~---~~~~~~~~~~----------~~~~~~ 298 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------VRI---ITDVRNLKFP----------LLFTQK 298 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------HHH---HHHHHTTCCC----------HHHHHH
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------HHH---HHHhhccCCC----------cccccC
Confidence 999999999999999999999999999999999998774211 111 1111111111 111222
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 456 MLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 456 ~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+.+++.+||+.||.+|||+.+++++
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 3447889999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=341.91 Aligned_cols=263 Identities=21% Similarity=0.357 Sum_probs=196.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||+|+||.||+|.+. ..||||+++...... ...+.+.+|+.++++++||||+++++++ .....+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTP--QQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS----SEEEEEEESCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc----CceEEEEEeccCCCH--HHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 477899999999999999999753 359999997654332 2367789999999999999999999965 556789
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 96 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp EEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred EEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccc
Confidence 99999999999999964 3466899999999999999999999 67899999999999999999999999999986
Q ss_pred CCCCCccceecccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQ---TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
..............||+.|+|||++. +..++.++||||||+++|+|++|+.||.+... ...+...+........
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQIIEMVGRGSLSPD 246 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC---HHHHHHHHHHTSCCCC
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch---HHHHHHHhcccccCcc
Confidence 65433333334467999999999986 56788999999999999999999999976532 2223332222111111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
... +... ....+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 247 ~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 247 LSK-----VRSN----CPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TTS-----SCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hhh-----cccc----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 110 0111 12348889999999999999999999999988753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=361.43 Aligned_cols=259 Identities=20% Similarity=0.280 Sum_probs=205.2
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..++|...+.||+|+||.||+|.... +++.||+|++....... ......+.+|+.++..++||||+++++++.+...+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKS-TRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECC-CCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 34778999999999999999998764 78899999997532111 11134477899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+|||||+||+|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 145 ~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999975 35899999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLK----FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.... ......+......
T Consensus 217 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 217 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNHKNSL 292 (410)
T ss_dssp ECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHHHHC
T ss_pred eeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHHHHHHhccccc
Confidence 7655432 2234578999999999997765 789999999999999999999999754221 1111111111111
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEE--RPNSKDVRSML 484 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 484 (531)
..+.. . .. ...+.+++.+||..+|.+ ||++.+|++|-
T Consensus 293 ~~p~~---~----~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 293 TFPDD---N----DI----SKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp CCCTT---C----CC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred cCCCc---c----cc----cHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 11110 0 11 124788999999999988 99999999863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=365.82 Aligned_cols=262 Identities=25% Similarity=0.409 Sum_probs=205.3
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|...+.||+|+||.||+|.+. .+..||||+++..... .+.+.+|+.+|++++||||+++++++.. +..
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC--CCceEEEEEeccCCCC-----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 4567889999999999999999885 4577999999864432 4578899999999999999999998876 678
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++... ....+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||+++
T Consensus 254 ~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp EEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred EEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccce
Confidence 9999999999999999641 2345899999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
........ ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||.+... ..+...+........+
T Consensus 329 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~~~~i~~~~~~~~~ 403 (452)
T 1fmk_A 329 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQVERGYRMPCP 403 (452)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTTCCCCCC
T ss_pred ecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCCCC
Confidence 76543221 1223457889999999998899999999999999999999 9999876532 2222222221111111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCCCch
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDV 493 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 493 (531)
..+ ...+.+++.+||+.||.+|||+.++++.|+++.....+
T Consensus 404 ----------~~~---~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 404 ----------PEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp ----------TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ----------CCC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 111 12478899999999999999999999999987654444
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=342.36 Aligned_cols=266 Identities=21% Similarity=0.323 Sum_probs=200.2
Q ss_pred hcccccccccccccceeEEEEEeeeCC--CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPES--NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
..+.|...+.||+|+||.||+|.+... ++..||||.+....... .....+.+|+.++++++||||+++++++...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ--REIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch--hHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 567899999999999999999987543 34589999997644332 22577889999999999999999999988755
Q ss_pred -----ceEEEEeccCCCCHHHHHhhcc--CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCE
Q 009595 279 -----CHLLVSEFMKNGSLLEILNDVS--QGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA 351 (531)
Q Consensus 279 -----~~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v 351 (531)
..++||||+++|+|.+++.... .....+++..++.++.|+++||.||| +.+++||||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcE
Confidence 3499999999999999985422 23467999999999999999999999 7889999999999999999999
Q ss_pred EEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHH
Q 009595 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~ 430 (531)
||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.... .+...+
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~ 262 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH----EMYDYL 262 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHH
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH----HHHHHH
Confidence 9999999987655433233334567889999999999999999999999999999999 88998764332 222222
Q ss_pred HHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.. ...+.. . ... ...+.+++.+||..||.+|||+.+++++|+.+.
T Consensus 263 ~~---~~~~~~--~----~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 263 LH---GHRLKQ--P----EDC----LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp HT---TCCCCC--B----TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hc---CCCCCC--C----ccc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 21 111111 0 111 124788999999999999999999999998753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=346.43 Aligned_cols=300 Identities=23% Similarity=0.310 Sum_probs=213.6
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC--
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD-- 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-- 278 (531)
..+.|...+.||+|+||.||+|.... +|+.||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 99 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETT-TCCEEEEEECSSTTSS--HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred ecceEEEeEEeeecCCeEEEEEEECC-CCCEEEEEEeCccccC--HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence 35789999999999999999998754 7899999999654322 223577889999999999999999999987653
Q ss_pred ----ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe
Q 009595 279 ----CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 279 ----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
.+|+||||+ +++|.+++.. ..+++..+..++.|+++||.||| +.||+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~ 170 (367)
T 1cm8_A 100 DDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKIL 170 (367)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred ccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEE
Confidence 459999999 7799999975 46899999999999999999999 6789999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+...+. .
T Consensus 171 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~-~ 241 (367)
T 1cm8_A 171 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMK-V 241 (367)
T ss_dssp CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH-H
T ss_pred eeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHH-h
Confidence 99999875432 233578999999999877 67999999999999999999999999764221 11111111 1
Q ss_pred hccCCCCcccc-------------------ccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCc
Q 009595 434 MTSENPNRAID-------------------SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKD 492 (531)
Q Consensus 434 ~~~~~~~~~~d-------------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~ 492 (531)
.. .+..... ..-...........+.+++.+||..||.+|||+.++++| +..+....+
T Consensus 242 ~g--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 242 TG--TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 319 (367)
T ss_dssp HC--CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred cC--CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence 11 0100000 000001111122357889999999999999999999995 455433222
Q ss_pred hhhhhhccCCCCCC-hHHHHHhhHHHHhhhhcc
Q 009595 493 VDFLKMHKRMDFDN-DDCVELIQQEIYTEWLSS 524 (531)
Q Consensus 493 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 524 (531)
..... +....++. +...+.+++.+|.++..-
T Consensus 320 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (367)
T 1cm8_A 320 EPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSF 351 (367)
T ss_dssp --CCC-CCCCC-----CCHHHHHHHHHHHHHTC
T ss_pred CCCCC-CCCCChhhhcCCHHHHHHHHHHHHHHh
Confidence 11111 11222222 336788889999988753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=344.52 Aligned_cols=265 Identities=21% Similarity=0.287 Sum_probs=200.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|+||.||+|.... +|+.||||++...... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRD-TGQIVAIKKFLESEDD--PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCC-CCcEEEEEEeeccccc--hHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 578999999999999999998754 6899999999764432 2235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++++|.+++.. ...+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 80 VFEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLL 152 (311)
T ss_dssp EEECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence 9999999999998864 466899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC--
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP-- 439 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~-- 439 (531)
...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+........ .+........+
T Consensus 153 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~ 226 (311)
T 4agu_A 153 TGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY----LIRKTLGDLIPRH 226 (311)
T ss_dssp C--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHHHCSCCHHH
T ss_pred cCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHHHhccccccc
Confidence 543222 233578999999999876 568999999999999999999999997643222111 11111110000
Q ss_pred ------------CccccccccC---CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 440 ------------NRAIDSKLLG---NGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 440 ------------~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
....++.... ...+.....+.+++.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 0001122347889999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.97 Aligned_cols=255 Identities=23% Similarity=0.299 Sum_probs=206.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|.+.+.||+|+||.||+|.... +|+.||+|++....... .....+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcC-CCceEEEEEeecccCCH--HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 4789999999999999999998754 78899999997654322 22567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC---EEEeecCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME---ARIADFGL 358 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~---vkL~Dfgl 358 (531)
+||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++. +||+|||+
T Consensus 82 ~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 99999999999999875 356899999999999999999999 678999999999999987655 99999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+......... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+... ......+..... ..
T Consensus 155 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~-~~ 226 (284)
T 3kk8_A 155 AIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYAQIKAGAY-DY 226 (284)
T ss_dssp CEECCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCC-CC
T ss_pred eEEcccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch----hHHHHHHHhccc-cC
Confidence 9876554322 335789999999999999999999999999999999999999865422 222222221110 00
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+.. ..... ...+.+++.+||+.||.+|||+.+++++
T Consensus 227 ~~~-----~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 PSP-----EWDTV----TPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CTT-----TTTTS----CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred Cch-----hhccc----CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 100 00111 1247889999999999999999999884
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=351.22 Aligned_cols=266 Identities=21% Similarity=0.301 Sum_probs=212.2
Q ss_pred hcccccccccccccceeEEEEEeeeCC----CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEE
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPES----NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMV 275 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 275 (531)
..++|...+.||+|+||.||+|..... .+..||+|.+....... ....+.+|+.+++++ +||||+++++++.
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD---EKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH---HHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 457899999999999999999987532 22479999997654322 256788999999999 8999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccC----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQ----------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl 345 (531)
..+..++||||+++|+|.+++..... ....+++..++.++.|++.||.||| +.+++||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEE
Confidence 99999999999999999999975321 1346799999999999999999999 6789999999999999
Q ss_pred CCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhh
Q 009595 346 DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEK 424 (531)
Q Consensus 346 ~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~ 424 (531)
+.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||.+.... .
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~ 274 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN---S 274 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS---H
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh---H
Confidence 9999999999999987654433333344567889999999998899999999999999999998 99998765332 2
Q ss_pred HHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 425 SLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 425 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.+...+........+. .. ...+.+++.+||+.||.+|||+.+++++|+++.
T Consensus 275 ~~~~~~~~~~~~~~~~----------~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 275 KFYKLVKDGYQMAQPA----------FA---PKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHHHHHTCCCCCCT----------TC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCCC----------CC---CHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 2222222221111111 11 124788999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=349.45 Aligned_cols=250 Identities=21% Similarity=0.259 Sum_probs=197.1
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEe
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 285 (531)
...+.||+|+||.||+|.... +|+.||+|++....... .+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~-~g~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETA-TGLKLAAKIIKTRGMKD----KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp EEEEECC-----CEEEEEETT-TCCEEEEEEEECCSHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcC-CCcEEEEEEEccccccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 346789999999999998754 78999999998654322 5678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee--CCCCCEEEeecCCCccCC
Q 009595 286 FMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI--DDDMEARIADFGLARLMP 363 (531)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl--~~~~~vkL~Dfgla~~~~ 363 (531)
|+++|+|.+++.. ....+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++..+.
T Consensus 167 ~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 167 YVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp CCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred CCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 9999999999864 2356899999999999999999999 6789999999999999 667899999999998775
Q ss_pred CCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccc
Q 009595 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443 (531)
Q Consensus 364 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 443 (531)
..... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...+...+. .....
T Consensus 241 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~----~~~~~--- 307 (373)
T 2x4f_A 241 PREKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AETLNNILA----CRWDL--- 307 (373)
T ss_dssp TTCBC---CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHH----TCCCS---
T ss_pred Ccccc---ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----ccCCC---
Confidence 54322 235699999999999988999999999999999999999999976422 112222211 11110
Q ss_pred cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 444 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
....... ....+.+++.+||+.||.+|||+.+++++
T Consensus 308 ~~~~~~~----~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 308 EDEEFQD----ISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp CSGGGTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Chhhhcc----CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0111111 12347889999999999999999999984
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=340.24 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=196.5
Q ss_pred hcccccccccccccceeEEEEEeeeCC--CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPES--NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
..++|...+.||+|+||.||+|.+... .+..||+|.+..... ....+.+.+|+.++++++||||+++++++. .+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS---DSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 347889999999999999999987532 356799999875432 223677889999999999999999999874 56
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
..++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred ccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccc
Confidence 78999999999999999975 2346899999999999999999999 67899999999999999999999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
+......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.... .....+.. ..
T Consensus 163 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~----~~~~~i~~---~~ 234 (281)
T 1mp8_A 163 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIEN---GE 234 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHHT---TC
T ss_pred ccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH----HHHHHHHc---CC
Confidence 9876544322 1233457889999999998899999999999999999997 99999765332 22222211 11
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.+. .. ... ...+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 235 ~~~--~~----~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 235 RLP--MP----PNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp CCC--CC----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC--CC----CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 11 111 124788999999999999999999999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=346.65 Aligned_cols=255 Identities=19% Similarity=0.254 Sum_probs=194.2
Q ss_pred cccccccccccccceeEEEEEeee--CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELP--ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.++|...+.||+|+||.||+|... ..+|+.||+|++..............+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 367899999999999999999864 247899999999764322212225667889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.|+||||+++|+|.+++.. ...+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999975 356889999999999999999999 678999999999999999999999999998
Q ss_pred ccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+... ...... ..... .
T Consensus 169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~---i~~~~-~ 238 (327)
T 3a62_A 169 KESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR----KKTIDK---ILKCK-L 238 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHH---HHHTC-C
T ss_pred cccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH----HHHHHH---HHhCC-C
Confidence 86443221 12346799999999999998999999999999999999999999976422 112211 11111 1
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
. +. ... ...+.+++.+||..||.+|| ++.++++|
T Consensus 239 ~--~p----~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 N--LP----PYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp C--CC----TTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred C--CC----CCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0 00 011 12478899999999999999 67777764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=347.85 Aligned_cols=261 Identities=20% Similarity=0.321 Sum_probs=199.6
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeE----EEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKM----IAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 276 (531)
..++|...+.||+|+||.||+|.+.. +++. ||+|.+....... ....+.+|+.++++++||||+++++++..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~iK~~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPK---ANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC-TTCSCCEEEEEEEECCCSSCC---CHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcC-CCceEEEEEEEEeeccccCHH---HHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 35789999999999999999998754 4543 5777775432211 25678899999999999999999999987
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
.. .++|+||+.+|+|.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~Df 161 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCT
T ss_pred CC-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccC
Confidence 54 7899999999999999975 2456899999999999999999999 678999999999999999999999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
|++................||+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.... .+...+.....
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~~~~~~~~ 237 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEKGER 237 (327)
T ss_dssp TC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHHTTCC
T ss_pred cceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHHHHHcCCC
Confidence 99987755443333344567889999999999999999999999999999999 99999765332 22222222111
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
...+ ... ...+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 238 ~~~~----------~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 LPQP----------PIC---TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCC----------TTB---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCC----------ccC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111 011 1247889999999999999999999999988754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=336.88 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=208.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++++++||||+++++++...+..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTTBC-----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEec--CCCeEEEEEccccCCC-----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 467889999999999999999875 6788999999865433 356889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 80 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp EEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred EEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccc
Confidence 99999999999999975 2356899999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
...... .......|++.|+|||++.+..++.++||||||+++|+|++ |+.||..... ......+.. .....
T Consensus 154 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~i~~---~~~~~ 225 (267)
T 3t9t_A 154 VLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEVVEDIST---GFRLY 225 (267)
T ss_dssp BCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHT---TCCCC
T ss_pred cccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH----HHHHHHHhc---CCcCC
Confidence 644321 11223457889999999998899999999999999999999 8999876422 222222221 11110
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.+. .. ...+.+++.+||+.||.+|||+.+++++|+++.
T Consensus 226 ---~~~----~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 226 ---KPR----LA---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp ---CCT----TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCc----cC---cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011 11 124788999999999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=352.03 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=189.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||+|+||.||+|.... +++.||||++..... .+.+.+|+.++++++||||+++++++......+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKG-TQKPYALKVLKKTVD------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECC-CCcEEEEEEeccchh------HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 4678999999999999999998764 688999999986432 456778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC---CCCEEEeecCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD---DMEARIADFGL 358 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkL~Dfgl 358 (531)
+||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+|||++. ++.+||+|||+
T Consensus 125 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp EEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 99999999999999964 456899999999999999999999 678999999999999975 88999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ...... .......
T Consensus 198 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~---~i~~~~~ 268 (349)
T 2w4o_A 198 SKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG---DQFMFR---RILNCEY 268 (349)
T ss_dssp ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC---HHHHHH---HHHTTCC
T ss_pred ccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc---cHHHHH---HHHhCCC
Confidence 987644321 2346789999999999998999999999999999999999999865422 111211 1111111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. .. ..+......+.+++.+||..||.+|||+.+++++
T Consensus 269 ~~---~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 269 YF---IS----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CC---CT----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cc---CC----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 00 0111122347889999999999999999999885
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=345.46 Aligned_cols=267 Identities=18% Similarity=0.284 Sum_probs=212.5
Q ss_pred hcccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 276 (531)
..++|...+.||+|+||.||+|.+.. .+++.||||.+...... .....+.+|+.++++++||||+++++++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM---RERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH---HHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH---HHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 35789999999999999999998652 24678999999754332 225678899999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHhhccC------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQ------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME 350 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~ 350 (531)
.+..++||||+++|+|.+++..... ....+++..+..++.|++.||.||| +++++||||||+||+++.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCe
Confidence 9999999999999999999975321 1245789999999999999999999 678999999999999999999
Q ss_pred EEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHH
Q 009595 351 ARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRW 429 (531)
Q Consensus 351 vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~ 429 (531)
+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.+... ..+...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~ 252 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----EQVLRF 252 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----HHHHHH
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH----HHHHHH
Confidence 99999999986644332222234567899999999998899999999999999999999 8999876422 222222
Q ss_pred HHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCC
Q 009595 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALI 490 (531)
Q Consensus 430 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 490 (531)
+. ....+.. . .. ....+.+++.+||+.||.+|||+.+++++|+++...
T Consensus 253 ~~---~~~~~~~--~----~~----~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 253 VM---EGGLLDK--P----DN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HH---TTCCCCC--C----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HH---cCCcCCC--C----CC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 21 1111110 0 11 112478899999999999999999999999987543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=342.96 Aligned_cols=257 Identities=20% Similarity=0.300 Sum_probs=206.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhh--hHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLL--NIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.+.|.+.+.||+|+||.||+|.... +|+.||||.+........ ......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hccEEEeeEeeecCCEEEEEEEECC-CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4678999999999999999998754 789999999976433211 1125678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC----CEEEee
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM----EARIAD 355 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~----~vkL~D 355 (531)
.++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++ .+||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999975 467899999999999999999999 67899999999999999887 799999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ..... ....
T Consensus 163 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~---~i~~ 232 (321)
T 2a2a_A 163 FGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLA---NITS 232 (321)
T ss_dssp CTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHH---HHHT
T ss_pred CccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH----HHHHH---HHHh
Confidence 999987765422 2335689999999999998999999999999999999999999875422 11111 1111
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. . ..++...... ...+.+++.+||..||.+|||+.+++++
T Consensus 233 ~~-~--~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 233 VS-Y--DFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TC-C--CCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc-c--ccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 0 0111111111 1347889999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=346.15 Aligned_cols=262 Identities=19% Similarity=0.238 Sum_probs=197.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce-
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH- 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~- 280 (531)
.++|.+.+.||+|+||.||+|.... +++.||||++....... ......+.+|+.++.+++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLR-DHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECTTTTTS-HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECC-CCceEEEEEeCccccCC-HHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 4779999999999999999998654 78999999997643322 23356788999999999999999999998765543
Q ss_pred ---EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 281 ---LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 281 ---~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
|+||||+++|+|.+++.. ...+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred cccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 999999999999999975 356899999999999999999999 6789999999999999999999999999
Q ss_pred CCccCCCCCcc-ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 358 LARLMPDGHAQ-VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 358 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
++..+...... .......||+.|+|||++.+..++.++||||||+++|+|+||+.||.+.... .. .......
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---~~----~~~~~~~ 234 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SV----AYQHVRE 234 (311)
T ss_dssp CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH----HHHHHHC
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HH----HHHHhcC
Confidence 99876543222 2223457899999999999999999999999999999999999999764321 11 1111111
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH-Hhcc
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS-MLSD 486 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~-~L~~ 486 (531)
...... ..... ....+.+++.+||+.||.+||+..+++. .|..
T Consensus 235 ~~~~~~----~~~~~---~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 235 DPIPPS----ARHEG---LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CCCCHH----HHSTT---CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCCcc----cccCC---CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 111100 00011 1224788999999999999997766554 4433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=348.91 Aligned_cols=255 Identities=20% Similarity=0.317 Sum_probs=196.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCC--CcccccceeEEeCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH--RNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~ 279 (531)
.+.|.+.+.||+|+||.||++... +++.||||++....... .....+.+|+.++.+++| |||+++++++.....
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADN--QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeeccccch--HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 467999999999999999999764 68899999997644322 235778999999999976 999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++|||+ .+|+|.+++.. ...+++..+..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||++
T Consensus 84 ~~lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a 154 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIA 154 (343)
T ss_dssp EEEEECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred EEEEEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccc
Confidence 9999995 57799999976 467899999999999999999999 67899999999999997 578999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHH
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQT-----------LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR 428 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~ 428 (531)
................||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... . .
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~-~ 228 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I-S 228 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----H-H
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----H-H
Confidence 87765443333345679999999999864 67899999999999999999999999764321 1 1
Q ss_pred HHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 429 WMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 429 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
.+........... . +... ...+.+++.+||+.||.+|||+.+++++.
T Consensus 229 ~~~~~~~~~~~~~-~-----~~~~---~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 229 KLHAIIDPNHEIE-F-----PDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HHHHHHCTTSCCC-C-----CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHhcCCcccC-C-----cccC---CHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1111111111110 0 0111 12478899999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=342.12 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=197.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||+|+||.||+|.+ .++.||||.+..... .+.+.+|+.++++++||||+++++++. +..+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~ 75 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW---RAKDVAIKQIESESE------RKAFIVELRQLSRVNHPNIVKLYGACL--NPVC 75 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE---TTEEEEEEECSSTTH------HHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTE
T ss_pred HhHeeeeeEeecCCCceEEEEEE---CCeeEEEEEecChhH------HHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcE
Confidence 36788899999999999999987 578899999964321 567889999999999999999999876 4589
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC-EEEeecCCCc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME-ARIADFGLAR 360 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~-vkL~Dfgla~ 360 (531)
+||||+++|+|.+++... .....++...++.++.|+++||.|||+.+.++++||||||+|||++.++. +||+|||++.
T Consensus 76 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 999999999999999752 11234788999999999999999999644489999999999999998886 7999999987
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
...... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... . ...........+.
T Consensus 155 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~---~~~~~~~~~~~~~ 224 (307)
T 2eva_A 155 DIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--F---RIMWAVHNGTRPP 224 (307)
T ss_dssp ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--H---HHHHHHHTTCCCC
T ss_pred cccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--H---HHHHHHhcCCCCC
Confidence 654321 23468999999999999999999999999999999999999997543211 1 1111111211111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
. .... ...+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 225 ~------~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 225 L------IKNL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp C------BTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred c------cccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1 1111 124788999999999999999999999997753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=341.14 Aligned_cols=267 Identities=19% Similarity=0.293 Sum_probs=206.2
Q ss_pred cccccccccccccceeEEEEEee---eCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC-
Q 009595 202 EDCSASLEKIRSRASGEIYIAEL---PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP- 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~- 277 (531)
...|...+.||+|+||.||+|.+ ...+++.||||++....... ....+.+|+.++++++||||+++++++...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN---HIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C---CHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch---hHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 35688899999999999999984 33478999999997543221 256788999999999999999999999876
Q ss_pred -CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 278 -DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 278 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
...++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+||
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Df 170 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDF 170 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred CceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcc
Confidence 6689999999999999999642 356899999999999999999999 678999999999999999999999999
Q ss_pred CCCccCCCCCcc-ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCccc--------chhhhHHH
Q 009595 357 GLARLMPDGHAQ-VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQ--------HTEEKSLV 427 (531)
Q Consensus 357 gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~--------~~~~~~l~ 427 (531)
|++......... .......||..|+|||.+.+..++.++||||||+++|+|+||..|+..... ........
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 999877654322 222345688899999999998999999999999999999999998653211 00111111
Q ss_pred HHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 428 RWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 428 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.............. . .. ....+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 251 ~~~~~~~~~~~~~~--~----~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 251 RLVNTLKEGKRLPC--P----PN----CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHHTTCCCCC--C----TT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCC--C----CC----CCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 11222111111110 0 11 123478899999999999999999999999764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=338.22 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=199.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||+|+||.||+|.... ++..||+|++....... ....+.+|+.++++++||||+++++++......+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERS-SGLERVIKTINKDRSQV---PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEGGGCCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeccCCCeEEEEEEEcc-CCceEEEEEeeccccch---hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 3678899999999999999998754 78899999997644221 1567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee---CCCCCEEEeecCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI---DDDMEARIADFGL 358 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl---~~~~~vkL~Dfgl 358 (531)
+||||+++|+|.+++.........+++..+..++.|++.||.||| +.+++||||||+||++ +.++.+||+|||+
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 999999999999999764444567999999999999999999999 6789999999999999 4567899999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+........ .....||+.|+|||.+. ..++.++||||||+++|+|++|+.||.+... ..+...... ..
T Consensus 174 a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~----~~~~~~~~~----~~ 241 (285)
T 3is5_A 174 AELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL----EEVQQKATY----KE 241 (285)
T ss_dssp CCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH----CC
T ss_pred ceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH----HHHHhhhcc----CC
Confidence 987654322 23457899999999886 4689999999999999999999999976422 111111111 11
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+...... ... ...+.+++.+||+.||.+|||+.+++++
T Consensus 242 ~~~~~~~---~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 242 PNYAVEC---RPL----TPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCCC-----CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccccc---CcC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111110 011 1247789999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=342.05 Aligned_cols=256 Identities=16% Similarity=0.241 Sum_probs=202.1
Q ss_pred cccccccccccccceeEEEEEeeeCCC------CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESN------GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMV 275 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~ 275 (531)
.++|...+.||+|+||.||+|...... +..||+|.+....... .+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY----SESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGG----HHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHH----HHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 467889999999999999999876422 1579999997644332 567889999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC-----
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME----- 350 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~----- 350 (531)
..+..++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +++++||||||+|||++.++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~ 156 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGN 156 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred eCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccc
Confidence 99999999999999999999975 2344899999999999999999999 678999999999999998887
Q ss_pred ---EEEeecCCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCC-CCCcccchhhhH
Q 009595 351 ---ARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLP-SDDFFQHTEEKS 425 (531)
Q Consensus 351 ---vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P-~~~~~~~~~~~~ 425 (531)
+||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..| |... . ...
T Consensus 157 ~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-~---~~~ 226 (289)
T 4fvq_A 157 PPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-D---SQR 226 (289)
T ss_dssp CCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-C---HHH
T ss_pred cceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-c---hHH
Confidence 999999998754332 23457999999999987 6789999999999999999996554 4332 1 111
Q ss_pred HHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCCCc
Q 009595 426 LVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKD 492 (531)
Q Consensus 426 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 492 (531)
...... .......... ..+.+++.+||+.||.+|||+.+++++|+++..+..
T Consensus 227 ~~~~~~---~~~~~~~~~~------------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 227 KLQFYE---DRHQLPAPKA------------AELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp HHHHHH---TTCCCCCCSS------------CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred HHHHhh---ccCCCCCCCC------------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 111111 1111111111 127789999999999999999999999999865443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=360.66 Aligned_cols=252 Identities=26% Similarity=0.403 Sum_probs=206.5
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|.+.+.||+|+||.||+|.... +|+.||||++....... ......+.+|+.+++.++||||+++++++...+..|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~-~g~~vAvK~i~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHEL-TGHKVAVKILNRQKIRS-LDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETT-TCCEEEEEEEEHHHHHH-TTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhhhccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3778999999999999999998754 78999999997532211 112567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 93 lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 93 MVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp EEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 99999999999999964 567999999999999999999999 78899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKF-SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+... ..+...+ .... ..
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i---~~~~-~~ 234 (476)
T 2y94_A 166 MSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV----PTLFKKI---CDGI-FY 234 (476)
T ss_dssp CCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS----HHHHHHH---HTTC-CC
T ss_pred cccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH----HHHHHHH---hcCC-cC
Confidence 755432 234679999999999988765 7899999999999999999999976432 2222221 1111 10
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. + ... ...+.+++.+||+.||.+|||+.+++++
T Consensus 235 ~---p----~~~---s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 235 T---P----QYL---NPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp C---C----TTC---CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred C---C----ccC---CHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0 0 011 1247889999999999999999999984
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=344.06 Aligned_cols=270 Identities=20% Similarity=0.268 Sum_probs=209.8
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe----
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR---- 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~---- 276 (531)
..++|...+.||+|+||.||++.... +|+.||||++...... ....+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLH-DGHFYALKRILCHEQQ----DREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETT-TCCEEEEEEEEESSHH----HHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecC-CCcEEEEEEEecCCHH----HHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 45789999999999999999998654 7899999999764332 26778899999999999999999999873
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
....++||||+++|+|.+++.........+++..++.++.|++.||.||| ..+++||||||+||+++.++.+||+||
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEec
Confidence 34778999999999999999876556678999999999999999999999 678999999999999999999999999
Q ss_pred CCCccCCCCCccc-------eecccccCccccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHH
Q 009595 357 GLARLMPDGHAQV-------STSIVAGTVGYIAPEYHQTLK---FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSL 426 (531)
Q Consensus 357 gla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l 426 (531)
|++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........ .+
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~ 256 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SV 256 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hh
Confidence 9988654221110 012345799999999987654 68899999999999999999999864322111 11
Q ss_pred HHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCCCch
Q 009595 427 VRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDV 493 (531)
Q Consensus 427 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 493 (531)
......... .+. . ... ...+.+++.+||+.||.+|||+.+++++|+.+.++.+.
T Consensus 257 ~~~~~~~~~--~~~---~----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 257 ALAVQNQLS--IPQ---S----PRH----SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp HHHHHCC----CCC---C----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred hHHhhccCC--CCc---c----ccC----CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 111111000 000 0 111 12488899999999999999999999999998765443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=348.60 Aligned_cols=253 Identities=20% Similarity=0.229 Sum_probs=203.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
.++|...+.||+|+||.||+|.... +|+.||||++....... ......+..|..++..+ +||||+++++++...+..
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT-EEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 4678999999999999999998754 68899999997642211 11256778899999988 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+||||++||+|.+++.. ...+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 999999999999999975 356899999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ..+...+ .... ..
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i---~~~~-~~ 239 (353)
T 2i0e_A 170 ENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSI---MEHN-VA 239 (353)
T ss_dssp CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH---HHCC-CC
T ss_pred ccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH----HHHHHHH---HhCC-CC
Confidence 6433222 22446899999999999999999999999999999999999999975422 2222222 1111 11
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-----SKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 483 (531)
. . ... ...+.+++.+||..||.+||+ +.++++|
T Consensus 240 ~--p----~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 Y--P----KSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp C--C----TTS----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred C--C----CCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 0 111 124788999999999999996 4666654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=342.55 Aligned_cols=270 Identities=23% Similarity=0.350 Sum_probs=201.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhc--CCCCcccccceeEEeC--
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQ--IRHRNIVPLLAHMVRP-- 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~-- 277 (531)
.++|.+.+.||+|+||.||+|.+ +|+.||||++.... ...+..|..++.. ++||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW---RGEKVAVKVFFTTE-------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccceEEEeEeecCCCeEEEEEEE---CCceEEEEEEeccc-------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 46789999999999999999987 58999999997533 2233445555554 4999999999999887
Q ss_pred --CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeeccCCCCeeeCCCCC
Q 009595 278 --DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY-----HRPRIIHRNITPSSVLIDDDME 350 (531)
Q Consensus 278 --~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlkp~NILl~~~~~ 350 (531)
...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +..+++||||||+|||++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 678999999999999999975 4689999999999999999999932 0128999999999999999999
Q ss_pred EEEeecCCCccCCCCCccc--eecccccCccccCcccccCCCCCch------hhHHHHHHHHHHHHhC----------CC
Q 009595 351 ARIADFGLARLMPDGHAQV--STSIVAGTVGYIAPEYHQTLKFSEK------CDIYSFGVLLAVLVMG----------KL 412 (531)
Q Consensus 351 vkL~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~elltg----------~~ 412 (531)
+||+|||++..+....... ......||+.|+|||++.+..++.. +|||||||++|||+|| ..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999998765432221 1224579999999999987765554 9999999999999999 77
Q ss_pred CCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCCCc
Q 009595 413 PSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKD 492 (531)
Q Consensus 413 P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 492 (531)
||............ +.................. .......+.+++.+||+.||.+|||+.+++++|+.+....+
T Consensus 261 p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 261 PYHDLVPSDPSYED---MREIVCIKKLRPSFPNRWS---SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TTTTTSCSSCCHHH---HHHHHTTSCCCCCCCGGGG---GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred cHhhhcCCCCchhh---hHHHHhhhccCccccccch---hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 77654332222111 1111111111111111111 12445568899999999999999999999999988765443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=341.65 Aligned_cols=271 Identities=22% Similarity=0.295 Sum_probs=203.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|.+.+.||+|+||.||+|.... +|+.||||++....... ......+.+|+.++++++||||+++++++...+..+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLL-DGVPVALKKVQIFDLMD-AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETT-TCCEEEEEEECTTSSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcC-CCceEEEEeeehhhccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 4678999999999999999998654 78999999997533222 223677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.........+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 999999999999999765555677999999999999999999999 67899999999999999999999999999887
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
....... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||.+.... .............+..
T Consensus 186 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~ 258 (310)
T 2wqm_A 186 FSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKIEQCDYPPL 258 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-----HHHHHHHHHTTCSCCC
T ss_pred ecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-----HHHHHHHhhcccCCCC
Confidence 6543221 22356899999999999999999999999999999999999998653211 1112222222111111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCCCch
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDV 493 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 493 (531)
. .... ...+.+++.+||..||.+|||+.++++.|+++.+..++
T Consensus 259 ~------~~~~---~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 259 P------SDHY---SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp C------TTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred c------cccc---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 0 1111 12478899999999999999999999999988654433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=353.67 Aligned_cols=258 Identities=20% Similarity=0.241 Sum_probs=197.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHH-HhcCCCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMT-AGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
.++|..++.||+|+||.||+|+... +++.||||++........ .....+..|..+ ++.++||||+++++++.+.+..
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~~~~~~~~~~-~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKA-EEVFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETT-TCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcC-CCCEEEEEEEEHHHhhhh-HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 4678999999999999999998764 788999999976443221 124556667776 5778999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+||||++||+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.+|.+||+|||+++
T Consensus 115 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 999999999999999975 456889999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+... ..+.. ...... ..
T Consensus 188 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~~~~---~i~~~~-~~ 257 (373)
T 2r5t_A 188 ENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYD---NILNKP-LQ 257 (373)
T ss_dssp GGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH----HHHHH---HHHHSC-CC
T ss_pred ccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----HHHHH---HHHhcc-cC
Confidence 6433221 22456899999999999999999999999999999999999999975422 22222 111111 10
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
+. .... ..+.+++.+||+.||.+||++.+.++.+....
T Consensus 258 --~~----~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~ 295 (373)
T 2r5t_A 258 --LK----PNIT----NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295 (373)
T ss_dssp --CC----SSSC----HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSG
T ss_pred --CC----CCCC----HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCc
Confidence 11 1111 24788999999999999999865444444433
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=353.95 Aligned_cols=307 Identities=20% Similarity=0.227 Sum_probs=217.5
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC---
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--- 277 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--- 277 (531)
-.++|.+.+.||+|+||.||+|.... +|+.||||++....... ...+.+.+|+.+|+.++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKN-TEKNVAIKKVNRMFEDL--IDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECSTTTSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECC-CCcEEEEEEeCchhcCh--HHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence 45789999999999999999998764 78999999997643322 2367889999999999999999999998776
Q ss_pred --CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 278 --DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 278 --~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
...|+||||+.+ +|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~~lv~e~~~~-~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~D 172 (432)
T 3n9x_A 101 KFDELYIVLEIADS-DLKKLFKT----PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCD 172 (432)
T ss_dssp TCCCEEEEEECCSE-EHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEecCCc-CHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEcc
Confidence 568999999965 99999964 467999999999999999999999 67899999999999999999999999
Q ss_pred cCCCccCCCCCcc--------------------ceecccccCccccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 009595 356 FGLARLMPDGHAQ--------------------VSTSIVAGTVGYIAPEYH-QTLKFSEKCDIYSFGVLLAVLVMGKLPS 414 (531)
Q Consensus 356 fgla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~P~ 414 (531)
||+++........ ......+||+.|+|||++ .+..++.++|||||||++|||++|..||
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 9999976543211 112456899999999986 5567999999999999999999865554
Q ss_pred CCcc-------cch------------------hhhHHHHHHHHHhccCCC--------------------Ccccc-cccc
Q 009595 415 DDFF-------QHT------------------EEKSLVRWMRNVMTSENP--------------------NRAID-SKLL 448 (531)
Q Consensus 415 ~~~~-------~~~------------------~~~~l~~~~~~~~~~~~~--------------------~~~~d-~~l~ 448 (531)
.... +.. ...++ ..+......+.. ....+ ....
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql-~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQL-NIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY 331 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHH-HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHH-HHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC
Confidence 3210 000 00111 111111111100 00000 0000
Q ss_pred CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCchhhhhhccCCCCC--ChHHHHHhhHHHHhhhhc
Q 009595 449 GNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKDVDFLKMHKRMDFD--NDDCVELIQQEIYTEWLS 523 (531)
Q Consensus 449 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 523 (531)
+ .....+.+|+.+||+.||.+|||+.+++++ +.++...........+...+|+ .....+.++..+|.|...
T Consensus 332 ~----~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 406 (432)
T 3n9x_A 332 P----SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQS 406 (432)
T ss_dssp T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHHHH
T ss_pred C----CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHHHH
Confidence 1 122347889999999999999999999985 4555443332233333333343 234667778888877654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=333.12 Aligned_cols=252 Identities=23% Similarity=0.282 Sum_probs=203.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||+|+||.||+|.... ++..||+|++....... .+.+.+|+.++++++||||+++++++......+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~a~k~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKG-TRIRRAAKKIPKYFVED----VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCSC----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCC-CCcEEEEEeehhhccch----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 4678999999999999999998754 67889999997654333 567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee---CCCCCEEEeecCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI---DDDMEARIADFGL 358 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl---~~~~~vkL~Dfgl 358 (531)
+||||+++++|.+++.. ...+++..+..++.|++.||.||| +++++||||||+||++ +.++.+||+|||+
T Consensus 83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~ 155 (277)
T 3f3z_A 83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGL 155 (277)
T ss_dssp EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence 99999999999999875 456899999999999999999999 6789999999999999 7889999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+......... ....||+.|+|||.+.+. ++.++||||||+++|+|++|+.||..... ......+. ....
T Consensus 156 ~~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~---~~~~ 224 (277)
T 3f3z_A 156 AARFKPGKMM---RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD----SEVMLKIR---EGTF 224 (277)
T ss_dssp CEECCTTSCB---CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH---HCCC
T ss_pred ceeccCccch---hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH----HHHHHHHH---hCCC
Confidence 9876544322 335789999999998764 89999999999999999999999976422 11211111 1111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. ....... ....+.+++.+||+.||.+|||+.+++++
T Consensus 225 ~~---~~~~~~~----~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 225 TF---PEKDWLN----VSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CC---CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CC---Cchhhhc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 0000001 12347889999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=351.19 Aligned_cols=274 Identities=16% Similarity=0.203 Sum_probs=205.3
Q ss_pred hcccccccccccccceeEEEEEeeeCC----CCeEEEEEEEeccCchhhhH-------HHHHHHHHHHHHhcCCCCcccc
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPES----NGKMIAIKKVKQVDNSLLNI-------KMRQVRAEIMTAGQIRHRNIVP 269 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~-------~~~~~~~Ei~~l~~l~hpnIv~ 269 (531)
..+.|.+.+.||+|+||.||+|.+... .++.||||++.......... ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 356899999999999999999987542 25789999997654321110 0123455677888899999999
Q ss_pred cceeEEeC----CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee
Q 009595 270 LLAHMVRP----DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345 (531)
Q Consensus 270 l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl 345 (531)
+++++... ...++||||+ +++|.+++.. ....+++..+..++.||+.||.||| +.+|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEE
Confidence 99998765 4579999999 9999999975 2367999999999999999999999 6789999999999999
Q ss_pred C--CCCCEEEeecCCCccCCCCCcc-----ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 009595 346 D--DDMEARIADFGLARLMPDGHAQ-----VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFF 418 (531)
Q Consensus 346 ~--~~~~vkL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~ 418 (531)
+ .++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+..
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 8899999999999876533211 11133569999999999999999999999999999999999999998643
Q ss_pred cchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 419 QHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 419 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
... ............. ....+++.+.....+ ..+.+++..||..||.+|||+.+|++.|.++.
T Consensus 266 ~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 266 KDP---KYVRDSKIRYREN-IASLMDKCFPAANAP---GEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp TCH---HHHHHHHHHHHHC-HHHHHHHHSCTTCCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCH---HHHHHHHHHhhhh-HHHHHHHhcccccCH---HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 222 2222222111111 111111111111111 24778889999999999999999999997753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=338.36 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=206.6
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|...+.||+|+||.||+|... ++..||||.+...... .+.+.+|+.++++++||||+++++++. .+..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 82 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSMS-----PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPI 82 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCCccc-----HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCc
Confidence 3467899999999999999999864 6778999999764432 467889999999999999999999876 4568
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++++|.+++.. .....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.
T Consensus 83 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp EEEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 999999999999999964 11236899999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+... ..+...+.. ....
T Consensus 158 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~---~~~~ 229 (279)
T 1qpc_A 158 LIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----PEVIQNLER---GYRM 229 (279)
T ss_dssp ECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHT---TCCC
T ss_pred cccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH----HHHHHHHhc---ccCC
Confidence 77554322 2233457889999999988889999999999999999999 9999876422 222222221 1111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.. .... ...+.+++.+||..||.+|||+.++++.|+++.
T Consensus 230 ~~-------~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 230 VR-------PDNC---PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CC-------CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-------cccc---cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 10 0111 124788999999999999999999999998764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=338.76 Aligned_cols=264 Identities=21% Similarity=0.289 Sum_probs=209.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe--CCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR--PDC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~ 279 (531)
.++|...+.||+|+||.||+|.... +|+.||+|.+....... ...+.+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECC-CCcEEEEEEEEcccCCH--HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 4678999999999999999998754 78999999998654332 236778999999999999999999998854 567
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEeeccCCCCeeeCCCCCEEEe
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR-----IIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
.++||||+++|+|.+++.........+++..++.++.|++.||.||| ..+ ++||||||+||+++.++.+||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 89999999999999999865444566999999999999999999999 455 9999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
|||++......... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..+...+..
T Consensus 159 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~i~~-- 230 (279)
T 2w5a_A 159 DFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIRE-- 230 (279)
T ss_dssp CCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH--
T ss_pred cCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH----HHHHHHHhh--
Confidence 99998876543221 1235689999999999998999999999999999999999999876422 222222222
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCC
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALI 490 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 490 (531)
...+. +. ... ...+.+++.+||+.||.+|||+.++++++...++.
T Consensus 231 -~~~~~--~~----~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 231 -GKFRR--IP----YRY----SDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp -TCCCC--CC----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred -ccccc--CC----ccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 11111 00 111 12478899999999999999999999988665543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=362.09 Aligned_cols=254 Identities=20% Similarity=0.256 Sum_probs=196.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.... +|+.||||++....... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKA-TGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcC-CCCEEEEEEEEhhhhhh-hHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 3678999999999999999998754 78999999997532111 122466788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+||+||||||+|||++.++.+||+|||+++.
T Consensus 225 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 99999999999999975 4578999999999999999999993 27899999999999999999999999999986
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ..+...+.. .......
T Consensus 299 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~--~~~~~p~ 370 (446)
T 4ejn_A 299 GIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILM--EEIRFPR 370 (446)
T ss_dssp TCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH--CCCCCCT
T ss_pred ccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHHHHHHHh--CCCCCCc
Confidence 443322 22346899999999999999999999999999999999999999865422 222222211 1111111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
.. ...+.+++.+||+.||.+|| |+.++++|
T Consensus 371 --------~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 371 --------TL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp --------TS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------cC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11 12478899999999999999 99999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=357.04 Aligned_cols=311 Identities=17% Similarity=0.233 Sum_probs=204.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC----
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP---- 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 277 (531)
.++|.+.+.||+|+||+||+|.... +|+.||||++....... ...+.+.+|+.+|+.++||||+++++++...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKL-EKRVVAIKKILRVFEDL--IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC---CEEEEEEECSTTSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECC-CCcEEEEEEechhhcCH--HHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 4789999999999999999998764 78999999997543322 2367789999999999999999999998543
Q ss_pred -CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 278 -DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 278 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
..+|+||||+. |+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 129 ~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DF 200 (458)
T 3rp9_A 129 FDELYVVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDF 200 (458)
T ss_dssp CCCEEEEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeeccc
Confidence 56899999985 599999964 467999999999999999999999 678999999999999999999999999
Q ss_pred CCCccCCCCCcc-------------------------ceecccccCccccCcccc-cCCCCCchhhHHHHHHHHHHHHh-
Q 009595 357 GLARLMPDGHAQ-------------------------VSTSIVAGTVGYIAPEYH-QTLKFSEKCDIYSFGVLLAVLVM- 409 (531)
Q Consensus 357 gla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~ellt- 409 (531)
|+++........ ......+||+.|+|||++ .+..++.++|||||||++|||+|
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 999876432110 112346789999999976 45679999999999999999999
Q ss_pred ----------CCCCCCCcccc----------------hhhhHHHHHHHHHhccCCCCcc-----------------cccc
Q 009595 410 ----------GKLPSDDFFQH----------------TEEKSLVRWMRNVMTSENPNRA-----------------IDSK 446 (531)
Q Consensus 410 ----------g~~P~~~~~~~----------------~~~~~l~~~~~~~~~~~~~~~~-----------------~d~~ 446 (531)
|+.+|.+.... .........+......+..... ....
T Consensus 281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (458)
T 3rp9_A 281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360 (458)
T ss_dssp STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence 55555442110 0001111111111111100000 0000
Q ss_pred ccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCchhhhhhccCCCCC--ChHHHHHhhHHHHhhhh
Q 009595 447 LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKDVDFLKMHKRMDFD--NDDCVELIQQEIYTEWL 522 (531)
Q Consensus 447 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 522 (531)
-....++.....+.+|+.+||..||.+|||+.++++| +.++...........+....|+ .....+.++..+|.|..
T Consensus 361 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 440 (458)
T 3rp9_A 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQ 440 (458)
T ss_dssp CGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHHHHHHHHHHT
T ss_pred CHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHH
Confidence 0001111223457889999999999999999999996 3444322211111122222232 23355667777777764
Q ss_pred c
Q 009595 523 S 523 (531)
Q Consensus 523 ~ 523 (531)
.
T Consensus 441 ~ 441 (458)
T 3rp9_A 441 R 441 (458)
T ss_dssp T
T ss_pred H
Confidence 3
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=351.73 Aligned_cols=255 Identities=20% Similarity=0.322 Sum_probs=197.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC--CCcccccceeEEeCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR--HRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~~ 279 (531)
...|.+.+.||+|+||.||+|... +++.||||++...... ......+.+|+.++.+++ ||||+++++++...+.
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEAD--NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCceEEEEEEccCCCeEEEEEEcC--CCCEEEEEEEeccccc--HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 356999999999999999999764 5889999999764432 223677899999999996 5999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
+|+||| +.+++|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||++
T Consensus 131 ~~lv~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a 201 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIA 201 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred EEEEEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence 999999 557899999976 457889999999999999999999 78899999999999995 579999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHH
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQT-----------LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR 428 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~ 428 (531)
..+............+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ..
T Consensus 202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~ 275 (390)
T 2zmd_A 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------IS 275 (390)
T ss_dssp CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HH
T ss_pred ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------HH
Confidence 87755433333345679999999999865 36899999999999999999999999754221 11
Q ss_pred HHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 429 WMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 429 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
.+........... . +... ...+.+++.+||..||.+|||+.+++++.
T Consensus 276 ~~~~~~~~~~~~~-~-----~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 276 KLHAIIDPNHEIE-F-----PDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp HHHHHHCTTSCCC-C-----CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHhCccccCC-C-----Cccc---hHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 1222222111110 0 0111 12478899999999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=342.78 Aligned_cols=268 Identities=20% Similarity=0.224 Sum_probs=199.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhh-hHHHHHHHHHHHHHhcC---CCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLL-NIKMRQVRAEIMTAGQI---RHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~ 277 (531)
.++|.+.+.||+|+||+||+|.... +|+.||||++........ ......+.+|+.+++.+ +||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPH-SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTT-TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4689999999999999999998654 789999999975332110 00123455677766666 599999999999876
Q ss_pred C-----ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEE
Q 009595 278 D-----CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEAR 352 (531)
Q Consensus 278 ~-----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vk 352 (531)
. ..++||||+. |+|.+++.. .....+++..+..++.|++.||.||| +.+++||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEE
Confidence 5 4789999997 599999976 33345999999999999999999999 67899999999999999999999
Q ss_pred EeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHH
Q 009595 353 IADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN 432 (531)
Q Consensus 353 L~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~ 432 (531)
|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... ..+.. +..
T Consensus 161 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~-i~~ 233 (308)
T 3g33_A 161 LADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGK-IFD 233 (308)
T ss_dssp ECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHH-HHH
T ss_pred EeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-HHH
Confidence 999999987654322 23467899999999999999999999999999999999999999764322 22222 222
Q ss_pred HhccCCCCcccc----c-cccC----C----CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 433 VMTSENPNRAID----S-KLLG----N----GYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 433 ~~~~~~~~~~~d----~-~l~~----~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
............ + .... . ..+.....+.+++.+||+.||.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 221111110000 0 0000 0 001112357889999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=357.48 Aligned_cols=260 Identities=22% Similarity=0.274 Sum_probs=203.8
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..++|...+.||+|+||.||+|.... +|+.||||++....... ......+.+|..++..++||||+++++++.+.+..
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~-~~~~vAiK~l~k~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQ-TGQVYAMKIMNKWDMLK-RGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHH-HGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeHHHhhh-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 34789999999999999999998754 78999999997532211 11245578899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+||||+++|+|.+++... ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++++||+|||++.
T Consensus 137 ~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp EEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 9999999999999999752 246899999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCccccc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQ-------TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
....... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.........+..+ .
T Consensus 211 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~---~ 286 (412)
T 2vd5_A 211 KLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY---K 286 (412)
T ss_dssp ECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH---H
T ss_pred eccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc---c
Confidence 7655432 2223468999999999987 356899999999999999999999999764321111111111 1
Q ss_pred hccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 009595 434 MTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEER---PNSKDVRSM 483 (531)
Q Consensus 434 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~ 483 (531)
.....+. .+ ... ...+.+++.+||. +|.+| |++.++++|
T Consensus 287 ~~~~~p~--~~----~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 287 EHLSLPL--VD----EGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHCCCC----------CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cCcCCCc--cc----cCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1111110 00 011 1247889999999 99998 689998875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=347.76 Aligned_cols=267 Identities=24% Similarity=0.294 Sum_probs=202.1
Q ss_pred hhhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchh-hhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 199 LEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSL-LNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 199 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
....++|...+.||+|+||.||+|.... +++.||+|++....... .......+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQ-TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECC-CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456789999999999999999998754 78899999997532110 112257789999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHhhccCC------------------------------------CccCCHHHHHHHHHHHHHH
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQG------------------------------------RRELEWLARHRIARGIVSG 321 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~~ 321 (531)
+..++||||+++|+|.+++...... ...+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998531111 2234677888999999999
Q ss_pred HHHHHhcCCCCeEeeccCCCCeeeCCCC--CEEEeecCCCccCCCCC--ccceecccccCccccCcccccC--CCCCchh
Q 009595 322 LEYLHMYHRPRIIHRNITPSSVLIDDDM--EARIADFGLARLMPDGH--AQVSTSIVAGTVGYIAPEYHQT--LKFSEKC 395 (531)
Q Consensus 322 L~~LH~~~~~~ivH~Dlkp~NILl~~~~--~vkL~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 395 (531)
|.||| +.+++||||||+|||++.++ .+||+|||++..+.... .........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999 67899999999999998776 89999999998654321 1112234679999999999875 5789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCC
Q 009595 396 DIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP 475 (531)
Q Consensus 396 DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 475 (531)
||||||+++|+|++|+.||.+.... ..+. ........... + ........+.+++.+||+.||.+||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~---~~~~----~~~~~~~~~~~--~-----~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA---DTIS----QVLNKKLCFEN--P-----NYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCCCTTS--G-----GGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH---HHHH----HHHhcccccCC--c-----ccccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999999999764321 1111 11111111110 0 0011123478899999999999999
Q ss_pred CHHHHHHH
Q 009595 476 NSKDVRSM 483 (531)
Q Consensus 476 s~~evl~~ 483 (531)
|+.+++++
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999884
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=334.79 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=201.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|.+.+.||+|+||.||+|.... ++..||||++....... ......+.+|+.++++++||||+++++++......+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHH-HTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEcc-CCcEEEEEEEeccccch-hhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 3678999999999999999998764 78899999997533221 112466889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEecccccc
Confidence 99999999999999976 356899999999999999999999 78899999999999999999999999999865
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
..... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||..... ......+... ....+
T Consensus 159 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~-~~~~~-- 227 (279)
T 3fdn_A 159 APSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----QETYKRISRV-EFTFP-- 227 (279)
T ss_dssp C------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHT-CCCCC--
T ss_pred CCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH----HHHHHHHHhC-CCCCC--
Confidence 44332 1335789999999999998999999999999999999999999875422 1111111111 00101
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
... ...+.+++.+||+.||.+|||+.+++++
T Consensus 228 --------~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 228 --------DFV---TEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --------TTS---CHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --------CcC---CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111 1247789999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=363.79 Aligned_cols=260 Identities=25% Similarity=0.309 Sum_probs=208.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||+|+||.||+|.... +|+.||||++....... ......+..|+.++++++||||+++++++......|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~-tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKA-TGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 4678899999999999999998754 78999999997533211 112467888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||++||+|.+++.........+++..+..++.||+.||.||| +.+|+||||||+|||++.+|.+||+|||++..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 999999999999999764444567999999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
+...... ....+||+.|+|||++.+..++.++|||||||++|||+||+.||...........+...+ .... ...
T Consensus 339 ~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i---~~~~-~~~ 412 (543)
T 3c4z_A 339 LKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV---LEQA-VTY 412 (543)
T ss_dssp CCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH---HHCC-CCC
T ss_pred ccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH---hhcc-cCC
Confidence 7554322 234589999999999999999999999999999999999999997643222222232222 2111 110
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS-----KDVRS 482 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 482 (531)
. ... ...+.+++.+||+.||.+||++ .++++
T Consensus 413 --p----~~~----s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 413 --P----DKF----SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --C----TTS----CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --C----ccc----CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0 111 1247789999999999999975 56665
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=334.33 Aligned_cols=256 Identities=22% Similarity=0.363 Sum_probs=205.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.... +++.||||++....... ....+.+|+.+++.++||||+++++++...+..+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVD---CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEGGGCTT---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECC-CCcEEEEEEeeeccchh---hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 4678999999999999999998754 78899999997543321 2567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 154 (276)
T ss_dssp EEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence 99999999999998854 467899999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKF-SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
..............||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||....... .....+.. .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~----~~-~~ 227 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKE----KK-TY 227 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--HHHHHHHT----TC-TT
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHhhh----cc-cc
Confidence 643322222344678999999999987765 789999999999999999999997643211 11222211 11 10
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
... .......+.+++.+||..||.+|||+.+++++
T Consensus 228 ~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 LNP--------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp STT--------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCc--------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 000 01112247889999999999999999998874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=366.17 Aligned_cols=258 Identities=24% Similarity=0.340 Sum_probs=208.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||+|+||.||+|.... +|+.||||++....... ......+.+|+.+|..++||||+++++++.+.+..|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4678999999999999999998754 78999999997532211 112466788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||++||+|.+++.. .....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 261 lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 99999999999999975 33445999999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+... ...
T Consensus 336 ~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----~~~- 407 (576)
T 2acx_A 336 VPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----PEE- 407 (576)
T ss_dssp CCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----CCC-
T ss_pred cccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----ccc-
Confidence 755432 233589999999999999899999999999999999999999997653322223333322221 111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
+. ... ...+.+++.+||+.||.+|| ++.++++|
T Consensus 408 -~p----~~~----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 408 -YS----ERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -CC----TTS----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -CC----ccC----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 00 111 12478899999999999999 77888875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=351.59 Aligned_cols=254 Identities=19% Similarity=0.286 Sum_probs=191.1
Q ss_pred cccccc-ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHh-cCCCCcccccceeEEe----
Q 009595 203 DCSASL-EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAG-QIRHRNIVPLLAHMVR---- 276 (531)
Q Consensus 203 ~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~---- 276 (531)
+.|... +.||+|+||.||+|.... +|+.||||++... ..+.+|+.++. ..+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~-~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKR-TQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccceeccceeeeccCeEEEEEEECC-CCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 556665 689999999999998754 7899999999742 23557888764 4589999999998875
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC---CCCEEE
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD---DMEARI 353 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkL 353 (531)
...+|+|||||++|+|.+++.. .....+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl 205 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKL 205 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEE
T ss_pred CcEEEEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEE
Confidence 5678999999999999999975 33456999999999999999999999 678999999999999997 789999
Q ss_pred eecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
+|||+++....... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.............+..
T Consensus 206 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~- 281 (400)
T 1nxk_A 206 TDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM- 281 (400)
T ss_dssp CCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH-
T ss_pred EecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc-
Confidence 99999987654322 23467899999999999999999999999999999999999999764332211112111111
Q ss_pred hccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 434 MTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 434 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
+.... .. ..+......+.+++.+||+.||.+|||+.+++++-
T Consensus 282 ---~~~~~--~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 282 ---GQYEF--PN----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp ---TCCCC--CT----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ---CcccC--CC----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 11000 00 00111123478899999999999999999999863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.17 Aligned_cols=253 Identities=24% Similarity=0.373 Sum_probs=203.2
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|...+.||+|+||.||+|.... +|+.||||++....... ......+.+|+.++++++||||+++++++...+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 129 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 129 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEESCSSCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEcc-CCeEEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeE
Confidence 34668899999999999999998653 78999999997644322 22356788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+. |+|.+++.. ....+++..+..++.|+++||.||| +.+++||||||+|||++.++.+||+|||++.
T Consensus 130 ~lv~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 202 (348)
T 1u5q_A 130 WLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 202 (348)
T ss_dssp EEEEECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred EEEEecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCce
Confidence 99999997 589888864 2357899999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQ---TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
..... ....||+.|+|||++. +..++.++|||||||++|||++|+.||.+... ...+ .......
T Consensus 203 ~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~----~~~~~~~ 269 (348)
T 1u5q_A 203 IMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSAL----YHIAQNE 269 (348)
T ss_dssp SSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH----HHHHHSC
T ss_pred ecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHH----HHHHhcC
Confidence 65432 2357899999999884 56789999999999999999999999865422 1111 1222222
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
.+.. ....++ ..+.+++.+||+.||.+|||+.+++++.
T Consensus 270 ~~~~------~~~~~~---~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 270 SPAL------QSGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CCCC------CCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCCC------CCCCCC---HHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 1111 011111 2477899999999999999999998764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=335.44 Aligned_cols=261 Identities=22% Similarity=0.333 Sum_probs=203.8
Q ss_pred cccccccccccccceeEEEEEeeeCC--CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPES--NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
...|...+.||+|+||.||+|.+... ++..||+|.+...... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM---QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence 34566679999999999999986432 3347999999754332 236778899999999999999999999987665
Q ss_pred e-EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 280 H-LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 280 ~-~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
. ++||||+.+|+|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred CcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCC
Confidence 5 999999999999999964 3466899999999999999999999 67899999999999999999999999999
Q ss_pred CccCCCCCc--cceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 359 ARLMPDGHA--QVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 359 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
+........ ........||+.|+|||.+.+..++.++||||||+++|+|++|..|+.... ....+...+......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~ 247 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI---DPFDLTHFLAQGRRL 247 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CGGGHHHHHHTTCCC
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC---CHHHHHHHhhcCCCC
Confidence 986654321 112234567899999999999999999999999999999999655543221 122232222221111
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
..+ ... ...+.+++.+||+.||.+|||+.++++.|+++
T Consensus 248 ~~~----------~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 248 PQP----------EYC---PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp CCC----------TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----------ccc---hHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111 111 12478899999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=335.20 Aligned_cols=259 Identities=20% Similarity=0.288 Sum_probs=206.3
Q ss_pred cccccccc-cccccceeEEEEEeee-CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 202 EDCSASLE-KIRSRASGEIYIAELP-ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~-~ig~G~~g~Vy~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.++|.+.+ .||+|+||.||+|.+. ..++..||||++...... ...+.+.+|+.++++++||||+++++++ ..+.
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 35566666 9999999999999863 235788999999864322 2367788999999999999999999998 5567
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++||||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp EEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred cEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccce
Confidence 8999999999999999963 3456899999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCccc-eecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 360 RLMPDGHAQV-STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 360 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
.......... ......||+.|+|||++.+..++.++||||||+++|+|+| |+.||..... ..+...+.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~i~~---~~ 230 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVMAFIEQ---GK 230 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HHHHHHHHT---TC
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHhc---CC
Confidence 8775443221 1223457899999999988889999999999999999998 9999976432 222222221 11
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.+. .. ... ...+.+++..||..||.+|||+.+++++|..+
T Consensus 231 ~~~--~~----~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 231 RME--CP----PEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp CCC--CC----TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC--CC----CCc----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 00 111 22488899999999999999999999999876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=344.83 Aligned_cols=269 Identities=22% Similarity=0.300 Sum_probs=209.7
Q ss_pred hcccccccccccccceeEEEEEee---eCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe-
Q 009595 201 KEDCSASLEKIRSRASGEIYIAEL---PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR- 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~- 276 (531)
..++|...+.||+|+||.||+|.+ ...+++.||||++....... .+.+.+|+.++++++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ----QRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHH----HHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHH----HHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 457889999999999999999985 34478999999997654322 5678899999999999999999998874
Q ss_pred -CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 277 -PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 277 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
....++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECC
T ss_pred CCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcc
Confidence 45689999999999999999752 246899999999999999999999 67899999999999999999999999
Q ss_pred cCCCccCCCCCcc-ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch--------hhhHH
Q 009595 356 FGLARLMPDGHAQ-VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHT--------EEKSL 426 (531)
Q Consensus 356 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~--------~~~~l 426 (531)
||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .....
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred cccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence 9999877544322 12234568889999999998889999999999999999999999976432110 00001
Q ss_pred HHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 427 VRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 427 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
.... .....+.... . .......+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 251 ~~~~-~~~~~~~~~~-~--------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 251 SRLL-ELLEEGQRLP-A--------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHH-HHHHTTCCCC-C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHH-HHhhcccCCC-C--------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111 1111111110 0 01112347889999999999999999999999988754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=337.24 Aligned_cols=264 Identities=19% Similarity=0.232 Sum_probs=201.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
-+.|...+.||+|+||.||+|.... +++.||||++....... ......+.+|+.++.+++||||+++++++...+..+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV-RERIVALKLMSETLSSD-PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT-TTEEEEEEECGGGGGGS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC-CCeEEEEEecCcccccC-HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 4789999999999999999998654 78999999997643322 233577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 111 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 99999999999999975 356899999999999999999999 67899999999999999999999999999887
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC-
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN- 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~- 440 (531)
....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..+ ........+.
T Consensus 184 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~----~~~~~~~~~~~ 254 (309)
T 2h34_A 184 TTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL----SVM----GAHINQAIPRP 254 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH----HHH----HHHHHSCCCCG
T ss_pred ccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH----HHH----HHHhccCCCCc
Confidence 6543221 12345689999999999998999999999999999999999999876421 111 1111111111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhccCcCCC
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-NSKDVRSMLSDTALIK 491 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 491 (531)
....+. ....+.+++.+||+.||.+|| |+.++++.|.......
T Consensus 255 ~~~~~~--------~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 255 STVRPG--------IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp GGTSTT--------CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred cccCCC--------CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 111111 112478899999999999999 9999999998865443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=347.85 Aligned_cols=265 Identities=20% Similarity=0.236 Sum_probs=195.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||+||+|.... +++.||||++...... ......+.+|+.++++++||||+++++++......+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTV-TNETVAIKRIRLEHEE--EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT-TTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECC-CCceEEEEEEcccccc--cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 4789999999999999999997654 7899999999754332 222456778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC-----CCCCEEEeec
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID-----DDMEARIADF 356 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~-----~~~~vkL~Df 356 (531)
+||||+++ +|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++ .++.+||+||
T Consensus 110 lv~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 99999975 99999976 456899999999999999999999 67899999999999994 4556999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
|++......... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... ...+...+.. ..
T Consensus 182 g~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~-~~ 255 (329)
T 3gbz_A 182 GLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE---IDQLFKIFEV-LG 255 (329)
T ss_dssp THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHH-HC
T ss_pred CCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---HHHHHHHHHH-hC
Confidence 999876543222 2335689999999999875 489999999999999999999999976422 2222222222 11
Q ss_pred cCCCCccc-----------cccccCCCcHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPNRAI-----------DSKLLGNGYEE-----QMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~~~~-----------d~~l~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+...... .+......... ....+.+++.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 11110000 00000000111 12457889999999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=356.30 Aligned_cols=264 Identities=22% Similarity=0.273 Sum_probs=198.1
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC--
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD-- 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-- 278 (531)
..++|..++.||+|+||.||+|.... +|+.||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEESGGGS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECC-CCCEEEEEEECccccC--hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence 35789999999999999999998654 7899999999764322 223677889999999999999999999987653
Q ss_pred ----ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe
Q 009595 279 ----CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 279 ----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
..|+||||+++ +|.+.+. ..+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~ 206 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 206 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEE
Confidence 46999999976 6777774 34899999999999999999999 6789999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
|||+++....... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+... ...+...+ ...
T Consensus 207 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~i~-~~l 279 (464)
T 3ttj_A 207 DFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVI-EQL 279 (464)
T ss_dssp CCCCC-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH-HHH
T ss_pred EEEeeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH-Hhc
Confidence 9999987654322 2346799999999999999999999999999999999999999976422 11111111 111
Q ss_pred ccCCCC--------------------ccccccc-----cCCC---cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 435 TSENPN--------------------RAIDSKL-----LGNG---YEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 435 ~~~~~~--------------------~~~d~~l-----~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
..+.+. ....+.. .... .......+.+|+.+||+.||.+|||+.++++|-
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 111000 0000000 0000 111245688999999999999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=335.98 Aligned_cols=259 Identities=22% Similarity=0.291 Sum_probs=204.1
Q ss_pred cccccccc-cccccceeEEEEEeee-CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 202 EDCSASLE-KIRSRASGEIYIAELP-ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~-~ig~G~~g~Vy~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.+.|.+.+ .||+|+||.||+|.+. ..+++.||||++...... ....+.+.+|+.++++++||||+++++++ ..+.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 46677777 9999999999999653 235788999999764322 22357789999999999999999999998 5678
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++
T Consensus 92 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 8999999999999999976 456899999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCccc-eecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 360 RLMPDGHAQV-STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 360 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
.......... ......|++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+... ..+...+.. ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~---~~ 237 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEK---GE 237 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHT---TC
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHc---CC
Confidence 8775543221 1223456789999999988889999999999999999999 9999876432 222222221 11
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.+.. . .. ....+.+++.+||+.||.+|||+.++++.|+++
T Consensus 238 ~~~~--~----~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 238 RMGC--P----AG----CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp CCCC--C----TT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCC--C----CC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1110 0 11 122488899999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=341.89 Aligned_cols=261 Identities=23% Similarity=0.384 Sum_probs=201.7
Q ss_pred cccccccccccccceeEEEEEeeeCCC---CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESN---GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
...|...+.||+|+||.||+|.+...+ +..||||.+...... .....+.+|+.++++++||||+++++++...+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE---KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 467888999999999999999876432 346999999764322 22567889999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
..++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCc
Confidence 99999999999999999975 2357899999999999999999999 67899999999999999999999999999
Q ss_pred CccCCCCCcc-ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 359 ARLMPDGHAQ-VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 359 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
+......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+... ..+...+. ..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----~~~~~~~~---~~ 266 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMKAIN---DG 266 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHH---TT
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHH---CC
Confidence 9876543221 12223456889999999998899999999999999999999 9999876422 22222222 11
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..+.. . ... ...+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 267 ~~~~~--~----~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 267 FRLPT--P----MDC----PSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CCCCC--C----TTC----BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CcCCC--c----ccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 0 111 124788999999999999999999999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=344.99 Aligned_cols=260 Identities=22% Similarity=0.322 Sum_probs=202.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-----CCcccccceeEEe
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-----HRNIVPLLAHMVR 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----hpnIv~l~~~~~~ 276 (531)
.++|.+.++||+|+||.||+|.... +++.||||++..... ....+..|+.++..+. ||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHID-NKKYYAVKVVRNIKK-----YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECSCHH-----HHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECC-CCeEEEEEEeccchh-----hhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 5789999999999999999998754 788999999974321 2456777999999886 9999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC---------
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD--------- 347 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~--------- 347 (531)
.+..++||||+ +++|.+++.. .....+++..+..++.||+.||.||| +++|+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITR--NNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred CCeeEEEEcCC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccc
Confidence 99999999999 8899999986 33346899999999999999999999 678999999999999975
Q ss_pred ----------------CCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCC
Q 009595 348 ----------------DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGK 411 (531)
Q Consensus 348 ----------------~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~ 411 (531)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 7899999999998654432 2357899999999999999999999999999999999999
Q ss_pred CCCCCcccchhhhHHHHHHHHHhccCCCCccccc------------c-c---cCC--CcHH---------------HHHH
Q 009595 412 LPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS------------K-L---LGN--GYEE---------------QMLL 458 (531)
Q Consensus 412 ~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~------------~-l---~~~--~~~~---------------~~~~ 458 (531)
.||..... ......+...... .+...... . + .+. .... ....
T Consensus 257 ~pf~~~~~----~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 257 LLFRTHEH----MEHLAMMESIIQP-IPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp CSCCCSSH----HHHHHHHHHHTCC-CCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred CCCCCCcH----HHHHHHHHHhcCC-CCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 99976422 1122222221111 11000000 0 0 000 0000 0145
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 459 VLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 459 l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+.+++.+||+.||.+|||+.+++++
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcC
Confidence 7789999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=339.49 Aligned_cols=248 Identities=16% Similarity=0.227 Sum_probs=193.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~ 281 (531)
++|...++||+|+||+||+|.... +|+.||||++......... ......|+..+.++ +||||+++++++...+..+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~--~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKE-DGRLYAVKRSMSPFRGPKD--RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT-TSCEEEEEEESSSCCSHHH--HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hheeeeheeccCCCeEEEEEEECC-CCeEEEEEEecccccChHH--HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 678999999999999999998764 7899999998754433221 34445566555555 9999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+ +++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 134 lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 999999 66999998752 356999999999999999999999 67899999999999999999999999999887
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... .....||+.|+|||++.+ .++.++|||||||++|||++|..|+.+. .. .. .. ..+...
T Consensus 207 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~~----~~---~~-~~~~~~- 270 (311)
T 3p1a_A 207 LGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---EG----WQ---QL-RQGYLP- 270 (311)
T ss_dssp CC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HH----HH---HH-TTTCCC-
T ss_pred cccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---cH----HH---HH-hccCCC-
Confidence 654322 234569999999999876 7999999999999999999997765432 11 11 11 111111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+..... ....+.+++.+||+.||.+|||+.+++++
T Consensus 271 ---~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 271 ---PEFTAG----LSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---HHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---cccccC----CCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111111 12348889999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=335.70 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=191.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.... +|+.||||++....... .....+.++...++.++||||+++++++...+..+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVP-SGQIMAVKRIRATVNSQ--EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEC---CHH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecC-CCeEEEEEEeecccCcH--HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 4788999999999999999998754 78999999997643332 22444555666788899999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP-RIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
+||||+++ +|.+++.........+++..+..++.|++.||.||| ++ |++||||||+||+++.++.+||+|||++.
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 99999975 999988765555678999999999999999999999 55 89999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYH----QTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
....... .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||..... ....+. .....
T Consensus 159 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~----~~~~~ 229 (290)
T 3fme_A 159 YLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLK----QVVEE 229 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHH----HHHHS
T ss_pred ccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHH----HHhcc
Confidence 7654422 2234689999999996 556789999999999999999999999975321 111121 12222
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..+... .... ...+.+++.+||+.||.+|||+.+++++
T Consensus 230 ~~~~~~------~~~~---~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 230 PSPQLP------ADKF---SAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CCCCCC------TTTS---CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCcc------cccC---CHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 222111 0111 1247889999999999999999999873
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.68 Aligned_cols=273 Identities=22% Similarity=0.287 Sum_probs=212.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC--c
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD--C 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~ 279 (531)
.+.|.+.+.||+|+||.||+|.+.. +|+.||||++....... ....+.+|+.++++++||||+++++++.... .
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECGGGGGS---CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECC-CCcEEEEEEeccccccc---hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 4678999999999999999998764 68999999997533221 1466788999999999999999999998765 6
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee----CCCCCEEEee
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI----DDDMEARIAD 355 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl----~~~~~vkL~D 355 (531)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred eEEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence 7999999999999999975221 233899999999999999999999 6789999999999999 7788899999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHH
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT--------LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLV 427 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~ 427 (531)
||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............
T Consensus 160 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 160 FGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp GGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred CCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 999987655422 233579999999998865 467889999999999999999999997543322222222
Q ss_pred HHHHHHhccCCCCccc--------------cccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 428 RWMRNVMTSENPNRAI--------------DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 428 ~~~~~~~~~~~~~~~~--------------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
........+.... +..............+.+++.+||+.||.+|||+.++++.+.++-
T Consensus 237 ---~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 237 ---YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp ---HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred ---HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 2222221111000 000112233556667889999999999999999999999997753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=343.96 Aligned_cols=273 Identities=16% Similarity=0.207 Sum_probs=202.1
Q ss_pred cccccccccccccceeEEEEEeeeC--CCCeEEEEEEEeccCchhhhH-------HHHHHHHHHHHHhcCCCCcccccce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE--SNGKMIAIKKVKQVDNSLLNI-------KMRQVRAEIMTAGQIRHRNIVPLLA 272 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~-------~~~~~~~Ei~~l~~l~hpnIv~l~~ 272 (531)
.++|.+.+.||+|+||.||+|.... .++..||||++.......... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4789999999999999999998753 146789999998654321110 1234678899999999999999999
Q ss_pred eEEe----CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC
Q 009595 273 HMVR----PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD 348 (531)
Q Consensus 273 ~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~ 348 (531)
++.. ....++||||+ +++|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccC
Confidence 9988 67889999999 9999999975 347999999999999999999999 6789999999999999887
Q ss_pred C--CEEEeecCCCccCCCCCcc-----ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch
Q 009595 349 M--EARIADFGLARLMPDGHAQ-----VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHT 421 (531)
Q Consensus 349 ~--~vkL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~ 421 (531)
+ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.....
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999876432111 11134579999999999999899999999999999999999999996532211
Q ss_pred hhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 422 EEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 422 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
. .............+.. ......... ....+.+++.+||..||.+|||+.+|++.|+++..
T Consensus 268 ~---~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 V---AVQTAKTNLLDELPQS-VLKWAPSGS---SCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp H---HHHHHHHHHHHTTTHH-HHHHSCTTS---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred H---HHHHHHHhhcccccHH-HHhhccccc---cHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1 1111111111111111 000000001 11248889999999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=340.07 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=202.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC---
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--- 277 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--- 277 (531)
..++|...+.||+|+||.||+|.... +++.||||++...... .....+.+|+.++.+++||||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQ---TYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCTTCH---HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred ccccEEEEEEeecCCCeEEEEEEECC-CCeEEEEEEeccccCc---HHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 35789999999999999999998654 7899999999753322 2257788999999999999999999998765
Q ss_pred --CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 278 --DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 278 --~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
...++||||+.+ +|.+++.. ..+++..+..++.|++.||.||| ++||+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~~iv~e~~~~-~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 101 QMKDVYIVQDLMET-DLYKLLKT-----QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp TCCCEEEEEECCSE-EHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred ccceEEEEEcccCc-CHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEe
Confidence 367999999975 99999975 46899999999999999999999 67899999999999999999999999
Q ss_pred cCCCccCCCCCccc-eecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHH-
Q 009595 356 FGLARLMPDGHAQV-STSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN- 432 (531)
Q Consensus 356 fgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~- 432 (531)
||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+...+..
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99998765432211 12345799999999986544 5899999999999999999999999765332222222111000
Q ss_pred ----------------HhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 433 ----------------VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 433 ----------------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
....+.........+.... ...+.+++.+||+.||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA----DSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCC----CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000111111 2347889999999999999999999985
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=345.81 Aligned_cols=253 Identities=21% Similarity=0.280 Sum_probs=200.3
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
.+.|...+.||+|+||.||+|.... +|+.||||++...... ..+|+.++.++ +||||+++++++.+....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~--------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKA-TNMEFAVKIIDKSKRD--------PTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTTCC--------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEcccCC--------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 4678999999999999999998754 7899999999764432 23588888887 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC----CCEEEeec
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD----MEARIADF 356 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~----~~vkL~Df 356 (531)
|+|||||++|+|.+++.. ...+++..+..++.||+.||.||| +.||+||||||+|||+..+ +.+||+||
T Consensus 92 ~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Df 164 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDF 164 (342)
T ss_dssp EEEECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence 999999999999999965 457899999999999999999999 6789999999999998543 35999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
|++......... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .....+...+. ..
T Consensus 165 g~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~---~~ 238 (342)
T 2qr7_A 165 GFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIG---SG 238 (342)
T ss_dssp TTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHH---HC
T ss_pred CCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHc---cC
Confidence 999876544322 2346789999999999888899999999999999999999999975322 12222222221 11
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. ... . ...+......+.+++.+||..||.+|||+.+++++
T Consensus 239 ~-~~~--~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 239 K-FSL--S----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp C-CCC--C----STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred C-ccc--C----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 110 0 01111122347889999999999999999998875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=332.10 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=200.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe----C
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR----P 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~ 277 (531)
...|...+.||+|+||.||+|.... ++..||+|.+....... .....+.+|+.++++++||||+++++++.. .
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~va~k~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ceeEEeeeeccCCCCeEEEEeEecC-CceEEEEEEecchhhCH--HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 3557788899999999999998754 78899999998644332 236778999999999999999999998875 3
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeeccCCCCeeeC-CCCCEEEe
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR--IIHRNITPSSVLID-DDMEARIA 354 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NILl~-~~~~vkL~ 354 (531)
...++||||+++|+|.+++.. ...+++..+..++.|++.||.||| ..+ ++||||||+|||++ .++.+||+
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~ 174 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred ceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEe
Confidence 557999999999999999975 356899999999999999999999 666 99999999999997 78999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
|||++........ ....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+... ..... ....
T Consensus 175 Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~---~~~~ 243 (290)
T 1t4h_A 175 DLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIY---RRVT 243 (290)
T ss_dssp CTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---HHHHH---HHHT
T ss_pred eCCCccccccccc----ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc---HHHHH---HHHh
Confidence 9999976544321 23568999999998864 589999999999999999999999976422 11121 2221
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. +......+. ... ..+.+++.+||+.||.+|||+.+++++
T Consensus 244 ~-~~~~~~~~~----~~~----~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 244 S-GVKPASFDK----VAI----PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp T-TCCCGGGGG----CCC----HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c-cCCccccCC----CCC----HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 111111111 111 247889999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=333.87 Aligned_cols=259 Identities=19% Similarity=0.274 Sum_probs=203.3
Q ss_pred cccccccccccccceeEEEEEeeeCCC--CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESN--GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.++|...+.||+|+||.||+|.+...+ +..||+|.+...... ...+.+.+|+.++++++||||+++++++.. +.
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL---DNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH---HHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc---hHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 467889999999999999999875433 346999999764322 225778899999999999999999998765 46
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++||||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++
T Consensus 87 ~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp CEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred CEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCC
Confidence 7899999999999999975 2345899999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
......... ......+|+.|+|||++.+..++.++||||||+++|+|+| |+.||...... .....+........
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~----~~~~~~~~~~~~~~ 235 (281)
T 3cc6_A 161 RYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK----DVIGVLEKGDRLPK 235 (281)
T ss_dssp GCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG----GHHHHHHHTCCCCC
T ss_pred ccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH----HHHHHHhcCCCCCC
Confidence 876543221 1233557889999999988899999999999999999998 99998754322 22222222111111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
+ ... ...+.+++.+||..||.+|||+.+++++|+++.
T Consensus 236 ~----------~~~---~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 236 P----------DLC---PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp C----------TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----------CCC---CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 1 011 124788999999999999999999999998763
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=346.30 Aligned_cols=299 Identities=22% Similarity=0.297 Sum_probs=202.4
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC---
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--- 277 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--- 277 (531)
..++|...+.||+|+||.||+|.... +|+.||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSI--IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETT-TTEEEEEEECSSTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECC-CCCEEEEEEeCccccCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence 35789999999999999999997654 78999999997543222 2356788999999999999999999998754
Q ss_pred ---CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe
Q 009595 278 ---DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 278 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
...|+|+||+ +++|.+++.. ..+++..+..++.||++||.||| +.||+||||||+|||++.++.+||+
T Consensus 104 ~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~ 174 (367)
T 2fst_X 104 EEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 174 (367)
T ss_dssp GGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEe
Confidence 5679999999 6799998863 56899999999999999999999 6789999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+... ...+ ..+...
T Consensus 175 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l-~~i~~~ 245 (367)
T 2fst_X 175 DFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQL-KLILRL 245 (367)
T ss_dssp C--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH-HHHHHH
T ss_pred ecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH-HHHHHH
Confidence 99999865432 233578999999999877 6789999999999999999999999976432 1111 111111
Q ss_pred hccCCCCccccccc---------------cCCCc----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCc
Q 009595 434 MTSENPNRAIDSKL---------------LGNGY----EEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKD 492 (531)
Q Consensus 434 ~~~~~~~~~~d~~l---------------~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~ 492 (531)
...+ .....+.+ ....+ ......+.+|+.+||..||.+|||+.+++++ +.+...+.+
T Consensus 246 ~g~p--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~ 323 (367)
T 2fst_X 246 VGTP--GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 323 (367)
T ss_dssp HCSC--CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred hCCC--CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCC
Confidence 1111 00000000 00000 0112347889999999999999999999986 343322221
Q ss_pred hhhhhhccCCCC-CChHHHHHhhHHHHhhhhc
Q 009595 493 VDFLKMHKRMDF-DNDDCVELIQQEIYTEWLS 523 (531)
Q Consensus 493 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 523 (531)
....+ +....+ ..+...+.+++.+|.|...
T Consensus 324 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~e~~~ 354 (367)
T 2fst_X 324 EPVAD-PYDQSLESRDLLIDEWKSLTYDEVIS 354 (367)
T ss_dssp CCCCC-CCCGGGSSCCCCHHHHHHHHHHHHHH
T ss_pred CCCCC-CCCcchhhccCCHHHHHHHHHHHHHH
Confidence 11111 111111 1233678889999988765
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=334.36 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=207.1
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|...+.||+|+||.||+|.... +++.||||++....... ....+.+|+.++++++||||+++++++......
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEAED---EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEETTTCST---THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECC-CCcEEEEEEecccccHH---HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 45678999999999999999997654 78899999997644322 257788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++++|.+++.. ..+++..+..++.|++.||.||| ..+++||||||+||+++.++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp EEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccce
Confidence 999999999999999963 56899999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+. ....+.
T Consensus 168 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~---~~~~~~ 238 (303)
T 3a7i_A 168 QLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----MKVLFLIP---KNNPPT 238 (303)
T ss_dssp ECBTTBCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHH---HSCCCC
T ss_pred ecCccccc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH----HHHHHHhh---cCCCCC
Confidence 76544322 2345789999999999999999999999999999999999999876432 11111111 111111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
+..... ..+.+++.+||+.||.+|||+.+++++.
T Consensus 239 ------~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 239 ------LEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ------CCSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ------CccccC----HHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 111111 2478899999999999999999998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=344.65 Aligned_cols=269 Identities=22% Similarity=0.303 Sum_probs=202.0
Q ss_pred hhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 200 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
...++|...+.||+|+||.||+|.... +|+.||||++...... ......+.+|+.++++++||||+++++++...+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKD-TGRIVAIKKFLESDDD--KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETT-TCCEEEEEEEESCSSC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECC-CCceEEEEEEecCCCc--hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence 345789999999999999999998754 6899999999764432 2235667899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++
T Consensus 99 ~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171 (331)
T ss_dssp EEEEEECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCc
Confidence 9999999999988888753 456999999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc---
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT--- 435 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~--- 435 (531)
......... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+... ...+...+.....
T Consensus 172 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 246 (331)
T 4aaa_A 172 RTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD---IDQLYHIMMCLGNLIP 246 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCH
T ss_pred eeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCCh
Confidence 876543222 2335689999999998875 789999999999999999999999976432 1222221111000
Q ss_pred -------c-CCCCccccccccCC-----CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 -------S-ENPNRAIDSKLLGN-----GYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 -------~-~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. +.......+..... ..+.....+.+++.+||+.||.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00000000000000 011123458889999999999999999998874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=331.88 Aligned_cols=256 Identities=21% Similarity=0.310 Sum_probs=202.6
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhh--hHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLL--NIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
++|...+.||+|+||.||+|.... +|+.||+|.+........ ....+.+.+|+.++++++||||+++++++......
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKG-TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcC-CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 568899999999999999998754 688999999976432211 11256788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC----CEEEeec
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM----EARIADF 356 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~----~vkL~Df 356 (531)
++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999975 456899999999999999999999 67899999999999998877 8999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
|++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ......+ ...
T Consensus 157 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~---~~~ 226 (283)
T 3bhy_A 157 GIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNI---SAV 226 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHH---HTT
T ss_pred ccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch----HHHHHHh---Hhc
Confidence 99987654322 2335689999999999988999999999999999999999999876422 1111111 111
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. .. ......... ...+.+++.+||..||.+|||+.+++++
T Consensus 227 ~-~~--~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 227 N-YD--FDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp C-CC--CCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred c-cC--CcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 1 10 111111111 2347889999999999999999999984
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=343.05 Aligned_cols=269 Identities=22% Similarity=0.288 Sum_probs=195.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe-----
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR----- 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----- 276 (531)
.++|...+.||+|+||.||+|.. +++.||||++...... ......|+..+..++||||+++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~-----~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFANRQ-----NFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGGHH-----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred hHHhheeeecccCCCeEEEEEEE---CCeEEEEEEeeccchh-----hHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 37889999999999999999976 7899999999754321 1112234444556899999999986543
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeEeeccCCCCeeeCC
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP---------RIIHRNITPSSVLIDD 347 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~---------~ivH~Dlkp~NILl~~ 347 (531)
...+++||||+++|+|.+++.. ...++..+..++.|+++||.||| .. +|+||||||+|||++.
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKN 155 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred CceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcC
Confidence 2356899999999999999975 34588899999999999999999 56 8999999999999999
Q ss_pred CCCEEEeecCCCccCCCCCc------cceecccccCccccCcccccC-------CCCCchhhHHHHHHHHHHHHhCCCCC
Q 009595 348 DMEARIADFGLARLMPDGHA------QVSTSIVAGTVGYIAPEYHQT-------LKFSEKCDIYSFGVLLAVLVMGKLPS 414 (531)
Q Consensus 348 ~~~vkL~Dfgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~elltg~~P~ 414 (531)
++.+||+|||++..+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 99999999999987654321 112234579999999999987 35678999999999999999997775
Q ss_pred CCcccchhhh-H---------HHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 415 DDFFQHTEEK-S---------LVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 415 ~~~~~~~~~~-~---------l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
.......... . ....+............+... ..........+.+++.+||+.||.+|||+.++++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 3321110000 0 001111111111111111111 111223445689999999999999999999999999
Q ss_pred ccCc
Q 009595 485 SDTA 488 (531)
Q Consensus 485 ~~~~ 488 (531)
+++.
T Consensus 314 ~~ll 317 (336)
T 3g2f_A 314 AELM 317 (336)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8853
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=334.93 Aligned_cols=262 Identities=23% Similarity=0.316 Sum_probs=202.0
Q ss_pred hcccccccccccccceeEEEEEeeeCCC--CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe-C
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESN--GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR-P 277 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~ 277 (531)
....|...+.||+|+||.||+|.+...+ +..||+|.+...... .....+.+|+.++++++||||+++++++.. .
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH---HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 3466888999999999999999864323 336899998754332 225778899999999999999999998654 5
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
...++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg 173 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFG 173 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred CceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccc
Confidence 678999999999999999964 3456899999999999999999999 6789999999999999999999999999
Q ss_pred CCccCCCCCcc--ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHh
Q 009595 358 LARLMPDGHAQ--VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 358 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
++......... .......||+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.... .....+..
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~----~~~~~~~~-- 247 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLLQ-- 247 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT----THHHHHHT--
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH----HHHHHHhc--
Confidence 99876543211 12234567889999999999899999999999999999999 55666543221 12111111
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..... .+ ... ...+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 248 -~~~~~---~~----~~~---~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 248 -GRRLL---QP----EYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp -TCCCC---CC----TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCC---CC----ccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11110 01 111 124788999999999999999999999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=344.58 Aligned_cols=248 Identities=23% Similarity=0.304 Sum_probs=203.2
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhh----hHHHHHHHHHHHHHhcCCCCcccccceeEEe
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLL----NIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 276 (531)
..++|...+.||+|+||.||+|.... +++.||||++........ ......+.+|+.++++++||||+++++++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKE-KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETT-TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccceEEEeEEEecCCEEEEEEEECC-CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 35789999999999999999998654 789999999986432110 0013456779999999999999999999999
Q ss_pred CCceEEEEeccCCC-CHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 277 PDCHLLVSEFMKNG-SLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 277 ~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
.+..++||||+.+| +|.+++.. ...+++..+..++.|++.||.||| ..+++||||||+|||++.++.+||+|
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEee
Confidence 99999999999776 99999975 457999999999999999999999 67899999999999999999999999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKF-SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
||++......... ....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....... .
T Consensus 174 fg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------~ 238 (335)
T 3dls_A 174 FGSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------E 238 (335)
T ss_dssp CTTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------T
T ss_pred cccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------h
Confidence 9999877654322 23579999999999988876 889999999999999999999997532100 0
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
....+. ... ...+.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~---------~~~---~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AAIHPP---------YLV---SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCCCCS---------SCC---CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hccCCC---------ccc---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 011 1247889999999999999999999996
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=338.74 Aligned_cols=262 Identities=23% Similarity=0.316 Sum_probs=204.3
Q ss_pred ccccccccccceeEEEEEeee---CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--Cc
Q 009595 205 SASLEKIRSRASGEIYIAELP---ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--DC 279 (531)
Q Consensus 205 ~~~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~ 279 (531)
|..++.||+|+||.||++.+. ..+++.||||++...... .....+.+|+.++++++||||+++++++... ..
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP---QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh---HHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 488999999999999888652 236889999999864322 2367789999999999999999999999874 57
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccc
Confidence 8999999999999999974 34899999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCccc-eecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch--------hhhHHHHHH
Q 009595 360 RLMPDGHAQV-STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHT--------EEKSLVRWM 430 (531)
Q Consensus 360 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~--------~~~~l~~~~ 430 (531)
.......... ......||+.|+|||++.+..++.++||||||+++|+|+||..||....... ....... +
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 260 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-L 260 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH-H
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH-H
Confidence 9876543221 2234567889999999999899999999999999999999999986532110 0011111 1
Q ss_pred HHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
......+.... .. .. ....+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 261 ~~~~~~~~~~~-~~----~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 261 TELLERGERLP-RP----DK----CPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHHHTTCCCC-CC----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcccCCC-CC----cc----ccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11111111110 00 11 123488899999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=348.21 Aligned_cols=260 Identities=23% Similarity=0.327 Sum_probs=194.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCC--eEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe-CCc
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNG--KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR-PDC 279 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~ 279 (531)
..|...+.||+|+||.||+|.+...++ ..||||.+...... ...+.+.+|+.++++++||||+++++++.. .+.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS---HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 456778999999999999998754343 36899988653322 226788999999999999999999998764 457
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++||||+++|+|.+++.. ....+++..+..++.|+++||.||| +++++||||||+|||++.++.+||+|||++
T Consensus 166 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp CEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccc
Confidence 8999999999999999964 3456889999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCcc--ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 360 RLMPDGHAQ--VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 360 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
+.+...... .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.+..... +...+.. .
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~----~~~~~~~---~ 312 (373)
T 3c1x_A 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLLQ---G 312 (373)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC----HHHHHHT---T
T ss_pred ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH----HHHHHHc---C
Confidence 876443211 11233457889999999999999999999999999999999 677876543222 2121111 1
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..+. .+ ... ...+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 313 ~~~~---~p----~~~---~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 313 RRLL---QP----EYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp CCCC---CC----TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC---CC----CCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 11 111 124788999999999999999999999998853
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=334.56 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=204.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeE-EeCCc
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM-VRPDC 279 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~ 279 (531)
..++|...+.||+|+||.||+|.... +++.||||++..... ...+..|+.++..++|+|++..++.+ ...+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcC-CCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 35789999999999999999998654 789999998765432 23467899999999998888877766 55677
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee---CCCCCEEEeec
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI---DDDMEARIADF 356 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl---~~~~~vkL~Df 356 (531)
.++||||+ +++|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+|||+ +.++.+||+||
T Consensus 80 ~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Df 152 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp EEEEEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred eEEEEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecC
Confidence 89999999 8899999974 2356999999999999999999999 6789999999999999 78899999999
Q ss_pred CCCccCCCCCcc-----ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHH
Q 009595 357 GLARLMPDGHAQ-----VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMR 431 (531)
Q Consensus 357 gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~ 431 (531)
|++......... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 4hgt_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred ccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc
Confidence 999876554321 122346799999999999999999999999999999999999999987544333333333222
Q ss_pred HHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 432 NVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 432 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.....+ ... +.... ...+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 233 ~~~~~~--~~~----~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 233 KKMSTP--IEV----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHSC--HHH----HTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred ccccch--hhh----hhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 222111 000 00111 124888999999999999999999999998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=343.05 Aligned_cols=266 Identities=23% Similarity=0.324 Sum_probs=204.6
Q ss_pred hcccccccccccccceeEEEEEeee----CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 276 (531)
..++|...+.||+|+||.||+|.+. ..++..||||.+...... .....+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE---QDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch---hhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 3478899999999999999999852 236778999999754322 225678899999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCC---CccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC---CCC
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQG---RRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD---DME 350 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~ 350 (531)
....++||||+++|+|.+++...... ...+++..++.++.|++.||.||| +.+++||||||+|||++. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcce
Confidence 99999999999999999999863321 245899999999999999999999 678999999999999984 446
Q ss_pred EEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHH
Q 009595 351 ARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRW 429 (531)
Q Consensus 351 vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~ 429 (531)
+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||..... ..+...
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~ 257 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----QEVLEF 257 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHH
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH----HHHHHH
Confidence 99999999876544332222334568999999999988899999999999999999998 9999875422 222222
Q ss_pred HHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 430 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
+.. ...+.. . ... ...+.+++.+||+.||.+|||+.+++++|..+..
T Consensus 258 ~~~---~~~~~~--~----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 258 VTS---GGRMDP--P----KNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHT---TCCCCC--C----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Hhc---CCCCCC--C----CCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 221 111110 0 111 1247889999999999999999999999987643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=341.55 Aligned_cols=259 Identities=23% Similarity=0.319 Sum_probs=203.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEE--EEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCc
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMI--AIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 279 (531)
++|...+.||+|+||.||+|.... ++..+ |+|.+...... .....+.+|+.++.++ +||||+++++++...+.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~v~iK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred HHccceeeeecCCCceEEEEEEcc-CCcccceeeeeeccccch---HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 678889999999999999998764 56644 99998753221 1256688999999999 99999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhcc------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVS------------QGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~ 347 (531)
.++||||+++|+|.+++.... .....+++..++.++.|++.||.||| +++++||||||+|||++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGE 177 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcC
Confidence 999999999999999997532 12347899999999999999999999 678999999999999999
Q ss_pred CCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHH
Q 009595 348 DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSL 426 (531)
Q Consensus 348 ~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l 426 (531)
++.+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|+| |+.||.+... ..+
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----~~~ 250 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AEL 250 (327)
T ss_dssp GGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHH
T ss_pred CCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH----HHH
Confidence 9999999999987543221 1123457889999999988889999999999999999998 9999876422 112
Q ss_pred HHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 427 VRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 427 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.. .......+... ... ...+.+++.+||..||.+|||+.+++++|..+.
T Consensus 251 ~~---~~~~~~~~~~~------~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 251 YE---KLPQGYRLEKP------LNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HH---HGGGTCCCCCC------TTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HhhcCCCCCCC------CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 11111111100 111 124788999999999999999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=345.05 Aligned_cols=259 Identities=20% Similarity=0.329 Sum_probs=203.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.... ++..||+|++...... .....+.+|+.++++++||||+++++++...+..+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~va~K~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEECCCCH---HHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECC-CCcEEEEEEeccccCH---HHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 4678999999999999999998754 7899999999865322 23577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ...+++..+..++.+++.||.|||+ ..+++||||||+|||++.++.+||+|||++..
T Consensus 108 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp EEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999999976 3568999999999999999999994 13799999999999999999999999999875
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHH---------------
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSL--------------- 426 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l--------------- 426 (531)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+
T Consensus 182 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 182 LIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 4322 123357899999999999999999999999999999999999999764321111000
Q ss_pred --------------------HHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 427 --------------------VRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 427 --------------------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+........+.. .... ....+.+++.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~---~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL------PSGV---FSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCC------CTTT---SCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCC------Cccc---ccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000111111110000 0011 12247889999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.08 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=196.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC-Cce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP-DCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-~~~ 280 (531)
.++|...+.||+|+||.||+|.. +|+.||||++..... .+.+.+|+.++++++||||+++++++... +..
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDAT------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred hhhceEEeEEecCCCceEEEEEE---cCCEEEEEEecchhH------HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 47789999999999999999987 688999999975432 56788999999999999999999987654 478
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++... ....+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165 (278)
T ss_dssp EEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred EEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccc
Confidence 9999999999999999752 2234889999999999999999999 6789999999999999999999999999988
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
...... ....+++.|+|||.+.+..++.++||||||+++|+|+| |+.||..... ..+...+. ....+
T Consensus 166 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~~~~---~~~~~ 233 (278)
T 1byg_A 166 EASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRVE---KGYKM 233 (278)
T ss_dssp ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHHHHHT---TTCCC
T ss_pred cccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHh---cCCCC
Confidence 654331 22357889999999998899999999999999999998 9999876432 12222111 11111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
. ..... ...+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 234 ~------~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 234 D------APDGC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp C------CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C------CcccC----CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 0 00111 224788999999999999999999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=347.56 Aligned_cols=262 Identities=17% Similarity=0.247 Sum_probs=196.6
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|+||.||+|.... +++.||||++....... ....+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL-TDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECC-CCcEEEEEEEecccccc---cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence 578999999999999999998754 78899999997543221 12234579999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++ +|.+++.. ....+++..+..++.|++.||.||| +.||+||||||+|||++.++.+||+|||++...
T Consensus 78 v~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 150 (324)
T 3mtl_A 78 VFEYLDK-DLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAK 150 (324)
T ss_dssp EEECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred Eeccccc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence 9999975 99999875 2456899999999999999999999 678999999999999999999999999999865
Q ss_pred CCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... ......+......+....
T Consensus 151 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~ 224 (324)
T 3mtl_A 151 SIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV----EEQLHFIFRILGTPTEET 224 (324)
T ss_dssp --------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTT
T ss_pred cCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChHh
Confidence 443222 233568999999999876 5689999999999999999999999976432 222222333222221111
Q ss_pred cccccccC--------------CC----cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AIDSKLLG--------------NG----YEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~--------------~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. +.... .. .+.....+.+++.+||+.||.+|||+.+++++
T Consensus 225 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 225 W--PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp S--TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred c--hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 1 00000 00 00112347889999999999999999999984
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.85 Aligned_cols=262 Identities=25% Similarity=0.409 Sum_probs=210.2
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|.+.+.||+|+||.||+|.+. .+..||||+++..... .+.+.+|+.+|++++||||+++++++.. ...
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TTEEEEEEEECTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred chhhhhhheecccCCCeEEEEEEEC--CCceEEEEEeCCCCCC-----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 4567889999999999999999885 4677999999864432 4578899999999999999999998876 678
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++... ....+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 337 ~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp EEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred eEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 9999999999999999642 2245899999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||.+... ..+...+........+
T Consensus 412 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~----~~~~~~i~~~~~~~~~ 486 (535)
T 2h8h_A 412 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQVERGYRMPCP 486 (535)
T ss_dssp TCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH----HHHHHHHHTTCCCCCC
T ss_pred ecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCCCC
Confidence 7654311 11123456789999999998899999999999999999999 9999876532 2222222221111111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCCCch
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDV 493 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 493 (531)
..+ ...+.+++.+||+.||.+|||+.+|++.|+.+.....+
T Consensus 487 ----------~~~---~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 487 ----------PEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp ----------TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred ----------CCC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 111 12478899999999999999999999999987654433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=356.59 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=198.4
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|..++.||+|+||+||+|.... ++..||||++......... ...+.+|+.+++.++||||+++++++......|+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKV-THVERAIKIIRKTSVSTSS--NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETT-TCCEEEEEEEEC-----CT--THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECC-CCcEEEEEEEeccccCchH--HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 568999999999999999998754 7889999999764322111 4568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC---CCEEEeecCCC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD---MEARIADFGLA 359 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~---~~vkL~Dfgla 359 (531)
|||||++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.. +.+||+|||++
T Consensus 114 v~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 114 VMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999999875 356899999999999999999999 6789999999999999764 45999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
........ ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+... ..+...+.. ....
T Consensus 187 ~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~---~~~~ 255 (494)
T 3lij_A 187 AVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD----QEILRKVEK---GKYT 255 (494)
T ss_dssp EECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH---TCCC
T ss_pred eECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh---CCCC
Confidence 87654422 23467999999999886 4699999999999999999999999976422 222222221 1111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. ....... ....+.+++.+||+.||.+|||+.+++++
T Consensus 256 ~---~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 F---DSPEWKN----VSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp C---CSGGGTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred C---Cchhccc----CCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0 0000111 12347889999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=332.55 Aligned_cols=264 Identities=22% Similarity=0.290 Sum_probs=208.0
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeE-EeCCc
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM-VRPDC 279 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~ 279 (531)
..++|...+.||+|+||.||+|.... +|+.||||++..... ...+.+|+.++..++|++++..++++ .....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcC-CCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence 35789999999999999999998643 799999999876443 23577899999999999887777766 45667
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC---CCCCEEEeec
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID---DDMEARIADF 356 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~---~~~~vkL~Df 356 (531)
.++||||+ +++|.+++.. ....+++..+..++.|++.||.||| +++++||||||+|||++ .++.+||+||
T Consensus 80 ~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp EEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred eEEEEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 79999999 8899999974 2356999999999999999999999 67899999999999994 7889999999
Q ss_pred CCCccCCCCCccc-----eecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHH
Q 009595 357 GLARLMPDGHAQV-----STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMR 431 (531)
Q Consensus 357 gla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~ 431 (531)
|++.......... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.........+.....
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence 9998765543211 12346799999999999999999999999999999999999999987543333333322222
Q ss_pred HHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 432 NVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 432 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
....... .. +.... ...+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 233 ~~~~~~~--~~----~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 233 KKMSTPI--EV----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHSCH--HH----HTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred cccCCch--HH----HHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 2221110 00 00111 124788999999999999999999999998763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=330.97 Aligned_cols=250 Identities=18% Similarity=0.240 Sum_probs=199.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
.++|...+.||+|+||.||+|.... +++.||||++........ ....+.+|+..+..+ +||||+++++++...+..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~--~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSV--DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCCTTSH--HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcC-CCceEEEEEecccccccH--HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 4678999999999999999998754 789999999986433322 256788899999999 999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC------------
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD------------ 348 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~------------ 348 (531)
++||||+++|+|.+++.........+++..+..++.|++.||.||| +++++||||||+|||++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC--------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 9999999999999999864333467899999999999999999999 6789999999999999844
Q ss_pred -------CCEEEeecCCCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 009595 349 -------MEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQH 420 (531)
Q Consensus 349 -------~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~ 420 (531)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|+|++|..|+....
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-- 235 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-- 235 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--
T ss_pred ccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--
Confidence 479999999998765432 23589999999998876 56789999999999999999988764321
Q ss_pred hhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 421 TEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 421 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. ...+ .....+. +.... ...+.+++.+||+.||.+|||+.+++++
T Consensus 236 ----~-~~~~---~~~~~~~------~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 ----Q-WHEI---RQGRLPR------IPQVL----SQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ----H-HHHH---HTTCCCC------CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----H-HHHH---HcCCCCC------CCccc----CHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1 1111 1111111 00111 1247889999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=356.68 Aligned_cols=254 Identities=20% Similarity=0.323 Sum_probs=202.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|.+.+.||+|+||+||+|.... +++.||||++....... .....+.+|+.++++++||||+++++++......|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETT-TCCEEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECC-CCCEEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 4678999999999999999998754 78999999996532211 11567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC---CCCCEEEeecCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID---DDMEARIADFGL 358 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~---~~~~vkL~Dfgl 358 (531)
+|||||++|+|.+++.. ...+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||+
T Consensus 98 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred EEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 99999999999999875 356899999999999999999999 67899999999999995 456799999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ..+...+ .....
T Consensus 171 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i---~~~~~ 239 (486)
T 3mwu_A 171 STCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----YDILKRV---ETGKY 239 (486)
T ss_dssp TTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH---HHTCC
T ss_pred CeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH---HhCCC
Confidence 987654422 234579999999999876 599999999999999999999999876422 2222222 11111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..... .+......+.+++.+||+.||.+|||+.+++++
T Consensus 240 ~~~~~-------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 240 AFDLP-------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CSCSG-------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCc-------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11100 011112347889999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.80 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=206.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.... +++.||+|++....... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECC-CCceEEEEEechhhccC-HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 4778999999999999999998754 68899999997643221 223567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 92 VVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 99999999999999875 357899999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... .... ....... ..
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~---~~~~~~~-~~- 233 (294)
T 2rku_A 165 VEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----KETY---LRIKKNE-YS- 233 (294)
T ss_dssp CCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHH---HHHHTTC-CC-
T ss_pred cccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH---HHHhhcc-CC-
Confidence 6543222 2345789999999999998899999999999999999999999976422 1111 1111111 10
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. ... ...+.+++.+||+.||.+|||+.+++++
T Consensus 234 -~~----~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 -IP----KHI----NPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CC----TTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -Cc----ccc----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 111 1247789999999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=338.09 Aligned_cols=260 Identities=21% Similarity=0.304 Sum_probs=196.7
Q ss_pred ccccccc-ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCc
Q 009595 202 EDCSASL-EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 279 (531)
.+.|.+. +.||+|+||.||+|.... +++.||||++....... ...+.+|+.++.++ +||||+++++++...+.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLI-TSQEYAVKIIEKQPGHI----RSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSS-SCCEEEEEEEECCSSCC----HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcC-CCcEEEEEEEeeCcchh----HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 3567764 789999999999998654 78899999997654322 56788999999885 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC---EEEeec
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME---ARIADF 356 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~---vkL~Df 356 (531)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+|||++.++. +||+||
T Consensus 86 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred EEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 9999999999999999976 356899999999999999999999 678999999999999998776 999999
Q ss_pred CCCccCCCCCc-----cceecccccCccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh----
Q 009595 357 GLARLMPDGHA-----QVSTSIVAGTVGYIAPEYHQT-----LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTE---- 422 (531)
Q Consensus 357 gla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~---- 422 (531)
|++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 238 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence 99886543211 111123569999999999875 4578999999999999999999999976432110
Q ss_pred -------hhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 423 -------EKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 423 -------~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+... ... +.... ....... ....+.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~---i~~-~~~~~--~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 239 GEACPACQNMLFES---IQE-GKYEF--PDKDWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp --CCHHHHHHHHHH---HHH-CCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccchhHHHHHHHH---Hhc-cCccc--Cchhccc----CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111111 111 11110 0000011 12347889999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=330.43 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=183.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.... +|+.||||.+....... ......+.+|+.++++++||||+++++++...+..+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIH-TGLEVAIKMIDKKAMYK-AGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred cccceeeeeecCCCceEEEEEEEcc-CCceEEEEEeehhhhhh-hhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 3678999999999999999998653 78999999997532211 112467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 88 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 99999999999999974 2357899999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ +.......
T Consensus 162 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~---- 228 (278)
T 3cok_A 162 LKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-------LNKVVLAD---- 228 (278)
T ss_dssp CC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSSC----
T ss_pred ccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-------HHHHhhcc----
Confidence 6543221 1235689999999999988899999999999999999999999875422110 00000000
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
... +... ...+.+++.+||+.||.+|||+.+++++
T Consensus 229 ---~~~-~~~~---~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 ---YEM-PSFL---SIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ---CCC-CTTS---CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---cCC-cccc---CHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 000 1111 1247889999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.00 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=202.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||+|+||.||+|.... +|+.||+|.+....... ...+.+|+.++++++||||+++++++......+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFR----DSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECC-CCCEEEEEEEecccccc----hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 3678899999999999999998754 78999999998643322 456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee---CCCCCEEEeecCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI---DDDMEARIADFGL 358 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl---~~~~~vkL~Dfgl 358 (531)
+||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||++ +.++.+||+|||+
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~ 155 (304)
T 2jam_A 83 LVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGL 155 (304)
T ss_dssp EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred EEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence 99999999999999975 356899999999999999999999 6789999999999999 7889999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ..+...+.. ...
T Consensus 156 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~---~~~ 224 (304)
T 2jam_A 156 SKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE----SKLFEKIKE---GYY 224 (304)
T ss_dssp TCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHH---CCC
T ss_pred ceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHc---CCC
Confidence 87654321 1235689999999999999999999999999999999999999875422 222222221 111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. ....... ....+.+++.+||..||.+|||+.+++++
T Consensus 225 ~~---~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 225 EF---ESPFWDD----ISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CC---CTTTTTT----SCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CC---Ccccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 0001111 12347889999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=330.75 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=204.5
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|...+.||+|+||.||+|.... +++.||||++....... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQ-NKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcC-CCcEEEEEEEcccccch-HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 3678999999999999999998754 78899999997532211 112467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp EEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 99999999999999975 356899999999999999999999 78899999999999999999999999999876
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
..... .....|++.|+|||++.+..++.++||||||+++|+|++|..||..... .... ....... ..
T Consensus 164 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~---~~~~~~~-~~- 230 (284)
T 2vgo_A 164 APSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH----TETH---RRIVNVD-LK- 230 (284)
T ss_dssp CSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHH---HHHHTTC-CC-
T ss_pred Ccccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH----hHHH---HHHhccc-cC-
Confidence 54332 2335789999999999998999999999999999999999999975422 1111 1111111 10
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. ... ...+.+++.+||+.||.+|||+.+++++
T Consensus 231 -~~----~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 231 -FP----PFL----SDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -CC----TTS----CHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -CC----CcC----CHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 00 111 1247889999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.54 Aligned_cols=256 Identities=13% Similarity=0.092 Sum_probs=203.4
Q ss_pred hcccccccccccccceeEEEEEee----eCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC---CCccccccee
Q 009595 201 KEDCSASLEKIRSRASGEIYIAEL----PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR---HRNIVPLLAH 273 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~ 273 (531)
..+.|...+.||+|+||+||+|.+ ...+++.||||++.... ...+..|+.++..++ ||||++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 457799999999999999999952 22378899999997643 345667777777775 9999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHHhhccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC-----
Q 009595 274 MVRPDCHLLVSEFMKNGSLLEILNDVSQ-GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD----- 347 (531)
Q Consensus 274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~----- 347 (531)
+...+..|+|||||++|+|.+++..... ....+++..+..++.||+.||.||| +.+|+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCc
Confidence 9999999999999999999999975333 3567999999999999999999999 788999999999999998
Q ss_pred ------CCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch
Q 009595 348 ------DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHT 421 (531)
Q Consensus 348 ------~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~ 421 (531)
++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999976543333333455789999999999999999999999999999999999999985432110
Q ss_pred hhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHhccCc
Q 009595 422 EEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEER-PNSKDVRSMLSDTA 488 (531)
Q Consensus 422 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~ 488 (531)
. .+...+..... ...+.+++..|++.+|.+| |++.++.+.|++..
T Consensus 293 ~-------------------~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 C-------------------KPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp E-------------------EECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred e-------------------eechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 0 00000001111 2246678888999999999 67888888887653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=348.57 Aligned_cols=261 Identities=21% Similarity=0.315 Sum_probs=203.2
Q ss_pred cccccccccccccceeEEEEEeeeC--CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE--SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPD 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~ 278 (531)
.++|...+.||+|+||.||+|.... .+|+.||||+++.............+.+|+.++..+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 3689999999999999999998732 378999999986532111111134566799999999 6999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
..++||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999975 356899999999999999999999 67899999999999999999999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL--KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
++.+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.. .....
T Consensus 206 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~ 281 (355)
T 1vzo_A 206 SKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---RILKS 281 (355)
T ss_dssp EEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH---HHHHC
T ss_pred CeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH---HHhcc
Confidence 9876543222 22346799999999999863 478999999999999999999999975432222222222 22221
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSML 484 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 484 (531)
..+ . . .. ....+.+++.+||..||.+|| |+.+++++.
T Consensus 282 ~~~-~--~----~~----~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 EPP-Y--P----QE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCC-C--C----TT----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCC-C--C----cc----cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111 0 0 11 112478899999999999999 899998865
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.93 Aligned_cols=301 Identities=20% Similarity=0.244 Sum_probs=209.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC---
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD--- 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 278 (531)
.++|...+.||+|+||.||+|.... +++.||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEECTTSS--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECC-CCceEEEEEeccccCC--hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 4789999999999999999997654 7899999999764322 223567889999999999999999999987654
Q ss_pred ---ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 279 ---CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 279 ---~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
..|+||||+++ +|.+++. ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~D 170 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 170 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEE
Confidence 67999999975 8988885 34889999999999999999999 67899999999999999999999999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... ..+.. +.....
T Consensus 171 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~-i~~~~~ 243 (371)
T 2xrw_A 171 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNK-VIEQLG 243 (371)
T ss_dssp CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH-HHC-CC
T ss_pred eeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-HHHHhC
Confidence 99998764432 123457899999999999999999999999999999999999999764221 11111 111000
Q ss_pred cCC------------------CCc---c----ccccccCCC---cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh--c
Q 009595 436 SEN------------------PNR---A----IDSKLLGNG---YEEQMLLVLKIACFCTLDDPEERPNSKDVRSML--S 485 (531)
Q Consensus 436 ~~~------------------~~~---~----~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L--~ 485 (531)
.+. +.. . ......+.. .......+.+++.+||..||.+|||+.+++++- .
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 000 000 0 000000000 112245688999999999999999999999854 3
Q ss_pred cCcCCCchhh--hhhccCCCCCChHHHHHhhHHHHhhhh
Q 009595 486 DTALIKDVDF--LKMHKRMDFDNDDCVELIQQEIYTEWL 522 (531)
Q Consensus 486 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (531)
....+..... ...+....-......+.+++.+|.+.+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (371)
T 2xrw_A 324 VWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVM 362 (371)
T ss_dssp TTCCHHHHTCCCCCCCTTTTCCCCCCHHHHHHHHHHHHH
T ss_pred hhcCccccCCCCCCCCChhhccccCcHHHHHHHHHHHHH
Confidence 2111100000 011111111223367888888888754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=330.62 Aligned_cols=256 Identities=20% Similarity=0.244 Sum_probs=201.1
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEE--eCCce
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMV--RPDCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~ 280 (531)
++|.+.+.||+|+||.||+|.... +++.||+|++..............+.+|+.++++++||||+++++++. .....
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSE-TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTT-TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred cceeEeeEEecCCCeEEEEEEECC-CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 678999999999999999998654 788999999976432221223577899999999999999999999984 44578
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||++++ |.+++.. .....+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDS--VPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHH--STTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHh--CcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999875 8888865 33467899999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLK--FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
...............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+... ..+...+. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~i~---~~~- 229 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI----YKLFENIG---KGS- 229 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH---HCC-
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH----HHHHHHHh---cCC-
Confidence 775443333334567999999999987654 47899999999999999999999976421 12222111 111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. + ..... ..+.+++.+||..||.+|||+.+++++
T Consensus 230 ~~--~----~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 YA--I----PGDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC--C----CSSSC----HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC--C----CCccC----HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 0 01111 247789999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=333.99 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=200.4
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|...+.||+|+||.||+|.... +|+.||||.+..... ...+.+|+.++.+++||||+++++++......
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKE-TGQIVAIKQVPVESD------LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETT-TCCEEEEEEEETTSC------CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECC-CCCEEEEEecCchHH------HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 45789999999999999999998754 689999999986432 45678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++|+|.+++.. ....+++..+..++.|++.||.||| ..+++|+||||+||+++.++.+||+|||++.
T Consensus 100 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAG 173 (314)
T ss_dssp EEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccch
Confidence 999999999999999963 2457899999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.... ..+ ........+.
T Consensus 174 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~~~~ 244 (314)
T 3com_A 174 QLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM---RAI----FMIPTNPPPT 244 (314)
T ss_dssp ECBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH----HHHHHSCCCC
T ss_pred hhhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHH----HHHhcCCCcc
Confidence 76543221 23356899999999999989999999999999999999999999764221 111 1111111111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. ..+. .....+.+++.+||..||.+|||+.+++++
T Consensus 245 ~-~~~~-------~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 245 F-RKPE-------LWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp C-SSGG-------GSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred c-CCcc-------cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1 1111 112347889999999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=339.33 Aligned_cols=298 Identities=21% Similarity=0.269 Sum_probs=213.3
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
-.+.|...+.||+|+||.||+|.... +|+.||||++...... ......+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 116 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred ccccEEEEeEEecCCCeEEEEEEECC-CCCEEEEEEecccccc--hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence 35789999999999999999998654 7999999999764332 23367788999999999999999999999877655
Q ss_pred ------EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEe
Q 009595 281 ------LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIA 354 (531)
Q Consensus 281 ------~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~ 354 (531)
++||||+. ++|.+++. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 117 ~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~ 186 (371)
T 4exu_A 117 RNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKIL 186 (371)
T ss_dssp TTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred ccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEE
Confidence 99999997 48988873 34899999999999999999999 6789999999999999999999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... ..+...+. .
T Consensus 187 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~-~ 257 (371)
T 4exu_A 187 DFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILK-V 257 (371)
T ss_dssp STTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH-H
T ss_pred ecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHH-H
Confidence 99999865432 233578999999999887 67899999999999999999999999764321 11111111 1
Q ss_pred hccCCCCccccccc---------------cCCC----cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCc
Q 009595 434 MTSENPNRAIDSKL---------------LGNG----YEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKD 492 (531)
Q Consensus 434 ~~~~~~~~~~d~~l---------------~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~ 492 (531)
.. .+.......+ .... .+.....+.+++.+||+.||.+|||+.+++++ ++.+..+..
T Consensus 258 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 335 (371)
T 4exu_A 258 TG--VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE 335 (371)
T ss_dssp HC--CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred hC--CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccc
Confidence 10 0000000000 0000 00112358889999999999999999999986 343322111
Q ss_pred hhhhhhccC-CCCCChHHHHHhhHHHHhhhh
Q 009595 493 VDFLKMHKR-MDFDNDDCVELIQQEIYTEWL 522 (531)
Q Consensus 493 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 522 (531)
..-...+.. .....+..++.+++.+|.+..
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (371)
T 4exu_A 336 ETEAQQPFDDSLEHEKLTVDEWKQHIYKEIV 366 (371)
T ss_dssp CCCCSSCCCCTTSSCCCCHHHHHHHHHHHHH
T ss_pred ccccccCcCcchhhcccchHHHHHHHHHHHH
Confidence 100011100 011223357788888887654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=344.47 Aligned_cols=265 Identities=16% Similarity=0.149 Sum_probs=204.8
Q ss_pred cccccccccccccceeEEEEEeeeCC-------CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccc-----
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPES-------NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVP----- 269 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~----- 269 (531)
.++|...+.||+|+||.||+|..... .++.||||.+... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhh
Confidence 47899999999999999999987642 3789999999753 24668999999999999988
Q ss_pred ----------cceeEEe-CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecc
Q 009595 270 ----------LLAHMVR-PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNI 338 (531)
Q Consensus 270 ----------l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 338 (531)
+++++.. ....++||||+ +++|.+++.. .....+++..+..++.|++.||.||| +++++||||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Di 185 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDV--SPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNV 185 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHH--SGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCC
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHh--CCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCC
Confidence 6677766 67889999999 9999999986 22367999999999999999999999 678999999
Q ss_pred CCCCeeeCCCC--CEEEeecCCCccCCCCCcc-----ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCC
Q 009595 339 TPSSVLIDDDM--EARIADFGLARLMPDGHAQ-----VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGK 411 (531)
Q Consensus 339 kp~NILl~~~~--~vkL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~ 411 (531)
||+|||++.++ .+||+|||++..+...... .......||+.|+|||++.+..++.++||||||+++|+|++|+
T Consensus 186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999998 9999999999876533211 1113357999999999999999999999999999999999999
Q ss_pred CCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 412 LPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 412 ~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.||...... ...+........... . ........... ....+.+++.+||..||.+|||+.++++.|+++.
T Consensus 266 ~pf~~~~~~--~~~~~~~~~~~~~~~-~-~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 266 LPWTNCLPN--TEDIMKQKQKFVDKP-G-PFVGPCGHWIR---PSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp CTTGGGTTC--HHHHHHHHHHHHHSC-C-CEECTTSCEEC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CCcccCCcC--HHHHHHHHHhccCCh-h-hhhhhccccCC---CcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 999765321 222323222222111 1 11111000001 1134888999999999999999999999998864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=338.13 Aligned_cols=268 Identities=21% Similarity=0.351 Sum_probs=207.3
Q ss_pred cccccccccccccceeEEEEEee---eCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 202 EDCSASLEKIRSRASGEIYIAEL---PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
.+.|.+.+.||+|+||.||+|.+ ...+|+.||||++...... ..+.+.+|+.++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE----HLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSH----HHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHH----HHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 46788999999999999999985 2347899999999764432 2577899999999999999999999887644
Q ss_pred --ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 279 --CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 279 --~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
..++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred CCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecC
Confidence 78999999999999999975 2346899999999999999999999 678999999999999999999999999
Q ss_pred CCCccCCCCCccce-ecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc--------hhhhHHH
Q 009595 357 GLARLMPDGHAQVS-TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQH--------TEEKSLV 427 (531)
Q Consensus 357 gla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~--------~~~~~l~ 427 (531)
|++........... .....++..|+|||.+.+..++.++||||||+++|+|+||..||...... .......
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence 99987765432211 22345778899999999888999999999999999999999997542110 0001111
Q ss_pred HHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 428 RWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 428 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
..+......+.... . ... ....+.+++.+||..||.+|||+.++++.|+++.
T Consensus 270 ~~~~~~~~~~~~~~-~-----~~~---~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 270 FHLIELLKNNGRLP-R-----PDG---CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHHHTTCCCC-C-----CTT---CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCC-C-----CCc---ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111111100 0 011 1234788999999999999999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=339.68 Aligned_cols=258 Identities=22% Similarity=0.344 Sum_probs=206.0
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCc----hhhhHHHHHHHHHHHHHhcC-CCCcccccceeEE
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDN----SLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMV 275 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 275 (531)
..++|...+.||+|+||.||+|.... +|+.||||++..... .......+.+.+|+.++.++ +||||+++++++.
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRA-TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhcccceEEecCCCEEEEEEEECC-CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 45679999999999999999998753 689999999976442 22233356788999999999 8999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
.....++||||+++|+|.+++.. ...+++..+..++.||+.||.||| +.|++||||||+|||++.++.+||+|
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999975 356899999999999999999999 67899999999999999999999999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHH
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT------LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRW 429 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~ 429 (531)
||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......
T Consensus 244 fG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~~~~~~ 316 (365)
T 2y7j_A 244 FGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ----ILMLRM 316 (365)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH
T ss_pred cCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH----HHHHHH
Confidence 999987765432 234679999999998863 3588899999999999999999999865321 112221
Q ss_pred HHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 430 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. ....... ....... ...+.+++.+||+.||.+|||+.+++++
T Consensus 317 i~---~~~~~~~---~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 317 IM---EGQYQFS---SPEWDDR----SSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HH---HTCCCCC---HHHHSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HH---hCCCCCC---CcccccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 1111100 0000111 1247889999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=336.93 Aligned_cols=254 Identities=23% Similarity=0.314 Sum_probs=206.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..++|...+.||+|+||.||++.... +++.||+|++....... ......+.+|+.+++.++||||+++++++...+..
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEechhhhcC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 45789999999999999999998754 68899999997643221 22367788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++.
T Consensus 117 ~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189 (335)
T ss_dssp EEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence 999999999999999875 357899999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+. ... ..
T Consensus 190 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~---~~~-~~ 259 (335)
T 2owb_A 190 KVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----KETYLRIK---KNE-YS 259 (335)
T ss_dssp ECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHH---HTC-CC
T ss_pred ecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH----HHHHHHHh---cCC-CC
Confidence 76543222 2346789999999999998899999999999999999999999975422 11111111 111 10
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. .... ..+.+++.+||+.||.+|||+.+++++
T Consensus 260 --~~----~~~~----~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 260 --IP----KHIN----PVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --CC----TTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CC----ccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 1111 247789999999999999999999984
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=338.16 Aligned_cols=267 Identities=23% Similarity=0.321 Sum_probs=206.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhc--CCCCcccccceeEEeCC-
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQ--IRHRNIVPLLAHMVRPD- 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~~- 278 (531)
.+.|...+.||+|+||.||+|.+ +|+.||||++.... ...+..|+.++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE-------ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECGGG-------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred cccEEEEeeecCCCCcEEEEEEE---cCccEEEEEeCchh-------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 46789999999999999999987 68999999997532 3456678888876 79999999999998876
Q ss_pred ---ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeeccCCCCeeeCCCCC
Q 009595 279 ---CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY-----HRPRIIHRNITPSSVLIDDDME 350 (531)
Q Consensus 279 ---~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlkp~NILl~~~~~ 350 (531)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||.. ++.+++||||||+|||++.+++
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred ccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence 78999999999999999975 4689999999999999999999932 1467999999999999999999
Q ss_pred EEEeecCCCccCCCCCccc--eecccccCccccCcccccCC------CCCchhhHHHHHHHHHHHHhC----------CC
Q 009595 351 ARIADFGLARLMPDGHAQV--STSIVAGTVGYIAPEYHQTL------KFSEKCDIYSFGVLLAVLVMG----------KL 412 (531)
Q Consensus 351 vkL~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg----------~~ 412 (531)
+||+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|||+|| ..
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 9999999998765443221 22345799999999998775 234789999999999999999 78
Q ss_pred CCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 413 PSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 413 P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
||......... ...+.......... ..+.... ........+.+++.+||+.||.+|||+.+++++|+++..
T Consensus 266 p~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 266 PYYDLVPSDPS--VEEMRKVVCEQKLR-PNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TTTTTSCSSCC--HHHHHHHHTTSCCC-CCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccccCcCccc--HHHHHHHHHHHHhC-CCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 88654332211 11122222211111 1111111 112445568899999999999999999999999988643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.08 Aligned_cols=248 Identities=21% Similarity=0.367 Sum_probs=202.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe-----
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR----- 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----- 276 (531)
.++|...+.||+|+||.||+|.... +|+.||+|.+..... .+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~--------~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRI-DGKTYVIKRVKYNNE--------KAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETT-TCCEEEEEEEECCSG--------GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred ccccceeeeeccCCceEEEEEEEcC-CCeEEEEEEeccccH--------HHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 3678899999999999999998754 689999999986432 35579999999999999999998854
Q ss_pred -----------CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee
Q 009595 277 -----------PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345 (531)
Q Consensus 277 -----------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl 345 (531)
....++||||+++|+|.+++... ....+++..+..++.|++.||.||| +.+++||||||+||++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFL 155 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEE
Confidence 34579999999999999999752 2357899999999999999999999 6789999999999999
Q ss_pred CCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhH
Q 009595 346 DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKS 425 (531)
Q Consensus 346 ~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~ 425 (531)
+.++.+||+|||++......... ....||+.|+|||.+.+..++.++||||||+++|+|++|..|+... ..
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~~ 226 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------SK 226 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------HH
T ss_pred cCCCCEEECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------HH
Confidence 99999999999999877654322 2356899999999999989999999999999999999999885321 11
Q ss_pred HHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 426 LVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 426 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.. ... ..+.... ..+ ..+.+++.+||..||.+|||+.+++++|..+.
T Consensus 227 ~~---~~~-~~~~~~~---------~~~---~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 227 FF---TDL-RDGIISD---------IFD---KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HH---HHH-HTTCCCT---------TSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HH---HHh-hcccccc---------cCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11 111 1111111 111 23778999999999999999999999998764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=355.12 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=201.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchh---------hhHHHHHHHHHHHHHhcCCCCcccccce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSL---------LNIKMRQVRAEIMTAGQIRHRNIVPLLA 272 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~~Ei~~l~~l~hpnIv~l~~ 272 (531)
.+.|.++++||+|+||+||+|.... +++.||||++....... .....+.+.+|+.++++++||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKN-GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETT-TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECC-CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4779999999999999999998754 78899999997643211 0112567889999999999999999999
Q ss_pred eEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC---
Q 009595 273 HMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM--- 349 (531)
Q Consensus 273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~--- 349 (531)
++.+....|+|||||++|+|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999975 456999999999999999999999 67899999999999998776
Q ss_pred CEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHH
Q 009595 350 EARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRW 429 (531)
Q Consensus 350 ~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~ 429 (531)
.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ..+...
T Consensus 187 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~ 258 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND----QDIIKK 258 (504)
T ss_dssp SEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH
T ss_pred cEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH
Confidence 699999999987755422 234679999999999874 689999999999999999999999976422 222222
Q ss_pred HHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 430 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. ... ... +...... ....+.+++.+||+.||.+|||+.+++++
T Consensus 259 i~---~~~-~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 VE---KGK-YYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HH---HCC-CCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH---cCC-CCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 22 111 110 0000111 12347889999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=342.37 Aligned_cols=270 Identities=21% Similarity=0.270 Sum_probs=204.3
Q ss_pred hhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC--
Q 009595 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP-- 277 (531)
Q Consensus 200 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-- 277 (531)
...++|...+.||+|+||.||+|.... +|+.||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETT-TCCEEEEEECCCSSCSS--SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred ccccceeEEEEEecCCCcEEEEEEECC-CCCEEEEEEEecccccc--cchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 345789999999999999999998754 78999999986543321 1134577899999999999999999998873
Q ss_pred ------CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCE
Q 009595 278 ------DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA 351 (531)
Q Consensus 278 ------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v 351 (531)
+..++||||+++ +|.+.+.. ....+++..+..++.|++.||.||| +.||+||||||+|||++.++.+
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCE
Confidence 468999999976 88888764 2356999999999999999999999 6789999999999999999999
Q ss_pred EEeecCCCccCCCCCc--cceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHH
Q 009595 352 RIADFGLARLMPDGHA--QVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR 428 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~ 428 (531)
||+|||++..+..... ........||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+... .....
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~ 239 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE----QHQLA 239 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHH
Confidence 9999999987653221 1222346789999999988764 589999999999999999999999876432 22222
Q ss_pred HHHHHhccCCCCccccc---cc---------cCCCcHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 429 WMRNVMTSENPNRAIDS---KL---------LGNGYEEQ------MLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 429 ~~~~~~~~~~~~~~~d~---~l---------~~~~~~~~------~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+........+...... .. ........ ...+.+++.+||+.||.+|||+.+++++
T Consensus 240 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 22222222211110000 00 00001111 1347889999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=342.78 Aligned_cols=269 Identities=23% Similarity=0.240 Sum_probs=199.3
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhh-hHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLL-NIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
.+.|...+.||+|+||.||+|.... +|+.||||++........ ......+.+|+.++++++||||+++++++...+..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSS-CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred hcccEEEeEEeecCCEEEEEEEECC-CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4778999999999999999998754 689999999975332211 11134677899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++ +|.+++.. ....+++..+..++.|+++||.||| +.+++||||||+|||++.++.+||+|||++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999986 89998864 3356888899999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
.+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ...+...+.. ......
T Consensus 161 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~-~~~~~~ 234 (346)
T 1ua2_A 161 SFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFET-LGTPTE 234 (346)
T ss_dssp TTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHH-HCCCCT
T ss_pred eccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHH-cCCCCh
Confidence 76543222 2345789999999998764 589999999999999999999999876422 2222222222 111111
Q ss_pred Cccccc----c-----ccCCC-----cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 009595 440 NRAIDS----K-----LLGNG-----YEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484 (531)
Q Consensus 440 ~~~~d~----~-----l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 484 (531)
....+. . ..... .......+.+++.+||+.||.+|||+.+++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 110000 0 00000 011124588899999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=327.72 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=197.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.+.....||+|+||.||+|.... +++.||||.+....... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLS-NQVRIAIKEIPERDSRY----SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETT-TCCEEEEEEEECCCC-------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECC-CCeEEEEEEccCCchHH----HHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence 344556689999999999998754 78899999997654322 5678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC-CCCEEEeecCCCcc
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD-DMEARIADFGLARL 361 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~vkL~Dfgla~~ 361 (531)
||||+++++|.+++... .....+++..+..++.|++.||.||| +.+++|+||||+||+++. ++.+||+|||++..
T Consensus 97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp EEECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred EEEeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence 99999999999999762 22345678889999999999999999 678999999999999987 89999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLK--FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
....... .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....... .... ........+
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~---~~~~~~~~~ 245 (295)
T 2clq_A 173 LAGINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--AAMF---KVGMFKVHP 245 (295)
T ss_dssp SCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--HHHH---HHHHHCCCC
T ss_pred cCCCCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--HHHH---hhccccccc
Confidence 6543221 23457899999999987653 8899999999999999999999986532211 1111 111111111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. +.... ...+.+++.+||+.||.+|||+.+++++
T Consensus 246 ~------~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 246 E------IPESM----SAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp C------CCTTS----CHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred c------ccccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 11111 1247889999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=349.50 Aligned_cols=258 Identities=21% Similarity=0.285 Sum_probs=193.2
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch----hhhHHHHHHHHHHHHHhcCCCCcccccceeEEe
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS----LLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 276 (531)
..+.|...+.||+|+||.||+|.... +++.||||++...... ........+.+|+.+|++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERK-TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECC-CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 35789999999999999999998754 7889999999754321 011113357889999999999999999998754
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC---CEEE
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM---EARI 353 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~---~vkL 353 (531)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||.||| +++|+||||||+|||++.++ .+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEE
Confidence 568999999999999998854 567999999999999999999999 67899999999999997544 5999
Q ss_pred eecCCCccCCCCCccceecccccCccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHH
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT---LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~ 430 (531)
+|||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... ..+...+
T Consensus 284 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~~i 357 (419)
T 3i6u_A 284 TDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ---VSLKDQI 357 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS---CCHHHHH
T ss_pred eecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch---HHHHHHH
Confidence 99999987654322 234679999999999863 56889999999999999999999999764221 1122211
Q ss_pred HHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. +.... .+..... ....+.+++.+||+.||.+|||+.+++++
T Consensus 358 ~~----~~~~~--~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 TS----GKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HT----TCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hc----CCCCC--Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11 11110 0111111 12348889999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=327.36 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=196.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|.+.+.||+|+||.||+|.... +|+.||||.+....... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQL-TGHKVAVKILNRQKIRS-LDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECC-CCceEEEEEeccccccc-hhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 3678999999999999999998754 78899999997532211 112567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 88 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred EEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccc
Confidence 99999999999999975 356899999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKF-SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
...... .....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ..+...+.. +...
T Consensus 161 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~----~~~~ 229 (276)
T 2h6d_A 161 MSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV----PTLFKKIRG----GVFY 229 (276)
T ss_dssp CCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH----CCCC
T ss_pred cCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHhhc----Cccc
Confidence 654322 123568999999999988765 6899999999999999999999875422 222222221 1110
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. +... ...+.+++.+||+.||.+|||+.+++++
T Consensus 230 --~-----~~~~---~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 --I-----PEYL---NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --C-----CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --C-----chhc---CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 0111 1247889999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=356.74 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=205.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|...+.||+|+||.||+|.... +|+.||||++....... ......+.+|+.++++++||||+++++++......+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTCCB-SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECC-CCCEEEEEEEEhhhccc-chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3678899999999999999998754 78999999997543211 112567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee---CCCCCEEEeecCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI---DDDMEARIADFGL 358 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl---~~~~~vkL~Dfgl 358 (531)
+|||||.+|+|.+++.. ...+++..+..++.|++.||.||| +++|+||||||+|||+ +.++.+||+|||+
T Consensus 103 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 99999999999999965 467999999999999999999999 6789999999999999 5678999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+..+...... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ..+...+. ....
T Consensus 176 a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~---~~~~ 244 (484)
T 3nyv_A 176 STHFEASKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE----YDILKKVE---KGKY 244 (484)
T ss_dssp HHHBCCCCSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH---HCCC
T ss_pred eEEccccccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHH---cCCC
Confidence 9877554322 33579999999999876 699999999999999999999999976422 22222221 1111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..... .+......+.+++.+||+.||.+|||+.++++|
T Consensus 245 ~~~~~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 245 TFELP-------QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCCSG-------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCc-------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 11100 011122347889999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.38 Aligned_cols=258 Identities=20% Similarity=0.280 Sum_probs=200.4
Q ss_pred ccccccc-cccccceeEEEEEeeeC-CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 203 DCSASLE-KIRSRASGEIYIAELPE-SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 203 ~~~~~~~-~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
+++...+ .||+|+||.||+|.+.. .++..||||+++...... ..+.+.+|+.+|++++||||+++++++.. +..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA---DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST---THHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH---HHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 3344444 79999999999998753 245679999997643221 25778999999999999999999999876 568
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++|||||++|+|.+++.. ....+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 411 ~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp EEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred EEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 999999999999999964 2456999999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccc-eecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 361 LMPDGHAQV-STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 361 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
.+....... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||.+... ..+...+.. ...
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~~~~i~~---~~~ 557 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVMAFIEQ---GKR 557 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS----HHHHHHHHT---TCC
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH----HHHHHHHHc---CCC
Confidence 765432211 1123346789999999998899999999999999999998 9999987533 222222222 111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
... +..+ ...+.+++..||+.||.+|||+.+|++.|+.+
T Consensus 558 ~~~-------p~~~---~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 558 MEC-------PPEC---PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CCC-------CTTC---CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCC-------CCcC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 110 0111 12478899999999999999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.51 Aligned_cols=263 Identities=19% Similarity=0.239 Sum_probs=200.0
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC---
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP--- 277 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--- 277 (531)
..++|...+.||+|+||.||+|.... +|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIE-SGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETT-TCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccceEEEEEEEEeccCEEEEEEEECC-CCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 35789999999999999999998754 7899999999764322 23699999999999999999998543
Q ss_pred -----------------------------------CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHH
Q 009595 278 -----------------------------------DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGL 322 (531)
Q Consensus 278 -----------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L 322 (531)
...++||||+++ +|.+.+.........+++..+..++.|+++||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 337899999985 99988876555667899999999999999999
Q ss_pred HHHHhcCCCCeEeeccCCCCeeeC-CCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHH
Q 009595 323 EYLHMYHRPRIIHRNITPSSVLID-DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSF 400 (531)
Q Consensus 323 ~~LH~~~~~~ivH~Dlkp~NILl~-~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSl 400 (531)
.||| +.||+||||||+|||++ .++.+||+|||++..+...... ....||+.|+|||++.+. .++.++|||||
T Consensus 155 ~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 155 GFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 9999 78899999999999997 6889999999999876554332 235689999999998775 48999999999
Q ss_pred HHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC----------CccccccccCCCcH-----HHHHHHHHHHHH
Q 009595 401 GVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP----------NRAIDSKLLGNGYE-----EQMLLVLKIACF 465 (531)
Q Consensus 401 Gvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~----------~~~~d~~l~~~~~~-----~~~~~l~~li~~ 465 (531)
||++|||++|+.||.+... ...+...+.. ...+.. .....+......+. .....+.+++.+
T Consensus 229 G~il~ell~g~~pf~~~~~---~~~~~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 304 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGETS---IDQLVRIIQI-MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ 304 (383)
T ss_dssp HHHHHHHHHSSCSSCCSSH---HHHHHHHHHH-HCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCh---HHHHHHHHHH-hCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence 9999999999999976432 2222222221 111000 00000000011111 112347889999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 009595 466 CTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 466 cl~~dP~~RPs~~evl~~ 483 (531)
||+.||.+|||+.++++|
T Consensus 305 ~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 305 ILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HCCSSGGGSCCHHHHHTS
T ss_pred HccCChhhCCCHHHHhcC
Confidence 999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=332.91 Aligned_cols=265 Identities=24% Similarity=0.329 Sum_probs=199.2
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCe--EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGK--MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
..++|...+.||+|+||.||+|.+...+++ .||||++....... ....+.+.+|+.++++++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 357889999999999999999987544444 68999987543221 223678899999999999999999999987754
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
.++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred -ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccc
Confidence 88999999999999999752 356899999999999999999999 67899999999999999999999999999
Q ss_pred CccCCCCCccc-eecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 359 ARLMPDGHAQV-STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 359 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
+.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+... ..+.. .....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~---~~~~~ 240 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----SQILH---KIDKE 240 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHH---HHHTS
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH----HHHHH---HHHcc
Confidence 98776543221 2233567889999999988889999999999999999999 9999876422 22222 11111
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
.... ... .. ....+.+++.+||..||.+|||+.+++++|+++.+
T Consensus 241 ~~~~-~~~----~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 241 GERL-PRP----ED----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCC-CCC----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCC-CCC----cC----cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1111 000 11 12347889999999999999999999999988654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=336.14 Aligned_cols=256 Identities=22% Similarity=0.332 Sum_probs=198.9
Q ss_pred hhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 200 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
...+.|.+.+.||+|+||.||+|.... +++.||+|++....... ...+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKE-TGALAAAKVIETKSEEE----LEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETT-TCCEEEEEEEC----CC----HHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred CCccceeecceeccCCCeEEEEEEEcC-CCcEEEEEEecCCCHHH----HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence 345789999999999999999998754 68899999997543322 5678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++||||+++++|.+++... ...+++..+..++.|++.||.||| ..+++||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred EEEEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 99999999999999998642 356899999999999999999999 678999999999999999999999999987
Q ss_pred ccCCCCCccceecccccCccccCcccc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYH-----QTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
....... .......||+.|+|||++ .+..++.++||||||+++|+|++|..||...... .. +....
T Consensus 165 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~----~~~~~ 235 (302)
T 2j7t_A 165 AKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RV----LLKIA 235 (302)
T ss_dssp HHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HH----HHHHH
T ss_pred ccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH---HH----HHHHh
Confidence 5432111 111235689999999988 3667899999999999999999999998764321 11 11122
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
....+...... .+ ...+.+++.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~-----~~---~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 236 KSDPPTLLTPS-----KW---SVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HSCCCCCSSGG-----GS---CHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ccCCcccCCcc-----cc---CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 22222111111 11 1247889999999999999999998764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=350.68 Aligned_cols=249 Identities=12% Similarity=0.091 Sum_probs=189.5
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHH---HHHhcCCCCcccccc------
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEI---MTAGQIRHRNIVPLL------ 271 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei---~~l~~l~hpnIv~l~------ 271 (531)
..+.|...+.||+|+||.||+|.... +|+.||||++........ ...+.+.+|+ .++++++||||++++
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQE-TGESFEVHVPYFTERPPS-NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-C-CCCEEEEEEEEECC-CCT-THHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCceEEEcceeecCCCEEEEEEEECC-CCcEEEEEEEeeccccch-HHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 35778999999999999999998753 689999999975322211 1257788999 556666899999998
Q ss_pred -eeEEeCC-----------------ceEEEEeccCCCCHHHHHhhccC---CCccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 009595 272 -AHMVRPD-----------------CHLLVSEFMKNGSLLEILNDVSQ---GRRELEWLARHRIARGIVSGLEYLHMYHR 330 (531)
Q Consensus 272 -~~~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 330 (531)
+++...+ ..|+||||+ +|+|.+++..... ....+++..++.++.||+.||.||| +
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 224 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---H 224 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---h
Confidence 5555443 278999999 6799999975221 1234556888899999999999999 6
Q ss_pred CCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCC-----------CCCchhhHHH
Q 009595 331 PRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-----------KFSEKCDIYS 399 (531)
Q Consensus 331 ~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwS 399 (531)
.+|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||
T Consensus 225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred CCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 7899999999999999999999999999986432 2234567 999999999887 8999999999
Q ss_pred HHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 009595 400 FGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKD 479 (531)
Q Consensus 400 lGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 479 (531)
|||++|||+||+.||.+......... +... .... ...+.+++.+||+.||.+|||+.+
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~~~~-----------------~~~~-~~~~----~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGGSEW-----------------IFRS-CKNI----PQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp HHHHHHHHHHSSCCC------CCSGG-----------------GGSS-CCCC----CHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred HHHHHHHHHHCCCCCcccccccchhh-----------------hhhh-ccCC----CHHHHHHHHHHcCCCchhCCCHHH
Confidence 99999999999999865422111000 0000 0111 124788999999999999999999
Q ss_pred HHHH
Q 009595 480 VRSM 483 (531)
Q Consensus 480 vl~~ 483 (531)
++++
T Consensus 357 ~l~h 360 (377)
T 3byv_A 357 AMET 360 (377)
T ss_dssp HHTS
T ss_pred HhhC
Confidence 9874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.40 Aligned_cols=259 Identities=22% Similarity=0.292 Sum_probs=187.6
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEE----
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMV---- 275 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~---- 275 (531)
...+|.+.+.||+|+||.||+|.+.. +++.||||++....... ...+.+|+.++.++. ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVG-SGREYALKRLLSNEEEK----NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEEEESSHHH----HHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECC-CCcEEEEEEecCCchHH----HHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 34688999999999999999998754 78899999996644322 567889999999995 999999999984
Q ss_pred ----eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeeccCCCCeeeCCCC
Q 009595 276 ----RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR--IIHRNITPSSVLIDDDM 349 (531)
Q Consensus 276 ----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NILl~~~~ 349 (531)
....+++||||+. |+|.+++..... ...+++..++.++.|++.||.||| ..+ ++||||||+|||++.++
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTS
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCC
Confidence 2345789999996 699999875322 356999999999999999999999 677 99999999999999999
Q ss_pred CEEEeecCCCccCCCCCccc----------eecccccCccccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009595 350 EARIADFGLARLMPDGHAQV----------STSIVAGTVGYIAPEYH---QTLKFSEKCDIYSFGVLLAVLVMGKLPSDD 416 (531)
Q Consensus 350 ~vkL~Dfgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~P~~~ 416 (531)
.+||+|||++.......... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||.+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999998765432211 11135689999999998 566789999999999999999999999865
Q ss_pred cccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 417 FFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 417 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
... . ..+....... +.. ... ..+.+++.+||+.||.+|||+.+++++|..+..
T Consensus 256 ~~~----~---~~~~~~~~~~-~~~--------~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 256 GAK----L---RIVNGKYSIP-PHD--------TQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -----------------CCCC-TTC--------CSS----GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhH----H---HhhcCcccCC-ccc--------ccc----hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 321 1 1111111111 000 000 126789999999999999999999999987643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=334.93 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=196.4
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEe---
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVR--- 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~--- 276 (531)
..+.|.+.+.||+|+||.||+|.... +|+.||||++...... ...+.+|+.++.++ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTGDE-----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSST-----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECC-CCCeEEEEEEecCccc-----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 56889999999999999999998754 7889999999764432 45678899999999 89999999999987
Q ss_pred ---CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEE
Q 009595 277 ---PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARI 353 (531)
Q Consensus 277 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL 353 (531)
....++||||+++|+|.+++... ....+++..+..++.|++.||.||| ..+++||||||+||+++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEE
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEE
Confidence 46789999999999999999762 2357899999999999999999999 678999999999999999999999
Q ss_pred eecCCCccCCCCCccceecccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHH
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ-----TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR 428 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~ 428 (531)
+|||++......... .....||+.|+|||++. +..++.++||||||+++|+|++|..||.+.... ..+.
T Consensus 171 ~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~- 244 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALF- 244 (326)
T ss_dssp CCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH-
T ss_pred eeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHH-
Confidence 999998876543221 23356899999999987 456889999999999999999999999764321 1111
Q ss_pred HHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 429 WMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 429 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.......+.. . ...+ ...+.+++.+||..||.+|||+.+++++
T Consensus 245 ---~~~~~~~~~~-~-----~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 245 ---LIPRNPAPRL-K-----SKKW---SKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ---HHHHSCCCCC-S-----CSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---HhhcCccccC-C-----cccc---CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111111111 0 1111 1247889999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=340.02 Aligned_cols=274 Identities=18% Similarity=0.204 Sum_probs=195.3
Q ss_pred hhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 200 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
...++|.+.+.||+|+||.||+|.... +|+.||||++...... .....+++..+..++||||+++++++.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKS-TGMSVAIKKVIQDPRF-----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHTTEEEC----------CEEEEETT-TCCEEEEEEEECCTTC-----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhccceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEecCccc-----cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 345889999999999999999998754 7899999998654332 2345668888888999999999999876443
Q ss_pred -------eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC-CCCE
Q 009595 280 -------HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD-DMEA 351 (531)
Q Consensus 280 -------~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~v 351 (531)
.++||||+++ +|.+.+.........+++..+..++.|++.||.|||.. ..+|+||||||+|||++. ++.+
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcE
Confidence 7899999976 77766655445567889999999999999999999943 578999999999999996 8999
Q ss_pred EEeecCCCccCCCCCccceecccccCccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHH
Q 009595 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLK-FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~ 430 (531)
||+|||++......... ....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.... ..+...+
T Consensus 172 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~~ 245 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEIV 245 (360)
T ss_dssp EECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH
T ss_pred EEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHHH
Confidence 99999999877654322 3357899999999987654 899999999999999999999999764322 2222222
Q ss_pred HHHhccCC---------CCcccc---------ccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCc
Q 009595 431 RNVMTSEN---------PNRAID---------SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTA 488 (531)
Q Consensus 431 ~~~~~~~~---------~~~~~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 488 (531)
+. ...+. .....+ ..............+.+++.+||+.||.+|||+.+++++ +.++.
T Consensus 246 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 246 RV-LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HH-HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HH-cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 11 11000 000000 000111111134568899999999999999999999985 45543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=335.17 Aligned_cols=268 Identities=26% Similarity=0.389 Sum_probs=187.0
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..+.|...+.||+|+||.||+|.... +++.||||.+...... .....+.+|+.++++++||||+++++++...+..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAP-KKEKVAIKRINLEKCQ---TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC-----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred chhhhhhhheeccccceEEEEEEECC-CCcEEEEEEEEhhhcc---hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 45789999999999999999998654 6889999998653321 1256788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccC----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 281 LLVSEFMKNGSLLEILNDVSQ----GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
++||||+++|+|.+++..... ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 999999999999999974221 2356899999999999999999999 678999999999999999999999999
Q ss_pred CCCccCCCCCc---cceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHH
Q 009595 357 GLARLMPDGHA---QVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN 432 (531)
Q Consensus 357 gla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~ 432 (531)
|++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~ 242 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLMLTLQN 242 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHTS
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHHHHhcc
Confidence 99887654321 111234578999999999876 468999999999999999999999997653211 11111110
Q ss_pred HhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 433 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..........++...... ...+.+++.+||+.||.+|||+.+++++
T Consensus 243 -~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 -DPPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -SCCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -CCCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000000111111111111 2347889999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=326.62 Aligned_cols=256 Identities=21% Similarity=0.321 Sum_probs=204.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCc-----hhhhHHHHHHHHHHHHHhcCC-CCcccccceeEE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDN-----SLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMV 275 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~ 275 (531)
.++|...+.||+|+||.||+|.... +|+.||||++..... .......+.+.+|+.+++++. ||||+++++++.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhccceeeeecCCCceEEEEEEEcC-cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4788999999999999999998754 789999999976431 122233567889999999995 999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
.....++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999975 357899999999999999999999 67899999999999999999999999
Q ss_pred cCCCccCCCCCccceecccccCccccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHH
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ------TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRW 429 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~ 429 (531)
||++........ .....||+.|+|||++. ...++.++||||||+++|+|++|+.||..... ......
T Consensus 168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~ 240 (298)
T 1phk_A 168 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----MLMLRM 240 (298)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH
T ss_pred ccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH----HHHHHH
Confidence 999987654432 23356899999999885 45688999999999999999999999865422 112111
Q ss_pred HHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 009595 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS 482 (531)
Q Consensus 430 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 482 (531)
+. ....... ..........+.+++.+||+.||.+|||+.++++
T Consensus 241 ~~---~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IM---SGNYQFG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HH---HTCCCCC-------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Hh---cCCcccC-------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11 1111100 0011112234888999999999999999999886
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=364.96 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=198.0
Q ss_pred ccccccceeEEEEEeeeC-CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPE-SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
+.||+|+||.||+|.+.. ..++.||||+++...... ...+.+.+|+.+|.+++||||+++++++.. +..++|||||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP--ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG--GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence 479999999999997642 246789999997643221 225778999999999999999999998864 5688999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 452 ~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 452 ELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp TTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999999975 467899999999999999999999 67899999999999999999999999999987754432
Q ss_pred c-ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCccccc
Q 009595 368 Q-VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS 445 (531)
Q Consensus 368 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 445 (531)
. .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+... ..+...+........+.
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~~~~i~~~~~~~~p~----- 595 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEKGERMGCPA----- 595 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTTCCCCCCT-----
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCCCCC-----
Confidence 1 12233457889999999999999999999999999999998 9999976532 22222222211111111
Q ss_pred cccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 446 KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 446 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.+ ...+.+++..||+.||.+|||+.+|++.|+++
T Consensus 596 -----~~---~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 596 -----GC---PREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp -----TC---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 13478899999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=331.80 Aligned_cols=260 Identities=20% Similarity=0.274 Sum_probs=200.1
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEe--C
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVR--P 277 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~--~ 277 (531)
..++|...+.||+|+||.||+|.... +++.||||++.... .+.+.+|+.++++++ ||||+++++++.. .
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINIT-NNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCCceEEEEEecccCCeEEEEEEECC-CCcEEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 45789999999999999999998654 78999999997533 456889999999997 9999999999987 5
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC-CEEEeec
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM-EARIADF 356 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkL~Df 356 (531)
...++||||+++++|.+++. .+++..+..++.|++.||.||| +.+++||||||+|||++.++ .+||+||
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Df 175 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDW 175 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence 67899999999999999984 3788999999999999999999 67899999999999999776 8999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH--
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV-- 433 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~-- 433 (531)
|++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ....+.......
T Consensus 176 g~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~l~~~~~~~~~ 250 (330)
T 3nsz_A 176 GLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGT 250 (330)
T ss_dssp TTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCH
T ss_pred CCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc--hHHHHHHHHHhcCC
Confidence 99987654432 233578999999999877 5789999999999999999999999854322 111111111100
Q ss_pred ------hccCC--------------CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 434 ------MTSEN--------------PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 434 ------~~~~~--------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..... ....................+.+++.+||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred chhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 000000000011111123458889999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=337.17 Aligned_cols=257 Identities=16% Similarity=0.219 Sum_probs=200.1
Q ss_pred ccccccc-ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCc
Q 009595 202 EDCSASL-EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 279 (531)
.+.|.+. +.||+|+||.||+|.... +|+.||||++........ ....+.+|+.++..+ .||||+++++++.....
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKS-TGQEYAAKFLKKRRRGQD--CRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEESEETTEE--CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECC-CCCEEEEEEEehhhcchH--HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3556666 889999999999998754 789999999976433221 156788999999999 56999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC---CCCEEEeec
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD---DMEARIADF 356 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkL~Df 356 (531)
.++||||+++|+|.+++.. .....+++..+..++.|++.||.||| ..|++||||||+|||++. ++.+||+||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999854 33467999999999999999999999 678999999999999988 789999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
|++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+.... .
T Consensus 179 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~-~ 250 (327)
T 3lm5_A 179 GMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN----QETYLNISQVN-V 250 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTC-C
T ss_pred ccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHHHhcc-c
Confidence 99987654422 2335799999999999999999999999999999999999999876422 11111111111 1
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..+.. ........+.+++.+||+.||.+|||+.+++++
T Consensus 251 ~~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 251 DYSEE---------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCCTT---------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccCch---------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11110 011112347889999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=345.00 Aligned_cols=263 Identities=21% Similarity=0.271 Sum_probs=199.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC----
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP---- 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 277 (531)
...|...+.||+|+||.||+|.+.. +|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECC-CCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 4578999999999999999998764 689999999975432 133699999999999999999988642
Q ss_pred --CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC-CCEEEe
Q 009595 278 --DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD-MEARIA 354 (531)
Q Consensus 278 --~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkL~ 354 (531)
...++||||+++ +|.+.+.........+++..+..++.||++||.||| +.+|+||||||+|||++.+ +.+||+
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~ 199 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLC 199 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEec
Confidence 136799999976 788877654455678999999999999999999999 7889999999999999965 568999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
|||+++.+...... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.. ....+...++..
T Consensus 200 DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~---~~~~l~~i~~~l 273 (420)
T 1j1b_A 200 DFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS---GVDQLVEIIKVL 273 (420)
T ss_dssp CCTTCEECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHH
T ss_pred cchhhhhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHh
Confidence 99999876544322 235789999999998765 78999999999999999999999997642 222333333211
Q ss_pred hc---------cCCCCccccccccCCCcH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 434 MT---------SENPNRAIDSKLLGNGYE-----EQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 434 ~~---------~~~~~~~~d~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
-. .+.......+.+....+. .....+.+|+.+||..||.+|||+.++++|
T Consensus 274 g~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 274 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00 000000000111011111 112358889999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=343.07 Aligned_cols=264 Identities=19% Similarity=0.213 Sum_probs=202.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC--------CCccccccee
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR--------HRNIVPLLAH 273 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--------hpnIv~l~~~ 273 (531)
.++|.+.+.||+|+||.||+|.... +++.||||++.... .....+.+|+.+++.++ ||||++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQ-GKKFVAMKVVKSAE-----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecC-CCeEEEEEEEecCC-----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 3779999999999999999997654 78999999997532 12567888999999885 7889999999
Q ss_pred EE----eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeeccCCCCeeeCCC
Q 009595 274 MV----RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP-RIIHRNITPSSVLIDDD 348 (531)
Q Consensus 274 ~~----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NILl~~~ 348 (531)
+. .....++||||+ +++|.+++.. .....+++..+..++.||+.||.||| ++ ||+||||||+|||++.+
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVN 183 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCC
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEecc
Confidence 87 456789999999 5678777764 33456999999999999999999999 55 89999999999999977
Q ss_pred C-------------------------------------------------CEEEeecCCCccCCCCCccceecccccCcc
Q 009595 349 M-------------------------------------------------EARIADFGLARLMPDGHAQVSTSIVAGTVG 379 (531)
Q Consensus 349 ~-------------------------------------------------~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~ 379 (531)
+ .+||+|||++...... .....||+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~ 258 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQ 258 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGG
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCc
Confidence 5 7999999999876433 233578999
Q ss_pred ccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh--hHHHHHHHHHhccCCCCcc----------ccc--
Q 009595 380 YIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEE--KSLVRWMRNVMTSENPNRA----------IDS-- 445 (531)
Q Consensus 380 y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~--~~l~~~~~~~~~~~~~~~~----------~d~-- 445 (531)
|+|||++.+..++.++|||||||++|+|+||+.||......... ......+....... +... +..
T Consensus 259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKV-PRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSC-CHHHHHHCTTGGGTBCTTS
T ss_pred ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCC-ChHHhhcccccccccCCcc
Confidence 99999999999999999999999999999999999764332211 11111111111110 0000 000
Q ss_pred ------cc-----------cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 446 ------KL-----------LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 446 ------~l-----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. ...........+.+|+.+||+.||.+|||+.+++++
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00 001234555678999999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.43 Aligned_cols=306 Identities=20% Similarity=0.207 Sum_probs=210.8
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch-------hhhHHHHHHHHHHHHHhcCCCCccccccee
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS-------LLNIKMRQVRAEIMTAGQIRHRNIVPLLAH 273 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~ 273 (531)
..+.|...+.||+|+||.||+|... +|+.||||++...... ......+.+.+|+.++++++||||++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred hccceEEeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 5688999999999999999999764 5899999999653321 112234778999999999999999999999
Q ss_pred EEeC-----CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC
Q 009595 274 MVRP-----DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD 348 (531)
Q Consensus 274 ~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~ 348 (531)
+... ...|+||||+. |+|.+++.. ....+++..+..++.|++.||.||| ..+++||||||+|||++.+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~ 170 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADN 170 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcCC
Confidence 8543 35799999997 589988863 3457899999999999999999999 6789999999999999999
Q ss_pred CCEEEeecCCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHH
Q 009595 349 MEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLV 427 (531)
Q Consensus 349 ~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~ 427 (531)
+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 171 NDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp CCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999986544322 233578999999999877 678999999999999999999999997643222211111
Q ss_pred HHHHHHhccCCCC------------------ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccC
Q 009595 428 RWMRNVMTSENPN------------------RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDT 487 (531)
Q Consensus 428 ~~~~~~~~~~~~~------------------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 487 (531)
. ....+... ............+.....+.+++.+||+.||.+|||+.+++++ ++.+
T Consensus 248 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 248 E----VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp H----HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred H----HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 1 11110000 0000000000001112347889999999999999999999985 3444
Q ss_pred cCCCchhhhhhccCCCCC-ChHHHHHhhHHHHhhhhc
Q 009595 488 ALIKDVDFLKMHKRMDFD-NDDCVELIQQEIYTEWLS 523 (531)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 523 (531)
..+.+.. .....+..+. ....+..+.+..+.|+.+
T Consensus 324 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 359 (362)
T 3pg1_A 324 FDPLDLT-EGLSERFHFDESVTDVYDMHKIFTAEVER 359 (362)
T ss_dssp CCGGGGT-TTCCCCCCCCTTCCCHHHHHHHHHHHHHH
T ss_pred cCccccc-cccccccChhhhhhhHHHHHHHHHHHHHH
Confidence 3322221 1122223322 223456666666666543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=332.87 Aligned_cols=257 Identities=23% Similarity=0.312 Sum_probs=197.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch----hhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS----LLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
.+.|.+.+.||+|+||.||+|.... +++.||||++...... ........+.+|+.++++++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERK-TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcC-CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3678999999999999999998754 7899999999653221 1111234578899999999999999999998765
Q ss_pred CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC---EEEe
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME---ARIA 354 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~---vkL~ 354 (531)
. .++||||+++|+|.+++.. ...+++..+..++.|++.||.||| +++++||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 4 8999999999999999864 567899999999999999999999 678999999999999987654 9999
Q ss_pred ecCCCccCCCCCccceecccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ---TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMR 431 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~ 431 (531)
|||++........ .....||+.|+|||++. +..++.++|||||||++|+|++|..||....... .+...+.
T Consensus 160 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~ 233 (322)
T 2ycf_A 160 DFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQIT 233 (322)
T ss_dssp CCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---CHHHHHH
T ss_pred cCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---HHHHHHH
Confidence 9999987654321 12356899999999874 4578999999999999999999999997643221 1222221
Q ss_pred HHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 432 NVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 432 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
. +... ..+..... ....+.+++.+||..||.+|||+.+++++
T Consensus 234 ~----~~~~--~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 S----GKYN--FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp H----TCCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred h----Cccc--cCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1 1110 01111111 12347889999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=331.12 Aligned_cols=301 Identities=19% Similarity=0.268 Sum_probs=214.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC----
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP---- 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 277 (531)
.++|...+.||+|+||.||+|.... +|+.||||++...... .....+.+|+.++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKP-TGEIVAIKKIEPFDKP---LFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCCSSH---HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccceEEeeEEcCCCCeEEEEEEECC-CCcEEEEEeecccccc---hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 4789999999999999999998754 7899999999753322 2256678999999999999999999987654
Q ss_pred -CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 278 -DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 278 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
...++||||+. |+|.+++.. ..+++..+..++.|++.||.||| +.|++||||||+|||++.++.+||+||
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Df 156 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDF 156 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred cceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEec
Confidence 67899999997 499999875 46899999999999999999999 678999999999999999999999999
Q ss_pred CCCccCCCCCccc--------eecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHH
Q 009595 357 GLARLMPDGHAQV--------STSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLV 427 (531)
Q Consensus 357 gla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~ 427 (531)
|++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... ...+
T Consensus 157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~- 232 (353)
T 2b9h_A 157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY---RHQL- 232 (353)
T ss_dssp TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH-
T ss_pred ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHH-
Confidence 9998765432111 1123578999999998764 6789999999999999999999999976422 1111
Q ss_pred HHHHHHhccCCCCccccc--------------cccCC----CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccC
Q 009595 428 RWMRNVMTSENPNRAIDS--------------KLLGN----GYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDT 487 (531)
Q Consensus 428 ~~~~~~~~~~~~~~~~d~--------------~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 487 (531)
..+......+........ ..... ..+.....+.+++.+||+.||.+|||+.+++++ +...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 111111111110000000 00000 001112347889999999999999999999985 4443
Q ss_pred cCCC--------chhhhhhccCCCCCChHHHHHhhHHHHhhhh
Q 009595 488 ALIK--------DVDFLKMHKRMDFDNDDCVELIQQEIYTEWL 522 (531)
Q Consensus 488 ~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (531)
.... ++.+.+... +........++..+|.|.+
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 313 HDPNDEPEGEPIPPSFFEFDH---YKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp CCTTSSCCCCCCCGGGGGGGC---CSSCCCHHHHHHHHHHHHT
T ss_pred CCcccccccCCCCcceeeecc---hhhcCCHHHHHHHHHHHhh
Confidence 2221 122222222 2333355566666666654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=345.70 Aligned_cols=199 Identities=21% Similarity=0.273 Sum_probs=171.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC------CCCcccccceeEE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI------RHRNIVPLLAHMV 275 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l------~hpnIv~l~~~~~ 275 (531)
..+|.+.+.||+|+||.||+|.... +++.||||++..... ....+..|+.++..+ +||||+++++++.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~-~~~~vAvK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHK-VHQHVALKMVRNEKR-----FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETT-TTEEEEEEEECSCHH-----HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECC-CCcEEEEEEECCccc-----hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 4679999999999999999998654 789999999975321 145566787777766 6789999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC--EEE
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME--ARI 353 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~--vkL 353 (531)
.....++||||+. ++|.+++.. .....+++..+..++.||+.||.||| +.+|+||||||+|||++.++. +||
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL 243 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKV 243 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEE
T ss_pred cCCeEEEEEeccC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEE
Confidence 9999999999996 599999976 33355899999999999999999999 678999999999999999887 999
Q ss_pred eecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDF 417 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~ 417 (531)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.
T Consensus 244 ~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 244 IDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999765432 12357899999999999999999999999999999999999998764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=335.42 Aligned_cols=273 Identities=20% Similarity=0.276 Sum_probs=203.0
Q ss_pred hhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC---CCCcccccceeEE-
Q 009595 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI---RHRNIVPLLAHMV- 275 (531)
Q Consensus 200 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~- 275 (531)
...+.|...+.||+|+||.||+|.....+|+.||+|++........ ....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc--CCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 3457899999999999999999987545789999999975432210 022345677666655 8999999999987
Q ss_pred ----eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCE
Q 009595 276 ----RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA 351 (531)
Q Consensus 276 ----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v 351 (531)
.....++||||+. |+|.+++.. .....+++..+..++.|++.||.||| ..|++||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~ 159 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQI 159 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCE
Confidence 4567899999997 599999976 33445899999999999999999999 6789999999999999999999
Q ss_pred EEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHH
Q 009595 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMR 431 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~ 431 (531)
||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.... ..+...+
T Consensus 160 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~- 232 (326)
T 1blx_A 160 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKIL- 232 (326)
T ss_dssp EECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH-
T ss_pred EEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH-
Confidence 999999998764332 223467899999999999989999999999999999999999999764321 1222222
Q ss_pred HHhccCC----CCcccccc---------ccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccC
Q 009595 432 NVMTSEN----PNRAIDSK---------LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDT 487 (531)
Q Consensus 432 ~~~~~~~----~~~~~d~~---------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 487 (531)
.....+. +.....+. ............+.+++.+||..||.+|||+.+++++ +.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 1111110 00000000 0000011122347889999999999999999999964 4444
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.52 Aligned_cols=298 Identities=20% Similarity=0.265 Sum_probs=212.5
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc--
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC-- 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-- 279 (531)
.+.|...+.||+|+||.||+|.... +|+.||||++...... ......+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEESSTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECC-CCCEEEEEEecccccc--hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 4678999999999999999998754 7999999999764322 2235678899999999999999999999987654
Q ss_pred ----eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 280 ----HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 280 ----~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
+++||||+.+ +|.+++. ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~D 169 (353)
T 3coi_A 100 NFYDFYLVMPFMQT-DLQKIMG------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILD 169 (353)
T ss_dssp GCCCCEEEEECCSE-EGGGTTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECS
T ss_pred cceeEEEEeccccC-CHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEee
Confidence 4999999974 8887763 35899999999999999999999 67899999999999999999999999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
||++...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.... ..+...+. ..
T Consensus 170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~-~~ 240 (353)
T 3coi_A 170 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILK-VT 240 (353)
T ss_dssp TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHH-HH
T ss_pred cccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHH-Hh
Confidence 9999865432 223568999999999877 67899999999999999999999999764321 11111111 11
Q ss_pred ccC-------------------CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCch
Q 009595 435 TSE-------------------NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKDV 493 (531)
Q Consensus 435 ~~~-------------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~ 493 (531)
..+ .+.. .... .....+.....+.+++.+||..||.+|||+.+++++ +.....+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~ 318 (353)
T 3coi_A 241 GVPGTEFVQKLNDKAAKSYIQSLPQT-PRKD-FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE 318 (353)
T ss_dssp CBCCHHHHTTCSCHHHHHHHHTSCBC-SSCC-TTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred CCCCHHHHHHHhhHHHHHHHHhCcCC-CCcc-HHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcccc
Confidence 000 0000 0000 011111223458889999999999999999999875 3443222111
Q ss_pred hhhhhccCCC-CCChHHHHHhhHHHHhhhhc
Q 009595 494 DFLKMHKRMD-FDNDDCVELIQQEIYTEWLS 523 (531)
Q Consensus 494 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 523 (531)
.....+-... ......++.+++.+|.+-..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (353)
T 3coi_A 319 TEAQQPFDDSLEHEKLTVDEWKQHIYKEIVN 349 (353)
T ss_dssp CCCSSCCCCTTTTCCCCHHHHHHHHHHHHHT
T ss_pred ccCCCCCccchhhccCCHHHHHHHHHHHHHh
Confidence 0111111100 12233677888888887543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=362.78 Aligned_cols=253 Identities=20% Similarity=0.235 Sum_probs=204.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~ 280 (531)
.++|.+++.||+|+||.||+|.... +++.||||+++...... ......+..|..++..+ +||||+++++++.+.+.+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESS-SCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECC-CCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4678999999999999999998764 78899999997532111 11246678899999988 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+||||+++|+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999976 356999999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+... ..+.. .+.... ..
T Consensus 491 ~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~----~~~~~---~i~~~~-~~ 560 (674)
T 3pfq_A 491 ENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQ---SIMEHN-VA 560 (674)
T ss_dssp ECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH---HHHSSC-CC
T ss_pred ccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH----HHHHH---HHHhCC-CC
Confidence 6443322 23457899999999999999999999999999999999999999976422 22222 222211 11
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS-----KDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 483 (531)
. . ... ...+.+|+..||+.||.+||++ .+|++|
T Consensus 561 ~--p----~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 561 Y--P----KSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp C--C----TTS----CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred C--C----ccC----CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 0 0 111 1247889999999999999998 666653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=342.66 Aligned_cols=266 Identities=20% Similarity=0.243 Sum_probs=198.5
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc--
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC-- 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-- 279 (531)
...|...+.||+|+||.||+|... .+..||+|++...... ..+|+.+++.++||||+++++++.....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~--~~~~~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLV--ESDEVAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEET--TTEEEEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEEC--CCCeEEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 467999999999999999999875 3455999988654322 2369999999999999999999865443
Q ss_pred ----eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC-CCCCEEEe
Q 009595 280 ----HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID-DDMEARIA 354 (531)
Q Consensus 280 ----~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~-~~~~vkL~ 354 (531)
.++||||+++ +|.+.+.........+++..+..++.|+++||.||| +.||+||||||+|||++ .++.+||+
T Consensus 109 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~ 184 (394)
T 4e7w_A 109 DEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLI 184 (394)
T ss_dssp SCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred CceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEe
Confidence 7899999987 565555443344578999999999999999999999 67899999999999998 78999999
Q ss_pred ecCCCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 355 DFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 355 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
|||+++........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ...+...++..
T Consensus 185 DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~l~~i~~~~ 258 (394)
T 4e7w_A 185 DFGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG---IDQLVEIIKVL 258 (394)
T ss_dssp CCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHH
T ss_pred eCCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHh
Confidence 99999877554332 235789999999998765 589999999999999999999999976432 22222222211
Q ss_pred hccCCC--------C--ccccccccCCCcH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCc
Q 009595 434 MTSENP--------N--RAIDSKLLGNGYE-----EQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTA 488 (531)
Q Consensus 434 ~~~~~~--------~--~~~d~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 488 (531)
..+.. . ....+......+. .....+.+++.+||+.||.+|||+.++++| ++++.
T Consensus 259 -g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 259 -GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp -CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred -CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 00000 0 0000000000000 112358889999999999999999999986 55543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.56 Aligned_cols=261 Identities=19% Similarity=0.293 Sum_probs=203.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCc------ccccceeEE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN------IVPLLAHMV 275 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn------Iv~l~~~~~ 275 (531)
.++|.+.+.||+|+||.||+|.....+++.||||++.... .....+.+|+.++..++|+| |+++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-----chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 3689999999999999999998755578999999997532 12566788999998886654 999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC--------
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD-------- 347 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-------- 347 (531)
..+..++||||+ +++|.+++.. .....+++..+..++.|++.||.||| +++++||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred cCCcEEEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccC
Confidence 999999999999 8899999976 33356899999999999999999999 678999999999999987
Q ss_pred -----------CCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009595 348 -----------DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDD 416 (531)
Q Consensus 348 -----------~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~ 416 (531)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 6789999999998654331 235789999999999999999999999999999999999999976
Q ss_pred cccchhhhHHHHHHHHHhccCCCCcccc----------cc---------------------ccCCCcHHHHHHHHHHHHH
Q 009595 417 FFQHTEEKSLVRWMRNVMTSENPNRAID----------SK---------------------LLGNGYEEQMLLVLKIACF 465 (531)
Q Consensus 417 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d----------~~---------------------l~~~~~~~~~~~l~~li~~ 465 (531)
.... .....+...... .+..... .. -...........+.+++.+
T Consensus 237 ~~~~----~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 311 (339)
T 1z57_A 237 HDSK----EHLAMMERILGP-LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQK 311 (339)
T ss_dssp SCHH----HHHHHHHHHHCS-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred CChH----HHHHHHHHHhCC-CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHH
Confidence 4321 111112211111 0000000 00 0001122334568899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 009595 466 CTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 466 cl~~dP~~RPs~~evl~~ 483 (531)
||+.||.+|||+.+++++
T Consensus 312 ~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 312 MLEYDPAKRITLREALKH 329 (339)
T ss_dssp HTCSSTTTSCCHHHHTTS
T ss_pred HhCcCcccccCHHHHhcC
Confidence 999999999999999865
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=340.82 Aligned_cols=258 Identities=11% Similarity=0.040 Sum_probs=181.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHH---HHHhcCCCCcccccc-------
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEI---MTAGQIRHRNIVPLL------- 271 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei---~~l~~l~hpnIv~l~------- 271 (531)
...|...+.||+|+||.||+|.+.. +|+.||||++....... ......+.+|+ ..|+. +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVE-RLEDFALKVFTMGAENS-RSELERLHEATFAAARLLG-ESPEEARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEECCSTTH-HHHHHHHHHHHHHHHHHHC-----------CBCCCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECC-CCceeEEEEEEeccccc-ccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeee
Confidence 3458899999999999999998754 78999999998755322 23356677785 45555 799988755
Q ss_pred eeEEeC-----------------CceEEEEeccCCCCHHHHHhhccCCCccCCHHHH------HHHHHHHHHHHHHHHhc
Q 009595 272 AHMVRP-----------------DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLAR------HRIARGIVSGLEYLHMY 328 (531)
Q Consensus 272 ~~~~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~ 328 (531)
+++... ...|+|||||+ |+|.+++... ...+++..+ ..++.||++||.|||
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH-- 211 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQ-- 211 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHH--
Confidence 444332 23799999998 7999999763 223444455 678899999999999
Q ss_pred CCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccC--CCCCchhhHHHHHHHHHH
Q 009595 329 HRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT--LKFSEKCDIYSFGVLLAV 406 (531)
Q Consensus 329 ~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~e 406 (531)
+++|+||||||+|||++.++.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++||
T Consensus 212 -~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 212 -SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp -HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred -HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence 6789999999999999999999999999998764321 13457799999999987 679999999999999999
Q ss_pred HHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 407 LVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 407 lltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
|+||+.||.+........ .........................+.+++.+||+.||.+|||+.+++++
T Consensus 286 lltg~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 286 VWCLFLPFGLVTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp HHHSSCSTTBCCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred HHhCCCCCCCcCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 999999997653211100 00000000000000000011122358889999999999999999998763
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.58 Aligned_cols=262 Identities=21% Similarity=0.272 Sum_probs=205.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCC-cccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHR-NIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp-nIv~l~~~~~~~~~~ 280 (531)
.+.|.+.++||+|+||.||+|.+.. +++.||||++..... ...+..|+.++..+.|+ +|..+..++...+..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~~------~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTK------HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETT-TCCEEEEEEEETTCS------SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECC-CCcEEEEEEeccccc------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 4679999999999999999998653 789999999875443 23467899999999874 555566666777888
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee---CCCCCEEEeecC
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI---DDDMEARIADFG 357 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl---~~~~~vkL~Dfg 357 (531)
++||||+ +++|.+++.. ....+++..++.++.||+.||.||| .++|+||||||+|||+ +.++.+||+|||
T Consensus 79 ~lvme~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 151 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (483)
T ss_dssp EEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCC
Confidence 9999999 8899999974 2456999999999999999999999 6789999999999999 588999999999
Q ss_pred CCccCCCCCccc-----eecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHH
Q 009595 358 LARLMPDGHAQV-----STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN 432 (531)
Q Consensus 358 la~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~ 432 (531)
+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+......
T Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (483)
T 3sv0_A 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (483)
T ss_dssp TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH
T ss_pred cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc
Confidence 998765543211 123567999999999999999999999999999999999999999876443333333222222
Q ss_pred HhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 433 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
..... .. .+.... ...+.+++..||..||.+||++.+|++.|+++
T Consensus 232 ~~~~~-~~-----~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 232 KVATS-IE-----ALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHSC-HH-----HHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccccc-HH-----HHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 21110 00 000111 12478899999999999999999999999775
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=332.63 Aligned_cols=201 Identities=20% Similarity=0.250 Sum_probs=171.3
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CC-----cccccceeEE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HR-----NIVPLLAHMV 275 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp-----nIv~l~~~~~ 275 (531)
.++|.+.+.||+|+||.||+|.... +++.||||++..... ....+..|+.++..++ |+ +|+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRV-EQEWVAIKIIKNKKA-----FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECSSHH-----HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcC-CCcEEEEEEEeccHH-----HHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 4789999999999999999998654 789999999975321 2456777888888774 54 4999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC--CCCCEEE
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID--DDMEARI 353 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~--~~~~vkL 353 (531)
..+..++||||+.+ +|.+++.. .....+++..+..++.|++.||.|||+. ..+|+||||||+|||++ .++.+||
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRN--TNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred cCCceEEEEecCCC-CHHHHHhh--cCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEE
Confidence 99999999999965 99999976 3335689999999999999999999953 46899999999999994 4788999
Q ss_pred eecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDF 417 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~ 417 (531)
+|||++....... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.
T Consensus 203 ~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 203 VDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998764431 2357899999999999999999999999999999999999999764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=326.72 Aligned_cols=254 Identities=22% Similarity=0.395 Sum_probs=192.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe-----
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR----- 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----- 276 (531)
.++|...+.||+|+||.||+|.... +|+.||||++.... .....+.+|+.++++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNAL-DSRYYAIKKIRHTE-----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEEEH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred cccchhhheeccCCcEEEEEEEEcC-CCeEEEEEEEeccH-----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 4678999999999999999998654 78999999996532 225778899999999999999999998865
Q ss_pred --------CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC
Q 009595 277 --------PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD 348 (531)
Q Consensus 277 --------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~ 348 (531)
....++||||+++|+|.+++.. ....+++..++.++.|++.||.||| +.+++||||||+||+++.+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~ 152 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDES 152 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTT
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCC
Confidence 3567999999999999999975 2356788899999999999999999 6789999999999999999
Q ss_pred CCEEEeecCCCccCCCCCc------------cceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Q 009595 349 MEARIADFGLARLMPDGHA------------QVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSD 415 (531)
Q Consensus 349 ~~vkL~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~ 415 (531)
+.+||+|||++........ ........||+.|+|||++.+. .++.++||||||+++|+|++ ||.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS 229 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence 9999999999987643210 1112345689999999998765 68999999999999999998 543
Q ss_pred CcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 416 DFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 416 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. .........+.. .... ..+. ........+.+++.+||+.||.+|||+.+++++
T Consensus 230 ~~---~~~~~~~~~~~~----~~~~--~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 230 TG---MERVNILKKLRS----VSIE--FPPD----FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp SH---HHHHHHHHHHHS----TTCC--CCTT----CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cc---hhHHHHHHhccc----cccc--cCcc----ccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 22 111222222211 1110 1111 111122347889999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=327.44 Aligned_cols=255 Identities=21% Similarity=0.315 Sum_probs=195.3
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC--CCcccccceeEEeCC
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR--HRNIVPLLAHMVRPD 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~ 278 (531)
..+.|.+.+.||+|+||.||+|... +++.||||++....... .....+.+|+.++.+++ ||||+++++++...+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADN--QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC--CCcEEEEEEeccccccc--cchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 3467999999999999999999874 68899999997644322 23677899999999997 599999999999999
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
..++||| +.+++|.+++.. ...+++..+..++.|+++||.||| +.+++||||||+|||+++ +.+||+|||+
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred EEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccc
Confidence 9999999 557799999976 457899999999999999999999 678999999999999964 8999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHH
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-----------LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLV 427 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~ 427 (531)
+................||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ..
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~--- 247 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--IS--- 247 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HH---
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--HH---
Confidence 987755433333344678999999999875 46888999999999999999999999764321 11
Q ss_pred HHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 428 RWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 428 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+........... . .... ...+.+++.+||..||.+|||+.+++++
T Consensus 248 -~~~~~~~~~~~~~-~-----~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 248 -KLHAIIDPNHEIE-F-----PDIP---EKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -HHHHHHCTTSCCC-C-----CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHhcccccC-C-----cccc---hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1122221111110 0 0111 1247889999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=321.95 Aligned_cols=254 Identities=20% Similarity=0.319 Sum_probs=202.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|.+.+.||+|+||.||+|.... +++.||||++........ ....+.+|+.++++++||||+++++++......+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~valK~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAKNK--DTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGBSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcC-CCcEEEEEEecccccchH--HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 4689999999999999999998754 788999999976433211 2567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC---CCEEEeecCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD---MEARIADFGL 358 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~---~~vkL~Dfgl 358 (531)
+||||+++++|.+++.. ...+++..+..++.|++.||.||| ..+++||||||+||+++.+ +.+||+|||+
T Consensus 98 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 99999999999999865 356899999999999999999999 6789999999999999764 4799999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+......... ....||+.|+|||.+.+ .++.++||||||+++|+|++|..||.+... ..+.. .......
T Consensus 171 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~---~~~~~~~ 239 (287)
T 2wei_A 171 STCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----YDILK---RVETGKY 239 (287)
T ss_dssp GGTBCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH---HHHHCCC
T ss_pred ceeecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH----HHHHH---HHHcCCC
Confidence 9876543221 23458999999999876 489999999999999999999999876422 12222 1111111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
... .. ..... ...+.+++.+||..||.+|||+.+++++
T Consensus 240 ~~~-~~--~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 240 AFD-LP--QWRTI----SDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCC-SG--GGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCC-ch--hhhhc----CHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 110 00 00111 2347889999999999999999999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=341.04 Aligned_cols=271 Identities=21% Similarity=0.246 Sum_probs=184.9
Q ss_pred ccccc-cccccccceeEEEEEeeeC-CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe--CC
Q 009595 203 DCSAS-LEKIRSRASGEIYIAELPE-SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR--PD 278 (531)
Q Consensus 203 ~~~~~-~~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~ 278 (531)
+.|.. .++||+|+||.||+|.+.. .+++.||||++..... ...+.+|+.+|++++||||+++++++.. ..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 34554 4589999999999998642 3578899999975433 2357789999999999999999999965 66
Q ss_pred ceEEEEeccCCCCHHHHHhhccC-----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee----CCCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQ-----GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI----DDDM 349 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl----~~~~ 349 (531)
..++||||+.+ +|.+++..... ....+++..+..++.||+.||.||| ..+|+||||||+|||+ +.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCC
Confidence 88999999975 89888864221 1235899999999999999999999 6789999999999999 6778
Q ss_pred CEEEeecCCCccCCCCCc-cceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccch------
Q 009595 350 EARIADFGLARLMPDGHA-QVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHT------ 421 (531)
Q Consensus 350 ~vkL~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~------ 421 (531)
.+||+|||++..+..... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 999999999987654321 1222346799999999998874 58999999999999999999999996532210
Q ss_pred hhhHHHHHHHHHhccCCCCccccccccC---------------C-CcHH--------HHHHHHHHHHHcccCCCCCCCCH
Q 009595 422 EEKSLVRWMRNVMTSENPNRAIDSKLLG---------------N-GYEE--------QMLLVLKIACFCTLDDPEERPNS 477 (531)
Q Consensus 422 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~---------------~-~~~~--------~~~~l~~li~~cl~~dP~~RPs~ 477 (531)
....+...+ .....+............ . .... ....+.+|+.+||+.||.+|||+
T Consensus 250 ~~~~l~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 250 HHDQLDRIF-NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CHHHHHHHH-HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred hHHHHHHHH-HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 011222221 222111111100000000 0 0000 02347889999999999999999
Q ss_pred HHHHHHh
Q 009595 478 KDVRSML 484 (531)
Q Consensus 478 ~evl~~L 484 (531)
.++++|-
T Consensus 329 ~e~L~hp 335 (405)
T 3rgf_A 329 EQAMQDP 335 (405)
T ss_dssp HHHHTSG
T ss_pred HHHhcCh
Confidence 9999853
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=327.96 Aligned_cols=266 Identities=20% Similarity=0.315 Sum_probs=194.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEE------
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMV------ 275 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~------ 275 (531)
.++|...+.||+|+||.||+|.... +|+.||||++...... ..+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDND-CDKRVAIKKIVLTDPQ----SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETT-TTEEEEEEEEECCSHH----HHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CCceeEEEEeccCCCeEEEEEEECC-CCeEEEEEEEecCChH----HHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 4789999999999999999998754 6899999999764432 2577889999999999999999999873
Q ss_pred --------eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC-
Q 009595 276 --------RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID- 346 (531)
Q Consensus 276 --------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~- 346 (531)
.....++||||++ |+|.+++.. ..+++..+..++.|++.||.||| +.+++||||||+||+++
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINT 155 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEET
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcC
Confidence 3467799999997 599999863 56899999999999999999999 67899999999999997
Q ss_pred CCCCEEEeecCCCccCCCCCc-cceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhh
Q 009595 347 DDMEARIADFGLARLMPDGHA-QVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK 424 (531)
Q Consensus 347 ~~~~vkL~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~ 424 (531)
.++.+||+|||++........ ........||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.....
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--- 232 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE--- 232 (320)
T ss_dssp TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---
Confidence 567999999999987643211 111233567999999998765 678999999999999999999999997653211
Q ss_pred HHHHHHHHHhc--------------------cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH-
Q 009595 425 SLVRWMRNVMT--------------------SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM- 483 (531)
Q Consensus 425 ~l~~~~~~~~~--------------------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~- 483 (531)
.+...+..... ...+.... ...... ....+.+++.+||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 233 QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL-TQLLPG----ISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCH-HHHSTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCCh-hHhcch----hhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 11111111000 00000000 000011 12348889999999999999999999874
Q ss_pred -hccCcC
Q 009595 484 -LSDTAL 489 (531)
Q Consensus 484 -L~~~~~ 489 (531)
+.....
T Consensus 308 ~~~~~~~ 314 (320)
T 2i6l_A 308 YMSIYSF 314 (320)
T ss_dssp HHHTTCC
T ss_pred ccccccC
Confidence 454443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=332.55 Aligned_cols=264 Identities=20% Similarity=0.297 Sum_probs=204.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhh-------------HHHHHHHHHHHHHhcCCCCccc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLN-------------IKMRQVRAEIMTAGQIRHRNIV 268 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~-------------~~~~~~~~Ei~~l~~l~hpnIv 268 (531)
.++|...+.||+|+||.||+|.. +|+.||||.+......... .....+.+|+.++++++||||+
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 47899999999999999999987 7999999999753221100 0126788999999999999999
Q ss_pred ccceeEEeCCceEEEEeccCCCCHHHH------HhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCC
Q 009595 269 PLLAHMVRPDCHLLVSEFMKNGSLLEI------LNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSS 342 (531)
Q Consensus 269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 342 (531)
++++++...+..++||||+++|+|.++ +.. .....+++..+..++.|++.||.|||+ ..|++||||||+|
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~N 182 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSN 182 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGG
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHh
Confidence 999999999999999999999999998 432 225679999999999999999999993 2789999999999
Q ss_pred eeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCcccc
Q 009595 343 VLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSE-KCDIYSFGVLLAVLVMGKLPSDDFFQH 420 (531)
Q Consensus 343 ILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~elltg~~P~~~~~~~ 420 (531)
|+++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|+.||......
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999999876443 22446789999999999887 6666 999999999999999999999764321
Q ss_pred hhhhHHHHHHHHHhccCCCCccccc-----cccC----CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 421 TEEKSLVRWMRNVMTSENPNRAIDS-----KLLG----NGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 421 ~~~~~l~~~~~~~~~~~~~~~~~d~-----~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..+...+. . +......+. .... .........+.+++.+||+.||.+|||+.+++++
T Consensus 259 ---~~~~~~i~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 ---VELFNNIR---T-KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ---HHHHHHHT---S-CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHHHh---c-cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22222211 1 111111000 0000 0001122357889999999999999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=330.47 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=198.3
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..++|...+.||+|+||.||+|.+. + .||+|.+........ ..+.+.+|+.++++++||||+++++++...+..
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~---~-~~avk~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWH---G-EVAIRLIDIERDNED--QLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEES---S-SEEEEECCCCSCCCC--CCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEc---C-eEEEEEeecCCCCHH--HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 3578899999999999999999873 2 499999975432211 134567899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||+++ ++.+||+|||++.
T Consensus 105 ~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred EEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 999999999999999964 2346899999999999999999999 67899999999999998 6799999999987
Q ss_pred cCCCCC---ccceecccccCccccCcccccC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHH
Q 009595 361 LMPDGH---AQVSTSIVAGTVGYIAPEYHQT---------LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR 428 (531)
Q Consensus 361 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~ 428 (531)
...... .........||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .....
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~ 253 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIW 253 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH----HHHHH
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHH
Confidence 653221 1112233568999999999864 3578999999999999999999999976422 12221
Q ss_pred HHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCCC
Q 009595 429 WMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIK 491 (531)
Q Consensus 429 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 491 (531)
.+. ....+. ...... + ..+.+++.+||..||.+|||+.++++.|+.+....
T Consensus 254 ~~~---~~~~~~-~~~~~~-~-------~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 254 QMG---TGMKPN-LSQIGM-G-------KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHH---TTCCCC-CCCSSC-C-------TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred Hhc---cCCCCC-CCcCCC-C-------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 111111 111111 1 13788999999999999999999999999986543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.61 Aligned_cols=263 Identities=19% Similarity=0.279 Sum_probs=199.5
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-----------CCccccc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-----------HRNIVPL 270 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------hpnIv~l 270 (531)
.++|.+.+.||+|+||.||+|.... +++.||||++..... ....+.+|+.++.+++ ||||+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIVRGDKV-----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSCHH-----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC-CCcEEEEEEecCCcc-----chhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 4689999999999999999998654 789999999975321 2456778999998886 8999999
Q ss_pred ceeEEeCC----ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeeccCCCCeee
Q 009595 271 LAHMVRPD----CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRP-RIIHRNITPSSVLI 345 (531)
Q Consensus 271 ~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NILl 345 (531)
++++...+ ..++||||+ +++|.+++.. .....+++..+..++.||+.||.||| ++ +|+||||||+|||+
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll 165 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLM 165 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEE
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHH--hhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEE
Confidence 99988654 789999999 8899999976 33456899999999999999999999 55 89999999999999
Q ss_pred C------CCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 009595 346 D------DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQ 419 (531)
Q Consensus 346 ~------~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~ 419 (531)
+ ..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 166 ~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 240 (373)
T 1q8y_A 166 EIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240 (373)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 4 4458999999999876443 1235689999999999999999999999999999999999999975432
Q ss_pred ch---hhhHHHHHHHHHhccCCCCc-------------------cccc----------cccCCCcHHHHHHHHHHHHHcc
Q 009595 420 HT---EEKSLVRWMRNVMTSENPNR-------------------AIDS----------KLLGNGYEEQMLLVLKIACFCT 467 (531)
Q Consensus 420 ~~---~~~~l~~~~~~~~~~~~~~~-------------------~~d~----------~l~~~~~~~~~~~l~~li~~cl 467 (531)
.. ....+...+ ..... .+.. .+.. .............+.+++.+||
T Consensus 241 ~~~~~~~~~~~~~~-~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 318 (373)
T 1q8y_A 241 HSYTKDDDHIAQII-ELLGE-LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318 (373)
T ss_dssp ----CHHHHHHHHH-HHHCS-CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred cccCChHHHHHHHH-HhcCC-CCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence 11 111111111 11111 0000 0000 0001123455667899999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 009595 468 LDDPEERPNSKDVRSM 483 (531)
Q Consensus 468 ~~dP~~RPs~~evl~~ 483 (531)
+.||.+|||+.+++++
T Consensus 319 ~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 319 QLDPRKRADAGGLVNH 334 (373)
T ss_dssp CSSTTTCBCHHHHHTC
T ss_pred ccCccccCCHHHHhhC
Confidence 9999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=357.24 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=204.0
Q ss_pred hcccccccccccccceeEEEEEeeeC--CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPE--SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
..+.|...+.||+|+||.||+|.+.. ..+..||||.+...... ...+.+.+|+.++++++||||+++++++. .+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD---SVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 34678889999999999999998753 23567999998754322 23577899999999999999999999885 46
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
..++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCC
Confidence 78999999999999999975 2346899999999999999999999 67899999999999999999999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
+......... ......||+.|+|||++.+..++.++||||||+++|||++ |..||.+... ......+.. ..
T Consensus 538 a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----~~~~~~i~~---~~ 609 (656)
T 2j0j_A 538 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIEN---GE 609 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHH---TC
T ss_pred CeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHc---CC
Confidence 9877554322 2233557889999999998899999999999999999997 9999876432 222222221 11
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.+.. . ... ...+.+++.+||..||.+|||+.++++.|+.+.
T Consensus 610 ~~~~--~----~~~----~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 610 RLPM--P----PNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CCCC--C----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC--C----ccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1110 0 111 124788999999999999999999999998763
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=327.28 Aligned_cols=261 Identities=16% Similarity=0.242 Sum_probs=201.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCc------ccccceeEE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN------IVPLLAHMV 275 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn------Iv~l~~~~~ 275 (531)
.++|.+.+.||+|+||.||+|.....+++.||||++..... ....+..|+.+++.++|+| ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK-----YREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH-----HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc-----chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 47899999999999999999987654558999999975321 2566778999999887666 899999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee----------
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI---------- 345 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl---------- 345 (531)
..+..++||||+ +++|.+++.. .....+++..+..++.||+.||.||| +.+|+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred eCCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccc
Confidence 999999999999 6688888865 33356899999999999999999999 7889999999999999
Q ss_pred ---------CCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 009595 346 ---------DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDD 416 (531)
Q Consensus 346 ---------~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~ 416 (531)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 567899999999998654332 335789999999999999999999999999999999999999976
Q ss_pred cccchhhhHHHHHHHHHhccCCCCccc----------ccc---------------------ccCCCcHHHHHHHHHHHHH
Q 009595 417 FFQHTEEKSLVRWMRNVMTSENPNRAI----------DSK---------------------LLGNGYEEQMLLVLKIACF 465 (531)
Q Consensus 417 ~~~~~~~~~l~~~~~~~~~~~~~~~~~----------d~~---------------------l~~~~~~~~~~~l~~li~~ 465 (531)
... ......+...... .+.... ... ............+.+++.+
T Consensus 242 ~~~----~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 316 (355)
T 2eu9_A 242 HEN----REHLVMMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR 316 (355)
T ss_dssp SSH----HHHHHHHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred CCH----HHHHHHHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH
Confidence 432 1111222221111 010000 000 0001112234468899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 009595 466 CTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 466 cl~~dP~~RPs~~evl~~ 483 (531)
||+.||.+|||+.+++++
T Consensus 317 ~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 317 MLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HTCSSTTTSCCHHHHTTS
T ss_pred HhcCChhhCcCHHHHhcC
Confidence 999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=327.70 Aligned_cols=259 Identities=21% Similarity=0.332 Sum_probs=180.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHH-HHhcCCCCcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIM-TAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
.++|...+.||+|+||.||+|.... +|+.||||++....... ....+..|+. +++.++||||+++++++...+..
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKP-SGQIMAVKRIRSTVDEK---EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETT-TTEEEEEEEEECCCCHH---HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcC-CCCEEEEEEeecccCch---HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 4778899999999999999998754 78999999998654322 1344555665 77888999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 281 LLVSEFMKNGSLLEILNDVS-QGRRELEWLARHRIARGIVSGLEYLHMYHRP-RIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
++||||+++ +|.+++.... .....+++..+..++.|++.||.||| .. +++||||||+||+++.++.+||+|||+
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 999999986 8888876422 23467899999999999999999999 55 899999999999999999999999999
Q ss_pred CccCCCCCccceecccccCccccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYH----QTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
+........ .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||.+... ....+....
T Consensus 173 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~ 243 (327)
T 3aln_A 173 SGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS------VFDQLTQVV 243 (327)
T ss_dssp SCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCC
T ss_pred ceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch------HHHHHHHHh
Confidence 987654322 1234689999999998 456789999999999999999999999975421 011111111
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
....+. +...........+.+++.+||..||.+|||+.+++++
T Consensus 244 ~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 244 KGDPPQ------LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CSCCCC------CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCC------CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 111111 0010011112347889999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=322.91 Aligned_cols=257 Identities=19% Similarity=0.303 Sum_probs=182.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
..++|...+.||+|+||.||+|.... +|+.||||++....... ...+.+..+..+++.++||||+++++++...+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRK-TGHVIAVKQMRRSGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETT-TCCEEEEEEEETTSCHH--HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhccccccceeeecCCeeEEEEEEec-CCeEEEEEEecccccch--HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 34788999999999999999998754 78899999998654332 2234455556678888999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++||||+ ++.+..+... ....+++..+..++.|++.||.|||+. .+++||||||+||+++.++.+||+|||++.
T Consensus 100 ~lv~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISG 173 (318)
T ss_dssp EEEECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred EEEEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence 9999999 5566665543 235689999999999999999999941 389999999999999999999999999998
Q ss_pred cCCCCCccceecccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQ-----TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
....... .....||+.|+|||++. ...++.++||||||+++|+|++|+.||..... .... +.....
T Consensus 174 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~---~~~~~~ 244 (318)
T 2dyl_A 174 RLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT---DFEV---LTKVLQ 244 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS---HHHH---HHHHHH
T ss_pred hccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc---cHHH---HHHHhc
Confidence 7654322 22356899999999984 45688999999999999999999999975322 1111 222222
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+...... .. ...+.+++.+||+.||.+|||+.+++++
T Consensus 245 ~~~~~~~~~~----~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 245 EEPPLLPGHM----GF----SGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp SCCCCCCSSS----CC----CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cCCCCCCccC----CC----CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2221111000 11 1247889999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=326.77 Aligned_cols=254 Identities=20% Similarity=0.285 Sum_probs=171.8
Q ss_pred cccccccc-cccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe----
Q 009595 202 EDCSASLE-KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR---- 276 (531)
Q Consensus 202 ~~~~~~~~-~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~---- 276 (531)
.++|.+.+ .||+|+||.||+|.... +|+.||||++..... ........+..+.||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~--------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRR-TGQKCALKLLYDSPK--------ARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEESSHH--------HHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cceeEecceeeeeCCCeEEEEEEECC-CCCEEEEEEecCcHH--------HHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 46788755 69999999999998764 789999999975321 11222334566799999999999876
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC---CCCEEE
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD---DMEARI 353 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkL 353 (531)
....++||||+++|+|.+++.. .....+++..++.++.|++.||.||| .++++||||||+|||++. ++.+||
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred CceEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEE
Confidence 4458999999999999999975 33457999999999999999999999 678999999999999976 455999
Q ss_pred eecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...............+..
T Consensus 173 ~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 247 (336)
T 3fhr_A 173 TDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL- 247 (336)
T ss_dssp CCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred eccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-
Confidence 9999998665432 22356899999999998888999999999999999999999998654322111111111110
Q ss_pred hccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 434 MTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 434 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.... ... ..+......+.+++.+||..||.+|||+.+++++
T Consensus 248 ---~~~~--~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 248 ---GQYG--FPN----PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ------C--CCT----TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---cccc--cCc----hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 000 0011112347889999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=339.37 Aligned_cols=255 Identities=20% Similarity=0.301 Sum_probs=185.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~ 281 (531)
+.|...+.||+|+||+||.+... +|+.||||++.... ...+.+|+.++.++ +||||+++++++......|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~--~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEES--SSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEE--CCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 44556788999999999765432 78999999997532 34567899999876 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCcc---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC----------
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRE---LEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD---------- 348 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~---------- 348 (531)
+|||||. |+|.+++......... .++..+..++.||+.||.||| +.+|+||||||+|||++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccC
Confidence 9999996 5999999753221111 123345679999999999999 6789999999999999654
Q ss_pred ---CCEEEeecCCCccCCCCCccc--eecccccCccccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 009595 349 ---MEARIADFGLARLMPDGHAQV--STSIVAGTVGYIAPEYHQT-------LKFSEKCDIYSFGVLLAVLVM-GKLPSD 415 (531)
Q Consensus 349 ---~~vkL~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~P~~ 415 (531)
+.+||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 489999999999876543221 1234679999999999875 568999999999999999999 999997
Q ss_pred CcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 416 DFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 416 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+..... ...+......... ...........+.+++.+||+.||.+|||+.+++++
T Consensus 242 ~~~~~~-----~~i~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 242 DKYSRE-----SNIIRGIFSLDEM--------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp STTTHH-----HHHHHTCCCCCCC--------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CchhhH-----HHHhcCCCCcccc--------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 543211 1111111111111 011223445568899999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=321.87 Aligned_cols=246 Identities=20% Similarity=0.320 Sum_probs=197.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhh--HHHHHHHHHHHHHhcCC--CCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLN--IKMRQVRAEIMTAGQIR--HRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~ 277 (531)
.++|...+.||+|+||.||+|.... +++.||||++......... .....+..|+.++++++ ||||+++++++...
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETT-TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 4779999999999999999998654 7899999999764321100 01234567999999996 59999999999999
Q ss_pred CceEEEEeccCC-CCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC-CCCCEEEee
Q 009595 278 DCHLLVSEFMKN-GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID-DDMEARIAD 355 (531)
Q Consensus 278 ~~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~-~~~~vkL~D 355 (531)
+..++|||++.+ ++|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+|||++ .++.+||+|
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred CcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 999999999976 899999975 457899999999999999999999 67899999999999999 778999999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKF-SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .. .
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~---~---- 256 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EI---I---- 256 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH---H----
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hh---h----
Confidence 99998765432 223568999999999887765 688999999999999999999986531 11 0
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
... .. .. ... ...+.+++.+||+.||.+|||+.+++++
T Consensus 257 ~~~-~~--~~-----~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 RGQ-VF--FR-----QRV---SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HCC-CC--CS-----SCC---CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccc-cc--cc-----ccC---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 00 00 111 1247889999999999999999999884
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=319.32 Aligned_cols=246 Identities=18% Similarity=0.255 Sum_probs=190.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhh--HHHHHHHHHHHHHhcC----CCCcccccceeEE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLN--IKMRQVRAEIMTAGQI----RHRNIVPLLAHMV 275 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~Ei~~l~~l----~hpnIv~l~~~~~ 275 (531)
.++|...+.||+|+||.||+|.... +++.||||++......... .....+..|+.++.++ +||||+++++++.
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLT-DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTT-TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhceEEeeEEEcCCCEEEEEEEEcc-CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 5779999999999999999997654 7889999999754322100 1133456788888888 8999999999999
Q ss_pred eCCceEEEEec-cCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC-CCCCEEE
Q 009595 276 RPDCHLLVSEF-MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID-DDMEARI 353 (531)
Q Consensus 276 ~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~-~~~~vkL 353 (531)
..+..++|||| +.+++|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++ .++.+||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence 99999999999 789999999976 356899999999999999999999 67899999999999999 8899999
Q ss_pred eecCCCccCCCCCccceecccccCccccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHH
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFS-EKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN 432 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~ 432 (531)
+|||++....... .....||+.|+|||++.+..+. .++||||||+++|+|++|+.||.... .+. .
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~---~- 247 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EIL---E- 247 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH---H-
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHh---h-
Confidence 9999998765432 2335689999999998877664 58999999999999999999986531 110 0
Q ss_pred HhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 433 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. .. +. ... ...+.+++.+||+.||.+|||+.+++++
T Consensus 248 ---~~-~~--~~----~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 ---AE-LH--FP----AHV----SPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---TC-CC--CC----TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---hc-cC--Cc----ccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 00 111 1247889999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=330.26 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=185.0
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCc
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 279 (531)
....|...+.||+|+||+||.... .+|+.||||++...... .+.+|+.+++.+ +||||+++++++.+...
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~--~~~~~vAvK~~~~~~~~-------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGM--FDNRDVAVKRILPECFS-------FADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEE--SSSSEEEEEEECTTTEE-------ECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred ccEEEecCCeeecCcCEEEEEEEE--eCCeEEEEEEECHHHHH-------HHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 445788999999999999654322 27899999999754322 245799999999 89999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC-----CCCEEEe
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD-----DMEARIA 354 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-----~~~vkL~ 354 (531)
.|+|||||. |+|.+++... ....+...+..++.||+.||.||| +.+|+||||||+|||++. ...+||+
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred EEEEEECCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 999999996 4999999752 233444456789999999999999 678999999999999953 3368899
Q ss_pred ecCCCccCCCCCcc-ceecccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHH
Q 009595 355 DFGLARLMPDGHAQ-VSTSIVAGTVGYIAPEYHQ---TLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRW 429 (531)
Q Consensus 355 Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~ 429 (531)
|||++......... .......||+.|+|||++. ...++.++|||||||++|||+| |..||...... ..
T Consensus 166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~~--- 238 (432)
T 3p23_A 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----QA--- 238 (432)
T ss_dssp CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----HH---
T ss_pred cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----HH---
Confidence 99999877543221 2223467999999999997 4567889999999999999999 99998653221 11
Q ss_pred HHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 430 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
....... ......+ .......+.+++.+||+.||.+|||+.++++|
T Consensus 239 -~~~~~~~-~~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 239 -NILLGAC-SLDCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -HHHTTCC-CCTTSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -HHHhccC-CccccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1111111 1111111 11223347789999999999999999999964
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.29 Aligned_cols=261 Identities=22% Similarity=0.253 Sum_probs=196.1
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe------
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR------ 276 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------ 276 (531)
++|.+.+.||+|+||.||+|.... +|+.||||++...... .....+.+|+.++++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~-tg~~VAVKvi~~~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQD-TGEQVAIKQCRQELSP---KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTT-TTCCEEECCCCSCCCH---HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEecccCCH---HHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 678999999999999999998654 7899999998764322 235778899999999999999999998755
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCC---EEE
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME---ARI 353 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~---vkL 353 (531)
.+..++||||+++|+|.+++.... ....+++..+..++.|++.||.||| ..|++||||||+||+++.++. +||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEE
Confidence 667899999999999999997522 2236888899999999999999999 678999999999999987765 999
Q ss_pred eecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...|....
T Consensus 166 ~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~------~~~~~~~i 236 (676)
T 3qa8_A 166 IDLGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ------PVQWHGKV 236 (676)
T ss_dssp CSCCCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH------HHHSSTTC
T ss_pred ccccccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc------hhhhhhhh
Confidence 999999877554322 346799999999999999999999999999999999999999965321 01111000
Q ss_pred hcc------------CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 009595 434 MTS------------ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480 (531)
Q Consensus 434 ~~~------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 480 (531)
... +.....................+.+++..||..||.+|||+.++
T Consensus 237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000 00000000000111223344568889999999999999999874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=306.51 Aligned_cols=232 Identities=19% Similarity=0.299 Sum_probs=176.7
Q ss_pred cccccc-ccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHH-hcCCCCcccccceeEEe----
Q 009595 203 DCSASL-EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTA-GQIRHRNIVPLLAHMVR---- 276 (531)
Q Consensus 203 ~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l-~~l~hpnIv~l~~~~~~---- 276 (531)
+.|... +.||+|+||.||+|.... +++.||+|++... ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKR-TQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cchhhcCcccccCCCeEEEEEEEcC-CCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 566666 779999999999998754 7899999999742 3455788887 55699999999999876
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC---CCCEEE
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD---DMEARI 353 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkL 353 (531)
....++||||+++|+|.+++.. .....+++..+..++.|++.||.||| +.+++||||||+||+++. ++.+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl 161 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKL 161 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred CceEEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEE
Confidence 6678999999999999999986 33457999999999999999999999 678999999999999998 789999
Q ss_pred eecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
+|||++.... +..++.++|||||||++|+|++|+.||.+......... +...
T Consensus 162 ~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~----~~~~ 213 (299)
T 3m2w_A 162 TDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----MKTR 213 (299)
T ss_dssp CCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC----SCCS
T ss_pred eccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH----HHHH
Confidence 9999976432 13467899999999999999999999965422110000 0000
Q ss_pred hccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 434 MTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 434 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...... ....... ......+.+++.+||+.||.+|||+.+++++
T Consensus 214 ~~~~~~--~~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 214 IRMGQY--EFPNPEW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCTTCC--SSCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Hhhccc--cCCchhc----ccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 0000000 1112358889999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=342.92 Aligned_cols=240 Identities=19% Similarity=0.256 Sum_probs=192.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc--
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC-- 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-- 279 (531)
.++|.+.+.||+|+||.||+|.+...+|+.||||++...... .....+.+|+.++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA---EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH---HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH---HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 378999999999999999999886557899999998753322 225678899999999999999999999987665
Q ss_pred ---eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 280 ---HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 280 ---~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
.|+||||++|++|.+++. ..+++..+..++.||++||.||| ++||+||||||+|||++.+ .+||+||
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp CEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCC
T ss_pred CceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEec
Confidence 699999999999998774 26899999999999999999999 6789999999999999986 9999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
|++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.....
T Consensus 226 G~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------- 283 (681)
T 2pzi_A 226 GAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------- 283 (681)
T ss_dssp TTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------
T ss_pred ccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc---------------
Confidence 999876543 335699999999998765 4899999999999999999998876532210
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHhc
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-SKDVRSMLS 485 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~ 485 (531)
.+. ..........+.+++.+||+.||.+||+ +.++.+.|.
T Consensus 284 -~~~--------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 284 -LPE--------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp -CCT--------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -ccc--------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 000 0001112245788999999999999996 455555443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=301.80 Aligned_cols=236 Identities=13% Similarity=0.125 Sum_probs=182.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.+.||+|+||.||+|.... +|+.||||++....... ......+.+|+.++.+++||||+++++++...+..|+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTA-LDRQVALTFVDPQGVLP-DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETT-TTEEEEEEESCTTCCSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecC-CCceEEEEEECcccccC-HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 679999999999999999998753 68999999998654322 2235778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||++|++|.+++.. . .....+..++.|++.||.||| ++||+||||||+|||++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999999953 2 344567889999999999999 6789999999999999999999998443
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
|++ .++.++|||||||++|||+||+.||.+........... .... ...
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~----~~~ 222 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----RDTA----GQP 222 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----BCTT----SCB
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----HHhc----cCC
Confidence 333 36889999999999999999999997643211000000 0000 000
Q ss_pred ccc-cccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCCC
Q 009595 443 IDS-KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIK 491 (531)
Q Consensus 443 ~d~-~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 491 (531)
..+ ..... ....+.+++.+||+.||.+| |+.++++.|.++....
T Consensus 223 ~~~~~~~~~----~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 223 IEPADIDRD----IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CCHHHHCTT----SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CChhhcccC----CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 000 00111 12347889999999999999 9999999998875543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=319.51 Aligned_cols=248 Identities=13% Similarity=0.104 Sum_probs=182.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCC-Ccccccc---------
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH-RNIVPLL--------- 271 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~--------- 271 (531)
...|...+.||+|+||.||+|.+.. +|+.||||++....... ....+.+.+|+.++..+.| +|+....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~~~~~~~~~-~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQE-TGESFEVHVPYFTERPP-SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred ceeEEEecccccCCCEEEEEEEecC-CCCceEEEEEecCCCcc-HHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 3457778899999999999998754 78999999987433222 1225678899999999977 3221111
Q ss_pred ------------eeEEe-----CCceEEEEeccCCCCHHHHHhhc---cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 009595 272 ------------AHMVR-----PDCHLLVSEFMKNGSLLEILNDV---SQGRRELEWLARHRIARGIVSGLEYLHMYHRP 331 (531)
Q Consensus 272 ------------~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 331 (531)
.++.. ...++++|+++ +++|.+++... ......+++..+..++.|+++||.||| ++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~ 230 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HY 230 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 11111 22457778876 56999998532 233566888999999999999999999 67
Q ss_pred CeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccc----------cCCCCCchhhHHHHH
Q 009595 332 RIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH----------QTLKFSEKCDIYSFG 401 (531)
Q Consensus 332 ~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlG 401 (531)
+|+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++||||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 8999999999999999999999999998865432 234577 999999998 555688999999999
Q ss_pred HHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 009595 402 VLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVR 481 (531)
Q Consensus 402 vil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 481 (531)
|++|||+||+.||........... ... .. ... ...+.+++.+||+.||.+|||+.+++
T Consensus 305 vil~elltg~~Pf~~~~~~~~~~~-------~~~-~~----------~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGGSEW-------IFR-SC----------KNI----PQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSCSGG-------GGS-SC----------CCC----CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHHHCCCCCCCcchhhhHHH-------HHh-hc----------ccC----CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999999976432111100 000 00 011 13488899999999999999987776
Q ss_pred HH
Q 009595 482 SM 483 (531)
Q Consensus 482 ~~ 483 (531)
++
T Consensus 363 ~~ 364 (413)
T 3dzo_A 363 ET 364 (413)
T ss_dssp TS
T ss_pred hC
Confidence 53
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.20 Aligned_cols=249 Identities=16% Similarity=0.130 Sum_probs=182.4
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch----hhhHHHHHHHHHHHHHhcCC---------CCccc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS----LLNIKMRQVRAEIMTAGQIR---------HRNIV 268 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~Ei~~l~~l~---------hpnIv 268 (531)
.++|...+.||+|+||+||+|.. +|+.||||++...... ......+.+.+|+.+++.++ ||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 46788999999999999999987 6899999999865321 01111466778888888875 55554
Q ss_pred -----------------ccceeEEe-------------CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHH
Q 009595 269 -----------------PLLAHMVR-------------PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGI 318 (531)
Q Consensus 269 -----------------~l~~~~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i 318 (531)
++++++.. ....|+|||||++|++.+.+.. ..+++..+..++.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQL 170 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHH
Confidence 44544443 6789999999999987776642 568999999999999
Q ss_pred HHHHHHHHhcCCCCeEeeccCCCCeeeCCCC--------------------CEEEeecCCCccCCCCCccceecccccCc
Q 009595 319 VSGLEYLHMYHRPRIIHRNITPSSVLIDDDM--------------------EARIADFGLARLMPDGHAQVSTSIVAGTV 378 (531)
Q Consensus 319 a~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~--------------------~vkL~Dfgla~~~~~~~~~~~~~~~~gt~ 378 (531)
+.||.|||+ +.+|+||||||+|||++.++ .+||+|||+++..... ..+||+
T Consensus 171 ~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~ 241 (336)
T 2vuw_A 171 TASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD 241 (336)
T ss_dssp HHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred HHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence 999999992 24699999999999999887 8999999999876432 247999
Q ss_pred cccCcccccCCCCCchhhHHHHHHH-HHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHH
Q 009595 379 GYIAPEYHQTLKFSEKCDIYSFGVL-LAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQML 457 (531)
Q Consensus 379 ~y~aPE~~~~~~~~~~~DvwSlGvi-l~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 457 (531)
.|+|||++.+.. +.++||||+|++ .+++++|..||.+... ...+.+. ........... ..........
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~---~~~~~~~---~~~~~~~~~~~----~~~~~~~~s~ 310 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW---LHYLTDK---MLKQMTFKTKC----NTPAMKQIKR 310 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH---HHHHHHH---HHHTCCCSSCC----CSHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh---hhHHHHh---hhhhhccCccc----chhhhhhcCH
Confidence 999999998766 899999998777 7788999999743210 0111111 11111111000 0112334556
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHH-HH
Q 009595 458 LVLKIACFCTLDDPEERPNSKDVR-SM 483 (531)
Q Consensus 458 ~l~~li~~cl~~dP~~RPs~~evl-~~ 483 (531)
.+.+++.+||+.| |+.+++ +|
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHHhccC-----CHHHHHhcC
Confidence 7899999999976 999888 54
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=279.29 Aligned_cols=190 Identities=17% Similarity=0.062 Sum_probs=132.5
Q ss_pred cccccceeEEEEEeeeCCCCeEEEEEEEeccCc------hhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCceEE
Q 009595 210 KIRSRASGEIYIAELPESNGKMIAIKKVKQVDN------SLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 210 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l 282 (531)
..+.|+.|.+..+... ..|+.|+||.+..... ...+...+.|.+|+.+|+++ .|+||+++++++.++...||
T Consensus 241 ~~~~~~~~~h~~~rr~-~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRY-FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp C-C--------CCEEE-EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred ccccCCcccccccccc-cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3556666655544322 2688899999975421 22334467899999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||++|++|.++|.. ..+++.. .|+.||++||.||| ++|||||||||+|||++.+|++||+|||+++..
T Consensus 320 VMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999999975 4556654 58999999999999 788999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P 413 (531)
...... ....+||+.|||||++.+ .+...+|+||+|++++++.++..|
T Consensus 390 ~~~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 554322 234689999999999876 467789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=255.81 Aligned_cols=189 Identities=17% Similarity=0.139 Sum_probs=149.8
Q ss_pred ccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch----hhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS----LLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 207 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
..+.||+|+||.||+|.. .+..+++|........ ......+++.+|+.++++++||||+++..++...+..|+
T Consensus 340 ~~~~LG~G~fg~Vy~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY---LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp --------CCEEEEEEEC---SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCEEeeCCCEEEEEEEE---CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 456899999999999965 6788999987543221 122235668999999999999999988887788888999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. +..++.|+++||.||| +++|+||||||+|||++. ++||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999963 4579999999999999 678999999999999999 9999999999987
Q ss_pred CCCCccc-----eecccccCccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009595 363 PDGHAQV-----STSIVAGTVGYIAPEYHQT--LKFSEKCDIYSFGVLLAVLVMGKLPSD 415 (531)
Q Consensus 363 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~P~~ 415 (531)
....... ......||+.|||||++.. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 6542211 1235679999999999987 568888999999999998888877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-23 Score=205.41 Aligned_cols=152 Identities=12% Similarity=0.095 Sum_probs=119.5
Q ss_pred hhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhh--------------hHHHHHHHHHHHHHhcCCCC
Q 009595 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLL--------------NIKMRQVRAEIMTAGQIRHR 265 (531)
Q Consensus 200 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--------------~~~~~~~~~Ei~~l~~l~hp 265 (531)
.....|...+.||+|+||.||+|.+ .+|+.||||.++....... ......+.+|+.++++++
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred hCCeEEEecCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3455677889999999999999987 3799999999964322110 012567889999999999
Q ss_pred cccccceeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeee
Q 009595 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLI 345 (531)
Q Consensus 266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl 345 (531)
| +++++++.. +..|+||||++||+|.+ +.. .....++.|++.||.||| +.|++||||||+|||+
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl 226 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLV 226 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEE
Confidence 5 777775544 56799999999999988 421 123469999999999999 7789999999999999
Q ss_pred CCCCCEEEeecCCCccCCCCCccceecccccCccccCccccc
Q 009595 346 DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387 (531)
Q Consensus 346 ~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 387 (531)
+ ++.+||+|||++.. +..++|||++.
T Consensus 227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9 99999999999763 34578888764
|
| >3qfl_A MLA10; coiled-coil, (CC) domain, NLRS, nucleotide-binding domain, L rich repeat containing receptors, protein binding; 2.00A {Hordeum vulgare} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.1e-21 Score=160.90 Aligned_cols=81 Identities=16% Similarity=0.274 Sum_probs=77.2
Q ss_pred HHHHHHHHHHHHHHHHHHHhHhchHHHHHHHHHHHHHHHHHHHHHhhh--hcCchHHHHHHHHHHHHHhchhhhhhHHHH
Q 009595 25 ENIETILKKLTKDWLGQFARDAQIQADLIGWKKMMAKINKVLDDAIEK--QTKEESVKIWLGKLQHLACDVDFLLDEFQT 102 (531)
Q Consensus 25 ~~~~~~~~kl~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~a~~~--~~~~~~~~~w~~~~~~~~yd~ed~~d~~~~ 102 (531)
|+++++++||++++.+||.+.+||++++++|+++|++|++||.||+++ +.+++.|+.|+.+|||++||||||||+|.+
T Consensus 1 a~v~~ll~KL~~ll~~E~~l~~gv~~~i~~Lk~eL~~m~a~L~da~~~~~~~~d~~vk~W~~~vrdlaYD~ED~iD~f~~ 80 (115)
T 3qfl_A 1 AAISNLIPKLGELLTEEFKLHKGVKKNIEDLGKELESMNAALIKIGEVPREQLDSQDKLWADEVRELSYVIEDVVDKFLV 80 (115)
T ss_dssp CTTCSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCGGGCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHHhchHHHHHHHHHHHHHHHHHHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999999999999999999999999999999998 778999999999999999999999999999
Q ss_pred HHH
Q 009595 103 EAF 105 (531)
Q Consensus 103 ~~~ 105 (531)
+.-
T Consensus 81 ~~~ 83 (115)
T 3qfl_A 81 QVD 83 (115)
T ss_dssp HHH
T ss_pred Hhc
Confidence 863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=6.6e-19 Score=171.16 Aligned_cols=146 Identities=16% Similarity=0.194 Sum_probs=107.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeE--EEEEEEeccCchh--------------------hhHHHHHHHHHHHHHh
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKM--IAIKKVKQVDNSL--------------------LNIKMRQVRAEIMTAG 260 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~--vavK~~~~~~~~~--------------------~~~~~~~~~~Ei~~l~ 260 (531)
.-|.+.+.||+|+||.||+|.... +|+. ||||+++...... .......+.+|+.++.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~-~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVF-DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEE-TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcC-CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 345678899999999999998732 7888 9999976432110 1112346788999999
Q ss_pred cCCCCcccccceeEEeCCceEEEEeccCC-C----CHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 009595 261 QIRHRNIVPLLAHMVRPDCHLLVSEFMKN-G----SLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIH 335 (531)
Q Consensus 261 ~l~hpnIv~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 335 (531)
.+.|+||.-..-+.. ...++||||+.+ | +|.++... .++..+..++.|++.||.|||. ..||+|
T Consensus 126 ~l~~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~--~~givH 194 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQ--EAELVH 194 (258)
T ss_dssp HHHHTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHH--TSCEEC
T ss_pred HHHhCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHH--HCCEEe
Confidence 998887532222222 367899999942 3 77776532 2234567899999999999994 357999
Q ss_pred eccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 336 RNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 336 ~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|||||+|||++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.1e-17 Score=166.36 Aligned_cols=145 Identities=13% Similarity=0.127 Sum_probs=99.8
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch------------------hhhHHHHHHHHHHHHHhcC
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS------------------LLNIKMRQVRAEIMTAGQI 262 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~~~~~Ei~~l~~l 262 (531)
...-|.+...||.|++|.||+|... +|+.||||+++..... ......-...+|...|.++
T Consensus 93 rg~iY~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL 170 (397)
T 4gyi_A 93 RKDVYSVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL 170 (397)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 3445889999999999999999764 7999999997642111 0000011123455666666
Q ss_pred CCCcccccceeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCC
Q 009595 263 RHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSS 342 (531)
Q Consensus 263 ~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 342 (531)
.++++.-..-+.. ...+|||||++|++|.++.. .+ ....++.|++.+|.||| +.|+|||||||.|
T Consensus 171 ~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~~--~~~~l~~qll~~l~~lH---~~gIVHrDLKp~N 235 (397)
T 4gyi_A 171 YEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------VP--DPASLYADLIALILRLA---KHGLIHGDFNEFN 235 (397)
T ss_dssp HHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC--------CS--CHHHHHHHHHHHHHHHH---HTTEECSCCSTTS
T ss_pred HhcCCCCCeeeec--cCceEEEEecCCccHhhhcc--------cH--HHHHHHHHHHHHHHHHH---HCCCcCCCCCHHH
Confidence 4444332222222 23479999999988765432 11 23467899999999999 6789999999999
Q ss_pred eeeCCCC----------CEEEeecCCCccC
Q 009595 343 VLIDDDM----------EARIADFGLARLM 362 (531)
Q Consensus 343 ILl~~~~----------~vkL~Dfgla~~~ 362 (531)
||++.++ .+.|+||+-+...
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9998776 3899999977653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=5.5e-12 Score=122.13 Aligned_cols=142 Identities=11% Similarity=0.062 Sum_probs=109.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCceE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~ 281 (531)
+.|.....++.|+.+.||++.. .+..+++|......... ...+.+|+.+++.+. +.++.++++++...+..|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~---~~~~~vlK~~~~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC---SSCEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC---CCCcEEEEeCCcccCCC----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 4577778888888899999864 46789999997532111 234778999998884 677889999998888999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH-------------------------------- 329 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------- 329 (531)
+||||++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 87 lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred EEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 99999999999876421 1122467889999999999721
Q ss_pred ------------------------CCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 330 ------------------------RPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 330 ------------------------~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
...++|+|++|.||+++.+..+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1459999999999999876566799998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.1e-10 Score=112.43 Aligned_cols=131 Identities=9% Similarity=0.126 Sum_probs=94.6
Q ss_pred cccc-ccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCc--ccccceeEEeCCceEEEEe
Q 009595 209 EKIR-SRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN--IVPLLAHMVRPDCHLLVSE 285 (531)
Q Consensus 209 ~~ig-~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~E 285 (531)
..++ .|..+.||++... +|..+++|...... ...+..|+.+++.+.+.+ +.+++++....+..++|||
T Consensus 25 ~~~~~gg~~~~v~~~~~~--~g~~~vlK~~~~~~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 25 AQQTIGCSDAAVFRLSAQ--GRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp EECSCTTSSCEEEEEECT--TSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred EecccCCCCceEEEEecC--CCCeEEEEeCCccc-------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3444 5556999998643 57789999976531 234667888888885444 5568888887778899999
Q ss_pred ccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 009595 286 FMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH------------------------------------ 329 (531)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------ 329 (531)
|++|.+|. ... .+ ...++.++++.|..||...
T Consensus 96 ~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 96 EVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp CCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred ecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 99998874 211 11 1256777888888888532
Q ss_pred -------------------CCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 330 -------------------RPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 330 -------------------~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
...++|+|++|.||+++.++.+.|+|||.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999877667799999754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=2.7e-10 Score=115.60 Aligned_cols=144 Identities=12% Similarity=0.149 Sum_probs=106.0
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEe--ccCchhhhHHHHHHHHHHHHHhcCC--CCcccccceeEEeC---C
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVK--QVDNSLLNIKMRQVRAEIMTAGQIR--HRNIVPLLAHMVRP---D 278 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~---~ 278 (531)
..++.|+.|.++.||++.. .+..+++|+.. ...... ....+.+|+.+++.+. +.++++++.++.+. +
T Consensus 41 ~~~~~l~~G~sn~~y~v~~---~~~~~vlr~~~~p~~~~~~---~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g 114 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT---PGQTYVMRAKPGPKSKLLP---SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG 114 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC---SSCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred ceEEEcCCcccceEEEEEE---CCceEEEEeCCCCCCCCCC---cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence 3467899999999999876 35678888876 322111 1345778999999886 45678888888766 3
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH----------------------------- 329 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------- 329 (531)
..++||||++|.++.+.. ...++......++.++++.|..||...
T Consensus 115 ~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL 188 (359)
T ss_dssp SCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred CeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence 478999999997764321 234677788889999999999999731
Q ss_pred --------------------------CCCeEeeccCCCCeeeCCCCC--EEEeecCCCcc
Q 009595 330 --------------------------RPRIIHRNITPSSVLIDDDME--ARIADFGLARL 361 (531)
Q Consensus 330 --------------------------~~~ivH~Dlkp~NILl~~~~~--vkL~Dfgla~~ 361 (531)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998774
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.87 E-value=6.9e-10 Score=109.86 Aligned_cols=187 Identities=17% Similarity=0.157 Sum_probs=119.3
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCc--ccccceeEEeCC---ceE
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRN--IVPLLAHMVRPD---CHL 281 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpn--Iv~l~~~~~~~~---~~~ 281 (531)
++.++.|.++.||++. ..+++|+.... .....+.+|+.+++.+ .+.. +.+++....... ..|
T Consensus 25 i~~~~~G~~n~v~~v~------~~~vlR~~~~~------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~ 92 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN------RDFIFKFPKHS------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSF 92 (304)
T ss_dssp CCEEEECSSEEEEEST------TSEEEEEESSH------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSC
T ss_pred eEecCCCCcceEEEEC------CEEEEEecCCc------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcce
Confidence 4568999999999863 34889886532 1146688899999887 3333 334444333322 348
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH-------------------------------- 329 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------- 329 (531)
+||++++|.+|.+... ..++...+..++.++++.|..||...
T Consensus 93 ~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (304)
T 3sg8_A 93 AGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK 166 (304)
T ss_dssp EEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred EEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence 8999999988865432 24566777778888888888888521
Q ss_pred -----------------------CCCeEeeccCCCCeeeCC--CCCEEEeecCCCccCCCCCccceecc-----------
Q 009595 330 -----------------------RPRIIHRNITPSSVLIDD--DMEARIADFGLARLMPDGHAQVSTSI----------- 373 (531)
Q Consensus 330 -----------------------~~~ivH~Dlkp~NILl~~--~~~vkL~Dfgla~~~~~~~~~~~~~~----------- 373 (531)
...++|+|++|.||+++. +..+.|+||+.+..............
T Consensus 167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHH
T ss_pred cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHH
Confidence 135899999999999988 45678999998775322100000000
Q ss_pred -cccCccccC-cccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 009595 374 -VAGTVGYIA-PEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPS 414 (531)
Q Consensus 374 -~~gt~~y~a-PE~~~~~~~~~~~DvwSlGvil~elltg~~P~ 414 (531)
......... |+.... .....+.|++|.++|.+.+|..+|
T Consensus 247 ~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000001111 121111 122368999999999999998774
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=8.3e-07 Score=85.77 Aligned_cols=136 Identities=15% Similarity=0.177 Sum_probs=97.0
Q ss_pred cccccccee-EEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCceEEEEec
Q 009595 209 EKIRSRASG-EIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCHLLVSEF 286 (531)
Q Consensus 209 ~~ig~G~~g-~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~ 286 (531)
+.+..|.+| .||+.... ..+..+++|+-.... ...+..|...|+.+. +-.+.++++++.+.+..++|||+
T Consensus 30 ~~~~~G~S~~~v~rl~~~-~~~~~~~lk~~~~~~-------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~ 101 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGK-PNAPELFLKHGKGSV-------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA 101 (272)
T ss_dssp EEEECSSSSCEEEEEECC-TTCCCEEEEEEETHH-------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred EEccCCCcCCeEEEEEec-CCCeEEEEEECCCCC-------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence 456667666 58887654 256679999876432 345778988888773 33467888888888899999999
Q ss_pred cCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 009595 287 MKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH------------------------------------- 329 (531)
Q Consensus 287 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------- 329 (531)
++|.++.+..... ......++.+++..|..||...
T Consensus 102 l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 102 IPGKTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp CCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred eCCccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 9998888765431 1122345666777777777421
Q ss_pred ------------------CCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 330 ------------------RPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 330 ------------------~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
...++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999987777799998755
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1e-06 Score=87.12 Aligned_cols=136 Identities=18% Similarity=0.129 Sum_probs=91.6
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCC---cccccceeEE-eCCceEEE
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHR---NIVPLLAHMV-RPDCHLLV 283 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~l~~~~~-~~~~~~lv 283 (531)
++.++.|....||+. |..+++|+-.. . .....+..|+.+|..+.+. .+.+++.++. ..+..++|
T Consensus 24 v~~l~~G~~n~v~~v------g~~~VlR~~~~--~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v 91 (306)
T 3tdw_A 24 VESLGEGFRNYAILV------NGDWVFRFPKS--Q----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVG 91 (306)
T ss_dssp EEEEEECSSEEEEEE------TTTEEEEEESS--H----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEE
T ss_pred eeecCCCcceeEEEE------CCEEEEEecCC--c----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEE
Confidence 556888999999987 34588888532 1 1146788999999998642 3556666654 34457899
Q ss_pred EeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 009595 284 SEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY----------------------------------- 328 (531)
Q Consensus 284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------------------------------- 328 (531)
|||++|.+|.+..- ..++......++.++++.|..||+.
T Consensus 92 ~e~i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~ 165 (306)
T 3tdw_A 92 YRKVQGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD 165 (306)
T ss_dssp EECCCSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred EeccCCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence 99999988876321 1223344444455555555555532
Q ss_pred ----------------------CCCCeEeeccCCCCeeeCC---CCC-EEEeecCCCcc
Q 009595 329 ----------------------HRPRIIHRNITPSSVLIDD---DME-ARIADFGLARL 361 (531)
Q Consensus 329 ----------------------~~~~ivH~Dlkp~NILl~~---~~~-vkL~Dfgla~~ 361 (531)
....++|+|+.|.||+++. ++. +.|+||+.+..
T Consensus 166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1345799999999999987 455 48999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=5.4e-06 Score=83.49 Aligned_cols=86 Identities=3% Similarity=-0.021 Sum_probs=53.6
Q ss_pred ccccc-cccceeEEEEEeee--CC---CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-C--CcccccceeEEeC
Q 009595 207 SLEKI-RSRASGEIYIAELP--ES---NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-H--RNIVPLLAHMVRP 277 (531)
Q Consensus 207 ~~~~i-g~G~~g~Vy~~~~~--~~---~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h--pnIv~l~~~~~~~ 277 (531)
..+.| +.|.++.+|+.... .. ++..+++|+.......... ....+..|+.+++.+. + -.+.+++.++.+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~-~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVF-PTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSS-SCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccC-chhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 34677 88989999988652 00 1567889886543200000 0123557888887773 2 3466777776654
Q ss_pred ---CceEEEEeccCCCCHH
Q 009595 278 ---DCHLLVSEFMKNGSLL 293 (531)
Q Consensus 278 ---~~~~lv~E~~~~gsL~ 293 (531)
+..++||||++|.++.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3468999999886643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=9.4e-05 Score=73.54 Aligned_cols=31 Identities=13% Similarity=0.383 Sum_probs=27.7
Q ss_pred CCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 330 RPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 330 ~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
...++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999888899999998654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=4.7e-05 Score=77.85 Aligned_cols=81 Identities=10% Similarity=0.084 Sum_probs=49.3
Q ss_pred ccccccccceeEEEEEeeeCCCCeEEEEEEEeccCc---hhhhHHHHHHHHHHHHHhcCCC--Cc-ccccceeEEeCCce
Q 009595 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDN---SLLNIKMRQVRAEIMTAGQIRH--RN-IVPLLAHMVRPDCH 280 (531)
Q Consensus 207 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~Ei~~l~~l~h--pn-Iv~l~~~~~~~~~~ 280 (531)
..+.||.|.++.||++.... +++.++||....... ........++..|..++..+.. |. +.+++.+ +.+..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~-~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp EEEECCSSSSEEEEEEEC-----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred EEEECCCCceEEEEEEEECC-CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 35689999999999996532 467899998753211 0000012445678888877632 43 3455543 45567
Q ss_pred EEEEeccCCC
Q 009595 281 LLVSEFMKNG 290 (531)
Q Consensus 281 ~lv~E~~~~g 290 (531)
++||||+++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.79 E-value=8.8e-05 Score=73.20 Aligned_cols=77 Identities=16% Similarity=0.097 Sum_probs=60.2
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC---CCcccccceeEEeCCceEE
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR---HRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~l 282 (531)
...+.|+.|.+..+|+... ++..+++|+..... ...+..|...|+.|. ...+++++.++...+..++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~~-------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~l 108 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND---EVQTVFVKINERSY-------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFL 108 (312)
T ss_dssp CEEEEECCSSSSEEEEEES---SSCEEEEEEEEGGG-------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEE
T ss_pred eeeEEeCCccceeeeEEEE---CCCeEEEEeCCccc-------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEE
Confidence 3457899999999999865 46779999876431 456778988888873 3568888888887788999
Q ss_pred EEeccCCCCH
Q 009595 283 VSEFMKNGSL 292 (531)
Q Consensus 283 v~E~~~~gsL 292 (531)
||||+++.++
T Consensus 109 vme~l~G~~~ 118 (312)
T 3jr1_A 109 LLEALNKSKN 118 (312)
T ss_dssp EEECCCCCCC
T ss_pred EEEeccCCCC
Confidence 9999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00036 Score=71.83 Aligned_cols=31 Identities=19% Similarity=0.385 Sum_probs=27.9
Q ss_pred CCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 330 RPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 330 ~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
...++|+|+.|.|||++.++ +.|+||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 67899999999999998876 99999998775
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0011 Score=64.26 Aligned_cols=79 Identities=16% Similarity=0.180 Sum_probs=54.4
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCC---cccccceeEEeCCce
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHR---NIVPLLAHMVRPDCH 280 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~l~~~~~~~~~~ 280 (531)
....++.+|.|..+.||+.... +|+.|++|+-....... ...+..|+..|+.|... .+.+++++ +..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~~~~~~----~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~ 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA--DGTPLFVKALPDDAPAL----DGLFRAEALGLDWLGRSFGSPVPQVAGW----DDR 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET--TSCEEEEEECCTTCCCC----TTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETT
T ss_pred CeEEEEecCCCCCeEEEEEEEC--CCCEEEEEEeCCCCcch----hhHHHHHHHHHHHHHhhCCCCcceEEec----cCc
Confidence 3456788999999999999875 79999999876433221 23467899888877422 23444443 234
Q ss_pred EEEEeccCCCCH
Q 009595 281 LLVSEFMKNGSL 292 (531)
Q Consensus 281 ~lv~E~~~~gsL 292 (531)
++||||++++..
T Consensus 86 ~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 TLAMEWVDERPP 97 (288)
T ss_dssp EEEEECCCCCCC
T ss_pred eEEEEeecccCC
Confidence 789999987643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00074 Score=66.02 Aligned_cols=71 Identities=8% Similarity=0.128 Sum_probs=43.1
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcc-cccceeEEeCCceEEEEec
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI-VPLLAHMVRPDCHLLVSEF 286 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~ 286 (531)
++.|+.|....+|++ ..+++|+........ .....|+.+++.+...++ .+++++ ..+.-++++||
T Consensus 23 i~~l~gG~tN~~~~~-------~~~vlR~~~~~~~~~-----~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~ 88 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-------GDLCLRIPGKGTEEY-----INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRY 88 (301)
T ss_dssp CEEEESCSSEEEEEE-------TTEEEEEECC----C-----CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEEC
T ss_pred eeEcCCcccccccee-------eeEEEECCCCCccce-----eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEee
Confidence 678999999999998 238888886532111 112357777766632233 344443 34445789999
Q ss_pred c-CCCCH
Q 009595 287 M-KNGSL 292 (531)
Q Consensus 287 ~-~~gsL 292 (531)
+ +|.+|
T Consensus 89 i~~g~~l 95 (301)
T 3dxq_A 89 IAGAQTM 95 (301)
T ss_dssp CTTCEEC
T ss_pred cCCCccC
Confidence 9 65444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0026 Score=62.78 Aligned_cols=144 Identities=11% Similarity=0.097 Sum_probs=78.4
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCC--ccccccee-----EEeCCce
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHR--NIVPLLAH-----MVRPDCH 280 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~-----~~~~~~~ 280 (531)
+..++ |....||++... +|+.+++|........ ...+..|..++..+... .+++++.. ....+..
T Consensus 31 ~~~l~-g~~n~~y~v~~~--~g~~~vlK~~~~~~~~-----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~ 102 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQDE--DRRRFVVKFYRPERWT-----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFY 102 (328)
T ss_dssp CEEEC-CSSSEEEEECCT--TCCCEEEEEECTTTSC-----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEE
T ss_pred EEeec-CcccceEEEEcC--CCCEEEEEEcCCCCCC-----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEE
Confidence 34566 888899988653 5667999998743221 23455677777666321 23444432 2224456
Q ss_pred EEEEeccCCCCHH-----H------H---HhhccCC-----CccCCHHHH----HHH---------------HHHHHHHH
Q 009595 281 LLVSEFMKNGSLL-----E------I---LNDVSQG-----RRELEWLAR----HRI---------------ARGIVSGL 322 (531)
Q Consensus 281 ~lv~E~~~~gsL~-----~------~---l~~~~~~-----~~~l~~~~~----~~i---------------~~~ia~~L 322 (531)
+++|+|++|.++. . . ++..... ....++... ..+ ...+...+
T Consensus 103 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 182 (328)
T 1zyl_A 103 FAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELI 182 (328)
T ss_dssp EEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHH
T ss_pred EEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHH
Confidence 7899999874421 1 1 1111110 111222110 000 11111223
Q ss_pred HHHHhc----CCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 323 EYLHMY----HRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 323 ~~LH~~----~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
..+... ....++|+|+.+.||+++ + .+.|+||+.+..
T Consensus 183 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 183 AAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 333211 245689999999999999 4 899999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.001 Score=65.93 Aligned_cols=32 Identities=22% Similarity=0.348 Sum_probs=27.9
Q ss_pred CCCeEeeccCCCCeeeCCC----CCEEEeecCCCcc
Q 009595 330 RPRIIHRNITPSSVLIDDD----MEARIADFGLARL 361 (531)
Q Consensus 330 ~~~ivH~Dlkp~NILl~~~----~~vkL~Dfgla~~ 361 (531)
...++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 5679999999999999875 6799999998765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.004 Score=61.21 Aligned_cols=145 Identities=13% Similarity=0.139 Sum_probs=76.7
Q ss_pred ccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-----CCcccccc-e--eEEeCC
Q 009595 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-----HRNIVPLL-A--HMVRPD 278 (531)
Q Consensus 207 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----hpnIv~l~-~--~~~~~~ 278 (531)
.++.|+.|....+|++... +| .+++|+...... ...+..|+.++..+. -|.++... | +....+
T Consensus 26 ~~~~i~~G~~n~~~~v~~~--~g-~~vlk~~~~~~~------~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT--KD-PLILTLYEKRVE------KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEEECC---EEEEEEEES--SC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred EeeccCCCcccceEEEEeC--Cc-cEEEEEeCCCCC------HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 3566778888999998753 34 688998875211 122345666665552 23333211 1 112345
Q ss_pred ceEEEEeccCCCCHHH--------------HHhhccCC--Cc---cC---CHHHHHH------------HHHHHHHHHHH
Q 009595 279 CHLLVSEFMKNGSLLE--------------ILNDVSQG--RR---EL---EWLARHR------------IARGIVSGLEY 324 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~--------------~l~~~~~~--~~---~l---~~~~~~~------------i~~~ia~~L~~ 324 (531)
..+++|+|++|.++.. .++..... .. .. .|..... +...+...+.+
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 6789999998854310 01111000 00 01 1211000 00113444555
Q ss_pred HHhc----CCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 325 LHMY----HRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 325 LH~~----~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++.. ...+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 5432 13579999999999999887666899998654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.002 Score=65.13 Aligned_cols=144 Identities=10% Similarity=0.133 Sum_probs=80.1
Q ss_pred cccccccceeEEEEEeeeC------CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCce
Q 009595 208 LEKIRSRASGEIYIAELPE------SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~ 280 (531)
++.|..|-...+|++.... .+++.|++|+....... ...+.+|..+++.+. +.-..++++.+.+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~-----~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG-----VDSLVLESVMFAILAERSLGPQLYGVFPE---- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC-----HHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch-----HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence 4567788899999987631 12467899886432111 344557888888773 3223566665543
Q ss_pred EEEEeccCCCCHHH--------------HH---hhccC-CCccC--CHHHHHHHHHHHHH-------------------H
Q 009595 281 LLVSEFMKNGSLLE--------------IL---NDVSQ-GRREL--EWLARHRIARGIVS-------------------G 321 (531)
Q Consensus 281 ~lv~E~~~~gsL~~--------------~l---~~~~~-~~~~l--~~~~~~~i~~~ia~-------------------~ 321 (531)
.+||||++|.+|.. .| +.... ..... .+....++..++.. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 28999998755431 11 11100 01111 23444445444322 1
Q ss_pred HHHHH----hc-CCCCeEeeccCCCCeeeCCC----CCEEEeecCCCc
Q 009595 322 LEYLH----MY-HRPRIIHRNITPSSVLIDDD----MEARIADFGLAR 360 (531)
Q Consensus 322 L~~LH----~~-~~~~ivH~Dlkp~NILl~~~----~~vkL~Dfgla~ 360 (531)
+..|. .. ....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 23332 11 23469999999999999876 789999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0036 Score=65.02 Aligned_cols=76 Identities=13% Similarity=0.145 Sum_probs=47.0
Q ss_pred ccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcc-cccceeEEeCCceEEEEe
Q 009595 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI-VPLLAHMVRPDCHLLVSE 285 (531)
Q Consensus 207 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E 285 (531)
.++.|+.|-...+|++.... .+..|++|+.........+ ...|..++..|...++ .++++.+. + .+|||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~~~~id-----R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e 181 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMS-KQAKYLIRLYGPKTDEIIN-----REREKKISCILYNKNIAKKIYVFFT--N--GRIEE 181 (458)
T ss_dssp EEEEECC--CEEEEEEEETT-TTEEEEEEEECC-CCSCSC-----HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEE
T ss_pred EEEEcCCCeEeEEEEEEECC-CCceEEEEECCCChhhhcC-----HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEE
Confidence 35678888899999997631 2477889987543221111 1468888888865444 46666652 2 35999
Q ss_pred ccCCCCH
Q 009595 286 FMKNGSL 292 (531)
Q Consensus 286 ~~~~gsL 292 (531)
|++|.+|
T Consensus 182 ~I~G~~l 188 (458)
T 2qg7_A 182 FMDGYAL 188 (458)
T ss_dssp CCCSEEC
T ss_pred eeCCccC
Confidence 9987444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0026 Score=65.61 Aligned_cols=74 Identities=12% Similarity=0.222 Sum_probs=47.4
Q ss_pred cccccccceeEEEEEeeeCC------CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcc-cccceeEEeCCce
Q 009595 208 LEKIRSRASGEIYIAELPES------NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI-VPLLAHMVRPDCH 280 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~ 280 (531)
++.|+.|....+|++..... .+..+++|+...... ...+..|..++..+...++ .++++.+.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~------~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET------ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC------HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc------HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 56788888999999976421 246789998843211 1234468888887743333 566665432
Q ss_pred EEEEeccCCCC
Q 009595 281 LLVSEFMKNGS 291 (531)
Q Consensus 281 ~lv~E~~~~gs 291 (531)
.+|+||++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 38999998643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0081 Score=59.73 Aligned_cols=32 Identities=22% Similarity=0.367 Sum_probs=28.0
Q ss_pred CCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 330 RPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 330 ~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35799999999999999888899999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.51 E-value=0.012 Score=53.94 Aligned_cols=103 Identities=18% Similarity=0.074 Sum_probs=67.3
Q ss_pred CCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCccc
Q 009595 290 GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQV 369 (531)
Q Consensus 290 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~ 369 (531)
-||.+.|.. .+.++++.++|.++.|.+.+|.-+-. .+.-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc---------
Confidence 389999975 35789999999999999998877621 11111233446899999999988764 1110
Q ss_pred eecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 009595 370 STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP 413 (531)
Q Consensus 370 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P 413 (531)
.....+.|||... ...+.+.=|||+|+++|..+-=..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888764 3457889999999999999874444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0024 Score=64.26 Aligned_cols=75 Identities=12% Similarity=0.130 Sum_probs=42.3
Q ss_pred cccccccceeEEEEEeeeCC-------CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCc-ccccceeEEeCCc
Q 009595 208 LEKIRSRASGEIYIAELPES-------NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN-IVPLLAHMVRPDC 279 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~ 279 (531)
++.|+.|....+|++..... .+..+++|+........ .....|..++..+...+ +.++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-----~~~~~E~~~l~~L~~~g~~P~~~~~~--~-- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-----YNTISEFEVYKTMSKYKIAPQLLNTF--N-- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-----SCHHHHHHHHHHHHHTTSSCCEEEEE--T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-----ecHHHHHHHHHHHHhcCCCCceEEec--C--
Confidence 45778888899999876310 12578888875432211 11246777777774333 34555543 2
Q ss_pred eEEEEeccCCCC
Q 009595 280 HLLVSEFMKNGS 291 (531)
Q Consensus 280 ~~lv~E~~~~gs 291 (531)
-++||||++|.+
T Consensus 109 ~~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 GGRIEEWLYGDP 120 (369)
T ss_dssp TEEEEECCCSEE
T ss_pred CcEEEEEecCCc
Confidence 368999998754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.20 E-value=0.035 Score=56.85 Aligned_cols=77 Identities=12% Similarity=0.205 Sum_probs=47.1
Q ss_pred ccccccccceeEEEEEeeeCCC------CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCc
Q 009595 207 SLEKIRSRASGEIYIAELPESN------GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDC 279 (531)
Q Consensus 207 ~~~~ig~G~~g~Vy~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~ 279 (531)
.++.+..|-...+|+....... +..|++++........ -...+|..+++.+. +.-..++++.+ .
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-----idR~~E~~~l~~L~~~gi~P~l~~~~--~-- 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-----YDSKVELDVFRYLSNINIAPNIIADF--P-- 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-----CCHHHHHHHHHHHHHTTSSCCEEEEE--T--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-----cCHHHHHHHHHHHHhcCCCCCEEEEc--C--
Confidence 3567778889999998764211 5779998875432211 11235777777774 22234555433 2
Q ss_pred eEEEEeccCCCCH
Q 009595 280 HLLVSEFMKNGSL 292 (531)
Q Consensus 280 ~~lv~E~~~~gsL 292 (531)
-++||||++|.+|
T Consensus 145 ~~~I~efI~G~~l 157 (424)
T 3mes_A 145 EGRIEEFIDGEPL 157 (424)
T ss_dssp TEEEEECCCSEEC
T ss_pred CCEEEEEeCCccC
Confidence 3789999998653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.37 E-value=0.59 Score=42.67 Aligned_cols=121 Identities=13% Similarity=0.057 Sum_probs=81.1
Q ss_pred CCCCcccccceeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCC
Q 009595 262 IRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341 (531)
Q Consensus 262 l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 341 (531)
..||+.+.. .+-...+.+.+.++.-+++ .++-. -...+...+++++.+|+....+++ .-+|--|.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~--~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNH--TPFDN-----IKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTS--EEGGG-----GGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCccc--CCHHH-----HHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecc
Confidence 368888876 5666667766666654422 22211 245788889999999988775555 2578899999
Q ss_pred CeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 009595 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQ 419 (531)
Q Consensus 342 NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~ 419 (531)
||+++.++.+++.=-|+-.. ++|. ..+...=.-.+=+++..+++++..|++...
T Consensus 109 NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~ 162 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVE 162 (215)
T ss_dssp GEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHH
T ss_pred eEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHc
Confidence 99999999999876654221 2332 122222344577889999999999876543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.43 E-value=0.12 Score=53.53 Aligned_cols=65 Identities=6% Similarity=-0.054 Sum_probs=18.7
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEE------EEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAI------KKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 276 (531)
...++|| ||+||+|.+.. +..+||| |..+..... ......+.+|..++..++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~-~~~~Vav~~~~~~K~~~~~~~~--~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYK-KHMPVLKETHDERDSTGQDGVS--EKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC----------CCBGGGC-------------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccc-cCCchhhhhccCcccccccccc--ccccccccccccccccccccccCCCcceEEe
Confidence 3455665 99999999853 2457888 766542222 1224568889999999999999999987653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.19 E-value=2.3 Score=38.88 Aligned_cols=117 Identities=16% Similarity=0.182 Sum_probs=77.9
Q ss_pred CCCcccccceeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEeeccCCC
Q 009595 263 RHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLE-YLHMYHRPRIIHRNITPS 341 (531)
Q Consensus 263 ~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~ivH~Dlkp~ 341 (531)
.||++ -...-.+++.+.+.++.-+++.=...+ ..++...+++++.+|+.... +++ .-+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence 67777 334446677777777765454333344 34678888888888877655 443 4678899999
Q ss_pred CeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 009595 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDF 417 (531)
Q Consensus 342 NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~ 417 (531)
||+++.++.+++.=.|+- .-++|.- .+..-=.-++=+++..++.++..|++.
T Consensus 114 NL~f~~~~~p~i~hRGi~-------------------~~lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~l 165 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVK-------------------ESLPPDE-----WDDERLLREVKATVLALTEGEYRFDEY 165 (219)
T ss_dssp GEEECTTCCEEESCCEET-------------------TTBSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred eEEEeCCCcEEEEEcCCc-------------------ccCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 999999999998766542 2233432 121222345678888999999887654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 531 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-12 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 7e-50
Identities = 55/280 (19%), Positives = 125/280 (44%), Gaps = 28/280 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
++I S + G +Y + +A+K + + +++ + E+ + RH NI
Sbjct: 13 GQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPT--PQQLQAFKNEVGVLRKTRHVNI 66
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+ + + P +V+++ + SL L+ + + E + IAR G++YLH
Sbjct: 67 LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
IIHR++ +++ + +D+ +I DFGLA + ++G++ ++APE +
Sbjct: 123 ---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 388 TLK---FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444
+S + D+Y+FG++L L+ G+LP + ++ + S + ++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSK--- 233
Query: 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484
+ + + M ++ C +ERP + + +
Sbjct: 234 ---VRSNCPKAM---KRLMAECLKKKRDERPLFPQILASI 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-46
Identities = 58/280 (20%), Positives = 112/280 (40%), Gaps = 32/280 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L+++ + G + + +AIK +K+ ++ + E + H +
Sbjct: 9 LKELGTGQFGVVKYGKWR--GQYDVAIKMIKEG-----SMSEDEFIEEAKVMMNLSHEKL 61
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L + +++E+M NG LL L + R + + + + +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
+ +HR++ + L++D +++DFGL+R + D S V + PE
Sbjct: 119 ---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWSPPEVLM 174
Query: 388 TLKFSEKCDIYSFGVLL-AVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSK 446
KFS K DI++FGVL+ + +GK+P + F + + + +R +
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT-- 232
Query: 447 LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
I C + +ERP K + S + D
Sbjct: 233 ---------------IMYSCWHEKADERPTFKILLSNILD 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-46
Identities = 55/290 (18%), Positives = 108/290 (37%), Gaps = 21/290 (7%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+ ++ + G ++ S G ++A K + + Q+ E+ + I
Sbjct: 11 ISELGAGNGGVVFKVSHKPS-GLVMARKLIHL---EIKPAIRNQIIRELQVLHECNSPYI 66
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V + E M GSL ++L + +++ ++ GL YL
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR- 121
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
+ +I+HR++ PS++L++ E ++ DFG++ + D + GT Y++PE Q
Sbjct: 122 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQ 176
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447
+S + DI+S G+ L + +G+ P ++ + + V
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYP---IPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDVDFLK 497
M +A F LD P K + S DF+
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ----DFVN 279
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 3e-46
Identities = 62/279 (22%), Positives = 123/279 (44%), Gaps = 30/279 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+E++ + GE+++ +A+K +KQ ++ AE Q++H+ +
Sbjct: 18 VERLGAGQFGEVWMGYYN--GHTKVAVKSLKQG-----SMSPDAFLAEANLMKQLQHQRL 70
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L A + + ++ ++E+M+NGSL++ L +L +A I G+ ++
Sbjct: 71 VRLYAVVTQEPIYI-ITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
IHR++ +++L+ D + +IADFGLARL+ D + + APE
Sbjct: 127 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAIN 183
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447
F+ K D++SFG+LL +V + +++ + P+ +
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVIQNLERGYRMVRPDNCPEE-- 238
Query: 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
+ ++ C + PE+RP +RS+L D
Sbjct: 239 -----------LYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 7e-46
Identities = 62/279 (22%), Positives = 117/279 (41%), Gaps = 30/279 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
K+ GE+++ +AIK +K + E ++RH +
Sbjct: 22 EVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPG-----TMSPEAFLQEAQVMKKLRHEKL 74
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L A +V + +V+E+M GSLL+ + + L +A I SG+ Y+
Sbjct: 75 VQLYA-VVSEEPIYIVTEYMSKGSLLDF--LKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
+ +HR++ +++L+ +++ ++ADFGLARL+ D + + APE
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK-FPIKWTAPEAAL 187
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447
+F+ K D++SFG+LL L + + ++ + P +S
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVLDQVERGYRMPCPPECPES-- 242
Query: 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
+ + C C +PEERP + +++ L D
Sbjct: 243 -----------LHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-45
Identities = 63/312 (20%), Positives = 119/312 (38%), Gaps = 37/312 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
E I GE++ + G+ +A+K + + AEI +RH NI
Sbjct: 8 QESIGKGRFGEVWRGKW---RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENI 59
Query: 268 VPLLAHMVRPDCHL----LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLE 323
+ +A + + LVS++ ++GSL + LN R + ++A SGL
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLA 114
Query: 324 YLHM-----YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDG--HAQVSTSIVAG 376
+LHM +P I HR++ ++L+ + IAD GLA ++ + G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 377 TVGYIAPEY------HQTLKFSEKCDIYSFGVLLAVLVMGKLPSD---DFFQHTEEKSLV 427
T Y+APE + + ++ DIY+ G++ + D+ +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 428 RWMRNVMTSENPNRAIDSKLLGNGYE-EQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
M + + + E + ++ KI C + R + ++ LS
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
Query: 487 TALIKDVDFLKM 498
+ + +KM
Sbjct: 295 ---LSQQEGIKM 303
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-45
Identities = 52/277 (18%), Positives = 112/277 (40%), Gaps = 26/277 (9%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L I + + G +S+GK++ K++ S+ + + + +E+ +++H NI
Sbjct: 9 LYTIGTGSYGRCQKIRR-KSDGKILVWKELDY--GSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 268 VPLLAHMVRP--DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYL 325
V ++ +V E+ + G L ++ ++ R+ L+ R+ + L+
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 326 HMYHR--PRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAP 383
H ++HR++ P++V +D ++ DFGLAR++ + GT Y++P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSP 183
Query: 384 EYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443
E + ++EK DI+S G LL L P F Q + + +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 243
Query: 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
+ ++ + RP+ +++
Sbjct: 244 E-------------IITR----MLNLKDYHRPSVEEI 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-44
Identities = 66/280 (23%), Positives = 116/280 (41%), Gaps = 36/280 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L+ I G++ + + G +A+K +K + + AE Q+RH N+
Sbjct: 12 LQTIGKGEFGDVMLGDY---RGNKVAVKCIKN------DATAQAFLAEASVMTQLRHSNL 62
Query: 268 VPLLAHMVRPDCHL-LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
V LL +V L +V+E+M GSL++ L S+GR L + + + +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
+HR++ +VL+ +D A+++DFGL + + V + APE
Sbjct: 121 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEAL 172
Query: 387 QTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSK 446
+ KFS K D++SFG+LL + + K +V + + P+ +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRV---PYPRIPLKDVVPRVEKGYKMDAPDGCPPA- 228
Query: 447 LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
V ++ C D RP+ +R L
Sbjct: 229 ------------VYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (394), Expect = 4e-44
Identities = 57/294 (19%), Positives = 125/294 (42%), Gaps = 30/294 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+ I + GE+ L GK +K + + + R +E GQ H N+
Sbjct: 31 EQVIGAGEFGEVCSGHLKLP-GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 89
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+ L + + ++++EFM+NGSL L ++ + + RGI +G++YL
Sbjct: 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV---GMLRGIAAGMKYLAD 146
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIV---AGTVGYIAPE 384
+HR++ ++L++ ++ +++DFGL+R + D + + + + + APE
Sbjct: 147 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203
Query: 385 YHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443
Q KF+ D++S+G+++ ++ G+ P + + ++ + P
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERP----YWDMTNQDVINAIEQDYRLPPPMDCP 259
Query: 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDVDFLK 497
+ + ++ C D RP + + L +I++ + LK
Sbjct: 260 SA-------------LHQLMLDCWQKDRNHRPKFGQIVNTLDK--MIRNPNSLK 298
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 5e-44
Identities = 57/277 (20%), Positives = 113/277 (40%), Gaps = 33/277 (11%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV 268
+I + +Y E +A +++ D L + ++ + E ++H NIV
Sbjct: 15 IEIGRGSFKTVYKGLDTE-TTVEVAWCELQ--DRKLTKSERQRFKEEAEMLKGLQHPNIV 71
Query: 269 PLLAHMV----RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEY 324
C +LV+E M +G+L L + + ++ R I+ GL++
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQF 127
Query: 325 LHMYHRPRIIHRNITPSSVLIDD-DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAP 383
LH P IIHR++ ++ I +I D GLA L V GT ++AP
Sbjct: 128 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAP 182
Query: 384 EYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443
E ++ K+ E D+Y+FG+ + + + P + + + R + + + + ++
Sbjct: 183 EMYEE-KYDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
++ +I C + +ER + KD+
Sbjct: 239 IPEV------------KEIIEGCIRQNKDERYSIKDL 263
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (391), Expect = 1e-43
Identities = 57/301 (18%), Positives = 111/301 (36%), Gaps = 46/301 (15%)
Query: 208 LEKIRSRASGEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR 263
+ I A G ++ A P M+A+K +K+ + E +
Sbjct: 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE---EASADMQADFQREAALMAEFD 74
Query: 264 HRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILND--------------------VSQGR 303
+ NIV LL L+ E+M G L E L S G
Sbjct: 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 304 RELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMP 363
L + IAR + +G+ YL + +HR++ + L+ ++M +IADFGL+R +
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 364 DGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEE 423
+ A + ++ PE +++ + D++++GV+L + L +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ---PYYGMAH 248
Query: 424 KSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483
+ ++ ++R+ P + + C P +RP+ + +
Sbjct: 249 EEVIYYVRDGNILACPENCPLE-------------LYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 484 L 484
L
Sbjct: 296 L 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (389), Expect = 1e-43
Identities = 62/277 (22%), Positives = 116/277 (41%), Gaps = 28/277 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
K+ GE+Y + +A+K +K+ +++ + E +I+H N+
Sbjct: 22 KHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNL 75
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V LL R +++EFM G+LL+ L + R+E+ + +A I S +EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE- 132
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
+ IHR++ + L+ ++ ++ADFGL+RLM + + APE
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLA 189
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447
KFS K D+++FGVLL + + + + + + E P +
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQVYELLEKDYRMERPEGCPEK-- 244
Query: 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484
V ++ C +P +RP+ ++
Sbjct: 245 -----------VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-43
Identities = 60/292 (20%), Positives = 108/292 (36%), Gaps = 30/292 (10%)
Query: 198 FLEKEDCSASLEKIRSRASGEIYIAELPESN-GKMIAIKKVKQVDNSLLNIKMRQVRAEI 256
+L+++ + +++ S G + K +A+K +K N ++ AE
Sbjct: 2 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEA 59
Query: 257 MTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIAR 316
Q+ + IV ++ + + +LV E + G L + L R ++ +
Sbjct: 60 NVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVH 114
Query: 317 GIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI-VA 375
+ G++YL +HR++ +VL+ A+I+DFGL++ +
Sbjct: 115 QVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 376 GTVGYIAPEYHQTLKFSEKCDIYSFGVLL-AVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434
V + APE KFS K D++SFGVL+ G+ P L + R
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 231
Query: 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
+ P D + C D E RP V L +
Sbjct: 232 PAGCPREMYD-----------------LMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-43
Identities = 59/284 (20%), Positives = 120/284 (42%), Gaps = 25/284 (8%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHM 274
GE+Y L S+GK +K + + E GQ H NI+ L +
Sbjct: 19 EFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 78
Query: 275 VRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRII 334
+ ++++E+M+NG+L + L + E L + RGI +G++Y +
Sbjct: 79 SKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKY---LANMNYV 132
Query: 335 HRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI-VAGTVGYIAPEYHQTLKFSE 393
HR++ ++L++ ++ +++DFGL+R++ D T+ + + APE KF+
Sbjct: 133 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS 192
Query: 394 KCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYE 453
D++SFG+++ ++ + +++ + + P
Sbjct: 193 ASDVWSFGIVMWEVMTYGER---PYWELSNHEVMKAINDGFRLPTP-------------M 236
Query: 454 EQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDVDFLK 497
+ + ++ C + RP D+ S+L LI+ D LK
Sbjct: 237 DCPSAIYQLMMQCWQQERARRPKFADIVSILDK--LIRAPDSLK 278
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-43
Identities = 55/278 (19%), Positives = 108/278 (38%), Gaps = 33/278 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+ ++ A G++Y A+ E + A K + ++ EI H NI
Sbjct: 17 IGELGDGAFGKVYKAQNKE-TSVLAAAKVIDTKSEE----ELEDYMVEIDILASCDHPNI 71
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V LL + ++ EF G++ ++ + R L + + + L YLH
Sbjct: 72 VKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLH- 127
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
+IIHR++ ++L D + ++ADFG++ + + GT ++APE
Sbjct: 128 --DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 388 TL-----KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442
+ K D++S G+ L + + P + + +R + + SE P A
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE-------LNPMRVLLKIAKSEPPTLA 236
Query: 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
S+ N + + K C + + R + +
Sbjct: 237 QPSRWSSNFKD----FLKK----CLEKNVDARWTTSQL 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-43
Identities = 64/276 (23%), Positives = 120/276 (43%), Gaps = 27/276 (9%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
++ + A GE+ +A + + +A+K V ++ EI + H N+
Sbjct: 10 VQTLGEGAYGEVQLAVNRVT-EEAVAVKIVDM---KRAVDCPENIKKEICINKMLNHENV 65
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V H + L E+ G L + + + + R +++G+ YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH- 120
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
I HR+I P ++L+D+ +I+DFGLA + + + + + GT+ Y+APE +
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 388 TLKF-SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSK 446
+F +E D++S G++L ++ G+LP + Q ++ + T NP + IDS
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235
Query: 447 LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS 482
L L+ KI +P R D++
Sbjct: 236 PLA--------LLHKILVE----NPSARITIPDIKK 259
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-43
Identities = 61/281 (21%), Positives = 108/281 (38%), Gaps = 26/281 (9%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV 268
E I G +Y L +++GK I VK ++ ++ Q E + H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCA-VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 269 PLLAHMVRPD-CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
LL +R + L+V +MK+G L + + G+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGM---KF 145
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI--VAGTVGYIAPEY 385
+ +HR++ + ++D+ ++ADFGLAR M D + V ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 386 HQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS 445
QT KF+ K D++SFGVLL L+ P + + ++ P D
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDVNTFDITVYLLQGRRLLQPEYCPDP 262
Query: 446 KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
+ ++ C E RP+ ++ S +S
Sbjct: 263 -------------LYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-43
Identities = 58/297 (19%), Positives = 114/297 (38%), Gaps = 39/297 (13%)
Query: 190 LIEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKM 249
+I+ +L F+++ I S G +++ N +AIK +++ +
Sbjct: 1 VIDPSELTFVQE---------IGSGQFGLVHLGYWL--NKDKVAIKTIREG-----AMSE 44
Query: 250 RQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWL 309
E ++ H +V L + LV EFM++G L + + R
Sbjct: 45 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAE 101
Query: 310 ARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQV 369
+ + G+ YL +IHR++ + L+ ++ +++DFG+ R + D
Sbjct: 102 TLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158
Query: 370 STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRW 429
ST V + +PE ++S K D++SFGVL+ + +++ +V
Sbjct: 159 STGTK-FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVVED 214
Query: 430 MRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
+ P A V +I C + PE+RP + L++
Sbjct: 215 ISTGFRLYKPRLASTH-------------VYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 8e-43
Identities = 57/273 (20%), Positives = 110/273 (40%), Gaps = 31/273 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+ G +Y+A +S ++A+K + + ++ Q+R E+ +RH NI
Sbjct: 11 GRPLGKGKFGNVYLAREKQS-KFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNI 68
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+ L + L+ E+ G++ L Q + + + + L Y H
Sbjct: 69 LRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH- 123
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
R+IHR+I P ++L+ E +IADFG + P + + GT+ Y+ PE +
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIE 177
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447
EK D++S GVL ++GK P + + + + E ++
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA-------NTYQETYKRISRVEFTFPDFVTEG 230
Query: 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
+ L+ + +P +RP ++V
Sbjct: 231 ARD-------LISR----LLKHNPSQRPMLREV 252
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-42
Identities = 66/341 (19%), Positives = 125/341 (36%), Gaps = 48/341 (14%)
Query: 184 PTIFSPLIEKEDLAFLEKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS 243
PTI+ P+++ D+ F + I G++ A + + +M A +K++
Sbjct: 1 PTIY-PVLDWNDIKFQDV---------IGEGNFGQVLKARIKKDGLRMDA--AIKRMKEY 48
Query: 244 LLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILND---- 298
R E+ ++ H NI+ LL L E+ +G+LL+ L
Sbjct: 49 ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL 108
Query: 299 --------VSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDME 350
+ L A + G++YL + + IHR++ ++L+ ++
Sbjct: 109 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 165
Query: 351 ARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMG 410
A+IADFGL+R ++ V ++A E ++ D++S+GVLL +V
Sbjct: 166 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 222
Query: 411 KLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDD 470
+ L + E P D V + C +
Sbjct: 223 GGT---PYCGMTCAELYEKLPQGYRLEKPLNCDDE-------------VYDLMRQCWREK 266
Query: 471 PEERPNSKDVRSMLSD-TALIKDVDFLKMHKRMDFDNDDCV 510
P ERP+ + L+ K ++++ + DC
Sbjct: 267 PYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCS 307
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-42
Identities = 56/292 (19%), Positives = 116/292 (39%), Gaps = 30/292 (10%)
Query: 198 FLEKEDCSASLEKIRSRASGEIYIAELPESNGKM-IAIKKVKQVDNSLLNIKMRQVRAEI 256
FL++++ + ++ G + ++ +AIK +KQ ++ E
Sbjct: 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ---GTEKADTEEMMREA 60
Query: 257 MTAGQIRHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIAR 316
Q+ + IV L+ + + + +LV E G L + L R E+ +
Sbjct: 61 QIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLH 116
Query: 317 GIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM-PDGHAQVSTSIVA 375
+ G++YL +HR++ +VL+ + A+I+DFGL++ + D + S
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 376 GTVGYIAPEYHQTLKFSEKCDIYSFGVLLA-VLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434
+ + APE KFS + D++S+GV + L G+ P ++ + ++ ++
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPEVMAFIEQGK 229
Query: 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
E P + + C + E+RP+ V +
Sbjct: 230 RMECPPECPPE-------------LYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 5e-42
Identities = 60/276 (21%), Positives = 111/276 (40%), Gaps = 34/276 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L +I + G +Y A N +++AIKK+ N K + + E+ ++RH N
Sbjct: 20 LREIGHGSFGAVYFARDVR-NSEVVAIKKMSY-SGKQSNEKWQDIIKEVRFLQKLRHPNT 77
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+ +R LV E+ + + ++ L+ + + G + GL YLH
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLH- 132
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
+IHR++ ++L+ + ++ DFG A +M ++ V GT ++APE
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVIL 184
Query: 388 TL---KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444
+ ++ K D++S G+ L K P F +L +N +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNESPALQS----- 236
Query: 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
G+ E V C P++RP S+ +
Sbjct: 237 ----GHWSEYFRNFVDS----CLQKIPQDRPTSEVL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 5e-42
Identities = 60/299 (20%), Positives = 113/299 (37%), Gaps = 41/299 (13%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIK-KVKQVDNSLLNIKMRQVRAEIMTAGQI-RHR 265
+ + S A G++ A + ++I+ VK + + + + +E+ Q+ H
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILN-------------------DVSQGRREL 306
NIV LL L+ E+ G LL L + + L
Sbjct: 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161
Query: 307 EWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGH 366
+ A + G+E+L +HR++ +VL+ +I DFGLAR +
Sbjct: 162 TFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 218
Query: 367 AQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLV-MGKLPSDDFFQHTEEKS 425
V V ++APE ++ K D++S+G+LL + +G P + + +
Sbjct: 219 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP---YPGIPVDAN 275
Query: 426 LVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484
+ ++N + P A + + I C D +RP+ ++ S L
Sbjct: 276 FYKLIQNGFKMDQPFYATEE-------------IYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 2e-40
Identities = 59/273 (21%), Positives = 116/273 (42%), Gaps = 30/273 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
EKI ASG +Y A + G+ +AI+++ K + EI+ + ++ NI
Sbjct: 25 FEKIGQGASGTVYTAMD-VATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNI 79
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L + D +V E++ GSL +++ ++ + R + LE+LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH- 133
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
++IHR+I ++L+ D ++ DFG + ++ ST + GT ++APE
Sbjct: 134 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447
+ K DI+S G++ ++ G+ P + ++L N + +
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
+ + C D E+R ++K++
Sbjct: 247 RD--------FLNR----CLDMDVEKRGSAKEL 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-40
Identities = 52/296 (17%), Positives = 104/296 (35%), Gaps = 40/296 (13%)
Query: 208 LEKIRSRASGEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI- 262
+ + + A G++ A +A+K +K + + + +E+ +
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL---TEREALMSELKVLSYLG 84
Query: 263 RHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILND--------------VSQGRRELEW 308
H NIV LL L+++E+ G LL L + L+
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 309 LARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ 368
+ + G+ +L IHR++ ++L+ +I DFGLAR + +
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 369 VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR 428
V V ++APE ++ + D++S+G+ L L + + +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--PYPGMPVDSKFYK 259
Query: 429 WMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSML 484
++ +P A + I C DP +RP K + ++
Sbjct: 260 MIKEGFRMLSPEHAPAE-------------MYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-39
Identities = 57/298 (19%), Positives = 116/298 (38%), Gaps = 33/298 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+ + + + +A + AIK +++ + + K+ V E ++ H
Sbjct: 13 GKILGEGSFSTVVLARELA-TSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L + + KNG LL+ + + E R A + L
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEI----VSALEY 123
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
H IIHR++ P ++L+++DM +I DFG A+++ Q + GT Y++PE
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT--SENPNRAIDS 445
+ D+++ G ++ LV G P F E + ++ + +A D
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPP---FRAGNEYLIFQKIIKLEYDFPEKFFPKARD- 239
Query: 446 KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKDVDFLKMHKR 501
L+ E++L++ D +R +++ L + V + +H++
Sbjct: 240 -LV-----EKLLVL----------DATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-39
Identities = 64/283 (22%), Positives = 107/283 (37%), Gaps = 28/283 (9%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIK--MRQVRAEIMTAGQIRHR 265
LEK+ + G + E +GK +++ VK + +L+ M E+ + HR
Sbjct: 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVA-VKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYL 325
N++ L ++ P + V+E GSLL+ L + R A + G+ YL
Sbjct: 72 NLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 326 HMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ-VSTSIVAGTVGYIAPE 384
R IHR++ ++L+ +I DFGL R +P V + APE
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 385 YHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAI 443
+T FS D + FGV L + G+ P + + L + + P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 444 DSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
+ + C PE+RP +R L +
Sbjct: 242 QD-------------IYNVMVQCWAHKPEDRPTFVALRDFLLE 271
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-38
Identities = 45/278 (16%), Positives = 99/278 (35%), Gaps = 23/278 (8%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
++ + S A G +Y K+ +K++ + +++ E + + ++
Sbjct: 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 73
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
LL + L+ + M G LL+ + + + + I G+ YL
Sbjct: 74 CRLLGICLTSTVQLIT-QLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
R++HR++ +VL+ +I DFGLA+L+ + + ++A E
Sbjct: 130 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447
++ + D++S+GV + L+ + + + P
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPASEISSILEKGERLPQPPICTID-- 241
Query: 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485
V I C + D + RP +++ S
Sbjct: 242 -----------VYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-37
Identities = 48/289 (16%), Positives = 109/289 (37%), Gaps = 32/289 (11%)
Query: 208 LEKIRSRASGEIYIAEL----PESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR 263
++ + G +Y + +AIK V + + + + E +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS---MRERIEFLNEASVMKEFN 81
Query: 264 HRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQG------RRELEWLARHRIARG 317
++V LL + + L++ E M G L L + ++A
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 318 IVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGT 377
I G+ YL+ + +HR++ + ++ +D +I DFG+ R + +
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 378 VGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437
V +++PE + F+ D++SFGV+L + +Q + ++R++ +
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVMEGGLLD 255
Query: 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
P+ D + ++ C +P+ RP+ ++ S + +
Sbjct: 256 KPDNCPDM-------------LFELMRMCWQYNPKMRPSFLEIISSIKE 291
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-36
Identities = 55/280 (19%), Positives = 102/280 (36%), Gaps = 27/280 (9%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
I G+++ +A+ +K N + + E +T Q H +I
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVA-IKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L+ + + ++ E G L L + L+ + A + + L
Sbjct: 71 VKLIGVITE-NPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTAL---AY 123
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
R +HR+I +VL+ + ++ DFGL+R M D ++ + ++APE
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK-LPIKWMAPESIN 182
Query: 388 TLKFSEKCDIYSFGVLL-AVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSK 446
+F+ D++ FGV + +L+ G P + + R M P
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS-- 240
Query: 447 LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
L+ K C DP RP ++++ LS
Sbjct: 241 -----------LMTK----CWAYDPSRRPRFTELKAQLST 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 1e-36
Identities = 60/297 (20%), Positives = 113/297 (38%), Gaps = 41/297 (13%)
Query: 208 LEKIRSRASGEIYIAELPESN------GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQ 261
+ + A G++ +AE + +A+K +K + + +E+
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEMEMMKM 74
Query: 262 I-RHRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEIL------------NDVSQGRRELEW 308
I +H+NI+ LL + ++ E+ G+L E L N +L
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 309 LARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQ 368
A + G+EYL + IHR++ +VL+ +D +IADFGLAR +
Sbjct: 135 KDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 369 VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR 428
T+ V ++APE ++ + D++SFGVLL + + + L +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPGVPVEELFK 248
Query: 429 WMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485
++ + P+ + + + C P +RP K + L
Sbjct: 249 LLKEGHRMDKPSNCTNE-------------LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 137 bits (345), Expect = 1e-36
Identities = 58/275 (21%), Positives = 101/275 (36%), Gaps = 30/275 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
E++ + A G ++ G A K V S VR EI T +RH +
Sbjct: 31 HEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPHES----DKETVRKEIQTMSVLRHPTL 85
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L + +++ EFM G L E + D ++ R + GL ++
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHM-- 140
Query: 328 YHRPRIIHRNITPSSVLI--DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEY 385
H +H ++ P +++ E ++ DFGL + + T+ GT + APE
Sbjct: 141 -HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV 196
Query: 386 HQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS 445
+ D++S GVL +L+ G P F + +R +++ + +D
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSP----FGGENDDETLRNVKSC------DWNMDD 246
Query: 446 KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
E+ + K L DP R
Sbjct: 247 SAFSGISEDGKDFIRK----LLLADPNTRMTIHQA 277
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-36
Identities = 61/297 (20%), Positives = 129/297 (43%), Gaps = 37/297 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+ + + G++++AE ++ + AIK +K+ + + + + + + H +
Sbjct: 7 HKMLGKGSFGKVFLAEFKKT-NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+ + V E++ G L+ + Q + + A I+ GL++LH
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
I++R++ ++L+D D +IADFG+ + G A+ +T GT YIAPE
Sbjct: 122 KG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILL 176
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN---VMTSENPNRAID 444
K++ D +SFGVLL +++G+ P F +E+ L +R A D
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEELFHSIRMDNPFYPRWLEKEAKD 232
Query: 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDVDFLKMHKR 501
L++K + +PE+R + + L +++++ ++ ++
Sbjct: 233 -------------LLVK----LFVREPEKRLGVRG---DIRQHPLFREINWEELERK 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 5e-36
Identities = 59/275 (21%), Positives = 100/275 (36%), Gaps = 31/275 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
E + G ++ S+ K K VK + V+ EI RHRNI
Sbjct: 10 AEDLGRGEFGIVHRCVET-SSKKTYMAKFVK-----VKGTDQVLVKKEISILNIARHRNI 63
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+ L + +++ EF+ + E +N EL + L++L
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFL-- 118
Query: 328 YHRPRIIHRNITPSSVLID--DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEY 385
H I H +I P +++ +I +FG AR + G + ++ Y APE
Sbjct: 119 -HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEV 174
Query: 386 HQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS 445
HQ S D++S G L+ VL+ G P F T ++ + M N D
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINP---FLAETNQQIIENIM-------NAEYTFDE 224
Query: 446 KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
+ E M V + + + + R + +
Sbjct: 225 EAFKEISIEAMDFVDR----LLVKERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (337), Expect = 6e-36
Identities = 62/276 (22%), Positives = 115/276 (41%), Gaps = 31/276 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+ + + A E+ +AE + K++AIK + L K + EI +I+H NI
Sbjct: 14 RDVLGTGAFSEVILAEDKRT-QKLVAIKCIA---KKALEGKEGSMENEIAVLHKIKHPNI 69
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L L+ + + G L + + + + R+ ++ ++YLH
Sbjct: 70 VALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD 125
Query: 328 YHRPRIIHRNITPSSVLI---DDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE 384
I+HR++ P ++L D+D + I+DFGL+++ G S GT GY+APE
Sbjct: 126 LG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPE 179
Query: 385 YHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444
+S+ D +S GV+ +L+ G P F+ + K + ++ ++P
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPP---FYDENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
S + + DPE+R +
Sbjct: 237 SDSAKD-------FIRH----LMEKDPEKRFTCEQA 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 133 bits (335), Expect = 3e-35
Identities = 51/275 (18%), Positives = 99/275 (36%), Gaps = 30/275 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
LE++ S A G ++ ++ G++ K + + V+ EI Q+ H +
Sbjct: 34 LEELGSGAFGVVHRCVE-KATGRVFVAKFINTPYP----LDKYTVKNEISIMNQLHHPKL 88
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+ L +L+ EF+ G L + + + ++ R GL+++
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHM-- 143
Query: 328 YHRPRIIHRNITPSSVLID--DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEY 385
H I+H +I P +++ + +I DFGLA + + T + APE
Sbjct: 144 -HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEI 199
Query: 386 HQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS 445
D+++ GVL VL+ G P F + ++L R + + S
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSP---FAGEDDLETLQNVKRCDWEFDEDAFSSVS 256
Query: 446 KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
+ + +P +R D
Sbjct: 257 PEAKD-------FIKN----LLQKEPRKRLTVHDA 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-34
Identities = 52/296 (17%), Positives = 108/296 (36%), Gaps = 37/296 (12%)
Query: 208 LEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR 263
+ + A G++ A+ + + +A+K +K+ + + + +
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE--GATHSEHRALMSELKILIHIGH 75
Query: 264 HRNIVPLLAHMVRPDCHL-LVSEFMKNGSLLEILND------------VSQGRRELEWLA 310
H N+V LL +P L ++ EF K G+L L + L
Sbjct: 76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 311 RHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVS 370
+ + G+E+L + IHR++ ++L+ + +I DFGLAR + V
Sbjct: 136 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 371 TSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM 430
+ ++APE ++ + D++SFGVLL + + ++ R +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--PYPGVKIDEEFCRRL 250
Query: 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
+ P+ + + C +P +RP ++ L +
Sbjct: 251 KEGTRMRAPDYTTPE-------------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 127 bits (319), Expect = 9e-34
Identities = 58/285 (20%), Positives = 110/285 (38%), Gaps = 37/285 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKM-----RQVRAEIMTAGQI 262
E + S + + K A+K + + + E+ ++
Sbjct: 8 KEILGRGVSSVVRRCIH-KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 263 R-HRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSG 321
H NI+ L LV + MK G L + L + + L +I R ++
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEV 122
Query: 322 LEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI 381
+ LH + I+HR++ P ++L+DDDM ++ DFG + + G V GT Y+
Sbjct: 123 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYL 176
Query: 382 APEYHQT------LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435
APE + + ++ D++S GV++ L+ G P F+ + L M
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP---FWHRKQMLMLRMIMSGNYQ 233
Query: 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
+P S + + LV + + P++R +++
Sbjct: 234 FGSPEWDDYSDTVKD-------LVSR----FLVVQPQKRYTAEEA 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (315), Expect = 5e-33
Identities = 57/288 (19%), Positives = 105/288 (36%), Gaps = 33/288 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
KI S + G+IY+ + G+ +AIK + K Q+ E ++
Sbjct: 12 GRKIGSGSFGDIYLGTD-IAAGEEVAIKLEC------VKTKHPQLHIESKIYKMMQGGVG 64
Query: 268 VPLL-AHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
+P + D +++V E + R+ +A ++S +EY+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIH 120
Query: 327 MYHRPRIIHRNITPSSVLI---DDDMEARIADFGLARLMPDGHAQV-----STSIVAGTV 378
IHR++ P + L+ I DFGLA+ D + GT
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 379 GYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438
Y + H ++ S + D+ S G +L +G LP T+ + R M+
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--- 234
Query: 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
++L GY + L C +++P+ +R + +
Sbjct: 235 ----TPIEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQLFRN 275
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 124 bits (312), Expect = 8e-33
Identities = 54/275 (19%), Positives = 107/275 (38%), Gaps = 28/275 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
E + E+++A + +A+K ++ D + + R E A + H I
Sbjct: 12 GEILGFGGMSEVHLARDLR-LHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 268 VPLLAHMVRPD----CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLE 323
V + +V E++ +L +I++ + + L
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALN 125
Query: 324 YLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR-LMPDGHAQVSTSIVAGTVGYIA 382
+ H + IIHR++ P++++I ++ DFG+AR + G++ T+ V GT Y++
Sbjct: 126 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 383 PEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442
PE + + D+YS G +L ++ G+ P F + + +R +
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS 477
S L +VLK +PE R +
Sbjct: 240 GLSADLDA-------VVLK----ALAKNPENRYQT 263
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-32
Identities = 55/279 (19%), Positives = 112/279 (40%), Gaps = 31/279 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVK--QVDNSLLNIKMRQVRAEIMTAGQIRHR 265
E++ S + +S G A K +K + +S + + E+ +I+H
Sbjct: 15 GEELGSGQFAVVKKCRE-KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYL 325
N++ L +L+ E + G L + L + + L + I++G+
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGV--- 126
Query: 326 HMYHRPRIIHRNITPSSVLIDDDMEAR----IADFGLARLMPDGHAQVSTSIVAGTVGYI 381
+ H +I H ++ P ++++ D + I DFGLA + G+ + GT ++
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFV 183
Query: 382 APEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441
APE + D++S GV+ +L+ G P F T++++L E+
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVNYEFEDEYF 240
Query: 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
+ S L + + + + DP++R +D
Sbjct: 241 SNTSALAKD-------FIRR----LLVKDPKKRMTIQDS 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 4e-32
Identities = 58/288 (20%), Positives = 105/288 (36%), Gaps = 28/288 (9%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKM-RQVRAEIMTAGQIRHRN 266
L+ + +Y A + +++AIKK+K S + R EI ++ H N
Sbjct: 3 LDFLGEGQFATVYKARDKNT-NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 267 IVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLH 326
I+ LL LV +FM+ + I L + GLEYLH
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 327 MYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
+ I+HR++ P+++L+D++ ++ADFGLA+ + + + T Y APE
Sbjct: 118 ---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELL 172
Query: 387 QTLK-FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS 445
+ + D+++ G +LA L++ ++ L R + T
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPF---LPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 446 KLLGNGYEEQMLLVLKIACFCTLD-------------DPEERPNSKDV 480
L + + F +P R +
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 122 bits (306), Expect = 8e-32
Identities = 45/289 (15%), Positives = 101/289 (34%), Gaps = 33/289 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+I + G I+ N + +AIK + Q+R E T +
Sbjct: 10 GRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPR------RSDAPQLRDEYRTYKLLAGCTG 62
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+P + + + H ++ + SL ++L+ R+ A+ +++ ++ +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIH- 118
Query: 328 YHRPRIIHRNITPSSVLIDDDME-----ARIADFGLARLMPDG-----HAQVSTSIVAGT 377
+++R+I P + LI + DFG+ + D ++GT
Sbjct: 119 --EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 378 VGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437
Y++ H + S + D+ + G + + G LP T ++ R +
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-- 234
Query: 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSD 486
+ L G+ E+ + + P+ ++ + S
Sbjct: 235 -----TPLRELCAGFPEEFYKYMHY---ARNLAFDATPDYDYLQGLFSK 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (307), Expect = 1e-31
Identities = 55/296 (18%), Positives = 123/296 (41%), Gaps = 35/296 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L + + + G +++ NG+ A+K +K+ + + ++ E + + H I
Sbjct: 9 LRTLGTGSFGRVHLIRS-RHNGRYYAMKVLKK-EIVVRLKQVEHTNDERLMLSIVTHPFI 66
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+ + ++ ++++ G L +L + +R +A+ A + L
Sbjct: 67 IRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAK-FYAAEV---CLALEY 119
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
H II+R++ P ++L+D + +I DFG A+ +PD + GT YIAPE
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVS 174
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447
T +++ D +SFG+L+ ++ G P D + ++ ++ +E ++
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYD-------SNTMKTYEKILNAELRFPPFFNED 227
Query: 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSK--DVRSMLSDTALIKDVDFLKMHKR 501
+ + L+ + D +R + + + K+V + K+ R
Sbjct: 228 VKD-------LLSR----LITRDLSQRLGNLQNGTEDVKNH-PWFKEVVWEKLLSR 271
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 5e-31
Identities = 55/287 (19%), Positives = 112/287 (39%), Gaps = 22/287 (7%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVK-QVDNSLLNIKMRQVRAEIMTAGQIRHRN 266
+ +I A G+++ A ++ G+ +A+K+V+ Q + + + A + H N
Sbjct: 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71
Query: 267 IVPLLAHMVRP----DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGL 322
+V L + L + + L L+ V + E + + ++ GL
Sbjct: 72 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD--MMFQLLRGL 129
Query: 323 EYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIA 382
++LH R++HR++ P ++L+ + ++ADFGLAR+ A S V T+ Y A
Sbjct: 130 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVVTLWYRA 183
Query: 383 PEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDD---------FFQHTEEKSLVRWMRNV 433
PE ++ D++S G + A + K W R+V
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 434 MTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
+ ++ + + L + C +P +R ++
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 120 bits (302), Expect = 1e-30
Identities = 64/298 (21%), Positives = 107/298 (35%), Gaps = 31/298 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKV--KQVDNSLLNIKMRQVRAEIMTAGQIRHR 265
I GE+Y + GKM A+K + K++ R +
Sbjct: 9 HRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 266 NIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYL 325
IV + PD + + M G L L SQ E R A I+ GLE++
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMR-FYAAEIILGLEHM 123
Query: 326 HMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEY 385
H +++R++ P+++L+D+ RI+D GLA GT GY+APE
Sbjct: 124 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEV 176
Query: 386 HQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444
Q + + D +S G +L L+ G P F+ + K R +T
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 445 SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS-KDVRSMLSDTALIKDVDFLKMHKR 501
S L + L+ D R + ++ + +D+ + +
Sbjct: 233 SPELRS-------LLEG----LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQ 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-30
Identities = 65/334 (19%), Positives = 124/334 (37%), Gaps = 32/334 (9%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L I A G + A N +AIKK+ ++ ++ EI + RH NI
Sbjct: 13 LSYIGEGAYGMVCSAYDNV-NKVRVAIKKISPFEHQ---TYCQRTLREIKILLRFRHENI 68
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+ + + P + ++ + L + + + L I+ GL+Y+H
Sbjct: 69 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIH- 126
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVST-SIVAGTVGYIAPEY- 385
++HR++ PS++L++ + +I DFGLAR+ H + T Y APE
Sbjct: 127 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 386 HQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS 445
+ +++ DI+S G +LA ++ + F L + + + +
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPI---FPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 446 KLLGNGYEEQMLLVLKI---ACFCTLD-------------DPEERPNSKDVRSM--LSDT 487
L Y + K+ F D +P +R + + L
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
Query: 488 ALIKDVDFLKMHKRMDFDNDD-CVELIQQEIYTE 520
D + + D + DD E +++ I+ E
Sbjct: 302 YDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEE 335
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-30
Identities = 56/281 (19%), Positives = 106/281 (37%), Gaps = 41/281 (14%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVK----QVDNSLLNIKMRQVRAEIMTAGQIR 263
+ S G +Y S+ +AIK V+ L N + ++
Sbjct: 9 GPLLGSGGFGSVYSGIR-VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 264 HRNIVPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLE 323
++ LL RPD +L+ E + L +++ E LAR ++ +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDF--ITERGALQEELARS-FFWQVLEAVR 124
Query: 324 YLHMYHRPRIIHRNITPSSVLID-DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIA 382
+ H ++HR+I ++LID + E ++ DFG L+ D + GT Y
Sbjct: 125 HCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSP 177
Query: 383 PEYHQTLKF-SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441
PE+ + ++ ++S G+LL +V G +P F+H EE + + +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEE---IIRGQVFFRQRVSSE 230
Query: 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRS 482
L+ C P +RP +++++
Sbjct: 231 CQH-------------LIRW----CLALRPSDRPTFEEIQN 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 8e-30
Identities = 59/285 (20%), Positives = 108/285 (37%), Gaps = 30/285 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+ I + + G +Y A+L +S G+++AIKKV Q R E+ ++ H NI
Sbjct: 25 TKVIGNGSFGVVYQAKLCDS-GELVAIKKVLQ--------DKRFKNRELQIMRKLDHCNI 75
Query: 268 VPLLAHMVRPDCH------LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSG 321
V L LV +++ + S+ ++ L + +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 322 LEYLHMYHRPRIIHRNITPSSVLIDDD-MEARIADFGLARLMPDGHAQVSTSIVAGTVGY 380
L Y+H I HR+I P ++L+D D ++ DFG A+ + G VS +
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYR 189
Query: 381 IAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440
++ D++S G +LA L++G+ F + LV ++ + T
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPI---FPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKD-VRSML 484
+ Y E +K + + P P + +L
Sbjct: 247 IREMNP----NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 287
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 115 bits (288), Expect = 2e-29
Identities = 64/287 (22%), Positives = 108/287 (37%), Gaps = 29/287 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
LEKI G +Y A+ G+ A+KK++ EI +++H NI
Sbjct: 7 LEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKED--EGIPSTTIREISILKELKHSNI 62
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L + +LV E + + LE + +++G+ Y H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCH- 117
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
R++HR++ P ++LI+ + E +IADFGLAR + + +
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMG 174
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447
+ K+S DI+S G + A +V G F +E L+R R + T + N ++L
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPL---FPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 448 LGNGYEEQMLLVLKIACF--------------CTLDDPEERPNSKDV 480
+ L F DP +R +K
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 5e-29
Identities = 54/298 (18%), Positives = 110/298 (36%), Gaps = 36/298 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L+ + G++ + ++ G+ A+K +++ + + ++ E RH +
Sbjct: 10 LKLLGKGTFGKVILVRE-KATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
L D V E+ G L L+ + R E AR A + L
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEI----VSALEY 120
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
H +++R+I ++++D D +I DFGL + A GT Y+APE +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLE 178
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT--SENPNRAIDS 445
+ D + GV++ ++ G+LP F+ E+ + + A
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHERLFELILMEEIRFPRTLSPEAKS- 234
Query: 446 KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSK--DVRSMLSDTALIKDVDFLKMHKR 501
LL +L DP++R D + ++ +++ + ++
Sbjct: 235 -LL-----AGLLKK----------DPKQRLGGGPSDAKEVMEH-RFFLSINWQDVVQK 275
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 6e-29
Identities = 65/292 (22%), Positives = 117/292 (40%), Gaps = 37/292 (12%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
+EKI G +Y A + G+++A+KK++ + EI ++ H NI
Sbjct: 7 VEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNI 63
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V LL + + LV EF+ + + + ++ GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMD---ASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE-YH 386
R++HR++ P ++LI+ + ++ADFGLAR + + T+ Y APE
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILL 175
Query: 387 QTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE--------- 437
+S DI+S G + A +V + F +E L R R + T +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRAL---FPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 438 ---------NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
R SK++ E+ L+ ++ + DP +R ++K
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHY----DPNKRISAKAA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 5e-28
Identities = 50/274 (18%), Positives = 101/274 (36%), Gaps = 36/274 (13%)
Query: 215 ASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLL-- 271
+G++ + A+K ++ + R E+ + + +IV ++
Sbjct: 24 INGKVLQIFNKR-TQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 272 --AHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH 329
C L+V E + G L + D +G + I + I ++YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 330 RPRIIHRNITPSSVLIDDDME---ARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYH 386
I HR++ P ++L ++ DFG A+ ++ + T Y+APE
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVL 185
Query: 387 QTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSK 446
K+ + CD++S GV++ +L+ G P F ++ M+ + +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTRIRMGQYE--FPNP 239
Query: 447 LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDV 480
EE +L+ +P +R +
Sbjct: 240 EWSEVSEEVKMLIRN----LLKTEPTQRMTITEF 269
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 9e-28
Identities = 52/288 (18%), Positives = 110/288 (38%), Gaps = 29/288 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
LEKI G ++ A+ E+ +++A+K+V+ D+ EI +++H+NI
Sbjct: 7 LEKIGEGTYGTVFKAKNRET-HEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNI 63
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L + LV EF ++ +L+ ++ GL + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
++HR++ P ++LI+ + E ++A+FGLAR + ++ V
Sbjct: 120 R---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFG 175
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM--TSENPNRAIDS 445
+S D++S G + A L P F + ++ + ++ +E ++
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRP---LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 446 KLLGNGYEEQMLLVLKIACFCTLD-------------DPEERPNSKDV 480
Y + L+ +P +R ++++
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-27
Identities = 56/289 (19%), Positives = 104/289 (35%), Gaps = 26/289 (8%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L KI GE++ A G+ +A+KKV + EI ++H N+
Sbjct: 15 LAKIGQGTFGEVFKARH-RKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENV 71
Query: 268 VPLL--------AHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIV 319
V L+ + LV +F ++ + N + R+ + +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQML- 126
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSI--VAGT 377
L L+ HR +I+HR++ ++VLI D ++ADFGLAR T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 378 VGYIAPEYHQTLK-FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436
+ Y PE + + D++ G ++A + Q E+ + + + S
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQLALISQLCGS 240
Query: 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKD-VRSML 484
P + + +++ K L P + D + +L
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 289
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-27
Identities = 59/333 (17%), Positives = 121/333 (36%), Gaps = 37/333 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L+ + S A G + A G +AIKK+ + S + ++ E+ +RH N+
Sbjct: 23 LQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHENV 79
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+ LL + ++F + +L + ++ GL Y+H
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
HR++ P ++ +++D E +I DFGLAR T V
Sbjct: 140 AGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVVTRWYRAPEVILN 192
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447
+++++ DI+S G ++A ++ GK F+ ++ ++ + V + +
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTL----FKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 448 LGNGYEEQMLLVLKIACFCTLD-----------------DPEERPNSKDVRSM-----LS 485
+ L L+ F ++ D E+R + + + L
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
Query: 486 DTALIKDVD-FLKMHKRMDFDNDDCVELIQQEI 517
DT V + +D D+ + +E+
Sbjct: 309 DTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEV 341
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 4e-26
Identities = 61/301 (20%), Positives = 118/301 (39%), Gaps = 30/301 (9%)
Query: 208 LEKIRSRASGEIYIAELP--ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHR 265
L+ + + A G++++ GK+ A+K +K+ R E IR
Sbjct: 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88
Query: 266 NIVPLLAHMVRPDCHLLVS-EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEY 324
+ L + + + L + +++ G L L+ R IV LE+
Sbjct: 89 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEH 144
Query: 325 LHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPE 384
LH + II+R+I ++L+D + + DFGL++ + GT+ Y+AP+
Sbjct: 145 LH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPD 200
Query: 385 YHQTLK--FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442
+ + D +S GVL+ L+ G P F E+ S R ++ SE P
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASP---FTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNS--KDVRSMLSDTALIKDVDFLKMHK 500
S L + L+ + + DP++R +D + + +++ +
Sbjct: 258 EMSALAKD-------LIQR----LLMKDPKKRLGCGPRDADEIKEH-LFFQKINWDDLAA 305
Query: 501 R 501
+
Sbjct: 306 K 306
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (266), Expect = 6e-26
Identities = 51/296 (17%), Positives = 108/296 (36%), Gaps = 35/296 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
++ + + + G + + + E +G A+K + + + ++ E + +
Sbjct: 46 IKTLGTGSFGRVMLVKHKE-SGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
V L +V E++ G + L A IV EYLH
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLH- 158
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
+I+R++ P ++LID ++ DFG A+ + + GT +APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEALAPEIIL 211
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447
+ +++ D ++ GVL+ + G P F + + + + + + D K
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVSGKVRFPSHFSSDLKD 267
Query: 448 LGNGYEEQMLLVLKIACFCTLDDPEERPNSK--DVRSMLSDTALIKDVDFLKMHKR 501
L +L V D +R + V + + D++ +++R
Sbjct: 268 L----LRNLLQV----------DLTKRFGNLKNGVNDIKNH-KWFATTDWIAIYQR 308
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (253), Expect = 2e-24
Identities = 51/242 (21%), Positives = 99/242 (40%), Gaps = 29/242 (11%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRN 266
+ K+ E++ A N + + +K +K +K ++++ EI +R N
Sbjct: 40 VRKLGRGKYSEVFEAINIT-NNEKVVVKILK-------PVKKKKIKREIKILENLRGGPN 91
Query: 267 IVPLLAHMVRPDCHL--LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEY 324
I+ L + P LV E + N ++ + L I+ L+Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDY 144
Query: 325 LHMYHRPRIIHRNITPSSVLID-DDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAP 383
H I+HR++ P +V+ID + + R+ D+GLA G ++ + + P
Sbjct: 145 CHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGP 198
Query: 384 EYHQTLK-FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442
E + + D++S G +LA ++ K P FF + + + V+ +E+
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTEDLYDY 255
Query: 443 ID 444
ID
Sbjct: 256 ID 257
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.6 bits (234), Expect = 7e-22
Identities = 64/332 (19%), Positives = 122/332 (36%), Gaps = 35/332 (10%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L + S A G + A + G +A+KK+ + S+++ K + E+ ++H N+
Sbjct: 23 LSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAK--RTYRELRLLKHMKHENV 79
Query: 268 VPLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHM 327
+ LL ++ L+ + ++L + I+ GL+Y+
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI-- 137
Query: 328 YHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQ 387
H IIHR++ PS++ +++D E +I DFGLAR D T VA
Sbjct: 138 -HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLN 192
Query: 388 TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDSKL 447
+ +++ DI+S G ++A L+ G+ F L +R V T S
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTL---FPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 448 LGNGYEEQMLLVLKIACFCTLD----------------DPEERPNSKDVRSM--LSDTAL 489
Y + + + K+ D ++R + + +
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 490 IKDVD----FLKMHKRMDFDNDDCVELIQQEI 517
D + + + D D+ L E+
Sbjct: 310 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEV 341
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.7 bits (229), Expect = 4e-21
Identities = 70/348 (20%), Positives = 126/348 (36%), Gaps = 54/348 (15%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNI 267
L+ I S A G + A + +AIKK+ + + ++ E++ + H+NI
Sbjct: 22 LKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNI 78
Query: 268 VPLLAHMVRPDC------HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSG 321
+ LL LV E M I + EL+ + ++ G
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQMLCG 131
Query: 322 LEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYI 381
+++LH IHR++ PS++++ D +I DFGLAR + T Y
Sbjct: 132 IKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYR 185
Query: 382 APEYHQTLKFSEKCDIYSFGVLLAVLVMGKLP------SDDFFQHTEE---------KSL 426
APE + + E DI+S G ++ +V K+ D + + E+ K L
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 427 VRWMRNVMTSENPNRAID-SKLLGNGYEEQMLLVLKIACFCTLD--------DPEERPNS 477
+RN + + + KL + K+ D DP +R +
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 478 KDVRS--------MLSDTALIKDVDFLKMHKRMDFDNDDCVELIQQEI 517
D ++ + K + ++ ELI +E+
Sbjct: 306 DDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEV 353
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.0 bits (214), Expect = 3e-19
Identities = 54/300 (18%), Positives = 107/300 (35%), Gaps = 18/300 (6%)
Query: 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIK-----MRQVR-AEIMTAGQ 261
+ K+ +++A+ N +A+K V+ + +++V A+
Sbjct: 18 VRKLGWGHFSTVWLAKD-MVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 262 IRHRNIVPLLAHMV--RPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIV 319
+ +I+ LL H P+ +V F G L L + R + +I++ ++
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK-QISKQLL 135
Query: 320 SGLEYLHMYHRPRIIHRNITPSSVLID-DDMEARIADFGLARLMPDGHAQVSTSIVAGTV 378
GL+Y+H R IIH +I P +VL++ D + +A L + T
Sbjct: 136 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 379 GYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV-MTSE 437
Y +PE + DI+S L+ L+ G + H+ K + + + E
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
Query: 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALIKDVDFLK 497
P+ + + + L+ I+ + + DFL
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS----DFLS 309
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 63.3 bits (153), Expect = 3e-12
Identities = 19/191 (9%), Positives = 60/191 (31%), Gaps = 12/191 (6%)
Query: 209 EKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIV 268
+ + ++ +K K S +K ++ ++ +
Sbjct: 6 KLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 269 PLLAHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY 328
+ + + + G+ + + ++ + + I+ + +
Sbjct: 64 EF-RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY-- 120
Query: 329 HRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT 388
I+H +++ +VL+ + I DF + + + + I+ V I + +
Sbjct: 121 -HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWR---EILERDVRNIITYFSR- 174
Query: 389 LKFSEKCDIYS 399
+ + DI S
Sbjct: 175 -TYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 531 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.39 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.7 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.58 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.4 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.07 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=413.98 Aligned_cols=256 Identities=21% Similarity=0.321 Sum_probs=204.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|++++.||+|+||+||+|.... +|+.||||++....... ..+.+.+|+.+|++++|||||++++++.+++..|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~~---~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVD---CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEehhhcch---HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence 4679999999999999999998764 78999999997643221 2456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+|||||++|+|.+++.. ...+++..+..++.|+++||.||| +++|+||||||+|||++.++++||+|||+++.
T Consensus 80 ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 152 (271)
T ss_dssp EEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhhee
Confidence 99999999999999854 567999999999999999999999 67899999999999999999999999999998
Q ss_pred CCCCCccceecccccCccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKF-SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
+............+||+.|+|||++.+..+ +.++|||||||++|||+||+.||...... ........ ... ..
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~~~~~---~~~-~~ 225 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDWK---EKK-TY 225 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT---SHHHHHHH---TTC-TT
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH---HHHHHHHh---cCC-CC
Confidence 755433333345789999999999988876 57899999999999999999999754321 11111111 111 11
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.... ......+.+++.+||+.||.+|||+.+++++
T Consensus 226 ~~~~--------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 LNPW--------KKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp STTG--------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCcc--------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1001 1112347789999999999999999998763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=411.98 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=208.5
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|..++.||+|+||+||+|.... +|+.||||++....... .+.+.+|+.+|++++|||||++++++.+.+.+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~-~~~~vAvK~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQPK----KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTT-TCCEEEEEEEEGGGCSC----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECC-CCCEEEEEEEecccChH----HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence 3579999999999999999998654 79999999997644332 567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+|||||+||+|.+++.. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++++||+|||+++.
T Consensus 94 ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (293)
T ss_dssp EEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhhee
Confidence 99999999999998864 46899999999999999999999 67899999999999999999999999999998
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
+...... ....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+... ...+.. ....+.+..
T Consensus 166 ~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~----~~~~~~~~~ 236 (293)
T d1yhwa1 166 ITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYL----IATNGTPEL 236 (293)
T ss_dssp CCSTTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHH----HHHHCSCCC
T ss_pred ecccccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHHHHH----HHhCCCCCC
Confidence 7554322 2346799999999999999999999999999999999999999976422 112221 122222211
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+. ....+.+++.+||+.||.+|||+.++++|
T Consensus 237 ~~~~~--------~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 QNPEK--------LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SSGGG--------SCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCccc--------CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111 12347889999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-52 Score=409.82 Aligned_cols=260 Identities=24% Similarity=0.363 Sum_probs=213.6
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|+||+||+|.+.. +|+.||||+++..... .+++.+|+.+|++++|||||+++++|.+++..++
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTME-----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGG-GTEEEEEEECCTTCSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECC-CCeEEEEEEECCccch-----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 568889999999999999998764 6899999999764432 5678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|||||++|+|.+++.. .....+++..+..++.||++||.||| +++|+||||||+|||++.++++||+|||+++..
T Consensus 91 v~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999975 44567999999999999999999999 678999999999999999999999999999977
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
...... ......||+.|+|||++.+..|+.++|||||||++|||++|..||.... ....+...+........+
T Consensus 166 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~---~~~~~~~~i~~~~~~~~~--- 238 (287)
T d1opja_ 166 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLEKDYRMERP--- 238 (287)
T ss_dssp CSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHHHHTTCCCCCC---
T ss_pred CCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc---hHHHHHHHHhcCCCCCCC---
Confidence 654332 2344568999999999999999999999999999999999877754322 223333333221111111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCC
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALI 490 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 490 (531)
... ...+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 239 -------~~~---~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 239 -------EGC---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp -------TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred -------ccc---hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 111 12478899999999999999999999999876543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=406.09 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=199.0
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|...+.||+|+||+||+|.+. +++.||||+++..... .+.+.+|+.++++++|||||+++|+|..++..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET--TTEEEEEEECCSSSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC--CCCEEEEEEECCCcCc-----HHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 46888999999999999999875 6788999999764433 4568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|||||++|+|.+++.. ....+++..+..++.|+++||.||| +++|+||||||+|||++.++++||+|||+++..
T Consensus 78 v~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp EEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred EEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheec
Confidence 9999999999999864 3466899999999999999999999 678999999999999999999999999999877
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMG-KLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
....... .....||+.|+|||++.+..|+.++|||||||++|||+|+ .+||... ....+...+........
T Consensus 152 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~----~~~~~~~~i~~~~~~~~--- 223 (263)
T d1sm2a_ 152 LDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----SNSEVVEDISTGFRLYK--- 223 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC----CHHHHHHHHHHTCCCCC---
T ss_pred cCCCcee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC----CHHHHHHHHHhcCCCCC---
Confidence 5543322 2345789999999999999999999999999999999995 5554432 22333333332211111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
+.. . ...+.+++.+||+.||++|||+.+|+++|+++.
T Consensus 224 ---p~~----~---~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 224 ---PRL----A---STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp ---CTT----S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---ccc----c---CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 111 1 124788999999999999999999999998763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=409.88 Aligned_cols=262 Identities=21% Similarity=0.363 Sum_probs=202.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|.+.+.||+|+||+||+|++. + .||||+++...... ...+.|.+|+.+|++++|||||++++++.. +.++
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~-~vAvK~~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---G-DVAVKMLNVTAPTP--QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---S-EEEEEECCCSSCCT--THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---C-EEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 467888999999999999999763 3 59999997543332 226789999999999999999999998754 5689
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+|||||++|+|.+++.. ....+++..+..++.||++||.||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 80 lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp EEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred EEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceee
Confidence 99999999999999964 2456999999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQT---LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
..............||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+... ...+...+......+.
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~---~~~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQIIFMVGRGYLSPD 230 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHHHHHHHTSCCCC
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh---HHHHHHHHhcCCCCCc
Confidence 765444334455789999999999864 3589999999999999999999999976532 1222222222111111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.. .. ...+ ...+.+++.+||+.||.+|||+.+|+++|+.+.
T Consensus 231 ~~-----~~-~~~~---~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 231 LS-----KV-RSNC---PKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp GG-----GS-CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ch-----hc-cccc---hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 00 01 1111 234788999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=408.84 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=197.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe--CCce
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR--PDCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~ 280 (531)
++|++++.||+|+||+||+|.... +|+.||||.+....... ...+.+.+|+.+|++++|||||++++++.+ ...+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECCTTSCH--HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEChhhCCH--HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 578999999999999999998754 78999999997654332 236778999999999999999999999865 4568
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH--RPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
|+|||||++|+|.+++.........+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 9999999999999999764444578999999999999999999999642 23599999999999999999999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
++.+...... .....||+.|+|||++.+..|+.++|||||||++|||+||+.||.+... ..+...+. ....
T Consensus 161 a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~----~~~~~~i~---~~~~ 231 (269)
T d2java1 161 ARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIR---EGKF 231 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH---HTCC
T ss_pred eeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH----HHHHHHHH---cCCC
Confidence 9987654322 2346799999999999999999999999999999999999999976422 22222222 1111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. + +..++ ..+.+++.+||+.||.+|||+.+++++
T Consensus 232 ~~--~-----~~~~s---~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 RR--I-----PYRYS---DELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CC--C-----CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC--C-----CcccC---HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11 1 11111 247889999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-52 Score=403.48 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=206.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.+.||+|+||+||+|.... +|+.||+|++....... ......+.+|+.++++++|||||++++++.+++..|+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECC-CCcEEEEEEEchHHccC-hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 568999999999999999998764 78999999997533221 1225678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|||||++|+|.+++.. ...+++..+..++.||++||.||| +++|+||||||+|||++.++.+||+|||++...
T Consensus 84 vmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeec
Confidence 9999999999999975 457999999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
.... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+... ..+.. ...... +.
T Consensus 157 ~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~---~i~~~~-~~-- 222 (263)
T d2j4za1 157 PSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----QETYK---RISRVE-FT-- 222 (263)
T ss_dssp CCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHH---HHHTTC-CC--
T ss_pred CCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH----HHHHH---HHHcCC-CC--
Confidence 5442 2346799999999999999999999999999999999999999976422 22222 111111 11
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. ... ...+.+++.+||+.||.+|||+.++++|
T Consensus 223 ~p-----~~~---s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 223 FP-----DFV---TEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CC-----TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CC-----ccC---CHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 10 111 1247789999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=409.90 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=207.1
Q ss_pred hhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 200 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.+++.|.+++.||+|+||+||+|.... +|+.||||++....... .+.+.+|+.+|++++|||||++++++.+++.
T Consensus 9 ~p~d~Y~i~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~----~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 9 NPEDFWEIIGELGDGAFGKVYKAQNKE-TSVLAAAKVIDTKSEEE----LEDYMVEIDILASCDHPNIVKLLDAFYYENN 83 (288)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECSSSGG----GGGTHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CcccCeEEeEEEeeCCCcEEEEEEECC-CCeEEEEEEECcCCHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe
Confidence 345778999999999999999998764 78999999997654333 5678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++|||||++|+|.+++... ...+++..+..++.||++||.||| +++|+||||||+|||++.++++||+|||++
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a 157 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS 157 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhh
Confidence 99999999999999998641 356999999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCccceecccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQ-----TLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
........ ......||+.|+|||++. +..|+.++|||||||++|||+||+.||.+..... .+. ...
T Consensus 158 ~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~----~i~ 228 (288)
T d2jfla1 158 AKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLL----KIA 228 (288)
T ss_dssp EECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH----HHH
T ss_pred hccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHH----HHH
Confidence 76533211 123467999999999984 4568999999999999999999999997653321 111 122
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
....+.....+ .....+.+++.+||+.||.+|||+.++++|
T Consensus 229 ~~~~~~~~~~~--------~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 229 KSEPPTLAQPS--------RWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HSCCCCCSSGG--------GSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cCCCCCCCccc--------cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22222111111 112347889999999999999999999774
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-51 Score=407.90 Aligned_cols=259 Identities=22% Similarity=0.366 Sum_probs=198.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCC--eEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNG--KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
++|...+.||+|+||+||+|.+...++ ..||||.+...... ...+.|.+|+.+|++++|||||+++|++..++.+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE---KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH---HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 567888999999999999998764322 36888888654332 2356799999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
++|||||++|+|.+++.. ....+++..+..++.||++||.||| +++|+||||||+|||++.++++||+|||+++
T Consensus 103 ~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp EEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccce
Confidence 999999999999998864 3456999999999999999999999 6789999999999999999999999999998
Q ss_pred cCCCCCccc---eecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 361 LMPDGHAQV---STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 361 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
.+....... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+... ..+...+...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~----~~~~~~i~~~--- 249 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN----QDVINAIEQD--- 249 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTT---
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH----HHHHHHHHcC---
Confidence 775442221 1123457999999999999999999999999999999998 8999876432 2333333221
Q ss_pred CCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 437 ENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 437 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
..+... .. ....+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 250 ~~~~~~-------~~---~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 250 YRLPPP-------MD---CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp CCCCCC-------TT---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCC-------cc---chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111110 11 123478899999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=404.16 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=205.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|.+.+.||+|+||+||+|.++ +++.||||+++..... .+.|.+|+.+|++++|||||+++|++.+ +..+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSMS-----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEccCcCC-----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 367888999999999999999875 6788999999764433 4678999999999999999999998754 5679
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+|||||++|+|.+++.. .....+++..+..++.||++||.||| +++|+||||||+||||+.++.+||+|||+++.
T Consensus 84 iv~Ey~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp EEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEE
Confidence 99999999999998864 22346899999999999999999999 67899999999999999999999999999998
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
+...... ......||+.|+|||++.+..++.++|||||||++|||+||..|+.... ....+...+.. ...+..
T Consensus 159 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~---~~~~~~~~i~~---~~~~~~ 231 (272)
T d1qpca_ 159 IEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLER---GYRMVR 231 (272)
T ss_dssp CSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHT---TCCCCC
T ss_pred ccCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC---CHHHHHHHHHh---cCCCCC
Confidence 7654332 2244678999999999998899999999999999999999766543321 22223322222 111111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
+...+ ..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 232 -------p~~~~---~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 232 -------PDNCP---EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp -------CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------cccCh---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 11111 2478899999999999999999999998763
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=395.69 Aligned_cols=254 Identities=23% Similarity=0.343 Sum_probs=211.1
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|+..++||+|+||+||+|+++ +++.||||.++..... .+.+.+|+.++++++||||++++|+|.+.+.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~~~-----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET--TTEEEEEEEEESSSSC-----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcCcCC-----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 57888999999999999999975 7889999999865443 4568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+++|+|.+++.. ....+++..+..++.|+++||.||| ++||+||||||+|||++.++.+||+|||+++.+
T Consensus 77 v~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~ 150 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 150 (258)
T ss_dssp EEECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred EEEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheec
Confidence 9999999999999764 3467899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+... ..+...+.... .+.
T Consensus 151 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~----~~~~~~i~~~~---~~~- 221 (258)
T d1k2pa_ 151 LDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETAEHIAQGL---RLY- 221 (258)
T ss_dssp SSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHHHHHHHTTC---CCC-
T ss_pred cCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH----HHHHHHHHhCC---CCC-
Confidence 654332 2234678999999999999999999999999999999998 8999977532 22322222211 111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.+. ..+ ..+.+++.+||+.||++|||+.+|+++|.++
T Consensus 222 --~p~----~~~---~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 --RPH----LAS---EKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --CCT----TCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --Ccc----ccc---HHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 111 111 2478899999999999999999999999764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=406.76 Aligned_cols=254 Identities=20% Similarity=0.277 Sum_probs=204.6
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.+.||+|+||+||+|.... +|+.||||++....... ......+.+|+.+|++++||||+++++++.+.+.+|+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEehHHccC-HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 568999999999999999998754 78999999997532211 1225678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|||||++|+|.+++.. .+.+++..+..++.|++.||.||| +++|+||||||+|||+++++.+||+|||+++.+
T Consensus 86 vmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceec
Confidence 9999999999999875 467999999999999999999999 778999999999999999999999999999987
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
............+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+... ..+.. ...... +.
T Consensus 159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~~~~---~i~~~~-~~-- 228 (288)
T d1uu3a_ 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQ---KIIKLE-YD-- 228 (288)
T ss_dssp C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH---HHHTTC-CC--
T ss_pred ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH----HHHHH---HHHcCC-CC--
Confidence 654443344457899999999999999999999999999999999999999975422 22221 122211 11
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+. .... ..+.+|+.+||+.||++|||+.|++++
T Consensus 229 ~p----~~~s----~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 229 FP----EKFF----PKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CC----TTCC----HHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CC----ccCC----HHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11 1111 247889999999999999999997543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=411.73 Aligned_cols=202 Identities=22% Similarity=0.376 Sum_probs=178.0
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.++|+++++||+|+||+||+|.... +|+.||+|+++...... ....+.+|+.+|++++|||||+++++|.+++.+|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKPA---IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETT-TTEEEEEEEEECCCCTT---HHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEChhhCHH---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5789999999999999999998754 79999999997643222 2567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+|||||++|+|.+++.+ ...+++..+..++.|++.||.|||+ .++|+||||||+|||++.++++||+|||+|+.
T Consensus 81 iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 99999999999999975 4569999999999999999999994 24799999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDF 417 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~ 417 (531)
+.... ....+||+.|+|||++.+.+|+.++||||+||++|||++|+.||.+.
T Consensus 155 ~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 155 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp HHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred cCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 54321 23468999999999999999999999999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=393.60 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=197.9
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe----CCceE
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR----PDCHL 281 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~ 281 (531)
...++||+|+||+||+|.... ++..||+|.+....... ...+.+.+|+.+|++++|||||++++++.. ...+|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~-~~~~va~K~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EeeeEEecCcCcEEEEEEECC-CCeEEEEEEEchhhCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 456789999999999998764 78899999997644322 236778999999999999999999999865 34579
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeeccCCCCeeeC-CCCCEEEeecCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPR--IIHRNITPSSVLID-DDMEARIADFGL 358 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NILl~-~~~~vkL~Dfgl 358 (531)
+|||||++|+|.+++.. ...+++..+..++.||++||.||| +++ |+||||||+|||++ .++.+||+|||+
T Consensus 89 ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 99999999999999975 467899999999999999999999 556 99999999999996 478999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
++...... ....+||+.|+|||++.+ +++.++|||||||++|||+||+.||.+... ...+.. .... +.
T Consensus 162 a~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~---~~~~~~---~i~~-~~ 229 (270)
T d1t4ha_ 162 ATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIYR---RVTS-GV 229 (270)
T ss_dssp GGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---HHHHHH---HHTT-TC
T ss_pred ceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc---HHHHHH---HHHc-CC
Confidence 98654332 234679999999999865 699999999999999999999999975422 122222 2222 21
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
....++. ... ..+.+++.+||+.||++|||+.|+++|
T Consensus 230 ~~~~~~~----~~~----~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 230 KPASFDK----VAI----PEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CCGGGGG----CCC----HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCcccCc----cCC----HHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1111111 112 237889999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-51 Score=398.38 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=200.0
Q ss_pred ccccccceeEEEEEeeeC-CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEecc
Q 009595 209 EKIRSRASGEIYIAELPE-SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSEFM 287 (531)
Q Consensus 209 ~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 287 (531)
++||+|+||+||+|.+.. ..++.||||+++..... ....+.+.+|+.+|++++|||||+++|+|.. +..++|||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC--HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence 469999999999998743 34578999999754322 2235789999999999999999999999865 5678999999
Q ss_pred CCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCCCc
Q 009595 288 KNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDGHA 367 (531)
Q Consensus 288 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~ 367 (531)
++|+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 90 ~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 90 ELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp TTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999999975 567999999999999999999999 67899999999999999999999999999997755433
Q ss_pred cc-eecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCCccccc
Q 009595 368 QV-STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAIDS 445 (531)
Q Consensus 368 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 445 (531)
.. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+... ..+...+.. ...+..
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----~~~~~~i~~---~~~~~~---- 231 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEK---GERMGC---- 231 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHT---TCCCCC----
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH----HHHHHHHHc---CCCCCC----
Confidence 22 2234678999999999999999999999999999999998 8999976532 233333322 111111
Q ss_pred cccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 446 KLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 446 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
+..++ ..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 232 ---p~~~~---~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 ---PAGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp ---CTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---CcccC---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 11111 2478899999999999999999999988753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-51 Score=404.95 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=204.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
+..|+.++.||+|+||+||+|.... +|+.||||++....... ....+.+.+|+.+|++++|||||++++++.+++..|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEECCSSCH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECC-CCcEEEEEEEchhhccC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 3568999999999999999998754 79999999998654332 233577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+|||||.+|+|..++.. ...+++..+..++.||++||.||| ++||+||||||+|||++.++.+||+|||++..
T Consensus 92 iv~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp EEEECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEEEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccc
Confidence 99999999999877654 467999999999999999999999 67899999999999999999999999999986
Q ss_pred CCCCCccceecccccCccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQT---LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
.... ....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+... ...+ ........
T Consensus 165 ~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---~~~~----~~i~~~~~ 231 (309)
T d1u5ra_ 165 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSAL----YHIAQNES 231 (309)
T ss_dssp SSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH----HHHHHSCC
T ss_pred cCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---HHHH----HHHHhCCC
Confidence 5432 23579999999999864 4589999999999999999999999876422 1111 12222221
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+.. . ...++ ..+.+++.+||+.||.+|||+.++++|
T Consensus 232 ~~~-~-----~~~~s---~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 232 PAL-Q-----SGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CCC-S-----CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC-C-----CCCCC---HHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 111 1 11111 247889999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=409.74 Aligned_cols=262 Identities=23% Similarity=0.285 Sum_probs=208.3
Q ss_pred cccccccccccccceeEEEEEeeeCCC----CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEe
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESN----GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVR 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 276 (531)
.++|.+.+.||+|+||+||+|.+...+ ...||||.+...... .....+.+|+.+|.++ +|||||++++++.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS---SEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH---HHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 467889999999999999999875422 236899998654322 2256788999999998 89999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHhhccC-------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQ-------------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRN 337 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 337 (531)
.+..++|||||++|+|.+++..... ....+++..+..++.||++||.||| +++|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecc
Confidence 9999999999999999999975321 1245899999999999999999999 67899999
Q ss_pred cCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 009595 338 ITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDD 416 (531)
Q Consensus 338 lkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~ 416 (531)
|||+|||++.++++||+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987665544444455678999999999999999999999999999999998 8999976
Q ss_pred cccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 009595 417 FFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLS 485 (531)
Q Consensus 417 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 485 (531)
.... ..+...+........+ ... ...+.+|+.+||+.||++|||+.+|+++|.
T Consensus 270 ~~~~---~~~~~~~~~~~~~~~p----------~~~---~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVD---ANFYKLIQNGFKMDQP----------FYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCS---HHHHHHHHTTCCCCCC----------TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHH---HHHHHHHhcCCCCCCC----------CcC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 5332 2233333222111111 111 124788999999999999999999999984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=399.12 Aligned_cols=259 Identities=20% Similarity=0.280 Sum_probs=206.5
Q ss_pred cccccccc-cccccceeEEEEEeeeC-CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 202 EDCSASLE-KIRSRASGEIYIAELPE-SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~-~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.+++...+ +||+|+||+||+|.+.. .++..||||+++..... ...+.|.+|+.+|++++|||||+++|++.. +.
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH---HHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 35566666 49999999999997743 24567999999764332 236789999999999999999999998865 56
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
+|+|||||++|+|.+++.. ....+++..+..++.||++||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp EEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhh
Confidence 8999999999999999853 3467999999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCcc-ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 360 RLMPDGHAQ-VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 360 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
+.+...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+... ..+...+.. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~----~~~~~~i~~---~~ 229 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVMAFIEQ---GK 229 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HHHHHHHHT---TC
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH----HHHHHHHHc---CC
Confidence 987654322 22234568999999999999999999999999999999998 9999986532 222222222 11
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.+.. +... ...+.+++.+||+.||++|||+.+|.+.|+..
T Consensus 230 ~~~~-------p~~~---~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 230 RMEC-------PPEC---PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CCCC-------CTTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC-------CCcC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 0111 12478899999999999999999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-50 Score=402.61 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=191.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceE
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~ 281 (531)
.+.|.+.+.||+|+||+||+|.... +|+.||||++....... ....+.+|+.+|++++|||||++++++.+++.+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKR-TQKLVAIKCIAKKALEG---KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETT-TCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECC-CCCEEEEEEEchHHhhh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3669999999999999999998754 78999999997644322 1456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC---CCCCEEEeecCC
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID---DDMEARIADFGL 358 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~---~~~~vkL~Dfgl 358 (531)
+|||||+||+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||+. .++.+||+|||+
T Consensus 84 lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp EEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred EEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccce
Confidence 99999999999999965 567999999999999999999999 77899999999999994 578999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
++....... ....+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+... ..+... ......
T Consensus 157 a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~~~~~---i~~~~~ 226 (307)
T d1a06a_ 157 SKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND----AKLFEQ---ILKAEY 226 (307)
T ss_dssp -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHH---HHTTCC
T ss_pred eEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH----HHHHHH---HhccCC
Confidence 987654432 2346799999999999999999999999999999999999999976422 222221 121111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.. ........ ...+.+++.+||+.||.+|||+.++++|
T Consensus 227 ~~---~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 EF---DSPYWDDI----SDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CC---CTTTTTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC---CCccccCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11 00011111 2247889999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=395.30 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=200.4
Q ss_pred ccccccccccccceeEEEEEeeeCCCC---eEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNG---KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
++|+..+.||+|+||.||+|.+...++ ..||||++...... .....|.+|+.++++++|||||+++|++...+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE---KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh---HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 467888999999999999998864332 47999999754432 225678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++|||||.+|+|.+++.. ....+++..+..++.|++.||.||| +++|+||||||+||||+.++.+||+|||++
T Consensus 84 ~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp EEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchh
Confidence 9999999999999998864 3467999999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCcc-ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 360 RLMPDGHAQ-VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 360 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+.+...... .......||+.|+|||++.+..++.++|||||||++|||+||..|+.... ....+...+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~---~~~~~~~~i~~~---~~ 231 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---SNHEVMKAINDG---FR 231 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTT---CC
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC---CHHHHHHHHhcc---CC
Confidence 877554222 22234568999999999999999999999999999999999766654321 222333333221 11
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
+... .. ....+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 232 ~~~~-------~~---~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 232 LPTP-------MD---CPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp CCCC-------TT---CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCc-------hh---hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 1110 11 1134788999999999999999999999998753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-49 Score=402.89 Aligned_cols=256 Identities=23% Similarity=0.285 Sum_probs=208.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.+.||+|+||.||+|.... +|+.||||++....... .+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~-~g~~vAvK~i~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPHESD----KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECCCSHHH----HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEcccchhh----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 579999999999999999998754 79999999997654332 5678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC--CCCCEEEeecCCCc
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID--DDMEARIADFGLAR 360 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~--~~~~vkL~Dfgla~ 360 (531)
|||||+||+|.+++.. ....+++..+..++.||+.||.||| ++||+||||||+|||++ .++.+||+|||+++
T Consensus 101 vmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~ 174 (350)
T d1koaa2 101 IYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 174 (350)
T ss_dssp EECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchhe
Confidence 9999999999999853 2456999999999999999999999 77899999999999995 46789999999999
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
.+...... ....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+... ..... .........
T Consensus 175 ~~~~~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~---~i~~~~~~~ 244 (350)
T d1koaa2 175 HLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----DETLR---NVKSCDWNM 244 (350)
T ss_dssp ECCTTSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH---HHHHTCCCS
T ss_pred eccccccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH----HHHHH---HHHhCCCCC
Confidence 87654332 346799999999999999999999999999999999999999975422 22222 222111110
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcc
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSD 486 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~ 486 (531)
....... ....+.+++.+||+.||++|||+.++++| +..
T Consensus 245 ---~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~ 285 (350)
T d1koaa2 245 ---DDSAFSG----ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285 (350)
T ss_dssp ---CCGGGGG----CCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred ---CcccccC----CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0111111 12247889999999999999999999996 544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-49 Score=400.89 Aligned_cols=253 Identities=19% Similarity=0.237 Sum_probs=207.5
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
+.|.+++.||+|+||.||+|.... +|+.||||++....... ...+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYPLD----KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSHHH----HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEECCcchhH----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 578999999999999999998754 79999999998654332 4678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeC--CCCCEEEeecCCCc
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLID--DDMEARIADFGLAR 360 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~--~~~~vkL~Dfgla~ 360 (531)
|||||+||+|.+++.. ....+++..+..++.||+.||.||| ++||+||||||+|||++ .++.+||+|||++.
T Consensus 104 vmE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~ 177 (352)
T d1koba_ 104 ILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 177 (352)
T ss_dssp EEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccce
Confidence 9999999999998753 3456999999999999999999999 77899999999999997 57899999999999
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
.+...... ....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+... ..+...+ ......
T Consensus 178 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i---~~~~~~- 246 (352)
T d1koba_ 178 KLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNV---KRCDWE- 246 (352)
T ss_dssp ECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHH---HHCCCC-
T ss_pred ecCCCCce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH---HhCCCC-
Confidence 87654332 346799999999999999999999999999999999999999976422 2222211 111111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+........ ...+.+|+.+||+.||.+|||+.++++|
T Consensus 247 --~~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 247 --FDEDAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp --CCSSTTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --CCcccccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111111 2247889999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=393.00 Aligned_cols=257 Identities=21% Similarity=0.310 Sum_probs=207.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchh--hhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSL--LNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.+.|.+.+.||+|+||+||+|.... +|+.||||++....... .....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~-~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3679999999999999999998754 79999999997543221 11125678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC----CEEEee
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM----EARIAD 355 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~----~vkL~D 355 (531)
+|+|||||++|+|.+++.. ...+++..+..++.|++.||.||| +++|+||||||+|||++.++ .+||+|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecc
Confidence 9999999999999999976 457999999999999999999999 67899999999999998776 599999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
||++......... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+... .... .....
T Consensus 161 fG~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~~~---~~i~~ 230 (293)
T d1jksa_ 161 FGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETL---ANVSA 230 (293)
T ss_dssp CTTCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH---HHHHT
T ss_pred hhhhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH----HHHH---HHHHh
Confidence 9999887654322 335789999999999999999999999999999999999999976422 1111 11111
Q ss_pred cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 436 SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 436 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.... ..+...... ...+.+++.+||+.||.+|||+.++++|
T Consensus 231 ~~~~---~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 231 VNYE---FEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp TCCC---CCHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCC---CCchhcCCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 011111111 2347889999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-50 Score=393.45 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=201.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.+.||+|+||+||+|.++ ++..||||+++..... .+.|.+|+.+|++++|||||+++|++. .+..++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~--~~~~vAiK~l~~~~~~-----~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~l 88 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 88 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC--CCCEEEEEEECcccCC-----HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEE
Confidence 57899999999999999999875 5678999999764432 467899999999999999999999985 456899
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|||||++|+|..++.. .....+++..+..++.||+.||.||| .++|+||||||+|||++.++++||+|||+++.+
T Consensus 89 v~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp EECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 9999999999999875 22356999999999999999999999 678999999999999999999999999999877
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
...... ......||+.|+|||++.+..++.++|||||||++|||+||..|+... .....+...+......+.+
T Consensus 164 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~---~~~~~~~~~i~~~~~~~~~--- 236 (285)
T d1fmka3 164 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG---MVNREVLDQVERGYRMPCP--- 236 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT---CCHHHHHHHHHTTCCCCCC---
T ss_pred cCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC---CCHHHHHHHHHhcCCCCCC---
Confidence 544332 223467899999999999999999999999999999999976665432 2223333333322111111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcCC
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTALI 490 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 490 (531)
... ...+.+++.+||+.||++|||+.+|++.|++....
T Consensus 237 -------~~~---~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 237 -------PEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp -------TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -------ccc---CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 111 12478899999999999999999999999886543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-49 Score=394.11 Aligned_cols=264 Identities=22% Similarity=0.340 Sum_probs=211.7
Q ss_pred hcccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~ 276 (531)
+.++|...+.||+|+||+||+|++.. .+++.||||++...... ...+.+.+|+.+|++++||||+++++++..
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---DMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh---HHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 45789999999999999999998752 35678999999754332 235778999999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHhhcc--------------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEee
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVS--------------------QGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHR 336 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 336 (531)
....+++|||+++|+|.+++.... .....+++..+..++.|++.||+||| +++++||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEee
Confidence 999999999999999999996521 11235889999999999999999999 6789999
Q ss_pred ccCCCCeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCC
Q 009595 337 NITPSSVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGK-LPSD 415 (531)
Q Consensus 337 Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~P~~ 415 (531)
||||+|||++.++++||+|||+++.+.........+...||+.|+|||.+.+..|+.++|||||||++|||++|. .||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999998765544444445567899999999999999999999999999999999986 5666
Q ss_pred CcccchhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 416 DFFQHTEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 416 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
+.. ...+...+.. ...+.. . .... ..+.+|+.+||+.||.+|||+.+|++.|+++
T Consensus 245 ~~~----~~e~~~~v~~---~~~~~~--p----~~~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 245 GMA----HEEVIYYVRD---GNILAC--P----ENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TSC----HHHHHHHHHT---TCCCCC--C----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCC----HHHHHHHHHc---CCCCCC--C----ccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 542 2233333322 221111 1 1111 2478899999999999999999999999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-49 Score=394.72 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=207.4
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+++.||+|+||.||+|+... +|+.||||+++...... ......+.+|+.+|++++||||+++++++.+.+.+|+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 578999999999999999998754 79999999997542211 1125778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|||||+||+|.+++.. ...+++..+..++.||+.||.||| ++||+||||||+|||++.+|.+||+|||+++..
T Consensus 83 v~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 83 VMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred ceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence 9999999999999976 567899999999999999999999 778999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
...... ....+||+.|+|||++.+.+|+.++|||||||++|||++|+.||.+... ..+..... . +.+..
T Consensus 156 ~~~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~----~~~~~~i~---~-~~~~~- 224 (337)
T d1o6la_ 156 ISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELIL---M-EEIRF- 224 (337)
T ss_dssp CCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH---H-CCCCC-
T ss_pred ccCCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH----HHHHHHHh---c-CCCCC-
Confidence 543322 2347899999999999999999999999999999999999999876422 22222221 1 11111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-----SKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 483 (531)
. .... ..+.+++.+||+.||.+||+ +.++++|
T Consensus 225 -p----~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 225 -P----RTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -C----TTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -C----ccCC----HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 0 1111 23778999999999999995 7888775
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=386.63 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=197.0
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe-CCceE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR-PDCHL 281 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~ 281 (531)
++|...+.||+|+||.||+|.+ +|+.||||+++.... .+.+.+|+.++++++||||++++|+|.+ .+.+|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~i~~~~~------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDAT------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred HHeEEeEEEecCCCeEEEEEEE---CCeEEEEEEECcHHH------HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 5678889999999999999987 588999999975432 5678899999999999999999999865 45689
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+||||+++|+|.+++.. .....+++..+..++.||+.||.||| +++++||||||+|||++.++.+||+|||+++.
T Consensus 78 lv~ey~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152 (262)
T ss_dssp EEECCCTTEEHHHHHHH--HHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeeccccccee
Confidence 99999999999999975 22346899999999999999999999 67899999999999999999999999999986
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
..... ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||..... .++...+.. ...+.
T Consensus 153 ~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~----~~~~~~i~~---~~~~~ 220 (262)
T d1byga_ 153 ASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRVEK---GYKMD 220 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHHHHHTT---TCCCC
T ss_pred cCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH----HHHHHHHHc---CCCCC
Confidence 54332 23467899999999999999999999999999999998 6888765432 233333322 11111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
. . .... ..+.+++.+||..||.+|||+.+++++|+++
T Consensus 221 ~--~----~~~~----~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 221 A--P----DGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp C--C----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C--C----ccCC----HHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1 1 1111 2478899999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-48 Score=390.44 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=205.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+++.||+|+||+||+|+... +|+.||||+++...... ....+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~-~g~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECC-CCCEEEEEEEchHHccC-HHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 568999999999999999998754 79999999997532211 1225778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|||||+||+|..++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.+|.+||+|||+++..
T Consensus 82 vmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 82 IMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEe
Confidence 9999999999999976 567888899999999999999999 788999999999999999999999999999986
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
.... ...+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+... ..+. .........
T Consensus 155 ~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~---~~i~~~~~~--- 219 (316)
T d1fota_ 155 PDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----MKTY---EKILNAELR--- 219 (316)
T ss_dssp SSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHH---HHHHHCCCC---
T ss_pred cccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH----HHHH---HHHHcCCCC---
Confidence 5432 346799999999999999999999999999999999999999976422 1121 222221111
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
+.+ ... ..+.+++.+||..||.+|| |+.++++|
T Consensus 220 ~p~----~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 FPP----FFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCT----TSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCC----CCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111 111 2378899999999999996 88998875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=394.89 Aligned_cols=258 Identities=20% Similarity=0.320 Sum_probs=202.5
Q ss_pred ccccccccccccceeEEEEEeeeCCCCe----EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGK----MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~ 278 (531)
..|..++.||+|+||+||+|.+.. +|+ .||+|.++..... ...+.+.+|+.++++++|||||+++|+|.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~-~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSP---KANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred HHCEEeeEEecCCCeEEEEEEEcC-CCCEEEEEEEEEEeccccCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 569999999999999999998754 443 6889988653221 1256789999999999999999999999864
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGL 358 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgl 358 (531)
..++++||+.+|+|.+++.. ....+++..+..++.||+.||.||| +++|+||||||+|||++.++++||+|||+
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGl 157 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGL 157 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred CeeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeecccc
Confidence 56788999999999998875 3567999999999999999999999 67899999999999999999999999999
Q ss_pred CccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 359 ARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 359 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
++.+.............||+.|+|||++.++.|+.++|||||||++|||+| |..||++... ..+...+.......
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~----~~~~~~i~~~~~~~ 233 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEISSILEKGERLP 233 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG----GGHHHHHHHTCCCC
T ss_pred ceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH----HHHHHHHHcCCCCC
Confidence 998766544444445678999999999999999999999999999999998 7889876533 22333333221111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
.+ ... ...+.+++.+||+.||.+|||+.+|+++|..+.
T Consensus 234 ~p----------~~~---~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 234 QP----------PIC---TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CC----------TTB---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC----------ccc---CHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 11 111 124788999999999999999999999987753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=390.49 Aligned_cols=264 Identities=21% Similarity=0.289 Sum_probs=199.8
Q ss_pred cccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEe
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVR 276 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~ 276 (531)
.++|.+.+.||+|+||.||+|.+.. .+++.||||+++...... ..+.+..|+..+.++ +||||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~---~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS---EHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH---HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH---HHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 4678999999999999999998743 245789999997543322 256677788888777 78999999998876
Q ss_pred C-CceEEEEeccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCe
Q 009595 277 P-DCHLLVSEFMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSV 343 (531)
Q Consensus 277 ~-~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 343 (531)
. ..+++|||||++|+|.+++..... ....+++..+..++.||++||.||| +++|+||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccce
Confidence 5 468999999999999999975321 1345899999999999999999999 67899999999999
Q ss_pred eeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCcccchh
Q 009595 344 LIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMG-KLPSDDFFQHTE 422 (531)
Q Consensus 344 Ll~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~P~~~~~~~~~ 422 (531)
|++.++++||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+|| ..||.+...
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~--- 242 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--- 242 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC---
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH---
Confidence 9999999999999999877655444444557899999999999999999999999999999999987 457765422
Q ss_pred hhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 423 EKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 423 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
...+...+........+ ... ...+.+++.+||+.||.+|||+.+|+++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~----------~~~---~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 243 DEEFCRRLKEGTRMRAP----------DYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp SHHHHHHHHHTCCCCCC----------TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCC----------ccC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22233333222111111 111 12478899999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=385.88 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=196.3
Q ss_pred cccccccccccccceeEEEEEeeeCCC--CeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESN--GKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.++|.+.+.||+|+||.||+|.+...+ +..||||.++.... +.....+.+|+.+|++++|||||+++|++. .+.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS---DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence 357889999999999999999875432 35688888865332 223677999999999999999999999885 467
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++|||||++|+|.+++.. ....+++..+..++.||++||.||| +++++||||||+||+++.++.+||+|||++
T Consensus 82 ~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp CEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhh
Confidence 8999999999999998764 3457899999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccCC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSEN 438 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~~ 438 (531)
+.+...... ......||+.|+|||++.+..++.++|||||||++|||+| |..||.+.... .+...+.. ...
T Consensus 156 ~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~----~~~~~i~~---~~~ 227 (273)
T d1mp8a_ 156 RYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIEN---GER 227 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHHT---TCC
T ss_pred eeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH----HHHHHHHc---CCC
Confidence 876544322 2344678999999999999999999999999999999998 89998765332 22222222 111
Q ss_pred CCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 439 PNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 439 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
+. +.+ . . ...+.+++.+||..||.+|||+.+|+++|+.+
T Consensus 228 ~~--~~~----~-~---~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 228 LP--MPP----N-C---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp CC--CCT----T-C---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC--CCC----C-C---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 111 1 1 12478899999999999999999999999765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=387.97 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=198.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCe--EEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCc
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGK--MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~ 279 (531)
.++|++.+.||+|+||.||+|++...+++ .||||++....... ....+.|.+|+.+|++++||||++++|++.+ +.
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 45689999999999999999987654443 78999987543322 2336789999999999999999999999965 47
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.++|||||++|+|.+++.. ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 85 ~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred hheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhh
Confidence 7899999999999998864 2356999999999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCccc-eecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 360 RLMPDGHAQV-STSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 360 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
+.+....... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.+... ..+...+ ...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~----~~~~~~i---~~~~ 231 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----SQILHKI---DKEG 231 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHH---HTSC
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH----HHHHHHH---HhCC
Confidence 9876553322 2234567889999999999999999999999999999998 8999876422 2222222 2222
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.... .. .... ..+.+++.+||+.||++|||+.+|.+.|.+.
T Consensus 232 ~~~~-~~----~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ERLP-RP----EDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCC-CC----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC-Cc----cccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111 00 1111 2478899999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-48 Score=382.01 Aligned_cols=262 Identities=19% Similarity=0.253 Sum_probs=202.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC---
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD--- 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 278 (531)
.++|.+.+.||+|+||.||+|.... +|+.||||+++...... ......+.+|+.+++.++||||+++++++...+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLR-LHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSTTTTC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred cceeEEeEEEeeCCCeEEEEEEECC-CCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 3679999999999999999998754 79999999997654332 223567999999999999999999999987654
Q ss_pred -ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 279 -CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 279 -~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
.+|+|||||+||+|.+++.. ...+++..+..++.||+.||.||| ++||+||||||+|||++.++.++|+|||
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCT
T ss_pred ceEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhh
Confidence 37899999999999999875 457999999999999999999999 7789999999999999999999999999
Q ss_pred CCccCCCCC-ccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhcc
Q 009595 358 LARLMPDGH-AQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTS 436 (531)
Q Consensus 358 la~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~ 436 (531)
.+....... ........+||+.|+|||++.+..++.++|||||||++|||+||+.||.+... .. .+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~----~~~~~~~~ 229 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VS----VAYQHVRE 229 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HH----HHHHHHHC
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH---HH----HHHHHHhc
Confidence 988664432 22233456799999999999999999999999999999999999999976422 11 12222222
Q ss_pred C-CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhccC
Q 009595 437 E-NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-NSKDVRSMLSDT 487 (531)
Q Consensus 437 ~-~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~ 487 (531)
. .+.....+ .. ...+.+++.+||+.||.+|| |++++++.|..+
T Consensus 230 ~~~~~~~~~~----~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 230 DPIPPSARHE----GL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CCCCGGGTSS----SC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCCchhcc----CC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 2 12111111 11 12478899999999999999 899998877653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.5e-48 Score=378.62 Aligned_cols=256 Identities=21% Similarity=0.330 Sum_probs=206.8
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch-----hhhHHHHHHHHHHHHHhcCC-CCcccccceeEEe
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS-----LLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVR 276 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~ 276 (531)
++|++.+.||+|+||+||+|+... +|+.||||++...... ......+.+.+|+.++++++ ||||+++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~-~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred ccCEEceEEecCcCeEEEEEEECC-CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 678999999999999999998654 7999999999764432 22233567889999999996 9999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
++..|+|||||++|+|.+++.. ...+++..+..++.||++||.||| +++|+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999975 457999999999999999999999 678999999999999999999999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHH
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT------LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~ 430 (531)
|++..+..... .....||+.|+|||.+.+ ..++.++||||+||++|||+||+.||.+... .....
T Consensus 155 G~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~----~~~~~-- 225 (277)
T d1phka_ 155 GFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----MLMLR-- 225 (277)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH--
T ss_pred hheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH----HHHHH--
Confidence 99998765432 234679999999998853 3478899999999999999999999976422 11211
Q ss_pred HHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.......... ..........+.+++.+||+.||.+|||+.++++|
T Consensus 226 -~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 226 -MIMSGNYQFG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -HHHHTCCCCC-------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -HHHhCCCCCC-------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111111100 00111112348889999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=385.32 Aligned_cols=252 Identities=21% Similarity=0.268 Sum_probs=205.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+.+.||+|+||+||+|.... +|+.||||.++..... ...+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~-~~~~~AiK~i~~~~~~-----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVKGTD-----QVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCCTHH-----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEcCCccc-----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 678999999999999999998754 7899999999764322 3457899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC--CCEEEeecCCCc
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD--MEARIADFGLAR 360 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~--~~vkL~Dfgla~ 360 (531)
|||||+||+|.+++.. ....+++..+..++.||++||.||| +.||+||||||+|||++.+ +.+||+|||++.
T Consensus 79 vmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhh
Confidence 9999999999999964 2346999999999999999999999 6789999999999999854 589999999998
Q ss_pred cCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPN 440 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~ 440 (531)
....... .....||+.|+|||.+.+..|+.++|||||||++|+|++|..||.+... ..+.. ........
T Consensus 153 ~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~----~~~~~---~i~~~~~~- 221 (321)
T d1tkia_ 153 QLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----QQIIE---NIMNAEYT- 221 (321)
T ss_dssp ECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHH---HHHHTCCC-
T ss_pred ccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH----HHHHH---HHHhCCCC-
Confidence 7755432 2335789999999999999999999999999999999999999976422 22222 22211111
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 441 RAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 441 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
++....... ...+.+++.+||..||.+|||+.++++|
T Consensus 222 --~~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 --FDEEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --CCHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CChhhccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111111 1247889999999999999999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-48 Score=390.42 Aligned_cols=249 Identities=18% Similarity=0.217 Sum_probs=205.3
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+++.||+|+||.||+|.... +|+.||||++....... ....+.+.+|+.+|+.++|||||++++++......++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~-~g~~~AvK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC-CCCEEEEEEEchHHccC-HHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 579999999999999999998754 79999999997532211 1225678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+.+|+|.+++.. ...+++..+..++.||+.||.||| +++||||||||+|||++.++++||+|||+++.+
T Consensus 119 v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 9999999999999976 457999999999999999999999 678999999999999999999999999999977
Q ss_pred CCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
.... ....||+.|||||++.+..++.++|||||||++|||+||+.||.+... ..+.. ...... +..
T Consensus 192 ~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~---~i~~~~-~~~- 257 (350)
T d1rdqe_ 192 KGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----IQIYE---KIVSGK-VRF- 257 (350)
T ss_dssp SSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH---HHHHCC-CCC-
T ss_pred cccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH----HHHHH---HHhcCC-CCC-
Confidence 5432 336799999999999999999999999999999999999999975421 22222 122111 110
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERP-----NSKDVRSM 483 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 483 (531)
. .... ..+.+++.+||+.||.+|+ |+.++++|
T Consensus 258 -p----~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 258 -P----SHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -C----TTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -C----ccCC----HHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 0 1111 2378899999999999994 89998874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=384.13 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=201.2
Q ss_pred cccccccceeEEEEEeeeCCCC--eEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC-CceEEEE
Q 009595 208 LEKIRSRASGEIYIAELPESNG--KMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP-DCHLLVS 284 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-~~~~lv~ 284 (531)
.++||+|+||+||+|.+...++ ..||||+++.... ....+.|.+|+.+|++++||||++++|++... ...++||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD---IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC---HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 5789999999999999865333 3689999975332 22367899999999999999999999998764 5789999
Q ss_pred eccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCC
Q 009595 285 EFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPD 364 (531)
Q Consensus 285 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~ 364 (531)
|||++|+|.+++.. ....+++..+..++.|++.||.||| +++|+||||||+|||+++++.+||+|||+++....
T Consensus 109 E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp ECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 99999999999874 3456788889999999999999999 67899999999999999999999999999997754
Q ss_pred CCcc--ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcc
Q 009595 365 GHAQ--VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRA 442 (531)
Q Consensus 365 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 442 (531)
.... .......||+.|+|||.+.+..++.++||||||+++|||+||..||..... ..++...+ .....+..
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~---~~~~~~~i---~~g~~~~~- 255 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYL---LQGRRLLQ- 255 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHH---HTTCCCCC-
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC---HHHHHHHH---HcCCCCCC-
Confidence 4322 122345689999999999999999999999999999999998888754321 12222222 22222211
Q ss_pred ccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 443 IDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 443 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
+ ... ...+.+++.+||+.||++|||+.+|+++|+.+.
T Consensus 256 --p----~~~---~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 256 --P----EYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp --C----TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --c----ccC---cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 111 124788999999999999999999999998763
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=390.29 Aligned_cols=253 Identities=19% Similarity=0.290 Sum_probs=198.5
Q ss_pred ccccccc-cccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEe----
Q 009595 203 DCSASLE-KIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVR---- 276 (531)
Q Consensus 203 ~~~~~~~-~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~---- 276 (531)
++|.++. .||+|+||.||+|.... +|+.||||+++. ...+.+|+.++.++ +|||||++++++.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~-~~~~vAiK~i~~---------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKR-TQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cCEEEeeEEeeeccCeEEEEEEECC-CCCEEEEEEECC---------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 5788775 59999999999998754 789999999974 23466799887655 89999999999875
Q ss_pred CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC---CCCEEE
Q 009595 277 PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD---DMEARI 353 (531)
Q Consensus 277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkL 353 (531)
...+|+|||||+||+|.+++.. .+...+++..+..++.||+.||.||| ++||+||||||+|||++. ++.+||
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred CCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccc
Confidence 4568999999999999999975 33457999999999999999999999 778999999999999985 567999
Q ss_pred eecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHH
Q 009595 354 ADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNV 433 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~ 433 (531)
+|||+++........ ...+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+..... ....+...
T Consensus 156 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~----~~~~~~~~ 228 (335)
T d2ozaa1 156 TDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKTR 228 (335)
T ss_dssp CCCTTCEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------C
T ss_pred cccceeeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH----HHHHHHHH
Confidence 999999877654332 34679999999999999999999999999999999999999996542211 11111111
Q ss_pred hccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 434 MTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 434 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+.... ...........+.+|+.+||+.||++|||+.++++|
T Consensus 229 i~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 229 IRMGQYEF------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCSCSSSC------CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCC------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11111100 011112233458899999999999999999999985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=383.12 Aligned_cols=264 Identities=23% Similarity=0.303 Sum_probs=208.8
Q ss_pred hcccccccccccccceeEEEEEeeeCC------CCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCccccccee
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPES------NGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAH 273 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~ 273 (531)
..++|.+.+.||+|+||.||+|+.... ++..||||+++..... .....+..|+..+.++ +|||||+++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE---KDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh---HHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 346888899999999999999986432 2357999999764432 2256788899999888 89999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHHhhccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCC
Q 009595 274 MVRPDCHLLVSEFMKNGSLLEILNDVSQ------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341 (531)
Q Consensus 274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 341 (531)
|.+++..++|||||++|+|.+++..... ....+++..+..++.||+.||.||| +++++||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeeccc
Confidence 9999999999999999999999975321 2356899999999999999999999 778999999999
Q ss_pred CeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccc
Q 009595 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQH 420 (531)
Q Consensus 342 NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~ 420 (531)
|||++.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||+| |..||.+...
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~- 243 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 243 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-
Confidence 99999999999999999998766544444456779999999999999999999999999999999998 6888865432
Q ss_pred hhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 421 TEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 421 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
..+...+... ..+.. . ... ...+.+++.+||+.||++|||+.+|++.|+++
T Consensus 244 ---~~~~~~i~~~---~~~~~--p-----~~~---~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 244 ---EELFKLLKEG---HRMDK--P-----SNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HHHHHHHHTT---CCCCC--C-----SSC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHcC---CCCCC--C-----ccc---hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 2333333321 11111 1 111 12488899999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=386.68 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=202.7
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHh-cCCCCcccccceeEEeCCceE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAG-QIRHRNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~~~~~~ 281 (531)
++|.+.+.||+|+||+||+|+... +|+.||||+++...... ......+..|+.++. .++|||||++++++.+++..|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~-t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC-CCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 578999999999999999998764 79999999997532211 112455666777665 689999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 282 LVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 282 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
+|||||++|+|.+++.. ...+++..+..++.||+.||.||| +++++||||||+|||++.++++||+|||+++.
T Consensus 80 ivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhh
Confidence 99999999999999975 467899999999999999999999 67899999999999999999999999999987
Q ss_pred CCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 362 MPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 362 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+... ..+...+. . +.+..
T Consensus 153 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~----~~~~~~i~---~-~~~~~ 222 (320)
T d1xjda_ 153 NMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIR---M-DNPFY 222 (320)
T ss_dssp CCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH---H-CCCCC
T ss_pred ccccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH----HHHHHHHH---c-CCCCC
Confidence 6544322 2346799999999999999999999999999999999999999976422 22222222 1 11111
Q ss_pred cccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 009595 442 AIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSK-DVRS 482 (531)
Q Consensus 442 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 482 (531)
. ... ...+.+|+.+||..||.+|||+. ++++
T Consensus 223 --p-----~~~---s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 --P-----RWL---EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --C-----TTS---CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --C-----ccC---CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0 111 12378899999999999999996 6765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-47 Score=389.77 Aligned_cols=254 Identities=21% Similarity=0.253 Sum_probs=200.5
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhh--hHHHHHHHHHHHHHhcCCCCcccccceeEEeCCce
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLL--NIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~ 280 (531)
++|.+.+.||+|+||.||+|+... +|+.||||++........ .........|+.+++.++|||||++++++.+.+.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~-t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECC-CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 679999999999999999998754 799999999975322111 11122233457788888999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
|+|||||+||+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.+|.+||+|||+++
T Consensus 83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999976 467889999999999999999999 7889999999999999999999999999999
Q ss_pred cCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCC
Q 009595 361 LMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENP 439 (531)
Q Consensus 361 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~ 439 (531)
.+..... ...+||+.|+|||++.. ..|+.++|||||||++|||+||+.||.+..... .....+.... ..+
T Consensus 156 ~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~~~~~~~-~~~ 226 (364)
T d1omwa3 156 DFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLT-MAV 226 (364)
T ss_dssp ECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC----HHHHHHHSSS-CCC
T ss_pred ecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhccc-CCC
Confidence 7755422 34579999999999875 468999999999999999999999997643221 1111121111 111
Q ss_pred CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 009595 440 NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-----SKDVRSM 483 (531)
Q Consensus 440 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 483 (531)
. +. .... ..+.+++.+||+.||.+||| +.++++|
T Consensus 227 ~--~~----~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 E--LP----DSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp C--CC----SSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred C--CC----CCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1 01 1111 24788999999999999999 6888764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-48 Score=383.26 Aligned_cols=265 Identities=20% Similarity=0.300 Sum_probs=213.6
Q ss_pred hcccccccccccccceeEEEEEeee----CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEE
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELP----ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMV 275 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~ 275 (531)
..+.|.+.+.||+|+||.||+|++. ..+++.||||+++..... .....+.+|+.+++++ +|||||++++++.
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL---TEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH---HHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 3468888999999999999999863 246679999999764432 2256788999999999 7999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHhhccC--------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCC
Q 009595 276 RPDCHLLVSEFMKNGSLLEILNDVSQ--------------GRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPS 341 (531)
Q Consensus 276 ~~~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 341 (531)
+.+..++|||||++|+|.+++..... ....+++..+..++.||++||.||| +++++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccc
Confidence 99999999999999999999976321 2346899999999999999999999 678999999999
Q ss_pred CeeeCCCCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccc
Q 009595 342 SVLIDDDMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVM-GKLPSDDFFQH 420 (531)
Q Consensus 342 NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~ 420 (531)
||+++.++.+|++|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||.....
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~- 253 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV- 253 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999998876655555556789999999999999999999999999999999999 5555544322
Q ss_pred hhhhHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 421 TEEKSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 421 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
...+...+........+ .. ....+.+|+.+||+.||.+|||+.+|++.|+++
T Consensus 254 --~~~~~~~i~~~~~~~~~----------~~---~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 254 --DSKFYKMIKEGFRMLSP----------EH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp --SHHHHHHHHHTCCCCCC----------TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHHhcCCCCCCc----------cc---ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 22233333322211111 11 112488899999999999999999999999764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=384.98 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=203.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCe--EEEEEEEeccCchhhhHHHHHHHHHHHHHhcC-CCCcccccceeEEeCCc
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGK--MIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI-RHRNIVPLLAHMVRPDC 279 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~ 279 (531)
++|++.+.||+|+||+||+|.+.. +|. .||||.+...... ...+.+.+|+.+|+++ +|||||+++|++...+.
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC-CCeEEEEEEEEECcccCh---HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 677888999999999999999865 454 4778887643222 1256789999999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhc------------cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC
Q 009595 280 HLLVSEFMKNGSLLEILNDV------------SQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD 347 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~ 347 (531)
.++||||+++|+|.+++... ......+++..+..++.||+.||.||| +++++||||||+|||++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcC
Confidence 99999999999999999652 123467999999999999999999999 678999999999999999
Q ss_pred CCCEEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCcccchhhhHH
Q 009595 348 DMEARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGK-LPSDDFFQHTEEKSL 426 (531)
Q Consensus 348 ~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~P~~~~~~~~~~~~l 426 (531)
++.+||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|. .||.+.. ...+
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~----~~~~ 235 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAEL 235 (309)
T ss_dssp GGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHH
T ss_pred CCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC----HHHH
Confidence 99999999999986543322 12356899999999999999999999999999999999975 4665432 2223
Q ss_pred HHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 427 VRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 427 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
...+ .....+... ... ...+.+++.+||+.||++|||+.+|+++|+++..
T Consensus 236 ~~~i---~~~~~~~~~-------~~~---~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 236 YEKL---PQGYRLEKP-------LNC---DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHHG---GGTCCCCCC-------TTB---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH---HhcCCCCCC-------ccC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2222 222222111 111 1248889999999999999999999999988643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=380.48 Aligned_cols=270 Identities=23% Similarity=0.300 Sum_probs=200.5
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC----
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD---- 278 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---- 278 (531)
..|...+.||+|+||.||+|++ +|+.||||++...... ......|+..+.+++|||||++++++...+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~~~~-----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREER-----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE---TTEEEEEEEECGGGHH-----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccchh-----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 3567788999999999999987 7899999999753321 222334666667889999999999998654
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeeccCCCCeeeCCCCCEEE
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMY-----HRPRIIHRNITPSSVLIDDDMEARI 353 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlkp~NILl~~~~~vkL 353 (531)
.+++|||||++|+|.+++++ ..+++..+..++.|++.||.|||+. +.++|+||||||+||||+.++++||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl 149 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred EEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence 57899999999999999975 4689999999999999999999953 2479999999999999999999999
Q ss_pred eecCCCccCCCCCcc--ceecccccCccccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh--
Q 009595 354 ADFGLARLMPDGHAQ--VSTSIVAGTVGYIAPEYHQTL------KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEE-- 423 (531)
Q Consensus 354 ~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~-- 423 (531)
+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||..||.........
T Consensus 150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~ 229 (303)
T d1vjya_ 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence 999999977544322 223456799999999998764 2677999999999999999998876432111000
Q ss_pred -----hHHHHHHHHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCc
Q 009595 424 -----KSLVRWMRNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTA 488 (531)
Q Consensus 424 -----~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 488 (531)
......+......+.....+... ....+....+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGG---GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcccccchHHHHHHHHhccccCCCCCcc---cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 00111112222111111111111 112234456889999999999999999999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=384.56 Aligned_cols=271 Identities=22% Similarity=0.224 Sum_probs=200.9
Q ss_pred ccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhh-hHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEEEEe
Q 009595 207 SLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLL-NIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLLVSE 285 (531)
Q Consensus 207 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 285 (531)
.+++||+|+||+||+|.... +|+.||||+++....... +...+.+.+|+.+|++++|||||++++++..++..|+|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSS-CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECC-CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 46789999999999998764 789999999975433211 1123568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccCCCC
Q 009595 286 FMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLMPDG 365 (531)
Q Consensus 286 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~ 365 (531)
||.++++..+.. ....+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 81 FMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp CCSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hhcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCC
Confidence 999877666553 3567888999999999999999999 778999999999999999999999999999876554
Q ss_pred CccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCcccc
Q 009595 366 HAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNRAID 444 (531)
Q Consensus 366 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 444 (531)
... ....+||+.|+|||++.+. .|+.++|||||||++|||+||..||.+... ...+.. +......+......+
T Consensus 154 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~-i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 154 NRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTR-IFETLGTPTEEQWPD 227 (299)
T ss_dssp CCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH-HHHHHCCCCTTTSSS
T ss_pred ccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHH-HHHhcCCCChhhccc
Confidence 322 2346799999999988755 579999999999999999999999875422 222222 222221111110000
Q ss_pred cc---------ccCCC-----cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCC
Q 009595 445 SK---------LLGNG-----YEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIK 491 (531)
Q Consensus 445 ~~---------l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~ 491 (531)
.. ..... .+.....+.+|+.+||+.||++|||+.|+++| |++...+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~ 290 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence 00 00000 01112458889999999999999999999985 66554433
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=379.66 Aligned_cols=265 Identities=18% Similarity=0.289 Sum_probs=213.1
Q ss_pred cccccccccccccceeEEEEEeeeC----CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPE----SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~ 277 (531)
.++|...+.||+|+||+||+|.+.. .+++.||||+++..... .....+.+|+.++++++||||++++|++...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM---RERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH---HHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh---HHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 4678899999999999999998742 23578999999754322 2356789999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHhhcc------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCE
Q 009595 278 DCHLLVSEFMKNGSLLEILNDVS------QGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA 351 (531)
Q Consensus 278 ~~~~lv~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v 351 (531)
+..++|||||++|+|.+++.... .....+++..+..++.|+++||.||| .++|+||||||+|||++.++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceE
Confidence 99999999999999999986522 12245788999999999999999999 6789999999999999999999
Q ss_pred EEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCcccchhhhHHHHHH
Q 009595 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGK-LPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~P~~~~~~~~~~~~l~~~~ 430 (531)
||+|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+||. .||.+.. .......+
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~----~~~~~~~i 248 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----NEQVLRFV 248 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----HHHHHHHH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC----HHHHHHHH
Confidence 999999998776554444445567899999999999999999999999999999999984 6765532 22222222
Q ss_pred HHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCcC
Q 009595 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDTAL 489 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 489 (531)
.....+.. +... ...+.+++.+||+.||.+|||+.+|+++|++...
T Consensus 249 ---~~~~~~~~-------p~~~---~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 ---MEGGLLDK-------PDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---HTTCCCCC-------CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---HhCCCCCC-------cccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 22222111 0111 1248889999999999999999999999988643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=379.91 Aligned_cols=270 Identities=23% Similarity=0.296 Sum_probs=205.9
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|.+++.||+|+||+||+|+... +|+.||||+++..... .....++.+|+.+|++++|||||++++++.+++.+|+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC-CCCEEEEEEEehhhcC--hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence 579999999999999999998754 7899999999654322 1225678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
||||+.+ ++.+++.. .....+++..+..++.|++.||.||| +++||||||||+|||++.++++||+|||+++..
T Consensus 79 v~e~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 79 VFEFLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 152 (298)
T ss_dssp EEECCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred EEeecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceec
Confidence 9999976 56666543 34567999999999999999999999 778999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLK-FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... .....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+... ...+......... +..
T Consensus 153 ~~~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~~~~~~---~~~ 224 (298)
T d1gz8a_ 153 GVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTLGT---PDE 224 (298)
T ss_dssp CCCSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC---CCT
T ss_pred cCCccc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHHHhcCC---Cch
Confidence 544322 23457999999999877765 57899999999999999999999976422 2222222222111 111
Q ss_pred cccccc-------------cCCCc----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcC
Q 009595 442 AIDSKL-------------LGNGY----EEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTAL 489 (531)
Q Consensus 442 ~~d~~l-------------~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~ 489 (531)
...+.. ..... ......+.+++.+||+.||++|||+.++++| ++++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred hhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 100000 00000 1112457889999999999999999999986 666543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=373.36 Aligned_cols=308 Identities=21% Similarity=0.251 Sum_probs=217.3
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC---
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD--- 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 278 (531)
..+|..+++||+|+||+||+|.... +|+.||||++...... ...+.+.+|+.+|++++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKISPFEHQ---TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETT-TCSEEEEEEECCTTCH---HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred CCCeEEEEEEeeccCeEEEEEEECC-CCcEEEEEEEehhcCh---HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 4679999999999999999998654 7999999999754322 22567889999999999999999999987643
Q ss_pred -ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecC
Q 009595 279 -CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFG 357 (531)
Q Consensus 279 -~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfg 357 (531)
..+++++|+.+|+|.+++.. ..+++..+..++.|++.||.||| ++||+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG 154 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFG 154 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccC
Confidence 23455566678999999975 46899999999999999999999 6789999999999999999999999999
Q ss_pred CCccCCCCCcc-ceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 358 LARLMPDGHAQ-VSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 358 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
++......... ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+..... ....... ...
T Consensus 155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~---~~~~~~~-~~~ 230 (345)
T d1pmea_ 155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILG-ILG 230 (345)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH-HHC
T ss_pred ceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH---HHHHHhh-hcc
Confidence 99876543222 12234679999999999854 467899999999999999999999997642211 1111111 110
Q ss_pred cC---------------------CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCc
Q 009595 436 SE---------------------NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKD 492 (531)
Q Consensus 436 ~~---------------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~ 492 (531)
.. .........+..... ..+.+++.+||+.||.+|||+.++++| |++...+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~ 306 (345)
T d1pmea_ 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 306 (345)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCC----HHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCcc
Confidence 00 000000001111111 247889999999999999999999987 665443322
Q ss_pred hhhhhhccCCCC-CChHHHHHhhHHHHhhhhccCCCCC
Q 009595 493 VDFLKMHKRMDF-DNDDCVELIQQEIYTEWLSSLDSYN 529 (531)
Q Consensus 493 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (531)
......+...+. ..+...+.+++.+++|..+-...|.
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~e~~~~~~~~~ 344 (345)
T d1pmea_ 307 EPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 344 (345)
T ss_dssp SCCCSSCC--------CCHHHHHHHHHHHSGGGSTTTC
T ss_pred CccccCccCCChhhhhCCHHHHHHHHHHHHHhcCCCCC
Confidence 222222222211 1122455677778888877666663
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=376.39 Aligned_cols=268 Identities=19% Similarity=0.232 Sum_probs=198.9
Q ss_pred hcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcC---CCCcccccceeEEe-
Q 009595 201 KEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQI---RHRNIVPLLAHMVR- 276 (531)
Q Consensus 201 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~- 276 (531)
..++|.+++.||+|+||+||+|.....+++.||||+++........ ...+.+|+.+|+.+ +||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~--~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM--PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC--BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH--HHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 4578999999999999999999876656788999999754322111 23355677766655 89999999998863
Q ss_pred ----CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEE
Q 009595 277 ----PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEAR 352 (531)
Q Consensus 277 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vk 352 (531)
....+++|||+.+|++..... .....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~k 156 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIK 156 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred ccccCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCee
Confidence 246789999998876654443 34567899999999999999999999 67899999999999999999999
Q ss_pred EeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHH
Q 009595 353 IADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN 432 (531)
Q Consensus 353 L~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~ 432 (531)
|+|||++....... ......||+.|+|||++.+.+|+.++||||+||++|||+||+.||.+... ...+...+..
T Consensus 157 l~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~ 230 (305)
T d1blxa_ 157 LADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDV 230 (305)
T ss_dssp ECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHH
T ss_pred ecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HHHHHHHHHh
Confidence 99999988654332 22457899999999999999999999999999999999999999976422 2222222221
Q ss_pred HhccCCCCcc----------cccc---ccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 433 VMTSENPNRA----------IDSK---LLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 433 ~~~~~~~~~~----------~d~~---l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
...+..... .... ............+.+|+.+||+.||.+|||+.|+++|
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 231 -IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp -HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111100000 0000 0000011112347789999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-46 Score=369.88 Aligned_cols=264 Identities=24% Similarity=0.275 Sum_probs=200.5
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|..+++||+|+||+||+|++. +|+.||||++....... ....++.+|+.+|++++||||+++++++...+..++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDE--GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGG--CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcCh--HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence 57899999999999999999875 78999999997644321 225678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
+|||+.++.+..+... ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 78 ~~e~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF 150 (286)
T ss_dssp EEECCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred EEEeehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceec
Confidence 9999988666666543 577999999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+... ...+...... ........
T Consensus 151 ~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~---~~~~~~i~~~-~~~~~~~~ 224 (286)
T d1ob3a_ 151 GIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRI-LGTPNSKN 224 (286)
T ss_dssp CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHH-HCCCCTTT
T ss_pred ccCccc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH---HHHHHHHHHh-hCCCChhh
Confidence 544322 2335689999999998765 568999999999999999999999976432 2222222221 11111000
Q ss_pred cccc----c----c-------cCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AIDS----K----L-------LGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~d~----~----l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
..+. . . ...........+.+++.+||+.||++|||++|+++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 0 0 000011112357889999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=370.50 Aligned_cols=296 Identities=23% Similarity=0.297 Sum_probs=209.7
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCC---
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPD--- 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--- 278 (531)
.+.|..+++||+|+||+||+|.... +|+.||||+++..... ....+.+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETT-TCCEEEEEECSSTTSS--HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEchhhcC--hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 5789999999999999999998754 7999999999754332 223677889999999999999999999998654
Q ss_pred ---ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEee
Q 009595 279 ---CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIAD 355 (531)
Q Consensus 279 ---~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~D 355 (531)
.+|+||||| +++|..++.. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++.+|++|
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~D 164 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILD 164 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred ccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccc
Confidence 469999999 5588887764 56999999999999999999999 77899999999999999999999999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
||+++...... +...||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+... ...+........
T Consensus 165 fg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~---~~~~~~~~~~~~ 236 (346)
T d1cm8a_ 165 FGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTG 236 (346)
T ss_dssp CTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHC
T ss_pred ccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh---HHHHHHHHhccC
Confidence 99998765432 346799999999998764 568999999999999999999999976422 111111111100
Q ss_pred c--------------------cCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCcCCCc
Q 009595 435 T--------------------SENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTALIKD 492 (531)
Q Consensus 435 ~--------------------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~ 492 (531)
. ...........+.... ...+.+|+.+||..||.+|||+.++++| |+++....+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~ 312 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA----SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTC----CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCC----CHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccc
Confidence 0 0000000001111111 2247789999999999999999999996 666543222
Q ss_pred hhhhhhccCCCC-CChHHHHHhhHHHHhhhh
Q 009595 493 VDFLKMHKRMDF-DNDDCVELIQQEIYTEWL 522 (531)
Q Consensus 493 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 522 (531)
..-... ....+ +-+...+.+++.+|.|.+
T Consensus 313 ~~~~~~-~~~~~~~~~~~~~e~k~~~~~e~~ 342 (346)
T d1cm8a_ 313 EPQVQK-YDDSFDDVDRTLDEWKRVTYKEVL 342 (346)
T ss_dssp --CCCC-CCCC-----CCHHHHHHHHHHHHH
T ss_pred cccCCC-CCCchhhhhcCHHHHHHHHHHHhh
Confidence 111100 00111 112356777888887765
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=369.06 Aligned_cols=246 Identities=20% Similarity=0.314 Sum_probs=197.2
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhh--HHHHHHHHHHHHHhcCC--CCcccccceeEEeC
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLN--IKMRQVRAEIMTAGQIR--HRNIVPLLAHMVRP 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~ 277 (531)
.++|.+.+.||+|+||+||+|.... +|+.||||++......... ....++.+|+.+|++++ |||||++++++.+.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECC-CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4679999999999999999998754 7899999999753221100 01234567999999986 89999999999999
Q ss_pred CceEEEEeccCC-CCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCC-CCEEEee
Q 009595 278 DCHLLVSEFMKN-GSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDD-MEARIAD 355 (531)
Q Consensus 278 ~~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~vkL~D 355 (531)
+..++||||+.+ +++.+++.. ...+++..+..++.||++||.||| +++|+||||||+|||++.+ +.+||+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECc
Confidence 999999999976 688888865 467999999999999999999999 7789999999999999854 7999999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKF-SEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
||++....... .+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... .+.
T Consensus 155 FG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~------- 217 (273)
T d1xwsa_ 155 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII------- 217 (273)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH-------
T ss_pred cccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHh-------
Confidence 99998754432 234679999999999987765 577999999999999999999986531 111
Q ss_pred ccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 435 TSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 435 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
... . .+.+ ... ..+.+++.+||+.||++|||+.+++++
T Consensus 218 ~~~-~--~~~~----~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 218 RGQ-V--FFRQ----RVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HCC-C--CCSS----CCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hcc-c--CCCC----CCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111 0 0111 111 247889999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=361.46 Aligned_cols=270 Identities=21% Similarity=0.253 Sum_probs=199.3
Q ss_pred hhcccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEe---
Q 009595 200 EKEDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVR--- 276 (531)
Q Consensus 200 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--- 276 (531)
...++|.++++||+|+||+||+|.... +|+.||||++....... ....++.+|+.+|++++||||+++++++..
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEC----CTT--SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEehhhcch--HHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 345889999999999999999998754 79999999986543321 125668899999999999999999998865
Q ss_pred -----CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCE
Q 009595 277 -----PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA 351 (531)
Q Consensus 277 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v 351 (531)
....|+|||||.++++..+. .....+++..+..++.|++.||.||| ++||+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCE
T ss_pred cccccCceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcE
Confidence 34579999999886655444 33567899999999999999999999 7789999999999999999999
Q ss_pred EEeecCCCccCCCCCc--cceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHH
Q 009595 352 RIADFGLARLMPDGHA--QVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVR 428 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~ 428 (531)
||+|||++..+..... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... .....
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~----~~~~~ 232 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE----QHQLA 232 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH----HHHHH
Confidence 9999999987654321 1122345799999999998765 689999999999999999999999976422 22222
Q ss_pred HHHHHhccCCCCcc--cccc-c---------cCCCcHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 429 WMRNVMTSENPNRA--IDSK-L---------LGNGYEEQ------MLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 429 ~~~~~~~~~~~~~~--~d~~-l---------~~~~~~~~------~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
.+........+... .+.. . ........ ...+++|+.+||+.||++|||++|+++|
T Consensus 233 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 22222221111100 0000 0 00001111 1346789999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=366.67 Aligned_cols=267 Identities=20% Similarity=0.240 Sum_probs=198.4
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC-----
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP----- 277 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 277 (531)
-.|+..++||+|+||+||+|++.. +|+.||||++...... ..+|+.+|++++||||++++++|...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred CCcEeeeEEeeCcCeEEEEEEECC-CCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 368888999999999999998764 7899999999764432 23699999999999999999998643
Q ss_pred -CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC-CEEEee
Q 009595 278 -DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM-EARIAD 355 (531)
Q Consensus 278 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkL~D 355 (531)
..+|+|||||++| +.+.+.........+++..+..++.||+.||.||| ++||+||||||+|||++.++ .+||+|
T Consensus 91 ~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~D 166 (350)
T d1q5ka_ 91 EVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCD 166 (350)
T ss_dssp CCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECC
T ss_pred ceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEec
Confidence 3468999999774 55545433345678999999999999999999999 78999999999999999875 899999
Q ss_pred cCCCccCCCCCccceecccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHh
Q 009595 356 FGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQT-LKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVM 434 (531)
Q Consensus 356 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~ 434 (531)
||++..+...... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+...++..-
T Consensus 167 FG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~---~~~l~~i~~~~g 240 (350)
T d1q5ka_ 167 FGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLG 240 (350)
T ss_dssp CTTCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHC
T ss_pred ccchhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH---HHHHHHHHHHhC
Confidence 9999887654332 23579999999998765 4689999999999999999999999975432 222222221100
Q ss_pred ----------ccCCCCcccc----ccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCc
Q 009595 435 ----------TSENPNRAID----SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTA 488 (531)
Q Consensus 435 ----------~~~~~~~~~d----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 488 (531)
.......... ..............+.+|+.+||+.||.+|||+.|+++| ++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0000000000 000000011112347889999999999999999999985 55553
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=353.01 Aligned_cols=266 Identities=20% Similarity=0.219 Sum_probs=206.2
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeCCceEE
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l 282 (531)
++|..++.||+|+||+||+|+... +|+.||||+++..... .....++.+|+.+|+.++||||+++++++......++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~-~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEESSCSS--TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECC-CCcEEEEEEEehhhCC--hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence 579999999999999999998764 7899999999764432 2236788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCCccC
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLARLM 362 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~~ 362 (531)
|++++.+++|..++.. ...+++..+..++.|++.||+||| .++|+||||||+|||++.++.+||+|||.+...
T Consensus 79 v~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp EEECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred Eeeecccccccccccc----ccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcc
Confidence 9999999988888754 567899999999999999999999 678999999999999999999999999999987
Q ss_pred CCCCccceecccccCccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccCCCCc
Q 009595 363 PDGHAQVSTSIVAGTVGYIAPEYHQTLK-FSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSENPNR 441 (531)
Q Consensus 363 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 441 (531)
...... .....+++.|+|||++.+.. ++.++|||||||++|||++|+.||... .........+...........
T Consensus 152 ~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~ 226 (292)
T d1unla_ 152 GIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG---NDVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC---SSHHHHHHHHHHHHCCCCTTT
T ss_pred cCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC---CCHHHHHHHHHhhcCCCChhh
Confidence 654322 22345788999999987765 689999999999999999999997432 122222222222222111100
Q ss_pred ccc---------------ccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 442 AID---------------SKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 442 ~~d---------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
... ..............+.+|+.+||+.||.+|||++|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000111122347888999999999999999999885
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=364.67 Aligned_cols=259 Identities=22% Similarity=0.309 Sum_probs=202.8
Q ss_pred ccccccccccccceeEEEEEeee--CCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCC-CcccccceeEEeCCc
Q 009595 203 DCSASLEKIRSRASGEIYIAELP--ESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH-RNIVPLLAHMVRPDC 279 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~ 279 (531)
++|.+++.||+|+||+||+|+.. ..+|+.||||+++...........+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 66999999999999999999763 236889999998643221111114567789999999966 899999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeecCCC
Q 009595 280 HLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADFGLA 359 (531)
Q Consensus 280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla 359 (531)
.+++|||+.+|+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999976 456788899999999999999999 678999999999999999999999999999
Q ss_pred ccCCCCCccceecccccCccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhccC
Q 009595 360 RLMPDGHAQVSTSIVAGTVGYIAPEYHQTL--KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMTSE 437 (531)
Q Consensus 360 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~~~ 437 (531)
+.+....... .....|++.|+|||.+.+. .++.++|||||||++|+|+||+.||.+.........+... .....
T Consensus 177 ~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~---~~~~~ 252 (322)
T d1vzoa_ 177 KEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR---ILKSE 252 (322)
T ss_dssp EECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH---HHHCC
T ss_pred hhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh---cccCC
Confidence 8775543322 2346799999999998765 4688999999999999999999999765443333333222 11111
Q ss_pred CCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 009595 438 NPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPN-----SKDVRSM 483 (531)
Q Consensus 438 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 483 (531)
+.. .... ...+.+++.+||.+||.+||| ++|+++|
T Consensus 253 -~~~------~~~~----s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 -PPY------PQEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -CCC------CTTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -CCC------cccC----CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 110 0111 224888999999999999995 6777753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-43 Score=349.39 Aligned_cols=262 Identities=18% Similarity=0.212 Sum_probs=205.8
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCC-CcccccceeEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRH-RNIVPLLAHMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~ 280 (531)
.++|.+.+.||+|+||+||+|.+.. +|+.||||++..... ...+.+|++.+..+.| +||+.+++++......
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 3679999999999999999998754 799999999865432 2346678899999965 8999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC-----CCCEEEee
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD-----DMEARIAD 355 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-----~~~vkL~D 355 (531)
++||||+ +|+|.+++.. ....++...+..++.|++.||.||| ++||+||||||+|||++. ++.+||+|
T Consensus 77 ~~vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp EEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred EEEEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcc
Confidence 9999999 6799999865 2456899999999999999999999 888999999999999974 57899999
Q ss_pred cCCCccCCCCCcc-----ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHH
Q 009595 356 FGLARLMPDGHAQ-----VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM 430 (531)
Q Consensus 356 fgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~ 430 (531)
||+++.+...... ......+||+.|||||++.+..++.++|||||||++|||+||+.||.+..............
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~ 229 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence 9999976543221 12234679999999999999999999999999999999999999997654333222222111
Q ss_pred HHHhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 431 RNVMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 431 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
.... .. +.. .+..... ..+.+++..|+..+|++||+++.+.+.|+++
T Consensus 230 ~~~~-~~-~~~----~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 230 EKKQ-ST-PLR----ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHH-HS-CHH----HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hccC-CC-ChH----HhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1111 11 110 1111111 2477888899999999999999999888764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.8e-44 Score=352.70 Aligned_cols=262 Identities=22% Similarity=0.283 Sum_probs=198.9
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccce-eEEeCCce
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLA-HMVRPDCH 280 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~-~~~~~~~~ 280 (531)
.++|.+.+.||+|+||.||+|.+.. +|+.||||++..... ...+..|+.+++.++|+|++..++ ++...+..
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~~------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEESCTT------SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECC-CCCEEEEEEEchhcc------CHHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 3679999999999999999998754 789999999876432 234678999999998877665554 55677788
Q ss_pred EEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCC---CCCEEEeecC
Q 009595 281 LLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDD---DMEARIADFG 357 (531)
Q Consensus 281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~vkL~Dfg 357 (531)
++||||+ +|+|.+.+.. ....+++..+..++.|++.||+||| +++|+||||||+|||++. +..+||+|||
T Consensus 79 ~ivme~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEEEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccC
Confidence 9999999 5577777653 3467999999999999999999999 678999999999999864 4579999999
Q ss_pred CCccCCCCCcc-----ceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHH
Q 009595 358 LARLMPDGHAQ-----VSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRN 432 (531)
Q Consensus 358 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~ 432 (531)
+++.+...... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||..................
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence 99987654321 1224567999999999999999999999999999999999999999775443333322222222
Q ss_pred HhccCCCCccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 009595 433 VMTSENPNRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSMLSDT 487 (531)
Q Consensus 433 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 487 (531)
....+ .. .+..... ..+.+++..||+.||.+||++.++.+.|+++
T Consensus 232 ~~~~~--~~----~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 232 KMSTP--IE----VLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHSC--HH----HHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred cCCCC--hh----HhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11111 00 0111111 2478889999999999999999998888764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-43 Score=356.38 Aligned_cols=261 Identities=19% Similarity=0.287 Sum_probs=196.6
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeC--C
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRP--D 278 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~--~ 278 (531)
.++|.++++||+|+||+||+|+... +|+.||||+++... .+++.+|+.+|+++. ||||+++++++... .
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINIT-NNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 4679999999999999999998754 79999999997533 456788999999995 99999999998754 5
Q ss_pred ceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC-CEEEeecC
Q 009595 279 CHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM-EARIADFG 357 (531)
Q Consensus 279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~vkL~Dfg 357 (531)
..++|||||.+|+|..+. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++ .+||+|||
T Consensus 106 ~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG 175 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG 175 (328)
T ss_dssp SEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGG
T ss_pred ceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccc
Confidence 689999999999987653 45899999999999999999999 77899999999999998755 69999999
Q ss_pred CCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhh-HHHH-------
Q 009595 358 LARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEK-SLVR------- 428 (531)
Q Consensus 358 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~-~l~~------- 428 (531)
++........ .....||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.......... .+..
T Consensus 176 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~ 252 (328)
T d3bqca1 176 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252 (328)
T ss_dssp GCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred cceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence 9987765432 2346789999999998765 47999999999999999999999986542211110 0110
Q ss_pred --HHHHHhccCCC----------CccccccccCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 429 --WMRNVMTSENP----------NRAIDSKLLGNGYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 429 --~~~~~~~~~~~----------~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
+.........+ ...................+.+|+.+||+.||.+|||++++++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 10000000000 00000000011111122357889999999999999999999873
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=356.71 Aligned_cols=265 Identities=21% Similarity=0.308 Sum_probs=198.1
Q ss_pred cccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC----
Q 009595 202 EDCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP---- 277 (531)
Q Consensus 202 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---- 277 (531)
.++|..++.||+|+||+||+|.... +|+.||||++....... ...+++.+|+.+|++++|||||++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~--~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSI--IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETT-TTEEEEEEECSCTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECC-CCCEEEEEEECchhcCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence 5779999999999999999998654 79999999997654332 2256788999999999999999999998643
Q ss_pred -CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 278 -DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 278 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
...+++++|+.+|+|.+++.. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++.+|++||
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred cCceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCcccccccccccccccc
Confidence 344667778889999999863 46999999999999999999999 778999999999999999999999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHHHHHhc
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTL-KFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWMRNVMT 435 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~~~~~~ 435 (531)
|++...... .....||+.|+|||...+. .++.++|||||||++|+|++|+.||.+.... .....+.....
T Consensus 166 g~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~----~~~~~i~~~~~ 236 (348)
T d2gfsa1 166 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI----DQLKLILRLVG 236 (348)
T ss_dssp ----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHC
T ss_pred chhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcC
Confidence 998765332 2346789999999987765 4688999999999999999999999754221 11111111111
Q ss_pred cCCCCccccc---------------cccCCC----cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCc
Q 009595 436 SENPNRAIDS---------------KLLGNG----YEEQMLLVLKIACFCTLDDPEERPNSKDVRSM--LSDTA 488 (531)
Q Consensus 436 ~~~~~~~~d~---------------~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 488 (531)
. +...... ...... .......+.+|+.+||+.||.+|||+.|+++| +.++.
T Consensus 237 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 237 T--PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp C--CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred C--CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0 0000000 000000 00112347889999999999999999999984 56553
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=359.19 Aligned_cols=265 Identities=22% Similarity=0.283 Sum_probs=191.7
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCcccccceeEEeC-----
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRNIVPLLAHMVRP----- 277 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~----- 277 (531)
++|.++++||+|+||+||+|.+.. +|+.||||++....... ....++.+|+.++++++||||+++++++...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~-t~~~vAvK~i~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETT-TTEEEEEEEEESTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECC-CCCEEEEEEEChhhcCH--HHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 679999999999999999998754 79999999998654332 2356788999999999999999999998643
Q ss_pred -CceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCEEEeec
Q 009595 278 -DCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEARIADF 356 (531)
Q Consensus 278 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~vkL~Df 356 (531)
..+|+|||||.+ ++.+.+. ..+++..+..++.||+.||.||| .+||+||||||+|||++.++.+|++||
T Consensus 94 ~~~~~iv~Ey~~~-~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 94 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp CCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred CceeEEEEeccch-HHHHhhh------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeech
Confidence 577999999976 5555553 45899999999999999999999 778999999999999999999999999
Q ss_pred CCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhhHHHHHH------
Q 009595 357 GLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTEEKSLVRWM------ 430 (531)
Q Consensus 357 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~l~~~~------ 430 (531)
|+++....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.........+....
T Consensus 164 ~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 164 GLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp CC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred hhhhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence 99887655432 234678999999999999999999999999999999999999997542211111111000
Q ss_pred ---------HHHhccC-CCCcc-----ccccccCC---CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 009595 431 ---------RNVMTSE-NPNRA-----IDSKLLGN---GYEEQMLLVLKIACFCTLDDPEERPNSKDVRSM 483 (531)
Q Consensus 431 ---------~~~~~~~-~~~~~-----~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 483 (531)
....... ..... +....... ........+.+|+.+||..||++|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000100 00000 00000011 122234568899999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-38 Score=318.95 Aligned_cols=271 Identities=21% Similarity=0.227 Sum_probs=193.0
Q ss_pred ccccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-----------CCcccccc
Q 009595 203 DCSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-----------HRNIVPLL 271 (531)
Q Consensus 203 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------hpnIv~l~ 271 (531)
++|.++++||+|+||+||+|+... +|+.||||+++..... .+.+.+|+.+++.++ ||||++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~-~g~~vAvKvi~~~~~~-----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIVRGDKVY-----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSCHHH-----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeccccc-----hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 459999999999999999998654 7999999999753221 456678888887775 57899999
Q ss_pred eeEEe--CCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCC
Q 009595 272 AHMVR--PDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDM 349 (531)
Q Consensus 272 ~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~ 349 (531)
+++.. ....+++++++..+........ ......+++..+..++.||+.||.|||+ ..||+||||||+|||++.++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVD 163 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEE
T ss_pred EEeeeccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccC
Confidence 98764 3455667776655443333222 1445678999999999999999999995 47899999999999998665
Q ss_pred C------EEEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh-
Q 009595 350 E------ARIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGVLLAVLVMGKLPSDDFFQHTE- 422 (531)
Q Consensus 350 ~------vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~- 422 (531)
. ++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||........
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 3 999999998865432 2346799999999999999999999999999999999999999975322111
Q ss_pred --hhHHHHHHHHHhc-----------------cCCCCcccccc----------ccCCCcHHHHHHHHHHHHHcccCCCCC
Q 009595 423 --EKSLVRWMRNVMT-----------------SENPNRAIDSK----------LLGNGYEEQMLLVLKIACFCTLDDPEE 473 (531)
Q Consensus 423 --~~~l~~~~~~~~~-----------------~~~~~~~~d~~----------l~~~~~~~~~~~l~~li~~cl~~dP~~ 473 (531)
...+...+...-. .......+... ............+.+|+.+||..||.+
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 318 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence 1111111111100 00000000000 011123455667899999999999999
Q ss_pred CCCHHHHHHH--hccC
Q 009595 474 RPNSKDVRSM--LSDT 487 (531)
Q Consensus 474 RPs~~evl~~--L~~~ 487 (531)
|||++|+++| +++.
T Consensus 319 Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 319 RADAGGLVNHPWLKDT 334 (362)
T ss_dssp CBCHHHHHTCGGGTTC
T ss_pred CcCHHHHhcCcccCCC
Confidence 9999999986 5544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=2.1e-23 Score=191.27 Aligned_cols=171 Identities=13% Similarity=0.110 Sum_probs=119.4
Q ss_pred cccccccccceeEEEEEeeeCCCCeEEEEEEEeccCch--------------hhhHHHHHHHHHHHHHhcCCCCcccccc
Q 009595 206 ASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS--------------LLNIKMRQVRAEIMTAGQIRHRNIVPLL 271 (531)
Q Consensus 206 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~~~~~Ei~~l~~l~hpnIv~l~ 271 (531)
.+.++||+|+||+||+|... +|+.||||+++..... ...........|...+.++.|++++..+
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred hhCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 46789999999999999864 7899999987532111 1112234556789999999999999887
Q ss_pred eeEEeCCceEEEEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeccCCCCeeeCCCCCE
Q 009595 272 AHMVRPDCHLLVSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYHRPRIIHRNITPSSVLIDDDMEA 351 (531)
Q Consensus 272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~v 351 (531)
++. ..+++|||++++.+.+ ++......++.|++.+|.||| +.||+||||||+|||++++ .+
T Consensus 81 ~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 81 AWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EE
T ss_pred Eec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CE
Confidence 653 2479999998754322 333445679999999999999 6789999999999999865 59
Q ss_pred EEeecCCCccCCCCCccceecccccCccccCcccccCCCCCchhhHHHHHH
Q 009595 352 RIADFGLARLMPDGHAQVSTSIVAGTVGYIAPEYHQTLKFSEKCDIYSFGV 402 (531)
Q Consensus 352 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv 402 (531)
+|+|||++.............. .... -.+.+ ...|+.++|+||..-
T Consensus 142 ~liDFG~a~~~~~~~~~~~l~r---d~~~-~~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWREILER---DVRN-IITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp EECCCTTCEETTSTTHHHHHHH---HHHH-HHHHH-HHHHCCCCCHHHHHH
T ss_pred EEEECCCcccCCCCCcHHHHHH---HHHH-HHHHH-cCCCCCcccHHHHHH
Confidence 9999999987643322110000 0000 01111 345788899999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.39 E-value=5.3e-07 Score=84.36 Aligned_cols=141 Identities=11% Similarity=0.073 Sum_probs=92.4
Q ss_pred cccccccccccceeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCceEE
Q 009595 204 CSASLEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCHLL 282 (531)
Q Consensus 204 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~l 282 (531)
.|...+..+.++.+.||+... ++..+++|+........ ...+.+|...+..+. +--+.+++.+...++..++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~---~~~~~vlk~~~~~~~~~----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEEC---SSCEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEEe---CCCeEEEEEcCCCcccc----hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 444444443344468998864 56668899886543322 234556777776663 3335677888888888999
Q ss_pred EEeccCCCCHHHHHhhccCCCccCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 009595 283 VSEFMKNGSLLEILNDVSQGRRELEWLARHRIARGIVSGLEYLHMYH--------------------------------- 329 (531)
Q Consensus 283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------- 329 (531)
||++++|.++.+.... ... ...++.+++..+..||+..
T Consensus 88 v~~~l~G~~~~~~~~~------~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 88 LMSEADGVLCSEEYED------EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHTTT------CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEecccccccccccc------ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999888665421 011 2234555556666666321
Q ss_pred -----------------------CCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 330 -----------------------RPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 330 -----------------------~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987666799998755
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=1.1e-05 Score=74.66 Aligned_cols=75 Identities=8% Similarity=0.036 Sum_probs=50.9
Q ss_pred ccccccce-eEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC--CCcccccceeEEeCCceEEEEe
Q 009595 209 EKIRSRAS-GEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR--HRNIVPLLAHMVRPDCHLLVSE 285 (531)
Q Consensus 209 ~~ig~G~~-g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~~~~lv~E 285 (531)
+.+..|.+ +.||+.... .+..+++|........ .+..|...++.+. .-.+.+++.+...++..++||+
T Consensus 16 ~~~~~G~s~~~v~r~~~~--~~~~~vlK~~~~~~~~-------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~ 86 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQ--GRPVLFVKTDLSGALN-------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 86 (255)
T ss_dssp EECSCTTSSCEEEEEECT--TSCCEEEEEECSCTTS-------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred EEcCCcccCCeEEEEEeC--CCCEEEEEeCCccCHh-------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEE
Confidence 34555664 578988653 5667888987654322 2456777776663 2336677888788888899999
Q ss_pred ccCCCCH
Q 009595 286 FMKNGSL 292 (531)
Q Consensus 286 ~~~~gsL 292 (531)
+++|.++
T Consensus 87 ~i~G~~~ 93 (255)
T d1nd4a_ 87 EVPGQDL 93 (255)
T ss_dssp CCSSEET
T ss_pred eeecccc
Confidence 9988654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.70 E-value=5e-05 Score=75.16 Aligned_cols=81 Identities=11% Similarity=0.087 Sum_probs=48.2
Q ss_pred cccccccceeEEEEEeeeCCCCeEEEEEEEeccCch---hhhHHHHHHHHHHHHHhcC-CC--CcccccceeEEeCCceE
Q 009595 208 LEKIRSRASGEIYIAELPESNGKMIAIKKVKQVDNS---LLNIKMRQVRAEIMTAGQI-RH--RNIVPLLAHMVRPDCHL 281 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~Ei~~l~~l-~h--pnIv~l~~~~~~~~~~~ 281 (531)
.+.||.|....||++.... +++.|+||.-...... .......+...|...|..+ .+ ..+++++. .+++..+
T Consensus 31 ~~eig~G~~N~vfrV~~~~-~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTE
T ss_pred EEEeCCCceEeEEEEEeCC-CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCE
Confidence 4568999999999997543 5678999976431110 0000133455677777665 22 33445554 3556778
Q ss_pred EEEeccCCCC
Q 009595 282 LVSEFMKNGS 291 (531)
Q Consensus 282 lv~E~~~~gs 291 (531)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 9999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.58 E-value=0.0044 Score=58.87 Aligned_cols=137 Identities=11% Similarity=0.041 Sum_probs=75.1
Q ss_pred eeEEEEEeeeCCCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCCCCc-----ccccce--eEEeCCceEEEEeccC
Q 009595 216 SGEIYIAELPESNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIRHRN-----IVPLLA--HMVRPDCHLLVSEFMK 288 (531)
Q Consensus 216 ~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-----Iv~l~~--~~~~~~~~~lv~E~~~ 288 (531)
-..||++... +|+.|++|+.+....+ ..++..|...+..|...+ .+..-+ .+...+..+.++++++
T Consensus 35 EN~vy~v~~~--dg~~~VlK~~rp~~~s-----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 35 ENRVYQFQDE--DRRRFVVKFYRPERWT-----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SSEEEEECCT--TCCCEEEEEECTTTSC-----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred cceeEEEEcC--CCCEEEEEEeCCCCCC-----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 3689999764 7889999998764332 355667887777663222 122211 3344566788899987
Q ss_pred CCCH-----HHHH---------hh----ccC-CCccCCH-------------------HHHHHHHHHHHHHHHHHHh---
Q 009595 289 NGSL-----LEIL---------ND----VSQ-GRRELEW-------------------LARHRIARGIVSGLEYLHM--- 327 (531)
Q Consensus 289 ~gsL-----~~~l---------~~----~~~-~~~~l~~-------------------~~~~~i~~~ia~~L~~LH~--- 327 (531)
|..+ ..+. +. ... .....+. .....+...+...+..+..
T Consensus 108 G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~ 187 (325)
T d1zyla1 108 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 187 (325)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcc
Confidence 5322 1111 00 000 0011111 1111122222233333322
Q ss_pred -cCCCCeEeeccCCCCeeeCCCCCEEEeecCCCcc
Q 009595 328 -YHRPRIIHRNITPSSVLIDDDMEARIADFGLARL 361 (531)
Q Consensus 328 -~~~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~~ 361 (531)
....++||+|+.|.|||++++ ..++||+-+..
T Consensus 188 ~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 188 EDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 124579999999999999753 45899987663
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.40 E-value=0.0044 Score=60.62 Aligned_cols=75 Identities=12% Similarity=0.175 Sum_probs=47.9
Q ss_pred cccccccceeEEEEEeeeC------CCCeEEEEEEEeccCchhhhHHHHHHHHHHHHHhcCC-CCcccccceeEEeCCce
Q 009595 208 LEKIRSRASGEIYIAELPE------SNGKMIAIKKVKQVDNSLLNIKMRQVRAEIMTAGQIR-HRNIVPLLAHMVRPDCH 280 (531)
Q Consensus 208 ~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~ 280 (531)
++.|+.|-.-.+|++.... ...+.|.+++... .... ....+|..+++.+. +.-..++++++.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~-----idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE-----SHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH-----HHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh-----hHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 4678889999999997642 1234566766653 2221 22446888888774 4334467776642
Q ss_pred EEEEeccCCCCH
Q 009595 281 LLVSEFMKNGSL 292 (531)
Q Consensus 281 ~lv~E~~~~gsL 292 (531)
.+|+||++|.+|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 589999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.07 E-value=0.0089 Score=56.19 Aligned_cols=31 Identities=23% Similarity=0.317 Sum_probs=27.4
Q ss_pred CCCeEeeccCCCCeeeCCCCCEEEeecCCCc
Q 009595 330 RPRIIHRNITPSSVLIDDDMEARIADFGLAR 360 (531)
Q Consensus 330 ~~~ivH~Dlkp~NILl~~~~~vkL~Dfgla~ 360 (531)
..|+||+|+.++||+++++...-|+||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5689999999999999988777899999754
|